Citrus Sinensis ID: 008854

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-
Protein Sequence
MLLSIIRLTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLHILY
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccHHHHHHHHHHHHHHHccccccccEEEEcccccccEEEEEEccccccHHHHHHHHHHHHHHHHHcccccccEEEEEcccccEEEEEccccccccccccccEEEcccccccccHHHHHHHHHHHHHHHHHHHHcccccccEEEEEEcccccccEEEEEEccccccHHHHHHHHHHHHHHHHHccccccccEEEccccEEEEEccccccccccccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHcccccccccccccccccEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHccccccHHHHccccccccEEEEEEcccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEccccccccccccccccccccccccccccccccccccccEEcccccccHHHHcccccccccccccHHHEEEEHHccccccccccccccccHHHHHHHHccccc
Secondary Structure Prediction (SSPRO)
cEEEEEEEccccccccccccccccHHHHHHHHHHHHcccccccccccEEccccccccEEEEEEEEcccccHHHHHHHHHHHHHHHHHHcccccEEEEEEccccEEEEEEEcccHcccccccccEEEEccccccccHHHHHHHHHHHHHHHHHHHHccccccHEcccccccccccEEEEEEEEcccccHHHHHHHHHHHHHHcHHHcccccccEEEEcEEEEEEEEEcccccccccccccccccccccccccccccccccccccHEEEEEEHHHHHHHHHHHHHHHHHHHHHHccccccccccHHccccccHHEEcHHHHHHHHccccHHccccccccccEEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHEEcccccEEEEEEEcccccccEEEEcHHHcccccHHHHHHHHHHHHHHHHHHHHccHcccccccccHHHEEEcccccEEEcccccccEccHHcccccccEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHccc
Coil and Loop (DISEMBL)
MLLSIIrltsgqtcydtgnfttnstygknrDLFLSSLASTVtankgfytatigqipDEVYGLAlcrgdsspescasclnftvldmmkncpnqkeaiswegmdfpcvvryssrsffgklelkpteiahnvnnitssLTQFDRIWRSLMDRVLAKASlgtsklkfatdeanltSSETIYALMqctpdisqsdcEFCLRQSMADvqsccygkkgsyimgpscifrwemypfygatadslspsplsppstttdttiakdkggnsissGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNlrkadeintveslqfdfstirdatnnfstdnklgqggfgaVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYefvpnssvdkFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASnilldadmipkisDFGMARLFEmdqsqgdtsrivgtfgymapeyvtrghfsiksdvFSFGVLVLEIISgqknnsfrigEEAEDLLTYVsnnlhily
Flexible Loop (DISEMBL)
MLLSIIRltsgqtcydtgnfttnstygkNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLElkpteiahnvnnitssltQFDRIWRSLMDRVLAKASlgtsklkfatdeANLTSSETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLSPPSTTTDttiakdkggnsissGTVVIIVVSTSTFIIALVALITCVFLRRRKKkqkqnlrkadeintveslqfdfSTIRDATnnfstdnklgqGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEfvpnssvdkfIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEaedlltyvsnnlhily
Low Complexity Region (SEG)
MLLSIIRLTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGatadslspsplsppstttdttIAKDKGGNsissgtvviivvststfiiALVALITCVFlrrrkkkqkqnlrkADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLHILY
Disordered region (IsUnstruct)
**LSIIRLTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGAT*******************************GTVVIIVVSTSTFIIALVALITCVFL*********************SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLHI**
Disordered Region (DISOPRED)
MLLSIIRLTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATAD*******************************VVIIVVSTSTFIIALVALITCVFL**********************LQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLHILY
Disordered Region (DISEMBL)
MLLSIIRLTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATAD***************TTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRR**********ADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLHILY
Disordered Region (DISPRO)
MLLSIIRLTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGAT*****************************SSGTVVIIVVSTSTFIIALVALITCVFLRRRKK******RKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLHILY
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLLSIIRLTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLHILY
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	551	2.2.26 [Sep-21-2011]
Q8H199	658	Cysteine-rich receptor-li	yes	no	0.960	0.803	0.517	1e-155
Q9ZP16	667	Cysteine-rich receptor-li	no	no	0.967	0.799	0.522	1e-155
Q9LDT0	700	Putative cysteine-rich re	no	no	0.976	0.768	0.500	1e-151
Q9LDQ3	669	Putative cysteine-rich re	no	no	0.950	0.783	0.488	1e-149
O65476	662	Putative cysteine-rich re	no	no	0.958	0.797	0.493	1e-144
Q9T0J1	665	Cysteine-rich receptor-li	no	no	0.961	0.796	0.488	1e-144
Q8L710	686	Cysteine-rich receptor-li	no	no	0.965	0.775	0.503	1e-142
O65472	690	Putative cysteine-rich re	no	no	0.956	0.763	0.484	1e-142
Q8RX80	659	Cysteine-rich receptor-li	no	no	0.950	0.795	0.514	1e-141
Q9LDN1	636	Putative cysteine-rich re	no	no	0.934	0.809	0.479	1e-140

>sp|Q8H199|CRK14_ARATH Cysteine-rich receptor-like protein kinase 14 OS=Arabidopsis thaliana GN=CRK14 PE=2 SV=2

 Score =  548 bits (1413), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 280/541 (51%), Positives = 361/541 (66%), Gaps = 12/541 (2%)

Query: 8   LTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALCRG 67
           + S Q C  TG F   S Y  NR L LSSL S V+A  GFY ++IGQ PD VY L +C  
Sbjct: 19  VVSAQECGKTGFFVPQSRYETNRGLLLSSLPSNVSARGGFYNSSIGQGPDRVYALGMCIE 78

Query: 68  DSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEIAH 127
            + P+ C+ C+ +    ++  C NQ E ++W      C+VRYS+ SFFG L+ +P    H
Sbjct: 79  GAEPDVCSDCIEYASNLLLDTCLNQTEGLAWPEKRILCMVRYSNSSFFGSLKAEPHFYIH 138

Query: 128 NVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKF-ATDEANLTSSETIYALMQCTPDI 186
           NV++ITS+LT+FD++W  L  R++A  +  +SK K+ A D A LT+ + IYALMQCTPD+
Sbjct: 139 NVDDITSNLTEFDQVWEELARRMIASTTSPSSKRKYYAADVAALTAFQIIYALMQCTPDL 198

Query: 187 SQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATAD-SLSPSPLSP-- 243
           S  DC  CLRQS+ D ++CC GK+G  +   SC+FRWE++PF  A +  SL+P P SP  
Sbjct: 199 SLEDCHICLRQSVGDYETCCNGKQGGIVYRASCVFRWELFPFSEAFSRISLAPPPQSPAF 258

Query: 244 PSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRKA 303
           P+    T  A  KG  +IS G V  I++ T   +  ++  +  V  RRRK  Q      +
Sbjct: 259 PTLPAVTNTATKKGSITISIGIVWAIIIPTVIVVFLVLLALGFVVYRRRKSYQG----SS 314

Query: 304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
            +I    SLQFDF  I DATN FS  N +G+GGFG V+ G L +G E+A+KRLSK S QG
Sbjct: 315 TDITITHSLQFDFKAIEDATNKFSESNIIGRGGFGEVFMGVL-NGTEVAIKRLSKASRQG 373

Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
             EFKNEV++VA+L HRNLV+LLGF  E  E++L+YEFVPN S+D F+FD  K+ QLDW 
Sbjct: 374 AREFKNEVVVVAKLHHRNLVKLLGFCLEGEEKILVYEFVPNKSLDYFLFDPTKQGQLDWT 433

Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
            RY II GI RGILYLH+DSRL IIHRDLKASNILLDADM PKI+DFGMAR+F +DQS  
Sbjct: 434 KRYNIIRGITRGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGIDQSGA 493

Query: 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF--RIGEEAEDLLT 541
           +T +I GT GYM PEYV +G FS +SDV+SFGVLVLEII G +NN F  +     E+L+T
Sbjct: 494 NTKKIAGTRGYMPPEYVRQGQFSTRSDVYSFGVLVLEIICG-RNNRFIHQSDTTVENLVT 552

Query: 542 Y 542
           Y
Sbjct: 553 Y 553

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9ZP16|CRK11_ARATH Cysteine-rich receptor-like protein kinase 11 OS=Arabidopsis thaliana GN=CRK11 PE=2 SV=2

 Score =  547 bits (1410), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 288/551 (52%), Positives = 363/551 (65%), Gaps = 18/551 (3%)

Query: 10  SGQTCY-DTGNFTTNSTYGKNRDLFLSSLASTVTANKG-FYTATIGQIPDEVYGLALCRG 67
           S QTC  D G F  N TY  NR L LSSL S VT   G +Y  +IGQ P+ VY + +C  
Sbjct: 23  SAQTCTTDKGTFRPNGTYDVNRRLILSSLPSNVTDQDGLYYNGSIGQQPNRVYAIGMCIP 82

Query: 68  DSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEIAH 127
            S+ E C+ C+       +KNCPNQ EA SW G    C VRYS+ SF G  +L P     
Sbjct: 83  GSTSEDCSDCIKKESEFFLKNCPNQTEAYSWPGEPTLCYVRYSNTSFSGSADLNPRNWLT 142

Query: 128 NVNNITSSLTQFDRIWRSLMDRVL-----AKASLGTSKLKFATDEANLTSSETIYALMQC 182
           N  ++ S+LT+F +IW  LM R++     AK++  +S   ++ D A LT    IYALMQC
Sbjct: 143 NTGDLDSNLTEFTKIWEGLMGRMISAASTAKSTPSSSDNHYSADSAVLTPLLNIYALMQC 202

Query: 183 TPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLS 242
           TPD+S  DCE CLRQS  D QSCC  K+G  +M PSC  RW++Y +  A  D+L+ +   
Sbjct: 203 TPDLSSGDCENCLRQSAIDYQSCCSQKRGGVVMRPSCFLRWDLYTYSNA-FDNLTVASPP 261

Query: 243 PPSTTTDTTIAKDKGG------NSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQ 296
           P    T    A D+          IS+G VV I V T   I+ L+ L   V  RRRK  Q
Sbjct: 262 PEPPVTVPQPAGDQDNPTNNDSKGISAGVVVAITVPTVIAILILLVL-GFVLFRRRKSYQ 320

Query: 297 KQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRL 356
           +       +I+T +SL +DF TI  ATN FST NKLG+GGFGAVYKG+LS+G ++AVKRL
Sbjct: 321 RTKTESESDISTTDSLVYDFKTIEAATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRL 380

Query: 357 SKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIK 416
           SK S QG  EF+NE +LV +LQHRNLVRLLGF  E  E++LIYEFV N S+D F+FD  K
Sbjct: 381 SKKSGQGTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEK 440

Query: 417 RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476
           + QLDW  RYKIIGGIARGILYLH+DSRL+IIHRDLKASNILLDADM PKI+DFG+A +F
Sbjct: 441 QSQLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLATIF 500

Query: 477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE- 535
            ++Q+QG+T+RI GT+ YM+PEY   G +S+KSD++SFGVLVLEIISG+KN+     +E 
Sbjct: 501 GVEQTQGNTNRIAGTYAYMSPEYAMHGQYSMKSDIYSFGVLVLEIISGKKNSGVYQMDET 560

Query: 536 --AEDLLTYVS 544
             A +L+TY S
Sbjct: 561 STAGNLVTYAS 571

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LDT0|CRK30_ARATH Putative cysteine-rich receptor-like protein kinase 30 OS=Arabidopsis thaliana GN=CRK30 PE=3 SV=1

 Score =  535 bits (1377), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 278/555 (50%), Positives = 368/555 (66%), Gaps = 17/555 (3%)

Query: 3   LSIIRLTSGQTCYDT-GNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYG 61
           +S+I + S Q C +  G FT   T+ KNR + LSSL S VTA  GFY A+IG  PD++Y 
Sbjct: 16  VSLIIVVSAQLCSEKFGTFTPGGTFDKNRRIILSSLPSEVTAQDGFYNASIGTDPDQLYA 75

Query: 62  LALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGM-DFPCVVRYSSRSFFGKLEL 120
           + +C   +  + C  C+      +++ CPNQ  AI W G     C+ RY ++     L+L
Sbjct: 76  MGMCIPGAKQKLCRDCIMDVTRQLIQTCPNQTAAIHWSGGGKTVCMARYYNQPSSRPLDL 135

Query: 121 KPTEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLK-------FATDEANLTSS 173
           +   I +NV N++++LT FDR+W  L+  ++ KAS  + K         +A DE NLT+S
Sbjct: 136 ESVSIGYNVGNLSTNLTDFDRLWERLIAHMVTKASSASIKYLSFDNSRFYAADETNLTNS 195

Query: 174 ETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGA-T 232
           + +YALMQCTPD+S S+C  CL+QS+ D   CC+GK+G Y+  PSCIFRW++YPF GA  
Sbjct: 196 QMVYALMQCTPDVSPSNCNTCLKQSVDDYVGCCHGKQGGYVYRPSCIFRWDLYPFNGAFD 255

Query: 233 ADSLSPSPLSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRR 292
             +L+P P S   +    T   +K  ++ +   +VI+V       +  + +  C   R R
Sbjct: 256 LLTLAPPPSSQLQSPPPVTNKDEKTIHTGTIIGIVIVVAMVIIMALLALGVSVC---RSR 312

Query: 293 KKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIA 352
           KK Q      AD+I TV  LQFD   I  AT+NF   NK+GQGGFG VYKG LS+G E+A
Sbjct: 313 KKYQAFASETADDITTVGYLQFDIKDIEAATSNFLASNKIGQGGFGEVYKGTLSNGTEVA 372

Query: 353 VKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIF 412
           VKRLS+ S QGELEFKNEVLLVA+LQHRNLVRLLGF+ +  E++L++EFVPN S+D F+F
Sbjct: 373 VKRLSRTSDQGELEFKNEVLLVAKLQHRNLVRLLGFALQGEEKILVFEFVPNKSLDYFLF 432

Query: 413 ---DAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD 469
              +  K+ QLDW  RY IIGGI RG+LYLH+DSRL IIHRD+KASNILLDADM PKI+D
Sbjct: 433 GSTNPTKKGQLDWTRRYNIIGGITRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIAD 492

Query: 470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529
           FGMAR F   Q++  T R+VGTFGYM PEYV  G FS KSDV+SFGVL+LEI+SG+KN+S
Sbjct: 493 FGMARNFRDHQTEDSTGRVVGTFGYMPPEYVAHGQFSTKSDVYSFGVLILEIVSGRKNSS 552

Query: 530 F-RIGEEAEDLLTYV 543
           F ++     +L+TYV
Sbjct: 553 FYQMDGSVCNLVTYV 567

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3

 Score =  528 bits (1361), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 278/569 (48%), Positives = 375/569 (65%), Gaps = 45/569 (7%)

Query: 1   MLLSIIRLTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVY 60
            L+S+  +T+ + C+ +G F  NSTY  NR   LS+L+S VT++ GF+ +  GQ P+ V+
Sbjct: 14  FLISLDSVTAQEICF-SGFFKPNSTYDLNRRQILSTLSSNVTSHNGFFNSKFGQAPNRVF 72

Query: 61  GLALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLEL 120
              +C   + PE+C+ C+      + ++CPN+ +A +W      C+VRYS+ SF G L +
Sbjct: 73  INGMCIPGTKPETCSDCIKGASDKISESCPNKTDAYTWPDC---CMVRYSNVSFSGSLVM 129

Query: 121 KPTEIAHNVNNIT---SSLTQFDRIWRSLMDRVLAKASLGTSKLK------FATDEANLT 171
           +P+E  ++  +I    ++LT FDRIW  LM R +  ASL +S         FA + A+LT
Sbjct: 130 EPSETLYHTGDIEDTGTNLTVFDRIWEELMLRTITAASLSSSNGSSFGQKYFAAEVASLT 189

Query: 172 SSETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGA 231
           + +T+YA+MQCTPD+S  DCEFCL+ S+ D +SCC GK+G  ++ PSC  RW++YP+ GA
Sbjct: 190 TFQTMYAMMQCTPDVSSKDCEFCLKTSVGDYESCCRGKQGGAVIRPSCFVRWDLYPYAGA 249

Query: 232 TAD----------------SLSPSPLSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTST 275
             +                SL P P+S            D+   +I    V I+V     
Sbjct: 250 FENVTFPPPPPQSLPQPPVSLIPPPVS------------DRANTTIKGIIVAIVVPIIVI 297

Query: 276 FIIALVALITCVFLRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQG 335
            +  +V L+ C   RR+K  +   ++  DEI T  SLQF F TI  AT+ FS  N +G+G
Sbjct: 298 LVSLVVLLVVC---RRKKSYKTTEVQATDEITTTHSLQFSFKTIEAATDKFSDSNMIGRG 354

Query: 336 GFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER 395
           GFG VY+G+LS G E+AVKRLSK S QG  EFKNE +LV++LQH+NLVRLLGF  E  E+
Sbjct: 355 GFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEK 414

Query: 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 455
           +L+YEFVPN S+D F+FD  K+ +LDW  RY IIGGIARGILYLH+DSRL IIHRDLKAS
Sbjct: 415 ILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKAS 474

Query: 456 NILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFG 515
           NILLDADM PKI+DFGMAR+F +DQSQ +T RI GTFGYM+PEY  RGHFS+KSDV+SFG
Sbjct: 475 NILLDADMNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFG 534

Query: 516 VLVLEIISGQKNNSF-RIGEEAEDLLTYV 543
           VLVLEIISG+KN+SF  I +   +L+T+ 
Sbjct: 535 VLVLEIISGKKNSSFYNIDDSGSNLVTHA 563

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65476|CRK16_ARATH Putative cysteine-rich receptor-like protein kinase 16 OS=Arabidopsis thaliana GN=CRK16 PE=3 SV=2

 Score =  512 bits (1319), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 266/539 (49%), Positives = 347/539 (64%), Gaps = 11/539 (2%)

Query: 8   LTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALCRG 67
           ++S Q C  TG F  N  Y  NR L LSSLAS V+A  GFY A+IGQ PD +Y    C  
Sbjct: 23  ISSAQKCGKTGLFKPNDKYDINRHLLLSSLASNVSARGGFYNASIGQGPDRLYASGTCIQ 82

Query: 68  DSSPESCASCLNFTVLDMMKNCPNQKEAISWEGM--DFPCVVRYSSRSFFGKLELKPTEI 125
            S PE C++C++   + ++K C NQ EA+ W     ++PC++RYS+RSFFG LE+ P   
Sbjct: 83  GSEPELCSACIDSAFIRVIKKCHNQTEALDWSSFNEEYPCMIRYSNRSFFGLLEMTPFFK 142

Query: 126 AHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPD 185
            +N  +   +LT+F + W +LM  V+A A + +   KF          +T+YA + C+ D
Sbjct: 143 NYNATDFQVNLTEFYQKWEALMLGVIADA-ISSPNPKFYGAGTGKIGIQTVYAFVLCSKD 201

Query: 186 ISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLSPPS 245
           IS  +C  CLR ++ + +  C GK   +   PSC  RW++Y FYG      SP+    P 
Sbjct: 202 ISPWNCSRCLRGNVDNYKLSCSGKPRGHSFSPSCYMRWDLYQFYGFIEYRASPTL---PR 258

Query: 246 TTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRKADE 305
                +   D GG  IS+  ++ I V+ + FI  L+ L    +   R++K  Q     ++
Sbjct: 259 EKGRISELSDDGGK-ISTRNILGITVALAFFITVLLVL---GYALSRRRKAYQEFATEND 314

Query: 306 INTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGEL 365
           I T  SLQFDF  I  ATNNF   NKLG GGFG V+KG   +G E+AVKRLSK S QGE 
Sbjct: 315 ITTSGSLQFDFKAIEAATNNFQKSNKLGHGGFGEVFKGTFPNGTEVAVKRLSKISGQGEE 374

Query: 366 EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETR 425
           EFKNEVLLVA+LQHRNLVRLLGFS E  E++L+YE++PN S+D F+FD  +R QLDW TR
Sbjct: 375 EFKNEVLLVAKLQHRNLVRLLGFSVEGEEKILVYEYMPNKSLDYFLFDHRRRGQLDWRTR 434

Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485
           Y II G+ RGILYLH+DSRL IIHRDLKA NILLD DM PKI+DFG+AR F +DQ++  T
Sbjct: 435 YNIIRGVTRGILYLHQDSRLTIIHRDLKAGNILLDVDMNPKIADFGVARNFRVDQTEATT 494

Query: 486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR-IGEEAEDLLTYV 543
            R+VGTFGYM PEYV  G FS+KSDV+SFGVL+LEII G+K++SF  I     +L+TYV
Sbjct: 495 GRVVGTFGYMPPEYVANGQFSMKSDVYSFGVLILEIIVGKKSSSFHEIDGSVGNLVTYV 553

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9T0J1|CRK26_ARATH Cysteine-rich receptor-like protein kinase 26 OS=Arabidopsis thaliana GN=CRK26 PE=2 SV=1

 Score =  511 bits (1316), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 265/542 (48%), Positives = 360/542 (66%), Gaps = 12/542 (2%)

Query: 12  QTCYD-TGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALCRGDSS 70
           Q C + TGNFT N+ Y  N D  +SSL+S      GFY  ++G   ++V  ++ CRGD  
Sbjct: 29  QICSNVTGNFTVNTPYAVNLDRLISSLSSLRRNVNGFYNISVGDSDEKVNSISQCRGDVK 88

Query: 71  PESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEIAHNVN 130
            E C +C+      ++  CP QKEAI W      C  RYS+R+ F +LE+ P        
Sbjct: 89  LEVCINCIAMAGKRLVTLCPVQKEAIIWYD---KCTFRYSNRTIFNRLEISPHTSITGTR 145

Query: 131 NITSSLTQFDRIWRSLMDRVLAKAS-LGTSKLKFATDEANLTSSETIYALMQCTPDISQS 189
           N T     +++  R L++ +  +AS +G SK  F   E +  S +T++ L+QCTPDIS+ 
Sbjct: 146 NFTGDRDSWEKSLRGLLEGLKNRASVIGRSKKNFVVGETSGPSFQTLFGLVQCTPDISEE 205

Query: 190 DCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGAT----ADSLSPSPLSPPS 245
           DC +CL Q +A + SCC  K GSY+M PSC+  +  + FY         S+  +P  PP 
Sbjct: 206 DCSYCLSQGIAKIPSCCDMKMGSYVMSPSCMLAYAPWRFYDPVDTDDPSSVPATPSRPPK 265

Query: 246 TTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRKADE 305
             T +    DK  N      ++    S +  ++ +V L+  + LRR++  +    +  +E
Sbjct: 266 NETRSVTQGDK--NRGVPKALIFASASVAIVVLFIVLLVVFLKLRRKENIRNSENKHENE 323

Query: 306 INTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGEL 365
             + +S++FDFS ++DAT++FS +NKLG+GGFGAVYKG LS GQ+IAVKRLSKN+ QGE 
Sbjct: 324 NISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSKNAQQGET 383

Query: 366 EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETR 425
           EFKNE LLVA+LQHRNLV+LLG+S E TERLL+YEF+P++S+DKFIFD I+  +L+WE R
Sbjct: 384 EFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNELEWEIR 443

Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ-SQGD 484
           YKIIGG+ARG+LYLH+DSRLRIIHRDLKASNILLD +M PKI+DFGMARLF++D  +Q  
Sbjct: 444 YKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDIDHTTQRY 503

Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS 544
           T+RIVGTFGYMAPEYV  G FS K+DV+SFGVLVLEIISG+KN+ F   +   DL+++  
Sbjct: 504 TNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISGKKNSGFSSEDSMGDLISFAW 563

Query: 545 NN 546
            N
Sbjct: 564 RN 565

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8L710|CRK17_ARATH Cysteine-rich receptor-like protein kinase 17 OS=Arabidopsis thaliana GN=CRK17 PE=2 SV=2

 Score =  507 bits (1305), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 284/564 (50%), Positives = 367/564 (65%), Gaps = 32/564 (5%)

Query: 5   IIRLTSGQTCYDT-GNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLA 63
           +I +++ QTC +T G+F  NSTY  NR L LS+ AS VTA  G++  + G   D VY + 
Sbjct: 21  VISVSAQQTCDNTAGSFKPNSTYDNNRRLLLSTFASNVTAQNGYFNGSFGLGTDRVYAMG 80

Query: 64  LCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPT 123
           +C   + P+ C++C+  T   +++ C NQ +  SW G +  C+VRYS++SF G L L+P+
Sbjct: 81  MCAPGAEPDVCSNCIKNTAEGLLQICLNQTDGFSWSGEETLCLVRYSNKSFSGLLGLEPS 140

Query: 124 EIAHNVNNI-TSSLTQFDRIWRSLMDRVLAKASLGT---------SKLKFATDEANLTSS 173
               NVN I      +FD ++  LM R +  AS            S   +A D A     
Sbjct: 141 NDFFNVNEIRKEDQKEFDSVFDELMFRTIQGASSSVRNNSNSLSLSGKYYAKDVAPEPVY 200

Query: 174 ETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATA 233
             I  +MQCTPD+S  DC  CL +S+   +    GK+G+ I+ PSC FRWE+Y F+GA  
Sbjct: 201 GNISVVMQCTPDVSSKDCNLCLERSLDFYKKWYNGKRGTIILRPSCFFRWELYTFFGA-F 259

Query: 234 DSLSP------------SPLSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALV 281
           DS++              PL  PS T  T I K K  + IS GT+  IVV     II +V
Sbjct: 260 DSINARHPPPPPRPLSPPPLKTPSVTNQTNITK-KNDSRISGGTIAAIVVVVVVTIILIV 318

Query: 282 -ALITCVFLRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAV 340
             L+ C     +++KQKQ +     +N  ES+QFD  TI  AT NFS  NKLG GGFG V
Sbjct: 319 VGLVIC-----KRRKQKQEIELPIVLNEAESVQFDLKTIEAATGNFSEHNKLGAGGFGEV 373

Query: 341 YKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400
           YKG L +G EIAVKRLSK S QGE+EFKNEV++VA+LQH NLVRLLGFS +  E+LL+YE
Sbjct: 374 YKGMLLNGTEIAVKRLSKTSGQGEIEFKNEVVVVAKLQHINLVRLLGFSLQGEEKLLVYE 433

Query: 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 460
           FVPN S+D F+FD  KR QLDW  R  IIGGI RGILYLH+DSRL+IIHRDLKASNILLD
Sbjct: 434 FVPNKSLDYFLFDPNKRNQLDWTVRRNIIGGITRGILYLHQDSRLKIIHRDLKASNILLD 493

Query: 461 ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLE 520
           ADM PKI+DFGMAR+F +DQ+  +T+R+VGTFGYM+PEYVT G FS+KSDV+SFGVL+LE
Sbjct: 494 ADMNPKIADFGMARIFGVDQTVANTARVVGTFGYMSPEYVTHGQFSMKSDVYSFGVLILE 553

Query: 521 IISGQKNNSF-RIGEEAEDLLTYV 543
           IISG+KN+SF ++     +L+TYV
Sbjct: 554 IISGKKNSSFYQMDGLVNNLVTYV 577

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65472|CRK12_ARATH Putative cysteine-rich receptor-like protein kinase 12 OS=Arabidopsis thaliana GN=CRK12 PE=3 SV=2

 Score =  507 bits (1305), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 274/565 (48%), Positives = 359/565 (63%), Gaps = 38/565 (6%)

Query: 14  CYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALCRGDSSPES 73
           C +T  F  NSTY  NR + LS L S VT++ GF+  +IGQ P+ VY + +C   +  ES
Sbjct: 24  CINTTYFIPNSTYDTNRRVILSLLPSNVTSHFGFFNGSIGQAPNRVYAVGMCLPGTEEES 83

Query: 74  CASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEIAHNVNNIT 133
           C  CL      +++ C  ++ A+ W      C++RYS  SF G  EL+P     +++   
Sbjct: 84  CIGCLLSASNTLLETCLTEENALIWIANRTICMIRYSDTSFVGSFELEPHREFLSIHGYK 143

Query: 134 SSLTQFDRIWRSLMDRVLAKASLGT----SKLKFAT-DEANLTSSETIYALMQCTPDISQ 188
           ++ T+F+ +W  L  R++ +AS  T    S  K+ T D A L  S+T+YA+MQCTPD+S 
Sbjct: 144 TNETEFNTVWSRLTQRMVQEASSSTDATWSGAKYYTADVAALPDSQTLYAMMQCTPDLSP 203

Query: 189 SDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGA-TADSLSPSPLSPPSTT 247
           ++C  CL +S+ + QSCC G++G  I+  SC FR E+YPF GA T  +  P    PPS  
Sbjct: 204 AECNLCLTESVVNYQSCCLGRQGGSIVRLSCAFRAELYPFGGAFTVMTARPLSQPPPSLI 263

Query: 248 TDTTIAKDKGGNS------ISSGTVVIIV--------VSTST--------------FIIA 279
                      NS      I +  VV+++         ST T              F++ 
Sbjct: 264 KKGEFFAKFMSNSQEPVKMIQNLYVVVLIFYFLDSGKFSTETIAAIVVPIIVVAIIFLVL 323

Query: 280 LVALITCVFLRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGA 339
           LV  ++ +F RRRK  Q+ +L ++  I T+   Q DF TI  AT NF+  NKLGQGGFG 
Sbjct: 324 LV--LSRLFARRRKSYQEIDLDQSG-ITTLHFQQLDFKTIEVATENFAKTNKLGQGGFGE 380

Query: 340 VYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399
           VYKG L +G E+AVKRLSK S QG  EFKNEV+LVA+LQHRNLV+LLG+  E  E++L+Y
Sbjct: 381 VYKGTLVNGTEVAVKRLSKTSEQGAQEFKNEVVLVAKLQHRNLVKLLGYCLEPEEKILVY 440

Query: 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 459
           EFVPN S+D F+FD  K+ QLDW  RY IIGGI RGILYLH+DSRL IIHRDLKASNILL
Sbjct: 441 EFVPNKSLDYFLFDPTKQGQLDWTKRYNIIGGITRGILYLHQDSRLTIIHRDLKASNILL 500

Query: 460 DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVL 519
           DADMIPKI+DFGMAR+  +DQS  +T RI GTFGYM PEYV  G FS+KSDV+SFGVL+L
Sbjct: 501 DADMIPKIADFGMARISGIDQSVANTKRIAGTFGYMPPEYVIHGQFSMKSDVYSFGVLIL 560

Query: 520 EIISGQKNNSFRIGE-EAEDLLTYV 543
           EII G+KN SF   + +AE+L+TYV
Sbjct: 561 EIICGKKNRSFYQADTKAENLVTYV 585

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8RX80|CRK18_ARATH Cysteine-rich receptor-like protein kinase 18 OS=Arabidopsis thaliana GN=CRK18 PE=2 SV=2

 Score =  502 bits (1293), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 279/542 (51%), Positives = 363/542 (66%), Gaps = 18/542 (3%)

Query: 10  SGQTCYDT-GNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALCRGD 68
           S QTC +T G F  NS Y KNR L LS+LAS VTA +G++  +IG  PD+V+   +C   
Sbjct: 26  SAQTCDNTTGTFIPNSPYDKNRRLILSTLASNVTAQEGYFIGSIGIAPDQVFATGMCAPG 85

Query: 69  SSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEIAHN 128
           S  + C+ C+  T   ++++C +Q +A  W G +  C+VRY++R F G L + P     N
Sbjct: 86  SERDVCSLCIRSTSESLLQSCLDQADAFFWSGEETLCLVRYANRPFSGLLVMDPLGAIFN 145

Query: 129 VNNITSSLTQFDRIWRSLMDRVLAKASLGTSKL----KFATDEANLTSS-ETIYALMQCT 183
              + ++ T FD  W +L   ++A  +  +S      K+ +D+  L    + I ALMQCT
Sbjct: 146 TGELNTNQTVFDIEWNNLTSSMIAGITSSSSGGNNSSKYYSDDIALVPDFKNISALMQCT 205

Query: 184 PDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLSP 243
           PD+S  DC  CLRQ++ D  +CC G +G  +  P+C FRWE+YPF GA  D ++     P
Sbjct: 206 PDVSSEDCNTCLRQNVVDYDNCCRGHQGGVMSRPNCFFRWEVYPFSGAI-DQINLPKSPP 264

Query: 244 PSTTTDTTIAK-DKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRK 302
           PS T+ + IA   K  + IS G +  IVV T   II +V     V   RRK+KQ+ +L  
Sbjct: 265 PSVTSPSPIANITKNDSRISGGKIAAIVVVTVVTIILVVLGF--VISNRRKQKQEMDL-- 320

Query: 303 ADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ 362
                  ES+QFD  TI  AT+NFS  NKLG+GGFG VYKG L +G EIAVKRLSK S Q
Sbjct: 321 -----PTESVQFDLKTIESATSNFSERNKLGKGGFGEVYKGMLMNGTEIAVKRLSKTSGQ 375

Query: 363 GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDW 422
           GE+EFKNEV++VA+LQH NLVRLLGFS +  E+LL+YEFV N S+D F+FD  KR QLDW
Sbjct: 376 GEVEFKNEVVVVAKLQHINLVRLLGFSLQGEEKLLVYEFVSNKSLDYFLFDPTKRNQLDW 435

Query: 423 ETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482
             R  IIGGI RGILYLH+DSRL+IIHRDLKASNILLDADM PKI+DFGMAR+F +DQ+ 
Sbjct: 436 TMRRNIIGGITRGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGMARIFGVDQTV 495

Query: 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF-RIGEEAEDLLT 541
            +T R+VGTFGYM+PEYVT G FS+KSDV+SFGVL+LEIISG+KN+SF ++     +L+T
Sbjct: 496 ANTGRVVGTFGYMSPEYVTHGQFSMKSDVYSFGVLILEIISGKKNSSFYQMDGLVNNLVT 555

Query: 542 YV 543
           YV
Sbjct: 556 YV 557

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LDN1|CRK33_ARATH Putative cysteine-rich receptor-like protein kinase 33 OS=Arabidopsis thaliana GN=CRK33 PE=2 SV=1

 Score =  499 bits (1286), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 264/551 (47%), Positives = 350/551 (63%), Gaps = 36/551 (6%)

Query: 1   MLLSIIRLTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVY 60
           +L+SII   S Q C +TG F    TY  NR   L+SLAS V  + GFY ++IG++PDEV+
Sbjct: 15  VLISIIGAISSQQCNETGYFEPWKTYDTNRRQILTSLASKVVDHYGFYNSSIGKVPDEVH 74

Query: 61  GLALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLEL 120
            + +C   + P  C+ CL      + +NCPNQ EA +W      C  RYS+ SFF ++ L
Sbjct: 75  VMGMCIDGTEPTVCSDCLKVAADQLQENCPNQTEAYTWTPHKTLCFARYSNSSFFKRVGL 134

Query: 121 KPTEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLG-----TSKLKFATDEANLTSSET 175
            P  + H+  +I S+LT  + IW +L DR+++ AS       +S+  +A +  NLT+ + 
Sbjct: 135 HPLYMEHSNVDIKSNLTYLNTIWEALTDRLMSDASSDYNASLSSRRYYAANVTNLTNFQN 194

Query: 176 IYALMQCTPDISQSDCEFCLRQSMADVQSCCYGK---KGSYIMGPSCIFRWEMYPFYGAT 232
           IYALM CTPD+ +  C  CL +++++     YG    +   +  PSC FRW++YPF GA 
Sbjct: 195 IYALMLCTPDLEKGACHNCLEKAVSE-----YGNLRMQRGIVAWPSCCFRWDLYPFIGAF 249

Query: 233 ADSLSPSPLSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRR 292
             +LSP P S                 +IS G  V IVV+T   I  L  L+  +  R+R
Sbjct: 250 NLTLSPPPGS---------------KRNISVGFFVAIVVATGVVISVLSTLVVVLVCRKR 294

Query: 293 KKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIA 352
           K    +   K        SLQ+D  TI  AT  FS  N LGQGGFG V+KG L  G EIA
Sbjct: 295 KTDPPEESPKY-------SLQYDLKTIEAATCTFSKCNMLGQGGFGEVFKGVLQDGSEIA 347

Query: 353 VKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIF 412
           VKRLSK S QG  EF+NE  LVA+LQHRNLV +LGF  E  E++L+YEFVPN S+D+F+F
Sbjct: 348 VKRLSKESAQGVQEFQNETSLVAKLQHRNLVGVLGFCMEGEEKILVYEFVPNKSLDQFLF 407

Query: 413 DAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472
           +  K+ QLDW  RYKII G ARGILYLH DS L+IIHRDLKASNILLDA+M PK++DFGM
Sbjct: 408 EPTKKGQLDWAKRYKIIVGTARGILYLHHDSPLKIIHRDLKASNILLDAEMEPKVADFGM 467

Query: 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR- 531
           AR+F +DQS+ DT R+VGT GY++PEY+  G FS+KSDV+SFGVLVLEIISG++N++F  
Sbjct: 468 ARIFRVDQSRADTRRVVGTHGYISPEYLMHGQFSVKSDVYSFGVLVLEIISGKRNSNFHE 527

Query: 532 IGEEAEDLLTY 542
             E  ++L+TY
Sbjct: 528 TDESGKNLVTY 538

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	551
224113943	641	predicted protein [Populus trichocarpa]	0.927	0.797	0.579	1e-179
224116134	668	predicted protein [Populus trichocarpa]	0.960	0.791	0.566	1e-168
224113947	645	predicted protein [Populus trichocarpa]	0.956	0.817	0.563	1e-168
224113951	645	predicted protein [Populus trichocarpa]	0.956	0.817	0.561	1e-167
356575765	666	PREDICTED: cysteine-rich receptor-like p	0.963	0.797	0.547	1e-165
356575763	665	PREDICTED: cysteine-rich receptor-like p	0.961	0.796	0.549	1e-164
359496752	751	PREDICTED: cysteine-rich receptor-like p	0.967	0.709	0.528	1e-163
356574368	656	PREDICTED: cysteine-rich receptor-like p	0.949	0.797	0.544	1e-163
356574361	846	PREDICTED: cysteine-rich receptor-like p	0.980	0.638	0.544	1e-163
359497268	675	PREDICTED: cysteine-rich receptor-like p	0.978	0.798	0.534	1e-162

>gi|224113943|ref|XP_002316622.1| predicted protein [Populus trichocarpa] gi|222859687|gb|EEE97234.1| predicted protein [Populus trichocarpa]

 Score =  635 bits (1639), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 314/542 (57%), Positives = 384/542 (70%), Gaps = 31/542 (5%)

Query: 6   IRLTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALC 65
           I LT  + CY+TGNFT NSTY KNRDL L SLAS VT N GFY  TIG   D VYGL LC
Sbjct: 18  ITLTGAEVCYNTGNFTANSTYAKNRDLVLRSLASNVTNNGGFYNTTIGLGNDTVYGLVLC 77

Query: 66  RGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEI 125
               S E+C+ C++  +  +   CPNQKEAISW G   PC+V Y++R F G LE  P  I
Sbjct: 78  MASPSAENCSRCVSSAIQTLTAGCPNQKEAISWGGNPLPCIVHYANRYFLGSLEQSPNSI 137

Query: 126 AHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPD 185
            +NV  + ++  QF++ W  L + V   AS G+S+L  A + A+L S++  Y  MQCTPD
Sbjct: 138 LYNVGILDATFRQFEQFWSGLGETV-KNASTGSSRLMPAVETADLPSNQKAYVFMQCTPD 196

Query: 186 ISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLSPPS 245
           +S S+C  CL+QS+ D  SCCYG +G  +  P+C+FRW++                    
Sbjct: 197 VSPSNCSVCLQQSVNDYXSCCYGHQGGIVQKPNCVFRWDL-------------------- 236

Query: 246 TTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALI-TCVFLRRRKKKQKQNLRKAD 304
               T +   K  N     TV IIV++    + A++ +I  C+F+R RK+++K+ +   D
Sbjct: 237 ---ATLVYAGKKSN-----TVRIIVITVVPAVGAVILVICMCLFIRTRKQREKERIETGD 288

Query: 305 EINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGE 364
           EI + ESLQF FSTIRDAT +FS  NKLGQGGFGAVYKG L  GQEIAVKRLSK+S QG+
Sbjct: 289 EIESAESLQFAFSTIRDATEDFSEKNKLGQGGFGAVYKGALPSGQEIAVKRLSKDSGQGD 348

Query: 365 LEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWET 424
           LEFKNEVLLVARLQHRNLVRLLGF  +  ERLLIYEFVPN+S+D FIFD IKRV L+WE 
Sbjct: 349 LEFKNEVLLVARLQHRNLVRLLGFCLQGIERLLIYEFVPNASLDHFIFDPIKRVHLNWER 408

Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
           RYKIIGGIARG+LYLHEDSRLRIIHRDLKASNILLD +M PKISDFGMARLF +DQ+QG+
Sbjct: 409 RYKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDEEMNPKISDFGMARLFVVDQTQGN 468

Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS 544
           TSRIVGT+GYMAPEY  +GHFS+KSDVFSFGVLVLEI++G+K NSFR G + E LL++  
Sbjct: 469 TSRIVGTYGYMAPEYAMQGHFSVKSDVFSFGVLVLEIVTGKK-NSFRNGNDIEHLLSHAW 527

Query: 545 NN 546
            N
Sbjct: 528 RN 529

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116134|ref|XP_002317220.1| predicted protein [Populus trichocarpa] gi|222860285|gb|EEE97832.1| predicted protein [Populus trichocarpa]

 Score =  598 bits (1543), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 310/547 (56%), Positives = 380/547 (69%), Gaps = 18/547 (3%)

Query: 6   IRLTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALC 65
           I LT  + CY+TGNFT NSTY KNRDL L SLAS VTAN GFY  TIG   D VYGL LC
Sbjct: 18  ITLTGAEVCYNTGNFTANSTYAKNRDLVLRSLASNVTANGGFYNTTIGLGNDTVYGLVLC 77

Query: 66  RGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEI 125
               S E C+SC+N  +  +M  CPNQKEAISW G   PC+V Y++R FFG LE  P+  
Sbjct: 78  MASPSAEICSSCVNSAIQTLMAACPNQKEAISWGGNPLPCIVHYANRYFFGSLEPSPSSA 137

Query: 126 AHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPD 185
            +N   + ++  QFD+ W  L + V  KAS  +S+L    + A+L+S++ IY  MQCTPD
Sbjct: 138 FYNTGILDATFRQFDQFWSGLGETV-TKASTASSRLMPVAETADLSSTQKIYVFMQCTPD 196

Query: 186 ISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYG----------ATADS 235
           +S S+C  CL+QS+   +SCCYG KG     P+C FRW++YPFY           + + S
Sbjct: 197 VSPSNCSVCLQQSVDYYKSCCYGHKGGGAQKPNCFFRWDLYPFYDLFPQVTSPPPSPSPS 256

Query: 236 LSPSPLSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKK 295
            SP  +      T+TTI K  G  + +S TV++ +V T+ F+ ALV LI  VF   R +K
Sbjct: 257 PSPPFVISSPPPTNTTIRK--GKENTASRTVIVTIVPTAIFL-ALVILILTVF---RFRK 310

Query: 296 QKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKR 355
            KQ +   DEI+  + L+F F+TI+ ATN+FS DNKLGQGGFGAVYKG L+ GQ IAVKR
Sbjct: 311 PKQEVENFDEISIAKCLEFKFATIKLATNDFSDDNKLGQGGFGAVYKGILADGQAIAVKR 370

Query: 356 LSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI 415
           LS NS QGE+EFKNEV L+A+L HRNLVRLLGF  E TE+LLIYEFVPNSS+D+FI D  
Sbjct: 371 LSSNSGQGEVEFKNEVRLLAKLDHRNLVRLLGFCLEGTEKLLIYEFVPNSSLDQFIHDPN 430

Query: 416 KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475
           KR  LDWE RYKII GIARGILYLH+DS+LRIIHRDLK SNILLD  M  KISDFGMA+L
Sbjct: 431 KRFILDWEKRYKIIEGIARGILYLHQDSQLRIIHRDLKPSNILLDGKMNAKISDFGMAKL 490

Query: 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
            + DQ+    SRI GTFGY+APEY  +  FS+KSDVFSFGVLVLEI+SGQK  SFR G++
Sbjct: 491 MKTDQTHDAASRIAGTFGYIAPEYARQRQFSVKSDVFSFGVLVLEIVSGQK-PSFRDGDD 549

Query: 536 AEDLLTY 542
            E L ++
Sbjct: 550 MEHLTSH 556

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113947|ref|XP_002316623.1| predicted protein [Populus trichocarpa] gi|222859688|gb|EEE97235.1| predicted protein [Populus trichocarpa]

 Score =  597 bits (1538), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 303/538 (56%), Positives = 378/538 (70%), Gaps = 11/538 (2%)

Query: 6   IRLTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALC 65
           I LT  + CY+TGNFT NSTY KNRDL L SLAS VTAN GFY  TIG   D VYGL  C
Sbjct: 18  ITLTGAEVCYNTGNFTANSTYAKNRDLVLRSLASNVTANGGFYNTTIGLGNDTVYGLVFC 77

Query: 66  RGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEI 125
               S E C+SC+N  +  +M  CPNQKEAISW G   PC+V Y++R F G LEL PT+ 
Sbjct: 78  MASPSAEICSSCVNSAIQTLMAACPNQKEAISWGGNPVPCIVHYANRYFLGSLELSPTDA 137

Query: 126 AHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPD 185
            +N   +  S  QF +IW  LM   +  AS G+S+ K A + A+L+S++ IY  MQCTPD
Sbjct: 138 GYNTGILDPSFRQFLQIWSGLMTDTVTIASTGSSRFKLAAETADLSSTQKIYVFMQCTPD 197

Query: 186 ISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLSPPS 245
           +S S+C  CL+ S+   +SCC G +G Y   P+C+FRW++YPFY     +L P   SP  
Sbjct: 198 VSPSNCRDCLQHSVDYYKSCCNGYQGGYAQKPNCVFRWDLYPFY-----NLFPQVTSPSP 252

Query: 246 TTTDTTIAK-DKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRKAD 304
           ++   T     KG  + +S TV++ +V TS F+ ALV LI  +F   R +K KQ ++  D
Sbjct: 253 SSPPPTNTTIRKGKENNASRTVIVTIVPTSIFL-ALVILILTIF---RFRKPKQEVKNFD 308

Query: 305 EINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGE 364
           E ++ +  +F F+TI+ ATN+FS DNKLGQGGFGAVYKG L+ GQ IAVKRLS NS QG 
Sbjct: 309 ENSSTKCWEFKFATIKLATNDFSDDNKLGQGGFGAVYKGILADGQAIAVKRLSSNSGQGA 368

Query: 365 LEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWET 424
           +EF+NEV L+A+L HRNLVRLLGF  E TE+LLIYEFVPNSS+D+FI D  KR+ LDWE 
Sbjct: 369 VEFRNEVGLLAKLAHRNLVRLLGFCLEGTEKLLIYEFVPNSSLDQFIHDPNKRLVLDWEK 428

Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
           RYKII GIARGI+YLH+DS+L IIHRDLK  NILLD +M  KISDFGMA+L + DQ+   
Sbjct: 429 RYKIIEGIARGIVYLHQDSQLWIIHRDLKPGNILLDGNMNAKISDFGMAKLMKTDQTHDA 488

Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY 542
           TSRI GTFGY+APEY  +G FS+KSDVFSFGVLVLEI+SGQK  SFR G++ E L ++
Sbjct: 489 TSRIAGTFGYIAPEYAWKGQFSVKSDVFSFGVLVLEIVSGQK-PSFRNGDDMEHLTSH 545

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113951|ref|XP_002316624.1| predicted protein [Populus trichocarpa] gi|222859689|gb|EEE97236.1| predicted protein [Populus trichocarpa]

 Score =  594 bits (1532), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 302/538 (56%), Positives = 378/538 (70%), Gaps = 11/538 (2%)

Query: 6   IRLTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALC 65
           I LT  + CY+TGNFT NSTY KNRDL L SLAS VTAN GFY  TIG   D VYGL  C
Sbjct: 18  ITLTGAEVCYNTGNFTANSTYAKNRDLVLRSLASNVTANGGFYNTTIGLGNDTVYGLVFC 77

Query: 66  RGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEI 125
              +S E C+SC+N  +  +M  CPNQKEAISW G   PC+V Y++R F G LEL PT+ 
Sbjct: 78  MASASAEICSSCVNSAIQTLMAACPNQKEAISWGGNPVPCIVHYANRYFLGSLELSPTDA 137

Query: 126 AHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPD 185
            +N   +  S  QF +IW  LM   +  AS G+S+ K A + A+L+S++ IY  MQCTPD
Sbjct: 138 GYNTGILDPSFRQFLQIWSGLMTDTVTIASTGSSRFKLAAETADLSSTQKIYVFMQCTPD 197

Query: 186 ISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLSPPS 245
           +S S+C  CL+ S+   +SCC G +G Y   P+C+FRW++YPFY     +L P   SP  
Sbjct: 198 VSPSNCRDCLQHSVDYYKSCCNGYQGGYAQKPNCVFRWDLYPFY-----NLFPQVTSPSP 252

Query: 246 TTTDTTIAK-DKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRKAD 304
           ++   T     KG  + +S TV++ +V TS F+ ALV LI  +F   R +K KQ ++  D
Sbjct: 253 SSPPPTNTTIRKGKENNASRTVIVTIVPTSIFL-ALVILILTIF---RFRKPKQEVKNFD 308

Query: 305 EINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGE 364
           E ++ +  +F F+TI+ ATN+FS DNKLGQGGFGAVYKG ++ GQ IAVKRLS NS QG 
Sbjct: 309 ENSSTKCWEFKFATIKLATNDFSDDNKLGQGGFGAVYKGIIADGQAIAVKRLSSNSGQGA 368

Query: 365 LEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWET 424
           +EF+NEV L+A+L HRNLVRLLGF  E TE+LLIYEFVPNSS+D+FI D  KR+ LDWE 
Sbjct: 369 VEFRNEVGLLAKLAHRNLVRLLGFCLEGTEKLLIYEFVPNSSLDQFIHDPNKRLVLDWEK 428

Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
           RYKII GIARGILYLH+DS+L IIHRDLK  NILLD +M  KISD GMA+L + DQ+   
Sbjct: 429 RYKIIEGIARGILYLHQDSQLWIIHRDLKPGNILLDGNMNAKISDSGMAKLMKTDQTHDA 488

Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY 542
           TSRI GTFGY+APEY  +G FS+KSDVFSFGVLVLEI+SGQK  SFR G++ E L ++
Sbjct: 489 TSRIAGTFGYIAPEYAWKGQFSVKSDVFSFGVLVLEIVSGQK-PSFRNGDDMEHLTSH 545

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356575765|ref|XP_003556007.1| PREDICTED: cysteine-rich receptor-like protein kinase 29-like isoform 2 [Glycine max]

 Score =  587 bits (1512), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 300/548 (54%), Positives = 383/548 (69%), Gaps = 17/548 (3%)

Query: 5   IIRLTSGQT-C-YDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGL 62
           II   S QT C  D GN+T NSTY  N +  LS+ +S      GFY  + GQ PD+VY +
Sbjct: 19  IISQASAQTNCDNDKGNYTINSTYHSNLNTLLSNFSSHTDIYYGFYNFSYGQDPDKVYAI 78

Query: 63  ALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKP 122
            LCRGD +P+ C  CLN + + +   CPNQKEAI+W G    C++RYS+RS FG++E +P
Sbjct: 79  GLCRGDQNPDQCLKCLNESRVSLADECPNQKEAINWRG---ECMLRYSNRSIFGRMENQP 135

Query: 123 TEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQC 182
           T     + N+T S+ +F+ +  SLM  + + A+ G S+ K+AT        +T Y   QC
Sbjct: 136 TSRIVYLKNVTGSVDEFNDVLESLMRNLSSTAASGDSRRKYATGSKPAPDFQTTYGYTQC 195

Query: 183 TPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLS 242
           TPD+S  DC  CL ++++D+ +   GK G  ++ PSC  R++ Y +YG T   L   P +
Sbjct: 196 TPDLSSEDCTTCLGEAISDIPNYFNGKAGGNVLKPSCRIRFDPYSYYGPT---LKLDPDA 252

Query: 243 PPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRK 302
            P+ T +T+ ++++ GN+    + +II +      + LV ++ C++LR RK + KQN  K
Sbjct: 253 SPTMTNNTSSSQERKGNT----SRIIIAIVVPVASVVLVLILFCIYLRARKSR-KQNESK 307

Query: 303 AD----EINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSK 358
            D    EI+  ESLQFDF TIR ATN F+  NK+GQGGFGAVY+G+LS+GQEIAVKRLS+
Sbjct: 308 EDNNEDEISFAESLQFDFDTIRVATNEFADCNKIGQGGFGAVYRGQLSNGQEIAVKRLSR 367

Query: 359 NSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV 418
           +S QG++EFKNEVLLVA+LQHRNLVRLLGF  E TERLL+YEFVPN S+D FIFD IK+ 
Sbjct: 368 DSGQGDMEFKNEVLLVAKLQHRNLVRLLGFCLEGTERLLVYEFVPNKSLDYFIFDPIKKA 427

Query: 419 QLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478
           QLDW+ RYKIIGGIARG+LYLHEDSRLRIIHRDLKASNILLD +M PKISDFGMARL  M
Sbjct: 428 QLDWQRRYKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDEEMHPKISDFGMARLVHM 487

Query: 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAED 538
           DQ+Q +TSRIVGT+GYMAPEY   G FS KSDVFSFGVLVLEIISG KN+  R GE  ED
Sbjct: 488 DQTQENTSRIVGTYGYMAPEYAIYGQFSAKSDVFSFGVLVLEIISGHKNSGVRRGENVED 547

Query: 539 LLTYVSNN 546
           LL +   N
Sbjct: 548 LLCFAWRN 555

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356575763|ref|XP_003556006.1| PREDICTED: cysteine-rich receptor-like protein kinase 29-like isoform 1 [Glycine max]

 Score =  584 bits (1506), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 301/548 (54%), Positives = 380/548 (69%), Gaps = 18/548 (3%)

Query: 5   IIRLTSGQT-C-YDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGL 62
           II   S QT C  D GN+T NSTY  N +  LS+ +S      GFY  + GQ PD+VY +
Sbjct: 19  IISQASAQTNCDNDKGNYTINSTYHSNLNTLLSNFSSHTDIYYGFYNFSYGQDPDKVYAI 78

Query: 63  ALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKP 122
            LCRGD +P+ C  CLN + + +   CPNQKEAI+W G    C++RYS+RS FG++E +P
Sbjct: 79  GLCRGDQNPDQCLKCLNESRVSLADECPNQKEAINWRG---ECMLRYSNRSIFGRMENQP 135

Query: 123 TEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQC 182
           T     + N+T S+ +F+ +  SLM  + + A+ G S+ K+AT        +T Y   QC
Sbjct: 136 TSRIVYLKNVTGSVDEFNDVLESLMRNLSSTAASGDSRRKYATGSKPAPDFQTTYGYTQC 195

Query: 183 TPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLS 242
           TPD+S  DC  CL ++++D+ +   GK G  ++ PSC  R++ Y +YG T   L   P +
Sbjct: 196 TPDLSSEDCTTCLGEAISDIPNYFNGKAGGNVLKPSCRIRFDPYSYYGPT---LKLDPDA 252

Query: 243 PPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRK 302
            P+ T +T+ ++ KG  S      +II +      + LV ++ C++LR RK + KQN  K
Sbjct: 253 SPTMTNNTSSSQGKGNTS-----RIIIAIVVPVASVVLVLILFCIYLRARKSR-KQNESK 306

Query: 303 AD----EINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSK 358
            D    EI+  ESLQFDF TIR ATN F+  NK+GQGGFGAVY+G+LS+GQEIAVKRLS+
Sbjct: 307 EDNNEDEISFAESLQFDFDTIRVATNEFADCNKIGQGGFGAVYRGQLSNGQEIAVKRLSR 366

Query: 359 NSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV 418
           +S QG++EFKNEVLLVA+LQHRNLVRLLGF  E TERLL+YEFVPN S+D FIFD IK+ 
Sbjct: 367 DSGQGDMEFKNEVLLVAKLQHRNLVRLLGFCLEGTERLLVYEFVPNKSLDYFIFDPIKKA 426

Query: 419 QLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478
           QLDW+ RYKIIGGIARG+LYLHEDSRLRIIHRDLKASNILLD +M PKISDFGMARL  M
Sbjct: 427 QLDWQRRYKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDEEMHPKISDFGMARLVHM 486

Query: 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAED 538
           DQ+Q +TSRIVGT+GYMAPEY   G FS KSDVFSFGVLVLEIISG KN+  R GE  ED
Sbjct: 487 DQTQENTSRIVGTYGYMAPEYAIYGQFSAKSDVFSFGVLVLEIISGHKNSGVRRGENVED 546

Query: 539 LLTYVSNN 546
           LL +   N
Sbjct: 547 LLCFAWRN 554

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496752|ref|XP_003635322.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera]

 Score =  583 bits (1502), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 301/570 (52%), Positives = 394/570 (69%), Gaps = 37/570 (6%)

Query: 1   MLLSIIRLTSGQTCY-------DTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIG 53
           ++L ++ +T+ Q  +         GN+T NSTY  N +  L+SL+S    + GFY  + G
Sbjct: 84  LILHLLAVTNAQPKFLYYRCSNGVGNYTNNSTYKANLNTLLTSLSSNNEIDYGFYNFSAG 143

Query: 54  QIPDEVYGLALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISW-EGMDFPCVVRYSSR 112
           Q  D+V  +ALCRGD  P +C SC+N + + + + CPNQKEAI W +G    C++RYS+ 
Sbjct: 144 QNSDKVNAIALCRGDVMPTACRSCINDSRIQLTRLCPNQKEAIGWYDG----CMLRYSND 199

Query: 113 SFFGKLELKPTEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTS 172
           S FGK +  P+    N+ N+ S++  F+++  +LM  + +KA+ G  + KFAT+EAN+TS
Sbjct: 200 SIFGKAQTSPSFTMWNLQNV-SNVEDFNQVLGNLMASLRSKAASGDWRRKFATEEANVTS 258

Query: 173 SETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGAT 232
            ++IY LMQCTPD+S+  C  CL  ++ ++ +CC  +K   ++ PSC  R+  Y FY  T
Sbjct: 259 FQSIYGLMQCTPDLSELSCSNCLEGAINEIPTCCNRRKAGRVVKPSCNLRYGTYRFYYFT 318

Query: 233 ADS----------------LSPSPLSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTF 276
           A +                LSP PL+  ++T +T         S SS T+++I+V +   
Sbjct: 319 AANAPPPTATPQPSPPSADLSPQPLANTTSTQET--------RSNSSRTIILIIVPSVII 370

Query: 277 IIALVALITCVFLRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGG 336
           +I ++    C F R+R   +K      D+I  VESL FDF TIR ATNNFS  NKLGQGG
Sbjct: 371 LIIILVGFICFFSRKRSSMEKLETNDEDDIINVESLHFDFDTIRVATNNFSDSNKLGQGG 430

Query: 337 FGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL 396
           FG VYKG+LS+GQ+IAVKRLS  S QGELEFKNEV+LVA+LQHRNLVRLLGF  +  ERL
Sbjct: 431 FGPVYKGKLSNGQDIAVKRLSSGSGQGELEFKNEVVLVAKLQHRNLVRLLGFCLDGAERL 490

Query: 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 456
           LIYEFVPN+S+D FIFD I+R QLDWE RYKIIGGIARG+LYLHEDSRLRIIHRDLKASN
Sbjct: 491 LIYEFVPNTSLDHFIFDPIRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKASN 550

Query: 457 ILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGV 516
           ILLDA+M PKISDFGMARLF +DQ+QG+TSRIVGT+GYMAPEY   GHFS+K+DV+SFGV
Sbjct: 551 ILLDAEMNPKISDFGMARLFLVDQTQGNTSRIVGTYGYMAPEYAMHGHFSVKTDVYSFGV 610

Query: 517 LVLEIISGQKNNSFRIGEEAEDLLTYVSNN 546
           LVLE++SGQ+NN FR+ E  E LL+Y   N
Sbjct: 611 LVLELVSGQRNNCFRVSENIEHLLSYAWKN 640

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356574368|ref|XP_003555320.1| PREDICTED: cysteine-rich receptor-like protein kinase 29-like [Glycine max]

 Score =  582 bits (1499), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 297/545 (54%), Positives = 374/545 (68%), Gaps = 22/545 (4%)

Query: 5   IIRLTSGQTCYDT--GNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGL 62
           II   S QT  D   GN+T NSTY  N +  LS+ +S      GFY  + GQ PD+VY +
Sbjct: 19  IISRASAQTYCDNHKGNYTINSTYHNNLNTLLSTFSSHTDIYYGFYNFSYGQDPDKVYAI 78

Query: 63  ALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKP 122
            LCRGD + + C +CL+    +  + CPNQKEAI+W+G    C++RYS+RS FG +E +P
Sbjct: 79  GLCRGDQNQDDCLACLDDARANFTQLCPNQKEAINWDG---ECMLRYSNRSIFGIMENEP 135

Query: 123 TEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQC 182
                   N+T  + QF+   +SLM  + + A+ G S+ K+ T   +  + +TIY   QC
Sbjct: 136 FVETVLTMNVTGPVDQFNEALQSLMRNLTSTAASGDSRRKYGTASTHAPNFQTIYGYAQC 195

Query: 183 TPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLS 242
           TPD+S  DC  CL +++A++  CC GK G  ++ PSC  R++ Y F+G T    SPSP  
Sbjct: 196 TPDLSLEDCTNCLGEAIAEIPRCCSGKAGGNVLKPSCRIRFDPYNFFGPTIPLPSPSP-- 253

Query: 243 PPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQK-QNLR 301
                       +  G S +S T++ IVV  ++  + LV  + C++LR RK ++K +   
Sbjct: 254 ------------NSQGKSKTSRTIIAIVVPAAS--VVLVVSLFCIYLRARKPRKKIEKDS 299

Query: 302 KADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV 361
             DEI   ESLQF+F TIR ATN F+  NKLGQGGFGAVY+G+LS+GQEIAVKRLS++S 
Sbjct: 300 HEDEITFAESLQFNFDTIRAATNEFADSNKLGQGGFGAVYRGQLSNGQEIAVKRLSRDSG 359

Query: 362 QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLD 421
           QG +EFKNEVLLVA+LQHRNLV+LLGF  E  ERLLIYEFVPN S+D FIFD IK+ QLD
Sbjct: 360 QGNMEFKNEVLLVAKLQHRNLVKLLGFCLEGRERLLIYEFVPNKSLDYFIFDPIKKAQLD 419

Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
           W+ RY IIGGIARGILYLHEDSRLRIIHRDLKASNILLD +M PKISDFGMARL  MD++
Sbjct: 420 WQRRYNIIGGIARGILYLHEDSRLRIIHRDLKASNILLDEEMNPKISDFGMARLVHMDET 479

Query: 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLT 541
           QG+TSRIVGT+GYMAPEYV  G FS KSDVFSFGVLVLEIISGQKN+  R GE  E LL+
Sbjct: 480 QGNTSRIVGTYGYMAPEYVLYGQFSAKSDVFSFGVLVLEIISGQKNSGIRHGENVEHLLS 539

Query: 542 YVSNN 546
           +   N
Sbjct: 540 FAWRN 544

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356574361|ref|XP_003555317.1| PREDICTED: cysteine-rich receptor-like protein kinase 28-like [Glycine max]

 Score =  580 bits (1494), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 299/549 (54%), Positives = 374/549 (68%), Gaps = 9/549 (1%)

Query: 1   MLLSIIRLTSGQTCYDT--GNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDE 58
           + + II   S QT  D   GN+T +STY  N +  LSS +S      GFY  + GQ  D+
Sbjct: 196 LFVIIISQASSQTPCDNSKGNYTIHSTYHNNLNTLLSSFSSHTEIKYGFYNFSYGQGTDK 255

Query: 59  VYGLALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKL 118
           VY + LCRGD  P+ C   LN T + + K+CPNQKEAI W      C++RY++RS  G +
Sbjct: 256 VYAIGLCRGDLKPDECLRILNDTRVSLTKDCPNQKEAIMWT---VECMLRYTNRSILGVM 312

Query: 119 ELKPTEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYA 178
           E +PT   +   N+T S+ QF+    SLM  +   A+ G S+ K+AT  A   + +TIYA
Sbjct: 313 ENQPTNHNYYDKNVTGSVNQFNDALESLMRNLTRTAASGDSRSKYATASAKAPNFQTIYA 372

Query: 179 LMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSP 238
             QCTPDIS  DC  CL ++++ +  CC GK G  ++ PSC  R++ Y FYG T   L  
Sbjct: 373 QAQCTPDISSEDCTKCLEEAISIIPECCSGKAGGNVVKPSCRIRFDPYIFYGPT---LKL 429

Query: 239 SPLSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQK- 297
            P +PP+T   +    +      S+ +  II +      + LV  + C++LR  K ++K 
Sbjct: 430 DPDAPPTTPLQSPSTNNTSSQGKSNTSRTIIAIVVPVGSVVLVLSLFCIYLRLWKPRKKI 489

Query: 298 QNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLS 357
           +  +  DEI   ESLQF+F TIR ATN F   NKLGQGGFGAVYKG+LS+GQ IAVKRLS
Sbjct: 490 EKDKDEDEITFAESLQFNFDTIRVATNEFDDCNKLGQGGFGAVYKGQLSNGQVIAVKRLS 549

Query: 358 KNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKR 417
           ++S QG++EF+NEVLLVA+LQHRNLVRLLGFS E  ERLL+YEFVPN S+D FIFD IK+
Sbjct: 550 RDSGQGDMEFENEVLLVAKLQHRNLVRLLGFSLEGRERLLVYEFVPNKSLDYFIFDPIKK 609

Query: 418 VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477
           +QL+W+ RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD  M PKISDFGMARL  
Sbjct: 610 IQLNWQKRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDEQMHPKISDFGMARLIR 669

Query: 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAE 537
           +DQ+QG+TSRIVGT+GYMAPEY   G FS KSDVFSFGVLVLEI+SGQKN+  R GE  E
Sbjct: 670 VDQTQGNTSRIVGTYGYMAPEYAIYGQFSAKSDVFSFGVLVLEIVSGQKNSGIRRGENVE 729

Query: 538 DLLTYVSNN 546
           DLLT+V  N
Sbjct: 730 DLLTFVWRN 738

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497268|ref|XP_003635466.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera]

 Score =  578 bits (1491), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 298/558 (53%), Positives = 388/558 (69%), Gaps = 19/558 (3%)

Query: 1   MLLSIIRLTSGQTCY-------DTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIG 53
           ++L ++ +T+ Q  +         GN+T NSTY  N +  L+SL+S    + GFY  + G
Sbjct: 14  LILHLLAVTNAQPKFLYYRCSNGVGNYTNNSTYKANLNTLLTSLSSNNEIDYGFYNFSAG 73

Query: 54  QIPDEVYGLALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISW-EGMDFPCVVRYSSR 112
           Q  D+V  +ALCRGD  P +C SC+N + + + + CPNQKEAI W +G    C++RYS+ 
Sbjct: 74  QNSDKVNAIALCRGDVMPTACRSCINDSRIQLTRLCPNQKEAIGWYDG----CMLRYSND 129

Query: 113 SFFGKLELKPTEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTS 172
           S FGK +  PT    N+ N+ S++  F+++  +LM  + +KA+ G  + KFAT+EAN+TS
Sbjct: 130 SIFGKAQTSPTFTMWNLQNV-SNVEDFNQVLGNLMASLRSKAASGDWRRKFATEEANVTS 188

Query: 173 SETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGAT 232
            ++IY LMQCTPD+S+  C  CL  ++ ++ +CC  +K   ++ PSC  R+  Y FY  T
Sbjct: 189 FQSIYGLMQCTPDLSELSCSNCLEGAINEIPTCCNRRKAGRVVKPSCNLRYATYHFYDIT 248

Query: 233 ADSLSPSPLSPPSTT----TDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVF 288
           A +  P        +     +TT  ++   NS  S T+++I+V +   +I ++    C F
Sbjct: 249 AANAPPPSPPSADLSPPPLANTTSTQETRSNS--SRTIILIIVPSVIILIIILVGFICFF 306

Query: 289 LRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHG 348
            R+R   +K      DEI  VESL FDF TIR ATNNFS  NKLGQGGFG VYKG+LS+G
Sbjct: 307 SRKRSSMEKLETHDEDEITNVESLHFDFDTIRVATNNFSDSNKLGQGGFGPVYKGKLSNG 366

Query: 349 QEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD 408
           Q +AVKRLS  S QGELEFKNEV+LVA+LQHRNLVRLLGF  +  ERLLIYEFVPN+S+D
Sbjct: 367 QNVAVKRLSSGSAQGELEFKNEVVLVAKLQHRNLVRLLGFCLDGAERLLIYEFVPNTSLD 426

Query: 409 KFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS 468
            FIFD I+R QLDWE RYKIIGGIARG+LYLHEDSRLRIIHRDLKASNILLDA+M PKIS
Sbjct: 427 HFIFDLIRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDAEMNPKIS 486

Query: 469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNN 528
           DFGMARLF +DQ+QG TSRIVGT+GYMAPEY   GHFS+K+DV+SFGVLVLE++SGQ+NN
Sbjct: 487 DFGMARLFLVDQTQGSTSRIVGTYGYMAPEYAMHGHFSVKTDVYSFGVLVLELVSGQRNN 546

Query: 529 SFRIGEEAEDLLTYVSNN 546
            FR+ E  E LL+Y   N
Sbjct: 547 CFRVSENIEHLLSYAWKN 564

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	551
TAIR|locus:2123111	669	CRK34 "cysteine-rich RLK (RECE	0.433	0.357	0.683	4e-136
TAIR|locus:2123116	700	CRK30 "cysteine-rich RLK (RECE	0.437	0.344	0.657	5.2e-136
TAIR|locus:2121691	667	CRK11 "cysteine-rich RLK (RECE	0.435	0.359	0.658	4.6e-135
TAIR|locus:2141762	665	CRK26 "cysteine-rich RLK (RECE	0.439	0.363	0.688	3e-129
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.433	0.357	0.690	1.5e-125
TAIR|locus:2123126	666	CRK31 "cysteine-rich RLK (RECE	0.435	0.360	0.651	1.5e-123
TAIR|locus:2121651	676	CRK8 "cysteine-rich RLK (RECEP	0.433	0.353	0.686	3.1e-123
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.435	0.355	0.658	3.1e-123
TAIR|locus:2137144	646	CRK37 "cysteine-rich RLK (RECE	0.470	0.400	0.621	4e-123
TAIR|locus:2123056	656	CRK32 "cysteine-rich RLK (RECE	0.435	0.365	0.626	1.7e-122

TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)]

 Score = 849 (303.9 bits), Expect = 4.0e-136, Sum P(2) = 4.0e-136
 Identities = 164/240 (68%), Positives = 195/240 (81%)

Query:   304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
             DEI T  SLQF F TI  AT+ FS  N +G+GGFG VY+G+LS G E+AVKRLSK S QG
Sbjct:   323 DEITTTHSLQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQG 382

Query:   364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
               EFKNE +LV++LQH+NLVRLLGF  E  E++L+YEFVPN S+D F+FD  K+ +LDW 
Sbjct:   383 AEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWT 442

Query:   424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
              RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDADM PKI+DFGMAR+F +DQSQ 
Sbjct:   443 RRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQA 502

Query:   484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF-RIGEEAEDLLTY 542
             +T RI GTFGYM+PEY  RGHFS+KSDV+SFGVLVLEIISG+KN+SF  I +   +L+T+
Sbjct:   503 NTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGSNLVTH 562

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2123116 CRK30 "cysteine-rich RLK (RECEPTOR-like protein kinase) 30" [Arabidopsis thaliana (taxid:3702)]

 Score = 816 (292.3 bits), Expect = 5.2e-136, Sum P(2) = 5.2e-136
 Identities = 161/245 (65%), Positives = 194/245 (79%)

Query:   303 ADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ 362
             AD+I TV  LQFD   I  AT+NF   NK+GQGGFG VYKG LS+G E+AVKRLS+ S Q
Sbjct:   323 ADDITTVGYLQFDIKDIEAATSNFLASNKIGQGGFGEVYKGTLSNGTEVAVKRLSRTSDQ 382

Query:   363 GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI---KRVQ 419
             GELEFKNEVLLVA+LQHRNLVRLLGF+ +  E++L++EFVPN S+D F+F +    K+ Q
Sbjct:   383 GELEFKNEVLLVAKLQHRNLVRLLGFALQGEEKILVFEFVPNKSLDYFLFGSTNPTKKGQ 442

Query:   420 LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479
             LDW  RY IIGGI RG+LYLH+DSRL IIHRD+KASNILLDADM PKI+DFGMAR F   
Sbjct:   443 LDWTRRYNIIGGITRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRDH 502

Query:   480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF-RIGEEAED 538
             Q++  T R+VGTFGYM PEYV  G FS KSDV+SFGVL+LEI+SG+KN+SF ++     +
Sbjct:   503 QTEDSTGRVVGTFGYMPPEYVAHGQFSTKSDVYSFGVLILEIVSGRKNSSFYQMDGSVCN 562

Query:   539 LLTYV 543
             L+TYV
Sbjct:   563 LVTYV 567

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 828 (296.5 bits), Expect = 4.6e-135, Sum P(2) = 4.6e-135
 Identities = 160/243 (65%), Positives = 200/243 (82%)

Query:   305 EINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGE 364
             +I+T +SL +DF TI  ATN FST NKLG+GGFGAVYKG+LS+G ++AVKRLSK S QG 
Sbjct:   329 DISTTDSLVYDFKTIEAATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRLSKKSGQGT 388

Query:   365 LEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWET 424
              EF+NE +LV +LQHRNLVRLLGF  E  E++LIYEFV N S+D F+FD  K+ QLDW  
Sbjct:   389 REFRNEAVLVTKLQHRNLVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEKQSQLDWTR 448

Query:   425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
             RYKIIGGIARGILYLH+DSRL+IIHRDLKASNILLDADM PKI+DFG+A +F ++Q+QG+
Sbjct:   449 RYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLATIFGVEQTQGN 508

Query:   485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS-FRIGEE--AEDLLT 541
             T+RI GT+ YM+PEY   G +S+KSD++SFGVLVLEIISG+KN+  +++ E   A +L+T
Sbjct:   509 TNRIAGTYAYMSPEYAMHGQYSMKSDIYSFGVLVLEIISGKKNSGVYQMDETSTAGNLVT 568

Query:   542 YVS 544
             Y S
Sbjct:   569 YAS 571

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IEP;RCA

GO:0009816 "defense response to bacterium, incompatible interaction" evidence=IEP

GO:0016020 "membrane" evidence=ISS

GO:0009611 "response to wounding" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)]

 Score = 870 (311.3 bits), Expect = 3.0e-129, Sum P(2) = 3.0e-129
 Identities = 168/244 (68%), Positives = 209/244 (85%)

Query:   304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
             + I+T +S++FDFS ++DAT++FS +NKLG+GGFGAVYKG LS GQ+IAVKRLSKN+ QG
Sbjct:   323 ENIST-DSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSKNAQQG 381

Query:   364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
             E EFKNE LLVA+LQHRNLV+LLG+S E TERLL+YEF+P++S+DKFIFD I+  +L+WE
Sbjct:   382 ETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNELEWE 441

Query:   424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS-Q 482
              RYKIIGG+ARG+LYLH+DSRLRIIHRDLKASNILLD +M PKI+DFGMARLF++D + Q
Sbjct:   442 IRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDIDHTTQ 501

Query:   483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY 542
               T+RIVGTFGYMAPEYV  G FS K+DV+SFGVLVLEIISG+KN+ F   +   DL+++
Sbjct:   502 RYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISGKKNSGFSSEDSMGDLISF 561

Query:   543 VSNN 546
                N
Sbjct:   562 AWRN 565

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 866 (309.9 bits), Expect = 1.5e-125, Sum P(2) = 1.5e-125
 Identities = 165/239 (69%), Positives = 202/239 (84%)

Query:   304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
             D+I T +SLQ D+ TI+ AT++F   NK+GQGGFG VYKG LS G E+AVKRLSK+S QG
Sbjct:   326 DDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQG 385

Query:   364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
             E+EFKNEV+LVA+LQHRNLVRLLGF  +  ER+L+YE+VPN S+D F+FD  K+ QLDW 
Sbjct:   386 EVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWT 445

Query:   424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
              RYKIIGG+ARGILYLH+DSRL IIHRDLKASNILLDADM PKI+DFGMAR+F +DQ++ 
Sbjct:   446 RRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEE 505

Query:   484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY 542
             +TSRIVGT+GYM+PEY   G +S+KSDV+SFGVLVLEIISG+KN+SF   + A DL++Y
Sbjct:   506 NTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSY 564

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2123126 CRK31 "cysteine-rich RLK (RECEPTOR-like protein kinase) 31" [Arabidopsis thaliana (taxid:3702)]

 Score = 823 (294.8 bits), Expect = 1.5e-123, Sum P(2) = 1.5e-123
 Identities = 157/241 (65%), Positives = 196/241 (81%)

Query:   304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
             D++ + +SLQFDF+TI  AT+NFS +NKLGQGGFG VYKG L +  EIAVKRLS NS QG
Sbjct:   317 DDMTSPQSLQFDFTTIEVATDNFSRNNKLGQGGFGEVYKGMLPNETEIAVKRLSSNSGQG 376

Query:   364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
               EFKNEV++VA+LQH+NLVRLLGF  E  E++L+YEFV N S+D F+FD   + QLDW+
Sbjct:   377 TQEFKNEVVIVAKLQHKNLVRLLGFCIERDEQILVYEFVSNKSLDYFLFDPKMKSQLDWK 436

Query:   424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
              RY IIGG+ RG+LYLH+DSRL IIHRD+KASNILLDADM PKI+DFGMAR F +DQ++ 
Sbjct:   437 RRYNIIGGVTRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRVDQTED 496

Query:   484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF-RIGEEAEDLLTY 542
              T R+VGTFGYM PEYVT G FS KSDV+SFGVL+LEI+ G+KN+SF ++ +   +L+T+
Sbjct:   497 QTGRVVGTFGYMPPEYVTHGQFSTKSDVYSFGVLILEIVCGKKNSSFFQMDDSGGNLVTH 556

Query:   543 V 543
             V
Sbjct:   557 V 557

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 864 (309.2 bits), Expect = 3.1e-123, Sum P(2) = 3.1e-123
 Identities = 164/239 (68%), Positives = 202/239 (84%)

Query:   304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
             D++ T +SLQ D+ TI+ ATN+F+  NK+G+GGFG VYKG  S+G+E+AVKRLSKNS QG
Sbjct:   331 DDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQG 390

Query:   364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
             E EFK EV++VA+LQHRNLVRLLGFS +  ER+L+YE++PN S+D  +FD  K+ QLDW 
Sbjct:   391 EAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWM 450

Query:   424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
              RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDAD+ PKI+DFGMAR+F +DQ+Q 
Sbjct:   451 QRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQD 510

Query:   484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY 542
             +TSRIVGT+GYMAPEY   G FS+KSDV+SFGVLVLEIISG+KN+SF   + A+DLLT+
Sbjct:   511 NTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLTH 569

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 815 (292.0 bits), Expect = 3.1e-123, Sum P(2) = 3.1e-123
 Identities = 158/240 (65%), Positives = 191/240 (79%)

Query:   304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
             D I + E+LQF FS I  ATN FS  NKLG GGFG VYKG+L  G+ +A+KRLS+ S QG
Sbjct:   325 DGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQG 384

Query:   364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
               EFKNEV +VA+LQHRNL +LLG+  +  E++L+YEFVPN S+D F+FD  KR  LDW+
Sbjct:   385 AEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQ 444

Query:   424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
              RYKII GIARGILYLH DSRL IIHRDLKASNILLDADM PKISDFGMAR+F +DQ+Q 
Sbjct:   445 RRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQA 504

Query:   484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
             +T RIVGT+GYM+PEY   G +S+KSDV+SFGVLVLE+I+G+KN+SF   +   DL+TYV
Sbjct:   505 NTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGDLVTYV 564

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2137144 CRK37 "cysteine-rich RLK (RECEPTOR-like protein kinase) 37" [Arabidopsis thaliana (taxid:3702)]

 Score = 819 (293.4 bits), Expect = 4.0e-123, Sum P(2) = 4.0e-123
 Identities = 161/259 (62%), Positives = 193/259 (74%)

Query:   280 LVALITCVFXXXXXXXXXXXXXXADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGA 339
             L+  +  +F               D  N    L+FD   I  ATNNFS +NKLGQGGFG+
Sbjct:   299 LIIFVVLIFSWKRKQSHTIINDVFDSNNGQSMLRFDLRMIVTATNNFSLENKLGQGGFGS 358

Query:   340 VYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399
             VYKG L  GQEIAVKRL K S QG +EFKNEVLL+ RLQHRNLV+LLGF  E+ E +L+Y
Sbjct:   359 VYKGILPSGQEIAVKRLRKGSGQGGMEFKNEVLLLTRLQHRNLVKLLGFCNEKDEEILVY 418

Query:   400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 459
             EFVPNSS+D FIFD  KR  L W+ RY II G+ARG+LYLHEDS+LRIIHRDLKASNILL
Sbjct:   419 EFVPNSSLDHFIFDEEKRRVLTWDVRYTIIEGVARGLLYLHEDSQLRIIHRDLKASNILL 478

Query:   460 DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVL 519
             DA+M PK++DFGMARLF+MD+++G TSR+VGT+GYMAPEY T G FS KSDV+SFGV++L
Sbjct:   479 DAEMNPKVADFGMARLFDMDETRGQTSRVVGTYGYMAPEYATYGQFSTKSDVYSFGVMLL 538

Query:   520 EIISGQKNNSFRIGEEAED 538
             E+ISG+ N      EE E+
Sbjct:   539 EMISGKSNKKLEKEEEEEE 557

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

TAIR|locus:2123056 CRK32 "cysteine-rich RLK (RECEPTOR-like protein kinase) 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 802 (287.4 bits), Expect = 1.7e-122, Sum P(2) = 1.7e-122
 Identities = 156/249 (62%), Positives = 197/249 (79%)

Query:   304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
             D++ + +SLQFDF T+  AT+ FS +NKLG+GGFG VYKG L +  E+AVKRLS NS QG
Sbjct:   299 DDMTSPQSLQFDFMTLEAATDKFSRNNKLGKGGFGEVYKGMLPNETEVAVKRLSSNSGQG 358

Query:   364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIF--------DAI 415
               EFKNEV++VA+LQH+NLVRLLGF  E  E++L+YEFVPN S++ F+F        D  
Sbjct:   359 TQEFKNEVVIVAKLQHKNLVRLLGFCLERDEQILVYEFVPNKSLNYFLFGNKQKHLLDPT 418

Query:   416 KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475
             K+ QLDW+ RY IIGGI RG+LYLH+DSRL IIHRD+KASNILLDADM PKI+DFGMAR 
Sbjct:   419 KKSQLDWKRRYNIIGGITRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARN 478

Query:   476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF-RIGE 534
             F +DQ++ +T R+VGTFGYM PEYVT G FS KSDV+SFGVL+LEI+ G+KN+SF +I +
Sbjct:   479 FRVDQTEDNTRRVVGTFGYMPPEYVTHGQFSTKSDVYSFGVLILEIVCGKKNSSFYKIDD 538

Query:   535 EAEDLLTYV 543
                +L+T+V
Sbjct:   539 SGGNLVTHV 547

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8H199	CRK14_ARATH	2, ., 7, ., 1, 1, ., -	0.5175	0.9600	0.8039	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.XI.1918.1 hypothetical protein (598 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	551
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-50
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-50
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-47
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-46
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-46
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-34
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-32
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-30
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-30
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-29
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-29
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-29
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-29
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	9e-29
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-28
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-28
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-28
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-28
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-28
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-27
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-27
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-27
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-27
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-27
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-26
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-26
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	3e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-25
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-25
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-25
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-24
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-24
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-24
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-24
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-24
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-24
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-24
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-23
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-23
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-23
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-23
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-22
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-22
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-22
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-21
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-21
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-21
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-21
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-21
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-21
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-21
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-20
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-20
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-20
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-20
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-20
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-20
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-19
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-19
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-18
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-18
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-18
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-18
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-18
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-17
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-17
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-17
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-17
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-17
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-17
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-16
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-16
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	9e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-15
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-15
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	9e-15
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-14
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-14
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-13
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-13
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-13
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-13
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-13
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-11
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	9e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-09
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-04
pfam01636	238	pfam01636, APH, Phosphotransferase enzyme family	0.001
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.001
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.001
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  172 bits (438), Expect = 5e-50
 Identities = 74/208 (35%), Positives = 111/208 (53%), Gaps = 19/208 (9%)

Query: 329 DNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNL 382
             KLG+G FG VYKG+L         E+AVK L +++ + ++ EF  E  ++ +L H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           V+LLG   EE    ++ E++    +  ++     R +L           IARG+ YL   
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLE-- 119

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT---FGYMAPEY 499
                IHRDL A N L+  +++ KISDFG++R    D    D  R  G      +MAPE 
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPES 174

Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
           +  G F+ KSDV+SFGVL+ EI + G++
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQ 202

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  170 bits (433), Expect = 7e-50
 Identities = 71/194 (36%), Positives = 110/194 (56%), Gaps = 11/194 (5%)

Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFS 389
           LG+GGFG VY  R    G+++A+K + K      LE    E+ ++ +L H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            +E    L+ E+    S+   + +     +L  +   +I+  I  G+ YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 450 RDLKASNILLDAD-MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE-YVTRGHFSI 507
           RDLK  NILLD+D    K++DFG+++L   D+S      IVGT  YMAPE  + +G++S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 508 KSDVFSFGVLVLEI 521
           KSD++S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  170 bits (432), Expect = 5e-49
 Identities = 74/204 (36%), Positives = 108/204 (52%), Gaps = 17/204 (8%)

Query: 329 DNKLGQGGFGAVYKGRLS-----HGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNL 382
             KLG+G FG VYKG L         E+AVK L ++ S Q   EF  E  ++ +L H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           V+LLG   EE   +++ E++P   +  ++    +  +L           IARG+ YL   
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLE-- 120

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT---FGYMAPEY 499
                IHRDL A N L+  +++ KISDFG++R    D    D  ++ G      +MAPE 
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPES 175

Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS 523
           +  G F+ KSDV+SFGVL+ EI +
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  164 bits (417), Expect = 7e-47
 Identities = 65/203 (32%), Positives = 105/203 (51%), Gaps = 13/203 (6%)

Query: 326 FSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLV 383
           +    KLG+G FG VY  R    G+ +A+K + K  ++ + E    E+ ++ +L+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLD-WETRYKIIGGIARGILYLHED 442
           RL     +E +  L+ E+     +   +    KR +L   E R+  +  I   + YLH  
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARF-YLRQILSALEYLHS- 115

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
               I+HRDLK  NILLD D   K++DFG+AR           +  VGT  YMAPE +  
Sbjct: 116 --KGIVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLG 170

Query: 503 GHFSIKSDVFSFGVLVLEIISGQ 525
             +    D++S GV++ E+++G+
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  163 bits (416), Expect = 1e-46
 Identities = 69/201 (34%), Positives = 109/201 (54%), Gaps = 13/201 (6%)

Query: 331 KLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVR 384
           KLG+G FG VYKG L         ++AVK L + + + E  EF  E  ++ +L H N+VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           LLG   +     ++ E++P   +  F+       +L  +   ++   IA+G+ YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLRK--HGEKLTLKDLLQMALQIAKGMEYLES--- 120

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
              +HRDL A N L+  +++ KISDFG++R ++E D  +      +    +MAPE +  G
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK-WMAPESLKDG 179

Query: 504 HFSIKSDVFSFGVLVLEIISG 524
            F+ KSDV+SFGVL+ EI + 
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  163 bits (415), Expect = 1e-46
 Identities = 71/200 (35%), Positives = 106/200 (53%), Gaps = 14/200 (7%)

Query: 331 KLGQGGFGAVYKGRLSH-GQEIAVKRLSK--NSVQGELEFKNEVLLVARLQHRNLVRLLG 387
           KLG G FG VYK +    G+ +AVK L K     + +   + E+ ++ RL H N+VRL+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
              ++    L+ E+     +  ++    +   L  +   KI   I RG+ YLH      I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NGI 119

Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH--F 505
           IHRDLK  NILLD + + KI+DFG+A+      S    +  VGT  YMAPE V  G   +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPE-VLLGGNGY 176

Query: 506 SIKSDVFSFGVLVLEIISGQ 525
             K DV+S GV++ E+++G+
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  163 bits (414), Expect = 2e-46
 Identities = 71/207 (34%), Positives = 111/207 (53%), Gaps = 18/207 (8%)

Query: 330 NKLGQGGFGAVYKGRLSHGQ----EIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVR 384
            KLG+G FG VYKG+L        E+AVK L +++ + E  +F  E  ++ +L H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKIIGGIARGILY 438
           LLG   EE    L+ E++    +  ++      F + ++  L  +        IA+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMA 496
           L      + +HRDL A N L+  D++ KISDFG++R  ++        +  G     +MA
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR--DVYDDDYYRKKTGGKLPIRWMA 175

Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           PE +  G F+ KSDV+SFGVL+ EI +
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  139 bits (352), Expect = 1e-37
 Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 17/204 (8%)

Query: 330 NKLGQGGFGAVYKGRLSH-GQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRNLVRLL 386
             LG+G FG+VY       G+ +AVK   LS +S +     + E+ +++ LQH N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 387 GFSFEETER-LLIY-EFVPNSSVDKFIFDAIKRVQLDWET---RYKIIGGIARGILYLHE 441
           G   +E +  L I+ E+V   S    +   +K+     E    +Y     I  G+ YLH 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGS----LSSLLKKFGKLPEPVIRKY--TRQILEGLAYLH- 118

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
                I+HRD+K +NIL+D+D + K++DFG A+     ++   T  + GT  +MAPE + 
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 502 RGHFSIKSDVFSFGVLVLEIISGQ 525
              +   +D++S G  V+E+ +G+
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  129 bits (326), Expect = 5e-34
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 19/206 (9%)

Query: 326 FSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           F    K+G+GGFG VYK R    G+E+A+K +   S + + +  NE+ ++ + +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGIL----YL 439
             G   ++ E  ++ EF    S+     D +K   Q   E+    I  + + +L    YL
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLK----DLLKSTNQTLTES---QIAYVCKELLKGLEYL 114

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
           H      IIHRD+KA+NILL +D   K+ DFG++            + +VGT  +MAPE 
Sbjct: 115 HS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS---DTKARNTMVGTPYWMAPEV 168

Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +    +  K+D++S G+  +E+  G+
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  127 bits (320), Expect = 3e-33
 Identities = 70/217 (32%), Positives = 113/217 (52%), Gaps = 7/217 (3%)

Query: 326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           F+ + KLG G FG V++G   +   +A+K L  + +  + +F+ EV  + RL+H++L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
                      +I E +   S+  F+     +V L   +   +   +A G+ YL E    
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ--- 123

Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
             IHRDL A NIL+  D++ K++DFG+ARL + D       +I   + + APE  + G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181

Query: 506 SIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLT 541
           S KSDV+SFG+L+ E+ + GQ         E  D +T
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  124 bits (313), Expect = 3e-32
 Identities = 65/206 (31%), Positives = 110/206 (53%), Gaps = 15/206 (7%)

Query: 325 NFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGE--LEFKNEVLLVARLQHRN 381
           N+   + +G+G FG VYKG  L  G  +A+K++S   ++ E       E+ L+  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFI--FDAIKRVQLDWETRYKIIGGIARGILYL 439
           +V+ +G         +I E+  N S+ + I  F       +     Y  +  + +G+ YL
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV---AVY--VYQVLQGLAYL 115

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
           HE     +IHRD+KA+NIL   D + K++DFG+A   +++    D + +VGT  +MAPE 
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVAT--KLNDVSKDDASVVGTPYWMAPEV 170

Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +     S  SD++S G  V+E+++G 
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  120 bits (303), Expect = 1e-30
 Identities = 66/211 (31%), Positives = 109/211 (51%), Gaps = 17/211 (8%)

Query: 330 NKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLV 383
            +LG+G FG V   R      + G+++AVK L+ +  +    +F+ E+ ++  L H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 384 RLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           +  G   +   R   LI E++P+ S+  ++     R Q++ +        I +G+ YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS--QGDTSRIVGTFGYMAPEY 499
               R IHRDL A NIL++++ + KISDFG+A++   D+             F Y APE 
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183

Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS 529
           +    FS  SDV+SFGV + E+ + G  + S
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  118 bits (298), Expect = 3e-30
 Identities = 69/217 (31%), Positives = 110/217 (50%), Gaps = 17/217 (7%)

Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391
           +G+G FG V  G    GQ++AVK L K+       F  E  ++  L+H NLV+LLG   +
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 392 ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRD 451
                ++ E++   S+  ++  +  R  +    +      +  G+ YL E      +HRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127

Query: 452 LKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTRGHFSIKS 509
           L A N+L+  D++ K+SDFG+A+    + SQG  S   G     + APE +    FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK----EASQGQDS---GKLPVKWTAPEALREKKFSTKS 180

Query: 510 DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNN 546
           DV+SFG+L+ EI S  +    RI    +D++ +V   
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIP--LKDVVPHVEKG 215

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  118 bits (297), Expect = 7e-30
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 29/214 (13%)

Query: 332 LGQGGFGAVYKGRLSHGQE------IAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVR 384
           LG+G FG V+ G   H +       +AVK L + +      +F+ E  L+   QH N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIF----DAI-------KRVQLDWETRYKIIGGIA 433
             G   E    ++++E++ +  ++KF+     DA           +L      +I   IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT-- 491
            G++YL   +    +HRDL   N L+  D++ KI DFGM+R    D    D  R+ G   
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185

Query: 492 --FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               +M PE +    F+ +SDV+SFGV++ EI +
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 1e-29
 Identities = 71/208 (34%), Positives = 102/208 (49%), Gaps = 22/208 (10%)

Query: 330 NKLGQGGFGAVYKG--RLSHGQEI--AVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVR 384
            +LG G FG+V KG   +  G+E+  AVK L +     G+ EF  E  ++A+L H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFD--AIKRVQL-DWETRYKIIGGIARGILYLHE 441
           L+G    E   +L+ E  P   + K++     I    L +   +      +A G+ YL  
Sbjct: 61  LIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEY 499
                 +HRDL A N+LL      KISDFGM+R      S    +   G +   + APE 
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG-SDYYRATTAGRWPLKWYAPEC 169

Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
           +  G FS KSDV+S+GV + E  S G K
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAK 197

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 2e-29
 Identities = 69/203 (33%), Positives = 106/203 (52%), Gaps = 12/203 (5%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
            +   + KLG G FG V+ G  +   ++AVK L   ++  E  F  E  ++ +L+H  LV
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLV 64

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +L     EE    ++ E++   S+  F+     + +L       +   IA G+ YL    
Sbjct: 65  QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYLE--- 120

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ---SQGDTSRIVGTFGYMAPEYV 500
               IHRDL A NIL+  +++ KI+DFG+ARL E D+    +G    I  T    APE  
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAA 176

Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
             G F+IKSDV+SFG+L+ EI++
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 2e-29
 Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 16/200 (8%)

Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLG 387
           LG+G FG V   R    G+  A+K L K  +   +       E  +++R+ H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRL 445
           ++F+  E+L L+ E+ P   +   +    K  +   E R +     I   + YLH    L
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLS---KEGRFS-EERARFYAAEIVLALEYLH---SL 112

Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
            II+RDLK  NILLDAD   K++DFG+A+    + S+ +T    GT  Y+APE +    +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGY 170

Query: 506 SIKSDVFSFGVLVLEIISGQ 525
               D +S GVL+ E+++G+
Sbjct: 171 GKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  114 bits (289), Expect = 8e-29
 Identities = 60/203 (29%), Positives = 107/203 (52%), Gaps = 21/203 (10%)

Query: 331 KLGQGGFGAVYKGRLSH---GQEIAVKRL-SKNSVQGELEFKNEVLLVARLQHRNLVRLL 386
            LGQG  G VYK R  H   G+  A+K++      +   +   E+  +   +   +V+  
Sbjct: 8   VLGQGSSGVVYKVR--HKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65

Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL----YLHED 442
           G  ++E E  ++ E++   S+     D +K+V    E    ++  IAR IL    YLH  
Sbjct: 66  GAFYKEGEISIVLEYMDGGSLA----DLLKKVGKIPE---PVLAYIARQILKGLDYLH-- 116

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
           ++  IIHRD+K SN+L+++    KI+DFG++++  ++ +    +  VGT  YM+PE +  
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGTVTYMSPERIQG 174

Query: 503 GHFSIKSDVFSFGVLVLEIISGQ 525
             +S  +D++S G+ +LE   G+
Sbjct: 175 ESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  114 bits (288), Expect = 8e-29
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 23/208 (11%)

Query: 330 NKLGQGGFGAVYKGRLSHGQEI-AVKRLS-KNSVQGELEF-KNEVLLVARLQHRNLVRLL 386
            ++G+G FG VY  R     ++  +K +   N  + E E   NEV ++ +L H N+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 387 GFSFEETERLLI-YEFVPNSSVDKFIFDAIKRVQ-------LDWETRYKIIGGIARGILY 438
             SFEE  +L I  E+     + + I    K  +       LDW  +      +   + Y
Sbjct: 66  E-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKY 118

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           LH     +I+HRD+K  NI L ++ + K+ DFG++++         T  +VGT  Y++PE
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPE 173

Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQK 526
                 ++ KSD++S G ++ E+ + + 
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  114 bits (288), Expect = 8e-29
 Identities = 64/211 (30%), Positives = 116/211 (54%), Gaps = 15/211 (7%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGE-LEFKNEVLLVARLQ 378
           +  + +  +G G FG V +GRL    +    +A+K L   S   + L+F  E  ++ +  
Sbjct: 4   SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63

Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++RL G   +    ++I E++ N S+DKF+ +     +        ++ GIA G+ Y
Sbjct: 64  HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKY 121

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS--RIVGTFGYMA 496
           L   S +  +HRDL A NIL++++++ K+SDFG++R  E  ++   T   +I     + A
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTA 176

Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
           PE +    F+  SDV+SFG+++ E++S G++
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score =  109 bits (275), Expect = 9e-29
 Identities = 45/102 (44%), Positives = 57/102 (55%), Gaps = 6/102 (5%)

Query: 16  DTGNFTT-NSTYGKNRDLFLSSLAS--TVTANKGFYTATIGQIPDEVYGLALCRGDSSPE 72
            +GN+TT NST+  N +  LSSL+S    ++ KGF   T G  PD VYGLA CRGD S  
Sbjct: 8   TSGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSAS 67

Query: 73  SCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSF 114
            C SCL   V ++ + CPN+K    W      C +RY S  F
Sbjct: 68  DCRSCLATAVSELRRCCPNKKGGRIWYD---SCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  114 bits (288), Expect = 1e-28
 Identities = 72/212 (33%), Positives = 104/212 (49%), Gaps = 25/212 (11%)

Query: 330 NKLGQGGFGAVYKGRLSHG------QEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNL 382
             LG G FG VY+G            ++AVK L ++ S Q E +F  E L++++  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV----QLDWETRYKIIGGIARGILY 438
           VRL+G SFE   R ++ E +    +  F+ +   R      L  +        +A+G  Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 439 LHEDSRLRIIHRDLKASNILLD---ADMIPKISDFGMARLFEMDQSQGDTSRIVGT---- 491
           L E+     IHRD+ A N LL       + KI+DFGMAR    D  +    R  G     
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAMLP 184

Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             +M PE    G F+ K+DV+SFGVL+ EI S
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 2e-28
 Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 21/206 (10%)

Query: 332 LGQGGFGAVYKGR-LSHGQ----EIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRL 385
           LG G FG VYKG  +  G+     +A+K L + +  +   E  +E  ++A + H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIARGILYLHE 441
           LG         LI + +P   +  ++ +    +     L+W  +      IA+G+ YL E
Sbjct: 75  LGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               R++HRDL A N+L+      KI+DFG+A+L ++D+ +           +MA E + 
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 502 RGHFSIKSDVFSFGVLVLEIIS-GQK 526
              ++ KSDV+S+GV V E+++ G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  115 bits (289), Expect = 3e-28
 Identities = 70/213 (32%), Positives = 106/213 (49%), Gaps = 17/213 (7%)

Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE---FKNEVLLVARLQH-R 380
           ++    KLG+G FG VY  R    + +A+K L+K       E   F  E+ ++A L H  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           N+V+L  F  +E    L+ E+V   S++  +    ++  L       I+  I   + YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 441 EDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMDQS----QGDTSRIVGTFGYM 495
                 IIHRD+K  NILLD D  + K+ DFG+A+L     S        S  VGT GYM
Sbjct: 119 S---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 496 APEYVT---RGHFSIKSDVFSFGVLVLEIISGQ 525
           APE +      + S  SD++S G+ + E+++G 
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208

Length = 384

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  112 bits (283), Expect = 4e-28
 Identities = 68/207 (32%), Positives = 113/207 (54%), Gaps = 28/207 (13%)

Query: 332 LGQGGFGAVYKG-RLSHGQEIAVK--------RLSKNSVQGELEFKNEVLLVARLQHRNL 382
           LG G FG+VY+G  L  G   AVK        +  + +V+ +LE   E+ L+++LQH N+
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK-QLE--QEIALLSKLQHPNI 64

Query: 383 VRLLGFSFEETERLLIY-EFVPNSSVDKFI--FDAIKRVQLDWETRYKIIGGIARGILYL 439
           V+ LG   EE + L I+ E VP  S+ K +  + +     +   TR +I+ G+     YL
Sbjct: 65  VQYLGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----YL 118

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
           H+      +HRD+K +NIL+D + + K++DFGMA+               G+  +MAPE 
Sbjct: 119 HDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV---EFSFAKSFKGSPYWMAPEV 172

Query: 500 VTR-GHFSIKSDVFSFGVLVLEIISGQ 525
           + + G + + +D++S G  VLE+ +G+
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  113 bits (284), Expect = 4e-28
 Identities = 72/216 (33%), Positives = 105/216 (48%), Gaps = 31/216 (14%)

Query: 332 LGQGGFGAVYKGRL------SHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVR 384
           LG+G FG VYKG L           +A+K L +N   + + EF+ E  L++ LQH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 385 LLGFSFEETERLLIYEFV-------------PNSSVDKFIFDAIKRVQLDWETRYKIIGG 431
           LLG   +E    +++E++             P+S V     D   +  LD      I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
           IA G+ YL   S    +HRDL A N L+   +  KISDFG++R    D    D  R+   
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR----DIYSADYYRVQSK 185

Query: 492 ----FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                 +M PE +  G F+ +SD++SFGV++ EI S
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  112 bits (282), Expect = 5e-28
 Identities = 71/195 (36%), Positives = 110/195 (56%), Gaps = 11/195 (5%)

Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLG G FG V+ G  +   ++A+K L + S+  E  F  E  L+ +LQH  LVRL     
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           +E    +I E++ N S+  F+    + ++L       +   IA G+ ++    R   IHR
Sbjct: 72  QEP-IYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHR 126

Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTRGHFSIK 508
           DL+A+NIL+   +  KI+DFG+ARL E ++    T+R    F   + APE +  G F+IK
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ EI++
Sbjct: 184 SDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  111 bits (278), Expect = 1e-27
 Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 13/196 (6%)

Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           ++G G FG V+ G     +++A+K + + ++  E +F  E  ++ +L H  LV+L G   
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE-DFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           E +   L++EF+ +  +  ++    +R +   ET   +   +  G+ YL   +   +IHR
Sbjct: 70  ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT---FGYMAPEYVTRGHFSI 507
           DL A N L+  + + K+SDFGM R    DQ    T    GT     + +PE  +   +S 
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180

Query: 508 KSDVFSFGVLVLEIIS 523
           KSDV+SFGVL+ E+ S
Sbjct: 181 KSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  110 bits (276), Expect = 3e-27
 Identities = 74/198 (37%), Positives = 110/198 (55%), Gaps = 16/198 (8%)

Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           KLG G FG V+ G  ++  ++AVK L     SVQ  LE  N   L+  LQH  LVRL   
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEAN---LMKTLQHDKLVRLYAV 69

Query: 389 SFEETERLLIYEFVPNSSVDKFI-FDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             +E    +I E++   S+  F+  D   +V L     +     IA G+ Y+    R   
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFS--AQIAEGMAYIE---RKNY 124

Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTRGHF 505
           IHRDL+A+N+L+   ++ KI+DFG+AR+ E ++    T+R    F   + APE +  G F
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSF 181

Query: 506 SIKSDVFSFGVLVLEIIS 523
           +IKSDV+SFG+L+ EI++
Sbjct: 182 TIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  110 bits (276), Expect = 3e-27
 Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 20/208 (9%)

Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRL---SKNSVQGELEFKN---EVLLVARLQHRNLV 383
             LG+G +G VY G  + GQ IAVK++   + N +  E E++    EV L+  L+H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFI--FDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           + LG   ++    +  EFVP  S+   +  F  +        T+      I  G+ YLH 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ-----ILDGVAYLHN 120

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV----GTFGYMAP 497
           +    ++HRD+K +N++L  + I K+ DFG AR        G  S ++    GT  +MAP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +    +  KSD++S G  V E+ +G+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  109 bits (276), Expect = 5e-27
 Identities = 65/227 (28%), Positives = 108/227 (47%), Gaps = 33/227 (14%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSK---NSVQGELEFKNEVLLVARL-Q 378
           ++F     +G+G F  V   +     +E A+K L K      +     K E  ++ RL  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWE-TRYKIIGGIARGI 436
           H  +++L  ++F++ E L  + E+ PN  + ++I    K   LD + TR+     I   +
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRF-YAAEILLAL 115

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF-------------EMDQSQG 483
            YLH      IIHRDLK  NILLD DM  KI+DFG A++                  SQ 
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 484 DTSRI-----VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           + +R      VGT  Y++PE +        SD+++ G ++ ++++G+
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  109 bits (274), Expect = 7e-27
 Identities = 59/203 (29%), Positives = 106/203 (52%), Gaps = 16/203 (7%)

Query: 326 FSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLV 383
           F    KLG+G +G+VYK      GQ +A+K +    V+ +L E   E+ ++ +     +V
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQEIIKEISILKQCDSPYIV 61

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ--LDWETRYKIIGGIARGILYLHE 441
           +  G  F+ T+  ++ E+    SV     D +K     L  E    I+    +G+ YLH 
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVS----DIMKITNKTLTEEEIAAILYQTLKGLEYLH- 116

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               + IHRD+KA NILL+ +   K++DFG++   ++  +    + ++GT  +MAPE + 
Sbjct: 117 --SNKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQ 172

Query: 502 RGHFSIKSDVFSFGVLVLEIISG 524
              ++ K+D++S G+  +E+  G
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEG 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  108 bits (271), Expect = 1e-26
 Identities = 67/195 (34%), Positives = 108/195 (55%), Gaps = 11/195 (5%)

Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLG G FG V+ G  +   ++AVK L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++   S+  F+ D   R  L       +   +A G+ Y+    R+  IHR
Sbjct: 72  EEP-IYIVTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126

Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTRGHFSIK 508
           DL+++NIL+   ++ KI+DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+++
Sbjct: 184 SDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  108 bits (271), Expect = 1e-26
 Identities = 65/197 (32%), Positives = 108/197 (54%), Gaps = 15/197 (7%)

Query: 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NLV+LLG 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70

Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
              E    +I EF+   ++  ++ +   R +++      +   I+  + YL + +    I
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FI 126

Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD--TSRIVGTF--GYMAPEYVTRGH 504
           HRDL A N L+  + + K++DFG++RL       GD  T+     F   + APE +    
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPESLAYNK 181

Query: 505 FSIKSDVFSFGVLVLEI 521
           FSIKSDV++FGVL+ EI
Sbjct: 182 FSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 2e-26
 Identities = 61/195 (31%), Positives = 102/195 (52%), Gaps = 10/195 (5%)

Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLG G FG V++G  ++   +AVK L   ++  + +F  E  ++ +L+H  L++L     
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
            E    ++ E +   S+ +++     R  L       +   +A G+ YL   +    IHR
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127

Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTRGHFSIK 508
           DL A N+L+  + I K++DFG+AR+ + D      +R    F   + APE      FSIK
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIY---EAREGAKFPIKWTAPEAALYNRFSIK 184

Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ EI++
Sbjct: 185 SDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score =  102 bits (256), Expect = 3e-26
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 2/101 (1%)

Query: 128 NVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPDIS 187
              N T++ + F+    +L+  + + A+  + K  FA    +  + +T+Y L QC  D+S
Sbjct: 8   TSGNYTTANSTFESNLNALLSSLSSNAASSSGKG-FAAG-TSGAAPDTVYGLAQCRGDLS 65

Query: 188 QSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPF 228
            SDC  CL  ++++++ CC  KKG  I   SC  R+E YPF
Sbjct: 66  ASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 5e-26
 Identities = 63/197 (31%), Positives = 101/197 (51%), Gaps = 10/197 (5%)

Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFS 389
           K+G+G FG VYKG L    E+AVK             F  E  ++ +  H N+V+L+G  
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            ++    ++ E VP  S+  F+    K+ +L  +   ++    A G+ YL  +S+   IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRK--KKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116

Query: 450 RDLKASNILLDADMIPKISDFGMARLFE--MDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
           RDL A N L+  + + KISDFGM+R  E  +        +I     + APE +  G ++ 
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTS 174

Query: 508 KSDVFSFGVLVLEIISG 524
           +SDV+S+G+L+ E  S 
Sbjct: 175 ESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  106 bits (268), Expect = 9e-26
 Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 19/211 (9%)

Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQH 379
           D    +    K+G+G  G VYK      G+E+A+K++     Q +    NE+L++   +H
Sbjct: 16  DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKH 74

Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSS----VDKFIFDAIKRVQLDWETRYKIIGGIAR 434
            N+V     S+   + L ++ E++   S    + +     +   Q+ +     +   + +
Sbjct: 75  PNIVDYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAY-----VCREVLQ 127

Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           G+ YLH      +IHRD+K+ NILL  D   K++DFG A     ++S+ ++  +VGT  +
Sbjct: 128 GLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYW 182

Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           MAPE + R  +  K D++S G++ +E+  G+
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  105 bits (265), Expect = 1e-25
 Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 26/206 (12%)

Query: 330 NKLGQGGFGAVYKGRLSH---GQEIAVKRL---SKNSVQGELEFKNEVLLVARLQHRNLV 383
            +LG G  G V K    H   G+ +AVK +      ++Q ++  + ++L   +     +V
Sbjct: 7   GELGAGNSGVVSKVL--HRPTGKIMAVKTIRLEINEAIQKQILRELDILH--KCNSPYIV 62

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL----YL 439
              G  +   +  +  E++   S+DK + +   R+         I+G IA  +L    YL
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPER------ILGKIAVAVLKGLTYL 116

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
           HE    +IIHRD+K SNIL+++    K+ DFG++   ++  S   T   VGT  YMAPE 
Sbjct: 117 HEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSG--QLVNSLAKTF--VGTSSYMAPER 170

Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +    +S+KSD++S G+ ++E+ +G+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  105 bits (263), Expect = 2e-25
 Identities = 74/216 (34%), Positives = 113/216 (52%), Gaps = 27/216 (12%)

Query: 332 LGQGGFGAVYKGRL-------SHGQEIAVKRLSKNSVQGE-LEFKNEVLLVARLQHRNLV 383
           LG G FG VY+G         S    +AVK L K +   E  EF  E  L++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ------LDWETRYKIIGGIARGIL 437
           +LLG       + +I E +    +  ++ DA  RV+      L  +    I   +A+G +
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDA--RVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 438 YLHEDSRLRIIHRDLKASNILL-----DADMIPKISDFGMAR-LFEMDQSQGDTSRIVGT 491
           YL    ++  IHRDL A N L+     DAD + KI DFG+AR +++ D  + +   ++  
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL-P 176

Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
             +MAPE +  G F+ +SDV+SFGVL+ EI++ GQ+
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 8e-25
 Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 13/198 (6%)

Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391
           LG G FG V+ G+     ++A+K + +     E +F  E  ++ +L H NLV+L G   +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 392 ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRD 451
           +    ++ E++ N  +  ++ +   ++  +W     +   +   + YL  +     IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 452 LKASNILLDADMIPKISDFGMARLFEMDQ---SQGDTSRIVGTFGYMAPEYVTRGHFSIK 508
           L A N L+  D + K+SDFG+AR    DQ   SQG    +     +  PE      FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV----KWAPPEVFDYSRFSSK 181

Query: 509 SDVFSFGVLVLEIISGQK 526
           SDV+SFGVL+ E+ S  K
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  103 bits (258), Expect = 8e-25
 Identities = 70/201 (34%), Positives = 112/201 (55%), Gaps = 19/201 (9%)

Query: 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           + KLG G FG V+    +   ++AVK +   S+  E  F  E  ++  LQH  LV+L   
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAV 69

Query: 389 SFEETERLLIYEFVPNSSVDKFI-FDAIKRVQLDWETRYKII---GGIARGILYLHEDSR 444
             +E    +I EF+   S+  F+  D   +  L      K+I     IA G+ ++ + + 
Sbjct: 70  VTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLP-----KLIDFSAQIAEGMAFIEQRN- 122

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTR 502
              IHRDL+A+NIL+ A ++ KI+DFG+AR+ E ++    T+R    F   + APE +  
Sbjct: 123 --YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINF 177

Query: 503 GHFSIKSDVFSFGVLVLEIIS 523
           G F+IKSDV+SFG+L++EI++
Sbjct: 178 GSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  103 bits (257), Expect = 1e-24
 Identities = 69/197 (35%), Positives = 110/197 (55%), Gaps = 11/197 (5%)

Query: 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           D KLGQG FG V+ G  +   ++A+K L   ++  E  F  E  ++ +L+H  LV L   
Sbjct: 11  DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYAV 69

Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
             EE    ++ EF+   S+  F+ +   +  L       +   IA G+ Y+    R+  I
Sbjct: 70  VSEEP-IYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAYIE---RMNYI 124

Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTRGHFS 506
           HRDL+A+NIL+  +++ KI+DFG+ARL E ++    T+R    F   + APE    G F+
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFT 181

Query: 507 IKSDVFSFGVLVLEIIS 523
           IKSDV+SFG+L+ E+++
Sbjct: 182 IKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  102 bits (256), Expect = 1e-24
 Identities = 67/197 (34%), Positives = 108/197 (54%), Gaps = 21/197 (10%)

Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
            +G+G FGAV +G  + GQ++AVK + K  V  +  F  E  ++ +L H+NLVRLLG   
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNI-KCDVTAQ-AFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 391 EETERLLIYEFVPNSSVDKFIFD----AIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
                 ++ E +   ++  F+       +  +QL    ++ +   +A G+ YL      +
Sbjct: 70  HNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQL---LQFSL--DVAEGMEYLESK---K 120

Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
           ++HRDL A NIL+  D + K+SDFG+AR+  M     D S++     + APE +    FS
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSM---GVDNSKL--PVKWTAPEALKHKKFS 175

Query: 507 IKSDVFSFGVLVLEIIS 523
            KSDV+S+GVL+ E+ S
Sbjct: 176 SKSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 1e-24
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 31/221 (14%)

Query: 324 NNFSTDNKLGQGGFGAVYKG---RLSHGQ---EIAVKRLSKNSVQGE-LEFKNEVLLVAR 376
              +   +LGQG FG VY+G    +  G+    +A+K +++N+   E +EF NE  ++  
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65

Query: 377 LQHRNLVRLLGFSFEETERLLIYEFV-------------PNSSVDKFIFDAIKRVQLDWE 423
               ++VRLLG        L++ E +             P +  +          +    
Sbjct: 66  FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPG-LGPPTLQKF--- 121

Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQ 482
              ++   IA G+ YL      + +HRDL A N ++  D+  KI DFGM R ++E D  +
Sbjct: 122 --IQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176

Query: 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                ++    +MAPE +  G F+ KSDV+SFGV++ E+ +
Sbjct: 177 KGGKGLL-PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  102 bits (256), Expect = 2e-24
 Identities = 76/230 (33%), Positives = 120/230 (52%), Gaps = 34/230 (14%)

Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELE---------FKNEVLLVARLQHRN 381
           +G G FG+VY G   S G+ +AVK++   SV    +            E+ L+  LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFI--FDAIKRVQLDWETRYK-IIGGIARGILY 438
           +V+ LG S +     +  E+VP  SV   +  + A +      ET  +  +  I +G+ Y
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE------ETLVRNFVRQILKGLNY 121

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR----IVGTFGY 494
           LH  +R  IIHRD+K +NIL+D     KISDFG+++  E +     T+     + G+  +
Sbjct: 122 LH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISG--------QKNNSFRIGEEA 536
           MAPE V +  ++ K+D++S G LV+E+++G        Q    F+IGE A
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  102 bits (255), Expect = 2e-24
 Identities = 65/195 (33%), Positives = 108/195 (55%), Gaps = 11/195 (5%)

Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++   S+  F+   + +  L       +   IA G+ Y+    R+  +HR
Sbjct: 72  EEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 126

Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 184 SDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  102 bits (257), Expect = 2e-24
 Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 33/210 (15%)

Query: 332 LGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLL 386
           LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 387 GFSFEETER--LLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKIIGGIARGILY 438
           G  +    R   L+ E++P  S+  ++       D  K +    +        I +G+ Y
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ-----SQGDTSRIVGTFG 493
           L      R +HRDL   NIL++++   KI DFG+ ++   D+      +   S I   F 
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI---FW 177

Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           Y APE +T   FS+ SDV+SFGV++ E+ +
Sbjct: 178 Y-APESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  101 bits (253), Expect = 5e-24
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 33/215 (15%)

Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKR--LSKNSVQGELE--------FKNEVLLVARLQHR 380
           +G+G +G VY    ++ G+ +AVK+  L                   ++E+  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVD-------KFIFDAIKRVQLDWETRYKIIGGIA 433
           N+V+ LGF   E    +  E+VP  S+        +F    ++       T  +++ G+A
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFF-----TE-QVLEGLA 122

Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
               YLH      I+HRDLKA N+L+DAD I KISDFG+++  +          + G+  
Sbjct: 123 ----YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF 175

Query: 494 YMAPEYVTRGH--FSIKSDVFSFGVLVLEIISGQK 526
           +MAPE +      +S K D++S G +VLE+ +G++
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  101 bits (253), Expect = 5e-24
 Identities = 68/218 (31%), Positives = 112/218 (51%), Gaps = 33/218 (15%)

Query: 331 KLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRNL 382
           +LG+  FG VYKG L         Q +A+K L K+  +G L  EFK+E ++ +RLQH N+
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIF-------------DAIKRVQLDWETRYKII 429
           V LLG   +E    +I+ +  +S + +F+              D   +  L+      I+
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
             IA G+ +L   S   ++H+DL   N+L+   +  KISD G+ R    +    D  +++
Sbjct: 131 TQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR----EVYAADYYKLM 183

Query: 490 GT----FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           G       +M+PE +  G FSI SD++S+GV++ E+ S
Sbjct: 184 GNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  101 bits (253), Expect = 7e-24
 Identities = 67/202 (33%), Positives = 116/202 (57%), Gaps = 20/202 (9%)

Query: 332 LGQGGFGAVYKG-RLSHGQEI----AVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRL 385
           LG G FG VYKG  +  G+ +    A+K L++ +  +  +EF +E L++A + H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIF---DAI-KRVQLDWETRYKIIGGIARGILYLHE 441
           LG     T +L + + +P+  +  ++    D I  ++ L+W  +      IA+G++YL E
Sbjct: 75  LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               R++HRDL A N+L+ +    KI+DFG+ARL E D+ + +         +MA E + 
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
              F+ +SDV+S+GV + E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  100 bits (250), Expect = 9e-24
 Identities = 67/205 (32%), Positives = 109/205 (53%), Gaps = 13/205 (6%)

Query: 325 NFSTDNKLGQGGFGAVYK-GRLSHGQEIAVKR--LSKNSVQGELEFKNEVLLVARLQHRN 381
           +F    KLG+G +G+VYK  RLS  Q  A+K   L   S +   +  NE+ ++A + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 382 LVRLLGFSFEETERLLI-YEFVPNSSVDKFIFD-AIKRVQLDWETRYKIIGGIARGILYL 439
           ++     +F +  +L I  E+ P   + K I     KR  +  +  ++I   + RG+  L
Sbjct: 61  IISY-KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
           HE    +I+HRDLK++NILL A+ + KI D G++++      +      +GT  YMAPE 
Sbjct: 120 HE---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEV 172

Query: 500 VTRGHFSIKSDVFSFGVLVLEIISG 524
                +S KSD++S G L+ E+ + 
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATF 197

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  100 bits (250), Expect = 1e-23
 Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 30/212 (14%)

Query: 331 KLGQGGFGAVYKGR----LSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRL 385
           KLG G FG V +G           +AVK L  + +   + +F  E  ++  L H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQL---------DWETRYKIIGGIARGI 436
            G        +++ E  P  S    + D +++  L         D+  +      IA G+
Sbjct: 62  YGVVLTHP-LMMVTELAPLGS----LLDRLRKDALGHFLISTLCDYAVQ------IANGM 110

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGTFGYM 495
            YL      R IHRDL A NILL +D   KI DFG+ R L + +        +   F + 
Sbjct: 111 RYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC 167

Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
           APE +    FS  SDV+ FGV + E+ + G++
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFTYGEE 199

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  100 bits (250), Expect = 1e-23
 Identities = 64/206 (31%), Positives = 112/206 (54%), Gaps = 25/206 (12%)

Query: 332 LGQGGFGAVYKGRLSH-GQE---IAVKRL-SKNSVQGELEFKNEVLLVARLQHRNLVRLL 386
           +G G FG V +GRL   G+    +A+K L S  + +   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 387 GFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKIIGGIARGILYLH 440
           G   +    ++I EF+ N ++D F+      F  I+ V         ++ GIA G+ YL 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLV--------GMLRGIAAGMKYLS 123

Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG---TFGYMAP 497
           E   +  +HRDL A NIL++++++ K+SDFG++R  E D S    +  +G      + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
           E +    F+  SDV+S+G+++ E++S
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  100 bits (251), Expect = 1e-23
 Identities = 65/214 (30%), Positives = 113/214 (52%), Gaps = 20/214 (9%)

Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVA 375
           ++ D    ++   K+GQG  G VY    ++ GQE+A+K+++ +   + EL   NE+L++ 
Sbjct: 13  SVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL-IINEILVMR 71

Query: 376 RLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARG 435
             +H N+V  L       E  ++ E++   S+     D +    +D       I  + R 
Sbjct: 72  ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMD----EGQIAAVCRE 123

Query: 436 IL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
            L    +LH +   ++IHRD+K+ NILL  D   K++DFG       +QS+  T  +VGT
Sbjct: 124 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
             +MAPE VTR  +  K D++S G++ +E++ G+
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =   99 bits (250), Expect = 2e-23
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 39/214 (18%)

Query: 330 NKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEF----KNEVLLVARLQHRNLVR 384
            ++G+G +G VYK R    G+ +A+K++       +  F      E+ L+ +L+H N+VR
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 385 LLG--FSFEETERLLIYEFVPN-------SSVDKFIFDAIKRV--QLDWETRYKIIGGIA 433
           L     S  +    +++E++ +       S   KF    IK    QL             
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL------------L 110

Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
            G+ YLH +    I+HRD+K SNIL++ D + K++DFG+AR +    S   T+R++ T  
Sbjct: 111 EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLW 166

Query: 494 YMAPEYV---TRGHFSIKSDVFSFGVLVLEIISG 524
           Y  PE +   TR  +  + D++S G ++ E+  G
Sbjct: 167 YRPPELLLGATR--YGPEVDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 99.5 bits (249), Expect = 3e-23
 Identities = 66/212 (31%), Positives = 110/212 (51%), Gaps = 28/212 (13%)

Query: 326 FSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---------EVLLVA 375
           +    KLG+G +G VYK R    G+ +A+K++        L+ +          E+ L+ 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-------RLDNEEEGIPSTALREISLLK 53

Query: 376 RLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARG 435
            L+H N+V+LL     E +  L++E+  +  + K++    +   L       I+  + RG
Sbjct: 54  ELKHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYL--DKRPGPLSPNLIKSIMYQLLRG 110

Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
           + Y H  S  RI+HRDLK  NIL++ D + K++DFG+AR F +      T  +V T  Y 
Sbjct: 111 LAYCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVV-TLWYR 165

Query: 496 APEYVTRG--HFSIKSDVFSFGVLVLEIISGQ 525
           APE +  G  H+S   D++S G +  E+I+G+
Sbjct: 166 APE-ILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 98.9 bits (246), Expect = 3e-23
 Identities = 64/203 (31%), Positives = 117/203 (57%), Gaps = 21/203 (10%)

Query: 332 LGQGGFGAVYKG--RLSHGQE--IAVKRLSKNSVQGE-LEFKNEVLLVARLQHRNLVRLL 386
           +G G FG V++G  ++   +E  +A+K L     + +  +F +E  ++ +  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE-TRYKIIG---GIARGILYLHED 442
           G   +    ++I E++ N ++DK++ D       D E + Y+++G   GIA G+ YL   
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDH------DGEFSSYQLVGMLRGIAAGMKYL--- 123

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYV 500
           S +  +HRDL A NIL+++++  K+SDFG++R+ E D  +G  +   G     + APE +
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEAI 182

Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               F+  SDV+SFG+++ E++S
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 98.1 bits (245), Expect = 6e-23
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 12/205 (5%)

Query: 330 NKLGQGGFGAVYK-GRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQHRNLVRL 385
             +G+G FG V K  R S G+ +  K +   ++  E E +   +EV ++  L+H N+VR 
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRY 64

Query: 386 LG-FSFEETERLLIY-EFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGILYLH-- 440
                    + L I  E+     + + I    K R  ++ E  ++I+  +   +   H  
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124

Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
            D    ++HRDLK +NI LDA+   K+ DFG+A++  +          VGT  YM+PE +
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYVGTPYYMSPEQL 182

Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
               +  KSD++S G L+ E+ +  
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 98.2 bits (245), Expect = 6e-23
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 34/215 (15%)

Query: 330 NKLGQGGFGAVYKG-RLSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRNLVRLL 386
           NK+G G FG VY    L  G+ +AVK  R+  N  +   E  +E+ ++  L+H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 387 GFSFEETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWET---RYKIIGGIARGILYLHED 442
           G      E++ I+ E+    +    + + ++  ++  E     Y +   +  G+ YLH  
Sbjct: 66  GVEVHR-EKVYIFMEYCSGGT----LEELLEHGRILDEHVIRVYTL--QLLEGLAYLHSH 118

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMA--------RLFEMDQSQGDTSRIVGTFGY 494
               I+HRD+K +NI LD + + K+ DFG A         + E  QS      + GT  Y
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS------LAGTPAY 169

Query: 495 MAPEYVTRGHFSIK---SDVFSFGVLVLEIISGQK 526
           MAPE +T G        +D++S G +VLE+ +G++
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 98.5 bits (245), Expect = 6e-23
 Identities = 69/214 (32%), Positives = 106/214 (49%), Gaps = 25/214 (11%)

Query: 331 KLGQGGFGAVYKGRL-----SHGQEIAVKRLSK-NSVQGELEFKNEVLLVARLQHRNLVR 384
           +LG+  FG +YKG L      H Q +A+K L   N+ Q   EF+ E  L+A L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIF--------------DAIKRVQLDWETRYKIIG 430
           LLG   +E    +++E++    + +F+               D   +  LD      I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIV 489
            IA G+ YL   S    +H+DL A NIL+   +  KISD G++R ++  D  +     ++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               +M PE +  G FS  SD++SFGV++ EI S
Sbjct: 189 -PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 98.3 bits (245), Expect = 9e-23
 Identities = 71/243 (29%), Positives = 106/243 (43%), Gaps = 42/243 (17%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRL----SKNSVQG----ELEFKNEVLLVA 375
                 ++LG+G  G+V K RL +   I   +         +Q     ELE         
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC---- 56

Query: 376 RLQHRNLVRLLGFSFEETERLL--IYEFVPNSSVDKFIFDAIKRV-QLDWETRYKIIGGI 432
             +   +V+  G   +E+   +    E+    S+D       K+V +       K++G I
Sbjct: 57  --KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY----KKVKKRGGRIGEKVLGKI 110

Query: 433 ARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
           A  +L    YLH     +IIHRD+K SNILL      K+ DFG++   E+  S   T   
Sbjct: 111 AESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGT--F 163

Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAE------DLLTY 542
            GT  YMAPE +    +SI SDV+S G+ +LE+      N F    E E      +LL+Y
Sbjct: 164 TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVA----QNRFPFPPEGEPPLGPIELLSY 219

Query: 543 VSN 545
           + N
Sbjct: 220 IVN 222

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 97.8 bits (243), Expect = 1e-22
 Identities = 69/234 (29%), Positives = 115/234 (49%), Gaps = 30/234 (12%)

Query: 331 KLGQGGFGAVYKGRLSH---GQE---IAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           +LG+G FG V+     +    Q+   +AVK L + S     +F+ E  L+  LQH+++VR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 385 LLGFSFEETERLLIYEFVPNSSVDKF---------IFDAIKRV---QLDWETRYKIIGGI 432
             G   E    L+++E++ +  +++F         I    + V   QL       I   I
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG-- 490
           A G++YL   + L  +HRDL   N L+   ++ KI DFGM+R    D    D  R+ G  
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRT 184

Query: 491 --TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGE-EAEDLLT 541
                +M PE +    F+ +SD++SFGV++ EI +  K   +++   EA + +T
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 56/202 (27%), Positives = 107/202 (52%), Gaps = 17/202 (8%)

Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQHRNLVRLLG 387
           ++G+G  G V+K +    G+ +A+K+++   ++G    +   E+  +   QH  +V+LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 388 FSFEETERLLIYEFVPN--SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
                +  +L+ E++P+  S V +     +   Q+    R      + +G+ Y+H     
Sbjct: 67  VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRM-----LLKGVAYMHA---N 118

Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE--YVTRG 503
            I+HRDLK +N+L+ AD + KI+DFG+ARLF  ++ +  + + V T  Y APE  Y  R 
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPELLYGAR- 176

Query: 504 HFSIKSDVFSFGVLVLEIISGQ 525
            +    D+++ G +  E+++G 
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 97.3 bits (243), Expect = 1e-22
 Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 13/202 (6%)

Query: 326 FSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLV 383
           F+    +G+G FG VYK       Q +A+K +     + E+E    E+  +++ +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +  G SF +  +L +I E+    S      D +K  +LD      I+  +  G+ YLHE+
Sbjct: 63  KYYG-SFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE 117

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
                IHRD+KA+NILL  +   K++DFG++       S+ +T   VGT  +MAPE + +
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQ 172

Query: 503 GHFSIKSDVFSFGVLVLEIISG 524
             +  K+D++S G+  +E+  G
Sbjct: 173 SGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 10/201 (4%)

Query: 330 NKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEF-KNEVLLVARLQHRNLVRLLG 387
             +G G    VY    L + +++A+KR+     Q  ++  + EV  +++  H N+V+   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
            SF   + L L+  ++   S+   +  +  R  LD      ++  + +G+ YLH + +  
Sbjct: 67  -SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123

Query: 447 IIHRDLKASNILLDADMIPKISDFGM-ARLFE-MDQSQGDTSRIVGTFGYMAPEYVTRGH 504
            IHRD+KA NILL  D   KI+DFG+ A L +  D+++      VGT  +MAPE + + H
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182

Query: 505 -FSIKSDVFSFGVLVLEIISG 524
            +  K+D++SFG+  +E+ +G
Sbjct: 183 GYDFKADIWSFGITAIELATG 203

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 96.8 bits (241), Expect = 2e-22
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 23/215 (10%)

Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQE------IAVKRLSKNSVQG-ELEFKNEVLLVARL 377
           N      LG+G FG V+  +    +E      + VK L K   +  + EF+ E+ +  +L
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKIIGG 431
            H+N+VRLLG   E     +I E+     + +F+       + +K   L  + +  +   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
           IA G+ +L   S  R +HRDL A N L+ +    K+S   +++    D    +  ++   
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK----DVYNSEYYKLRNA 178

Query: 492 FG---YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                ++APE V    FS KSDV+SFGVL+ E+ +
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 96.7 bits (240), Expect = 2e-22
 Identities = 62/211 (29%), Positives = 112/211 (53%), Gaps = 11/211 (5%)

Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELE-FKNEVLLVARLQ 378
           D    F+   ++G+G FG VYKG  +  +E+ A+K +     + E+E  + E+ ++++  
Sbjct: 1   DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
              + R  G   + T+  +I E++   S      D +K   L+      I+  I +G+ Y
Sbjct: 61  SPYITRYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDY 116

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           LH +   R IHRD+KA+N+LL      K++DFG+A   ++  +Q   +  VGT  +MAPE
Sbjct: 117 LHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPE 171

Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529
            + +  +  K+D++S G+  +E+  G+  NS
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 96.0 bits (239), Expect = 3e-22
 Identities = 63/205 (30%), Positives = 111/205 (54%), Gaps = 11/205 (5%)

Query: 325 NFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKR--LSKNSVQGELEFKNEVLLVARLQHRN 381
           +F   NK+G+G FG V+K  R +  +  A+K+  LSK + +   E  +E  ++A+L    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 382 LVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           ++R    SF +  +L ++ E+  N  + K +     R  L  +  ++    I  G+ +LH
Sbjct: 61  IIRYYE-SFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLH 118

Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                +I+HRD+K+ N+ LDA    KI D G+A+L   + +  +T  IVGT  Y++PE  
Sbjct: 119 SK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELC 173

Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
               ++ KSDV++ GV++ E  +G+
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 96.4 bits (240), Expect = 4e-22
 Identities = 60/227 (26%), Positives = 108/227 (47%), Gaps = 31/227 (13%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR---LSHGQE---IAVKRLSKN-SVQGELEFKNEVLLVAR 376
           NN      +GQG FG V++ R   L   +    +AVK L +  S   + +F+ E  L+A 
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFD-------------------AIKR 417
             H N+V+LLG         L++E++    +++F+                      +  
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 418 VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LF 476
           + L    +  I   +A G+ YL E    + +HRDL   N L+  +M+ KI+DFG++R ++
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             D  +   +  +    +M PE +    ++ +SDV+++GV++ EI S
Sbjct: 182 SADYYKASENDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 95.7 bits (238), Expect = 4e-22
 Identities = 63/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)

Query: 332 LGQGGFGAVYKGRLSHG----QEIAVKRLS-KNSVQGELE-FKNEVLLVARLQHRNLVRL 385
           LG+G FG+V +G+LS       ++AVK +        E+E F +E   +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 386 LGFSFEETER------LLIYEFVPNSSVDKFIFD---AIKRVQLDWETRYKIIGGIARGI 436
           +G  FE +        ++I  F+ +  +  F+          +L  +T  K +  IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMD-QSQGDTSRIVGTFGY 494
            YL   S    IHRDL A N +L  DM   ++DFG+++ ++  D   QG  +++     +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181

Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQ 525
           +A E +    ++ KSDV++FGV + EI + GQ
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 94.7 bits (236), Expect = 8e-22
 Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 21/208 (10%)

Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSK------NSVQGELEFKNEVLLVARL 377
           +F     +G+G FG V   +    +++ A+K ++K       SV+  L   NE  ++  L
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL---NERRILQEL 57

Query: 378 QHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
            H  LV L  +SF++ E + L+ + +    +    +   ++V+   E     I  I   +
Sbjct: 58  NHPFLVNLW-YSFQDEENMYLVVDLLLGGDLR---YHLSQKVKFSEEQVKFWICEIVLAL 113

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH      IIHRD+K  NILLD      I+DF +A     D     TS   GT GYMA
Sbjct: 114 EYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMA 167

Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE + R  +S+  D +S GV   E + G
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRG 195

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 94.8 bits (236), Expect = 9e-22
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 18/208 (8%)

Query: 323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKR------LSKNSVQGELEFKNEVLLVA 375
             NF  + K+G+G F  VYK   L  G+ +A+K+      +   + Q  L+   E+ L+ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLK 57

Query: 376 RLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI--FDAIKRVQLDWETRYKIIGGIA 433
           +L H N+++ L    E  E  ++ E      + + I  F   KR+ +   T +K    + 
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIWKYFVQLC 116

Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             + ++H     RI+HRD+K +N+ + A  + K+ D G+ R F    +   +  +VGT  
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 171

Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
           YM+PE +    ++ KSD++S G L+ E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 29/215 (13%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRL--------SKNSVQGELEFKNEV 371
            N+     LGQG FG VY   L +    G+E+AVK++        +K  V      + E+
Sbjct: 2   TNWRRGKLLGQGAFGRVY---LCYDVDTGRELAVKQVPFDPDSPETKKEVN---ALECEI 55

Query: 372 LLVARLQHRNLVRLLGFSFEETERLLIY-EFVPNSSVDKFIFDAIKRV-QLDWETRYKII 429
            L+  LQH  +V+  G    + E L I+ E++P  SV     D +K    L      K  
Sbjct: 56  QLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVK----DQLKAYGALTETVTRKYT 110

Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA-RLFEMDQSQGDTSRI 488
             I  G+ YLH +    I+HRD+K +NIL D+    K+ DFG + RL  +  S      +
Sbjct: 111 RQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV 167

Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            GT  +M+PE ++   +  K+DV+S G  V+E+++
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 94.3 bits (234), Expect = 1e-21
 Identities = 66/193 (34%), Positives = 103/193 (53%), Gaps = 13/193 (6%)

Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391
           +G+G FG V  G    G ++AVK + KN    +  F  E  ++ +L+H NLV+LLG   E
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 392 ETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           E   L I  E++   S+  ++  +  R  L  +   K    +   + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126

Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSD 510
           DL A N+L+  D + K+SDFG+ +  E   +Q DT ++     + APE +    FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKL--PVKWTAPEALREKKFSTKSD 181

Query: 511 VFSFGVLVLEIIS 523
           V+SFG+L+ EI S
Sbjct: 182 VWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 13/200 (6%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           LG+G +G VY  R LS    IA+K + +   +       E+ L + L+HRN+V+ LG S 
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG-SD 74

Query: 391 EETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            E     I+ E VP  S+   +      ++ + +T       I  G+ YLH+    +I+H
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVH 131

Query: 450 RDLKASNILLDA-DMIPKISDFGMA-RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH--F 505
           RD+K  N+L++    + KISDFG + RL  ++     T    GT  YMAPE + +G   +
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYMAPEVIDKGPRGY 188

Query: 506 SIKSDVFSFGVLVLEIISGQ 525
              +D++S G  ++E+ +G+
Sbjct: 189 GAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 94.2 bits (234), Expect = 1e-21
 Identities = 65/217 (29%), Positives = 115/217 (52%), Gaps = 28/217 (12%)

Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQE---IAVKRLSKNSVQGEL-EFKNEVLLVA 375
           DA+     +  +G G FG V  GRL   G+    +A+K L     + +  +F +E  ++ 
Sbjct: 2   DASC-IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60

Query: 376 RLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKII 429
           +  H N++ L G   +    +++ E++ N S+D F+      F  I+ V         ++
Sbjct: 61  QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLV--------GML 112

Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
            GIA G+ YL   S +  +HRDL A NIL++++++ K+SDFG++R+ E D     T+R  
Sbjct: 113 RGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-- 167

Query: 490 G---TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           G      + APE +    F+  SDV+S+G+++ E++S
Sbjct: 168 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 93.8 bits (233), Expect = 2e-21
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 28/210 (13%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLS----KNSVQGEL--EFKNEVLLVARLQHRNLVR 384
           LG G F + Y+ R +  G  +AVK+++     +S Q E+    + E+ L+ARL H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFI--FDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +LG + E++   L  E++   SV   +  + A K   +     Y     + RG+ YLHE+
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI---INY--TEQLLRGLSYLHEN 122

Query: 443 SRLRIIHRDLKASNILLDAD-MIPKISDFGMA-----RLFEMDQSQGDTSRIVGTFGYMA 496
              +IIHRD+K +N+L+D+     +I+DFG A     +     + QG   +++GT  +MA
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176

Query: 497 PEYVTRGH-FSIKSDVFSFGVLVLEIISGQ 525
           PE V RG  +    DV+S G +++E+ + +
Sbjct: 177 PE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 94.4 bits (234), Expect = 2e-21
 Identities = 59/209 (28%), Positives = 110/209 (52%), Gaps = 10/209 (4%)

Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR 376
           +I D    ++   K+GQG  G V+    ++ GQE+A+K+++      +    NE+L++  
Sbjct: 13  SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L++ N+V  L       E  ++ E++   S+     D +    +D      +     + +
Sbjct: 73  LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQAL 128

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            +LH +   ++IHRD+K+ N+LL  D   K++DFG       +QS+  T  +VGT  +MA
Sbjct: 129 EFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183

Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           PE VTR  +  K D++S G++ +E++ G+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 93.2 bits (232), Expect = 4e-21
 Identities = 71/217 (32%), Positives = 112/217 (51%), Gaps = 38/217 (17%)

Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---------EVLLV 374
           +++   K+G+G +G VYKGR    GQ +A+K++        LE +          E+ L+
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-------RLESEEEGVPSTAIREISLL 53

Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD-KFIFDAIKRVQ-LDWETRYKIIGGI 432
             LQH N+V L     +E+   LI+EF+   S+D K   D++ + Q +D E     +  I
Sbjct: 54  KELQHPNIVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQI 110

Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI---- 488
            +GIL+ H     R++HRDLK  N+L+D   + K++DFG+AR F      G   R+    
Sbjct: 111 LQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF------GIPVRVYTHE 161

Query: 489 VGTFGYMAPEYVTRG--HFSIKSDVFSFGVLVLEIIS 523
           V T  Y APE V  G   +S   D++S G +  E+ +
Sbjct: 162 VVTLWYRAPE-VLLGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 93.1 bits (231), Expect = 5e-21
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 30/226 (13%)

Query: 331 KLGQGGFGAVYKGR---LSHGQE---IAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           +LG+G FG V+      LS  ++   +AVK L   ++    +F+ E  L+  LQH ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIF----DAIKRV---------QLDWETRYKIIGG 431
             G   +    ++++E++ +  ++KF+     DA+  V         +L       I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG- 490
           IA G++YL   +    +HRDL   N L+ A+++ KI DFGM+R    D    D  R+ G 
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGH 184

Query: 491 ---TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIG 533
                 +M PE +    F+ +SDV+SFGV++ EI +  K   F++ 
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 93.3 bits (232), Expect = 5e-21
 Identities = 67/203 (33%), Positives = 98/203 (48%), Gaps = 19/203 (9%)

Query: 326 FSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLS---KNSVQGELEFKNEVLLVARLQHRN 381
           F+   ++G G FGAVY  R     E+ A+K++S   K S +   +   EV  + +L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
            +   G    E    L+ E+   S+ D  I +  K+   + E    I  G  +G+ YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQEVEIA-AICHGALQGLAYLHS 133

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV- 500
             R   IHRD+KA NILL      K++DFG A L     S       VGT  +MAPE + 
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPEVIL 184

Query: 501 --TRGHFSIKSDVFSFGVLVLEI 521
               G +  K DV+S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 91.9 bits (228), Expect = 7e-21
 Identities = 61/195 (31%), Positives = 100/195 (51%), Gaps = 11/195 (5%)

Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           +LG G FG V  G+     ++A+K + + S+  E EF  E  ++ +L H  LV+L G   
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           ++    ++ E++ N  +  ++ +  KR Q       ++   +  G+ YL      + IHR
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLESK---QFIHR 124

Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTRGHFSIK 508
           DL A N L+D     K+SDFG++R    D+    TS +   F   +  PE +    FS K
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLLYSKFSSK 181

Query: 509 SDVFSFGVLVLEIIS 523
           SDV++FGVL+ E+ S
Sbjct: 182 SDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 92.9 bits (230), Expect = 8e-21
 Identities = 59/209 (28%), Positives = 109/209 (52%), Gaps = 10/209 (4%)

Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR 376
           ++ D    ++   K+GQG  G VY    ++ GQE+A+++++      +    NE+L++  
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
            ++ N+V  L       E  ++ E++   S+     D +    +D      +     + +
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 129

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            +LH +   ++IHRD+K+ NILL  D   K++DFG       +QS+   S +VGT  +MA
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMA 184

Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           PE VTR  +  K D++S G++ +E+I G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 92.9 bits (230), Expect = 8e-21
 Identities = 59/209 (28%), Positives = 109/209 (52%), Gaps = 10/209 (4%)

Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR 376
           ++ D    ++   K+GQG  G VY    ++ GQE+A+K+++      +    NE+L++  
Sbjct: 13  SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
            ++ N+V  L       E  ++ E++   S+     D +    +D      +     + +
Sbjct: 73  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 128

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            +LH +   ++IHRD+K+ NILL  D   K++DFG       +QS+  T  +VGT  +MA
Sbjct: 129 DFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183

Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           PE VTR  +  K D++S G++ +E++ G+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 9e-21
 Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 25/203 (12%)

Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---------EVLLVARLQHR 380
           K+G+G +G VYK R    G+ +A+K++        LE ++         E+ L+  L H 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKI-------RLETEDEGVPSTAIREISLLKELNHP 58

Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           N+VRLL     E +  L++EF+ +  + K++ D+     LD       +  + +GI Y H
Sbjct: 59  NIVRLLDVVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCH 116

Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
             S  R++HRDLK  N+L+D +   K++DFG+AR F +   +  T  +V T  Y APE +
Sbjct: 117 --SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 171

Query: 501 TRG-HFSIKSDVFSFGVLVLEII 522
                +S   D++S G +  E++
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMV 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 19/200 (9%)

Query: 332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-VQGELE--FKNEVLLVARLQHRNLVRLLG 387
           LG GGFG V   ++ S  +  A+K + K   V+   +    +E  ++    H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQL--DWETRYKIIGGIARGILYLHEDSR 444
            +F++ + + ++ E+         ++  ++   L  ++  R+  I  +     YLH    
Sbjct: 61  -TFKDKKYIYMLMEYCLG----GELWTILRDRGLFDEYTARF-YIACVVLAFEYLH---N 111

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
             II+RDLK  N+LLD++   K+ DFG A+     +S   T    GT  Y+APE +    
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPEIILNKG 168

Query: 505 FSIKSDVFSFGVLVLEIISG 524
           +    D +S G+L+ E+++G
Sbjct: 169 YDFSVDYWSLGILLYELLTG 188

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 37/223 (16%)

Query: 331 KLGQGGFGAVY---------------KGRLSHGQE--IAVKRLSKNSVQGEL-EFKNEVL 372
           KLG+G FG V+                   +      +AVK L  ++      +F  EV 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI--------FDAIKRVQLDWET 424
           +++RL   N+ RLLG    +    +I E++ N  +++F+          A     L + T
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
              +   IA G+ YL     L  +HRDL   N L+  +   KI+DFGM+R    +    D
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSSD 184

Query: 485 TSRIVGT----FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             R+ G       +MA E V  G F+ KSDV++FGV + EI++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 91.2 bits (226), Expect = 1e-20
 Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 7/193 (3%)

Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG-ELEFKNEVLLVARLQHRNLVRLLGFSF 390
           LG+G FG V+KG L     +AVK   ++  Q  +++F +E  ++ +  H N+V+L+G   
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           +     ++ E VP    D   F   K+ +L  +   K     A G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSD 510
           DL A N L+  + + KISDFGM+R  E D     +        + APE +  G +S +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 511 VFSFGVLVLEIIS 523
           V+S+G+L+ E  S
Sbjct: 177 VWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 25/202 (12%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV--QGELE-FKNEVLLVARLQHRNLVRLLG 387
           LG G FG V   R     +  A+K LSK  +    ++E   NE  ++  ++H  LV L G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQ---LDWETRYKIIGGIARGILYLHEDS 443
            SF++   L L+ E+VP       +F  +++           Y     +   + YLH   
Sbjct: 69  -SFQDDSNLYLVMEYVPGGE----LFSHLRKSGRFPEPVARFY--AAQVVLALEYLH--- 118

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV-TR 502
            L I++RDLK  N+LLD+D   KI+DFG A+  +     G T  + GT  Y+APE + ++
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-----GRTYTLCGTPEYLAPEIILSK 173

Query: 503 GHFSIKSDVFSFGVLVLEIISG 524
           G+     D ++ G+L+ E+++G
Sbjct: 174 GYGK-AVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 65/227 (28%), Positives = 108/227 (47%), Gaps = 31/227 (13%)

Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQ------EIAVKRLSKNSVQGEL-EFKNEVLLVARL 377
           N      LG+G FG V K      +       +AVK L +N+   EL +  +E  L+ ++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIK-------------RVQLDWET 424
            H ++++L G   ++   LLI E+    S+  F+ ++ K                LD   
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 425 RYKIIGG--------IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476
              +  G        I+RG+ YL E   ++++HRDL A N+L+      KISDFG++R  
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             + S    S+      +MA E +    ++ +SDV+SFGVL+ EI++
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 57/196 (29%), Positives = 102/196 (52%), Gaps = 7/196 (3%)

Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           +LG G FG V+ G+     ++A+K +++ ++  E +F  E  ++ +L H  LV+L G   
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-DFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           ++    ++ EF+ N  +  ++    ++ +L  +    +   +  G+ YL  +S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSD 510
           DL A N L+ +  + K+SDFGM R + +D     +S       +  PE      +S KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183

Query: 511 VFSFGVLVLEIISGQK 526
           V+SFGVL+ E+ +  K
Sbjct: 184 VWSFGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 90.5 bits (224), Expect = 3e-20
 Identities = 59/211 (27%), Positives = 113/211 (53%), Gaps = 11/211 (5%)

Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELE-FKNEVLLVARLQ 378
           D    F+   K+G+G FG V+KG  +  Q++ A+K +     + E+E  + E+ ++++  
Sbjct: 1   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
              + +  G   ++T+  +I E++   S      D ++   LD      I+  I +G+ Y
Sbjct: 61  SPYVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDY 116

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           LH + +   IHRD+KA+N+LL      K++DFG+A   ++  +Q   +  VGT  +MAPE
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPE 171

Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529
            + +  +  K+D++S G+  +E+  G+  +S
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 24/222 (10%)

Query: 320 RDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARL- 377
            D T  F     +G+G +G VYK R    GQ +A+K +     + E E K E  ++ +  
Sbjct: 2   PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-EIKEEYNILRKYS 60

Query: 378 QHRNLVRLLGFSF------EETERLLIYEFVPNSSVD---KFIFDAIKRVQLDWETRYKI 428
            H N+    G          + +  L+ E     SV    K +    KR++ +W   Y I
Sbjct: 61  NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-IAY-I 118

Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
           +    RG+ YLHE+   ++IHRD+K  NILL  +   K+ DFG++   ++D + G  +  
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTF 173

Query: 489 VGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQ 525
           +GT  +MAPE +         +  +SDV+S G+  +E+  G+
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 90.9 bits (225), Expect = 3e-20
 Identities = 57/196 (29%), Positives = 102/196 (52%), Gaps = 10/196 (5%)

Query: 331 KLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
           K+G+G  G V   R  H G+++AVK +     Q      NEV+++   QH+N+V +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
               E  ++ EF+   ++     D + + +L+ E    +   + + + YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKS 509
           RD+K+ +ILL  D   K+SDFG       D  +     +VGT  +MAPE ++R  +  + 
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEV 198

Query: 510 DVFSFGVLVLEIISGQ 525
           D++S G++V+E++ G+
Sbjct: 199 DIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 90.2 bits (224), Expect = 4e-20
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 18/210 (8%)

Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG-ELEFKNEVLLVARLQ 378
           D  +      K+G+G  G V      S G+++AVK++     Q  EL F NEV+++   Q
Sbjct: 16  DPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-NEVVIMRDYQ 74

Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V +        E  ++ EF+   ++     D +   +++ E    +   + + + +
Sbjct: 75  HPNIVEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSF 130

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR---IVGTFGYM 495
           LH      +IHRD+K+ +ILL +D   K+SDFG        Q   +  R   +VGT  +M
Sbjct: 131 LHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC-----AQVSKEVPRRKSLVGTPYWM 182

Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           APE ++R  +  + D++S G++V+E++ G+
Sbjct: 183 APEVISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 90.0 bits (223), Expect = 6e-20
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 26/206 (12%)

Query: 332 LGQGGFGAVYKGRLS-----HGQEIAVKRL-SKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           LG+G FG V            G+ +AVK L  +   Q    +K E+ ++  L H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G   E+  +   LI E+VP  S+  ++     + +L+          I  G+ YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQ- 126

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMAR------LFEMDQSQGDTSRIVGTFGYMAP 497
               IHRDL A N+LLD D + KI DFG+A+       +   +  GD+      F Y A 
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP----VFWY-AV 179

Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
           E +    FS  SDV+SFGV + E+++
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 89.5 bits (222), Expect = 7e-20
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 13/199 (6%)

Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLG 387
           LG+GGFG V   ++   G+  A K+L K  +   +GE    NE  ++ ++  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRLR 446
           ++FE  + L +   + N    K+    +       E R       I  G+ +LH   + R
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP-EARAIFYAAQIICGLEHLH---QRR 115

Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
           I++RDLK  N+LLD     +ISD G+A   E+   +    R  GT GYMAPE +    + 
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGR-AGTPGYMAPEVLQGEVYD 172

Query: 507 IKSDVFSFGVLVLEIISGQ 525
              D F+ G  + E+I+G+
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 89.4 bits (222), Expect = 8e-20
 Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 17/198 (8%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFS 389
           LG G FG VYK +    G   A K +   S + ELE F  E+ +++  +H N+V L    
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAY 71

Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
           F E +  ++ EF    ++D  I   ++R   + + RY +   +   + +LH     ++IH
Sbjct: 72  FYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIH 126

Query: 450 RDLKASNILLDADMIPKISDFGM-ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS-- 506
           RDLKA NILL  D   K++DFG+ A+     Q +      +GT  +MAPE V    F   
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR---DTFIGTPYWMAPEVVACETFKDN 183

Query: 507 ---IKSDVFSFGVLVLEI 521
               K+D++S G+ ++E+
Sbjct: 184 PYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 89.3 bits (221), Expect = 9e-20
 Identities = 64/204 (31%), Positives = 110/204 (53%), Gaps = 24/204 (11%)

Query: 332 LGQGGFGAVYKGRLSHGQE-----IAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRL 385
           LG G FG VYKG      E     +A+K L +N S +   E  +E  ++A +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIARGILYLHE 441
           LG     T +L + + +P   +  ++ +   R+     L+W  +      IA+G+ YL E
Sbjct: 75  LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ--GDTSRIVGTFGYMAPEY 499
              +R++HRDL A N+L+ +    KI+DFG+ARL ++D+++   D  ++     +MA E 
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALES 182

Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS 523
           +    F+ +SDV+S+GV V E+++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 60/204 (29%), Positives = 109/204 (53%), Gaps = 25/204 (12%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQH---RNLVRLL 386
           +G+G +GAVY+G+ +  G+ +A+K ++ ++   ++ + + EV L+++L+     N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 387 GFSFEETERLLIYEFVPNSSVDKFI-FDAIKRVQLDWETRYKIIGGIARGIL----YLHE 441
           G   +     +I E+    SV   +    I           K I  I R +L    Y+H+
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAE---------KYISVIIREVLVALKYIHK 119

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
                +IHRD+KA+NIL+      K+ DFG+A L   +Q+    S  VGT  +MAPE +T
Sbjct: 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVIT 174

Query: 502 RG-HFSIKSDVFSFGVLVLEIISG 524
            G ++  K+D++S G+ + E+ +G
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 14/200 (7%)

Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---EVLLVARLQHRNLVRLL 386
           K+G+G +G VYK R    G+ +A+K++     + E   K    E+ L+  L H N+++LL
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKL-RFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
                + +  L++EF+ ++ + K I D   +  L        +  + +G+ + H      
Sbjct: 65  DVFRHKGDLYLVFEFM-DTDLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCH---SHG 118

Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE-YVTRGHF 505
           I+HRDLK  N+L++ + + K++DFG+AR F         +  V T  Y APE  +    +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGDKGY 176

Query: 506 SIKSDVFSFGVLVLEIISGQ 525
           S   D++S G +  E++S +
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 88.2 bits (218), Expect = 3e-19
 Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 27/229 (11%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR---LSHGQE---IAVKRLSKNSVQGELEFKNEVLLVARL 377
           +N     +LG+G FG V+      L   Q+   +AVK L   S     +F  E  L+  L
Sbjct: 5   HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64

Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIF----DAI------KRVQLDWETRYK 427
           QH ++V+  G   E    ++++E++ +  ++KF+     DA+      +  +L       
Sbjct: 65  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
           I   IA G++YL   +    +HRDL   N L+  +++ KI DFGM+R    D    D  R
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYR 177

Query: 488 IVG----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRI 532
           + G       +M PE +    F+ +SDV+S GV++ EI +  K   +++
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 88.1 bits (218), Expect = 3e-19
 Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 20/204 (9%)

Query: 332 LGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRL 385
           LG+G FG V   R      + G+++AVK L   S    + + K E+ ++  L H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G   E+      LI EF+P+ S+ +++     ++ L  + +Y +   I +G+ YL   S
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYL--GS 127

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS----QGDTSRIVGTFGYMAPEY 499
           R + +HRDL A N+L++++   KI DFG+ +  E D+     + D    V  F Y APE 
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV--FWY-APEC 183

Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS 523
           + +  F I SDV+SFGV + E+++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)

Query: 332 LGQGGFGAVYKGRLSH---GQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQH-RNLVRLL 386
           +G+G FG V K    H   G  +AVKR+     + E      ++ +V R      +V+  
Sbjct: 12  IGRGAFGTVNKML--HKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69

Query: 387 GFSFEETERLLIYEFVPNSSVDKF--IFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           G  F E +  +  E + + S+DKF      + +  +  E   KI     + + YL E+  
Sbjct: 70  GALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE-- 126

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV---T 501
           L+IIHRD+K SNILLD +   K+ DFG++       ++   +R  G   YMAPE +    
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSA 183

Query: 502 RGHFSIKSDVFSFGVLVLEIISG 524
           R  + ++SDV+S G+ + E+ +G
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATG 206

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 66/204 (32%), Positives = 108/204 (52%), Gaps = 11/204 (5%)

Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFK-NEVLLVARLQHRNL 382
           NF    KLG+G +  VYKGR     EI A+K +  ++ +G       E+ L+  L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           VRL      E + +L++E++    + K++     R  LD  T       + +GI + HE+
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDKD-LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
              R++HRDLK  N+L++     K++DFG+AR F +  +    S  V T  Y AP+ V  
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVVTLWYRAPD-VLL 173

Query: 503 GH--FSIKSDVFSFGVLVLEIISG 524
           G   +S   D++S G ++ E+I+G
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 87.8 bits (217), Expect = 4e-19
 Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 21/201 (10%)

Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFS 389
           +LG G FG VYK +      +A  ++ +   + ELE +  E+ ++A   H  +V+LLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL----YLHEDSRL 445
           + + +  ++ EF P  +VD  +      ++LD       I  I R +L    YLH    +
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIM------LELDRGLTEPQIQVICRQMLEALQYLHS---M 129

Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV----- 500
           +IIHRDLKA N+LL  D   K++DFG++        + D+   +GT  +MAPE V     
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETM 187

Query: 501 TRGHFSIKSDVFSFGVLVLEI 521
               +  K+D++S G+ ++E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 87.0 bits (215), Expect = 5e-19
 Identities = 57/211 (27%), Positives = 111/211 (52%), Gaps = 11/211 (5%)

Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELE-FKNEVLLVARLQ 378
           D    F+   ++G+G FG V+KG  +  Q++ A+K +     + E+E  + E+ ++++  
Sbjct: 1   DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
              + +  G   + T+  +I E++   S      D ++    D      ++  I +G+ Y
Sbjct: 61  SPYVTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDY 116

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           LH + +   IHRD+KA+N+LL      K++DFG+A   ++  +Q   +  VGT  +MAPE
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPE 171

Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529
            + +  +  K+D++S G+  +E+  G+  NS
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 86.2 bits (213), Expect = 5e-19
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 11/197 (5%)

Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE--FKNEVLLVARLQHRNLVRLLGF 388
           ++G+G FG V+ GRL         +  + ++  +L+  F  E  ++ +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
             ++    ++ E V       F+     R+++  +   +++   A G+ YL        I
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKV--KELIQMVENAAAGMEYLESKH---CI 116

Query: 449 HRDLKASNILLDADMIPKISDFGMARLFE--MDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
           HRDL A N L+    + KISDFGM+R  E  +  S G   +I     + APE +  G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174

Query: 507 IKSDVFSFGVLVLEIIS 523
            +SDV+SFG+L+ E  S
Sbjct: 175 SESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 86.6 bits (214), Expect = 8e-19
 Identities = 55/196 (28%), Positives = 101/196 (51%), Gaps = 10/196 (5%)

Query: 331 KLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
           K+G+G  G V      H G+++AVK++     Q      NEV+++    H N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
               E  ++ EF+   ++     D +   +++ E    +   + R + YLH      +IH
Sbjct: 89  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKS 509
           RD+K+ +ILL +D   K+SDFG     ++ +       +VGT  +MAPE ++R  +  + 
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 510 DVFSFGVLVLEIISGQ 525
           D++S G++V+E+I G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 85.9 bits (212), Expect = 1e-18
 Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 21/207 (10%)

Query: 331 KLGQGGFGAVYKGRLSHG-------QEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNL 382
           +LGQG FG VY+G ++ G         +A+K +++  S++  +EF NE  ++      ++
Sbjct: 13  ELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKII---GGIARG 435
           VRLLG   +    L+I E +    +  ++      ++        +  K+I   G IA G
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGTFGY 494
           + YL+ +   + +HRDL A N ++  D   KI DFGM R ++E D  +     ++    +
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRW 187

Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEI 521
           M+PE +  G F+  SDV+SFGV++ EI
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 59/206 (28%), Positives = 107/206 (51%), Gaps = 16/206 (7%)

Query: 326 FSTDNKLGQGGFGAVYKGR-LSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARLQH 379
           F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            ++ RLLG     T +L I + +P   +  ++ +    +   +   + +   IA+G+ YL
Sbjct: 69  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV--QIAKGMNYL 125

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS--QGDTSRIVGTFGYMAP 497
            E    R++HRDL A N+L+      KI+DFG+A+L   D+     +  ++     +MA 
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PIKWMAL 180

Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
           E +    ++ +SDV+S+GV V E+++
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 89.5 bits (222), Expect = 1e-18
 Identities = 64/263 (24%), Positives = 124/263 (47%), Gaps = 23/263 (8%)

Query: 268 IIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRKADEINTVESLQFDFS---TIRDATN 324
            I  +   F++  +     VF+R R   + + +   D    ++      S   TI D  +
Sbjct: 631 YITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILS 690

Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSK-NSVQGELEFKNEVLLVARLQHRNL 382
           +   +N + +G  GA YKG+ + +G +  VK ++  NS+       +E+  + +LQH N+
Sbjct: 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNI 745

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           V+L+G    E    LI+E++   ++ + + +      L WE R KI  GIA+ + +LH  
Sbjct: 746 VKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCR 799

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
               ++  +L    I++D    P +    +  L   D     +S       Y+APE    
Sbjct: 800 CSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRET 852

Query: 503 GHFSIKSDVFSFGVLVLEIISGQ 525
              + KSD++ FG++++E+++G+
Sbjct: 853 KDITEKSDIYGFGLILIELLTGK 875

Length = 968

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 66/203 (32%), Positives = 109/203 (53%), Gaps = 19/203 (9%)

Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLL 386
           +G+G FG VY G L  S GQ+I  AVK L++ +   E+E F  E +++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 387 GFSF-EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
           G     E   L++  ++ +  +  FI     R +    T   +IG    +A+G+ YL   
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFI-----RSETHNPTVKDLIGFGLQVAKGMEYLASK 117

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMD-QSQGDTSRIVGTFGYMAPEYV 500
              + +HRDL A N +LD     K++DFG+AR +++ +  S  + +       +MA E +
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174

Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               F+ KSDV+SFGVL+ E+++
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 86.7 bits (215), Expect = 2e-18
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 27/211 (12%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFK---NE--VLLVARL 377
            +F    ++GQGG+G V+  +     EI A+KR+ K+ +    E +    E  +L   + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK- 59

Query: 378 QHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
               LV+LL ++F++ E L L  E+VP       + +    V  +   R+ +       +
Sbjct: 60  -SEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFE-AV 114

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR---IVGTFG 493
             LH    L  IHRDLK  N L+DA    K++DFG+        S+G  +    +VG+  
Sbjct: 115 DALH---ELGYIHRDLKPENFLIDASGHIKLTDFGL--------SKGIVTYANSVVGSPD 163

Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           YMAPE +    +    D +S G ++ E + G
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 66/203 (32%), Positives = 112/203 (55%), Gaps = 19/203 (9%)

Query: 330 NKLGQGGFGAVYKGR-LSHGQEIAVKRLS-KNSVQG-ELEFKNEVLLVARLQ---HRNLV 383
            ++G+G +G VYK R L+ G+ +A+K++    S +G  L    E+ L+ +L+   H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 384 RLLG-FSFEETER----LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           RLL       T+R     L++E V +  +  ++    K   L  ET   ++  + RG+ +
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPG-LPPETIKDLMRQLLRGVDF 122

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           LH     RI+HRDLK  NIL+ +D   KI+DFG+AR++  + +   TS +V T  Y APE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TS-VVVTLWYRAPE 176

Query: 499 YVTRGHFSIKSDVFSFGVLVLEI 521
            + +  ++   D++S G +  E+
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 21/211 (9%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN----EVLLVARLQ 378
           N +     +G+G +G V K R  + G+ +A+K+  K S   E + K     EV ++ +L+
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDE-DVKKTALREVKVLRQLR 58

Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQ--LDWETRYKIIGGIARG 435
           H N+V L    F    RL L++E+V  +     + + ++     L  +     I  + + 
Sbjct: 59  HENIVNLKEA-FRRKGRLYLVFEYVERT-----LLELLEASPGGLPPDAVRSYIWQLLQA 112

Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
           I Y H      IIHRD+K  NIL+    + K+ DFG AR      +   T   V T  Y 
Sbjct: 113 IAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-YVATRWYR 168

Query: 496 APE-YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           APE  V   ++    DV++ G ++ E++ G+
Sbjct: 169 APELLVGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 20/202 (9%)

Query: 332 LGQGGFGAVYKG-RLSHGQEI----AVKRL-SKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           LG G FG V+KG  +  G  I    A+K +  ++  Q   E  + +L +  L H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIF---DAIK-RVQLDWETRYKIIGGIARGILYLHE 441
           LG         L+ +  P  S+   +    D++  +  L+W  +      IA+G+ YL E
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               R++HR+L A NILL +D I +I+DFG+A L   D  +   S       +MA E + 
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184

Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
            G ++ +SDV+S+GV V E++S
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 85.6 bits (212), Expect = 3e-18
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)

Query: 332 LGQGGFGAVYKGR----LSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRL 385
           LGQG FG V+  R       GQ  A+K L K +  V+  +  K E  ++A + H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 386 LGFSFEETERL-LIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDS 443
             ++F+   +L LI +F+    +    F  + K V    E     +  +A  + +LH   
Sbjct: 64  -HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH--- 115

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
            L II+RDLK  NILLD +   K++DFG+++  E    +       GT  YMAPE V R 
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 173

Query: 504 HFSIKSDVFSFGVLVLEIISG 524
             +  +D +SFGVL+ E+++G
Sbjct: 174 GHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 19/204 (9%)

Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEF-KNEVLLVARLQHRNLVRLLGF 388
            ++G G +G VYK R     E+   ++ K     + E  + E+ ++   +H N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG- 67

Query: 389 SFEETERLLI-YEFVPNSSVD---KFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           S+   ++L I  E+    S+    +     +  +Q+ +  R  +     +G+ YLHE   
Sbjct: 68  SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLHE--- 119

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV---T 501
              IHRD+K +NILL  D   K++DFG++   ++  +       +GT  +MAPE      
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSA--QLTATIAKRKSFIGTPYWMAPEVAAVER 177

Query: 502 RGHFSIKSDVFSFGVLVLEIISGQ 525
           +G +  K D+++ G+  +E+   Q
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQ 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 84.0 bits (208), Expect = 4e-18
 Identities = 54/197 (27%), Positives = 98/197 (49%), Gaps = 17/197 (8%)

Query: 332 LGQGGFG-AVYKGRLSHGQEIAVKR--LSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G FG A    R      +  K   L++ S +   +  NE+++++ LQH N++     
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN- 66

Query: 389 SFEETERLLI-YEFVPNSSVDKFIFDAIKRVQ---LDWETRYKIIGGIARGILYLHEDSR 444
            F +   LLI  E+    +    ++D I R +    + E     +  I   + Y+H+   
Sbjct: 67  HFMDDNTLLIEMEYANGGT----LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG- 121

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
             I+HRD+K  NI L    + K+ DFG++++   + S  +T  +VGT  YM+PE      
Sbjct: 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVK 177

Query: 505 FSIKSDVFSFGVLVLEI 521
           ++ KSD+++ G ++ E+
Sbjct: 178 YNFKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 85.0 bits (210), Expect = 4e-18
 Identities = 69/215 (32%), Positives = 108/215 (50%), Gaps = 26/215 (12%)

Query: 332 LGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRN 381
           LG+G FG V         K R      +AVK L  N+   +L +  +E+ L+  + +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFI-----------FDAIK--RVQLDWETRYKI 428
           ++ LLG   +E    +I E+    ++ +F+           FD  K    QL ++     
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
              +ARG+ YL  +SR R IHRDL A N+L+  D + KI+DFG+AR          TS  
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                +MAPE +    ++ +SDV+SFG+L+ EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 83.8 bits (207), Expect = 4e-18
 Identities = 55/199 (27%), Positives = 103/199 (51%), Gaps = 17/199 (8%)

Query: 332 LGQGGFGAVY--KGRLSHG----QEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +G+G FG V+  + +        ++I V++++K+     L  +NE  ++  L H N++  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE---RLAAQNECQVLKLLSHPNIIEY 64

Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
                E+   +++ E+ P  ++ ++I        LD +T   I+    + +L LH     
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDT---ILHFFVQILLALHHVHTK 120

Query: 446 RIIHRDLKASNILLDA-DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
            I+HRDLK  NILLD   M+ KI DFG++++     S+     +VGT  Y++PE      
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPELCEGKP 177

Query: 505 FSIKSDVFSFGVLVLEIIS 523
           ++ KSD+++ G ++ E+ S
Sbjct: 178 YNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 83.8 bits (207), Expect = 5e-18
 Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 22/207 (10%)

Query: 331 KLGQGGFGAVYKG--RLSHGQ-EIAVKRLSKNSVQGELEFKNEVLLVARLQHR----NLV 383
           +LG G FG V KG  ++   Q ++A+K L   +   E   ++E++  A + H+     +V
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIV 58

Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           R++G    E E L L+ E      ++KF+  + K+ ++      +++  ++ G+ YL   
Sbjct: 59  RMIGVC--EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGK 114

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYV 500
           +    +HRDL A N+LL      KISDFG+++    D S    +R  G +   + APE +
Sbjct: 115 N---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECI 170

Query: 501 TRGHFSIKSDVFSFGVLVLEIIS-GQK 526
               FS +SDV+S+G+ + E  S GQK
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 84.0 bits (207), Expect = 5e-18
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 20/219 (9%)

Query: 319 IRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL 377
           +RD    F     +G G +G VYKGR +  GQ  A+K +     + E E K E+ ++ + 
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKKY 59

Query: 378 -QHRNLVRLLGFSFEET------ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
             HRN+    G   ++       +  L+ EF    SV   I +  K   L  E    I  
Sbjct: 60  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICR 118

Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
            I RG+ +LH+    ++IHRD+K  N+LL  +   K+ DFG++   ++D++ G  +  +G
Sbjct: 119 EILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIG 173

Query: 491 TFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISG 524
           T  +MAPE +         +  KSD++S G+  +E+  G
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.5 bits (206), Expect = 5e-18
 Identities = 61/209 (29%), Positives = 110/209 (52%), Gaps = 26/209 (12%)

Query: 325 NFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKR--LSKNSVQGELEFKNEVLLVARLQHR 380
            +    K+G+G FG +Y  K + S  +   +K   L+K  V+ +   K EV+L+A+++H 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 381 NLVRLLGFSFEETERLLI-YEFVPNSSVDKFIFDAIKRVQLDWETRY---KIIG---GIA 433
           N+V     SF+E  RL I  E+           D +KR+       +   +I+     I+
Sbjct: 60  NIVTFFA-SFQENGRLFIVMEYCDGG-------DLMKRINRQRGVLFSEDQILSWFVQIS 111

Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMDQSQGDTSRIVGTF 492
            G+ ++H+    +I+HRD+K+ NI L  + M+ K+ DFG+AR  +++ S       VGT 
Sbjct: 112 LGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYTCVGTP 166

Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
            Y++PE      ++ K+D++S G ++ E+
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 84.3 bits (209), Expect = 6e-18
 Identities = 63/200 (31%), Positives = 92/200 (46%), Gaps = 34/200 (17%)

Query: 322 ATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKR-LSKNSVQG-ELEFKNEVLLVARLQ 378
              ++    KLG+G FG VYK R +  G+ +A+K+ L  N   G  +    E+ ++ +L+
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 379 HRNLVRLLGFSFEETE-----RLLIYEFVP-----------NSSVDKFIFDAIKRVQLDW 422
           H N+V L+  + E  +     R  +Y   P           N SV K     IK   L  
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV-KLTESQIKCYMLQ- 123

Query: 423 ETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482
                    +  GI YLHE+    I+HRD+KA+NIL+D   I KI+DFG+AR ++     
Sbjct: 124 ---------LLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171

Query: 483 GDTSRIVGTFGYMAPEYVTR 502
                  GT  Y     VTR
Sbjct: 172 PKGGGGGGTRKY-TNLVVTR 190

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 83.9 bits (207), Expect = 7e-18
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 11/198 (5%)

Query: 332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLG 387
           LG+GGFG V   ++ + G+  A K+L K  ++   GE    NE  ++ ++  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66

Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
           +++E  + L +   + N    KF    +     +          I  G+  LH++   RI
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RI 123

Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
           ++RDLK  NILLD     +ISD G+A    + + Q    R VGT GYMAPE V    ++ 
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAPEVVKNERYTF 180

Query: 508 KSDVFSFGVLVLEIISGQ 525
             D ++ G L+ E+I+GQ
Sbjct: 181 SPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 84.0 bits (208), Expect = 8e-18
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 38/208 (18%)

Query: 313 QFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKR-LSKNSVQG-ELEFKN 369
           Q++F    +  + +    K+GQG FG V+K R     Q +A+K+ L +N  +G  +    
Sbjct: 2   QYEFPFCDE-VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR 60

Query: 370 EVLLVARLQHRNLVRLL--------GFSFEETERLLIYEF--------VPNSSVDKFIFD 413
           E+ ++  L+H N+V L+         ++  +    L++EF        + N +V KF   
Sbjct: 61  EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV-KFTLS 119

Query: 414 AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473
            IK+V          +  +  G+ Y+H   R +I+HRD+KA+NIL+  D I K++DFG+A
Sbjct: 120 EIKKV----------MKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166

Query: 474 RLF---EMDQSQGDTSRIVGTFGYMAPE 498
           R F   +  +    T+R+V T  Y  PE
Sbjct: 167 RAFSLSKNSKPNRYTNRVV-TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 83.2 bits (205), Expect = 8e-18
 Identities = 60/224 (26%), Positives = 113/224 (50%), Gaps = 16/224 (7%)

Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLS---KNSVQGELEFKNEVLLVARLQHR 380
           NF  + K+G+G F  VY+   L   + +A+K++        +   +   E+ L+ +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE-TRYKIIGGIARGILYL 439
           N+++ L    E+ E  ++ E      + + I    K+ +L  E T +K    +   + ++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
           H  SR R++HRD+K +N+ + A  + K+ D G+ R F    +   +  +VGT  YM+PE 
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177

Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS------GQKNNSFRIGEEAE 537
           +    ++ KSD++S G L+ E+ +      G K N F + ++ E
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE 221

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 51/240 (21%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV--QGE-LEFKNEVLLVARLQH 379
           ++F     +G+G FG V+  R     ++ A+K L K+ +  + +    + E  ++A    
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 380 RNLVRLLGFSFEETERL-LIYEFVP-----NSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
             +V+L  +SF++ E L L+ E++P     N  + K +F        +    Y     IA
Sbjct: 61  PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETARFY-----IA 108

Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA--------RLFEMDQSQGDT 485
             +L L    +L  IHRD+K  NIL+DAD   K++DFG+         R + ++ S    
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168

Query: 486 SR-------------------IVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQ 525
            R                    VGT  Y+APE V RG  + ++ D +S GV++ E++ G 
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEMLYGF 227

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 56/207 (27%), Positives = 106/207 (51%), Gaps = 12/207 (5%)

Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLS---KNSVQGELEFKNEVLLVARLQHR 380
           NF  + K+G+G F  VY+   L  G  +A+K++        +   +   E+ L+ +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFI--FDAIKRVQLDWETRYKIIGGIARGILY 438
           N+++      E+ E  ++ E      + + I  F   KR+ +  +T +K    +   + +
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCSALEH 121

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           +H  SR R++HRD+K +N+ + A  + K+ D G+ R F    +   +  +VGT  YM+PE
Sbjct: 122 MH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 176

Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            +    ++ KSD++S G L+ E+ + Q
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQ 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 59/198 (29%), Positives = 101/198 (51%), Gaps = 15/198 (7%)

Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFS 389
           +LG G FG VYK +      +A  ++     + ELE +  E+ ++A   H N+V+LL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII-GGIARGILYLHEDSRLRII 448
           + E    ++ EF    +VD  + +  + +    E + +++       + YLHE+   +II
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHEN---KII 125

Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV-----TRG 503
           HRDLKA NIL   D   K++DFG++        + D+   +GT  +MAPE V        
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDR 183

Query: 504 HFSIKSDVFSFGVLVLEI 521
            +  K+DV+S G+ ++E+
Sbjct: 184 PYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 83.2 bits (205), Expect = 2e-17
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 19/208 (9%)

Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKN---EVLLVAR 376
           D    F+   ++G G FGAVY  R     E+ A+K++S +  Q   ++++   EV  + R
Sbjct: 22  DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQR 81

Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           ++H N +   G    E    L+ E+   S+ D  + +  K+   + E    I  G  +G+
Sbjct: 82  IKHPNSIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AITHGALQGL 138

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH  +   +IHRD+KA NILL      K++DFG A +     S       VGT  +MA
Sbjct: 139 AYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMA 189

Query: 497 PEYV---TRGHFSIKSDVFSFGVLVLEI 521
           PE +     G +  K DV+S G+  +E+
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 83.2 bits (205), Expect = 2e-17
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 19/208 (9%)

Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---EVLLVAR 376
           D    FS   ++G G FGAVY  R + + + +A+K++S +  Q   ++++   EV  + +
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71

Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L+H N ++  G    E    L+ E+   S+ D  + +  K+   + E    +  G  +G+
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AVTHGALQGL 128

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH  +   +IHRD+KA NILL    + K+ DFG A +             VGT  +MA
Sbjct: 129 AYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMA 179

Query: 497 PEYV---TRGHFSIKSDVFSFGVLVLEI 521
           PE +     G +  K DV+S G+  +E+
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 22/206 (10%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEF---KNEVLLVARLQHRNLVRLLG 387
           + +G +G V+  +  S G   A+K + K  +  + +      E  ++++ Q   +V+L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 388 FSFEETERL-LIYEFVPNSSVDKFI--FDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           +SF+  + L L+ E++P   +   +    +     LD +     I  I   + YLH    
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGS-----LDEDVARIYIAEIVLALEYLH---S 111

Query: 445 LRIIHRDLKASNILLDADMIPKISDFG------MARLFEMDQSQGDTSRIVGTFGYMAPE 498
             IIHRDLK  NIL+D++   K++DFG      + R   ++  + +  RIVGT  Y+APE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171

Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISG 524
            +     S   D +S G ++ E + G
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 66/199 (33%), Positives = 101/199 (50%), Gaps = 13/199 (6%)

Query: 332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLG 387
           LG+GGFG V   ++ + G+  A K+L K  ++   GE    NE  ++ ++  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66

Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
           +++E  + L +   + N    KF    +     D E        I  G+  LH   R RI
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERI 123

Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMAPEYVTRGHFS 506
           ++RDLK  NILLD     +ISD G+A    ++  +G+T R  VGT GYMAPE V    ++
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAPEVVKNERYT 179

Query: 507 IKSDVFSFGVLVLEIISGQ 525
              D +  G L+ E+I G+
Sbjct: 180 FSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 81.9 bits (202), Expect = 3e-17
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 15/209 (7%)

Query: 332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLG 387
           LG+GGFG V   ++ + G+  A KRL K  ++   GE    NE  ++ ++  + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66

Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
           +++E  + L +   + N    KF    +     + E        I  G+  LH ++    
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---T 123

Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMAPEYVTRGHFS 506
           ++RDLK  NILLD     +ISD G+A    +   +G++ R  VGT GYMAPE +    ++
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLA----VKIPEGESIRGRVGTVGYMAPEVLNNQRYT 179

Query: 507 IKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           +  D +  G L+ E+I GQ  + FR  +E
Sbjct: 180 LSPDYWGLGCLIYEMIEGQ--SPFRGRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 53/196 (27%), Positives = 100/196 (51%), Gaps = 10/196 (5%)

Query: 331 KLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
           K+G+G  G V    + S G+ +AVK++     Q      NEV+++   QH N+V +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
               E  ++ EF+   ++     D +   +++ E    +   + + +  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139

Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKS 509
           RD+K+ +ILL  D   K+SDFG     ++ +       +VGT  +MAPE ++R  +  + 
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197

Query: 510 DVFSFGVLVLEIISGQ 525
           D++S G++V+E++ G+
Sbjct: 198 DIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 66/228 (28%), Positives = 111/228 (48%), Gaps = 30/228 (13%)

Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLL 373
           D S +RD    F     +G G +G VYKGR +  GQ  A+K +     + E E K E+ +
Sbjct: 7   DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE-EIKLEINM 65

Query: 374 VARL-QHRNLVRLLGFSFEET------ERLLIYEFVPNSSVDKFIFDAIKR-----VQLD 421
           + +   HRN+    G   +++      +  L+ EF    SV     D +K      ++ D
Sbjct: 66  LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVT----DLVKNTKGNALKED 121

Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
           W     I   I RG+ +LH     ++IHRD+K  N+LL  +   K+ DFG++   ++D++
Sbjct: 122 WIAY--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRT 174

Query: 482 QGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISG 524
            G  +  +GT  +MAPE +         +  +SD++S G+  +E+  G
Sbjct: 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 19/212 (8%)

Query: 329 DNKLGQGGFGAVYKG--RLSHGQEI--AVKRLSKNSVQGELE-FKNEVLLVARLQHRNLV 383
              +G+G FG VY+G       ++I  AVK     +     E F  E  ++ +  H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +L+G    E    ++ E  P   +  ++   + +  LD  +       ++  + YL    
Sbjct: 71  KLIGV-ITENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES-- 125

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
             R +HRD+ A N+L+ +    K+ DFG++R  E D+S    S+      +MAPE +   
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFR 183

Query: 504 HFSIKSDVFSFGVLVLEIIS-------GQKNN 528
            F+  SDV+ FGV + EI+        G KNN
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPFQGVKNN 215

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 61/200 (30%), Positives = 103/200 (51%), Gaps = 19/200 (9%)

Query: 332 LGQGGFGAVYK-GRLSHGQEIAVKRL---SKNSVQGELEFKNEVLLVARLQHRNLVRLLG 387
           LG G  G+V K   +  G  +A K +   +K+SV+ ++  + +++   R  +  +V   G
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY--IVSFYG 70

Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRV--QLDWETRYKIIGGIARGILYLHEDSRL 445
               E    +  EF+     D    D I +    +  E   KI   +  G+ YL+     
Sbjct: 71  AFLNENNICMCMEFM-----DCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VH 123

Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
           RI+HRD+K SNIL+++    K+ DFG++   E+  S  DT   VGT  YM+PE +  G +
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSG--ELINSIADT--FVGTSTYMSPERIQGGKY 179

Query: 506 SIKSDVFSFGVLVLEIISGQ 525
           ++KSDV+S G+ ++E+  G+
Sbjct: 180 TVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 81.9 bits (202), Expect = 3e-17
 Identities = 64/212 (30%), Positives = 112/212 (52%), Gaps = 27/212 (12%)

Query: 331 KLGQGGFGAVYKG---RLSHGQ---EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLV 383
           +LGQG FG VY+G    +  G+    +AVK ++++ S++  +EF NE  ++      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE--------TRYKII---GGI 432
           RLLG   +    L++ E + +  +  ++    + ++ + E        T  ++I     I
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGT 491
           A G+ YL+     + +HRDL A N ++  D   KI DFGM R ++E D  +     ++  
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-P 184

Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             +MAPE +  G F+  SD++SFGV++ EI S
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 29/212 (13%)

Query: 325 NFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN-----EVLLVARLQ 378
            +    KLG+G +  VYK R    G+ +A+K++     +   +  N     E+ L+  L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYK-IIGGIARGI 436
           H N++ LL   F     + L++EF+  + ++K I D    +        K  +    RG+
Sbjct: 61  HPNIIGLLDV-FGHKSNINLVFEFME-TDLEKVIKDKSIVLT---PADIKSYMLMTLRGL 115

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI----VGTF 492
            YLH      I+HRDLK +N+L+ +D + K++DFG+AR F      G  +R     V T 
Sbjct: 116 EYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF------GSPNRKMTHQVVTR 166

Query: 493 GYMAPE--YVTRGHFSIKSDVFSFGVLVLEII 522
            Y APE  +  R H+ +  D++S G +  E++
Sbjct: 167 WYRAPELLFGAR-HYGVGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 81.6 bits (201), Expect = 4e-17
 Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 13/199 (6%)

Query: 332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLG 387
           LG+GGFG V   ++ + G+  A K+L K  ++   GE    NE  ++ ++  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66

Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
           +++E  + L +   + N    KF    +     D +        +  G+  L    R RI
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERI 123

Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMAPEYVTRGHFS 506
           ++RDLK  NILLD     +ISD G+A    +   +G+T R  VGT GYMAPE +    ++
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINNEKYT 179

Query: 507 IKSDVFSFGVLVLEIISGQ 525
              D +  G L+ E+I GQ
Sbjct: 180 FSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 82.0 bits (202), Expect = 4e-17
 Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 19/199 (9%)

Query: 330 NKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKN---EVLLVARLQHRNLVRL 385
           +++G G FGAVY    SH  E+ AVK++S +  Q   ++++   EV  + +L+H N +  
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
            G   +E    L+ E+   S+ D  + +  K+   + E    I  G  +G+ YLH  +  
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AITHGALQGLAYLHSHN-- 141

Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV---TR 502
            +IHRD+KA NILL      K++DFG A       S       VGT  +MAPE +     
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDE 194

Query: 503 GHFSIKSDVFSFGVLVLEI 521
           G +  K DV+S G+  +E+
Sbjct: 195 GQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 81.0 bits (200), Expect = 6e-17
 Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 11/203 (5%)

Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRN 381
           NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           +V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ + H 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               R++HRDLK  N+L++ +   K++DFG+AR F +   +  T  +V T  Y APE + 
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILL 173

Query: 502 RGHF-SIKSDVFSFGVLVLEIIS 523
              + S   D++S G +  E+++
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 82.0 bits (203), Expect = 7e-17
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 45/215 (20%)

Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN---EVLLVARLQHRNLVRLLG 387
           +G G +G V     +  G+++A+K+LS+   Q  +  K    E+ L+  + H N++ LL 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSR-PFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81

Query: 388 FSFEETERLLIYEFVPNSSVDKF--------IFDA-----IKRVQL-DWETRYKIIGGIA 433
                        F P SS++ F        +  A     +K  +L D   ++ ++  I 
Sbjct: 82  V------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQIL 128

Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL--FEMDQSQGDTSRIVGT 491
           RG+ Y+H      IIHRDLK SNI ++ D   KI DFG+AR    EM          V T
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG-------YVAT 178

Query: 492 FGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
             Y APE +    H++   D++S G ++ E+++G+
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 81.0 bits (200), Expect = 8e-17
 Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 18/211 (8%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR---LSHGQ---EIAVKRLSKNSVQGELE-FKNEVLLVAR 376
           NN S    LG G FG V +     LS      ++AVK L   +   E E   +E+ +++ 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARG 435
           L  H N+V LLG        L+I E+     +  F+    +   L  E        +A+G
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKG 153

Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ---SQGDTSRIVGTF 492
           + +L   +    IHRDL A N+LL    I KI DFG+AR    D     +G+    V   
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV--- 207

Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            +MAPE +    ++ +SDV+S+G+L+ EI S
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 80.8 bits (199), Expect = 9e-17
 Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 34/223 (15%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHG---QEIAVKRLSKNSVQGE-LEFKNEVLLVARL-Q 378
           N+    + +G+G FG V K R+       + A+KR+ + + + +  +F  E+ ++ +L  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-----------FDAIKRV--QLDWETR 425
           H N++ LLG         L  E+ P+ ++  F+           F         L  +  
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485
                 +ARG+ YL   S+ + IHRDL A NIL+  + + KI+DFG++R        G  
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQE 175

Query: 486 SRIVGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             +  T G     +MA E +    ++  SDV+S+GVL+ EI+S
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 36/222 (16%)

Query: 331 KLGQGGFGAVYKGRLSHGQE---------------IAVKRLSKNSVQ-GELEFKNEVLLV 374
           KLG+G FG V+        E               +AVK L  +  +    +F  E+ ++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQL---------DWETR 425
           +RL++ N++RLLG    +    +I E++ N  +++F+                       
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485
             +   IA G+ YL   + L  +HRDL   N L+      KI+DFGM+R    +   GD 
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR----NLYSGDY 184

Query: 486 SRIVG----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            RI G       +MA E +  G F+  SDV++FGV + E+ +
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 62/211 (29%), Positives = 108/211 (51%), Gaps = 22/211 (10%)

Query: 332 LGQGGFGAVYKGRLSHGQEI---AVKRLS-KNSVQGELE-FKNEVLLVARLQHRNLVRLL 386
           LG+G FG+V +G+L+    I   AVK +      + E+E F +E + +    H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 387 GFSFEETER------LLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKIIGGIARGIL 437
           G   +  E       ++I  F+ +  +  F+  +        L  +   K +  IA G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA-RLFEMD-QSQGDTSRIVGTFGYM 495
           YL   S    IHRDL A N +L+ +M   ++DFG++ +++  D   QG  +++     ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKWI 181

Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIIS-GQ 525
           A E +    ++ KSDV+SFGV + EI + GQ
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQ 212

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 18/206 (8%)

Query: 330 NKLGQGGFGAVYKGRLSHGQEIA---VKRL-SKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +++G G FG V  G    G   A   VK L +  +   +L F  EV     L H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRY--KIIGGIARGILYLHEDS 443
           LG   E    LL+ EF P   +  ++      V    +     ++   +A G+L+LH   
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMA-RLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
           +   IH DL   N  L AD+  KI D+G+A   +  D         V    ++APE V  
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEI 176

Query: 503 GHFSI-------KSDVFSFGVLVLEI 521
               +       KS+++S GV + E+
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 20/203 (9%)

Query: 331 KLGQGGFGAVYKGRLSH-GQEIAVKRL---SKNSVQGELEFKNEVLLVARLQHRNLVRLL 386
            +G+G +G V K +    GQ +A+K+      + +  ++  + E+ ++ +L+H NLV L+
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLI 66

Query: 387 GFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQ--LDWETRYKIIGGIARGILYLHEDS 443
              F   +RL L++EFV     D  + D +++    LD     K +  I RGI + H  +
Sbjct: 67  EV-FRRKKRLYLVFEFV-----DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY-VTR 502
              IIHRD+K  NIL+    + K+ DFG AR   +       +  V T  Y APE  V  
Sbjct: 121 ---IIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDYVATRWYRAPELLVGD 175

Query: 503 GHFSIKSDVFSFGVLVLEIISGQ 525
             +    D+++ G LV E+++G+
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 28/208 (13%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRL--SKNSVQGELEFKNEVLLVARLQH-RNLVRLLG 387
           LG+G +G V K R +  G  +AVKR+  + NS Q +     ++ +  R       V   G
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFYG 67

Query: 388 FSFEETERLLIYEFVPNSSVDKF---IFDAIKRVQLDWETRYKIIGGIARGIL----YLH 440
             F E +  +  E V ++S+DKF   ++D    +  D      I+G IA  I+    YLH
Sbjct: 68  ALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPED------ILGKIAVSIVKALEYLH 120

Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
              +L +IHRD+K SN+L++ +   K+ DFG++    +  S   T    G   YMAPE +
Sbjct: 121 S--KLSVIHRDVKPSNVLINRNGQVKLCDFGISG--YLVDSVAKTIDA-GCKPYMAPERI 175

Query: 501 ----TRGHFSIKSDVFSFGVLVLEIISG 524
                +  + +KSDV+S G+ ++E+ +G
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATG 203

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 68/234 (29%), Positives = 110/234 (47%), Gaps = 51/234 (21%)

Query: 331 KLGQGGFGAVYKGRLSHGQE-----------------IAVKRL----SKNSVQGELEFKN 369
           KLG+G FG V+   + + Q+                 +AVK L    +KN+     +F  
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN---DFLK 68

Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI----------------FD 413
           EV +++RL+  N++RLLG   +E    +I E++ N  +++F+                  
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 414 AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473
           A     + + +   +   IA G+ YL   S L  +HRDL   N L+  ++  KI+DFGM+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 474 RLFEMDQSQGDTSRIVG----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           R    +   GD  RI G       +MA E +  G F+  SDV++FGV + EI+ 
Sbjct: 186 R----NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 12/198 (6%)

Query: 331 KLGQGGFGAVYKGRLSHGQE-IAVK--RLSKNSVQGELEFKNEVLLVARLQHRNLVRLLG 387
           K+G+G +G VYK R     E IA+K  RL +           E+ L+  +QH N+VRL  
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
               E    L++E++ +  + K + D+      +       +  I RGI Y H  S  R+
Sbjct: 69  VVHSEKRLYLVFEYL-DLDLKKHM-DSSPDFAKNPRLIKTYLYQILRGIAYCH--SH-RV 123

Query: 448 IHRDLKASNILLD-ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HF 505
           +HRDLK  N+L+D      K++DFG+AR F +   +  T  +V T  Y APE +    H+
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-TLWYRAPEILLGSRHY 181

Query: 506 SIKSDVFSFGVLVLEIIS 523
           S   D++S G +  E+++
Sbjct: 182 STPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 78.8 bits (194), Expect = 3e-16
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 15/199 (7%)

Query: 332 LGQGGFGAVYKG--RLSHGQE--IAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLL 386
           LG G FG + +G  +L   +E  +A+  L    S +    F  E L + +  H N+VRL 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
           G        +++ E++ N ++D F+       QL       ++ G+A G+ YL E   + 
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSE---MG 127

Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG--TFGYMAPEYVTRGH 504
            +H+ L A  +L+++D++ KIS F   RL E D+S+   + + G     + APE +   H
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR--RLQE-DKSEAIYTTMSGKSPVLWAAPEAIQYHH 184

Query: 505 FSIKSDVFSFGVLVLEIIS 523
           FS  SDV+SFG+++ E++S
Sbjct: 185 FSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 61/223 (27%), Positives = 109/223 (48%), Gaps = 34/223 (15%)

Query: 327 STDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-Q 378
           +    LG+G FG V K         +    +AVK L  ++ + +L +  +E+ ++  + +
Sbjct: 15  TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 74

Query: 379 HRNLVRLLGFSFEETERLLIYEFV-------------PNSSVDKFIFDAIKRVQLDWETR 425
           H+N++ LLG   +E    ++ E+              P                L   T+
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL---TQ 131

Query: 426 YKIIG---GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQS 481
             ++     +ARG+ +L   S+ + IHRDL A N+L+  D + KI+DFG+AR +  +D  
Sbjct: 132 KDLVSFAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188

Query: 482 QGDTS-RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +  T+ R+     +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 189 RKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 78.4 bits (193), Expect = 3e-16
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 30/232 (12%)

Query: 331 KLGQGGFGAVYKGRLSHG---QEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLL 386
           ++G G FG V  G ++ G    ++ VK L  + SVQ +++F  E      LQH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFD--AIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           G   E T  LL+ EF P   +  ++      + +  D  T  ++   IA G+L+LH+++ 
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
              IH DL   N LL AD+  KI D+G++     +       ++     ++APE V   H
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 505 FSI-------KSDVFSFGVLVLEIISGQKNNSFRIGEEA------EDLLTYV 543
            ++       +S+V+S GV + E+        F +G +       E +LTY 
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL--------FELGSQPYRHLSDEQVLTYT 222

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 56/205 (27%), Positives = 103/205 (50%), Gaps = 21/205 (10%)

Query: 334 QGGFGAVYKGRLSHG-----QEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLG 387
           +G FG ++ G L        +E+ VK +  ++ + ++     E  L+  L H+N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 388 FSFEETER-LLIYEFVPNSSVDKFIFD---AIKRVQLDWETRYKIIGG--IARGILYLHE 441
              E+ E   ++Y ++   ++  F+               T+  +     IA G+ YLH 
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMD-QSQGDT-SRIVGTFGYMAPE 498
             +  +IH+D+ A N ++D ++  KI+D  ++R LF MD    GD  +R V    +MA E
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---WMALE 189

Query: 499 YVTRGHFSIKSDVFSFGVLVLEIIS 523
            +    +S  SDV+SFGVL+ E+++
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 19/202 (9%)

Query: 331 KLGQGGFGAVYKGRLSH-GQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ---HRNLVR 384
           ++G G +G VYK R  H G  +A+K  R+  N     L    EV L+ RL+   H N+VR
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 385 LLGF-----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
           L+       +  ET+  L++E V      +   D +    L  ET   ++    RG+ +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQDL--RTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
           H +    I+HRDLK  NIL+ +    K++DFG+AR++     Q   + +V T  Y APE 
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178

Query: 500 VTRGHFSIKSDVFSFGVLVLEI 521
           + +  ++   D++S G +  E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 78.2 bits (192), Expect = 4e-16
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 17/209 (8%)

Query: 325 NFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELE-----FKNEVLLVARLQ 378
           N+     LGQG FG VY       G+E+AVK++  +    E        + E+ L+  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 379 HRNLVRLLGFSFEETERLL--IYEFVPNSSVDKFIFDAIKRV-QLDWETRYKIIGGIARG 435
           H  +V+  G   +  ER L    E +P  S+     D +K    L      K    I  G
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEG 118

Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA-RLFEMDQSQGDTSRIVGTFGY 494
           + YLH +    I+HRD+K +NIL D+    K+ DFG + RL  +  S      + GT  +
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175

Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           M+PE ++   +  K+D++S G  V+E+++
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 9/197 (4%)

Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLGF 388
           LG+GGFG V   ++ + G+  A K+L K  ++ +   K  +L    L+  N   +  L +
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
           +FE    L +   + N    K+    +    L+ E        I  GIL+LH    + I+
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117

Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIK 508
           +RD+K  N+LLD     ++SD G+A   E+   +  T R  GT GYMAPE +    +S  
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQR-AGTNGYMAPEILKEEPYSYP 174

Query: 509 SDVFSFGVLVLEIISGQ 525
            D F+ G  + E+++G+
Sbjct: 175 VDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 7e-16
 Identities = 54/183 (29%), Positives = 88/183 (48%), Gaps = 19/183 (10%)

Query: 331 KLGQGGFGAVYKGRL---SHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQHRNLVR 384
            +G+G +G VYK +      G+E A+K+   +  Q          E+ L+  L+H N+V 
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 385 LLGFSFEETERL--LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           L+    E  ++   L++++  +    + KF   A KRV +       ++  I  G+ YLH
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQA-KRVSIPPSMVKSLLWQILNGVHYLH 125

Query: 441 EDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLF-EMDQSQGDTSRIVGTFGYM 495
            +    ++HRDLK +NIL+  +       KI D G+ARLF    +   D   +V T  Y 
Sbjct: 126 SN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYR 182

Query: 496 APE 498
           APE
Sbjct: 183 APE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 77.3 bits (190), Expect = 7e-16
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 22/207 (10%)

Query: 331 KLGQGGFGAVYKG--RLSHGQEIAVKRLSKNSVQGELEFKNEVL----LVARLQHRNLVR 384
           +LG G FG V KG  ++   ++    ++ KN        K+E+L    ++ +L +  +VR
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP-ALKDELLREANVMQQLDNPYIVR 60

Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           ++G   E    +L+ E      ++KF+    K   +  +   +++  ++ G+ YL E + 
Sbjct: 61  MIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN- 115

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMD----QSQGDTSRIVGTFGYMAPEYV 500
              +HRDL A N+LL      KISDFG+++    D    +++      V    + APE +
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPV---KWYAPECM 170

Query: 501 TRGHFSIKSDVFSFGVLVLEIIS-GQK 526
               FS KSDV+SFGVL+ E  S GQK
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 78.2 bits (193), Expect = 8e-16
 Identities = 58/190 (30%), Positives = 94/190 (49%), Gaps = 35/190 (18%)

Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKN--EVLLVARLQHRN 381
            F   N++G+G +G VY+ R +   EI A+K++  ++ +  +   +  E+ L+  L+H N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDW------------ETRYK-I 428
           +V L              E V    +D  IF  ++  + D             E++ K +
Sbjct: 68  IVELK-------------EVVVGKHLDS-IFLVMEYCEQDLASLLDNMPTPFSESQVKCL 113

Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
           +  + RG+ YLHE+    IIHRDLK SN+LL      KI+DFG+AR + +      T ++
Sbjct: 114 MLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-TPKV 169

Query: 489 VGTFGYMAPE 498
           V T  Y APE
Sbjct: 170 V-TLWYRAPE 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 77.0 bits (189), Expect = 9e-16
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)

Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELE-----FKNEVLLVARLQHRNLVRL 385
           LGQG FG VY    +  G+E+A K++  +    E        + E+ L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 386 LGFSFEETERLL--IYEFVPNSSVDKFIFDAIKRV-QLDWETRYKIIGGIARGILYLHED 442
            G   +  E+ L    E++P  SV     D +K    L      K    I  G+ YLH +
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMAPEYVT 501
               I+HRD+K +NIL D+    K+ DFG ++  +     G   R + GT  +M+PE ++
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
              +  K+DV+S G  V+E+++
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 29/202 (14%)

Query: 334 QGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL--------V 383
           +G FG+VY  K R + G   A+K L K+     +  KN+V  V + +   +        V
Sbjct: 6   KGAFGSVYLAKKRST-GDYFAIKVLKKSD----MIAKNQVTNV-KAERAIMMIQGESPYV 59

Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
             L +SF+  + L L+ E++        I   +  +  DW  +Y  I  +  G+  LH+ 
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQY--IAEVVLGVEDLHQR 116

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
               IIHRD+K  N+L+D     K++DFG++R    ++      + VGT  Y+APE +  
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILG 167

Query: 503 GHFSIKSDVFSFGVLVLEIISG 524
                 SD +S G ++ E + G
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 25/206 (12%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR--NLVRLLGF 388
           +G G  G VYK R    G  +AVK++ +   + E +     L V    H    +V+  G+
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL----YLHEDSR 444
              +++  +  E + ++ +DK +    KR+Q        I+G +   I+    YL E   
Sbjct: 83  FITDSDVFICMELM-STCLDKLL----KRIQGPIPED--ILGKMTVAIVKALHYLKEKHG 135

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMA-RLFEMDQSQGDTSRIVGTFGYMAPEYVT-- 501
             +IHRD+K SNILLDA    K+ DFG++ RL +   S+  T R  G   YMAPE +   
Sbjct: 136 --VIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKT-RSAGCAAYMAPERIDPP 189

Query: 502 --RGHFSIKSDVFSFGVLVLEIISGQ 525
                + I++DV+S G+ ++E+ +GQ
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 65/214 (30%), Positives = 110/214 (51%), Gaps = 15/214 (7%)

Query: 332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN---EVLLVARLQHRNLVRLLG 387
           LG+GGFG V   ++ + G+  A K+L+K  ++    ++    E  ++A++  R +V  L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS-LA 59

Query: 388 FSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRL 445
           ++F+ +T+  L+   +    +   I++  +      E R       I  G+ +LH+    
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116

Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
           RII+RDLK  N+LLD D   +ISD G+A   E+   Q  T    GT G+MAPE +    +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEEY 174

Query: 506 SIKSDVFSFGVLVLEIISGQKNNSFRI-GEEAED 538
               D F+ GV + E+I+ +    FR  GE+ E+
Sbjct: 175 DFSVDYFALGVTLYEMIAAR--GPFRARGEKVEN 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 63/223 (28%), Positives = 107/223 (47%), Gaps = 37/223 (16%)

Query: 331 KLGQGGFGAVY----KGRLSHGQE-------------IAVKRLSKNSVQ-GELEFKNEVL 372
           KLG+G FG V+    +G      +             +AVK L +++ +    +F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI--------FDAIKRVQLDWET 424
           +++RL+  N++RLL          +I E++ N  +++F+         +    V + + T
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
              +   IA G+ YL   S L  +HRDL   N L+  +   KI+DFGM+R    +   GD
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSGD 184

Query: 485 TSRIVG----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             RI G       +M+ E +  G F+  SDV++FGV + EI++
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 76.4 bits (189), Expect = 2e-15
 Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 22/204 (10%)

Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSK--NSVQGELEFKNEVLLVARLQ-HRNLVRLL 386
           +LG G FG+VY  R    G+ +A+K++ K   S +  +  + EV  + +L  H N+V+L 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKLNEHPNIVKLK 64

Query: 387 GFSFEETERL-LIYEFVPNSSVDKFIFDAIKR---VQLDWETRYKIIGGIARGILYLHED 442
              F E + L  ++E++     +  ++  +K              II  I +G+ ++H  
Sbjct: 65  E-VFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH-- 116

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
            +    HRDLK  N+L+    + KI+DFG+AR  E+ +S+   +  V T  Y APE + R
Sbjct: 117 -KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EI-RSRPPYTDYVSTRWYRAPEILLR 172

Query: 503 -GHFSIKSDVFSFGVLVLEIISGQ 525
              +S   D+++ G ++ E+ + +
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 76.8 bits (189), Expect = 3e-15
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 15/199 (7%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEV----LLVARLQHRNLVRLL 386
           +G+G FG V   +  + G+  AVK L K ++  + E K+ +    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRL 445
            +SF+  ++L    FV +      +F  ++R +   E R +     IA  + YLH    L
Sbjct: 62  HYSFQTADKLY---FVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS---L 115

Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
            II+RDLK  NILLD+     ++DFG+ +  E  +    TS   GT  Y+APE + +  +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173

Query: 506 SIKSDVFSFGVLVLEIISG 524
               D +  G ++ E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 58/203 (28%), Positives = 108/203 (53%), Gaps = 20/203 (9%)

Query: 331 KLGQGGFGAVYKGR--LSHGQEIAVKRLS-KNSVQG-ELEFKNEVLLVARLQ---HRNLV 383
           ++G+G +G V+K R   + G+ +A+KR+  +   +G  L    EV ++  L+   H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 384 RLLGF-----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           RL        +  ET+  L++E V +  +  ++ D +    +  ET   ++  + RG+ +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           LH     R++HRDLK  NIL+ +    K++DFG+AR++     Q   + +V T  Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE 179

Query: 499 YVTRGHFSIKSDVFSFGVLVLEI 521
            + +  ++   D++S G +  E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 22/203 (10%)

Query: 330 NKLGQGGFGAVYKGR-LSHGQEIAVKRLSK--NSVQGELEFKNEVLLVARLQ-HRNLVRL 385
            K+G+G F  V K +    G+  A+K + K   S++       E+  + RL  H N++RL
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRL 63

Query: 386 LGFSFEE-TERL-LIYEFVPNSSVDKFIFDAIK-RVQLDWETRYK-IIGGIARGILYLHE 441
           +   F+  T RL L++E +     D  +++ IK R +   E R K  +  + + + ++H 
Sbjct: 64  IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH- 117

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE-YV 500
             R  I HRD+K  NIL+  D++ K++DFG  R   +      T  I  T  Y APE  +
Sbjct: 118 --RNGIFHRDIKPENILIKDDIL-KLADFGSCR--GIYSKPPYTEYI-STRWYRAPECLL 171

Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
           T G++  K D+++ G +  EI+S
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 76.0 bits (187), Expect = 6e-15
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 31/209 (14%)

Query: 330 NKLGQGGFGAVYKGR-LSHGQEIAVKRLSKN---SVQGELEFKNEVLLVARLQHRNLVRL 385
           N++G G  G VYK      G+  A+K +  N   +V+ ++  + E+L      H N+V+ 
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV--NHPNVVKC 137

Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR----GILYLHE 441
                   E  ++ EF+   S++         +    + ++  +  +AR    GI YLH 
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSLEG------THI---ADEQF--LADVARQILSGIAYLH- 185

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV- 500
             R  I+HRD+K SN+L+++    KI+DFG++R+  + Q+    +  VGT  YM+PE + 
Sbjct: 186 --RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTIAYMSPERIN 241

Query: 501 ---TRGHFS-IKSDVFSFGVLVLEIISGQ 525
                G +     D++S GV +LE   G+
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 74.9 bits (184), Expect = 7e-15
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 31/212 (14%)

Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
           LG G  G VYK   L   + +AVK +  + +V+ + +  +E+ ++ +     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA----RGILYLHEDSRL 445
           F E    +  EF+   S+D +            +    ++G IA    +G+ YL     L
Sbjct: 69  FVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS---L 114

Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
           +I+HRD+K SN+L++     K+ DFG++   ++  S   T   VGT  YMAPE ++   +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVST--QLVNSIAKT--YVGTNAYMAPERISGEQY 170

Query: 506 SIKSDVFSFGVLVLEIISG-------QKNNSF 530
            I SDV+S G+  +E+  G       QKN   
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGS 202

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 75.1 bits (185), Expect = 8e-15
 Identities = 67/203 (33%), Positives = 104/203 (51%), Gaps = 21/203 (10%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFK---NE--VLLVARLQHRNLVRL 385
           LG+G FG V    L    E+ AVK L K+ +  + + +    E  VL +A  +H  L +L
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQL 61

Query: 386 LGFS-FEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHED 442
              S F+  +RL  + E+V    +   +F   +  + D E R +     I  G+ +LHE 
Sbjct: 62  --HSCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFD-EPRARFYAAEIVLGLQFLHER 115

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
               II+RDLK  N+LLD++   KI+DFGM +  E       TS   GT  Y+APE ++ 
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSY 170

Query: 503 GHFSIKSDVFSFGVLVLEIISGQ 525
             +    D ++ GVL+ E+++GQ
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 75.1 bits (184), Expect = 8e-15
 Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 28/216 (12%)

Query: 332 LGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRN 381
           LG+G FG V         K +      +AVK L  ++ + +L +  +E+ ++  + +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFI-----------FDAIKRV---QLDWETRYK 427
           ++ LLG   ++    +I E+    ++ +++           +D I RV   Q+ ++    
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-IARVPDEQMTFKDLVS 141

Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
               +ARG+ YL   +  + IHRDL A N+L+  + + KI+DFG+AR          T+ 
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198

Query: 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                 +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 75.9 bits (187), Expect = 8e-15
 Identities = 34/95 (35%), Positives = 58/95 (61%), Gaps = 5/95 (5%)

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
           I RG+ YLH      I+HRD+K  N+L++++ + KI DFG+AR+ E D+S+  T  +V  
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 492 FGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           + Y APE +    H++   D++S G +  E++  +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 75.3 bits (185), Expect = 8e-15
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 19/202 (9%)

Query: 332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFK-----NEVLLVARLQHRNLVRL 385
           LG+G FG V   RL   G+  AVK L K+ +  + + +       +L +AR  H  L +L
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61

Query: 386 LGFSFEETERLL-IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDS 443
               F+  +RL  + EFV    +   +F   K  + D E R +     I   +++LH+  
Sbjct: 62  Y-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFYAAEITSALMFLHDKG 116

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
              II+RDLK  N+LLD +   K++DFGM +  E   +   TS   GT  Y+APE +   
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEM 171

Query: 504 HFSIKSDVFSFGVLVLEIISGQ 525
            +    D ++ GVL+ E++ G 
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGH 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 74.4 bits (183), Expect = 9e-15
 Identities = 43/149 (28%), Positives = 81/149 (54%), Gaps = 9/149 (6%)

Query: 331 KLGQGGFGAVYKGRLSHGQEI-AVKRLS-KNSVQGELEFK-NEVLLVARLQHRNLVRLLG 387
           K+G+G +G V+K +     EI A+KR+   +  +G       E+ L+  L+H+N+VRL  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
               + +  L++E+  +  + K+ FD+     +D E     +  + +G+ + H      +
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKY-FDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH---NV 120

Query: 448 IHRDLKASNILLDADMIPKISDFGMARLF 476
           +HRDLK  N+L++ +   K++DFG+AR F
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAF 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 29/206 (14%)

Query: 331 KLGQGGFGAVY---------KGRLSHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHR 380
           +LG+G FG VY         + RL   +EI V  L+ N +VQ   E +    L+++L H 
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQ----LLSKLDHP 62

Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWET--RYKIIGGIAR---G 435
            +V+      E     +I E+     +D      ++ ++   +T    ++     +   G
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLD----CKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
           + Y+H+    RI+HRDLKA NI L  +++ KI DFG++RL  M      T+   GT  YM
Sbjct: 119 VHYMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-MGSCDLATT-FTGTPYYM 172

Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEI 521
           +PE +    +  KSD++S G ++ E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 62/220 (28%), Positives = 109/220 (49%), Gaps = 27/220 (12%)

Query: 326 FSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSK--NSVQGELEFKNEVLLVARLQH 379
           F+    LG+G FG+V + +L       Q++AVK L     S     EF  E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 380 RNLVRLLGFSFEETER------LLIYEFVPNSSVDKFIFDAIKRV-----QLDWETRYKI 428
            N+++L+G S     +      ++I  F+ +  +  F+   + R+      L  +T  + 
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL--MSRIGEEPFTLPLQTLVRF 118

Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMD-QSQGDTS 486
           +  IA G+ YL   S    IHRDL A N +L+ +M   ++DFG+++ ++  D   QG  S
Sbjct: 119 MIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175

Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQ 525
           ++     ++A E +    ++  SDV++FGV + EI++ GQ
Sbjct: 176 KL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 18/202 (8%)

Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN----EVLLVARLQHRNLVRL 385
           K+G+G +G V+K R    GQ +A+K+  ++  + +   K     E+ ++ +L+H NLV L
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVES--EDDPVIKKIALREIRMLKQLKHPNLVNL 65

Query: 386 LGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           +   F    +L L++E+  ++ +++   +   R  +      KII    + + + H   +
Sbjct: 66  IEV-FRRKRKLHLVFEYCDHTVLNEL--EKNPR-GVPEHLIKKIIWQTLQAVNFCH---K 118

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY-VTRG 503
              IHRD+K  NIL+      K+ DFG AR+  +     D +  V T  Y APE  V   
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELLVGDT 176

Query: 504 HFSIKSDVFSFGVLVLEIISGQ 525
            +    DV++ G +  E+++GQ
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 61/216 (28%), Positives = 112/216 (51%), Gaps = 28/216 (12%)

Query: 332 LGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRN 381
           LG+G FG V         K + +    +AVK L  ++   +L +  +E+ ++  + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFI-----------FDAIK--RVQLDWETRYKI 428
           ++ LLG   ++    ++ E+    ++ +++           FD  K    QL ++     
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSR 487
              +ARG+ YL   +  + IHRDL A N+L+  D + KI+DFG+AR +  +D  +  T+ 
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            +    +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 197 RL-PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 21/229 (9%)

Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYK-GRLSHGQEIAVKRLSKNS-VQGELEF 367
            S      ++ D T+ +     +G+G +G VYK      G   AVK L   S V  E+E 
Sbjct: 8   NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA 67

Query: 368 KNEVLLVARLQHRNLVRLLGFSFEETERL------LIYEFVPNSSVDKFIFDAIKRVQ-L 420
           +  +L      H N+V+  G  F + ++L      L+ E     SV + +   +   Q L
Sbjct: 68  EYNILQSLP-NHPNVVKFYGM-FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL 125

Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
           D      I+ G   G+ +LH +   RIIHRD+K +NILL  +   K+ DFG++      +
Sbjct: 126 DEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182

Query: 481 SQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISG 524
            + +TS  VGT  +MAPE +         +  + DV+S G+  +E+  G
Sbjct: 183 LRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 57/206 (27%), Positives = 113/206 (54%), Gaps = 15/206 (7%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR-NL 382
           ++F   ++LG G  G V K +      I  ++L    ++  +  +N+++   ++ H  N 
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAI--RNQIIRELQVLHECNS 62

Query: 383 VRLLGFS---FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
             ++GF    + + E  +  E +   S+D+ + +A KR+    E   K+   + RG+ YL
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA-KRIP--EEILGKVSIAVLRGLAYL 119

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
            E  + +I+HRD+K SNIL+++    K+ DFG++   ++  S  ++   VGT  YM+PE 
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPER 173

Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +   H+S++SD++S G+ ++E+  G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 60/217 (27%), Positives = 113/217 (52%), Gaps = 30/217 (13%)

Query: 332 LGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRN 381
           LG+G FG V         K + +   ++AVK L  ++ + +L +  +E+ ++  + +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIF-------------DAIKRVQLDWETRYKI 428
           ++ LLG   ++    +I E+    ++ +++                +   QL ++     
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTS- 486
              +ARG+ YL   +  + IHRDL A N+L+  D + KI+DFG+AR +  +D  +  T+ 
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           R+     +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 203 RL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 17/209 (8%)

Query: 325 NFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRL-----SKNSVQGELEFKNEVLLVARLQ 378
           N+     LG+G FG VY       G+E+AVK++     S+ + +     + E+ L+  L+
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 379 HRNLVRLLGFSFEETERLL--IYEFVPNSSVDKFIFDAIKRV-QLDWETRYKIIGGIARG 435
           H  +V+  G   +  E+ L    E++P  S+     D +K    L      +    I +G
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQG 118

Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA-RLFEMDQSQGDTSRIVGTFGY 494
           + YLH +    I+HRD+K +NIL D+    K+ DFG + R+  +  S      + GT  +
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175

Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           M+PE ++   +  K+DV+S    V+E+++
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 42/113 (37%), Positives = 64/113 (56%), Gaps = 10/113 (8%)

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVG 490
           IA G+ +LH      II+RDLK  N++LDA+   KI+DFGM +        G T+R   G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG---GKTTRTFCG 163

Query: 491 TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           T  Y+APE +    +    D ++FGVL+ E+++GQ    F  GE+ ++L   +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP--PFD-GEDEDELFQSI 213

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 37/106 (34%), Positives = 59/106 (55%), Gaps = 22/106 (20%)

Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG--------MARLFEM 478
           KI   + RG+ YL E  + +I+HRD+K SNIL+++    K+ DFG        MA  F  
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-- 158

Query: 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
                     VGT  YM+PE +   H++++SD++S G+ ++E+  G
Sbjct: 159 ----------VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 64/199 (32%), Positives = 89/199 (44%), Gaps = 13/199 (6%)

Query: 332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLL 386
           LG+G FG V+   L    Q  A+K L K+ V      E     + +L    +H  L  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
             +F+  E L       N     F   +  +  L   T Y     I  G+ +LH      
Sbjct: 63  -CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYA--AEIICGLQFLHSKG--- 116

Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
           I++RDLK  NILLD D   KI+DFGM +  E       T    GT  Y+APE +    ++
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174

Query: 507 IKSDVFSFGVLVLEIISGQ 525
              D +SFGVL+ E++ GQ
Sbjct: 175 TSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.1 bits (177), Expect = 7e-14
 Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 22/213 (10%)

Query: 325 NFSTDNKLGQGGFGAVY----KGRLSHGQEIAVKRLSKNSV---QGELEF-KNEVLLVAR 376
           NF     LG G +G V+     G    G+  A+K L K ++       E  + E  ++  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 377 LQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIAR 434
           ++    +  L ++F+   +L LI ++V        +F  + + +   E+  ++ I  I  
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGE----LFTHLYQREHFTESEVRVYIAEIVL 116

Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
            + +LH+   L II+RD+K  NILLD++    ++DFG+++ F  ++ +   S   GT  Y
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEY 172

Query: 495 MAPEYV---TRGHFSIKSDVFSFGVLVLEIISG 524
           MAPE +   + GH     D +S GVL  E+++G
Sbjct: 173 MAPEVIRGGSGGHDKA-VDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 72.3 bits (177), Expect = 7e-14
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 17/200 (8%)

Query: 332 LGQGGFGAVY-KGRLSHGQEIAVKRLSKNSVQGELEFKNEV----LLVARLQHRNLVRLL 386
           +G+G FG V    R S G   AVK L K ++  + E  + +    +L+  L+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61

Query: 387 GFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSR 444
            +SF+  E+L  + ++V        +F  ++R +   E R +     +A  I YLH    
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGE----LFFHLQRERCFLEPRARFYAAEVASAIGYLHS--- 114

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
           L II+RDLK  NILLD+     ++DFG+ +  E  + +  TS   GT  Y+APE + +  
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEP 172

Query: 505 FSIKSDVFSFGVLVLEIISG 524
           +    D +  G ++ E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 72.1 bits (177), Expect = 7e-14
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 25/211 (11%)

Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRN-LVRLL 386
           K+G+G +G VYK R  + G+ +A+K  RL  +          E+ L+  L     +VRLL
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 387 GFSFEETER-------LLIYEFVPNSSVDKFIFDAIKRVQ---LDWETRYKIIGGIARGI 436
               E  E         L++E++ +S + KF+ D+  R     L  +T    +  + +G+
Sbjct: 68  --DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQLLKGV 123

Query: 437 LYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            + H   +  ++HRDLK  N+L+D    + KI+D G+ R F +   +  T  IV T  Y 
Sbjct: 124 AHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV-TLWYR 178

Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           APE +    H+S   D++S G +  E+   Q
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 33/217 (15%)

Query: 331 KLGQGGFGAVYKGRLSHG---QEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL-- 385
           K+G+G +G VYK +   G   +E A+K++    +   +    E+ L+  L+H N++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIALQK 65

Query: 386 -----------LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
                      L F + E +   I +F   S  +K      K +QL       ++  I  
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANK------KPMQLPRSMVKSLLYQILD 119

Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEMD-QSQGDTSRIV 489
           GI YLH +    ++HRDLK +NIL+  +       KI+D G ARLF    +   D   +V
Sbjct: 120 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 490 GTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
            TF Y APE +    H++   D+++ G +  E+++ +
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 58/218 (26%), Positives = 107/218 (49%), Gaps = 38/218 (17%)

Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQHR 380
            +   N++ +G +G VY+ R    G+ +A+K+L K   + E   +    E+ ++ +LQH 
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLREINILLKLQHP 64

Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG--------- 431
           N+V              + E V  S++DK I+  ++ V+ D ++  + +           
Sbjct: 65  NIVT-------------VKEVVVGSNLDK-IYMVMEYVEHDLKSLMETMKQPFLQSEVKC 110

Query: 432 ----IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
               +  G+ +LH++    I+HRDLK SN+LL+   I KI DFG+AR +         ++
Sbjct: 111 LMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG--SPLKPYTQ 165

Query: 488 IVGTFGYMAPE-YVTRGHFSIKSDVFSFGVLVLEIISG 524
           +V T  Y APE  +    +S   D++S G +  E+++ 
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 18/215 (8%)

Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSK---NSVQGELEFKNEV 371
           F T+ + TN +     +G G FG V   R    GQ +A+K++ K     V  +  ++ E+
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-EL 60

Query: 372 LLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG 431
            L+  L+H N++ L        E +     +  + + + +       Q      Y+I+  
Sbjct: 61  KLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQIL-- 118

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
             RG+ Y+H      ++HRDLK SNIL++ +   KI DFG+AR+ +  Q  G     V T
Sbjct: 119 --RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD-PQMTG----YVST 168

Query: 492 FGYMAPE-YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
             Y APE  +T   + ++ D++S G +  E++ G+
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 27/208 (12%)

Query: 332 LGQGGFGAVYKGRLSHG-------QEIAV--------KRLSKNSVQGELEFKNEVLLV-A 375
           LG G FG VYK R  +        +EI V        KR    S+    +  +EV ++  
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIG---DIVSEVTIIKE 64

Query: 376 RLQHRNLVRLLGFSFEETERL-LIYEFVPNSSV-DKFIFDAIKRVQLDWETRYKIIGGIA 433
           +L+H N+VR    +F E +RL ++ + +  + + + F     K+ +   E  + I   + 
Sbjct: 65  QLRHPNIVRYYK-TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123

Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             + YLH++ R  I+HRDL  +NI+L  D    I+DFG+A+     Q +   + +VGT  
Sbjct: 124 LALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTIL 178

Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
           Y  PE V    +  K+DV++FG ++ ++
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 29/206 (14%)

Query: 331 KLGQGGFG-AVYKGRLSHGQEIAVKRL--SKNSVQGELEFKNEVLLVARLQHRNLVRLLG 387
           K+G+G FG A+       G++  +K +  SK S +   E + EV +++ ++H N+V+   
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 388 FSFEETERLLI----------YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
            SFEE   L I          Y+ +       F  D I    LDW  +      I   + 
Sbjct: 67  -SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI----LDWFVQ------ICLALK 115

Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           ++H+    +I+HRD+K+ NI L  D   K+ DFG+AR+         T   +GT  Y++P
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC--IGTPYYLSP 170

Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
           E      ++ KSD+++ G ++ E+ +
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 29/220 (13%)

Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEF------KNEVLLVARLQHRNLVR 384
           LG+G FG V        G+  A+K L K  +    E       K         +H  LV 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 385 LLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDW--ETRYKIIGG-IARGILYLH 440
           L    F+  + +  + E+           D +  +  D   E R       +  G+ YLH
Sbjct: 67  LFA-CFQTEDHVCFVMEYAAGG-------DLMMHIHTDVFSEPRAVFYAACVVLGLQYLH 118

Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD-TSRIVGTFGYMAPEY 499
           E+   +I++RDLK  N+LLD +   KI+DFG   L +     GD TS   GT  ++APE 
Sbjct: 119 EN---KIVYRDLKLDNLLLDTEGFVKIADFG---LCKEGMGFGDRTSTFCGTPEFLAPEV 172

Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDL 539
           +T   ++   D +  GVL+ E++ G+  + F  G++ E++
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGE--SPFP-GDDEEEV 209

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 24/208 (11%)

Query: 330 NKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHR----NL 382
           ++LG+G +G+VYK      G  +A+K  RL  +    E +F N++++   + H+     +
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD----ESKF-NQIIMELDILHKAVSPYI 61

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           V   G  F E    +  E++   S+DK     +    +  +   +I   + +G+ +L E+
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT- 501
               IIHRD+K +N+L++ +   K+ DFG++       ++ +    +G   YMAPE +  
Sbjct: 122 --HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPERIKS 175

Query: 502 -----RGHFSIKSDVFSFGVLVLEIISG 524
                   ++++SDV+S G+ +LE+  G
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALG 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 56/217 (25%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLS-KNSVQGELEF-KNEVLLVARLQHRNLVRLLGF 388
           +G+G +G V   R  + G++  +K+L+ +N+ + E +  + E  L+++L+H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV----- 62

Query: 389 SFEET---ERLLIY--------------------EFVPNSSVDKFIFDAIKRVQLDWETR 425
           ++ E+   E  L+Y                    + +P + V            ++W  +
Sbjct: 63  AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQV------------VEWFVQ 110

Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD- 484
                 IA  + YLHE     I+HRDLK  N+ L    I K+ D G+AR+ E   +Q D 
Sbjct: 111 ------IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE---NQCDM 158

Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
            S ++GT  YM+PE  +   ++ KSDV++ G  V E+
Sbjct: 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 41/213 (19%)

Query: 332 LGQGGFGAV---YKGRLSHGQEIAVKRLSK--NSVQGELEFKNEVLLVARLQHRNLVRLL 386
           +G G +G+V   Y  RL   Q++AVK+LS+   S+        E+ L+  ++H N++ LL
Sbjct: 23  VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 387 GFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLDWETRYKIIGGIA 433
                         F P +S++ F             + + +K  +L  E    +I  + 
Sbjct: 81  DV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128

Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           RG+ Y+H      IIHRDLK SN+ ++ D   +I DFG+AR     Q+  + +  V T  
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRW 180

Query: 494 YMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           Y APE +    H++   D++S G ++ E++ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 19/202 (9%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEF-----KNEVLLVARLQHRNLVRL 385
           LG+G FG V    L    E+ A+K L K+ +  + +      +  +L +A  +H  L  L
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61

Query: 386 LGFSFEETERLL-IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDS 443
               F+  +RL  + E+V    +   +F   +  + D E R +     +   +++LH   
Sbjct: 62  HC-CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFD-EPRSRFYAAEVTLALMFLHRHG 116

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
              +I+RDLK  NILLDA+   K++DFGM +  E   +   T+   GT  Y+APE +   
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQEL 171

Query: 504 HFSIKSDVFSFGVLVLEIISGQ 525
            +    D ++ GVL+ E+++GQ
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 17/200 (8%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKNEV----LLVARLQHRNLVRLL 386
           +G+G FG V   R    ++  AVK L K ++  + E K+ +    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61

Query: 387 GFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSR 444
            FSF+  ++L  + +++        +F  ++R +   E R +     IA  + YLH    
Sbjct: 62  HFSFQTADKLYFVLDYINGGE----LFYHLQRERCFLEPRARFYAAEIASALGYLHS--- 114

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
           L I++RDLK  NILLD+     ++DFG+ +  E  +  G TS   GT  Y+APE + +  
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 505 FSIKSDVFSFGVLVLEIISG 524
           +    D +  G ++ E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 23/228 (10%)

Query: 326 FSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLS-KNSVQG-ELEFKNEVLLVARLQHRNL 382
           F    ++G+G +G VYK R    G+ +A+K++   N  +G  +    E+ ++ +L HRN+
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 383 VRL----------LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI 432
           V L          L F  ++    L++E++ +   D         V    +     +  +
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH---DLMGLLESGLVHFSEDHIKSFMKQL 125

Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF 492
             G+ Y H+ + L   HRD+K SNILL+     K++DFG+ARL+  ++S+  T++++ T 
Sbjct: 126 LEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TL 181

Query: 493 GYMAPEYVT-RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDL 539
            Y  PE +     +    DV+S G ++ E+ +  K   F+  +E   L
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFT--KKPIFQANQELAQL 227

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 48/208 (23%), Positives = 100/208 (48%), Gaps = 16/208 (7%)

Query: 320 RDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ 378
           R+   +F    ++G G +G VYK R ++ G+  A+K +     +     + E++++   +
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64

Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKF--IFDAIKRVQLDWETRYKIIGGIARGI 436
           H N+V   G      +  +  EF    S+     +   +   Q+ + +R  +     +G+
Sbjct: 65  HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGL 119

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH   +   +HRD+K +NILL  +   K++DFG++   ++  +       +GT  +MA
Sbjct: 120 YYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMA 174

Query: 497 PEYVT---RGHFSIKSDVFSFGVLVLEI 521
           PE      +G ++   D+++ G+  +E+
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 70.1 bits (171), Expect = 4e-13
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 33/217 (15%)

Query: 331 KLGQGGFGAVYKGRLSHGQE---IAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL-- 385
           K+G+G +G VYK +   G++    A+K++    +   +    E+ L+  L+H N++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQK 65

Query: 386 -----------LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
                      L F + E +   I +F   S  +K      K VQL       ++  I  
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANK------KPVQLPRGMVKSLLYQILD 119

Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEMD-QSQGDTSRIV 489
           GI YLH +    ++HRDLK +NIL+  +       KI+D G ARLF    +   D   +V
Sbjct: 120 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 490 GTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
            TF Y APE +    H++   D+++ G +  E+++ +
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 68/204 (33%), Positives = 96/204 (47%), Gaps = 23/204 (11%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELE--------FKNEVLLVARLQHRNL 382
           LG+G FG V    L    E  A+K L K+ V   LE         +  VL +A  +H  L
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVV---LEDDDVECTMVERRVLALA-WEHPFL 58

Query: 383 VRLLGFSFEETERLL-IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
             L   +F+  E L  + E++ N     F   +  R        Y     I  G+ +LH+
Sbjct: 59  THLF-CTFQTKEHLFFVMEYL-NGGDLMFHIQSSGRFDEARARFYA--AEIICGLQFLHK 114

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
                II+RDLK  N+LLD D   KI+DFGM +   M   +G  S   GT  Y+APE + 
Sbjct: 115 KG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE-NM-NGEGKASTFCGTPDYIAPEILK 169

Query: 502 RGHFSIKSDVFSFGVLVLEIISGQ 525
              ++   D +SFGVL+ E++ GQ
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 20/204 (9%)

Query: 332 LGQGGFGAVYKGRLSHGQE----IAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLV 383
           LG+GG+G V++ R   G +     A+K L K ++    +     K E  ++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWE-TRYKIIGGIARGILYLHE 441
            L+ ++F+   +L LI E++        +F  ++R  +  E T    +  I+  + +LH 
Sbjct: 64  DLI-YAFQTGGKLYLILEYLSGGE----LFMHLEREGIFMEDTACFYLSEISLALEHLH- 117

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
             +  II+RDLK  NILLDA    K++DFG+ +  E       T    GT  YMAPE + 
Sbjct: 118 --QQGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILM 173

Query: 502 RGHFSIKSDVFSFGVLVLEIISGQ 525
           R       D +S G L+ ++++G 
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGA 197

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 42/197 (21%)

Query: 348 GQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN 404
           GQ +A+K+LS+   N    +  ++ E++L+  + H+N++ LL              F P 
Sbjct: 41  GQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLNV------------FTPQ 87

Query: 405 SSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDL 452
            S+++F        + DA    + ++ LD E    ++  +  GI +LH      IIHRDL
Sbjct: 88  KSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 144

Query: 453 KASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIK 508
           K SNI++ +D   KI DFG+AR     F M      T  +V T  Y APE +    +   
Sbjct: 145 KPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVV-TRYYRAPEVILGMGYKEN 197

Query: 509 SDVFSFGVLVLEIISGQ 525
            D++S G ++ E+I G 
Sbjct: 198 VDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 38/220 (17%)

Query: 329 DNKLGQGGFGAVYKGRLSHG---QEIAVKRLSKNSVQGE-LEFKNEVLLVARL-QHRNLV 383
           ++ +G+G FG V +  +         A+K L + + + +  +F  E+ ++ +L  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV---------------QLDWETRYKI 428
            LLG         +  E+ P  ++  F+  +  RV                L  +   + 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKS--RVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
              +A G+ YL E    + IHRDL A N+L+  ++  KI+DFG++R        G+   +
Sbjct: 125 ASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--------GEEVYV 173

Query: 489 VGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             T G     +MA E +    ++ KSDV+SFGVL+ EI+S
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 71.4 bits (175), Expect = 6e-13
 Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 20/191 (10%)

Query: 348 GQEIAVKRLSKNSVQGELE---FKNEVLLVARLQHRNLVRLLGFSFEETERLL-IYEFVP 403
           G E+A+K L  ++ + E +   F+ E  L ARL H N+V LL         L  ++E+VP
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 404 NSSV-DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA- 461
             ++ +    D      L      +++  +   +   H      I+HRDLK  NI++   
Sbjct: 63  GRTLREVLAADGA----LPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQT 115

Query: 462 DMIP--KISDFGMARLF----EMDQSQGD-TSRIVGTFGYMAPEYVTRGHFSIKSDVFSF 514
            + P  K+ DFG+  L     + D +    T+ ++GT  Y APE +     +  SD++++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 515 GVLVLEIISGQ 525
           G++ LE ++GQ
Sbjct: 176 GLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 69.5 bits (171), Expect = 7e-13
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 63/226 (27%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---------EVLLVARLQHRN 381
           +G G +G V        G+++A+K++S         F +         E+ L+  L+H N
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60

Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKF--------IFDA-----IK-RVQLDWETRYK 427
           ++ LL             + +   S + F        + +      IK    L  +   +
Sbjct: 61  IIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLT-DDHIQ 106

Query: 428 -IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS-QGDT 485
             +  I RG+ YLH  +   +IHRDLK SNIL++++   KI DFG+AR  + D+  +G  
Sbjct: 107 YFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163

Query: 486 SRIVGTFGYMAPE-------YVTRGHFSIKSDVFSFGVLVLEIISG 524
           +  V T  Y APE       Y      +I  D++S G +  E+++ 
Sbjct: 164 TEYVVTRWYRAPELLLSSSRY----TKAI--DIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 69.5 bits (170), Expect = 8e-13
 Identities = 42/95 (44%), Positives = 59/95 (62%), Gaps = 9/95 (9%)

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS---QGDTSRI 488
           +ARG+ +L   SR + IHRDL A NILL  + + KI DFG+AR    D     +GD +R+
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD-ARL 237

Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                +MAPE +    ++ +SDV+SFGVL+ EI S
Sbjct: 238 --PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 68.4 bits (167), Expect = 8e-13
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 30/208 (14%)

Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRN--LVRL 385
           +G+GGFG VY  R +  G+  A+K L K  +   QGE    NE ++++ +   +   +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE-------TRYKIIGGIARGILY 438
           + ++F   ++L             FI D +    L +        +  ++    A  IL 
Sbjct: 62  MSYAFHTPDKL------------SFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILG 109

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           L       +++RDLK +NILLD     +ISD G+A     D S+      VGT GYMAPE
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPE 165

Query: 499 YVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
            + +G  +   +D FS G ++ +++ G 
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGH 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 69.3 bits (169), Expect = 9e-13
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 21/217 (9%)

Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 11  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70

Query: 375 ARLQHRNLVRLLGF-----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
             ++H N++ LL       S EE   + +   +  + ++    + +K  +L  +    +I
Sbjct: 71  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLI 126

Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
             I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +  + +  V
Sbjct: 127 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYV 178

Query: 490 GTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
            T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 53/209 (25%), Positives = 102/209 (48%), Gaps = 18/209 (8%)

Query: 320 RDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEF-KNEVLLVARLQ 378
           R+  +++    ++G G +G VYK R  H  E+A  ++ K     +    + E+ +V   +
Sbjct: 5   RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK 64

Query: 379 HRNLVRLLGFSFEETERLLI-YEFVPNSSVDKF--IFDAIKRVQLDWETRYKIIGGIARG 435
           H N+V   G S+   E+L I  E+    S+     +   +  +Q+ +  R  +     +G
Sbjct: 65  HCNIVAYFG-SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QG 118

Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
           + YLH   ++   HRD+K +NILL  +   K++DFG+A   ++  +       +GT  +M
Sbjct: 119 LAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWM 173

Query: 496 APEYVT---RGHFSIKSDVFSFGVLVLEI 521
           APE       G ++   D+++ G+  +E+
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 39/212 (18%)

Query: 332 LGQGGFGAV-YKGRLSHGQEIAVKRLSKNSVQGELEFKN---EVLLVARLQHRNLVRLLG 387
           +G G +G V        G ++A+K+L +   Q EL  K    E+ L+  ++H N++ LL 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHENVIGLLD 81

Query: 388 FSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLDWETRYKIIGGIAR 434
                        F P+ S+D+F             +   +K  +L  +    ++  + +
Sbjct: 82  V------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLK 129

Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           G+ Y+H      IIHRDLK  N+ ++ D   KI DFG+AR     Q+  + +  V T  Y
Sbjct: 130 GLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWY 181

Query: 495 MAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
            APE +    H++   D++S G ++ E+++G+
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 17/205 (8%)

Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSV---QGELEFKNEVLLVARLQHR 380
           +      +G G FG V+  R    +   A+K ++   V   + E    NE  ++  + H 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
            ++RL     ++    ++ E+VP   +  ++ ++ +       T       I   + YLH
Sbjct: 62  FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYLH 118

Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                 I++RDLK  NILLD +   K++DFG A+     + +  T  + GT  Y+APE +
Sbjct: 119 S---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEVI 170

Query: 501 -TRGHFSIKSDVFSFGVLVLEIISG 524
            ++GH +   D ++ G+L+ E++ G
Sbjct: 171 QSKGH-NKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 34/215 (15%)

Query: 332 LGQGGFGAVYKGRLSHG---QEIAVKRLSKNSVQGE-LEFKNEVLLVARL-QHRNLVRLL 386
           +G+G FG V K R+       + A+KR+ + + + +  +F  E+ ++ +L  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFD--------AIKRVQ-----LDWETRYKIIGGIA 433
           G         L  E+ P+ ++  F+          A          L  +        +A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           RG+ YL +    + IHRDL A NIL+  + + KI+DFG++R        G    +  T G
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTMG 171

Query: 494 -----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                +MA E +    ++  SDV+S+GVL+ EI+S
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 66/200 (33%), Positives = 93/200 (46%), Gaps = 15/200 (7%)

Query: 332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLL 386
           LG+G FG V    L   G+  AVK L K+ V      E     + +L    ++  L  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 387 GFSFEETERLL-IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
             +F+  E L  + EF+    +   I D   R  L   T Y     I  G+ +LH     
Sbjct: 63  C-TFQTKEHLFFVMEFLNGGDLMFHIQDK-GRFDLYRATFYA--AEIVCGLQFLHSKG-- 116

Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
            II+RDLK  N++LD D   KI+DFGM +  E        S   GT  Y+APE +    +
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKY 173

Query: 506 SIKSDVFSFGVLVLEIISGQ 525
           +   D +SFGVL+ E++ GQ
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 63/243 (25%), Positives = 106/243 (43%), Gaps = 27/243 (11%)

Query: 288 FLRRRKKKQKQNLRKADEINTVESLQF-DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLS 346
           FL+  +  +K++     E      +++ DF+ IR           LG G FG V      
Sbjct: 3   FLKNLQLHKKKDSDSTKEPKRKNKMKYEDFNFIR----------TLGTGSFGRVILATYK 52

Query: 347 HGQ--EIAVKRLSKNSVQGELEFK---NEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401
           +     +A+KR  K+ +  + +     +E  ++  + H   V L G   +E+   L+ EF
Sbjct: 53  NEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEF 112

Query: 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 461
           V       F+    KR   D    Y      A+ +L       L I++RDLK  N+LLD 
Sbjct: 113 VIGGEFFTFLRRN-KRFPNDVGCFYA-----AQIVLIFEYLQSLNIVYRDLKPENLLLDK 166

Query: 462 DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
           D   K++DFG A++ +       T  + GT  Y+APE +        +D ++ G+ + EI
Sbjct: 167 DGFIKMTDFGFAKVVDT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221

Query: 522 ISG 524
           + G
Sbjct: 222 LVG 224

Length = 340

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 67.6 bits (166), Expect = 3e-12
 Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 26/210 (12%)

Query: 330 NKLGQGGFGAVYKGR-LSHGQEIAVKRLS---KNSVQGELEFKNEVLLVARL-QHRNLVR 384
            KLG+G +G V+K       + +A+K++    +N+   +  F+ E++ +  L  H N+V+
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVK 71

Query: 385 LLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQL-DWETRYKIIGGIARGILYLHE 441
           LL     E ++   L++E++     +  +   I+   L D   RY I+  + + + Y+H 
Sbjct: 72  LLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKALKYIH- 124

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLF---EMDQSQGDTSRIVGTFGYMAPE 498
            S   +IHRDLK SNILL++D   K++DFG+AR     E +      +  V T  Y APE
Sbjct: 125 -SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182

Query: 499 YV---TRGHFSIKSDVFSFGVLVLEIISGQ 525
            +   TR    +  D++S G ++ E++ G+
Sbjct: 183 ILLGSTRYTKGV--DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 18/211 (8%)

Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGELEF----KNEVLLVAR 376
           NF     LG G +G V+  R   G +     A+K L K ++  + +     + E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 377 LQHRNLVRLLGFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARG 435
           ++    +  L ++F+ +T+  LI +++    +   +    +R +   +      G I   
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVLA 117

Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
           + +LH   +L II+RD+K  NILLD++    ++DFG+++ F  D+ +   S   GT  YM
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYM 173

Query: 496 APEYVTRGH--FSIKSDVFSFGVLVLEIISG 524
           AP+ V  G        D +S GVL+ E+++G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 67.7 bits (165), Expect = 4e-12
 Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 42/196 (21%)

Query: 348 GQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN 404
           G  +AVK+LS+   N    +  ++ E++L+  + H+N++ LL              F P 
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNV------------FTPQ 92

Query: 405 SSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDL 452
            S+++F        + DA    +  ++LD E    ++  +  GI +LH      IIHRDL
Sbjct: 93  KSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 149

Query: 453 KASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIK 508
           K SNI++ +D   KI DFG+AR     F M      T  +V  + Y APE +    +   
Sbjct: 150 KPSNIVVKSDCTLKILDFGLARTACTNFMM------TPYVVTRY-YRAPEVILGMGYKEN 202

Query: 509 SDVFSFGVLVLEIISG 524
            D++S G ++ E++ G
Sbjct: 203 VDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 44/215 (20%)

Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRN--LVRL 385
           +G+GGFG VY  R +  G+  A+K L K  +   QGE    NE ++++ +   +   +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDW-----------ETRY---KIIGG 431
           + ++F   ++L             FI D +    L +           E R+   +II G
Sbjct: 62  MTYAFHTPDKLC------------FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG 109

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
           +       H  +R  +++RDLK +NILLD     +ISD G+A     D S+      VGT
Sbjct: 110 LE------HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGT 158

Query: 492 FGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
            GYMAPE + +G  +   +D FS G ++ +++ G 
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGH 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 20/216 (9%)

Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN---EVLL 373
           T+ +    +++  ++G G +G+V        G+++A+K+LS+   Q E+  K    E+ L
Sbjct: 9   TVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTL 67

Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEF---VPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
           +  +QH N++ LL             +F   +P    D      I    L  +    ++ 
Sbjct: 68  LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVY 124

Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
            +  G+ Y+H      IIHRDLK  N+ ++ D   KI DFG+AR      +  + +  V 
Sbjct: 125 QMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVV 176

Query: 491 TFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 54/210 (25%), Positives = 113/210 (53%), Gaps = 23/210 (10%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR-NL 382
           ++F   ++LG G  G V+K        I  ++L    ++  +  +N+++   ++ H  N 
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAI--RNQIIRELQVLHECNS 62

Query: 383 VRLLGFS---FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA----RG 435
             ++GF    + + E  +  E +   S+D+ +  A +  +       +I+G ++    +G
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIAVIKG 115

Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
           + YL E  + +I+HRD+K SNIL+++    K+ DFG++   ++  S  ++   VGT  YM
Sbjct: 116 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYM 169

Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +PE +   H+S++SD++S G+ ++E+  G+
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.2 bits (164), Expect = 5e-12
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 9/154 (5%)

Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
           E +L+  + H +++R+           ++   +P+ S D + +   +   L  +    I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
             I  G+ YLH     RIIHRD+K  NI ++      I D G A+   +         + 
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLA 217

Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           GT    APE + R  ++ K+D++S G+++ E+++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 53/228 (23%), Positives = 103/228 (45%), Gaps = 41/228 (17%)

Query: 329 DNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN--------------EVLL 373
              LG+G +G V K      G+ +A+K++    +  ++                  E+ +
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
           +  ++H N++ L+    E     L+ + +  S + K + D   +++L       I+  I 
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDR--KIRLTESQVKCILLQIL 129

Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD--------- 484
            G+  LH+      +HRDL  +NI +++  I KI+DFG+AR +                 
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186

Query: 485 ----TSRIVGTFGYMAPEYV---TRGHFSIKSDVFSFGVLVLEIISGQ 525
               TS++V T  Y APE +    + HF++  D++S G +  E+++G+
Sbjct: 187 REEMTSKVV-TLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 42/221 (19%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKN----EVLLVARLQH 379
           N F     +G+G +G V K R    +EI   +  K+S + E E K     E+ ++  L+ 
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQ 59

Query: 380 RNLVRL-----------LGFSFEETERLLIYEFVPNSS----VDKFIFDAIKRVQLDWET 424
            N+V L           L F + E   L + E +PN      V  +I+  IK        
Sbjct: 60  ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIK-------- 111

Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
                      I + H++    I+HRD+K  N+L+  + + K+ DFG AR    + S  +
Sbjct: 112 ----------AIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNAN 157

Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            +  V T  Y +PE +    +    D++S G ++ E+  GQ
Sbjct: 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 61/225 (27%), Positives = 107/225 (47%), Gaps = 25/225 (11%)

Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYK-GRLSHGQEIAVKRLSK-NSVQGELEFKNEVLL 373
           F +  D ++ +     +G+G +G V+K     +G + AVK L   + +  E+E +  +L 
Sbjct: 10  FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNIL- 68

Query: 374 VARLQHRNLVRLLGFSFEETER-----LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI 428
            A   H N+V+  G  +++  +      L+ E     SV   +   +KR +   E    I
Sbjct: 69  KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP---I 125

Query: 429 IGGIAR----GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
           I  I      G+ +LH +   + IHRD+K +NILL  +   K+ DFG++      + + +
Sbjct: 126 IAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182

Query: 485 TSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISG 524
           TS  VGT  +MAPE +         +  + DV+S G+  +E+  G
Sbjct: 183 TS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 36/95 (37%), Positives = 58/95 (61%), Gaps = 7/95 (7%)

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVG 490
           I+ G+ +LH      II+RDLK  N++LD++   KI+DFGM +   +D   G T+R   G
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---GVTTRTFCG 163

Query: 491 TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           T  Y+APE +    +    D +++GVL+ E+++GQ
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 17/200 (8%)

Query: 332 LGQGGFGAVY-KGRLSHGQEIAVKRLSKNSVQGELEFKNEV----LLVARLQHRNLVRLL 386
           +G+G FG V    R   G+  AVK L K  V    E K+ +    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 387 GFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLHEDSR 444
            +SF+ TE+L  + +FV        +F  ++R +   E R +     IA  + YLH    
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGE----LFFHLQRERSFPEPRARFYAAEIASALGYLHS--- 114

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
           + I++RDLK  NILLD+     ++DFG+ +  E       T+   GT  Y+APE + +  
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQP 172

Query: 505 FSIKSDVFSFGVLVLEIISG 524
           +    D +  G ++ E++ G
Sbjct: 173 YDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 18/201 (8%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKN---EVLLVARLQHRNLVRLLG 387
           LG+G FG V   R     +  A+K L K  +  + E  +   E  ++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-K 61

Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRL 445
           +SF+  +RL  + E+         +F  + R ++  E R +  G  I   + YLH     
Sbjct: 62  YSFQTHDRLCFVMEYANGGE----LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD-- 115

Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT-SRIVGTFGYMAPEYVTRGH 504
            +++RDLK  N++LD D   KI+DFG+ +      S G T     GT  Y+APE +    
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDND 171

Query: 505 FSIKSDVFSFGVLVLEIISGQ 525
           +    D +  GV++ E++ G+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 42/95 (44%), Positives = 60/95 (63%), Gaps = 9/95 (9%)

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS---QGDTSRI 488
           +A+G+ +L   SR + IHRDL A NILL  + + KI DFG+AR    D     +GD +R+
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD-ARL 243

Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                +MAPE +    ++I+SDV+SFGVL+ EI S
Sbjct: 244 --PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 40/94 (42%), Positives = 59/94 (62%), Gaps = 7/94 (7%)

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF--EMDQSQGDTSRIV 489
           +ARG+ +L   SR + IHRDL A NILL  + + KI DFG+AR    + D  +  ++R+ 
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238

Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               +MAPE +    ++ +SDV+SFGVL+ EI S
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 34/216 (15%)

Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLS---KNSVQGELEFKNEVLLVARLQHRNLVRLLG 387
           LG G  G V+    S   + +AVK++      SV+  L    E+ ++ RL H N+V++  
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALR---EIKIIRRLDHDNIVKVYE 69

Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII---GGIA----------- 433
                   L                +++  VQ   ET    +   G ++           
Sbjct: 70  VLGPSGSDL------TEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQL 123

Query: 434 -RGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEMDQS-QGDTSRIVG 490
            RG+ Y+H  +   ++HRDLK +N+ ++  D++ KI DFG+AR+ +   S +G  S  + 
Sbjct: 124 LRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180

Query: 491 TFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQ 525
           T  Y +P  +    +++   D+++ G +  E+++G+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 22/199 (11%)

Query: 332 LGQGGFG-AVYKGRLSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           +G+G FG A+    ++  Q+ A+K  RL K+S   E   K  VLL A+++H N+V     
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLL-AKMKHPNIVAFKE- 65

Query: 389 SFEETERL-LIYEFVPNSSVDKFIFDAIKRV-----QLDWETRYKIIGGIARGILYLHED 442
           SFE    L ++ E+     + + I     ++      L W  +      +  G+ ++HE 
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK 119

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
              R++HRD+K+ NI L  +   K+ DFG ARL     +   T   VGT  Y+ PE    
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWEN 174

Query: 503 GHFSIKSDVFSFGVLVLEI 521
             ++ KSD++S G ++ E+
Sbjct: 175 MPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 65.5 bits (159), Expect = 3e-11
 Identities = 47/178 (26%), Positives = 88/178 (49%), Gaps = 17/178 (9%)

Query: 353 VKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD---- 408
           + +  K   +  ++ +NE+L + RL H N++++     EE  R     ++     D    
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKI-----EEILRSEANTYMITQKYDFDLY 250

Query: 409 KFIFDAI---KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465
            F++D     K   L  +TR  I+  +   + Y+H+    ++IHRD+K  NI L+ D   
Sbjct: 251 SFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKI 306

Query: 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            + DFG A  FE ++   D    VGT    +PE +    +   +D++S G+++L+++S
Sbjct: 307 VLGDFGTAMPFEKEREAFDYG-WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 47/220 (21%)

Query: 325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN------EVLLVARL 377
           +F     LG G FG V   +    G+  A+K L K  +   L+ K       E  ++  L
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI---LKMKQVQHVAQEKSILMEL 75

Query: 378 QHRNLVRLLGFSFEETERL-LIYEFVPNS-------SVDKFIFDAIK----RVQLDWETR 425
            H  +V ++  SF++  R+  + EFV             +F  D  K     + L +E  
Sbjct: 76  SHPFIVNMMC-SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE-- 132

Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485
                       YLH      II+RDLK  N+LLD     K++DFG A+     +    T
Sbjct: 133 ------------YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRT 172

Query: 486 SRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISG 524
             + GT  Y+APE + ++GH     D ++ GVL+ E I+G
Sbjct: 173 FTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 39/212 (18%)

Query: 331 KLGQGGFGAVYKG--RLSHGQEIAVKRLSKNSVQGELEFK--NEVLLVARLQHRNLVRLL 386
           KLG+G +  VYKG  R++ GQ +A+K +S  + +G + F    E  L+  L+H N+V   
Sbjct: 12  KLGEGSYATVYKGISRIN-GQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIV--- 66

Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI------------AR 434
                     L+++ +       F+F+ +      +  ++   GG+             R
Sbjct: 67  ----------LLHDIIHTKETLTFVFEYMHTDLAQYMIQHP--GGLHPYNVRLFMFQLLR 114

Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           G+ Y+H      I+HRDLK  N+L+      K++DFG+AR   +  SQ  +S +V T  Y
Sbjct: 115 GLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVV-TLWY 169

Query: 495 MAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             P+ +     +S   D++  G + +E++ GQ
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 19/211 (9%)

Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNS-VQGEL---EFKNEVLLVAR 376
           NF     LG G +G V+  R   G +     A+K L K + VQ        + E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 377 LQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARG 435
           ++    +  L ++F+   +L LI ++V        +F  + +     E   +   G    
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGE----MFTHLYQRDNFSEDEVRFYSG--EI 114

Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
           IL L    +L I++RD+K  NILLD++    ++DFG+++ F + + +  T    GT  YM
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYM 173

Query: 496 APEYV--TRGHFSIKSDVFSFGVLVLEIISG 524
           APE +    GH     D +S G+L+ E+++G
Sbjct: 174 APEIIRGKGGHGKA-VDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.9 bits (158), Expect = 4e-11
 Identities = 34/89 (38%), Positives = 56/89 (62%), Gaps = 2/89 (2%)

Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGY 494
           +L +H      +IHRD+K++NILL ++ + K+ DFG ++++    S  D  R   GT  Y
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS-DDVGRTFCGTPYY 211

Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +APE   R  +S K+D+FS GVL+ E+++
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLT 240

Length = 496

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 16/200 (8%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---EVLLVARLQHRNLVRLLG 387
           LG+G FG V   R  + G+  A+K L K  +  + E  +   E  ++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-K 61

Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRL 445
           +SF+  +RL  + E+V        +F  + R ++  E R +  G  I   + YLH     
Sbjct: 62  YSFQTKDRLCFVMEYVNGGE----LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG--- 114

Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
           +I++RDLK  N++LD D   KI+DFG+ +    D +   T    GT  Y+APE +    +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDNDY 172

Query: 506 SIKSDVFSFGVLVLEIISGQ 525
               D +  GV++ E++ G+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 44/212 (20%)

Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV- 91

Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  S+++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140

Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRY- 190

Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           Y APE +    +    D++S G ++ E+I G 
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 37/95 (38%), Positives = 57/95 (60%), Gaps = 7/95 (7%)

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVG 490
           IA G+ +LH      II+RDLK  N++LD++   KI+DFGM +    D   G T++   G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---GVTTKTFCG 163

Query: 491 TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           T  Y+APE +    +    D ++FGVL+ E+++GQ
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 8e-11
 Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 23/212 (10%)

Query: 325 NFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGE-LEFKNEVLLVARLQHRNL 382
            +   + +G+G +G V        G ++A+K++S    Q        E+ ++ R +H N+
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65

Query: 383 VRLLGF----SFEE-TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           + +L      SFE   +  ++ E +        ++  IK   L  +     +  I RG+ 
Sbjct: 66  IGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQILRGLK 120

Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI----VGTFG 493
           Y+H  +   ++HRDLK SN+LL+ +   KI DFG+AR+      + D +      V T  
Sbjct: 121 YIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI---ADPEHDHTGFLTEYVATRW 174

Query: 494 YMAPE-YVTRGHFSIKSDVFSFGVLVLEIISG 524
           Y APE  +    ++   D++S G ++ E++S 
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 63.1 bits (154), Expect = 9e-11
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 10/96 (10%)

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI--- 488
           + RG+ Y+H  +   +IHRDLK SN+L++ D   +I DFGMAR   +  S  +       
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR--GLSSSPTEHKYFMTE 170

Query: 489 -VGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEII 522
            V T  Y APE + +   ++   D++S G +  E++
Sbjct: 171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 63.2 bits (153), Expect = 1e-10
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 36/205 (17%)

Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 29  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNV- 84

Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  S+++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 85  -----------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 133

Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           +LH      IIHRDLK SNI++ +D   KI DFG+AR      S   T  +V  + Y AP
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAP 187

Query: 498 EYVTRGHFSIKSDVFSFGVLVLEII 522
           E +    +    D++S G ++ E++
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 13/199 (6%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEF---KNEVLLVARLQHRNLVRLLG 387
           +G+G +  V   RL    +I A+K + K  V  + +    + E  +  +      +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
             F+ T RL L+ E+V    +   +F   ++ +L  E        I   + +LHE     
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHERG--- 116

Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
           II+RDLK  N+LLDAD   K++D+GM +  E       TS   GT  Y+APE +    + 
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174

Query: 507 IKSDVFSFGVLVLEIISGQ 525
              D ++ GVL+ E+++G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 33/215 (15%)

Query: 332 LGQGGFGAVYKGRL---------SHGQEIAV--KRLSKNSVQGELEFKNEVLLVARLQHR 380
           LGQG F  +YKG L           GQE++V  K L  +     L F     L+++L H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHK 61

Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           +LV+L G    + E +++ E+V    +D F+      V L W  +  +   +A  + YL 
Sbjct: 62  HLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118

Query: 441 EDSRLRIIHRDLKASNILL-----DADMIP--KISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +    +++H ++   NIL+     +   +P  K+SD G+        +       V    
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI------TVLSREERVERIP 169

Query: 494 YMAPEYVTRGHFSIKS--DVFSFGVLVLEIISGQK 526
           ++APE +  G  S+    D +SFG  +LEI S  +
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 23/204 (11%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGE-----LEFKNEVLLVARLQHRNLVRL 385
           +G+G +  V    L   + I A+K + K  V  +     ++ +  V   A   H  LV L
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS-NHPFLVGL 61

Query: 386 LGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
               F+   RL  + EFV    +   +F   ++ +L  E        I+  + +LHE   
Sbjct: 62  HS-CFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNFLHERG- 116

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
             II+RDLK  N+LLDA+   K++D+GM +  E  +    TS   GT  Y+APE + RG 
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPE-ILRGE 171

Query: 505 ---FSIKSDVFSFGVLVLEIISGQ 525
              FS+  D ++ GVL+ E+++G+
Sbjct: 172 DYGFSV--DWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 14/198 (7%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKN---EVLLVARLQHRNLVRLLG 387
           +G+G FG V + R    Q I A+K + K  +    E  +   E  ++A++    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59

Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
           FSF+  E+L L+  F+        +F  ++R      +R +     A  +  L    +  
Sbjct: 60  FSFQSPEKLYLVLAFINGGE----LFHHLQREGRFDLSRARFY--TAELLCALENLHKFN 113

Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
           +I+RDLK  NILLD      + DFG+ +L   D  + +T    GT  Y+APE +    ++
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGYT 171

Query: 507 IKSDVFSFGVLVLEIISG 524
              D ++ GVL+ E+++G
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 45/156 (28%), Positives = 82/156 (52%), Gaps = 2/156 (1%)

Query: 368 KNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYK 427
           ++E+  +A   H  +V+       + + LLI E+     ++K I   +K   L ++  Y+
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKE-HLPFQ-EYE 170

Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
           +     + +L L E    +++HRDLK++NI L    I K+ DFG ++ +    S    S 
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230

Query: 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             GT  Y+APE   R  +S K+D++S GV++ E+++
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)

Query: 330 NKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQGE-LEFKNEVLLVARLQHRNLVRLLG 387
            KLG+G +  V+KGR    +  +A+K +     +G       EV L+  L+H N+V L  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 388 FSFEETERLLIYEFVPNSSVDKFIFD-----AIKRVQLDWETRYKIIGGIARGILYLHED 442
               +    L++E++ +  + +++ D     ++  V++        +  I RG+ Y H  
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKI-------FLYQILRGLAYCH-- 121

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT- 501
            R +++HRDLK  N+L++     K++DFG+AR   +       S  V T  Y  P+ +  
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLG 178

Query: 502 RGHFSIKSDVFSFGVLVLEIISGQ 525
              +S + D++  G +  E+ SG+
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 11/199 (5%)

Query: 330 NKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQGE-LEFKNEVLLVARLQHRNLVRLLG 387
           +KLG+G +  VYKGR       +A+K +     +G       EV L+  L+H N+V L  
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
               E    L++E++ +  + +++ D    + +        +  + RG+ Y H   R ++
Sbjct: 72  IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINM--HNVKLFLFQLLRGLNYCH---RRKV 125

Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-RGHFS 506
           +HRDLK  N+L++     K++DFG+AR   +       S  V T  Y  P+ +     +S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYS 183

Query: 507 IKSDVFSFGVLVLEIISGQ 525
            + D++  G +  E+ +G+
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 34/210 (16%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEF-----KNEVLLVARLQHRNLVRL 385
           +G+G FG VY+ R    + I A+K LSK  +  + E      +  +L+   L     +  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDW---------ETRYKIIGGIARGI 436
           L FSF+    L              + D +   +L W         E R K    IA  +
Sbjct: 61  LKFSFQTDSDLY------------LVTDYMSGGELFWHLQKEGRFSEDRAKFY--IAELV 106

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYM 495
           L L    +  I++RDLK  NILLDA     + DFG+++    + +   T+    GT  Y+
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEYL 163

Query: 496 APE-YVTRGHFSIKSDVFSFGVLVLEIISG 524
           APE  +    ++   D +S GVLV E+  G
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 12/198 (6%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLGF 388
           LG+G FG V   R  + G+  A+K L K  +  + E  + V     LQ+     +  L +
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRLRI 447
           +F+  +RL    FV   +    +F  + R ++  E R +  G  I   + YLH      +
Sbjct: 63  AFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---V 116

Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
           ++RD+K  N++LD D   KI+DFG+ +    D +   T    GT  Y+APE +    +  
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDYGR 174

Query: 508 KSDVFSFGVLVLEIISGQ 525
             D +  GV++ E++ G+
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 11/198 (5%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLGF 388
           LG+G FG V   +  + G+  A+K L K  +  + E  + +     LQ+     +  L +
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRLRI 447
           SF+  +RL    FV   +    +F  + R ++  E R +  G  I   + YLH  S   +
Sbjct: 63  SFQTHDRLC---FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH--SEKNV 117

Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
           ++RDLK  N++LD D   KI+DFG+ +  E  +         GT  Y+APE +    +  
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175

Query: 508 KSDVFSFGVLVLEIISGQ 525
             D +  GV++ E++ G+
Sbjct: 176 AVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 9/95 (9%)

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS---QGDTSRI 488
           +A+G+ +L   +    IHRDL A NILL    I KI DFG+AR    D +   +G+    
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           V    +MAPE +    ++ +SDV+S+G+L+ EI S
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 38/95 (40%), Positives = 54/95 (56%), Gaps = 9/95 (9%)

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ---SQGDTSRI 488
           +ARG+ +L   +    +HRDL A N+LL    I KI DFG+AR    D    S+G T   
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           V    +MAPE +    ++  SDV+S+G+L+ EI S
Sbjct: 303 V---KWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 45/215 (20%)

Query: 331 KLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFK--NEVLLVARLQHRNLVRLLG 387
           KLG+G +  VYKGR    GQ +A+K +     +G   F    E  L+  L+H N+V L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHD 70

Query: 388 FSFEETERLLIYEFV-----------PN----SSVDKFIFDAIKRVQLDWETRYKIIGGI 432
               +    L++E++                  +V  F+F      QL            
Sbjct: 71  IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLF------QL------------ 112

Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF 492
            RG+ Y H   + R++HRDLK  N+L+      K++DFG+AR   +  S+  ++ +V T 
Sbjct: 113 LRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSV-PSKTYSNEVV-TL 167

Query: 493 GYMAPEYVTRG--HFSIKSDVFSFGVLVLEIISGQ 525
            Y  P+ V  G   +S   D++  G +  E+ +G+
Sbjct: 168 WYRPPD-VLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 10/157 (6%)

Query: 370 EVLLVARLQHRNLVRLLG-FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI 428
           E  ++  + H ++++L G F++ +   L++    P    D + + A KR  +       I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL----PRYKTDLYCYLAAKR-NIAICDILAI 187

Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
              + R I YLHE+   RIIHRD+KA NI ++      + DFG A  F +D +       
Sbjct: 188 ERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGW 243

Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            GT    APE + R  +    D++S G+++ E+ +  
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 32/83 (38%), Positives = 50/83 (60%), Gaps = 6/83 (7%)

Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQS---QGDTSRIVGTFGYMAPEYVTRGH 504
           IHRD+ A N+LL    + KI DFG+AR    D +   +G+    V    +MAPE +    
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV---KWMAPESIFDCV 290

Query: 505 FSIKSDVFSFGVLVLEIISGQKN 527
           ++++SDV+S+G+L+ EI S  K+
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 56/218 (25%), Positives = 105/218 (48%), Gaps = 25/218 (11%)

Query: 320 RDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN-EVLLVARL 377
           R    ++   N +G G FG VY+   +   +++A+K++ ++      ++KN E+L++  L
Sbjct: 62  RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNL 116

Query: 378 QHRNLVRLLGFSFEETERL--------LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
            H N++ L  + + E  +         ++ EF+P + V K++    +          K+ 
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT-VHKYMKHYARNNHALPLFLVKLY 175

Query: 430 G-GIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSR 487
              + R + Y+H      I HRDLK  N+L+D +    K+ DFG A+   +   Q   S 
Sbjct: 176 SYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NLLAGQRSVSY 230

Query: 488 IVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISG 524
           I   F Y APE +    +++   D++S G ++ E+I G
Sbjct: 231 ICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 52/199 (26%), Positives = 94/199 (47%), Gaps = 13/199 (6%)

Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE----FKNEVLLVARLQHRNLVRLLG 387
           +G+G +  V   RL   + I   ++ K  +  + E     + E  +  +  +   +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 388 FSFEETERLL-IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
             F+   RL  + E+V    +   +F   ++ +L  E        I+  + YLHE     
Sbjct: 63  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 116

Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
           II+RDLK  N+LLD++   K++D+GM +  E  +    TS   GT  Y+APE +    + 
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174

Query: 507 IKSDVFSFGVLVLEIISGQ 525
              D ++ GVL+ E+++G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 59.4 bits (144), Expect = 4e-09
 Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 43/227 (18%)

Query: 331 KLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSVQGEL---EFKNEVLLVARLQHRNLV 383
            +G+GG G VY   L++     + +A+K++ ++  +  L    F  E  + A L H  +V
Sbjct: 9   LIGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65

Query: 384 RLLGFSFEETERLLIYE--FVPNSSVDKFIFDAIKRVQLDWETRYK--------IIGGIA 433
            +  +S       + Y   ++   ++   +    ++  L  E   K        I   I 
Sbjct: 66  PV--YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123

Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS-QGDTS------ 486
             I Y+H  S+  ++HRDLK  NILL       I D+G A   ++++    D        
Sbjct: 124 ATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 487 ---------RIVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIIS 523
                    +IVGT  YMAPE +  G   S  +D+++ GV++ ++++
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERL-LGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 30/213 (14%)

Query: 331 KLGQGGFGAV----YKGRLSHGQEIAVKRLSKNSVQGELEFKN---EVLLVARLQ-HRNL 382
           +LGQG +G V         S  + +A+K+++ N    ++  K    E+ L+   + H+N+
Sbjct: 7   ELGQGAYGIVCSARNAET-SEEETVAIKKIT-NVFSKKILAKRALRELKLLRHFRGHKNI 64

Query: 383 VRLLGF------SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYK-IIGGIARG 435
             L         +F E   L +YE +  + + + I    +  Q   +  ++  I  I  G
Sbjct: 65  TCLYDMDIVFPGNFNE---LYLYEELMEADLHQII----RSGQPLTDAHFQSFIYQILCG 117

Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD--QSQGDTSRIVGTFG 493
           + Y+H  +   ++HRDLK  N+L++AD   KI DFG+AR F  +  ++ G  +  V T  
Sbjct: 118 LKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174

Query: 494 YMAPEYVTRGHFSIKS-DVFSFGVLVLEIISGQ 525
           Y APE +       K+ DV+S G ++ E++  +
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 21/214 (9%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELE---FKNE--VLLVARL 377
           ++F     +G+G FG V   ++ H + I A+K L+K  +    E   F+ E  VL+    
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 378 QHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           Q    +  L ++F++   L L+ ++     +   +     R+  D    Y     IA  +
Sbjct: 61  Q---WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMV 112

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
           L +H   +L  +HRD+K  N+LLD +   +++DFG   L         +S  VGT  Y++
Sbjct: 113 LAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC-LKMNQDGTVQSSVAVGTPDYIS 171

Query: 497 PEYVT-----RGHFSIKSDVFSFGVLVLEIISGQ 525
           PE +       G +  + D +S GV + E++ G+
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 57.0 bits (138), Expect = 9e-09
 Identities = 63/251 (25%), Positives = 104/251 (41%), Gaps = 66/251 (26%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSVQGELEFKNEV-------- 371
           ++F +   +G+G FG V   RL      G   A+K+L K+    E+  K +V        
Sbjct: 1   DDFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLRKS----EMLEKEQVAHVRAERD 53

Query: 372 LLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQL-DWETRYKII 429
           +L         V  L +SF++   L LI E++P   +   +   +K+    + ETR+ I 
Sbjct: 54  ILAE--ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYI- 107

Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE----------MD 479
              A  IL +    +L  IHRD+K  N+LLDA    K+SDFG+    +          + 
Sbjct: 108 ---AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164

Query: 480 QSQGDTSR--------------------------IVGTFGYMAPEYVTRGHFSIKSDVFS 513
            +                                 VGT  Y+APE   +  ++ + D +S
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS 224

Query: 514 FGVLVLEIISG 524
            GV++ E++ G
Sbjct: 225 LGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 62/262 (23%), Positives = 102/262 (38%), Gaps = 79/262 (30%)

Query: 324 NNFSTDNKLGQGGFGAV-YKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
            +F T   +G+G FG V    +   G+  A+K L K+ +     FK + L   + +   L
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-----FKKDQLAHVKAERDVL 55

Query: 383 -------VRLLGFSFEETERL-LIYEFVPNSSV-------DKFIFDAIKRVQLDWETRYK 427
                  V  L +SF++ + L LI EF+P   +       D F  D          TR+ 
Sbjct: 56  AESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---------TRFY 106

Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA-------------R 474
           +    A  +L +    +L  IHRD+K  NIL+D     K+SDFG++             +
Sbjct: 107 M----AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQK 162

Query: 475 LFEMDQSQGDTS---------------------------RI-----VGTFGYMAPEYVTR 502
           L +   ++                               R+     VGT  Y+APE   +
Sbjct: 163 LLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222

Query: 503 GHFSIKSDVFSFGVLVLEIISG 524
             +  + D +S G ++ E + G
Sbjct: 223 QGYGQECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 55.9 bits (134), Expect = 1e-08
 Identities = 51/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGE-LEFKNEVLLVARLQHRN 381
           +++    KLG+G +  VYKG+   +G+ +A+K +     +G       E  L+  L+H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           +V L      +    L++E+V ++ + +++      +  +    +  +  + RG+ Y+H+
Sbjct: 65  IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLF--LFQLLRGLSYIHQ 121

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
                I+HRDLK  N+L+      K++DFG+AR   +  S   ++ +V T  Y  P+ + 
Sbjct: 122 RY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVV-TLWYRPPDVLL 176

Query: 502 -RGHFSIKSDVFSFGVLVLEIISG 524
               +S   D++  G + +E+I G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 13/200 (6%)

Query: 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGE-LEFKNEVLLVARLQHRNLVRLLG 387
           +KLG+G +  V+KGR       +A+K +     +G       EV L+  L+H N+V L  
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLHEDSRLR 446
               E    L++E++ +S + +++ +    + +      KI +  + RG+ Y H   + +
Sbjct: 71  IIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMH---NVKIFMFQLLRGLSYCH---KRK 123

Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-RGHF 505
           I+HRDLK  N+L++     K++DFG+AR   +       S  V T  Y  P+ +     +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSTEY 181

Query: 506 SIKSDVFSFGVLVLEIISGQ 525
           S   D++  G ++ E+ +G+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 52/213 (24%), Positives = 101/213 (47%), Gaps = 18/213 (8%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELE---FKNEVLLVARLQH 379
            +F   + +G+G FG V   R     +I A+K + K+ +  +     F+ E  +++    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
             + +L  ++F++ + L L+ E+ P   +   +     +   D    Y     +A  +L 
Sbjct: 61  PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----LAELVLA 114

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           +H   ++  +HRD+K  N+L+D     K++DFG A     ++        VGT  Y+APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP-VGTPDYIAPE 173

Query: 499 YVT------RGHFSIKSDVFSFGVLVLEIISGQ 525
            +T      +G + ++ D +S GV+  E+I G+
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 62/246 (25%), Positives = 113/246 (45%), Gaps = 31/246 (12%)

Query: 292 RKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEI 351
           RK K   N      +N  E +      ++    ++     +G+G FG V   R    Q++
Sbjct: 16  RKNKNIDNF-----LNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKV 70

Query: 352 -AVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSV 407
            A+K LSK  +  + +  F  E   +    +   V  L  +F++ + L ++ E++P   +
Sbjct: 71  YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL 130

Query: 408 DKFI--FDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465
              +  +D  ++    W   Y      A  +L L     + +IHRD+K  N+LLD     
Sbjct: 131 VNLMSNYDVPEK----WAKFYT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL 181

Query: 466 KISDFGMARLFEMDQS---QGDTSRIVGTFGYMAPEYVTR----GHFSIKSDVFSFGVLV 518
           K++DFG     +MD++   + DT+  VGT  Y++PE +      G++  + D +S GV +
Sbjct: 182 KLADFGTC--MKMDETGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237

Query: 519 LEIISG 524
            E++ G
Sbjct: 238 FEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 59/245 (24%), Positives = 98/245 (40%), Gaps = 63/245 (25%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLG 387
           +G G FG V   R      + A+K L K  V         K E  ++A   +  +V+L  
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67

Query: 388 FSFEETERL-LIYEFVPNSS-----VDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           +SF++ + L  + +++P        +   IF+       D    Y  I  +   I  +H 
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEE------DLARFY--IAELTCAIESVH- 118

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLF--------------------EMDQS 481
             ++  IHRD+K  NIL+D D   K++DFG+   F                    E  + 
Sbjct: 119 --KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176

Query: 482 QGDTSR---------------------IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLE 520
             +  R                     +VGT  Y+APE + R  ++   D +S GV++ E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236

Query: 521 IISGQ 525
           ++ GQ
Sbjct: 237 MLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
           +A G+ +L   +    +HRDL A N+L+    + KI DFG+AR    D +          
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             +MAPE +    ++  SDV+SFG+L+ EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 36/101 (35%), Positives = 55/101 (54%), Gaps = 18/101 (17%)

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
           + RG+ Y+H  +   ++HRDLK SN+LL+A+   KI DFG+AR    ++    T  +V T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVV-T 171

Query: 492 FGYMAPE-------YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
             Y APE       Y T    +I  DV+S G +  E++  +
Sbjct: 172 RWYRAPELLLNCSEYTT----AI--DVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 63/244 (25%), Positives = 107/244 (43%), Gaps = 27/244 (11%)

Query: 292 RKKKQKQNL--RKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQ 349
           RK K   N   R  D IN +  L       R    ++     +G+G FG V   R    +
Sbjct: 16  RKNKNIDNFLNRYKDTINKIRDL-------RMKAEDYEVVKVIGRGAFGEVQLVRHKSTR 68

Query: 350 EI-AVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNS 405
           ++ A+K LSK  +  + +  F  E   +    +   V  L ++F++   L ++ E++P  
Sbjct: 69  KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 128

Query: 406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465
            +   + +    V   W   Y      A  +L L     +  IHRD+K  N+LLD     
Sbjct: 129 DLVNLMSNY--DVPEKWARFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 181

Query: 466 KISDFGMARLFEMD-QSQGDTSRIVGTFGYMAPEYVTR----GHFSIKSDVFSFGVLVLE 520
           K++DFG       +   + DT+  VGT  Y++PE +      G++  + D +S GV + E
Sbjct: 182 KLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239

Query: 521 IISG 524
           ++ G
Sbjct: 240 MLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 28/99 (28%), Positives = 53/99 (53%), Gaps = 6/99 (6%)

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
           +A  +L +    +L  +HRD+K  N+LLD +   +++DFG   L  +      ++  VGT
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSC-LRLLADGTVQSNVAVGT 166

Query: 492 FGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQ 525
             Y++PE +      +G +  + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 35/213 (16%)

Query: 331 KLGQGGFGAVYKGRLSHGQEIA---VKRLSKNSVQGELEFKNEVLLVAR----LQHRNLV 383
           ++G G FG V    +     +A   VK L  N+   E   +NE L        LQH N++
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE---QNEFLQQGDPYRILQHPNIL 58

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETR-------YKIIGGIARGI 436
           + LG   E    LL++E+     +  ++       Q  W  R        ++   IA G+
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAAGV 112

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA-RLFEMDQSQGDTSRIVGTFGYM 495
            ++H   +   +H DL   N  L +D+  K+ D+G+    ++ D  + +  + V    ++
Sbjct: 113 THMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWL 168

Query: 496 APEYVTRGHFSI-------KSDVFSFGVLVLEI 521
           APE V   H  +        S+V++ GV + E+
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 49/210 (23%), Positives = 93/210 (44%), Gaps = 28/210 (13%)

Query: 332 LGQGGFGAVYKGRLS--------HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
           LGQG F  ++KG           H  E+ +K L K+       F     ++++L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
              G      E +++ E+V   S+D ++      + + W  + ++   +A  + +L +  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120

Query: 444 RLRIIHRDLKASNILL-----DADMIP---KISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
              + H ++ A N+LL          P   K+SD G++    +   +    RI     ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERI----PWV 171

Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISG 524
            PE +    + S+ +D +SFG  + EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 61/249 (24%), Positives = 111/249 (44%), Gaps = 25/249 (10%)

Query: 286 CVFLRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL 345
           C     RK K   N      ++  E      + +R    +F     +G+G FG V   R 
Sbjct: 10  CDIPALRKNKNIDNF-----LSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRH 64

Query: 346 SHGQEI-AVKRLSKNSVQGELE---FKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYE 400
              +++ A+K LSK  +    +   F  E  ++A      +V+L  ++F++ + L ++ E
Sbjct: 65  KSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH-YAFQDDKYLYMVME 123

Query: 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 460
           ++P   +   + +    +   W   Y      A  +L L     +  IHRD+K  N+LLD
Sbjct: 124 YMPGGDLVNLMSNY--DIPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLD 176

Query: 461 ADMIPKISDFGMA-RLFEMDQSQGDTSRIVGTFGYMAPEYVTR----GHFSIKSDVFSFG 515
                K++DFG   ++      + DT+  VGT  Y++PE +      G++  + D +S G
Sbjct: 177 KSGHLKLADFGTCMKMDANGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234

Query: 516 VLVLEIISG 524
           V + E++ G
Sbjct: 235 VFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 50/211 (23%), Positives = 101/211 (47%), Gaps = 17/211 (8%)

Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELE---FKNEVLLVARLQHR 380
           +F     +G+G FG V   +L +  ++ A+K L+K  +    E   F+ E  ++    ++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 381 NLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
             +  L ++F++   L L+ ++     +   +     R+  D    Y     +A  ++ +
Sbjct: 62  -WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVIAI 115

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
               +L  +HRD+K  NIL+D +   +++DFG   L  M+     +S  VGT  Y++PE 
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC-LKLMEDGTVQSSVAVGTPDYISPEI 174

Query: 500 VT-----RGHFSIKSDVFSFGVLVLEIISGQ 525
           +      +G +  + D +S GV + E++ G+
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 50.9 bits (122), Expect = 9e-07
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 10/97 (10%)

Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL-FEMDQSQGDTSRIVGTF 492
           R + Y+H  +   + HRDLK  NIL +AD   KI DFG+AR+ F    +    +  V T 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 493 GYMAPEYVTRGHFSIKS----DVFSFGVLVLEIISGQ 525
            Y APE    G F  K     D++S G +  E+++G+
Sbjct: 171 WYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 62/250 (24%), Positives = 100/250 (40%), Gaps = 57/250 (22%)

Query: 326 FSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRN 381
           F     LG G FG V   R +      A+K L K  V         K E  ++A   +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 382 LVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           +VRL  +SF++ + L  + +++P   +   +     R+ +  E   +    IA     + 
Sbjct: 63  VVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLI----RMGIFPEDLARFY--IAELTCAVE 115

Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE------------------MDQSQ 482
              ++  IHRD+K  NIL+D D   K++DFG+   F                   MD S 
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175

Query: 483 --GDTSR-------------------------IVGTFGYMAPEYVTRGHFSIKSDVFSFG 515
             GD +                          +VGT  Y+APE + R  ++   D +S G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235

Query: 516 VLVLEIISGQ 525
           V++ E++ GQ
Sbjct: 236 VILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 49/236 (20%)

Query: 314 FDFSTIRDATNNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFKNEV 371
            DF TI+  +N          G +GAVY  + + +  Q  A+K+++K +    L  +N++
Sbjct: 1   EDFETIKLISN----------GAYGAVYLVRHKETR-QRFAMKKINKQN----LILRNQI 45

Query: 372 --LLVAR----LQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWET 424
             + V R          V  +  SFE    L ++ E+V        +   I  + +D   
Sbjct: 46  QQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL-KNIGALPVDMAR 104

Query: 425 RYKIIGGIARGIL---YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL------ 475
            Y      A  +L   YLH      I+HRDLK  N+L+ +    K++DFG++++      
Sbjct: 105 MY-----FAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156

Query: 476 -------FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
                   E D  +    ++ GT  Y+APE + R  +    D ++ G+++ E + G
Sbjct: 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 48/212 (22%), Positives = 91/212 (42%), Gaps = 32/212 (15%)

Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGE--LEFKNEVLLVARLQHRNLVRLLGFS 389
                   + K + +    +AVK+++ +S   E     + E++   +LQH N++  +  S
Sbjct: 10  FEDLMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-TS 67

Query: 390 FEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDW--ET--RYKIIGGIARGILYLHEDSR 444
           F     L ++   +   S +    D +K    +   E    + I+  +   + Y+H    
Sbjct: 68  FIVDSELYVVSPLMAYGSCE----DLLKTHFPEGLPELAIAF-ILKDVLNALDYIH---S 119

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--------YMA 496
              IHR +KAS+ILL  D    +S  G+     M    G   R+V  F         +++
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMI-KHGKRQRVVHDFPKSSVKNLPWLS 176

Query: 497 PEYVT---RGHFSIKSDVFSFGVLVLEIISGQ 525
           PE +    +G ++ KSD++S G+   E+ +G 
Sbjct: 177 PEVLQQNLQG-YNEKSDIYSVGITACELANGH 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 59/244 (24%), Positives = 101/244 (41%), Gaps = 57/244 (23%)

Query: 332 LGQGGFGAV-YKGRLSHGQEIAVKRLSKNSVQGELEF---KNEVLLVARLQHRNLVRLLG 387
           LG G FG V    ++      A+K L K  V    +    K E  ++A   +  +V+L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY- 67

Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
           +SF++ + L  + +++P   +   +     R+++  E   +    IA   L +    ++ 
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMMSLLI----RMEVFPEVLARFY--IAELTLAIESVHKMG 121

Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFE------------------MDQSQ------ 482
            IHRD+K  NIL+D D   K++DFG+   F                   M+ S       
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181

Query: 483 ----GD-----------------TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
               GD                    +VGT  Y+APE + R  ++   D +S GV++ E+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241

Query: 522 ISGQ 525
           + GQ
Sbjct: 242 LVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 31/108 (28%), Positives = 64/108 (59%), Gaps = 16/108 (14%)

Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
           I+ G  RG+ YLH++     IHR++KAS+IL+  D +  +S  G++ L+ + ++ G  ++
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRN-GQKAK 159

Query: 488 IVGTFG--------YMAPEYVTRG--HFSIKSDVFSFGVLVLEIISGQ 525
           +V  F         +++PE + +    +++KSD++S G+   E+ +G+
Sbjct: 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 49.0 bits (116), Expect = 5e-06
 Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 42/243 (17%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE------IAVKRLSKNSVQGELEFKNEVLLVARL 377
           N +    K+G G FG V+  +    QE      I+ + L K   + +L    EV ++  L
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVI--EVNVMREL 69

Query: 378 QHRNLVRLLG-FSFEETERLLI-YEFVPNSSVDKFIFDAIKRV-QLDWETRYKIIGGIAR 434
           +H+N+VR +  F  +  ++L I  EF     + + I    K   +++      I   +  
Sbjct: 70  KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129

Query: 435 GILYLHE----DSRLRIIHRDLKASNILLDADM-----------------IPKISDFGMA 473
            + Y H      +  R++HRDLK  NI L   +                 I KI DFG++
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQ----KN 527
           +   ++         VGT  Y +PE +      +  KSD+++ G ++ E+ SG+    K 
Sbjct: 190 KNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246

Query: 528 NSF 530
           N+F
Sbjct: 247 NNF 249

Length = 1021

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 63/247 (25%), Positives = 102/247 (41%), Gaps = 61/247 (24%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSVQGELEFKNEVLLVARLQH 379
           ++F +   +G+G FG V   RL      G   A+K L K  +      + E +   R + 
Sbjct: 1   DDFESLKVIGRGAFGEV---RLVQKKDTGHIYAMKILRKADM-----LEKEQVAHIRAER 52

Query: 380 RNLVRLLG-------FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG 431
             LV   G       +SF++   L LI EF+P   +   +    K    +  T++ I   
Sbjct: 53  DILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYI--- 107

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM------------------- 472
            A  +L +    +L  IHRD+K  N+LLDA    K+SDFG+                   
Sbjct: 108 -AETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166

Query: 473 ---------------ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
                          A  ++ ++ Q   S  VGT  Y+APE   +  ++   D +S GV+
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYS-TVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225

Query: 518 VLEIISG 524
           + E++ G
Sbjct: 226 MYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 53/242 (21%)

Query: 325 NFSTDNKLGQGGFGAV---YKGRLSHGQEIAVKR----LSKNSVQGELEFKNEVLLVARL 377
           +F +   +G+G FG V    K    H   + + R    L K  V G +  + ++L+ A  
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQV-GHIRAERDILVEA-- 58

Query: 378 QHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
               +V++  +SF++   L LI EF+P   +   +    K    + ET++ I    A  +
Sbjct: 59  DSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYI----AETV 111

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM------------------------ 472
           L +    +L  IHRD+K  N+LLD+    K+SDFG+                        
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171

Query: 473 ----------ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
                     A  ++ ++ Q   S  VGT  Y+APE   +  ++   D +S GV++ E++
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFS-TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 523 SG 524
            G
Sbjct: 231 IG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (112), Expect = 2e-05
 Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 53/234 (22%)

Query: 331 KLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGE-----LEFKNEVLLVARLQHRNLVR 384
            LG+G  G V+  RL   G+  A+K L K  +        +  + E+L  A L H  L  
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATLDHPFLPT 65

Query: 385 LLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL----YL 439
           L   SF+    L L+ ++ P           + + Q       ++    A  +L    YL
Sbjct: 66  LYA-SFQTETYLCLVMDYCPGGE-----LFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL------FEMDQSQGDTSR------ 487
           H    L I++RDLK  NILL       +SDF +++             +  + R      
Sbjct: 120 H---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 488 ---------------IVGTFGYMAPEYVT-RGH-FSIKSDVFSFGVLVLEIISG 524
                           VGT  Y+APE ++  GH  ++  D ++ G+L+ E++ G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.9 bits (106), Expect = 4e-05
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 32/211 (15%)

Query: 332 LGQGGFGAVYKGRL-----------SHGQEIAV--KRLSKNSVQGELEFKNEVLLVARLQ 378
           LG+G    +Y G L           S+ +EI V  K L  +     L F     ++ ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H+++V L G    + E +++ EFV    +D F+      +   W  ++K+   +A  + Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120

Query: 439 LHEDSRLRIIHRDLKASNILL-----DADMIP--KISDFGMARLFEMDQSQGDTSRIVGT 491
           L ED  L  +H ++   NILL     D +  P  K+SD G+     +   Q    RI   
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECVERI--- 172

Query: 492 FGYMAPEYVT-RGHFSIKSDVFSFGVLVLEI 521
             ++APE V    + SI +D +SFG  + EI
Sbjct: 173 -PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 30/153 (19%), Positives = 56/153 (36%), Gaps = 17/153 (11%)

Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV-RLLGFS 389
            L  G    VY        +  +K         + E +  +L +   +    V ++L   
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKINPSREKGADREREVAILQLLA-RKGLPVPKVLASG 62

Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
             +    L+ E++   ++D          ++  E +  I   +A  +  LH+   L + H
Sbjct: 63  ESDGWSYLLMEWIEGETLD----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCH 112

Query: 450 RDLKASNILLDADMIPKISDFGMA----RLFEM 478
            DL   NIL+D   I  I D+  A      F++
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGYGPPAFDL 145

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.8 bits (106), Expect = 7e-05
 Identities = 40/168 (23%), Positives = 73/168 (43%), Gaps = 17/168 (10%)

Query: 370 EVLLVARLQHRNLVRLL-GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ-LDWETRYK 427
           E+ ++  + HR ++ L+  + ++ T  +++    P    D F +  + R   L  E    
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVM----PKYKCDLFTY--VDRSGPLPLEQAIT 189

Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
           I   +   + YLH      IIHRD+K  NI LD      + DFG A   +          
Sbjct: 190 IQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246

Query: 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEI------ISGQKNNS 529
             GT    +PE +    +  K+D++S G+++ E+      + G++  S
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294

Length = 392

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 44.5 bits (106), Expect = 7e-05
 Identities = 45/180 (25%), Positives = 78/180 (43%), Gaps = 25/180 (13%)

Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ-LDW-ETRYKIIGGIARGI 436
           + N ++L          +LI +++     D  +FD +K+   L   E + KII  +   +
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVK-KIIRQLVEAL 122

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
             LH   +  IIH D+K  N+L D       + D+G+ +        G  S   GT  Y 
Sbjct: 123 NDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK------IIGTPSCYDGTLDYF 173

Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISGQ---KNNSFRIGEE--AEDLLTYVSNNLHIL 550
           +PE +   ++ +  D ++ GVL  E+++G+   K +     EE   E LL      L  +
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE---DEELDLESLLKRQQKKLPFI 230

Length = 267

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 46/184 (25%), Positives = 73/184 (39%), Gaps = 48/184 (26%)

Query: 325 NFSTDNKLGQGGFGAVYKG-----RLSHGQEIAVKRLSKNSVQGELE-FKNEVLL----- 373
           +F    KLG+G FG VYK      +     +  +K+ ++    G +E + NE +      
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATE---YGAVEIWMNERVRRACPN 189

Query: 374 -VARLQHRNLVRLLGF-----SFEETERLLIYEFVPNSS-------------VDKFIFDA 414
             A   +       GF     S +E E  L++ +   S+             V+ ++   
Sbjct: 190 SCADFVY-------GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGK 242

Query: 415 IKRVQLDWETRYKIIGGIARGILY----LHEDSRLRIIHRDLKASNILLDADMIP-KISD 469
           ++ +    E   KII  I R IL+    LH      I+HRD+K  NI+        KI D
Sbjct: 243 VQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIID 299

Query: 470 FGMA 473
            G A
Sbjct: 300 LGAA 303

Length = 566

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 44/223 (19%)

Query: 332 LGQGGFGAVYKGRL-----------------------SHGQEIAV--KRLSKNSVQGELE 366
           LGQG    +Y GRL                       ++G+E+ V  K L  +     L 
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 367 FKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRY 426
           F     L++++ H +L  + G     +E +++ EFV +  +D  +     RV + W  + 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120

Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNIL-----LDADMIP--KISDFGMARLFEMD 479
            +   +A  + YL ED  L  +H ++ A NIL     L     P  K+SD G++  F   
Sbjct: 121 TVAQQLASALSYL-EDKNL--VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTAL 175

Query: 480 QSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEI 521
             +    RI     ++APE V  G   S  +D +SFG  +LEI
Sbjct: 176 SREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 41.3 bits (97), Expect = 9e-04
 Identities = 33/178 (18%), Positives = 79/178 (44%), Gaps = 18/178 (10%)

Query: 354 KRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL----LIYEFVPNSSVDK 409
           K+  K         +NE+  + R+   N++++ GF  +  + L    LI E+     + +
Sbjct: 52  KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111

Query: 410 FIFDAIKRVQLDWETRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDADMIPKIS 468
            +    K   L ++T+  +     +G+  L++  ++    +++L + + L+  +   KI 
Sbjct: 112 VLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKNLTSVSFLVTENYKLKII 165

Query: 469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISG 524
             G+ ++      +      V    Y + + +      ++IK D++S GV++ EI +G
Sbjct: 166 CHGLEKILSSPPFKN-----VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG 218

Length = 283

>gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 24/109 (22%), Positives = 39/109 (35%), Gaps = 19/109 (17%)

Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI 432
           L+ARL H      L  +     RL +   +           A  R  +  E   ++    
Sbjct: 101 LLARL-HSVPPEALPLARRLRRRLKLLRQL----------AAALRRLVAAELLDRLAELW 149

Query: 433 ARGILYLHE---DSRLRIIHRDLKASNILLDADMIPKIS---DFGMARL 475
            R +  L        L ++H DL   N+L+D     +++   DF  A L
Sbjct: 150 ERLLAALLALLPALPLVLVHGDLHPGNLLVDPG--GRVTGVIDFEDAGL 196

This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 41.8 bits (98), Expect = 0.001
 Identities = 21/55 (38%), Positives = 32/55 (58%), Gaps = 3/55 (5%)

Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475
           D E   K I  +A  + YLH      IIHRDLK  N+L+  +   K++DFG++++
Sbjct: 102 DEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 44/194 (22%), Positives = 87/194 (44%), Gaps = 27/194 (13%)

Query: 348 GQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFVPNS 405
           G+ + V+R++  +   E+  F    L V++L  H N+V        + E  ++  F+   
Sbjct: 25  GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84

Query: 406 SVDKFI----FDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 461
           S    I     D +  + + +     I+ G+ + + Y+H    +  +HR +KAS+IL+  
Sbjct: 85  SAKDLICTHFMDGMSELAIAY-----ILQGVLKALDYIHH---MGYVHRSVKASHILISV 136

Query: 462 DMIPKISDFGMARLFEMDQSQGDTSRIVGTF--------GYMAPEYVTRG--HFSIKSDV 511
           D   K+   G+     M  + G   R+V  F         +++PE + +    +  KSD+
Sbjct: 137 D--GKVYLSGLRSNLSM-INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 193

Query: 512 FSFGVLVLEIISGQ 525
           +S G+   E+ +G 
Sbjct: 194 YSVGITACELANGH 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)

Query: 429 IGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
           +  +AR +L    Y+H +    IIHRD+K  N+L++      + DFG A       S   
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318

Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLE 520
              I GT    APE +    ++   D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	551
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.98
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.98
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.98
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.98
KOG0586	596	consensus Serine/threonine protein kinase [General	99.98
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.98
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.98
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.98
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.98
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.98
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.98
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.98
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.98
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.98
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.98
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.98
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.98
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.98
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.98
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.98
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.98
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.98
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.98
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.98
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.98
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.98
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.98
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.98
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.98
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.98
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.98
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.98
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.98
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.98
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.98
PTZ00284	467	protein kinase; Provisional	99.98
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.98
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.98
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.97
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.97
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.96
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.96
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.96
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.96
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.93
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.93
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.91
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.9
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.89
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
PLN00181	793	protein SPA1-RELATED; Provisional	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.84
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.83
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.82
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
PRK10345	210	hypothetical protein; Provisional	99.78
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.77
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.77
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.76
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
smart00090	237	RIO RIO-like kinase.	99.73
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.72
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.7
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.64
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.63
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.6
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.59
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.58
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.49
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.36
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.32
KOG1243	690	consensus Protein kinase [General function predict	99.25
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.2
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.2
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.19
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.18
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.18
KOG3087	229	consensus Serine/threonine protein kinase [General	99.18
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.91
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.91
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.9
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.89
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.89
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.72
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.68
COG4248	637	Uncharacterized protein with protein kinase and he	98.67
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.59
PRK09902	216	hypothetical protein; Provisional	98.5
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.45
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.35
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.32
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.27
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.23
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.22
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.2
PF01636	239	APH: Phosphotransferase enzyme family This family	98.18
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.18
PLN02876	822	acyl-CoA dehydrogenase	98.05
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.0
PRK10593	297	hypothetical protein; Provisional	97.91
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.9
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.84
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.83
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.8
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.62
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.49
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.44
PRK05231	319	homoserine kinase; Provisional	97.43
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.19
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.17
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.04
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.95
PLN02236	344	choline kinase	96.9
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.79
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.79
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.79
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.72
KOG2270	520	consensus Serine/threonine protein kinase involved	96.68
PLN02756	418	S-methyl-5-thioribose kinase	96.5
PRK12396	409	5-methylribose kinase; Reviewed	96.44
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.26
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.23
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.08
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.0
COG2334	331	Putative homoserine kinase type II (protein kinase	95.76
PRK11768	325	serine/threonine protein kinase; Provisional	95.75
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.75
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.69
PRK06148	1013	hypothetical protein; Provisional	95.48
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.06
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.85
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.74

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-50  Score=406.31  Aligned_cols=237  Identities=49%  Similarity=0.798  Sum_probs=210.0

Q ss_pred             cccccChhHHHhhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEE
Q 008854          310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS  389 (551)
Q Consensus       310 ~~~~~~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  389 (551)
                      ....|++.+++.+|++|...+.||+|+||.||+|.+.+|..||||++.....+...+|.+|+.++.+++|||||+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            34568999999999999999999999999999999999999999988776543255699999999999999999999999


Q ss_pred             ecCC-ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEe
Q 008854          390 FEET-ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS  468 (551)
Q Consensus       390 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~  468 (551)
                      .+.+ +.+||||||++|+|.++|+..... +++|..|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9998 499999999999999999874333 89999999999999999999999998899999999999999999999999


Q ss_pred             ecCCccccccCCCccccccc-ccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCCcCcccHHHHHHhhh
Q 008854          469 DFGMARLFEMDQSQGDTSRI-VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNL  547 (551)
Q Consensus       469 Dfgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~  547 (551)
                      |||+++.....  ....... .||.+|++||++..+..+.|+|||||||+|+||+||+++.+...+.....++.|+|..|
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999754431  1111222 79999999999999999999999999999999999999988665555667999999988


Q ss_pred             hh
Q 008854          548 HI  549 (551)
Q Consensus       548 ~~  549 (551)
                      .+
T Consensus       298 ~~  299 (361)
T KOG1187|consen  298 EE  299 (361)
T ss_pred             HC
Confidence            75

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=349.16  Aligned_cols=201  Identities=30%  Similarity=0.535  Sum_probs=180.3

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ..+|...++||.|.|++||+|++. ++.+||||.+.+.  ..+..+.+..|+.+|+.++|||||.+++++..++..+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            467888899999999999999954 5789999999776  4455556889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC------CCeEEeecCCc
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD------MIPKISDFGMA  473 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~------~~~kl~Dfgla  473 (551)
                      ||+.+|+|.+|++   +.+.+++.....++.|||.||++||+++   ||||||||.||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            9999999999998   4558999999999999999999999998   9999999999999765      35899999999


Q ss_pred             cccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC
Q 008854          474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRI  532 (551)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~  532 (551)
                      +.+...   ......+|++-|||||++...+|+.|+|+||+|+++||+++|+.||+...
T Consensus       163 R~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  163 RFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             hhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            987632   33456799999999999999999999999999999999999999998443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=348.92  Aligned_cols=199  Identities=34%  Similarity=0.607  Sum_probs=174.1

Q ss_pred             cCcccCcCCceeEEEeecCCCCEEEEEEeecCChhc--HHHHHHHHHHHhcCCCCCccceeeEEecCC-ceEEEEEccCC
Q 008854          328 TDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQHRNLVRLLGFSFEET-ERLLIYEFVPN  404 (551)
Q Consensus       328 ~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~~~  404 (551)
                      ..+.||+|+||+||+|.+.....||||++.......  ..+|.+|+.+|.+++|||||+++|++.+.. ...+||||+++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            445699999999999999654449999997654322  458999999999999999999999999887 78999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC-CeEEeecCCccccccCCCcc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~~  483 (551)
                      |+|..+|+.. ....+++..+++++.|||+||.|||+++.  ||||||||+||||+.++ ++||+|||+++......  .
T Consensus       125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~  199 (362)
T KOG0192|consen  125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T  199 (362)
T ss_pred             CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence            9999999864 46789999999999999999999999873  99999999999999998 99999999998654321  2


Q ss_pred             cccccccCCCcccccccc--cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVT--RGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ......||+.|||||++.  ...|+.|+|||||||++|||+||+.||+..
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~  249 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDL  249 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCC
Confidence            233368999999999999  679999999999999999999999999743

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=331.86  Aligned_cols=201  Identities=26%  Similarity=0.402  Sum_probs=180.5

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      .++|++.+.||+|+||+||.++. +.++.+|+|++++...   .......+|..+|.+++||+||+++-.|++.+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            46799999999999999999984 4688999999987632   3445688999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      +||+.||.|..+|+   ++..+++..+.-++.+|+.||.|||+.+   ||||||||+|||||++|+++|+||||++....
T Consensus       104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999997   4677999989999999999999999998   99999999999999999999999999985432


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      .  ...+..++||+.|||||++.+..|+..+|+||+||++|||++|.+||...
T Consensus       178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~  228 (357)
T KOG0598|consen  178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE  228 (357)
T ss_pred             C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence            2  23455689999999999999999999999999999999999999999643

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=344.85  Aligned_cols=198  Identities=33%  Similarity=0.554  Sum_probs=175.6

Q ss_pred             CCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCC
Q 008854          326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS  405 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  405 (551)
                      +...+.||+|.||+||.|.+++...||+|.++.... ....|.+|+++|++|+|+|||+++|+|..+...+||||||++|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            456789999999999999998878999999987643 3457889999999999999999999999999999999999999


Q ss_pred             ChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccc
Q 008854          406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT  485 (551)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  485 (551)
                      +|.++|.+ ..+..+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+||||++....+.... .
T Consensus       287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~-~  361 (468)
T KOG0197|consen  287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA-S  361 (468)
T ss_pred             cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee-c
Confidence            99999986 35677999999999999999999999998   9999999999999999999999999999655443322 2


Q ss_pred             cccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       486 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ....-+..|.|||.+..+.|+.|||||||||+||||+| |+.|+.
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~  406 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP  406 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC
Confidence            23344779999999999999999999999999999999 888875

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-41  Score=341.20  Aligned_cols=200  Identities=29%  Similarity=0.492  Sum_probs=182.9

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      .+|...+.||+|||+.||+++. ..|+.||+|++.+..   ....+.+.+||+|.++|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5789999999999999999995 889999999998742   233457889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      |++++++|..++.   .++++++.++..++.||+.||.|||+.+   |||||||-.|+||+++.++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999886   5788999999999999999999999988   999999999999999999999999999887643


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      .  .+....+|||-|+|||++.....+..+||||+|||||-||.|++||+..
T Consensus       172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk  221 (592)
T KOG0575|consen  172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK  221 (592)
T ss_pred             c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence            2  3456789999999999999999999999999999999999999999744

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-41  Score=323.13  Aligned_cols=211  Identities=28%  Similarity=0.410  Sum_probs=180.6

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCC-ceEEEEEc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET-ERLLIYEF  401 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~  401 (551)
                      +++..+.||+|..|+|||++++ +++.+|+|.+... ...-.+++.+|++++.+.+||+||+++|.|.... +..++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4456789999999999999965 5788999999554 3344567999999999999999999999999888 49999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      |++|+|+.++..   .+.+++...-+|+.++++||.|||+..  +||||||||+||||+..|.+||+|||.+..+...  
T Consensus       160 MDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  160 MDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             cCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            999999999863   367999999999999999999999742  4999999999999999999999999999876533  


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC--CcCcccHHHHHH
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRI--GEEAEDLLTYVS  544 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~--~~~~~~l~~~~~  544 (551)
                        .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....  ...--+|+.+|-
T Consensus       233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv  295 (364)
T KOG0581|consen  233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV  295 (364)
T ss_pred             --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh
Confidence              3456799999999999999999999999999999999999999997541  122234555554

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.4e-41  Score=353.27  Aligned_cols=206  Identities=31%  Similarity=0.496  Sum_probs=178.9

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCChh-cHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETE  394 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  394 (551)
                      ...+....+.||+|.||+||+|+..      +.+.||||.+++.... ...+|++|++++..++|||||+|+|+|.+++.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            4456677899999999999999843      2346999999887554 67799999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhc-------c----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC
Q 008854          395 RLLIYEFVPNSSVDKFIFDAI-------K----RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM  463 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~  463 (551)
                      .+||+|||..|+|.+||....       .    ..+++..+.+.|+.|||.||.||-++.   +|||||..+|+||.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence            999999999999999997421       1    234889999999999999999999887   99999999999999999


Q ss_pred             CeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          464 IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       464 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      .+||+||||++.....+.........-+.+|||||.|..++||.+||||||||+|||++| |+.|+.-
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g  708 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG  708 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc
Confidence            999999999997655444433334455789999999999999999999999999999999 8889863

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-41  Score=313.93  Aligned_cols=205  Identities=27%  Similarity=0.453  Sum_probs=177.4

Q ss_pred             cCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeE-EecCCc-eEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGF-SFEETE-RLLI  398 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~-~~lV  398 (551)
                      .+|+++++||.|.||+|||+. +.+|..+|.|.+.-..  .+....+..|+.+|++|+|||||++++. +.++.+ .+||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            467889999999999999997 6789999999997442  3344568899999999999999999984 444445 7899


Q ss_pred             EEccCCCChhHHhhhhcc-cCCCCHHHHHHHHHHHHHHHHHHhhCCC-CCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          399 YEFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGILYLHEDSR-LRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      ||++..|+|..++....+ ...+++..+++++.|++.||..+|..-+ ..|+||||||.||+|+.+|.+||+||||++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999976433 4568999999999999999999998431 12999999999999999999999999999988


Q ss_pred             ccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....  .....+|||.||+||.+....|+.||||||+|+++|||..-+.||..
T Consensus       179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g  230 (375)
T KOG0591|consen  179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG  230 (375)
T ss_pred             cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc
Confidence            75432  34567899999999999999999999999999999999999999963

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-40  Score=321.51  Aligned_cols=194  Identities=33%  Similarity=0.569  Sum_probs=167.2

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhc--CCCCCccceeeEEecCC----ceEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR--LQHRNLVRLLGFSFEET----ERLL  397 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~l  397 (551)
                      ...++.+.||+|.||.||||.+. ++.||||++...   ....|.+|-+|.+.  ++|+||+++++.-...+    +++|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            45567789999999999999995 499999999654   34467777666555  58999999999877655    8899


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhC------CCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED------SRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                      |+||.++|+|.++|.    ...++|....+|+..+++||+|||+.      .+|+|+|||||++||||..|+++.|+|||
T Consensus       286 Vt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            999999999999995    56799999999999999999999975      46789999999999999999999999999


Q ss_pred             CccccccCCCcccccccccCCCcccccccccC-CCC-----cchhhHhHHHHHHHHHhCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFS-----IKSDVFSFGVLVLEIISGQ  525 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~sDv~S~Gvll~elltG~  525 (551)
                      ||.++............+||.+|||||++.+. .+.     .+.||||+|.+||||++.=
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC  421 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC  421 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence            99998877777777778999999999999764 222     3689999999999999854

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-40  Score=304.99  Aligned_cols=196  Identities=30%  Similarity=0.426  Sum_probs=179.2

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|+..+.||.|+||.|.+++.+ +|.-+|+|++++...   ...+...+|..+|+.+.||+++++.+.+.+.+..+|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46888899999999999999854 578899999987633   33446789999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++|.|..+|+   +.+++++....-++.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||+|+...  
T Consensus       124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--  195 (355)
T KOG0616|consen  124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS--  195 (355)
T ss_pred             eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence            9999999999997   5678999999999999999999999998   9999999999999999999999999998754  


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                         ..+...+|||.|+|||.+..+.+...+|+|+|||++|||+.|..||..
T Consensus       196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~  243 (355)
T KOG0616|consen  196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD  243 (355)
T ss_pred             ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC
Confidence               236778999999999999999999999999999999999999999963

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-40  Score=319.19  Aligned_cols=203  Identities=27%  Similarity=0.425  Sum_probs=174.7

Q ss_pred             hhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChh-------cHHHHHHHHHHHhcCCCCCccceeeEEecCC
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQ-------GELEFKNEVLLVARLQHRNLVRLLGFSFEET  393 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  393 (551)
                      ..+.|.+.+.||+|+||.|-+|. .++|+.||||++++....       ......+|+++|++|+|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            45678888999999999999997 567999999999775221       2224679999999999999999999999999


Q ss_pred             ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC---CCeEEeec
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDF  470 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~kl~Df  470 (551)
                      ..||||||+++|.|.+.+-   ..+.+.+.....++.|++.|+.|||+++   |+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            9999999999999999886   3456777778889999999999999998   9999999999999766   78999999


Q ss_pred             CCccccccCCCcccccccccCCCcccccccccCCC--C-cchhhHhHHHHHHHHHhCCCCCCCCCC
Q 008854          471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF--S-IKSDVFSFGVLVLEIISGQKNNSFRIG  533 (551)
Q Consensus       471 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~-~~sDv~S~Gvll~elltG~~p~~~~~~  533 (551)
                      |+|+...   ....+...+||+.|.|||++.++..  + .+.|+||+||+||-+++|-+||+....
T Consensus       324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~  386 (475)
T KOG0615|consen  324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT  386 (475)
T ss_pred             chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC
Confidence            9999754   2345677899999999999976643  3 478999999999999999999975433

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-39  Score=321.17  Aligned_cols=200  Identities=28%  Similarity=0.484  Sum_probs=173.0

Q ss_pred             cCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChh--cHHHHHHHHHHHhcCCCCCccceeeEEecC--CceEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERLLI  398 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV  398 (551)
                      +.|+.+++||+|+||.|||++ ..+|+.||+|++.....+  ...-..+||.||++|+||||++|.+...+.  ...|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            457778999999999999998 668999999999876432  233467999999999999999999988776  689999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      +|||++ +|..++..  ..-.|++.++..++.|++.||.|+|..+   |+|||||.+|||||.+|.+||+|||||+++..
T Consensus       197 FeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             Eecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence            999977 46666543  3557999999999999999999999998   99999999999999999999999999998876


Q ss_pred             CCCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ......+++ +-|+.|.|||++.+. .|+...|+||.|+||.||+.|+..+..
T Consensus       271 ~~~~~~T~r-VvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G  322 (560)
T KOG0600|consen  271 SGSAPYTSR-VVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG  322 (560)
T ss_pred             CCCcccccc-eEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC
Confidence            665544444 559999999998875 899999999999999999999988853

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-39  Score=322.08  Aligned_cols=200  Identities=32%  Similarity=0.522  Sum_probs=182.2

Q ss_pred             hhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ....|...++||+|+-|.||.++ ...++.||||++........+-+.+|+.+|+..+|+|||++++.+...+++++|||
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            45678888999999999999997 56789999999987766666678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      ||++|+|.+++.    ...+++.++..|++++++||.|||.++   |+|||||++|||++.+|.+||+|||++..+...+
T Consensus       351 ym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  351 YMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             ecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            999999999874    455999999999999999999999998   9999999999999999999999999998776554


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .  .....+||+.|||||++....|.+|.||||||++++||+.|++||-.
T Consensus       424 ~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln  471 (550)
T KOG0578|consen  424 S--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN  471 (550)
T ss_pred             C--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence            3  45567999999999999999999999999999999999999999964

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=317.29  Aligned_cols=202  Identities=30%  Similarity=0.451  Sum_probs=178.4

Q ss_pred             hhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChh---cHHHHHHHHHHHhcC-CCCCccceeeEEecCCceE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQ---GELEFKNEVLLVARL-QHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  396 (551)
                      ..++|...+.||+|+|++|++++ ...++++|||++.+.-.-   ..+-+..|-+.|.+| .||.|++|+-.|+++..+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            44678899999999999999998 556899999999775322   222366788899999 8999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +|+||.++|+|.++|.   +-+.|++.....++.+|+.+|+|||+.+   ||||||||+|||||.||++||+|||-|+.+
T Consensus       151 FvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             EEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999997   4577999999999999999999999998   999999999999999999999999999987


Q ss_pred             ccCCCc---------ccc--cccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          477 EMDQSQ---------GDT--SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       477 ~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ......         ...  ..++||..|.+||++..+..++.+|+|+|||+||+|+.|++||.
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFr  288 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFR  288 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCc
Confidence            543222         111  45899999999999999999999999999999999999999995

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.3e-38  Score=314.16  Aligned_cols=217  Identities=24%  Similarity=0.348  Sum_probs=184.6

Q ss_pred             hhhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      ...++|+++..||+|+||+||+++ ...|+.+|+|++++...   .....+..|-.+|...++|.||+|+..|++...+|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            346789999999999999999998 45699999999988643   33446788999999999999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      |||||++||++..+|.   +...|++.....++.+++-|+.-||+.+   +|||||||+|+|||..|++||+||||+.-+
T Consensus       218 LiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence            9999999999999996   5678999999999999999999999988   999999999999999999999999998532


Q ss_pred             cc---------------C-------CCcc----c-------------------ccccccCCCcccccccccCCCCcchhh
Q 008854          477 EM---------------D-------QSQG----D-------------------TSRIVGTFGYMAPEYVTRGHFSIKSDV  511 (551)
Q Consensus       477 ~~---------------~-------~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~sDv  511 (551)
                      ..               .       ....    .                   ....+|||.|||||++.+..|+...|+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            11               0       0000    0                   012479999999999999999999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCCCcCc-ccHHHHH
Q 008854          512 FSFGVLVLEIISGQKNNSFRIGEEA-EDLLTYV  543 (551)
Q Consensus       512 ~S~Gvll~elltG~~p~~~~~~~~~-~~l~~~~  543 (551)
                      ||+|+|+||||.|-+||....+.+. ..++.|-
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr  404 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR  404 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            9999999999999999987666554 3444443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.7e-38  Score=295.60  Aligned_cols=198  Identities=24%  Similarity=0.409  Sum_probs=172.2

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      +.|+.+.++|+|+||+|||++.+ .|+.||||++.....  .-.+-.++|+++|++++|||+|.++++|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46788899999999999999965 589999999976533  223346899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |++..-|+++-.   ....++...+.+++.|+++|+.|+|+++   +|||||||+||||+.++.+||+|||+|+.+..  
T Consensus        82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--  153 (396)
T KOG0593|consen   82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--  153 (396)
T ss_pred             ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence            999887776532   3456889999999999999999999998   99999999999999999999999999998763  


Q ss_pred             CcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .....+..+.|..|.|||.+.+ .+|....|||++|+++.||++|++-|.
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P  203 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP  203 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC
Confidence            2223445677999999999887 689999999999999999999998774

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.8e-38  Score=316.65  Aligned_cols=197  Identities=29%  Similarity=0.457  Sum_probs=177.7

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+...  ++.+.+.+|++|+++++||||+.++++|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46788899999999999999854 578899999977533  345568999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+.+ +|..+|.   ....+++..+..|+.+++.||.|||+..   |+|||+||.|||++.++.+|++|||+++.+....
T Consensus        82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9988 9999997   4577999999999999999999999987   9999999999999999999999999999765432


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                        .....+.|||-|||||.+.+.+|+..+|+||+|+|+|||++|++||-
T Consensus       155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~  201 (808)
T KOG0597|consen  155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY  201 (808)
T ss_pred             --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence              33456789999999999999999999999999999999999999994

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=333.62  Aligned_cols=199  Identities=30%  Similarity=0.532  Sum_probs=174.5

Q ss_pred             CCCcCcccCcCCceeEEEeecCC----CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ...+.+.||.|.||+|++|+++-    ...||||.++... .+...+|+.|..||.+++||||++|.|+.......+||.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            34567899999999999998652    3469999998764 345568999999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      |||+||+|+.||..  +..++++.++..++++||.||.||-+.+   +|||||.++||||+.+..+|++||||++.++.+
T Consensus       710 EyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence            99999999999986  4577999999999999999999999887   999999999999999999999999999987655


Q ss_pred             CCcc-cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCC
Q 008854          480 QSQG-DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNN  528 (551)
Q Consensus       480 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~  528 (551)
                      .... .+....-+.+|.|||.+..+++|.+||||||||+|||.++ |++|+
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY  835 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY  835 (996)
T ss_pred             CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence            4221 1222233679999999999999999999999999999877 99998

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-38  Score=340.00  Aligned_cols=205  Identities=33%  Similarity=0.541  Sum_probs=176.7

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCC--CC----EEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSH--GQ----EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER  395 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~--g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  395 (551)
                      ..+.+..+.||+|.||.||+|...+  |.    .||||.+++. +.+...+|.+|..+|++++|||||+++|++.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4556677899999999999998543  33    4899999876 455667899999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhhc----ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          396 LLIYEFVPNSSVDKFIFDAI----KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                      +|++|||++|+|..||++..    ....+...+.+.++.|||+|+.||++++   +|||||..+|+||++...+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999998631    2456899999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ||+.+...+.........-+.+|||||.+..+.||.|+|||||||++|||+| |..|+..
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~  907 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS  907 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC
Confidence            9995544433333333344679999999999999999999999999999999 8888853

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-38  Score=316.91  Aligned_cols=203  Identities=32%  Similarity=0.539  Sum_probs=173.2

Q ss_pred             HHhhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          319 IRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       319 i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      .+...+.+.+.+.||+|.||+||+|+|.  ..||||++....  .+..+.|++|+.++++-+|.||+-++|+|..... .
T Consensus       387 WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  387 WEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A  463 (678)
T ss_pred             cccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence            3344556677899999999999999984  579999997653  3455679999999999999999999999988776 9


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      ||..++++.+|..+|+.  .+..|+..+.+.|++||++||.|||.++   |||||||++||+|.+++.+||+||||+..-
T Consensus       464 IiTqwCeGsSLY~hlHv--~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHV--QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             eeehhccCchhhhhccc--hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeee
Confidence            99999999999999986  4567999999999999999999999998   999999999999999999999999998643


Q ss_pred             ccCCCcccccccccCCCccccccccc---CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTR---GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ..-.........-|..-|||||++..   .+|++.+||||||+++|||++|..|+.
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys  594 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS  594 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence            22111112233457789999999864   478999999999999999999999997

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=317.09  Aligned_cols=201  Identities=26%  Similarity=0.377  Sum_probs=176.6

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCC-CCCccceeeEEecCCceE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERL  396 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  396 (551)
                      .-++|.+.+.||+|.||+|+++..+ +++.+|||.+++...   .+.+..+.|.+|+.... ||.++.++.+++..+..+
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            3468899999999999999999865 567899999998743   34456778888887775 999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +||||+.+|++..+.    ....+++..+.-++..|+.||.|||+++   |||||||-+|||||.+|.+||+||||++..
T Consensus       446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999944332    4577999999999999999999999998   999999999999999999999999999853


Q ss_pred             ccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      .  .....+++++|||.|||||++.+..|+...|+|||||+|||||.|+.||+..
T Consensus       519 m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd  571 (694)
T KOG0694|consen  519 M--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD  571 (694)
T ss_pred             C--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            2  1234678899999999999999999999999999999999999999999743

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=315.73  Aligned_cols=186  Identities=32%  Similarity=0.497  Sum_probs=167.6

Q ss_pred             CcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCC
Q 008854          327 STDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSS  406 (551)
Q Consensus       327 ~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  406 (551)
                      ..++-||.|+.|.||+|++. ++.||||+++.-       -+.+|+.|++|+||||+.+.|+|.....++|||||+..|.
T Consensus       127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            34588999999999999994 589999988532       2357888999999999999999999999999999999999


Q ss_pred             hhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccccc
Q 008854          407 VDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS  486 (551)
Q Consensus       407 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  486 (551)
                      |.++|.   .+..++......+..+||.||.|||.+.   |||||||+-||||..+..+||+|||-++.+...   ....
T Consensus       199 L~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkM  269 (904)
T KOG4721|consen  199 LYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKM  269 (904)
T ss_pred             HHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhh
Confidence            999997   4567889999999999999999999987   999999999999999999999999999865532   3345


Q ss_pred             ccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       487 ~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .++||..|||||++.+.+.++|.|||||||+|||||||+.|+.
T Consensus       270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYk  312 (904)
T KOG4721|consen  270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYK  312 (904)
T ss_pred             hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcc
Confidence            6899999999999999999999999999999999999999995

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=309.17  Aligned_cols=202  Identities=27%  Similarity=0.462  Sum_probs=177.9

Q ss_pred             hhhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecC----Ch-hcHHHHHHHHHHHhcCC-CCCccceeeEEecCC
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKN----SV-QGELEFKNEVLLVARLQ-HRNLVRLLGFSFEET  393 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  393 (551)
                      ...++|.+.+.||+|+||+|+.+. ...+..||+|++.+.    .. .....+.+|+.++++++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            345789999999999999999997 456899999977654    11 23445778999999999 999999999999999


Q ss_pred             ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC-CCeEEeecCC
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGM  472 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~Dfgl  472 (551)
                      ..++||||+.+|+|.+++.+   ..++.+.+..++++|++.|++|+|+.+   |+||||||+|||++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999974   567889999999999999999999988   9999999999999999 9999999999


Q ss_pred             ccccccCCCcccccccccCCCcccccccccCC-CC-cchhhHhHHHHHHHHHhCCCCCCC
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH-FS-IKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +....  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.
T Consensus       168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d  225 (370)
T KOG0583|consen  168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD  225 (370)
T ss_pred             ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence            98763  2233456679999999999999877 76 789999999999999999999975

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.9e-37  Score=280.73  Aligned_cols=197  Identities=28%  Similarity=0.471  Sum_probs=171.6

Q ss_pred             cCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChhc--HHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .+|...++||+|.||.||+|+ ...|+.||||+++.....+  .....+|+..|+.++|+||+.++++|...+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            467888999999999999998 5679999999998764332  3457899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      ||+ .+|...+.+  +...+...++..++.++++|++|+|.+.   |+||||||.|+|++++|.+||+|||+++.+....
T Consensus        82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            995 578888875  5667999999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                      .....  .+-|..|.|||.+.+ +.|+...||||.|||+.||+-|.+-|
T Consensus       156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f  202 (318)
T KOG0659|consen  156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF  202 (318)
T ss_pred             ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC
Confidence            32222  256889999998876 47899999999999999999888654

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=308.18  Aligned_cols=204  Identities=29%  Similarity=0.456  Sum_probs=179.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChh-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .+...+.++||+|-||+|..+....+..||||+++..... ...+|.+|+++|.+++||||++++|+|..++..++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            3456678999999999999999988899999999877544 447899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      |++|+|.+||....-. .+.-...++|+.||+.||+||.+.+   +|||||.++|+|++.++++||+|||+++.+...+.
T Consensus       617 mEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence            9999999999864222 2455667889999999999999887   99999999999999999999999999997766655


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh--CCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS--GQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt--G~~p~~~  530 (551)
                      .....+.+-+.+|||||.+..+++|.+||||+|||.+||+++  .++|++.
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~  743 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQ  743 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhh
Confidence            555666777899999999999999999999999999999754  7788863

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=297.28  Aligned_cols=205  Identities=25%  Similarity=0.396  Sum_probs=178.5

Q ss_pred             hcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChhc-HHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG-ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .+.|++.+.||.|.-++||+|+ ...+..||||++..+..+. ...+.+|+..++.++||||++.+..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4678999999999999999998 5567999999997664443 4678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      ||.+|++.+++.... ...+++..+..|++++++||.|||+++   .||||||+.||||+.+|.+||+|||.+..+....
T Consensus       105 fMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999998653 345999999999999999999999998   9999999999999999999999999976543322


Q ss_pred             C-cccc-cccccCCCccccccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          481 S-QGDT-SRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       481 ~-~~~~-~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      . .... ..+.||+.|||||++..  ..|+.|+|||||||..+||.+|..||+..
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~  235 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY  235 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC
Confidence            1 1112 56789999999999654  46899999999999999999999999744

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-37  Score=300.43  Aligned_cols=202  Identities=31%  Similarity=0.497  Sum_probs=171.5

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCC--ceEEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET--ERLLIYE  400 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~e  400 (551)
                      .++...+.||+|.||.||++... +|...|||.+..........+.+|+.+|.+++|||||+.+|......  ...+.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45677899999999999999854 48999999997764333556899999999999999999999855444  5889999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC-CCCeEEeecCCcccccc-
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEM-  478 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~Dfgla~~~~~-  478 (551)
                      |+++|+|.+++...  ...+++..+..+.+||++||.|||+++   |||+||||+||||+. ++.+||+|||++..... 
T Consensus        97 y~~~GsL~~~~~~~--g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRY--GGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            99999999999753  227999999999999999999999987   999999999999999 79999999999987653 


Q ss_pred             CCCcccccccccCCCcccccccccCC-CCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...........||+.|||||++..+. ...++||||||++++||+||+.||..
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence            11122344578999999999998643 34599999999999999999999874

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=315.34  Aligned_cols=200  Identities=33%  Similarity=0.517  Sum_probs=170.7

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCC--C--CE-EEEEEeecC---ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSH--G--QE-IAVKRLSKN---SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE  394 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~--g--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  394 (551)
                      .++..+.++||+|+||+||+|++..  +  .. ||||..+..   ......+|++|.+++++++|||||+++|++..+.+
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            3445566999999999999998543  2  23 899999852   34566789999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .++|||++++|+|+++|.+  +...++..+++.++.+.|.||+|||+++   +|||||.++|+|++.++.+||+||||++
T Consensus       236 l~ivmEl~~gGsL~~~L~k--~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKK--NKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             cEEEEEecCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence            9999999999999999985  3336999999999999999999999998   9999999999999999999999999987


Q ss_pred             ccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      .-..  .........-+.+|+|||.+..+.|++++|||||||++||+++ |..|+.
T Consensus       311 ~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~  364 (474)
T KOG0194|consen  311 AGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYP  364 (474)
T ss_pred             CCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCC
Confidence            5331  1111111234679999999999999999999999999999999 788875

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.2e-36  Score=311.44  Aligned_cols=201  Identities=25%  Similarity=0.348  Sum_probs=173.6

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|+..+.||+|+||+||+++. .+++.||+|++.+...   .....+.+|+.++.+++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4688899999999999999985 4588999999976422   22346788999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999999863   457899999999999999999999987   999999999999999999999999998754321


Q ss_pred             CCc---------------------------------ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCC
Q 008854          480 QSQ---------------------------------GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK  526 (551)
Q Consensus       480 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~  526 (551)
                      ...                                 .......||+.|+|||.+.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123579999999999999999999999999999999999999


Q ss_pred             CCCC
Q 008854          527 NNSF  530 (551)
Q Consensus       527 p~~~  530 (551)
                      ||..
T Consensus       235 Pf~~  238 (363)
T cd05628         235 PFCS  238 (363)
T ss_pred             CCCC
Confidence            9963

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.1e-36  Score=305.77  Aligned_cols=206  Identities=30%  Similarity=0.435  Sum_probs=171.0

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec------CCCCEEEEEEeecCCh-hcHHHHHHHHHHHhcC-CCCCccceeeEEecCC
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFSFEET  393 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  393 (551)
                      ..++|++.++||+|+||.||++..      ..+..||||+++.... .....+.+|+.++.++ +||||+++++++....
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            346789999999999999999963      2346799999975432 3345689999999999 8999999999887644


Q ss_pred             -ceEEEEEccCCCChhHHhhhhcc--------------------------------------------------------
Q 008854          394 -ERLLIYEFVPNSSVDKFIFDAIK--------------------------------------------------------  416 (551)
Q Consensus       394 -~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------  416 (551)
                       ..++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             57899999999999999864211                                                        


Q ss_pred             ---cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCC
Q 008854          417 ---RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG  493 (551)
Q Consensus       417 ---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~  493 (551)
                         ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...............+++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               134788899999999999999999987   99999999999999999999999999986543322222233456788


Q ss_pred             cccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       494 y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      |+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~  279 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG  279 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999999999997 9999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.2e-35  Score=295.67  Aligned_cols=199  Identities=28%  Similarity=0.425  Sum_probs=173.0

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .|+..+.||+|+||.||++.. .+++.||+|.+.+...   .....+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367789999999999999985 5789999999875432   233457899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|..++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            99999999887642 3346899999999999999999999987   9999999999999999999999999997653221


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                         ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  203 (285)
T cd05631         157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK  203 (285)
T ss_pred             ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCC
Confidence               12345789999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-36  Score=291.74  Aligned_cols=198  Identities=24%  Similarity=0.457  Sum_probs=179.4

Q ss_pred             hcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChhc---HHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG---ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ..+|++.+.||+|.||.|-++. ...|+.||||.+++....+   ...+.+||+||..|+||||+.++.+|...+..+||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            4578888999999999999998 4679999999998775444   44578999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||..+|.|.+++.   .+..+++.+..++++||.+++.|.|.+.   ++|||||.+|||||+|+++||+||||+.++..
T Consensus       132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999997   4678999999999999999999999987   99999999999999999999999999987653


Q ss_pred             CCCcccccccccCCCcccccccccCCCC-cchhhHhHHHHHHHHHhCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFS-IKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .   .....++|++-|.+||++.+.+|. +..|-||+||+||.|+.|.-||+
T Consensus       206 ~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD  254 (668)
T KOG0611|consen  206 K---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD  254 (668)
T ss_pred             c---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC
Confidence            3   235678999999999999999885 89999999999999999999996

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6e-36  Score=310.19  Aligned_cols=201  Identities=25%  Similarity=0.340  Sum_probs=172.1

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .|+..+.||+|+||+||+++. .+++.||+|++.+..   ......+.+|+.++.+++||||+++++++.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578889999999999999984 467899999997642   2234568899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999999863   456889999999999999999999987   9999999999999999999999999976432100


Q ss_pred             Cc---------------------------------------------ccccccccCCCcccccccccCCCCcchhhHhHH
Q 008854          481 SQ---------------------------------------------GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFG  515 (551)
Q Consensus       481 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G  515 (551)
                      ..                                             .......||+.|+|||.+.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            00                                             001235799999999999988999999999999


Q ss_pred             HHHHHHHhCCCCCCCC
Q 008854          516 VLVLEIISGQKNNSFR  531 (551)
Q Consensus       516 vll~elltG~~p~~~~  531 (551)
                      |++|||++|+.||...
T Consensus       236 ~il~elltG~~Pf~~~  251 (381)
T cd05626         236 VILFEMLVGQPPFLAP  251 (381)
T ss_pred             hHHHHHHhCCCCCcCC
Confidence            9999999999999643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-36  Score=298.50  Aligned_cols=196  Identities=25%  Similarity=0.375  Sum_probs=173.2

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|+||.||++... +++.||+|++....   ......+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999854 68899999997542   223456889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            99999999999863   456899999999999999999999987   999999999999999999999999999765321


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                           .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  200 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD  200 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                 2235689999999999998999999999999999999999999864

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-36  Score=310.02  Aligned_cols=201  Identities=25%  Similarity=0.327  Sum_probs=171.9

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|.+.++||+|+||+||+++. .+++.||||++.+..   ......+.+|++++.+++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688899999999999999974 468899999986542   223346788999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999999863   456889999999999999999999987   999999999999999999999999998643210


Q ss_pred             CCc------------c---------------------------------cccccccCCCcccccccccCCCCcchhhHhH
Q 008854          480 QSQ------------G---------------------------------DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSF  514 (551)
Q Consensus       480 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~  514 (551)
                      ...            .                                 ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000            0                                 0012469999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCC
Q 008854          515 GVLVLEIISGQKNNSF  530 (551)
Q Consensus       515 Gvll~elltG~~p~~~  530 (551)
                      ||++|||++|+.||..
T Consensus       235 Gvil~elltG~~Pf~~  250 (377)
T cd05629         235 GAIMFECLIGWPPFCS  250 (377)
T ss_pred             chhhhhhhcCCCCCCC
Confidence            9999999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-36  Score=274.75  Aligned_cols=201  Identities=29%  Similarity=0.471  Sum_probs=179.7

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|.||.||.|+. +++-.||+|++.+...   +...++.+|+++-+.|+||||++++++|.++...||++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            5789999999999999999984 4577899999977533   33557899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||.++|+|...|++. ...++++.....++.|+|.||.|+|..+   +|||||||+|+|++.++..||+|||-+..-+  
T Consensus       102 Eya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            999999999999864 4567899999999999999999999887   9999999999999999999999999886422  


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRI  532 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~  532 (551)
                        .......+||..|.+||...+...+...|+|++||+.||++.|.+||+...
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~  226 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS  226 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence              344567899999999999999999999999999999999999999997543

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-36  Score=293.05  Aligned_cols=196  Identities=29%  Similarity=0.489  Sum_probs=163.8

Q ss_pred             HHhhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhc--CCCCCccceeeEEecCC---
Q 008854          319 IRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR--LQHRNLVRLLGFSFEET---  393 (551)
Q Consensus       319 i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---  393 (551)
                      .+...+...+.+.||+|.||+||+|++ .|+.||||++...+   +....+|.+|.+.  |+|+||+.+++.-..++   
T Consensus       206 QRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  206 QRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             HHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            455567888999999999999999999 58999999997653   4456666666655  59999999998876543   


Q ss_pred             -ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhh-----CCCCCeEeccCCCCCeeeCCCCCeEE
Q 008854          394 -ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE-----DSRLRIIHRDLKASNILLDADMIPKI  467 (551)
Q Consensus       394 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~iiH~Dlk~~NIll~~~~~~kl  467 (551)
                       +++||.+|.++|||.+||.    +..++....++++..+|.||++||.     +++|.|.|||||++||||..++.+.|
T Consensus       282 TQLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             EEEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence             6789999999999999995    4679999999999999999999994     58899999999999999999999999


Q ss_pred             eecCCccccccCC--CcccccccccCCCcccccccccC----CCC--cchhhHhHHHHHHHHH
Q 008854          468 SDFGMARLFEMDQ--SQGDTSRIVGTFGYMAPEYVTRG----HFS--IKSDVFSFGVLVLEII  522 (551)
Q Consensus       468 ~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~----~~~--~~sDv~S~Gvll~ell  522 (551)
                      +|+|||.....+.  .....+..+||.+|||||++...    .+.  ..+||||||.++||+.
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia  420 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA  420 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence            9999998765442  23345667899999999998643    222  3599999999999975

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-36  Score=308.22  Aligned_cols=201  Identities=26%  Similarity=0.363  Sum_probs=173.4

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.++||+|+||+||+++.. +++.||||++.+..   ......+.+|+.++..++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46889999999999999999854 68899999997642   223345788999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999999863   456899999999999999999999987   999999999999999999999999998754321


Q ss_pred             CCcc------------------------------------cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh
Q 008854          480 QSQG------------------------------------DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS  523 (551)
Q Consensus       480 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt  523 (551)
                      ....                                    ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1000                                    0112468999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 008854          524 GQKNNSF  530 (551)
Q Consensus       524 G~~p~~~  530 (551)
                      |+.||..
T Consensus       235 G~~Pf~~  241 (364)
T cd05599         235 GYPPFCS  241 (364)
T ss_pred             CCCCCCC
Confidence            9999963

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-36  Score=304.15  Aligned_cols=196  Identities=27%  Similarity=0.400  Sum_probs=174.1

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.++||+|+||.||+++.. +++.||+|++++..   ......+.+|+.++..++||||+++++++......++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46888999999999999999865 58899999997642   223446889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            99999999999863   456899999999999999999999987   99999999999999999999999999975432 


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                          ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  200 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG  200 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC
Confidence                23345789999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-36  Score=303.96  Aligned_cols=197  Identities=28%  Similarity=0.430  Sum_probs=176.2

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      +-|++.+.||.|+-|.|-.|+. ..|+.+|||++.+...   .....+.+|+.||+.+.||||+++++++....++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4678889999999999999984 5799999999977522   22346889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++|.|.++|.   ..+++.+.+..+++.||+.|+.|.|..+   |+||||||+|+|||.++++||+|||+|.+... 
T Consensus        92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP-  164 (786)
T ss_pred             EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC-
Confidence            9999999999986   5678999999999999999999999988   99999999999999999999999999976332 


Q ss_pred             CCcccccccccCCCcccccccccCCCC-cchhhHhHHHHHHHHHhCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFS-IKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvll~elltG~~p~~  529 (551)
                        ..-...-+|++.|.+||++.+.+|. .++||||.||||+.||+|+.||+
T Consensus       165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd  213 (786)
T KOG0588|consen  165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD  213 (786)
T ss_pred             --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC
Confidence              2233456899999999999999885 78999999999999999999996

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1e-35  Score=308.71  Aligned_cols=200  Identities=26%  Similarity=0.361  Sum_probs=171.3

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      +|+..++||+|+||+||+++. .+++.||+|++.+..   ......+.+|+.++++++||||+++++.+.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999985 467899999997542   2234468899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++|+|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999998863   356888999999999999999999987   9999999999999999999999999975321100


Q ss_pred             C---------------------------------------------cccccccccCCCcccccccccCCCCcchhhHhHH
Q 008854          481 S---------------------------------------------QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFG  515 (551)
Q Consensus       481 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G  515 (551)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001234689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCC
Q 008854          516 VLVLEIISGQKNNSF  530 (551)
Q Consensus       516 vll~elltG~~p~~~  530 (551)
                      |++|||++|+.||..
T Consensus       236 vil~elltG~~Pf~~  250 (382)
T cd05625         236 VILYEMLVGQPPFLA  250 (382)
T ss_pred             HHHHHHHhCCCCCCC
Confidence            999999999999964

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.8e-36  Score=302.42  Aligned_cols=196  Identities=27%  Similarity=0.370  Sum_probs=173.5

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|+||.||+++.. +++.||+|++.+..   ......+.+|+.++.+++||||+++++++...+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888999999999999999864 58899999997642   223446889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999998863   456889999999999999999999987   999999999999999999999999999865322


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                           .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  217 (329)
T PTZ00263        172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD  217 (329)
T ss_pred             -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence                 2235789999999999999999999999999999999999999853

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-35  Score=302.73  Aligned_cols=197  Identities=26%  Similarity=0.358  Sum_probs=172.8

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCC--CCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSH--GQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~--g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      -++|++.+.||+|+||.||++...+  +..||+|++.+..   ......+.+|+.++..++||||+++++++.+....++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3568889999999999999997543  3689999996542   2234467899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999999863   456899999999999999999999987   9999999999999999999999999997653


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~  230 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA  230 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence            21     2345789999999999988899999999999999999999999964

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=8e-36  Score=308.87  Aligned_cols=202  Identities=25%  Similarity=0.365  Sum_probs=172.2

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.++||+|+||.||+++. .+++.||||++.+...   .....+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3688999999999999999984 4588999999965422   23346789999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            99999999999863   456888999999999999999999987   999999999999999999999999997532100


Q ss_pred             C-----------------------------------------CcccccccccCCCcccccccccCCCCcchhhHhHHHHH
Q 008854          480 Q-----------------------------------------SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLV  518 (551)
Q Consensus       480 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll  518 (551)
                      .                                         .........||+.|||||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                         00001235799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCC
Q 008854          519 LEIISGQKNNSFR  531 (551)
Q Consensus       519 ~elltG~~p~~~~  531 (551)
                      |||++|+.||...
T Consensus       235 yell~G~~Pf~~~  247 (376)
T cd05598         235 YEMLVGQPPFLAD  247 (376)
T ss_pred             eehhhCCCCCCCC
Confidence            9999999999643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.1e-35  Score=299.23  Aligned_cols=192  Identities=24%  Similarity=0.292  Sum_probs=167.8

Q ss_pred             cccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCC
Q 008854          330 NKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS  405 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  405 (551)
                      +.||+|+||.||+++. .+|+.||+|++++..   ......+.+|+.++.+++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 468899999997642   223346788999999999999999999999999999999999999


Q ss_pred             ChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccc
Q 008854          406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT  485 (551)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  485 (551)
                      +|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~  152 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence            99988863   457899999999999999999999987   999999999999999999999999998743211  1223


Q ss_pred             cccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       486 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  196 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY  196 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCC
Confidence            34579999999999999999999999999999999999999985

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=297.21  Aligned_cols=199  Identities=27%  Similarity=0.423  Sum_probs=172.4

Q ss_pred             hhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChh-cHHHHHHHHHHHhcCC-CCCccceeeEEecCC-ceEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQ-HRNLVRLLGFSFEET-ERLL  397 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l  397 (551)
                      ..++|...++||.|+||.||+|+ ...+..||||++++.-.. ++.-=.+|+..|++|+ ||||+++.+++.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            45688899999999999999998 567899999999775332 2223468999999998 999999999999888 8999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      |||||+ .+|.+++.+  ++..+++..+..|+.||++||+|+|++|   +.|||+||+|||+..+..+||+|||+||.+.
T Consensus        88 VfE~Md-~NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   88 VFEFMD-CNLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eHHhhh-hhHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence            999995 468887776  3778999999999999999999999998   9999999999999999999999999999765


Q ss_pred             cCCCcccccccccCCCcccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ..   ...+..+.|..|.|||++. .+.|+.+.|||++|+|++||.+-++-|.
T Consensus       162 Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP  211 (538)
T KOG0661|consen  162 SK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP  211 (538)
T ss_pred             cC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC
Confidence            33   2344567899999999875 5789999999999999999999998774

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.5e-35  Score=305.49  Aligned_cols=204  Identities=22%  Similarity=0.302  Sum_probs=173.9

Q ss_pred             HHhhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 008854          319 IRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE  394 (551)
Q Consensus       319 i~~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  394 (551)
                      +....++|++.++||+|+||.||+++.. +++.+|+|++.+..   ......+.+|+.+++.++||||+++++++..+..
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3445678999999999999999999854 57889999997532   2233457899999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .++||||+++|+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence            9999999999999998853    35788999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCCCcccccccccCCCcccccccccC----CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRG----HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...... ........||+.|+|||.+.+.    .++.++||||||+++|||++|+.||..
T Consensus       191 ~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~  249 (370)
T cd05621         191 KMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA  249 (370)
T ss_pred             ecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence            654221 1122345799999999998654    378899999999999999999999963

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8.1e-35  Score=292.43  Aligned_cols=204  Identities=29%  Similarity=0.449  Sum_probs=170.0

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCC-----------------CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSH-----------------GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVR  384 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  384 (551)
                      .++|.+.++||+|+||.||++.+.+                 +..||+|.+.... .....++.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578889999999999999997532                 3369999987653 334557899999999999999999


Q ss_pred             eeeEEecCCceEEEEEccCCCChhHHhhhhc----------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 008854          385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAI----------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRII  448 (551)
Q Consensus       385 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii  448 (551)
                      +++++.+.+..++||||+++++|.+++....                ....+++..+++++.||+.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999999986421                1134788999999999999999999987   99


Q ss_pred             eccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhC--CC
Q 008854          449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG--QK  526 (551)
Q Consensus       449 H~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG--~~  526 (551)
                      ||||||+|||+++++.+||+|||+++.+.............++..|+|||.+..+.++.++||||||+++|||+++  ..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999999865433222223334567899999999988999999999999999999974  45


Q ss_pred             CCC
Q 008854          527 NNS  529 (551)
Q Consensus       527 p~~  529 (551)
                      |+.
T Consensus       241 p~~  243 (304)
T cd05096         241 PYG  243 (304)
T ss_pred             CCC
Confidence            554

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.6e-35  Score=296.70  Aligned_cols=193  Identities=24%  Similarity=0.293  Sum_probs=167.5

Q ss_pred             cccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCC
Q 008854          330 NKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS  405 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  405 (551)
                      +.||+|+||.||+++. .+|+.||+|+++...   ......+.+|+.+++.++||||+++++.+......++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999985 468999999997642   223345778999999999999999999999999999999999999


Q ss_pred             ChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccc
Q 008854          406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT  485 (551)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  485 (551)
                      +|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            99888763   456899999999999999999999987   9999999999999999999999999987532211  122


Q ss_pred             cccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       486 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  197 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC
Confidence            345789999999999999999999999999999999999999853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.9e-35  Score=297.12  Aligned_cols=193  Identities=25%  Similarity=0.303  Sum_probs=168.1

Q ss_pred             cccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCC
Q 008854          330 NKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS  405 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  405 (551)
                      +.||+|+||.||+++. .+++.||+|++.+..   ......+.+|+.+++.++||||+++.+++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999984 468999999997642   233456788999999999999999999999999999999999999


Q ss_pred             ChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccc
Q 008854          406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT  485 (551)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  485 (551)
                      +|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~  152 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM  152 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence            99888763   456899999999999999999999987   999999999999999999999999998753221  1123


Q ss_pred             cccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       486 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~  197 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC
Confidence            345789999999999999999999999999999999999999953

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-35  Score=295.24  Aligned_cols=190  Identities=25%  Similarity=0.321  Sum_probs=166.7

Q ss_pred             cCcCCceeEEEeecC-CCCEEEEEEeecC---ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCCh
Q 008854          332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKN---SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSV  407 (551)
Q Consensus       332 LG~G~~g~Vyk~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  407 (551)
                      ||+|+||.||+++.. +++.||+|++++.   .......+.+|+.++.+++||||+++++++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999854 5789999999753   223345678899999999999999999999999999999999999999


Q ss_pred             hHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccc
Q 008854          408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR  487 (551)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  487 (551)
                      .+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            999863   456899999999999999999999987   9999999999999999999999999987532221  22344


Q ss_pred             cccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       488 ~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~  194 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY  194 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcC
Confidence            578999999999999999999999999999999999999985

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=288.78  Aligned_cols=203  Identities=29%  Similarity=0.460  Sum_probs=168.6

Q ss_pred             hhhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChh--------------cHHHHHHHHHHHhcCCCCCccce
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQ--------------GELEFKNEVLLVARLQHRNLVRL  385 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~h~niv~l  385 (551)
                      ..-+.|++.+.||+|.||.|-+++ ..+++.||||++.+....              ..+...+||.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            345789999999999999999998 457899999999764221              12468899999999999999999


Q ss_pred             eeEEec--CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC
Q 008854          386 LGFSFE--ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM  463 (551)
Q Consensus       386 ~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~  463 (551)
                      +++.-+  .+..|||+||+..|.+...--   ....+++.+..+++++++.||+|||.++   ||||||||+|+||+++|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            999865  567899999999998765421   2223899999999999999999999998   99999999999999999


Q ss_pred             CeEEeecCCccccccCC---CcccccccccCCCcccccccccCC----CCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          464 IPKISDFGMARLFEMDQ---SQGDTSRIVGTFGYMAPEYVTRGH----FSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       464 ~~kl~Dfgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ++||+|||.+..+....   .........|||.|||||...++.    .+.+.||||+||.||-|+.|+.||-
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence            99999999998663221   112234578999999999887632    3468999999999999999999993

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3e-35  Score=302.76  Aligned_cols=202  Identities=25%  Similarity=0.357  Sum_probs=173.3

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|+..+.||+|+||.||++... +++.||+|++....   ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999854 68899999997532   223446788999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999999863   456899999999999999999999987   999999999999999999999999998754221


Q ss_pred             CC---------------------------------cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCC
Q 008854          480 QS---------------------------------QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK  526 (551)
Q Consensus       480 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~  526 (551)
                      ..                                 ........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            10                                 000123579999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 008854          527 NNSFR  531 (551)
Q Consensus       527 p~~~~  531 (551)
                      ||...
T Consensus       235 Pf~~~  239 (360)
T cd05627         235 PFCSE  239 (360)
T ss_pred             CCCCC
Confidence            99643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.4e-34  Score=294.20  Aligned_cols=200  Identities=26%  Similarity=0.382  Sum_probs=175.0

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .++|++.++||+|+||.||+++.. ++..+|+|.+.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            467899999999999999999854 57889999987653 2334578999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            9999999999863   456899999999999999999999854  4999999999999999999999999998754322 


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                         ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence               223456899999999999999999999999999999999999999643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.9e-35  Score=301.27  Aligned_cols=206  Identities=22%  Similarity=0.297  Sum_probs=174.7

Q ss_pred             hHHHhhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecC
Q 008854          317 STIRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE  392 (551)
Q Consensus       317 ~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  392 (551)
                      ..++...++|++.+.||+|+||.||+++.. +++.+|+|++.+..   ......+.+|+.++..++||||+++++.+...
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344455689999999999999999999854 57889999986532   22334578899999999999999999999999


Q ss_pred             CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCC
Q 008854          393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM  472 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl  472 (551)
                      ...++||||+++++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            999999999999999998853    35788889999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCcccccccccC----CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG----HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ++...... ........||+.|+|||++.+.    .++.++|||||||++|||++|+.||..
T Consensus       189 a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  249 (371)
T cd05622         189 CMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  249 (371)
T ss_pred             eeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence            98654221 1122345799999999998654    378999999999999999999999963

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.8e-35  Score=282.18  Aligned_cols=204  Identities=23%  Similarity=0.315  Sum_probs=175.2

Q ss_pred             cCCCcCcccCcCCceeEEEeecCC-CCEEEEEEeecCChh---cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~-g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++++.||.|.-|+||++.+.+ +..+|+|++.+....   ...+...|-+||+.++||.++.|+..+..+...+|||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            456778999999999999999765 478999999886443   3345677999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc-
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM-  478 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~-  478 (551)
                      ||++||+|...++.+ ....+++..+.-++.+++-||+|||-.+   ||+|||||+||||.++|++.|+||+|+..... 
T Consensus       157 eyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            999999999988754 5667999999999999999999999988   99999999999999999999999999743210 


Q ss_pred             --------------------------------C-C--------------------CcccccccccCCCcccccccccCCC
Q 008854          479 --------------------------------D-Q--------------------SQGDTSRIVGTFGYMAPEYVTRGHF  505 (551)
Q Consensus       479 --------------------------------~-~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~  505 (551)
                                                      . .                    .......++||.+|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                    0012334689999999999999999


Q ss_pred             CcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          506 SIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       506 ~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      +.+.|+|.|||++|||+.|+.||...
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~  338 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGS  338 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCC
Confidence            99999999999999999999999633

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-34  Score=308.88  Aligned_cols=203  Identities=22%  Similarity=0.299  Sum_probs=176.2

Q ss_pred             CCCcCcccCcCCceeEEEeecC-C-CCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-H-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      .|.+.+.||+|++|.||++... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888899999999999999743 3 5778888876655555556888999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          403 PNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       403 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      ++++|.++|.+.. ...++++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            9999999886533 3456899999999999999999999987   99999999999999999999999999987643322


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ........||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~  273 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG  273 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence            2234456799999999999999999999999999999999999999863

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1e-34  Score=294.22  Aligned_cols=193  Identities=28%  Similarity=0.386  Sum_probs=166.8

Q ss_pred             cccCcCCceeEEEeec----CCCCEEEEEEeecCC----hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          330 NKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNS----VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ++||+|+||.||+++.    ..++.||+|++++..    ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6899999999999974    357889999997542    12234578899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++..   ...+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-  154 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence            999999998863   456788899999999999999999987   9999999999999999999999999987432221 


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                       .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~  202 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA  202 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence             123345789999999999988899999999999999999999999863

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=295.29  Aligned_cols=201  Identities=23%  Similarity=0.329  Sum_probs=171.6

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|+||+||+++.. +++.||+|++.+..   ......+.+|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999854 58899999997532   223345888999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999864  2456899999999999999999999987   999999999999999999999999998765432


Q ss_pred             CCcccccccccCCCccccccccc-----CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTR-----GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .. .......||+.|+|||++..     ..++.++|||||||++|||++|+.||..
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            21 12233468999999999863     4578899999999999999999999853

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.7e-35  Score=275.48  Aligned_cols=198  Identities=25%  Similarity=0.414  Sum_probs=168.3

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhc--HHHHHHHHHHHhcCCCCCccceeeEEecC--CceEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERLLI  398 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV  398 (551)
                      +.|+.+++|++|+||.||+|+. ++++.||+|+++......  -..-.+||.+|.+++|||||.+-.+....  +..|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            4688899999999999999985 467889999997654221  12357999999999999999999887654  468999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++ +|..++...  ..++...+..-+..|+++|+.|||...   |+|||||++|+|+++.|.+||+|||||+.+..
T Consensus       156 Me~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999976 677777642  367899999999999999999999998   99999999999999999999999999998764


Q ss_pred             CCCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ..  ...+..+-|+.|.|||.+.+. .|+...|+||+|+|+.||+++++-|.
T Consensus       230 p~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~  279 (419)
T KOG0663|consen  230 PL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP  279 (419)
T ss_pred             Cc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC
Confidence            32  234456779999999988764 78999999999999999999998775

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.5e-35  Score=302.12  Aligned_cols=201  Identities=23%  Similarity=0.310  Sum_probs=171.6

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      ..++|++.++||+|+||.||+++.. +++.||+|++.+..   ......+.+|+.+++.++||||+++++++.+....++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4567899999999999999999854 68899999997532   2233457889999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+++|+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999998853    35788889999999999999999987   9999999999999999999999999997654


Q ss_pred             cCCCcccccccccCCCcccccccccC----CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRG----HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ... ........||+.|+|||.+.+.    .++.++|||||||++|||++|+.||..
T Consensus       194 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  249 (370)
T cd05596         194 ANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  249 (370)
T ss_pred             CCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence            221 1122345799999999988653    478999999999999999999999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.2e-35  Score=296.32  Aligned_cols=200  Identities=23%  Similarity=0.318  Sum_probs=171.7

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|.+.++||+|+||+||+++.. +++.||+|++.+..   ......+.+|+.++..++|+||+++++++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999854 57889999997532   122345788999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++|+|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999974  2356899999999999999999999987   999999999999999999999999999765432


Q ss_pred             CCcccccccccCCCccccccccc-----CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTR-----GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .. .......||+.|+|||.+.+     +.++.++||||||+++|||++|+.||.
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~  209 (331)
T cd05624         156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence            21 12233568999999998865     567889999999999999999999985

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-36  Score=309.32  Aligned_cols=200  Identities=33%  Similarity=0.518  Sum_probs=176.7

Q ss_pred             CCcCcccCcCCceeEEEeec-CCCC----EEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          326 FSTDNKLGQGGFGAVYKGRL-SHGQ----EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~-~~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ....++||+|+||+||||.+ ..|+    +||+|++... ..+...++.+|+.+|.+++||||++|+|+|.... ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34568899999999999984 3443    6899998665 4455678999999999999999999999998776 78999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      +||+.|+|.++++.  .+..+.....+.|..|||+||.|||++.   ++||||..+||||.+-..+||.|||+++.+..+
T Consensus       777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999986  5667889999999999999999999876   999999999999999999999999999998877


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFR  531 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~~  531 (551)
                      ..........-.+.|||-|.+....|+.++|||||||.+|||+| |.+|++-.
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi  904 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI  904 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC
Confidence            66655555666789999999999999999999999999999999 99999743

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.5e-34  Score=287.98  Aligned_cols=200  Identities=23%  Similarity=0.355  Sum_probs=171.8

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ++|++.+.||+|+||.||+++.. +++.||+|+++....  .....+.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999865 578899999976422  234467899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |++++.+..+..   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999987765543   2356899999999999999999999887   9999999999999999999999999998654222


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                       ........|++.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~  203 (287)
T cd07848         155 -NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG  203 (287)
T ss_pred             -cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence             1122345689999999999998999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-35  Score=300.37  Aligned_cols=201  Identities=26%  Similarity=0.400  Sum_probs=175.5

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|.+.++||+|+||+||+++.. +++.||+|++++...   .....+.+|+.++..++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999854 689999999976421   33456889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            99999999999874   367899999999999999999999977   999999999999999999999999999765432


Q ss_pred             C---------------------------CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 Q---------------------------SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .                           .........||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~  232 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS  232 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence            2                           00122345789999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.6e-34  Score=292.85  Aligned_cols=198  Identities=28%  Similarity=0.336  Sum_probs=169.2

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      +|++.+.||+|+||.||+++.. +++.||+|++++...   .....+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999854 578999999976422   2233466788888777 5899999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999988863   456899999999999999999999987   999999999999999999999999998753221


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        ........||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~  203 (323)
T cd05616         155 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG  203 (323)
T ss_pred             --CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC
Confidence              1123345789999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.4e-34  Score=291.93  Aligned_cols=193  Identities=27%  Similarity=0.359  Sum_probs=166.9

Q ss_pred             cccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      +.||+|+||+||+++. .+++.+|+|++++...   .....+.+|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999985 4578899999986532   2334578899999888 699999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~  152 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT  152 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence            999988753   456999999999999999999999987   999999999999999999999999998742211  112


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~  198 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  198 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence            3346789999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.6e-34  Score=294.12  Aligned_cols=199  Identities=27%  Similarity=0.391  Sum_probs=169.9

Q ss_pred             CCCcCcccCcCCceeEEEeec----CCCCEEEEEEeecCC----hhcHHHHHHHHHHHhcCC-CCCccceeeEEecCCce
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNS----VQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETER  395 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  395 (551)
                      +|++.++||+|+||.||+++.    ..++.||+|++.+..    ......+.+|+.++..++ ||||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478889999999999999874    357899999997532    122345788999999994 99999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999998863   456899999999999999999999987   99999999999999999999999999976


Q ss_pred             cccCCCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          476 FEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +..... .......||+.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  209 (332)
T cd05614         155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL  209 (332)
T ss_pred             ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence            432221 223345799999999998765 478899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.8e-34  Score=292.54  Aligned_cols=198  Identities=27%  Similarity=0.329  Sum_probs=169.1

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCC-CccceeeEEecCCceEEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHR-NLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~  399 (551)
                      +|++.+.||+|+||.||+|+.. +++.||+|++.+..   ......+..|.+++..++|+ +|+++.+++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999854 56789999997642   22344678899999999765 5888889999889999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999988863   456899999999999999999999987   999999999999999999999999998643211


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        ........||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~  203 (324)
T cd05587         155 --GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG  203 (324)
T ss_pred             --CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence              1123345789999999999999999999999999999999999999963

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.1e-34  Score=291.42  Aligned_cols=193  Identities=27%  Similarity=0.360  Sum_probs=167.1

Q ss_pred             cccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      +.||+|+||.||+++.. +++.||+|++++...   .....+.+|..++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999854 688999999986422   2334578899999888 699999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~  152 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence            999888753   457999999999999999999999987   999999999999999999999999998642111  122


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||+.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence            3346789999999999999999999999999999999999999963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.3e-34  Score=299.28  Aligned_cols=204  Identities=31%  Similarity=0.443  Sum_probs=170.8

Q ss_pred             hcCCCcCcccCcCCceeEEEeec------CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETE  394 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  394 (551)
                      .++|++.++||+|+||.||+++.      ..+..||||+++... ......+.+|+.++..+ +||||+++++++.....
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45789999999999999999963      235689999997543 23345688999999999 89999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhc-----------------------------------------------------------
Q 008854          395 RLLIYEFVPNSSVDKFIFDAI-----------------------------------------------------------  415 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~-----------------------------------------------------------  415 (551)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986421                                                           


Q ss_pred             -------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          416 -------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       416 -------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                                   ....+++..+++++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                         1125789999999999999999999987   999999999999999999999999999865433221


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~  318 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP  318 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            12222345678999999999999999999999999999998 888875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.5e-34  Score=308.04  Aligned_cols=210  Identities=22%  Similarity=0.335  Sum_probs=178.1

Q ss_pred             hHHHhhhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCC
Q 008854          317 STIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEET  393 (551)
Q Consensus       317 ~~i~~~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  393 (551)
                      .+.+...++|.+.+.||+|+||+||+++ ..+++.||||++....  ......+.+|+.++..++|+||+++...+....
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            4445566899999999999999999998 4578999999997643  334456889999999999999999988765432


Q ss_pred             --------ceEEEEEccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC
Q 008854          394 --------ERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI  464 (551)
Q Consensus       394 --------~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~  464 (551)
                              ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL  181 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence                    2579999999999999987533 2456899999999999999999999987   999999999999999999


Q ss_pred             eEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       465 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      +||+|||+++.+.............||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~  246 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD  246 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            99999999987653332333345679999999999999999999999999999999999999986

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.4e-35  Score=294.79  Aligned_cols=193  Identities=23%  Similarity=0.286  Sum_probs=166.7

Q ss_pred             cccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCC
Q 008854          330 NKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS  405 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  405 (551)
                      +.||+|+||.||+++. .+++.||+|++++..   ......+.+|++++..++||||+++.+++......++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999984 468899999997642   223446778999999999999999999999999999999999999


Q ss_pred             ChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      +|..++..   ...+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            99988763   4568999999999999999999997 55   9999999999999999999999999987432211  12


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~  198 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  198 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC
Confidence            2345689999999999999999999999999999999999999953

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.4e-34  Score=294.46  Aligned_cols=200  Identities=23%  Similarity=0.323  Sum_probs=170.6

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.++||+|+||+||+++.. .++.+|+|++.+..   ......+.+|+.++..++|+||+++++.+......++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999865 46789999996532   122334788999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++|+|.+++.+  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999974  2456899999999999999999999987   999999999999999999999999998754322


Q ss_pred             CCcccccccccCCCcccccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .. .......||+.|+|||++.     ...++.++|||||||++|||++|+.||.
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~  209 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY  209 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence            21 1223457999999999886     3467899999999999999999999985

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.6e-34  Score=290.93  Aligned_cols=193  Identities=26%  Similarity=0.355  Sum_probs=166.3

Q ss_pred             cccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      +.||+|+||.||+++.. +++.||+|++++..   ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999854 57899999997642   22334577888888776 799999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~  152 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCc
Confidence            999888753   456899999999999999999999987   999999999999999999999999998753211  112


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence            3346789999999999999999999999999999999999999963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2e-34  Score=287.37  Aligned_cols=199  Identities=25%  Similarity=0.402  Sum_probs=169.2

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ++|+..++||+|+||.||+++.. +++.||+|+++.... .....+.+|+.++++++||||+++++++..+...++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888999999999999999854 688999999975432 2334678999999999999999999999999899999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++ +|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++...... 
T Consensus        85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-  157 (288)
T cd07871          85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-  157 (288)
T ss_pred             CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence            985 88888753  2345789999999999999999999987   9999999999999999999999999997543221 


Q ss_pred             cccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                       .......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||..
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~  206 (288)
T cd07871         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG  206 (288)
T ss_pred             -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence             12233467899999998865 5689999999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.4e-34  Score=290.53  Aligned_cols=193  Identities=30%  Similarity=0.383  Sum_probs=163.7

Q ss_pred             cccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhc-CCCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVAR-LQHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      +.||+|+||.||+++.. +++.||+|+++...   ......+..|..++.. .+||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999854 57889999997642   1223345566666664 4899999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            999988863   456899999999999999999999987   9999999999999999999999999997543221  22


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~  198 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC
Confidence            3446789999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.9e-34  Score=291.10  Aligned_cols=200  Identities=25%  Similarity=0.380  Sum_probs=174.3

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .++|++.++||+|+||.||++... ++..+|+|++.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999865 57889999887653 2334568999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|.+++..   ...+++..+..++.+++.||.|||+.+  +|+|+||||+|||+++++.+||+|||++..+... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            9999999999863   456889999999999999999999753  3999999999999999999999999998754322 


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                         ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence               123346899999999999889999999999999999999999998644

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.3e-35  Score=297.31  Aligned_cols=201  Identities=24%  Similarity=0.368  Sum_probs=173.2

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|.+.++||+|+||+||+++. .+++.||+|++++...   .....+.+|+.++..++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4688899999999999999985 4688999999976422   23446889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999998642  357899999999999999999999987   999999999999999999999999999865432


Q ss_pred             CCcccccccccCCCcccccccc------cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVT------RGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ... ......||+.|+|||.+.      ...++.++||||||+++|||++|+.||..
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  211 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE  211 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence            221 223346899999999886      45678999999999999999999999853

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.3e-34  Score=287.85  Aligned_cols=200  Identities=26%  Similarity=0.413  Sum_probs=169.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .++|++.++||+|+||.||+++.. +++.||+|++..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999864 688999999975432 223457889999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |++ ++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 577777653  3456889999999999999999999987   9999999999999999999999999987543211


Q ss_pred             CcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  206 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG  206 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence              12233567899999998865 4578999999999999999999999963

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.7e-34  Score=298.21  Aligned_cols=206  Identities=29%  Similarity=0.446  Sum_probs=171.2

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec------CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcC-CCCCccceeeEEecCC
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEET  393 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  393 (551)
                      ..++|++.+.||+|+||.||+++.      .++..||+|+++... ......+.+|+.+++.+ +||||+++++.+....
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            345788999999999999999873      234579999997653 23344688999999999 8999999999999999


Q ss_pred             ceEEEEEccCCCChhHHhhhhcc---------------------------------------------------------
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIK---------------------------------------------------------  416 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------  416 (551)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            99999999999999999864211                                                         


Q ss_pred             ----------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccccc
Q 008854          417 ----------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS  486 (551)
Q Consensus       417 ----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  486 (551)
                                ..++++.++++++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++............
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                      124788999999999999999999987   9999999999999999999999999997653322111122


Q ss_pred             ccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       487 ~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ...++..|||||++.+..++.++||||||+++|||++ |+.||..
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~  317 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG  317 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence            2335678999999999999999999999999999997 9999853

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.5e-34  Score=277.78  Aligned_cols=200  Identities=29%  Similarity=0.484  Sum_probs=168.6

Q ss_pred             cCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChh--cHHHHHHHHHHHhcCCCCC-ccceeeEEecCC------
Q 008854          324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRN-LVRLLGFSFEET------  393 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------  393 (551)
                      ..|...++||+|+||+||+|+ ..+|+.||+|++.....+  ......+|+.++++++|+| |+++.+++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            456667899999999999998 457899999999766432  2234689999999999999 999999998877      


Q ss_pred             ceEEEEEccCCCChhHHhhhhccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCC
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM  472 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl  472 (551)
                      ..++|+||+ ..+|..++...... ..++...+..++.||++||+|||+++   |+||||||.||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            778999999 55788888653322 45777889999999999999999988   99999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      |+.+.....  .....++|..|.|||++.+. .|+...||||+|+|+.||++++.-|.
T Consensus       167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFp  222 (323)
T KOG0594|consen  167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFP  222 (323)
T ss_pred             HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCC
Confidence            996553322  23456789999999999876 78999999999999999999887664

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.7e-34  Score=291.31  Aligned_cols=196  Identities=27%  Similarity=0.364  Sum_probs=166.8

Q ss_pred             CCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHH---hcCCCCCccceeeEEecCCceEEE
Q 008854          326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLV---ARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      |++.+.||+|+||.||++... +++.||||++++..   ......+.+|++++   +.++||||+++++++......++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999854 68899999997542   12233566665554   567899999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|..++.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999988774    346899999999999999999999987   99999999999999999999999999874322


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .  ........|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~  203 (324)
T cd05589         154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG  203 (324)
T ss_pred             C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence            1  1223446789999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=289.91  Aligned_cols=203  Identities=26%  Similarity=0.397  Sum_probs=178.2

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ...|+..+.||+|.||.||||.. ..++.||+|++.-... ....++.+|+.+|.+++++||.+.++.+..+..++++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            34577789999999999999984 4678999999976543 345678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+.+|++.+.|.   ....+++..+.-|+++++.||.|||.++   .+|||||+.|||+..+|.+||+|||.+..+....
T Consensus        92 y~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   92 YCGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HhcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence            999999999885   2344588888889999999999999998   9999999999999999999999999998765443


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIG  533 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~~  533 (551)
                      .  ....++||+.|||||++....|+.|+||||||+..+||.+|.+|+.-.++
T Consensus       166 ~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP  216 (467)
T KOG0201|consen  166 K--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP  216 (467)
T ss_pred             h--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence            3  33678999999999999988999999999999999999999999974443

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2e-34  Score=286.46  Aligned_cols=191  Identities=18%  Similarity=0.327  Sum_probs=164.8

Q ss_pred             CcccCcCCceeEEEeecCCCCEEEEEEeecCChhc---HHHHHHHHHHHhcCCCCCccceeeEEec----CCceEEEEEc
Q 008854          329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG---ELEFKNEVLLVARLQHRNLVRLLGFSFE----ETERLLIYEF  401 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~  401 (551)
                      ...||+|++|.||+|++ +|+.||||+++......   .+.+.+|+.++.+++||||++++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 68999999997654332   3567899999999999999999999876    3467899999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++|+|.+++..   ...+++...++++.+++.||.|||+..  +++||||||+|||+++++.+||+|||+++...... 
T Consensus       104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            999999999874   457899999999999999999999852  27899999999999999999999999998653221 


Q ss_pred             cccccccccCCCccccccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                          ....++..|+|||.+.+  ..++.++|||||||++|||++|+.||..
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~  224 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN  224 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC
Confidence                23467889999999876  6899999999999999999999999963

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2e-34  Score=291.81  Aligned_cols=193  Identities=27%  Similarity=0.352  Sum_probs=166.0

Q ss_pred             cccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      +.||+|+||.||+|+.. +++.||+|++++..   ......+..|.+++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999854 57899999997642   22334577888888866 799999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~  152 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT  152 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence            999988863   456899999999999999999999987   9999999999999999999999999987532211  12


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~  198 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA  198 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC
Confidence            3345789999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.7e-34  Score=290.29  Aligned_cols=201  Identities=29%  Similarity=0.486  Sum_probs=169.5

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCC----EEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQ----EIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      .+|+..+.||+|+||.||+|++. +++    .||+|+++... .....++.+|+.+++.++||||++++|++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46889999999999999999853 333    38999987543 33455788999999999999999999998764 5679


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      |+||+++|+|.+++..  ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            9999999999999875  2446889999999999999999999987   9999999999999999999999999998765


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~  214 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG  214 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence            4332222222334678999999999999999999999999999998 9999863

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.3e-34  Score=290.06  Aligned_cols=193  Identities=28%  Similarity=0.381  Sum_probs=165.9

Q ss_pred             cccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      +.||+|+||+||+++.. +++.||+|++.+..   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999854 57899999997542   22334567888888776 699999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      ++|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~  152 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKT  152 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCc
Confidence            999988863   456899999999999999999999987   999999999999999999999999998753211  122


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA  198 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence            3345789999999999999999999999999999999999999963

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5e-34  Score=281.04  Aligned_cols=201  Identities=27%  Similarity=0.446  Sum_probs=170.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC----CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS----HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++... ......+.+|+.++.+++||||+++++++......++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356888999999999999999753    35689999997653 2334578999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+++++|.+++..  ....+++..++.++.||+.||+|||+.+   ++||||||+|||++.++.+|++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            9999999999999864  2357899999999999999999999887   9999999999999999999999999876432


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      .... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~  210 (266)
T cd05064         159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYW  210 (266)
T ss_pred             ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcC
Confidence            1111 11122345678999999999999999999999999999875 999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.9e-34  Score=282.70  Aligned_cols=194  Identities=29%  Similarity=0.412  Sum_probs=167.6

Q ss_pred             cCcCCceeEEEeec-CCCCEEEEEEeecCChh---cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCCh
Q 008854          332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSV  407 (551)
Q Consensus       332 LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  407 (551)
                      ||+|+||+||++.. .+++.+|+|++.+....   ....+..|+.++++++||||+++.+++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999985 46889999999754322   234577899999999999999999999999999999999999999


Q ss_pred             hHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccccc
Q 008854          408 DKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS  486 (551)
Q Consensus       408 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  486 (551)
                      ..++.... ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            98875432 3456899999999999999999999987   99999999999999999999999999976543221  233


Q ss_pred             ccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       487 ~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  199 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA  199 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            45789999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.6e-34  Score=289.40  Aligned_cols=198  Identities=26%  Similarity=0.334  Sum_probs=168.8

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  399 (551)
                      +|+..+.||+|+||+||+++. .+++.||+|++.+..   ......+..|..++..+. |++|+++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            367789999999999999985 468899999997642   223345778888888886 577888999999989999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..   ...+++.++..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999998863   456899999999999999999999987   999999999999999999999999998753221


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~  203 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG  203 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC
Confidence            1  123345689999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.4e-34  Score=289.63  Aligned_cols=193  Identities=25%  Similarity=0.327  Sum_probs=163.9

Q ss_pred             cccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHH-HHhcCCCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVL-LVARLQHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      +.||+|+||+||+++.. +|+.||+|++.+...   .....+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999854 689999999975421   22234455544 56789999999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT  152 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence            999998863   456899999999999999999999987   999999999999999999999999998743211  122


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  198 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence            3445789999999999999999999999999999999999999853

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.1e-34  Score=291.00  Aligned_cols=193  Identities=25%  Similarity=0.326  Sum_probs=164.2

Q ss_pred             cccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHH-HHhcCCCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVL-LVARLQHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      +.||+|+||+||+++. .+|+.+|+|++.+..   ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999984 468999999997542   122334555554 57779999999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      ++|..++.   +...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~  152 (325)
T cd05604          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT  152 (325)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence            99988875   3457899999999999999999999987   999999999999999999999999998743211  122


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~  198 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC  198 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC
Confidence            3345789999999999999999999999999999999999999963

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.3e-34  Score=291.47  Aligned_cols=199  Identities=25%  Similarity=0.412  Sum_probs=166.5

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCC-----ceE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET-----ERL  396 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  396 (551)
                      +|++.++||+|+||.||+|+. .+++.||||++...  .......+.+|+.++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            477889999999999999984 46899999998753  2233446889999999999999999999886432     478


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +||||+. ++|.+++.   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 68888775   3456899999999999999999999987   999999999999999999999999999754


Q ss_pred             ccCCC-cccccccccCCCccccccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          477 EMDQS-QGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       477 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..... ........||+.|+|||++.+  ..++.++||||||+++|||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~  210 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG  210 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            32211 112234578999999998865  6789999999999999999999999853

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-34  Score=283.08  Aligned_cols=200  Identities=30%  Similarity=0.438  Sum_probs=172.9

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      +|+..++||+|+||+||++.. .+++.||+|++.....   .....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            477889999999999999985 4688999999975432   223457789999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||+++......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999888642 3356899999999999999999999987   9999999999999999999999999997653222


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                         ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~  204 (285)
T cd05605         157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR  204 (285)
T ss_pred             ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence               122346899999999999999999999999999999999999999743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.1e-34  Score=288.93  Aligned_cols=193  Identities=26%  Similarity=0.334  Sum_probs=163.4

Q ss_pred             cccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHH-HHHhcCCCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEV-LLVARLQHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      +.||+|+||.||+++.. +++.||+|++.+...   .....+..|. .+++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999854 678999999975422   2233455554 467889999999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      ++|...+.   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (321)
T cd05603          81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET  152 (321)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence            99988875   3456888999999999999999999987   999999999999999999999999998743211  122


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  198 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence            3445789999999999998999999999999999999999999963

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.9e-34  Score=294.68  Aligned_cols=206  Identities=28%  Similarity=0.395  Sum_probs=172.8

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCC-CCCccceeeEEecCC
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQ-HRNLVRLLGFSFEET  393 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  393 (551)
                      ..++|.+.++||+|+||.||+|+..      .+..||||+++.... .....+.+|+.++.++. ||||+++++++.+..
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            4568889999999999999999742      234699999975432 33457899999999996 999999999999999


Q ss_pred             ceEEEEEccCCCChhHHhhhhcc---------------------------------------------------------
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIK---------------------------------------------------------  416 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------  416 (551)
                      ..+|||||+++|+|.++|.....                                                         
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            99999999999999999864211                                                         


Q ss_pred             ------------------------------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC
Q 008854          417 ------------------------------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD  460 (551)
Q Consensus       417 ------------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~  460 (551)
                                                          ...+++..++.++.||++||.|||+.+   |+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence                                                124788899999999999999999987   99999999999999


Q ss_pred             CCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          461 ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       461 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~  342 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG  342 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence            999999999999986543322222333456788999999999999999999999999999997 8888753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.1e-34  Score=295.21  Aligned_cols=193  Identities=21%  Similarity=0.273  Sum_probs=166.8

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ..+|++.++||+|+||.||++.. ..++.||+|....      ..+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            35799999999999999999984 4688999997532      2467899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +. ++|..++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..... .
T Consensus       165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~  236 (391)
T PHA03212        165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-N  236 (391)
T ss_pred             CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-c
Confidence            85 678777753   456899999999999999999999987   999999999999999999999999999753221 1


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ........||+.|+|||++.+..++.++||||||+++|||++|+.|+.
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            122334579999999999999999999999999999999999998764

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.1e-34  Score=286.62  Aligned_cols=193  Identities=29%  Similarity=0.391  Sum_probs=164.5

Q ss_pred             cccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhc-CCCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVAR-LQHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      +.||+|+||+||+++.. +++.||||+++...   ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999864 57889999997642   1223346667777775 4899999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      ++|.+++..   ...+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  152 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCc
Confidence            999998863   356899999999999999999999987   999999999999999999999999998743211  112


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~  198 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence            3345789999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.8e-34  Score=291.86  Aligned_cols=194  Identities=28%  Similarity=0.416  Sum_probs=163.9

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ++|+..++||+|+||.||+++. .+++.||||++..... .....+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            4566778999999999999985 4689999999965432 3345789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|...       ....+..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.... 
T Consensus       154 ~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-  222 (353)
T PLN00034        154 MDGGSLEGT-------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-  222 (353)
T ss_pred             CCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence            999998643       23567788899999999999999987   9999999999999999999999999998654321 


Q ss_pred             cccccccccCCCccccccccc-----CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTR-----GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                       .......||..|+|||.+..     ...+.++|||||||++|||++|+.||.
T Consensus       223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~  274 (353)
T PLN00034        223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG  274 (353)
T ss_pred             -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence             12234578999999998743     234568999999999999999999996

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.9e-34  Score=282.40  Aligned_cols=199  Identities=27%  Similarity=0.454  Sum_probs=164.8

Q ss_pred             cCCCcCcccCcCCceeEEEeec--CCCCEEEEEEeecCCh--hcHHHHHHHHHHHhcC---CCCCccceeeEEec-----
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL--SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARL---QHRNLVRLLGFSFE-----  391 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~--~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----  391 (551)
                      ++|++.+.||+|+||.||+++.  .+++.||+|+++....  .....+.+|+.++..+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3688899999999999999985  2467899999875422  2233556677766655   69999999998852     


Q ss_pred             CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          392 ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       392 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                      ....++||||++ ++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            345789999996 5888888642 3345899999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +++.....   .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  211 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG  211 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence            99765422   223445789999999999888999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=7e-34  Score=281.84  Aligned_cols=203  Identities=29%  Similarity=0.515  Sum_probs=173.7

Q ss_pred             cCCCcCcccCcCCceeEEEeecCC------CCEEEEEEeecCChh-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      ++|.+.+.||+|+||.||+|...+      +..||+|.++..... ....+.+|++++.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            467888999999999999998533      478999999765443 4568999999999999999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhhc-----------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCe
Q 008854          397 LIYEFVPNSSVDKFIFDAI-----------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP  465 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~  465 (551)
                      +||||+++++|.+++....           ....+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999997421           2345889999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       466 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~  226 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY  226 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCC
Confidence            9999999975433222222233345788999999999999999999999999999999 999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.5e-34  Score=290.85  Aligned_cols=193  Identities=32%  Similarity=0.400  Sum_probs=167.9

Q ss_pred             cccCcCCceeEEEeec----CCCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccC
Q 008854          330 NKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~----~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      +.||+|+||.||+++.    .+|+.+|+|++.+...  .....+.+|++++.+++||||+++++++......++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999874    3578999999976432  233457789999999999999999999999999999999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      +++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  .
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            9999998863   456899999999999999999999987   9999999999999999999999999987543221  1


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  200 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG  200 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence            23345789999999999988899999999999999999999999863

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.3e-34  Score=287.49  Aligned_cols=193  Identities=25%  Similarity=0.335  Sum_probs=162.8

Q ss_pred             cccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHH-HHHhcCCCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEV-LLVARLQHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      +.||+|+||+||+++.. +++.||+|++.+...   .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999854 577899999975421   2223444444 457889999999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      ++|.+++..   ...+.+.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~  152 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT  152 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence            999998863   456788888999999999999999987   999999999999999999999999998753211  122


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  198 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence            3445799999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8.9e-34  Score=286.41  Aligned_cols=193  Identities=30%  Similarity=0.396  Sum_probs=164.7

Q ss_pred             cccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhc-CCCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVAR-LQHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      +.||+|+||.||+++.. +++.||+|++++..   ......+..|..++.. ++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999854 57899999997642   1223456677777765 4899999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      ++|..++..   ...+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  152 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence            999988863   456899999999999999999999987   999999999999999999999999998743211  122


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~  198 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence            3446789999999999999999999999999999999999999963

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3e-34  Score=281.45  Aligned_cols=198  Identities=36%  Similarity=0.612  Sum_probs=165.9

Q ss_pred             cCcccCcCCceeEEEeecC-----CCCEEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          328 TDNKLGQGGFGAVYKGRLS-----HGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       328 ~~~~LG~G~~g~Vyk~~~~-----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +.+.||.|.||.||+|.+.     .+..|+||.++.. ..+....+.+|++++.+++||||++++|++......++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999875     2567999999654 333467899999999999999999999999988889999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++|+|.++|... ....+++..++.|+.||++||.|||+.+   ++|+||+++|||+++++.+||+|||+++.......
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999863 3567999999999999999999999987   99999999999999999999999999987632222


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ............|+|||.+....++.++||||||+++|||++ |+.|+.
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~  207 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFS  207 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            222333456779999999999999999999999999999999 677875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.3e-33  Score=280.58  Aligned_cols=203  Identities=33%  Similarity=0.545  Sum_probs=172.1

Q ss_pred             cCCCcCcccCcCCceeEEEeecCC------CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      ++|++.+.||+|+||.||+|....      ...|++|.+.... ......+.+|+.++.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            367888999999999999998533      2579999987543 233456899999999999999999999999988999


Q ss_pred             EEEEccCCCChhHHhhhhcc-------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC
Q 008854          397 LIYEFVPNSSVDKFIFDAIK-------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM  463 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~  463 (551)
                      ++|||+++++|.+++.....             ...+++..++.++.|++.||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999875311             145889999999999999999999987   99999999999999999


Q ss_pred             CeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          464 IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       464 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      .+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~  228 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY  228 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence            999999999976543322222334456889999999998999999999999999999998 998885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.1e-33  Score=310.03  Aligned_cols=204  Identities=22%  Similarity=0.337  Sum_probs=173.4

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.++||+|+||.||+|... .++.||+|++.....   ....++.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57889999999999999999854 588999999975422   23456899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcc--------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          400 EFVPNSSVDKFIFDAIK--------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                      ||+++++|.+++.....        ...+++..+++++.||++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999864211        234667888999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCCC----------------cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          472 MARLFEMDQS----------------QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       472 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +++.......                ........||+.|||||.+.+..++.++||||||+++|||++|+.||..
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9986521110                0011235799999999999999999999999999999999999999853

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.2e-33  Score=323.39  Aligned_cols=206  Identities=25%  Similarity=0.492  Sum_probs=169.6

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      +....+...+.||+|+||.||+|+. .++..||||+++.....    ..+|++++++++||||+++++++.+....++||
T Consensus       687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            3345678889999999999999985 57899999998654322    234688899999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++|+|.++++      .++|.++.+++.|+++||+|||....++|+||||||+||+++.++..++. ||....... 
T Consensus       763 Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-  834 (968)
T PLN00113        763 EYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-  834 (968)
T ss_pred             eCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-
Confidence            9999999999985      28999999999999999999997655679999999999999999988875 665543221 


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCCcCcccHHHHHH
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS  544 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~  544 (551)
                           .....+|+.|||||++.+..++.++|||||||++|||++|+.|+..... ....+..|++
T Consensus       835 -----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~  893 (968)
T PLN00113        835 -----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWAR  893 (968)
T ss_pred             -----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHH
Confidence                 1123678999999999999999999999999999999999999853322 2234555544

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=295.76  Aligned_cols=201  Identities=29%  Similarity=0.498  Sum_probs=175.0

Q ss_pred             CCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecC------CceE
Q 008854          325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------TERL  396 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  396 (551)
                      .+...+.||+|+||.||+|+ -..|+.||||.+.+.. ....+...+|+++|++++|||||+++++-.+.      ...+
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            45566899999999999999 4579999999997753 33445678999999999999999999986544      3568


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC--CCC--CeEEeecCC
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--ADM--IPKISDFGM  472 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~--~~~--~~kl~Dfgl  472 (551)
                      +||||+.+|+|...|.+..+...+++.+.+.++.++..||.|||+++   |+||||||.||++-  ++|  .-||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999998888889999999999999999999999887   99999999999983  333  469999999


Q ss_pred             ccccccCCCcccccccccCCCcccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      |+.++.+.   ....++||..|++||... .+.|+...|.|||||++||..||..||...
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            99776443   456689999999999998 488999999999999999999999999744

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2e-33  Score=278.79  Aligned_cols=201  Identities=33%  Similarity=0.460  Sum_probs=167.9

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCC----EEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQ----EIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      ++|++.+.||+|+||+||+|++. +++    .+++|.+..... ....++..|+.++.+++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            46778899999999999999853 344    477888754432 23456788899999999999999999875 455778


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ++||+++++|.+++..  ....+++..+..++.||+.||.|||+.+   ++||||||+|||+++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            9999999999999874  3456899999999999999999999987   9999999999999999999999999998654


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ............++..|++||.+.++.++.++||||||+++|||++ |+.|+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~  214 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG  214 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            3332222334557789999999998999999999999999999998 9988854

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.4e-33  Score=285.21  Aligned_cols=192  Identities=30%  Similarity=0.376  Sum_probs=165.7

Q ss_pred             cccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      +.||+|+||+||+++.. +++.||+|++++..   ......+.+|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 57899999997642   22334567888888887 699999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      ++|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~  152 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVT  152 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCc
Confidence            999988763   457899999999999999999999987   999999999999999999999999998642211  122


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .....|++.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~  197 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE  197 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCC
Confidence            334568999999999999999999999999999999999999986

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.2e-33  Score=279.86  Aligned_cols=205  Identities=28%  Similarity=0.501  Sum_probs=171.3

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE  394 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  394 (551)
                      .+++|++.+.||+|+||.||+|...      .+..||+|++.... .....++.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999998742      24679999986542 2344568899999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcc-------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEE
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIK-------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI  467 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl  467 (551)
                      .++||||+++++|.+++.+...       ...+++..++.++.|+++||.|||+.+   ++|+||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999865221       234688899999999999999999987   999999999999999999999


Q ss_pred             eecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       468 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      +|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |+.|+.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~  223 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ  223 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            99999875543222222222345778999999999999999999999999999999 677775

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.9e-33  Score=275.82  Aligned_cols=201  Identities=32%  Similarity=0.524  Sum_probs=174.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      .++|++.++||+|++|.||+|...+++.||+|.+..... ....+.+|+.++++++|+||+++++.+......++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            357888999999999999999988888999999865432 3457899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++++|.+++... ....+++..++.++.|+++||.|||+.+   ++|+||||+||++++++.+||+|||+++........
T Consensus        84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            999999998653 3456889999999999999999999987   999999999999999999999999999865432211


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                       ......++..|+|||.+....++.++||||||+++|||++ |+.||.
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~  206 (261)
T cd05072         160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYP  206 (261)
T ss_pred             -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCC
Confidence             1222345678999999998899999999999999999998 888885

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.2e-33  Score=274.61  Aligned_cols=200  Identities=29%  Similarity=0.471  Sum_probs=171.5

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccC
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      ++|+..+.||+|+||.||++.+.++..+|+|.+.... .....+.+|+.++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            3577889999999999999998888899999986543 234578899999999999999999999999999999999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      +++|.+++...  ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            99999988642  346899999999999999999999987   999999999999999999999999998754322111 


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~  204 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK  204 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence            1122235668999999988889999999999999999999 8888853

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.9e-33  Score=277.54  Aligned_cols=198  Identities=30%  Similarity=0.435  Sum_probs=171.2

Q ss_pred             CCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          326 FSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      |+..+.||+|+||.||++.. .+++.+|+|.+.....   .....+.+|+.++++++|+||+++++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            66778999999999999985 4688999999875432   2234577899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++....... 
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            9999999988642 3346899999999999999999999887   9999999999999999999999999987543222 


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~  203 (285)
T cd05630         157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ  203 (285)
T ss_pred             --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence              12234789999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.9e-33  Score=279.33  Aligned_cols=203  Identities=33%  Similarity=0.501  Sum_probs=171.1

Q ss_pred             cCCCcCcccCcCCceeEEEeec-----CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      +.|++.++||+|+||.||+|..     ..+..+++|.+.... .+....+.+|+.++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            3577889999999999999973     245789999997543 3344578899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhc--------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC
Q 008854          398 IYEFVPNSSVDKFIFDAI--------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM  463 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~  463 (551)
                      ||||+++++|.+++....              ....+++...+.++.|++.||.|||+.+   |+||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999985321              1235789999999999999999999987   99999999999999999


Q ss_pred             CeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          464 IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       464 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      .+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~  228 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY  228 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            999999999976543322222333445778999999988889999999999999999999 888874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.2e-33  Score=278.54  Aligned_cols=203  Identities=28%  Similarity=0.490  Sum_probs=173.1

Q ss_pred             cCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      ++|.+.+.||+|+||.||++...      ++..+|+|.+..........+.+|+.++.+++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56888999999999999999742      345689999977665556679999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhc----------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEE
Q 008854          398 IYEFVPNSSVDKFIFDAI----------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI  467 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl  467 (551)
                      ||||+++++|.+++....          ....+++..++.++.|++.+|.|||+.+   ++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            999999999999986421          2235899999999999999999999987   999999999999999999999


Q ss_pred             eecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       468 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      +|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~  224 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY  224 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999976543222222233345778999999998899999999999999999999 888875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=289.19  Aligned_cols=206  Identities=31%  Similarity=0.488  Sum_probs=178.5

Q ss_pred             HHHhhhcCCCcCcccCcCCceeEEEeecCC-CCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          318 TIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       318 ~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      +.+-...++...++||.|.||.||.|.|+. .-.||||.++.+.. ...+|..|..+|+.++|||+|+|+|+|..+..+|
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            333344556677999999999999999864 56799999987654 4568999999999999999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      ||.|||.+|+|.++|.+. ++..++....+.++.||..||.||...+   +|||||..+|+|+.++..+||+||||++++
T Consensus       340 IiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             EEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence            999999999999999864 4566788889999999999999999987   999999999999999999999999999988


Q ss_pred             ccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ..+.. ..+....-+..|.|||.+....++.|+|||+|||+||||.| |-.|+.
T Consensus       416 tgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP  468 (1157)
T KOG4278|consen  416 TGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP  468 (1157)
T ss_pred             cCCce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC
Confidence            75533 22333345779999999999999999999999999999988 777774

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.3e-33  Score=276.08  Aligned_cols=192  Identities=28%  Similarity=0.416  Sum_probs=165.4

Q ss_pred             cCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCCh
Q 008854          332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSV  407 (551)
Q Consensus       332 LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  407 (551)
                      ||+|+||.||+++. .+|+.+|+|++.....   .....+..|++++.+++||||+++++.+......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999985 4589999999965322   2233566799999999999999999999999999999999999999


Q ss_pred             hHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccc
Q 008854          408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR  487 (551)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  487 (551)
                      ..++... ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            9887643 3445899999999999999999999987   9999999999999999999999999987654321   1223


Q ss_pred             cccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       488 ~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~  196 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD  196 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence            4689999999999988899999999999999999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.7e-33  Score=278.54  Aligned_cols=203  Identities=28%  Similarity=0.496  Sum_probs=173.8

Q ss_pred             cCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      .+|.+.+.||+|+||.||+++..      ++..+++|.++.........+.+|+.++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45778899999999999999742      345689999877666666779999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhc-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC
Q 008854          398 IYEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI  464 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~  464 (551)
                      ||||+++++|.+++....             ....+++..++.++.||+.+|.|||+.+   |+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999986431             1235899999999999999999999987   999999999999999999


Q ss_pred             eEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       465 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      +||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  227 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF  227 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999976543322222333456788999999999999999999999999999999 999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-33  Score=273.50  Aligned_cols=201  Identities=29%  Similarity=0.480  Sum_probs=173.2

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      .++|++.+.||+|++|.||++...+++.||+|.++.... ...++.+|+.++++++||||+++++++......++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            456888999999999999999987788999999876542 3557899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++++|.+++... ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++....... 
T Consensus        84 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  158 (261)
T cd05068          84 KYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-  158 (261)
T ss_pred             cCCcHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence            999999998653 2356899999999999999999999987   99999999999999999999999999987642211 


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ........+..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  206 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYP  206 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence            11112223468999999998899999999999999999999 888875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.6e-33  Score=288.54  Aligned_cols=199  Identities=27%  Similarity=0.439  Sum_probs=167.8

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCC-----ceE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET-----ERL  396 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  396 (551)
                      +|++.++||+|+||.||++.. .+++.||+|++...  .......+.+|+++++.++||||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999984 57899999998653  2233457889999999999999999999998766     789


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +|+||+. ++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 56777664   3457899999999999999999999987   999999999999999999999999999865


Q ss_pred             ccCCCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ..... .......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus       154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  208 (372)
T cd07853         154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ  208 (372)
T ss_pred             ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence            43221 122334678999999998764 5789999999999999999999999643

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-33  Score=273.80  Aligned_cols=201  Identities=31%  Similarity=0.549  Sum_probs=171.7

Q ss_pred             cCCCcCcccCcCCceeEEEeecCC----CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ++|++.+.||+|+||.||+|.+..    ...||||.++... .....++.+|+.++.+++||||+++++++......++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568889999999999999998642    3579999987553 33345788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|.+++..  ....+++..+++++.|++.||.|||+.+   |+|+||||+|||+++++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999999864  2347899999999999999999999987   99999999999999999999999999987642


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ...........+++.|+|||.+.+..++.++||||||+++|||++ |..|+.
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~  210 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW  210 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence            222112222345678999999998999999999999999999998 988874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.3e-33  Score=284.61  Aligned_cols=205  Identities=29%  Similarity=0.422  Sum_probs=170.6

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcC-CCCCccceeeEEecC-C
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEE-T  393 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  393 (551)
                      .++|++.+.||+|+||.||+|...      .++.||+|+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            457899999999999999999632      24689999987543 23345678899999999 799999999988654 5


Q ss_pred             ceEEEEEccCCCChhHHhhhhcc---------------------------------------------------------
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIK---------------------------------------------------------  416 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------  416 (551)
                      ..+++|||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            67899999999999999864211                                                         


Q ss_pred             -cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCcc
Q 008854          417 -RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM  495 (551)
Q Consensus       417 -~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~  495 (551)
                       ..+++|..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             136899999999999999999999987   9999999999999999999999999998654333222233445677899


Q ss_pred             cccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          496 APEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       496 aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      |||++.+..++.++|||||||++|||++ |+.||..
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~  278 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG  278 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999999999999998 9999853

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-34  Score=271.74  Aligned_cols=202  Identities=27%  Similarity=0.458  Sum_probs=171.5

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEec-----C
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFE-----E  392 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~  392 (551)
                      .....|...+.||+|+||.|.++.. .+|+.||||++...  ..-..++..+|+.+|+.++|+||+.+.+++..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            3456677789999999999999984 46899999999743  33445578899999999999999999998865     3


Q ss_pred             CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCC
Q 008854          393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM  472 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl  472 (551)
                      ...|+|+|+| ..+|..++.   .+..++......++.||++||.|+|+.+   |+||||||+|+|++.+...||+|||+
T Consensus        99 ~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence            4679999999 667777775   3344999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCcccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      |+...........+..+-|..|.|||++. ..+||...||||.|+|+.||++|++-|.
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp  229 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP  229 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC
Confidence            99875443334456677899999999875 4689999999999999999999999885

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.3e-33  Score=273.57  Aligned_cols=200  Identities=28%  Similarity=0.458  Sum_probs=171.8

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccC
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      ++|.+.+.||+|+||.||+++..++..+|+|.+..... ...++.+|+.++.+++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            35778899999999999999987777899999875433 34578999999999999999999999998888999999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      +++|.+++...  ...+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....... .
T Consensus        83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~  156 (256)
T cd05113          83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T  156 (256)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence            99999998642  336899999999999999999999987   99999999999999999999999999876533221 1


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ......++..|++||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~  204 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER  204 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence            1122335678999999988889999999999999999999 9988853

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.6e-34  Score=275.65  Aligned_cols=195  Identities=28%  Similarity=0.471  Sum_probs=160.1

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCc-----eEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE-----RLLI  398 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lV  398 (551)
                      .|...+.+|.|.||.||+|++. ++++||||++..+...    -.+|+++|+.++|||||+|+-+|....+     ..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4666789999999999999954 5789999998654321    2368999999999999999998865332     3489


Q ss_pred             EEccCCCChhHHhhhh-cccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC-CCeEEeecCCcccc
Q 008854          399 YEFVPNSSVDKFIFDA-IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLF  476 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~Dfgla~~~  476 (551)
                      |||||. +|.+++... ..+..++...+.-+..||.+||.|||+.+   |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999975 677776542 12466788888889999999999999977   9999999999999977 89999999999987


Q ss_pred             ccCCCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ......   ....-|.-|.|||.+.+. +|+.+.||||.|+++.||+-|+.-|..
T Consensus       177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG  228 (364)
T KOG0658|consen  177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG  228 (364)
T ss_pred             ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence            654332   334568899999998874 899999999999999999999988753

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-33  Score=290.12  Aligned_cols=197  Identities=20%  Similarity=0.296  Sum_probs=170.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC---CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS---HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ..+|.+.++||+|+||.||++...   .+..|++|.+....     ...+|++++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999743   35679999886532     3568999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      |++. ++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus       166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9986 57777773   4567999999999999999999999987   999999999999999999999999999765543


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ..........||+.|+|||.+....++.++|||||||++|||++|+.||...
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            3333334567999999999999999999999999999999999999998643

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.5e-33  Score=275.96  Aligned_cols=198  Identities=29%  Similarity=0.422  Sum_probs=171.3

Q ss_pred             CCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          326 FSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      |+..+.||+|+||+||++.. .+++.+|+|.+.....   .....+.+|++++.+++|+||+++.+.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            56778999999999999985 4688999999976432   2234577899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            9999999888642 3346999999999999999999999987   9999999999999999999999999987543221 


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~  203 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG  203 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence              12334689999999999989999999999999999999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.7e-33  Score=274.74  Aligned_cols=203  Identities=33%  Similarity=0.536  Sum_probs=177.6

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ...+|+..++||.|+||.||+|...+++.+++|.+..........+.+|+.+++.++||||+++++++......++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            44678889999999999999999888899999999877655566789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++.+. ....+++..+..++.||+.||.|||+.+   |+|+||||+||++++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            9999999999753 3456899999999999999999999987   99999999999999999999999999976543221


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      .  .....++..|++||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus       160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~  207 (261)
T cd05148         160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG  207 (261)
T ss_pred             c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Confidence            1  112345678999999988899999999999999999998 8888853

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.6e-33  Score=271.06  Aligned_cols=195  Identities=30%  Similarity=0.479  Sum_probs=164.9

Q ss_pred             cccCcCCceeEEEeecC-CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCCh
Q 008854          330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSV  407 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  407 (551)
                      ++||+|+||.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999864 68899999886543 33455789999999999999999999999999999999999999999


Q ss_pred             hHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccc
Q 008854          408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR  487 (551)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  487 (551)
                      .+++..  ....+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            999864  3446899999999999999999999887   99999999999999999999999999875432211111111


Q ss_pred             cccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       488 ~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ...+..|+|||.+.++.++.++||||||+++|||++ |..|+.
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~  198 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA  198 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            223457999999999999999999999999999998 888875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-33  Score=283.94  Aligned_cols=201  Identities=29%  Similarity=0.442  Sum_probs=179.4

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh---cHHHHHHHHHHHhcCC-CCCccceeeEEecCCce
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQ-HRNLVRLLGFSFEETER  395 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  395 (551)
                      .....|++.+.||+|.||.||+++.. +|+.+|+|.+.+....   ....+.+|+.+|+++. |||||.+.+.+......
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            34567888899999999999999855 4999999999876543   3357899999999998 99999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC----CCeEEeecC
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD----MIPKISDFG  471 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~----~~~kl~Dfg  471 (551)
                      ++|||++.+|.|.+.+...    .+++.....++.|++.++.|||+.+   |+||||||+|+|+...    +.+|++|||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            9999999999999998754    3999999999999999999999987   9999999999999543    479999999


Q ss_pred             CccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ++.....   .......+||+.|+|||++....|+...||||+||++|.|++|..||...
T Consensus       185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~  241 (382)
T KOG0032|consen  185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE  241 (382)
T ss_pred             CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC
Confidence            9987654   34566789999999999999999999999999999999999999999643

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=7.9e-33  Score=272.42  Aligned_cols=199  Identities=24%  Similarity=0.381  Sum_probs=172.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .++|++.++||+|+||.||+|+. .+++.||+|++..........+.+|+.++.+++||||+++++.+......++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            45789999999999999999985 56889999999765444455688999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++..   ...+++..+..++.|++++|.|||+.+   |+||||||+||+++.++.+||+|||++..+.... 
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06646          88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-  160 (267)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence            999999998863   456899999999999999999999887   9999999999999999999999999998653221 


Q ss_pred             cccccccccCCCcccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                       .......+++.|+|||.+.   ...++.++||||||+++|||++|+.|+.
T Consensus       161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~  210 (267)
T cd06646         161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF  210 (267)
T ss_pred             -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence             1123346888999999874   4457889999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.8e-33  Score=274.85  Aligned_cols=202  Identities=30%  Similarity=0.501  Sum_probs=169.0

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCC----EEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQ----EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      .++|+..++||+|+||+||+|++ .+++    .||+|+++.. ......++.+|+.++..++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            35678889999999999999984 3444    4899998754 33345578899999999999999999999875 4567


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +++||+++|+|.+++.+  ....+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        85 l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            99999999999999864  2456899999999999999999999987   999999999999999999999999999876


Q ss_pred             ccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      .............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  214 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG  214 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            43322212222345678999999998999999999999999999998 8888853

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-35  Score=271.20  Aligned_cols=196  Identities=28%  Similarity=0.502  Sum_probs=176.9

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccC
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      -|.+.++||+|+||.|||+.++ .|+.+|||.+....  +.+++..|+.++.+.+.|++|+++|.+.....+++||||+.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            3667899999999999999854 68999999987653  45688999999999999999999999999999999999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      .|+..+++.-  +++++.+.++..+++..++||+|||...   -||||||+.||||+.+|.+||+|||.+..+....  .
T Consensus       112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--A  184 (502)
T KOG0574|consen  112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--A  184 (502)
T ss_pred             CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--H
Confidence            9999999874  6788999999999999999999999876   7999999999999999999999999997654322  3


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ....++||+-|||||++..-.|+.++||||+|+...||..|++|+.
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYs  230 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYS  230 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcc
Confidence            3456799999999999999999999999999999999999999996

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-34  Score=257.56  Aligned_cols=209  Identities=25%  Similarity=0.317  Sum_probs=177.8

Q ss_pred             HhhhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecC-----C
Q 008854          320 RDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-----T  393 (551)
Q Consensus       320 ~~~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  393 (551)
                      ....++|.+.++||+|||+.||.++ +.+++.+|+|++.....++.+..++|++..++++||||++++++...+     .
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            3456789999999999999999998 678899999999988877888899999999999999999999887543     3


Q ss_pred             ceEEEEEccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCC
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM  472 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl  472 (551)
                      +.||+++|...|+|.+.+.... ++..+++.++++|+.+|.+||.+||+.. ++++||||||.|||+.+.+.++|.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence            4899999999999999987643 4457999999999999999999999986 5799999999999999999999999999


Q ss_pred             ccccccCCCc-------ccccccccCCCcccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          473 ARLFEMDQSQ-------GDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       473 a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      +......-..       ........|..|.|||.+.   +...++++||||||++||+|+.|..||+
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe  242 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE  242 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence            8654321110       0111234588999999874   5577899999999999999999999996

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.5e-33  Score=292.50  Aligned_cols=194  Identities=23%  Similarity=0.273  Sum_probs=166.7

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ..+|.+.++||+|+||.||++... .++.||||....      ..+.+|++++++++|+||+++++++..+...++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            347889999999999999999864 478899996432      2457899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +. ++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 688887754  2346999999999999999999999987   99999999999999999999999999986543322


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                      ........||+.|+|||++.+..++.++|||||||++|||++|..++
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            22233457999999999999999999999999999999999988765

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.9e-33  Score=274.61  Aligned_cols=203  Identities=29%  Similarity=0.483  Sum_probs=172.6

Q ss_pred             cCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      .+|...++||+|+||.||++...      ++..+++|.+..........+.+|++++..++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46778899999999999999632      356799999887666666689999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcc------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCe
Q 008854          398 IYEFVPNSSVDKFIFDAIK------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP  465 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~  465 (551)
                      ||||+++++|.+++.....            ...+++..++.++.|++.||.|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999864311            135889999999999999999999887   9999999999999999999


Q ss_pred             EEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       466 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  226 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY  226 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence            9999999875543222222233345788999999999999999999999999999998 888874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-33  Score=282.54  Aligned_cols=202  Identities=26%  Similarity=0.407  Sum_probs=179.0

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCc-eEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE-RLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~  399 (551)
                      ++|...+++|+|+||.++..+.+ +++.+++|.+.-..  ........+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999988754 57789999986543  2333467899999999999999999999998888 89999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      +|++||+|.+.+.+. +...+++..+.+++.|++.|+.|||+..   |+|||||+.||+++.+..+||+|||+++.+..+
T Consensus        84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            999999999999764 3577999999999999999999999776   999999999999999999999999999987654


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      .  ......+||+.||.||.+.+.+|..|+||||||+++|||.+-+++|+..
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~  209 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS  209 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc
Confidence            3  2455678999999999999999999999999999999999999999743

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-33  Score=271.06  Aligned_cols=198  Identities=30%  Similarity=0.488  Sum_probs=169.5

Q ss_pred             CCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCC
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      +|++.+.||+|+||.||++...++..+|+|++.+... ....+.+|+.++++++||||+++++++......++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            4778899999999999999987777899999865432 344688899999999999999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      ++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++....... ..
T Consensus        84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~  157 (256)
T cd05059          84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TS  157 (256)
T ss_pred             CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-cc
Confidence            9999998642  346899999999999999999999987   99999999999999999999999999876432211 11


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~  203 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE  203 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCC
Confidence            112223467999999999999999999999999999999 788875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8.9e-33  Score=278.30  Aligned_cols=200  Identities=25%  Similarity=0.412  Sum_probs=168.6

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ++|.+.++||+|+||.||+++.. +++.||+|+++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999854 578899999975432 2334678899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++ +|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  158 (309)
T cd07872          86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-  158 (309)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence            985 77777754  2345889999999999999999999987   9999999999999999999999999987543221 


Q ss_pred             cccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                       .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  208 (309)
T cd07872         159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS  208 (309)
T ss_pred             -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence             11223467899999998865 46889999999999999999999999643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-32  Score=269.78  Aligned_cols=200  Identities=30%  Similarity=0.458  Sum_probs=172.0

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh-----hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV-----QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      ++|.+.+.||+|++|.||++.. .+++++++|.+.....     .....+.+|++++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5788999999999999999985 4689999999865421     123468899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      |+||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999998863   356889999999999999999999987   9999999999999999999999999987653


Q ss_pred             cCCCcc-cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          478 MDQSQG-DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       478 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~  208 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA  208 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence            221111 1123457889999999999889999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.5e-32  Score=276.57  Aligned_cols=198  Identities=26%  Similarity=0.370  Sum_probs=171.6

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ++|++.++||+|+||.||++... ++..+|+|.+.... ......+.+|++++.+++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999854 57889999887542 23345688999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++..   ...+++..+..++.|+++||.|||+..  +++|+||||+|||++.++.+||+|||++......  
T Consensus        81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  153 (308)
T cd06615          81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  153 (308)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence            999999999863   356899999999999999999999742  3999999999999999999999999998754321  


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~  200 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP  200 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence              12335688999999999888899999999999999999999999853

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8.6e-33  Score=286.81  Aligned_cols=206  Identities=26%  Similarity=0.407  Sum_probs=171.4

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCChh-cHHHHHHHHHHHhcCC-CCCccceeeEEecCC
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQ-HRNLVRLLGFSFEET  393 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  393 (551)
                      ..++|.+.++||+|+||.||++++.      .++.||+|+++..... ....+.+|+.++.++. ||||+++++++....
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3456788899999999999999853      2457999999765322 2346889999999997 999999999999999


Q ss_pred             ceEEEEEccCCCChhHHhhhhc----------------------------------------------------------
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAI----------------------------------------------------------  415 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------  415 (551)
                      ..++||||+++|+|.++++...                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999996421                                                          


Q ss_pred             -------------------------------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCee
Q 008854          416 -------------------------------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL  458 (551)
Q Consensus       416 -------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIl  458 (551)
                                                           ....+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence                                                 1124678889999999999999999876   999999999999


Q ss_pred             eCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       459 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      +++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~  344 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE  344 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence            99999999999999986533222112223456789999999998889999999999999999998 8888753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.7e-33  Score=274.20  Aligned_cols=206  Identities=33%  Similarity=0.536  Sum_probs=171.0

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCC------CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE  394 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  394 (551)
                      .+++|.+.+.||+|++|.||++.+.+      +..|++|.+.... ......+.+|+.++++++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            35678899999999999999998643      4678999886543 3344578999999999999999999999999889


Q ss_pred             eEEEEEccCCCChhHHhhhhcc----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC---CeEE
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIK----RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM---IPKI  467 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl  467 (551)
                      .++||||+++++|.+++.....    ...+++..+++++.||+.||.|||+.+   ++|+||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            9999999999999999875321    235899999999999999999999987   99999999999998765   6999


Q ss_pred             eecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       468 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      +|||+++................+..|+|||.+.+..++.++|||||||++|||++ |+.||+.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~  224 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG  224 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            99999986532221111222234568999999999999999999999999999997 8888864

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=9.5e-33  Score=276.33  Aligned_cols=201  Identities=29%  Similarity=0.477  Sum_probs=176.3

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ....+|+..+.||+|++|.||+++. .+++.|++|.+..........+.+|+.+++.++||||+++++.+......++||
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            3446889999999999999999984 468899999998765555667899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++.+    ..+++.++..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++......
T Consensus        97 e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          97 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             cccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            99999999998853    45889999999999999999999987   999999999999999999999999998764332


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..  ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       170 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~  218 (296)
T cd06654         170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN  218 (296)
T ss_pred             cc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            21  12334688899999999988899999999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.6e-32  Score=268.18  Aligned_cols=200  Identities=27%  Similarity=0.426  Sum_probs=174.4

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +|+..+.||+|++|.||++... +++.|++|.+...  ......++.+|++++++++||||+++++++......++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677899999999999999854 6889999998653  334455788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++... ....+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.+||+|||+++.+.....
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999998753 3457899999999999999999999887   99999999999999999999999999886543221


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        ......|++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  203 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA  203 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence              22334678899999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.2e-32  Score=271.32  Aligned_cols=193  Identities=26%  Similarity=0.419  Sum_probs=168.9

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ++|+..++||+|+||.||+++. .+++.||+|++... ......++.+|+.++.+++||||+++++.+......++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577889999999999999984 56889999998765 233445789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|..+       ..+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||++..+...  
T Consensus        81 ~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            999998754       24678889999999999999999987   999999999999999999999999999754322  


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        ......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence              22345789999999999999999999999999999999999999853

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-32  Score=274.85  Aligned_cols=202  Identities=30%  Similarity=0.422  Sum_probs=169.7

Q ss_pred             CCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      +|++.+.||+|+||.||+|...      ....+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999742      235689998876532 334578899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhc---------------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCC
Q 008854          398 IYEFVPNSSVDKFIFDAI---------------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASN  456 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~N  456 (551)
                      |+||+++++|.+++....                     ....+++..++.++.|++.+|.|||+.+   |+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999986421                     1235889999999999999999999887   9999999999


Q ss_pred             eeeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          457 ILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       457 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  231 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  231 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence            9999999999999999976543322222233345778999999988889999999999999999999 888875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.2e-32  Score=270.67  Aligned_cols=200  Identities=31%  Similarity=0.510  Sum_probs=170.9

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      ..|...++||+|++|.||++... .++.|++|+++... ....++.+|++++.+++||||+++++++..+...++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            35777899999999999999854 57889999987543 33457889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++++|.+++... ....+++..++.++.|++++|.|||+.+   ++||||||+||++++++.+||+|||+++....... 
T Consensus        85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-  159 (263)
T cd05052          85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-  159 (263)
T ss_pred             CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee-
Confidence            999999998643 3456899999999999999999999887   99999999999999999999999999976543221 


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..|+.
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~  207 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP  207 (263)
T ss_pred             eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            11122234668999999999999999999999999999998 888875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.6e-32  Score=270.75  Aligned_cols=198  Identities=30%  Similarity=0.452  Sum_probs=163.0

Q ss_pred             cccCcCCceeEEEeecCC---CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCC
Q 008854          330 NKLGQGGFGAVYKGRLSH---GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS  405 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  405 (551)
                      +.||+|+||.||+|...+   +..+++|.++... ......+.+|+.++++++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998543   3579999987653 234457889999999999999999999999988999999999999


Q ss_pred             ChhHHhhhhcc--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          406 SVDKFIFDAIK--RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       406 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      +|.+++.....  ....++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999975322  235677888899999999999999987   9999999999999999999999999987543222222


Q ss_pred             cccccccCCCcccccccccC-------CCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRG-------HFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ......++..|+|||++.+.       .++.++||||||+++|||++ |+.||..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~  212 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH  212 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence            22334578899999988542       35789999999999999996 9999853

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-32  Score=270.25  Aligned_cols=201  Identities=29%  Similarity=0.465  Sum_probs=167.3

Q ss_pred             CCcCcccCcCCceeEEEeecCC----CCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCc-----
Q 008854          326 FSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE-----  394 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~~----g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  394 (551)
                      |.+.+.||+|+||.||+|.+..    +..||+|+++...  ......+.+|+.+++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998542    3679999987542  2334578999999999999999999998876554     


Q ss_pred             -eEEEEEccCCCChhHHhhhhc---ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeec
Q 008854          395 -RLLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF  470 (551)
Q Consensus       395 -~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df  470 (551)
                       .++|+||+++++|..++....   ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             689999999999999986532   2346899999999999999999999987   999999999999999999999999


Q ss_pred             CCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       471 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      |+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~  217 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP  217 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            99986543322222222345678999999988899999999999999999999 888875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=8e-33  Score=291.33  Aligned_cols=198  Identities=26%  Similarity=0.432  Sum_probs=162.4

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecC--------
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--------  392 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  392 (551)
                      ..++|.+.++||+|+||.||+|.. ..++.||||++....    ....+|+.+++.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            356799999999999999999985 468899999986542    1345799999999999999999876432        


Q ss_pred             CceEEEEEccCCCChhHHhhhh-cccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC-CeEEeec
Q 008854          393 TERLLIYEFVPNSSVDKFIFDA-IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDF  470 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Df  470 (551)
                      ...++||||+++ +|.+++... .....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            135689999985 666666432 23567899999999999999999999987   99999999999998665 7999999


Q ss_pred             CCccccccCCCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       471 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      |+++.+....   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus       216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  273 (440)
T PTZ00036        216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG  273 (440)
T ss_pred             ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9998654322   22235679999999988664 689999999999999999999999864

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=7.1e-33  Score=275.22  Aligned_cols=202  Identities=31%  Similarity=0.490  Sum_probs=169.0

Q ss_pred             CCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCChh-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      +|.+.++||+|+||.||+|...      .++.||+|+++..... ....+.+|+.++.+++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4667789999999999999853      2478999999765432 23468899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhc-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC
Q 008854          398 IYEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI  464 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~  464 (551)
                      ++||+++++|.+++....             ....+++..++.++.|++.||.|||+.+   |+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            999999999999985311             1235889999999999999999999887   999999999999999999


Q ss_pred             eEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       465 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      +||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..|+.
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~  228 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC  228 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence            99999999876543222222233456789999999988899999999999999999998 777774

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.4e-32  Score=268.55  Aligned_cols=201  Identities=27%  Similarity=0.457  Sum_probs=164.2

Q ss_pred             CCcCcccCcCCceeEEEeecCCC-C--EEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecC------Cc
Q 008854          326 FSTDNKLGQGGFGAVYKGRLSHG-Q--EIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------TE  394 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~~g-~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  394 (551)
                      |.+.++||+|+||.||+|.+.+. .  .+|+|.++..  .......+.+|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            34678999999999999986543 2  5899988754  233445788999999999999999999987532      24


Q ss_pred             eEEEEEccCCCChhHHhhhhc---ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          395 RLLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                      .++||||+++++|.+++....   ....+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            689999999999999875321   2345899999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      +++.+.............+++.|++||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  216 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP  216 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence            9986543222111222345778999999999999999999999999999999 788875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.2e-32  Score=273.25  Aligned_cols=205  Identities=24%  Similarity=0.373  Sum_probs=172.8

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCC-----CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEec-CCc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSH-----GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFE-ETE  394 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~-----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  394 (551)
                      ..++|.+.+.||+|+||.||+|...+     +..|++|++.... ......+.+|+.++++++||||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35678889999999999999998655     6789999987543 3345568899999999999999999998776 467


Q ss_pred             eEEEEEccCCCChhHHhhhhccc-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEee
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKR-----VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD  469 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~D  469 (551)
                      .++++||+++++|.+++......     ..+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            88999999999999998653222     56899999999999999999999887   99999999999999999999999


Q ss_pred             cCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       470 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  221 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV  221 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcC
Confidence            999986543322211223345778999999998899999999999999999999 999885

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-33  Score=273.40  Aligned_cols=204  Identities=28%  Similarity=0.475  Sum_probs=172.9

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCC------CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER  395 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  395 (551)
                      .++|.+.+.||+|+||.||++....      +..||+|.+.... ......+.+|+.++..++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4578889999999999999997532      3679999987553 33445788999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhhc-------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEe
Q 008854          396 LLIYEFVPNSSVDKFIFDAI-------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS  468 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~  468 (551)
                      ++||||+++++|.+++....       ....+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            99999999999999986532       1234789999999999999999999887   9999999999999999999999


Q ss_pred             ecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       469 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      |||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.|+.
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  223 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ  223 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCc
Confidence            9999976543322222333456789999999988889999999999999999998 888875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.6e-32  Score=270.71  Aligned_cols=198  Identities=26%  Similarity=0.394  Sum_probs=160.1

Q ss_pred             cccCcCCceeEEEeecCC---CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCC
Q 008854          330 NKLGQGGFGAVYKGRLSH---GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS  405 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  405 (551)
                      +.||+|+||+||+|...+   ...+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||++++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997543   3468888876543 233456889999999999999999999999999999999999999


Q ss_pred             ChhHHhhhhcc--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          406 SVDKFIFDAIK--RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       406 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      +|.+++.....  ....++.....++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999975322  233567888999999999999999987   9999999999999999999999999986533222111


Q ss_pred             cccccccCCCccccccccc-------CCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTR-------GHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |+.|+..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~  212 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD  212 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence            2233345778999998643       456889999999999999999 7777753

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=261.25  Aligned_cols=199  Identities=27%  Similarity=0.434  Sum_probs=172.8

Q ss_pred             hhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      .++.|++.+.||+|.|+.|++.. ...|+.+|+|++...  +..+.+++.+|++|...|+||||++|...+.+....+||
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            35678888999999999999986 456888999987432  344667899999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC---CCeEEeecCCccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARL  475 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~kl~Dfgla~~  475 (551)
                      +|+|.+++|..-+-   .+.-+++......++||+++|.|.|.++   |||||+||.|+|+-..   --+||+|||++..
T Consensus        89 Fe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence            99999999865443   3456788889999999999999999998   9999999999999533   3589999999987


Q ss_pred             cccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      +.   .........|||+|||||++...+|+..+|||+.||+|+-|+.|..||.
T Consensus       163 l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~  213 (355)
T KOG0033|consen  163 VN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW  213 (355)
T ss_pred             eC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCC
Confidence            65   2334566789999999999999999999999999999999999999996

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.9e-32  Score=272.04  Aligned_cols=197  Identities=29%  Similarity=0.440  Sum_probs=170.6

Q ss_pred             CCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCC
Q 008854          326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      |++.++||+|+||.||++... ++..+++|.+..........+.+|+++++.++||||+++++++......++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            567789999999999999865 4778899998776655566789999999999999999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      ++|..++..  ...++++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++.......  ..
T Consensus        87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~  159 (282)
T cd06643          87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR  159 (282)
T ss_pred             CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence            999988764  3457899999999999999999999987   9999999999999999999999999987543221  12


Q ss_pred             ccccccCCCcccccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .....+++.|+|||.+.     +..++.++|||||||++|||++|+.||.
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~  209 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH  209 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcc
Confidence            23456889999999874     4567889999999999999999999985

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-33  Score=284.42  Aligned_cols=191  Identities=27%  Similarity=0.346  Sum_probs=160.2

Q ss_pred             cCcCCceeEEEeecC-CCCEEEEEEeecCChh---cHHHHHHHHHHHhcC---CCCCccceeeEEecCCceEEEEEccCC
Q 008854          332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARL---QHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       332 LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      ||+|+||+||+++.. +++.||+|++.+....   ....+..|..++...   +||||+++++.+......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999854 5889999999754221   222345566666655   699999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      ++|..++.   +...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            99998886   3456899999999999999999999987   9999999999999999999999999987532211  22


Q ss_pred             ccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~  199 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA  199 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence            3345799999999998764 479999999999999999999999853

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=9.8e-33  Score=283.96  Aligned_cols=197  Identities=28%  Similarity=0.369  Sum_probs=166.2

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCC-----
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET-----  393 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  393 (551)
                      ..++|+..+.||+|+||.||++.. ..|+.||+|++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            347899999999999999999985 45889999999754  2233456789999999999999999999886543     


Q ss_pred             -ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCC
Q 008854          394 -ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM  472 (551)
Q Consensus       394 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl  472 (551)
                       ..++||||++++ |...+.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             468999999764 555443     24788899999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ++.....   .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~  224 (359)
T cd07876         170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG  224 (359)
T ss_pred             ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            9754322   122345789999999999999999999999999999999999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.5e-32  Score=272.70  Aligned_cols=200  Identities=29%  Similarity=0.438  Sum_probs=173.3

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .++|++.++||+|+||.||+|+.. +++.+++|.+..........+.+|+.+++.++||||+++++.+..+...++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            467889999999999999999864 5889999999877666667789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|..++.+  ....+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++......  
T Consensus        91 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--  163 (292)
T cd06644          91 CPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--  163 (292)
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence            999999888754  2456899999999999999999999887   999999999999999999999999998753321  


Q ss_pred             cccccccccCCCcccccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ........+++.|+|||.+.     ...++.++||||||+++|||++|+.|+.
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  216 (292)
T cd06644         164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH  216 (292)
T ss_pred             ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCc
Confidence            11223446788999999884     3457889999999999999999999985

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.8e-33  Score=271.75  Aligned_cols=199  Identities=24%  Similarity=0.406  Sum_probs=173.0

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .++|...++||+|+||.||+++. .+++.||+|.++.........+.+|+.+++.++||||+++++.+......++||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            35788889999999999999985 46889999999776555555688999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++..   ...+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+...  
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--  159 (267)
T cd06645          88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--  159 (267)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence            999999998863   457899999999999999999999987   999999999999999999999999998765322  


Q ss_pred             cccccccccCCCcccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ........|+..|+|||.+.   ...++.++|||||||++|||++|+.|+.
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~  210 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF  210 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence            12233457899999999874   4568899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.1e-32  Score=272.98  Aligned_cols=196  Identities=29%  Similarity=0.410  Sum_probs=173.2

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|++|.||++... +++.+|+|.+....   ......+.+|++++++++||||+++++++..+...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999854 58899999997542   223456889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..   ...+++..+..++.|++++|.|||+.+   |+|+||+|+||++++++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            99999999999864   357899999999999999999999987   999999999999999999999999998765432


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                           .....+++.|+|||.+.+...+.++||||||+++|||++|+.||..
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  200 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD  200 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence                 2344688999999999888889999999999999999999999853

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3e-32  Score=265.49  Aligned_cols=194  Identities=31%  Similarity=0.492  Sum_probs=166.6

Q ss_pred             cccCcCCceeEEEeecCCCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCChh
Q 008854          330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD  408 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  408 (551)
                      ++||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            47999999999999988889999999876532 33446889999999999999999999999999999999999999999


Q ss_pred             HHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccccccc
Q 008854          409 KFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI  488 (551)
Q Consensus       409 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  488 (551)
                      +++..  ....+++..++.++.|++.+|.|||+.+   ++|+||||+||++++++.+||+|||++........ ......
T Consensus        81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~  154 (250)
T cd05085          81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLK  154 (250)
T ss_pred             HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCC
Confidence            98864  3456899999999999999999999887   99999999999999999999999999875432211 111222


Q ss_pred             ccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       489 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      .++..|+|||++....++.++||||||+++|||++ |..||.
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~  196 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYP  196 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCC
Confidence            34678999999998899999999999999999999 888885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.2e-32  Score=271.90  Aligned_cols=203  Identities=32%  Similarity=0.511  Sum_probs=171.8

Q ss_pred             HhhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeEEecC-----
Q 008854          320 RDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEE-----  392 (551)
Q Consensus       320 ~~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----  392 (551)
                      +++++.|+..+.||+|+||.||+|... .++.||+|++.... .....+.+|+.++.++ +||||+++++++...     
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            456788999999999999999999854 57889999987653 3445788999999998 699999999998753     


Q ss_pred             -CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          393 -TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       393 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                       ...++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence             3578999999999999998742 3456899999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCCCcccccccccCCCcccccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ++.......  .......|++.|+|||++.     +..++.++|||||||++|||++|+.|+.
T Consensus       157 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~  217 (272)
T cd06637         157 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC  217 (272)
T ss_pred             Cceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            987653221  2233457899999999886     3467889999999999999999999985

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.3e-32  Score=274.13  Aligned_cols=205  Identities=28%  Similarity=0.486  Sum_probs=170.6

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE  394 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  394 (551)
                      ..++|++.++||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578899999999999999999643      24579999986543 2334468899999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcc-------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEE
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIK-------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI  467 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl  467 (551)
                      .++||||+++++|.+++.....       ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999964211       234577889999999999999999887   999999999999999999999


Q ss_pred             eecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       468 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      +|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.|+.
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~  223 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ  223 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCC
Confidence            99999986543222222223345678999999998999999999999999999999 677774

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.8e-32  Score=269.37  Aligned_cols=200  Identities=30%  Similarity=0.508  Sum_probs=169.7

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      .++|++.++||+|+||.||+|+..+...||+|+++.... ....+.+|+.++.+++||||+++++.+. ....++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            356889999999999999999877777899999976432 3457899999999999999999999874 45678999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++++|.+++... ....+++..+..++.|++++|.|||+.+   |+|+||||+||++++++.+||+|||+++.+..... 
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-  157 (262)
T cd05071          83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  157 (262)
T ss_pred             CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc-
Confidence            999999998743 2346799999999999999999999987   99999999999999999999999999976543221 


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~  205 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP  205 (262)
T ss_pred             ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence            11223345678999999998999999999999999999999 777775

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.8e-32  Score=267.17  Aligned_cols=193  Identities=30%  Similarity=0.484  Sum_probs=161.3

Q ss_pred             ccCcCCceeEEEeecC---CCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCC
Q 008854          331 KLGQGGFGAVYKGRLS---HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSS  406 (551)
Q Consensus       331 ~LG~G~~g~Vyk~~~~---~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  406 (551)
                      .||+|+||.||+|.+.   .+..||+|++..... .....+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999753   345699999876532 33456899999999999999999999875 457789999999999


Q ss_pred             hhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc-c
Q 008854          407 VDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD-T  485 (551)
Q Consensus       407 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~  485 (551)
                      |.+++..  ....+++..+++++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.+........ .
T Consensus        81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9999864  3457899999999999999999999987   99999999999999999999999999976543322111 1


Q ss_pred             cccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       486 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ....++..|+|||.+....++.++||||||+++|||++ |+.||.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  200 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK  200 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence            11233578999999988889999999999999999996 999985

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.8e-33  Score=276.38  Aligned_cols=206  Identities=28%  Similarity=0.435  Sum_probs=172.6

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcC-CCCCccceeeEEecC
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEE  392 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  392 (551)
                      ...++|+..+.||+|+||.||++...      ....+|+|++.... .....++.+|+.++.++ +||||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            34467888999999999999999853      23579999987642 23345688999999999 799999999999999


Q ss_pred             CceEEEEEccCCCChhHHhhhh-------------cccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee
Q 008854          393 TERLLIYEFVPNSSVDKFIFDA-------------IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL  459 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll  459 (551)
                      ...++||||+++++|..++...             .....+++..+++++.|++.||.|||+.+   |+||||||+|||+
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence            9999999999999999998642             12456899999999999999999999887   9999999999999


Q ss_pred             CCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          460 DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       460 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+.
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  236 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP  236 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence            9999999999999986543322222222345678999999988999999999999999999998 888875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.6e-32  Score=274.86  Aligned_cols=201  Identities=29%  Similarity=0.473  Sum_probs=176.8

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ...++|+..+.||+|++|.||++.. .+++.||+|.+..........+.+|+.+++.++||||+++++++..+...++||
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            3457899999999999999999984 578999999998765555567889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++.+    ..+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          96 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             cccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            99999999998753    45889999999999999999999987   999999999999999999999999998765432


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..  ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~  217 (297)
T cd06656         169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (297)
T ss_pred             cc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            21  12334678899999999999999999999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.2e-32  Score=269.15  Aligned_cols=201  Identities=24%  Similarity=0.452  Sum_probs=173.1

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC---ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN---SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|+||.||+++. .+++.||||.+...   .......+.+|+++++.++||||+++++++......++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4788999999999999999985 46899999988653   2233456889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          400 EFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      ||+++++|.+++.... +...+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999999886432 2345889999999999999999999987   99999999999999999999999999886543


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ...  ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~  207 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY  207 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence            221  1223467889999999988889999999999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=265.37  Aligned_cols=201  Identities=24%  Similarity=0.313  Sum_probs=176.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcH---HHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      -++|..++.||+|.||.|.+++- ..++.+|+|++++...-..   ..-..|-++|...+||.+..|.-.|+..+.+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            46788899999999999999984 4688999999988744332   3456799999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||..+|.|.-+|.   ....+++....-+-.+|+.+|.|||+++   ||.||||.+|.|||.+|++||+||||++.-- 
T Consensus       247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-  319 (516)
T ss_pred             EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence            99999999998886   3566888888888899999999999987   9999999999999999999999999997421 


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                       .....+..++|||.|+|||++....|....|+|.+||++|||++|+.||...
T Consensus       320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~  371 (516)
T KOG0690|consen  320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK  371 (516)
T ss_pred             -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence             2234567899999999999999999999999999999999999999999644

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.8e-32  Score=271.04  Aligned_cols=201  Identities=29%  Similarity=0.519  Sum_probs=168.9

Q ss_pred             cCCCcCcccCcCCceeEEEeec-----CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEec--CCceE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE--ETERL  396 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  396 (551)
                      ++|++.+.||+|+||.||++..     .++..||+|++..........+.+|++++.+++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4788899999999999999874     2578899999987666666789999999999999999999998754  34678


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +||||+++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++..
T Consensus        84 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            99999999999999864  2346899999999999999999999987   999999999999999999999999999865


Q ss_pred             ccCCCccc-ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          477 EMDQSQGD-TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       477 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ........ .....++..|+|||.+.+..++.++||||||+++|||++|..++.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~  212 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC  212 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence            43221111 111223456999999998899999999999999999999876643

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-32  Score=274.05  Aligned_cols=204  Identities=28%  Similarity=0.417  Sum_probs=168.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCC---------------CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCcccee
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSH---------------GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLL  386 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~---------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~  386 (551)
                      .++|++.++||+|+||.||+++..+               ...||+|.++... ......+.+|++++++++||||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578899999999999999987532               1248999987653 23345689999999999999999999


Q ss_pred             eEEecCCceEEEEEccCCCChhHHhhhhcc---------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCe
Q 008854          387 GFSFEETERLLIYEFVPNSSVDKFIFDAIK---------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI  457 (551)
Q Consensus       387 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NI  457 (551)
                      +++......++||||+++++|.+++.....         ...+++..++.++.|++.||.|||+.+   ++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            999999999999999999999999864211         124788999999999999999999987   99999999999


Q ss_pred             eeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh--CCCCCC
Q 008854          458 LLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS--GQKNNS  529 (551)
Q Consensus       458 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt--G~~p~~  529 (551)
                      ++++++.+||+|||++..+.............++..|+|||.+..+.++.++||||||+++|||++  |..||.
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~  234 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS  234 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence            999999999999999976543222222223345778999999998899999999999999999998  445554

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-32  Score=275.64  Aligned_cols=205  Identities=27%  Similarity=0.435  Sum_probs=171.6

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec--------CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcC-CCCCccceeeEEec
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL--------SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFE  391 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~--------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  391 (551)
                      ..++|.+.+.||+|+||.||+++.        .++..||+|.+.... .....++.+|+.++..+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            346788889999999999999963        123479999987542 33456789999999999 89999999999999


Q ss_pred             CCceEEEEEccCCCChhHHhhhhc-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCee
Q 008854          392 ETERLLIYEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL  458 (551)
Q Consensus       392 ~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIl  458 (551)
                      ....++||||+++++|.+++....             ....+++.+++.++.||++||.|||+.+   |+||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence            999999999999999999997531             1245889999999999999999999987   999999999999


Q ss_pred             eCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       459 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      +++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  241 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP  241 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            99999999999999986643322222333455678999999988889999999999999999998 777764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.3e-32  Score=268.21  Aligned_cols=205  Identities=28%  Similarity=0.449  Sum_probs=172.5

Q ss_pred             HhhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          320 RDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       320 ~~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      +.+++++.....||+|+||.||+|+. .++..|++|.+..........+.+|+.++++++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            34566677778999999999999984 45778999999877666667899999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC-CCCeEEeecCCccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFE  477 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~Dfgla~~~~  477 (551)
                      +||+++++|.+++.........++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.+||+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            999999999999875322222388889999999999999999887   999999999999976 6799999999987543


Q ss_pred             cCCCcccccccccCCCcccccccccC--CCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRG--HFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ...  .......+++.|+|||.+...  .++.++||||||+++|||++|+.|+.
T Consensus       161 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~  212 (268)
T cd06624         161 GIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI  212 (268)
T ss_pred             cCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCc
Confidence            221  112234578999999998654  37889999999999999999999985

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-32  Score=269.64  Aligned_cols=198  Identities=33%  Similarity=0.571  Sum_probs=172.8

Q ss_pred             CCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHH--HHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      |++.+.||+|+||+||+++.. +++.+|+|++.........  ...+|+.++.+++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            566789999999999999954 4668999999887544332  3456999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++++|.+++.   +...+++..+..++.|+++||.+||+.+   |+|+||||+||+++.++.++|+|||.+....  ...
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence            9999999997   4567899999999999999999999987   9999999999999999999999999987541  122


Q ss_pred             ccccccccCCCcccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      .......++..|+|||.+. +...+.++||||+|+++|||++|+.|+...
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            2344567899999999998 888999999999999999999999999744

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.3e-32  Score=268.09  Aligned_cols=199  Identities=31%  Similarity=0.531  Sum_probs=170.0

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccC
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      ++|++.++||+|+||.||++...++..+|+|.++.... ....+.+|+.++++++|||++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            46888999999999999999988888999999976543 3457899999999999999999999875 456789999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      +++|.+++.+. ....+++..+..++.+++.+|.|||+.+   |+|+||||+||++++++.++|+|||++..+...... 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05070          84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence            99999998653 2345899999999999999999999987   999999999999999999999999999765432211 


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~  205 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP  205 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCC
Confidence            1122235668999999988899999999999999999999 888885

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.4e-32  Score=276.61  Aligned_cols=204  Identities=28%  Similarity=0.434  Sum_probs=169.7

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC--------CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcC-CCCCccceeeEEecC
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS--------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEE  392 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  392 (551)
                      .++|.+.++||+|+||.||+++..        ....+|+|.++... .....++.+|+.++..+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            357889999999999999999742        23469999997642 33445688899999999 799999999999999


Q ss_pred             CceEEEEEccCCCChhHHhhhhc-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee
Q 008854          393 TERLLIYEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL  459 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll  459 (551)
                      ...++||||+++++|.+++....             ....+++.++++++.|++.||+|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            99999999999999999997532             1235899999999999999999999887   9999999999999


Q ss_pred             CCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          460 DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       460 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~  244 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  244 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999876542221111222234568999999998899999999999999999998 777774

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.8e-32  Score=275.67  Aligned_cols=196  Identities=28%  Similarity=0.469  Sum_probs=159.7

Q ss_pred             CcccCcCCceeEEEeecC---CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEec--CCceEEEEEccC
Q 008854          329 DNKLGQGGFGAVYKGRLS---HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE--ETERLLIYEFVP  403 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~  403 (551)
                      .++||+|+||+||+++..   +++.+|+|.+.....  ...+.+|+.++++++||||+++++++..  ....++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999854   457899999865432  3357889999999999999999998854  345789999986


Q ss_pred             CCChhHHhhhhc------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee----CCCCCeEEeecCCc
Q 008854          404 NSSVDKFIFDAI------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DADMIPKISDFGMA  473 (551)
Q Consensus       404 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~kl~Dfgla  473 (551)
                      + +|.+++....      +...+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 7777764321      1235889999999999999999999987   9999999999999    45678999999999


Q ss_pred             cccccCCC-cccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          474 RLFEMDQS-QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       474 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +.+..... ........+|+.|+|||++.+ ..++.++||||+|+++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            87643321 122345678999999999876 4589999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.6e-33  Score=257.27  Aligned_cols=205  Identities=26%  Similarity=0.455  Sum_probs=174.3

Q ss_pred             ChhHHHhhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh----hc----HHHHHHHHHHHhcC-CCCCccc
Q 008854          315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV----QG----ELEFKNEVLLVARL-QHRNLVR  384 (551)
Q Consensus       315 ~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~----~~----~~~~~~E~~~l~~l-~h~niv~  384 (551)
                      +...-+..-++|...+.||.|..++|-+... ..|+++|+|++.....    ..    .+.-.+|+.||+++ .||+|++
T Consensus         8 d~~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~   87 (411)
T KOG0599|consen    8 DKDAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIID   87 (411)
T ss_pred             chhhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEE
Confidence            3344445567888899999999999998874 4688999999864311    11    12356799999998 5999999


Q ss_pred             eeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC
Q 008854          385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI  464 (551)
Q Consensus       385 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~  464 (551)
                      +.++++...-.++|+|.|+.|.|.++|.+   .-.+++.+..+|++|+.+|+.|||..+   ||||||||+|||+|++.+
T Consensus        88 l~D~yes~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~  161 (411)
T KOG0599|consen   88 LQDVYESDAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMN  161 (411)
T ss_pred             eeeeccCcchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccc
Confidence            99999999999999999999999999974   456899999999999999999999998   999999999999999999


Q ss_pred             eEEeecCCccccccCCCcccccccccCCCcccccccc------cCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT------RGHFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       465 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                      +||+|||++..+....   .....+|||+|+|||.+.      ...|+...|+|+.|||+|.|+.|-+||
T Consensus       162 i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF  228 (411)
T KOG0599|consen  162 IKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF  228 (411)
T ss_pred             eEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence            9999999998765432   345679999999999874      345788999999999999999999998

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.3e-32  Score=267.74  Aligned_cols=200  Identities=27%  Similarity=0.415  Sum_probs=168.8

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC-----hhcHHHHHHHHHHHhcCCCCCccceeeEEecC--Cce
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-----VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TER  395 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  395 (551)
                      .+|++.+.||+|+||.||++.. .++..|++|.+....     ......+.+|+.++.+++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4788899999999999999985 458899999886431     12234688899999999999999999988764  456


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++||||+++++|.+++..   ...+++...++++.|++.+|.|||+.+   |+|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            799999999999998863   345788999999999999999999987   99999999999999999999999999876


Q ss_pred             cccCCC-cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          476 FEMDQS-QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       476 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  210 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA  210 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCC
Confidence            532111 112233468889999999988889999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-32  Score=270.45  Aligned_cols=202  Identities=30%  Similarity=0.503  Sum_probs=169.9

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCC----EEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQ----EIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      .+|++.++||+|+||+||+|... +|.    .+|+|.+..... ....++.+|+.++.+++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            56788899999999999999853 233    589998876543 344578899999999999999999999987 78899


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+++++|.+++..  ....+++..++.++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||+++...
T Consensus        86 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            9999999999999874  3445899999999999999999999976   9999999999999999999999999998654


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFR  531 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~~  531 (551)
                      ............++..|+|||.+....++.++||||||+++|||++ |+.|+...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  215 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI  215 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            3322111122234568999999988899999999999999999999 99998643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.5e-32  Score=274.13  Aligned_cols=203  Identities=31%  Similarity=0.437  Sum_probs=171.0

Q ss_pred             hcCCCcCcccCcCCceeEEEeec------CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETE  394 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  394 (551)
                      .++|...+.||+|+||.||++..      ..+..||+|+++... ......+.+|+.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            35788999999999999999963      134579999987653 23345688999999999 79999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .++||||+++++|.+++... ....+++.++..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||+++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            99999999999999998642 2234899999999999999999999987   9999999999999999999999999997


Q ss_pred             ccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      .+.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~  245 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP  245 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcC
Confidence            6543222111222345778999999999999999999999999999998 898875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.8e-32  Score=265.56  Aligned_cols=199  Identities=28%  Similarity=0.454  Sum_probs=175.2

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCC-CCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .++|+..++||+|++|.||+++..+ ++.+++|.+.....  ..++.+|++++++++||||+++++.+......++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3678899999999999999999754 78999999976532  56899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++..  ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            999999999864  3467899999999999999999999987   99999999999999999999999999876543221


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~  201 (256)
T cd06612         155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD  201 (256)
T ss_pred             --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence              22334578899999999988999999999999999999999999853

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.6e-32  Score=273.12  Aligned_cols=199  Identities=28%  Similarity=0.487  Sum_probs=175.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ..+|+..+.||.|++|.||++.. .+++.|++|.+..........+.+|+.+++.++||||+++++++......++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            35688999999999999999984 57899999999766555566788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|..++.+    ..+++.++..++.+++.+|.|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          98 LAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             cCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            999999998753    45899999999999999999999987   99999999999999999999999999876543321


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        ......++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~  217 (296)
T cd06655         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (296)
T ss_pred             --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence              12334678899999999988899999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-32  Score=266.04  Aligned_cols=201  Identities=24%  Similarity=0.382  Sum_probs=175.8

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .++|+..+.||+|+||.||++... +++.+++|.+..........+.+|+.++++++||||+++++++......+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            357888999999999999999854 5788999999876555667899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++..  ....+++..+..++.|++.+|.|||+.+   |+|+||+|+||+++.++.+||+|||++....... 
T Consensus        82 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  155 (262)
T cd06613          82 CGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-  155 (262)
T ss_pred             CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence            999999998864  2357899999999999999999999987   9999999999999999999999999987654321 


Q ss_pred             cccccccccCCCcccccccccC---CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRG---HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                       .......++..|+|||.+.+.   .++.++||||||+++|||++|+.|+..
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~  206 (262)
T cd06613         156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD  206 (262)
T ss_pred             -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence             122334678899999998776   889999999999999999999999853

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-32  Score=271.24  Aligned_cols=201  Identities=27%  Similarity=0.415  Sum_probs=174.7

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .++|++.++||+|++|.||++... +++.+|+|.++.........+.+|++++++++||||+++++.+......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467899999999999999999864 6889999999876656666789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++.+  ....+++..+..++.|++.+|.|||+.+   |+|+||||+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (280)
T cd06611          84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-  157 (280)
T ss_pred             cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence            999999999864  2456899999999999999999999987   9999999999999999999999999987543221 


Q ss_pred             cccccccccCCCcccccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                       .......+++.|++||.+.     ...++.++||||||+++|||++|+.||..
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~  210 (280)
T cd06611         158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE  210 (280)
T ss_pred             -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence             1223456889999999874     34577899999999999999999999853

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.2e-32  Score=272.26  Aligned_cols=204  Identities=30%  Similarity=0.444  Sum_probs=171.8

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCC-----------------CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSH-----------------GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVR  384 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  384 (551)
                      .++|++.++||+|+||.||++...+                 +..||+|++.... ......+.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578899999999999999987532                 2458999987653 334567899999999999999999


Q ss_pred             eeeEEecCCceEEEEEccCCCChhHHhhhhc--------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCC
Q 008854          385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAI--------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASN  456 (551)
Q Consensus       385 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~N  456 (551)
                      +++++..+...++||||+++++|.+++....        ....+++..++.++.|++.||.|||+.+   |+|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999987532        1236899999999999999999999887   9999999999


Q ss_pred             eeeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh--CCCCCC
Q 008854          457 ILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS--GQKNNS  529 (551)
Q Consensus       457 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt--G~~p~~  529 (551)
                      |+++.++.++|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++  |..|+.
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            9999999999999999976543322222334456789999999988889999999999999999998  555664

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.1e-32  Score=267.19  Aligned_cols=200  Identities=33%  Similarity=0.543  Sum_probs=171.8

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      .++|++.++||+|+||.||++...+++.||+|.+..... ....+.+|+.++++++||||+++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            467888999999999999999988899999999976543 3457899999999999999999999864 45689999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++++|.+++... ....+++.++..++.|++.+|.|||+.+   ++|+||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            999999988643 3457899999999999999999999887   999999999999999999999999999765422211


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                       ......++..|+|||.+....++.++||||||+++|||++ |+.||.
T Consensus       159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  205 (260)
T cd05067         159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYP  205 (260)
T ss_pred             -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCC
Confidence             1122345678999999998899999999999999999999 999985

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.1e-32  Score=267.01  Aligned_cols=199  Identities=31%  Similarity=0.498  Sum_probs=171.6

Q ss_pred             CCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCCh------hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV------QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      +|...+.||+|+||+||+|...+++.+|+|.+.....      .....+.+|++++++++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4678899999999999999987889999999865321      1234588999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|.+++.+   ...+++..+..++.|++.+|.|||+.+   |+|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999999863   356889999999999999999999887   99999999999999999999999999876432


Q ss_pred             CCC----cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          479 DQS----QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       479 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ...    ........++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~  209 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA  209 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccc
Confidence            111    111233468899999999998889999999999999999999999985

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3e-32  Score=272.86  Aligned_cols=201  Identities=29%  Similarity=0.462  Sum_probs=166.7

Q ss_pred             cCCCcCcccCcCCceeEEEeecCC-CC--EEEEEEeecC-ChhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSH-GQ--EIAVKRLSKN-SVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ++|++.+.||+|+||.||+|...+ +.  .+++|.++.. .......+.+|+.++.++ +||||+++++++......++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            468888999999999999998643 33  4788888753 333445789999999999 799999999999999999999


Q ss_pred             EEccCCCChhHHhhhhc-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCe
Q 008854          399 YEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP  465 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~  465 (551)
                      +||+++++|.+++....             ....+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999986421             1135889999999999999999999887   9999999999999999999


Q ss_pred             EEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       466 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ||+|||++......   ........+..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~  221 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG  221 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            99999998642211   11111223557999999998899999999999999999998 9999853

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-33  Score=292.48  Aligned_cols=205  Identities=26%  Similarity=0.366  Sum_probs=172.8

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCC-CEEEEEEeecCChhcHHHHHHHHHHHhcCC-CCCccceee-EEec------CC
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHG-QEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLG-FSFE------ET  393 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~------~~  393 (551)
                      ..++++.+.|.+|||+.||.+....+ .++|+|++-..+.+....+++|+++|++|+ |||||.+++ ....      .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            34567789999999999999997665 999999998888788888999999999997 999999999 3321      13


Q ss_pred             ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCc
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA  473 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla  473 (551)
                      +.+|.||||.+|.|-+++..+.... |++.++++|+.++++|+++||... ++|||||||.+||||+.+++.||+|||.+
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence            5689999999999999998765444 999999999999999999999985 78999999999999999999999999998


Q ss_pred             cccccCCCc-c------cccccccCCCccccccc---ccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          474 RLFEMDQSQ-G------DTSRIVGTFGYMAPEYV---TRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       474 ~~~~~~~~~-~------~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .-....... .      ..-...-|+-|.|||.+   .+..+++|+|||+|||+||-|.....||+
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe  259 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFE  259 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcC
Confidence            632211110 0      01122458999999976   46789999999999999999999999997

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3e-32  Score=278.53  Aligned_cols=205  Identities=29%  Similarity=0.431  Sum_probs=168.6

Q ss_pred             hcCCCcCcccCcCCceeEEEeec------CCCCEEEEEEeecCCh-hcHHHHHHHHHHHhcC-CCCCccceeeEEecC-C
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFSFEE-T  393 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  393 (551)
                      .++|++.++||+|+||.||+|..      ..++.||||+++.... .....+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            45789999999999999999963      3467899999976432 3345688999999999 689999999988654 4


Q ss_pred             ceEEEEEccCCCChhHHhhhhcc---------------------------------------------------------
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIK---------------------------------------------------------  416 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------  416 (551)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            57899999999999999864210                                                         


Q ss_pred             -------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccccc
Q 008854          417 -------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV  489 (551)
Q Consensus       417 -------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  489 (551)
                             ...+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   124788899999999999999999987   9999999999999999999999999997653322222222334


Q ss_pred             cCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       490 gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..|+..
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  284 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  284 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            5678999999988999999999999999999997 8888753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.4e-32  Score=265.66  Aligned_cols=192  Identities=31%  Similarity=0.484  Sum_probs=161.8

Q ss_pred             ccCcCCceeEEEeec---CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCC
Q 008854          331 KLGQGGFGAVYKGRL---SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS  405 (551)
Q Consensus       331 ~LG~G~~g~Vyk~~~---~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  405 (551)
                      +||+|+||.||+|.+   .+++.+|+|+++...  .....++.+|+.+++.++||||+++++++. ....++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999964   357889999986543  233457899999999999999999999875 45678999999999


Q ss_pred             ChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc-c
Q 008854          406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG-D  484 (551)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~  484 (551)
                      +|.+++..   ...+++..+..++.|++.+|.|||+.+   |+||||||+||++++++.+||+|||+++......... .
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            99999863   356899999999999999999999987   9999999999999999999999999998654332211 1


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.||.
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  200 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYK  200 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            122334678999999988889999999999999999998 999986

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.9e-32  Score=268.81  Aligned_cols=200  Identities=32%  Similarity=0.556  Sum_probs=168.2

Q ss_pred             CCCcCcccCcCCceeEEEeecCC-C---CEEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLSH-G---QEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~~-g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      .|++.+.||+|+||.||+|.... +   ..||+|+++.. ......+|..|+.++++++||||+++++++..+...++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46778999999999999998543 3   36999998764 3334567999999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..  ....+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          85 EFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             ecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence            99999999999864  3456899999999999999999999987   999999999999999999999999998765432


Q ss_pred             CCccc-ccccc--cCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          480 QSQGD-TSRIV--GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       480 ~~~~~-~~~~~--gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ..... .....  .+..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~  213 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW  213 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCC
Confidence            21111 11111  2457999999999999999999999999999886 999885

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.2e-32  Score=266.39  Aligned_cols=195  Identities=32%  Similarity=0.482  Sum_probs=167.5

Q ss_pred             cccCcCCceeEEEeecCC--C--CEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLSH--G--QEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      ++||+|++|.||++.+..  +  ..||+|.+..... .....+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            478999999999998643  3  3699999987765 556679999999999999999999999988 888999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc-c
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-G  483 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~  483 (551)
                      ++|.+++.+... ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999875322 56899999999999999999999987   999999999999999999999999999876432211 1


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  202 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA  202 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            1223456789999999998899999999999999999999 999984

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.6e-32  Score=281.34  Aligned_cols=197  Identities=27%  Similarity=0.349  Sum_probs=166.3

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecC------
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------  392 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  392 (551)
                      ..++|...+.||+|+||.||++.. ..++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            357899999999999999999984 457889999997542  23345678999999999999999999987543      


Q ss_pred             CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCC
Q 008854          393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM  472 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl  472 (551)
                      ...++||||+++ +|.+.+.     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            346899999975 5666553     24788999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ++.....   .......+|..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       173 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  227 (364)
T cd07875         173 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG  227 (364)
T ss_pred             ccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence            9764322   122345689999999999999999999999999999999999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=274.44  Aligned_cols=201  Identities=29%  Similarity=0.412  Sum_probs=177.8

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      .+.|..-+.||+|+||+|+-.+. ..|+-+|.|++.+..   .+++.-.++|-.||.+++.+.||.+--.+...+.++||
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            45688889999999999999874 468999999986643   34455678999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      +..|.+|+|.-+|... ....+++...+-++.+|+-||++||+..   ||.|||||+|||||+.|+++|+|+|||..+..
T Consensus       264 LtlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            9999999999888754 4467999999999999999999999987   99999999999999999999999999987654


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .+.   ....+||.+|||||++.++.|+...|+||+|+++|||+.|+.||.-
T Consensus       340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~  388 (591)
T KOG0986|consen  340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ  388 (591)
T ss_pred             CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence            332   2334899999999999999999999999999999999999999963

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.5e-32  Score=266.97  Aligned_cols=199  Identities=33%  Similarity=0.551  Sum_probs=170.7

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChh---------cHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---------GELEFKNEVLLVARLQHRNLVRLLGFSFEETE  394 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  394 (551)
                      +|.+.+.||+|++|.||+|.. .+++.+|+|.+......         ....+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            467788999999999999985 45789999988654321         12457889999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .++||||+++++|.+++..   ...+++..+..++.|++.+|.|||+.+   ++||||+|+||++++++.+||+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999999863   356889999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCCCc----ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          475 LFEMDQSQ----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       475 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ........    .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  213 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFP  213 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence            66432111    11223457889999999998899999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-33  Score=278.96  Aligned_cols=199  Identities=29%  Similarity=0.492  Sum_probs=172.4

Q ss_pred             cCCCcCcccCcCCceeEEEeecCC---CC--EEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSH---GQ--EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~---g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      +...+.++||+|-||.||+|...+   |+  .||||..+.+ .....+.|..|..++++++||||++++|+|.+ ...++
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            445566889999999999998432   32  4899999875 34456679999999999999999999999965 46799


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      |||..+-|.|..+|+.  +...++......++.||..+|.|||+..   +|||||..+|||+....-+||+||||++.++
T Consensus       468 vmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             EEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            9999999999999985  4566888999999999999999999987   9999999999999999999999999999877


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      .+... ..+...-+..|||||.+.-.++|.+||||-|||.+||+++ |.+||.
T Consensus       543 d~~yY-kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfq  594 (974)
T KOG4257|consen  543 DDAYY-KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQ  594 (974)
T ss_pred             ccchh-hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccc
Confidence            54433 3345566889999999999999999999999999999877 999996

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.8e-32  Score=275.35  Aligned_cols=204  Identities=30%  Similarity=0.449  Sum_probs=169.6

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC--------CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcC-CCCCccceeeEEecC
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS--------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEE  392 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  392 (551)
                      .++|.+.++||+|+||.||+++..        ....+|+|+++... .....++.+|+.++.++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            357888999999999999999631        24569999987543 33445688999999999 699999999999998


Q ss_pred             CceEEEEEccCCCChhHHhhhhc-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee
Q 008854          393 TERLLIYEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL  459 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll  459 (551)
                      ...++||||+++++|.+++....             ....+++.++.+++.|++.||.|||+.+   |+||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            89999999999999999997532             1245899999999999999999999887   9999999999999


Q ss_pred             CCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          460 DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       460 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~  238 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP  238 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence            9999999999999986543222111222234567999999998999999999999999999999 888875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.7e-32  Score=266.00  Aligned_cols=202  Identities=26%  Similarity=0.456  Sum_probs=174.9

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecC---ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN---SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|++|.||++... +|+.||+|.++..   .......+.+|++++++++|+||+++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999865 7899999988643   2233457889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          400 EFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      ||+++++|.+++.... ....+++..++.++.++++||.|||+.+   |+|+||+|+||+++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999986532 2456899999999999999999999987   99999999999999999999999999876543


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...  ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  208 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence            221  12234678899999999988999999999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-32  Score=278.73  Aligned_cols=192  Identities=22%  Similarity=0.339  Sum_probs=164.7

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ...+|.+.+.||+|+||.||+++.. .++.||+|+....      ....|+.++++++||||+++++++......++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999864 4678999975433      23568999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      ++. ++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..... 
T Consensus       138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  210 (357)
T PHA03209        138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-  210 (357)
T ss_pred             ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence            995 578887754  3457899999999999999999999987   999999999999999999999999999753221 


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                        .......||+.|+|||.+.+..++.++|||||||++|||+++..++
T Consensus       211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence              1223456899999999999999999999999999999999976655

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.9e-32  Score=270.05  Aligned_cols=200  Identities=31%  Similarity=0.477  Sum_probs=169.1

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +|+..+.||+|++|.||+|+.. +++.||+|+++....  .....+.+|+.++.+++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999854 688999999865422  2235688999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      ++ ++|.+++........+++..+..++.||++||.|||+.+   |+|+||||+||++++++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 688888765434467899999999999999999999987   9999999999999999999999999987543221 


Q ss_pred             cccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                       .......+++.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~  204 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG  204 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence             112233568899999987654 578999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-33  Score=284.36  Aligned_cols=218  Identities=28%  Similarity=0.419  Sum_probs=182.9

Q ss_pred             CcCcccCcCCceeEEEeecC--CCC--EEEEEEeecCChh-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          327 STDNKLGQGGFGAVYKGRLS--HGQ--EIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       327 ~~~~~LG~G~~g~Vyk~~~~--~g~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .+.++||+|.||.|++|.|.  +|+  .||||+++..... ...+|.+|+.+|.+|+|||+++|+|+..+ ....||||.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            45689999999999999875  344  5899999877554 56689999999999999999999999987 778899999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      .+.|+|.+.|++ .....|-......++.|||.||.||..+.   +|||||..+|+||-....+||+||||.+-+.....
T Consensus       192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            999999999987 45677888999999999999999999987   99999999999999999999999999997764432


Q ss_pred             c-ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC----------------CCC-cCcccHHHH
Q 008854          482 Q-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF----------------RIG-EEAEDLLTY  542 (551)
Q Consensus       482 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~----------------~~~-~~~~~l~~~  542 (551)
                      . .......-...|.|||.+....|+.+||||+|||.+|||+| |+-||..                .-+ .-.+|+++.
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~i  347 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQI  347 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHH
Confidence            2 22222334678999999999999999999999999999999 6678741                111 224678888


Q ss_pred             HHhhhhh
Q 008854          543 VSNNLHI  549 (551)
Q Consensus       543 ~~~~~~~  549 (551)
                      +.+.|.-
T Consensus       348 mk~cWah  354 (1039)
T KOG0199|consen  348 MKNCWAH  354 (1039)
T ss_pred             HHHhccC
Confidence            8888863

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.5e-32  Score=265.89  Aligned_cols=200  Identities=28%  Similarity=0.430  Sum_probs=169.2

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh-----hcHHHHHHHHHHHhcCCCCCccceeeEEecC--Cce
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV-----QGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TER  395 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  395 (551)
                      .+|+..+.||+|+||.||++.. ..+..|++|++.....     .....+.+|+.++++++||||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4788899999999999999985 4588999999865321     2234688899999999999999999988753  556


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++++||+++++|.+++..   ...+++...+.++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999999863   345889999999999999999999887   99999999999999999999999999876


Q ss_pred             cccCCC-cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          476 FEMDQS-QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       476 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~  210 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA  210 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcc
Confidence            532111 111223457889999999998899999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.7e-32  Score=272.06  Aligned_cols=204  Identities=28%  Similarity=0.446  Sum_probs=169.6

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-----------------CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-----------------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVR  384 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-----------------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  384 (551)
                      .++|++.++||+|+||.||++...                 ++..+|+|++.... ......+.+|+.++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            357899999999999999998532                 23468999997653 334457899999999999999999


Q ss_pred             eeeEEecCCceEEEEEccCCCChhHHhhhhcc--------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCC
Q 008854          385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIK--------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASN  456 (551)
Q Consensus       385 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~N  456 (551)
                      +++++......++||||+++++|.+++.....        ...+++..++.++.|++.||.|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            99999999999999999999999999875321        134788899999999999999999987   9999999999


Q ss_pred             eeeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh--CCCCCC
Q 008854          457 ILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS--GQKNNS  529 (551)
Q Consensus       457 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt--G~~p~~  529 (551)
                      ||++.++.++|+|||+++.+.............++..|++||....+.++.++||||||+++|||++  |..|+.
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~  235 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS  235 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence            9999999999999999976543222222223345678999999888899999999999999999998  666764

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-32  Score=278.69  Aligned_cols=197  Identities=27%  Similarity=0.419  Sum_probs=166.7

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecC-----
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-----  392 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  392 (551)
                      ...++|...+.||+|+||.||++.. .+++.||||++....  ......+.+|+.++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3457899999999999999999984 467899999997542  22334677899999999999999999987543     


Q ss_pred             -CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          393 -TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       393 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                       ...++++|++ +++|.+++.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3468999987 778887763    356999999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +++.....     .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  218 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            99864321     233568999999999876 5789999999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7e-32  Score=263.85  Aligned_cols=200  Identities=24%  Similarity=0.402  Sum_probs=174.1

Q ss_pred             CCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +|+..+.||+|+||.||.++ ..+++.+++|.+...  ......++.+|+.++++++|+||+++++++.+....+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            57888999999999999887 446889999998654  334455788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++... ....+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            9999999998643 2456899999999999999999999887   99999999999999999999999999976543321


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA  203 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence              22345689999999999888899999999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4e-32  Score=267.50  Aligned_cols=202  Identities=29%  Similarity=0.508  Sum_probs=170.1

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-C---CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-H---GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      .+|++.+.||+|+||.||+|... +   +..+|+|.++... ......+.+|+.++.+++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788899999999999999853 2   3369999987543 23345789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|.+++..  ....+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999999864  3356899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCCcc-cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          479 DQSQG-DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       479 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ..... ......++..|++||.+.+..++.++||||||+++||+++ |+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~  212 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE  212 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc
Confidence            22111 1122233568999999998899999999999999999887 9999853

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.7e-32  Score=269.73  Aligned_cols=201  Identities=25%  Similarity=0.431  Sum_probs=170.7

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ++|++.+.||+|+||.||+++.. .++.||+|.++.. .......+.+|+.++.+++||||+++++.+......++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36788899999999999999865 6899999998754 223345788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|..++........+++..+..++.+++.+|.|||+..  +|+|+||||+||+++.++.+||+|||++..+...  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            999999998865333447899999999999999999999742  3999999999999999999999999998754322  


Q ss_pred             cccccccccCCCcccccccccC------CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRG------HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        ......+++.|+|||.+.+.      .++.++||||||+++|||++|+.||..
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  209 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP  209 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence              12234578899999988554      358899999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-32  Score=264.84  Aligned_cols=198  Identities=35%  Similarity=0.556  Sum_probs=171.7

Q ss_pred             cccCcCCceeEEEeecCC----CCEEEEEEeecCChhc-HHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSVQG-ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~----g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      ++||+|+||.||++....    +..+++|.+....... ...+.+|++++..++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999998653    7889999997664333 56789999999999999999999999999999999999999


Q ss_pred             CChhHHhhhhcc------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          405 SSVDKFIFDAIK------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       405 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      ++|.+++.....      ...+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999875321      367999999999999999999999987   99999999999999999999999999987654


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ...........++..|+|||.+....++.++||||+|++++||++ |+.|+..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  210 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG  210 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCC
Confidence            332223344567889999999988889999999999999999999 5888864

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.9e-32  Score=266.26  Aligned_cols=189  Identities=26%  Similarity=0.431  Sum_probs=159.2

Q ss_pred             cccCcCCceeEEEeecCC-------------CCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          330 NKLGQGGFGAVYKGRLSH-------------GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~-------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      +.||+|+||.||+|++..             ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2258889886655444557889999999999999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC-------eEEee
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI-------PKISD  469 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~-------~kl~D  469 (551)
                      +||||+++++|+.++..  ....+++..+++++.||++||.|||+.+   |+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999988764  3456899999999999999999999987   999999999999987664       89999


Q ss_pred             cCCccccccCCCcccccccccCCCcccccccc-cCCCCcchhhHhHHHHHHHHH-hCCCCCC
Q 008854          470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEII-SGQKNNS  529 (551)
Q Consensus       470 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvll~ell-tG~~p~~  529 (551)
                      ||++......      ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+.
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~  211 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK  211 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9998654321      2235788999999886 467899999999999999998 5777774

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.1e-32  Score=271.32  Aligned_cols=197  Identities=29%  Similarity=0.486  Sum_probs=162.6

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh--cHHHHHHHHHHHhcC---CCCCccceeeEEecC-----C
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARL---QHRNLVRLLGFSFEE-----T  393 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~  393 (551)
                      +|++.+.||+|+||+||+++.. +++.||+|.++.....  ....+.+|+.+++.+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999854 6889999998754221  223456677766655   799999999987642     3


Q ss_pred             ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCc
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA  473 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla  473 (551)
                      ..++||||+++ +|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            46899999985 788877642 3345899999999999999999999987   999999999999999999999999999


Q ss_pred             cccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      +......   ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~  208 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC  208 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence            8654221   2233567899999999998899999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-32  Score=268.37  Aligned_cols=197  Identities=26%  Similarity=0.423  Sum_probs=173.7

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ++|+..+.||.|++|.||+++.. +++.|++|.+.... ......+.+|+.+++.++||||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36788899999999999999854 68899999997653 33445788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++..    ..+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||+++...... 
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            999999998863    27899999999999999999999987   9999999999999999999999999998765332 


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                       .......+++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~  199 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS  199 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence             12334567889999999998889999999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.1e-32  Score=267.44  Aligned_cols=202  Identities=30%  Similarity=0.541  Sum_probs=170.2

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCC---EEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQ---EIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      .++|+..+.||+|+||.||+|+.. +++   .+++|.++... ......+.+|++++.+++||||+++.+++......++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            346788899999999999999864 233   69999987552 3344578899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+++++|.+++..  ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999999864  3457899999999999999999999987   9999999999999999999999999987654


Q ss_pred             cCCCccc-ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          478 MDQSQGD-TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       478 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ....... ......+..|+|||.+....++.++||||||+++|||++ |+.|+.
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~  212 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYW  212 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCC
Confidence            3221111 111223457999999998899999999999999999998 999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-32  Score=263.44  Aligned_cols=195  Identities=32%  Similarity=0.493  Sum_probs=167.0

Q ss_pred             cccCcCCceeEEEeecCCCCEEEEEEeecCChh-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCChh
Q 008854          330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD  408 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  408 (551)
                      ++||+|++|.||++...+++.|++|+++..... ....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999777999999998765433 4567899999999999999999999999999999999999999999


Q ss_pred             HHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccccccc
Q 008854          409 KFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI  488 (551)
Q Consensus       409 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  488 (551)
                      +++..  ....+++..++.++.+++.+|.|||+.+   ++||||||+||+++.++.+||+|||++...............
T Consensus        81 ~~l~~--~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            99864  2346889999999999999999999887   999999999999999999999999999754322111111222


Q ss_pred             ccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       489 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ..+..|+|||.+.++.++.++||||||+++|||++ |..|+.
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~  197 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP  197 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCc
Confidence            34567999999988899999999999999999999 777774

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.5e-32  Score=300.67  Aligned_cols=205  Identities=25%  Similarity=0.415  Sum_probs=169.2

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecC--CceE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERL  396 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  396 (551)
                      ..++|.+.++||+|+||+||+++.. .+..+|+|.+....  ......+..|+.++.+|+||||+++++++...  ...+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            4468999999999999999999854 56789999987542  23345688999999999999999999988643  4578


Q ss_pred             EEEEccCCCChhHHhhhhcc-cCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeEeccCCCCCeeeCC----------
Q 008854          397 LIYEFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGILYLHEDSR----LRIIHRDLKASNILLDA----------  461 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~iiH~Dlk~~NIll~~----------  461 (551)
                      |||||+++++|.++|..... ...+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            99999999999999875322 3579999999999999999999998542    34999999999999964          


Q ss_pred             -------CCCeEEeecCCccccccCCCcccccccccCCCccccccccc--CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          462 -------DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       462 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                             ...+||+|||++..+....   ......||+.|+|||++.+  ..++.++|||||||+||||++|+.||.
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                   2358999999997653221   2234578999999998854  458899999999999999999999995

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-33  Score=284.29  Aligned_cols=194  Identities=28%  Similarity=0.456  Sum_probs=165.0

Q ss_pred             CcCcccCcCCceeEEEeecC-CCCEEEEEEeecC----ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCc--eEEEE
Q 008854          327 STDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN----SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE--RLLIY  399 (551)
Q Consensus       327 ~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lV~  399 (551)
                      .....||+|+|-+||||... .|-+||--.++..    +......|..|+.+|+.|+||||++++..+.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            44578999999999999853 4667765444322    23344679999999999999999999999887665  66899


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC-CCCeEEeecCCcccccc
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEM  478 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~Dfgla~~~~~  478 (551)
                      |.+..|+|..|+.   +.+.++...+..|++||++||.|||++. |||||||||-+||+|+. -|.+||+|+|||.+...
T Consensus       123 EL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            9999999999987   4566889999999999999999999986 78999999999999975 47999999999987542


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                          .....++|||.|||||... ..|+...||||||+.++||+|+..|++
T Consensus       199 ----s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs  244 (632)
T KOG0584|consen  199 ----SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS  244 (632)
T ss_pred             ----cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence                2334479999999999776 889999999999999999999999996

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.1e-32  Score=269.33  Aligned_cols=199  Identities=28%  Similarity=0.414  Sum_probs=172.8

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ++|++.++||+|+||+||++.. .+++.||+|++.... ......+.+|++++..++||||+++++.+......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            4678889999999999999985 468899999886543 23355789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++..   ...+++..+..++.+++.+|.|||+..  +++|+||||+||++++++.++|+|||++......  
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--  157 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--  157 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence            999999998763   456899999999999999999999742  3999999999999999999999999998654321  


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                        ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~  205 (284)
T cd06620         158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS  205 (284)
T ss_pred             --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence              123457899999999998889999999999999999999999999743

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4e-32  Score=267.31  Aligned_cols=201  Identities=24%  Similarity=0.461  Sum_probs=173.6

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|++|.||++.. .+++.++||.+....   .....++.+|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4678889999999999999984 578999999886532   223457889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          400 EFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      ||+++++|.+++.... ....+++..++.++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999886422 2456899999999999999999999987   99999999999999999999999999876543


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  207 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY  207 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcc
Confidence            221  1223468889999999988889999999999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-32  Score=263.87  Aligned_cols=196  Identities=32%  Similarity=0.541  Sum_probs=171.5

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      .++|++.+.||.|++|.||++.. .++.||+|.++.... ...++.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            35788889999999999999987 478999999977654 4567899999999999999999999999989999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++++|.+++... ....+++..+..++.|++.+|.|||+.+   ++|+||||+||++++++.+||+|||+++....... 
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            999999998643 2236899999999999999999999987   99999999999999999999999999986532211 


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                          ....+..|+|||.+....++.++||||||+++|||++ |+.|+.
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~  201 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP  201 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCC
Confidence                2234668999999988899999999999999999997 888875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.3e-32  Score=268.99  Aligned_cols=198  Identities=31%  Similarity=0.443  Sum_probs=165.6

Q ss_pred             CCcCcccCcCCceeEEEee-----cCCCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecC--CceEE
Q 008854          326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERLL  397 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~-----~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  397 (551)
                      |...+.||+|+||+||++.     ..+++.||+|.++.... .....+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            3788999999999998764     23577899999976532 3455788999999999999999999988654  35789


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+++++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999998853    35899999999999999999999987   9999999999999999999999999998654


Q ss_pred             cCCCccc-ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          478 MDQSQGD-TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++|..|+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~  212 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS  212 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence            3221111 1222356679999999888999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-32  Score=265.65  Aligned_cols=201  Identities=33%  Similarity=0.548  Sum_probs=173.6

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      .++|.+.++||+|+||.||++..++++.++||.+..... ...++.+|+.++++++||||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            467889999999999999999987888999999876443 3457899999999999999999999999888999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++++|.+++.+. ....+++..+..++.+++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+..... 
T Consensus        84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (261)
T cd05034          84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-  158 (261)
T ss_pred             CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence            999999998753 2346899999999999999999999987   99999999999999999999999999876543211 


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  206 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYP  206 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            11112234568999999998899999999999999999999 898874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.6e-32  Score=280.35  Aligned_cols=197  Identities=26%  Similarity=0.343  Sum_probs=166.0

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecC------
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------  392 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  392 (551)
                      ..++|+..+.||+|+||.||++.. ..++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            457899999999999999999984 357899999997542  23345678899999999999999999988643      


Q ss_pred             CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCC
Q 008854          393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM  472 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl  472 (551)
                      ...++||||+++ +|.+.+.     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence            246899999976 5555543     24788999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ++.....   .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  220 (355)
T cd07874         166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_pred             cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9754322   122345789999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-33  Score=259.10  Aligned_cols=198  Identities=28%  Similarity=0.429  Sum_probs=171.0

Q ss_pred             cccCcCCceeEEEee-cCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEEEccCCCCh
Q 008854          330 NKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEFVPNSSV  407 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL  407 (551)
                      +.||+|+++.|--++ +.+|.++|||++.+........+.+|++++.+.+ |+||++|+++|.+++..|||||-|.+|+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            689999999999887 7789999999999887777778999999999996 99999999999999999999999999999


Q ss_pred             hHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC---CeEEeecCCccccccCC----
Q 008854          408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM---IPKISDFGMARLFEMDQ----  480 (551)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl~Dfgla~~~~~~~----  480 (551)
                      ..+++   ++..+++.+..+++++|+.||.+||.++   |.||||||+|||..+..   -+||+||.|..-+....    
T Consensus       164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            99987   5678999999999999999999999998   99999999999996554   37999999875432211    


Q ss_pred             -CcccccccccCCCcccccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCCCC
Q 008854          481 -SQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIG  533 (551)
Q Consensus       481 -~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~elltG~~p~~~~~~  533 (551)
                       ........+|+..|||||+..     ...|+.+.|.||||||||-||+|-.||....+
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg  296 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG  296 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence             112234568999999999763     23678899999999999999999999975444

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.6e-32  Score=270.18  Aligned_cols=204  Identities=28%  Similarity=0.495  Sum_probs=171.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER  395 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  395 (551)
                      .++|+..++||+|+||.||++...      ++..+|+|++.... .....++.+|+.++++++||||+++++++..+...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467889999999999999999853      46789999987653 33455789999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhhc-------------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCC
Q 008854          396 LLIYEFVPNSSVDKFIFDAI-------------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASN  456 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~N  456 (551)
                      ++||||+++++|.+++....                   ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999997421                   1235788999999999999999999987   9999999999


Q ss_pred             eeeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          457 ILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       457 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      |+++.++.+||+|||+++................+..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999875433222111222344668999999998999999999999999999998 877874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.2e-32  Score=268.66  Aligned_cols=198  Identities=26%  Similarity=0.406  Sum_probs=169.8

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ++|+..+.||+|++|.||+++.. +++.||+|++....  ....+.+.+|+.++++++||||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999865 58899999986542  2233467899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|..++.   ....+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999998888764   3346899999999999999999999987   9999999999999999999999999998654322


Q ss_pred             CcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~  202 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP  202 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence            1  1223457889999998876 567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.1e-32  Score=272.66  Aligned_cols=200  Identities=32%  Similarity=0.563  Sum_probs=166.8

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCC----EEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQ----EIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      ++|+..+.||+|+||.||++.+. ++.    .+|+|.+..... ....++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            46778899999999999999853 444    478888865432 3344688999999999999999999998654 4679


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ++||+++|+|.+++..  ....+++..++.++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            9999999999999864  2346889999999999999999999987   9999999999999999999999999998654


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ............++..|++||.+.+..++.++||||||+++|||++ |+.|+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~  213 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD  213 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            3322222223345778999999998999999999999999999998 888885

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.1e-32  Score=272.07  Aligned_cols=197  Identities=27%  Similarity=0.458  Sum_probs=171.3

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      +.|.....||+|+||.||++.. .++..||||.+..........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            3444457899999999999985 468899999987665555667899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++++|.+++.    ...+++.++..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||++.......  
T Consensus       102 ~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--  172 (292)
T cd06658         102 EGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--  172 (292)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence            9999999874    345899999999999999999999987   9999999999999999999999999987543222  


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .......++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~  219 (292)
T cd06658         173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF  219 (292)
T ss_pred             ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            12233568899999999988899999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.4e-32  Score=264.59  Aligned_cols=200  Identities=23%  Similarity=0.338  Sum_probs=173.0

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      +|++.++||+|+||.||++... +++.+|+|.++.. .......+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999854 6889999998654 2334457889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++++|.+++... ....+++..++.++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||++..+....  
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--  154 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--  154 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--
Confidence            999999987642 3456889999999999999999999987   9999999999999999999999999997654321  


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~  202 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA  202 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC
Confidence            122335688899999999988899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.98  E-value=4e-32  Score=272.73  Aligned_cols=200  Identities=31%  Similarity=0.506  Sum_probs=166.7

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCC--EEEEEEeecC-ChhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQ--EIAVKRLSKN-SVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ++|++.+.||+|+||.||++... ++.  .+++|.++.. .......+.+|++++.++ +||||+++++++..+...++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46788899999999999999854 454  4577777653 233455788999999999 899999999999999999999


Q ss_pred             EEccCCCChhHHhhhhc-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCe
Q 008854          399 YEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP  465 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~  465 (551)
                      |||+++++|.+++....             ....+++.+++.++.|++.||+|||+.+   |+||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999987432             1235889999999999999999999887   9999999999999999999


Q ss_pred             EEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       466 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ||+|||+++.....   .......++..|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus       164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  225 (303)
T cd05088         164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC  225 (303)
T ss_pred             EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcc
Confidence            99999998642211   11112234668999999988889999999999999999998 999885

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.98  E-value=1e-31  Score=264.07  Aligned_cols=204  Identities=26%  Similarity=0.424  Sum_probs=176.0

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ++|++.+.||.|++|+||++.. .++..+++|++.... ......+.+|+.+++.++|+||+++++.+......++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4688899999999999999985 467899999997543 23456789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++........+++.....++.|++.+|.|||+.+   ++|+||+|+||++++++.+||+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999875433457899999999999999999999887   99999999999999999999999999876653322


Q ss_pred             cc--cccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QG--DTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..  ......++..|++||.+... .++.++||||||+++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~  209 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK  209 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccc
Confidence            21  22344688999999998777 789999999999999999999999853

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.98  E-value=8.8e-32  Score=263.15  Aligned_cols=196  Identities=31%  Similarity=0.501  Sum_probs=171.1

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC-----hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-----VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      +|+..+.||+|++|.||+|... +++.|++|.+....     .+....+.+|+.+++.++||||+++++++......++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677789999999999999865 78999999986543     22345788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      +||+++++|.+++..   ...+++..+..++.|++++|.|||+.+   |+|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999863   346899999999999999999999987   99999999999999999999999999876533


Q ss_pred             CCCcccccccccCCCcccccccccCC-CCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ..   ......++..|++||.+.... ++.++|+||||+++|||++|+.||.
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~  203 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS  203 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence            22   223456788999999987776 8999999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.98  E-value=7e-32  Score=270.71  Aligned_cols=199  Identities=25%  Similarity=0.415  Sum_probs=168.1

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ++|...++||+|+||.||+++.. +++.||+|.++... ......+.+|+.++++++||||+++++++......++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46888999999999999999854 57899999987543 22334678899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      ++ ++|.+++..  ....+++..+..++.||++||.|||+.+   |+|+||||+||++++++.+||+|||++....... 
T Consensus        86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  158 (301)
T cd07873          86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  158 (301)
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence            97 588888764  2456889999999999999999999987   9999999999999999999999999987543221 


Q ss_pred             cccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                       .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~  207 (301)
T cd07873         159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG  207 (301)
T ss_pred             -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence             11223456889999998765 4578899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=1.9e-32  Score=278.21  Aligned_cols=199  Identities=26%  Similarity=0.441  Sum_probs=177.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhc--HHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ...|.+...||+|.|++|.+++. ..+.+||||.+.+...+.  ...+.+|++++..++|||||+++.+......+++||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            46789999999999999999984 468999999998864433  345889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||..+|.+.++|..   ...+.+.....++.|+.++++|+|++.   |+|||||++||||+.+.++||+|||++..+...
T Consensus       135 eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  135 EYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence            99999999999973   455666888899999999999999998   999999999999999999999999999887632


Q ss_pred             CCcccccccccCCCcccccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                         ......+|++.|.|||+..+.++ .++.|+||+||++|-|+.|..||+.
T Consensus       209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG  257 (596)
T KOG0586|consen  209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG  257 (596)
T ss_pred             ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence               33456799999999999988776 4899999999999999999999973

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.98  E-value=7.5e-32  Score=268.13  Aligned_cols=200  Identities=30%  Similarity=0.500  Sum_probs=168.3

Q ss_pred             cCCCcCcccCcCCceeEEEeec-----CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecC--Cce
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TER  395 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  395 (551)
                      ..|++.+.||+|+||.||+++.     .++..||+|.++... ......+.+|+.++++++||||+++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4568889999999999999873     357789999987553 33345789999999999999999999998775  567


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++||||+++++|.+++..  ....+++..++.++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            899999999999999864  2346899999999999999999999987   99999999999999999999999999986


Q ss_pred             cccCCCc-ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          476 FEMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                      +...... .......++..|+|||.+.+..++.++||||||+++|||++++.|.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence            5432211 1122345677899999998889999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.98  E-value=4.8e-32  Score=271.36  Aligned_cols=194  Identities=28%  Similarity=0.477  Sum_probs=169.5

Q ss_pred             CcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCC
Q 008854          327 STDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS  405 (551)
Q Consensus       327 ~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  405 (551)
                      ....+||+|+||.||++.. .+++.||+|.+..........+.+|+.++..++||||+++++++..+...++|+||++++
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            3345799999999999985 468899999997655445567889999999999999999999999999999999999999


Q ss_pred             ChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccc
Q 008854          406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT  485 (551)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  485 (551)
                      +|..++.    ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+....  ...
T Consensus       104 ~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~  174 (297)
T cd06659         104 ALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKR  174 (297)
T ss_pred             CHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccc
Confidence            9998764    346899999999999999999999987   9999999999999999999999999987544322  122


Q ss_pred             cccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       486 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  218 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF  218 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            33568899999999998899999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.98  E-value=1e-31  Score=263.60  Aligned_cols=199  Identities=32%  Similarity=0.525  Sum_probs=168.8

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccC
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      ++|.+.++||+|++|.||++...++..+|+|++..... ....+.+|+.++++++|||++++++++. ....++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            46788899999999999999987777899998865432 3457889999999999999999998875 456789999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++........ .
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-c
Confidence            99999998653 3345899999999999999999999887   99999999999999999999999999976543221 1


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  205 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP  205 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            1122345678999999998999999999999999999999 888885

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.98  E-value=6.2e-32  Score=267.32  Aligned_cols=189  Identities=25%  Similarity=0.378  Sum_probs=157.6

Q ss_pred             ccCcCCceeEEEeecCC-------------------------CCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccce
Q 008854          331 KLGQGGFGAVYKGRLSH-------------------------GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL  385 (551)
Q Consensus       331 ~LG~G~~g~Vyk~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  385 (551)
                      +||+|+||.||+|.+..                         ...|++|++.........++.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         13488998866544445578899999999999999999


Q ss_pred             eeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC--
Q 008854          386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM--  463 (551)
Q Consensus       386 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~--  463 (551)
                      ++++......++||||+++++|..++..  ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999998864  3456899999999999999999999887   99999999999997654  


Q ss_pred             -----CeEEeecCCccccccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHH-HhCCCCCCC
Q 008854          464 -----IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEI-ISGQKNNSF  530 (551)
Q Consensus       464 -----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~el-ltG~~p~~~  530 (551)
                           .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++||| ++|+.|+..
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  224 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE  224 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence                 3799999987643211      12356788999998865 5689999999999999998 478888853

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.98  E-value=8.4e-32  Score=272.03  Aligned_cols=195  Identities=28%  Similarity=0.472  Sum_probs=158.6

Q ss_pred             cccCcCCceeEEEeecC---CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEec--CCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLS---HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE--ETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~  404 (551)
                      .+||+|+||+||+++..   .+..||+|.+.....  ...+.+|+.++++++||||+++++++..  ....++||||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            68999999999999854   346899999875432  3357889999999999999999998854  4567899999875


Q ss_pred             CChhHHhhhh------cccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee----CCCCCeEEeecCCcc
Q 008854          405 SSVDKFIFDA------IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DADMIPKISDFGMAR  474 (551)
Q Consensus       405 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~kl~Dfgla~  474 (551)
                       +|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             666665421      12235889999999999999999999987   9999999999999    566799999999998


Q ss_pred             ccccCCCc-ccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQSQ-GDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ........ .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            76433221 12334578999999998876 4579999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.98  E-value=1.4e-31  Score=261.90  Aligned_cols=187  Identities=27%  Similarity=0.480  Sum_probs=158.6

Q ss_pred             cccCcCCceeEEEeecCCCC-----------EEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          330 NKLGQGGFGAVYKGRLSHGQ-----------EIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~g~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      +.||+|+||.||+|...+..           .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            47999999999999875433           4788877654433 5688999999999999999999999988 778999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC-------CeEEeecC
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-------IPKISDFG  471 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~-------~~kl~Dfg  471 (551)
                      |||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999998752  237899999999999999999999887   99999999999999888       79999999


Q ss_pred             CccccccCCCcccccccccCCCcccccccccC--CCCcchhhHhHHHHHHHHHhC-CCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG--HFSIKSDVFSFGVLVLEIISG-QKNNS  529 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvll~elltG-~~p~~  529 (551)
                      ++.....      .....++..|+|||.+...  .++.++||||||+++|||++| ..|+.
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~  208 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS  208 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcc
Confidence            9875432      1223466789999998876  789999999999999999995 66664

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.98  E-value=2.6e-32  Score=280.04  Aligned_cols=209  Identities=25%  Similarity=0.370  Sum_probs=172.4

Q ss_pred             cCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-C-----CCccceeeEEecCCceE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-H-----RNLVRLLGFSFEETERL  396 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~  396 (551)
                      .+|++.+.||+|.||.|.|+. ..+++.||||+++.... -..+-..|+.+|..|+ |     -|+|+++++|...+..+
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            378999999999999999997 55689999999976532 2234567899999987 4     48999999999999999


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC--CeEEeecCCcc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM--IPKISDFGMAR  474 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~--~~kl~Dfgla~  474 (551)
                      ||+|.+ ..+|.++|... +...++...+..|+.||+.+|..||+.+   |||.||||+||||.+-.  .+||+|||.+.
T Consensus       265 iVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence            999987 56899998754 5567999999999999999999999887   99999999999996544  79999999998


Q ss_pred             ccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCCcCcccHHHHHHhh
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNN  546 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~  546 (551)
                      ......     ...+-+.-|.|||++.+.+|+.+.||||||+|+.||++|.+-|.   ++...|-+.++.+.
T Consensus       340 ~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp---G~ne~DQl~~I~e~  403 (586)
T KOG0667|consen  340 FESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP---GDNEYDQLARIIEV  403 (586)
T ss_pred             ccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC---CCCHHHHHHHHHHH
Confidence            643221     13455778999999999999999999999999999999976553   33444555555443

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.98  E-value=1.1e-31  Score=264.91  Aligned_cols=199  Identities=30%  Similarity=0.490  Sum_probs=168.9

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChh----------cHHHHHHHHHHHhcCCCCCccceeeEEecCC
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ----------GELEFKNEVLLVARLQHRNLVRLLGFSFEET  393 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  393 (551)
                      +|...+.||+|++|.||+|.. .+++.+|+|.++.....          ..+.+.+|+.++++++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467789999999999999974 46889999988642110          1235788999999999999999999999999


Q ss_pred             ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCc
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA  473 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla  473 (551)
                      ..++||||+++++|.+++..   ...+++..+..++.||+.+|.|||+.+   ++|+||+|+||++++++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            99999999999999999864   357899999999999999999999987   999999999999999999999999999


Q ss_pred             cccccCCCcccccccccCCCcccccccccCC--CCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH--FSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      +...............++..|+|||.+....  ++.++||||||+++|||++|+.|+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  213 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS  213 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence            7643222222233456788999999987654  7899999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.2e-33  Score=281.23  Aligned_cols=194  Identities=30%  Similarity=0.475  Sum_probs=169.0

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      +.|..++.||.|+||.||-++. .+.+.||||+++-..   ...+.++..|+..|.+++|||++.+.|+|..+...||||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            3466778999999999999984 467889999997543   344667999999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+-| +-.++|.-  -.+++.+.++..|..+.+.||.|||+.+   .||||||+.||||++.|.+||+|||.+.+..  
T Consensus       106 EYClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--  177 (948)
T KOG0577|consen  106 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA--  177 (948)
T ss_pred             HHHhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC--
Confidence            99954 55555542  3567999999999999999999999988   8999999999999999999999999987644  


Q ss_pred             CCcccccccccCCCcccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                          ....++|||.|||||++.   .++|+-|.||||+||...||...++|..
T Consensus       178 ----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF  226 (948)
T KOG0577|consen  178 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  226 (948)
T ss_pred             ----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence                244689999999999874   5799999999999999999999998874

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.4e-32  Score=269.90  Aligned_cols=203  Identities=26%  Similarity=0.401  Sum_probs=177.8

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChh--cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ..-|.+.+.||+|.|..|-++++ -.|..||||++.+....  ....+.+|++.|+.++|||||+|+++......+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            45688889999999999999973 47999999999876443  3346889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC-CCCCeEEeecCCcccccc
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPKISDFGMARLFEM  478 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~Dfgla~~~~~  478 (551)
                      |.=++|+|.+|+.+.  ...+.+....+++.||+.++.|.|+.+   +|||||||+||.+- .-|-+||.|||++-.+..
T Consensus        97 ELGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            999999999999763  456899999999999999999999987   99999999998875 557899999999977654


Q ss_pred             CCCcccccccccCCCcccccccccCCCC-cchhhHhHHHHHHHHHhCCCCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFS-IKSDVFSFGVLVLEIISGQKNNSFRIG  533 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvll~elltG~~p~~~~~~  533 (551)
                      .+   .....+|++.|-|||++.+..|+ ++.||||+|||||.|++|+.||+..+.
T Consensus       172 G~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND  224 (864)
T KOG4717|consen  172 GK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND  224 (864)
T ss_pred             cc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc
Confidence            33   34567999999999999999887 789999999999999999999985544

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.98  E-value=7.7e-32  Score=274.52  Aligned_cols=203  Identities=28%  Similarity=0.430  Sum_probs=168.9

Q ss_pred             cCCCcCcccCcCCceeEEEeecC--------CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcC-CCCCccceeeEEecCC
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS--------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEET  393 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  393 (551)
                      .+|++.+.||+|+||.||++...        .+..||+|.++... .....++.+|+.++.++ +||||+++++++....
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888999999999999999632        12368999887543 33455789999999999 7999999999999999


Q ss_pred             ceEEEEEccCCCChhHHhhhhc-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD  460 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~  460 (551)
                      ..+++|||+++++|.+++....             ....+++..++.++.|++.||.|||+.+   |+||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999987521             2345889999999999999999999987   99999999999999


Q ss_pred             CCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          461 ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       461 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  238 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP  238 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence            999999999999976543221112222334568999999999999999999999999999998 777774

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.98  E-value=1.9e-31  Score=260.90  Aligned_cols=200  Identities=27%  Similarity=0.384  Sum_probs=170.9

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecC-CceEEEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-TERLLIYE  400 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e  400 (551)
                      +|++.+.||+|++|.||+++.. +++.+++|++....  ......+.+|++++++++|||++++++.+... ...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788899999999999999854 57889999997542  23445688999999999999999999887644 45789999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|.+++... ....+++.++..++.+++.++.+||+.+   |+|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999998753 3456899999999999999999999987   9999999999999999999999999997654322


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        .......+++.|+|||.+.+..++.++||||||++++||++|+.||..
T Consensus       157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~  204 (257)
T cd08223         157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA  204 (257)
T ss_pred             --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence              122345678999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.98  E-value=1.3e-31  Score=272.07  Aligned_cols=198  Identities=19%  Similarity=0.276  Sum_probs=164.0

Q ss_pred             cCcccCcC--CceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          328 TDNKLGQG--GFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       328 ~~~~LG~G--~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      +.++||+|  +|++||++.. .+|+.||+|++....  ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  7899999985 568999999997642  223346778999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC-
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS-  481 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-  481 (551)
                      ++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++++||+.......... 
T Consensus        82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            999999998643 2345899999999999999999999987   99999999999999999999999986543221110 


Q ss_pred             ----cccccccccCCCccccccccc--CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 ----QGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                          ........++..|+|||++.+  ..++.++||||||+++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  211 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK  211 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence                001122346778999999876  468899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.98  E-value=1.7e-31  Score=262.08  Aligned_cols=200  Identities=28%  Similarity=0.423  Sum_probs=176.3

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ++|++.+.||+|++|.||+++.. +++.|++|++..... .....+.+|+.++.+++|+||+++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888899999999999999865 589999999977643 3456799999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      +++++|.+++..   ...+++..++.++.|++++|.|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            999999999864   3678999999999999999999999 77   9999999999999999999999999998654322


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ..  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...
T Consensus       155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~  203 (264)
T cd06623         155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP  203 (264)
T ss_pred             Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            21  22446788999999999999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.5e-31  Score=270.08  Aligned_cols=202  Identities=26%  Similarity=0.348  Sum_probs=173.5

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh---cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|+..+.||+|++|.||++... +++.+|+|.+......   ....+.+|++++..++||||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999865 4899999999765332   3456889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+.+++|.+++... ....+++..+..++.|++++|.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999988642 3457899999999999999999999987   999999999999999999999999998754321


Q ss_pred             CCc---------------------------ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          480 QSQ---------------------------GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       480 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ...                           .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  233 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK  233 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence            110                           01123468889999999998889999999999999999999999985

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.98  E-value=1.2e-31  Score=262.93  Aligned_cols=201  Identities=31%  Similarity=0.502  Sum_probs=171.6

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      .++|.+.++||+|+||.||++...++..+++|.+.... .....+.+|+.++++++|+||+++.+.+.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            46788999999999999999997778889999887543 234578899999999999999999999877 7789999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++++|.+++... ....+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.+||+|||++..+..... 
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  157 (260)
T cd05073          83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-  157 (260)
T ss_pred             CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence            999999998753 3456889999999999999999999887   99999999999999999999999999976543221 


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      .......++..|+|||.+..+.++.++|+||||+++|||++ |+.||..
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~  206 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG  206 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence            11222345678999999998899999999999999999999 8888853

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4.2e-33  Score=298.19  Aligned_cols=212  Identities=24%  Similarity=0.313  Sum_probs=182.5

Q ss_pred             ccccChhHHHhhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCcccee
Q 008854          311 SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLL  386 (551)
Q Consensus       311 ~~~~~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~  386 (551)
                      +......+++-..++|.+++.||+|+||.|..++.. .++.+|+|++.+...   ....-|.+|-.+|.--+.+-|+.++
T Consensus        62 p~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh  141 (1317)
T KOG0612|consen   62 PIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLH  141 (1317)
T ss_pred             HHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHH
Confidence            334445666777889999999999999999999854 578899999987422   2233588899999988999999999


Q ss_pred             eEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeE
Q 008854          387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPK  466 (551)
Q Consensus       387 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~k  466 (551)
                      -.|++...+|+|||||+||+|-.+|.+   ..++++.....++..|+-||.-||+.|   +|||||||+|||||..|++|
T Consensus       142 yAFQD~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHik  215 (1317)
T KOG0612|consen  142 YAFQDERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIK  215 (1317)
T ss_pred             HHhcCccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEe
Confidence            999999999999999999999999874   337888888889999999999999988   99999999999999999999


Q ss_pred             EeecCCccccccCCCcccccccccCCCcccccccc----c-CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          467 ISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT----R-GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       467 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      |+|||-+-.+..+. .......+|||.|++||++.    + +.|++..|+||+||++|||+.|..||.
T Consensus       216 LADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY  282 (1317)
T KOG0612|consen  216 LADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY  282 (1317)
T ss_pred             eccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence            99999997766443 33455678999999999884    3 678999999999999999999999994

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.98  E-value=1.5e-31  Score=268.88  Aligned_cols=200  Identities=22%  Similarity=0.334  Sum_probs=170.2

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|+..+.||+|+||.||++... .++.|++|.+.....   .....+.+|+++++.++||||+++++.+..+...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999854 578999999876532   23446789999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999863   356899999999999999999999987   999999999999999999999999998642111


Q ss_pred             CC-------------cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          480 QS-------------QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       480 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ..             ........++..|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~  217 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF  217 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            00             001112457889999999988889999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.98  E-value=1.4e-31  Score=261.82  Aligned_cols=200  Identities=30%  Similarity=0.520  Sum_probs=171.3

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccC
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      .+|+..+.||+|+||.||++.+.++..+|+|.++.... ....+.+|++++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            35777899999999999999887788999999875433 34578999999999999999999999999999999999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      +++|.+++..  ....+++..+..++.+++.+|.|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            9999998864  3346889999999999999999999887   999999999999999999999999998754322111 


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ......++.+|+|||.+.++.++.++||||||+++|||++ |+.||..
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  204 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN  204 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            1122234678999999998899999999999999999998 8988853

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.98  E-value=6.3e-32  Score=268.71  Aligned_cols=198  Identities=28%  Similarity=0.433  Sum_probs=169.3

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh--cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ++|+..++||+|+||.||++... +++.||+|++......  ....+.+|+++++.++||||+++++++......++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888899999999999999965 5889999998654322  34468899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|..+..   ....+++..++.++.||+++|.|||+.+   |+|+||+|+||++++++.++|+|||++..+....
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            999999888764   2345899999999999999999999987   9999999999999999999999999987654322


Q ss_pred             CcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                        .......++..|+|||.+.+ ..++.++||||||+++|||++|++||.
T Consensus       155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~  202 (286)
T cd07846         155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP  202 (286)
T ss_pred             --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence              12233457889999998875 457889999999999999999998885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.98  E-value=1.1e-31  Score=267.03  Aligned_cols=210  Identities=25%  Similarity=0.408  Sum_probs=174.2

Q ss_pred             cChhHHHhhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeEEe-
Q 008854          314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSF-  390 (551)
Q Consensus       314 ~~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-  390 (551)
                      +.++.+....++|++.+.||+|+||.||+++. .+++.+|+|+++... .....+.+|+.++..+ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            34456667889999999999999999999985 457899999886532 2234678899999999 6999999999874 


Q ss_pred             ----cCCceEEEEEccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCe
Q 008854          391 ----EETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP  465 (551)
Q Consensus       391 ----~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~  465 (551)
                          .+...++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence                3456799999999999999886432 3456889999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCccccccCCCcccccccccCCCccccccccc-----CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-----GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       466 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ||+|||+++......  .......|++.|+|||++..     ..++.++||||||+++|||++|+.|+.
T Consensus       164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~  230 (286)
T cd06638         164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA  230 (286)
T ss_pred             EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCC
Confidence            999999987654221  12233468999999998753     457889999999999999999999985

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.98  E-value=7.6e-32  Score=264.02  Aligned_cols=199  Identities=29%  Similarity=0.386  Sum_probs=174.6

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      +|++.+.||.|+||.||++... +++.+|+|.+.+...   .....+.+|++++++++||||+++++.+......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999865 588999999976432   345678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|.+++..   ..++++..+..++.|++++|.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            9999999999864   357899999999999999999999887   9999999999999999999999999987654321


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRI  532 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~  532 (551)
                         ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+....
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  203 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS  203 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence               2234567889999999988889999999999999999999999987544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.98  E-value=2e-31  Score=262.81  Aligned_cols=197  Identities=23%  Similarity=0.363  Sum_probs=157.9

Q ss_pred             cccCcCCceeEEEeecCCCC---EEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCC
Q 008854          330 NKLGQGGFGAVYKGRLSHGQ---EIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS  405 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~g~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  405 (551)
                      ++||+|+||.||++...++.   .+++|.++... ......+.+|+.++..++||||+++++.+......++||||++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            36999999999999754433   45677665543 334567899999999999999999999999999999999999999


Q ss_pred             ChhHHhhhhcc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          406 SVDKFIFDAIK-RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       406 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      +|.+++.+... ...+++..+..++.||++||.|||+.+   ++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999975322 244677788899999999999999887   99999999999999999999999999864222111112


Q ss_pred             ccccccCCCccccccccc-------CCCCcchhhHhHHHHHHHHHhC-CCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTR-------GHFSIKSDVFSFGVLVLEIISG-QKNNS  529 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~S~Gvll~elltG-~~p~~  529 (551)
                      .....++..|+|||++..       ..++.++||||||+++|||+++ ..|+.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~  210 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS  210 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence            234567889999998743       3457899999999999999975 55664

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=9.2e-33  Score=281.09  Aligned_cols=192  Identities=32%  Similarity=0.508  Sum_probs=168.8

Q ss_pred             ccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCChhH
Q 008854          331 KLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDK  409 (551)
Q Consensus       331 ~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  409 (551)
                      .||+|.||+||.|+.. +...+|||-+.....+..+.+.+||.+.++|+|+|||+++|.+.+.+..-+.||.+|+|+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999954 455799999977665666678999999999999999999999999998889999999999999


Q ss_pred             HhhhhcccCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC-CCCCeEEeecCCccccccCCCccccc
Q 008854          410 FIFDAIKRVQL--DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPKISDFGMARLFEMDQSQGDTS  486 (551)
Q Consensus       410 ~l~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~  486 (551)
                      +|..  +-+++  ++.++-.+.+||++||.|||++.   |||||||-+||||+ -.|.+||+|||-++.+..  ...-+.
T Consensus       662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE  734 (1226)
T KOG4279|consen  662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE  734 (1226)
T ss_pred             HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence            9986  44555  88889999999999999999988   99999999999996 568999999999986542  233456


Q ss_pred             ccccCCCcccccccccC--CCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          487 RIVGTFGYMAPEYVTRG--HFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       487 ~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .+-||+.|||||++..+  .|...+||||||+.+.||.||++||.
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~  779 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFV  779 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCee
Confidence            67899999999999876  57889999999999999999999995

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.98  E-value=2.5e-31  Score=261.75  Aligned_cols=200  Identities=28%  Similarity=0.485  Sum_probs=171.3

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh------hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV------QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      +|+..+.||+|++|.||++.. .+++.+|+|.+.....      .....+.+|+.++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999984 5789999999875321      123568899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC-CeEEeecCCcccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLF  476 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~~  476 (551)
                      ||||+++++|.+++.+   ..++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999863   356899999999999999999999987   99999999999998776 5999999998765


Q ss_pred             ccCCCc--ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          477 EMDQSQ--GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       477 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ......  .......++..|+|||.+.+..++.++||||+|++++||++|+.|+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  210 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA  210 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            432111  112234678899999999888899999999999999999999999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2.2e-31  Score=261.74  Aligned_cols=200  Identities=26%  Similarity=0.419  Sum_probs=169.2

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC-----ChhcHHHHHHHHHHHhcCCCCCccceeeEEecC--Cce
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN-----SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TER  395 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  395 (551)
                      .+|.+.+.||+|+||.||++.. .+++.|++|.+...     ..+....+.+|+.++++++||||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4788899999999999999985 46889999988532     122345688999999999999999999998764  457


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++|+||+++++|.+++..   ...+++.....++.|++.+|.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999998863   345889999999999999999999887   99999999999999999999999999986


Q ss_pred             cccCCC-cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          476 FEMDQS-QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       476 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  210 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA  210 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            532111 111223568899999999988889999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.98  E-value=8.5e-32  Score=266.67  Aligned_cols=196  Identities=28%  Similarity=0.463  Sum_probs=170.0

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      .|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++......++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4566788999999999999854 57889999987543 333457889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++++|.+++.    ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++..+....  
T Consensus        85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06642          85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--  155 (277)
T ss_pred             CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence            9999998874    346899999999999999999999887   9999999999999999999999999987654321  


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~  202 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS  202 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCc
Confidence            12223457889999999998899999999999999999999999975

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.98  E-value=1.4e-31  Score=263.93  Aligned_cols=201  Identities=25%  Similarity=0.427  Sum_probs=168.2

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCC----CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      .++|.+.++||+|+||.||+|...+    ...|++|...... ....+.+.+|+.++++++||||+++++++.. ...++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3467888999999999999998543    2468999887654 3445578999999999999999999998865 45789


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+++++|.+++..  ....+++..++.++.+++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++...
T Consensus        84 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          84 VMELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEcCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence            9999999999999864  2346899999999999999999999887   9999999999999999999999999997654


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ..... ......++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus       159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~  211 (270)
T cd05056         159 DESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG  211 (270)
T ss_pred             cccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence            33211 1122334568999999988889999999999999999996 9999853

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.98  E-value=1.7e-31  Score=266.44  Aligned_cols=201  Identities=26%  Similarity=0.409  Sum_probs=167.9

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChh-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++++|...+.||+|+||.||+|.. .+++.|++|++...... ....+.+|+.+++.++|+||+++.+++..+...++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            357899999999999999999984 46889999999755322 2346788999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+. ++|.+++..  ....+.+..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 667666643  2345788889999999999999999987   999999999999999999999999998754322


Q ss_pred             CCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .  .......+++.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~  206 (291)
T cd07870         157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG  206 (291)
T ss_pred             C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            1  112234568899999988754 578899999999999999999999863

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.98  E-value=1.7e-31  Score=266.85  Aligned_cols=198  Identities=29%  Similarity=0.487  Sum_probs=173.9

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .++|...+.||+|+||.||++.. .+++.|++|.+..........+.+|+.++++++||||+++++.+......++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            46888999999999999999984 46789999998765444556788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++.+    ..+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            999999998853    35789999999999999999999987   99999999999999999999999999875543221


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                        ......+++.|++||.+.+..++.++||||||+++|||++|+.||.
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~  216 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL  216 (293)
T ss_pred             --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence              2233468889999999988889999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PTZ00284 protein kinase; Provisional

Probab=99.98  E-value=8.3e-32  Score=286.49  Aligned_cols=199  Identities=22%  Similarity=0.291  Sum_probs=161.0

Q ss_pred             HHhhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC------CCCccceeeEEec
Q 008854          319 IRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ------HRNLVRLLGFSFE  391 (551)
Q Consensus       319 i~~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~  391 (551)
                      +...+++|++.++||+|+||+||++.. ..++.||||+++.... ...++..|+.++..++      |++++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            344568899999999999999999985 4578899999965322 2234555666666654      4568888888876


Q ss_pred             C-CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCCeeeCCCC------
Q 008854          392 E-TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDADM------  463 (551)
Q Consensus       392 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlk~~NIll~~~~------  463 (551)
                      . ...++|||++ +++|.+++.+   ...+++..+..|+.||+.||.|||++ +   ||||||||+|||++.++      
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence            5 4577899987 6778887753   45799999999999999999999974 5   99999999999998765      


Q ss_pred             ----------CeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          464 ----------IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       464 ----------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                                .+||+|||++....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             cccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                      49999999875322     123346799999999999999999999999999999999999999964

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.98  E-value=2.4e-31  Score=262.44  Aligned_cols=194  Identities=31%  Similarity=0.512  Sum_probs=161.2

Q ss_pred             cccCcCCceeEEEeecCC-CC--EEEEEEeecC-ChhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLSH-GQ--EIAVKRLSKN-SVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      +.||+|+||.||+|++.+ +.  .+++|.++.. .......+.+|++++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999998643 43  4688888754 233445788999999999 799999999999999999999999999


Q ss_pred             CChhHHhhhhc-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          405 SSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       405 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                      ++|.+++....             ....+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999986431             1235789999999999999999999877   9999999999999999999999999


Q ss_pred             CccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ++......   ........+..|+|||++....++.++||||||+++|||++ |+.||.
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~  213 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC  213 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            98632211   11111233567999999988899999999999999999997 999884

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.98  E-value=1.7e-31  Score=266.50  Aligned_cols=199  Identities=26%  Similarity=0.438  Sum_probs=167.8

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ++|+..++||+|++|.||++... +++.||+|.+...... ....+.+|++++++++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999854 6789999998754322 223567899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++ +|.+++...  ...+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 898887642  346899999999999999999999987   99999999999999999999999999875432111


Q ss_pred             cccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~  206 (291)
T cd07844         159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG  206 (291)
T ss_pred             --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence              1122346789999998865 4578999999999999999999999853

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=2.2e-31  Score=263.75  Aligned_cols=197  Identities=27%  Similarity=0.444  Sum_probs=172.1

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ..|+..++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45777899999999999999854 57899999987653 34456789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++.    ..++++.....++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++..+.... 
T Consensus        84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06640          84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence            99999999875    246889999999999999999999887   9999999999999999999999999997654322 


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                       .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       156 -~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~  202 (277)
T cd06640         156 -IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS  202 (277)
T ss_pred             -cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCC
Confidence             12233467889999999988889999999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=2.5e-31  Score=260.83  Aligned_cols=194  Identities=28%  Similarity=0.460  Sum_probs=158.6

Q ss_pred             cccCcCCceeEEEeecC----CCCEEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEec-CCceEEEEEccC
Q 008854          330 NKLGQGGFGAVYKGRLS----HGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFE-ETERLLIYEFVP  403 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~~  403 (551)
                      +.||+|+||.||+|...    +...+|+|++... .......+.+|+.+++.++||||+++++++.. +...++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    2357999998643 33345578899999999999999999998764 556789999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc-
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-  482 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-  482 (551)
                      +++|.+++..  ....+.+..++.++.|+++||.|||+.+   ++||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRS--ETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            9999999864  2344678888999999999999999887   999999999999999999999999999754322111 


Q ss_pred             -ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCC-CC
Q 008854          483 -GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK-NN  528 (551)
Q Consensus       483 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~-p~  528 (551)
                       .......++..|+|||.+.+..++.++||||||+++|||++|+. |+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~  203 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY  203 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCC
Confidence             11123345778999999988899999999999999999999654 44

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=2.5e-31  Score=260.09  Aligned_cols=195  Identities=30%  Similarity=0.495  Sum_probs=166.3

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEe-cCCceEEEEEcc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF-EETERLLIYEFV  402 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~  402 (551)
                      ++|.+.+.||+|+||.||++.. .+..+++|.++...  ....+.+|+.++++++|+|++++++++. .....++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            4678889999999999999986 47889999986543  2456889999999999999999999765 455688999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++++|.+++... ....+++..++.++.|++.+|+|||+.+   ++||||||+||++++++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999998643 2345899999999999999999999987   9999999999999999999999999987543221  


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                         ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~  202 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  202 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence               12234568999999998899999999999999999998 8888753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=3e-31  Score=259.66  Aligned_cols=194  Identities=35%  Similarity=0.523  Sum_probs=162.6

Q ss_pred             cccCcCCceeEEEeecC--C--CCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLS--H--GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~--~--g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      ++||+|+||.||+|+..  +  +..+|+|.+..... ....++.+|+.+++++.||||+++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999742  2  26899999976543 34557899999999999999999999875 4567999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc-
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG-  483 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  483 (551)
                      ++|.+++..   ...+++..+..++.|++.+|.|||..+   ++|+||||+|||++.++.+||+|||+++......... 
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            999999874   336899999999999999999999887   9999999999999999999999999998654332211 


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~  201 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE  201 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCccc
Confidence            1111223568999999998999999999999999999998 9999853

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=1.2e-31  Score=264.09  Aligned_cols=197  Identities=35%  Similarity=0.531  Sum_probs=165.1

Q ss_pred             cccCcCCceeEEEeecCC-------CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          330 NKLGQGGFGAVYKGRLSH-------GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~-------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +.||+|+||.||+|+..+       +..+++|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            469999999999998542       2579999886543 23455788999999999999999999999998999999999


Q ss_pred             cCCCChhHHhhhhc----ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC-----CeEEeecCC
Q 008854          402 VPNSSVDKFIFDAI----KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-----IPKISDFGM  472 (551)
Q Consensus       402 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~-----~~kl~Dfgl  472 (551)
                      +++++|.+++....    ....+++.+++.++.|++.+|.|||+.+   ++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999997532    2234789999999999999999999887   99999999999999887     899999999


Q ss_pred             ccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~  215 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP  215 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCc
Confidence            875533222222223345778999999999999999999999999999998 998875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=3.2e-31  Score=260.27  Aligned_cols=199  Identities=29%  Similarity=0.500  Sum_probs=172.6

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChh--cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +|+..++||+|+||.||++.. .+++.|++|.++.....  ....+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            477889999999999999985 46889999999766442  556789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++..   ...+++..+..++.++++||.|||+.+   |+|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999999863   345889999999999999999999987   99999999999999999999999999876543222


Q ss_pred             ccc--ccccccCCCcccccccccCC---CCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGD--TSRIVGTFGYMAPEYVTRGH---FSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ...  .....++..|+|||.+....   .+.++||||||+++|||++|+.||.
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~  207 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS  207 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCcc
Confidence            111  12346788999999988766   8899999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=2.5e-31  Score=265.30  Aligned_cols=210  Identities=28%  Similarity=0.425  Sum_probs=174.8

Q ss_pred             cChhHHHhhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeEEec
Q 008854          314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFE  391 (551)
Q Consensus       314 ~~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  391 (551)
                      +....+..++++|...+.||+|+||.||++.. .+++.+|+|.+..... ....+.+|+.++.++ +||||+++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            44566677789999999999999999999985 4688999999865432 234677899999998 79999999999875


Q ss_pred             C-----CceEEEEEccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCe
Q 008854          392 E-----TERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP  465 (551)
Q Consensus       392 ~-----~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~  465 (551)
                      .     ...++||||+++++|.+++.... ....+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence            3     35789999999999999886432 3456899999999999999999999887   9999999999999999999


Q ss_pred             EEeecCCccccccCCCcccccccccCCCcccccccccC-----CCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-----HFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       466 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ||+|||+++.......  ......++..|+|||.+...     .++.++||||||+++|||++|+.|+.
T Consensus       168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~  234 (291)
T cd06639         168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF  234 (291)
T ss_pred             EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCC
Confidence            9999999876542221  12234678899999987543     36889999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=2e-31  Score=263.52  Aligned_cols=202  Identities=28%  Similarity=0.428  Sum_probs=170.3

Q ss_pred             cCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCChh-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      ++|+....||+|+||.||+++..      +.+.+++|.+...... ...++.+|++++.+++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888999999999999999853      2467999988665433 3457899999999999999999999999988999


Q ss_pred             EEEEccCCCChhHHhhhhccc------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeec
Q 008854          397 LIYEFVPNSSVDKFIFDAIKR------VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF  470 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df  470 (551)
                      +||||+++++|.+++......      ..+++..+..++.|++.+|.|||+.+   |+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998753321      26899999999999999999999987   999999999999999999999999


Q ss_pred             CCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       471 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      |++....... ........++..|+|||.+.+...+.++||||||+++|||++ |..||.
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~  220 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY  220 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            9986443221 112233456778999999988889999999999999999999 777774

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=1.2e-31  Score=266.44  Aligned_cols=197  Identities=24%  Similarity=0.418  Sum_probs=166.3

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +|+..++||+|+||.||+++.. +|+.+|+|+++....  .....+.+|+.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999854 688999999975422  2234678899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      ++ ++|.+++..  ....+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+.... 
T Consensus        81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-  153 (284)
T cd07839          81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-  153 (284)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence            97 477777653  2456899999999999999999999987   9999999999999999999999999997654322 


Q ss_pred             cccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                       .......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+.
T Consensus       154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~  201 (284)
T cd07839         154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  201 (284)
T ss_pred             -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence             112234578899999988764 46899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-32  Score=264.07  Aligned_cols=212  Identities=27%  Similarity=0.356  Sum_probs=177.0

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCC-CCEEEEEEeecCChh---cHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQ---GELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~-g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  397 (551)
                      ..+|..+..||+|+||.|-++..+. .+.+|||++++...-   +.+--+.|-++|... +-|.+++++.+++.-+.+++
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            3468888999999999999997543 467999999887432   222245677777776 47899999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+.+|+|--++++   -..+.+....-++.+||-||-+||+++   ||.||||.+||+||.+|++||+|||+++.--
T Consensus       428 VMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence            9999999999888763   456888889999999999999999998   9999999999999999999999999997421


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCCcCcccHHHHHHh
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSN  545 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~  545 (551)
                        .....+..++|||.|+|||++...+|+...|+|||||+||||+.|+.||+   +|+.+.|..-+-+
T Consensus       502 --~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd---GeDE~elF~aI~e  564 (683)
T KOG0696|consen  502 --FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD---GEDEDELFQAIME  564 (683)
T ss_pred             --cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC---CCCHHHHHHHHHH
Confidence              12234667899999999999999999999999999999999999999997   3444555554443

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.97  E-value=4e-31  Score=262.83  Aligned_cols=198  Identities=26%  Similarity=0.435  Sum_probs=170.0

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +|++.+.||+|++|.||++.. .+++.|++|++....  ......+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            477889999999999999985 468999999997654  22345789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      + +++|.+++..  ....+++.++..++.||+++|.|||+.+   ++|+||||+||++++++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRD--EERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 9999998864  2366999999999999999999999987   99999999999999999999999999986543221


Q ss_pred             cccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                       .......++..|+|||.+.+. .++.++||||+|++++||++|+.++.
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~  202 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP  202 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence             122334688999999988654 46899999999999999999977764

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=3.6e-31  Score=258.80  Aligned_cols=199  Identities=23%  Similarity=0.384  Sum_probs=172.0

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +|++.++||+|+||.||+++. .+++.|++|++...  ......++.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478889999999999999984 46889999998754  233445789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++... ....+++..++.++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            9999999988642 2345789999999999999999999987   99999999999999999999999999976543211


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                        ......|++.|+|||.+.+..++.++||||||++++||++|+.|+.
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~  202 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE  202 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCcc
Confidence              1223457889999999998899999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=2.6e-31  Score=263.74  Aligned_cols=202  Identities=30%  Similarity=0.478  Sum_probs=170.8

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-----CCCEEEEEEeecCChh-cHHHHHHHHHHHhcCCCCCccceeeEEec--CCce
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-----HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFE--ETER  395 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  395 (551)
                      +.|+..+.||+|+||.||++++.     .++.+|+|.++..... ....+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999853     3678999999766443 45679999999999999999999999877  5578


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999998642  336899999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCc-ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          476 FEMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ....... .......++..|++||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~  214 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS  214 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence            6522211 111123445679999999888999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.97  E-value=3.8e-31  Score=262.81  Aligned_cols=201  Identities=30%  Similarity=0.489  Sum_probs=170.4

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      +|+..++||+|++|.||+|+.. +|+.||+|+++..... ....+.+|+.++++++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5788899999999999999964 6889999999765332 3446778999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++ +|.+++........+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++..+..... 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 88888765434457899999999999999999999887   99999999999999999999999999976543211 


Q ss_pred             ccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                       ......++..|++||.+.+. .++.++||||||+++|||++|+.||+..
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  204 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT  204 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence             12234568899999987654 5688999999999999999999998644

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=2.2e-31  Score=261.68  Aligned_cols=198  Identities=27%  Similarity=0.426  Sum_probs=173.1

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ++|+..+.||+|++|.||++... +++.+++|++.... .....++.+|++++++++||||+++++.+......++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35778899999999999999865 58899999987653 33455788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      +++++|.+++...  ...+++..+..++.|++++|.|||+ .+   ++|+||||+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            9999999998642  2678999999999999999999998 66   9999999999999999999999999987553221


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .    ....++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  201 (265)
T cd06605         156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP  201 (265)
T ss_pred             h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence            1    115678899999999999999999999999999999999999854

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=3.4e-31  Score=262.98  Aligned_cols=200  Identities=28%  Similarity=0.436  Sum_probs=164.9

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC-hhcHHHHHHHHHH-HhcCCCCCccceeeEEecCCceEEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLL-VARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ++|++.+.||+|+||.||+++.. +|+.||+|+++... .....++..|+.+ ++.++||||+++++++......++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999854 68999999997653 2334455566665 666789999999999999999999999


Q ss_pred             ccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          401 FVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      |++ ++|.+++.... ....+++..++.++.||+.||.|||++.  +++||||||+||+++.++.+||+|||+++.+...
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            996 68888876432 3456899999999999999999999862  3999999999999999999999999998765322


Q ss_pred             CCcccccccccCCCccccccccc----CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTR----GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .   ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.|+.
T Consensus       158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  208 (283)
T cd06617         158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD  208 (283)
T ss_pred             c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCC
Confidence            1   1223467889999998764    456889999999999999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=6.4e-31  Score=260.46  Aligned_cols=192  Identities=28%  Similarity=0.401  Sum_probs=165.3

Q ss_pred             cCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCCh
Q 008854          332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSV  407 (551)
Q Consensus       332 LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  407 (551)
                      ||+|+||+||++.. .+|+.+++|.+.....   .....+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999974 4688999999865422   2234567899999999999999999999999999999999999999


Q ss_pred             hHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccc
Q 008854          408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR  487 (551)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  487 (551)
                      .+++... ....+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.+||+|||++......   .....
T Consensus        81 ~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~  153 (277)
T cd05577          81 KYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG  153 (277)
T ss_pred             HHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence            9998753 2246899999999999999999999987   999999999999999999999999998765421   11223


Q ss_pred             cccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       488 ~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..++..|++||.+.+..++.++||||||++++||++|+.||..
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  196 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ  196 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence            4578899999999888899999999999999999999999854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=5e-31  Score=259.84  Aligned_cols=201  Identities=26%  Similarity=0.461  Sum_probs=169.3

Q ss_pred             CCCcCcccCcCCceeEEEeecCC--CCEEEEEEeecCC----------hhcHHHHHHHHHHHhc-CCCCCccceeeEEec
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLSH--GQEIAVKRLSKNS----------VQGELEFKNEVLLVAR-LQHRNLVRLLGFSFE  391 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~~--g~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  391 (551)
                      +|++.+.||+|+||.||++....  ++.+|+|.+....          .....++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999654  6789999885321          1223456778888865 799999999999999


Q ss_pred             CCceEEEEEccCCCChhHHhhhh-cccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeec
Q 008854          392 ETERLLIYEFVPNSSVDKFIFDA-IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF  470 (551)
Q Consensus       392 ~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df  470 (551)
                      .+..++||||+++++|.+++... .....+++..+++++.|++.+|.|||+..  +++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999988642 23456899999999999999999999632  3999999999999999999999999


Q ss_pred             CCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       471 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      |++.......   ......++..|++||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~  215 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS  215 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence            9997654322   23345688899999999988899999999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=3.2e-31  Score=263.18  Aligned_cols=208  Identities=30%  Similarity=0.505  Sum_probs=173.6

Q ss_pred             ChhHHHhhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeEEec-
Q 008854          315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFE-  391 (551)
Q Consensus       315 ~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  391 (551)
                      ++.++....+.|+..+.||+|+||.||+++. .+++.+|+|++..... ...++..|+.++.++ +||||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            4455566778999999999999999999985 4678999999866532 334688899999998 69999999999853 


Q ss_pred             -----CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeE
Q 008854          392 -----ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPK  466 (551)
Q Consensus       392 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~k  466 (551)
                           ....+++|||+++++|.+++... ....+++..+..++.||+++|.|||+.+   |+|+||||+||++++++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 34678999999999999988643 3445888889999999999999999987   99999999999999999999


Q ss_pred             EeecCCccccccCCCcccccccccCCCcccccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          467 ISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       467 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      |+|||++.......  .......|++.|+|||.+.     +..++.++||||||+++|||++|+.||.
T Consensus       162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~  227 (282)
T cd06636         162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC  227 (282)
T ss_pred             EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence            99999987543221  1223456889999999875     3467889999999999999999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=3.9e-31  Score=266.95  Aligned_cols=204  Identities=27%  Similarity=0.451  Sum_probs=167.9

Q ss_pred             CCCcCcccCcCCceeEEEeecC---CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecC--CceE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS---HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERL  396 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  396 (551)
                      +|++.++||+|++|.||+|...   +++.||+|.+....   ......+.+|+.++.+++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999864   47899999997743   22334678899999999999999999999887  7789


Q ss_pred             EEEEccCCCChhHHhhhhcc--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC----CCCeEEeec
Q 008854          397 LIYEFVPNSSVDKFIFDAIK--RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA----DMIPKISDF  470 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~----~~~~kl~Df  470 (551)
                      +||||+++ +|.+++.....  ...+++..+..++.||+.||.|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 56666543222  236889999999999999999999987   999999999999999    899999999


Q ss_pred             CCccccccCCC-cccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCC
Q 008854          471 GMARLFEMDQS-QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRI  532 (551)
Q Consensus       471 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~~~  532 (551)
                      |++..+..... ........+++.|+|||.+.+ ..++.++||||||++++||++|+.||....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            99986543222 112334567889999998766 457899999999999999999999997443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=5.8e-31  Score=257.18  Aligned_cols=199  Identities=25%  Similarity=0.443  Sum_probs=171.3

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +|+..+.||+|++|.||++.. .+++.+|+|.+....  ......+.+|++++++++||||+++++.+..+...++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478889999999999999985 467899999987643  23455788999999999999999999999988999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC-CeEEeecCCccccccCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQ  480 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~  480 (551)
                      +++++|.+++... ....+++..+..++.+++++|.|||+.+   ++|+||+|+||++++++ .+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999999753 2445899999999999999999999987   99999999999998654 68999999998654322


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                         ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  203 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA  203 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc
Confidence               22235678899999999988899999999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.97  E-value=2.8e-31  Score=264.26  Aligned_cols=199  Identities=26%  Similarity=0.412  Sum_probs=170.9

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ++|++.++||+|++|.||++... +++.|++|+++...  ......+.+|++++++++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999865 57899999986542  2234578999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |++++.+..+..   +...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999877766553   3455899999999999999999999987   9999999999999999999999999988655332


Q ss_pred             CcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      . .......++..|+|||++.+. .++.++||||||+++|||++|+.|+.
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~  203 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP  203 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            2 122335678899999999887 88999999999999999999998885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=5.1e-31  Score=262.34  Aligned_cols=202  Identities=28%  Similarity=0.486  Sum_probs=176.7

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      +.++.|+..+.||+|++|.||++... +++.+++|++..... ....+.+|++++++++|+||+++++.+......++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            45678889999999999999999975 688999999976654 4567889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++...  ...+++..+..++.|++.+|.|||+.+   |+|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQN--FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            999999999999753  247999999999999999999999977   999999999999999999999999998654322


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..  ......++..|++||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~  218 (286)
T cd06614         170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR  218 (286)
T ss_pred             hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence            11  22234578899999999888899999999999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.1e-33  Score=278.82  Aligned_cols=200  Identities=27%  Similarity=0.414  Sum_probs=174.9

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCC-CCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .+.|+++..||.|+||.|||++.++ +-..|.|++...+.....++.-||+||...+||+||+|++.|..++.+++..||
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            3456778899999999999998654 334677888777777777899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +.||..+.++.+  -...+++.++..++.|++.+|.|||++.   |||||||+.|||++-+|.++|+|||.+.....  .
T Consensus       111 C~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t  183 (1187)
T KOG0579|consen  111 CGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T  183 (1187)
T ss_pred             cCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--H
Confidence            999999999875  4667999999999999999999999998   99999999999999999999999999864321  1


Q ss_pred             cccccccccCCCcccccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ......++|||.|||||+..     ..+|+.++|||||||.|.||..+.+|.+
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh  236 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH  236 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc
Confidence            22344679999999999863     5689999999999999999999999886

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=6.8e-31  Score=256.73  Aligned_cols=199  Identities=35%  Similarity=0.560  Sum_probs=169.4

Q ss_pred             CCcCcccCcCCceeEEEeecCC-----CCEEEEEEeecCChh-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          326 FSTDNKLGQGGFGAVYKGRLSH-----GQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~~-----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      |++.+.||.|+||.||+++..+     +..||+|++...... ....+.+|+.++..++|+||+++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567899999999999998653     378999999765433 4567899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++.... ...+++..+..++.|++.+|.|||+.+   ++|+||||+||++++++.++|+|||+++.....
T Consensus        81 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            9999999999987421 122899999999999999999999987   999999999999999999999999999865533


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ...... ...+++.|+|||.+....++.++||||+|++++||++ |+.|+.
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~  206 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYP  206 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            221111 2236789999999988889999999999999999998 777775

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.6e-31  Score=261.30  Aligned_cols=196  Identities=29%  Similarity=0.499  Sum_probs=169.6

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC-ChhcHHHHHHHHHHHhcCC---CCCccceeeEEecCCceEEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQ---HRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~  399 (551)
                      .|+..+.||+|+||.||+|.. .+++.+++|.+... ......++.+|+.++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477889999999999999985 56889999998754 2334456889999999996   999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..    ..+++...+.++.|++++|.|||+.+   |+|+||+|+||++++++.++|+|||++..+...
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999998753    36899999999999999999999987   999999999999999999999999999765433


Q ss_pred             CCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .  .......|+..|+|||.+.++ .++.++||||||+++|||++|+.||.
T Consensus       155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~  203 (277)
T cd06917         155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYS  203 (277)
T ss_pred             c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCC
Confidence            2  222334688999999988654 56899999999999999999999985

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=7.8e-31  Score=259.84  Aligned_cols=196  Identities=28%  Similarity=0.456  Sum_probs=170.3

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      -|+..++||+|+||.||+|.. .++..+|+|.+.... ......+.+|+.++.+++||||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            467788999999999999985 467899999986543 233456889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++++|.+++.    ...+++..+..++.+++.++.|||+.+   ++|+||+|+||+++.++.++|+|||++..+....  
T Consensus        85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06641          85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  155 (277)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence            9999998875    346899999999999999999999987   9999999999999999999999999987654321  


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  202 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHS  202 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            11223467889999999988889999999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=4.8e-31  Score=258.73  Aligned_cols=192  Identities=27%  Similarity=0.425  Sum_probs=166.7

Q ss_pred             cCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCCh
Q 008854          332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSV  407 (551)
Q Consensus       332 LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  407 (551)
                      ||+|+||.||+++.. +++.+++|.+.....   .....+.+|++++.+++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999965 489999999976543   3455788999999999999999999999999999999999999999


Q ss_pred             hHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC------
Q 008854          408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS------  481 (551)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~------  481 (551)
                      .+++..   ...+++..+..++.|++++|.|||+.+   ++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            999864   247899999999999999999999987   99999999999999999999999999875432211      


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ........++..|++||.......+.++||||||+++|||++|+.||.
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~  202 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH  202 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence            112234567889999999988889999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=8.3e-31  Score=258.79  Aligned_cols=201  Identities=27%  Similarity=0.459  Sum_probs=164.8

Q ss_pred             CCcCcccCcCCceeEEEeecC----CCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCC------
Q 008854          326 FSTDNKLGQGGFGAVYKGRLS----HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEET------  393 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~----~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  393 (551)
                      |.+.+.||+|+||.||+|.+.    .++.||||++....  .....++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566789999999999999753    36789999997642  334557889999999999999999999886532      


Q ss_pred             ceEEEEEccCCCChhHHhhhhc---ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeec
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF  470 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df  470 (551)
                      ..++++||+++++|.+++....   +...+++...+.++.|++.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2368899999999998875321   1235789999999999999999999887   999999999999999999999999


Q ss_pred             CCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       471 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      |+++...............+++.|++||.+....++.++||||||+++|||++ |+.|+.
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~  217 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA  217 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCC
Confidence            99986543322222223345678999999998889999999999999999999 888875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.97  E-value=5.1e-31  Score=263.90  Aligned_cols=197  Identities=29%  Similarity=0.469  Sum_probs=167.4

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh-----cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ-----GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      +|+..+.||+|++|.||+|... +++.|++|++......     ....+.+|+.++++++|+||+++++++......++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999854 6889999999765432     234577899999999999999999999998899999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+ +++|.+++...  ...+++..+..++.||++||.|||+.+   |+|+||+|+||+++.++.+||+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 99999998642  236999999999999999999999987   99999999999999999999999999976543


Q ss_pred             CCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ..  .......+++.|+|||.+.+ ..++.++||||||+++|||++|..+|.
T Consensus       155 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~  204 (298)
T cd07841         155 PN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP  204 (298)
T ss_pred             CC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcccc
Confidence            21  11223356788999998854 467899999999999999999977664

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=7.7e-31  Score=261.07  Aligned_cols=196  Identities=27%  Similarity=0.456  Sum_probs=171.3

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccC
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      .|...++||+|++|.||++.. .+++.+++|++..........+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            455568999999999999984 4688999999876555555678899999999999999999999999999999999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      +++|.+++..    ..+++..+..++.|++.+|.|||+.+   |+||||+|+||+++.++.++|+|||++........  
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            9999998863    46899999999999999999999987   99999999999999999999999998875443221  


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~  216 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYF  216 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCc
Confidence            1223468899999999988889999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=1.8e-31  Score=261.53  Aligned_cols=188  Identities=24%  Similarity=0.398  Sum_probs=158.9

Q ss_pred             cccCcCCceeEEEeecCC--------CCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          330 NKLGQGGFGAVYKGRLSH--------GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +.||+|+||.||+|....        ..++++|.+..........+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            479999999999997532        235888888765555556788999999999999999999999998999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC--------eEEeecCCc
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI--------PKISDFGMA  473 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~--------~kl~Dfgla  473 (551)
                      +++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKK--NKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999874  2346899999999999999999999987   999999999999987765        699999988


Q ss_pred             cccccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCC-CCC
Q 008854          474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQ-KNN  528 (551)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~-~p~  528 (551)
                      .....      .....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~  206 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL  206 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence            64321      223457889999999876 45789999999999999999995 454

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=7.3e-31  Score=264.08  Aligned_cols=196  Identities=30%  Similarity=0.451  Sum_probs=166.9

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      ..+.|+..++||+|+||+||+++.. +++.||+|++....   .....++.+|+++++.++||||+++.+++......++
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            3456888999999999999999854 68899999986442   2233568899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||++ ++|.+++..  ....+++..+..++.|++.+|.|||+.+   |+|+||+|+||++++++.+||+|||++....
T Consensus        93 v~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          93 VMEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             EHHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            999997 566666543  2346899999999999999999999987   9999999999999999999999999987543


Q ss_pred             cCCCcccccccccCCCcccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ..      ....++..|+|||.+.   ...++.++||||||+++|||++|+.|+.
T Consensus       167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~  215 (307)
T cd06607         167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (307)
T ss_pred             CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence            21      2345788999999874   4568899999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=8.6e-31  Score=259.87  Aligned_cols=190  Identities=28%  Similarity=0.403  Sum_probs=157.5

Q ss_pred             ccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHH---HhcCCCCCccceeeEEecCCceEEEEEccC
Q 008854          331 KLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLL---VARLQHRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       331 ~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      .||+|+||.||++.. .+++.+|+|.+.+...   .....+.+|..+   +...+||||+.+.+.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999985 4688999999865422   122234444443   334479999999999999899999999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      +++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||||+|||+++++.++|+|||++......    
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----  150 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----  150 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc----
Confidence            9999998863   456999999999999999999999987   999999999999999999999999998754321    


Q ss_pred             cccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  198 (279)
T cd05633         151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ  198 (279)
T ss_pred             CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence            1223468999999998864 5688999999999999999999999963

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=7.6e-31  Score=261.67  Aligned_cols=199  Identities=28%  Similarity=0.403  Sum_probs=168.8

Q ss_pred             CCCcCcccCcCCceeEEEeec----CCCCEEEEEEeecCCh----hcHHHHHHHHHHHhcC-CCCCccceeeEEecCCce
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSV----QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETER  395 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  395 (551)
                      +|++.+.||+|+||.||+++.    .+|+.||+|++.....    .....+.+|+.++.++ +|+||+++.+++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999975    3688999999976422    2234678899999999 599999999999988889


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++||||+++++|.+++..   ...+++..+..++.|++++|.|||+.+   ++||||+|+|||+++++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999999863   456889999999999999999999987   99999999999999999999999999976


Q ss_pred             cccCCCcccccccccCCCcccccccccC--CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          476 FEMDQSQGDTSRIVGTFGYMAPEYVTRG--HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...... .......|+..|+|||.+...  .++.++||||||+++|||++|+.|+..
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  210 (290)
T cd05613         155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV  210 (290)
T ss_pred             cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence            543221 122345688999999988753  467899999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=5.4e-31  Score=257.44  Aligned_cols=193  Identities=33%  Similarity=0.556  Sum_probs=165.1

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccC
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      ++|++.+.||+|+||.||++.. .++.+|+|.++...  ....+.+|+.++.+++||||+++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4578889999999999999975 67889999986543  234788999999999999999999998654 5789999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      +++|.+++... ....+++..++.++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++......    
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            99999998753 3346899999999999999999999887   999999999999999999999999998753321    


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                       ......+..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~  199 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYP  199 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCc
Confidence             112234568999999998899999999999999999998 888875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=1.2e-30  Score=259.85  Aligned_cols=201  Identities=27%  Similarity=0.387  Sum_probs=171.1

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecC--CceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~  399 (551)
                      ++|+..++||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++...  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999964 578899999975432 3455789999999999999999999988654  3578999


Q ss_pred             EccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          400 EFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      ||+++++|.+++.... ....+++..+..++.||+.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            9999999999876432 3456889999999999999999999987   99999999999999999999999999865432


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ..    .....++..|++||.+.+..++.++||||||+++|||++|+.|+...
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            21    12345688999999999999999999999999999999999998744

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=5.8e-31  Score=261.57  Aligned_cols=199  Identities=27%  Similarity=0.465  Sum_probs=167.9

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +|+..+.||+|++|.||+++.. +++.||||++.....  .....+.+|++++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999854 688999999865432  2234688999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +. ++|.+++... ....+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-  154 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  154 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence            96 6888887643 3456899999999999999999999887   9999999999999999999999999987653221 


Q ss_pred             cccccccccCCCcccccccccCC-CCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                       .......+++.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~  203 (284)
T cd07860         155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG  203 (284)
T ss_pred             -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence             1122335688999999887644 58899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=1.3e-30  Score=253.31  Aligned_cols=199  Identities=31%  Similarity=0.530  Sum_probs=175.6

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccC
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      .|+..+.||+|++|.||++... +++.+++|++..........+.+|++++++++||||+++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677899999999999999865 688999999977655556689999999999999999999999999999999999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      +++|.+++...  ...+++..+..++.|++++|.+||+.+   ++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            99999988642  257899999999999999999999976   99999999999999999999999999876543221  


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                       .....++..|++||.+....++.++||||||++++||++|+.|+...
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  200 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL  200 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence             33456888999999998888999999999999999999999998643

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=9.1e-31  Score=256.99  Aligned_cols=191  Identities=27%  Similarity=0.401  Sum_probs=167.3

Q ss_pred             cCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCCh
Q 008854          332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSV  407 (551)
Q Consensus       332 LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  407 (551)
                      ||.|++|.||+++.. +++.+++|++.+...   .....+.+|+.+++.++||||+++++.+.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999964 488999999976432   2345789999999999999999999999999999999999999999


Q ss_pred             hHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccc
Q 008854          408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR  487 (551)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  487 (551)
                      .+++..   ...+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++.......   ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            999864   345899999999999999999999987   9999999999999999999999999998654322   2233


Q ss_pred             cccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       488 ~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ..+++.|++||.+.+..++.++|+||||+++|||++|+.|+...
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  195 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED  195 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCC
Confidence            46788999999998888999999999999999999999999644

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=6.2e-32  Score=267.64  Aligned_cols=193  Identities=28%  Similarity=0.458  Sum_probs=169.9

Q ss_pred             CcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCC
Q 008854          329 DNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS  405 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  405 (551)
                      .+.||.|.||+||-|+. ++|+.||||++.+.  ..+.+..+.+|+.||.+++||.||.+.--|+..+..++|||-+.+.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            47899999999999984 57999999999775  3455668999999999999999999999999999999999999777


Q ss_pred             ChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC---CCeEEeecCCccccccCCCc
Q 008854          406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~kl~Dfgla~~~~~~~~~  482 (551)
                      -|+-+|..  ....+++.....++.||+.||.|||.++   |+|.||||+||||.+.   -.+||+|||+++++....  
T Consensus       649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--  721 (888)
T KOG4236|consen  649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--  721 (888)
T ss_pred             HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence            77776654  4567888888889999999999999988   9999999999999654   379999999999876443  


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                       ....++||+.|+|||++..+.|...-|+||.|||+|--++|..||.
T Consensus       722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN  767 (888)
T KOG4236|consen  722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN  767 (888)
T ss_pred             -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence             2345789999999999999999999999999999999999999984

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=1.3e-30  Score=255.73  Aligned_cols=205  Identities=27%  Similarity=0.448  Sum_probs=171.3

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEec--CCceEEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFE--ETERLLIY  399 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~  399 (551)
                      +|++.+.||.|+||.||++.. .+++.+++|.+....  ......+.+|+.++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999984 467899999987542  2334568899999999999999999998764  34578999


Q ss_pred             EccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          400 EFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      ||+++++|.+++.... ....+++..++.++.||+.||.|||..+  ..+++|+||+|+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            9999999999986532 2467899999999999999999999332  234999999999999999999999999999865


Q ss_pred             ccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      .....  ......+++.|+|||.+.+..++.++||||||+++|+|++|+.|+...
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  213 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR  213 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence            43321  122346889999999999888999999999999999999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9.1e-31  Score=258.36  Aligned_cols=203  Identities=31%  Similarity=0.490  Sum_probs=171.8

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeEEecCC-----
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEET-----  393 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  393 (551)
                      ..+++|++.+.||+|++|.||++... +++.+++|++..... ....+.+|+.+++++ +||||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            45789999999999999999999864 578899999876543 345789999999999 6999999999997644     


Q ss_pred             -ceEEEEEccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          394 -ERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       394 -~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                       ..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             3789999999999999886532 2467899999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCCCcccccccccCCCccccccccc-----CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-----GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ++.......  .......++..|+|||.+..     ..++.++||||||++++||++|+.||.
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  219 (275)
T cd06608         159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC  219 (275)
T ss_pred             cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcc
Confidence            987543221  12233468889999998753     356789999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=3.7e-31  Score=282.85  Aligned_cols=202  Identities=23%  Similarity=0.396  Sum_probs=157.8

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCC--CCEEEEE--------------Eeec---CChhcHHHHHHHHHHHhcCCCCCc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSH--GQEIAVK--------------RLSK---NSVQGELEFKNEVLLVARLQHRNL  382 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~--g~~vavK--------------~~~~---~~~~~~~~~~~E~~~l~~l~h~ni  382 (551)
                      ..++|++.++||+|+||+||++....  +...++|              .+.+   ........+.+|+.++.+++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            34689999999999999999986432  1122222              1111   111223457899999999999999


Q ss_pred             cceeeEEecCCceEEEEEccCCCChhHHhhhhcc--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC
Q 008854          383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIK--RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD  460 (551)
Q Consensus       383 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~  460 (551)
                      +++++++...+..++|+|++. ++|.+++.....  ...........++.||+.||.|||+.+   |+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence            999999999999999999985 466666643211  122345667889999999999999987   99999999999999


Q ss_pred             CCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          461 ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       461 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                      .++.+||+|||+++.+..... .......||..|+|||.+.+..++.++|||||||++|||++|+.++
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            999999999999986643221 2223457999999999999999999999999999999999998644

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=1.1e-30  Score=260.98  Aligned_cols=194  Identities=27%  Similarity=0.439  Sum_probs=168.8

Q ss_pred             cCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCC
Q 008854          328 TDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSS  406 (551)
Q Consensus       328 ~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  406 (551)
                      ...+||+|+||.||++.. .+++.||+|++..........+.+|+.+++.++|+||+++++.+...+..++||||+++++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            346899999999999985 4688999999866554555678999999999999999999999999999999999999999


Q ss_pred             hhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccccc
Q 008854          407 VDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS  486 (551)
Q Consensus       407 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  486 (551)
                      |.+++.    ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ...
T Consensus       104 L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~  174 (292)
T cd06657         104 LTDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRK  174 (292)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--ccc
Confidence            998774    345899999999999999999999987   99999999999999999999999999875432221  123


Q ss_pred             ccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       487 ~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...+++.|++||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~  218 (292)
T cd06657         175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN  218 (292)
T ss_pred             ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            34678999999999888899999999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=1e-30  Score=261.18  Aligned_cols=200  Identities=25%  Similarity=0.415  Sum_probs=168.4

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh--cHHHHHHHHHHHhcCCCCCccceeeEEecC--CceEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERLLI  398 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV  398 (551)
                      ++|+..+.||+|+||.||+|... +++.+++|.++.....  ....+.+|+.++.+++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999865 5789999999755322  223567899999999999999999998877  789999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++ +|.+++..  ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+..
T Consensus        85 ~e~~~~-~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMET--MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999974 88888764  2346899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ..  .......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||...
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~  210 (293)
T cd07843         159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK  210 (293)
T ss_pred             Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            21  122334578899999988654 4689999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=1.3e-30  Score=262.34  Aligned_cols=201  Identities=26%  Similarity=0.460  Sum_probs=165.1

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCC-------
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEET-------  393 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  393 (551)
                      ++|+..++||+|+||.||++... +++.||||++.....  .....+.+|+.++++++||||+++++++....       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            57899999999999999999854 688999999865422  22335678999999999999999999987654       


Q ss_pred             -ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCC
Q 008854          394 -ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM  472 (551)
Q Consensus       394 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl  472 (551)
                       ..++||||+.+ +|.+++..  ....+++.++..++.||++||.|||+.+   ++|+||||+||+++.++.+||+|||+
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence             34899999975 77777653  2346899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCCCc--ccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          473 ARLFEMDQSQ--GDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       473 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +..+......  .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~  226 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG  226 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            9865432221  112234578899999988664 478899999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=5.2e-32  Score=252.97  Aligned_cols=202  Identities=28%  Similarity=0.428  Sum_probs=166.2

Q ss_pred             cCCCcCcccCcCCceeEEEeecCC-----CCEEEEEEeecCChhc--HHHHHHHHHHHhcCCCCCccceeeEEec-CCce
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSH-----GQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQHRNLVRLLGFSFE-ETER  395 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~-----g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  395 (551)
                      ..|+...+||+|.||.|||+.-.+     .+++|+|+++......  .....+|+.+++.++||||+.|..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            467888999999999999996322     2369999997653221  2357899999999999999999999877 7788


Q ss_pred             EEEEEccCCCChhHHhhh--hcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC----CCeEEee
Q 008854          396 LLIYEFVPNSSVDKFIFD--AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD----MIPKISD  469 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~----~~~kl~D  469 (551)
                      +|++||.+.. |..+++-  ..+...++......|+.||+.|+.|||++.   |+||||||.||||..+    |.+||+|
T Consensus       104 ~l~fdYAEhD-L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEHD-LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhhh-HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            9999999874 5555542  223467899999999999999999999999   9999999999999877    8999999


Q ss_pred             cCCccccccCCCcc-cccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          470 FGMARLFEMDQSQG-DTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       470 fgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ||+++++...-... ....++-|..|.|||.+.+. .||.+.|||++|||+.||++-++-|.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~  241 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK  241 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence            99999886432222 34456779999999998874 79999999999999999999987774

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=2.2e-30  Score=258.82  Aligned_cols=200  Identities=27%  Similarity=0.415  Sum_probs=165.1

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCC-CCCccceeeEEecCCc-----
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETE-----  394 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  394 (551)
                      ++|++.+.||+|+||.||++... +++.||+|+++....  .....+.+|+.+++.++ ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999854 688999999865432  22346888999999995 6999999999877655     


Q ss_pred             eEEEEEccCCCChhHHhhhhcc--cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC-CCCeEEeecC
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIK--RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFG  471 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~Dfg  471 (551)
                      .++||||+++ +|.+++.....  ...+++..++.++.||++||.|||+.+   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 78888764322  346899999999999999999999987   999999999999998 8899999999


Q ss_pred             CccccccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      +++.+.....  ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~  213 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP  213 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence            9876532211  1122356788999998865 457899999999999999999999885

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=2.4e-30  Score=255.02  Aligned_cols=195  Identities=21%  Similarity=0.325  Sum_probs=162.2

Q ss_pred             HhhhcCCCcCccc--CcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCce
Q 008854          320 RDATNNFSTDNKL--GQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETER  395 (551)
Q Consensus       320 ~~~~~~f~~~~~L--G~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  395 (551)
                      ....++|++.+.+  |+|+||.||++.. .++..+|+|.+........     |+.....+ +||||+++++.+...+..
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            3445677777776  9999999999984 4678899999875432211     22222212 799999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC-CeEEeecCCcc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMAR  474 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~  474 (551)
                      ++||||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++ .++|+|||+++
T Consensus        85 ~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~  158 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK  158 (267)
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence            999999999999999864   347999999999999999999999987   99999999999999998 99999999987


Q ss_pred             ccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      .....      ....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       159 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  209 (267)
T PHA03390        159 IIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED  209 (267)
T ss_pred             ecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            54322      2245788999999999999999999999999999999999999733

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=2.5e-30  Score=256.40  Aligned_cols=191  Identities=29%  Similarity=0.408  Sum_probs=158.4

Q ss_pred             ccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHH---HHHhcCCCCCccceeeEEecCCceEEEEEccC
Q 008854          331 KLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEV---LLVARLQHRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       331 ~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      .||+|+||.||++.. .+++.||+|.+.+...   .....+.+|.   .++....||+|+++++.+......++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999985 4588999999876432   1122233443   34455689999999999999999999999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      +++|..++.   +...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++..+...    
T Consensus        81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----  150 (278)
T cd05606          81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----  150 (278)
T ss_pred             CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence            999998875   3457999999999999999999999987   999999999999999999999999998754322    


Q ss_pred             cccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ......|+..|+|||.+.++ .++.++||||+|+++|||++|+.||...
T Consensus       151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence            12234689999999998754 6899999999999999999999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.7e-32  Score=262.50  Aligned_cols=206  Identities=29%  Similarity=0.381  Sum_probs=171.1

Q ss_pred             hhhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCC-hhcH------HHHHHHHHHHhcCCCCCccceeeEEec-
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNS-VQGE------LEFKNEVLLVARLQHRNLVRLLGFSFE-  391 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~-~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~-  391 (551)
                      ...++|-++++||+|||++|||+. +...+-||||+-..+. +.++      +...+|.+|.+.|+||.||++++++.- 
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            345788889999999999999997 5556778999864432 2221      235789999999999999999999864 


Q ss_pred             CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC---CCCeEEe
Q 008854          392 ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKIS  468 (551)
Q Consensus       392 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~  468 (551)
                      .+.++-|+||+++.+|+-+|..   ...+++.+...|+.||+.+|.||.+.. +||||-||||.||||-.   -|.+||.
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             cccceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence            5567899999999999999973   466899999999999999999999875 78999999999999943   4689999


Q ss_pred             ecCCccccccCCCc-----ccccccccCCCccccccccc----CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          469 DFGMARLFEMDQSQ-----GDTSRIVGTFGYMAPEYVTR----GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       469 Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ||||+++++.+...     .-++...||..|++||.+.-    .+++.|.||||+|||+|..+.|++||..
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh  686 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH  686 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence            99999988754332     12556789999999997743    3578899999999999999999999964

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-30  Score=257.72  Aligned_cols=197  Identities=29%  Similarity=0.480  Sum_probs=166.4

Q ss_pred             CCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          326 FSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      |+..++||.|++|.||++.. .+|..||+|++.....  .....+.+|++++++++||||+++++++......++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            56778999999999999985 4789999999975532  22346889999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      + ++|.+++... ....+++..++.++.|++++|.|||+.+   ++|+||+|+||+++.++.++|+|||+++....... 
T Consensus        81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  154 (283)
T cd07835          81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-  154 (283)
T ss_pred             C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence            5 6898888642 2246899999999999999999999987   99999999999999999999999999975532211 


Q ss_pred             ccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                       ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  201 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP  201 (283)
T ss_pred             -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence             11223568899999987664 57899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=2.5e-30  Score=252.44  Aligned_cols=201  Identities=29%  Similarity=0.463  Sum_probs=175.0

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecC--CceEEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERLLIY  399 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~  399 (551)
                      +|...+.||+|++|.||+|... +++.|++|++.....  .....+.+|+.++++++||||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677899999999999999865 688999999976542  4456789999999999999999999999888  7889999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..   ...+++..+..++.|++++|.|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            99999999999864   238999999999999999999999977   999999999999999999999999999876543


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ..........++..|++||.+.....+.++||||||++++||++|+.|+...
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL  206 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            3211133456788999999998888999999999999999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=1.5e-30  Score=254.43  Aligned_cols=199  Identities=25%  Similarity=0.441  Sum_probs=170.6

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +|...+.||+|+||.||++... +|..+|+|.+....  ......+.+|+.++++++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999864 57899999986542  23345688999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC-CeEEeecCCccccccCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQ  480 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~  480 (551)
                      +++++|.+++... ....+++..+..++.|++++|.|||+.+   ++|+||||+||++++++ .+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999988642 2345899999999999999999999987   99999999999999886 46999999987654322


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .  ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  203 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE  203 (257)
T ss_pred             c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            1  1223458889999999988889999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=2.1e-30  Score=266.07  Aligned_cols=197  Identities=29%  Similarity=0.381  Sum_probs=166.5

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecC------
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------  392 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  392 (551)
                      ..++|+..+.||+|+||.||+++. .+++.||+|++.+.  .......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999984 46899999998653  223344677899999999999999999988643      


Q ss_pred             CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCC
Q 008854          393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM  472 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl  472 (551)
                      ...++||||+.+ +|.+.+..     .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            246899999964 77776642     2888999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ++......   ......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  219 (353)
T cd07850         165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG  219 (353)
T ss_pred             ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence            98654321   12334678899999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=2.1e-30  Score=261.05  Aligned_cols=200  Identities=27%  Similarity=0.446  Sum_probs=166.5

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh--cHHHHHHHHHHHhcCCCCCccceeeEEecC--CceEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERLL  397 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  397 (551)
                      .++|++.+.||+|+||.||++... +|+.||+|+++.....  ....+.+|+.++.+++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467899999999999999999854 5899999998754322  123567899999999999999999998765  45789


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+.+ +|.+++..  ....+++..+..++.||++||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDN--MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 78887764  2356899999999999999999999987   9999999999999999999999999998654


Q ss_pred             cCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...  .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~  211 (309)
T cd07845         160 LPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG  211 (309)
T ss_pred             Ccc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            322  11222345788999998865 4678999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-30  Score=265.81  Aligned_cols=200  Identities=25%  Similarity=0.424  Sum_probs=165.6

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCC-----c
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEET-----E  394 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~  394 (551)
                      .+++|++.++||+|+||.||+|+. .+++.||+|+++... ......+.+|+.++++++||||+++++++....     .
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            357899999999999999999984 468999999996532 223456788999999999999999999876543     4


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .++|+||+++ +|.+++.    ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        83 ~~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          83 VYIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence            7899999975 6666653    456899999999999999999999987   9999999999999999999999999987


Q ss_pred             ccccCCCc-ccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          475 LFEMDQSQ-GDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       475 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ........ .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~  211 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP  211 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            65432211 11233568899999998754 568999999999999999999999985

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.1e-30  Score=252.92  Aligned_cols=188  Identities=26%  Similarity=0.354  Sum_probs=159.6

Q ss_pred             cccCcCCceeEEEeec-CCCCEEEEEEeecCChh---cHHHHHHHHHH-HhcCCCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---GELEFKNEVLL-VARLQHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      +.||+|++|.||++.. .+++.||+|.+.+....   ....+..|..+ ....+|||++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999985 46889999999764322   22234445444 4556899999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      ++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++....      
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            999999863   356899999999999999999999987   99999999999999999999999999875332      


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .....++..|++||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  194 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH  194 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCC
Confidence            223467889999999988888999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=2.6e-30  Score=258.30  Aligned_cols=200  Identities=28%  Similarity=0.444  Sum_probs=165.1

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ++|+..+.||+|++|+||+|+.. +++.||+|++.....  .....+.+|++++++++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999864 688999999865432  223468899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC-CCCeEEeecCCccccccC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEMD  479 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~Dfgla~~~~~~  479 (551)
                      |++ ++|.+++... ....+++..+..++.||+.||.|||+.+   ++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 4777776432 2334678888999999999999999987   999999999999985 567999999999764322


Q ss_pred             CCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .  .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~  206 (294)
T PLN00009        157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG  206 (294)
T ss_pred             c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            1  11223456889999998866 4578999999999999999999999863

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=2.3e-30  Score=258.82  Aligned_cols=203  Identities=18%  Similarity=0.238  Sum_probs=153.5

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCCC----CEEEEEEeecCChh--cH---------HHHHHHHHHHhcCCCCCcccee
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSHG----QEIAVKRLSKNSVQ--GE---------LEFKNEVLLVARLQHRNLVRLL  386 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~g----~~vavK~~~~~~~~--~~---------~~~~~E~~~l~~l~h~niv~l~  386 (551)
                      ..++|.+.++||+|+||.||+|...+.    ..+++|+.......  .+         .....+...+..++|+|+++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            346899999999999999999986543    45666654322211  11         1122344456677999999999


Q ss_pred             eEEecCC----ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC
Q 008854          387 GFSFEET----ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD  462 (551)
Q Consensus       387 ~~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~  462 (551)
                      +++....    ..++++|++.. ++.+.+..   ....++..+..++.|+++||.|||+.+   |+||||||+|||++.+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~  162 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN  162 (294)
T ss_pred             EeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence            9766543    23577777643 45555432   234578889999999999999999987   9999999999999999


Q ss_pred             CCeEEeecCCccccccCCCc-----ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          463 MIPKISDFGMARLFEMDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       463 ~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      +.++|+|||+++.+......     .......||+.|+|||...+..++.++||||||+++|||++|+.||...
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~  236 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF  236 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            99999999999866432211     1122346999999999999999999999999999999999999999644

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=4.7e-30  Score=259.43  Aligned_cols=193  Identities=30%  Similarity=0.466  Sum_probs=164.8

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .|...+.||+|+||.||+++. .++..+|+|++.....   .....+.+|+.++++++|||++++++++..+...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            367788999999999999985 4688999999875422   233468899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++ +|.+++..  ....+++.++..++.+++.+|.|||+.+   |+|+||+|+||+++.++.+||+|||++.....  
T Consensus       106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            9975 77776643  3456899999999999999999999987   99999999999999999999999999865332  


Q ss_pred             CcccccccccCCCcccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                          .....+++.|+|||.+.   .+.++.++||||||+++|||++|+.|+.
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~  225 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  225 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence                22346788999999873   4578899999999999999999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.9e-30  Score=250.10  Aligned_cols=197  Identities=31%  Similarity=0.495  Sum_probs=173.1

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +|++.++||+|++|.||+++.. +++.+++|.+.....  .....+.+|++++.+++|||++++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999854 678999999977654  3455789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++..   ...+++..+..++.|++.+|.|||+.+   |+|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            999999998864   367899999999999999999999887   99999999999999999999999999986543222


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                        ......++..|+|||.+.+..++.++||||+|+++|||++|+.|+.
T Consensus       155 --~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~  200 (254)
T cd06627         155 --DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYY  200 (254)
T ss_pred             --cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence              1233467889999999988888999999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=2.8e-30  Score=256.62  Aligned_cols=198  Identities=26%  Similarity=0.470  Sum_probs=167.1

Q ss_pred             CCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecC--CceEEEEE
Q 008854          326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERLLIYE  400 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e  400 (551)
                      |++.++||+|++|.||+++.. +++.+|+|++....  ......+.+|+.++++++|||++++++++...  ...++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999865 57899999998763  23345688999999999999999999999887  78999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++ +|.+++...  ...+++..++.++.||++||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9985 888877542  257899999999999999999999987   9999999999999999999999999998654332


Q ss_pred             CcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      . .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+.
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~  204 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG  204 (287)
T ss_pred             c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            1 11223456788999997764 4678999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=2e-30  Score=264.47  Aligned_cols=201  Identities=26%  Similarity=0.421  Sum_probs=166.9

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecC--ChhcHHHHHHHHHHHhcC-CCCCccceeeEEecC--Cce
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN--SVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEE--TER  395 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~  395 (551)
                      ..++|++.+.||+|+||.||+|... +++.+|+|++...  .......+.+|+.++.++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4567889999999999999999864 5789999998643  223344677899999999 999999999988654  357


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++||||++ ++|..++..    ..+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            89999997 588887753    27889999999999999999999987   99999999999999999999999999986


Q ss_pred             cccCCCc---ccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          476 FEMDQSQ---GDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       476 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .......   .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~  215 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG  215 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence            5433211   12234568899999998765 5678899999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=1.8e-30  Score=257.04  Aligned_cols=201  Identities=29%  Similarity=0.453  Sum_probs=174.1

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV  398 (551)
                      ++|.+.+.||+|++|.||++... +++.|++|++.+..   ......+.+|..++.+++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888899999999999999854 68999999987632   233456889999999998 99999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|.+++..   ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999999864   347999999999999999999999987   99999999999999999999999999876543


Q ss_pred             CCC------------------cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQS------------------QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...                  ........++..|++||.+....++.++||||||++++||++|+.|+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  224 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG  224 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence            221                  1222345678999999999888899999999999999999999999864

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-32  Score=296.65  Aligned_cols=206  Identities=29%  Similarity=0.463  Sum_probs=174.9

Q ss_pred             HHHhhhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 008854          318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETE  394 (551)
Q Consensus       318 ~i~~~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  394 (551)
                      .++..+-++....+||.|.||.||-+. .++|...|||-++....  .......+|+.++..++|||+|+.+|+-.+++.
T Consensus      1229 ~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1229 SLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred             HhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence            344556788888999999999999998 56788899998865432  334467899999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .+|.|||+++|+|.+.+..   ....++.....+..|++.|+.|||+++   ||||||||.||+|+.+|.+|++|||.|.
T Consensus      1309 v~IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred             HHHHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccccee
Confidence            9999999999999999863   344566667778899999999999998   9999999999999999999999999998


Q ss_pred             ccccCC--CcccccccccCCCcccccccccCC---CCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          475 LFEMDQ--SQGDTSRIVGTFGYMAPEYVTRGH---FSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       475 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .+....  .........||+-|||||++.+..   ..-+.||||+|++++||+||++||.
T Consensus      1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~ 1442 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWA 1442 (1509)
T ss_pred             EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchh
Confidence            765432  123345678999999999997643   3568999999999999999999996

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=3.4e-30  Score=258.37  Aligned_cols=203  Identities=25%  Similarity=0.437  Sum_probs=167.6

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCC----
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEET----  393 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  393 (551)
                      ...++|++.++||+|+||.||+|... +++.||+|+++....  .....+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34578999999999999999999964 588999999975432  23346788999999999999999999887654    


Q ss_pred             ------ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEE
Q 008854          394 ------ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI  467 (551)
Q Consensus       394 ------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl  467 (551)
                            ..++|+||+++ +|...+..  ....+++..+..++.||+.||.|||+.+   |+|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  68899999986 66666653  2346899999999999999999999987   999999999999999999999


Q ss_pred             eecCCccccccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       468 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +|||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~  220 (302)
T cd07864         158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA  220 (302)
T ss_pred             CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            99999986543221 11222345778999998765 4578999999999999999999998863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=5.6e-30  Score=249.98  Aligned_cols=202  Identities=23%  Similarity=0.403  Sum_probs=175.9

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +|...+.||.|++|.||++... +++.+++|++.....  .....+.+|++++++++|||++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999854 588999999976533  4456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          402 VPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       402 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      +++++|.+++.... ....+++..+..++.++++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999987532 2467999999999999999999999987   9999999999999999999999999997654332


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                        .......|++.|+|||.+.+..++.++||||+|+++++|++|+.|+...
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  206 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE  206 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence              1223346888999999998888999999999999999999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.97  E-value=2.1e-30  Score=258.09  Aligned_cols=199  Identities=29%  Similarity=0.437  Sum_probs=163.5

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEEEc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +|...++||+|+||.||++.. .+++.+|+|++.... ......+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            455678999999999999985 468899999987543 234457889999999996 99999999999998899999999


Q ss_pred             cCCCChhHHhhh--hcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          402 VPNSSVDKFIFD--AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       402 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      +.. +|.++...  ......+++..+..++.+++.||.|||+..  +|+||||||+||+++.++.+||+|||+++.+...
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 55443321  113467899999999999999999999752  3999999999999999999999999999754322


Q ss_pred             CCcccccccccCCCcccccccccC---CCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRG---HFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .   ......|++.|+|||.+.+.   .++.++||||||+++|||++|+.||.
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  211 (288)
T cd06616         162 I---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP  211 (288)
T ss_pred             C---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence            1   12233578899999998766   68999999999999999999999985

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.97  E-value=5.4e-30  Score=254.15  Aligned_cols=195  Identities=25%  Similarity=0.385  Sum_probs=161.5

Q ss_pred             CCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCC-CCCccceeeEEecC--CceEEEEE
Q 008854          326 FSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQ-HRNLVRLLGFSFEE--TERLLIYE  400 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~e  400 (551)
                      |++.++||+|+||.||++.. .+++.+|+|+++.... .......+|+.++.++. ||||+++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            56778999999999999984 4688999999876422 22234557888888885 99999999999887  78899999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |++ ++|.+++..  ....+++..+..++.|++.||.|||+.+   ++||||+|+||+++. +.+||+|||+++......
T Consensus        81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 577777754  2356899999999999999999999987   999999999999999 999999999998654322


Q ss_pred             CcccccccccCCCcccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .   .....++..|+|||.+. ++.++.++|||||||++|||++|+.||..
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~  201 (282)
T cd07831         154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG  201 (282)
T ss_pred             C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence            1   12345788999999764 45678999999999999999999999964

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=3.7e-30  Score=251.33  Aligned_cols=199  Identities=31%  Similarity=0.468  Sum_probs=173.2

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +|++.++||+|++|.||+++. .+++.+++|.+....  .....++.+|+.++++++||||+++.+++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477889999999999999974 467899999997643  23345678999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          402 VPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       402 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      +++++|.+++.+.. ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999986532 2356899999999999999999999987   999999999999999999999999999876533 


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                         ......+++.|++||.+.+..++.++|+||||+++|||++|+.|+..
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~  203 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA  203 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence               12224578899999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-30  Score=281.86  Aligned_cols=208  Identities=30%  Similarity=0.411  Sum_probs=171.6

Q ss_pred             HHhhhcCCCcCcccCcCCceeEEEeecC----C----CCEEEEEEeecCCh-hcHHHHHHHHHHHhcC-CCCCccceeeE
Q 008854          319 IRDATNNFSTDNKLGQGGFGAVYKGRLS----H----GQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGF  388 (551)
Q Consensus       319 i~~~~~~f~~~~~LG~G~~g~Vyk~~~~----~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~  388 (551)
                      .+...++..+.+.||+|.||.|++|...    .    ...||||.++.... .+...+..|+++++.+ +||||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            3344455566679999999999999743    1    34699999987643 4556799999999999 59999999999


Q ss_pred             EecCCceEEEEEccCCCChhHHhhhhc-----cc--------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCC
Q 008854          389 SFEETERLLIYEFVPNSSVDKFIFDAI-----KR--------VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKAS  455 (551)
Q Consensus       389 ~~~~~~~~lV~e~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~  455 (551)
                      |..++..++|+||+..|+|.++|....     ..        ..++..+.+.++.|||.||+||++..   +|||||..+
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence            999999999999999999999998643     00        23889999999999999999999987   999999999


Q ss_pred             CeeeCCCCCeEEeecCCccccccCCCcc-cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          456 NILLDADMIPKISDFGMARLFEMDQSQG-DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       456 NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      |||+.++..+||+|||+++......... ......-+..|||||.+....|+.|||||||||+||||+| |..|+.
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp  523 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP  523 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence            9999999999999999998654433322 1111113557999999999999999999999999999999 777775

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=3e-30  Score=262.78  Aligned_cols=201  Identities=22%  Similarity=0.371  Sum_probs=167.2

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEec----CCce
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFE----ETER  395 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  395 (551)
                      .++|++.+.||+|++|.||++.. .+++.||+|++....  ......+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            46889999999999999999984 468999999997642  2334567889999999999999999998753    3457


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++||||+. ++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||+++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            89999996 588888753   455899999999999999999999987   99999999999999999999999999976


Q ss_pred             cccCCCc--ccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          476 FEMDQSQ--GDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       476 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .......  .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~  214 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG  214 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence            5432211  11223468899999998765 4688999999999999999999999853

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=8.7e-31  Score=261.76  Aligned_cols=201  Identities=26%  Similarity=0.406  Sum_probs=171.2

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV  398 (551)
                      ....|+++++||.||.+.|||+...+.+.+|+|++...  +.+...-|.+|+..|.+|+ |.+||+|++|-..++..|||
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            45678999999999999999999888888999987543  4455567999999999996 99999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||= ..+|..+|... .....+| .+..+..|++.++.++|+++   |||.||||.|+|+ -.|.+||+|||+|..+..
T Consensus       439 mE~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANAIQP  511 (677)
T ss_pred             eecc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcccCc
Confidence            9965 66899998753 2233345 67788999999999999998   9999999999998 578999999999998877


Q ss_pred             CCCcccccccccCCCcccccccccC-----------CCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRG-----------HFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      +........-+||+-||+||.+...           +.+.+|||||+|+|||+|+.|+.||.
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~  573 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG  573 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence            6666555667899999999988532           25678999999999999999999995

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=7.4e-31  Score=264.98  Aligned_cols=209  Identities=26%  Similarity=0.376  Sum_probs=175.9

Q ss_pred             hcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ...|..++.||-|+||+|.++. .+....+|+|.+.+.+.   +.....+.|-.||...+.+-||+|+-.|++.+.+|+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            3568888999999999999997 44567799999977532   3344678899999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++|++-.+|-   +.+.|.+.....++.++.-++++.|..+   +|||||||+|||||.+|++||.||||+.-+.-
T Consensus       708 MdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             EeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence            99999999998885   4566778888888999999999999887   99999999999999999999999999864310


Q ss_pred             --C------CCcc--------------------------------cccccccCCCcccccccccCCCCcchhhHhHHHHH
Q 008854          479 --D------QSQG--------------------------------DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLV  518 (551)
Q Consensus       479 --~------~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll  518 (551)
                        +      ....                                .....+||+.|+|||++....++...|+||.||||
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence              0      0000                                01124799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCCcCcc
Q 008854          519 LEIISGQKNNSFRIGEEAE  537 (551)
Q Consensus       519 ~elltG~~p~~~~~~~~~~  537 (551)
                      +||+.|+.||....+.+.+
T Consensus       862 ~em~~g~~pf~~~tp~~tq  880 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADTPGETQ  880 (1034)
T ss_pred             HHHhhCCCCccCCCCCcce
Confidence            9999999999866665544

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=5.6e-30  Score=261.93  Aligned_cols=201  Identities=27%  Similarity=0.427  Sum_probs=167.9

Q ss_pred             hHHHhhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecC-
Q 008854          317 STIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-  392 (551)
Q Consensus       317 ~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  392 (551)
                      .++...+++|.+.+.||+|+||.||++.. .+++.||+|+++...  ......+.+|+.++.+++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            45566789999999999999999999984 578899999997542  22345678899999999999999999987543 


Q ss_pred             -----CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEE
Q 008854          393 -----TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI  467 (551)
Q Consensus       393 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl  467 (551)
                           ...+++++++ +++|.+++.    ...+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence                 2356777776 788887764    346899999999999999999999987   999999999999999999999


Q ss_pred             eecCCccccccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       468 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +|||+++....     ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       162 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  220 (345)
T cd07877         162 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  220 (345)
T ss_pred             ecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999875322     1233467889999998866 5688999999999999999999999853

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=226.04  Aligned_cols=212  Identities=25%  Similarity=0.396  Sum_probs=171.0

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChh--cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +|...++||+|.||+|||++. +.++.||+|++......  ......+|+-+++.++|+|||+++++...+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            466678999999999999994 45788999999765322  234678999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +. .+|..+...  -.+.++......++.|+++||.+.|+++   +.||||||.|.||+.+|..|++|||+++.+.....
T Consensus        83 cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            94 456666543  3567899999999999999999999988   99999999999999999999999999997654321


Q ss_pred             cccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCCCcCcccHHHHHHh
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSN  545 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~  545 (551)
                        -.+..+-|..|.+|+++.+. -|+...|+||-|+++.||....+|.. +..+..+.+.+..|.
T Consensus       157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf-pg~dvddqlkrif~~  218 (292)
T KOG0662|consen  157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF-PGNDVDDQLKRIFRL  218 (292)
T ss_pred             --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC-CCCcHHHHHHHHHHH
Confidence              12334568999999998875 57889999999999999988666653 333333445555443

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-31  Score=242.32  Aligned_cols=196  Identities=28%  Similarity=0.450  Sum_probs=162.0

Q ss_pred             CcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEEEccC
Q 008854          327 STDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       327 ~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      +.+..||.|..|+|||.+. ..|..+|||.+.+.. .+..+++...+.++.+-+ .|.||+.+|+|......++.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            4567899999999999985 458899999998764 444556777777766654 8999999999999999999999884


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                       ..++.+|..  ...++++.-+-++...+.+||.||.+++  +|||||+||+|||+|+.|++|++|||++..+-...   
T Consensus       175 -~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---  246 (391)
T KOG0983|consen  175 -TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---  246 (391)
T ss_pred             -HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc---
Confidence             334555543  3456888888899999999999999876  69999999999999999999999999997654332   


Q ss_pred             cccccccCCCccccccccc---CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTR---GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..++..|-+.|||||.+..   ..|+.++|||||||.++||.||+.||..
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~  296 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG  296 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence            2345678999999998853   4788999999999999999999999963

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.9e-32  Score=265.44  Aligned_cols=200  Identities=25%  Similarity=0.311  Sum_probs=177.8

Q ss_pred             CCCcCcccCcCCceeEEEeecCCCC-EEEEEEeecC---ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKN---SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~~g~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      +++.+..||-|+||.|=+++.+... .+|+|++++.   ....+..+..|-++|.+.+.|.||+++..|.+....|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            4556678999999999999865433 3899998765   33445568899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      -+-+|.|..+|.   +++.++..+...++..+++|++|||.++   ||+|||||+|++|+.+|-+||.|||+|+.+..  
T Consensus       501 aClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~--  572 (732)
T KOG0614|consen  501 ACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS--  572 (732)
T ss_pred             hhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc--
Confidence            999999999997   5677899999999999999999999988   99999999999999999999999999998763  


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIG  533 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~~  533 (551)
                       ...+..++|||.|.|||++.++..+...|.||+||+++||++|++||+...+
T Consensus       573 -g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp  624 (732)
T KOG0614|consen  573 -GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP  624 (732)
T ss_pred             -CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence             3467889999999999999999999999999999999999999999985543

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=5.4e-30  Score=255.25  Aligned_cols=198  Identities=28%  Similarity=0.405  Sum_probs=167.6

Q ss_pred             CCCcCcccCcCCceeEEEeec----CCCCEEEEEEeecCCh----hcHHHHHHHHHHHhcC-CCCCccceeeEEecCCce
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSV----QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETER  395 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  395 (551)
                      +|++.+.||+|++|.||+++.    .+++.||||.+++...    .....+.+|+.++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            467789999999999999874    3568899999975422    2234678999999999 599999999999988899


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++||||+++++|.+++..   ...+++..+..++.|++++|.|||+.+   ++|+||+|+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999998863   356899999999999999999999877   99999999999999999999999999876


Q ss_pred             cccCCCcccccccccCCCcccccccccCC--CCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGH--FSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      +..... .......|+..|++||.+.+..  .+.++||||||+++|||++|+.|+.
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~  209 (288)
T cd05583         155 FLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT  209 (288)
T ss_pred             cccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence            543321 1222346789999999987655  7889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=7.9e-30  Score=255.17  Aligned_cols=199  Identities=27%  Similarity=0.470  Sum_probs=163.8

Q ss_pred             cCCCcCcccCcCCceeEEEeecCC-CCEEEEEEeecCCh-hcHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~-g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ++|++.+.||+|++|.||+++..+ ++.||||+++.... ....++..|+.++.+.. ||||+++++++......++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            567888999999999999999764 88999999976532 23445667777666665 9999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++ +|.+++..  ....+++..+..++.|+++||.|||+..  +|+||||+|+||++++++.+||+|||++..+....
T Consensus        95 ~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          95 LMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             ccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9854 67666543  2347899999999999999999999742  39999999999999999999999999987654322


Q ss_pred             CcccccccccCCCcccccccccCC----CCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGH----FSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .   .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||..
T Consensus       170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  220 (296)
T cd06618         170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN  220 (296)
T ss_pred             c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence            1   12235788999999987553    78999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=1e-29  Score=256.47  Aligned_cols=197  Identities=19%  Similarity=0.243  Sum_probs=163.0

Q ss_pred             cCcccCcCCceeEEEeecCCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCC
Q 008854          328 TDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS  405 (551)
Q Consensus       328 ~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  405 (551)
                      +.+.+|.|+++.|+++.. +++.||||++...  .......+.+|+++++.++||||+++++++......+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            345556666666666665 6899999999765  3344567899999999999999999999999999999999999999


Q ss_pred             ChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC----
Q 008854          406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS----  481 (551)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~----  481 (551)
                      +|.+++... ....+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||.+........    
T Consensus        85 ~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            999998753 2346889999999999999999999987   99999999999999999999999998865432111    


Q ss_pred             -cccccccccCCCccccccccc--CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 -QGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 -~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                       ........++..|+|||.+..  ..++.++||||||+++|||++|+.||.
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~  211 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK  211 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence             111223456788999999866  357899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=1.4e-29  Score=257.98  Aligned_cols=202  Identities=24%  Similarity=0.407  Sum_probs=165.9

Q ss_pred             hcCCCc-CcccCcCCceeEEEeecC-CCCEEEEEEeecCChhc--------------HHHHHHHHHHHhcCCCCCcccee
Q 008854          323 TNNFST-DNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQG--------------ELEFKNEVLLVARLQHRNLVRLL  386 (551)
Q Consensus       323 ~~~f~~-~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~  386 (551)
                      .++|.. .+.||+|+||+||++... .++.||+|+++......              ...+.+|++++.+++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            345654 477999999999999854 68899999987543221              12477899999999999999999


Q ss_pred             eEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeE
Q 008854          387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPK  466 (551)
Q Consensus       387 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~k  466 (551)
                      +++......++||||++ ++|.+++.   ....+++.....++.|++.||.|||+.+   |+|+||+|+||+++.++.+|
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence            99999999999999997 58888875   3456899999999999999999999987   99999999999999999999


Q ss_pred             EeecCCccccccCC------------CcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          467 ISDFGMARLFEMDQ------------SQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       467 l~Dfgla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      |+|||+++......            .........+++.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999997654110            01111223467889999988764 4689999999999999999999998643

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=2.4e-29  Score=253.75  Aligned_cols=192  Identities=30%  Similarity=0.456  Sum_probs=163.6

Q ss_pred             CCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          326 FSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      |...++||+|+||+||+|+. .+++.|++|++.....   .....+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66678899999999999985 4688999999875422   2334688899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +. ++|.+++..  ...++++.++..++.||+.+|.|||+.+   ++|+||+|+||+++.++.+||+|||++....    
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~----  172 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----  172 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence            96 567666643  3456899999999999999999999987   9999999999999999999999999986422    


Q ss_pred             cccccccccCCCcccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                        ......|+..|+|||.+.   ...++.++||||||+++|||++|+.|+.
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~  221 (313)
T cd06633         173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  221 (313)
T ss_pred             --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence              122456888999999874   4668899999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.1e-29  Score=259.45  Aligned_cols=198  Identities=25%  Similarity=0.416  Sum_probs=166.8

Q ss_pred             HhhhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCC---
Q 008854          320 RDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEET---  393 (551)
Q Consensus       320 ~~~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  393 (551)
                      ....++|+..+.||+|+||.||++. ..+++.||||++....  ......+.+|+.++++++||||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            3456789999999999999999998 4478999999986532  223346789999999999999999999887543   


Q ss_pred             ---ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeec
Q 008854          394 ---ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF  470 (551)
Q Consensus       394 ---~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df  470 (551)
                         ..++||||+ +++|.+++.    ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence               358999998 678887764    346899999999999999999999987   999999999999999999999999


Q ss_pred             CCccccccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       471 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      |++......     .....+++.|++||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~  218 (343)
T cd07880         163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG  218 (343)
T ss_pred             ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999754321     223456889999998876 4588999999999999999999999863

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=7.7e-30  Score=256.78  Aligned_cols=201  Identities=27%  Similarity=0.465  Sum_probs=164.2

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh--cHHHHHHHHHHHhcCCCCCccceeeEEecCC------
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEET------  393 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  393 (551)
                      .++|++.++||+|++|.||++... +++.+++|++......  ....+.+|++++++++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999854 6889999998654322  2335778999999999999999999875433      


Q ss_pred             --ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          394 --ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       394 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                        ..++|+||+.. +|...+..  ....+++..+..++.|++++|.|||+.+   |+|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              35899999975 56666543  3456999999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCCCcc---------cccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          472 MARLFEMDQSQG---------DTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       472 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      +++.........         ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~  228 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ  228 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCC
Confidence            997654322111         11234568889999987654 57899999999999999999999885

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=7.5e-30  Score=260.19  Aligned_cols=199  Identities=24%  Similarity=0.400  Sum_probs=166.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecC-----Cc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-----TE  394 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  394 (551)
                      .++|.+.+.||+|+||+||+++. .+++.||||.+...  .......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45789999999999999999984 46889999998754  222344677899999999999999999987644     34


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .++|+||+. ++|.+++.   ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            789999996 67887775   3456999999999999999999999987   9999999999999999999999999997


Q ss_pred             ccccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ......  .......++..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  211 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG  211 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence            654321  12233457889999998765 4688999999999999999999999854

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=1.2e-29  Score=257.54  Aligned_cols=199  Identities=27%  Similarity=0.427  Sum_probs=167.4

Q ss_pred             HhhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEec-CCce
Q 008854          320 RDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFE-ETER  395 (551)
Q Consensus       320 ~~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  395 (551)
                      ...+++|+..+.||+|+||.||++.. .+++.||+|++.+..  ......+.+|+.++.+++||||+++.+++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            45678999999999999999999984 478999999986532  2234567899999999999999999998865 5578


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++|+||+ +++|..++.    ...+++..+..++.|+++||.|||+.+   |+|+||+|+||++++++.+||+|||++..
T Consensus        86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence            8999998 567887764    345788889999999999999999987   99999999999999999999999999875


Q ss_pred             cccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          476 FEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ...     ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       158 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~  209 (328)
T cd07856         158 QDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK  209 (328)
T ss_pred             cCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            322     1223456889999998766 57899999999999999999999998643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-30  Score=248.71  Aligned_cols=210  Identities=23%  Similarity=0.343  Sum_probs=173.2

Q ss_pred             hHHHhhhcCCCcCcccCcCCceeEEEeecCC------CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEE
Q 008854          317 STIRDATNNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFS  389 (551)
Q Consensus       317 ~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~  389 (551)
                      .++.....+++....+-+|.||.||.|.|.+      .+.|-+|.++.+. .-+...+..|..++..+.|||+.++.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            4444556778888899999999999996543      4567888887653 23344688899999999999999999998


Q ss_pred             ecC-CceEEEEEccCCCChhHHhh-----hhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC
Q 008854          390 FEE-TERLLIYEFVPNSSVDKFIF-----DAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM  463 (551)
Q Consensus       390 ~~~-~~~~lV~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~  463 (551)
                      .++ ...+++|.++.-|+|..||.     +......++-.+...++.|++.||+|||+++   +||.||..+|++||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence            764 46789999999999999998     4444456788889999999999999999988   99999999999999999


Q ss_pred             CeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          464 IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       464 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ++||+|=.+++-+-..+...--.....+..||+||.+.+..|+..+|||||||+||||+| |+.|+.
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya  500 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA  500 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc
Confidence            999999999986543333322222345779999999999999999999999999999998 888885

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-29  Score=251.55  Aligned_cols=197  Identities=27%  Similarity=0.438  Sum_probs=168.4

Q ss_pred             CCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh--cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      |+..+.||+|++|.||++... +++.+++|++......  ....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566789999999999999854 6889999998765332  3457888999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++ +|..++..  ....+++..+..++.|++++|.|||+.+   |+|+||||+||+++.++.+||+|||.+.......  
T Consensus        81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            75 78877764  2357899999999999999999999987   9999999999999999999999999997665432  


Q ss_pred             ccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .......++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~  201 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG  201 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            112234577889999998776 789999999999999999999988853

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.2e-29  Score=259.12  Aligned_cols=194  Identities=26%  Similarity=0.425  Sum_probs=162.5

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCC------
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEET------  393 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  393 (551)
                      .++|...+.||+|+||.||+|+. .+++.||+|++.+..  ......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            46899999999999999999985 468999999987542  122346789999999999999999999886542      


Q ss_pred             ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCc
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA  473 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla  473 (551)
                      ..++|+||+.. +|..++     ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            45899999964 565543     246899999999999999999999987   999999999999999999999999998


Q ss_pred             cccccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +....     ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~  217 (342)
T cd07879         165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  217 (342)
T ss_pred             cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            75422     1223467889999998876 4688999999999999999999999964

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=2.1e-29  Score=250.46  Aligned_cols=197  Identities=29%  Similarity=0.493  Sum_probs=163.6

Q ss_pred             CCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh--cHHHHHHHHHHHhcC---CCCCccceeeEEecCCc-----
Q 008854          326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARL---QHRNLVRLLGFSFEETE-----  394 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  394 (551)
                      |++.+.||+|+||.||+++.. +++.+|+|+++.....  ....+.+|+.++.++   +||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999975 4899999999754222  223566777776655   69999999999987766     


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .+++|||+++ +|.+++... ....+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 788887642 2346899999999999999999999987   9999999999999999999999999997


Q ss_pred             ccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .......   .....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~  208 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG  208 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence            6543221   2233578899999999999999999999999999999999988753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-30  Score=229.65  Aligned_cols=206  Identities=28%  Similarity=0.416  Sum_probs=168.9

Q ss_pred             HHhhhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecC-ChhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCce
Q 008854          319 IRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKN-SVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETER  395 (551)
Q Consensus       319 i~~~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  395 (551)
                      ++...+.......||+|++|.|-+-+ ..+|+..|+|++... ..+..++..+|+.+..+- ..|.+|.++|....+...
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            44445556667889999999998887 457999999999765 334556778888887665 689999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          396 LLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      ++.||.| ..||+.+-.+.. +...+++.-+-+|+..+.+||.|||++-  .+||||+||+||||+.+|++||+|||.+-
T Consensus       121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            9999988 457777665433 4567889999999999999999999865  69999999999999999999999999997


Q ss_pred             ccccCCCcccccccccCCCcccccccc----cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVT----RGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .+....   ..+...|-..|||||.+.    ...|+.||||||+|+.+.||.+++.|++.
T Consensus       198 ~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  198 YLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             eehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            654221   122235677899999875    34789999999999999999999999963

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=1.6e-29  Score=254.47  Aligned_cols=194  Identities=30%  Similarity=0.480  Sum_probs=164.5

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecC---ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN---SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      +.|+..+.||+|++|.||+|+.. +++.+++|.+...   ......++.+|+++++.++|+|++++.+++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            44777789999999999999854 5788999998643   2233446788999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+. ++|.+++..  ....+++..+..++.|++.+|.|||+.+   ++||||+|+||+++.++.+||+|||++......
T Consensus        95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9997 577776653  2456899999999999999999999887   999999999999999999999999998754321


Q ss_pred             CCcccccccccCCCcccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                            ....+++.|+|||.+.   ...++.++||||||+++|||++|+.|+.
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  215 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence                  2345788999999874   3567889999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.2e-29  Score=257.98  Aligned_cols=199  Identities=27%  Similarity=0.428  Sum_probs=169.5

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCC-----ceE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEET-----ERL  396 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  396 (551)
                      +|.+.++||+|++|.||+++.. .++.+++|++....  ....+.+.+|+.+++.++||||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999964 48899999997653  334457889999999999999999999988765     789


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +||||++ ++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999998 478887753   347999999999999999999999987   999999999999999999999999999865


Q ss_pred             ccCCC-cccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          477 EMDQS-QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       477 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~  209 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG  209 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCC
Confidence            43321 0122334678899999999887 889999999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=2.2e-29  Score=255.83  Aligned_cols=197  Identities=21%  Similarity=0.324  Sum_probs=161.3

Q ss_pred             cccCcC--CceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQG--GFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G--~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      ..||+|  +||+||+++. .+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..+...++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            567777  9999999985 478999999987543  22345788999999999999999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc-
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG-  483 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  483 (551)
                      ++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTY-FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            9999988753 2345899999999999999999999887   9999999999999999999999998654322111100 


Q ss_pred             ----cccccccCCCcccccccccC--CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          484 ----DTSRIVGTFGYMAPEYVTRG--HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       484 ----~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                          ......++..|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  212 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD  212 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                01112345679999998764  478999999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.5e-29  Score=243.68  Aligned_cols=191  Identities=30%  Similarity=0.408  Sum_probs=166.9

Q ss_pred             cCcCCceeEEEeecC-CCCEEEEEEeecCChh---cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCCh
Q 008854          332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSV  407 (551)
Q Consensus       332 LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  407 (551)
                      ||+|+||.||++... +++.+++|.+.+....   ....+.+|+.++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            799999999999864 5889999998765332   345788999999999999999999999999999999999999999


Q ss_pred             hHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccc
Q 008854          408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR  487 (551)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  487 (551)
                      .+++..   ...+++..+..++.|++++|.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            999863   346899999999999999999999977   9999999999999999999999999987654321  12334


Q ss_pred             cccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       488 ~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..++..|++||.+.+...+.++|+||||+++|||++|+.||..
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~  195 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA  195 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            5678899999999888889999999999999999999999853

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.96  E-value=1.2e-29  Score=259.27  Aligned_cols=199  Identities=23%  Similarity=0.405  Sum_probs=164.7

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecC---------
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE---------  392 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  392 (551)
                      ..+|...+.||.|+||.||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            46899999999999999999985 46889999999776555666789999999999999999999876543         


Q ss_pred             -----CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC-CCCCeE
Q 008854          393 -----TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPK  466 (551)
Q Consensus       393 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~k  466 (551)
                           ...++||||++ ++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+||+++ +++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 34689999997 57877764    346899999999999999999999987   99999999999997 456789


Q ss_pred             EeecCCccccccCCC-cccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          467 ISDFGMARLFEMDQS-QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       467 l~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      |+|||+++.+..... ........++..|+|||.+.. ..++.++||||||+++|||++|+.||.
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~  220 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA  220 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999976532211 111223457889999997654 567889999999999999999999995

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=2.3e-29  Score=249.78  Aligned_cols=197  Identities=27%  Similarity=0.416  Sum_probs=165.7

Q ss_pred             CCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEEEcc
Q 008854          326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      |.+.+.||+|++|+||+|+.. +++.|++|++..... .......+|+..+.+++ ||||+++++++......++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567789999999999999965 478899999865432 22334567999999999 999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                       +++|.+++... ....+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++.......  
T Consensus        81 -~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--  153 (283)
T cd07830          81 -EGNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--  153 (283)
T ss_pred             -CCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence             88898887643 2346899999999999999999999987   9999999999999999999999999997653221  


Q ss_pred             ccccccccCCCcccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                       ......++..|+|||.+. ...++.++|+||||+++|||++|+.||..
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~  201 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG  201 (283)
T ss_pred             -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCC
Confidence             122345788999999875 45678999999999999999999988853

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.96  E-value=2.8e-30  Score=278.78  Aligned_cols=197  Identities=32%  Similarity=0.522  Sum_probs=157.3

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEe---------
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSF---------  390 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---------  390 (551)
                      --.+|+..+.||+||||.|||++.+ ||..+|||++.... ......+.+|+..|++|+|||||+++..+.         
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            3467888999999999999999844 89999999997653 333446889999999999999999871000         


Q ss_pred             --------------------------------------------------------------------------------
Q 008854          391 --------------------------------------------------------------------------------  390 (551)
Q Consensus       391 --------------------------------------------------------------------------------  390 (551)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             c----------------------C--------CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHh
Q 008854          391 E----------------------E--------TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH  440 (551)
Q Consensus       391 ~----------------------~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH  440 (551)
                      +                      +        ..+||-|||++..+|++++.++.-.  -.....++++++|++||.|+|
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHH
Confidence            0                      0        1246789999999999888643211  146678899999999999999


Q ss_pred             hCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc----------------cCCCcccccccccCCCcccccccccC-
Q 008854          441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE----------------MDQSQGDTSRIVGTFGYMAPEYVTRG-  503 (551)
Q Consensus       441 ~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~-  503 (551)
                      +++   ||||||||.||+++++..+||+|||++....                ........+..+||.-|+|||++.+. 
T Consensus       715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            998   9999999999999999999999999998621                00111234567899999999998764 


Q ss_pred             --CCCcchhhHhHHHHHHHHHh
Q 008854          504 --HFSIKSDVFSFGVLVLEIIS  523 (551)
Q Consensus       504 --~~~~~sDv~S~Gvll~ellt  523 (551)
                        +|+.|+|+||+|||++||+.
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc
Confidence              59999999999999999874

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-29  Score=266.22  Aligned_cols=210  Identities=29%  Similarity=0.483  Sum_probs=182.3

Q ss_pred             cChhHHHhhhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeEEec
Q 008854          314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFE  391 (551)
Q Consensus       314 ~~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  391 (551)
                      .+++.+.+.++.|++.+.||+|.+|.||+++ .++++.+|+|++..... .+.+++.|.+|++.+ .|||++.++|++..
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            4566677788899999999999999999998 56789999999876543 345788889999888 59999999999864


Q ss_pred             -----CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeE
Q 008854          392 -----ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPK  466 (551)
Q Consensus       392 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~k  466 (551)
                           +++++||||||.+||..+++.... ...+.|..+..|++.++.||.+||...   ++|||||-.|||++.++.+|
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence                 568999999999999999987654 778999999999999999999999887   99999999999999999999


Q ss_pred             EeecCCccccccCCCcccccccccCCCccccccccc-----CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          467 ISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-----GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       467 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      |.|||++..+.  .+.......+||+.|||||++.-     ..|+.++|+||||++..||--|.+|+..
T Consensus       164 LvDFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D  230 (953)
T KOG0587|consen  164 LVDFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD  230 (953)
T ss_pred             Eeeeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence            99999997654  34455667899999999999853     3577899999999999999999999863

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=2.7e-29  Score=249.02  Aligned_cols=197  Identities=31%  Similarity=0.500  Sum_probs=167.8

Q ss_pred             CCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      |+..+.||+|++|.||+++.. +++.+++|++....  ......+.+|+.++++++|+||+++++++......++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999865 58999999997653  223456788999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      + ++|.+++...  ...+++..+..++.+++.+|.|||+.+   |+|+||+|+||++++++.+||+|||+++....... 
T Consensus        81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            8 5899988742  246999999999999999999999987   99999999999999999999999999976543221 


Q ss_pred             ccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                       ......++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  201 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG  201 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence             12223457789999998766 889999999999999999999988853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.96  E-value=3.3e-29  Score=254.97  Aligned_cols=199  Identities=27%  Similarity=0.382  Sum_probs=162.4

Q ss_pred             CCCcCcccCcCCceeEEEeecC-C--CCEEEEEEeecCC--hhcHHHHHHHHHHHhcC-CCCCccceeeEEecC----Cc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-H--GQEIAVKRLSKNS--VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEE----TE  394 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~--g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  394 (551)
                      +|++.+.||+|+||.||+++.. .  +..||+|++....  ......+.+|+.++.++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4777899999999999999854 3  6789999987532  22244678899999999 599999999875432    34


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .++++||+. ++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678888886 68888775   3457899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCCC--cccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQS--QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .+.....  ........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~  212 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG  212 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence            6543221  112234578999999998765 4689999999999999999999998864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9.8e-30  Score=239.68  Aligned_cols=201  Identities=26%  Similarity=0.353  Sum_probs=173.3

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh---cHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  397 (551)
                      -++|.++..||+|+|.+|-.+++. ..+.+|+|++++...+   +..-...|-.+..+. +||.+|.+..+|+.+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            367899999999999999999854 5678999999876332   223355666666655 79999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      |.||+++|+|--+++   ....+++.....+..+|.-+|.|||+.+   ||.||||.+|||||.+|++||.|+|+++.--
T Consensus       329 vieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999876665   4567899999999999999999999998   9999999999999999999999999997421


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                        .....++.++|||.|+|||++.+..|....|+|++||+++||+.|+.||+.-
T Consensus       403 --~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv  454 (593)
T KOG0695|consen  403 --GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV  454 (593)
T ss_pred             --CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence              2234567899999999999999999999999999999999999999999853

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-31  Score=243.18  Aligned_cols=199  Identities=29%  Similarity=0.425  Sum_probs=161.7

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh-hcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEEEc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +.+.+..||.|.||+|+|-.++ .|+..|||+++.... .+.+++..|.+...+- +.||||+++|.+..++..++.||.
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            3345578999999999998754 689999999987654 4556788888876655 689999999999999999999999


Q ss_pred             cCCCChhHHhhh--hcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          402 VPNSSVDKFIFD--AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       402 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      |. .||+.+-..  ..+...+++.-+-+|...+++||.||.+..  +|||||+||+||||+..|.+||+|||++..+...
T Consensus       145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence            84 455544321  124566888888889999999999998865  6999999999999999999999999998654321


Q ss_pred             CCcccccccccCCCccccccccc--CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                         ...+...|-..|||||.+..  ..|+.+|||||+|+.|+|+.||+.|+.
T Consensus       222 ---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr  270 (361)
T KOG1006|consen  222 ---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR  270 (361)
T ss_pred             ---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc
Confidence               12334567889999998853  358999999999999999999999985

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.96  E-value=3.8e-29  Score=245.13  Aligned_cols=199  Identities=26%  Similarity=0.396  Sum_probs=164.8

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecC-----ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN-----SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      +|.+.++||+|+||.||+++.. .+..+++|.++..     .......+..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4788899999999999999854 3445666665432     122334577899999999999999999999988899999


Q ss_pred             EEccCCCChhHHhhhh-cccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          399 YEFVPNSSVDKFIFDA-IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      |||+++++|.+++... .....+++..++.++.|+++||.|||+.+   ++|+||+|+||++++ +.+||+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988653 23457999999999999999999999987   999999999999975 569999999987653


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ....  ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.|+.
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~  206 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE  206 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            3221  2223457889999999988888999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.96  E-value=3e-29  Score=256.39  Aligned_cols=196  Identities=27%  Similarity=0.448  Sum_probs=166.1

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCc---
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE---  394 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  394 (551)
                      ...++|+..+.||+|++|.||+++.. +++.||+|++...  .......+.+|+.++++++||||+++++++.....   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999864 5789999998653  22233467789999999999999999998766554   


Q ss_pred             ---eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          395 ---RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       395 ---~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                         .++|+||+ +++|.+++.    ...+++..+..++.|++++|.|||+.+   |+||||||+||++++++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence               78999998 568888775    356899999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ++......     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~  217 (343)
T cd07851         164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP  217 (343)
T ss_pred             cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            99764322     223467889999998865 467899999999999999999999985

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=1.1e-28  Score=271.82  Aligned_cols=145  Identities=28%  Similarity=0.386  Sum_probs=129.8

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|.+.++||+|+||.||++... +++.||||+++....   .....+.+|+.++..++||||+++++++......+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999864 688999999976432   22356889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      ||+++++|.+++..   ...+++..++.++.||+.||.|||..+   |+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999863   346889999999999999999999987   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=1e-28  Score=259.49  Aligned_cols=204  Identities=20%  Similarity=0.317  Sum_probs=153.8

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-----------------CCCCEEEEEEeecCChhcHHH--------------HHHH
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-----------------SHGQEIAVKRLSKNSVQGELE--------------FKNE  370 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~E  370 (551)
                      ..++|++.++||+|+||.||+|..                 ..++.||||++.........+              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999963                 234679999986543222222              3347


Q ss_pred             HHHHhcCCCCCc-----cceeeEEec--------CCceEEEEEccCCCChhHHhhhhc---------------------c
Q 008854          371 VLLVARLQHRNL-----VRLLGFSFE--------ETERLLIYEFVPNSSVDKFIFDAI---------------------K  416 (551)
Q Consensus       371 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~---------------------~  416 (551)
                      +.++.+++|.++     +++++++..        ....+|||||+++++|.++|+...                     .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777876654     677777653        356799999999999999986421                     1


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCccc
Q 008854          417 RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA  496 (551)
Q Consensus       417 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a  496 (551)
                      ...++|..+..++.|++++|.|||+.+   |+||||||+|||++.++.+||+|||+++....... .......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence            123567889999999999999999987   99999999999999999999999999975432211 11222345789999


Q ss_pred             ccccccCCC----------------------CcchhhHhHHHHHHHHHhCCC-CCC
Q 008854          497 PEYVTRGHF----------------------SIKSDVFSFGVLVLEIISGQK-NNS  529 (551)
Q Consensus       497 PE~~~~~~~----------------------~~~sDv~S~Gvll~elltG~~-p~~  529 (551)
                      ||.+.....                      ..+.||||+||+++||++|.. |+.
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~  434 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA  434 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence            998754321                      134799999999999999985 553

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=1.1e-28  Score=238.69  Aligned_cols=179  Identities=22%  Similarity=0.221  Sum_probs=152.6

Q ss_pred             CCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCChhHHhhh
Q 008854          335 GGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFD  413 (551)
Q Consensus       335 G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~  413 (551)
                      |.+|.||+++. .+++.+|+|++....     .+.+|...+....||||+++++++......++||||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            88999999985 468899999997653     233455555666799999999999999999999999999999998864


Q ss_pred             hcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCC
Q 008854          414 AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG  493 (551)
Q Consensus       414 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~  493 (551)
                         ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.++++|||++......     .....++..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~  147 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM  147 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence               345899999999999999999999987   999999999999999999999999987654321     122345678


Q ss_pred             cccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       494 y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      |+|||.+.+..++.++||||+|+++|||++|+.|+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~  183 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE  183 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence            999999988889999999999999999999997654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=1.3e-27  Score=228.19  Aligned_cols=199  Identities=32%  Similarity=0.495  Sum_probs=171.5

Q ss_pred             CCcCcccCcCCceeEEEeecCC-CCEEEEEEeecCChh-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccC
Q 008854          326 FSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      |...+.||+|++|.||++...+ ++.+++|.+...... ....+.+|++.+.+++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567899999999999999765 889999999876544 56678999999999999999999999999999999999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      +++|.+++...  ...+++..+..++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~  154 (225)
T smart00221       81 GGDLFDYLRKK--GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A  154 (225)
T ss_pred             CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence            99999998642  112889999999999999999999986   99999999999999999999999999987653321 1


Q ss_pred             cccccccCCCccccccc-ccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22345678899999988 667788899999999999999999999953

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.95  E-value=4.7e-29  Score=232.22  Aligned_cols=196  Identities=26%  Similarity=0.327  Sum_probs=163.5

Q ss_pred             hhcCCCcC-cccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeEEec----CCc
Q 008854          322 ATNNFSTD-NKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFE----ETE  394 (551)
Q Consensus       322 ~~~~f~~~-~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  394 (551)
                      .+++|.+. ++||-|-.|.|-.... ..++.+|+|++....     ...+|+++.-.. .|||||.+++++..    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            34555553 6799999999998874 468889999985432     456777765554 69999999998854    345


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC---CCCeEEeecC
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFG  471 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~Dfg  471 (551)
                      +++|||.|++|.|...+++. ....+++.+...|++||..|+.|||+.+   |.||||||+|+|...   |-.+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            78999999999999998764 4556999999999999999999999988   999999999999964   4478999999


Q ss_pred             CccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      +|+.-   +........+-|+.|.|||++...+|+...|+||+||++|-|++|-+||-
T Consensus       210 FAK~t---~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY  264 (400)
T KOG0604|consen  210 FAKET---QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY  264 (400)
T ss_pred             ccccc---CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence            99853   22344556688999999999999999999999999999999999999995

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=251.03  Aligned_cols=194  Identities=26%  Similarity=0.378  Sum_probs=162.6

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      .++.|.....+|.|+|+.|-++.. ..++..+||++.+...    +-.+|+.++... +||||+++.+.+.+..+.++||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            356788888899999999999874 4678899999977622    234566555554 6999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee-CCCCCeEEeecCCcccccc
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-DADMIPKISDFGMARLFEM  478 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll-~~~~~~kl~Dfgla~~~~~  478 (551)
                      |.+.++-|.+.+..   ...+. .++..|+.+|+.++.|||+++   +|||||||+|||+ ++.++++|+|||.++....
T Consensus       396 e~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            99999987776653   22233 778889999999999999987   9999999999999 6999999999999986543


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      +     ....+-|..|.|||++....+++++||||||++|||||+|+.|+...
T Consensus       469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~  516 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAH  516 (612)
T ss_pred             h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccC
Confidence            3     22345688999999999999999999999999999999999999743

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.3e-29  Score=230.57  Aligned_cols=200  Identities=26%  Similarity=0.520  Sum_probs=161.5

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC-hhc-HHHHHHHHHHHhcCCCCCccceeeEEec--------C
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQG-ELEFKNEVLLVARLQHRNLVRLLGFSFE--------E  392 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~-~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  392 (551)
                      +.|+...+||+|.||+||+++.. .|+.||+|++-... ..+ -....+|+.+|..++|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45666789999999999999854 57778998764322 111 1245789999999999999999988753        2


Q ss_pred             CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCC
Q 008854          393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM  472 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl  472 (551)
                      ...+|||.+++. +|..+|.+  ....++..++.+++.++++||.|+|...   |+|||+|+.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            347899999976 56666653  2356889999999999999999999887   99999999999999999999999999


Q ss_pred             ccccccCCCc--ccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          473 ARLFEMDQSQ--GDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       473 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ++.+......  ......+-|+.|.+||.+.+ .+++++.|||.-|+++.||+++.+-+.
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq  230 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ  230 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence            9877544332  22334456999999998876 578999999999999999999997665

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.95  E-value=5.4e-27  Score=226.21  Aligned_cols=186  Identities=31%  Similarity=0.484  Sum_probs=163.9

Q ss_pred             CceeEEEeecC-CCCEEEEEEeecCChhc-HHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCChhHHhhh
Q 008854          336 GFGAVYKGRLS-HGQEIAVKRLSKNSVQG-ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFD  413 (551)
Q Consensus       336 ~~g~Vyk~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~  413 (551)
                      +||.||+++.. +++.+++|++....... ...+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999975 48999999997765444 66899999999999999999999999999999999999999999999864


Q ss_pred             hcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCC
Q 008854          414 AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG  493 (551)
Q Consensus       414 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~  493 (551)
                      .   ..+++..++.++.++++++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......   ......++..
T Consensus        81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            2   23899999999999999999999987   9999999999999999999999999998654332   2334567889


Q ss_pred             cccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       494 y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      |++||.+....++.++||||||++++||++|+.|+..
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999888899999999999999999999999864

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=4.3e-28  Score=243.28  Aligned_cols=196  Identities=26%  Similarity=0.424  Sum_probs=166.5

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcH--------HHHHHHHHHHhcCC---CCCccceeeEEec
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGE--------LEFKNEVLLVARLQ---HRNLVRLLGFSFE  391 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~--------~~~~~E~~~l~~l~---h~niv~l~~~~~~  391 (551)
                      ..|...+.+|+|+||.|+.+..+ +..+|+||.+.+...-..        -.+-.||.||..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35888999999999999999854 467899999987643211        12457999999998   9999999999999


Q ss_pred             CCceEEEEEccC-CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeec
Q 008854          392 ETERLLIYEFVP-NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF  470 (551)
Q Consensus       392 ~~~~~lV~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df  470 (551)
                      .+.++|+||-.. +-+|.+++.   ....+++.+...|++|++-|+++||+++   |||||||-+||.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            999999999654 556777764   4567999999999999999999999998   999999999999999999999999


Q ss_pred             CCccccccCCCcccccccccCCCcccccccccCCCC-cchhhHhHHHHHHHHHhCCCCCC
Q 008854          471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS-IKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       471 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      |.+.....    .....++||.+|.|||++.+.+|- ..-|||++||+||.++.-+.|+-
T Consensus       715 gsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99876432    334567899999999999888774 55899999999999998888873

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-29  Score=230.61  Aligned_cols=198  Identities=26%  Similarity=0.435  Sum_probs=161.1

Q ss_pred             CCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCC-----ceEE
Q 008854          326 FSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET-----ERLL  397 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l  397 (551)
                      .+..+.||-|+||.||.+.. ++|+.||+|++..-  +.-..+.+.+|+.+|.-++|.|++..++......     +.|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            34568999999999999974 47999999998653  2334457889999999999999999988765543     4567


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      |.|.| ..+|..++-   ....++...+.-++.||++||.|||+.+   |.||||||.|.|++.|..+||+|||+++..+
T Consensus       135 ~TELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence            77766 345555543   4567888888889999999999999987   9999999999999999999999999999876


Q ss_pred             cCCCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      .++... ....+-|-.|.|||++++. .|+...||||.|+|+.||+..+.-|...
T Consensus       208 ~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq  261 (449)
T KOG0664|consen  208 QRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA  261 (449)
T ss_pred             hhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence            554433 3334568899999999875 7899999999999999999888777643

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.95  E-value=2.9e-27  Score=254.52  Aligned_cols=200  Identities=23%  Similarity=0.295  Sum_probs=141.6

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-C----CCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeE------Ee
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-H----GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF------SF  390 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  390 (551)
                      ..++|++.++||+|+||.||+|++. +    +..||+|++......  ....+|  .+....+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999864 4    688999998654321  111111  1222223333332221      23


Q ss_pred             cCCceEEEEEccCCCChhHHhhhhcc-----------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCC
Q 008854          391 EETERLLIYEFVPNSSVDKFIFDAIK-----------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLK  453 (551)
Q Consensus       391 ~~~~~~lV~e~~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk  453 (551)
                      .+...++||||+++++|.+++.....                 ........+..++.||+.||.|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            55678999999999999998864210                 001123345679999999999999987   9999999


Q ss_pred             CCCeeeCC-CCCeEEeecCCccccccCCCcccccccccCCCcccccccccC----------------------CCCcchh
Q 008854          454 ASNILLDA-DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG----------------------HFSIKSD  510 (551)
Q Consensus       454 ~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD  510 (551)
                      |+|||+++ ++.+||+|||+++.+..... .......+++.|||||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 57999999999986543222 223446789999999965322                      2345679


Q ss_pred             hHhHHHHHHHHHhCCCCCC
Q 008854          511 VFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       511 v~S~Gvll~elltG~~p~~  529 (551)
                      ||||||++|||+++..+++
T Consensus       362 VwSlGviL~el~~~~~~~~  380 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSD  380 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCc
Confidence            9999999999999776543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=7.8e-28  Score=216.07  Aligned_cols=196  Identities=20%  Similarity=0.393  Sum_probs=165.1

Q ss_pred             hcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-CCCccceeeEEecCC--ceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEET--ERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lV  398 (551)
                      .++|++.+++|+|.+++||.|. ..+.+.++||+++.-.   .+.+.+|+.||..|. ||||++++++..+..  ..-||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4688999999999999999998 5677889999997543   347899999999997 999999999987654  45799


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC-CeEEeecCCccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFE  477 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~  477 (551)
                      +||+.+.+...+-      ..++...+...+.++++||.|.|+.+   |+|||+||.|++||... .++|+|+|||.++.
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999998876643      34777888999999999999999998   99999999999999765 68999999999876


Q ss_pred             cCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIG  533 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~~~~  533 (551)
                      ..+..   +..+.+..|.-||.+.. ..|+..-|+||||+++.+|+.-+.||.....
T Consensus       185 p~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d  238 (338)
T KOG0668|consen  185 PGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD  238 (338)
T ss_pred             CCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence            55432   33455667889998865 4678899999999999999999999965443

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.93  E-value=8.5e-27  Score=224.40  Aligned_cols=198  Identities=22%  Similarity=0.306  Sum_probs=165.6

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCC--C----CccceeeEEecCCc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH--R----NLVRLLGFSFEETE  394 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~~~  394 (551)
                      .+++|.+..++|+|.||.|-+.... .+..||||+++.-.... +.-+-|+++|.++.+  |    -+|.+.++|.-.+.
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYr-eAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYR-EAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHh-hHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            4789999999999999999999743 46789999997544332 245678999999942  3    27788889999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC-------------
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-------------  461 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~-------------  461 (551)
                      .++|+|.+ +.|+.++|.++ +..+++...+..|+.|+++++.+||+..   ++|.||||+|||+-+             
T Consensus       166 iCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             eEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence            99999977 66889998753 4567899999999999999999999987   999999999999821             


Q ss_pred             -------CCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          462 -------DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       462 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                             +..+||+|||.|..-..     ..+.++.|..|.|||++.+-.++..+||||+|+||.||.+|..-|..
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             ceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence                   23589999999976332     23567889999999999999999999999999999999999998863

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.93  E-value=9.4e-27  Score=243.27  Aligned_cols=196  Identities=29%  Similarity=0.426  Sum_probs=159.7

Q ss_pred             CCcCcccCcCCcee-EEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEEEccC
Q 008854          326 FSTDNKLGQGGFGA-VYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       326 f~~~~~LG~G~~g~-Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      |...+.+|.|+.|+ ||+|.. +|++||||++-...   ..-..+|+..|+.-+ |||||++++.-.++...||..|.+ 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            45557789999976 899998 67899999985432   224578999999884 999999999999999999999998 


Q ss_pred             CCChhHHhhhh-cccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC---C--CCeEEeecCCccccc
Q 008854          404 NSSVDKFIFDA-IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---D--MIPKISDFGMARLFE  477 (551)
Q Consensus       404 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~---~--~~~kl~Dfgla~~~~  477 (551)
                      ..+|++++... .......-...+.+..|+++||++||+.+   ||||||||.||||+.   +  .+++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            56899988653 11111121455778899999999999977   999999999999975   3  478999999999887


Q ss_pred             cCCCc-ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhC-CCCCC
Q 008854          478 MDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG-QKNNS  529 (551)
Q Consensus       478 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG-~~p~~  529 (551)
                      .++.. .......||.+|+|||.+....-+...||||+|+++|..++| ..||.
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG  716 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG  716 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC
Confidence            65443 335667899999999999988888899999999999999886 77886

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.92  E-value=4.4e-24  Score=200.77  Aligned_cols=183  Identities=37%  Similarity=0.616  Sum_probs=158.3

Q ss_pred             cCcCCceeEEEeecCC-CCEEEEEEeecCChh-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCChhH
Q 008854          332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDK  409 (551)
Q Consensus       332 LG~G~~g~Vyk~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  409 (551)
                      ||+|.+|.||++...+ ++++++|++...... ....+.+|+..++.++|++|+++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 899999999766432 34578999999999999999999999999999999999999999999


Q ss_pred             HhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC-CCCeEEeecCCccccccCCCccccccc
Q 008854          410 FIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEMDQSQGDTSRI  488 (551)
Q Consensus       410 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~  488 (551)
                      ++...  ...+++..+..++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKEN--EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            98642  146899999999999999999999987   999999999999999 89999999999976543211  12334


Q ss_pred             ccCCCcccccccccC-CCCcchhhHhHHHHHHHH
Q 008854          489 VGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEI  521 (551)
Q Consensus       489 ~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~el  521 (551)
                      .+...|++||.+... ..+.++|+|++|++++||
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            578899999998877 888999999999999998

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=2e-25  Score=217.87  Aligned_cols=212  Identities=24%  Similarity=0.393  Sum_probs=171.9

Q ss_pred             HHhhhcCCCcCcccCcCCceeEEEeecCC----CCEEEEEEeecCChhcHHHHHHHHHHHhcCC-CCCccceeeEEecCC
Q 008854          319 IRDATNNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEET  393 (551)
Q Consensus       319 i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  393 (551)
                      +....+.|..+++||+|.|++||++.+..    .+.||+|.+...+.  ...+.+|+++|..+. +.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            44456788999999999999999998543    56799999876543  235889999999995 999999999999999


Q ss_pred             ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC-CCeEEeecCC
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGM  472 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~Dfgl  472 (551)
                      ...+|+||+++....+++.+      ++..++..+++.+++||.++|..+   ||||||||+|+|.+.. +.-.|.||||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            99999999999999988753      678899999999999999999998   9999999999999754 5678999999


Q ss_pred             ccccccCC-------------Cc-----------------------------ccccccccCCCcccccccccC-CCCcch
Q 008854          473 ARLFEMDQ-------------SQ-----------------------------GDTSRIVGTFGYMAPEYVTRG-HFSIKS  509 (551)
Q Consensus       473 a~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~s  509 (551)
                      +......+             ..                             .......||++|.|||++... ..++++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            97221100             00                             001124699999999998764 568899


Q ss_pred             hhHhHHHHHHHHHhCCCCCCCCCCcCcccHHHH
Q 008854          510 DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY  542 (551)
Q Consensus       510 Dv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~  542 (551)
                      ||||-|||++-+++++.||. ...++.+.+...
T Consensus       260 Diws~GVI~Lslls~~~PFf-~a~dd~~al~ei  291 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFF-KAKDDADALAEI  291 (418)
T ss_pred             ceeeccceeehhhccccccc-cCccccchHHHH
Confidence            99999999999999999994 444455555443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=3.5e-26  Score=233.23  Aligned_cols=200  Identities=24%  Similarity=0.382  Sum_probs=176.1

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ...++|+....+|.|.+|.|||++. ..++..|+|+++........-+.+|+-+++..+||||+.++|-+......++.|
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            4567899999999999999999984 468899999998877666667889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+.+|+|+++-+   -..++++.++..+.++.++||.|||+.+   -+|||||-.|||+++.|.+|++|||.+..+.. 
T Consensus        92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita-  164 (829)
T KOG0576|consen   92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA-  164 (829)
T ss_pred             EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh-
Confidence            9999999999765   4578999999999999999999999998   79999999999999999999999999865432 


Q ss_pred             CCcccccccccCCCccccccc---ccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYV---TRGHFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                       .......++||+.|||||+.   ..+.|..++|||+.|+...|+-.-+.|.
T Consensus       165 -ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl  215 (829)
T KOG0576|consen  165 -TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL  215 (829)
T ss_pred             -hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence             23345668999999999976   4567889999999999999987777665

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.4e-25  Score=204.90  Aligned_cols=211  Identities=19%  Similarity=0.324  Sum_probs=164.3

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeE-EecCCceEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGF-SFEETERLLI  398 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lV  398 (551)
                      ..+.|.+.+.||+|.||.+-++.++ ..+.+++|-+.+... ...+|.+|..---.| .|.||+.-+++ |+..+..+++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            3467889999999999999999865 456799998876543 355788887755555 58999987765 4556677799


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC--CCCCeEEeecCCcccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--ADMIPKISDFGMARLF  476 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~--~~~~~kl~Dfgla~~~  476 (551)
                      +||+|.|+|.+-+    ....+.+.-..+++.|+++|+.|+|+.+   +||||||.+||||-  +..++||+|||+.+..
T Consensus       101 qE~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  101 QEFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             eccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence            9999999987755    4467888899999999999999999998   99999999999993  3458999999998754


Q ss_pred             ccCCCcccccccccCCCcccccccccC-----CCCcchhhHhHHHHHHHHHhCCCCCCCCCCcCcccHHHHHHhhhh
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTRG-----HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLH  548 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~  548 (551)
                      ..     ......-+..|.+||.....     ...+.+|||.|||+++.++||+.|+...   ...|-..|-|..|-
T Consensus       174 g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka---~~~d~~Y~~~~~w~  242 (378)
T KOG1345|consen  174 GT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA---SIMDKPYWEWEQWL  242 (378)
T ss_pred             Cc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh---hccCchHHHHHHHh
Confidence            32     12233446678999976432     3467899999999999999999999732   33455556666664

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.91  E-value=5.8e-25  Score=207.14  Aligned_cols=194  Identities=30%  Similarity=0.397  Sum_probs=161.0

Q ss_pred             hcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecC------C
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------T  393 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  393 (551)
                      ..+|.....+|.|.. .|-.+. .-.+++||+|++...  .....++..+|..++..++|+||++++.++.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            356777888999998 454443 335789999998654  233455778999999999999999999998643      3


Q ss_pred             ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCc
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA  473 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla  473 (551)
                      +.++|||+|. .+|...++     ..++-.++..|..|++.|+.|||+.+   |+||||||+||++..+..+||.|||++
T Consensus        95 e~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence            5689999994 56766665     34778889999999999999999988   999999999999999999999999999


Q ss_pred             cccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      +.-..+   -..+..+.|..|.|||++.+-.+.+..||||+|+++-||++|+--|.
T Consensus       166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~  218 (369)
T KOG0665|consen  166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP  218 (369)
T ss_pred             cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence            853322   34556778999999999998889999999999999999999998774

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.91  E-value=1.7e-24  Score=180.76  Aligned_cols=100  Identities=41%  Similarity=0.802  Sum_probs=78.4

Q ss_pred             CcCC-C-CCcc-cCCCcHHHHHHHHHHHhhhcccCC--CCceeeeecCCCceeEEEEeccCCCChhhhHHHHHHHHHHHH
Q 008854           12 QTCY-D-TGNF-TTNSTYGKNRDLFLSSLASTVTAN--KGFYTATIGQIPDEVYGLALCRGDSSPESCASCLNFTVLDMM   86 (551)
Q Consensus        12 ~~C~-~-~~~~-~~~s~~~~nl~~l~~~l~~~~~~~--~~~~~~~~g~~~~~vyg~~~C~~d~~~~~C~~Cl~~a~~~~~   86 (551)
                      |.|+ | .++| +++++|++||+.||..|...++..  .+|+++..|.++++|||++||++|+++++|..||+.|+..+.
T Consensus         2 ~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~   81 (106)
T PF01657_consen    2 HFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANIS   81 (106)
T ss_dssp             --E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHH
T ss_pred             CcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHH
Confidence            5788 4 3667 678889999999999999997765  589999989999999999999999999999999999999999


Q ss_pred             hcCCCccceeEecCCCcceEEEEccccc
Q 008854           87 KNCPNQKEAISWEGMDFPCVVRYSSRSF  114 (551)
Q Consensus        87 ~~C~~~~~a~~~~~~~~~C~~ry~~~~f  114 (551)
                      +.|+.+++|+||++   .|+||||+++|
T Consensus        82 ~~C~~~~g~~v~~~---~C~lRY~~~~F  106 (106)
T PF01657_consen   82 SCCPGSRGGRVWYD---SCFLRYENYPF  106 (106)
T ss_dssp             HHTTSBSSEEEEES---SEEEEEESS--
T ss_pred             HhCCCCceEEEECC---CEEEEEECCCC
Confidence            99999999999999   99999999998

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=9.3e-24  Score=213.03  Aligned_cols=170  Identities=19%  Similarity=0.198  Sum_probs=131.0

Q ss_pred             HHHhhhcCCCcCcccCcCCceeEEEeecC--CCCEEEEEEeecC-----ChhcHHHHHHHHHHHhcCCCCCccceeeEEe
Q 008854          318 TIRDATNNFSTDNKLGQGGFGAVYKGRLS--HGQEIAVKRLSKN-----SVQGELEFKNEVLLVARLQHRNLVRLLGFSF  390 (551)
Q Consensus       318 ~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~--~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  390 (551)
                      ......++|.+.+.||+|+||+||++...  +++.+|||++...     .......+.+|+++|++++|+|+++.+..  
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--   89 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--   89 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence            34456688999999999999999999854  5777899987533     11234468999999999999999864332  


Q ss_pred             cCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccC-CCCCeeeCCCCCeEEee
Q 008854          391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDL-KASNILLDADMIPKISD  469 (551)
Q Consensus       391 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl-k~~NIll~~~~~~kl~D  469 (551)
                       ....+|||||+++++|... .   .   ..   ...++.+++++|.|||+.+   |+|||| ||+|||++.++.+||+|
T Consensus        90 -~~~~~LVmE~~~G~~L~~~-~---~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         90 -TGKDGLVRGWTEGVPLHLA-R---P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             -cCCcEEEEEccCCCCHHHh-C---c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence             2457999999999998632 1   1   11   1467889999999999987   999999 99999999999999999


Q ss_pred             cCCccccccCCCcc------cccccccCCCcccccccccC
Q 008854          470 FGMARLFEMDQSQG------DTSRIVGTFGYMAPEYVTRG  503 (551)
Q Consensus       470 fgla~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~  503 (551)
                      ||+++.+.......      ......+++.|++||.+...
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99998765432111      12356788899999988644

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.90  E-value=2.5e-24  Score=213.83  Aligned_cols=212  Identities=21%  Similarity=0.289  Sum_probs=173.3

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCC------CCCccceeeEEecCC
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ------HRNLVRLLGFSFEET  393 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~  393 (551)
                      ....+|.+....|+|-|++|-+|... .|+.||||++..+..-. +.=+.|+++|++|+      .-|.++|+..|...+
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            34578888899999999999999844 57899999998764322 23457999999995      347899999999999


Q ss_pred             ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC-CeEEeecCC
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGM  472 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgl  472 (551)
                      .++||+|-+ .-+|.++|...-....|....+..++.|+.-+|..|...+   |+|.||||+||||++.. .+||+|||.
T Consensus       508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcc
Confidence            999999977 6689999987666777888999999999999999999887   99999999999998765 579999999


Q ss_pred             ccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCCcCcccHHHHHH
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS  544 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~  544 (551)
                      |.....+.    .....-+.-|.|||++.+-+|+...|+||.||.||||.||+..|....   +.+++.+.-
T Consensus       584 A~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T---NN~MLrl~m  648 (752)
T KOG0670|consen  584 ASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT---NNQMLRLFM  648 (752)
T ss_pred             cccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC---cHHHHHHHH
Confidence            97654332    222333557999999999999999999999999999999999886432   334554443

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-22  Score=200.78  Aligned_cols=132  Identities=23%  Similarity=0.347  Sum_probs=107.9

Q ss_pred             cCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-----C---CCccceeeEEec---
Q 008854          324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-----H---RNLVRLLGFSFE---  391 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~---  391 (551)
                      .+|...++||.|.|++||++. .++.+-||+|+.+...... +..+.||++|++++     |   ..||+|++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYt-EaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYT-EAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHH-HHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            688999999999999999998 4567789999997654332 34678999999984     3   369999999975   


Q ss_pred             -CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC
Q 008854          392 -ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD  460 (551)
Q Consensus       392 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~  460 (551)
                       +...+||+|++ +.+|..++... .-+.++...+.+|++||+.||.|||.+.  +|||.||||+|||+.
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence             45678999998 55566655432 4566899999999999999999999987  699999999999983

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=5.6e-22  Score=200.36  Aligned_cols=202  Identities=22%  Similarity=0.280  Sum_probs=163.8

Q ss_pred             CCCcCcccCcCCceeEEEeecCCC--CEEEEEEeecCChhcHHHHHHHHHHHhcCCC----CCccceeeEE-ecCCceEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLSHG--QEIAVKRLSKNSVQGELEFKNEVLLVARLQH----RNLVRLLGFS-FEETERLL  397 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~~g--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  397 (551)
                      +|.+.++||+|+||.||++.....  ..+|+|............+..|..++..+.+    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999985443  4788888876533322267788888888873    5888888888 46777899


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC-----CCeEEeecCC
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-----MIPKISDFGM  472 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~-----~~~kl~Dfgl  472 (551)
                      ||+.+ +.+|.++..... ...++..+.++|+.|++.+|.+||+.+   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99966 888998765432 578999999999999999999999998   9999999999999765     4689999999


Q ss_pred             cc--ccccCCCc----cc--ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          473 AR--LFEMDQSQ----GD--TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       473 a~--~~~~~~~~----~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ++  .+......    ..  .....||.+|.++....+.+.+.+.|+||++.++.||+.|..|+...
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~  240 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL  240 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence            98  33222211    11  23456999999999999999999999999999999999999998643

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.86  E-value=2e-22  Score=227.59  Aligned_cols=148  Identities=18%  Similarity=0.257  Sum_probs=113.5

Q ss_pred             cCCC-CCccceeeEE-------ecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 008854          376 RLQH-RNLVRLLGFS-------FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI  447 (551)
Q Consensus       376 ~l~h-~niv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  447 (551)
                      .++| +||.++++.+       ......++++||+ .++|.++|..  ....+++.+++.++.||++||.|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            3455 5888888876       2234567788887 5699999864  2456999999999999999999999987   9


Q ss_pred             EeccCCCCCeeeCC-------------------CCCeEEeecCCccccccCCC--------------cccccccccCCCc
Q 008854          448 IHRDLKASNILLDA-------------------DMIPKISDFGMARLFEMDQS--------------QGDTSRIVGTFGY  494 (551)
Q Consensus       448 iH~Dlk~~NIll~~-------------------~~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt~~y  494 (551)
                      +||||||+||||+.                   ++.+||+|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   44566667776654211000              0001124578899


Q ss_pred             ccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       495 ~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ||||++.+..++.++|||||||+||||++|..|+.
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~  216 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE  216 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence            99999999999999999999999999999988764

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=1.9e-20  Score=188.35  Aligned_cols=201  Identities=34%  Similarity=0.507  Sum_probs=169.1

Q ss_pred             CCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChh---cHHHHHHHHHHHhcCCCC-CccceeeEEecCCceEEEEEc
Q 008854          326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHR-NLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~  401 (551)
                      |...+.||.|+||.||++...  ..+++|.+......   ....+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            567789999999999999875  88999999765332   356799999999999988 799999999777778999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC-CeEEeecCCccccccCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQ  480 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~  480 (551)
                      +.++++.+++........+.......++.|++.++.|+|+.+   ++||||||+||+++... .+++.|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966643211126889999999999999999999988   99999999999999998 79999999998654333


Q ss_pred             Ccc----cccccccCCCccccccccc---CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          481 SQG----DTSRIVGTFGYMAPEYVTR---GHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       481 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ...    ......|+..|++||.+.+   ...+...|+||+|++++++++|..|+...
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~  214 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE  214 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            221    2456789999999999987   57889999999999999999999996543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=2e-21  Score=176.34  Aligned_cols=200  Identities=21%  Similarity=0.309  Sum_probs=165.7

Q ss_pred             hcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCC-CCccceeeEEecCCceEEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH-RNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .++|.++++||.|+||.+|.|. +.+|.+||||.-+......  .+..|..+...|+| ..|..+..+..++....|||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp--qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP--QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc--chhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4678999999999999999998 6789999999987664433  46678888888876 567777777888888899999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC---CCeEEeecCCccccc
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFE  477 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~kl~Dfgla~~~~  477 (551)
                      .+ +-+|+++..-  -...++..+.+-++.|++.-++|+|..+   +|||||||+|.|..-+   ..+.++||||++.+.
T Consensus        92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            77 7788886642  3456889999999999999999999988   9999999999998643   468999999998775


Q ss_pred             cCCCc-----ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          478 MDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       478 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...+.     .......||.+|.+--...+.+.+.+.|+-|+|.+|..+.-|..||..
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQg  223 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQG  223 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccc
Confidence            43222     123446799999998888888889999999999999999999999963

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=8.4e-21  Score=179.80  Aligned_cols=198  Identities=21%  Similarity=0.365  Sum_probs=166.2

Q ss_pred             cCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      -+|.+.++||+|.||++|.|+ +-++++||||.-...+.  ..++..|.+..+.|. .++|...+-+-.++....||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            368899999999999999998 56889999998755432  235777888888885 68898888888888888999997


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC-----CCeEEeecCCcccc
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-----MIPKISDFGMARLF  476 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~-----~~~kl~Dfgla~~~  476 (551)
                      + +-+|+++..  .-...++..+...++.|++.-++|+|+++   +|.|||||+|+||..-     ..+.|+|||+++.+
T Consensus       106 L-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            7 778888653  24567999999999999999999999998   9999999999999643     35899999999876


Q ss_pred             ccCCCc-----ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          477 EMDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       477 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ....+.     .......||.+||+--...+.+.+.+.|+-|+|-++...|-|..||.
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQ  237 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ  237 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccc
Confidence            543322     23455679999999999999999999999999999999999999996

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=5.6e-21  Score=177.36  Aligned_cols=139  Identities=17%  Similarity=0.182  Sum_probs=109.3

Q ss_pred             CcccCcCCceeEEEeecCCCCEEEEEEeecCChh--c------------------------HHHHHHHHHHHhcCCCCCc
Q 008854          329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ--G------------------------ELEFKNEVLLVARLQHRNL  382 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni  382 (551)
                      ...||+|++|.||+|...+|++||||+++.....  .                        ......|+.++.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999878999999999754211  1                        0122359999999988877


Q ss_pred             cceeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEeccCCCCCeeeCC
Q 008854          383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL-HEDSRLRIIHRDLKASNILLDA  461 (551)
Q Consensus       383 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~Dlk~~NIll~~  461 (551)
                      .....+..  ...+|||||++++++.....   ....+++.+...++.|++.+|.+| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            54433322  23489999999987765432   345788999999999999999999 6776   99999999999998 


Q ss_pred             CCCeEEeecCCcccc
Q 008854          462 DMIPKISDFGMARLF  476 (551)
Q Consensus       462 ~~~~kl~Dfgla~~~  476 (551)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=1.9e-21  Score=182.68  Aligned_cols=170  Identities=15%  Similarity=0.186  Sum_probs=133.1

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHH---------HHHHHHHHhcCCCCCccceeeEEecC
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE---------FKNEVLLVARLQHRNLVRLLGFSFEE  392 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~  392 (551)
                      ..++|...+.||.|+||.||.... ++..+|+|.+.......+..         +.+|+..+.+++||+|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            468999999999999999999765 57789999997653332222         67899999999999999998886533


Q ss_pred             --------CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC
Q 008854          393 --------TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI  464 (551)
Q Consensus       393 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~  464 (551)
                              ...+|||||+++.+|.++..       ++.    ....+++.+|..+|+.+   ++||||||+||++++++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    35789999999999987632       222    24568999999999988   99999999999999988 


Q ss_pred             eEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHH
Q 008854          465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEI  521 (551)
Q Consensus       465 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~el  521 (551)
                      ++|+|||.......+...              ..++....+..++|+|+||+.+..+
T Consensus       173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHH
Confidence            999999988654221110              1144555677899999999987654

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.84  E-value=3.3e-21  Score=160.89  Aligned_cols=90  Identities=37%  Similarity=0.760  Sum_probs=74.1

Q ss_pred             hHHHHHHHHHHHHHHHHhccCCCccceeeeeccCCCccceeeeccccCCCChhchHHHHHHhHHhhhhhcCCCcCceeeC
Q 008854          137 TQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMG  216 (551)
Q Consensus       137 ~~f~~~~~~l~~~l~~~a~~~~~~~~~a~~~~~~~~~~~vy~laQC~~dl~~~~C~~Cl~~~~~~~~~~~~~~~g~~v~~  216 (551)
                      ..|..++..||++|...|+..+ ..+|++++. ..+.++||||+||++||++++|..||+.++..++.+|+++.||+|++
T Consensus        17 ~~f~~~l~~ll~~l~~~a~~~~-~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g~~v~~   94 (106)
T PF01657_consen   17 STFEQNLNSLLSSLVSNAASSS-SKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGSRGGRVWY   94 (106)
T ss_dssp             -THHHHHHHHHHHHHHHGGGTT--TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSSEEEEE
T ss_pred             chHHHHHHHHHHHHHHHHhhcc-ccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCceEEEEC
Confidence            4599999999999999987653 345999986 45677999999999999999999999999999999999999999999


Q ss_pred             cccccccccCcc
Q 008854          217 PSCIFRWEMYPF  228 (551)
Q Consensus       217 ~~C~lr~~~~~F  228 (551)
                      ++|+|||+.++|
T Consensus        95 ~~C~lRY~~~~F  106 (106)
T PF01657_consen   95 DSCFLRYENYPF  106 (106)
T ss_dssp             SSEEEEEESS--
T ss_pred             CCEEEEEECCCC
Confidence            999999999998

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.83  E-value=5e-20  Score=171.53  Aligned_cols=140  Identities=22%  Similarity=0.277  Sum_probs=111.7

Q ss_pred             CcccCcCCceeEEEeecCCCCEEEEEEeecCChh---------------------c-----HHHHHHHHHHHhcCCCCCc
Q 008854          329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ---------------------G-----ELEFKNEVLLVARLQHRNL  382 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~ni  382 (551)
                      ...||+|++|.||+|...+|+.||||++......                     .     ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4789999999999999778999999999765211                     0     1124578999999999988


Q ss_pred             cceeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCeeeCC
Q 008854          383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDA  461 (551)
Q Consensus       383 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlk~~NIll~~  461 (551)
                      .....+...  ..+|||||++++++.....   ....++......++.+++.++.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            655544333  3489999999886543322   23457788899999999999999999 76   99999999999998 


Q ss_pred             CCCeEEeecCCccccc
Q 008854          462 DMIPKISDFGMARLFE  477 (551)
Q Consensus       462 ~~~~kl~Dfgla~~~~  477 (551)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8899999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.82  E-value=3.7e-20  Score=170.26  Aligned_cols=106  Identities=23%  Similarity=0.261  Sum_probs=93.2

Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      |+|.+++..  ....+++.+++.++.||++||.|||+.+         ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            688888864  2456999999999999999999999875         999999999999999  99987654321    


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                         ..||+.|||||++.+..++.++||||||+++|||++|+.||..
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~  106 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE  106 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence               2578999999999999999999999999999999999999853

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.82  E-value=5.7e-21  Score=176.07  Aligned_cols=194  Identities=22%  Similarity=0.343  Sum_probs=154.7

Q ss_pred             CcCcccCcCCceeEEEeecCCCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCC
Q 008854          327 STDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       327 ~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      .+.-+|.+...|+.|+|+++ |..+++|++.....  .-.++|.+|.-.|+.+.||||+.++|.|.......++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            34567899999999999995 56777888765422  2234688999999999999999999999999999999999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCccc
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      |+|..+|++. .....+..+..+++.+|++||+|||+..+ -|.---|.++.|+||++.+++|+ .+-.++.-      .
T Consensus       272 gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris-mad~kfsf------q  342 (448)
T KOG0195|consen  272 GSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS-MADTKFSF------Q  342 (448)
T ss_pred             hHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee-cccceeee------e
Confidence            9999999864 34457788899999999999999999863 34455789999999999998875 11121110      1


Q ss_pred             ccccccCCCcccccccccCCCC---cchhhHhHHHHHHHHHhCCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFS---IKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~---~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....-.+.||+||.+..++-+   ...|+|||+|++|||.|.+-||..
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfad  391 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFAD  391 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccccc
Confidence            1122347899999999877654   469999999999999999999963

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=4.1e-19  Score=163.29  Aligned_cols=185  Identities=18%  Similarity=0.136  Sum_probs=138.9

Q ss_pred             CcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhc----HHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEEEc
Q 008854          327 STDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG----ELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       327 ~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .....|++|+||+|+.+.- ++.+++.+.++......    ...+.+|+++|.+|. |+++.+++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3457899999999997765 67888888886654321    124789999999995 5889999886    456899999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccC-CCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDL-KASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl-k~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      +.+.+|...+..          ....++.|+.++|.++|+.+   |+|||| ||.|||+++++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999998654311          11357789999999999998   999999 7999999999999999999998544322


Q ss_pred             Cc----c-------cccccccCCCcccccccccC-CCC-cchhhHhHHHHHHHHHhCCCCCC
Q 008854          481 SQ----G-------DTSRIVGTFGYMAPEYVTRG-HFS-IKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       481 ~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ..    .       .......++.+++|+.-.-- ..+ ...++++-|..+|.++|++.++-
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            10    0       01122357788888743221 223 57899999999999999998763

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=2.3e-18  Score=161.37  Aligned_cols=137  Identities=22%  Similarity=0.380  Sum_probs=106.2

Q ss_pred             CcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcC-----CCCCccceeeEEecCC---ceE-E
Q 008854          327 STDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-----QHRNLVRLLGFSFEET---ERL-L  397 (551)
Q Consensus       327 ~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-l  397 (551)
                      ...+.||+|+||.||. .-.++.. +||++..........+.+|+.++.++     .||||++++|++.++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            4457899999999996 2223444 69988765444556799999999999     5799999999998764   323 7


Q ss_pred             EEEc--cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeEeccCCCCCeeeCC----CCCeEEee-
Q 008854          398 IYEF--VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI-LYLHEDSRLRIIHRDLKASNILLDA----DMIPKISD-  469 (551)
Q Consensus       398 V~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~iiH~Dlk~~NIll~~----~~~~kl~D-  469 (551)
                      |+||  .++++|.+++.+    ..+++.  ..++.+++.++ .|||+++   |+||||||+|||++.    +..++|+| 
T Consensus        83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  668999999954    235554  35677888777 9999988   999999999999974    34899999 


Q ss_pred             cCCcc
Q 008854          470 FGMAR  474 (551)
Q Consensus       470 fgla~  474 (551)
                      ||...
T Consensus       154 ~G~~~  158 (210)
T PRK10345        154 IGEST  158 (210)
T ss_pred             CCCcc
Confidence            45443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=1.4e-19  Score=194.70  Aligned_cols=202  Identities=26%  Similarity=0.389  Sum_probs=160.5

Q ss_pred             CcCcccCcCCceeEEEeec-CCCCEEEEEEee----cC-Chh-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          327 STDNKLGQGGFGAVYKGRL-SHGQEIAVKRLS----KN-SVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       327 ~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~----~~-~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ...+.+|.|.+|.|+.... ...+..+.|.+.    .. ... ....+..|..+-..+.|||++..+....+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            3567899999998777653 233434444332    11 111 1112667888888999999998888777766666669


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++ +|..++..   ...+...++..++.|+..|+.|||+.+   |.|||||++|+++..++.+||+|||.+..+...
T Consensus       401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 99888753   346888999999999999999999998   999999999999999999999999999876544


Q ss_pred             CCc--ccccccccCCCcccccccccCCCCcc-hhhHhHHHHHHHHHhCCCCCCCCCCcC
Q 008854          480 QSQ--GDTSRIVGTFGYMAPEYVTRGHFSIK-SDVFSFGVLVLEIISGQKNNSFRIGEE  535 (551)
Q Consensus       480 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~S~Gvll~elltG~~p~~~~~~~~  535 (551)
                      ...  .....++|+..|+|||.+.+.+|++. .||||.||++..|++|+.||.....++
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~  532 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSD  532 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccc
Confidence            333  45667889999999999999999864 899999999999999999998665543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.77  E-value=5.8e-20  Score=188.57  Aligned_cols=186  Identities=28%  Similarity=0.353  Sum_probs=154.7

Q ss_pred             ccCcCCceeEEEee----cCCCCEEEEEEeecCChhc--HHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEEEccC
Q 008854          331 KLGQGGFGAVYKGR----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       331 ~LG~G~~g~Vyk~~----~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      .+|+|.||.|+.++    .+.|+-+|+|.+++.....  ......|..++...+ ||.++++.-.++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999775    2346778999887653221  114556788888887 9999999999999999999999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      +|.|...+.   +...+++.........++-+++++|+.+   |+|||+|++||+++.+|++++.|||+++..-....  
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            999887765   4556777777778888999999999988   99999999999999999999999999986543222  


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                          .+||..|||||++.  ......|.||||++++||+||-.||..
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence                18999999999988  456789999999999999999999964

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=1.6e-18  Score=189.96  Aligned_cols=198  Identities=19%  Similarity=0.235  Sum_probs=158.7

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC---CCCccceeeEEecCCceEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ---HRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV  398 (551)
                      ..+.|.+.+.||+|+||+||+|...+|+.||+|+-+......   |.-=.+++.+|+   -+.|..+.....-.+.-+||
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            346788888999999999999998889999999987765432   222223344444   23445555555567778999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC-------CCCCeEEeecC
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-------ADMIPKISDFG  471 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~-------~~~~~kl~Dfg  471 (551)
                      +||.+.|+|.+++.   ..+.++|.....++.|+++.+..||..+   |||+||||+|.||.       ++.-++|+|||
T Consensus       773 ~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  773 SEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             eeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecc
Confidence            99999999999986   5677999999999999999999999988   99999999999993       23468999999


Q ss_pred             CccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                      .+--+..-.........++|-.+--+|...++.++.+.|.|.|+-+++-||.|+..-
T Consensus       847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q  903 (974)
T KOG1166|consen  847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME  903 (974)
T ss_pred             cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH
Confidence            986443333333455667899999999999999999999999999999999998643

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1.9e-17  Score=157.09  Aligned_cols=134  Identities=19%  Similarity=0.308  Sum_probs=113.6

Q ss_pred             cccCcCCceeEEEeecCCCCEEEEEEeecCChh--------cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ--------GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      +.||+|++|.||+|.. .|..+++|+.......        ....+.+|+.++..++|++|.....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            6799999999999987 6778999986543211        123577899999999999998888887777888999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      +++++|.+++...      .+ .+..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999987531      12 78899999999999999987   99999999999999 78999999999875

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=1.8e-17  Score=178.92  Aligned_cols=145  Identities=16%  Similarity=0.291  Sum_probs=115.4

Q ss_pred             hhHHHhhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEE-eecC-Ch------hcHHHHHHHHHHHhcCCCCCccceee
Q 008854          316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKR-LSKN-SV------QGELEFKNEVLLVARLQHRNLVRLLG  387 (551)
Q Consensus       316 ~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~-~~~~-~~------~~~~~~~~E~~~l~~l~h~niv~l~~  387 (551)
                      +.........|...++||+|+||+||+|.+.+.. +++|+ +.+. ..      .....+.+|++++..++|++++....
T Consensus       325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  403 (535)
T PRK09605        325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI  403 (535)
T ss_pred             eccccccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence            3333444556677899999999999999875444 44443 3221 11      11245789999999999999998888


Q ss_pred             EEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEE
Q 008854          388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI  467 (551)
Q Consensus       388 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl  467 (551)
                      +.......++||||+++++|.+++.           ....++.+++++|.+||+.+   ++||||||+|||+ +++.++|
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~l  468 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYL  468 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEE
Confidence            8877778899999999999998874           34678999999999999987   9999999999999 6789999


Q ss_pred             eecCCcccc
Q 008854          468 SDFGMARLF  476 (551)
Q Consensus       468 ~Dfgla~~~  476 (551)
                      +|||+++..
T Consensus       469 iDFGla~~~  477 (535)
T PRK09605        469 IDFGLGKYS  477 (535)
T ss_pred             EeCcccccC
Confidence            999999763

>smart00090 RIO RIO-like kinase

Probab=99.73  E-value=2.2e-17  Score=158.51  Aligned_cols=143  Identities=20%  Similarity=0.254  Sum_probs=111.6

Q ss_pred             cCCCcCcccCcCCceeEEEee--cCCCCEEEEEEeecCChh------------------------cHHHHHHHHHHHhcC
Q 008854          324 NNFSTDNKLGQGGFGAVYKGR--LSHGQEIAVKRLSKNSVQ------------------------GELEFKNEVLLVARL  377 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  377 (551)
                      ..|.+.+.||+|++|.||+|.  ..+|+.||+|++......                        ....+..|+.++.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357788999999999999998  568999999998754210                        012356899999999


Q ss_pred             CCCC--ccceeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCC
Q 008854          378 QHRN--LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKAS  455 (551)
Q Consensus       378 ~h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~  455 (551)
                      .+..  +.++++.    ...++||||+++.+|.....   ....+.......++.||+.++.+||+.+  +|+|+||||+
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~  178 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY  178 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence            7633  3344432    24589999999988876542   2334566677899999999999999876  4999999999


Q ss_pred             CeeeCCCCCeEEeecCCcccc
Q 008854          456 NILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       456 NIll~~~~~~kl~Dfgla~~~  476 (551)
                      ||+++ ++.++|+|||++...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 889999999998753

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=3.5e-17  Score=153.57  Aligned_cols=141  Identities=20%  Similarity=0.216  Sum_probs=110.2

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCCh--h--------------------cHHHHHHHHHHHhcCC
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV--Q--------------------GELEFKNEVLLVARLQ  378 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~--~--------------------~~~~~~~E~~~l~~l~  378 (551)
                      .....|.+.+.||+|+||.||++...+|+.||||++.....  .                    ....+..|+.++..+.
T Consensus        12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   91 (198)
T cd05144          12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY   91 (198)
T ss_pred             HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence            33344778899999999999999988899999998764320  0                    0113567888999998


Q ss_pred             CCC--ccceeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCC
Q 008854          379 HRN--LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASN  456 (551)
Q Consensus       379 h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~N  456 (551)
                      |++  +.+.++    ....++||||+++++|......         .....++.+++.++.++|+.+   |+||||||+|
T Consensus        92 ~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~N  155 (198)
T cd05144          92 EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFN  155 (198)
T ss_pred             HcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCccc
Confidence            874  444443    2456899999999998765320         234578899999999999977   9999999999


Q ss_pred             eeeCCCCCeEEeecCCccccc
Q 008854          457 ILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       457 Ill~~~~~~kl~Dfgla~~~~  477 (551)
                      |++++++.++|+|||++..+.
T Consensus       156 ill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         156 ILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             EEEcCCCcEEEEECCccccCC
Confidence            999999999999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.72  E-value=5.5e-17  Score=152.40  Aligned_cols=130  Identities=21%  Similarity=0.387  Sum_probs=107.1

Q ss_pred             ccCcCCceeEEEeecCCCCEEEEEEeecCChh--------cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ--------GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       331 ~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      .||+|++|.||+|.+ ++..+++|+.......        ....+.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999986 5788999986543211        1245778999999999988766666666677789999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++++|.+++...   ..       .++.+++.+|.+||+.+   ++|+|++|+||+++ ++.+++.|||+++.
T Consensus        80 ~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEG---ND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhc---HH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999887531   10       78999999999999987   99999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.70  E-value=1.1e-16  Score=155.15  Aligned_cols=201  Identities=18%  Similarity=0.273  Sum_probs=131.7

Q ss_pred             CCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCC----------CCccceeeEEe-
Q 008854          326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQH----------RNLVRLLGFSF-  390 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~-  390 (551)
                      +...+.||.|+++.||.+... .++++|||++....   ....+++++|......+.+          -.++..++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345678999999999999965 48999999985442   2345567777766666433          12222222221 


Q ss_pred             --------cCC--------ceEEEEEccCCCChhHHhhhhcc----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEec
Q 008854          391 --------EET--------ERLLIYEFVPNSSVDKFIFDAIK----RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR  450 (551)
Q Consensus       391 --------~~~--------~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~  450 (551)
                              ...        +.+++|+-+ .++|.+++.....    ...+....++.+..|+++.+++||..+   ++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence                    111        235677766 6778777542111    122445567778899999999999998   9999


Q ss_pred             cCCCCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCccccccccc--------CCCCcchhhHhHHHHHHHHH
Q 008854          451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR--------GHFSIKSDVFSFGVLVLEII  522 (551)
Q Consensus       451 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~S~Gvll~ell  522 (551)
                      ||+|+|++++++|.++|+||+.........     .....+..|.+||....        -.++.+.|.|++|+++|.|+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999998776533211     11234578999997643        25788999999999999999


Q ss_pred             hCCCCCCCCCCcC
Q 008854          523 SGQKNNSFRIGEE  535 (551)
Q Consensus       523 tG~~p~~~~~~~~  535 (551)
                      +|+.||....++.
T Consensus       245 C~~lPf~~~~~~~  257 (288)
T PF14531_consen  245 CGRLPFGLSSPEA  257 (288)
T ss_dssp             HSS-STCCCGGGS
T ss_pred             HccCCCCCCCccc
Confidence            9999998654433

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.68  E-value=1.1e-16  Score=164.62  Aligned_cols=168  Identities=27%  Similarity=0.479  Sum_probs=134.2

Q ss_pred             HhcCCCCCccceeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCC
Q 008854          374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLK  453 (551)
Q Consensus       374 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk  453 (551)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+..  ....++|.-...++++|+.||.|||...  --.|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            4578999999999999999999999999999999999975  4677999999999999999999999865  23999999


Q ss_pred             CCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccC-------CCCcchhhHhHHHHHHHHHhCCC
Q 008854          454 ASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-------HFSIKSDVFSFGVLVLEIISGQK  526 (551)
Q Consensus       454 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~S~Gvll~elltG~~  526 (551)
                      +.|+++|..+.+||+|||+..+..............-..-|.|||.+...       ..+.+.||||||++++|+++-+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998765421111112222235579999988653       14678999999999999999999


Q ss_pred             CCCCCCCcC-cccHHHHHHh
Q 008854          527 NNSFRIGEE-AEDLLTYVSN  545 (551)
Q Consensus       527 p~~~~~~~~-~~~l~~~~~~  545 (551)
                      ||+...... .+.++.++.+
T Consensus       157 ~~~~~~~~~~~~eii~~~~~  176 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK  176 (484)
T ss_pred             ccccccccCChHHHHHHHHh
Confidence            997543322 2345555443

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=1.6e-15  Score=135.03  Aligned_cols=135  Identities=21%  Similarity=0.232  Sum_probs=114.5

Q ss_pred             cCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCC--CCccceeeEEecCCceEEEEEccCCC
Q 008854          328 TDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH--RNLVRLLGFSFEETERLLIYEFVPNS  405 (551)
Q Consensus       328 ~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~g  405 (551)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+.+|+.++..++|  .++.+++++....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999744 7899999866543  4578899999999976  58999998888778899999999988


Q ss_pred             ChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      .+..+          +......++.+++++|.+||.....+++|+||+|+||++++++.+++.|||.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            76543          5566777899999999999987555699999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.64  E-value=1.4e-15  Score=141.25  Aligned_cols=136  Identities=21%  Similarity=0.262  Sum_probs=97.5

Q ss_pred             CcccCcCCceeEEEeecCCCCEEEEEEeecCChh--cHHH----------------------HHHHHHHHhcCCCCC--c
Q 008854          329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ--GELE----------------------FKNEVLLVARLQHRN--L  382 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i  382 (551)
                      .+.||+|+||+||++...++++||||++......  ....                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4689999999999999878999999998754221  1111                      134555666654432  3


Q ss_pred             cceeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCeeeCC
Q 008854          383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDA  461 (551)
Q Consensus       383 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlk~~NIll~~  461 (551)
                      .+.+++    ...++||||++++.+.........   .. .....++.+++.++.++|. .+   |+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            444433    346899999999554321111000   11 5677899999999999998 65   99999999999999 


Q ss_pred             CCCeEEeecCCcccc
Q 008854          462 DMIPKISDFGMARLF  476 (551)
Q Consensus       462 ~~~~kl~Dfgla~~~  476 (551)
                      ++.++|+|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            899999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.63  E-value=9.7e-16  Score=148.83  Aligned_cols=144  Identities=25%  Similarity=0.362  Sum_probs=105.9

Q ss_pred             CCCCccceeeEEecC---------------------------CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHH
Q 008854          378 QHRNLVRLLGFSFEE---------------------------TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG  430 (551)
Q Consensus       378 ~h~niv~l~~~~~~~---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  430 (551)
                      +|||||++.++|.++                           ..+|+||... ..+|.++|..    ...+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc----CCCchHHHHHHHH
Confidence            699999999876532                           2467888766 3478888753    3456666777899


Q ss_pred             HHHHHHHHHhhCCCCCeEeccCCCCCeee--CCCC--CeEEeecCCccccccC----CCcccccccccCCCccccccccc
Q 008854          431 GIARGILYLHEDSRLRIIHRDLKASNILL--DADM--IPKISDFGMARLFEMD----QSQGDTSRIVGTFGYMAPEYVTR  502 (551)
Q Consensus       431 ~ia~~L~yLH~~~~~~iiH~Dlk~~NIll--~~~~--~~kl~Dfgla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~  502 (551)
                      |+++|+.|||+++   |.|||+|++||||  |+|.  ...|+|||++---+..    ......-..-|...-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999988   9999999999998  4555  4689999997421110    00111222346778899998753


Q ss_pred             C--CC----CcchhhHhHHHHHHHHHhCCCCCC
Q 008854          503 G--HF----SIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       503 ~--~~----~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .  +.    -.|+|.|+.|-+.||++....||-
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY  458 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFY  458 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCccc
Confidence            2  21    258999999999999999999985

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.62  E-value=2e-16  Score=170.51  Aligned_cols=196  Identities=19%  Similarity=0.229  Sum_probs=144.8

Q ss_pred             CCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCC-hhcHHHHH---HHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS-VQGELEFK---NEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ++...+.||.+.|=+|.+++.++|. |+||++-+.. .-....|.   +|++ ...++|||.+++.-+-....-.|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5667789999999999999988777 9999986654 22333443   4444 555689999999887666667788888


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc-cC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE-MD  479 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~-~~  479 (551)
                      |+.+ +|.+.|.   .+.-+...+...|+.|++.||.-.|..+   |+|||||.+||||+.-.=+.|+||.--+-.. ..
T Consensus       102 yvkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            8855 4555543   3455777888999999999999999988   9999999999999998888999997654211 11


Q ss_pred             CCccccccc----ccCCCcccccccccC-----------CCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          480 QSQGDTSRI----VGTFGYMAPEYVTRG-----------HFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       480 ~~~~~~~~~----~gt~~y~aPE~~~~~-----------~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ++......+    ..-..|+|||.+...           ..+++-||||.|+++.||++ |+++|.
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            111111111    112369999976431           25788999999999999987 788885

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.60  E-value=5.5e-16  Score=167.14  Aligned_cols=169  Identities=25%  Similarity=0.388  Sum_probs=121.3

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ..+|+.++.|..|++|.||..+++ ..+++|+|+-+.+-.     +.+   ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li-----lRn---ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI-----LRN---ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccchh-----hhc---cccccCCccee------------------
Confidence            467889999999999999999865 357788844322210     111   33333444443                  


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC-
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ-  480 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-  480 (551)
                         |+-...+.   ..++++..        ++.+++|||+.+   |+|||+||+|.+|+.-|++|+.|||+++..-... 
T Consensus       136 ---gDc~tllk---~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLLK---NIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhcc---cCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               22222222   11222222        267899999987   9999999999999999999999999987532111 


Q ss_pred             ------------CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCCc
Q 008854          481 ------------SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGE  534 (551)
Q Consensus       481 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~~~  534 (551)
                                  .+.....++||+.|+|||++....|..-.|+|++|+|+||.+-|.-||....+|
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe  264 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE  264 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH
Confidence                        111234568999999999999999999999999999999999999999765443

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.59  E-value=1.1e-14  Score=140.09  Aligned_cols=135  Identities=21%  Similarity=0.260  Sum_probs=104.5

Q ss_pred             CcccC-cCCceeEEEeecCCCCEEEEEEeecCCh-------------hcHHHHHHHHHHHhcCCCCCc--cceeeEEecC
Q 008854          329 DNKLG-QGGFGAVYKGRLSHGQEIAVKRLSKNSV-------------QGELEFKNEVLLVARLQHRNL--VRLLGFSFEE  392 (551)
Q Consensus       329 ~~~LG-~G~~g~Vyk~~~~~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  392 (551)
                      ...|| .|+.|+||++... +..++||++.....             .....+.+|++++.+++|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 8999999999874 77899998854211             122357889999999998875  6677764432


Q ss_pred             Cc----eEEEEEccCC-CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEE
Q 008854          393 TE----RLLIYEFVPN-SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI  467 (551)
Q Consensus       393 ~~----~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl  467 (551)
                      ..    .++|||++++ .+|.+++.+    ..++..    .+.+|+.+|.+||+.+   |+|+||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence            22    2599999997 688888753    234443    3578999999999988   999999999999999999999


Q ss_pred             eecCCccc
Q 008854          468 SDFGMARL  475 (551)
Q Consensus       468 ~Dfgla~~  475 (551)
                      +|||.+..
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99999865

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.58  E-value=4.8e-16  Score=157.06  Aligned_cols=124  Identities=26%  Similarity=0.459  Sum_probs=108.5

Q ss_pred             ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCc
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA  473 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla  473 (551)
                      ..++.|+++...+|.++|.........++...+.++.|++.++.|   ++   .+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            467999999999999999765566778899999999999999999   44   899999999999999999999999998


Q ss_pred             cccccCC----CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh
Q 008854          474 RLFEMDQ----SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS  523 (551)
Q Consensus       474 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt  523 (551)
                      .......    .........||..||+||.+.+..|+.|+||||||+||+||+.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            6554333    1224556789999999999999999999999999999999998

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=3.9e-15  Score=160.40  Aligned_cols=209  Identities=23%  Similarity=0.335  Sum_probs=165.0

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCC--CCEEEEEEeecCC--hhcHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSH--GQEIAVKRLSKNS--VQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~--g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  397 (551)
                      ...|...+.||+|.|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++.+++........++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3456777889999999998887533  3456777665543  222233445777777776 9999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEeccCCCCCeeeCCCC-CeEEeecCCccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH-EDSRLRIIHRDLKASNILLDADM-IPKISDFGMARL  475 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~  475 (551)
                      +.+|..++++.+.+.. ......+......++.|+..++.|+| ..+   +.|+||||+|.+++..+ ..+++|||++..
T Consensus        99 ~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence            9999999998877631 12224566677788999999999999 766   99999999999999999 999999999987


Q ss_pred             ccc-CCCccccccccc-CCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCCCcC
Q 008854          476 FEM-DQSQGDTSRIVG-TFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE  535 (551)
Q Consensus       476 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~~~~~~  535 (551)
                      +.. +.........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++......
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~  237 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD  237 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence            765 444444556678 9999999998874 44678999999999999999999998765543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.48  E-value=1.7e-13  Score=143.36  Aligned_cols=141  Identities=24%  Similarity=0.332  Sum_probs=100.2

Q ss_pred             CcccCcCCceeEEEeecCCCCEEEEEEeecCChhc----------------------------------------HHHHH
Q 008854          329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG----------------------------------------ELEFK  368 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~----------------------------------------~~~~~  368 (551)
                      .+.||.|++|+||+|++.+|+.||||+.+......                                        +.+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            37899999999999999999999999986542111                                        01244


Q ss_pred             HHHHHHhcC----CCCCccceeeEEe-cCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHH-HHHHHhhC
Q 008854          369 NEVLLVARL----QHRNLVRLLGFSF-EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR-GILYLHED  442 (551)
Q Consensus       369 ~E~~~l~~l----~h~niv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~~  442 (551)
                      +|...+.++    +|.+-+.+-.++. ..+..+|||||+++++|.++....  ....+   +.+++..++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~--~~~~~---~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD--EAGLD---RKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH--hcCCC---HHHHHHHHHHHHHHHHHhC
Confidence            455555554    2333233333332 345679999999999998876431  11222   3456666665 46788887


Q ss_pred             CCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       443 ~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      +   ++|+|+||.||++++++.+++.|||++..+.
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            7   9999999999999999999999999997664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.36  E-value=2.5e-12  Score=117.28  Aligned_cols=130  Identities=22%  Similarity=0.177  Sum_probs=97.1

Q ss_pred             CcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccc-eeeEEecCCceEEEEEccCCCCh
Q 008854          329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR-LLGFSFEETERLLIYEFVPNSSV  407 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lV~e~~~~gsL  407 (551)
                      .+.|+.|.++.||++... ++.+++|....... ....+..|+.++..+.+.++++ ++.+.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            467899999999999864 78899999765432 2234678899999887655544 44432  3346899999999887


Q ss_pred             hHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      ....        .   ....++.+++++|..||...  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            6420        0   11235678999999999876  23469999999999999 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.32  E-value=5.9e-12  Score=133.24  Aligned_cols=143  Identities=19%  Similarity=0.272  Sum_probs=95.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCC-CCEEEEEEeecCChhc--------------------------------------
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQG--------------------------------------  363 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~-g~~vavK~~~~~~~~~--------------------------------------  363 (551)
                      -..|+. +.||.|++|+||++++.+ |++||||+..+...+.                                      
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345676 799999999999999887 9999999997542110                                      


Q ss_pred             --HHHHHHHHHHHhcCC----CCCccceeeEEec-CCceEEEEEccCCCChhHHhhhhcccCCCC-----HHHHHHHHHH
Q 008854          364 --ELEFKNEVLLVARLQ----HRNLVRLLGFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLD-----WETRYKIIGG  431 (551)
Q Consensus       364 --~~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~-----~~~~~~i~~~  431 (551)
                        +.++.+|...+.+++    +.+.+.+-.++.+ .+..+|||||++++.+.++..-  .....+     ......++.|
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l--~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL--RAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH--HhcCCCHHHHHHHHHHHHHHH
Confidence              012344444444442    3344444444433 4567899999999999875321  112222     2222223333


Q ss_pred             HHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC----CeEEeecCCcccccc
Q 008854          432 IARGILYLHEDSRLRIIHRDLKASNILLDADM----IPKISDFGMARLFEM  478 (551)
Q Consensus       432 ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~kl~Dfgla~~~~~  478 (551)
                      +       ...+   ++|+|+||.||+++.++    .+++.|||+...++.
T Consensus       276 i-------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 V-------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             H-------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3       3344   99999999999999988    999999999876643

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.25  E-value=7e-11  Score=123.28  Aligned_cols=166  Identities=16%  Similarity=0.208  Sum_probs=125.2

Q ss_pred             cCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHH
Q 008854          345 LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWET  424 (551)
Q Consensus       345 ~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~  424 (551)
                      ..++.+|.|+..+...........+-++.|+.++||||++++.....++..|||+|.+.  .|..++.+      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence            45788999998877665334457788899999999999999999999999999999874  35555543      22455


Q ss_pred             HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCC
Q 008854          425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH  504 (551)
Q Consensus       425 ~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  504 (551)
                      ....+.||+.||.+||+.+  +++|++|.-..|+|++.|..||++|.++........  ......---.|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence            6667899999999999776  599999999999999999999999988754322111  111111122456666543332


Q ss_pred             CCcchhhHhHHHHHHHHHhC
Q 008854          505 FSIKSDVFSFGVLVLEIISG  524 (551)
Q Consensus       505 ~~~~sDv~S~Gvll~elltG  524 (551)
                        -..|.|-||+++||++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              346999999999999999

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.20  E-value=2.6e-11  Score=115.81  Aligned_cols=156  Identities=22%  Similarity=0.287  Sum_probs=119.0

Q ss_pred             HHHHHhcCCCCCccceeeEEecC-----CceEEEEEccCCCChhHHhhhhcc-cCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 008854          370 EVLLVARLQHRNLVRLLGFSFEE-----TERLLIYEFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGILYLHEDS  443 (551)
Q Consensus       370 E~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~  443 (551)
                      -..-|-++.|.|||+++.++.+.     ....++.|||..|+|..+|++..+ ...+......+++.||+.||.|||+..
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            34456667899999999887543     345789999999999999986433 445777788899999999999999975


Q ss_pred             CCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC---CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHH
Q 008854          444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD---QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLE  520 (551)
Q Consensus       444 ~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~e  520 (551)
                       |+|+|+++.-+-|++..++.+||.-- ........   ..........+-++|.+||+=...+.+-.+|||+||+..+|
T Consensus       197 -PpiihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle  274 (458)
T KOG1266|consen  197 -PPIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE  274 (458)
T ss_pred             -CccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence             78999999999999999999998531 11111100   00111233346789999998777777889999999999999


Q ss_pred             HHhCCCC
Q 008854          521 IISGQKN  527 (551)
Q Consensus       521 lltG~~p  527 (551)
                      |--|+-.
T Consensus       275 mailEiq  281 (458)
T KOG1266|consen  275 MAILEIQ  281 (458)
T ss_pred             HHHheec
Confidence            9888764

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.20  E-value=2.3e-10  Score=105.45  Aligned_cols=135  Identities=17%  Similarity=0.153  Sum_probs=97.3

Q ss_pred             cccCcCCceeEEEeecCC-------CCEEEEEEeecCCh----------------------hcHHHH----HHHHHHHhc
Q 008854          330 NKLGQGGFGAVYKGRLSH-------GQEIAVKRLSKNSV----------------------QGELEF----KNEVLLVAR  376 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~-------g~~vavK~~~~~~~----------------------~~~~~~----~~E~~~l~~  376 (551)
                      ..||.|-.+.||.|...+       +..+|||+.+....                      .....+    ++|.+.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            578999999999997543       47899998753210                      001122    379999999


Q ss_pred             CCC--CCccceeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEeccCC
Q 008854          377 LQH--RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL-HEDSRLRIIHRDLK  453 (551)
Q Consensus       377 l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~Dlk  453 (551)
                      +..  -++.+++.+    ...+|||||+.+..+....   .+...++..+...+..+++.+|..| |+.+   |||+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~---Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK---LKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh---hhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            864  455666654    5678999999875442211   1222345556677889999999999 7776   9999999


Q ss_pred             CCCeeeCCCCCeEEeecCCccc
Q 008854          454 ASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       454 ~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      +.|||++ ++.+.|+|||.+..
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~  173 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVE  173 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCcee
Confidence            9999997 46799999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.19  E-value=2.9e-10  Score=101.28  Aligned_cols=131  Identities=20%  Similarity=0.326  Sum_probs=102.1

Q ss_pred             cccCcCCceeEEEeecCCCCEEEEEEe-ecC-Chhc------HHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          330 NKLGQGGFGAVYKGRLSHGQEIAVKRL-SKN-SVQG------ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~g~~vavK~~-~~~-~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ..+++|+.+.++.+.+.+ .++++|.= ++. ....      .....+|.+++.+++--.|.-..-+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            468899999999997744 44555543 332 1111      12356899999999877777777777888888999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      +++..|.+.+...          ...++..+-.-+.-||..+   |+|+||.++||++..+. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999988642          2556778888889999988   99999999999997665 89999999874

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.18  E-value=1.9e-10  Score=109.54  Aligned_cols=142  Identities=18%  Similarity=0.293  Sum_probs=108.3

Q ss_pred             cccCcCCceeEEEeecCCCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCC--CccceeeEEecCC---ceEEEEEccC
Q 008854          330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHR--NLVRLLGFSFEET---ERLLIYEFVP  403 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lV~e~~~  403 (551)
                      +.|+.|..+.||++...+|+.+++|....... .....+..|..++..+++.  ++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            67899999999999887778999999865432 1344688999999999764  4566777765532   5689999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS----------------------------------------  443 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------------  443 (551)
                      +.++...+.    ...++...+..++.++++.|..||+..                                        
T Consensus        84 G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            998876542    134667777778888888888888421                                        


Q ss_pred             -------------CCCeEeccCCCCCeeeCC--CCCeEEeecCCccc
Q 008854          444 -------------RLRIIHRDLKASNILLDA--DMIPKISDFGMARL  475 (551)
Q Consensus       444 -------------~~~iiH~Dlk~~NIll~~--~~~~kl~Dfgla~~  475 (551)
                                   ...++|+|+++.||++++  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         244799999999999998  66789999988753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.18  E-value=3.5e-11  Score=124.43  Aligned_cols=200  Identities=25%  Similarity=0.303  Sum_probs=153.5

Q ss_pred             cCCCcCcccCc--CCceeEEEeec---CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCC-CCCccceeeEEecCCce
Q 008854          324 NNFSTDNKLGQ--GGFGAVYKGRL---SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETER  395 (551)
Q Consensus       324 ~~f~~~~~LG~--G~~g~Vyk~~~---~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  395 (551)
                      ..|...+.+|.  |.+|.||++..   .++..+|+|+-+...  ......-.+|+....+++ |+|.++....+..++..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45667788999  99999999986   357789999854432  233334456777777775 99999988888888888


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeEeccCCCCCeeeCCC-CCeEEeec
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR----GILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDF  470 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~Df  470 (551)
                      ++-.|.+. .+|..+.+..  ...++....+.+..+...    ||.++|...   ++|-|+||.||+...+ ...+++||
T Consensus       194 fiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence            88888775 7777776642  233566677777777777    999999987   9999999999999999 88999999


Q ss_pred             CCccccccCCCcc---cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          471 GMARLFEMDQSQG---DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       471 gla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      |+...+.......   ...+..|...|++||.+ .+-++..+|+|++|.+++|...|..++..
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~  329 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSV  329 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccC
Confidence            9998776443221   12233678899999965 45568899999999999999888876653

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.18  E-value=3.7e-10  Score=99.98  Aligned_cols=143  Identities=28%  Similarity=0.352  Sum_probs=108.2

Q ss_pred             cCcccCcCCceeEEEeecCCCCEEEEE-EeecCCh-------hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          328 TDNKLGQGGFGAVYKGRLSHGQEIAVK-RLSKNSV-------QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       328 ~~~~LG~G~~g~Vyk~~~~~g~~vavK-~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ....|-+|+.+.|+++.+. |+...|| ++.+.-.       -.....++|+++|.+++--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5678999999999999984 5665555 3333211       12335788999999987767766666777778888999


Q ss_pred             EccCC-CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC---CeEEeecCCccc
Q 008854          400 EFVPN-SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM---IPKISDFGMARL  475 (551)
Q Consensus       400 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl~Dfgla~~  475 (551)
                      ||+++ .++.+++......... ......++..|-+.+.-||..+   |||+||..+||+|.+++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~-d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESE-DEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCccc-chhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 5788888764333322 2333678889999999999998   99999999999997665   458999999865

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.91  E-value=6.8e-09  Score=95.39  Aligned_cols=124  Identities=25%  Similarity=0.319  Sum_probs=81.1

Q ss_pred             eEEEeecCCCCEEEEEEeecCCh-------------h-------------cHHHHHHHHHHHhcCCCC--CccceeeEEe
Q 008854          339 AVYKGRLSHGQEIAVKRLSKNSV-------------Q-------------GELEFKNEVLLVARLQHR--NLVRLLGFSF  390 (551)
Q Consensus       339 ~Vyk~~~~~g~~vavK~~~~~~~-------------~-------------~~~~~~~E~~~l~~l~h~--niv~l~~~~~  390 (551)
                      .||.|...+|..+|||+.+....             .             ......+|.+.|.++..-  ++.+++.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            38999988899999998754210             0             012357899999999866  45666654  


Q ss_pred             cCCceEEEEEccC--CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHH-HhhCCCCCeEeccCCCCCeeeCCCCCeEE
Q 008854          391 EETERLLIYEFVP--NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY-LHEDSRLRIIHRDLKASNILLDADMIPKI  467 (551)
Q Consensus       391 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~iiH~Dlk~~NIll~~~~~~kl  467 (551)
                        ....|||||++  +..+..+...     .++......++.+++..+.. +|..+   |+|+||.+.|||++++ .+.|
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence              35689999999  6555543321     11133445667777775555 46766   9999999999999888 9999


Q ss_pred             eecCCccc
Q 008854          468 SDFGMARL  475 (551)
Q Consensus       468 ~Dfgla~~  475 (551)
                      +|||.+..
T Consensus       148 IDf~qav~  155 (188)
T PF01163_consen  148 IDFGQAVD  155 (188)
T ss_dssp             --GTTEEE
T ss_pred             EecCccee
Confidence            99998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.91  E-value=6.2e-10  Score=115.26  Aligned_cols=196  Identities=23%  Similarity=0.241  Sum_probs=147.1

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec--CCCCEEEEEEeecCChhcHH--HHHHHHHHHhcC-CCCCccceeeEEecCCceE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL--SHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARL-QHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~--~~g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  396 (551)
                      ...+|.++..||.|.|+.|++...  .++..+++|.+.+.......  .-..|+.+...+ .|.+++.....+..-...+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            456788999999999999998764  36778999988765332221  224566666666 4888888777666666777


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC-CCeEEeecCCccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARL  475 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~Dfgla~~  475 (551)
                      +--||+.++++...+.   ....++...++++..|++.++.++|+..   ++|+|+||+||++..+ +.-+++|||++..
T Consensus       343 ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             CchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence            8899999999876652   3455788889999999999999999877   9999999999999886 7889999999864


Q ss_pred             cccCCCcccccccccCCCcc--cccccccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          476 FEMDQSQGDTSRIVGTFGYM--APEYVTRGHFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                      +...     ........+++  +|+......+-.+.|++|||.-+.|.++|..-.
T Consensus       417 ~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls  466 (524)
T KOG0601|consen  417 LAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS  466 (524)
T ss_pred             ccee-----cccccccccccccchhhccccccccccccccccccccccccCcccC
Confidence            2211     11122333444  455556677889999999999999999888643

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.90  E-value=4.8e-10  Score=121.95  Aligned_cols=207  Identities=17%  Similarity=0.202  Sum_probs=145.6

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecC---ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN---SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      ..-+.+.+.+.+-.|.++.++..+-. .|...+.|.....   ..+..+....+-.++-..+||-++...--+.......
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            34467778888999999999987632 3434444433222   1111222333333333345676666555556677889


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      |+++|..+++|...|+.   ....+.......+..+...++|||...   +.|+|++|.|+|+..++..++.|||.....
T Consensus       881 L~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence            99999999999988874   334454444556667888999999876   899999999999999999999999843221


Q ss_pred             cc---------------------C----CCc----ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCC
Q 008854          477 EM---------------------D----QSQ----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKN  527 (551)
Q Consensus       477 ~~---------------------~----~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p  527 (551)
                      ..                     .    +..    .......+|+.|.+||.+.+......+|+|++|+.++|.++|..|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            10                     0    000    112345789999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 008854          528 NSFRIG  533 (551)
Q Consensus       528 ~~~~~~  533 (551)
                      |....+
T Consensus      1035 ~na~tp 1040 (1205)
T KOG0606|consen 1035 FNAETP 1040 (1205)
T ss_pred             CCCcch
Confidence            975443

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.89  E-value=1.4e-08  Score=103.09  Aligned_cols=169  Identities=20%  Similarity=0.337  Sum_probs=128.3

Q ss_pred             ceeEEEee-cCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEe----cCCceEEEEEccCC-CChhHH
Q 008854          337 FGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF----EETERLLIYEFVPN-SSVDKF  410 (551)
Q Consensus       337 ~g~Vyk~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lV~e~~~~-gsL~~~  410 (551)
                      -.+.||+. ..+|..|++|++.....+.......-+++++++.|+|||++.+++.    .+...++||+|.|+ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            35688887 4589999999995544333334456688999999999999999886    34567899999986 556665


Q ss_pred             hhhh------------cccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          411 IFDA------------IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       411 l~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      -+..            ......++..+|.++.|+..||.++|+.+   +..+-|.+++||++.+.+++|+..|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            5432            12345678999999999999999999998   88899999999999999999998887765443


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKN  527 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p  527 (551)
                      +..                |.+...   .+-|.=.||.+++-|.||...
T Consensus       446 d~~----------------~~le~~---Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT----------------EPLESQ---QQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----------------cchhHH---hhhhHHHHHHHHHHHhhcccc
Confidence            220                112221   256888999999999999644

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.89  E-value=2.6e-08  Score=97.14  Aligned_cols=135  Identities=19%  Similarity=0.172  Sum_probs=98.3

Q ss_pred             CceeEEEeecCCCCEEEEEEeecCChh-----------cHHHHHHHHHHHhcCCCCCc--cceeeEEec-----CCceEE
Q 008854          336 GFGAVYKGRLSHGQEIAVKRLSKNSVQ-----------GELEFKNEVLLVARLQHRNL--VRLLGFSFE-----ETERLL  397 (551)
Q Consensus       336 ~~g~Vyk~~~~~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----~~~~~l  397 (551)
                      ....|.+..+ +|+.+.||+.......           ....+.+|...+.++...+|  .+++++...     ....+|
T Consensus        34 ~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L  112 (268)
T PRK15123         34 EGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI  112 (268)
T ss_pred             CCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence            3344667666 6788999977543311           11137789998888854444  344555543     234689


Q ss_pred             EEEccCCC-ChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC-------CCCeEEee
Q 008854          398 IYEFVPNS-SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-------DMIPKISD  469 (551)
Q Consensus       398 V~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~-------~~~~kl~D  469 (551)
                      |+|++++. +|.+++.+.. ..+.+...+..++.+++..+.-||..+   |+|+|++++|||++.       +..+.++|
T Consensus       113 Vte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LID  188 (268)
T PRK15123        113 ITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVID  188 (268)
T ss_pred             EEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEE
Confidence            99999986 8998875321 234566777889999999999999998   999999999999975       46899999


Q ss_pred             cCCccc
Q 008854          470 FGMARL  475 (551)
Q Consensus       470 fgla~~  475 (551)
                      |+.++.
T Consensus       189 l~r~~~  194 (268)
T PRK15123        189 LHRAQI  194 (268)
T ss_pred             CCcccc
Confidence            998853

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.72  E-value=1.1e-07  Score=90.10  Aligned_cols=134  Identities=19%  Similarity=0.221  Sum_probs=94.5

Q ss_pred             CCcCcccCcCCceeEEEeecCCCCEEEEEEeecCC----------h------------hcHHHHHHHHHHHhcCCCC--C
Q 008854          326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS----------V------------QGELEFKNEVLLVARLQHR--N  381 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~----------~------------~~~~~~~~E~~~l~~l~h~--n  381 (551)
                      ..+.++||.|--+.||.|..+.|.++|||.=+...          .            -.....++|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45568999999999999999999999999532110          0            0112457899999999765  6


Q ss_pred             ccceeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC
Q 008854          382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA  461 (551)
Q Consensus       382 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~  461 (551)
                      |.+.+++    +...+|||++++-.|...-     -..-+...   ++..|+.-+..+-..+   |||+|+++-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~---il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDE---ILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc-----CcccCHHH---HHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            7777655    4567999999997665431     01222333   3344444444443444   999999999999999


Q ss_pred             CCCeEEeecCCcc
Q 008854          462 DMIPKISDFGMAR  474 (551)
Q Consensus       462 ~~~~kl~Dfgla~  474 (551)
                      ||.+.++||--+.
T Consensus       238 dg~~~vIDwPQ~v  250 (304)
T COG0478         238 DGDIVVIDWPQAV  250 (304)
T ss_pred             CCCEEEEeCcccc
Confidence            9999999996543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.68  E-value=8.1e-08  Score=101.35  Aligned_cols=142  Identities=20%  Similarity=0.268  Sum_probs=93.9

Q ss_pred             cccCcCCceeEEEeecCCCCEEEEEEeecCChhcH----------------------------------------HHHHH
Q 008854          330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGE----------------------------------------LEFKN  369 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~----------------------------------------~~~~~  369 (551)
                      +.|+.++-|+||+|++++|+.||||+....-.+..                                        .++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            78999999999999999999999999765422110                                        11334


Q ss_pred             HHHHHhcCC----CCCccceeeEEe-cCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 008854          370 EVLLVARLQ----HRNLVRLLGFSF-EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR  444 (551)
Q Consensus       370 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~  444 (551)
                      |...+.+++    +..-+++=.++. -.+..+|+|||++|..+.++..-  +...++...+.....++.  +.-+=..+ 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l--~~~g~d~k~ia~~~~~~f--~~q~~~dg-  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL--KSAGIDRKELAELLVRAF--LRQLLRDG-  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH--HhcCCCHHHHHHHHHHHH--HHHHHhcC-
Confidence            444444442    222222223333 35678999999999999988532  234556444333332222  12222234 


Q ss_pred             CCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       445 ~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                        ++|.|.+|.||+++.++++.+.|||+...+..
T Consensus       286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             --ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence              99999999999999999999999999876543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.67  E-value=2.5e-07  Score=91.93  Aligned_cols=192  Identities=16%  Similarity=0.180  Sum_probs=127.3

Q ss_pred             CcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeE----Ee--cCCc-eEEE
Q 008854          327 STDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGF----SF--EETE-RLLI  398 (551)
Q Consensus       327 ~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~----~~--~~~~-~~lV  398 (551)
                      .....||+|+.+.+|-.-  .-..-+.|++.........+.   +..|... .||-+..-+.+    -.  .+.. .-+.
T Consensus        14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            456789999999999542  112245677766543322222   2223333 46643331111    11  1222 4577


Q ss_pred             EEccCCCC-hhHHhhh---hcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          399 YEFVPNSS-VDKFIFD---AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       399 ~e~~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      |+.+++.. ...++.-   ...-...+|.-.++.++.++.+.+-||+.+   .+-+|+.++|+|+.+++.+.|.|=+.-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence            77776653 2222221   112345789999999999999999999998   8899999999999999999999854433


Q ss_pred             ccccCCCcccccccccCCCcccccccc-----cCCCCcchhhHhHHHHHHHHHhC-CCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISG-QKNNS  529 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~elltG-~~p~~  529 (551)
                      +-   .........+|...|.+||...     +-.-+..+|-|.+||+++||+.| +.||+
T Consensus       166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys  223 (637)
T COG4248         166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS  223 (637)
T ss_pred             ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence            21   2223344567899999999764     33456789999999999999887 88886

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.59  E-value=4.6e-07  Score=85.31  Aligned_cols=105  Identities=28%  Similarity=0.334  Sum_probs=82.7

Q ss_pred             HHHHHHHHHHhcCCCCC--ccceeeEEecCC----ceEEEEEccCCC-ChhHHhhhhcccCCCCHHHHHHHHHHHHHHHH
Q 008854          365 LEFKNEVLLVARLQHRN--LVRLLGFSFEET----ERLLIYEFVPNS-SVDKFIFDAIKRVQLDWETRYKIIGGIARGIL  437 (551)
Q Consensus       365 ~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~  437 (551)
                      ....+|...+..+....  +.+.+++.....    ..+||+|++++. +|.+++...   ...+......++.+++..+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHHH
Confidence            35778888888875433  455666665432    347999999984 799988642   22566778889999999999


Q ss_pred             HHhhCCCCCeEeccCCCCCeeeCCCC---CeEEeecCCccc
Q 008854          438 YLHEDSRLRIIHRDLKASNILLDADM---IPKISDFGMARL  475 (551)
Q Consensus       438 yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl~Dfgla~~  475 (551)
                      -||..+   |+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999998   99999999999999887   899999988764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.50  E-value=1.7e-06  Score=80.18  Aligned_cols=137  Identities=18%  Similarity=0.226  Sum_probs=102.0

Q ss_pred             cCcCCceeEEEeecCCCCEEEEEEeecC---C---hhcHHHHHHHHHHHhcCCCCC--ccceeeEEe-c----CCceEEE
Q 008854          332 LGQGGFGAVYKGRLSHGQEIAVKRLSKN---S---VQGELEFKNEVLLVARLQHRN--LVRLLGFSF-E----ETERLLI  398 (551)
Q Consensus       332 LG~G~~g~Vyk~~~~~g~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~-~----~~~~~lV  398 (551)
                      -|+||-+-|++..+. |+.+-+|+-...   +   ..+...|.+|+..|.++..-+  +.+++ ++. .    ...-+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            466888999998774 457888887522   1   335668999999999986433  44444 332 1    1235799


Q ss_pred             EEccCC-CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC--eEEeecCCcc
Q 008854          399 YEFVPN-SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI--PKISDFGMAR  474 (551)
Q Consensus       399 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~--~kl~Dfgla~  474 (551)
                      +|-+++ .+|.+++.+. ...+.+...+..++.+++..+.-||..+   +.|+|+.+.||+++.++.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997764 5788887542 2335677888899999999999999998   999999999999986666  9999997655

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.45  E-value=3.1e-06  Score=80.79  Aligned_cols=139  Identities=15%  Similarity=0.189  Sum_probs=85.1

Q ss_pred             cccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCC--ccceeeEEecCCceEEEEEccCCCC-
Q 008854          330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLGFSFEETERLLIYEFVPNSS-  406 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gs-  406 (551)
                      .+||+|..+.||+.   .+..+++|......  ......+|.+++..+..-.  +.+.+++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            67899999999984   25567888876533  2345788999998886443  4566777777777789999999973 


Q ss_pred             hhHHhh--------------h------hcccCCCCHHHHHHHH-H----------HHHH-HHHHHhh-CCCCCeEeccCC
Q 008854          407 VDKFIF--------------D------AIKRVQLDWETRYKII-G----------GIAR-GILYLHE-DSRLRIIHRDLK  453 (551)
Q Consensus       407 L~~~l~--------------~------~~~~~~l~~~~~~~i~-~----------~ia~-~L~yLH~-~~~~~iiH~Dlk  453 (551)
                      +...+.              +      ..............-. .          .+.+ ...+|.. ...+.++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            221111              0      0000111111111000 0          0011 1122221 123457999999


Q ss_pred             CCCeeeCCCCCeEEeecCCcc
Q 008854          454 ASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       454 ~~NIll~~~~~~kl~Dfgla~  474 (551)
                      |.||++++++ +.|+||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999888 9999998875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.35  E-value=9.6e-08  Score=99.48  Aligned_cols=196  Identities=19%  Similarity=0.177  Sum_probs=142.4

Q ss_pred             ChhHHHhhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCC-ccceeeEEecCC
Q 008854          315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN-LVRLLGFSFEET  393 (551)
Q Consensus       315 ~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~  393 (551)
                      +.-.+++.+.-+...+-+++++.++++|.+-.-.+...++.+...     ....-++++|.+++||| .+..++-+..+.
T Consensus       233 qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~  307 (829)
T KOG0576|consen  233 QPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGED  307 (829)
T ss_pred             CCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCccc
Confidence            333445555666666789999999999987433344445555433     35566889999999999 677777777777


Q ss_pred             ceEEEEEccCCC--ChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          394 ERLLIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       394 ~~~lV~e~~~~g--sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                      ..++++++...+  +.....   .....+...+...+.+.-++++++||+..   -+|+|    ||+..+ +..|..||+
T Consensus       308 ~~~i~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~  376 (829)
T KOG0576|consen  308 YLWIPMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFA  376 (829)
T ss_pred             ccchhhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-ccccccccc
Confidence            888999999877  221111   12223445556667777889999999864   48888    777755 678999999


Q ss_pred             CccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ....+....   ......+++.|+|||+.....+..+.|+|+.|+-..+|--|..|..
T Consensus       377 v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  377 VPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            887655332   3445678999999999999999999999999998778887877664

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.32  E-value=4.2e-06  Score=77.83  Aligned_cols=137  Identities=15%  Similarity=0.165  Sum_probs=92.3

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHH---------HHHHHHHhcCCCCC---ccceeeEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEF---------KNEVLLVARLQHRN---LVRLLGFS  389 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h~n---iv~l~~~~  389 (551)
                      ..++|...+.+-......|.+-.. +|+.+++|..+......++.|         .+++..+.+++...   ...++-+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            356777778887777777877766 578899998876543333322         34444444443322   22322222


Q ss_pred             e-----cCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC
Q 008854          390 F-----EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI  464 (551)
Q Consensus       390 ~-----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~  464 (551)
                      .     .....+|+|||++|..|.++..       ++.    .+...+.+.+.-||+.+   ++|+|..|.|+++++++ 
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence            2     2345579999999998776532       222    24466778899999988   99999999999998655 


Q ss_pred             eEEeecCCcc
Q 008854          465 PKISDFGMAR  474 (551)
Q Consensus       465 ~kl~Dfgla~  474 (551)
                      +++.||+..+
T Consensus       173 i~iID~~~k~  182 (229)
T PF06176_consen  173 IRIIDTQGKR  182 (229)
T ss_pred             EEEEECcccc
Confidence            8999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.27  E-value=5.6e-06  Score=87.24  Aligned_cols=142  Identities=20%  Similarity=0.287  Sum_probs=93.8

Q ss_pred             CcccCcCCceeEEEeecCCCCEEEEEEeecCChhc-------------------------------------HHHHHHHH
Q 008854          329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG-------------------------------------ELEFKNEV  371 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~-------------------------------------~~~~~~E~  371 (551)
                      .+.||..+.|.|+++++++|+.||||+-+..-...                                     +.+|.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            36899999999999999999999999865532111                                     11234444


Q ss_pred             HHHhcC----CCCCc---cceeeEEec-CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 008854          372 LLVARL----QHRNL---VRLLGFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS  443 (551)
Q Consensus       372 ~~l~~l----~h~ni---v~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~  443 (551)
                      +-..+.    .|-++   |.+=.++.+ ....+|+|||++|..+.+...  .....++...+..-+.+...-+-+-    
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~--i~~~gi~~~~i~~~l~~~~~~qIf~----  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA--IDKRGISPHDILNKLVEAYLEQIFK----  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH--HHHcCCCHHHHHHHHHHHHHHHHHh----
Confidence            433332    34441   112233333 457899999999999888743  3455666665554444433222222    


Q ss_pred             CCCeEeccCCCCCeeeCC----CCCeEEeecCCccccc
Q 008854          444 RLRIIHRDLKASNILLDA----DMIPKISDFGMARLFE  477 (551)
Q Consensus       444 ~~~iiH~Dlk~~NIll~~----~~~~kl~Dfgla~~~~  477 (551)
                       .+++|.|=+|.||++..    ++.+.+-|||+...+.
T Consensus       320 -~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 -TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             -cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence             24999999999999984    5689999999987554

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.23  E-value=1.5e-05  Score=77.12  Aligned_cols=140  Identities=16%  Similarity=0.212  Sum_probs=85.2

Q ss_pred             ccCcCCc-eeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEEEccCCCChh
Q 008854          331 KLGQGGF-GAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEFVPNSSVD  408 (551)
Q Consensus       331 ~LG~G~~-g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  408 (551)
                      .|..|.. ..||+.... +..+.||+.....   ...+.+|+++++.+. +--+.+++++....+..++|||++++.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3445555 789999764 4778888875543   235677888888774 334556777776666789999999998876


Q ss_pred             HHhh---------h---------hcc--cCCCC--HHHHHHHHH--------------------HHHHHHHHHhh----C
Q 008854          409 KFIF---------D---------AIK--RVQLD--WETRYKIIG--------------------GIARGILYLHE----D  442 (551)
Q Consensus       409 ~~l~---------~---------~~~--~~~l~--~~~~~~i~~--------------------~ia~~L~yLH~----~  442 (551)
                      ....         .         ...  ..++.  ....+....                    .+...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            4421         0         000  00111  000110000                    01111222211    1


Q ss_pred             CCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          443 SRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       443 ~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      ..+.++|+|+.|.|||++++....|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            23559999999999999998888899998775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.22  E-value=1.4e-05  Score=75.12  Aligned_cols=152  Identities=20%  Similarity=0.254  Sum_probs=99.1

Q ss_pred             ChhHHHhhhcCCCcCcc---cCcCCceeEEEeecCCCCEEEEEEeecCChhcH---------H---------------HH
Q 008854          315 DFSTIRDATNNFSTDNK---LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGE---------L---------------EF  367 (551)
Q Consensus       315 ~~~~i~~~~~~f~~~~~---LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~---------~---------------~~  367 (551)
                      +.+.+.....+..+.+.   |..|-.+.||+|...++..+|||+++.....-.         .               -.
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~  115 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA  115 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence            34555555555555444   566778889999987899999999865422110         0               12


Q ss_pred             HHHHHHHhcCC--CCCccceeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 008854          368 KNEVLLVARLQ--HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL  445 (551)
Q Consensus       368 ~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~  445 (551)
                      ..|..-|.++.  +=.+.+.+++    ....|||||+....+   -...++..++...+...+..++++.+.-|-...  
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~---pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a--  186 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGL---PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA--  186 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCC---CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence            35666666663  3344445544    245799999976521   111112223333356667778888888877633  


Q ss_pred             CeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          446 RIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       446 ~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      ++||+||+.=|||+. ++.+.|+|||-+...
T Consensus       187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             CcccccchhhheEEE-CCeEEEEECcccccc
Confidence            499999999999999 889999999987643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.20  E-value=3.1e-07  Score=96.83  Aligned_cols=97  Identities=26%  Similarity=0.445  Sum_probs=75.4

Q ss_pred             HHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc-------ccccccccCCCccccccccc
Q 008854          430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-------GDTSRIVGTFGYMAPEYVTR  502 (551)
Q Consensus       430 ~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~  502 (551)
                      .+++.||.|+|..-  ++||++|.|++|.++.++..||+.|+.+.........       ...........|.|||++.+
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34559999999865  6999999999999999999999999987654321110       11112234668999999999


Q ss_pred             CCCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          503 GHFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       503 ~~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                      ...+.++|+||+|++++-+..|.++-
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i  209 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSI  209 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcch
Confidence            88899999999999999999555443

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.18  E-value=9.2e-06  Score=77.73  Aligned_cols=143  Identities=20%  Similarity=0.204  Sum_probs=84.0

Q ss_pred             CcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCC--CccceeeEEec---CCceEEEEEccC
Q 008854          329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR--NLVRLLGFSFE---ETERLLIYEFVP  403 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lV~e~~~  403 (551)
                      ++.|+.|..+.||+....+ ..+++|.....  .....+.+|..++..+...  .+.+++.....   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3678999999999999866 69999997554  3455677888888887533  34566664432   234689999999


Q ss_pred             CCChhH----------------Hhh---hh-cccCCCCHHH---------HHHH------------HHHHHH-HHHHHhh
Q 008854          404 NSSVDK----------------FIF---DA-IKRVQLDWET---------RYKI------------IGGIAR-GILYLHE  441 (551)
Q Consensus       404 ~gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~~ia~-~L~yLH~  441 (551)
                      +..+..                .+.   .. .....+.+..         ....            ...+.+ .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            998877                111   00 0011111111         0000            111222 2333332


Q ss_pred             ----CCCCCeEeccCCCCCeeeC-CCCCeEEeecCCcc
Q 008854          442 ----DSRLRIIHRDLKASNILLD-ADMIPKISDFGMAR  474 (551)
Q Consensus       442 ----~~~~~iiH~Dlk~~NIll~-~~~~~kl~Dfgla~  474 (551)
                          .....++|+|+.|.|||++ +++.+.|.||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                2345699999999999999 56666899998775

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.18  E-value=7.6e-06  Score=75.53  Aligned_cols=105  Identities=24%  Similarity=0.205  Sum_probs=83.5

Q ss_pred             HHHHHHHhcCCC-CCccceeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 008854          368 KNEVLLVARLQH-RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR  446 (551)
Q Consensus       368 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  446 (551)
                      .+|..++..+++ +++.+++|.|    ..++|.||...+++...-.....-...+|..|.+|+.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458888888876 6999999998    45789999998765432100011234689999999999999999999865555


Q ss_pred             eEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          447 IIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       447 iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +.-.|++++|+-+++++++|+.|.+.+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            899999999999999999999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.05  E-value=4.9e-05  Score=86.52  Aligned_cols=79  Identities=11%  Similarity=0.276  Sum_probs=57.4

Q ss_pred             CcccCcCCceeEEEeecCCC---CEEEEEEeecCC-hhcHHHHHHHHHHHhcCC-CCCc--cceeeEEecC---CceEEE
Q 008854          329 DNKLGQGGFGAVYKGRLSHG---QEIAVKRLSKNS-VQGELEFKNEVLLVARLQ-HRNL--VRLLGFSFEE---TERLLI  398 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lV  398 (551)
                      .++|+.|.+..+|+....++   ..+++|+..... ......+.+|.++++.+. |++|  .+++.++.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999876554   467788764432 223346889999999995 6665  6777777654   357899


Q ss_pred             EEccCCCCh
Q 008854          399 YEFVPNSSV  407 (551)
Q Consensus       399 ~e~~~~gsL  407 (551)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998653

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.00  E-value=0.00012  Score=68.00  Aligned_cols=133  Identities=18%  Similarity=0.282  Sum_probs=90.5

Q ss_pred             cCcccCcCCceeEEEeecCCCCEEEEEEeecCC----------------hhcHHHHHHHHHHHhcCC------CCCccce
Q 008854          328 TDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS----------------VQGELEFKNEVLLVARLQ------HRNLVRL  385 (551)
Q Consensus       328 ~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l  385 (551)
                      ....||+|+.-.||.-  ++.....||+.....                .....+..+|+.-...+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            3568999999999964  445667888886655                112334556655555544      7889999


Q ss_pred             eeEEecCCceEEEEEccCC------CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee
Q 008854          386 LGFSFEETERLLIYEFVPN------SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL  459 (551)
Q Consensus       386 ~~~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll  459 (551)
                      +|+..+.....+|+|.+.+      -+|.+++    ....++. ...+.+.   +-..||-+.+   |+.+||+|.||++
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVV  151 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEE
Confidence            9999999999999998753      3456665    3445555 4444444   3445666555   9999999999999


Q ss_pred             CCCC----CeEEee-cCCc
Q 008854          460 DADM----IPKISD-FGMA  473 (551)
Q Consensus       460 ~~~~----~~kl~D-fgla  473 (551)
                      ..+.    .+.|+| ||..
T Consensus       152 ~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             EecCCCceEEEEEeCCCCc
Confidence            5332    467777 4443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=97.91  E-value=0.00022  Score=71.18  Aligned_cols=79  Identities=15%  Similarity=0.087  Sum_probs=56.9

Q ss_pred             CCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCC---CCccceeeEEec---CCceEEEE
Q 008854          326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH---RNLVRLLGFSFE---ETERLLIY  399 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lV~  399 (551)
                      ....+.||+|..+.||+....++ .+.+|..+...  ....+..|.+.|+.+..   -.+.++++++..   .+..+|||
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            34457899999999999876555 46667754311  22368889999888853   357788887754   35689999


Q ss_pred             EccCCCCh
Q 008854          400 EFVPNSSV  407 (551)
Q Consensus       400 e~~~~gsL  407 (551)
                      |++++.++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.90  E-value=8.8e-05  Score=71.38  Aligned_cols=74  Identities=16%  Similarity=0.223  Sum_probs=45.7

Q ss_pred             CcccCcCCce-eEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCC---CccceeeEEecC---CceEEEEEc
Q 008854          329 DNKLGQGGFG-AVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR---NLVRLLGFSFEE---TERLLIYEF  401 (551)
Q Consensus       329 ~~~LG~G~~g-~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lV~e~  401 (551)
                      ++.|+.|+.. .||+.    +..+++|..+...  ....+.+|.+++..+...   .+.+.++.....   ...+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            3567777766 59975    2457777654422  234688899988887532   233344433222   134789999


Q ss_pred             cCCCChh
Q 008854          402 VPNSSVD  408 (551)
Q Consensus       402 ~~~gsL~  408 (551)
                      +++.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9997774

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.84  E-value=0.00016  Score=69.43  Aligned_cols=74  Identities=18%  Similarity=0.255  Sum_probs=49.1

Q ss_pred             cccCcCCceeEEEeecCC--CCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccc-eeeEEecCCceEEEEEccCCCC
Q 008854          330 NKLGQGGFGAVYKGRLSH--GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR-LLGFSFEETERLLIYEFVPNSS  406 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~--g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lV~e~~~~gs  406 (551)
                      +.|..|-...+|+....+  ++.+++|+...... ......+|+.++..+...++++ +++.. +   ..+||||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~-~---~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATF-Q---NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEe-C---CcEEEEeeCCCc
Confidence            567788888999998654  67899997754321 1223457888888886444443 43332 2   248999999877


Q ss_pred             hh
Q 008854          407 VD  408 (551)
Q Consensus       407 L~  408 (551)
                      +.
T Consensus        79 l~   80 (235)
T cd05157          79 LE   80 (235)
T ss_pred             CC
Confidence            63

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.83  E-value=0.00016  Score=66.57  Aligned_cols=125  Identities=26%  Similarity=0.375  Sum_probs=88.7

Q ss_pred             cCCCcCcccCcCCc-eeEEEeecCCCCEEEEEEeecC---Ch------------------hcHHHHHHHHHHHhcCC---
Q 008854          324 NNFSTDNKLGQGGF-GAVYKGRLSHGQEIAVKRLSKN---SV------------------QGELEFKNEVLLVARLQ---  378 (551)
Q Consensus       324 ~~f~~~~~LG~G~~-g~Vyk~~~~~g~~vavK~~~~~---~~------------------~~~~~~~~E~~~l~~l~---  378 (551)
                      .+++.++.||.|.. |.|||+++ +|+.+|+|.++..   ..                  .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67788899999999 99999998 6789999994321   00                  00124778888877775   


Q ss_pred             CCCc--cceeeEEecCC------------------ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHH
Q 008854          379 HRNL--VRLLGFSFEET------------------ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY  438 (551)
Q Consensus       379 h~ni--v~l~~~~~~~~------------------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y  438 (551)
                      +.++  |+.+||..-..                  ...||.||++...            .+.    .+-+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence            4566  88999874220                  1247778776543            112    2235567777888


Q ss_pred             HhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCc
Q 008854          439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA  473 (551)
Q Consensus       439 LH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla  473 (551)
                      +|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99887   999999999986     4588999853

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.80  E-value=0.00014  Score=70.93  Aligned_cols=139  Identities=15%  Similarity=0.107  Sum_probs=79.9

Q ss_pred             ccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCcc-ceeeEEecCCceEEEEEccCCCChhH
Q 008854          331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV-RLLGFSFEETERLLIYEFVPNSSVDK  409 (551)
Q Consensus       331 ~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~gsL~~  409 (551)
                      .+..|-...+|+... +++.+++|........-.....+|..+++.+....++ +++...    ...+||||+++..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence            456677889998873 5678888876543222112457788888888654443 334332    2468999999877642


Q ss_pred             H-------h----------hhhc-ccCCCCHHHH-HHHHHH---------HHHHHHHHhhC-----CCCCeEeccCCCCC
Q 008854          410 F-------I----------FDAI-KRVQLDWETR-YKIIGG---------IARGILYLHED-----SRLRIIHRDLKASN  456 (551)
Q Consensus       410 ~-------l----------~~~~-~~~~l~~~~~-~~i~~~---------ia~~L~yLH~~-----~~~~iiH~Dlk~~N  456 (551)
                      -       +          +... ...+++.... .....+         +...+..+...     ..+.++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1       1          1100 1112222211 111111         11112222211     12358999999999


Q ss_pred             eeeCCCCCeEEeecCCccc
Q 008854          457 ILLDADMIPKISDFGMARL  475 (551)
Q Consensus       457 Ill~~~~~~kl~Dfgla~~  475 (551)
                      |++++++ +.|+||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999988754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.62  E-value=0.00049  Score=61.47  Aligned_cols=130  Identities=21%  Similarity=0.262  Sum_probs=87.5

Q ss_pred             CcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCC
Q 008854          327 STDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSS  406 (551)
Q Consensus       327 ~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  406 (551)
                      ...+.|++|++|.||+|.+. |.++|+|+-..++.  ...+..|.++|..+.-.++-+=+-.+   +..++.|||+.+-.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~   98 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcc
Confidence            44578999999999999985 45888888765543  34688899999988876665433222   23345599999988


Q ss_pred             hhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCC-CCCeeeCCCCCeEEeecCCccc
Q 008854          407 VDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLK-ASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       407 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk-~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      |.+.-..      .+..+++    .+++.-.-|...+   |-|+.|. |..++|-.++.+.|+||.-|..
T Consensus        99 L~~~~~~------~~rk~l~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIG------GDRKHLL----RVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhc------ccHHHHH----HHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            8775431      1233333    3444444444444   8888886 4445555555999999998863

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.49  E-value=0.0018  Score=66.63  Aligned_cols=76  Identities=13%  Similarity=0.168  Sum_probs=52.7

Q ss_pred             CcccCcCCceeEEEeecCCC-CEEEEEEeecC------C-hhcHHHHHHHHHHHhcCC---CCCccceeeEEecCCceEE
Q 008854          329 DNKLGQGGFGAVYKGRLSHG-QEIAVKRLSKN------S-VQGELEFKNEVLLVARLQ---HRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  397 (551)
                      .+.||.|.+..||++...+| +.++||.-...      . .........|.+.|..+.   ..++.+++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            36799999999999998776 48999985321      1 113345666777777763   2456666666  4455789


Q ss_pred             EEEccCCCC
Q 008854          398 IYEFVPNSS  406 (551)
Q Consensus       398 V~e~~~~gs  406 (551)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998644

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.44  E-value=0.0011  Score=65.99  Aligned_cols=143  Identities=19%  Similarity=0.176  Sum_probs=85.8

Q ss_pred             CcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCC--ccceeeE------EecCCceEEEEE
Q 008854          329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLGF------SFEETERLLIYE  400 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~e  400 (551)
                      .+.|..|....+|+.... +..+++|+....   ....+..|+.++..+.+.+  +.+++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            567888888899998764 457888987642   2345667777777775332  4444431      123345689999


Q ss_pred             ccCCCChhH----Hh----------hhhccc--------CCCCHHHHH----------HHHHHHHHHHHHHhh----CCC
Q 008854          401 FVPNSSVDK----FI----------FDAIKR--------VQLDWETRY----------KIIGGIARGILYLHE----DSR  444 (551)
Q Consensus       401 ~~~~gsL~~----~l----------~~~~~~--------~~l~~~~~~----------~i~~~ia~~L~yLH~----~~~  444 (551)
                      |+++..+..    ..          +.....        ....|....          .....+...+.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999877532    11          110000        111222211          011123344455543    123


Q ss_pred             CCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          445 LRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       445 ~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ..++|+|+.|.||++++++.+.|.||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4599999999999999987788999988753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.43  E-value=0.0026  Score=64.20  Aligned_cols=142  Identities=16%  Similarity=0.190  Sum_probs=76.7

Q ss_pred             CcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCC--ccceee------EEecCCceEEEEE
Q 008854          329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLG------FSFEETERLLIYE  400 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lV~e  400 (551)
                      .+.|+.|....+|+....+| .+++|++....   ...+..|+.++..|...+  +.+.+.      +....+..++++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            35677788889999886554 68899875222   223334445444443211  233332      1122455789999


Q ss_pred             ccCCCChhH-----H------h---hhhccc--------CCCCH-HHHHH------------HHH-HHHHHHHHHhhC--
Q 008854          401 FVPNSSVDK-----F------I---FDAIKR--------VQLDW-ETRYK------------IIG-GIARGILYLHED--  442 (551)
Q Consensus       401 ~~~~gsL~~-----~------l---~~~~~~--------~~l~~-~~~~~------------i~~-~ia~~L~yLH~~--  442 (551)
                      |+++..+..     .      |   +.....        ..+.| .....            .+. .+...+..+...  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            999875421     1      1   111110        11112 11111            111 111222333211  


Q ss_pred             --CCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          443 --SRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       443 --~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                        -+..+||+|+.+.||+++.+...-|+||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              23469999999999999877666899999875

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.19  E-value=0.0033  Score=62.89  Aligned_cols=141  Identities=25%  Similarity=0.324  Sum_probs=83.7

Q ss_pred             cccCcCCceeEEEeecCC-------CCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCcc-ceeeEEecCCceEEEEEc
Q 008854          330 NKLGQGGFGAVYKGRLSH-------GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV-RLLGFSFEETERLLIYEF  401 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~-------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~  401 (551)
                      +.|..|-...+|+....+       ++.+++|+..... .......+|.+++..+....+. ++++++.    -.+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence            456667777899988654       4789999976543 2223567788888887543343 4455443    2368999


Q ss_pred             cCCCChhHHh-----------------hhhcccC------CC--CHHHHHH--------------------------HHH
Q 008854          402 VPNSSVDKFI-----------------FDAIKRV------QL--DWETRYK--------------------------IIG  430 (551)
Q Consensus       402 ~~~gsL~~~l-----------------~~~~~~~------~l--~~~~~~~--------------------------i~~  430 (551)
                      +++.++....                 +......      ..  -|..+..                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            9987764321                 1100000      00  0111111                          112


Q ss_pred             HHHHHHHHHhh------CCCCCeEeccCCCCCeeeCCC----CCeEEeecCCccc
Q 008854          431 GIARGILYLHE------DSRLRIIHRDLKASNILLDAD----MIPKISDFGMARL  475 (551)
Q Consensus       431 ~ia~~L~yLH~------~~~~~iiH~Dlk~~NIll~~~----~~~kl~Dfgla~~  475 (551)
                      .+..-+..|..      .....++|+|+.+.|||++++    +.++++||..+..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22233334432      234569999999999999885    8899999988864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.17  E-value=0.011  Score=59.29  Aligned_cols=143  Identities=20%  Similarity=0.214  Sum_probs=81.9

Q ss_pred             CcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCC--ccceeeE------EecCCceEEEEE
Q 008854          329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLGF------SFEETERLLIYE  400 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~e  400 (551)
                      .+.++.|....+|+....+| .+++|+.....  ....+..|++++..|....  +.+++..      ....+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            46677787789999876444 67788875532  1234455666666664222  3344331      122345689999


Q ss_pred             ccCCCChhH----H----------hhhhccc---------CCCCHHHHH------------HHHHHHHHHHHHHhh----
Q 008854          401 FVPNSSVDK----F----------IFDAIKR---------VQLDWETRY------------KIIGGIARGILYLHE----  441 (551)
Q Consensus       401 ~~~~gsL~~----~----------l~~~~~~---------~~l~~~~~~------------~i~~~ia~~L~yLH~----  441 (551)
                      |+++..+..    .          ++.....         ..-.|....            .....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            999865421    1          1111110         001121111            011123344555542    


Q ss_pred             CCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          442 DSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       442 ~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .....++|+|+++.||++++++...|.||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            223569999999999999988877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.04  E-value=0.0054  Score=60.46  Aligned_cols=32  Identities=28%  Similarity=0.507  Sum_probs=26.3

Q ss_pred             CCCeEeccCCCCCeeeCCCCC-eEEeecCCccc
Q 008854          444 RLRIIHRDLKASNILLDADMI-PKISDFGMARL  475 (551)
Q Consensus       444 ~~~iiH~Dlk~~NIll~~~~~-~kl~Dfgla~~  475 (551)
                      .+.++|+|+++.|||+++++. .-|.||+.+..
T Consensus       184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            345899999999999997555 46999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.95  E-value=0.0082  Score=59.27  Aligned_cols=76  Identities=17%  Similarity=0.277  Sum_probs=48.0

Q ss_pred             CCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC---CCCccceeeEEecCCceEEEEEcc
Q 008854          326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ---HRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       326 f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      .+..+.|+.|....+|+.. .+++.+.||+-...   ....|..|..-|+.|.   --.+.+.+++....+..+||+||+
T Consensus        19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeeEecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            3445778999999999988 57789999988632   2235777777777773   445778888888777889999999


Q ss_pred             CCC
Q 008854          403 PNS  405 (551)
Q Consensus       403 ~~g  405 (551)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=96.90  E-value=0.0083  Score=61.17  Aligned_cols=141  Identities=18%  Similarity=0.208  Sum_probs=81.5

Q ss_pred             cccCcCCceeEEEeecCC-----CCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCcc-ceeeEEecCCceEEEEEccC
Q 008854          330 NKLGQGGFGAVYKGRLSH-----GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV-RLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~-----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~  403 (551)
                      +.|-.|-.-.+|+..+.+     ++.+++|+...... ......+|..++..+...++. ++++.+..+    .|.||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            455557777899886532     36788998865432 222346788888888655554 455554322    5899998


Q ss_pred             CCChhHH-----------------hhhhc-cc-C-CCCHHHHHHHHHHH-----------------HHHHHHH----hh-
Q 008854          404 NSSVDKF-----------------IFDAI-KR-V-QLDWETRYKIIGGI-----------------ARGILYL----HE-  441 (551)
Q Consensus       404 ~gsL~~~-----------------l~~~~-~~-~-~l~~~~~~~i~~~i-----------------a~~L~yL----H~-  441 (551)
                      +.+|...                 +|... .. . ...|.++.++..++                 ..-+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            8776422                 11100 00 1 11133332332211                 1111222    21 


Q ss_pred             CCCCCeEeccCCCCCeeeCC-CCCeEEeecCCccc
Q 008854          442 DSRLRIIHRDLKASNILLDA-DMIPKISDFGMARL  475 (551)
Q Consensus       442 ~~~~~iiH~Dlk~~NIll~~-~~~~kl~Dfgla~~  475 (551)
                      .....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22345899999999999986 46899999988764

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.79  E-value=0.0012  Score=64.45  Aligned_cols=144  Identities=19%  Similarity=0.242  Sum_probs=94.5

Q ss_pred             cChhHHHhhhc---CCCcCcccCcCCceeEEEeecCCCCEEEEEEeecC----------C----------h--hcHHHHH
Q 008854          314 FDFSTIRDATN---NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKN----------S----------V--QGELEFK  368 (551)
Q Consensus       314 ~~~~~i~~~~~---~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~----------~----------~--~~~~~~~  368 (551)
                      +++-.++...+   -+...++||-|--+-||.+...+|++.++|.=...          .          +  -......
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~  158 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT  158 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence            34444444433   35678999999999999999989999988842110          0          0  0112345


Q ss_pred             HHHHHHhcCC-CC-CccceeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 008854          369 NEVLLVARLQ-HR-NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR  446 (551)
Q Consensus       369 ~E~~~l~~l~-h~-niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  446 (551)
                      +|...|+.|. |. -+.+.+++    +..++|||++.+..|...-+      ..+..++..-   +..-+--|-.++   
T Consensus       159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~---lm~~Iv~la~~G---  222 (465)
T KOG2268|consen  159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDD---LMGLIVRLANHG---  222 (465)
T ss_pred             HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHH---HHHHHHHHHHcC---
Confidence            6777777775 32 23444443    45689999999888765421      1233343332   333344455555   


Q ss_pred             eEeccCCCCCeeeCCCCCeEEeecCCc
Q 008854          447 IIHRDLKASNILLDADMIPKISDFGMA  473 (551)
Q Consensus       447 iiH~Dlk~~NIll~~~~~~kl~Dfgla  473 (551)
                      +||+|+.--||+++++..++++||--.
T Consensus       223 lIHgDFNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  223 LIHGDFNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             ceecccchheeEEecCCCEEEeechHh
Confidence            999999999999999999999999644

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.79  E-value=0.0047  Score=69.72  Aligned_cols=154  Identities=19%  Similarity=0.237  Sum_probs=110.5

Q ss_pred             HHHHHHHHhcCCCCCccceeeEEecCCceE----EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhC
Q 008854          367 FKNEVLLVARLQHRNLVRLLGFSFEETERL----LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED  442 (551)
Q Consensus       367 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~  442 (551)
                      ..-|++.+.++.|+|++.++.+-.++...-    +..+++..-++...++.   -..++....+.+..++.+||.|+|+.
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            456778888999999999999877654332    34467777787777763   45577788888899999999999988


Q ss_pred             CCCCeEeccCCCC---CeeeCCCCCeEEe--ecCCccccccCCCcccccccccCCCcccccccccCCCCc--chhhHhHH
Q 008854          443 SRLRIIHRDLKAS---NILLDADMIPKIS--DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI--KSDVFSFG  515 (551)
Q Consensus       443 ~~~~iiH~Dlk~~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDv~S~G  515 (551)
                      .   ..|.-|..+   +-..+.++...++  ||+..+.+.....   .....-+..|.+||.........  ..|+|.+|
T Consensus       306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             c---cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHH
Confidence            5   555555544   5555667777777  8888775442211   11223355788888776665544  47999999


Q ss_pred             HHHHHHHhCCCCCC
Q 008854          516 VLVLEIISGQKNNS  529 (551)
Q Consensus       516 vll~elltG~~p~~  529 (551)
                      .++..+..|..+..
T Consensus       380 ll~~~~~~~~~i~~  393 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISE  393 (1351)
T ss_pred             HHHhhhhhcCcccc
Confidence            99999999987654

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.79  E-value=0.016  Score=57.69  Aligned_cols=145  Identities=19%  Similarity=0.288  Sum_probs=79.9

Q ss_pred             CcccCcCCceeEEEeecCCCCEEEEEEeec--CChhcHHHHHHHHHHHhcCCC--CCccceeeEEecCC--ceEEEEEcc
Q 008854          329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSK--NSVQGELEFKNEVLLVARLQH--RNLVRLLGFSFEET--ERLLIYEFV  402 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lV~e~~  402 (551)
                      .+.+..|.--.+|..... +++++++ ...  ..........+|..+++.+.-  --+.+.++.|.++.  ..+.||+|+
T Consensus        30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            344433444445544432 7788888 321  222334456778888877643  23445566666655  668999999


Q ss_pred             CCCChhHHhhhhc----------------------------------ccCC-CCHHHHHHH--------HHHHHHHHHHH
Q 008854          403 PNSSVDKFIFDAI----------------------------------KRVQ-LDWETRYKI--------IGGIARGILYL  439 (551)
Q Consensus       403 ~~gsL~~~l~~~~----------------------------------~~~~-l~~~~~~~i--------~~~ia~~L~yL  439 (551)
                      ++..+.+.+....                                  ...+ ..|...++.        +-....-..+|
T Consensus       108 eGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl  187 (321)
T COG3173         108 EGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL  187 (321)
T ss_pred             cceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence            8743322211000                                  0000 011111100        00112223344


Q ss_pred             hhC-----CCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          440 HED-----SRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       440 H~~-----~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      +..     +++.++|+|+++.||+++++.-+-+.||+++..
T Consensus       188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            332     335599999999999999998899999999875

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.72  E-value=0.02  Score=57.91  Aligned_cols=73  Identities=16%  Similarity=0.160  Sum_probs=45.5

Q ss_pred             ccCcCCceeEEEeecCCC-CEEEEEEeecC------C-hhcHHHHHHHHHHHhcCC--CC-CccceeeEEecCCceEEEE
Q 008854          331 KLGQGGFGAVYKGRLSHG-QEIAVKRLSKN------S-VQGELEFKNEVLLVARLQ--HR-NLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       331 ~LG~G~~g~Vyk~~~~~g-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lV~  399 (551)
                      .||.|.-..||++..++| +.|+||.-...      + .-...+..-|.+.|....  -| .+.+++.  .+.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            579999999999997654 58999975321      1 112234445666665543  24 3444443  3555667999


Q ss_pred             EccCCC
Q 008854          400 EFVPNS  405 (551)
Q Consensus       400 e~~~~g  405 (551)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            999653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.68  E-value=0.013  Score=58.39  Aligned_cols=139  Identities=20%  Similarity=0.251  Sum_probs=95.6

Q ss_pred             cCcccCcCCceeEEEeecCCCCEEEEEEeecCCh---------hcH-----------------HHHHHHHHHHhcCCCCC
Q 008854          328 TDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV---------QGE-----------------LEFKNEVLLVARLQHRN  381 (551)
Q Consensus       328 ~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~---------~~~-----------------~~~~~E~~~l~~l~h~n  381 (551)
                      +...|..|-.+.||.+.-.+|..+|||+++..-.         .++                 .-...|++-|.+++.-.
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            3456888999999999988999999998754210         011                 11345777777776544


Q ss_pred             ccceeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC
Q 008854          382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA  461 (551)
Q Consensus       382 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~  461 (551)
                      |.-.--...  ...+|||+|+....   +-...++...++...+..+-.+++.-|.-|-+..  ++||.||+--|+|+ .
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-h  299 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-H  299 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-E
Confidence            332111111  23579999996322   2222335556777778888888888888888776  59999999999999 5


Q ss_pred             CCCeEEeecCCcc
Q 008854          462 DMIPKISDFGMAR  474 (551)
Q Consensus       462 ~~~~kl~Dfgla~  474 (551)
                      +|.+.|+|-+-+.
T Consensus       300 dG~lyiIDVSQSV  312 (520)
T KOG2270|consen  300 DGKLYIIDVSQSV  312 (520)
T ss_pred             CCEEEEEEccccc
Confidence            6788899977654

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.50  E-value=0.049  Score=56.10  Aligned_cols=73  Identities=12%  Similarity=0.082  Sum_probs=48.3

Q ss_pred             CcccCcCCceeEEEeecCCCCEEEEEEeecCCh-------hcHHHHHHHHHHHhcCC---CCCccceeeEEecCCceEEE
Q 008854          329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV-------QGELEFKNEVLLVARLQ---HRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV  398 (551)
                      .+.||.|....||+... +++.++||+-.....       .....-..|.+.|..+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            56889999999999876 456789997652110       12223334455555543   346777887766  456889


Q ss_pred             EEccCC
Q 008854          399 YEFVPN  404 (551)
Q Consensus       399 ~e~~~~  404 (551)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.44  E-value=0.019  Score=58.79  Aligned_cols=74  Identities=11%  Similarity=0.139  Sum_probs=47.4

Q ss_pred             CcccCcCCceeEEEeecCC-CCEEEEEEeecC-----C-hhcHHHHHHHHHHHhcCC--CC-CccceeeEEecCCceEEE
Q 008854          329 DNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKN-----S-VQGELEFKNEVLLVARLQ--HR-NLVRLLGFSFEETERLLI  398 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~-g~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lV  398 (551)
                      .+.||.|.-..||++.... ++.|+||.-...     + .-...+..-|.+.|+...  -| .+.+++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4688999999999998743 568999964321     1 122334555666666553  34 34445443  55566789


Q ss_pred             EEccCC
Q 008854          399 YEFVPN  404 (551)
Q Consensus       399 ~e~~~~  404 (551)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999864

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.26  E-value=0.0012  Score=75.90  Aligned_cols=158  Identities=11%  Similarity=-0.041  Sum_probs=111.0

Q ss_pred             HHHHHHhcCCCCCccceeeEEe--cCCceEEEEEccCCCChhHHhhhhccc-CCCCHHHHHHHHHHHHHHHHHHhhCC--
Q 008854          369 NEVLLVARLQHRNLVRLLGFSF--EETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDS--  443 (551)
Q Consensus       369 ~E~~~l~~l~h~niv~l~~~~~--~~~~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~--  443 (551)
                      .|...+++..|+++.....-..  +..+.+.+++|+..|.+.+.+-+..++ ..++.......-.+......-.|...  
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            3444555668888766544332  345678899999999999998765443 33444433333333344455544432  


Q ss_pred             CCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh
Q 008854          444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS  523 (551)
Q Consensus       444 ~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt  523 (551)
                      ..-.+|++||+-|.+|..+.++|++++|+.++....  ........+++.|+.|+....-+++.++|+|..|..++++--
T Consensus      1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             CccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence            223689999999999999999999999999843221  122344567888999998888889999999999999999877


Q ss_pred             CCCCC
Q 008854          524 GQKNN  528 (551)
Q Consensus       524 G~~p~  528 (551)
                      |..++
T Consensus      1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred             ccHHH
Confidence            77665

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.23  E-value=0.051  Score=54.48  Aligned_cols=30  Identities=27%  Similarity=0.269  Sum_probs=25.5

Q ss_pred             CCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          444 RLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       444 ~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      ...++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            346999999999999987 678899998664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.08  E-value=0.016  Score=54.63  Aligned_cols=29  Identities=38%  Similarity=0.504  Sum_probs=20.8

Q ss_pred             CeEeccCCCCCeee-CCCCCeEEeecCCcc
Q 008854          446 RIIHRDLKASNILL-DADMIPKISDFGMAR  474 (551)
Q Consensus       446 ~iiH~Dlk~~NIll-~~~~~~kl~Dfgla~  474 (551)
                      .+.|.||.+.|||+ +.++.++++||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            47899999999999 889999999998775

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.00  E-value=0.049  Score=55.24  Aligned_cols=141  Identities=15%  Similarity=0.212  Sum_probs=79.5

Q ss_pred             cccCcCCceeEEEeecCC----CCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCcc-ceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV-RLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      +.|..|=...+|+....+    +..|++|+...... ....-.+|..+++.+..-++. ++++++. ..   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            445556667788886533    23788998765432 222446788888888765554 4555542 22   58999987


Q ss_pred             CChhHH-------h----------hhhc-c-cC-CCCHHHHHHHHHHH----------------------HHHHH----H
Q 008854          405 SSVDKF-------I----------FDAI-K-RV-QLDWETRYKIIGGI----------------------ARGIL----Y  438 (551)
Q Consensus       405 gsL~~~-------l----------~~~~-~-~~-~l~~~~~~~i~~~i----------------------a~~L~----y  438 (551)
                      .+|..-       +          |... . .. .--|..+.++..++                      .+-+.    +
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            766321       1          1100 0 01 11233332222221                      11111    1


Q ss_pred             Hhh-CCCCCeEeccCCCCCeeeCC-CCCeEEeecCCccc
Q 008854          439 LHE-DSRLRIIHRDLKASNILLDA-DMIPKISDFGMARL  475 (551)
Q Consensus       439 LH~-~~~~~iiH~Dlk~~NIll~~-~~~~kl~Dfgla~~  475 (551)
                      +.. ....-++|.|+.+.|||+++ ++.++++||..+..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            211 12234799999999999975 57899999988753

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.76  E-value=0.11  Score=52.24  Aligned_cols=140  Identities=21%  Similarity=0.295  Sum_probs=80.0

Q ss_pred             ccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCC------ccceee----EEecCCceEEEEE
Q 008854          331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN------LVRLLG----FSFEETERLLIYE  400 (551)
Q Consensus       331 ~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~----~~~~~~~~~lV~e  400 (551)
                      .|.+ .-..+|+....+|+. ++|+....  ....++..|+..+..|.-..      |..+=|    ........+-+++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            3444 556799988877666 88888765  33445666777777663222      111111    1112236678999


Q ss_pred             ccCCCChhH-H----h----------hhhccc---------CCCCHHH-------------HHHHHHHHHHHHHHHhhC-
Q 008854          401 FVPNSSVDK-F----I----------FDAIKR---------VQLDWET-------------RYKIIGGIARGILYLHED-  442 (551)
Q Consensus       401 ~~~~gsL~~-~----l----------~~~~~~---------~~l~~~~-------------~~~i~~~ia~~L~yLH~~-  442 (551)
                      |++|..+.. .    +          +...+.         ....|..             ......++...+..+.+. 
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999988872 1    1          110011         1123320             011222333344444332 


Q ss_pred             ---CC---CCeEeccCCCCCeeeCCCCC-eEEeecCCcc
Q 008854          443 ---SR---LRIIHRDLKASNILLDADMI-PKISDFGMAR  474 (551)
Q Consensus       443 ---~~---~~iiH~Dlk~~NIll~~~~~-~kl~Dfgla~  474 (551)
                         -.   ..+||+|+.|.||+++.+.. ..+.||+-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               11   22899999999999998885 8999999875

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.75  E-value=0.21  Score=50.51  Aligned_cols=72  Identities=14%  Similarity=0.121  Sum_probs=44.1

Q ss_pred             CCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCC--Ccccee---e--EEecCCceEEEEEccCCCCh
Q 008854          335 GGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR--NLVRLL---G--FSFEETERLLIYEFVPNSSV  407 (551)
Q Consensus       335 G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~---~--~~~~~~~~~lV~e~~~~gsL  407 (551)
                      +....||+....+++.+++|+..... ....++..|++.+..|...  .++..+   |  ....++..+.++++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            44567999988788899999875332 2344566677776666321  122222   1  12224456789999987653

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.75  E-value=0.11  Score=52.03  Aligned_cols=32  Identities=25%  Similarity=0.307  Sum_probs=28.1

Q ss_pred             CCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          444 RLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       444 ~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      +..++|+|+.+.|||+++++.+.|+||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34699999999999999999999999988753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.69  E-value=0.19  Score=47.23  Aligned_cols=77  Identities=14%  Similarity=0.223  Sum_probs=53.5

Q ss_pred             cCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC---CCCccceeeEEecCCceEEEEEccCC
Q 008854          328 TDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ---HRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       328 ~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      ..+++.-|.--+.|.... +..++.||+-...   ....|..|+.-|..+.   .-.+.+.+.+-......++|+||++-
T Consensus        20 er~~v~gG~inea~~v~d-g~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~   95 (286)
T COG3001          20 EREEVSGGDINEAWRLRD-GTDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT   95 (286)
T ss_pred             cccccCCccccceeEeec-CCcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence            345666666666676653 4578888875432   2345777766666553   45677788888888899999999998


Q ss_pred             CChh
Q 008854          405 SSVD  408 (551)
Q Consensus       405 gsL~  408 (551)
                      +.++
T Consensus        96 ~~~d   99 (286)
T COG3001          96 GPLD   99 (286)
T ss_pred             CCCC
Confidence            7776

>PRK06148 hypothetical protein; Provisional

Probab=95.48  E-value=0.17  Score=59.15  Aligned_cols=141  Identities=21%  Similarity=0.295  Sum_probs=76.6

Q ss_pred             cccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcC-------CCCCcccee-e----EEec-CC--c
Q 008854          330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-------QHRNLVRLL-G----FSFE-ET--E  394 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~l~-~----~~~~-~~--~  394 (551)
                      +.|+ |..-.+|+....+|..+++|+......  ......|...+..|       .-|.+++-. |    .... ++  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            3454 345778888877888999999876432  22333444444433       223333322 1    1111 22  3


Q ss_pred             eEEEEEccCCCChhHH-------h----------hhhc-------ccCCCCHHH-----------------HHHHHHHHH
Q 008854          395 RLLIYEFVPNSSVDKF-------I----------FDAI-------KRVQLDWET-----------------RYKIIGGIA  433 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~-------l----------~~~~-------~~~~l~~~~-----------------~~~i~~~ia  433 (551)
                      .+-+++|+++..+.+.       +          +...       ....+.|..                 ...++.++.
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            4678999999877651       1          1100       011223321                 112222333


Q ss_pred             HHHH-----HHhhCCCCCeEeccCCCCCeeeCCCC--CeE-EeecCCcc
Q 008854          434 RGIL-----YLHEDSRLRIIHRDLKASNILLDADM--IPK-ISDFGMAR  474 (551)
Q Consensus       434 ~~L~-----yLH~~~~~~iiH~Dlk~~NIll~~~~--~~k-l~Dfgla~  474 (551)
                      +...     .|. .-+..+||+|+.+.|||++.+.  ++. |+|||-+.
T Consensus       188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            2221     122 2234599999999999999875  454 99999875

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.06  E-value=0.16  Score=51.01  Aligned_cols=54  Identities=24%  Similarity=0.257  Sum_probs=48.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          419 QLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       419 ~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ...|.+.+.++.+-+..+.-+...-  ++-|||+.-.||||+ +|++.|+||-+++.
T Consensus       317 ~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         317 ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence            3578999999999988888887754  699999999999999 99999999999985

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.85  E-value=0.13  Score=52.40  Aligned_cols=63  Identities=19%  Similarity=0.160  Sum_probs=42.8

Q ss_pred             CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC
Q 008854          393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA  461 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~  461 (551)
                      ....|+-+|+++-++..++..    ...++....+++.-.++++.-+-.-.  .++|.|+.|.||++.-
T Consensus       318 ~~~vl~E~~~~Gl~v~~~v~~----~~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  318 TDLVLVETYERGLSVLRFVKW----KSQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRF  380 (565)
T ss_pred             ccceeeeeccccccHHhhhhc----ccChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEe
Confidence            345677788889888888753    33444556666666666655443322  3999999999999943

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.74  E-value=0.12  Score=48.25  Aligned_cols=117  Identities=17%  Similarity=0.193  Sum_probs=72.1

Q ss_pred             CCceeEEEeecCCCCEEEEEEeecCChh-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCChhHHhhh
Q 008854          335 GGFGAVYKGRLSHGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFD  413 (551)
Q Consensus       335 G~~g~Vyk~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~  413 (551)
                      ++..+.-+++.+-| +..+|++..-... ...-|.++.+++++++  .|+++..=  .....-++.|++-.-..      
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            34455555554333 3455655443333 4456778888887653  45666521  23345588887743210      


Q ss_pred             hcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCc
Q 008854          414 AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA  473 (551)
Q Consensus       414 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla  473 (551)
                            ..    ..++..=++.|.-.|+.+ .+.+|+|-.|+||+-|..|.+||.|=+..
T Consensus       142 ------~~----~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  142 ------NF----SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             ------ch----hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence                  00    111222246778889654 46999999999999999999999997653

The function of this family is unknown.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	551
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-48
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-47
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-39
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-39
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-38
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-37
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		7e-37
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-24
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-23
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-22
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-22
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-22
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-22
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-22
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-22
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-22
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-22
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-22
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-22
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-22
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-22
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-22
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-22
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-22
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-22
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-21
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-21
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-21
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-21
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-21
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-21
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-21
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-21
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-21
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-21
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-21
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-21
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-21
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-21
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-21
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-21
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-21
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-21
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-20
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-20
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-20
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-20
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-20
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-20
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-20
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-20
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-20
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-20
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-20
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-20
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-20
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-20
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-20
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-20
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-20
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-20
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-20
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-20
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-19
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-19
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-19
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-19
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-19
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-19
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-18
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-18
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-18
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-17
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-17
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-17
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-17
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-17
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-17
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-17
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-17
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-17
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-17
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-17
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-17
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-17
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-17
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-17
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-17
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-17
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-17
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-17
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-17
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-17
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-17
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-17
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-17
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-16
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-16
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-16
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-16
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-16
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-16
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-16
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-16
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-16
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-16
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-16
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-16
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-16
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-16
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		9e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-16
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-16
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-16
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-15
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-15
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-15
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-15
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-15
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-15
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-15
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		8e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		9e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-14
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-14
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-14
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-14
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-14
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-14
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-14
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-14
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-14
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-14
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-14
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-14
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-14
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-14
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-14
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-13
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-13
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-13
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-13
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-13
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-13
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-13
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-13
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-13
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		8e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-13
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		9e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-12
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-12
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-12
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-11
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-11
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-11
3soa_A	444	Full-Length Human Camkii Length = 444		3e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		7e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-11
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-11
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-11
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-11
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-10
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-10
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-10
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-10
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-10
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-10
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		9e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-10
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		8e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		8e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		8e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		8e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		9e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		6e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		8e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  188 bits (477), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 98/224 (43%), Positives = 147/224 (65%), Gaps = 3/224 (1%)
Query: 305 EINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG- 363
           E++  +  +F    ++ A++NFS  N LG+GGFG VYKGRL+ G  +AVKRL +   QG 
Sbjct: 19  EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGG 78
Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIK-RVQLDW 422
           EL+F+ EV +++   HRNL+RL GF    TERLL+Y ++ N SV   + +  + +  LDW
Sbjct: 79  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDW 138
Query: 423 ETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482
             R +I  G ARG+ YLH+    +IIHRD+KA+NILLD +    + DFG+A+L +     
Sbjct: 139 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXH 198
Query: 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK 526
              + + GT G++APEY++ G  S K+DVF +GV++LE+I+GQ+
Sbjct: 199 VXXA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 241

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  184 bits (468), Expect = 9e-47,   Method: Compositional matrix adjust.
 Identities = 96/224 (42%), Positives = 145/224 (64%), Gaps = 3/224 (1%)
Query: 305 EINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG- 363
           E++  +  +F    ++ A++NF   N LG+GGFG VYKGRL+ G  +AVKRL +   QG 
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGG 70
Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIK-RVQLDW 422
           EL+F+ EV +++   HRNL+RL GF    TERLL+Y ++ N SV   + +  + +  LDW
Sbjct: 71  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 423 ETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482
             R +I  G ARG+ YLH+    +IIHRD+KA+NILLD +    + DFG+A+L +     
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXH 190
Query: 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK 526
              + + G  G++APEY++ G  S K+DVF +GV++LE+I+GQ+
Sbjct: 191 VXXA-VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  161 bits (407), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 96/230 (41%), Positives = 137/230 (59%), Gaps = 15/230 (6%)
Query: 305 EINTVESLQFDFSTIRDATNNFST------DNKLGQGGFGAVYKGRLSHGQEIAVKRLSK 358
           E++      F F  +++ TNNF         NK+G+GGFG VYKG +++   +AVK+L+ 
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAA 64
Query: 359 ----NSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDA 414
                + + + +F  E+ ++A+ QH NLV LLGFS +  +  L+Y ++PN S+   +   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 415 IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474
                L W  R KI  G A GI +LHE+     IHRD+K++NILLD     KISDFG+AR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
             E        SRIVGT  YMAPE + RG  + KSD++SFGV++LEII+G
Sbjct: 182 ASEKFAQTVMXSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITG 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  159 bits (403), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 95/230 (41%), Positives = 136/230 (59%), Gaps = 15/230 (6%)
Query: 305 EINTVESLQFDFSTIRDATNNFST------DNKLGQGGFGAVYKGRLSHGQEIAVKRLSK 358
           E++      F F  +++ TNNF         NK+G+GGFG VYKG +++   +AVK+L+ 
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAA 64
Query: 359 ----NSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDA 414
                + + + +F  E+ ++A+ QH NLV LLGFS +  +  L+Y ++PN S+   +   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 415 IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474
                L W  R KI  G A GI +LHE+     IHRD+K++NILLD     KISDFG+AR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
             E         RIVGT  YMAPE + RG  + KSD++SFGV++LEII+G
Sbjct: 182 ASEKFAQTVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  159 bits (403), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 94/221 (42%), Positives = 133/221 (60%), Gaps = 15/221 (6%)
Query: 314 FDFSTIRDATNNFST------DNKLGQGGFGAVYKGRLSHGQEIAVKRLSK----NSVQG 363
           F F  +++ TNNF         NK+G+GGFG VYKG +++   +AVK+L+      + + 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
           + +F  E+ ++A+ QH NLV LLGFS +  +  L+Y ++PN S+   +        L W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
            R KI  G A GI +LHE+     IHRD+K++NILLD     KISDFG+AR  E      
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
              RIVGT  YMAPE + RG  + KSD++SFGV++LEII+G
Sbjct: 185 MXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITG 224

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 94/221 (42%), Positives = 130/221 (58%), Gaps = 15/221 (6%)
Query: 314 FDFSTIRDATNNFST------DNKLGQGGFGAVYKGRLSHGQEIAVKRLSK----NSVQG 363
           F F  +++ TNNF         NK G+GGFG VYKG +++   +AVK+L+      + + 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
           + +F  E+ + A+ QH NLV LLGFS +  +  L+Y + PN S+   +        L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
            R KI  G A GI +LHE+     IHRD+K++NILLD     KISDFG+AR  E      
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
             SRIVGT  Y APE + RG  + KSD++SFGV++LEII+G
Sbjct: 182 XXSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITG 221

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  154 bits (390), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 86/218 (39%), Positives = 137/218 (62%), Gaps = 6/218 (2%)
Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKN 369
           ES +     + +ATNNF     +G G FG VYKG L  G ++A+KR +  S QG  EF+ 
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDA-IKRVQLDWETRYKI 428
           E+  ++  +H +LV L+GF  E  E +LIY+++ N ++ + ++ + +  + + WE R +I
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL-FEMDQSQGDTSR 487
             G ARG+ YLH  +   IIHRD+K+ NILLD + +PKI+DFG+++   E+DQ+      
Sbjct: 145 CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXV- 200
Query: 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           + GT GY+ PEY  +G  + KSDV+SFGV++ E++  +
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  152 bits (383), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 85/218 (38%), Positives = 136/218 (62%), Gaps = 6/218 (2%)
Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKN 369
           ES +     + +ATNNF     +G G FG VYKG L  G ++A+KR +  S QG  EF+ 
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDA-IKRVQLDWETRYKI 428
           E+  ++  +H +LV L+GF  E  E +LIY+++ N ++ + ++ + +  + + WE R +I
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL-FEMDQSQGDTSR 487
             G ARG+ YLH  +   IIHRD+K+ NILLD + +PKI+DFG+++   E+ Q+      
Sbjct: 145 CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXV- 200
Query: 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           + GT GY+ PEY  +G  + KSDV+SFGV++ E++  +
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 74/229 (32%), Positives = 122/229 (53%), Gaps = 12/229 (5%)
Query: 305 EINTVESLQFDFSTIRDATN----NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS 360
           +I T E+L F  +   D  +    + +   K+G G FG V++    HG ++AVK L +  
Sbjct: 14  DIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQD 72
Query: 361 VQGEL--EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV 418
              E   EF  EV ++ RL+H N+V  +G   +     ++ E++   S+ + +  +  R 
Sbjct: 73  FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE 132
Query: 419 QLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478
           QLD   R  +   +A+G+ YLH +    I+HRDLK+ N+L+D     K+ DFG++RL   
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--- 188
Query: 479 DQSQGDTSRI-VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK 526
             S    S+   GT  +MAPE +     + KSDV+SFGV++ E+ + Q+
Sbjct: 189 KASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 121/228 (53%), Gaps = 10/228 (4%)
Query: 305 EINTVESLQFDFSTIRDATN----NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS 360
           +I T E+L F  +   D  +    + +   K+G G FG V++    HG ++AVK L +  
Sbjct: 14  DIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQD 72
Query: 361 VQGEL--EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV 418
              E   EF  EV ++ RL+H N+V  +G   +     ++ E++   S+ + +  +  R 
Sbjct: 73  FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE 132
Query: 419 QLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478
           QLD   R  +   +A+G+ YLH +    I+HR+LK+ N+L+D     K+ DFG++RL   
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--K 189
Query: 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK 526
             +   +    GT  +MAPE +     + KSDV+SFGV++ E+ + Q+
Sbjct: 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/226 (32%), Positives = 122/226 (53%), Gaps = 28/226 (12%)
Query: 312 LQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS---VQGELE-F 367
           L+ DF+ +       + +  +G GGFG VY+     G E+AVK    +    +   +E  
Sbjct: 2   LEIDFAEL-------TLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENV 53
Query: 368 KNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYK 427
           + E  L A L+H N++ L G   +E    L+ EF     +++ +  + KR+  D    + 
Sbjct: 54  RQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWA 111
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILL-----DADM---IPKISDFGMARLFEMD 479
           +   IARG+ YLH+++ + IIHRDLK+SNIL+     + D+   I KI+DFG+AR    +
Sbjct: 112 V--QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----E 165
Query: 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
             +       G + +MAPE +    FS  SDV+S+GVL+ E+++G+
Sbjct: 166 WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 118/219 (53%), Gaps = 25/219 (11%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQGEL-------EFKNEVLL 373
           A N    + ++G+GGFG V+KGRL   +  +A+K L     +GE        EF+ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
           ++ L H N+V+L G         ++ EFVP   +   + D  K   + W  + +++  IA
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 434 RGILYLHEDSRLRIIHRDLKASNILL-----DADMIPKISDFGMARLFEMDQSQGDTSRI 488
            GI Y+ ++    I+HRDL++ NI L     +A +  K++DFG+++     QS    S +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGL 186
Query: 489 VGTFGYMAPEYV--TRGHFSIKSDVFSFGVLVLEIISGQ 525
           +G F +MAPE +      ++ K+D +SF +++  I++G+
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 117/219 (53%), Gaps = 25/219 (11%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQGEL-------EFKNEVLL 373
           A N    + ++G+GGFG V+KGRL   +  +A+K L     +GE        EF+ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
           ++ L H N+V+L G         ++ EFVP   +   + D  K   + W  + +++  IA
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 434 RGILYLHEDSRLRIIHRDLKASNILL-----DADMIPKISDFGMARLFEMDQSQGDTSRI 488
            GI Y+ ++    I+HRDL++ NI L     +A +  K++DFG ++     QS    S +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGL 186
Query: 489 VGTFGYMAPEYV--TRGHFSIKSDVFSFGVLVLEIISGQ 525
           +G F +MAPE +      ++ K+D +SF +++  I++G+
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 111/195 (56%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           +LG G FG V+ G  +   ++AVK L + S+  +  F  E  L+ +LQH+ LVRL     
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVT 84
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           +E    +I E++ N S+  F+      ++L       +   IA G+ ++ E +    IHR
Sbjct: 85  QEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 139
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+   +  KI+DFG+ARL E ++    T+R    F   + APE +  G F+IK
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ EI++
Sbjct: 197 SDVWSFGILLTEIVT 211

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 111/195 (56%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           +LG G FG V+ G  +   ++AVK L + S+  +  F  E  L+ +LQH+ LVRL     
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVT 86
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           +E    +I E++ N S+  F+      ++L       +   IA G+ ++ E +    IHR
Sbjct: 87  QEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 141
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+   +  KI+DFG+ARL E ++    T+R    F   + APE +  G F+IK
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTIK 198
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ EI++
Sbjct: 199 SDVWSFGILLTEIVT 213

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 111/195 (56%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           +LG G FG V+ G  +   ++AVK L + S+  +  F  E  L+ +LQH+ LVRL     
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           +E    +I E++ N S+  F+      ++L       +   IA G+ ++ E +    IHR
Sbjct: 81  QEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 135
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+   +  KI+DFG+ARL E ++    T+R    F   + APE +  G F+IK
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTIK 192
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ EI++
Sbjct: 193 SDVWSFGILLTEIVT 207

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 111/195 (56%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           +LG G FG V+ G  +   ++AVK L + S+  +  F  E  L+ +LQH+ LVRL     
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           +E    +I E++ N S+  F+      ++L       +   IA G+ ++ E +    IHR
Sbjct: 88  QEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 142
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+   +  KI+DFG+ARL E ++    T+R    F   + APE +  G F+IK
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTIK 199
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ EI++
Sbjct: 200 SDVWSFGILLTEIVT 214

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 111/195 (56%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           +LG G FG V+ G  +   ++AVK L + S+  +  F  E  L+ +LQH+ LVRL     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           +E    +I E++ N S+  F+      ++L       +   IA G+ ++ E +    IHR
Sbjct: 79  QEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+   +  KI+DFG+ARL E ++    T+R    F   + APE +  G F+IK
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ EI++
Sbjct: 191 SDVWSFGILLTEIVT 205

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 111/195 (56%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           +LG G FG V+ G  +   ++AVK L + S+  +  F  E  L+ +LQH+ LVRL     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           +E    +I E++ N S+  F+      ++L       +   IA G+ ++ E +    IHR
Sbjct: 79  QEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+   +  KI+DFG+ARL E ++    T+R    F   + APE +  G F+IK
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ EI++
Sbjct: 191 SDVWSFGILLTEIVT 205

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 111/195 (56%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           +LG G FG V+ G  +   ++AVK L + S+  +  F  E  L+ +LQH+ LVRL     
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           +E    +I E++ N S+  F+      ++L       +   IA G+ ++ E +    IHR
Sbjct: 80  QEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 134
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+   +  KI+DFG+ARL E ++    T+R    F   + APE +  G F+IK
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTIK 191
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ EI++
Sbjct: 192 SDVWSFGILLTEIVT 206

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 111/195 (56%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           +LG G FG V+ G  +   ++AVK L + S+  +  F  E  L+ +LQH+ LVRL     
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           +E    +I E++ N S+  F+      ++L       +   IA G+ ++ E +    IHR
Sbjct: 85  QEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 139
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+   +  KI+DFG+ARL E ++    T+R    F   + APE +  G F+IK
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ EI++
Sbjct: 197 SDVWSFGILLTEIVT 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 111/195 (56%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           +LG G FG V+ G  +   ++AVK L + S+  +  F  E  L+ +LQH+ LVRL     
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           +E    +I E++ N S+  F+      ++L       +   IA G+ ++ E +    IHR
Sbjct: 84  QEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 138
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+   +  KI+DFG+ARL E ++    T+R    F   + APE +  G F+IK
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIK 195
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ EI++
Sbjct: 196 SDVWSFGILLTEIVT 210

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 117/219 (53%), Gaps = 25/219 (11%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQGEL-------EFKNEVLL 373
           A N    + ++G+GGFG V+KGRL   +  +A+K L     +GE        EF+ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
           ++ L H N+V+L G         ++ EFVP   +   + D  K   + W  + +++  IA
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 434 RGILYLHEDSRLRIIHRDLKASNILL-----DADMIPKISDFGMARLFEMDQSQGDTSRI 488
            GI Y+ ++    I+HRDL++ NI L     +A +  K++DF +++     QS    S +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGL 186
Query: 489 VGTFGYMAPEYV--TRGHFSIKSDVFSFGVLVLEIISGQ 525
           +G F +MAPE +      ++ K+D +SF +++  I++G+
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 111/195 (56%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           +LG G FG V+ G  +   ++AVK L + S+  +  F  E  L+ +LQH+ LVRL     
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVT 88
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           +E    +I E++ N S+  F+      ++L       +   IA G+ ++ E +    IHR
Sbjct: 89  QEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 143
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+   +  KI+DFG+ARL E ++    T+R    F   + APE +  G F+IK
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIK 200
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ EI++
Sbjct: 201 SDVWSFGILLTEIVT 215

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 76/202 (37%), Positives = 112/202 (55%), Gaps = 22/202 (10%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLG 387
            KLG G FG V+ G  ++  ++AVK L     SVQ  LE  N   L+  LQH  LVRL  
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEAN---LMKTLQHDKLVRLYA 74
Query: 388 FSFEETERLLIYEFVPNSSVDKFI-FDAIKRVQLDWETRYKII---GGIARGILYLHEDS 443
              +E    +I EF+   S+  F+  D   +V L      K+I     IA G+ Y+    
Sbjct: 75  VVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLP-----KLIDFSAQIAEGMAYIE--- 126
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVT 501
           R   IHRDL+A+N+L+   ++ KI+DFG+AR+ E ++    T+R    F   + APE + 
Sbjct: 127 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAIN 183
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
            G F+IKS+V+SFG+L+ EI++
Sbjct: 184 FGCFTIKSNVWSFGILLYEIVT 205

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 111/195 (56%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           +LG G FG V+ G  +   ++AVK L + S+  +  F  E  L+ +LQH+ LVRL     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           +E    +I E++ N S+  F+      ++L       +   IA G+ ++ E +    IHR
Sbjct: 79  QEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+   +  KI+DFG+ARL E ++    T+R    F   + APE +  G F+IK
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ EI++
Sbjct: 191 SDVWSFGILLTEIVT 205

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 111/195 (56%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           +LG G FG V+ G  +   ++AVK L + S+  +  F  E  L+ +LQH+ LVRL     
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           +E    +I E++ N S+  F+      ++L       +   IA G+ ++ E +    IHR
Sbjct: 74  QEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 128
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+   +  KI+DFG+ARL E ++    T+R    F   + APE +  G F+IK
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIK 185
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ EI++
Sbjct: 186 SDVWSFGILLTEIVT 200

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 21/220 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQ----EIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRL 385
           LG G FG VYKG  +  G+     +A+K L++ +  +  +EF +E L++A + H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIARGILYLHE 441
           LG     T +L + + +P+  + +++ +    +     L+W  +      IA+G++YL E
Sbjct: 106 LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 158
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               R++HRDL A N+L+ +    KI+DFG+ARL E D+ + +         +MA E + 
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 502 RGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLL 540
              F+ +SDV+S+GV + E+++ G K        E  DLL
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 255

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 109/195 (55%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE   ++I E++   S+  F+   + +  L       +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYIVI-EYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEX---TARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/202 (37%), Positives = 111/202 (54%), Gaps = 22/202 (10%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLG 387
            +LG G FG V+ G  ++  ++AVK L     SVQ  LE  N   L+  LQH  LVRL  
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEAN---LMKTLQHDKLVRLYA 75
Query: 388 FSFEETERLLIYEFVPNSSVDKFI-FDAIKRVQLDWETRYKII---GGIARGILYLHEDS 443
               E    +I E++   S+  F+  D   +V L      K+I     IA G+ Y+    
Sbjct: 76  VVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLP-----KLIDFSAQIAEGMAYIE--- 127
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVT 501
           R   IHRDL+A+N+L+   ++ KI+DFG+AR+ E ++    T+R    F   + APE + 
Sbjct: 128 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAIN 184
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
            G F+IKSDV+SFG+L+ EI++
Sbjct: 185 FGCFTIKSDVWSFGILLYEIVT 206

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 108/196 (55%), Gaps = 11/196 (5%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            +LG G FG V+ G  +   ++A+K L   ++  E  F  E  ++ +L+H  LV+L    
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE-SFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            EE    ++ E++   S+  F+ D   R  L       +   +A G+ Y+    R+  IH
Sbjct: 74  SEEP-IYIVTEYMNKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIE---RMNYIH 128
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSI 507
           RDL+++NIL+   +I KI+DFG+ARL E ++    T+R    F   + APE    G F+I
Sbjct: 129 RDLRSANILVGNGLICKIADFGLARLIEDNEX---TARQGAKFPIKWTAPEAALYGRFTI 185
Query: 508 KSDVFSFGVLVLEIIS 523
           KSDV+SFG+L+ E+++
Sbjct: 186 KSDVWSFGILLTELVT 201

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 118/221 (53%), Gaps = 24/221 (10%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGEL-EFKN 369
           +F+   DATN  S D  +G G FG V  GRL    +    +A+K L     + +  +F  
Sbjct: 37  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWE 423
           E  ++ +  H N++RL G   +    +++ E++ N S+D F+      F  I+ V +   
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM--- 152
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
                + GIA G+ YL   S +  +HRDL A NIL++++++ K+SDFG+AR+ E D    
Sbjct: 153 -----LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAA 204
Query: 484 DTSRIVG-TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            T+R       + +PE +    F+  SDV+S+G+++ E++S
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 21/220 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQ----EIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRL 385
           LG G FG VYKG  +  G+     +A+K L++ +  +  +EF +E L++A + H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIARGILYLHE 441
           LG     T +L + + +P+  + +++ +    +     L+W  +      IA+G++YL E
Sbjct: 83  LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 135
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               R++HRDL A N+L+ +    KI+DFG+ARL E D+ + +         +MA E + 
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 502 RGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLL 540
              F+ +SDV+S+GV + E+++ G K        E  DLL
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 232

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 109/195 (55%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE   ++I E++   S+  F+   + +  L       +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYIVI-EYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 118/221 (53%), Gaps = 24/221 (10%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGEL-EFKN 369
           +F+   DATN  S D  +G G FG V  GRL    +    +A+K L     + +  +F  
Sbjct: 8   EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 66
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWE 423
           E  ++ +  H N++RL G   +    +++ E++ N S+D F+      F  I+ V +   
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM--- 123
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
                + GIA G+ YL   S +  +HRDL A NIL++++++ K+SDFG++R+ E D    
Sbjct: 124 -----LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 484 DTSRIVG-TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            T+R       + +PE +    F+  SDV+S+G+++ E++S
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 118/221 (53%), Gaps = 24/221 (10%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGEL-EFKN 369
           +F+   DATN  S D  +G G FG V  GRL    +    +A+K L     + +  +F  
Sbjct: 25  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 83
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWE 423
           E  ++ +  H N++RL G   +    +++ E++ N S+D F+      F  I+ V +   
Sbjct: 84  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM--- 140
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
                + GIA G+ YL   S +  +HRDL A NIL++++++ K+SDFG++R+ E D    
Sbjct: 141 -----LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 192
Query: 484 DTSRIVG-TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            T+R       + +PE +    F+  SDV+S+G+++ E++S
Sbjct: 193 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 107/195 (54%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++   S+  F+     +  L       +   IA G+ Y+    R+  +HR
Sbjct: 333 EEP-IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 445 SDVWSFGILLTELTT 459

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 107/195 (54%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++   S+  F+     +  L       +   IA G+ Y+    R+  +HR
Sbjct: 250 EEP-IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 362 SDVWSFGILLTELTT 376

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 107/195 (54%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++   S+  F+     +  L       +   IA G+ Y+    R+  +HR
Sbjct: 250 EEP-IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 362 SDVWSFGILLTELTT 376

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 108/195 (55%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++   S+  F+   + +  L       +   IA G+ Y+    R+  +HR
Sbjct: 73  EEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 185 SDVWSFGILLTELTT 199

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/195 (35%), Positives = 111/195 (56%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           +LG G FG V+ G  +   ++AVK L + S+  +  F  E  L+ +LQH+ LVRL     
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           +E    +I E++ N S+  F+      ++L       +   IA G+ ++ E +    IHR
Sbjct: 75  QEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 129
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           +L+A+NIL+   +  KI+DFG+ARL E ++    T+R    F   + APE +  G F+IK
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIK 186
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ EI++
Sbjct: 187 SDVWSFGILLTEIVT 201

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 118/221 (53%), Gaps = 24/221 (10%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGEL-EFKN 369
           +F+   DATN  S D  +G G FG V  GRL    +    +A+K L     + +  +F  
Sbjct: 37  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWE 423
           E  ++ +  H N++RL G   +    +++ E++ N S+D F+      F  I+ V +   
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM--- 152
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
                + GIA G+ YL   S +  +HRDL A NIL++++++ K+SDFG++R+ E D    
Sbjct: 153 -----LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 484 DTSRIVG-TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            T+R       + +PE +    F+  SDV+S+G+++ E++S
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 107/195 (54%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++   S+  F+     +  L       +   IA G+ Y+    R+  +HR
Sbjct: 74  EEP-IXIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 128
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEX---TARQGAKFPIKWTAPEAALYGRFTIK 185
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 186 SDVWSFGILLTELTT 200

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 118/221 (53%), Gaps = 24/221 (10%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGEL-EFKN 369
           +F+   DATN  S D  +G G FG V  GRL    +    +A+K L     + +  +F  
Sbjct: 37  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWE 423
           E  ++ +  H N++RL G   +    +++ E++ N S+D F+      F  I+ V +   
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM--- 152
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
                + GIA G+ YL   S +  +HRDL A NIL++++++ K+SDFG++R+ E D    
Sbjct: 153 -----LRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 484 DTSRIVG-TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            T+R       + +PE +    F+  SDV+S+G+++ E++S
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 108/195 (55%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++   S+  F+   + +  L       +   IA G+ Y+    R+  +HR
Sbjct: 75  EEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 187 SDVWSFGILLTELTT 201

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 108/195 (55%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++   S+  F+   + +  L       +   IA G+ Y+    R+  +HR
Sbjct: 84  EEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 118/221 (53%), Gaps = 24/221 (10%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGEL-EFKN 369
           +F+   DATN  S D  +G G FG V  GRL    +    +A+K L     + +  +F  
Sbjct: 37  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWE 423
           E  ++ +  H N++RL G   +    +++ E++ N S+D F+      F  I+ V +   
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM--- 152
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
                + GIA G+ YL   S +  +HRDL A NIL++++++ K+SDFG++R+ E D    
Sbjct: 153 -----LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 484 DTSRIVG-TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            T+R       + +PE +    F+  SDV+S+G+++ E++S
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 118/221 (53%), Gaps = 24/221 (10%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGEL-EFKN 369
           +F+   DATN  S D  +G G FG V  GRL    +    +A+K L     + +  +F  
Sbjct: 37  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWE 423
           E  ++ +  H N++RL G   +    +++ E++ N S+D F+      F  I+ V +   
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM--- 152
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
                + GIA G+ YL   S +  +HRDL A NIL++++++ K+SDFG++R+ E D    
Sbjct: 153 -----LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 484 DTSRIVG-TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            T+R       + +PE +    F+  SDV+S+G+++ E++S
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 108/195 (55%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++   S+  F+   + +  L       +   IA G+ Y+    R+  +HR
Sbjct: 84  EEP-IYIVCEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 118/221 (53%), Gaps = 24/221 (10%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGEL-EFKN 369
           +F+   DATN  S D  +G G FG V  GRL    +    +A+K L     + +  +F  
Sbjct: 37  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWE 423
           E  ++ +  H N++RL G   +    +++ E++ N S+D F+      F  I+ V +   
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM--- 152
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
                + GIA G+ YL   S +  +HRDL A NIL++++++ K+SDFG++R+ E D    
Sbjct: 153 -----LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 484 DTSRIVG-TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            T+R       + +PE +    F+  SDV+S+G+++ E++S
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 118/212 (55%), Gaps = 25/212 (11%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRL--SKNSVQGELEFKNEVLLVARLQHRNL 382
             +   ++G G FG VYKG+  HG ++AVK L  +  + Q    FKNEV ++ + +H N+
Sbjct: 14  QITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKIIGGIARGI 436
           +  +G+S  + +  ++ ++   SS+   +      F+ IK + +  +T        A+G+
Sbjct: 72  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT--------AQGM 122
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH  S   IIHRDLK++NI L  D+  KI DFG+A +           ++ G+  +MA
Sbjct: 123 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 497 PEYVT---RGHFSIKSDVFSFGVLVLEIISGQ 525
           PE +    +  +S +SDV++FG+++ E+++GQ
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 118/212 (55%), Gaps = 25/212 (11%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRL--SKNSVQGELEFKNEVLLVARLQHRNL 382
             +   ++G G FG VYKG+  HG ++AVK L  +  + Q    FKNEV ++ + +H N+
Sbjct: 11  QITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 68
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKIIGGIARGI 436
           +  +G+S  + +  ++ ++   SS+   +      F+ IK + +  +T        A+G+
Sbjct: 69  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT--------AQGM 119
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH  S   IIHRDLK++NI L  D+  KI DFG+A +           ++ G+  +MA
Sbjct: 120 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 176
Query: 497 PEYVT---RGHFSIKSDVFSFGVLVLEIISGQ 525
           PE +    +  +S +SDV++FG+++ E+++GQ
Sbjct: 177 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 118/221 (53%), Gaps = 24/221 (10%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGEL-EFKN 369
           +F+   DATN  S D  +G G FG V  GRL    +    +A+K L     + +  +F  
Sbjct: 35  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 93
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWE 423
           E  ++ +  H N++RL G   +    +++ E++ N S+D F+      F  I+ V +   
Sbjct: 94  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM--- 150
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
                + GIA G+ YL   S +  +HRDL A NIL++++++ K+SDFG++R+ E D    
Sbjct: 151 -----LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 202
Query: 484 DTSRIVG-TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            T+R       + +PE +    F+  SDV+S+G+++ E++S
Sbjct: 203 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 118/212 (55%), Gaps = 25/212 (11%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRL--SKNSVQGELEFKNEVLLVARLQHRNL 382
             +   ++G G FG VYKG+  HG ++AVK L  +  + Q    FKNEV ++ + +H N+
Sbjct: 14  QITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKIIGGIARGI 436
           +  +G+S  + +  ++ ++   SS+   +      F+ IK + +  +T        A+G+
Sbjct: 72  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT--------AQGM 122
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH  S   IIHRDLK++NI L  D+  KI DFG+A +           ++ G+  +MA
Sbjct: 123 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 497 PEYVT---RGHFSIKSDVFSFGVLVLEIISGQ 525
           PE +    +  +S +SDV++FG+++ E+++GQ
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 118/212 (55%), Gaps = 25/212 (11%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRL--SKNSVQGELEFKNEVLLVARLQHRNL 382
             +   ++G G FG VYKG+  HG ++AVK L  +  + Q    FKNEV ++ + +H N+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKIIGGIARGI 436
           +  +G+S  + +  ++ ++   SS+   +      F+ IK + +  +T        A+G+
Sbjct: 67  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT--------AQGM 117
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH  S   IIHRDLK++NI L  D+  KI DFG+A +           ++ G+  +MA
Sbjct: 118 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 497 PEYVT---RGHFSIKSDVFSFGVLVLEIISGQ 525
           PE +    +  +S +SDV++FG+++ E+++GQ
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 107/195 (54%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++   S+  F+     +  L       +   IA G+ Y+    R+  +HR
Sbjct: 250 EEP-IYIVGEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 362 SDVWSFGILLTELTT 376

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 107/195 (54%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++   S+  F+     +  L       +   IA G+ Y+    R+  +HR
Sbjct: 77  EEP-IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 131
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 188
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 189 SDVWSFGILLTELTT 203

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 117/221 (52%), Gaps = 24/221 (10%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGEL-EFKN 369
           +F+   DATN  S D  +G G FG V  GRL    +    +A+K L     + +  +F  
Sbjct: 37  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWE 423
           E  ++ +  H N++RL G   +    +++ E++ N S+D F+      F  I+ V +   
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM--- 152
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
                + GIA G+ YL   S +  +HRDL A NIL++++++ K+SDFG+ R+ E D    
Sbjct: 153 -----LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
Query: 484 DTSRIVG-TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            T+R       + +PE +    F+  SDV+S+G+++ E++S
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 125/224 (55%), Gaps = 32/224 (14%)
Query: 320 RDATNNF-------STDNKLGQGGFGAVYKGRLSHGQEIAVKRL--SKNSVQGELEFKNE 370
           RD+++++       +   ++G G FG VYKG+  HG ++AVK L  +  + Q    FKNE
Sbjct: 25  RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNE 82
Query: 371 VLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWET 424
           V ++ + +H N++  +G+S  + +  ++ ++   SS+   +      F+ IK + +  +T
Sbjct: 83  VGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 141
Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
                   A+G+ YLH  S   IIHRDLK++NI L  D+  KI DFG+A +         
Sbjct: 142 --------AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 190
Query: 485 TSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQ 525
             ++ G+  +MAPE +    +  +S +SDV++FG+++ E+++GQ
Sbjct: 191 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 125/224 (55%), Gaps = 32/224 (14%)
Query: 320 RDATNNF-------STDNKLGQGGFGAVYKGRLSHGQEIAVKRL--SKNSVQGELEFKNE 370
           RD+++++       +   ++G G FG VYKG+  HG ++AVK L  +  + Q    FKNE
Sbjct: 24  RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNE 81
Query: 371 VLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWET 424
           V ++ + +H N++  +G+S  + +  ++ ++   SS+   +      F+ IK + +  +T
Sbjct: 82  VGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 140
Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
                   A+G+ YLH  S   IIHRDLK++NI L  D+  KI DFG+A +         
Sbjct: 141 --------AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 189
Query: 485 TSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQ 525
             ++ G+  +MAPE +    +  +S +SDV++FG+++ E+++GQ
Sbjct: 190 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 117/212 (55%), Gaps = 25/212 (11%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRL--SKNSVQGELEFKNEVLLVARLQHRNL 382
             +   ++G G FG VYKG+  HG ++AVK L  +  + Q    FKNEV ++ + +H N+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKIIGGIARGI 436
           +  +G+S    +  ++ ++   SS+   +      F+ IK + +  +T        A+G+
Sbjct: 67  LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT--------AQGM 117
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH  S   IIHRDLK++NI L  D+  KI DFG+A +           ++ G+  +MA
Sbjct: 118 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 497 PEYVT---RGHFSIKSDVFSFGVLVLEIISGQ 525
           PE +    +  +S +SDV++FG+++ E+++GQ
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 107/195 (54%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++   S+  F+   + +  L       +   IA G+ Y+    R+  +HR
Sbjct: 251 EEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ RL E ++    T+R    F   + APE    G F+IK
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 362
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 363 SDVWSFGILLTELTT 377

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 108/195 (55%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +++H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++   S+  F+   + +  L       +   IA G+ Y+    R+  +HR
Sbjct: 84  EEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 107/195 (54%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++   S+  F+   + +  L       +   IA G+ Y+    R+  +HR
Sbjct: 84  EEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 116/199 (58%), Gaps = 12/199 (6%)
Query: 332 LGQGGFGAVYKGRL--SHGQE---IAVKRLSKNSVQGE-LEFKNEVLLVARLQHRNLVRL 385
           +G G FG VYKG L  S G++   +A+K L     + + ++F  E  ++ +  H N++RL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
            G   +    ++I E++ N ++DKF+ +  K  +        ++ GIA G+ YL   + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMD-QSQGDTSRIVGTFGYMAPEYVTRGH 504
             +HRDL A NIL++++++ K+SDFG++R+ E D ++   TS       + APE ++   
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 505 FSIKSDVFSFGVLVLEIIS 523
           F+  SDV+SFG+++ E+++
Sbjct: 227 FTSASDVWSFGIVMWEVMT 245

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 107/195 (54%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++   S+  F+     +  L       +   IA G+ Y+    R+  +HR
Sbjct: 81  EEP-IYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEW---TARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 193 SDVWSFGILLTELTT 207

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 107/195 (54%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++   S+  F+     +  L       +   IA G+ Y+    R+  +HR
Sbjct: 81  EEP-IYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 193 SDVWSFGILLTELTT 207

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 107/195 (54%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++    +  F+   + +  L       +   IA G+ Y+    R+  +HR
Sbjct: 84  EEP-IYIVMEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 117/221 (52%), Gaps = 24/221 (10%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGEL-EFKN 369
           +F+   DATN  S D  +G G FG V  GRL    +    +A+K L     + +  +F  
Sbjct: 8   EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 66
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWE 423
           E  ++ +  H N++RL G   +    +++ E + N S+D F+      F  I+ V +   
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGM--- 123
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
                + GIA G+ YL   S +  +HRDL A NIL++++++ K+SDFG++R+ E D    
Sbjct: 124 -----LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 484 DTSRIVG-TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            T+R       + +PE +    F+  SDV+S+G+++ E++S
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 118/212 (55%), Gaps = 13/212 (6%)
Query: 319 IRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV--QGELE-FKNEVLLV 374
           I +   +F   N LG+G F  VY+    H G E+A+K + K ++   G ++  +NEV + 
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 375 ARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
            +L+H +++ L  + FE++  + L+ E   N  +++++ + +K    + E R+  +  I 
Sbjct: 66  CQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-ENEARH-FMHQII 122
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
            G+LYLH      I+HRDL  SN+LL  +M  KI+DFG+A   +M   +  T  + GT  
Sbjct: 123 TGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPN 177
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           Y++PE  TR    ++SDV+S G +   ++ G+
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 107/195 (54%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           EE    ++ E++    +  F+   + +  L       +   IA G+ Y+    R+  +HR
Sbjct: 84  EEP-IYIVTEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSIK 508
           DL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F   + APE    G F+IK
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 509 SDVFSFGVLVLEIIS 523
           SDV+SFG+L+ E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 69/196 (35%), Positives = 109/196 (55%), Gaps = 11/196 (5%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            +LG G  G V+ G  +   ++AVK L + S+  +  F  E  L+ +LQH+ LVRL    
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVV 77
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            +E    +I E++ N S+  F+      ++L       +   IA G+ ++ E +    IH
Sbjct: 78  TQEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSI 507
           RDL+A+NIL+   +  KI+DFG+ARL E  +    T+R    F   + APE +  G F+I
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDAEX---TAREGAKFPIKWTAPEAINYGTFTI 189
Query: 508 KSDVFSFGVLVLEIIS 523
           KSDV+SFG+L+ EI++
Sbjct: 190 KSDVWSFGILLTEIVT 205

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 117/212 (55%), Gaps = 25/212 (11%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRL--SKNSVQGELEFKNEVLLVARLQHRNL 382
             +   ++G G FG VYKG+  HG ++AVK L  +  + Q    FKNEV ++ + +H N+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKIIGGIARGI 436
           +  +G+S  + +  ++ ++   SS+   +      F+ IK + +  +T        A+G+
Sbjct: 67  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT--------AQGM 117
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH  S   IIHRDLK++NI L  D+  KI DFG+A             ++ G+  +MA
Sbjct: 118 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 174
Query: 497 PEYVT---RGHFSIKSDVFSFGVLVLEIISGQ 525
           PE +    +  +S +SDV++FG+++ E+++GQ
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 117/221 (52%), Gaps = 24/221 (10%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGEL-EFKN 369
           +F+   DATN  S D  +G G FG V  GRL    +    +A+K L     + +  +F  
Sbjct: 37  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWE 423
           E  ++ +  H N++RL G   +    +++ E + N S+D F+      F  I+ V +   
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGM--- 152
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
                + GIA G+ YL   S +  +HRDL A NIL++++++ K+SDFG++R+ E D    
Sbjct: 153 -----LRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 484 DTSRIVG-TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            T+R       + +PE +    F+  SDV+S+G+++ E++S
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 117/221 (52%), Gaps = 24/221 (10%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGEL-EFKN 369
           +F+   DATN  S D  +G G FG V  GRL    +    +A+K L     + +  +F  
Sbjct: 37  EFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWE 423
           E  ++ +  H N++RL G   +    +++ E + N S+D F+      F  I+ V +   
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGM--- 152
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
                + GIA G+ YL   S +  +HRDL A NIL++++++ K+SDFG++R+ E D    
Sbjct: 153 -----LRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 484 DTSRIVG-TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            T+R       + +PE +    F+  SDV+S+G+++ E++S
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 124/224 (55%), Gaps = 32/224 (14%)
Query: 320 RDATNNF-------STDNKLGQGGFGAVYKGRLSHGQEIAVKRL--SKNSVQGELEFKNE 370
           RD+++++       +   ++G G FG VYKG+  HG ++AVK L  +  + Q    FKNE
Sbjct: 17  RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNE 74
Query: 371 VLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWET 424
           V ++ + +H N++  +G+S  + +  ++ ++   SS+   +      F+ IK + +  +T
Sbjct: 75  VGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 133
Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
                   A+G+ YLH  S   IIHRDLK++NI L  D+  KI DFG+A           
Sbjct: 134 --------AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQ 182
Query: 485 TSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQ 525
             ++ G+  +MAPE +    +  +S +SDV++FG+++ E+++GQ
Sbjct: 183 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 124/224 (55%), Gaps = 32/224 (14%)
Query: 320 RDATNNF-------STDNKLGQGGFGAVYKGRLSHGQEIAVKRL--SKNSVQGELEFKNE 370
           RD+++++       +   ++G G FG VYKG+  HG ++AVK L  +  + Q    FKNE
Sbjct: 25  RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNE 82
Query: 371 VLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWET 424
           V ++ + +H N++  +G+S  + +  ++ ++   SS+   +      F+ IK + +  +T
Sbjct: 83  VGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 141
Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
                   A+G+ YLH  S   IIHRDLK++NI L  D+  KI DFG+A           
Sbjct: 142 --------AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQ 190
Query: 485 TSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQ 525
             ++ G+  +MAPE +    +  +S +SDV++FG+++ E+++GQ
Sbjct: 191 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 112/200 (56%), Gaps = 17/200 (8%)
Query: 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           + KLG G FG V+    +   ++AVK +   S+  E  F  E  ++  LQH  LV+L   
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 78
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII---GGIARGILYLHEDSRL 445
             +E    +I EF+   S    + D +K  +   +   K+I     IA G+ ++ + +  
Sbjct: 79  VTKEP-IYIITEFMAKGS----LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 131
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRG 503
             IHRDL+A+NIL+ A ++ KI+DFG+AR+ E ++    T+R    F   + APE +  G
Sbjct: 132 -YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFG 187
Query: 504 HFSIKSDVFSFGVLVLEIIS 523
            F+IKSDV+SFG+L++EI++
Sbjct: 188 SFTIKSDVWSFGILLMEIVT 207

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/218 (33%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSK-NSVQGELEFKNEVLLVAR 376
            N +    LG G FG VY+G++S         ++AVK L +  S Q EL+F  E L++++
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV----QLDWETRYKIIGGI 432
           L H+N+VR +G S +   R ++ E +    +  F+ +   R      L       +   I
Sbjct: 105 LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQGDTSRIV 489
           A G  YL E+     IHRD+ A N LL       + KI DFGMAR    D  +    R  
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 217
Query: 490 G----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           G       +M PE    G F+ K+D +SFGVL+ EI S
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 121/218 (55%), Gaps = 20/218 (9%)
Query: 320 RDATNNF-------STDNKLGQGGFGAVYKGRLSHGQEIAVKRL--SKNSVQGELEFKNE 370
           RD+++++       +   ++G G FG VYKG+  HG ++AVK L  +  + Q    FKNE
Sbjct: 1   RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNE 58
Query: 371 VLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
           V ++ + +H N++  +G+S  + +  ++ ++   SS+   +  +  + ++  +    I  
Sbjct: 59  VGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIAR 115
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
             ARG+ YLH  S   IIHRDLK++NI L  D   KI DFG+A +           ++ G
Sbjct: 116 QTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSG 172
Query: 491 TFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQ 525
           +  +MAPE +       +S +SDV++FG+++ E+++GQ
Sbjct: 173 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/218 (33%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSK-NSVQGELEFKNEVLLVAR 376
            N +    LG G FG VY+G++S         ++AVK L +  S Q EL+F  E L++++
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV----QLDWETRYKIIGGI 432
           L H+N+VR +G S +   R ++ E +    +  F+ +   R      L       +   I
Sbjct: 91  LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQGDTSRIV 489
           A G  YL E+     IHRD+ A N LL       + KI DFGMAR    D  +    R  
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 203
Query: 490 G----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           G       +M PE    G F+ K+D +SFGVL+ EI S
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 112/200 (56%), Gaps = 17/200 (8%)
Query: 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           + KLG G FG V+    +   ++AVK +   S+  E  F  E  ++  LQH  LV+L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 251
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII---GGIARGILYLHEDSRL 445
             +E    +I EF+   S    + D +K  +   +   K+I     IA G+ ++ + +  
Sbjct: 252 VTKEP-IYIITEFMAKGS----LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 304
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRG 503
             IHRDL+A+NIL+ A ++ KI+DFG+AR+ E ++    T+R    F   + APE +  G
Sbjct: 305 -YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFG 360
Query: 504 HFSIKSDVFSFGVLVLEIIS 523
            F+IKSDV+SFG+L++EI++
Sbjct: 361 SFTIKSDVWSFGILLMEIVT 380

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 104/218 (47%), Gaps = 25/218 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSK-NSVQGELEFKNEVLLVAR 376
            N +    LG G FG VY+G++S         ++AVK L +  S Q EL+F  E L++++
Sbjct: 47  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 106
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV----QLDWETRYKIIGGI 432
             H+N+VR +G S +   R ++ E +    +  F+ +   R      L       +   I
Sbjct: 107 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 166
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQGDTSRIV 489
           A G  YL E+     IHRD+ A N LL       + KI DFGMAR    D  +    R  
Sbjct: 167 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 219
Query: 490 G----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           G       +M PE    G F+ K+D +SFGVL+ EI S
Sbjct: 220 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 104/218 (47%), Gaps = 25/218 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSK-NSVQGELEFKNEVLLVAR 376
            N +    LG G FG VY+G++S         ++AVK L +  S Q EL+F  E L++++
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV----QLDWETRYKIIGGI 432
             H+N+VR +G S +   R ++ E +    +  F+ +   R      L       +   I
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQGDTSRIV 489
           A G  YL E+     IHRD+ A N LL       + KI DFGMAR    D  +    R  
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 217
Query: 490 G----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           G       +M PE    G F+ K+D +SFGVL+ EI S
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 104/218 (47%), Gaps = 25/218 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSK-NSVQGELEFKNEVLLVAR 376
            N +    LG G FG VY+G++S         ++AVK L +  S Q EL+F  E L++++
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV----QLDWETRYKIIGGI 432
             H+N+VR +G S +   R ++ E +    +  F+ +   R      L       +   I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQGDTSRIV 489
           A G  YL E+     IHRD+ A N LL       + KI DFGMAR    D  +    R  
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 202
Query: 490 G----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           G       +M PE    G F+ K+D +SFGVL+ EI S
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 116/203 (57%), Gaps = 19/203 (9%)
Query: 332 LGQGGFGAVYKGRL-SHGQE---IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G G FG V +GRL + G++   +A+K L     + +  EF +E  ++ + +H N++RL 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHEDS 443
           G        +++ EF+ N ++D F+     R+     T  +++G   GIA G+ YL E  
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFL-----RLNDGQFTVIQLVGMLRGIASGMRYLAE-- 136
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG-DTSRIVGTFG--YMAPEYV 500
            +  +HRDL A NIL++++++ K+SDFG++R  E + S   +TS + G     + APE +
Sbjct: 137 -MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               F+  SD +S+G+++ E++S
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 104/218 (47%), Gaps = 25/218 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSK-NSVQGELEFKNEVLLVAR 376
            N +    LG G FG VY+G++S         ++AVK L +  S Q EL+F  E L++++
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV----QLDWETRYKIIGGI 432
             H+N+VR +G S +   R ++ E +    +  F+ +   R      L       +   I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQGDTSRIV 489
           A G  YL E+     IHRD+ A N LL       + KI DFGMAR    D  +    R  
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 202
Query: 490 G----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           G       +M PE    G F+ K+D +SFGVL+ EI S
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 104/218 (47%), Gaps = 25/218 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSK-NSVQGELEFKNEVLLVAR 376
            N +    LG G FG VY+G++S         ++AVK L +  S Q EL+F  E L++++
Sbjct: 22  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 81
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV----QLDWETRYKIIGGI 432
             H+N+VR +G S +   R ++ E +    +  F+ +   R      L       +   I
Sbjct: 82  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 141
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQGDTSRIV 489
           A G  YL E+     IHRD+ A N LL       + KI DFGMAR    D  +    R  
Sbjct: 142 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 194
Query: 490 G----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           G       +M PE    G F+ K+D +SFGVL+ EI S
Sbjct: 195 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 104/218 (47%), Gaps = 25/218 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSK-NSVQGELEFKNEVLLVAR 376
            N +    LG G FG VY+G++S         ++AVK L +  S Q EL+F  E L++++
Sbjct: 37  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 96
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV----QLDWETRYKIIGGI 432
             H+N+VR +G S +   R ++ E +    +  F+ +   R      L       +   I
Sbjct: 97  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 156
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQGDTSRIV 489
           A G  YL E+     IHRD+ A N LL       + KI DFGMAR    D  +    R  
Sbjct: 157 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 209
Query: 490 G----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           G       +M PE    G F+ K+D +SFGVL+ EI S
Sbjct: 210 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 104/218 (47%), Gaps = 25/218 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSK-NSVQGELEFKNEVLLVAR 376
            N +    LG G FG VY+G++S         ++AVK L +  S Q EL+F  E L++++
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISK 104
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV----QLDWETRYKIIGGI 432
             H+N+VR +G S +   R ++ E +    +  F+ +   R      L       +   I
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQGDTSRIV 489
           A G  YL E+     IHRD+ A N LL       + KI DFGMAR    D  +    R  
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 217
Query: 490 G----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           G       +M PE    G F+ K+D +SFGVL+ EI S
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 104/218 (47%), Gaps = 25/218 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSK-NSVQGELEFKNEVLLVAR 376
            N +    LG G FG VY+G++S         ++AVK L +  S Q EL+F  E L++++
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV----QLDWETRYKIIGGI 432
             H+N+VR +G S +   R ++ E +    +  F+ +   R      L       +   I
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQGDTSRIV 489
           A G  YL E+     IHRD+ A N LL       + KI DFGMAR    D  +    R  
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 203
Query: 490 G----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           G       +M PE    G F+ K+D +SFGVL+ EI S
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 118/218 (54%), Gaps = 20/218 (9%)
Query: 320 RDATNNF-------STDNKLGQGGFGAVYKGRLSHGQEIAVKRL--SKNSVQGELEFKNE 370
           RDA +++       +   ++G G FG VYKG+  HG ++AVK L  +  + Q    FKNE
Sbjct: 13  RDAADDWEIPDGQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNE 70
Query: 371 VLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
           V ++ + +H N++  +G+S    +  ++ ++   SS+   +  +  + ++  +    I  
Sbjct: 71  VGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIAR 127
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
             ARG+ YLH  S   IIHRDLK++NI L  D   KI DFG+A             ++ G
Sbjct: 128 QTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 491 TFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQ 525
           +  +MAPE +       +S +SDV++FG+++ E+++GQ
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 104/218 (47%), Gaps = 25/218 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSK-NSVQGELEFKNEVLLVAR 376
            N +    LG G FG VY+G++S         ++AVK L +  S Q EL+F  E L++++
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV----QLDWETRYKIIGGI 432
             H+N+VR +G S +   R ++ E +    +  F+ +   R      L       +   I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQGDTSRIV 489
           A G  YL E+     IHRD+ A N LL       + KI DFGMAR    D  +    R  
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKG 243
Query: 490 G----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           G       +M PE    G F+ K+D +SFGVL+ EI S
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 104/218 (47%), Gaps = 25/218 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSK-NSVQGELEFKNEVLLVAR 376
            N +    LG G FG VY+G++S         ++AVK L +  S Q EL+F  E L++++
Sbjct: 48  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 107
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV----QLDWETRYKIIGGI 432
             H+N+VR +G S +   R ++ E +    +  F+ +   R      L       +   I
Sbjct: 108 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 167
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQGDTSRIV 489
           A G  YL E+     IHRD+ A N LL       + KI DFGMAR    D  +    R  
Sbjct: 168 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKG 220
Query: 490 G----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           G       +M PE    G F+ K+D +SFGVL+ EI S
Sbjct: 221 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 120/218 (55%), Gaps = 20/218 (9%)
Query: 320 RDATNNF-------STDNKLGQGGFGAVYKGRLSHGQEIAVKRL--SKNSVQGELEFKNE 370
           RD+++++       +   ++G G FG VYKG+  HG ++AVK L  +  + Q    FKNE
Sbjct: 13  RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNE 70
Query: 371 VLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
           V ++ + +H N++  +G+S  + +  ++ ++   SS+   +  +  + ++  +    I  
Sbjct: 71  VGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIAR 127
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
             ARG+ YLH  S   IIHRDLK++NI L  D   KI DFG+A             ++ G
Sbjct: 128 QTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 491 TFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQ 525
           +  +MAPE +       +S +SDV++FG+++ E+++GQ
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 104/197 (52%), Gaps = 7/197 (3%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            ++G G FG V+ G   +  ++A+K + + ++  E +F  E  ++ +L H  LV+L G  
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            E+    L++EF+ +  +  ++    +R     ET   +   +  G+ YL E S   +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VIH 126
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKS 509
           RDL A N L+  + + K+SDFGM R F +D     ++       + +PE  +   +S KS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 510 DVFSFGVLVLEIISGQK 526
           DV+SFGVL+ E+ S  K
Sbjct: 186 DVWSFGVLMWEVFSEGK 202

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 104/218 (47%), Gaps = 25/218 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSK-NSVQGELEFKNEVLLVAR 376
            N +    LG G FG VY+G++S         ++AVK L +  S Q EL+F  E L++++
Sbjct: 57  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 116
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV----QLDWETRYKIIGGI 432
             H+N+VR +G S +   R ++ E +    +  F+ +   R      L       +   I
Sbjct: 117 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 176
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQGDTSRIV 489
           A G  YL E+     IHRD+ A N LL       + KI DFGMAR    D  +    R  
Sbjct: 177 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 229
Query: 490 G----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           G       +M PE    G F+ K+D +SFGVL+ EI S
Sbjct: 230 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 114/203 (56%), Gaps = 19/203 (9%)
Query: 332 LGQGGFGAVYKGRL-SHGQE---IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G G FG V +GRL + G++   +A+K L     + +  EF +E  ++ + +H N++RL 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHEDS 443
           G        +++ EF+ N ++D F+     R+     T  +++G   GIA G+ YL E  
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFL-----RLNDGQFTVIQLVGMLRGIASGMRYLAE-- 134
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG---TFGYMAPEYV 500
            +  +HRDL A NIL++++++ K+SDFG++R  E + S    +  +G      + APE +
Sbjct: 135 -MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               F+  SD +S+G+++ E++S
Sbjct: 194 AFRKFTSASDAWSYGIVMWEVMS 216

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 111/219 (50%), Gaps = 33/219 (15%)
Query: 330 NKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRN 381
            +LG+  FG VYKG L         Q +A+K L K+  +G L  EF++E +L ARLQH N
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPN 90
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIF-------------DAIKRVQLDWETRYKI 428
           +V LLG   ++    +I+ +  +  + +F+              D   +  L+      +
Sbjct: 91  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 150
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
           +  IA G+ YL   S   ++H+DL   N+L+   +  KISD G+ R    +    D  ++
Sbjct: 151 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKL 203
Query: 489 VG----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +G       +MAPE +  G FSI SD++S+GV++ E+ S
Sbjct: 204 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 111/219 (50%), Gaps = 33/219 (15%)
Query: 330 NKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRN 381
            +LG+  FG VYKG L         Q +A+K L K+  +G L  EF++E +L ARLQH N
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIF-------------DAIKRVQLDWETRYKI 428
           +V LLG   ++    +I+ +  +  + +F+              D   +  L+      +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
           +  IA G+ YL   S   ++H+DL   N+L+   +  KISD G+ R    +    D  ++
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKL 186
Query: 489 VG----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +G       +MAPE +  G FSI SD++S+GV++ E+ S
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            ++G G FG V+ G   +  ++A+K + + S+  E +F  E  ++ +L H  LV+L G  
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS-EDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            E+    L++EF+ +  +  ++    +R     ET   +   +  G+ YL E     +IH
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKS 509
           RDL A N L+  + + K+SDFGM R F +D     ++       + +PE  +   +S KS
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 205
Query: 510 DVFSFGVLVLEIISGQK 526
           DV+SFGVL+ E+ S  K
Sbjct: 206 DVWSFGVLMWEVFSEGK 222

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            ++G G FG V+ G   +  ++A+K + + ++  E +F  E  ++ +L H  LV+L G  
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            E+    L++EF+ +  +  ++    +R     ET   +   +  G+ YL E     +IH
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKS 509
           RDL A N L+  + + K+SDFGM R F +D     ++       + +PE  +   +S KS
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 510 DVFSFGVLVLEIISGQK 526
           DV+SFGVL+ E+ S  K
Sbjct: 184 DVWSFGVLMWEVFSEGK 200

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 104/218 (47%), Gaps = 25/218 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSK-NSVQGELEFKNEVLLVAR 376
            N +    LG G FG VY+G++S         ++AVK L +  S Q EL+F  E L++++
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV----QLDWETRYKIIGGI 432
             H+N+VR +G S +   R ++ E +    +  F+ +   R      L       +   I
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQGDTSRIV 489
           A G  YL E+     IHRD+ A N LL       + KI DFGMA+    D  +    R  
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ----DIYRASYYRKG 203
Query: 490 G----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           G       +M PE    G F+ K+D +SFGVL+ EI S
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            ++G G FG V+ G   +  ++A+K + + ++  E +F  E  ++ +L H  LV+L G  
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            E+    L++EF+ +  +  ++    +R     ET   +   +  G+ YL E     +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKS 509
           RDL A N L+  + + K+SDFGM R F +D     ++       + +PE  +   +S KS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 510 DVFSFGVLVLEIISGQK 526
           DV+SFGVL+ E+ S  K
Sbjct: 186 DVWSFGVLMWEVFSEGK 202

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            ++G G FG V+ G   +  ++A+K + + ++  E +F  E  ++ +L H  LV+L G  
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            E+    L++EF+ +  +  ++    +R     ET   +   +  G+ YL E     +IH
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKS 509
           RDL A N L+  + + K+SDFGM R F +D     ++       + +PE  +   +S KS
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 188
Query: 510 DVFSFGVLVLEIISGQK 526
           DV+SFGVL+ E+ S  K
Sbjct: 189 DVWSFGVLMWEVFSEGK 205

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 109/209 (52%), Gaps = 10/209 (4%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR 376
           ++ D    ++   K+GQG  G VY    ++ GQE+A+++++      +    NE+L++  
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
            ++ N+V  L       E  ++ E++   S    + D +    +D      +     + +
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECLQAL 129
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            +LH +   ++IHRD+K+ NILL  D   K++DFG       +QS+   S +VGT  +MA
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMA 184
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           PE VTR  +  K D++S G++ +E+I G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 109/209 (52%), Gaps = 10/209 (4%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR 376
           ++ D    ++   K+GQG  G VY    ++ GQE+A+++++      +    NE+L++  
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
            ++ N+V  L       E  ++ E++   S    + D +    +D      +     + +
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECLQAL 129
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            +LH +   ++IHRD+K+ NILL  D   K++DFG       +QS+  T  +VGT  +MA
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 184
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           PE VTR  +  K D++S G++ +E+I G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 111/206 (53%), Gaps = 25/206 (12%)
Query: 332 LGQGGFGAVYKG--RLSHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G G FG V  G  +L   +EI  A+K L     + +  +F +E  ++ +  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 387 GFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKIIGGIARGILYLH 440
           G   + T  ++I EF+ N S+D F+      F  I+ V +        + GIA G+ YL 
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGM--------LRGIAAGMKYLA 152
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG---TFGYMAP 497
           +   +  +HRDL A NIL++++++ K+SDFG++R  E D S    +  +G      + AP
Sbjct: 153 D---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 209
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
           E +    F+  SDV+S+G+++ E++S
Sbjct: 210 EAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 109/209 (52%), Gaps = 10/209 (4%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR 376
           ++ D    ++   K+GQG  G VY    ++ GQE+A+++++      +    NE+L++  
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
            ++ N+V  L       E  ++ E++   S    + D +    +D      +     + +
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECLQAL 129
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            +LH +   ++IHRD+K+ NILL  D   K++DFG       +QS+   S +VGT  +MA
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMA 184
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           PE VTR  +  K D++S G++ +E+I G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 109/209 (52%), Gaps = 10/209 (4%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR 376
           ++ D    ++   K+GQG  G VY    ++ GQE+A+++++      +    NE+L++  
Sbjct: 15  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
            ++ N+V  L       E  ++ E++   S    + D +    +D      +     + +
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECLQAL 130
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            +LH +   ++IHRD+K+ NILL  D   K++DFG       +QS+   S +VGT  +MA
Sbjct: 131 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMA 185
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           PE VTR  +  K D++S G++ +E+I G+
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 7/197 (3%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            ++G G FG V+ G   +  ++A+K + + ++  E +F  E  ++ +L H  LV+L G  
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            E+    L+ EF+ +  +  ++    +R     ET   +   +  G+ YL E     +IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKS 509
           RDL A N L+  + + K+SDFGM R F +D     ++       + +PE  +   +S KS
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 510 DVFSFGVLVLEIISGQK 526
           DV+SFGVL+ E+ S  K
Sbjct: 187 DVWSFGVLMWEVFSEGK 203

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
           + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 77
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +LLG    E    +I EF+   ++  ++ +   R +++      +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN 136
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVT 501
               IHRDL A N L+  + + K++DFG++RL   D     T+     F   + APE + 
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX---TAHAGAKFPIKWTAPESLA 190
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
              FSIKSDV++FGVL+ EI +
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 116/221 (52%), Gaps = 15/221 (6%)
Query: 310 ESLQFDFSTIRDATNNFSTD----NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGE 364
           E+L F  S   D      TD    +KLG G +G VY+G    +   +AVK L +++++ E
Sbjct: 8   ENLYFQGSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE 67
Query: 365 LEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWET 424
            EF  E  ++  ++H NLV+LLG    E    +I EF+   ++  ++ +   R +++   
Sbjct: 68  -EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVV 125
Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
              +   I+  + YL + +    IHRDL A N L+  + + K++DFG++RL   D     
Sbjct: 126 LLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--- 179
Query: 485 TSRIVGTFG--YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           T+     F   + APE +    FSIKSDV++FGVL+ EI +
Sbjct: 180 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 11/203 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
            + +  +KLG G FG VY+G    +   +AVK L +++++ E EF  E  ++  ++H NL
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 69
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           V+LLG    E    +I EF+   ++  ++ +   R ++       +   I+  + YL + 
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYV 500
           +    IHRDL A N L+  + + K++DFG++RL   D     T+     F   + APE +
Sbjct: 129 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX---TAHAGAKFPIKWTAPESL 182
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               FSIKSDV++FGVL+ EI +
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
           + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 77
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +LLG    E    +I EF+   ++  ++ +   R +++      +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIIIEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN 136
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVT 501
               IHRDL A N L+  + + K++DFG++RL   D     T+     F   + APE + 
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLA 190
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
              FSIKSDV++FGVL+ EI +
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 109/209 (52%), Gaps = 10/209 (4%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR 376
           ++ D    ++   K+GQG  G VY    ++ GQE+A+++++      +    NE+L++  
Sbjct: 15  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
            ++ N+V  L       E  ++ E++   S    + D +    +D      +     + +
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECLQAL 130
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            +LH +   ++IHR++K+ NILL  D   K++DFG       +QS+  T  +VGT  +MA
Sbjct: 131 EFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 185
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           PE VTR  +  K D++S G++ +E+I G+
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
           + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NLV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 73
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +LLG    E    +I EF+   ++  ++ +   R +++      +   I+  + YL + +
Sbjct: 74  QLLGVCTREPPFYIIIEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN 132
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVT 501
               IHRDL A N L+  + + K++DFG++RL   D     T+     F   + APE + 
Sbjct: 133 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX---TAHAGAKFPIKWTAPESLA 186
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
              FSIKSDV++FGVL+ EI +
Sbjct: 187 YNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 107/200 (53%), Gaps = 7/200 (3%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
           + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 72
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +LLG    E    +I EF+   ++  ++ +   R +++      +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN 131
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
               IHRDL A N L+  + + K++DFG++RL   D              + APE +   
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYN 187
Query: 504 HFSIKSDVFSFGVLVLEIIS 523
            FSIKSDV++FGVL+ EI +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 107/200 (53%), Gaps = 7/200 (3%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
           + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 72
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +LLG    E    +I EF+   ++  ++ +   R +++      +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN 131
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
               IHRDL A N L+  + + K++DFG++RL   D              + APE +   
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYN 187
Query: 504 HFSIKSDVFSFGVLVLEIIS 523
            FSIKSDV++FGVL+ EI +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
           + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 77
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +LLG    E    +I EF+   ++  ++ +   R +++      +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN 136
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVT 501
               IHRDL A N L+  + + K++DFG++RL   D     T+     F   + APE + 
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLA 190
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
              FSIKSDV++FGVL+ EI +
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
           + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NLV
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 76
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +LLG    E    +I EF+   ++  ++ +   R +++      +   I+  + YL + +
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN 135
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVT 501
               IHRDL A N L+  + + K++DFG++RL   D     T+     F   + APE + 
Sbjct: 136 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLA 189
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
              FSIKSDV++FGVL+ EI +
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 109/204 (53%), Gaps = 15/204 (7%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
           + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NLV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 73
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +LLG    E    +I EF+   ++  ++ +   R +++      +   I+  + YL + +
Sbjct: 74  QLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN 132
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG----TFGYMAPEY 499
               IHRDL A N L+  + + K++DFG++RL       GDT            + APE 
Sbjct: 133 ---FIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAPAGAKFPIKWTAPES 184
Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS 523
           +    FSIKSDV++FGVL+ EI +
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
           + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 77
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +LLG    E    +I EF+   ++  ++ +   R +++      +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN 136
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVT 501
               IHRDL A N L+  + + K++DFG++RL   D     T+     F   + APE + 
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLA 190
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
              FSIKSDV++FGVL+ EI +
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 110/206 (53%), Gaps = 25/206 (12%)
Query: 332 LGQGGFGAVYKG--RLSHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G G FG V  G  +L   +EI  A+K L     + +  +F +E  ++ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 387 GFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKIIGGIARGILYLH 440
           G   + T  ++I EF+ N S+D F+      F  I+ V +        + GIA G+ YL 
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGM--------LRGIAAGMKYLA 126
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG---TFGYMAP 497
           +   +  +HR L A NIL++++++ K+SDFG++R  E D S    +  +G      + AP
Sbjct: 127 D---MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 183
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
           E +    F+  SDV+S+G+++ E++S
Sbjct: 184 EAIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 11/203 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
            + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 69
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           V+LLG    E    +I EF+   ++  ++ +   R ++       +   I+  + YL + 
Sbjct: 70  VQLLGVCTREPPFYIIIEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYV 500
           +    IHRDL A N L+  + + K++DFG++RL   D     T+     F   + APE +
Sbjct: 129 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX---TAHAGAKFPIKWTAPESL 182
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               FSIKSDV++FGVL+ EI +
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 107/198 (54%), Gaps = 23/198 (11%)
Query: 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           + KLG G FG V+    +   ++AVK +   S+  E  F  E  ++  LQH  LV+L   
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 245
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII---GGIARGILYLHEDSRL 445
             +E    +I EF+   S    + D +K  +   +   K+I     IA G+ ++ + +  
Sbjct: 246 VTKEP-IYIITEFMAKGS----LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 298
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
             IHRDL+A+NIL+ A ++ KI+DFG+AR+       G    I  T    APE +  G F
Sbjct: 299 -YIHRDLRAANILVSASLVCKIADFGLARV-------GAKFPIKWT----APEAINFGSF 346
Query: 506 SIKSDVFSFGVLVLEIIS 523
           +IKSDV+SFG+L++EI++
Sbjct: 347 TIKSDVWSFGILLMEIVT 364

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 109/204 (53%), Gaps = 15/204 (7%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
           + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 74
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +LLG    E    +I EF+   ++  ++ +   R +++      +   I+  + YL + +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN 133
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG----TFGYMAPEY 499
               IHRDL A N L+  + + K++DFG++RL       GDT            + APE 
Sbjct: 134 ---FIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAPAGAKFPIKWTAPES 185
Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS 523
           +    FSIKSDV++FGVL+ EI +
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
           + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 74
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +LLG    E    +I EF+   ++  ++ +   R +++      +   I+  + YL + +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN 133
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVT 501
               IHRDL A N L+  + + K++DFG++RL   D     T+     F   + APE + 
Sbjct: 134 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLA 187
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
              FSIKSDV++FGVL+ EI +
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 113/211 (53%), Gaps = 11/211 (5%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLS-KNSVQGELEFKNEVLLVARLQ 378
           D    F+  +++G+G FG VYKG  +H +E+ A+K +  + +     + + E+ ++++  
Sbjct: 16  DPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 75
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
              + R  G   + T+  +I E++   S      D +K   L+      I+  I +G+ Y
Sbjct: 76  SPYITRYFGSYLKSTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDY 131
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           LH +   R IHRD+KA+N+LL      K++DFG+A   ++  +Q   +  VGT  +MAPE
Sbjct: 132 LHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPE 186
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529
            + +  +  K+D++S G+  +E+  G+  NS
Sbjct: 187 VIKQSAYDFKADIWSLGITAIELAKGEPPNS 217

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 110/202 (54%), Gaps = 11/202 (5%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
           + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 74
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +LLG    E    +I EF+   ++  ++ +   R +++      +   I+  + YL + +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN 133
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVT 501
               IHRDL A N L+  + + K++DFG++RL   D     T+     F   + APE + 
Sbjct: 134 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLA 187
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
              FSIKSDV++FGVL+ EI +
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 331 KLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
           K+G+G  G V   R  H G+++AVK +     Q      NEV+++   QH N+V +    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
               E  ++ EF+   +    + D + +V+L+ E    +   + + + YLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGA----LTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKS 509
           RD+K+ +ILL  D   K+SDFG       D  +     +VGT  +MAPE ++R  ++ + 
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKXLVGTPYWMAPEVISRSLYATEV 222
Query: 510 DVFSFGVLVLEIISGQ 525
           D++S G++V+E++ G+
Sbjct: 223 DIWSLGIMVIEMVDGE 238

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 11/203 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
            + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 71
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           V+LLG    E    +I EF+   ++  ++ +   R ++       +   I+  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIIIEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYV 500
           +    IHRDL A N L+  + + K++DFG++RL   D     T+     F   + APE +
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESL 184
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               FSIKSDV++FGVL+ EI +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 331 KLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G  +    R   LI EF+P  S+ +++    +R+  D     +    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERI--DHIKLLQYTSQICKGMEYL---G 134
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-VGTFGYMAPEYVTR 502
             R IHRDL   NIL++ +   KI DFG+ ++   D+              + APE +T 
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 503 GHFSIKSDVFSFGVLVLEIIS 523
             FS+ SDV+SFGV++ E+ +
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 106/201 (52%), Gaps = 7/201 (3%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
            + +  +KLG G +G VY G    +   +AVK L +++++ E EF  E  ++  ++H NL
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 90
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           V+LLG    E    ++ E++P  ++  ++ +   R ++       +   I+  + YL + 
Sbjct: 91  VQLLGVCTLEPPFYIVTEYMPYGNLLDYLREC-NREEVTAVVLLYMATQISSAMEYLEKK 149
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
           +    IHRDL A N L+  + + K++DFG++RL   D              + APE +  
Sbjct: 150 N---FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 205
Query: 503 GHFSIKSDVFSFGVLVLEIIS 523
             FSIKSDV++FGVL+ EI +
Sbjct: 206 NTFSIKSDVWAFGVLLWEIAT 226

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 11/203 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
            + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 71
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           V+LLG    E    +I EF+   ++  ++ +   R ++       +   I+  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYV 500
           +    IHRDL A N L+  + + K++DFG++RL   D     T+     F   + APE +
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESL 184
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               FSIKSDV++FGVL+ EI +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 11/203 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
            + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 76
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           V+LLG    E    +I EF+   ++  ++ +   R ++       +   I+  + YL + 
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK 135
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYV 500
           +    IHRDL A N L+  + + K++DFG++RL   D     T+     F   + APE +
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESL 189
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               FSIKSDV++FGVL+ EI +
Sbjct: 190 AYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 11/203 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
            + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 71
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           V+LLG    E    +I EF+   ++  ++ +   R ++       +   I+  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIIIEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYV 500
           +    IHRDL A N L+  + + K++DFG++RL   D     T+     F   + APE +
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESL 184
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               FSIKSDV++FGVL+ EI +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 11/203 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
            + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 71
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           V+LLG    E    +I EF+   ++  ++ +   R ++       +   I+  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYV 500
           +    IHRDL A N L+  + + K++DFG++RL   D     T+     F   + APE +
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESL 184
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               FSIKSDV++FGVL+ EI +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 17/201 (8%)
Query: 332 LGQGGFGAVYKGRLS-HGQE---IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G G FG V  GRL   G+    +A+K L       +  +F +E  ++ +  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHEDS 443
           G   +    ++I E++ N S+D F+     R      T  +++G   GI  G+ YL   S
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRF-----TVIQLVGMLRGIGSGMKYL---S 127
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG-TFGYMAPEYVTR 502
            +  +HRDL A NIL++++++ K+SDFGM+R+ E D     T+R       + APE +  
Sbjct: 128 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 503 GHFSIKSDVFSFGVLVLEIIS 523
             F+  SDV+S+G+++ E++S
Sbjct: 188 RKFTSASDVWSYGIVMWEVMS 208

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 17/201 (8%)
Query: 332 LGQGGFGAVYKGRLS-HGQE---IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G G FG V  GRL   G+    +A+K L       +  +F +E  ++ +  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHEDS 443
           G   +    ++I E++ N S+D F+     R      T  +++G   GI  G+ YL   S
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRF-----TVIQLVGMLRGIGSGMKYL---S 148
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG-TFGYMAPEYVTR 502
            +  +HRDL A NIL++++++ K+SDFGM+R+ E D     T+R       + APE +  
Sbjct: 149 DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 208
Query: 503 GHFSIKSDVFSFGVLVLEIIS 523
             F+  SDV+S+G+++ E++S
Sbjct: 209 RKFTSASDVWSYGIVMWEVMS 229

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 17/201 (8%)
Query: 332 LGQGGFGAVYKGRLS-HGQE---IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G G FG V  GRL   G+    +A+K L       +  +F +E  ++ +  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHEDS 443
           G   +    ++I E++ N S+D F+     R      T  +++G   GI  G+ YL   S
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRF-----TVIQLVGMLRGIGSGMKYL---S 133
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG-TFGYMAPEYVTR 502
            +  +HRDL A NIL++++++ K+SDFGM+R+ E D     T+R       + APE +  
Sbjct: 134 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 503 GHFSIKSDVFSFGVLVLEIIS 523
             F+  SDV+S+G+++ E++S
Sbjct: 194 RKFTSASDVWSYGIVMWEVMS 214

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 11/203 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
            + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 69
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           V+LLG    E    +I EF+   ++  ++ +   R ++       +   I+  + YL + 
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYV 500
           +    IHRDL A N L+  + + K++DFG++RL   D     T+     F   + APE +
Sbjct: 129 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTF---TAHAGAKFPIKWTAPESL 182
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               FSIKSDV++FGVL+ EI +
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 112/209 (53%), Gaps = 14/209 (6%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           LG+G +G VY GR LS+   IA+K + +   +       E+ L   L+H+N+V+ LG SF
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-SF 88
Query: 391 EETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            E   + I+ E VP  S+   +      ++ + +T       I  G+ YLH++   +I+H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 450 RDLKASNILLDA-DMIPKISDFGMA-RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH--F 505
           RD+K  N+L++    + KISDFG + RL  ++     T    GT  YMAPE + +G   +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEIIDKGPRGY 202
Query: 506 SIKSDVFSFGVLVLEIISGQKNNSFRIGE 534
              +D++S G  ++E+ +G K   + +GE
Sbjct: 203 GKAADIWSLGCTIIEMATG-KPPFYELGE 230

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 108/202 (53%), Gaps = 16/202 (7%)
Query: 332 LGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRL 385
           LG+G FG V   R      + G+++AVK L   S    + + K E+ ++  L H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G   E+      LI EF+P+ S+ +++     ++ L  + +Y +   I +G+ YL   S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV--QICKGMDYL--GS 144
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS--RIVGTFGYMAPEYVT 501
           R + +HRDL A N+L++++   KI DFG+ +  E D+        R    F Y APE + 
Sbjct: 145 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 202
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
           +  F I SDV+SFGV + E+++
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 108/202 (53%), Gaps = 16/202 (7%)
Query: 332 LGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRL 385
           LG+G FG V   R      + G+++AVK L   S    + + K E+ ++  L H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G   E+      LI EF+P+ S+ +++     ++ L  + +Y +   I +G+ YL   S
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV--QICKGMDYL--GS 132
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS--RIVGTFGYMAPEYVT 501
           R + +HRDL A N+L++++   KI DFG+ +  E D+        R    F Y APE + 
Sbjct: 133 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 190
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
           +  F I SDV+SFGV + E+++
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 109/204 (53%), Gaps = 23/204 (11%)
Query: 332 LGQGGFGAVYKGRLS-HGQE---IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G G FG V  GRL   G+    +A+K L     + +  +F  E  ++ +  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 387 GFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKIIGGIARGILYLH 440
           G   +    +++ E++ N S+D F+      F  I+ V +        + GI+ G+ YL 
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGM--------LRGISAGMKYL- 140
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG-TFGYMAPEY 499
             S +  +HRDL A NIL++++++ K+SDFG++R+ E D     T+R       + APE 
Sbjct: 141 --SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 198
Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS 523
           +    F+  SDV+S+G+++ E++S
Sbjct: 199 IAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 331 KLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G  +    R   LI E++P  S+  ++    +R+  D     +    I +G+ YL    
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL---G 130
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-VGTFGYMAPEYVTR 502
             R IHRDL   NIL++ +   KI DFG+ ++   D+              + APE +T 
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 503 GHFSIKSDVFSFGVLVLEIIS 523
             FS+ SDV+SFGV++ E+ +
Sbjct: 191 SKFSVASDVWSFGVVLYELFT 211

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 331 KLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G  +    R   LI E++P  S+  ++    +R+  D     +    I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL---G 131
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-VGTFGYMAPEYVTR 502
             R IHRDL   NIL++ +   KI DFG+ ++   D+              + APE +T 
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 503 GHFSIKSDVFSFGVLVLEIIS 523
             FS+ SDV+SFGV++ E+ +
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 330 NKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
            +LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 385 LLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
             G  +    R   LI E++P  S+  ++    +R+  D     +    I +G+ YL   
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 128
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-VGTFGYMAPEYVT 501
              R IHRDL   NIL++ +   KI DFG+ ++   D+              + APE +T
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
              FS+ SDV+SFGV++ E+ +
Sbjct: 189 ESKFSVASDVWSFGVVLYELFT 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 330 NKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
            +LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 385 LLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
             G  +    R   LI E++P  S+  ++    +R+  D     +    I +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 161
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-VGTFGYMAPEYVT 501
              R IHRDL   NIL++ +   KI DFG+ ++   D+              + APE +T
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
              FS+ SDV+SFGV++ E+ +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 331 KLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G  +    R   LI E++P  S+  ++    +R+  D     +    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL---G 134
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-VGTFGYMAPEYVTR 502
             R IHRDL   NIL++ +   KI DFG+ ++   D+              + APE +T 
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 503 GHFSIKSDVFSFGVLVLEIIS 523
             FS+ SDV+SFGV++ E+ +
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 331 KLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G  +    R   LI E++P  S+  ++    +R+  D     +    I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL---G 131
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-VGTFGYMAPEYVTR 502
             R IHRDL   NIL++ +   KI DFG+ ++   D+              + APE +T 
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 503 GHFSIKSDVFSFGVLVLEIIS 523
             FS+ SDV+SFGV++ E+ +
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 331 KLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G  +    R   LI E++P  S+  ++    +R+  D     +    I +G+ YL    
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL---G 136
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-VGTFGYMAPEYVTR 502
             R IHRDL   NIL++ +   KI DFG+ ++   D+              + APE +T 
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 503 GHFSIKSDVFSFGVLVLEIIS 523
             FS+ SDV+SFGV++ E+ +
Sbjct: 197 SKFSVASDVWSFGVVLYELFT 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 331 KLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G  +    R   LI E++P  S+  ++    +R+  D     +    I +G+ YL    
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL---G 138
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-VGTFGYMAPEYVTR 502
             R IHRDL   NIL++ +   KI DFG+ ++   D+              + APE +T 
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 503 GHFSIKSDVFSFGVLVLEIIS 523
             FS+ SDV+SFGV++ E+ +
Sbjct: 199 SKFSVASDVWSFGVVLYELFT 219

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 331 KLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G  +    R   LI E++P  S+  ++    +R+  D     +    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERI--DHIKLLQYTSQICKGMEYL---G 134
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-VGTFGYMAPEYVTR 502
             R IHRDL   NIL++ +   KI DFG+ ++   D+              + APE +T 
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 503 GHFSIKSDVFSFGVLVLEIIS 523
             FS+ SDV+SFGV++ E+ +
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 331 KLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G  +    R   LI E++P  S+  ++    +R+  D     +    I +G+ YL    
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL---G 137
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-VGTFGYMAPEYVTR 502
             R IHRDL   NIL++ +   KI DFG+ ++   D+              + APE +T 
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 197
Query: 503 GHFSIKSDVFSFGVLVLEIIS 523
             FS+ SDV+SFGV++ E+ +
Sbjct: 198 SKFSVASDVWSFGVVLYELFT 218

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 330 NKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
            +LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 385 LLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
             G  +    R   LI E++P  S+  ++    +R+  D     +    I +G+ YL   
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 134
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-VGTFGYMAPEYVT 501
              R IHRDL   NIL++ +   KI DFG+ ++   D+              + APE +T
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
              FS+ SDV+SFGV++ E+ +
Sbjct: 195 ESKFSVASDVWSFGVVLYELFT 216

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 112/209 (53%), Gaps = 14/209 (6%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           LG+G +G VY GR LS+   IA+K + +   +       E+ L   L+H+N+V+ LG SF
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-SF 74
Query: 391 EETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            E   + I+ E VP  S+   +      ++ + +T       I  G+ YLH++   +I+H
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 131
Query: 450 RDLKASNILLDA-DMIPKISDFGMA-RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH--F 505
           RD+K  N+L++    + KISDFG + RL  ++     T    GT  YMAPE + +G   +
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEIIDKGPRGY 188
Query: 506 SIKSDVFSFGVLVLEIISGQKNNSFRIGE 534
              +D++S G  ++E+ +G K   + +GE
Sbjct: 189 GKAADIWSLGCTIIEMATG-KPPFYELGE 216

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 331 KLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G  +    R   LI E++P  S+  ++    +R+  D     +    I +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL---G 149
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-VGTFGYMAPEYVTR 502
             R IHRDL   NIL++ +   KI DFG+ ++   D+              + APE +T 
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 503 GHFSIKSDVFSFGVLVLEIIS 523
             FS+ SDV+SFGV++ E+ +
Sbjct: 210 SKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 331 KLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G  +    R   LI E++P  S+  ++    +R+  D     +    I +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL---G 149
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-VGTFGYMAPEYVTR 502
             R IHRDL   NIL++ +   KI DFG+ ++   D+              + APE +T 
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 503 GHFSIKSDVFSFGVLVLEIIS 523
             FS+ SDV+SFGV++ E+ +
Sbjct: 210 SKFSVASDVWSFGVVLYELFT 230

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 30/226 (13%)
Query: 330 NKLGQGGFGAVYKGR---LSHGQE---IAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
            +LG+G FG V+      LS  ++   +AVK L   ++    +F+ E  L+  LQH ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIF----DAIKRV---------QLDWETRYKIIG 430
           +  G   +    ++++E++ +  ++KF+     DA+  V         +L       I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
            IA G++YL   +    +HRDL   N L+ A+++ KI DFGM+R    D    D  R+ G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGG 193
Query: 491 ----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRI 532
                  +M PE +    F+ +SDV+SFGV++ EI +  K   F++
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 239

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 115/219 (52%), Gaps = 11/219 (5%)
Query: 308 TVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELE 366
           TV  +  ++        + +  +KLG G +G VY+G    +   +AVK L +++++ E E
Sbjct: 243 TVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-E 301
Query: 367 FKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRY 426
           F  E  ++  ++H NLV+LLG    E    +I EF+   ++  ++ +   R +++     
Sbjct: 302 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLL 360
Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486
            +   I+  + YL + +    IHR+L A N L+  + + K++DFG++RL   D     T+
Sbjct: 361 YMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY---TA 414
Query: 487 RIVGTFG--YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                F   + APE +    FSIKSDV++FGVL+ EI +
Sbjct: 415 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 109/202 (53%), Gaps = 11/202 (5%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
           + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NLV
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 279
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +LLG    E    +I EF+   ++  ++ +   R ++       +   I+  + YL + +
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVT 501
               IHR+L A N L+  + + K++DFG++RL   D     T+     F   + APE + 
Sbjct: 339 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLA 392
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
              FSIKSDV++FGVL+ EI +
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIAT 414

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 123
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG +       S+ DT  + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDT--LCGTLDYLPP 176
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P   V K   +  K  + D +     I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYK---ELQKLSKFDEQRTATYITELANALS 127
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 113/206 (54%), Gaps = 25/206 (12%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRNLVRLLGF 388
           ++G G FG VYKG+  HG ++AVK L       E    F+NEV ++ + +H N++  +G+
Sbjct: 43  RIGSGSFGTVYKGKW-HG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI------ARGILYLHED 442
             ++    ++ ++   SS+ K +      VQ   ET++++   I      A+G+ YLH  
Sbjct: 101 MTKDN-LAIVTQWCEGSSLYKHL-----HVQ---ETKFQMFQLIDIARQTAQGMDYLHAK 151
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT- 501
           +   IIHRD+K++NI L   +  KI DFG+A +           +  G+  +MAPE +  
Sbjct: 152 N---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRM 208
Query: 502 --RGHFSIKSDVFSFGVLVLEIISGQ 525
                FS +SDV+S+G+++ E+++G+
Sbjct: 209 QDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 23/206 (11%)
Query: 331 KLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G  +    R   LI E++P  S+  ++    +R+  D     +    I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL---G 131
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD------QSQGDTSRIVGTFGYMAP 497
             R IHRDL   NIL++ +   KI DFG+ ++   D      +  G++      F Y AP
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP----IFWY-AP 186
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
           E +T   FS+ SDV+SFGV++ E+ +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 25/205 (12%)
Query: 332 LGQGGFGAVYKGRLS-HGQE---IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G G  G V  GRL   GQ    +A+K L     + +  +F +E  ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHEDS 443
           G        +++ E++ N S+D F+     R      T  +++G   G+  G+ YL   S
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL-----RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG-----YMAPE 498
            L  +HRDL A N+L+D++++ K+SDFG++R+ E D     T+    T G     + APE
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT----TGGKIPIRWTAPE 224
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIIS 523
            +    FS  SDV+SFGV++ E+++
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 27/229 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR---LSHGQE---IAVKRLSKNSVQGELEFKNEVLLVARL 377
           +N     +LG+G FG V+      L   Q+   +AVK L   S     +F  E  L+  L
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIF----DAI------KRVQLDWETRYK 427
           QH ++V+  G   E    ++++E++ +  ++KF+     DA+         +L       
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
           I   IA G++YL   +    +HRDL   N L+  +++ KI DFGM+R    D    D  R
Sbjct: 133 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYR 185
Query: 488 IVG----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRI 532
           + G       +M PE +    F+ +SDV+S GV++ EI +  K   +++
Sbjct: 186 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 118/222 (53%), Gaps = 25/222 (11%)
Query: 332 LGQGGFGAVYKG-RLSHGQ----EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRL 385
           LG G FG VYKG  +  G+     +A+K L +N S +   E  +E  ++A +    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIARGILYLHE 441
           LG     T +L + + +P   +   + +   R+     L+W  +      IA+G+ YL +
Sbjct: 85  LGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKGMSYLED 137
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ--GDTSRIVGTFGYMAPEY 499
              +R++HRDL A N+L+ +    KI+DFG+ARL ++D+++   D  ++     +MA E 
Sbjct: 138 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALES 192
Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLL 540
           + R  F+ +SDV+S+GV V E+++ G K        E  DLL
Sbjct: 193 ILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 234

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P   V K   +  K  + D +     I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYK---ELQKLSKFDEQRTATYITELANALS 127
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +         + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLPP 180
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 26/208 (12%)
Query: 332 LGQGGFGAVYKGRLSH---GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G FG   K  ++H   G+ + +K L +   + +  F  EV ++  L+H N+++ +G 
Sbjct: 18  LGKGCFGQAIK--VTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 389 SFEETERLLIYEFVPNSSVDKFI--FDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
            +++     I E++   ++   I   D+    Q  W  R      IA G+ YLH    + 
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR------------IVGTFGY 494
           IIHRDL + N L+  +    ++DFG+ARL   +++Q +  R            +VG   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           MAPE +    +  K DVFSFG+++ EII
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 122
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPP 175
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 114/234 (48%), Gaps = 30/234 (12%)
Query: 331 KLGQGGFGAVYKGR---LSHGQE---IAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           +LG+G FG V+      L   Q+   +AVK L + S     +F+ E  L+  LQH+++VR
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIF------------DAIKRVQLDWETRYKIIGGI 432
             G   E    L+++E++ +  +++F+             + +    L       +   +
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG-- 490
           A G++YL   + L  +HRDL   N L+   ++ KI DFGM+R    D    D  R+ G  
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRT 197
Query: 491 --TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGE-EAEDLLT 541
                +M PE +    F+ +SDV+SFGV++ EI +  K   +++   EA D +T
Sbjct: 198 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 251

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 25/205 (12%)
Query: 332 LGQGGFGAVYKGRLS-HGQE---IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G G  G V  GRL   GQ    +A+K L     + +  +F +E  ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHEDS 443
           G        +++ E++ N S+D F+     R      T  +++G   G+  G+ YL   S
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL-----RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG-----YMAPE 498
            L  +HRDL A N+L+D++++ K+SDFG++R+ E D     T+    T G     + APE
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT----TGGKIPIRWTAPE 224
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIIS 523
            +    FS  SDV+SFGV++ E+++
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 114/234 (48%), Gaps = 30/234 (12%)
Query: 331 KLGQGGFGAVYKGR---LSHGQE---IAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           +LG+G FG V+      L   Q+   +AVK L + S     +F+ E  L+  LQH+++VR
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIF------------DAIKRVQLDWETRYKIIGGI 432
             G   E    L+++E++ +  +++F+             + +    L       +   +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG-- 490
           A G++YL   + L  +HRDL   N L+   ++ KI DFGM+R    D    D  R+ G  
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRT 191
Query: 491 --TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGE-EAEDLLT 541
                +M PE +    F+ +SDV+SFGV++ EI +  K   +++   EA D +T
Sbjct: 192 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 245

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARLQH 379
            +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSRFDEQRTATYITELANALSYC 128
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
           H     R+IHRD+K  N+LL ++   KI+DFG +       S+ DT  + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDT--LCGTLDYLPPEM 181
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISG 524
           +       K D++S GVL  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 122
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 125
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 122
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 175
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 127
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 127
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 114/234 (48%), Gaps = 30/234 (12%)
Query: 331 KLGQGGFGAVYKGR---LSHGQE---IAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           +LG+G FG V+      L   Q+   +AVK L + S     +F+ E  L+  LQH+++VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIF------------DAIKRVQLDWETRYKIIGGI 432
             G   E    L+++E++ +  +++F+             + +    L       +   +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG-- 490
           A G++YL   + L  +HRDL   N L+   ++ KI DFGM+R    D    D  R+ G  
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRT 220
Query: 491 --TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGE-EAEDLLT 541
                +M PE +    F+ +SDV+SFGV++ EI +  K   +++   EA D +T
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 125
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 178
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 123
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 176
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 139
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 192
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 331 KLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+ 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G  +    R   LI E++P  S+  ++    +R+  D     +    I +G+ YL    
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL---G 132
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-VGTFGYMAPEYVTR 502
             R IHR+L   NIL++ +   KI DFG+ ++   D+              + APE +T 
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 192
Query: 503 GHFSIKSDVFSFGVLVLEIIS 523
             FS+ SDV+SFGV++ E+ +
Sbjct: 193 SKFSVASDVWSFGVVLYELFT 213

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 127
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 180
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 110/222 (49%), Gaps = 24/222 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
            +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 380 RNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKIIGGIA 433
              V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+     I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFD-------ETCTRF-YTAEIV 142
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           Y++PE +T    S  SD+++ G ++ ++++G     FR G E
Sbjct: 200 YVSPELLTEKSASKSSDLWALGCIIYQLVAGLP--PFRAGNE 239

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 122
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPP 175
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 18/224 (8%)
Query: 313 QFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVL 372
           + D S +RD    F     +G G +G VYKGR     ++A  ++   +   E E K E+ 
Sbjct: 13  EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEIN 72
Query: 373 LVARL-QHRNLVRLLGFSFEET------ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETR 425
           ++ +   HRN+    G   ++       +  L+ EF    SV   I +  K   L  E  
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWI 131
Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485
             I   I RG+ +LH+    ++IHRD+K  N+LL  +   K+ DFG++   ++D++ G  
Sbjct: 132 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRR 186
Query: 486 SRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISG 524
           +  +GT  +MAPE +         +  KSD++S G+  +E+  G
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 122
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 148
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 201
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 121
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 174
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 122
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 126
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 179
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 125
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 107/201 (53%), Gaps = 20/201 (9%)
Query: 332 LGQGGFGAVYK--GRLSHGQEIAVKRLSKNSVQGE--LEFKNEVLLVARLQHRNLVRLLG 387
           LG+G FG V K   R++  QE AVK ++K S + +       EV L+ +L H N+++L  
Sbjct: 30  LGKGSFGEVLKCKDRITQ-QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
              + +   ++ E          +FD I KR +       +II  +  GI Y+H+ +   
Sbjct: 89  ILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 447 IIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
           I+HRDLK  NILL++   D   KI DFG++  F+ +    D    +GT  Y+APE V RG
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRG 197
Query: 504 HFSIKSDVFSFGVLVLEIISG 524
            +  K DV+S GV++  ++SG
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 124
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +         + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 177
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 107/201 (53%), Gaps = 20/201 (9%)
Query: 332 LGQGGFGAVYK--GRLSHGQEIAVKRLSKNSVQGE--LEFKNEVLLVARLQHRNLVRLLG 387
           LG+G FG V K   R++  QE AVK ++K S + +       EV L+ +L H N+++L  
Sbjct: 30  LGKGSFGEVLKCKDRITQ-QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
              + +   ++ E          +FD I KR +       +II  +  GI Y+H+ +   
Sbjct: 89  ILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 447 IIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
           I+HRDLK  NILL++   D   KI DFG++  F+ +    D    +GT  Y+APE V RG
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRG 197
Query: 504 HFSIKSDVFSFGVLVLEIISG 524
            +  K DV+S GV++  ++SG
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE--FKNEVLLVARLQHRNLVRLLG 387
            ++G+G FG V+ GRL     +   +  + ++  +L+  F  E  ++ +  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
              ++    ++ E V       F+     R+++  +T  +++G  A G+ YL        
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYLESKC---C 234
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG----TFGYMAPEYVTRG 503
           IHRDL A N L+    + KISDFGM+R    +++ G  +   G       + APE +  G
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 504 HFSIKSDVFSFGVLVLEIIS 523
            +S +SDV+SFG+L+ E  S
Sbjct: 291 RYSSESDVWSFGILLWETFS 310

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 148
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG +       S+ D   + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDD--LCGTLDYLPP 201
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 119
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 172
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 110/211 (52%), Gaps = 12/211 (5%)
Query: 317 STIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
           S  +     F    KLG+G +G+VYK      GQ +A+K++    V+ +L E   E+ ++
Sbjct: 22  SLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQEIIKEISIM 78
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
            +    ++V+  G  F+ T+  ++ E+    SV   I   ++   L  +    I+    +
Sbjct: 79  QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLK 136
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           G+ YLH    +R IHRD+KA NILL+ +   K++DFG+A   ++       + ++GT  +
Sbjct: 137 GLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDXMAKRNXVIGTPFW 191
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           MAPE +    ++  +D++S G+  +E+  G+
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 107/201 (53%), Gaps = 20/201 (9%)
Query: 332 LGQGGFGAVYK--GRLSHGQEIAVKRLSKNSVQGE--LEFKNEVLLVARLQHRNLVRLLG 387
           LG+G FG V K   R++  QE AVK ++K S + +       EV L+ +L H N+++L  
Sbjct: 30  LGKGSFGEVLKCKDRITQ-QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
              + +   ++ E          +FD I KR +       +II  +  GI Y+H+ +   
Sbjct: 89  ILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 447 IIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
           I+HRDLK  NILL++   D   KI DFG++  F+ +    D    +GT  Y+APE V RG
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRG 197
Query: 504 HFSIKSDVFSFGVLVLEIISG 524
            +  K DV+S GV++  ++SG
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 125
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +         + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 178
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 122
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +         + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 175
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---EVLLVAR 376
           D    FS   ++G G FGAVY  R + + + +A+K++S +  Q   ++++   EV  + +
Sbjct: 51  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 110
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L+H N ++  G    E    L+ E+   S+ D  + +  K+   + E    +  G  +G+
Sbjct: 111 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AVTHGALQGL 167
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH  +   +IHRD+KA NILL    + K+ DFG A +          +  VGT  +MA
Sbjct: 168 AYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMA 218
Query: 497 PEYV---TRGHFSIKSDVFSFGVLVLEI 521
           PE +     G +  K DV+S G+  +E+
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARLQH 379
            +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSRFDEQRTATYITELANALSYC 128
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
           H     R+IHRD+K  N+LL ++   KI+DFG    + +       + + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 181
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISG 524
           +       K D++S GVL  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE--FKNEVLLVARLQHRNLVRLLG 387
            ++G+G FG V+ GRL     +   +  + ++  +L+  F  E  ++ +  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
              ++    ++ E V       F+     R+++  +T  +++G  A G+ YL        
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYLESKC---C 234
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG----TFGYMAPEYVTRG 503
           IHRDL A N L+    + KISDFGM+R    +++ G  +   G       + APE +  G
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 504 HFSIKSDVFSFGVLVLEIIS 523
            +S +SDV+SFG+L+ E  S
Sbjct: 291 RYSSESDVWSFGILLWETFS 310

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 125
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI+DFG +       S+ D   + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDD--LCGTLDYLPP 178
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 110/226 (48%), Gaps = 24/226 (10%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVA 375
           +    +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 376 RLQHRNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKII 429
           RL H   V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+   
Sbjct: 66  RLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRF-YT 116
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
             I   + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  V
Sbjct: 117 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 173
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           GT  Y++PE +T       SD+++ G ++ ++++G     FR G E
Sbjct: 174 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNE 217

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 114/211 (54%), Gaps = 21/211 (9%)
Query: 323 TNNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFKN---EVLLVARL 377
           ++ +     LG+G FG V   K +++ GQE AVK +SK  V+ + + ++   EV L+ +L
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGI 436
            H N+++L  F  ++    L+ E          +FD I  R +       +II  +  GI
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 437 LYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
            Y+H++   +I+HRDLK  N+LL++   D   +I DFG++  FE  +   D    +GT  
Sbjct: 140 TYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAY 193
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           Y+APE V  G +  K DV+S GV++  ++SG
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 114/211 (54%), Gaps = 21/211 (9%)
Query: 323 TNNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFKN---EVLLVARL 377
           ++ +     LG+G FG V   K +++ GQE AVK +SK  V+ + + ++   EV L+ +L
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGI 436
            H N+++L  F  ++    L+ E          +FD I  R +       +II  +  GI
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQVLSGI 145
Query: 437 LYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
            Y+H++   +I+HRDLK  N+LL++   D   +I DFG++  FE  +   D    +GT  
Sbjct: 146 TYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAY 199
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           Y+APE V  G +  K DV+S GV++  ++SG
Sbjct: 200 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R  + + I A+K L K  ++    E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 122
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     ++IHRD+K  N+LL +    KI+DFG    + +       + + GT  Y+ P
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 123
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR---IVGTFGY 494
           Y H     R+IHRD+K  N+LL +    KI+DFG +           +SR   + GT  Y
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------CHAPSSRRTTLSGTLDY 173
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           + PE +       K D++S GVL  E + G+
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNE--VLLVARLQHRNLVRLLGFSF 390
            +G FG V+K +L + + +AVK      +Q +  ++NE  V  +  ++H N+++ +G   
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFP---IQDKQSWQNEYEVYSLPGMKHENILQFIGAEK 88
Query: 391 EET----ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED---- 442
             T    +  LI  F    S+  F+    K   + W     I   +ARG+ YLHED    
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGL 144
Query: 443 ---SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
               +  I HRD+K+ N+LL  ++   I+DFG+A  FE  +S GDT   VGT  YMAPE 
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE- 203
Query: 500 VTRGHFSIKSDVF------SFGVLVLEIIS 523
           V  G  + + D F      + G+++ E+ S
Sbjct: 204 VLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---EVLLVAR 376
           D    FS   ++G G FGAVY  R + + + +A+K++S +  Q   ++++   EV  + +
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L+H N ++  G    E    L+ E+   S+ D  + +  K+   + E    +  G  +G+
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AVTHGALQGL 128
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH  +   +IHRD+KA NILL    + K+ DFG A +          +  VGT  +MA
Sbjct: 129 AYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMA 179
Query: 497 PEYV---TRGHFSIKSDVFSFGVLVLEI 521
           PE +     G +  K DV+S G+  +E+
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
            +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 380 RNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKIIGGIA 433
              V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+     I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRF-YTAEIV 142
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           Y++PE +T       SD+++ G ++ ++++G     FR G E
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNE 239

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 108/203 (53%), Gaps = 15/203 (7%)
Query: 330 NKLGQGGFGAVYKGRLSH-----GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           ++LG+G FG+V   R        G  +AVK+L  +    + +F+ E+ ++  L    +V+
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 385 LLGFSFE--ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
             G S+     E  L+ E++P+  +  F+     R +LD          I +G+ YL   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--G 128
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG--TFGYMAPEYV 500
           SR R +HRDL A NIL++++   KI+DFG+A+L  +D+      R  G     + APE +
Sbjct: 129 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDX-XVVREPGQSPIFWYAPESL 186
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
           +   FS +SDV+SFGV++ E+ +
Sbjct: 187 SDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
            +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++RL H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 380 RNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKIIGGIA 433
              V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+     I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRF-YTAEIV 140
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           Y++PE +T       SD+++ G ++ ++++G     FR G E
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNE 237

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 110/226 (48%), Gaps = 24/226 (10%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVA 375
           +    +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 376 RLQHRNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKII 429
           RL H   V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+   
Sbjct: 63  RLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRF-YT 113
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
             I   + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  V
Sbjct: 114 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 170
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           GT  Y++PE +T       SD+++ G ++ ++++G     FR G E
Sbjct: 171 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNE 214

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 110/226 (48%), Gaps = 24/226 (10%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVA 375
           +    +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 376 RLQHRNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKII 429
           RL H   V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+   
Sbjct: 65  RLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRF-YT 115
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
             I   + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  V
Sbjct: 116 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 172
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           GT  Y++PE +T       SD+++ G ++ ++++G     FR G E
Sbjct: 173 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNE 216

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
            +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++RL H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 380 RNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKIIGGIA 433
              V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+     I 
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRF-YTAEIV 143
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 200
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           Y++PE +T       SD+++ G ++ ++++G     FR G E
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNE 240

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
            +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++RL H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 380 RNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKIIGGIA 433
              V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+     I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRF-YTAEIV 140
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           Y++PE +T       SD+++ G ++ ++++G     FR G E
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNE 237

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 124
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI++FG    + +       + + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 177
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 109/223 (48%), Gaps = 24/223 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
            +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 380 RNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKIIGGIA 433
              V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+     I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRF-YTAEIV 142
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEA 536
           Y++PE +T       SD+++ G ++ ++++G     FR G E 
Sbjct: 200 YVSPELLTEKSAXKSSDLWALGCIIYQLVAGLP--PFRAGNEG 240

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 110/226 (48%), Gaps = 24/226 (10%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVA 375
           +    +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 376 RLQHRNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKII 429
           RL H   V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+   
Sbjct: 64  RLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRF-YT 114
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
             I   + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  V
Sbjct: 115 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 171
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           GT  Y++PE +T       SD+++ G ++ ++++G     FR G E
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNE 215

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 14/217 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
            +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++RL H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 380 RNLVRLLGFSFEETERLLI-YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
              V+L  F+F++ E+L     +  N  + K+I    K    D          I   + Y
Sbjct: 95  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEY 150
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           LH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  Y++PE
Sbjct: 151 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
            +T       SD+++ G ++ ++++G     FR G E
Sbjct: 208 LLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNE 242

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
            +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++RL H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 380 RNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKIIGGIA 433
              V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+     I 
Sbjct: 74  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRF-YTAEIV 124
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  
Sbjct: 125 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 181
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           Y++PE +T       SD+++ G ++ ++++G     FR G E
Sbjct: 182 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNE 221

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
            +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 380 RNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKIIGGIA 433
              V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+     I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRF-YTAEIV 142
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           Y++PE +T       SD+++ G ++ ++++G     FR G E
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNE 239

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 114/211 (54%), Gaps = 21/211 (9%)
Query: 323 TNNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFKN---EVLLVARL 377
           ++ +     LG+G FG V   K +++ GQE AVK +SK  V+ + + ++   EV L+ +L
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGI 436
            H N+++L  F  ++    L+ E          +FD I  R +       +II  +  GI
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQVLSGI 162
Query: 437 LYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
            Y+H++   +I+HRDLK  N+LL++   D   +I DFG++  FE  +   D    +GT  
Sbjct: 163 TYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAY 216
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           Y+APE V  G +  K DV+S GV++  ++SG
Sbjct: 217 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
            +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++RL H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 380 RNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKIIGGIA 433
              V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+     I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRF-YTAEIV 140
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQ 197
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           Y++PE +T       SD+++ G ++ ++++G     FR G E
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNE 237

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 109/223 (48%), Gaps = 24/223 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
            +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 380 RNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKIIGGIA 433
              V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+     I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRF-YTAEIV 142
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEA 536
           Y++PE +T       SD+++ G ++ ++++G     FR G E 
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEG 240

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
            +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 380 RNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKIIGGIA 433
              V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+     I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRF-YTAEIV 142
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           Y++PE +T       SD+++ G ++ ++++G     FR G E
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNE 239

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
            +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++RL H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 380 RNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKIIGGIA 433
              V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+     I 
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRF-YTAEIV 143
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 200
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           Y++PE +T       SD+++ G ++ ++++G     FR G E
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNE 240

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 114/211 (54%), Gaps = 21/211 (9%)
Query: 323 TNNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFKN---EVLLVARL 377
           ++ +     LG+G FG V   K +++ GQE AVK +SK  V+ + + ++   EV L+ +L
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGI 436
            H N+++L  F  ++    L+ E          +FD I  R +       +II  +  GI
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQVLSGI 163
Query: 437 LYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
            Y+H++   +I+HRDLK  N+LL++   D   +I DFG++  FE  +   D    +GT  
Sbjct: 164 TYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAY 217
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           Y+APE V  G +  K DV+S GV++  ++SG
Sbjct: 218 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQG---ELEFKNEVLLVARL 377
           A  +F     LG+G FG VY  R    + I A+K L K  ++    E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++RL G+  + T   LI E+ P  +V +   +  K  + D +     I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 125
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H     R+IHRD+K  N+LL +    KI++FG    + +       + + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
            +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++RL H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 380 RNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKIIGGIA 433
              V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+     I 
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRF-YTAEIV 139
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 196
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           Y++PE +T       SD+++ G ++ ++++G     FR G E
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNE 236

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
            +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++RL H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 380 RNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKIIGGIA 433
              V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+     I 
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRF-YTAEIV 139
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 196
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           Y++PE +T       SD+++ G ++ ++++G     FR G E
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNE 236

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLS---KNSVQGELEFKNEVLLVARLQHR 380
           NF  + K+G+G F  VY+   L  G  +A+K++        +   +   E+ L+ +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFI--FDAIKRVQLDWETRYKIIGGIARGILY 438
           N+++      E+ E  ++ E      + + I  F   KR+ +   T +K    +   + +
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTVWKYFVQLCSALEH 151
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           +H  SR R++HRD+K +N+ + A  + K+ D G+ R F    +   +  +VGT  YM+PE
Sbjct: 152 MH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            +    ++ KSD++S G L+ E+ + Q
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ 233

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 100/196 (51%), Gaps = 11/196 (5%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            +LG G FG V  G+     ++A+K + + S+  E EF  E  ++  L H  LV+L G  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            ++    +I E++ N  +  ++ +   R Q   +   ++   +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSI 507
           RDL A N L++   + K+SDFG++R    D+   +TS +   F   +  PE +    FS 
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---ETSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 508 KSDVFSFGVLVLEIIS 523
           KSD+++FGVL+ EI S
Sbjct: 201 KSDIWAFGVLMWEIYS 216

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            +LG G FG V  G+     ++AVK + + S+  E EF  E   + +L H  LV+  G  
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLD--WETRYKIIGGIARGILYLHEDSRLRI 447
            +E    ++ E++ N  +  ++    K ++     E  Y +  G+A   L  H+      
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA--FLESHQ-----F 125
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT---FGYMAPEYVTRGH 504
           IHRDL A N L+D D+  K+SDFGM R    DQ        VGT     + APE      
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVFHYFK 181
Query: 505 FSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLT 541
           +S KSDV++FG+L+ E+        F +G+   DL T
Sbjct: 182 YSSKSDVWAFGILMWEV--------FSLGKMPYDLYT 210

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 14/217 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
            +F     LG+G F  V   R L+  +E A+K L K  +  E +      E  +++RL H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 380 RNLVRLLGFSFEETERLLI-YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
              V+L  F F++ E+L     +  N  + K+I    K    D          I   + Y
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEY 152
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           LH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  Y++PE
Sbjct: 153 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 209
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
            +T       SD+++ G ++ ++++G     FR G E
Sbjct: 210 LLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNE 244

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 101/196 (51%), Gaps = 10/196 (5%)
Query: 331 KLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
           K+G+G  G V      H G+++AVK++     Q      NEV+++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
               E  ++ EF+   +    + D +   +++ E    +   + R + YLH      +IH
Sbjct: 112 LVGDELWVVMEFLEGGA----LTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 164
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKS 509
           RD+K+ +ILL +D   K+SDFG     ++ +       +VGT  +MAPE ++R  +  + 
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 510 DVFSFGVLVLEIISGQ 525
           D++S G++V+E+I G+
Sbjct: 223 DIWSLGIMVIEMIDGE 238

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 27/221 (12%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHG-------QEIAVKRLSKN-SVQGELEFKNEVLL 373
           A    +   +LGQG FG VY+G ++ G         +A+K +++  S++  +EF NE  +
Sbjct: 8   AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKII 429
           +      ++VRLLG   +    L+I E +    +  ++      ++    L   +  K+I
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 430 ---GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486
              G IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R    D  + D  
Sbjct: 127 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXX 179
Query: 487 RIVG----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           R  G       +M+PE +  G F+  SDV+SFGV++ EI +
Sbjct: 180 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 33/209 (15%)
Query: 332 LGQGGFGAVYKGRLS----HGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G G FG V  GRL         +A+K L     + +  +F  E  ++ +  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 387 GFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKIIGGIARGILYLH 440
           G        +++ EF+ N ++D F+      F  I+ V +        + GIA G+ YL 
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGM--------LRGIAAGMRYLA 162
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG------Y 494
           +   +  +HRDL A NIL++++++ K+SDFG++R+ E      D   +  T G      +
Sbjct: 163 D---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIE-----DDPEAVYTTTGGKIPVRW 214
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            APE +    F+  SDV+S+G+++ E++S
Sbjct: 215 TAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 27/221 (12%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHG-------QEIAVKRLSKN-SVQGELEFKNEVLL 373
           A    +   +LGQG FG VY+G ++ G         +A+K +++  S++  +EF NE  +
Sbjct: 17  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKII 429
           +      ++VRLLG   +    L+I E +    +  ++      ++    L   +  K+I
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 430 ---GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486
              G IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R    D  + D  
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXX 188
Query: 487 RIVG----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           R  G       +M+PE +  G F+  SDV+SFGV++ EI +
Sbjct: 189 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 21/218 (9%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHG-------QEIAVKRLSKN-SVQGELEFKNEVLL 373
           A    +   +LGQG FG VY+G ++ G         +A+K +++  S++  +EF NE  +
Sbjct: 10  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKII 429
           +      ++VRLLG   +    L+I E +    +  ++      ++    L   +  K+I
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 430 ---GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDT 485
              G IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R ++E D  +   
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             ++    +M+PE +  G F+  SDV+SFGV++ EI +
Sbjct: 186 KGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 19/217 (8%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKN-SVQGELEFKNEVLLV 374
           A    +   +LGQG FG VY+G      +      +A+K +++  S++  +EF NE  ++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKII- 429
                 ++VRLLG   +    L+I E +    +  ++      ++    L   +  K+I 
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 142
Query: 430 --GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTS 486
             G IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R ++E D  +    
Sbjct: 143 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            ++    +M+PE +  G F+  SDV+SFGV++ EI +
Sbjct: 200 GLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 19/217 (8%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKN-SVQGELEFKNEVLLV 374
           A    +   +LGQG FG VY+G      +      +A+K +++  S++  +EF NE  ++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKII- 429
                 ++VRLLG   +    L+I E +    +  ++      ++    L   +  K+I 
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 430 --GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTS 486
             G IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R ++E D  +    
Sbjct: 136 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            ++    +M+PE +  G F+  SDV+SFGV++ EI +
Sbjct: 193 GLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 109/206 (52%), Gaps = 21/206 (10%)
Query: 330 NKLGQGGFGAVYKGRLSH-----GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           ++LG+G FG+V   R        G  +AVK+L  +    + +F+ E+ ++  L    +V+
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 385 LLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
             G S+    +   L+ E++P+  +  F+     R +LD          I +G+ YL   
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--G 132
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS-----QGDTSRIVGTFGYMAP 497
           SR R +HRDL A NIL++++   KI+DFG+A+L  +D+      +   S I     + AP
Sbjct: 133 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 187
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
           E ++   FS +SDV+SFGV++ E+ +
Sbjct: 188 ESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 109/206 (52%), Gaps = 21/206 (10%)
Query: 330 NKLGQGGFGAVYKGRLSH-----GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           ++LG+G FG+V   R        G  +AVK+L  +    + +F+ E+ ++  L    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 385 LLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
             G S+    +   L+ E++P+  +  F+     R +LD          I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--G 144
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS-----QGDTSRIVGTFGYMAP 497
           SR R +HRDL A NIL++++   KI+DFG+A+L  +D+      +   S I     + AP
Sbjct: 145 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 199
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
           E ++   FS +SDV+SFGV++ E+ +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 21/218 (9%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHG-------QEIAVKRLSKN-SVQGELEFKNEVLL 373
           A    +   +LGQG FG VY+G ++ G         +A+K +++  S++  +EF NE  +
Sbjct: 14  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKII 429
           +      ++VRLLG   +    L+I E +    +  ++      ++    L   +  K+I
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 430 ---GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDT 485
              G IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R ++E D  +   
Sbjct: 133 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             ++    +M+PE +  G F+  SDV+SFGV++ EI +
Sbjct: 190 KGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 19/217 (8%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKN-SVQGELEFKNEVLLV 374
           A    +   +LGQG FG VY+G      +      +A+K +++  S++  +EF NE  ++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKII- 429
                 ++VRLLG   +    L+I E +    +  ++      ++    L   +  K+I 
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 430 --GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTS 486
             G IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R ++E D  +    
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 193
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            ++    +M+PE +  G F+  SDV+SFGV++ EI +
Sbjct: 194 GLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 21/218 (9%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHG-------QEIAVKRLSKN-SVQGELEFKNEVLL 373
           A    +   +LGQG FG VY+G ++ G         +A+K +++  S++  +EF NE  +
Sbjct: 16  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKII 429
           +      ++VRLLG   +    L+I E +    +  ++      ++    L   +  K+I
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 430 ---GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDT 485
              G IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R ++E D  +   
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             ++    +M+PE +  G F+  SDV+SFGV++ EI +
Sbjct: 192 KGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 109/206 (52%), Gaps = 21/206 (10%)
Query: 330 NKLGQGGFGAVYKGRLSH-----GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           ++LG+G FG+V   R        G  +AVK+L  +    + +F+ E+ ++  L    +V+
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 385 LLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
             G S+    +   L+ E++P+  +  F+     R +LD          I +G+ YL   
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--G 131
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS-----QGDTSRIVGTFGYMAP 497
           SR R +HRDL A NIL++++   KI+DFG+A+L  +D+      +   S I     + AP
Sbjct: 132 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 186
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
           E ++   FS +SDV+SFGV++ E+ +
Sbjct: 187 ESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 106/199 (53%), Gaps = 11/199 (5%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFK--NEVLLVARLQHRNLVRLLG 387
            K+G+G +G VYK + S G+ +A+KR+  ++    +      E+ L+  L H N+V L+ 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
               E    L++EF+      K + D  K    D + +  +   + RG+ + H+    RI
Sbjct: 87  VIHSERCLTLVFEFMEKDL--KKVLDENKTGLQDSQIKIYLYQ-LLRGVAHCHQH---RI 140
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-RGHFS 506
           +HRDLK  N+L+++D   K++DFG+AR F +   +  T  +V T  Y AP+ +     +S
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPDVLMGSKKYS 198
Query: 507 IKSDVFSFGVLVLEIISGQ 525
              D++S G +  E+I+G+
Sbjct: 199 TSVDIWSIGCIFAEMITGK 217

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 24/222 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
            +F     LG+G F      R L+  +E A+K L K  +  E +      E  +++RL H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 380 RNLVRLLGFSFEETERLLI-YEFVPNSSVDKFI-----FDAIKRVQLDWETRYKIIGGIA 433
              V+L  F+F++ E+L     +  N  + K+I     FD       +  TR+     I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRF-YTAEIV 140
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             + YLH      IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           Y++PE +T       SD+++ G ++ ++++G     FR G E
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNE 237

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 106/199 (53%), Gaps = 11/199 (5%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFK--NEVLLVARLQHRNLVRLLG 387
            K+G+G +G VYK + S G+ +A+KR+  ++    +      E+ L+  L H N+V L+ 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
               E    L++EF+      K + D  K    D + +  +   + RG+ + H+    RI
Sbjct: 87  VIHSERCLTLVFEFMEKDL--KKVLDENKTGLQDSQIKIYLYQ-LLRGVAHCHQH---RI 140
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-RGHFS 506
           +HRDLK  N+L+++D   K++DFG+AR F +   +  T  +V T  Y AP+ +     +S
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPDVLMGSKKYS 198
Query: 507 IKSDVFSFGVLVLEIISGQ 525
              D++S G +  E+I+G+
Sbjct: 199 TSVDIWSIGCIFAEMITGK 217

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 21/218 (9%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHG-------QEIAVKRLSKN-SVQGELEFKNEVLL 373
           A    +   +LGQG FG VY+G ++ G         +A+K +++  S++  +EF NE  +
Sbjct: 45  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKII 429
           +      ++VRLLG   +    L+I E +    +  ++      ++    L   +  K+I
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 163
Query: 430 ---GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDT 485
              G IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R ++E D  +   
Sbjct: 164 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 220
Query: 486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             ++    +M+PE +  G F+  SDV+SFGV++ EI +
Sbjct: 221 KGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 109/202 (53%), Gaps = 21/202 (10%)
Query: 332 LGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFKN---EVLLVARLQHRNLVRLL 386
           LG+G FG V   K +++ GQE AVK +SK  V+ + + ++   EV L+ +L H N+ +L 
Sbjct: 34  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRL 445
            F  ++    L+ E          +FD I  R +       +II  +  GI Y H++   
Sbjct: 93  EFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQVLSGITYXHKN--- 145
Query: 446 RIIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
           +I+HRDLK  N+LL++   D   +I DFG++  FE  +   D    +GT  Y+APE V  
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK---IGTAYYIAPE-VLH 201
Query: 503 GHFSIKSDVFSFGVLVLEIISG 524
           G +  K DV+S GV++  ++SG
Sbjct: 202 GTYDEKCDVWSTGVILYILLSG 223

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 112/211 (53%), Gaps = 11/211 (5%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLS-KNSVQGELEFKNEVLLVARLQ 378
           D    F+   K+G+G FG V+KG  +  Q++ A+K +  + +     + + E+ ++++  
Sbjct: 24  DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 83
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
              + +  G   ++T+  +I E++   S      D ++   LD      I+  I +G+ Y
Sbjct: 84  SPYVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDY 139
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           LH + +   IHRD+KA+N+LL      K++DFG+A   ++  +Q   +  VGT  +MAPE
Sbjct: 140 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPE 194
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529
            + +  +  K+D++S G+  +E+  G+  +S
Sbjct: 195 VIKQSAYDSKADIWSLGITAIELARGEPPHS 225

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 113/219 (51%), Gaps = 14/219 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKG--RLSHGQ-EIAVKRLSKNSVQGELE-FKNEVLLVARLQH 379
           N    D +LG G FG+V +G  R+   Q ++A+K L + + + + E    E  ++ +L +
Sbjct: 10  NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 69
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
             +VRL+G    E   +L+ E      + KF+    KR ++      +++  ++ G+ YL
Sbjct: 70  PYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL 126
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAP 497
            E +    +HRDL A N+LL      KISDFG+++    D S   T+R  G +   + AP
Sbjct: 127 EEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAP 182
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEE 535
           E +    FS +SDV+S+GV + E +S GQK      G E
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 104/193 (53%), Gaps = 13/193 (6%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391
           +G+G FG V  G    G ++AVK + KN    +  F  E  ++ +L+H NLV+LLG   E
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 392 ETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           E   L ++ E++   S+  ++    + V L  +   K    +   + YL  ++    +HR
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSD 510
           DL A N+L+  D + K+SDFG+ +  E   +Q DT ++     + APE +    FS KSD
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKL--PVKWTAPEALREKKFSTKSD 368
Query: 511 VFSFGVLVLEIIS 523
           V+SFG+L+ EI S
Sbjct: 369 VWSFGILLWEIYS 381

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            +LG G FG V  G+     ++A+K + + S+  E EF  E  ++  L H  LV+L G  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            ++    +I E++ N  +  ++ +   R Q   +   ++   +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSI 507
           RDL A N L++   + K+SDFG++R    D+    TS +   F   +  PE +    FS 
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 508 KSDVFSFGVLVLEIIS 523
           KSD+++FGVL+ EI S
Sbjct: 201 KSDIWAFGVLMWEIYS 216

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            +LG G FG V  G+     ++A+K + + S+  E EF  E  ++  L H  LV+L G  
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            ++    +I E++ N  +  ++ +   R Q   +   ++   +   + YL      + +H
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 127
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSI 507
           RDL A N L++   + K+SDFG++R    D+    TS +   F   +  PE +    FS 
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 184
Query: 508 KSDVFSFGVLVLEIIS 523
           KSD+++FGVL+ EI S
Sbjct: 185 KSDIWAFGVLMWEIYS 200

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 112/211 (53%), Gaps = 11/211 (5%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLS-KNSVQGELEFKNEVLLVARLQ 378
           D    F+   K+G+G FG V+KG  +  Q++ A+K +  + +     + + E+ ++++  
Sbjct: 4   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 63
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
              + +  G   ++T+  +I E++   S      D ++   LD      I+  I +G+ Y
Sbjct: 64  SPYVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDY 119
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           LH + +   IHRD+KA+N+LL      K++DFG+A   ++  +Q   +  VGT  +MAPE
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPE 174
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529
            + +  +  K+D++S G+  +E+  G+  +S
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPPHS 205

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            +LG G FG V  G+     ++A+K + + S+  E EF  E  ++  L H  LV+L G  
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            ++    +I E++ N  +  ++ +   R Q   +   ++   +   + YL      + +H
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 134
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSI 507
           RDL A N L++   + K+SDFG++R    D+    TS +   F   +  PE +    FS 
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 191
Query: 508 KSDVFSFGVLVLEIIS 523
           KSD+++FGVL+ EI S
Sbjct: 192 KSDIWAFGVLMWEIYS 207

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 112/211 (53%), Gaps = 11/211 (5%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLS-KNSVQGELEFKNEVLLVARLQ 378
           D    F+   K+G+G FG V+KG  +  Q++ A+K +  + +     + + E+ ++++  
Sbjct: 4   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 63
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
              + +  G   ++T+  +I E++   S      D ++   LD      I+  I +G+ Y
Sbjct: 64  SPYVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDY 119
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           LH + +   IHRD+KA+N+LL      K++DFG+A   ++  +Q   +  VGT  +MAPE
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPE 174
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529
            + +  +  K+D++S G+  +E+  G+  +S
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPPHS 205

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 112/211 (53%), Gaps = 11/211 (5%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLS-KNSVQGELEFKNEVLLVARLQ 378
           D    F+   K+G+G FG V+KG  +  Q++ A+K +  + +     + + E+ ++++  
Sbjct: 19  DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
              + +  G   ++T+  +I E++   S      D ++   LD      I+  I +G+ Y
Sbjct: 79  SPYVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDY 134
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           LH + +   IHRD+KA+N+LL      K++DFG+A   ++  +Q   +  VGT  +MAPE
Sbjct: 135 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPE 189
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529
            + +  +  K+D++S G+  +E+  G+  +S
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPPHS 220

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            +LG G FG V  G+     ++A+K + + S+  E EF  E  ++  L H  LV+L G  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            ++    +I E++ N  +  ++ +   R Q   +   ++   +   + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSI 507
           RDL A N L++   + K+SDFG++R    D+    TS +   F   +  PE +    FS 
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 185
Query: 508 KSDVFSFGVLVLEIIS 523
           KSD+++FGVL+ EI S
Sbjct: 186 KSDIWAFGVLMWEIYS 201

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 31/212 (14%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLS---KNSVQGELEFKNEVLLVARLQHRNLVRLLGF- 388
            +G FG V+K +L +   +AVK      K S Q E     E+     ++H NL++ +   
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQSE----REIFSTPGMKHENLLQFIAAE 78
Query: 389 ---SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED--- 442
              S  E E  LI  F    S+  ++   I    + W     +   ++RG+ YLHED   
Sbjct: 79  KRGSNLEVELWLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLHEDVPW 134
Query: 443 -----SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
                 +  I HRD K+ N+LL +D+   ++DFG+A  FE  +  GDT   VGT  YMAP
Sbjct: 135 CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAP 194
Query: 498 EYVTRGHFSIKSDVF------SFGVLVLEIIS 523
           E V  G  + + D F      + G+++ E++S
Sbjct: 195 E-VLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 104/193 (53%), Gaps = 13/193 (6%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391
           +G+G FG V  G    G ++AVK + KN    +  F  E  ++ +L+H NLV+LLG   E
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 392 ETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           E   L ++ E++   S+  ++    + V L  +   K    +   + YL  ++    +HR
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNN---FVHR 132
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSD 510
           DL A N+L+  D + K+SDFG+ +  E   +Q DT ++     + APE +    FS KSD
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKL--PVKWTAPEALREAAFSTKSD 187
Query: 511 VFSFGVLVLEIIS 523
           V+SFG+L+ EI S
Sbjct: 188 VWSFGILLWEIYS 200

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 116/251 (46%), Gaps = 35/251 (13%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKN-SVQGELEFKNEVLLVAR 376
           NN      +G+G FG V++ R            +AVK L +  S   + +F+ E  L+A 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV-----QLDWETRYK---- 427
             + N+V+LLG         L++E++    +++F+              D  TR +    
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 428 ------------IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR- 474
                       I   +A G+ YL E    + +HRDL   N L+  +M+ KI+DFG++R 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGE 534
           ++  D  + D +  +    +M PE +    ++ +SDV+++GV++ EI S      +  G 
Sbjct: 224 IYSADYYKADGNDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY--GM 280
Query: 535 EAEDLLTYVSN 545
             E+++ YV +
Sbjct: 281 AHEEVIYYVRD 291

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            +LG G FG V  G+     ++A+K + + S+  E EF  E  ++  L H  LV+L G  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            ++    +I E++ N  +  ++ +   R Q   +   ++   +   + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 123
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYVTRGHFSI 507
           RDL A N L++   + K+SDFG++R    D+    TS +   F   +  PE +    FS 
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 508 KSDVFSFGVLVLEIIS 523
           KSD+++FGVL+ EI S
Sbjct: 181 KSDIWAFGVLMWEIYS 196

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 21/218 (9%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHG-------QEIAVKRLSKN-SVQGELEFKNEVLL 373
           A    +   +LGQG FG VY+G ++ G         +A+K +++  S++  +EF NE  +
Sbjct: 10  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKII 429
           +      ++VRLLG   +    L+I E +    +  ++      ++    L   +  K+I
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 430 ---GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDT 485
              G IA G+ YL+ +   + +HRDL A N  +  D   KI DFGM R ++E D  +   
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             ++    +M+PE +  G F+  SDV+SFGV++ EI +
Sbjct: 186 KGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 331 KLGQGGFGAVYKGR---LSHGQ---EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLV 383
           +LGQG FG VY+G    +  G+    +AVK ++++ S++  +EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIF-------DAIKRVQLDWETRYKIIGGIARGI 436
           RLLG   +    L++ E + +  +  ++        +   R     +   ++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG----TF 492
            YL+     + +HRDL A N ++  D   KI DFGM R    D  + D  R  G      
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPV 196
Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            +MAPE +  G F+  SD++SFGV++ EI S
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 104/193 (53%), Gaps = 13/193 (6%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391
           +G+G FG V  G    G ++AVK + KN    +  F  E  ++ +L+H NLV+LLG   E
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 392 ETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           E   L ++ E++   S+  ++    + V L  +   K    +   + YL  ++    +HR
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSD 510
           DL A N+L+  D + K+SDFG+ +  E   +Q DT ++     + APE +    FS KSD
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKL--PVKWTAPEALREKKFSTKSD 196
Query: 511 VFSFGVLVLEIIS 523
           V+SFG+L+ EI S
Sbjct: 197 VWSFGILLWEIYS 209

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 113/219 (51%), Gaps = 14/219 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKG--RLSHGQ-EIAVKRLSKNSVQGELE-FKNEVLLVARLQH 379
           N    D +LG G FG+V +G  R+   Q ++A+K L + + + + E    E  ++ +L +
Sbjct: 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 395
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
             +VRL+G    E   +L+ E      + KF+    KR ++      +++  ++ G+ YL
Sbjct: 396 PYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL 452
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAP 497
            E +    +HR+L A N+LL      KISDFG+++    D S   T+R  G +   + AP
Sbjct: 453 EEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAP 508
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEE 535
           E +    FS +SDV+S+GV + E +S GQK      G E
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 331 KLGQGGFGAVYKGR---LSHGQ---EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLV 383
           +LGQG FG VY+G    +  G+    +AVK ++++ S++  +EF NE  ++      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIF-------DAIKRVQLDWETRYKIIGGIARGI 436
           RLLG   +    L++ E + +  +  ++        +   R     +   ++   IA G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG----TF 492
            YL+     + +HRDL A N ++  D   KI DFGM R    D  + D  R  G      
Sbjct: 141 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPV 193
Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            +MAPE +  G F+  SD++SFGV++ EI S
Sbjct: 194 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 21/218 (9%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHG-------QEIAVKRLSKN-SVQGELEFKNEVLL 373
           A    +   +LGQG FG VY+G ++ G         +A+K +++  S++  +EF NE  +
Sbjct: 13  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKII 429
           +      ++VRLLG   +    L+I E +    +  ++      +     L   +  K+I
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 430 ---GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDT 485
              G IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R ++E D  +   
Sbjct: 132 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 188
Query: 486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             ++    +M+PE +  G F+  SDV+SFGV++ EI +
Sbjct: 189 KGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 19/217 (8%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKN-SVQGELEFKNEVLLV 374
           A    +   +LGQG FG VY+G      +      +A+K +++  S++  +EF NE  ++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKII- 429
                 ++VRLLG   +    L+I E +    +  ++      +     L   +  K+I 
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 430 --GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTS 486
             G IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R ++E D  +    
Sbjct: 143 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            ++    +M+PE +  G F+  SDV+SFGV++ EI +
Sbjct: 200 GLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 104/193 (53%), Gaps = 13/193 (6%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391
           +G+G FG V  G    G ++AVK + KN    +  F  E  ++ +L+H NLV+LLG   E
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 392 ETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
           E   L ++ E++   S+  ++    + V L  +   K    +   + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSD 510
           DL A N+L+  D + K+SDFG+ +  E   +Q DT ++     + APE +    FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKL--PVKWTAPEALREKKFSTKSD 181
Query: 511 VFSFGVLVLEIIS 523
           V+SFG+L+ EI S
Sbjct: 182 VWSFGILLWEIYS 194

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 331 KLGQGGFGAVYKGR---LSHGQ---EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLV 383
           +LGQG FG VY+G    +  G+    +AVK ++++ S++  +EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIF-------DAIKRVQLDWETRYKIIGGIARGI 436
           RLLG   +    L++ E + +  +  ++        +   R     +   ++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG----TF 492
            YL+     + +HRDL A N ++  D   KI DFGM R    D  + D  R  G      
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPV 196
Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            +MAPE +  G F+  SD++SFGV++ EI S
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 108/208 (51%), Gaps = 19/208 (9%)
Query: 331 KLGQGGFGAVYKGR---LSHGQ---EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLV 383
           +LGQG FG VY+G    +  G+    +AVK ++++ S++  +EF NE  ++      ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIF-------DAIKRVQLDWETRYKIIGGIARGI 436
           RLLG   +    L++ E + +  +  ++        +   R     +   ++   IA G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGTFGYM 495
            YL+     + +HRDL A N ++  D   KI DFGM R ++E D  +     ++    +M
Sbjct: 143 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWM 198
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           APE +  G F+  SD++SFGV++ EI S
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 108/208 (51%), Gaps = 19/208 (9%)
Query: 331 KLGQGGFGAVYKGR---LSHGQ---EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLV 383
           +LGQG FG VY+G    +  G+    +AVK ++++ S++  +EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIF-------DAIKRVQLDWETRYKIIGGIARGI 436
           RLLG   +    L++ E + +  +  ++        +   R     +   ++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGTFGYM 495
            YL+     + +HRDL A N ++  D   KI DFGM R ++E D  +     ++    +M
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWM 199
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           APE +  G F+  SD++SFGV++ EI S
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 107/202 (52%), Gaps = 20/202 (9%)
Query: 331 KLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK--NEVLLVARLQHRNLVRLL 386
           KLG G +G V   + +++H  E A+K + K SV      K   EV ++  L H N+++L 
Sbjct: 44  KLGSGAYGEVLLCRDKVTH-VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRL 445
            F  ++    L+ E          +FD I  R++ +      II  +  G+ YLH+ +  
Sbjct: 103 DFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN-- 156
Query: 446 RIIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
            I+HRDLK  N+LL++   D + KI DFG++ +FE   +Q      +GT  Y+APE V R
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE---NQKKMKERLGTAYYIAPE-VLR 211
Query: 503 GHFSIKSDVFSFGVLVLEIISG 524
             +  K DV+S GV++  +++G
Sbjct: 212 KKYDEKCDVWSIGVILFILLAG 233

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ + A L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 74  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 126
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 187 EPVDVWSCGIVLTAMLAGE 205

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 97/194 (50%), Gaps = 7/194 (3%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            +LG G FG V  G+     ++A+K + + S+  E EF  E  ++  L H  LV+L G  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            ++    +I E++ N  +  ++ +   R Q   +   ++   +   + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKS 509
           RDL A N L++   + K+SDFG++R + +D     +        +  PE +    FS KS
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 510 DVFSFGVLVLEIIS 523
           D+++FGVL+ EI S
Sbjct: 188 DIWAFGVLMWEIYS 201

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFS 389
           +LG G FG VYK +      +A  ++     + ELE +  E+ ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL-YLHEDSRLRII 448
           + E    ++ EF    +VD  + +  + +    E++ +++       L YLH++   +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHDN---KII 157
Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV-----TRG 503
           HRDLKA NIL   D   K++DFG++        + D+   +GT  +MAPE V        
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS--FIGTPYWMAPEVVMCETSKDR 215
Query: 504 HFSIKSDVFSFGVLVLEI 521
            +  K+DV+S G+ ++E+
Sbjct: 216 PYDYKADVWSLGITLIEM 233

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFS 389
           +LG G FG VYK +      +A  ++     + ELE +  E+ ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL-YLHEDSRLRII 448
           + E    ++ EF    +VD  + +  + +    E++ +++       L YLH++   +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHDN---KII 157
Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV-----TRG 503
           HRDLKA NIL   D   K++DFG++        + D+   +GT  +MAPE V        
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDR 215
Query: 504 HFSIKSDVFSFGVLVLEI 521
            +  K+DV+S G+ ++E+
Sbjct: 216 PYDYKADVWSLGITLIEM 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 21/204 (10%)
Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G+G FG VY G L  + G++I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 387 GFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
           G     E   L++  ++ +  +  FI     R +    T   +IG    +A+G+ +L   
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKFL--- 208
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLF---EMDQSQGDTSRIVGTFGYMAPEY 499
           +  + +HRDL A N +LD     K++DFG+AR     E D     T   +    +MA E 
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL-PVKWMALES 267
Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS 523
           +    F+ KSDV+SFGVL+ E+++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 21/204 (10%)
Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G+G FG VY G L  + G++I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 387 GFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
           G     E   L++  ++ +  +  FI     R +    T   +IG    +A+G+ +L   
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKFL--- 154
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLF---EMDQSQGDTSRIVGTFGYMAPEY 499
           +  + +HRDL A N +LD     K++DFG+AR     E D     T   +    +MA E 
Sbjct: 155 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL-PVKWMALES 213
Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS 523
           +    F+ KSDV+SFGVL+ E+++
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 21/204 (10%)
Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G+G FG VY G L  + G++I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 387 GFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
           G     E   L++  ++ +  +  FI     R +    T   +IG    +A+G+ +L   
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKFL--- 150
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLF---EMDQSQGDTSRIVGTFGYMAPEY 499
           +  + +HRDL A N +LD     K++DFG+AR     E D     T   +    +MA E 
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL-PVKWMALES 209
Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS 523
           +    F+ KSDV+SFGVL+ E+++
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 21/204 (10%)
Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G+G FG VY G L  + G++I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 387 GFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
           G     E   L++  ++ +  +  FI     R +    T   +IG    +A+G+ +L   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKFL--- 149
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLF---EMDQSQGDTSRIVGTFGYMAPEY 499
           +  + +HRDL A N +LD     K++DFG+AR     E D     T   +    +MA E 
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALES 208
Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS 523
           +    F+ KSDV+SFGVL+ E+++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 21/204 (10%)
Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G+G FG VY G L  + G++I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 387 GFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
           G     E   L++  ++ +  +  FI     R +    T   +IG    +A+G+ +L   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKFL--- 147
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLF---EMDQSQGDTSRIVGTFGYMAPEY 499
           +  + +HRDL A N +LD     K++DFG+AR     E D     T   +    +MA E 
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALES 206
Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS 523
           +    F+ KSDV+SFGVL+ E+++
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 101/198 (51%), Gaps = 15/198 (7%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFS 389
           +LG G FG VYK +      +A  ++     + ELE +  E+ ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL-YLHEDSRLRII 448
           + E    ++ EF    +VD  + +  + +    E++ +++       L YLH++   +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHDN---KII 157
Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV-----TRG 503
           HRDLKA NIL   D   K++DFG++        + D    +GT  +MAPE V        
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDX--FIGTPYWMAPEVVMCETSKDR 215
Query: 504 HFSIKSDVFSFGVLVLEI 521
            +  K+DV+S G+ ++E+
Sbjct: 216 PYDYKADVWSLGITLIEM 233

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 21/204 (10%)
Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G+G FG VY G L  + G++I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 387 GFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
           G     E   L++  ++ +  +  FI     R +    T   +IG    +A+G+ YL   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 148
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT---FGYMAPEY 499
           +  + +HRDL A N +LD     K++DFG+AR    D+         G      +MA E 
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEXXSVHNKTGAKLPVKWMALES 207
Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS 523
           +    F+ KSDV+SFGVL+ E+++
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 21/204 (10%)
Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G+G FG VY G L  + G++I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 387 GFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
           G     E   L++  ++ +  +  FI     R +    T   +IG    +A+G+ +L   
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKFL--- 150
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLF---EMDQSQGDTSRIVGTFGYMAPEY 499
           +  + +HRDL A N +LD     K++DFG+AR     E D     T   +    +MA E 
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKL-PVKWMALES 209
Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS 523
           +    F+ KSDV+SFGVL+ E+++
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 21/204 (10%)
Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G+G FG VY G L  + G++I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 387 GFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
           G     E   L++  ++ +  +  FI     R +    T   +IG    +A+G+ +L   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKFL--- 149
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLF---EMDQSQGDTSRIVGTFGYMAPEY 499
           +  + +HRDL A N +LD     K++DFG+AR     E D     T   +    +MA E 
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL-PVKWMALES 208
Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS 523
           +    F+ KSDV+SFGVL+ E+++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 32/215 (14%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391
           +G+G +GAVYKG L   + +AVK  S  + Q  +  KN +  V  ++H N+ R +     
Sbjct: 21  IGRGRYGAVYKGSLDE-RPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIARFIVGDER 78
Query: 392 ET-----ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH------ 440
            T     E LL+ E+ PN S+ K++         DW +  ++   + RG+ YLH      
Sbjct: 79  VTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLHTELPRG 134
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMA------RLFEMDQSQGDTSRIVGTFGY 494
           +  +  I HRDL + N+L+  D    ISDFG++      RL    +        VGT  Y
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194
Query: 495 MAPEYVTRGHFSIKS--------DVFSFGVLVLEI 521
           MAPE V  G  +++         D+++ G++  EI
Sbjct: 195 MAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 110/211 (52%), Gaps = 18/211 (8%)
Query: 322 ATNNFSTDNK---LGQGGFGAVYK-GRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL 377
           A N+F T +K   LG G FG V+K    + G ++A K +    ++ + E KNE+ ++ +L
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSV-DKFIFDAIKRVQLDWETRYKIIGGIARGI 436
            H NL++L      + + +L+ E+V    + D+ I ++    +LD       +  I  GI
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD---TILFMKQICEGI 200
Query: 437 LYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
            ++H+   + I+H DLK  NIL    DA  I KI DFG+AR +   + +       GT  
Sbjct: 201 RHMHQ---MYILHLDLKPENILCVNRDAKQI-KIIDFGLARRY---KPREKLKVNFGTPE 253
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           ++APE V     S  +D++S GV+   ++SG
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 326 FSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQ 378
           +    +LG GGFG V +      G+++A+K+  +     EL  KN      E+ ++ +L 
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-----ELSPKNRERWCLEIQIMKKLN 70
Query: 379 HRNLV--RLLGFSFEETER----LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI 432
           H N+V  R +    ++       LL  E+     + K++        L       ++  I
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIV 489
           +  + YLHE+   RIIHRDLK  NI+L      +I KI D G A+  E+DQ +  T   V
Sbjct: 131 SSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTE-FV 184
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           GT  Y+APE + +  +++  D +SFG L  E I+G
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 326 FSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQ 378
           +    +LG GGFG V +      G+++A+K+  +     EL  KN      E+ ++ +L 
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-----ELSPKNRERWCLEIQIMKKLN 71
Query: 379 HRNLV--RLLGFSFEETER----LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI 432
           H N+V  R +    ++       LL  E+     + K++        L       ++  I
Sbjct: 72  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 131
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIV 489
           +  + YLHE+   RIIHRDLK  NI+L      +I KI D G A+  E+DQ +  T   V
Sbjct: 132 SSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTE-FV 185
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           GT  Y+APE + +  +++  D +SFG L  E I+G
Sbjct: 186 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 108/208 (51%), Gaps = 19/208 (9%)
Query: 331 KLGQGGFGAVYKGR---LSHGQ---EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLV 383
           +LGQG FG VY+G    +  G+    +AVK ++++ S++  +EF NE  ++      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIF-------DAIKRVQLDWETRYKIIGGIARGI 436
           RLLG   +    L++ E + +  +  ++        +   R     +   ++   IA G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGTFGYM 495
            YL+     + +HR+L A N ++  D   KI DFGM R ++E D  +     ++    +M
Sbjct: 145 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWM 200
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           APE +  G F+  SD++SFGV++ EI S
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 112/215 (52%), Gaps = 11/215 (5%)
Query: 317 STIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLS-KNSVQGELEFKNEVLLV 374
           + I D    F+   ++G+G FG V+KG  +  Q++ A+K +  + +     + + E+ ++
Sbjct: 16  NNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
           ++     + +  G   + ++  +I E++   S      D ++    D      ++  I +
Sbjct: 76  SQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILK 131
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           G+ YLH + +   IHRD+KA+N+LL      K++DFG+A   ++  +Q   +  VGT  +
Sbjct: 132 GLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFW 186
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529
           MAPE + +  +  K+D++S G+  +E+  G+  NS
Sbjct: 187 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS 221

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 108/208 (51%), Gaps = 19/208 (9%)
Query: 331 KLGQGGFGAVYKGR---LSHGQ---EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLV 383
           +LGQG FG VY+G    +  G+    +AVK ++++ S++  +EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIF-------DAIKRVQLDWETRYKIIGGIARGI 436
           RLLG   +    L++ E + +  +  ++        +   R     +   ++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGTFGYM 495
            YL+     + +HR+L A N ++  D   KI DFGM R ++E D  +     ++    +M
Sbjct: 144 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWM 199
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           APE +  G F+  SD++SFGV++ EI S
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 118/239 (49%), Gaps = 32/239 (13%)
Query: 305 EINTVESLQFDFSTIRDATNN----------FSTDNKLGQGGFGAVYKG-RLSHGQEI-- 351
           +I T E+L F  S   +A N           F     LG G FG VYKG  +  G+++  
Sbjct: 13  DIPTTENLYFQGSG--EAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI 70
Query: 352 --AVKRLSK-NSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD 408
             A+K L +  S +   E  +E  ++A + + ++ RLLG     T +L I + +P   + 
Sbjct: 71  PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLL 129
Query: 409 KFIFDAIKRVQ----LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI 464
            ++ +    +     L+W  +      IA+G+ YL ED RL  +HRDL A N+L+     
Sbjct: 130 DYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQH 180
Query: 465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            KI+DFG+A+L   ++ +           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 181 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 79  DNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 132 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 188
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 19/211 (9%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLS-KNSVQG-ELEFKNEVLLVARLQ 378
           AT+ +    ++G G +G VYK R  H G  +A+K +   N  +G  +    EV L+ RL+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 379 ---HRNLVRLLGF-----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
              H N+VRL+       +  E +  L++E V +  +  ++ D      L  ET   ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
              RG+ +LH +    I+HRDLK  NIL+ +    K++DFG+AR++     Q   + +V 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALAPVVV 173
Query: 491 TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
           T  Y APE + +  ++   D++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQH 379
           D    +    +LG G FG VYK +      +A  ++ +   + ELE +  E+ ++A   H
Sbjct: 8   DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH 67
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL-- 437
             +V+LLG  + + +  ++ EF P  +VD  +       +LD       I  + R +L  
Sbjct: 68  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIML------ELDRGLTEPQIQVVCRQMLEA 121
Query: 438 --YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM-ARLFEMDQSQGDTSRIVGTFGY 494
             +LH     RIIHRDLKA N+L+  +   +++DFG+ A+  +  Q +      +GT  +
Sbjct: 122 LNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR---DSFIGTPYW 175
Query: 495 MAPEYV-----TRGHFSIKSDVFSFGVLVLEI 521
           MAPE V         +  K+D++S G+ ++E+
Sbjct: 176 MAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 111/203 (54%), Gaps = 19/203 (9%)
Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G+G FG VY G L  + G++I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 387 GFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
           G     E   L++  ++ +  +  FI     R +    T   +IG    +A+G+ YL   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 149
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMD-QSQGDTSRIVGTFGYMAPEYV 500
           +  + +HRDL A N +LD     K++DFG+AR +++ +  S  + +       +MA E +
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               F+ KSDV+SFGVL+ E+++
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 111/203 (54%), Gaps = 19/203 (9%)
Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G+G FG VY G L  + G++I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 387 GFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
           G     E   L++  ++ +  +  FI     R +    T   +IG    +A+G+ YL   
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 141
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMD-QSQGDTSRIVGTFGYMAPEYV 500
           +  + +HRDL A N +LD     K++DFG+AR +++ +  S  + +       +MA E +
Sbjct: 142 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 201
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               F+ KSDV+SFGVL+ E+++
Sbjct: 202 QTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 76  DNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 129 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 111/203 (54%), Gaps = 19/203 (9%)
Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G+G FG VY G L  + G++I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 387 GFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
           G     E   L++  ++ +  +  FI     R +    T   +IG    +A+G+ YL   
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 168
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMD-QSQGDTSRIVGTFGYMAPEYV 500
           +  + +HRDL A N +LD     K++DFG+AR +++ +  S  + +       +MA E +
Sbjct: 169 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 228
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               F+ KSDV+SFGVL+ E+++
Sbjct: 229 QTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 111/203 (54%), Gaps = 19/203 (9%)
Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G+G FG VY G L  + G++I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 387 GFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
           G     E   L++  ++ +  +  FI     R +    T   +IG    +A+G+ YL   
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 167
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMD-QSQGDTSRIVGTFGYMAPEYV 500
           +  + +HRDL A N +LD     K++DFG+AR +++ +  S  + +       +MA E +
Sbjct: 168 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 227
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               F+ KSDV+SFGVL+ E+++
Sbjct: 228 QTQKFTTKSDVWSFGVLLWELMT 250

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 125
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 78  DNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 131 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 111/203 (54%), Gaps = 19/203 (9%)
Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G+G FG VY G L  + G++I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 387 GFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
           G     E   L++  ++ +  +  FI     R +    T   +IG    +A+G+ YL   
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 146
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMD-QSQGDTSRIVGTFGYMAPEYV 500
           +  + +HRDL A N +LD     K++DFG+AR +++ +  S  + +       +MA E +
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 206
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               F+ KSDV+SFGVL+ E+++
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 111/203 (54%), Gaps = 19/203 (9%)
Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G+G FG VY G L  + G++I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 387 GFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
           G     E   L++  ++ +  +  FI     R +    T   +IG    +A+G+ YL   
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 144
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMD-QSQGDTSRIVGTFGYMAPEYV 500
           +  + +HRDL A N +LD     K++DFG+AR +++ +  S  + +       +MA E +
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               F+ KSDV+SFGVL+ E+++
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMT 227

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 130 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 111/203 (54%), Gaps = 19/203 (9%)
Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G+G FG VY G L  + G++I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 387 GFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
           G     E   L++  ++ +  +  FI     R +    T   +IG    +A+G+ YL   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 148
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMD-QSQGDTSRIVGTFGYMAPEYV 500
           +  + +HRDL A N +LD     K++DFG+AR +++ +  S  + +       +MA E +
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 208
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               F+ KSDV+SFGVL+ E+++
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 108/209 (51%), Gaps = 23/209 (11%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVK-----RLSKNSVQGELEFKNEVLLVARLQ 378
           N+     +G+G F  V   R +  G+E+A+K     +L+  S+Q   +   EV ++  L 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ---KLFREVRIMKILN 69
Query: 379 HRNLVRLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           H N+V+L  F   ETE+   LI E+     V  ++    +  + +  ++++    I   +
Sbjct: 70  HPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAV 124
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            Y H+    RI+HRDLKA N+LLDADM  KI+DFG +  F +    G      G+  Y A
Sbjct: 125 QYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDTFCGSPPYAA 178
Query: 497 PE-YVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +  + +   + DV+S GV++  ++SG
Sbjct: 179 PELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 128 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVK-----RLSKNSVQGELEFKNEVLLVARLQ 378
           N+     +G+G F  V   R +  G+E+A+K     +L+  S+Q   +   EV ++  L 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ---KLFREVRIMKILN 72
Query: 379 HRNLVRLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           H N+V+L  F   ETE+   LI E+     V  ++    +  + +  ++++    I   +
Sbjct: 73  HPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAV 127
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            Y H+    RI+HRDLKA N+LLDADM  KI+DFG +  F +    G      G   Y A
Sbjct: 128 QYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFCGAPPYAA 181
Query: 497 PE-YVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +  + +   + DV+S GV++  ++SG
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 111/203 (54%), Gaps = 19/203 (9%)
Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G+G FG VY G L  + G++I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 387 GFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
           G     E   L++  ++ +  +  FI     R +    T   +IG    +A+G+ YL   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 149
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMD-QSQGDTSRIVGTFGYMAPEYV 500
           +  + +HRDL A N +LD     K++DFG+AR +++ +  S  + +       +MA E +
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               F+ KSDV+SFGVL+ E+++
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 74  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 187 EPVDVWSCGIVLTAMLAGE 205

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQH 379
           D    +    +LG G FG VYK +      +A  ++ +   + ELE +  E+ ++A   H
Sbjct: 16  DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH 75
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL-- 437
             +V+LLG  + + +  ++ EF P  +VD  +       +LD       I  + R +L  
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIML------ELDRGLTEPQIQVVCRQMLEA 129
Query: 438 --YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
             +LH     RIIHRDLKA N+L+  +   +++DFG++        + D+   +GT  +M
Sbjct: 130 LNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWM 184
Query: 496 APEYV-----TRGHFSIKSDVFSFGVLVLEI 521
           APE V         +  K+D++S G+ ++E+
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 74  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 126
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 187 EPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 74  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 126
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 187 EPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 74  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 126
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 187 EPVDVWSCGIVLTAMLAGE 205

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 74  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 126
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 187 EPVDVWSCGIVLTAMLAGE 205

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 125
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 125
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 76  DNPHVCRLLGICLTSTVQL-IMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 129 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 82  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 135 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 111/203 (54%), Gaps = 19/203 (9%)
Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLL 386
           +G+G FG VY G L  + G++I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 387 GFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
           G     E   L++  ++ +  +  FI     R +    T   +IG    +A+G+ YL   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 147
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMD-QSQGDTSRIVGTFGYMAPEYV 500
           +  + +HRDL A N +LD     K++DFG+AR +++ +  S  + +       +MA E +
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 207
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               F+ KSDV+SFGVL+ E+++
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELMT 230

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 13  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 72  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 124
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 185 EPVDVWSCGIVLTAMLAGE 203

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 128 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 125
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 81  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 133
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 134 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 191 WMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 69  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 121
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 122 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 74  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 187 EPVDVWSCGIVLTAMLAGE 205

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 78  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 131 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 130 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 128 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 78  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 131 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLS-KNSVQG-ELEFKNEVLLVARLQ 378
           AT+ +    ++G G +G VYK R  H G  +A+K +   N  +G  +    EV L+ RL+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 379 ---HRNLVRLLGF-----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
              H N+VRL+       +  E +  L++E V +  +  ++ D      L  ET   ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
              RG+ +LH +    I+HRDLK  NIL+ +    K++DFG+AR++     Q     +V 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALDPVVV 173
Query: 491 TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
           T  Y APE + +  ++   D++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 128 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 125
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 85  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 137
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 138 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 194
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 195 WMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 78  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 131 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 107/205 (52%), Gaps = 13/205 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHR 380
            NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFI-FDAIKRVQLDWETRYKIIGGIARGILYL 439
           N+V+LL     E +  L++EF+ +  + KF+   A+  + L     Y  +  + +G+ + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 119
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
           H     R++HRDLK  N+L++ +   K++DFG+AR F +   +  T  +V T  Y APE 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 174
Query: 500 VT-RGHFSIKSDVFSFGVLVLEIIS 523
           +    ++S   D++S G +  E+++
Sbjct: 175 LLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHR 380
            NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                R++HRDLK  N+L++ +   K++DFG+AR F +   +  T  +V T  Y APE +
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 182
Query: 501 T-RGHFSIKSDVFSFGVLVLEIIS 523
               ++S   D++S G +  E+++
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHR 380
            NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                R++HRDLK  N+L++ +   K++DFG+AR F +   +  T  +V T  Y APE +
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 182
Query: 501 TR-GHFSIKSDVFSFGVLVLEIIS 523
               ++S   D++S G +  E+++
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 13/216 (6%)
Query: 311 SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN 369
            L  D    R   +NF    K+G+G  G V    + S G+ +AVK++     Q      N
Sbjct: 10  QLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN 66
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
           EV+++   QH N+V +        E  ++ EF+   +    + D +   +++ E    + 
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA----LTDIVTHTRMNEEQIAAVC 122
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
             + + +  LH      +IHRD+K+ +ILL  D   K+SDFG     ++ +       +V
Sbjct: 123 LAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLV 177
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           GT  +MAPE ++R  +  + D++S G++V+E++ G+
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +   +  T  +V T  Y APE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPE 174
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 74  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 126
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 186
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 187 EPVDVWSCGIVLTAMLAGE 205

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHR 380
            NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                R++HRDLK  N+L++ +   K++DFG+AR F +   +  T  +V T  Y APE +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 501 TR-GHFSIKSDVFSFGVLVLEIIS 523
               ++S   D++S G +  E+++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 13/216 (6%)
Query: 311 SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN 369
            L  D    R   +NF    K+G+G  G V    + S G+ +AVK++     Q      N
Sbjct: 14  QLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN 70
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
           EV+++   QH N+V +        E  ++ EF+   +    + D +   +++ E    + 
Sbjct: 71  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA----LTDIVTHTRMNEEQIAAVC 126
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
             + + +  LH      +IHRD+K+ +ILL  D   K+SDFG     ++ +       +V
Sbjct: 127 LAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLV 181
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           GT  +MAPE ++R  +  + D++S G++V+E++ G+
Sbjct: 182 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 217

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHR 380
            NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                R++HRDLK  N+L++ +   K++DFG+AR F +   +  T  +V T  Y APE +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 501 TR-GHFSIKSDVFSFGVLVLEIIS 523
               ++S   D++S G +  E+++
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHR 380
            NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                R++HRDLK  N+L++ +   K++DFG+AR F +   +  T  +V T  Y APE +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 501 TR-GHFSIKSDVFSFGVLVLEIIS 523
               ++S   D++S G +  E+++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G +G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHR 380
            NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                R++HRDLK  N+L++ +   K++DFG+AR F +   +  T  +V T  Y APE +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 501 TR-GHFSIKSDVFSFGVLVLEIIS 523
               ++S   D++S G +  E+++
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 331 KLGQGGFGAVYKGR---LSHGQ---EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLV 383
           +LGQG FG VY+G    +  G+    +AVK ++++ S++  +EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIF-------DAIKRVQLDWETRYKIIGGIARGI 436
           RLLG   +    L++ E + +  +  ++        +   R     +   ++   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YL+     + +HRDL A N ++  D   KI DFGM R            + +    +MA
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMA 200
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           PE +  G F+  SD++SFGV++ EI S
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 13/216 (6%)
Query: 311 SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN 369
            L  D    R   +NF    K+G+G  G V    + S G+ +AVK++     Q      N
Sbjct: 21  QLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN 77
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
           EV+++   QH N+V +        E  ++ EF+   +    + D +   +++ E    + 
Sbjct: 78  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA----LTDIVTHTRMNEEQIAAVC 133
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
             + + +  LH      +IHRD+K+ +ILL  D   K+SDFG     ++ +       +V
Sbjct: 134 LAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLV 188
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           GT  +MAPE ++R  +  + D++S G++V+E++ G+
Sbjct: 189 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 224

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 13/216 (6%)
Query: 311 SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN 369
            L  D    R   +NF    K+G+G  G V    + S G+ +AVK++     Q      N
Sbjct: 19  QLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN 75
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
           EV+++   QH N+V +        E  ++ EF+   +    + D +   +++ E    + 
Sbjct: 76  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA----LTDIVTHTRMNEEQIAAVC 131
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
             + + +  LH      +IHRD+K+ +ILL  D   K+SDFG     ++ +       +V
Sbjct: 132 LAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLV 186
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           GT  +MAPE ++R  +  + D++S G++V+E++ G+
Sbjct: 187 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 222

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 12/223 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
                +  +G+G FG V K +    +++A+K++   S +    F  E+  ++R+ H N+V
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKA--FIVELRQLSRVNHPNIV 65
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +L G         L+ E+    S+   +  A                  ++G+ YLH   
Sbjct: 66  KLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 123
Query: 444 RLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
              +IHRDLK  N+LL A   + KI DFG A   +   +        G+  +MAPE    
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK-----GSAAWMAPEVFEG 178
Query: 503 GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSN 545
            ++S K DVFS+G+++ E+I+ +K     IG  A  ++  V N
Sbjct: 179 SNYSEKCDVFSWGIILWEVITRRKPFD-EIGGPAFRIMWAVHN 220

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 12/223 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
                +  +G+G FG V K +    +++A+K++   S +    F  E+  ++R+ H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKA--FIVELRQLSRVNHPNIV 64
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +L G         L+ E+    S+   +  A                  ++G+ YLH   
Sbjct: 65  KLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 444 RLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
              +IHRDLK  N+LL A   + KI DFG A   +   +        G+  +MAPE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK-----GSAAWMAPEVFEG 177
Query: 503 GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSN 545
            ++S K DVFS+G+++ E+I+ +K     IG  A  ++  V N
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFD-EIGGPAFRIMWAVHN 219

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 72  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 124
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
            G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 125 EGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 181
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 182 WMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHR 380
            NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ + H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                R++HRDLK  N+L++ +   K++DFG+AR F +   +  T  +V T  Y APE +
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 179
Query: 501 TR-GHFSIKSDVFSFGVLVLEIIS 523
               ++S   D++S G +  E+++
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 79  DNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG A+L   ++ +           
Sbjct: 132 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 188
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG A+L   ++ +           
Sbjct: 130 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLS-KNSVQG-ELEFKNEVLLVARLQ 378
           AT+ +    ++G G +G VYK R  H G  +A+K +   N  +G  +    EV L+ RL+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 379 ---HRNLVRLLGF-----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
              H N+VRL+       +  E +  L++E V +  +  ++ D      L  ET   ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
              RG+ +LH +    I+HRDLK  NIL+ +    K++DFG+AR++     Q     +V 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALFPVVV 173
Query: 491 TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
           T  Y APE + +  ++   D++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG A+L   ++ +           
Sbjct: 130 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHR 380
            NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                R++HRDLK  N+L++ +   K++DFG+AR F +   +  T  +V T  Y APE +
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 501 TR-GHFSIKSDVFSFGVLVLEIIS 523
               ++S   D++S G +  E+++
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRL---SKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +KLG GG   VY    +    ++A+K +    +   +    F+ EV   ++L H+N+V +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
           +    E+    L+ E++   ++ ++I        L  +T       I  GI + H+   +
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHD---M 130
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
           RI+HRD+K  NIL+D++   KI DFG+A+    + S   T+ ++GT  Y +PE       
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 506 SIKSDVFSFGVLVLEIISGQ 525
              +D++S G+++ E++ G+
Sbjct: 190 DECTDIYSIGIVLYEMLVGE 209

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG A+L   ++ +           
Sbjct: 128 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 184
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG A+L   ++ +           
Sbjct: 130 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+     D     A+  + L     Y  +  + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAF 118
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPE 173
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 13/216 (6%)
Query: 311 SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN 369
            L  D    R   +NF    K+G+G  G V    + S G+ +AVK++     Q      N
Sbjct: 64  QLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN 120
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
           EV+++   QH N+V +        E  ++ EF+   +    + D +   +++ E    + 
Sbjct: 121 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA----LTDIVTHTRMNEEQIAAVC 176
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
             + + +  LH      +IHRD+K+ +ILL  D   K+SDFG     ++ +       +V
Sbjct: 177 LAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLV 231
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           GT  +MAPE ++R  +  + D++S G++V+E++ G+
Sbjct: 232 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 267

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 312 LQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNE 370
           L  D    R   +NF    K+G+G  G V    + S G+ +AVK++     Q      NE
Sbjct: 142 LVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNE 198
Query: 371 VLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
           V+++   QH N+V +        E  ++ EF+   +    + D +   +++ E    +  
Sbjct: 199 VVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA----LTDIVTHTRMNEEQIAAVCL 254
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
            + + +  LH      +IHRD+K+ +ILL  D   K+SDFG     ++ +       +VG
Sbjct: 255 AVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVG 309
Query: 491 TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           T  +MAPE ++R  +  + D++S G++V+E++ G+
Sbjct: 310 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 344

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 82  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG A+L   ++ +           
Sbjct: 135 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 191
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPE 173
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHR 380
            NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEIL 174
Query: 501 TR-GHFSIKSDVFSFGVLVLEIIS 523
               ++S   D++S G +  E+++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPE 175
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPE 176
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 23/230 (10%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           + T  +LG G F  V K R     L +  +   KR +K+S +G    + + EV ++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L      +T+ +LI E V    +  F+ +   +  L  E   + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYY 129
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPK----ISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH    L+I H DLK  NI+L    +PK    I DFG+A   +      +   I GT  +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPAF 183
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS 544
           +APE V      +++D++S GV+   ++SG    S  +G+  ++ L  VS
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGDTKQETLANVS 230

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPE 176
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPE 175
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPE 173
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPE 173
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE
Sbjct: 121 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPE 175
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+     D     A+  + L     Y  +  + +G+ +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAF 121
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPE 176
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ +
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPE 177
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPE 173
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKG--RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           LG+G  G V     R++  + +AVK +  K +V      K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAAGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRI 447
             E   + L  E+         +FD I+  + +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + R  F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 508 KS-DVFSFGVLVLEIISGQ 525
           +  DV+S G+++  +++G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPE 174
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPE 174
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+     D     A+  + L     Y  +  + +G+ +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAF 120
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPE 175
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHR 380
            NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE +
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEIL 176
Query: 501 TR-GHFSIKSDVFSFGVLVLEIIS 523
               ++S   D++S G +  E+++
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHR 380
            NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPEIL 174
Query: 501 TR-GHFSIKSDVFSFGVLVLEIIS 523
               ++S   D++S G +  E+++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     L  G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 82  DNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 135 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 10/198 (5%)
Query: 332 LGQGGFGAVYK-GRLSHGQEIAVKRLSKNSV-QGELE-FKNEVLLVARLQHRNLVRLLGF 388
           +G G +G   K  R S G+ +  K L   S+ + E +   +EV L+  L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 389 SFEETERLL--IYEFVPNSSVDKFIFDAIKRVQ-LDWETRYKIIGGIARGILYLHE--DS 443
             + T   L  + E+     +   I    K  Q LD E   +++  +   +   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
              ++HRDLK +N+ LD     K+ DFG+AR+   D S   T   VGT  YM+PE + R 
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRM 191
Query: 504 HFSIKSDVFSFGVLVLEI 521
            ++ KSD++S G L+ E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 332 LGQGGFGAVYKGRLSHGQ----EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLL 386
           LG+G FG VY+G  ++ +     +AVK   K+ ++  + +F +E +++  L H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
           G   EE    +I E  P   +  ++      +++     Y +   I + + YL     + 
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 133
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFE-MDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
            +HRD+   NIL+ +    K+ DFG++R  E  D  +   +R+     +M+PE +    F
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 191
Query: 506 SIKSDVFSFGVLVLEIISGQKNNSF 530
           +  SDV+ F V + EI+S  K   F
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 332 LGQGGFGAVYKGRLSHGQ----EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLL 386
           LG+G FG VY+G  ++ +     +AVK   K+ ++  + +F +E +++  L H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
           G   EE    +I E  P   +  ++      +++     Y +   I + + YL     + 
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 129
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFE-MDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
            +HRD+   NIL+ +    K+ DFG++R  E  D  +   +R+     +M+PE +    F
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 187
Query: 506 SIKSDVFSFGVLVLEIISGQKNNSF 530
           +  SDV+ F V + EI+S  K   F
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 38/225 (16%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHG---QEIAVKRLSKNSVQGE-LEFKNEVLLVARL-Q 378
           N+    + +G+G FG V K R+       + A+KR+ + + + +  +F  E+ ++ +L  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV---------------QLDWE 423
           H N++ LLG         L  E+ P+ ++  F+  +  RV                L  +
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS--RVLETDPAFAIANSTASTLSSQ 132
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
                   +ARG+ YL   S+ + IHRDL A NIL+  + + KI+DFG++R        G
Sbjct: 133 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------G 181
Query: 484 DTSRIVGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               +  T G     +MA E +    ++  SDV+S+GVL+ EI+S
Sbjct: 182 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 108/215 (50%), Gaps = 14/215 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSH--GQEI--AVKRLSKN-SVQGELEFKNEVLLVAR 376
           A  +   +  LG+G FG VY+G  ++  G++I  AVK   K+ ++  + +F +E +++  
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L H ++V+L+G   EE    +I E  P   +  ++      +++     Y +   I + +
Sbjct: 82  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAM 138
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE-MDQSQGDTSRIVGTFGYM 495
            YL     +  +HRD+   NIL+ +    K+ DFG++R  E  D  +   +R+     +M
Sbjct: 139 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWM 193
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF 530
           +PE +    F+  SDV+ F V + EI+S  K   F
Sbjct: 194 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     L  G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 82  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 135 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPE 176
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE-----FKNEVLLVARLQ 378
            NF    K+G+G +G VYK R     E+    L K  +  E E        E+ L+  L 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVA--LXKIRLDTETEGVPSTAIREISLLKELN 60
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +   +  T  +V T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPE 173
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE-----FKNEVLLVARLQ 378
            NF    K+G+G +G VYK R     E+    L K  +  E E        E+ L+  L 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVA--LXKIRLDTETEGVPSTAIREISLLKELN 59
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ +
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +   +  T  +V T  Y APE
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPE 172
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+ +  + KF+ DA     +        +  + +G+ +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAPE 174
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     L  G FG VYKG  +  G+++    A+K L +  S +   E  +E  ++A +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 128 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 38/225 (16%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHG---QEIAVKRLSKNSVQGE-LEFKNEVLLVARL-Q 378
           N+    + +G+G FG V K R+       + A+KR+ + + + +  +F  E+ ++ +L  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV---------------QLDWE 423
           H N++ LLG         L  E+ P+ ++  F+  +  RV                L  +
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS--RVLETDPAFAIANSTASTLSSQ 142
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
                   +ARG+ YL   S+ + IHRDL A NIL+  + + KI+DFG++R        G
Sbjct: 143 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------G 191
Query: 484 DTSRIVGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               +  T G     +MA E +    ++  SDV+S+GVL+ EI+S
Sbjct: 192 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    + T + +G G +G+V     +  G +IAVK+LS+   S+        E+ L+
Sbjct: 45  TIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLL 104
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P +S+++F             + + +K  +L 
Sbjct: 105 KHMKHENVIGLLDV------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLT 152
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 153 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 204
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H+++  D++S G ++ E+++G+
Sbjct: 205 DDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 22/214 (10%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQG-----ELEFKNEVLLVA 375
           AT+ +    ++G G +G VYK R  H G  +A+K +   +  G      +    EV L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 376 RLQ---HRNLVRLLGF-----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYK 427
           RL+   H N+VRL+       +  E +  L++E V +  +  ++ D      L  ET   
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
           ++    RG+ +LH +    I+HRDLK  NIL+ +    K++DFG+AR++     Q   + 
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALTP 178
Query: 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
           +V T  Y APE + +  ++   D++S G +  E+
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 14/214 (6%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGE---LEFKNE 370
           D  T     ++F     LG+G FG VY  R      I A+K L K+ ++ E    + + E
Sbjct: 14  DILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRRE 73
Query: 371 VLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
           + + A L H N++RL  + ++     LI E+ P   + K   +  K    D +    I+ 
Sbjct: 74  IEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYK---ELQKSCTFDEQRTATIME 130
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
            +A  ++Y H     ++IHRD+K  N+LL      KI+DFG    + +         + G
Sbjct: 131 ELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCG 183
Query: 491 TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           T  Y+ PE +     + K D++  GVL  E++ G
Sbjct: 184 TLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 23/230 (10%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           + T  +LG G F  V K R     L +  +   KR +K+S +G    + + EV ++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L      +T+ +LI E V    +  F+ +   +  L  E   + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYY 129
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPK----ISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH    L+I H DLK  NI+L    +PK    I DFG+A   +      +   I GT  +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEF 183
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS 544
           +APE V      +++D++S GV+   ++SG    S  +G+  ++ L  VS
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGDTKQETLANVS 230

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 122/252 (48%), Gaps = 47/252 (18%)
Query: 311 SLQFD-FSTIRDATNNFSTDN-----KLGQGGFGAVYKGRLSHGQ------EIAVKRLSK 358
           SL  D F  + D    F   N      LG+G FG V K    H +       +AVK L +
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 359 NSVQGEL-EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIK- 416
           N+   EL +  +E  ++ ++ H ++++L G   ++   LLI E+    S+  F+ ++ K 
Sbjct: 64  NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 417 ------------RVQLDWETRYKIIGG--------IARGILYLHEDSRLRIIHRDLKASN 456
                          LD      +  G        I++G+ YL E   ++++HRDL A N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARN 180
Query: 457 ILLDADMIPKISDFGMAR-LFEMD----QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDV 511
           IL+      KISDFG++R ++E D    +SQG   RI     +MA E +    ++ +SDV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSXVKRSQG---RI--PVKWMAIESLFDHIYTTQSDV 235
Query: 512 FSFGVLVLEIIS 523
           +SFGVL+ EI++
Sbjct: 236 WSFGVLLWEIVT 247

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 31/225 (13%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFK---NEVLLVARLQHRNLVRL 385
           LG G FG V+KG  +  G+ I +    K      G   F+   + +L +  L H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKR--------VQLDWETRYKIIGGIARGIL 437
           LG     + +L + +++P  S    + D +++        + L+W  +      IA+G+ 
Sbjct: 81  LGLCPGSSLQL-VTQYLPLGS----LLDHVRQHRGALGPQLLLNWGVQ------IAKGMY 129
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YL E     ++HR+L A N+LL +    +++DFG+A L   D  Q   S       +MA 
Sbjct: 130 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS--GQKNNSFRIGEEAEDLL 540
           E +  G ++ +SDV+S+GV V E+++   +     R+  E  DLL
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-EVPDLL 230

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 31/225 (13%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFK---NEVLLVARLQHRNLVRL 385
           LG G FG V+KG  +  G+ I +    K      G   F+   + +L +  L H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKR--------VQLDWETRYKIIGGIARGIL 437
           LG     + +L + +++P  S    + D +++        + L+W  +      IA+G+ 
Sbjct: 99  LGLCPGSSLQL-VTQYLPLGS----LLDHVRQHRGALGPQLLLNWGVQ------IAKGMY 147
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YL E     ++HR+L A N+LL +    +++DFG+A L   D  Q   S       +MA 
Sbjct: 148 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS--GQKNNSFRIGEEAEDLL 540
           E +  G ++ +SDV+S+GV V E+++   +     R+  E  DLL
Sbjct: 205 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-EVPDLL 248

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 122/252 (48%), Gaps = 47/252 (18%)
Query: 311 SLQFD-FSTIRDATNNFSTDN-----KLGQGGFGAVYKGRLSHGQ------EIAVKRLSK 358
           SL  D F  + D    F   N      LG+G FG V K    H +       +AVK L +
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 359 NSVQGEL-EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIK- 416
           N+   EL +  +E  ++ ++ H ++++L G   ++   LLI E+    S+  F+ ++ K 
Sbjct: 64  NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 417 ------------RVQLDWETRYKIIGG--------IARGILYLHEDSRLRIIHRDLKASN 456
                          LD      +  G        I++G+ YL E   ++++HRDL A N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARN 180
Query: 457 ILLDADMIPKISDFGMAR-LFEMD----QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDV 511
           IL+      KISDFG++R ++E D    +SQG   RI     +MA E +    ++ +SDV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQG---RI--PVKWMAIESLFDHIYTTQSDV 235
Query: 512 FSFGVLVLEIIS 523
           +SFGVL+ EI++
Sbjct: 236 WSFGVLLWEIVT 247

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 112/212 (52%), Gaps = 16/212 (7%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFK-NEVLLVARLQH 379
           +++ F    KLG G +  VYKG   + G  +A+K +  +S +G       E+ L+  L+H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKF-----IFDAIKRVQLDWETRYKIIGGIAR 434
            N+VRL      E +  L++EF+ N  + K+     + +  + ++L+    ++    + +
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQW--QLLQ 119
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           G+ + HE+   +I+HRDLK  N+L++     K+ DFG+AR F +  +   +   V T  Y
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE--VVTLWY 174
Query: 495 MAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQ 525
            AP+ +     +S   D++S G ++ E+I+G+
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARL 377
             F     LG G FG VYKG  +  G+++    A+  L +  S +   E  +E  ++A +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIA 433
            + ++ RLLG     T +L I + +P   +  ++ +    +     L+W  +      IA
Sbjct: 109 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 161
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ YL ED RL  +HRDL A N+L+      KI+DFG+A+L   ++ +           
Sbjct: 162 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MA E +    ++ +SDV+S+GV V E+++
Sbjct: 219 WMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 23/230 (10%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           + T  +LG G F  V K R     L +  +   KR +K+S +G    + + EV ++  +Q
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L      +T+ +LI E V    +  F+    ++  L  E   + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPK----ISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH    L+I H DLK  NI+L    +PK    I DFG+A   +      +   I GT  +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEF 183
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS 544
           +APE V      +++D++S GV+   ++SG    S  +G+  ++ L  VS
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGDTKQETLANVS 230

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-FDAIKRVQLDWETRYKIIGGIARGIL 437
           H N+V+LL     E +  L++E V +  + KF+   A+  + L     Y  +  + +G+ 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 120
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           + H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y AP
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAP 175
Query: 498 EYVTR-GHFSIKSDVFSFGVLVLEIIS 523
           E +    ++S   D++S G +  E+++
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 23/230 (10%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           + T  +LG G F  V K R     L +  +   KR +K+S +G    + + EV ++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L      +T+ +LI E V    +  F+    ++  L  E   + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPK----ISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH    L+I H DLK  NI+L    +PK    I DFG+A   +      +   I GT  +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEF 183
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS 544
           +APE V      +++D++S GV+   ++SG    S  +G+  ++ L  VS
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGDTKQETLANVS 230

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGR--LSHGQEIAVKRLSKNSVQGELEFKN--EVLLVARL 377
           A   +    ++G+G +G V+K R   + G+ +A+KR+   + +  +      EV ++  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 378 Q---HRNLVRLLGF-----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
           +   H N+VRL        +  ET+  L++E V +  +  ++ D +    +  ET   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
             + RG+ +LH     R++HRDLK  NIL+ +    K++DFG+AR++     Q   + +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVV 180
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
            T  Y APE + +  ++   D++S G +  E+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 23/230 (10%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           + T  +LG G F  V K R     L +  +   KR +K+S +G    + + EV ++  +Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L      +T+ +LI E V    +  F+    ++  L  E   + +  I  G+ Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 128
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPK----ISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH    L+I H DLK  NI+L    +PK    I DFG+A   +      +   I GT  +
Sbjct: 129 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEF 182
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS 544
           +APE V      +++D++S GV+   ++SG    S  +G+  ++ L  VS
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGDTKQETLANVS 229

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 109/213 (51%), Gaps = 25/213 (11%)
Query: 323 TNNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSV-----QGELEFKNEVLLVA 375
           ++ +    KLG G +G V   K +L+ G E A+K + K+SV      G L   +EV ++ 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGAL--LDEVAVLK 76
Query: 376 RLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII-GGIAR 434
           +L H N+++L  F  ++    L+ E          +FD I   Q   E    +I   +  
Sbjct: 77  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGE----LFDEIILRQKFSEVDAAVIMKQVLS 132
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
           G  YLH+ +   I+HRDLK  N+LL++   D + KI DFG++  FE+    G     +GT
Sbjct: 133 GTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GKMKERLGT 186
Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
             Y+APE V R  +  K DV+S GV++  ++ G
Sbjct: 187 AYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 23/230 (10%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           + T  +LG G F  V K R     L +  +   KR +K+S +G    + + EV ++  +Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L      +T+ +LI E V    +  F+    ++  L  E   + +  I  G+ Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 128
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPK----ISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH    L+I H DLK  NI+L    +PK    I DFG+A   +      +   I GT  +
Sbjct: 129 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEF 182
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS 544
           +APE V      +++D++S GV+   ++SG    S  +G+  ++ L  VS
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGDTKQETLANVS 229

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 23/230 (10%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           + T  +LG G F  V K R     L +  +   KR +K+S +G    + + EV ++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L      +T+ +LI E V    +  F+    ++  L  E   + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPK----ISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH    L+I H DLK  NI+L    +PK    I DFG+A   +      +   I GT  +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEF 183
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS 544
           +APE V      +++D++S GV+   ++SG    S  +G+  ++ L  VS
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGDTKQETLANVS 230

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 23/230 (10%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           + T  +LG G F  V K R     L +  +   KR +K+S +G    + + EV ++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L      +T+ +LI E V    +  F+ +   +  L  E   + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYY 129
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPK----ISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH    L+I H DLK  NI+L    +PK    I DFG+A   +      +   I GT  +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEF 183
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS 544
           +APE V      +++D++S GV+   ++SG    S  +G+  ++ L  VS
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGDTKQETLANVS 230

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 23/230 (10%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           + T  +LG G F  V K R     L +  +   KR +K+S +G    + + EV ++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L      +T+ +LI E V    +  F+ +   +  L  E   + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYY 129
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPK----ISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH    L+I H DLK  NI+L    +PK    I DFG+A   +      +   I GT  +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEF 183
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS 544
           +APE V      +++D++S GV+   ++SG    S  +G+  ++ L  VS
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGDTKQETLANVS 230

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHR 380
           N+     +G+G F  V   R +  G+E+AVK + K   NS   +  F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 381 NLVRLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           N+V+L  F   ETE+   L+ E+     V  ++    +  + +   +++    I   + Y
Sbjct: 74  NIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQY 128
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H+     I+HRDLKA N+LLDADM  KI+DFG +  F    ++ DT    G+  Y APE
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT--FCGSPPYAAPE 182
Query: 499 -YVTRGHFSIKSDVFSFGVLVLEIISG 524
            +  + +   + DV+S GV++  ++SG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 107/209 (51%), Gaps = 18/209 (8%)
Query: 324 NNFSTDNKLGQGGFGAVY----KGRLSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARL 377
           ++F     LGQG FG V+      R   G   A+K L K +  V+  +  K E  ++A +
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADV 87
Query: 378 QHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARG 435
            H  +V+L  ++F+   +L LI +F+        +F  + K V    E     +  +A G
Sbjct: 88  NHPFVVKL-HYAFQTEGKLYLILDFLRGGD----LFTRLSKEVMFTEEDVKFYLAELALG 142
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
           + +LH    L II+RDLK  NILLD +   K++DFG+++  E    +       GT  YM
Sbjct: 143 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGTVEYM 197
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           APE V R   S  +D +S+GVL+ E+++G
Sbjct: 198 APEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 22/216 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRN 381
           +++     +G G    V     +  +E +A+KR++    Q  + E   E+  +++  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ-----LDWETRYKIIGGIARGI 436
           +V        + E  L+ + +   SV   I   + + +     LD  T   I+  +  G+
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR------IVG 490
            YLH++ +   IHRD+KA NILL  D   +I+DFG++       + GD +R       VG
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL---ATGGDITRNKVRKTFVG 183
Query: 491 TFGYMAPEYV--TRGHFSIKSDVFSFGVLVLEIISG 524
           T  +MAPE +   RG +  K+D++SFG+  +E+ +G
Sbjct: 184 TPCWMAPEVMEQVRG-YDFKADIWSFGITAIELATG 218

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 23/230 (10%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           + T  +LG G F  V K R     L +  +   KR +K+S +G    + + EV ++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L      +T+ +LI E V    +  F+    ++  L  E   + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPK----ISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH    L+I H DLK  NI+L    +PK    I DFG+A   +      +   I GT  +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEF 183
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS 544
           +APE V      +++D++S GV+   ++SG    S  +G+  ++ L  VS
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGDTKQETLANVS 230

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 109/232 (46%), Gaps = 21/232 (9%)
Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQG 363
           E L +D S      +  +    LG+G FG V +       + +  + +AVK L + +   
Sbjct: 13  ERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 72
Query: 364 ELE-FKNEVLLVARL-QHRNLVRLLGFSFEETERLL-IYEFVPNSSVDKFI------FDA 414
           E     +E+ ++  +  H N+V LLG   +    L+ I EF    ++  ++      F  
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 415 IKRVQLDWETRYKIIG---GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471
            K +  D+ T   +I     +A+G+ +L   +  + IHRDL A NILL    + KI DFG
Sbjct: 133 YKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFG 189
Query: 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +AR    D              +MAPE +    ++I+SDV+SFGVL+ EI S
Sbjct: 190 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 109/213 (51%), Gaps = 25/213 (11%)
Query: 323 TNNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSV-----QGELEFKNEVLLVA 375
           ++ +    KLG G +G V   K +L+ G E A+K + K+SV      G L   +EV ++ 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGAL--LDEVAVLK 59
Query: 376 RLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII-GGIAR 434
           +L H N+++L  F  ++    L+ E          +FD I   Q   E    +I   +  
Sbjct: 60  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGE----LFDEIILRQKFSEVDAAVIMKQVLS 115
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
           G  YLH+ +   I+HRDLK  N+LL++   D + KI DFG++  FE+    G     +GT
Sbjct: 116 GTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GKMKERLGT 169
Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
             Y+APE V R  +  K DV+S GV++  ++ G
Sbjct: 170 AYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHR 380
           N+     +G+G F  V   R +  G+E+AVK + K   NS   +  F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 381 NLVRLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           N+V+L  F   ETE+   L+ E+     V  ++    +  + +   +++    I   + Y
Sbjct: 74  NIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQY 128
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H+     I+HRDLKA N+LLDADM  KI+DFG +  F    ++ DT    G+  Y APE
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT--FCGSPPYAAPE 182
Query: 499 -YVTRGHFSIKSDVFSFGVLVLEIISG 524
            +  + +   + DV+S GV++  ++SG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 116/230 (50%), Gaps = 22/230 (9%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGR--LSHGQEIAVKRLSKNSVQGELEFKN--EVLLVARL 377
           A   +    ++G+G +G V+K R   + G+ +A+KR+   + +  +      EV ++  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 378 Q---HRNLVRLLGF-----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
           +   H N+VRL        +  ET+  L++E V +  +  ++ D +    +  ET   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
             + RG+ +LH     R++HRDLK  NIL+ +    K++DFG+AR++     Q   + +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVV 180
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDL 539
            T  Y APE + +  ++   D++S G +  E+   ++   FR   + + L
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSDVDQL 228

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 23/230 (10%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           + T  +LG G F  V K R     L +  +   KR +K+S +G    + + EV ++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L      +T+ +LI E V    +  F+    ++  L  E   + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPK----ISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH    L+I H DLK  NI+L    +PK    I DFG+A   +      +   I GT  +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEF 183
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS 544
           +APE V      +++D++S GV+   ++SG    S  +G+  ++ L  VS
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGDTKQETLANVS 230

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 22/216 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRN 381
           +++     +G G    V     +  +E +A+KR++    Q  + E   E+  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ-----LDWETRYKIIGGIARGI 436
           +V        + E  L+ + +   SV   I   + + +     LD  T   I+  +  G+
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR------IVG 490
            YLH++ +   IHRD+KA NILL  D   +I+DFG++       + GD +R       VG
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL---ATGGDITRNKVRKTFVG 188
Query: 491 TFGYMAPEYV--TRGHFSIKSDVFSFGVLVLEIISG 524
           T  +MAPE +   RG +  K+D++SFG+  +E+ +G
Sbjct: 189 TPCWMAPEVMEQVRG-YDFKADIWSFGITAIELATG 223

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 23/230 (10%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           + T  +LG G F  V K R     L +  +   KR +K+S +G    + + EV ++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L      +T+ +LI E V    +  F+    ++  L  E   + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPK----ISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH    L+I H DLK  NI+L    +PK    I DFG+A   +      +   I GT  +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEF 183
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS 544
           +APE V      +++D++S GV+   ++SG    S  +G+  ++ L  VS
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGDTKQETLANVS 230

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 116/230 (50%), Gaps = 22/230 (9%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGR--LSHGQEIAVKRLSKNSVQGELEFKN--EVLLVARL 377
           A   +    ++G+G +G V+K R   + G+ +A+KR+   + +  +      EV ++  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 378 Q---HRNLVRLLGF-----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
           +   H N+VRL        +  ET+  L++E V +  +  ++ D +    +  ET   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
             + RG+ +LH     R++HRDLK  NIL+ +    K++DFG+AR++     Q   + +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVV 180
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDL 539
            T  Y APE + +  ++   D++S G +  E+   ++   FR   + + L
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSDVDQL 228

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 23/230 (10%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           + T  +LG G F  V K R     L +  +   KR +K+S +G    + + EV ++  +Q
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L      +T+ +LI E V    +  F+    ++  L  E   + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPK----ISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH    L+I H DLK  NI+L    +PK    I DFG+A   +      +   I GT  +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEF 183
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS 544
           +APE V      +++D++S GV+   ++SG    S  +G+  ++ L  VS
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGDTKQETLANVS 230

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 109/232 (46%), Gaps = 21/232 (9%)
Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQG 363
           E L +D S      +  +    LG+G FG V +       + +  + +AVK L + +   
Sbjct: 13  ERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 72
Query: 364 ELE-FKNEVLLVARL-QHRNLVRLLGFSFEETERLL-IYEFVPNSSVDKFI------FDA 414
           E     +E+ ++  +  H N+V LLG   +    L+ I EF    ++  ++      F  
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 415 IKRVQLDWETRYKIIG---GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471
            K +  D+ T   +I     +A+G+ +L   +  + IHRDL A NILL    + KI DFG
Sbjct: 133 YKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFG 189
Query: 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +AR    D              +MAPE +    ++I+SDV+SFGVL+ EI S
Sbjct: 190 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 121/252 (48%), Gaps = 47/252 (18%)
Query: 311 SLQFD-FSTIRDATNNFSTDN-----KLGQGGFGAVYKGRLSHGQ------EIAVKRLSK 358
           SL  D F  + D    F   N      LG+G FG V K    H +       +AVK L +
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 359 NSVQGEL-EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIK- 416
           N+   EL +  +E  ++ ++ H ++++L G   ++   LLI E+    S+  F+ ++ K 
Sbjct: 64  NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 417 ------------RVQLDWETRYKIIGG--------IARGILYLHEDSRLRIIHRDLKASN 456
                          LD      +  G        I++G+ YL E S   ++HRDL A N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARN 180
Query: 457 ILLDADMIPKISDFGMAR-LFEMD----QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDV 511
           IL+      KISDFG++R ++E D    +SQG   RI     +MA E +    ++ +SDV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSXVKRSQG---RI--PVKWMAIESLFDHIYTTQSDV 235
Query: 512 FSFGVLVLEIIS 523
           +SFGVL+ EI++
Sbjct: 236 WSFGVLLWEIVT 247

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ 378
           +  NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V+LL     E +  L++EF+ +  +  F+ DA     +        +  + +G+ +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H     R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPE 176
Query: 499 YVTR-GHFSIKSDVFSFGVLVLEIIS 523
            +    ++S   D++S G +  E+++
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR----LL 386
           +G GGFG V+K +    G+   +KR+  N+ + E     EV  +A+L H N+V       
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE----REVKALAKLDHVNIVHYNGCWD 74
Query: 387 GFSFE-----------ETERLLI-YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
           GF ++           +T+ L I  EF    +++++I +  +  +LD     ++   I +
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQITK 133
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           G+ Y+H     ++I+RDLK SNI L      KI DFG+    + D   G   R  GT  Y
Sbjct: 134 GVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRXRSKGTLRY 187
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           M+PE ++   +  + D+++ G+++ E++
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 23/230 (10%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           + T  +LG G F  V K R     L +  +   KR +K+S +G    + + EV ++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L      +T+ +LI E V    +  F+    ++  L  E   + +  I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPK----ISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH    L+I H DLK  NI+L    +PK    I DFG+A   +      +   I GT  +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEF 183
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS 544
           +APE V      +++D++S GV+   ++SG    S  +G+  ++ L  VS
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGDTKQETLANVS 230

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 332 LGQGGFGAVYK-GRLSHGQEIAVKRLSKNSV-QGELE-FKNEVLLVARLQHRNLVRLLGF 388
           +G G +G   K  R S G+ +  K L   S+ + E +   +EV L+  L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 389 SFEETERLL--IYEFVPNSSVDKFIFDAIKRVQ-LDWETRYKIIGGIARGILYLHE--DS 443
             + T   L  + E+     +   I    K  Q LD E   +++  +   +   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
              ++HRDLK +N+ LD     K+ DFG+AR+   D S       VGT  YM+PE + R 
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRM 191
Query: 504 HFSIKSDVFSFGVLVLEI 521
            ++ KSD++S G L+ E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 11/204 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHR 380
            NF    K+G+G +G VYK R    G+ +A+K  RL   +         E+ L+  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           N+V+LL     E +  L++E V +  +  F+ DA     +        +  + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                R++HRDLK  N+L++ +   K++DFG+AR F +   +  T  +V T  Y APE +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 501 TR-GHFSIKSDVFSFGVLVLEIIS 523
               ++S   D++S G +  E+++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 324 NNFSTDNKLGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
           +  +    LG+G FG V         K +      +AVK L  ++ + +L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-------------FDAIKRVQL 420
             + +H+N++ LLG   ++    +I E+    ++ +++              + +   Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            ++        +ARG+ YL   +  + IHRDL A N+L+  + + KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               T+       +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/211 (34%), Positives = 108/211 (51%), Gaps = 27/211 (12%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHR 380
           N+     +G+G F  V   R +  G+E+AVK + K   NS   +  F+ EV ++  L H 
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 66
Query: 381 NLVRLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDW----ETRYKIIGGIAR 434
           N+V+L  F   ETE+   L+ E+     V    FD +  V   W    E R K    I  
Sbjct: 67  NIVKL--FEVIETEKTLYLVMEYASGGEV----FDYL--VAHGWMKEKEARAKF-RQIVS 117
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
            + Y H+     I+HRDLKA N+LLDADM  KI+DFG +  F    ++ DT    G+  Y
Sbjct: 118 AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT--FCGSPPY 171
Query: 495 MAPE-YVTRGHFSIKSDVFSFGVLVLEIISG 524
            APE +  + +   + DV+S GV++  ++SG
Sbjct: 172 AAPELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 19/207 (9%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHR 380
           N+     +G+G F  V   R +  G+E+AVK + K   N    +  F+ EV ++  L H 
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 74
Query: 381 NLVRLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           N+V+L  F   ETE+   L+ E+     V  ++    +  + +   +++    I   + Y
Sbjct: 75  NIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQY 129
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H+     I+HRDLKA N+LLD DM  KI+DFG +  F +  ++ DT    G+  Y APE
Sbjct: 130 CHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVG-NKLDT--FCGSPPYAAPE 183
Query: 499 -YVTRGHFSIKSDVFSFGVLVLEIISG 524
            +  + +   + DV+S GV++  ++SG
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 38/225 (16%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHG---QEIAVKRLSKNSVQGE-LEFKNEVLLVARL-Q 378
           N+    + +G+G FG V K R+       + A+KR+ + + + +  +F  E+ ++ +L  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV---------------QLDWE 423
           H N++ LLG         L  E+ P+ ++  F+  +  RV                L  +
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS--RVLETDPAFAIANSTASTLSSQ 139
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
                   +ARG+ YL   S+ + IHR+L A NIL+  + + KI+DFG++R        G
Sbjct: 140 QLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR--------G 188
Query: 484 DTSRIVGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               +  T G     +MA E +    ++  SDV+S+GVL+ EI+S
Sbjct: 189 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 324 NNFSTDNKLGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
           +  +    LG+G FG V         K +      +AVK L  ++ + +L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-------------FDAIKRVQL 420
             + +H+N++ LLG   ++    +I E+    ++ +++              + +   Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            ++        +ARG+ YL   +  + IHRDL A N+L+  + + KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               T+       +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHR 380
           N+     +G+G F  V   R +  G+E+AVK + K   NS   +  F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 381 NLVRLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           N+V+L  F   ETE+   L+ E+     V  ++    +  + +   +++    I   + Y
Sbjct: 74  NIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQY 128
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H+     I+HRDLKA N+LLDADM  KI+DFG +  F             G   Y APE
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDAFCGAPPYAAPE 182
Query: 499 -YVTRGHFSIKSDVFSFGVLVLEIISG 524
            +  + +   + DV+S GV++  ++SG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 324 NNFSTDNKLGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
           +  +    LG+G FG V         K +      +AVK L  ++ + +L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-------------FDAIKRVQL 420
             + +H+N++ LLG   ++    +I E+    ++ +++              + +   Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            ++        +ARG+ YL   +  + IHRDL A N+L+  + + KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
              +T+       +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHR 380
           N+     +G+G F  V   R +  G+E+AV+ + K   NS   +  F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 381 NLVRLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           N+V+L  F   ETE+   L+ E+     V  ++    +  + +   +++    I   + Y
Sbjct: 74  NIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQY 128
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H+     I+HRDLKA N+LLDADM  KI+DFG +  F    ++ DT    G+  Y APE
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT--FCGSPPYAAPE 182
Query: 499 -YVTRGHFSIKSDVFSFGVLVLEIISG 524
            +  + +   + DV+S GV++  ++SG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 330 NKLGQGGFGAVYKGRLSHGQ----EIAVKRLSKNSV-QGEL--EFKNEVLLVARLQHRNL 382
            KLG G FG V +G           +AVK L  + + Q E   +F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIARGILY 438
           +RL G       ++ + E  P  S    + D +++ Q    L   +RY +   +A G+ Y
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGS----LLDRLRKHQGHFLLGTLSRYAV--QVAEGMGY 126
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM--DQSQGDTSRIVGTFGYMA 496
           L      R IHRDL A N+LL    + KI DFG+ R      D       R V  F + A
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCA 182
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
           PE +    FS  SD + FGV + E+ + GQ+
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 108/234 (46%), Gaps = 23/234 (9%)
Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQG 363
           E L +D S      +       LG+G FG V +       + +  + +AVK L + +   
Sbjct: 15  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 74
Query: 364 ELE-FKNEVLLVARL-QHRNLVRLLGFSFEETERLL-IYEFVP--------NSSVDKFIF 412
           E     +E+ ++  +  H N+V LLG   +    L+ I EF           S  ++F+ 
Sbjct: 75  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 134
Query: 413 DAIKRVQLDWETRYKIIG---GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD 469
              + +  D+ T   +I     +A+G+ +L   +  + IHRDL A NILL    + KI D
Sbjct: 135 YKPEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICD 191
Query: 470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           FG+AR    D              +MAPE +    ++I+SDV+SFGVL+ EI S
Sbjct: 192 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 332 LGQGGFGAVYK-GRLSHGQEIAVKRLSKNSV-QGELE-FKNEVLLVARLQHRNLVRLLGF 388
           +G G +G   K  R S G+ +  K L   S+ + E +   +EV L+  L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 389 SFEETERLL--IYEFVPNSSVDKFIFDAIKRVQ-LDWETRYKIIGGIARGILYLHE--DS 443
             + T   L  + E+     +   I    K  Q LD E   +++  +   +   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
              ++HRDLK +N+ LD     K+ DFG+AR+   D+        VGT  YM+PE + R 
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA--KEFVGTPYYMSPEQMNRM 191
Query: 504 HFSIKSDVFSFGVLVLEI 521
            ++ KSD++S G L+ E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 330 NKLGQGGFGAVYKGRLSHGQ----EIAVKRLSKNSV-QGEL--EFKNEVLLVARLQHRNL 382
            KLG G FG V +G           +AVK L  + + Q E   +F  EV  +  L HRNL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIARGILY 438
           +RL G       ++ + E  P  S    + D +++ Q    L   +RY +   +A G+ Y
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGS----LLDRLRKHQGHFLLGTLSRYAV--QVAEGMGY 130
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM--DQSQGDTSRIVGTFGYMA 496
           L      R IHRDL A N+LL    + KI DFG+ R      D       R V  F + A
Sbjct: 131 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCA 186
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
           PE +    FS  SD + FGV + E+ + GQ+
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMFTYGQE 217

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 330 NKLGQGGFGAVYKGRLSHGQ----EIAVKRLSKNSV-QGEL--EFKNEVLLVARLQHRNL 382
            KLG G FG V +G           +AVK L  + + Q E   +F  EV  +  L HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIARGILY 438
           +RL G       ++ + E  P  S    + D +++ Q    L   +RY +   +A G+ Y
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGS----LLDRLRKHQGHFLLGTLSRYAV--QVAEGMGY 136
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM--DQSQGDTSRIVGTFGYMA 496
           L      R IHRDL A N+LL    + KI DFG+ R      D       R V  F + A
Sbjct: 137 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCA 192
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
           PE +    FS  SD + FGV + E+ + GQ+
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 321 DATNNFSTDNKLGQGGFG-AVYKGRLSHGQEIAVKRLSKNSVQG-ELEFKNEVLLVARLQ 378
           D    F     LG G F   V     + G+  AVK + K +++G E   +NE+ ++ +++
Sbjct: 19  DIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIK 78
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V L           L+ + V    +   I +     + D  T   +I  +   + Y
Sbjct: 79  HENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAST---LIRQVLDAVYY 135
Query: 439 LHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDT-SRIVGTFGY 494
           LH   R+ I+HRDLK  N+L    D +    ISDFG++++    + +GD  S   GT GY
Sbjct: 136 LH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM----EGKGDVMSTACGTPGY 188
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           +APE + +  +S   D +S GV+   ++ G
Sbjct: 189 VAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHR 380
           N+     +G+G F  V   R +  G+E+AV+ + K   NS   +  F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 381 NLVRLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           N+V+L  F   ETE+   L+ E+     V  ++    +  + +   +++    I   + Y
Sbjct: 74  NIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQY 128
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H+     I+HRDLKA N+LLDADM  KI+DFG +  F             G+  Y APE
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDEFCGSPPYAAPE 182
Query: 499 -YVTRGHFSIKSDVFSFGVLVLEIISG 524
            +  + +   + DV+S GV++  ++SG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 18/221 (8%)
Query: 329 DNKLGQGGFGAVYKG--RLSHGQEIAVKRLSKNSVQGELEFKNEVL----LVARLQHRNL 382
           D +LG G FG V KG  ++    +    ++ KN    +   K+E+L    ++ +L +  +
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYI 74
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           VR++G   E    +L+ E      ++K++    +   +  +   +++  ++ G+ YL E 
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 130
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYV 500
           +    +HRDL A N+LL      KISDFG+++    D++    ++  G +   + APE +
Sbjct: 131 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXY-KAQTHGKWPVKWYAPECI 186
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLL 540
               FS KSDV+SFGVL+ E  S GQK      G E   +L
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 227

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 18/221 (8%)
Query: 329 DNKLGQGGFGAVYKG--RLSHGQEIAVKRLSKNSVQGELEFKNEVL----LVARLQHRNL 382
           D +LG G FG V KG  ++    +    ++ KN    +   K+E+L    ++ +L +  +
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYI 70
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           VR++G   E    +L+ E      ++K++    +   +  +   +++  ++ G+ YL E 
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYV 500
           +    +HRDL A N+LL      KISDFG+++    D++    ++  G +   + APE +
Sbjct: 127 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECI 182
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLL 540
               FS KSDV+SFGVL+ E  S GQK      G E   +L
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 112/221 (50%), Gaps = 18/221 (8%)
Query: 329 DNKLGQGGFGAVYKG--RLSHGQEIAVKRLSKNSVQGELEFKNEVL----LVARLQHRNL 382
           D +LG G FG V KG  ++    +    ++ KN    +   K+E+L    ++ +L +  +
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYI 90
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           VR++G    E+  +L+ E      ++K++    +   +  +   +++  ++ G+ YL E 
Sbjct: 91  VRMIGICEAES-WMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 146
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYV 500
           +    +HRDL A N+LL      KISDFG+++    D++    ++  G +   + APE +
Sbjct: 147 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECI 202
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLL 540
               FS KSDV+SFGVL+ E  S GQK      G E   +L
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 243

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 112/221 (50%), Gaps = 18/221 (8%)
Query: 329 DNKLGQGGFGAVYKG--RLSHGQEIAVKRLSKNSVQGELEFKNEVL----LVARLQHRNL 382
           D +LG G FG V KG  ++    +    ++ KN    +   K+E+L    ++ +L +  +
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYI 90
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           VR++G    E+  +L+ E      ++K++    +   +  +   +++  ++ G+ YL E 
Sbjct: 91  VRMIGICEAES-WMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 146
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYV 500
           +    +HRDL A N+LL      KISDFG+++    D++    ++  G +   + APE +
Sbjct: 147 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECI 202
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLL 540
               FS KSDV+SFGVL+ E  S GQK      G E   +L
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 243

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 111/223 (49%), Gaps = 36/223 (16%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKR-LSKNSVQG-ELEFKNEVLLVARL 377
           D  + +    K+GQG FG V+K R    GQ++A+K+ L +N  +G  +    E+ ++  L
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 74
Query: 378 QHRNLVRLL--------GFSFEETERLLIYEFVPN-------SSVDKFIFDAIKRVQLDW 422
           +H N+V L+         ++  +    L+++F  +       + + KF    IKRV    
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV---- 130
Query: 423 ETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM---D 479
                 +  +  G+ Y+H   R +I+HRD+KA+N+L+  D + K++DFG+AR F +    
Sbjct: 131 ------MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 480 QSQGDTSRIVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEI 521
           Q     +R+V T  Y  PE +     +    D++  G ++ E+
Sbjct: 182 QPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 110/235 (46%), Gaps = 24/235 (10%)
Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQG 363
           E L +D S      +  +    LG+G FG V +       + +  + +AVK L + +   
Sbjct: 14  ERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 73
Query: 364 ELE-FKNEVLLVARL-QHRNLVRLLGFSFEETERLL-IYEFVP--------NSSVDKFI- 411
           E     +E+ ++  +  H N+V LLG   +    L+ I EF           S  ++F+ 
Sbjct: 74  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 133
Query: 412 FDAIKRVQLDWETRYKIIG---GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS 468
           +   + +  D+ T   +I     +A+G+ +L   +  + IHRDL A NILL    + KI 
Sbjct: 134 YKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 190
Query: 469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           DFG+AR    D              +MAPE +    ++I+SDV+SFGVL+ EI S
Sbjct: 191 DFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 105/202 (51%), Gaps = 18/202 (8%)
Query: 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQG---ELEFKNEVLLVARLQHRNLVRL 385
           + LG G FG V  G+    G ++AVK L++  ++      + + E+  +   +H ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSR 444
                  ++  ++ E+V        +FD I K  +LD +   ++   I  G+ Y H   R
Sbjct: 82  YQVISTPSDIFMVMEYVSGGE----LFDYICKNGRLDEKESRRLFQQILSGVDYCH---R 134
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-VGTFGYMAPEYVT-R 502
             ++HRDLK  N+LLDA M  KI+DFG++ +     S G+  R   G+  Y APE ++ R
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM----SDGEFLRXSCGSPNYAAPEVISGR 190
Query: 503 GHFSIKSDVFSFGVLVLEIISG 524
            +   + D++S GV++  ++ G
Sbjct: 191 LYAGPEVDIWSSGVILYALLCG 212

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL-----VR 384
           +LG+G +G V K R +  GQ +AVKR+       E   +  +L+   +  R +     V 
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE---QKRLLMDLDISMRTVDCPFTVT 70
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ-LDWETRYKIIGGIARGILYLHEDS 443
             G  F E +  +  E + ++S+DKF    I + Q +  +   KI   I + + +LH  S
Sbjct: 71  FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--S 127
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV--- 500
           +L +IHRD+K SN+L++A    K+ DFG++  + +D    D     G   YMAPE +   
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDID--AGCKPYMAPERINPE 184
Query: 501 -TRGHFSIKSDVFSFGVLVLEI 521
             +  +S+KSD++S G+ ++E+
Sbjct: 185 LNQKGYSVKSDIWSLGITMIEL 206

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 18/221 (8%)
Query: 329 DNKLGQGGFGAVYKG--RLSHGQEIAVKRLSKNSVQGELEFKNEVL----LVARLQHRNL 382
           D +LG G FG V KG  ++    +    ++ KN    +   K+E+L    ++ +L +  +
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYI 74
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           VR++G   E    +L+ E      ++K++    +   +  +   +++  ++ G+ YL E 
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 130
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYV 500
           +    +HRDL A N+LL      KISDFG+++    D++    ++  G +   + APE +
Sbjct: 131 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECI 186
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLL 540
               FS KSDV+SFGVL+ E  S GQK      G E   +L
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 227

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 16/210 (7%)
Query: 320 RDATNNF-STDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ 378
           RDA ++F   +++LG+G    VY+ +    Q+    ++ K +V  ++  + E+ ++ RL 
Sbjct: 48  RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-VRTEIGVLLRLS 106
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGIL 437
           H N+++L       TE  L+ E V        +FD I ++           +  I   + 
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGE----LFDRIVEKGYYSERDAADAVKQILEAVA 162
Query: 438 YLHEDSRLRIIHRDLKASNILLD---ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           YLHE+    I+HRDLK  N+L      D   KI+DFG++++ E    Q     + GT GY
Sbjct: 163 YLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE---HQVLMKTVCGTPGY 216
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
            APE +    +  + D++S G++   ++ G
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 330 NKLGQGGFGAVYKGRLSHGQ----EIAVKRLSKNSV-QGEL--EFKNEVLLVARLQHRNL 382
            KLG G FG V +G           +AVK L  + + Q E   +F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIARGILY 438
           +RL G       ++ + E  P  S    + D +++ Q    L   +RY +   +A G+ Y
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGS----LLDRLRKHQGHFLLGTLSRYAV--QVAEGMGY 126
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM--DQSQGDTSRIVGTFGYMA 496
           L      R IHRDL A N+LL    + KI DFG+ R      D       R V  F + A
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCA 182
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
           PE +    FS  SD + FGV + E+ + GQ+
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 324 NNFSTDNKLGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
           +  +    LG+G FG V         K +      +AVK L  ++ + +L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-------------FDAIKRVQL 420
             + +H+N++ LLG   ++    +I E+    ++ +++              + +   Q+
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            ++        +ARG+ YL   +  + IHRDL A N+L+  + + KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               T+       +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 18/221 (8%)
Query: 329 DNKLGQGGFGAVYKG--RLSHGQEIAVKRLSKNSVQGELEFKNEVL----LVARLQHRNL 382
           D +LG G FG V KG  ++    +    ++ KN    +   K+E+L    ++ +L +  +
Sbjct: 10  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYI 68
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           VR++G   E    +L+ E      ++K++    +   +  +   +++  ++ G+ YL E 
Sbjct: 69  VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 124
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYV 500
           +    +HRDL A N+LL      KISDFG+++    D++    ++  G +   + APE +
Sbjct: 125 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECI 180
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLL 540
               FS KSDV+SFGVL+ E  S GQK      G E   +L
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 221

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 109/223 (48%), Gaps = 36/223 (16%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKR-LSKNSVQG-ELEFKNEVLLVARL 377
           D  + +    K+GQG FG V+K R    GQ++A+K+ L +N  +G  +    E+ ++  L
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 74
Query: 378 QHRNLVRLLGFSFEETERL--------LIYEFVPN-------SSVDKFIFDAIKRVQLDW 422
           +H N+V L+     +            L+++F  +       + + KF    IKRV    
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV---- 130
Query: 423 ETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM---D 479
                 +  +  G+ Y+H   R +I+HRD+KA+N+L+  D + K++DFG+AR F +    
Sbjct: 131 ------MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 480 QSQGDTSRIVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEI 521
           Q     +R+V T  Y  PE +     +    D++  G ++ E+
Sbjct: 182 QPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 330 NKLGQGGFGAVYKGRLSHGQ----EIAVKRLSKNSV-QGEL--EFKNEVLLVARLQHRNL 382
            KLG G FG V +G           +AVK L  + + Q E   +F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIARGILY 438
           +RL G       ++ + E  P  S    + D +++ Q    L   +RY +   +A G+ Y
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGS----LLDRLRKHQGHFLLGTLSRYAV--QVAEGMGY 126
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM--DQSQGDTSRIVGTFGYMA 496
           L      R IHRDL A N+LL    + KI DFG+ R      D       R V  F + A
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCA 182
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
           PE +    FS  SD + FGV + E+ + GQ+
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 18/221 (8%)
Query: 329 DNKLGQGGFGAVYKG--RLSHGQEIAVKRLSKNSVQGELEFKNEVL----LVARLQHRNL 382
           D +LG G FG V KG  ++    +    ++ KN    +   K+E+L    ++ +L +  +
Sbjct: 30  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYI 88
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           VR++G   E    +L+ E      ++K++    +   +  +   +++  ++ G+ YL E 
Sbjct: 89  VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 144
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYV 500
           +    +HRDL A N+LL      KISDFG+++    D++    ++  G +   + APE +
Sbjct: 145 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECI 200
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLL 540
               FS KSDV+SFGVL+ E  S GQK      G E   +L
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 241

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 24/202 (11%)
Query: 332 LGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
           LG G F  V+  K RL+ G+  A+K + K+    +   +NE+ ++ +++H N+V L    
Sbjct: 17  LGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
              T   L+ + V        +FD I +R     +    +I  +   + YLHE+    I+
Sbjct: 76  ESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IV 128
Query: 449 HRDLKASNILLDADMIPK------ISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
           HRDLK  N+L    + P+      I+DFG++++    +  G  S   GT GY+APE + +
Sbjct: 129 HRDLKPENLLY---LTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQ 181
Query: 503 GHFSIKSDVFSFGVLVLEIISG 524
             +S   D +S GV+   ++ G
Sbjct: 182 KPYSKAVDCWSIGVITYILLCG 203

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 330 NKLGQGGFGAVYKGRLSHGQ----EIAVKRLSKNSV-QGEL--EFKNEVLLVARLQHRNL 382
            KLG G FG V +G           +AVK L  + + Q E   +F  EV  +  L HRNL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIARGILY 438
           +RL G       ++ + E  P  S    + D +++ Q    L   +RY +   +A G+ Y
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGS----LLDRLRKHQGHFLLGTLSRYAV--QVAEGMGY 130
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM--DQSQGDTSRIVGTFGYMA 496
           L      R IHRDL A N+LL    + KI DFG+ R      D       R V  F + A
Sbjct: 131 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCA 186
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
           PE +    FS  SD + FGV + E+ + GQ+
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMFTYGQE 217

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 330 NKLGQGGFGAVYKGRLSHGQ----EIAVKRLSKNSV-QGEL--EFKNEVLLVARLQHRNL 382
            KLG G FG V +G           +AVK L  + + Q E   +F  EV  +  L HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIARGILY 438
           +RL G       ++ + E  P  S    + D +++ Q    L   +RY +   +A G+ Y
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGS----LLDRLRKHQGHFLLGTLSRYAV--QVAEGMGY 136
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM--DQSQGDTSRIVGTFGYMA 496
           L      R IHRDL A N+LL    + KI DFG+ R      D       R V  F + A
Sbjct: 137 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCA 192
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
           PE +    FS  SD + FGV + E+ + GQ+
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGE---LEFKNEVLLVARLQH 379
           ++F     LG+G FG VY  R    + I A+K L K+ ++ E    + + E+ + + L+H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            N++R+  +  +     L+ EF P   + K   +  K  + D +     +  +A  + Y 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYK---ELQKHGRFDEQRSATFMEELADALHYC 131
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
           HE    ++IHRD+K  N+L+      KI+DFG    + +         + GT  Y+ PE 
Sbjct: 132 HER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEM 184
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISG 524
           +       K D++  GVL  E + G
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 324 NNFSTDNKLGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
           +  +    LG+G FG V         K +      +AVK L  ++ + +L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-------------FDAIKRVQL 420
             + +H+N++ LLG   ++    +I E+    ++ +++              + +   Q+
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            ++        +ARG+ YL   +  + IHRDL A N+L+  + + KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               T+       +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 18/221 (8%)
Query: 329 DNKLGQGGFGAVYKG--RLSHGQEIAVKRLSKNSVQGELEFKNEVL----LVARLQHRNL 382
           D +LG G FG V KG  ++    +    ++ KN    +   K+E+L    ++ +L +  +
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYI 80
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           VR++G   E    +L+ E      ++K++    +   +  +   +++  ++ G+ YL E 
Sbjct: 81  VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYV 500
           +    +HRDL A N+LL      KISDFG+++    D++    ++  G +   + APE +
Sbjct: 137 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECI 192
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLL 540
               FS KSDV+SFGVL+ E  S GQK      G E   +L
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 324 NNFSTDNKLGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
           +  +    LG+G FG V         K +      +AVK L  ++ + +L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-------------FDAIKRVQL 420
             + +H+N++ LLG   ++    +I E+    ++ +++              + +   Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            ++        +ARG+ YL   +  + IHRDL A N+L+  + + KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               T+       +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 109/223 (48%), Gaps = 36/223 (16%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKR-LSKNSVQG-ELEFKNEVLLVARL 377
           D  + +    K+GQG FG V+K R    GQ++A+K+ L +N  +G  +    E+ ++  L
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 73
Query: 378 QHRNLVRLLGFSFEETERL--------LIYEFVPN-------SSVDKFIFDAIKRVQLDW 422
           +H N+V L+     +            L+++F  +       + + KF    IKRV    
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV---- 129
Query: 423 ETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM---D 479
                 +  +  G+ Y+H   R +I+HRD+KA+N+L+  D + K++DFG+AR F +    
Sbjct: 130 ------MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 480 QSQGDTSRIVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEI 521
           Q     +R+V T  Y  PE +     +    D++  G ++ E+
Sbjct: 181 QPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 109/223 (48%), Gaps = 36/223 (16%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKR-LSKNSVQG-ELEFKNEVLLVARL 377
           D  + +    K+GQG FG V+K R    GQ++A+K+ L +N  +G  +    E+ ++  L
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 74
Query: 378 QHRNLVRLLGFSFEETERL--------LIYEFVPN-------SSVDKFIFDAIKRVQLDW 422
           +H N+V L+     +            L+++F  +       + + KF    IKRV    
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV---- 130
Query: 423 ETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM---D 479
                 +  +  G+ Y+H   R +I+HRD+KA+N+L+  D + K++DFG+AR F +    
Sbjct: 131 ------MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 480 QSQGDTSRIVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEI 521
           Q     +R+V T  Y  PE +     +    D++  G ++ E+
Sbjct: 182 QPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 41/221 (18%)
Query: 332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL----L 386
           +G GGFG V+K +    G+   ++R+  N+ + E     EV  +A+L H N+V       
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE----REVKALAKLDHVNIVHYNGCWD 75
Query: 387 GFSFE------------------------ETERLLI-YEFVPNSSVDKFIFDAIKRVQLD 421
           GF ++                        +T+ L I  EF    +++++I +  +  +LD
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLD 134
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
                ++   I +G+ Y+H     ++IHRDLK SNI L      KI DFG+    + D  
Sbjct: 135 KVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-- 189
Query: 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
            G  +R  GT  YM+PE ++   +  + D+++ G+++ E++
Sbjct: 190 -GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 41/227 (18%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAV---YKGRLSHGQEIAVKRLSK--NSVQGELEFKNEVL 372
           T+ +          +G G +G+V   Y  RL   Q++AVK+LS+   S+        E+ 
Sbjct: 22  TVWEVPQRLQGLRPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELR 79
Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQ 419
           L+  L+H N++ LL              F P +S++ F             + + +K   
Sbjct: 80  LLKHLKHENVIGLLDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKSQA 127
Query: 420 LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479
           L  E    ++  + RG+ Y+H      IIHRDLK SN+ ++ D   +I DFG+AR     
Sbjct: 128 LSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR----- 179
Query: 480 QSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           Q+  + +  V T  Y APE +    H++   D++S G ++ E++ G+
Sbjct: 180 QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           K+G+G +G VYK + ++G+  A+K  RL K           E+ ++  L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
              +   +L++E + +  + K +   +    L+  T    +  +  GI Y H+    R++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-RGHFSI 507
           HRDLK  N+L++ +   KI+DFG+AR F +   +  T  IV T  Y AP+ +     +S 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIV-TLWYRAPDVLMGSKKYST 180
Query: 508 KSDVFSFGVLVLEIISG 524
             D++S G +  E+++G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 112/221 (50%), Gaps = 18/221 (8%)
Query: 329 DNKLGQGGFGAVYKG--RLSHGQEIAVKRLSKNSVQGELEFKNEVL----LVARLQHRNL 382
           D +LG G FG V KG  ++    +    ++ KN    +   K+E+L    ++ +L +  +
Sbjct: 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYI 432
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           VR++G    E+  +L+ E      ++K++    +   +  +   +++  ++ G+ YL E 
Sbjct: 433 VRMIGICEAES-WMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 488
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYV 500
           +    +HRDL A N+LL      KISDFG+++    D++    ++  G +   + APE +
Sbjct: 489 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHGKWPVKWYAPECI 544
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLL 540
               FS KSDV+SFGVL+ E  S GQK      G E   +L
Sbjct: 545 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 585

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 108/236 (45%), Gaps = 25/236 (10%)
Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQG 363
           E L +D S      +       LG+G FG V +       + +  + +AVK L + +   
Sbjct: 13  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 364 ELE-FKNEVLLVARL-QHRNLVRLLGFSFEETERLL-IYEFVP--------NSSVDKFIF 412
           E     +E+ ++  +  H N+V LLG   +    L+ I EF           S  ++F+ 
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 413 DAIKRVQL--DWETRYKIIG---GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467
             +    L  D+ T   +I     +A+G+ +L   +  + IHRDL A NILL    + KI
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189
Query: 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            DFG+AR    D              +MAPE +    ++I+SDV+SFGVL+ EI S
Sbjct: 190 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 324 NNFSTDNKLGQGGFGAVYK------GRLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVAR 376
           NN      LG G FG V +      G+     ++AVK L   +   E E   +E+ +++ 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-------FDAIKRVQLDWETRYKI 428
           L QH N+V LLG        L+I E+     +  F+        D      L+       
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
              +A+G+ +L   +    IHRD+ A N+LL    + KI DFG+AR    D +       
Sbjct: 158 SSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                +MAPE +    ++++SDV+S+G+L+ EI S
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 112/221 (50%), Gaps = 18/221 (8%)
Query: 329 DNKLGQGGFGAVYKG--RLSHGQEIAVKRLSKNSVQGELEFKNEVL----LVARLQHRNL 382
           D +LG G FG V KG  ++    +    ++ KN    +   K+E+L    ++ +L +  +
Sbjct: 375 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYI 433
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           VR++G    E+  +L+ E      ++K++    +   +  +   +++  ++ G+ YL E 
Sbjct: 434 VRMIGICEAES-WMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 489
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYV 500
           +    +HRDL A N+LL      KISDFG+++    D++    ++  G +   + APE +
Sbjct: 490 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHGKWPVKWYAPECI 545
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLL 540
               FS KSDV+SFGVL+ E  S GQK      G E   +L
Sbjct: 546 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 586

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 324 NNFSTDNKLGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
           +  +    LG+G FG V         K +      +AVK L  ++ + +L +  +E+ ++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-------------FDAIKRVQL 420
             + +H+N++ LLG   ++    +I E+    ++ +++              + +   Q+
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            ++        +ARG+ YL   +  + IHRDL A N+L+  + + KI+DFG+AR      
Sbjct: 147 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               T+       +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 332 LGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRN 381
           LG+G FG V         K + +   ++AVK L  ++ + +L +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFI-----------FDAIKRV--QLDWETRYKI 428
           ++ LLG   ++    +I E+    ++ +++           F+       QL  +     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
              +ARG+ YL   +  + IHRDL A N+L+  D + KI+DFG+AR          T+  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 19/209 (9%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQ--GELEFKN-EVLLVARL 377
           +  +F     LG G FG V+  R  H G+  A+K L K  V    ++E  N E L+++ +
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 378 QHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARG 435
            H  ++R+ G +F++ +++ +I +++        +F  +++ Q       K     +   
Sbjct: 64  THPFIIRMWG-TFQDAQQIFMIMDYIEGGE----LFSLLRKSQRFPNPVAKFYAAEVCLA 118
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
           + YLH      II+RDLK  NILLD +   KI+DFG A+          T  + GT  Y+
Sbjct: 119 LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYXLCGTPDYI 170
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           APE V+   ++   D +SFG+L+ E+++G
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 324 NNFSTDNKLGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
           +  +    LG+G FG V         K +      +AVK L  ++ + +L +  +E+ ++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-------------FDAIKRVQL 420
             + +H+N++ LLG   ++    +I E+    ++ +++              + +   Q+
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            ++        +ARG+ YL   +  + IHRDL A N+L+  + + KI+DFG+AR      
Sbjct: 144 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               T+       +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLLG 387
           LG+GGF   ++   +  +E+   ++   S+        +   E+ +   L H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
           F FE+ + + ++ E     S+        ++   + E RY  +  I  G  YLH   R R
Sbjct: 89  F-FEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNR 141
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
           +IHRDLK  N+ L+ D+  KI DFG+A   E D  +  T  + GT  Y+APE +++   S
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHS 199
Query: 507 IKSDVFSFGVLVLEIISGQ 525
            + DV+S G ++  ++ G+
Sbjct: 200 FEVDVWSIGCIMYTLLVGK 218

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 114/241 (47%), Gaps = 25/241 (10%)
Query: 317 STIR--DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGEL------EF 367
           ST R  D  +++    +LG G F  V K R    G+E A K + K  +          E 
Sbjct: 3   STFRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEI 62
Query: 368 KNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYK 427
           + EV ++  ++H N++ L      +T+ +LI E V    +  F+ +   +  L  +   +
Sbjct: 63  EREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQ 119
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEMDQSQG 483
            +  I  G+ YLH     RI H DLK  NI+L    +P    K+ DFG+A   E   +  
Sbjct: 120 FLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---AGN 173
Query: 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           +   I GT  ++APE V      +++D++S GV+   ++SG    S  +GE  ++ LT +
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGETKQETLTNI 230
Query: 544 S 544
           S
Sbjct: 231 S 231

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGE---LEFKNEVLLVARLQH 379
           ++F     LG+G FG VY  R    + I A+K L K+ ++ E    + + E+ + + L+H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            N++R+  +  +     L+ EF P   + K   +  K  + D +     +  +A  + Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYK---ELQKHGRFDEQRSATFMEELADALHYC 130
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
           HE    ++IHRD+K  N+L+      KI+DFG    + +         + GT  Y+ PE 
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEM 183
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISG 524
           +       K D++  GVL  E + G
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYK------GRLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVAR 376
           NN      LG G FG V +      G+     ++AVK L   +   E E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARG 435
           L QH N+V LLG        L+I E+     +  F+    + ++ D    + I    A  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD--PAFAIANSTAST 163
Query: 436 ILYLHEDSRL----------RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485
              LH  S++            IHRD+ A N+LL    + KI DFG+AR    D +    
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 223
Query: 486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                   +MAPE +    ++++SDV+S+G+L+ EI S
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 110/236 (46%), Gaps = 25/236 (10%)
Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQG 363
           E L +D S      +       LG+G FG V +       + +  + +AVK L + +   
Sbjct: 15  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 74
Query: 364 ELE-FKNEVLLVARL-QHRNLVRLLGFSFEETERLL-IYEFVP--------NSSVDKFIF 412
           E     +E+ ++  +  H N+V LLG   +    L+ I EF           S  ++F+ 
Sbjct: 75  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 134
Query: 413 --DAIKRVQLDWETRYKIIG---GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467
             +A + +  D+ T   +I     +A+G+ +L   +  + IHRDL A NILL    + KI
Sbjct: 135 YKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 191
Query: 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            DFG+AR    D              +MAPE +    ++I+SDV+SFGVL+ EI S
Sbjct: 192 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 324 NNFSTDNKLGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
           +  +    LG+G FG V         K +      +AVK L  ++ + +L +  +E+ ++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-------------FDAIKRVQL 420
             + +H+N++ LLG   ++    +I E+    ++ +++              + +   Q+
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            ++        +ARG+ YL   +  + IHRDL A N+L+  + + KI+DFG+AR      
Sbjct: 142 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               T+       +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 324 NNFSTDNKLGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
           +  +    LG+G FG V         K +      +AVK L  ++ + +L +  +E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-------------FDAIKRVQL 420
             + +H+N++ LLG   ++    +I E+    ++ +++              + +   Q+
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            ++        +ARG+ YL   +  + IHRDL A N+L+  + + KI+DFG+AR      
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               T+       +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 41/227 (18%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAV---YKGRLSHGQEIAVKRLSK--NSVQGELEFKNEVL 372
           T+ +          +G G +G+V   Y  RL   Q++AVK+LS+   S+        E+ 
Sbjct: 14  TVWEVPQRLQGLRPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELR 71
Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQ 419
           L+  L+H N++ LL              F P +S++ F             + + +K   
Sbjct: 72  LLKHLKHENVIGLLDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQA 119
Query: 420 LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479
           L  E    ++  + RG+ Y+H      IIHRDLK SN+ ++ D   +I DFG+AR     
Sbjct: 120 LSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR----- 171
Query: 480 QSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           Q+  + +  V T  Y APE +    H++   D++S G ++ E++ G+
Sbjct: 172 QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           K+G+G +G VYK + ++G+  A+K  RL K           E+ ++  L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
              +   +L++E + +  + K +   +    L+  T    +  +  GI Y H+    R++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-RGHFSI 507
           HRDLK  N+L++ +   KI+DFG+AR F +   +   +  V T  Y AP+ +     +S 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEVVTLWYRAPDVLMGSKKYST 180
Query: 508 KSDVFSFGVLVLEIISG 524
             D++S G +  E+++G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLLG 387
           LG+GGF   ++   +  +E+   ++   S+        +   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
           F FE+ + + ++ E     S+        ++   + E RY  +  I  G  YLH   R R
Sbjct: 85  F-FEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNR 137
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
           +IHRDLK  N+ L+ D+  KI DFG+A   E D  +  T  + GT  Y+APE +++   S
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHS 195
Query: 507 IKSDVFSFGVLVLEIISGQ 525
            + DV+S G ++  ++ G+
Sbjct: 196 FEVDVWSIGCIMYTLLVGK 214

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 324 NNFSTDNKLGQGGFGAVYK------GRLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVAR 376
           NN      LG G FG V +      G+     ++AVK L   +   E E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-------FDAIKRVQLDWETRYKI 428
           L QH N+V LLG        L+I E+     +  F+        D      L+       
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
              +A+G+ +L   +    IHRD+ A N+LL    + KI DFG+AR    D +       
Sbjct: 166 SSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                +MAPE +    ++++SDV+S+G+L+ EI S
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLLG 387
           LG+GGF   ++   +  +E+   ++   S+        +   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
           F FE+ + + ++ E     S+        ++   + E RY  +  I  G  YLH   R R
Sbjct: 85  F-FEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNR 137
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
           +IHRDLK  N+ L+ D+  KI DFG+A   E D  +  T  + GT  Y+APE +++   S
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHS 195
Query: 507 IKSDVFSFGVLVLEIISGQ 525
            + DV+S G ++  ++ G+
Sbjct: 196 FEVDVWSIGCIMYTLLVGK 214

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           K+G+G +G VYK + ++G+  A+K  RL K           E+ ++  L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
              +   +L++E + +  + K +   +    L+  T    +  +  GI Y H+    R++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-RGHFSI 507
           HRDLK  N+L++ +   KI+DFG+AR F +   +   +  V T  Y AP+ +     +S 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEVVTLWYRAPDVLMGSKKYST 180
Query: 508 KSDVFSFGVLVLEIISG 524
             D++S G +  E+++G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 27/211 (12%)
Query: 331 KLGQGGFGAVYKGRLSHGQ-EIAVKRL-------------SKNSVQGELEFKNEVLLVAR 376
           KLG G +G V   +  +G  E A+K +             +KN  +   E  NE+ L+  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L H N+++L     ++    L+ EF     + + I   I R + D      I+  I  GI
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFDECDAANIMKQILSGI 159
Query: 437 LYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
            YLH+ +   I+HRD+K  NILL+     +  KI DFG++  F  D    D    +GT  
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---LGTAY 213
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           Y+APE V +  ++ K DV+S GV++  ++ G
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 324 NNFSTDNKLGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
           +  +    LG+G FG V         K +      +AVK L  ++ + +L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-------------FDAIKRVQL 420
             + +H+N++ LLG   ++    +I E+    ++ +++              + +   Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            ++        +ARG+ YL   +  + IHRDL A N+L+  + + +I+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               T+       +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 25/237 (10%)
Query: 309 VESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQ 362
            E L +D S      +       LG+G FG V +       + +  + +AVK L + +  
Sbjct: 3   AERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 62
Query: 363 GELE-FKNEVLLVARL-QHRNLVRLLGFSFEETERLL-IYEFVP--------NSSVDKFI 411
            E     +E+ ++  +  H N+V LLG   +    L+ I EF           S  ++F+
Sbjct: 63  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 122
Query: 412 FDAIKRVQL--DWETRYKIIG---GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPK 466
              +    L  D+ T   +I     +A+G+ +L   +  + IHRDL A NILL    + K
Sbjct: 123 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVK 179
Query: 467 ISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           I DFG+AR    D              +MAPE +    ++I+SDV+SFGVL+ EI S
Sbjct: 180 ICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 106/244 (43%), Gaps = 39/244 (15%)
Query: 309 VESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQ 362
            E L +D S      +       LG+G FG V +       + +  + +AVK L + +  
Sbjct: 3   AERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 62
Query: 363 GELE-FKNEVLLVARL-QHRNLVRLLGFSFEETERLLIY------------------EFV 402
            E     +E+ ++  +  H N+V LLG   +    L++                   EFV
Sbjct: 63  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFV 122
Query: 403 PNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHEDSRLRIIHRDLKASNILL 459
           P     + ++        D+ T   +I     +A+G+ +L   +  + IHRDL A NILL
Sbjct: 123 PYKVAPEDLYK-------DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILL 172
Query: 460 DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVL 519
               + KI DFG+AR    D              +MAPE +    ++I+SDV+SFGVL+ 
Sbjct: 173 SEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 232
Query: 520 EIIS 523
           EI S
Sbjct: 233 EIFS 236

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 41/227 (18%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAV---YKGRLSHGQEIAVKRLSK--NSVQGELEFKNEVL 372
           T+ +          +G G +G+V   Y  RL   Q++AVK+LS+   S+        E+ 
Sbjct: 22  TVWEVPQRLQGLRPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELR 79
Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQ 419
           L+  L+H N++ LL              F P +S++ F             + + +K   
Sbjct: 80  LLKHLKHENVIGLLDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQA 127
Query: 420 LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479
           L  E    ++  + RG+ Y+H      IIHRDLK SN+ ++ D   +I DFG+AR     
Sbjct: 128 LSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR----- 179
Query: 480 QSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           Q+  + +  V T  Y APE +    H++   D++S G ++ E++ G+
Sbjct: 180 QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 29/212 (13%)
Query: 328 TDNKLGQGGFGAVYKGR-LSHGQ---EIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNL 382
           +D  +G+G FG VY G  +   Q   + A+K LS+ +   ++E F  E LL+  L H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKF----IFDAIKRVQLDWETRYKIIGG--IARGI 436
           + L+G        +L  E +P+  +       +   I+  Q +   +  I  G  +ARG+
Sbjct: 85  LALIGI-------MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGM 137
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ-----SQGDTSRIVGT 491
            YL E    + +HRDL A N +LD     K++DFG+AR   +D+      Q   +R+   
Sbjct: 138 EYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQHRHARL--P 191
Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             + A E +    F+ KSDV+SFGVL+ E+++
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 108/236 (45%), Gaps = 25/236 (10%)
Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQG 363
           E L +D S      +       LG+G FG V +       + +  + +AVK L + +   
Sbjct: 13  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 364 ELE-FKNEVLLVARL-QHRNLVRLLGFSFEETERLL-IYEFVP--------NSSVDKFIF 412
           E     +E+ ++  +  H N+V LLG   +    L+ I EF           S  ++F+ 
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 413 DAIKRVQL--DWETRYKIIG---GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467
             +    L  D+ T   +I     +A+G+ +L   +  + IHRDL A NILL    + KI
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189
Query: 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            DFG+AR    D              +MAPE +    ++I+SDV+SFGVL+ EI S
Sbjct: 190 CDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 113/212 (53%), Gaps = 26/212 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++    +QG+  FKN E+ ++ +L H N+VR
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGK-AFKNRELQIMRKLDHCNIVR 77
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 135
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 189
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQK 526
           APE +     ++   DV+S G ++ E++ GQ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++ ++       FKN E+ ++ +L H N+VR
Sbjct: 57  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVR 111
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 169
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 170 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 223
Query: 496 APEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
           APE +     ++   DV+S G ++ E++ GQ
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 23/219 (10%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH 379
           R          ++G+G +G V+ G+   G+++AVK     + +     + E+     ++H
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFF-TTEEASWFRETEIYQTVLMRH 90
Query: 380 RNLVRLLGFSFE----ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARG 435
            N++  +    +     T+  LI ++  N S    ++D +K   LD ++  K+      G
Sbjct: 91  ENILGFIAADIKGTGSWTQLYLITDYHENGS----LYDYLKSTTLDAKSMLKLAYSSVSG 146
Query: 436 ILYLHED-----SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD--TSRI 488
           + +LH +      +  I HRDLK+ NIL+  +    I+D G+A  F  D ++ D   +  
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 489 VGTFGYMAPEY----VTRGHFS--IKSDVFSFGVLVLEI 521
           VGT  YM PE     + R HF   I +D++SFG+++ E+
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 113/211 (53%), Gaps = 26/211 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++    +QG+  FKN E+ ++ +L H N+VR
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGK-AFKNRELQIMRKLDHCNIVR 77
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 135
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 189
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           APE +     ++   DV+S G ++ E++ GQ
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 108/236 (45%), Gaps = 25/236 (10%)
Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQG 363
           E L +D S      +       LG+G FG V +       + +  + +AVK L + +   
Sbjct: 13  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 364 ELE-FKNEVLLVARL-QHRNLVRLLGFSFEETERLL-IYEFVP--------NSSVDKFIF 412
           E     +E+ ++  +  H N+V LLG   +    L+ I EF           S  ++F+ 
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 413 DAIKRVQL--DWETRYKIIG---GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467
             +    L  D+ T   +I     +A+G+ +L   +  + IHRDL A NILL    + KI
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189
Query: 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            DFG+AR    D              +MAPE +    ++I+SDV+SFGVL+ EI S
Sbjct: 190 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 113/212 (53%), Gaps = 26/212 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++    +QG+  FKN E+ ++ +L H N+VR
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGK-AFKNRELQIMRKLDHCNIVR 77
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 135
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 189
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQK 526
           APE +     ++   DV+S G ++ E++ GQ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++ ++       FKN E+ ++ +L H N+VR
Sbjct: 51  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVR 105
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 163
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 164 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 217
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           APE +     ++   DV+S G ++ E++ GQ
Sbjct: 218 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 30/217 (13%)
Query: 332 LGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRN 381
           LG+G FG V         K + +   ++AVK L  ++ + +L +  +E+ ++  + +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV---------------QLDWETRY 426
           ++ LLG   ++    +I E+    ++ +++    +R                QL  +   
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486
                +ARG+ YL   +  + IHRDL A N+L+  D + KI+DFG+AR          T+
Sbjct: 139 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                  +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++ ++       FKN E+ ++ +L H N+VR
Sbjct: 57  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVR 111
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 169
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 170 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 223
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           APE +     ++   DV+S G ++ E++ GQ
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 106/243 (43%), Gaps = 39/243 (16%)
Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQG 363
           E L +D S      +       LG+G FG V +       + +  + +AVK L + +   
Sbjct: 4   ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 364 ELE-FKNEVLLVARL-QHRNLVRLLGFSFEETERLLIY------------------EFVP 403
           E     +E+ ++  +  H N+V LLG   +    L++                   EFVP
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP 123
Query: 404 NSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHEDSRLRIIHRDLKASNILLD 460
                + ++        D+ T   +I     +A+G+ +L   +  + IHRDL A NILL 
Sbjct: 124 YKVAPEDLYK-------DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLS 173
Query: 461 ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLE 520
              + KI DFG+AR    D              +MAPE +    ++I+SDV+SFGVL+ E
Sbjct: 174 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 233
Query: 521 IIS 523
           I S
Sbjct: 234 IFS 236

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYK------GRLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVAR 376
           NN      LG G FG V +      G+     ++AVK L   +   E E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFD-----------AIKRVQLDWET 424
           L QH N+V LLG        L+I E+     +  F+             AI    L    
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
                  +A+G+ +L   +    IHRD+ A N+LL    + KI DFG+AR    D +   
Sbjct: 166 LLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                    +MAPE +    ++++SDV+S+G+L+ EI S
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++ ++       FKN E+ ++ +L H N+VR
Sbjct: 59  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVR 113
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 171
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 172 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 225
Query: 496 APEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
           APE +     ++   DV+S G ++ E++ GQ
Sbjct: 226 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 30/217 (13%)
Query: 332 LGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRN 381
           LG+G FG V         K + +   ++AVK L  ++ + +L +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV---------------QLDWETRY 426
           ++ LLG   ++    +I E+    ++ +++    +R                QL  +   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486
                +ARG+ YL   +  + IHRDL A N+L+  D + KI+DFG+AR          T+
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                  +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++ ++       FKN E+ ++ +L H N+VR
Sbjct: 35  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVR 89
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 147
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 148 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 201
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           APE +     ++   DV+S G ++ E++ GQ
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 26/212 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++ ++       FKN E+ ++ +L H N+VR
Sbjct: 28  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVR 82
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 140
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 141 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 194
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQK 526
           APE +     ++   DV+S G ++ E++ GQ 
Sbjct: 195 APELIFGATDYTSSIDVWSAGCVLAELLLGQP 226

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++ ++       FKN E+ ++ +L H N+VR
Sbjct: 61  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVR 115
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 173
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 174 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 227
Query: 496 APEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
           APE +     ++   DV+S G ++ E++ GQ
Sbjct: 228 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRL--SKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           +G+G +G V K R    G+ +A+K+   S +    +     E+ L+ +L+H NLV LL  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
             ++    L++EFV ++ +D      +    LD++   K +  I  GI + H  +   II
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDL---ELFPNGLDYQVVQKYLFQIINGIGFCHSHN---II 146
Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE-YVTRGHFSI 507
           HRD+K  NIL+    + K+ DFG AR         D    V T  Y APE  V    +  
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VATRWYRAPELLVGDVKYGK 204
Query: 508 KSDVFSFGVLVLEIISGQ 525
             DV++ G LV E+  G+
Sbjct: 205 AVDVWAIGCLVTEMFMGE 222

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLLG 387
           LG+GGF   Y+      +E+   ++   S+      + +   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
           F  ++    ++ E     S+        ++   + E RY +   I +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
           IHRDLK  N+ L+ DM  KI DFG+A   E D  +  T  + GT  Y+APE + +   S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKGHSF 221
Query: 508 KSDVFSFGVLVLEIISGQ 525
           + D++S G ++  ++ G+
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAV-------KRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           +G+G FG V++G     +  A+       K  + +SV+ +  F  E L + +  H ++V+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 75
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           L+G    E    +I E      +  F+   +++  LD  +       ++  + YL     
Sbjct: 76  LIGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK-- 130
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
            R +HRD+ A N+L+ ++   K+ DFG++R  E D +    S+      +MAPE +    
Sbjct: 131 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKASKGKLPIKWMAPESINFRR 188
Query: 505 FSIKSDVFSFGVLVLEII-------SGQKNN 528
           F+  SDV+ FGV + EI+        G KNN
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++ ++       FKN E+ ++ +L H N+VR
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVR 77
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 135
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 189
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           APE +     ++   DV+S G ++ E++ GQ
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++ ++       FKN E+ ++ +L H N+VR
Sbjct: 24  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVR 78
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 136
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 137 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 190
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           APE +     ++   DV+S G ++ E++ GQ
Sbjct: 191 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 108/236 (45%), Gaps = 25/236 (10%)
Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQG 363
           E L +D S      +       LG+G FG V +       + +  + +AVK L + +   
Sbjct: 50  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 109
Query: 364 ELE-FKNEVLLVARL-QHRNLVRLLGFSFEETERLL-IYEFVP--------NSSVDKFIF 412
           E     +E+ ++  +  H N+V LLG   +    L+ I EF           S  ++F+ 
Sbjct: 110 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 169
Query: 413 DAIKRVQL--DWETRYKIIG---GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467
             +    L  D+ T   +I     +A+G+ +L   +  + IHRDL A NILL    + KI
Sbjct: 170 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 226
Query: 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            DFG+AR    D              +MAPE +    ++I+SDV+SFGVL+ EI S
Sbjct: 227 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++ ++       FKN E+ ++ +L H N+VR
Sbjct: 42  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVR 96
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 154
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 155 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 208
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           APE +     ++   DV+S G ++ E++ GQ
Sbjct: 209 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++ ++       FKN E+ ++ +L H N+VR
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVR 77
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 135
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 189
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           APE +     ++   DV+S G ++ E++ GQ
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++ ++       FKN E+ ++ +L H N+VR
Sbjct: 35  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVR 89
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 147
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 148 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 201
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           APE +     ++   DV+S G ++ E++ GQ
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 114/244 (46%), Gaps = 16/244 (6%)
Query: 312 LQFDFSTIRDATNN-FSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---GELE 366
           LQ+ +   +  T N F     LG+GGFG V   ++ + G+  A K+L K  ++   GE  
Sbjct: 171 LQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 367 FKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRY 426
             NE  ++ ++  R +V L  +++E  + L +   + N    KF    + +         
Sbjct: 231 ALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289
Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486
                I  G+  LH   R RI++RDLK  NILLD     +ISD G+A    + + Q    
Sbjct: 290 FYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKG 344
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIG----EEAEDLLTY 542
           R VGT GYMAPE V    ++   D ++ G L+ E+I+GQ     R      EE E L+  
Sbjct: 345 R-VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 403
Query: 543 VSNN 546
           V   
Sbjct: 404 VPEE 407

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++ ++       FKN E+ ++ +L H N+VR
Sbjct: 36  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVR 90
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 148
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 149 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 202
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           APE +     ++   DV+S G ++ E++ GQ
Sbjct: 203 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++ ++       FKN E+ ++ +L H N+VR
Sbjct: 31  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVR 85
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 143
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 144 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 197
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           APE +     ++   DV+S G ++ E++ GQ
Sbjct: 198 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++ ++       FKN E+ ++ +L H N+VR
Sbjct: 102 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVR 156
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 214
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 215 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 268
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           APE +     ++   DV+S G ++ E++ GQ
Sbjct: 269 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLLG 387
           LG+GGF   ++   +  +E+   ++   S+        +   E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
           F FE+ + + ++ E     S+        ++   + E RY  +  I  G  YLH   R R
Sbjct: 109 F-FEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNR 161
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV-GTFGYMAPEYVTRGHF 505
           +IHRDLK  N+ L+ D+  KI DFG+A   E D   G+  +++ GT  Y+APE +++   
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPEVLSKKGH 218
Query: 506 SIKSDVFSFGVLVLEIISGQ 525
           S + DV+S G ++  ++ G+
Sbjct: 219 SFEVDVWSIGCIMYTLLVGK 238

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++ ++       FKN E+ ++ +L H N+VR
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVR 77
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 135
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 189
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           APE +     ++   DV+S G ++ E++ GQ
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLLG 387
           LG+GGF   ++   +  +E+   ++   S+        +   E+ +   L H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
           F FE+ + + ++ E     S+        ++   + E RY  +  I  G  YLH   R R
Sbjct: 107 F-FEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNR 159
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV-GTFGYMAPEYVTRGHF 505
           +IHRDLK  N+ L+ D+  KI DFG+A   E D   G+  +++ GT  Y+APE +++   
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPEVLSKKGH 216
Query: 506 SIKSDVFSFGVLVLEIISGQ 525
           S + DV+S G ++  ++ G+
Sbjct: 217 SFEVDVWSIGCIMYTLLVGK 236

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 30/217 (13%)
Query: 332 LGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRN 381
           LG+G FG V         K + +   ++AVK L  ++ + +L +  +E+ ++  + +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV---------------QLDWETRY 426
           ++ LLG   ++    +I E+    ++ +++    +R                QL  +   
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486
                +ARG+ YL   +  + IHRDL A N+L+  D + KI+DFG+AR          T+
Sbjct: 143 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 199
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                  +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 200 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 30/217 (13%)
Query: 332 LGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRN 381
           LG+G FG V         K + +   ++AVK L  ++ + +L +  +E+ ++  + +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV---------------QLDWETRY 426
           ++ LLG   ++    +I E+    ++ +++    +R                QL  +   
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486
                +ARG+ YL   +  + IHRDL A N+L+  D + KI+DFG+AR          T+
Sbjct: 147 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 203
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                  +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 204 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 30/217 (13%)
Query: 332 LGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRN 381
           LG+G FG V         K + +   ++AVK L  ++ + +L +  +E+ ++  + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV---------------QLDWETRY 426
           ++ LLG   ++    +I E+    ++ +++    +R                QL  +   
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486
                +ARG+ YL   +  + IHRDL A N+L+  D + KI+DFG+AR          T+
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                  +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 30/217 (13%)
Query: 332 LGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRN 381
           LG+G FG V         K + +   ++AVK L  ++ + +L +  +E+ ++  + +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV---------------QLDWETRY 426
           ++ LLG   ++    +I E+    ++ +++    +R                QL  +   
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486
                +ARG+ YL   +  + IHRDL A N+L+  D + KI+DFG+AR          T+
Sbjct: 146 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 202
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                  +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 203 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 30/217 (13%)
Query: 332 LGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRN 381
           LG+G FG V         K + +   ++AVK L  ++ + +L +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV---------------QLDWETRY 426
           ++ LLG   ++    +I E+    ++ +++    +R                QL  +   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486
                +ARG+ YL   +  + IHRDL A N+L+  D + KI+DFG+AR          T+
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                  +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 20/202 (9%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL-----VR 384
           +LG+G +G V K R +  GQ +AVKR+       E   +  +L+   +  R +     V 
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE---QKRLLMDLDISMRTVDCPFTVT 114
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ-LDWETRYKIIGGIARGILYLHEDS 443
             G  F E +  +  E + ++S+DKF    I + Q +  +   KI   I + + +LH  S
Sbjct: 115 FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--S 171
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV--- 500
           +L +IHRD+K SN+L++A    K+ DFG++  + +D          G   YMAPE +   
Sbjct: 172 KLSVIHRDVKPSNVLINALGQVKMCDFGISG-YLVDSVAKTID--AGCKPYMAPERINPE 228
Query: 501 -TRGHFSIKSDVFSFGVLVLEI 521
             +  +S+KSD++S G+ ++E+
Sbjct: 229 LNQKGYSVKSDIWSLGITMIEL 250

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 107/223 (47%), Gaps = 26/223 (11%)
Query: 324 NNFSTDNKLGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
           +  +    LG+G FG V         K +      +AVK L  ++ + +L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-------------FDAIKRVQL 420
             + +H+N++ LLG   ++    +I  +    ++ +++              + +   Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            ++        +ARG+ YL   +  + IHRDL A N+L+  + + KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               T+       +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++ ++       FKN E+ ++ +L H N+VR
Sbjct: 27  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVR 81
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 139
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 140 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY-YR 193
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           APE +     ++   DV+S G ++ E++ GQ
Sbjct: 194 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 106/244 (43%), Gaps = 39/244 (15%)
Query: 309 VESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQ 362
            E L +D S      +       LG+G FG V +       + +  + +AVK L + +  
Sbjct: 3   AERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 62
Query: 363 GELE-FKNEVLLVARL-QHRNLVRLLGFSFEETERLLIY------------------EFV 402
            E     +E+ ++  +  H N+V LLG   +    L++                   EFV
Sbjct: 63  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFV 122
Query: 403 PNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHEDSRLRIIHRDLKASNILL 459
           P     + ++        D+ T   +I     +A+G+ +L   +  + IHRDL A NILL
Sbjct: 123 PYKVAPEDLYK-------DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILL 172
Query: 460 DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVL 519
               + KI DFG+AR    D              +MAPE +    ++I+SDV+SFGVL+ 
Sbjct: 173 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 232
Query: 520 EIIS 523
           EI S
Sbjct: 233 EIFS 236

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHR 380
           N+     +G+G F  V   R +  G+E+AVK + K   NS   +  F+ EV +   L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHP 73
Query: 381 NLVRLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           N+V+L  F   ETE+   L+ E+     V  ++    +  + +   +++    I   + Y
Sbjct: 74  NIVKL--FEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR---QIVSAVQY 128
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H+     I+HRDLKA N+LLDAD   KI+DFG +  F             G   Y APE
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK---LDAFCGAPPYAAPE 182
Query: 499 -YVTRGHFSIKSDVFSFGVLVLEIISG 524
            +  + +   + DV+S GV++  ++SG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 328 TDNK-LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLVR 384
           TD K +G G FG VY+ +L   G+ +A+K++ ++       FKN E+ ++ +L H N+VR
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVR 77
Query: 385 LLGFSFEETERL------LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L  F +   E+       L+ ++VP +   V +    A + + + +   Y  +  + R +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 135
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H      I HRD+K  N+LLD D  + K+ DFG A+  ++ + + + S I   + Y 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY-YR 189
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           APE +     ++   DV+S G ++ E++ GQ
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 332 LGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRN 381
           LG+G FG V         K + +   ++AVK L  ++ + +L +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFI-------------FDAIKRVQLDWETRYKI 428
           ++ LLG   ++    +I E+    ++ +++                    QL  +     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
              +ARG+ YL   +  + IHRDL A N+L+  D + KI+DFG+AR          T+  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 332 LGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARL-QHRNLV 383
           LG G FG V         +     ++AVK L + +   E E   +E+ ++ +L  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 384 RLLGFSFEETERLLIYEFV--------PNSSVDKFIFDAI-----KRVQ-------LDWE 423
            LLG         LI+E+           S  +KF  D I     KR++       L +E
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
                   +A+G+ +L   S    +HRDL A N+L+    + KI DFG+AR    D +  
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                     +MAPE +  G ++IKSDV+S+G+L+ EI S
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 332 LGQGGFGAVY-----KGRLSHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRL 385
           LG+G FG V            G+ +AVK L  +   Q    +K E+ ++  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G   ++ E+   L+ E+VP  S+     D + R  +           I  G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLHSQ- 136
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARL------FEMDQSQGDTSRIVGTFGYMAP 497
               IHR+L A N+LLD D + KI DFG+A+       +   +  GD+      F Y AP
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP----VFWY-AP 189
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
           E +    F   SDV+SFGV + E+++
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQG-ELEFKNEVLL 373
           +    D  + +   + LG G F  V        Q+ +A+K ++K +++G E   +NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRY---KIIG 430
           + +++H N+V L           LI + V        +FD I  V+  + T     ++I 
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE----LFDRI--VEKGFYTERDASRLIF 123
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNIL---LDADMIPKISDFGMARLFEMDQSQGDTSR 487
            +   + YLH+   L I+HRDLK  N+L   LD D    ISDFG+++   M+      S 
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLST 177
Query: 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
             GT GY+APE + +  +S   D +S GV+   ++ G
Sbjct: 178 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 72  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLT 119
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 171
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQG-ELEFKNEVLL 373
           +    D  + +   + LG G F  V        Q+ +A+K ++K +++G E   +NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRY---KIIG 430
           + +++H N+V L           LI + V        +FD I  V+  + T     ++I 
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE----LFDRI--VEKGFYTERDASRLIF 123
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNIL---LDADMIPKISDFGMARLFEMDQSQGDTSR 487
            +   + YLH+   L I+HRDLK  N+L   LD D    ISDFG+++   M+      S 
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLST 177
Query: 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
             GT GY+APE + +  +S   D +S GV+   ++ G
Sbjct: 178 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 16/200 (8%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLLG 387
           LG+GGF   ++   +  +E+   ++   S+        +   E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
           F FE+ + + ++ E     S+ +      ++   + E RY  +  I  G  YLH   R R
Sbjct: 83  F-FEDNDFVFVVLELCRRRSLLEL--HKRRKALTEPEARY-YLRQIVLGCQYLH---RNR 135
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV-GTFGYMAPEYVTRGHF 505
           +IHRDLK  N+ L+ D+  KI DFG+A   E D   G+  +++ GT  Y+APE +++   
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPEVLSKKGH 192
Query: 506 SIKSDVFSFGVLVLEIISGQ 525
           S + DV+S G ++  ++ G+
Sbjct: 193 SFEVDVWSIGCIMYTLLVGK 212

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 107/219 (48%), Gaps = 12/219 (5%)
Query: 312 LQFDFSTIRDATNN-FSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---GELE 366
           LQ+ +   +  T N F     LG+GGFG V   ++ + G+  A K+L K  ++   GE  
Sbjct: 171 LQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 367 FKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRY 426
             NE  ++ ++  R +V L  +++E  + L +   + N    KF    + +         
Sbjct: 231 ALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289
Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486
                I  G+  LH   R RI++RDLK  NILLD     +ISD G+A    + + Q    
Sbjct: 290 FYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKG 344
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           R VGT GYMAPE V    ++   D ++ G L+ E+I+GQ
Sbjct: 345 R-VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAV-------KRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           +G+G FG V++G     +  A+       K  + +SV+ +  F  E L + +  H ++V+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 75
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           L+G    E    +I E      +  F+   +++  LD  +       ++  + YL     
Sbjct: 76  LIGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK-- 130
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
            R +HRD+ A N+L+ A    K+ DFG++R  E D +    S+      +MAPE +    
Sbjct: 131 -RFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR 188
Query: 505 FSIKSDVFSFGVLVLEII-------SGQKNN 528
           F+  SDV+ FGV + EI+        G KNN
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQG-ELEFKNEVLL 373
           +    D  + +   + LG G F  V        Q+ +A+K ++K +++G E   +NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRY---KIIG 430
           + +++H N+V L           LI + V        +FD I  V+  + T     ++I 
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE----LFDRI--VEKGFYTERDASRLIF 123
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNIL---LDADMIPKISDFGMARLFEMDQSQGDTSR 487
            +   + YLH+   L I+HRDLK  N+L   LD D    ISDFG+++   M+      S 
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLST 177
Query: 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
             GT GY+APE + +  +S   D +S GV+   ++ G
Sbjct: 178 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 20/201 (9%)
Query: 332 LGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQG-ELEFKNEVLLVARLQHRNLVRLLGFS 389
           LG G F  V        Q+ +A+K ++K +++G E   +NE+ ++ +++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRY---KIIGGIARGILYLHEDSRLR 446
                  LI + V        +FD I  V+  + T     ++I  +   + YLH+   L 
Sbjct: 86  ESGGHLYLIMQLVSGGE----LFDRI--VEKGFYTERDASRLIFQVLDAVKYLHD---LG 136
Query: 447 IIHRDLKASNIL---LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
           I+HRDLK  N+L   LD D    ISDFG+++   M+      S   GT GY+APE + + 
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 504 HFSIKSDVFSFGVLVLEIISG 524
            +S   D +S GV+   ++ G
Sbjct: 194 PYSKAVDCWSIGVIAYILLCG 214

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 332 LGQGGFGAVY-----KGRLSHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRL 385
           LG+G FG V            G+ +AVK L  +   Q    +K E+ ++  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G   ++ E+   L+ E+VP  S+     D + R  +           I  G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLHAQ- 136
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARL------FEMDQSQGDTSRIVGTFGYMAP 497
               IHR+L A N+LLD D + KI DFG+A+       +   +  GD+      F Y AP
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP----VFWY-AP 189
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
           E +    F   SDV+SFGV + E+++
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAV-------KRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           +G+G FG V++G     +  A+       K  + +SV+ +  F  E L + +  H ++V+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 103
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           L+G    E    +I E      +  F+   +++  LD  +       ++  + YL     
Sbjct: 104 LIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK-- 158
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
            R +HRD+ A N+L+ ++   K+ DFG++R  E D +    S+      +MAPE +    
Sbjct: 159 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR 216
Query: 505 FSIKSDVFSFGVLVLEII-------SGQKNN 528
           F+  SDV+ FGV + EI+        G KNN
Sbjct: 217 FTSASDVWMFGVCMWEILMHGVKPFQGVKNN 247

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAV-------KRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           +G+G FG V++G     +  A+       K  + +SV+ +  F  E L + +  H ++V+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 75
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           L+G    E    +I E      +  F+   +++  LD  +       ++  + YL     
Sbjct: 76  LIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK-- 130
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
            R +HRD+ A N+L+ ++   K+ DFG++R  E D +    S+      +MAPE +    
Sbjct: 131 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR 188
Query: 505 FSIKSDVFSFGVLVLEII-------SGQKNN 528
           F+  SDV+ FGV + EI+        G KNN
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAV-------KRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           +G+G FG V++G     +  A+       K  + +SV+ +  F  E L + +  H ++V+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 75
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           L+G    E    +I E      +  F+   +++  LD  +       ++  + YL     
Sbjct: 76  LIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK-- 130
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
            R +HRD+ A N+L+ ++   K+ DFG++R  E D +    S+      +MAPE +    
Sbjct: 131 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR 188
Query: 505 FSIKSDVFSFGVLVLEII-------SGQKNN 528
           F+  SDV+ FGV + EI+        G KNN
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 111/212 (52%), Gaps = 23/212 (10%)
Query: 317 STIRDATN--NFSTDNKLGQGGFGAVYKG-RLSHGQEIAVK-----RLSKNSVQGELEFK 368
           S++ D  +  N+     LG+G FG V      + GQ++A+K      L+K+ +QG +E  
Sbjct: 4   SSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE-- 61
Query: 369 NEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYK 427
            E+  +  L+H ++++L      + E +++ E+  N      +FD I +R ++  +   +
Sbjct: 62  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNE-----LFDYIVQRDKMSEQEARR 116
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
               I   + Y H   R +I+HRDLK  N+LLD  +  KI+DFG++ +   D +   TS 
Sbjct: 117 FFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS- 171
Query: 488 IVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLV 518
             G+  Y APE ++ + +   + DV+S GV++
Sbjct: 172 -CGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 202

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQHRNLVRLLG 387
           LG GG   V+  R L   +++AVK L  +  +     L F+ E    A L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 388 FSFEETE----RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
               ET       ++ E+V   ++   +        +  +   ++I    + + + H++ 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG 136
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
              IIHRD+K +NIL+ A    K+ DFG+AR + +   S   T+ ++GT  Y++PE    
Sbjct: 137 ---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG 193
Query: 503 GHFSIKSDVFSFGVLVLEIISGQK 526
                +SDV+S G ++ E+++G+ 
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 332 LGQGGFGAVYKGRLSHG----QEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRL 385
           LGQG FG V+  +   G    Q  A+K L K +  V+  +  K E  ++  + H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 386 LGFSFEETERL-LIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDS 443
             ++F+   +L LI +F+        +F  + K V    E     +  +A  + +LH   
Sbjct: 92  -HYAFQTEGKLYLILDFLRGGD----LFTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 144
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
            L II+RDLK  NILLD +   K++DFG+++  E    +       GT  YMAPE V R 
Sbjct: 145 -LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 504 HFSIKSDVFSFGVLVLEIISG 524
             +  +D +SFGVL+ E+++G
Sbjct: 202 GHTQSADWWSFGVLMFEMLTG 222

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 107/223 (47%), Gaps = 26/223 (11%)
Query: 324 NNFSTDNKLGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
           +  +    LG+G FG V         K +      +AVK L  ++ + +L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-------------FDAIKRVQL 420
             + +H+N++ LLG   ++    +I  +    ++ +++              + +   Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            ++        +ARG+ YL   +  + IHRDL A N+L+  + + KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               T+       +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAV-------KRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           +G+G FG V++G     +  A+       K  + +SV+ +  F  E L + +  H ++V+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 80
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           L+G    E    +I E      +  F+   +++  LD  +       ++  + YL     
Sbjct: 81  LIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK-- 135
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
            R +HRD+ A N+L+ ++   K+ DFG++R  E D +    S+      +MAPE +    
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR 193
Query: 505 FSIKSDVFSFGVLVLEII-------SGQKNN 528
           F+  SDV+ FGV + EI+        G KNN
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 72  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 171
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 172 DDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 111/212 (52%), Gaps = 23/212 (10%)
Query: 317 STIRDATN--NFSTDNKLGQGGFGAVYKG-RLSHGQEIAVK-----RLSKNSVQGELEFK 368
           S++ D  +  N+     LG+G FG V      + GQ++A+K      L+K+ +QG +E  
Sbjct: 5   SSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE-- 62
Query: 369 NEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYK 427
            E+  +  L+H ++++L      + E +++ E+  N      +FD I +R ++  +   +
Sbjct: 63  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNE-----LFDYIVQRDKMSEQEARR 117
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
               I   + Y H   R +I+HRDLK  N+LLD  +  KI+DFG++ +   D +   TS 
Sbjct: 118 FFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS- 172
Query: 488 IVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLV 518
             G+  Y APE ++ + +   + DV+S GV++
Sbjct: 173 -CGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 203

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 113/206 (54%), Gaps = 15/206 (7%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR-NL 382
           ++F   ++LG G  G V K +      I  ++L    ++  +  +N+++   ++ H  N 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAI--RNQIIRELQVLHECNS 73
Query: 383 VRLLGFS---FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
             ++GF    + + E  +  E +   S+D+ + +A KR+    E   K+   + RG+ YL
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA-KRIP--EEILGKVSIAVLRGLAYL 130
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
            E  + +I+HRD+K SNIL+++    K+ DFG++   ++  S  ++   VGT  YMAPE 
Sbjct: 131 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMAPER 184
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +   H+S++SD++S G+ ++E+  G+
Sbjct: 185 LQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 21/202 (10%)
Query: 325 NFSTDNKLGQGGFGAVYKG-RLSHGQEIAVK-----RLSKNSVQGELEFKNEVLLVARLQ 378
           N+     LG+G FG V      + GQ++A+K      L+K+ +QG +E   E+  +  L+
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 62
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGIL 437
           H ++++L      + E +++ E+  N      +FD I +R ++  +   +    I   + 
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNE-----LFDYIVQRDKMSEQEARRFFQQIISAVE 117
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H   R +I+HRDLK  N+LLD  +  KI+DFG++ +   D +   TS   G+  Y AP
Sbjct: 118 YCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS--CGSPNYAAP 171
Query: 498 EYVT-RGHFSIKSDVFSFGVLV 518
           E ++ + +   + DV+S GV++
Sbjct: 172 EVISGKLYAGPEVDVWSCGVIL 193

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAV-------KRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           +G+G FG V++G     +  A+       K  + +SV+ +  F  E L + +  H ++V+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 72
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           L+G    E    +I E      +  F+   +++  LD  +       ++  + YL     
Sbjct: 73  LIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK-- 127
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
            R +HRD+ A N+L+ ++   K+ DFG++R  E D +    S+      +MAPE +    
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR 185
Query: 505 FSIKSDVFSFGVLVLEII-------SGQKNN 528
           F+  SDV+ FGV + EI+        G KNN
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAV-------KRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           +G+G FG V++G     +  A+       K  + +SV+ +  F  E L + +  H ++V+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 77
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           L+G    E    +I E      +  F+   +++  LD  +       ++  + YL     
Sbjct: 78  LIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK-- 132
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
            R +HRD+ A N+L+ ++   K+ DFG++R  E D +    S+      +MAPE +    
Sbjct: 133 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR 190
Query: 505 FSIKSDVFSFGVLVLEII-------SGQKNN 528
           F+  SDV+ FGV + EI+        G KNN
Sbjct: 191 FTSASDVWMFGVCMWEILMHGVKPFQGVKNN 221

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHG----QEIAVKRLSKNS--VQGELEFKNEVLLVARL 377
           + F     LGQG FG V+  +   G    Q  A+K L K +  V+  +  K E  ++  +
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 378 QHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARG 435
            H  +V+L  ++F+   +L LI +F+        +F  + K V    E     +  +A  
Sbjct: 84  NHPFIVKL-HYAFQTEGKLYLILDFLRGGD----LFTRLSKEVMFTEEDVKFYLAELALA 138
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
           + +LH    L II+RDLK  NILLD +   K++DFG+++  E    +       GT  YM
Sbjct: 139 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYM 193
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           APE V R   +  +D +SFGVL+ E+++G
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 21/202 (10%)
Query: 325 NFSTDNKLGQGGFGAVYKG-RLSHGQEIAVK-----RLSKNSVQGELEFKNEVLLVARLQ 378
           N+     LG+G FG V      + GQ++A+K      L+K+ +QG +E   E+  +  L+
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 66
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGIL 437
           H ++++L      + E +++ E+  N      +FD I +R ++  +   +    I   + 
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNE-----LFDYIVQRDKMSEQEARRFFQQIISAVE 121
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H   R +I+HRDLK  N+LLD  +  KI+DFG++ +   D +   TS   G+  Y AP
Sbjct: 122 YCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS--CGSPNYAAP 175
Query: 498 EYVT-RGHFSIKSDVFSFGVLV 518
           E ++ + +   + DV+S GV++
Sbjct: 176 EVISGKLYAGPEVDVWSCGVIL 197

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAV-------KRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           +G+G FG V++G     +  A+       K  + +SV+ +  F  E L + +  H ++V+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 78
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           L+G    E    +I E      +  F+   +++  LD  +       ++  + YL     
Sbjct: 79  LIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK-- 133
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
            R +HRD+ A N+L+ ++   K+ DFG++R  E D +    S+      +MAPE +    
Sbjct: 134 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR 191
Query: 505 FSIKSDVFSFGVLVLEII-------SGQKNN 528
           F+  SDV+ FGV + EI+        G KNN
Sbjct: 192 FTSASDVWMFGVCMWEILMHGVKPFQGVKNN 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHG----QEIAVKRLSKNS--VQGELEFKNEVLLVARL 377
           + F     LGQG FG V+  +   G    Q  A+K L K +  V+  +  K E  ++  +
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 378 QHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARG 435
            H  +V+L  ++F+   +L LI +F+        +F  + K V    E     +  +A  
Sbjct: 85  NHPFIVKL-HYAFQTEGKLYLILDFLRGGD----LFTRLSKEVMFTEEDVKFYLAELALA 139
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
           + +LH    L II+RDLK  NILLD +   K++DFG+++  E    +       GT  YM
Sbjct: 140 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYM 194
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           APE V R   +  +D +SFGVL+ E+++G
Sbjct: 195 APEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 43/230 (18%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLS-KNSVQGELEFKNEVLLVARLQHRNL 382
           +F     LG+GGFG V++ +        A+KR+   N      +   EV  +A+L+H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 383 VRLLGFSFEE--TERLLIYEFVPNSSVDKFIFDAI----KRVQLDW-------ETRYK-- 427
           VR      E+  TE+L        SS   +++  +    K    DW       E R +  
Sbjct: 66  VRYFNAWLEKNTTEKLQ------PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 428 ---IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
              I   IA  + +LH      ++HRDLK SNI    D + K+ DFG+  +  MDQ + +
Sbjct: 120 CLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGL--VTAMDQDEEE 174
Query: 485 TSRI------------VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
            + +            VGT  YM+PE +    +S K D+FS G+++ E++
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LSK   S+        E+ L+
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLL 87
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 88  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 136 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 187
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 188 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 25/230 (10%)
Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQ----EIAVKRLS-KNSVQGE 364
           E LQ     +    N       LG+G FG+V +G L        ++AVK +   NS Q E
Sbjct: 20  EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE 79
Query: 365 LE-FKNEVLLVARLQHRNLVRLLGFSFEETER-----LLIYEFVPNSSVDKFIF-----D 413
           +E F +E   +    H N++RLLG   E + +     ++I  F+    +  ++       
Sbjct: 80  IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET 139
Query: 414 AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473
             K + L  +T  K +  IA G+ YL   S    +HRDL A N +L  DM   ++DFG++
Sbjct: 140 GPKHIPL--QTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
Query: 474 -RLFEMD-QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
            +++  D   QG  +++     ++A E +    ++ KSDV++FGV + EI
Sbjct: 195 KKIYSGDYYRQGRIAKM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 72  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 171
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 110/208 (52%), Gaps = 23/208 (11%)
Query: 331 KLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN-----LVR 384
           ++G+G +G+V K      GQ +AVKR+     + E   + ++L+   +  R+     +V+
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE---QKQLLMDLDVVMRSSDCPYIVQ 85
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKF---IFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
             G  F E +  +  E + ++S DKF   ++  +  V +  E   KI     + + +L E
Sbjct: 86  FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDV-IPEEILGKITLATVKALNHLKE 143
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV- 500
           +  L+IIHRD+K SNILLD     K+ DFG++   ++  S   T R  G   YMAPE + 
Sbjct: 144 N--LKIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKT-RDAGCRPYMAPERID 198
Query: 501 ---TRGHFSIKSDVFSFGVLVLEIISGQ 525
              +R  + ++SDV+S G+ + E+ +G+
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN---EVLL 373
           T  +    + +   +G G +G+V        G+++A+K+LS+   Q E+  K    E+LL
Sbjct: 18  TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLL 76
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEF---VPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
           +  +QH N++ LL      +     Y+F   +P    D      I  ++   E    ++ 
Sbjct: 77  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD---LQKIMGLKFSEEKIQYLVY 133
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
            + +G+ Y+H      ++HRDLK  N+ ++ D   KI DFG+AR      +  + +  V 
Sbjct: 134 QMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVV 185
Query: 491 TFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
           T  Y APE + +  H++   D++S G ++ E+++G+
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQHRNLVRLLG 387
           LG GG   V+  R L   +++AVK L  +  +     L F+ E    A L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 388 FSFEETE----RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
               ET       ++ E+V   ++   +        +  +   ++I    + + + H++ 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG 136
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
              IIHRD+K +NI++ A    K+ DFG+AR + +   S   T+ ++GT  Y++PE    
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 503 GHFSIKSDVFSFGVLVLEIISGQK 526
                +SDV+S G ++ E+++G+ 
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 82  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 130 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 181
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 182 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 323 TNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLS--KNSVQGELEFKNEVLLVARLQH 379
           ++N+    +LG+G F  V +    + G E A K ++  K S +   + + E  +  +LQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            N+VRL     EE+   L+++ V      +   D + R           I  I   I Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGG---ELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 440 HEDSRLRIIHRDLKASNILLDADM---IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
           H +    I+HR+LK  N+LL +       K++DFG+A   E++ S+       GT GY++
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 175
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE + +  +S   D+++ GV++  ++ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 110/237 (46%), Gaps = 22/237 (9%)
Query: 304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQ----EIAVKRLSKN 359
           D +   + L+     +      F+    LG+G FG+V + +L        ++AVK L  +
Sbjct: 3   DSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD 62
Query: 360 SVQGE--LEFKNEVLLVARLQHRNLVRLLGFSFEETER------LLIYEFVPNSSVDKFI 411
            +      EF  E   +    H ++ +L+G S     +      ++I  F+ +  +  F+
Sbjct: 63  IIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL 122
Query: 412 FDAI---KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS 468
             +        L  +T  + +  IA G+ YL   S    IHRDL A N +L  DM   ++
Sbjct: 123 LASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVA 179
Query: 469 DFGMAR-LFEMD-QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           DFG++R ++  D   QG  S++     ++A E +    +++ SDV++FGV + EI++
Sbjct: 180 DFGLSRKIYSGDYYRQGCASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 96  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 144 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 195
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 196 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 110/232 (47%), Gaps = 23/232 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGEL------EFKNEVLLVAR 376
           +++    +LG G F  V K R    G+E A K + K  +          E + EV ++  
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           ++H N++ L      +T+ +LI E V    +  F+ +   +  L  +   + +  I  G+
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGV 142
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEMDQSQGDTSRIVGTF 492
            YLH     RI H DLK  NI+L    +P    K+ DFG+A   E   +  +   I GT 
Sbjct: 143 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---AGNEFKNIFGTP 196
Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS 544
            ++APE V      +++D++S GV+   ++SG    S  +GE  ++ LT +S
Sbjct: 197 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGETKQETLTNIS 245

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN---EVLL 373
           T  +    + +   +G G +G+V        G+++A+K+LS+   Q E+  K    E+LL
Sbjct: 36  TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLL 94
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEF---VPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
           +  +QH N++ LL      +     Y+F   +P    D      I  ++   E    ++ 
Sbjct: 95  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD---LQKIMGMEFSEEKIQYLVY 151
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
            + +G+ Y+H      ++HRDLK  N+ ++ D   KI DFG+AR      +  + +  V 
Sbjct: 152 QMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVV 203
Query: 491 TFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
           T  Y APE + +  H++   D++S G ++ E+++G+
Sbjct: 204 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 35  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 95  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 142
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 143 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 194
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 195 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQHRNLVRLLG 387
           LG GG   V+  R L   +++AVK L  +  +     L F+ E    A L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 388 FSFEETE----RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
               ET       ++ E+V   ++   +        +  +   ++I    + + + H++ 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG 136
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
              IIHRD+K +NI++ A    K+ DFG+AR + +   S   T+ ++GT  Y++PE    
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 503 GHFSIKSDVFSFGVLVLEIISGQK 526
                +SDV+S G ++ E+++G+ 
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 110/232 (47%), Gaps = 23/232 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGEL------EFKNEVLLVAR 376
           +++    +LG G F  V K R    G+E A K + K  +          E + EV ++  
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           ++H N++ L      +T+ +LI E V    +  F+ +   +  L  +   + +  I  G+
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGV 121
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEMDQSQGDTSRIVGTF 492
            YLH     RI H DLK  NI+L    +P    K+ DFG+A   E   +  +   I GT 
Sbjct: 122 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---AGNEFKNIFGTP 175
Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVS 544
            ++APE V      +++D++S GV+   ++SG    S  +GE  ++ LT +S
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA---SPFLGETKQETLTNIS 224

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +     +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 26  TIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 85
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 86  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 133
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 134 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 185
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 186 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 330 NKLGQGGFGAVYKG-RLSHGQEIAVKRLS--KNSVQGELEFKNEVLLVARLQHRNLVRLL 386
            +LG+G F  V +  ++  GQE A K ++  K S +   + + E  +   L+H N+VRL 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
               EE    LI++ V      +   D + R           I  I   +L+ H+   + 
Sbjct: 88  DSISEEGHHYLIFDLVTGG---ELFEDIVAREYYSEADASHCIQQILEAVLHCHQ---MG 141
Query: 447 IIHRDLKASNILLDADM---IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
           ++HRDLK  N+LL + +     K++DFG+A   E++  Q       GT GY++PE + + 
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEVLRKD 199
Query: 504 HFSIKSDVFSFGVLVLEIISG 524
            +    D+++ GV++  ++ G
Sbjct: 200 PYGKPVDLWACGVILYILLVG 220

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 323 TNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLS--KNSVQGELEFKNEVLLVARLQH 379
           ++N+    +LG+G F  V +    + G E A K ++  K S +   + + E  +  +LQH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            N+VRL     EE+   L+++ V      +   D + R           I  I   I Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGG---ELFEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 440 HEDSRLRIIHRDLKASNILLDADM---IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
           H +    I+HR+LK  N+LL +       K++DFG+A   E++ S+       GT GY++
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 174
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE + +  +S   D+++ GV++  ++ G
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLLG 387
           LG+GGF   Y+      +E+   ++   S+      + +   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
           F  ++    ++ E     S+        ++   + E RY +   I +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
           IHRDLK  N+ L+ DM  KI DFG+A   E D  +     + GT  Y+APE + +   S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPNYIAPEVLCKKGHSF 221
Query: 508 KSDVFSFGVLVLEIISGQ 525
           + D++S G ++  ++ G+
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQHRNLVRLLG 387
           LG GG   V+  R L   +++AVK L  +  +     L F+ E    A L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 388 FSFEETE----RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
               ET       ++ E+V   ++   +        +  +   ++I    + + + H++ 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG 136
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
              IIHRD+K +NI++ A    K+ DFG+AR + +   S   T+ ++GT  Y++PE    
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 503 GHFSIKSDVFSFGVLVLEIISGQK 526
                +SDV+S G ++ E+++G+ 
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLLG 387
           LG+GGF   Y+      +E+   ++   S+      + +   E+ +   L + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
           F  ++    ++ E     S+        ++   + E RY +   I +G+ YLH +   R+
Sbjct: 94  FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 147
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
           IHRDLK  N+ L+ DM  KI DFG+A   E D  +     + GT  Y+APE + +   S 
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPEVLCKKGHSF 205
Query: 508 KSDVFSFGVLVLEIISGQ 525
           + D++S G ++  ++ G+
Sbjct: 206 EVDIWSLGCILYTLLVGK 223

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 21  TIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 81  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 129 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HT 180
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 181 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 323 TNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLS--KNSVQGELEFKNEVLLVARLQH 379
           ++N+    +LG+G F  V +    + G E A K ++  K S +   + + E  +  +LQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            N+VRL     EE+   L+++ V      +   D + R           I  I   I Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGG---ELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 440 HEDSRLRIIHRDLKASNILLDADM---IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
           H +    I+HR+LK  N+LL +       K++DFG+A   E++ S+       GT GY++
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 175
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE + +  +S   D+++ GV++  ++ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 38/225 (16%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQH 379
           N+FS    +G+GGFG VY  R +  G+  A+K L K  +   QGE    NE ++++ +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 380 RN--LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII-------- 429
            +   +  + ++F   ++L             FI D +    L +      +        
Sbjct: 249 GDCPFIVCMSYAFHTPDKL------------SFILDLMNGGDLHYHLSQHGVFSEADMRF 296
Query: 430 --GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
               I  G+ ++H  +R  +++RDLK +NILLD     +ISD G+A     D S+     
Sbjct: 297 YAAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHA 349
Query: 488 IVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFR 531
            VGT GYMAPE + +G  +   +D FS G ++ +++ G  ++ FR
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG--HSPFR 392

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 38/225 (16%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQH 379
           N+FS    +G+GGFG VY  R +  G+  A+K L K  +   QGE    NE ++++ +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 380 RN--LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII-------- 429
            +   +  + ++F   ++L             FI D +    L +      +        
Sbjct: 249 GDCPFIVCMSYAFHTPDKL------------SFILDLMNGGDLHYHLSQHGVFSEADMRF 296
Query: 430 --GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
               I  G+ ++H  +R  +++RDLK +NILLD     +ISD G+A     D S+     
Sbjct: 297 YAAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHA 349
Query: 488 IVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFR 531
            VGT GYMAPE + +G  +   +D FS G ++ +++ G  ++ FR
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG--HSPFR 392

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLLG 387
           LG+GGF   Y+      +E+   ++   S+      + +   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
           F  ++    ++ E     S+        ++   + E RY +   I +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
           IHRDLK  N+ L+ DM  KI DFG+A   E D  +     + GT  Y+APE + +   S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPEVLCKKGHSF 221
Query: 508 KSDVFSFGVLVLEIISGQ 525
           + D++S G ++  ++ G+
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAV-------KRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           +G+G FG V++G     +  A+       K  + +SV+ +  F  E L + +  H ++V+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 455
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           L+G    E    +I E      +  F+   +++  LD  +       ++  + YL     
Sbjct: 456 LIGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK-- 510
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
            R +HRD+ A N+L+ A    K+ DFG++R  E D +    S+      +MAPE +    
Sbjct: 511 -RFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR 568
Query: 505 FSIKSDVFSFGVLVLEII-------SGQKNN 528
           F+  SDV+ FGV + EI+        G KNN
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 96  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 144 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 195
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             +    V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 196 DDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 83  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 131 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 182
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 183 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLL---VARLQH 379
           N+     ++G G  G V+K R    G  IAVK++ ++   G  E    +L+   V    H
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS---GNKEENKRILMDLDVVLKSH 81
Query: 380 --RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRY--KIIGGIARG 435
               +V+  G     T+  +  E +  +  +K      KR+Q     R   K+   I + 
Sbjct: 82  DCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLK----KRMQGPIPERILGKMTVAIVKA 136
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
           + YL E  +  +IHRD+K SNILLD     K+ DFG++     D+++    R  G   YM
Sbjct: 137 LYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYM 191
Query: 496 APEYV-----TRGHFSIKSDVFSFGVLVLEIISGQ 525
           APE +     T+  + I++DV+S G+ ++E+ +GQ
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 81  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 129 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 180
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 181 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 15  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 74
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 75  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 122
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 123 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 174
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 175 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 323 TNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLS--KNSVQGELEFKNEVLLVARLQH 379
           ++N+    +LG+G F  V +    + G E A K ++  K S +   + + E  +  +LQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            N+VRL     EE+   L+++ V      +   D + R           I  I   I Y 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGG---ELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 440 HEDSRLRIIHRDLKASNILLDADM---IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
           H +    I+HR+LK  N+LL +       K++DFG+A   E++ S+       GT GY++
Sbjct: 145 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 198
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE + +  +S   D+++ GV++  ++ G
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 78  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 126 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 177
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 178 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 13  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 73  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 120
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 121 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 172
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 173 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 81  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 129 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HT 180
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 181 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 22/223 (9%)
Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEI--AVKRLSKNSVQGELEF 367
           E+L F  ST  D    ++ +N +G+G +G V K  +  G  I  A K++ K  V+    F
Sbjct: 12  ENLYFQGSTKGDINQYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRF 70
Query: 368 KNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI--KRVQLDWETR 425
           K E+ ++  L H N++RL     + T+  L+ E          +F+ +  KRV  + +  
Sbjct: 71  KQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA 126
Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQ 482
            +I+  +   + Y H   +L + HRDLK  N L      D   K+ DFG+A  F+     
Sbjct: 127 -RIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK----P 178
Query: 483 GDTSRI-VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           G   R  VGT  Y++P+ V  G +  + D +S GV++  ++ G
Sbjct: 179 GKMMRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 38/225 (16%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQH 379
           N+FS    +G+GGFG VY  R +  G+  A+K L K  +   QGE    NE ++++ +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 380 RN--LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII-------- 429
            +   +  + ++F   ++L             FI D +    L +      +        
Sbjct: 249 GDCPFIVCMSYAFHTPDKL------------SFILDLMNGGDLHYHLSQHGVFSEADMRF 296
Query: 430 --GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
               I  G+ ++H  +R  +++RDLK +NILLD     +ISD G+A     D S+     
Sbjct: 297 YAAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHA 349
Query: 488 IVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFR 531
            VGT GYMAPE + +G  +   +D FS G ++ +++ G  ++ FR
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG--HSPFR 392

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 81  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 129 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 180
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 181 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 38/225 (16%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQH 379
           N+FS    +G+GGFG VY  R +  G+  A+K L K  +   QGE    NE ++++ +  
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 380 RN--LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII-------- 429
            +   +  + ++F   ++L             FI D +    L +      +        
Sbjct: 248 GDCPFIVCMSYAFHTPDKL------------SFILDLMNGGDLHYHLSQHGVFSEADMRF 295
Query: 430 --GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
               I  G+ ++H  +R  +++RDLK +NILLD     +ISD G+A     D S+     
Sbjct: 296 YAAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHA 348
Query: 488 IVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFR 531
            VGT GYMAPE + +G  +   +D FS G ++ +++ G  ++ FR
Sbjct: 349 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG--HSPFR 391

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 78  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 126 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 177
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 178 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 14  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 73
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 74  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 121
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 122 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 173
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 174 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 83  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 131 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 182
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 13  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 73  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 120
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 121 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 172
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 173 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 83  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 131 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 182
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 27  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 87  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 134
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 135 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HT 186
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 187 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 83  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 131 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 182
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 27  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 87  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 134
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 135 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 186
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 187 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 82  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 130 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 181
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 182 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAV-------KRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
           +G+G FG V++G     +  A+       K  + +SV+ +  F  E L + +  H ++V+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIVK 455
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           L+G    E    +I E      +  F+   +++  LD  +       ++  + YL     
Sbjct: 456 LIGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK-- 510
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
            R +HRD+ A N+L+ ++   K+ DFG++R  E D +    S+      +MAPE +    
Sbjct: 511 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR 568
Query: 505 FSIKSDVFSFGVLVLEII-------SGQKNN 528
           F+  SDV+ FGV + EI+        G KNN
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 88  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 136 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 187
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 188 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 88  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 136 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 187
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 188 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 78  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 126 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 177
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 178 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 72  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 171
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 82  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 130 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 181
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 182 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 35  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 95  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 142
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 143 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 194
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 195 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQHRNLVRLLG 387
           LG GG   V+  R L   +++AVK L  +  +     L F+ E    A L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 388 FSFEETE----RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
               ET       ++ E+V   ++   +        +  +   ++I    + + + H++ 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG 136
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
              IIHRD+K +NI++ A    K+ DFG+AR + +   S   T+ ++GT  Y++PE    
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 503 GHFSIKSDVFSFGVLVLEIISGQK 526
                +SDV+S G ++ E+++G+ 
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 39  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 99  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 146
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 147 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 198
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 199 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 82  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 130 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HT 181
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 182 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 96  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 144 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 195
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 196 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 78  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 126 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HT 177
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 178 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYK------GRLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVAR 376
           NN      LG G FG V +      G+     ++AVK L   +   E E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-----------FDAIKRVQLDWET 424
           L QH N+V LLG        L+I E+     +  F+           ++     +    +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 425 R--YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482
           R        +A+G+ +L   +    IHRD+ A N+LL    + KI DFG+AR    D + 
Sbjct: 166 RDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                      +MAPE +    ++++SDV+S+G+L+ EI S
Sbjct: 223 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 101/227 (44%), Gaps = 16/227 (7%)
Query: 319 IRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV----QGELEFKNEVLL 373
           I+    +F     LG+G FG V+        Q  A+K L K+ V      E     + +L
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 72
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
               +H  L  +   +F+  E L       N     +   +  +  L   T Y     I 
Sbjct: 73  SLAWEHPFLTHMFC-TFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA--AEII 129
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
            G+ +LH      I++RDLK  NILLD D   KI+DFGM +  E       T+   GT  
Sbjct: 130 LGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGTPD 184
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL 540
           Y+APE +    ++   D +SFGVL+ E++ GQ  + F  G++ E+L 
Sbjct: 185 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFH-GQDEEELF 228

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 39  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 99  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 146
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      +
Sbjct: 147 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 198
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             +    V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 199 DDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQHRNLVRLLG 387
           LG GG   V+  R L   +++AVK L  +  +     L F+ E    A L H  +V +  
Sbjct: 37  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 96
Query: 388 FSFEETE----RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
               ET       ++ E+V   ++   +        +  +   ++I    + + + H++ 
Sbjct: 97  TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG 153
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
              IIHRD+K +NI++ A    K+ DFG+AR + +   S   T+ ++GT  Y++PE    
Sbjct: 154 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 210
Query: 503 GHFSIKSDVFSFGVLVLEIISGQK 526
                +SDV+S G ++ E+++G+ 
Sbjct: 211 DSVDARSDVYSLGCVLYEVLTGEP 234

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 332 LGQGGFGAVY-----KGRLSHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRL 385
           LG+G FG V            G+ +AVK L +    Q    ++ E+ ++  L H ++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G   ++ E+   L+ E+VP  S+     D + R  +           I  G+ YLH   
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLHAQ- 130
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARL------FEMDQSQGDTSRIVGTFGYMAP 497
               IHR L A N+LLD D + KI DFG+A+       +   +  GD+      F Y AP
Sbjct: 131 --HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP----VFWY-AP 183
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
           E +    F   SDV+SFGV + E+++
Sbjct: 184 ECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 105/212 (49%), Gaps = 18/212 (8%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQG---ELEFKNEVLLVA 375
           R    ++   + LG G FG V  G     G ++AVK L++  ++      + K E+  + 
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 376 RLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIAR 434
             +H ++++L       T+  ++ E+V        +FD I K  +++     ++   I  
Sbjct: 67  LFRHPHIIKLYQVISTPTDFFMVMEYVSGGE----LFDYICKHGRVEEMEARRLFQQILS 122
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-VGTFG 493
            + Y H   R  ++HRDLK  N+LLDA M  KI+DFG++ +     S G+  R   G+  
Sbjct: 123 AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM----SDGEFLRTSCGSPN 175
Query: 494 YMAPEYVT-RGHFSIKSDVFSFGVLVLEIISG 524
           Y APE ++ R +   + D++S GV++  ++ G
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 332 LGQGGFGAVY-----KGRLSHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRL 385
           LG+G FG V            G+ +AVK L +    Q    ++ E+ ++  L H ++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G   ++ E+   L+ E+VP  S+     D + R  +           I  G+ YLH   
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLHAQ- 131
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARL------FEMDQSQGDTSRIVGTFGYMAP 497
               IHR L A N+LLD D + KI DFG+A+       +   +  GD+      F Y AP
Sbjct: 132 --HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP----VFWY-AP 184
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
           E +    F   SDV+SFGV + E+++
Sbjct: 185 ECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI D+G+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 26/206 (12%)
Query: 332 LGQGGFGAVY-----KGRLSHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRL 385
           LG+G FG V            G+ +AVK L  ++  Q    +K E+ ++  L H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 386 LGFSFEE--TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            G   +       L+ E+VP  S+     D + R  +           I  G+ YLH   
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLHAQ- 153
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ------SQGDTSRIVGTFGYMAP 497
               IHRDL A N+LLD D + KI DFG+A+              GD+      F Y AP
Sbjct: 154 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSP----VFWY-AP 206
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
           E +    F   SDV+SFGV + E+++
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 110/234 (47%), Gaps = 32/234 (13%)
Query: 306 INTVESLQFDFSTIRDATNNFSTD-------NKLGQGGFGAVYKGR-LSHGQEIAVKRLS 357
           I T E+L F     + A  NF           +LG+G +G V K R +  GQ  AVKR+ 
Sbjct: 14  IPTTENLYF-----QGAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIR 68
Query: 358 KNSVQGELEFKNEVLLVARLQHRNL-----VRLLGFSFEETERLLIYEFVPNSSVDKFIF 412
                 E   +  +L    +  R +     V   G  F E +  +  E   ++S+DKF  
Sbjct: 69  ATVNSQE---QKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXELX-DTSLDKFYK 124
Query: 413 DAIKRVQ-LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471
             I + Q +  +   KI   I + + +LH  S+L +IHRD+K SN+L++A    K  DFG
Sbjct: 125 QVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFG 182
Query: 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYV----TRGHFSIKSDVFSFGVLVLEI 521
           ++  + +D    D     G   Y APE +     +  +S+KSD++S G+  +E+
Sbjct: 183 ISG-YLVDDVAKDID--AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+ R      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 31/228 (13%)
Query: 324 NNFSTDNKLGQGGFGAVYK------GRLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVAR 376
           NN      LG G FG V +      G+     ++AVK L   +   E E   +E+ +++ 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI--------------------FDAI 415
           L QH N+V LLG        L+I E+     +  F+                     D  
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 416 KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475
               L+          +A+G+ +L   +    IHRD+ A N+LL    + KI DFG+AR 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
              D +            +MAPE +    ++++SDV+S+G+L+ EI S
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 323 TNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLS--KNSVQGELEFKNEVLLVARLQH 379
           T+ +     +G+G F  V +  +L  G E A K ++  K S +   + + E  +   L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            N+VRL     EE    L+++ V      +   D + R           I  I   +L+ 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGG---ELFEDIVAREYYSEADASHCIQQILEAVLHC 119
Query: 440 HEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
           H+   + ++HRDLK  N+LL +       K++DFG+A   E+   Q       GT GY++
Sbjct: 120 HQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLS 174
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE + +  +    D+++ GV++  ++ G
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 101/227 (44%), Gaps = 16/227 (7%)
Query: 319 IRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV----QGELEFKNEVLL 373
           I+    +F     LG+G FG V+        Q  A+K L K+ V      E     + +L
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
               +H  L  +   +F+  E L       N     +   +  +  L   T Y     I 
Sbjct: 72  SLAWEHPFLTHMFC-TFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA--AEII 128
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
            G+ +LH      I++RDLK  NILLD D   KI+DFGM +  E       T+   GT  
Sbjct: 129 LGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGTPD 183
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL 540
           Y+APE +    ++   D +SFGVL+ E++ GQ  + F  G++ E+L 
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFH-GQDEEELF 227

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 112/238 (47%), Gaps = 22/238 (9%)
Query: 317 STIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFK-----NE 370
           S+ R   +NF     LG+G FG V   R+   G   AVK L K+ +  + + +       
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 371 VLLVARLQHRNLVRLLGFSFEETERLL-IYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
           +L +AR  H  L +L    F+  +RL  + EFV    +   +F   K  + D E R +  
Sbjct: 76  ILSLAR-NHPFLTQLFC-CFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFY 129
Query: 430 GG-IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
              I   +++LH+     II+RDLK  N+LLD +   K++DFGM +  E   +   T+  
Sbjct: 130 AAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATF 184
Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNN 546
            GT  Y+APE +    +    D ++ GVL+ E++ G         E  +DL   + N+
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE---AENEDDLFEAILND 239

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 15/214 (7%)
Query: 332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVL---LVARLQHRNLVRLLG 387
           LG+GGFG V+  ++ + G+  A K+L+K  ++    ++  ++   ++A++  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-A 251
Query: 388 FSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLHEDSRL 445
           ++FE +T+  L+   +    +   I++  +      E R       I  G+ +LH+ +  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
            II+RDLK  N+LLD D   +ISD G+A   E+   Q  T    GT G+MAPE +    +
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 506 SIKSDVFSFGVLVLEIISGQKNNSFRI-GEEAED 538
               D F+ GV + E+I+ +    FR  GE+ E+
Sbjct: 367 DFSVDYFALGVTLYEMIAAR--GPFRARGEKVEN 398

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           +    +LG G F  V K R     L +  +   KR S+ S +G    E + EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L       T+ +LI E V    +  F+    ++  L  E     I  I  G+ Y
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNY 130
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH     +I H DLK  NI+L    IP    K+ DFG+A   E      +   I GT  +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTPEF 184
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           +APE V      +++D++S GV+   ++SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 44/211 (20%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  S+++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM------TPYVVTRY- 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           Y APE +    +    D++S GV++ E+I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 44/211 (20%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  S+++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM------TPYVVTRY- 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           Y APE +    +    D++S GV++ E+I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVY-KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V     +  G   A+K L K  V    E +   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+ P       +F  ++R+    E   +     I     
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+++D     K++DFG+A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQG---ELEFKNEVLLVA 375
           R    ++   + LG G FG V  G     G ++AVK L++  ++      + K E+  + 
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 376 RLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIAR 434
             +H ++++L       T+  ++ E+V        +FD I K  +++     ++   I  
Sbjct: 67  LFRHPHIIKLYQVISTPTDFFMVMEYVSGGE----LFDYICKHGRVEEMEARRLFQQILS 122
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
            + Y H   R  ++HRDLK  N+LLDA M  KI+DFG++ +    +   D+    G+  Y
Sbjct: 123 AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNY 176
Query: 495 MAPEYVT-RGHFSIKSDVFSFGVLVLEIISG 524
            APE ++ R +   + D++S GV++  ++ G
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 17/200 (8%)
Query: 332 LGQGGFGAVYKGRLSHGQEI--AVKRLSKNSVQGELEFKNEV----LLVARLQHRNLVRL 385
           +G+G FG V   R    +E+  AVK L K ++  + E K+ +    +L+  ++H  LV L
Sbjct: 46  IGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSR 444
             FSF+  ++L    FV +      +F  ++R +   E R +     IA  + YLH    
Sbjct: 105 -HFSFQTADKLY---FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS--- 157
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
           L I++RDLK  NILLD+     ++DFG+ +  E  +    TS   GT  Y+APE + +  
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQP 215
Query: 505 FSIKSDVFSFGVLVLEIISG 524
           +    D +  G ++ E++ G
Sbjct: 216 YDRTVDWWCLGAVLYEMLYG 235

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 15/214 (7%)
Query: 332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVL---LVARLQHRNLVRLLG 387
           LG+GGFG V+  ++ + G+  A K+L+K  ++    ++  ++   ++A++  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-A 251
Query: 388 FSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLHEDSRL 445
           ++FE +T+  L+   +    +   I++  +      E R       I  G+ +LH+ +  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
            II+RDLK  N+LLD D   +ISD G+A   E+   Q  T    GT G+MAPE +    +
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 506 SIKSDVFSFGVLVLEIISGQKNNSFRI-GEEAED 538
               D F+ GV + E+I+ +    FR  GE+ E+
Sbjct: 367 DFSVDYFALGVTLYEMIAAR--GPFRARGEKVEN 398

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           +    +LG G F  V K R     L +  +   KR S+ S +G    E + EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L       T+ +LI E V    +  F+    ++  L  E     I  I  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNY 130
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH     +I H DLK  NI+L    IP    K+ DFG+A   E      +   I GT  +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTPEF 184
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           +APE V      +++D++S GV+   ++SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           +    +LG G F  V K R     L +  +   KR S+ S +G    E + EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L       T+ +LI E V    +  F+    ++  L  E     I  I  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNY 130
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH     +I H DLK  NI+L    IP    K+ DFG+A   E      +   I GT  +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTPEF 184
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           +APE V      +++D++S GV+   ++SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR-NL 382
           ++F   ++LG G  G V+K  +SH     V       ++ +   +N+++   ++ H  N 
Sbjct: 68  DDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 125
Query: 383 VRLLGFS---FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
             ++GF    + + E  +  E +   S+D+ +  A +   +  +   K+   + +G+ YL
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 182
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
            E  + +I+HRD+K SNIL+++    K+ DFG++   ++  S  ++   VGT  YM+PE 
Sbjct: 183 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPER 236
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +   H+S++SD++S G+ ++E+  G+
Sbjct: 237 LQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKNEV---LLVARLQ-------HR 380
           LG+GGFG V+ G RL+   ++A+K + +N V G     + V   L VA L        H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
            ++RLL + FE  E  ++    P  + D F +   K    +  +R    G +   I + H
Sbjct: 99  GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC-FFGQVVAAIQHCH 156
Query: 441 EDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
                 ++HRD+K  NIL+D      K+ DFG   L   D+   D     GT  Y  PE+
Sbjct: 157 SRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTDFD---GTRVYSPPEW 209
Query: 500 VTRGHF-SIKSDVFSFGVLVLEIISG 524
           ++R  + ++ + V+S G+L+ +++ G
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 15/214 (7%)
Query: 332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVL---LVARLQHRNLVRLLG 387
           LG+GGFG V+  ++ + G+  A K+L+K  ++    ++  ++   ++A++  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-A 251
Query: 388 FSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLHEDSRL 445
           ++FE +T+  L+   +    +   I++  +      E R       I  G+ +LH+ +  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
            II+RDLK  N+LLD D   +ISD G+A   E+   Q  T    GT G+MAPE +    +
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 506 SIKSDVFSFGVLVLEIISGQKNNSFRI-GEEAED 538
               D F+ GV + E+I+ +    FR  GE+ E+
Sbjct: 367 DFSVDYFALGVTLYEMIAAR--GPFRARGEKVEN 398

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           +    +LG G F  V K R     L +  +   KR S+ S +G    E + EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L       T+ +LI E V    +  F+    ++  L  E     I  I  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNY 130
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH     +I H DLK  NI+L    IP    K+ DFG+A   E      +   I GT  +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTPEF 184
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           +APE V      +++D++S GV+   ++SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           LGQG FG V K R +   +  A+K++ +++ +      +EV+L+A L H+ +VR      
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 391 EETERLLIYEFVPNSSV---------DKFIFDAIKRVQLDWE--TRYKIIGGIARGILYL 439
           E    +     V   S          ++ ++D I    L+ +    +++   I   + Y+
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYI 132
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-------LFEMDQ-----SQGDTSR 487
           H      IIHRDLK  NI +D     KI DFG+A+       + ++D      S  + + 
Sbjct: 133 HSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189
Query: 488 IVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEII 522
            +GT  Y+A E +   GH++ K D++S G++  E+I
Sbjct: 190 AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           +    +LG G F  V K R     L +  +   KR S+ S +G    E + EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L       T+ +LI E V    +  F+    ++  L  E     I  I  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNY 130
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH     +I H DLK  NI+L    IP    K+ DFG+A   E      +   I GT  +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTPEF 184
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           +APE V      +++D++S GV+   ++SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 15/214 (7%)
Query: 332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVL---LVARLQHRNLVRLLG 387
           LG+GGFG V+  ++ + G+  A K+L+K  ++    ++  ++   ++A++  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-A 251
Query: 388 FSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLHEDSRL 445
           ++FE +T+  L+   +    +   I++  +      E R       I  G+ +LH+ +  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
            II+RDLK  N+LLD D   +ISD G+A   E+   Q  T    GT G+MAPE +    +
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 506 SIKSDVFSFGVLVLEIISGQKNNSFRI-GEEAED 538
               D F+ GV + E+I+ +    FR  GE+ E+
Sbjct: 367 DFSVDYFALGVTLYEMIAAR--GPFRARGEKVEN 398

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 105/221 (47%), Gaps = 34/221 (15%)
Query: 331 KLGQGGFGAVYKG-RLSHGQEIAVKRLS---KNSVQGELEFKNEVLLVARLQHRNLVRLL 386
           KLG+G +G V+K      G+ +AVK++    +NS   +  F+  ++L     H N+V LL
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 387 GFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
                + +R   L+++++        +   I+   L+   +  ++  + + I YLH    
Sbjct: 76  NVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG- 129
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLF-------------------EMDQSQGDT 485
             ++HRD+K SNILL+A+   K++DFG++R F                     D  Q   
Sbjct: 130 --LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 486 SRIVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEIISGQ 525
           +  V T  Y APE +     ++   D++S G ++ EI+ G+
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DF +AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 323 TNNFSTDNKLGQGGFGAVYKG-RLSHGQEIA--VKRLSKNSVQGELEFKNEVLLVARLQH 379
           T  +    +LG+G F  V +  ++  GQE A  +    K S +   + + E  +   L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            N+VRL     EE    LI++ V      +   D + R           I  I   +L+ 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGG---ELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 440 HEDSRLRIIHRDLKASNILLDADM---IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
           H+   + ++HR+LK  N+LL + +     K++DFG+A   E++  Q       GT GY++
Sbjct: 127 HQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLS 181
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE + +  +    D+++ GV++  ++ G
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVY-KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V     +  G   A+K L K  V    + +   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 102 PFLVKL-EFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFXEPHARFYAAQIVLTFE 156
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR-NL 382
           ++F   ++LG G  G V+K  +SH     V       ++ +   +N+++   ++ H  N 
Sbjct: 6   DDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 383 VRLLGFS---FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
             ++GF    + + E  +  E +   S+D+ +  A +   +  +   K+   + +G+ YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
            E  + +I+HRD+K SNIL+++    K+ DFG++   ++  S  ++   VGT  YM+PE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPER 174
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +   H+S++SD++S G+ ++E+  G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 17/229 (7%)
Query: 326 FSTDNKLGQGGFGAVY-KGRLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLV 383
           F    KLG G FG V+     S G E  +K ++K+  Q  +E  + E+ ++  L H N++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQ-LDWETRYKIIGGIARGILYLHE 441
           ++    FE+   + ++ E      + + I  A  R + L      +++  +   + Y H 
Sbjct: 84  KIFEV-FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142
Query: 442 DSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
                ++H+DLK  NIL   D  P    KI DFG+A LF+ D+    ++   GT  YMAP
Sbjct: 143 Q---HVVHKDLKPENILFQ-DTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAP 195
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNN 546
           E   R   + K D++S GV++  +++G    +    EE +   TY   N
Sbjct: 196 EVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN 243

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   + +  G   A+K L K  V    + +   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   + +  G   A+K L K  V    + +   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR-NL 382
           ++F   ++LG G  G V+K  +SH     V       ++ +   +N+++   ++ H  N 
Sbjct: 6   DDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 383 VRLLGFS---FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
             ++GF    + + E  +  E +   S+D+ +  A +   +  +   K+   + +G+ YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
            E  + +I+HRD+K SNIL+++    K+ DFG++   ++  S  ++   VGT  YM+PE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPER 174
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +   H+S++SD++S G+ ++E+  G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 326 FSTDNKLGQGGFGAVYKGR-----LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ 378
           +    +LG G F  V K R     L +  +   KR S+ S +G    E + EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ L       T+ +LI E V    +  F+    ++  L  E     I  I  G+ Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNY 130
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           LH     +I H DLK  NI+L    IP    K+ DFG+A   E      +   I GT  +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTPEF 184
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           +APE V      +++D++S GV+   ++SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR-NL 382
           ++F   ++LG G  G V+K  +SH     V       ++ +   +N+++   ++ H  N 
Sbjct: 6   DDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 383 VRLLGFS---FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
             ++GF    + + E  +  E +   S+D+ +  A +   +  +   K+   + +G+ YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
            E  + +I+HRD+K SNIL+++    K+ DFG++   ++  S  ++   VGT  YM+PE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPER 174
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +   H+S++SD++S G+ ++E+  G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR-NL 382
           ++F   ++LG G  G V+K  +SH     V       ++ +   +N+++   ++ H  N 
Sbjct: 6   DDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 383 VRLLGFS---FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
             ++GF    + + E  +  E +   S+D+ +  A +   +  +   K+   + +G+ YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
            E  + +I+HRD+K SNIL+++    K+ DFG++   ++  S  ++   VGT  YM+PE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPER 174
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +   H+S++SD++S G+ ++E+  G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 30/207 (14%)
Query: 331 KLGQGGFGAVYKGRLSHGQE-IAVKRL----SKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           KLG+G +G VYK   +   E +A+KR+     +  V G      EV L+  LQHRN++ L
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA--IREVSLLKELQHRNIIEL 98
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG----IARGILYLHE 441
                      LI+E+  N        D  K +  + +   ++I      +  G+ + H 
Sbjct: 99  KSVIHHNHRLHLIFEYAEN--------DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH- 149
Query: 442 DSRLRIIHRDLKASNILL---DADMIP--KISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            SR R +HRDLK  N+LL   DA   P  KI DFG+AR F +   Q  T  I+ T  Y  
Sbjct: 150 -SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-THEII-TLWYRP 205
Query: 497 PEYVTRG-HFSIKSDVFSFGVLVLEII 522
           PE +    H+S   D++S   +  E++
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     +G G FG V   + +  G   A+K L K  V    + +   NE  ++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     K++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 25/203 (12%)
Query: 330 NKLGQGGFG-AVYKGRLSHGQEIAVKRL--SKNSVQGELEFKNEVLLVARLQHRNLVRLL 386
            K+G+G FG A+       G++  +K +  S+ S +   E + EV ++A ++H N+V+  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 387 GFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQ------LDWETRYKIIGGIARGILYL 439
             SFEE   L ++ ++     + K I +A K V       LDW  +      I   + ++
Sbjct: 90  E-SFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQ------ICLALKHV 141
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-VGTFGYMAPE 498
           H+    +I+HRD+K+ NI L  D   ++ DFG+AR+     S  + +R  +GT  Y++PE
Sbjct: 142 HDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVELARACIGTPYYLSPE 195
Query: 499 YVTRGHFSIKSDVFSFGVLVLEI 521
                 ++ KSD+++ G ++ E+
Sbjct: 196 ICENKPYNNKSDIWALGCVLYEL 218

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR-NL 382
           ++F   ++LG G  G V+K  +SH     V       ++ +   +N+++   ++ H  N 
Sbjct: 6   DDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 383 VRLLGFS---FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
             ++GF    + + E  +  E +   S+D+ +  A +   +  +   K+   + +G+ YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
            E  + +I+HRD+K SNIL+++    K+ DFG++   ++  S  ++   VGT  YM+PE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPER 174
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +   H+S++SD++S G+ ++E+  G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 18/221 (8%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFK---NEVLLVARLQHRNLVRLLG 387
           LG+G FG V        +E+ A+K L K+ V  + + +    E  ++A L     +  L 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
             F+  +RL  + E+V N     +    + + +      Y     I+ G+ +LH+     
Sbjct: 87  SCFQTVDRLYFVMEYV-NGGDLMYHIQQVGKFKEPQAVFYA--AEISIGLFFLHKRG--- 140
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMAPEYVTRGHF 505
           II+RDLK  N++LD++   KI+DFGM +   MD   G T+R   GT  Y+APE +    +
Sbjct: 141 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMD---GVTTREFCGTPDYIAPEIIAYQPY 197
Query: 506 SIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNN 546
               D +++GVL+ E+++GQ       GE+ ++L   +  +
Sbjct: 198 GKSVDWWAYGVLLYEMLAGQPPFD---GEDEDELFQSIMEH 235

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   + +  G   A+K L K  V    + +   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 102 PFLVKL-EFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR-NL 382
           ++F   ++LG G  G V+K  +SH     V       ++ +   +N+++   ++ H  N 
Sbjct: 9   DDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 66
Query: 383 VRLLGFS---FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
             ++GF    + + E  +  E +   S+D+ +  A +   +  +   K+   + +G+ YL
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 123
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
            E  + +I+HRD+K SNIL+++    K+ DFG++    +D+     +  VGT  YM+PE 
Sbjct: 124 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDEM---ANEFVGTRSYMSPER 177
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +   H+S++SD++S G+ ++E+  G+
Sbjct: 178 LQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   + +  G   A+K L K  V    + +   NE  ++  +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 87  PFLVKL-EFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 141
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 142 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAP 193
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 194 EIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   + +  G   A+K L K  V    + +   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVY-KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V     +  G   A+K L K  V    + +   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVY-KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V     +  G   A+K L K  V    + +   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 102 PFLVKL-EFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAP 208
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   + +  G   A+K L K  V    + +   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 41/222 (18%)
Query: 332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           LGQG FG V K R +   +  A+K++ +++ +      +EV+L+A L H+ +VR      
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 391 EETERLLIYEFV-PNSSVDK----FI----------FDAIKRVQLDWE--TRYKIIGGIA 433
           E         FV P ++V K    FI          +D I    L+ +    +++   I 
Sbjct: 73  ERRN------FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-------LFEMDQ-----S 481
             + Y+H      IIHRDLK  NI +D     KI DFG+A+       + ++D      S
Sbjct: 127 EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 482 QGDTSRIVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEII 522
             + +  +GT  Y+A E +   GH++ K D++S G++  E+I
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 31/211 (14%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG---ELEFKNEVLLVARLQHRNLVRLLGF 388
           +G+G +G V++G L HG+ +AVK  S    Q    E E  N VLL    +H N++  +  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLL----RHDNILGFIAS 70
Query: 389 SF----EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-- 442
                   T+  LI  +  + S    ++D ++R  L+     ++    A G+ +LH +  
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGS----LYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIF 126
Query: 443 ---SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ---GDTSRIVGTFGYMA 496
               +  I HRD K+ N+L+ +++   I+D G+A +          G+  R VGT  YMA
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR-VGTKRYMA 185
Query: 497 PEYV-----TRGHFSIK-SDVFSFGVLVLEI 521
           PE +     T    S K +D+++FG+++ EI
Sbjct: 186 PEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 115/208 (55%), Gaps = 19/208 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE--FKNEVLLVARLQHR- 380
           ++F   ++LG G  G V+K  +SH     V  +++  +  E++   +N+++   ++ H  
Sbjct: 33  DDFEKISELGAGNGGVVFK--VSHKPSGLV--MARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 381 NLVRLLGFS---FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           N   ++GF    + + E  +  E +   S+D+ +  A +   +  +   K+   + +G+ 
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLT 145
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YL E  + +I+HRD+K SNIL+++    K+ DFG++   ++  S  ++   VGT  YM+P
Sbjct: 146 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSP 199
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +   H+S++SD++S G+ ++E+  G+
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVY-KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V     +  G   A+K L K  V    E +   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+ P       +F  ++R+    E   +     I     
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+++D     +++DFG+A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 123/229 (53%), Gaps = 20/229 (8%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE--FKNEVLLVARLQHR- 380
           ++F   ++LG G  G V+K  +SH     V  +++  +  E++   +N+++   ++ H  
Sbjct: 25  DDFEKISELGAGNGGVVFK--VSHKPSGLV--MARKLIHLEIKPAIRNQIIRELQVLHEC 80
Query: 381 NLVRLLGFS---FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           N   ++GF    + + E  +  E +   S+D+ +  A +   +  +   K+   + +G+ 
Sbjct: 81  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLT 137
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YL E  + +I+HRD+K SNIL+++    K+ DFG++   ++  S  ++   VGT  YM+P
Sbjct: 138 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSP 191
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAE-DLLTYVSN 545
           E +   H+S++SD++S G+ ++E+  G+       G  A  +LL Y+ N
Sbjct: 192 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVN 240

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 44/211 (20%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  S+++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPEVVTRY- 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           Y APE +    +    D++S G ++ E+I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   +    G   A+K L K  V    + +   NE  ++  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 94  PFLVKL-EFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFXEPHARFYAAQIVLTFE 148
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 200
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391
           +G+G FG V++G+   G+E+AVK  S    +     + E+     L+H N++  +    +
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 94
Query: 392 E----TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED----- 442
           +    T+  L+ ++  + S    +FD + R  +  E   K+    A G+ +LH +     
Sbjct: 95  DNGTWTQLWLVSDYHEHGS----LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-----VGTFGYMAP 497
            +  I HRDLK+ NIL+  +    I+D G+A   +   S  DT  I     VGT  YMAP
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD---SATDTIDIAPNHRVGTKRYMAP 207
Query: 498 EY----VTRGHFS--IKSDVFSFGVLVLEI 521
           E     +   HF    ++D+++ G++  EI
Sbjct: 208 EVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI  FG+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391
           +G+G FG V++G+   G+E+AVK  S    +     + E+     L+H N++  +    +
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 74
Query: 392 E----TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED----- 442
           +    T+  L+ ++  + S    +FD + R  +  E   K+    A G+ +LH +     
Sbjct: 75  DNGTWTQLWLVSDYHEHGS----LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-----VGTFGYMAP 497
            +  I HRDLK+ NIL+  +    I+D G+A   +   S  DT  I     VGT  YMAP
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD---SATDTIDIAPNHRVGTKRYMAP 187
Query: 498 EY----VTRGHFS--IKSDVFSFGVLVLEI 521
           E     +   HF    ++D+++ G++  EI
Sbjct: 188 EVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391
           +G+G FG V++G+   G+E+AVK  S    +     + E+     L+H N++  +    +
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 69
Query: 392 E----TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED----- 442
           +    T+  L+ ++  + S    +FD + R  +  E   K+    A G+ +LH +     
Sbjct: 70  DNGTWTQLWLVSDYHEHGS----LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-----VGTFGYMAP 497
            +  I HRDLK+ NIL+  +    I+D G+A   +   S  DT  I     VGT  YMAP
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD---SATDTIDIAPNHRVGTKRYMAP 182
Query: 498 EY----VTRGHFS--IKSDVFSFGVLVLEI 521
           E     +   HF    ++D+++ G++  EI
Sbjct: 183 EVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391
           +G+G FG V++G+   G+E+AVK  S    +     + E+     L+H N++  +    +
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 107
Query: 392 E----TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED----- 442
           +    T+  L+ ++  + S    +FD + R  +  E   K+    A G+ +LH +     
Sbjct: 108 DNGTWTQLWLVSDYHEHGS----LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-----VGTFGYMAP 497
            +  I HRDLK+ NIL+  +    I+D G+A   +   S  DT  I     VGT  YMAP
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD---SATDTIDIAPNHRVGTKRYMAP 220
Query: 498 EY----VTRGHFS--IKSDVFSFGVLVLEI 521
           E     +   HF    ++D+++ G++  EI
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI D G+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391
           +G+G FG V++G+   G+E+AVK  S    +     + E+     L+H N++  +    +
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 71
Query: 392 E----TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED----- 442
           +    T+  L+ ++  + S    +FD + R  +  E   K+    A G+ +LH +     
Sbjct: 72  DNGTWTQLWLVSDYHEHGS----LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-----VGTFGYMAP 497
            +  I HRDLK+ NIL+  +    I+D G+A   +   S  DT  I     VGT  YMAP
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD---SATDTIDIAPNHRVGTKRYMAP 184
Query: 498 EY----VTRGHFS--IKSDVFSFGVLVLEI 521
           E     +   HF    ++D+++ G++  EI
Sbjct: 185 EVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVY-KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V     +  G   A+K L K  V    + +   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+ P       +F  ++R+    E   +     I     
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+++D     K++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391
           +G+G FG V++G+   G+E+AVK  S    +     + E+     L+H N++  +    +
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 68
Query: 392 E----TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED----- 442
           +    T+  L+ ++  + S    +FD + R  +  E   K+    A G+ +LH +     
Sbjct: 69  DNGTWTQLWLVSDYHEHGS----LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI-----VGTFGYMAP 497
            +  I HRDLK+ NIL+  +    I+D G+A   +   S  DT  I     VGT  YMAP
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD---SATDTIDIAPNHRVGTKRYMAP 181
Query: 498 EY----VTRGHFS--IKSDVFSFGVLVLEI 521
           E     +   HF    ++D+++ G++  EI
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 113/237 (47%), Gaps = 47/237 (19%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSV------------------ 361
           N ++  +++G+G +G V   +L++ +      A+K LSK  +                  
Sbjct: 13  NQYTLKDEIGKGSYGVV---KLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 362 -------QGELE-FKNEVLLVARLQHRNLVRLLGFSFEETERLL--IYEFVPNSSVDKFI 411
                  +G +E    E+ ++ +L H N+V+L+    +  E  L  ++E V    V +  
Sbjct: 70  PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV- 128
Query: 412 FDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471
              +K +  D    Y     + +GI YLH     +IIHRD+K SN+L+  D   KI+DFG
Sbjct: 129 -PTLKPLSEDQARFY--FQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYV--TRGHFSIKS-DVFSFGVLVLEIISGQ 525
           ++  F+   S    S  VGT  +MAPE +  TR  FS K+ DV++ GV +   + GQ
Sbjct: 183 VSNEFK--GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 22/204 (10%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLS-KNSVQGELE-FKNEVLLVARLQHRNLVRLLGFS 389
           +G+G FG VY GR  HG E+A++ +  +   + +L+ FK EV+   + +H N+V  +G  
Sbjct: 41  IGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
                  +I       ++   + DA  ++ LD     +I   I +G+ YLH      I+H
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILH 153
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQS--QGDTSRIV-GTFGYMAPEYVT----- 501
           +DLK+ N+  D   +  I+DFG+  +  + Q+  + D  RI  G   ++APE +      
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 502 ----RGHFSIKSDVFSFGVLVLEI 521
               +  FS  SDVF+ G +  E+
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI D G+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   +    G   A+K L K  V    + +   NE  ++  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 94  PFLVKL-EFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 148
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 200
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSF 390
           +G G FG V++ +L    E+A+K++ ++       FKN  L + R+ +H N+V L  F +
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 391 EETERL------LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
              ++       L+ E+VP +        A  +  +        +  + R + Y+H    
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--- 159
Query: 445 LRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
           + I HRD+K  N+LLD    + K+ DFG A++  +   + + S I   + Y APE +   
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI--LIAGEPNVSXICSRY-YRAPELIFGA 216
Query: 504 -HFSIKSDVFSFGVLVLEIISGQ 525
            +++   D++S G ++ E++ GQ
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 324 NNFSTDNKLGQGGFGAVY-KGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
           + F     LG G FG V     +  G   A+K L K  V    + ++ +     LQ  N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 383 VRL--LGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILY 438
             L  L FSF++   L ++ E+ P       +F  ++R+    E   +     I     Y
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFXEPHARFYAAQIVLTFEY 157
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           LH    L +I+RDLK  N+++D     K++DFG A+     + +G T  + GT  Y+APE
Sbjct: 158 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPE 209
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISG 524
            +    ++   D ++ GVL+ E+ +G
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 310 ESLQFD-FSTIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLS--KNSVQGEL 365
           E+L F   +T    T+++    +LG+G F  V +  + +  QE A K ++  K S +   
Sbjct: 16  ENLYFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ 75
Query: 366 EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETR 425
           + + E  +   L+H N+VRL     EE    L+++ V      +   D + R        
Sbjct: 76  KLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGG---ELFEDIVAREYYSEADA 132
Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQ 482
              I  I   + ++H+     I+HRDLK  N+LL +       K++DFG+A   E+   Q
Sbjct: 133 SHCIHQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQ 187
Query: 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
                  GT GY++PE + +  +    D+++ GV++  ++ G
Sbjct: 188 QAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 106/242 (43%), Gaps = 17/242 (7%)
Query: 314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQGELEFKNEVL 372
            D   + D ++ +     +G G FG     R    +E +AVK + + +   E   + E++
Sbjct: 11  LDMPIMHD-SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQREII 68
Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI 432
               L+H N+VR        T   +I E+     + + I +A  R   D E R+     +
Sbjct: 69  NHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA-GRFSED-EARF-FFQQL 125
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIP--KISDFGMARLFEMDQSQGDTSRIVG 490
             G+ Y H    ++I HRDLK  N LLD    P  KI DFG ++   +      T   VG
Sbjct: 126 LSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VG 179
Query: 491 TFGYMAPEYVTRGHFSIK-SDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLHI 549
           T  Y+APE + R  +  K +DV+S GV +  ++ G     F   EE  D    +   L +
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAY--PFEDPEEPRDYRKTIQRILSV 237
Query: 550 LY 551
            Y
Sbjct: 238 KY 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   +    G   A+K L K  V    + +   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 102 PFLVKL-EFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 44/211 (20%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  S+++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM------TPYVVTRY- 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           Y APE +    +    D++S G ++ E+I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   +    G   A+K L K  V    + +   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 102 PFLVKL-EFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVY-KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V     +  G   A+K L K  V    + +   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+ P       +F  ++R+    E   +     I     
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+++D     K++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 44/211 (20%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A +   L  G  +AVK+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  ++++F        + DA    +  ++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM------TPYVVTRY- 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           Y APE +    ++   D++S G ++ E++ G
Sbjct: 191 YRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   +    G   A+K L K  V    + +   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 102 PFLVKL-EFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLD 421
             ++H N++ LL              F P  S+++F             + + +K  +L 
Sbjct: 76  KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI D G+AR      +
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR-----HT 175
Query: 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
             + +  V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 22/216 (10%)
Query: 317 STIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEI--AVKRLSKNSVQGELEFKNEVLLV 374
           ST  D    ++ +N +G+G +G V K  +  G  I  A K++ K  V+    FK E+ ++
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI--KRVQLDWETRYKIIGGI 432
             L H N++RL     + T+  L+ E          +F+ +  KRV  + +   +I+  +
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-RIMKDV 115
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRI- 488
              + Y H   +L + HRDLK  N L      D   K+ DFG+A  F+     G   R  
Sbjct: 116 LSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK----PGKMMRTK 168
Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           VGT  Y++P+ V  G +  + D +S GV++  ++ G
Sbjct: 169 VGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVY-KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     +G G FG V     +  G   A+K L K  V    + +   NE  ++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E++P       +F  ++R+    E   +     I     
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYMPGGD----MFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     K++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVY-KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     +G G FG V     +  G   A+K L K  V    + +   NE  ++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E++P       +F  ++R+    E   +     I     
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYMPGGD----MFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     K++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 324 NNFSTDNKLGQGGFGAVY-KGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
           + F     LG G FG V     +  G   A+K L K  V    + ++ +     LQ  N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 383 VRL--LGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILY 438
             L  L FSF++   L ++ E+ P       +F  ++R+    E   +     I     Y
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           LH    L +I+RDLK  N+++D     K++DFG A+     + +G T  + GT  Y+APE
Sbjct: 158 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPE 209
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISG 524
            +    ++   D ++ GVL+ E+ +G
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 44/211 (20%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  S+++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM------TPYVVTRY- 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           Y APE +    +    D++S G ++ E+I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 44/211 (20%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  S+++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRY- 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           Y APE +    +    D++S G ++ E+I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 44/211 (20%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 37  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV- 92
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  S+++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 93  -----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 141
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 142 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRY- 191
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           Y APE +    +    D++S G ++ E+I G
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 324 NNFSTDNKLGQGGFGAVY-KGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
           + F     LG G FG V     +  G   A+K L K  V    + ++ +     LQ  N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 383 VRL--LGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILY 438
             L  L FSF++   L ++ E+ P       +F  ++R+    E   +     I     Y
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           LH    L +I+RDLK  N+++D     K++DFG A+     + +G T  + GT  Y+APE
Sbjct: 158 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPE 209
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISG 524
            +    ++   D ++ GVL+ E+ +G
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 37/214 (17%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG---ELEFKNEVLLVARLQHRNLVRLLGF 388
           +G+G +G V++G    G+ +AVK  S    +    E E  N V+L    +H N+   LGF
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENI---LGF 96
Query: 389 -------SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH- 440
                      T+  LI  +    S    ++D ++   LD  +  +I+  IA G+ +LH 
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGS----LYDYLQLTTLDTVSCLRIVLSIASGLAHLHI 152
Query: 441 ----EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ---GDTSRIVGTFG 493
                  +  I HRDLK+ NIL+  +    I+D G+A +     +Q   G+  R VGT  
Sbjct: 153 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKR 211
Query: 494 YMAPEYVTRG------HFSIKSDVFSFGVLVLEI 521
           YMAPE +             + D+++FG+++ E+
Sbjct: 212 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   +    G   A+K L K  V    + +   NE  ++  +  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 122 PFLVKL-EFSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 176
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 228
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 44/211 (20%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  S+++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRY- 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           Y APE +    +    D++S G ++ E+I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/95 (44%), Positives = 58/95 (61%), Gaps = 9/95 (9%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS---QGDTSRI 488
           +ARG+ +L   S  + IHRDL A NILL  + + KI DFG+AR    +     +GDT R+
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDT-RL 263
Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                +MAPE +    +S KSDV+S+GVL+ EI S
Sbjct: 264 --PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 36/210 (17%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRL---SKNSVQGELEFKNEVLLVARLQHRNLVRLL 386
           K+G+G +G V+K R    GQ +A+K+      + V  ++  + E+ ++ +L+H NLV LL
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLL 68
Query: 387 GFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQ----------LDWETRYKIIGGIARG 435
              F    RL L++E+      D  +   + R Q          + W+T         + 
Sbjct: 69  EV-FRRKRRLHLVFEYC-----DHTVLHELDRYQRGVPEHLVKSITWQT--------LQA 114
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
           + + H+ +    IHRD+K  NIL+    + K+ DFG ARL        D    V T  Y 
Sbjct: 115 VNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYR 169
Query: 496 APE-YVTRGHFSIKSDVFSFGVLVLEIISG 524
           +PE  V    +    DV++ G +  E++SG
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 323 TNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLS--KNSVQGELEFKNEVLLVARLQH 379
           T+ +    +LG+G F  V +  ++  GQE A K ++  K S +   + + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            N+VRL     EE    L+++ V      +   D + R           I  I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGG---ELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 440 HEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
           H +    I+HRDLK  N+LL +       K++DFG+A   E+   Q       GT GY++
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLS 174
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE + +  +    D+++ GV++  ++ G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 331 KLGQGGFGAVYKGRLSHGQEI-AVKR--LSKNSVQGELEFKNEVLLVARLQHRNLVRLLG 387
           K+G+G +G V+K +     EI A+KR  L  +          E+ L+  L+H+N+VRL  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
               + +  L++EF  +  + K+ FD+     LD E     +  + +G+ + H  +   +
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKY-FDSCNG-DLDPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH-FS 506
           +HRDLK  N+L++ +   K++DFG+AR F +       S  V T  Y  P+ +     +S
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYS 180
Query: 507 IKSDVFSFGVLVLEIISGQK 526
              D++S G +  E+ +  +
Sbjct: 181 TSIDMWSAGCIFAELANAAR 200

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 42/210 (20%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 38  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV- 93
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  S+++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 94  -----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 142
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG---TFGY 494
           +LH      IIHRDLK SNI++ +D   KI DFG+AR      + G +  +V    T  Y
Sbjct: 143 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMVPFVVTRYY 193
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
            APE +    +    D++S G ++ E+I G
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 44/211 (20%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  S+++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM------TPYVVTRY- 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           Y APE +    +    D++S G ++ E+I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   +    G   A+K L K  V    + +   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  +SF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 101 PFLVKL-EYSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 44/211 (20%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  S+++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRY- 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           Y APE +    +    D++S G ++ E+I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 37/214 (17%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG---ELEFKNEVLLVARLQHRNLVRLLGF 388
           +G+G +G V++G    G+ +AVK  S    +    E E  N V+L    +H N+   LGF
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENI---LGF 67
Query: 389 -------SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH- 440
                      T+  LI  +    S    ++D ++   LD  +  +I+  IA G+ +LH 
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGS----LYDYLQLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 441 ----EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ---GDTSRIVGTFG 493
                  +  I HRDLK+ NIL+  +    I+D G+A +     +Q   G+  R VGT  
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKR 182
Query: 494 YMAPEYVTRG------HFSIKSDVFSFGVLVLEI 521
           YMAPE +             + D+++FG+++ E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 323 TNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLS--KNSVQGELEFKNEVLLVARLQH 379
           T+ +    +LG+G F  V +  ++  GQE A K ++  K S +   + + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            N+VRL     EE    L+++ V      +   D + R           I  I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGG---ELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 440 HEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
           H +    I+HRDLK  N+LL +       K++DFG+A   E+   Q       GT GY++
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLS 174
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE + +  +    D+++ GV++  ++ G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 37/214 (17%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG---ELEFKNEVLLVARLQHRNLVRLLGF 388
           +G+G +G V++G    G+ +AVK  S    +    E E  N V+L    +H N+   LGF
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENI---LGF 67
Query: 389 -------SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH- 440
                      T+  LI  +    S    ++D ++   LD  +  +I+  IA G+ +LH 
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGS----LYDYLQLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 441 ----EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ---GDTSRIVGTFG 493
                  +  I HRDLK+ NIL+  +    I+D G+A +     +Q   G+  R VGT  
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKR 182
Query: 494 YMAPEYVTRG------HFSIKSDVFSFGVLVLEI 521
           YMAPE +             + D+++FG+++ E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   +    G   A+K L K  V    + +   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+ P       +F  ++R+    E   +     I     
Sbjct: 102 PFLVKL-EFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+++D     K++DFG A+     + +G T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 25/221 (11%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLV---- 374
           R   + F  +   GQG FG V  G+  S G  +A+K++ ++       F+N  L +    
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDL 73
Query: 375 ARLQHRNLVRLLG--FSFEETERLLIY-----EFVPNSSVDKFIFDAIKRVQLDWETRYK 427
           A L H N+V+L    ++  E +R  IY     E+VP+ ++ +   +  +R         K
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIK 132
Query: 428 I-IGGIARGILYLHEDSRLRIIHRDLKASNILL-DADMIPKISDFGMARLFEMDQSQGDT 485
           + +  + R I  LH  S + + HRD+K  N+L+ +AD   K+ DFG A+  ++  S+ + 
Sbjct: 133 VFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAK--KLSPSEPNV 189
Query: 486 SRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
           + I   + Y APE +    H++   D++S G +  E++ G+
Sbjct: 190 AYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   +    G   A+K L K  V    + +   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  +SF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 101 PFLVKL-EYSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   +    G   A+K L K  V    + +   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  +SF++   L ++ E+VP       +F  ++R+    E   +     I     
Sbjct: 101 PFLVKL-EYSFKDNSNLYMVMEYVPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  ++++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM------TPYVVTRY- 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVY-KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V     +  G   A+K L K  V    + +   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+ P       +F  ++R+    E   +     I     
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYAPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+++D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 107/227 (47%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 22  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 81
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 142 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 242

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 107/227 (47%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 18  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 77
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 137
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 138 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 238

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 107/227 (47%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 25  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 84
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 144
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 145 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 201
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 245

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 107/227 (47%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 26  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 85
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 86  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 145
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 146 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 202
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 203 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 246

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 107/227 (47%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 17  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 76
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 77  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 136
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 137 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 193
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 194 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 237

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 107/227 (47%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 144 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 244

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 107/227 (47%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 140 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 240

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 107/227 (47%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 18  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 77
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 137
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 138 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 238

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 74  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNV- 129
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  ++++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 130 -----------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 178
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 179 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRY- 228
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 43/216 (19%)
Query: 330 NKLGQGGFGAV---YKGRLSHGQEIAVKRLSKNSVQGELEFKN---EVLLVARLQHRNLV 383
             +G G +GAV     GR   G ++A+K+L +   Q EL  K    E+ L+  ++H N++
Sbjct: 31  QPVGSGAYGAVCSAVDGRT--GAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRHENVI 87
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLDWETRYKIIG 430
            LL              F P+ ++D F             +   +K  +L  +    ++ 
Sbjct: 88  GLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY 135
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
            + +G+ Y+H      IIHRDLK  N+ ++ D   KI DFG+AR     Q+  +    V 
Sbjct: 136 QMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVV 187
Query: 491 TFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           T  Y APE +     ++   D++S G ++ E+I+G+
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 107/227 (47%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 144 IHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 244

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 107/227 (47%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 28  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 87
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 88  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 147
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 148 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 204
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 205 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 248

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 107/227 (47%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 140 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 240

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 107/227 (47%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 40  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 99
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 159
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 160 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 260

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 107/227 (47%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 140 IHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 240

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   +    G   A+K L K  V    + +   NE  +   +  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+ P       +F  ++R+    E   +     I     
Sbjct: 102 PFLVKL-EFSFKDNSNLYMVLEYAPGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     K++DFG A+     + +G T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 107/227 (47%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFR 83
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 144 IHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 244

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 108/228 (47%), Gaps = 12/228 (5%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQE--IAVKRLSKNSVQGELEFK-NEVLLVARL 377
           D    ++    +G+G +G V      H ++  +A+K++S    Q   +    E+ ++ R 
Sbjct: 40  DVGPRYTQLQYIGEGAYGMVSSA-YDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRF 98
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
           +H N++ +       T   +   ++    ++  ++  +K  QL  +     +  I RG+ 
Sbjct: 99  RHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLK 158
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMA 496
           Y+H  +   ++HRDLK SN+L++     KI DFG+AR+ + +    G  +  V T  Y A
Sbjct: 159 YIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRA 215
Query: 497 PEYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           PE +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 260

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  ++++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM------TPYVVTRY- 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 107/227 (47%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKY 143
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 144 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 244

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 36/207 (17%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A +   L  G  +AVK+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 34  AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNV- 89
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  ++++F        + DA    +  ++LD E    ++  +  GI 
Sbjct: 90  -----------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIK 138
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           +LH      IIHRDLK SNI++ +D   KI DFG+AR      +    +  V T  Y AP
Sbjct: 139 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TASTNFMMTPYVVTRYYRAP 192
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    +    D++S G ++ E++ G
Sbjct: 193 EVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           LGQG FG V K R +   +  A+K++ +++ +      +EV L+A L H+ +VR      
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVVRYYAAWL 72
Query: 391 EETERLLIYEFVPNSSV---------DKFIFDAIKRVQLDWE--TRYKIIGGIARGILYL 439
           E    +     V   S          ++ ++D I    L+ +    +++   I   + Y+
Sbjct: 73  ERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYI 132
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-------LFEMDQ-----SQGDTSR 487
           H      IIHR+LK  NI +D     KI DFG+A+       + ++D      S  + + 
Sbjct: 133 HSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189
Query: 488 IVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEII 522
            +GT  Y+A E +   GH++ K D +S G++  E I
Sbjct: 190 AIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  S+++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M+         V T  
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE-------VVTRY 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 106/227 (46%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G     V T  Y AP
Sbjct: 144 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 200
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 244

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 106/227 (46%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 25  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 84
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 144
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G     V T  Y AP
Sbjct: 145 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 201
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 245

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 107/227 (47%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 140 IHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 240

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  ++++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM------TPYVVTRY- 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  ++++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM------TPYVVTRY- 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQGELEFKNEVL 372
            D   + D ++ +     +G G FG     R     E +AVK + +     E   K E++
Sbjct: 10  MDLPIMHD-SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDE-NVKREII 67
Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI 432
               L+H N+VR        T   ++ E+     + + I +A  R   D E R+     +
Sbjct: 68  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSED-EARF-FFQQL 124
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIP--KISDFGMARLFEMDQSQGDTSRIVG 490
             G+ Y H    +++ HRDLK  N LLD    P  KI+DFG ++   +  SQ  ++  VG
Sbjct: 125 ISGVSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVL-HSQPKSA--VG 178
Query: 491 TFGYMAPEYVTRGHFSIK-SDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLHI 549
           T  Y+APE + +  +  K +DV+S GV +  ++ G     F   EE ++    +   L++
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAY--PFEDPEEPKNFRKTIHRILNV 236
Query: 550 LY 551
            Y
Sbjct: 237 QY 238

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 29  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNV- 84
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  ++++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 85  -----------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIK 133
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM------TPYVVTRY- 183
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
           +A+G+ +L   +  + IHRDL A NILL    + KI DFG+AR    D            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             +MAPE +    ++I+SDV+SFGVL+ EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
           +A+G+ +L   +  + IHRDL A NILL    + KI DFG+AR    D            
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             +MAPE +    ++I+SDV+SFGVL+ EI S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 107/227 (47%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A++++S    Q   +    E+ ++ R +
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFR 83
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 144 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 244

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
           +A+G+ +L   +  + IHRDL A NILL    + KI DFG+AR    D            
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             +MAPE +    ++I+SDV+SFGVL+ EI S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
           +A+G+ +L   +  + IHRDL A NILL    + KI DFG+AR    D            
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             +MAPE +    ++I+SDV+SFGVL+ EI S
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYK-GRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
           +++    +LG G FG V++    + G   A K +       +   + E+  ++ L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           V L     ++ E ++IYEF+    + + + D   ++  D    Y  +  + +G+ ++HE+
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--MRQVCKGLCHMHEN 274
Query: 443 SRLRIIHRDLKASNILLDADMIP--KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
           +    +H DLK  NI+         K+ DFG+    +  QS   T+   GT  + APE  
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 328
Query: 501 TRGHFSIKSDVFSFGVLVLEIISG 524
                   +D++S GVL   ++SG
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 7/209 (3%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 140 IHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQ 525
           E +       KS D++S G ++ E++S +
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 74  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNV- 129
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  ++++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 130 -----------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 178
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 179 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRY- 228
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   +    G   A+K L K  V    + +   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I     
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   + +  G   A+K L K  V    + +   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I     
Sbjct: 101 PFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 331 KLGQGGFGAVYKGRLSHGQEI-AVKR--LSKNSVQGELEFKNEVLLVARLQHRNLVRLLG 387
           K+G+G +G V+K +     EI A+KR  L  +          E+ L+  L+H+N+VRL  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
               + +  L++EF  +  + K+ FD+     LD E     +  + +G+ + H  +   +
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKY-FDSCNG-DLDPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH-FS 506
           +HRDLK  N+L++ +   K+++FG+AR F +       S  V T  Y  P+ +     +S
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYS 180
Query: 507 IKSDVFSFGVLVLEIISG 524
              D++S G +  E+ + 
Sbjct: 181 TSIDMWSAGCIFAELANA 198

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  S+++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M+         V T  
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE-------VVTRY 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 191 YRAPEVILGMGYKENVDLWSVGCIMGEMV 219

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 106/241 (43%), Gaps = 17/241 (7%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQGELEFKNEVLL 373
           D   + D ++ +     +G G FG     R     E +AVK + +     E   K E++ 
Sbjct: 10  DLPIMHD-SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDE-NVKREIIN 67
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
              L+H N+VR        T   ++ E+     + + I +A  R   D E R+     + 
Sbjct: 68  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSED-EARF-FFQQLI 124
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIP--KISDFGMARLFEMDQSQGDTSRIVGT 491
            G+ Y H    +++ HRDLK  N LLD    P  KI DFG ++   +      T   VGT
Sbjct: 125 SGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGT 178
Query: 492 FGYMAPEYVTRGHFSIK-SDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLHIL 550
             Y+APE + +  +  K +DV+S GV +  ++ G     F   EE ++    +   L++ 
Sbjct: 179 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAY--PFEDPEEPKNFRKTIHRILNVQ 236
Query: 551 Y 551
           Y
Sbjct: 237 Y 237

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 329 DNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLL 386
           D  LG+G F    K       Q  AVK +SK   + E   + E+  +   + H N+V+L 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLH 72
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYK-IIGGIARGILYLHEDSRL 445
               ++    L+ E +        +F+ IK+ +   ET    I+  +   + ++H+   +
Sbjct: 73  EVFHDQLHTFLVMELLNGGE----LFERIKKKKHFSETEASYIMRKLVSAVSHMHD---V 125
Query: 446 RIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
            ++HRDLK  N+L    + ++  KI DFG ARL   D     T     T  Y APE + +
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF--TLHYAAPELLNQ 183
Query: 503 GHFSIKSDVFSFGVLVLEIISGQ 525
             +    D++S GV++  ++SGQ
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQ 206

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 17/213 (7%)
Query: 320 RDATNNFSTDNKLGQGGFGAV-YKGRLSHGQEIAVKRLSKNSVQGELEF-----KNEVLL 373
           R   N F     LG+G FG V      + G+  A+K L K  +  + E      +N VL 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-I 432
            +R      +  L +SF+  +RL    FV   +    +F  + R ++  E R +  G  I
Sbjct: 64  NSR---HPFLTALKYSFQTHDRLC---FVMEYANGGELFFHLSRERVFSEDRARFYGAEI 117
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF 492
              + YLH  S   +++RDLK  N++LD D   KI+DFG+ +  E  +         GT 
Sbjct: 118 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTP 173
Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            Y+APE +    +    D +  GV++ E++ G+
Sbjct: 174 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 35  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNV- 90
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  ++++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 91  -----------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 139
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 140 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRY- 189
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 190 YRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 17/213 (7%)
Query: 320 RDATNNFSTDNKLGQGGFGAV-YKGRLSHGQEIAVKRLSKNSVQGELEF-----KNEVLL 373
           R   N F     LG+G FG V      + G+  A+K L K  +  + E      +N VL 
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-I 432
            +R      +  L +SF+  +RL    FV   +    +F  + R ++  E R +  G  I
Sbjct: 66  NSR---HPFLTALKYSFQTHDRLC---FVMEYANGGELFFHLSRERVFSEDRARFYGAEI 119
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF 492
              + YLH  S   +++RDLK  N++LD D   KI+DFG+ +  E  +         GT 
Sbjct: 120 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTP 175
Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            Y+APE +    +    D +  GV++ E++ G+
Sbjct: 176 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVK-----RLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +G+G F  V +      GQ+ AVK     + + +      + K E  +   L+H ++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL----YLHE 441
           L     +    +++EF+  + +    F+ +KR    +     +     R IL    Y H+
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 442 DSRLRIIHRDLKASNILLDA--DMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           ++   IIHRD+K  N+LL +  +  P K+ DFG+A   ++ +S       VGT  +MAPE
Sbjct: 149 NN---IIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGRVGTPHFMAPE 203
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISG 524
            V R  +    DV+  GV++  ++SG
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  ++++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRY- 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 17/213 (7%)
Query: 320 RDATNNFSTDNKLGQGGFGAV-YKGRLSHGQEIAVKRLSKNSVQGELEF-----KNEVLL 373
           R   N F     LG+G FG V      + G+  A+K L K  +  + E      +N VL 
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 64
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-I 432
            +R      +  L +SF+  +RL    FV   +    +F  + R ++  E R +  G  I
Sbjct: 65  NSR---HPFLTALKYSFQTHDRLC---FVMEYANGGELFFHLSRERVFSEDRARFYGAEI 118
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF 492
              + YLH  S   +++RDLK  N++LD D   KI+DFG+ +  E  +         GT 
Sbjct: 119 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTP 174
Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            Y+APE +    +    D +  GV++ E++ G+
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 30  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNV- 85
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  ++++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 86  -----------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 134
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 135 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRY- 184
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 37  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNV- 92
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  ++++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 93  -----------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 141
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 142 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRY- 191
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  ++++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 92  -----------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRY- 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 324 NNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQ 378
           + F     LG G FG V   K + S G   A+K L K  V    + +   NE  ++  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGI 436
              LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I    
Sbjct: 100 FPFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +    ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 37  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNV- 92
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  ++++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 93  -----------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 141
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 142 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRY- 191
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 30  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNV- 85
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  ++++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 86  -----------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 134
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 135 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRY- 184
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 324 NNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQ 378
           + F     LG G FG V   K + S G   A+K L K  V    + +   NE  ++  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGI 436
              LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I    
Sbjct: 100 FPFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +    ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYK-GRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
           +++    +LG G FG V++    + G   A K +       +   + E+  ++ L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           V L     ++ E ++IYEF+    + + + D   ++  D    Y  +  + +G+ ++HE+
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--MRQVCKGLCHMHEN 168
Query: 443 SRLRIIHRDLKASNILLDADMIP--KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
           +    +H DLK  NI+         K+ DFG+    +  QS   T+   GT  + APE  
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 222
Query: 501 TRGHFSIKSDVFSFGVLVLEIISG 524
                   +D++S GVL   ++SG
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 29  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNV- 84
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  ++++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 85  -----------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 133
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRY- 183
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 324 NNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQ 378
           + F     LG G FG V   K + S G   A+K L K  V    + +   NE  ++  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGI 436
              LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I    
Sbjct: 100 FPFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGTPEYLA 206
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +    ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 26/223 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVAR 376
           N  S    LG G FG V +       +      +AVK L  ++   E E   +E+ +++ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPNSSV--------DKFIFDAIKRVQLDWETRYK 427
           L  H N+V LLG        L+I E+     +        D FI        ++ +    
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 428 IIGG-------IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            +         +A+G+ +L   +    IHRDL A NILL    I KI DFG+AR  + D 
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKNDS 222
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +            +MAPE +    ++ +SDV+S+G+ + E+ S
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 324 NNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQ 378
           + F     LG G FG V   K + S G   A+K L K  V    + +   NE  ++  + 
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 94
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGI 436
              LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I    
Sbjct: 95  FPFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFXEPHARFYAAQIVLTF 149
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+A
Sbjct: 150 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 201
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +    ++   D ++ GVL+ E+ +G
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 324 NNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQ 378
           + F     LG G FG V   K + S G   A+K L K  V    + +   NE  ++  + 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGI 436
              LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I    
Sbjct: 121 FPFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFXEPHARFYAAQIVLTF 175
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+A
Sbjct: 176 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 227
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +    ++   D ++ GVL+ E+ +G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 17/242 (7%)
Query: 314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQGELEFKNEVL 372
            D   + D ++ +     +G G FG     R     E +AVK + +     E   K E++
Sbjct: 10  MDLPIMHD-SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDE-NVKREII 67
Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI 432
               L+H N+VR        T   ++ E+     + + I +A  R   D E R+     +
Sbjct: 68  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSED-EARF-FFQQL 124
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIP--KISDFGMARLFEMDQSQGDTSRIVG 490
             G+ Y H    +++ HRDLK  N LLD    P  KI  FG ++   +     DT   VG
Sbjct: 125 ISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT---VG 178
Query: 491 TFGYMAPEYVTRGHFSIK-SDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLHI 549
           T  Y+APE + +  +  K +DV+S GV +  ++ G     F   EE ++    +   L++
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAY--PFEDPEEPKNFRKTIHRILNV 236
Query: 550 LY 551
            Y
Sbjct: 237 QY 238

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 26/223 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVAR 376
           N  S    LG G FG V +       +      +AVK L  ++   E E   +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPNSSV--------DKFIFDAIKRVQLDWETRYK 427
           L  H N+V LLG        L+I E+     +        D FI        ++ +    
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 428 IIGG-------IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            +         +A+G+ +L   +    IHRDL A NILL    I KI DFG+AR  + D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +            +MAPE +    ++ +SDV+S+G+ + E+ S
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 103/241 (42%), Gaps = 15/241 (6%)
Query: 314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLL 373
            D   + D ++ +     +G G FG     R     E+   +  +   +     K E++ 
Sbjct: 10  MDLPIMHD-SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIIN 68
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
              L+H N+VR        T   ++ E+     + + I +A  R   D E R+     + 
Sbjct: 69  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSED-EARF-FFQQLI 125
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIP--KISDFGMARLFEMDQSQGDTSRIVGT 491
            G+ Y H    +++ HRDLK  N LLD    P  KI DFG ++   +      T   VGT
Sbjct: 126 SGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGT 179
Query: 492 FGYMAPEYVTRGHFSIK-SDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLHIL 550
             Y+APE + +  +  K +DV+S GV +  ++ G     F   EE ++    +   L++ 
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAY--PFEDPEEPKNFRKTIHRILNVQ 237
Query: 551 Y 551
           Y
Sbjct: 238 Y 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 324 NNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQ 378
           + F     LG G FG V   K + S G   A+K L K  V    + +   NE  ++  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGI 436
              LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I    
Sbjct: 100 FPFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFAEPHARFYAAQIVLTF 154
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +    ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 324 NNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQ 378
           + F     LG G FG V   K + S G   A+K L K  V    + +   NE  ++  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGI 436
              LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I    
Sbjct: 100 FPFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +    ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 30  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV- 85
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  S+++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 86  -----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 134
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 135 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRY- 184
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 185 YRAPEVILGMGYKENVDLWSVGCIMGEMV 213

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 109/226 (48%), Gaps = 23/226 (10%)
Query: 324 NNFS--TDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK----NSVQGELEFKNEVLLVAR 376
           NNF   T  +LG+G F  V +    S GQE A K L K       + E+  +  VL +A+
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
              R ++ L       +E +LI E+     +       +  +  + +   ++I  I  G+
Sbjct: 87  SCPR-VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV-IRLIKQILEGV 144
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEMDQSQGDTSRIVGTF 492
            YLH+++   I+H DLK  NILL + + P    KI DFGM+R         +   I+GT 
Sbjct: 145 YYLHQNN---IVHLDLKPQNILLSS-IYPLGDIKIVDFGMSRKI---GHACELREIMGTP 197
Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAED 538
            Y+APE +     +  +D+++ G++   +++   + S  +GE+ ++
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLT---HTSPFVGEDNQE 240

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 324 NNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQ 378
           + F     LG G FG V   K + S G   A+K L K  V    + +   NE  ++  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGI 436
              LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I    
Sbjct: 100 FPFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +    ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFK---NEVLLVARLQH 379
           + F     LG G FG V   +    G   A+K L K  V    + +   NE  ++  +  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I     
Sbjct: 88  PFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 142
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+AP
Sbjct: 143 YLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 194
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISG 524
           E +    ++   D ++ GVL+ E+ +G
Sbjct: 195 EIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 29/215 (13%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG-ELEFKNEVLLVARLQHRNLVRL---- 385
           K+G+G +G VYK +   G++     L +    G  +    E+ L+  L+H N++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 386 ---------LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
                    L F + E +   I +F   S  +K      K VQL       ++  I  GI
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANK------KPVQLPRGMVKSLLYQILDGI 141
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEMD-QSQGDTSRIVGT 491
            YLH +    ++HRDLK +NIL+  +       KI+D G ARLF    +   D   +V T
Sbjct: 142 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 492 FGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           F Y APE +    H++   D+++ G +  E+++ +
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 44/209 (21%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            QG   A Y   L   + +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 41  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV- 96
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
                      F P  S+++F        + DA    + +++LD E    ++  +  GI 
Sbjct: 97  -----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 145
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
           +LH      IIHRDLK SNI++ +D   KI DFG+AR     F M      T  +V  + 
Sbjct: 146 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRY- 195
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
           Y APE +    +    D++S G ++ E++
Sbjct: 196 YRAPEVILGMGYKENVDLWSVGCIMGEMV 224

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 324 NNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQ 378
           + F     LG G FG V   K + S G   A+K L K  V    + +   NE  ++  + 
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGI 436
              LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I    
Sbjct: 101 FPFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+A
Sbjct: 156 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 207
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +    ++   D ++ GVL+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 106/227 (46%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++ R +
Sbjct: 40  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 99
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    +   ++  +K   L  +     +  I RG+ Y
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 159
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 160 IHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 260

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 324 NNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQ 378
           + F     LG G FG V   K + S G   A+K L K  V    + +   NE  ++  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGI 436
              LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I    
Sbjct: 100 FPFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +    ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 324 NNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQ 378
           + F     LG G FG V   K + S G   A+K L K  V    + +   NE  ++  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGI 436
              LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I    
Sbjct: 100 FPFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPEYLA 206
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +    ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 324 NNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQ 378
           + F     LG G FG V   K + S G   A+K L K  V    + +   NE  ++  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGI 436
              LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I    
Sbjct: 100 FPFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +    ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 17/213 (7%)
Query: 320 RDATNNFSTDNKLGQGGFGAV-YKGRLSHGQEIAVKRLSKNSVQGELEF-----KNEVLL 373
           R   N F     LG+G FG V      + G+  A+K L K  +  + E      +N VL 
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-I 432
            +R      +  L +SF+  +RL    FV   +    +F  + R ++  E R +  G  I
Sbjct: 204 NSR---HPFLTALKYSFQTHDRLC---FVMEYANGGELFFHLSRERVFSEDRARFYGAEI 257
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF 492
              + YLH  S   +++RDLK  N++LD D   KI+DFG+ +    D +   T    GT 
Sbjct: 258 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTP 313
Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            Y+APE +    +    D +  GV++ E++ G+
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 324 NNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQ 378
           + F     LG G FG V   K + S G   A+K L K  V    + +   NE  ++  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGI 436
              LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I    
Sbjct: 100 FPFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +    ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 26/223 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVAR 376
           N  S    LG G FG V +       +      +AVK L  ++   E E   +E+ +++ 
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPNSSV--------DKFIFDAIKRVQLDWETRYK 427
           L  H N+V LLG        L+I E+     +        D FI        ++ +    
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 428 IIGG-------IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            +         +A+G+ +L   +    IHRDL A NILL    I KI DFG+AR  + D 
Sbjct: 159 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 215
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +            +MAPE +    ++ +SDV+S+G+ + E+ S
Sbjct: 216 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 26/223 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVAR 376
           N  S    LG G FG V +       +      +AVK L  ++   E E   +E+ +++ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPNSSV--------DKFIFDAIKRVQLDWETRYK 427
           L  H N+V LLG        L+I E+     +        D FI        ++ +    
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 428 IIGG-------IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            +         +A+G+ +L   +    IHRDL A NILL    I KI DFG+AR  + D 
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 222
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +            +MAPE +    ++ +SDV+S+G+ + E+ S
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 17/213 (7%)
Query: 320 RDATNNFSTDNKLGQGGFGAV-YKGRLSHGQEIAVKRLSKNSVQGELEF-----KNEVLL 373
           R   N F     LG+G FG V      + G+  A+K L K  +  + E      +N VL 
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 206
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-I 432
            +R      +  L +SF+  +RL    FV   +    +F  + R ++  E R +  G  I
Sbjct: 207 NSR---HPFLTALKYSFQTHDRLC---FVMEYANGGELFFHLSRERVFSEDRARFYGAEI 260
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF 492
              + YLH  S   +++RDLK  N++LD D   KI+DFG+ +    D +   T    GT 
Sbjct: 261 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTP 316
Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            Y+APE +    +    D +  GV++ E++ G+
Sbjct: 317 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 20/213 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI----AVKRLSKNSVQGELEF----KNEVLLVA 375
            NF     LG G +G V+  R   G +     A+K L K ++  + +     + E  ++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 376 RLQHRNLVRLLGFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIA 433
            ++    +  L ++F+ ET+  LI +++        +F  + + +   E   +I +G I 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGE----LFTHLSQRERFTEHEVQIYVGEIV 169
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             + +LH   +L II+RD+K  NILLD++    ++DFG+++ F  D+++       GT  
Sbjct: 170 LALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIE 225
Query: 494 YMAPEYVTRGH--FSIKSDVFSFGVLVLEIISG 524
           YMAP+ V  G        D +S GVL+ E+++G
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 26/223 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKG------RLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVAR 376
           N  S    LG G FG V +       +      +AVK L  ++   E E   +E+ +++ 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPNSSV--------DKFIFDAIKRVQLDWETRYK 427
           L  H N+V LLG        L+I E+     +        D FI        ++ +    
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 428 IIGG-------IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            +         +A+G+ +L   +    IHRDL A NILL    I KI DFG+AR  + D 
Sbjct: 161 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 217
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +            +MAPE +    ++ +SDV+S+G+ + E+ S
Sbjct: 218 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 324 NNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQ 378
           + F     LG G FG V   K + S G   A+K L K  V    + +   NE  ++  + 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGI 436
              LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I    
Sbjct: 121 FPFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTF 175
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+A
Sbjct: 176 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPEYLA 227
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +    ++   D ++ GVL+ E+ +G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 106/227 (46%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++   +
Sbjct: 22  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFR 81
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 142 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 242

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 330 NKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQG-ELEFKNEVLLVARLQHRNLVRLLG 387
           +KLG+G +  VYKG+       +A+K +     +G       EV L+  L+H N+V L  
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDA-----IKRVQLDWETRYKIIGGIARGILYLHED 442
               E    L++E++ +  + +++ D      +  V+L        +  + RG+ Y H  
Sbjct: 68  IIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKL-------FLFQLLRGLAYCH-- 117
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT- 501
            R +++HRDLK  N+L++     K++DFG+AR   +     D    V T  Y  P+ +  
Sbjct: 118 -RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE--VVTLWYRPPDILLG 174
Query: 502 RGHFSIKSDVFSFGVLVLEIISGQ 525
              +S + D++  G +  E+ +G+
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 106/220 (48%), Gaps = 26/220 (11%)
Query: 319 IRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK-NSVQGELEFKNEVLLVAR 376
           + + +++F   + LG+G +G V        G+ +A+K++   +     L    E+ ++  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 377 LQHRNLVRLLGF----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI 432
            +H N++ +       SFE    + I + +  + + + I     ++  D   +Y I   +
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS---TQMLSDDHIQYFIYQTL 122
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG-- 490
            R +  LH  +   +IHRDLK SN+L++++   K+ DFG+AR+  +D+S  D S   G  
Sbjct: 123 -RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQ 176
Query: 491 --------TFGYMAPE-YVTRGHFSIKSDVFSFGVLVLEI 521
                   T  Y APE  +T   +S   DV+S G ++ E+
Sbjct: 177 SGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 26/229 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKN---EVLLVARLQH 379
           ++F     +G+G FG V   + +  +++ A+K ++K       E +N   E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-----FDAIKRVQLDWETRYKIIGGIAR 434
             LV L  +SF++ E + +        VD  +     +   + V    ET    I  +  
Sbjct: 75  PFLVNLW-YSFQDEEDMFMV-------VDLLLGGDLRYHLQQNVHFKEETVKLFICELVM 126
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
            + YL      RIIHRD+K  NILLD      I+DF +A +      +   + + GT  Y
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKPY 180
Query: 495 MAPEYVTR---GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL 540
           MAPE  +      +S   D +S GV   E++ G++    R    +++++
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 106/220 (48%), Gaps = 26/220 (11%)
Query: 319 IRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK-NSVQGELEFKNEVLLVAR 376
           + + +++F   + LG+G +G V        G+ +A+K++   +     L    E+ ++  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 377 LQHRNLVRLLGF----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI 432
            +H N++ +       SFE    + I + +  + + + I     ++  D   +Y I   +
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS---TQMLSDDHIQYFIYQTL 122
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS------ 486
            R +  LH  +   +IHRDLK SN+L++++   K+ DFG+AR+  +D+S  D S      
Sbjct: 123 -RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQ 176
Query: 487 ----RIVGTFGYMAPE-YVTRGHFSIKSDVFSFGVLVLEI 521
                 V T  Y APE  +T   +S   DV+S G ++ E+
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 106/220 (48%), Gaps = 26/220 (11%)
Query: 319 IRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK-NSVQGELEFKNEVLLVAR 376
           + + +++F   + LG+G +G V        G+ +A+K++   +     L    E+ ++  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 377 LQHRNLVRLLGF----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI 432
            +H N++ +       SFE    + I + +  + + + I     ++  D   +Y I   +
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS---TQMLSDDHIQYFIYQTL 122
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG-- 490
            R +  LH  +   +IHRDLK SN+L++++   K+ DFG+AR+  +D+S  D S   G  
Sbjct: 123 -RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQ 176
Query: 491 --------TFGYMAPE-YVTRGHFSIKSDVFSFGVLVLEI 521
                   T  Y APE  +T   +S   DV+S G ++ E+
Sbjct: 177 SGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 23/202 (11%)
Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN-----EVLLVARLQHRNLVRL 385
           LG+G F  VYK R  +  Q +A+K++         +  N     E+ L+  L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
           L     ++   L+++F+  + ++  I D    +       Y ++    +G+ YLH+    
Sbjct: 78  LDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM--TLQGLEYLHQHW-- 132
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI----VGTFGYMAPEYVT 501
            I+HRDLK +N+LLD + + K++DFG+A+ F      G  +R     V T  Y APE + 
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSF------GSPNRAYXHQVVTRWYRAPELLF 185
Query: 502 RGH-FSIKSDVFSFGVLVLEII 522
               + +  D+++ G ++ E++
Sbjct: 186 GARMYGVGVDMWAVGCILAELL 207

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 324 NNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQ 378
           + F     LG G FG V   K + S G   A+K L K  V    + +   NE  ++  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGI 436
              LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I    
Sbjct: 100 FPFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH    L +I+RDLK  N+++D     +++DFG A+     + +G T  + GT  Y+A
Sbjct: 155 EYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +    ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 106/227 (46%), Gaps = 10/227 (4%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKNSVQGELEFK-NEVLLVARLQ 378
           D    ++  + +G+G +G V     +  +  +A+K++S    Q   +    E+ ++   +
Sbjct: 22  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFR 81
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++ +       T   +   ++    ++  ++  +K   L  +     +  I RG+ Y
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAP 497
           +H  +   ++HRDLK SN+LL+     KI DFG+AR+ + D    G  +  V T  Y AP
Sbjct: 142 IHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 498 EYVTRGHFSIKS-DVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYV 543
           E +       KS D++S G ++ E++S   N     G+   D L ++
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 242

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 106/203 (52%), Gaps = 23/203 (11%)
Query: 332 LGQGGFGAV-----YKGRLSHGQEIAVKRLSKNSVQG---ELEFKNEVLLVARLQHRNLV 383
           LG+G FG V     YK +    Q++A+K +S+  ++     +  + E+  +  L+H +++
Sbjct: 17  LGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +L       T+ +++ E+      D +I +  KR+  D   R+     I   I Y H   
Sbjct: 73  KLYDVITTPTDIVMVIEYAGGELFD-YIVEK-KRMTEDEGRRF--FQQIICAIEYCH--- 125
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-R 502
           R +I+HRDLK  N+LLD ++  KI+DFG++ +   D +   TS   G+  Y APE +  +
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTS--CGSPNYAAPEVINGK 182
Query: 503 GHFSIKSDVFSFGVLVLEIISGQ 525
            +   + DV+S G+++  ++ G+
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH--R 380
           N+F     LG+G FG V   R  + G+  A+K L K  +  + E  + V     LQ+   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYL 439
             +  L ++F+  +RL    FV   +    +F  + R ++  E R +  G  I   + YL
Sbjct: 65  PFLTALKYAFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMAPE 498
           H      +++RD+K  N++LD D   KI+DFG+ +      S G T +   GT  Y+APE
Sbjct: 122 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 175
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            +    +    D +  GV++ E++ G+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 324 NNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQ 378
           + F     LG G FG V   K + S G   A+K L K  V    + +   NE  ++  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGI 436
              LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I    
Sbjct: 100 FPFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +    ++   D ++ GVL+ ++ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH--R 380
           N+F     LG+G FG V   R  + G+  A+K L K  +  + E  + V     LQ+   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYL 439
             +  L ++F+  +RL    FV   +    +F  + R ++  E R +  G  I   + YL
Sbjct: 65  PFLTALKYAFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMAPE 498
           H      +++RD+K  N++LD D   KI+DFG+ +      S G T +   GT  Y+APE
Sbjct: 122 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 175
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            +    +    D +  GV++ E++ G+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH--R 380
           N+F     LG+G FG V   R  + G+  A+K L K  +  + E  + V     LQ+   
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYL 439
             +  L ++F+  +RL    FV   +    +F  + R ++  E R +  G  I   + YL
Sbjct: 68  PFLTALKYAFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 124
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMAPE 498
           H      +++RD+K  N++LD D   KI+DFG+ +      S G T +   GT  Y+APE
Sbjct: 125 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 178
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            +    +    D +  GV++ E++ G+
Sbjct: 179 VLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH--R 380
           N+F     LG+G FG V   R  + G+  A+K L K  +  + E  + V     LQ+   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYL 439
             +  L ++F+  +RL    FV   +    +F  + R ++  E R +  G  I   + YL
Sbjct: 65  PFLTALKYAFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMAPE 498
           H      +++RD+K  N++LD D   KI+DFG+ +      S G T +   GT  Y+APE
Sbjct: 122 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPE 175
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            +    +    D +  GV++ E++ G+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH--R 380
           N+F     LG+G FG V   R  + G+  A+K L K  +  + E  + V     LQ+   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYL 439
             +  L ++F+  +RL    FV   +    +F  + R ++  E R +  G  I   + YL
Sbjct: 65  PFLTALKYAFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMAPE 498
           H      +++RD+K  N++LD D   KI+DFG+ +      S G T +   GT  Y+APE
Sbjct: 122 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPE 175
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            +    +    D +  GV++ E++ G+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH--R 380
           N+F     LG+G FG V   R  + G+  A+K L K  +  + E  + V     LQ+   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYL 439
             +  L ++F+  +RL    FV   +    +F  + R ++  E R +  G  I   + YL
Sbjct: 65  PFLTALKYAFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMAPE 498
           H      +++RD+K  N++LD D   KI+DFG+ +      S G T +   GT  Y+APE
Sbjct: 122 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPE 175
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            +    +    D +  GV++ E++ G+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH--R 380
           N+F     LG+G FG V   R  + G+  A+K L K  +  + E  + V     LQ+   
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYL 439
             +  L ++F+  +RL    FV   +    +F  + R ++  E R +  G  I   + YL
Sbjct: 70  PFLTALKYAFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 126
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMAPE 498
           H      +++RD+K  N++LD D   KI+DFG+ +      S G T +   GT  Y+APE
Sbjct: 127 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPE 180
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            +    +    D +  GV++ E++ G+
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 20/203 (9%)
Query: 332 LGQGGFGAVYKGR----LSHGQEIAVKRLSK----NSVQGELEFKNEVLLVARLQHRNLV 383
           LG+GG+G V++ R     + G+  A+K L K     + +     K E  ++  ++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWE-TRYKIIGGIARGILYLHE 441
            L+ ++F+   +L LI E++        +F  ++R  +  E T    +  I+  + +LH+
Sbjct: 85  DLI-YAFQTGGKLYLILEYLSGGE----LFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
                II+RDLK  NI+L+     K++DFG+ +  E       T    GT  YMAPE + 
Sbjct: 140 KG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYMAPEILM 194
Query: 502 RGHFSIKSDVFSFGVLVLEIISG 524
           R   +   D +S G L+ ++++G
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 13/158 (8%)
Query: 366 EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-----IFDAIKRVQL 420
           +FKNE+ ++  +++   +   G      E  +IYE++ N S+ KF     + D      +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
             +    II  +     Y+H +    I HRD+K SNIL+D +   K+SDFG +      +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 481 SQGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGV 516
            +G  SR  GT+ +M PE+ +    +   K D++S G+
Sbjct: 207 IKG--SR--GTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 13/224 (5%)
Query: 307 NTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGEL 365
           NTV     + +  R    +F+    LG+G FG V         E+ AVK L K+ V  + 
Sbjct: 3   NTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD 62
Query: 366 EFK---NEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLD 421
           + +    E  ++A       +  L   F+  +RL  + E+V N     +    + R +  
Sbjct: 63  DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV-NGGDLMYHIQQVGRFKEP 121
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
               Y     IA G+ +L       II+RDLK  N++LD++   KI+DFGM +  E    
Sbjct: 122 HAVFYA--AEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWD 174
Query: 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
              T    GT  Y+APE +    +    D ++FGVL+ E+++GQ
Sbjct: 175 GVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 20/203 (9%)
Query: 332 LGQGGFGAVYKGR----LSHGQEIAVKRLSK----NSVQGELEFKNEVLLVARLQHRNLV 383
           LG+GG+G V++ R     + G+  A+K L K     + +     K E  ++  ++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWE-TRYKIIGGIARGILYLHE 441
            L+ ++F+   +L LI E++        +F  ++R  +  E T    +  I+  + +LH+
Sbjct: 85  DLI-YAFQTGGKLYLILEYLSGGE----LFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
                II+RDLK  NI+L+     K++DFG+ +  E       T    GT  YMAPE + 
Sbjct: 140 KG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 502 RGHFSIKSDVFSFGVLVLEIISG 524
           R   +   D +S G L+ ++++G
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 109/242 (45%), Gaps = 16/242 (6%)
Query: 307 NTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGEL 365
           NT+     + +  R    +F+    LG+G FG V         E+ AVK L K+ V  + 
Sbjct: 324 NTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD 383
Query: 366 EFKN---EVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLD 421
           + +    E  ++A       +  L   F+  +RL  + E+V N     +    + R +  
Sbjct: 384 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV-NGGDLMYHIQQVGRFKEP 442
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
               Y     IA G+ +L       II+RDLK  N++LD++   KI+DFGM +    D  
Sbjct: 443 HAVFY--AAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497
Query: 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLT 541
              T    GT  Y+APE +    +    D ++FGVL+ E+++GQ       GE+ ++L  
Sbjct: 498 T--TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDEDELFQ 552
Query: 542 YV 543
            +
Sbjct: 553 SI 554

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFK-NEVLLVARLQHRNLVRLLGFS 389
           LGQG    V++GR    G   A+K  +  S    ++ +  E  ++ +L H+N+V+L    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 390 FEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
            E T R  +LI EF P  S+   + +      L       ++  +  G+ +L E+    I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 448 IHRDLKASNILL----DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
           +HR++K  NI+     D   + K++DFG AR  E D+       + GT  Y+ P+   R 
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVXLYGTEEYLHPDMYERA 190
Query: 504 --------HFSIKSDVFSFGVLVLEIISG 524
                    +    D++S GV      +G
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 324 NNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQ 378
           + F     LG G FG V   K + S G   A+K L K  V    + +   NE  ++  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGI 436
              LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I    
Sbjct: 100 FPFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT  Y+A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           P  +    ++   D ++ GVL+ E+ +G
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 56/103 (54%), Gaps = 17/103 (16%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI--- 488
           IA  + +LH      ++HRDLK SNI    D + K+ DFG+  +  MDQ + + + +   
Sbjct: 173 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGL--VTAMDQDEEEQTVLTPM 227
Query: 489 ---------VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
                    VGT  YM+PE +   ++S K D+FS G+++ E++
Sbjct: 228 PAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 105/242 (43%), Gaps = 17/242 (7%)
Query: 314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQGELEFKNEVL 372
            D   + D ++ +     +G G FG     R     E +AVK + +     E   K E++
Sbjct: 10  MDLPIMHD-SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDE-NVKREII 67
Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI 432
               L+H N+VR        T   ++ E+     + + I +A  R   D E R+     +
Sbjct: 68  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSED-EARF-FFQQL 124
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIP--KISDFGMARLFEMDQSQGDTSRIVG 490
             G+ Y H    +++ HRDLK  N LLD    P  KI  FG ++   +      T   VG
Sbjct: 125 ISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST---VG 178
Query: 491 TFGYMAPEYVTRGHFSIK-SDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLHI 549
           T  Y+APE + +  +  K +DV+S GV +  ++ G     F   EE ++    +   L++
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAY--PFEDPEEPKNFRKTIHRILNV 236
Query: 550 LY 551
            Y
Sbjct: 237 QY 238

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL--QHRNLVRLLGFS 389
           +G+G +  V   RL     I   R+ K  +  + E  + V     +  Q  N   L+G  
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 390 --FEETERLL-IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
             F+   RL  + E+V    +   +F   ++ +L  E        I+  + YLHE     
Sbjct: 120 SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 173
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
           II+RDLK  N+LLD++   K++D+GM +  E  +    TS   GT  Y+APE +    + 
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 231
Query: 507 IKSDVFSFGVLVLEIISGQ 525
              D ++ GVL+ E+++G+
Sbjct: 232 FSVDWWALGVLMFEMMAGR 250

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 161
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 162 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 215
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 161
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 162 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 215
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 214
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 160
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 161 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 214
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 91  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 147
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 148 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 201
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 161
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 162 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 215
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 91  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 147
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 148 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 201
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 161
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 162 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 215
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 160
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 161 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 214
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 148
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 149 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 202
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFK-NEVLLVARLQHRNLVRLLGFS 389
           LGQG    V++GR    G   A+K  +  S    ++ +  E  ++ +L H+N+V+L    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 390 FEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
            E T R  +LI EF P  S+   + +      L       ++  +  G+ +L E+    I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 448 IHRDLKASNILL----DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
           +HR++K  NI+     D   + K++DFG AR  E D+       + GT  Y+ P+   R 
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERA 190
Query: 504 --------HFSIKSDVFSFGVLVLEIISG 524
                    +    D++S GV      +G
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 160
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 161 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 214
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 148
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 149 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 202
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 329 DNKLGQGGFGAVYKGRLSHGQ------EIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
           D ++G+G F  VYKG  +         E+  ++L+K+  Q    FK E   +  LQH N+
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNI 87
Query: 383 VRLLGFSFEETER-----LLIYEFVPNSSVDKFI--FDAIK-RVQLDWETRYKIIGGIAR 434
           VR    S+E T +     +L+ E   + ++  ++  F   K +V   W         I +
Sbjct: 88  VRFYD-SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW------CRQILK 140
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFG 493
           G+ +LH  +   IIHRDLK  NI +       KI D G+A L     ++     ++GT  
Sbjct: 141 GLQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPE 195
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           + APE      +    DV++FG   LE  + +
Sbjct: 196 FXAPEXYEE-KYDESVDVYAFGXCXLEXATSE 226

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 148
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 149 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 202
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 119 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 177 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 229
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 167
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 168 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 221
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 119 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 177 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 229
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 72  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHNX 129
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 182
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 19/154 (12%)
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGIL 437
           H N+++L       T   L+++ +        +FD + ++V L  +   KI+  +   I 
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGE----LFDYLTEKVTLSEKETRKIMRALLEVIC 125
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMA 496
            LH   +L I+HRDLK  NILLD DM  K++DFG    F      G+  R + GT  Y+A
Sbjct: 126 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFG----FSCQLDPGEKLREVCGTPSYLA 178
Query: 497 PEYV------TRGHFSIKSDVFSFGVLVLEIISG 524
           PE +          +  + D++S GV++  +++G
Sbjct: 179 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 124 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHNC 181
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 182 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 234
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 235 YHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL--QHRNLVRLLGFS 389
           +G+G +  V   RL     I   ++ K  +  + E  + V     +  Q  N   L+G  
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 390 --FEETERLL-IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
             F+   RL  + E+V    +   +F   ++ +L  E        I+  + YLHE     
Sbjct: 88  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 141
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
           II+RDLK  N+LLD++   K++D+GM +  E  +    TS   GT  Y+APE +    + 
Sbjct: 142 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG 199
Query: 507 IKSDVFSFGVLVLEIISGQ 525
              D ++ GVL+ E+++G+
Sbjct: 200 FSVDWWALGVLMFEMMAGR 218

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 19/154 (12%)
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGIL 437
           H N+++L       T   L+++ +        +FD + ++V L  +   KI+  +   I 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGE----LFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMA 496
            LH   +L I+HRDLK  NILLD DM  K++DFG    F      G+  R + GT  Y+A
Sbjct: 139 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFG----FSCQLDPGEKLRSVCGTPSYLA 191
Query: 497 PEYV------TRGHFSIKSDVFSFGVLVLEIISG 524
           PE +          +  + D++S GV++  +++G
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 76  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 132
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 133 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 186
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 77  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 133
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 134 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 187
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 77  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCH-- 132
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 133 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 187
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 77  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 133
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 134 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 187
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 19/154 (12%)
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGIL 437
           H N+++L       T   L+++ +        +FD + ++V L  +   KI+  +   I 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGE----LFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMA 496
            LH   +L I+HRDLK  NILLD DM  K++DFG    F      G+  R + GT  Y+A
Sbjct: 139 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFG----FSCQLDPGEKLREVCGTPSYLA 191
Query: 497 PEYV------TRGHFSIKSDVFSFGVLVLEIISG 524
           PE +          +  + D++S GV++  +++G
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 324 NNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQ 378
           + F     LG G FG V   K + S G   A+K L K  V    + +   NE  ++  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGI 436
              LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I    
Sbjct: 100 FPFLVKL-EFSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT   +A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEALA 206
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +    ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVAR 376
           + +     LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 377 LQH--RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
           +      ++RLL + FE  +  ++    P    D F F   +R  L  E        +  
Sbjct: 64  VSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLE 121
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFG 493
            + + H      ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  
Sbjct: 122 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRV 174
Query: 494 YMAPEYVTRGHFSIKS-DVFSFGVLVLEIISG 524
           Y  PE++    +  +S  V+S G+L+ +++ G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 72  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 182
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +RLL + FE  +  ++    P    D F F   +R  L  E        +   + + H  
Sbjct: 75  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHNC 132
Query: 443 SRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
               ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE++ 
Sbjct: 133 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEWIR 185
Query: 502 RGHFSIKS-DVFSFGVLVLEIISG 524
              +  +S  V+S G+L+ +++ G
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL--QHRNLVRLLGFS 389
           +G+G +  V   RL     I   ++ K  +  + E  + V     +  Q  N   L+G  
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 390 --FEETERLL-IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
             F+   RL  + E+V    +   +F   ++ +L  E        I+  + YLHE     
Sbjct: 77  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 130
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
           II+RDLK  N+LLD++   K++D+GM +  E  +    TS   GT  Y+APE +    + 
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG 188
Query: 507 IKSDVFSFGVLVLEIISGQ 525
              D ++ GVL+ E+++G+
Sbjct: 189 FSVDWWALGVLMFEMMAGR 207

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL--QHRNLVRLLGFS 389
           +G+G +  V   RL     I   ++ K  +  + E  + V     +  Q  N   L+G  
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 390 --FEETERLL-IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
             F+   RL  + E+V    +   +F   ++ +L  E        I+  + YLHE     
Sbjct: 73  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 126
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
           II+RDLK  N+LLD++   K++D+GM +  E  +    TS   GT  Y+APE +    + 
Sbjct: 127 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG 184
Query: 507 IKSDVFSFGVLVLEIISGQ 525
              D ++ GVL+ E+++G+
Sbjct: 185 FSVDWWALGVLMFEMMAGR 203

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVAR 376
           + +     LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ +
Sbjct: 31  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 90
Query: 377 LQH--RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
           +      ++RLL + FE  +  ++    P    D F F   +R  L  E        +  
Sbjct: 91  VSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLE 148
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFG 493
            + + H      ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  
Sbjct: 149 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRV 201
Query: 494 YMAPEYVTRGHFSIKS-DVFSFGVLVLEIISG 524
           Y  PE++    +  +S  V+S G+L+ +++ G
Sbjct: 202 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 107/229 (46%), Gaps = 31/229 (13%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKNEVLL 373
           D++  ++    +   + +G+G    V +    + G E AVK +   + +   E   EV  
Sbjct: 85  DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVRE 144
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQL-----------DW 422
             R +   L ++ G        + + +   +SS    +FD +++ +L           + 
Sbjct: 145 ATRRETHILRQVAG----HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK 200
Query: 423 ETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482
           ETR  I+  +   + +LH ++   I+HRDLK  NILLD +M  ++SDFG    F      
Sbjct: 201 ETR-SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFG----FSCHLEP 252
Query: 483 GDTSR-IVGTFGYMAPEYV------TRGHFSIKSDVFSFGVLVLEIISG 524
           G+  R + GT GY+APE +      T   +  + D+++ GV++  +++G
Sbjct: 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 328 TDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRL 385
           T   LG+G +  V     L +G+E AVK + K +         EV  + + Q ++N++ L
Sbjct: 17  TSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILEL 76
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
           + F  ++T   L++E +   S+   I    K+   +     +++  +A  + +LH     
Sbjct: 77  IEFFEDDTRFYLVFEKLQGGSILAHI---QKQKHFNEREASRVVRDVAAALDFLHTKG-- 131
Query: 446 RIIHRDLKASNILLDA--DMIP-KISDFGMARLFEMDQS-----QGDTSRIVGTFGYMAP 497
            I HRDLK  NIL ++   + P KI DF +    +++ S       + +   G+  YMAP
Sbjct: 132 -IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAP 190
Query: 498 EYV-----TRGHFSIKSDVFSFGVLVLEIISG 524
           E V         +  + D++S GV++  ++SG
Sbjct: 191 EVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 331 KLGQGGFGAVYK-GRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
           +LG G FG V++    + G+    K ++      +   KNE+ ++ +L H  L+ L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR----GILYLHEDSRL 445
            ++ E +LI EF+        +FD I     D++     +    R    G+ ++HE S  
Sbjct: 118 EDKYEMVLILEFLSGGE----LFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEHS-- 169
Query: 446 RIIHRDLKASNILLDADMIP--KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
            I+H D+K  NI+ +       KI DFG+A     D+    T+    T  + APE V R 
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDRE 225
Query: 504 HFSIKSDVFSFGVLVLEIISG 524
                +D+++ GVL   ++SG
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSG 246

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQ 378
           R+  +  +   +LG+G FG V++ +    G + AVK+     V+ E+    E++  A L 
Sbjct: 68  REEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKK-----VRLEVFRVEELVACAGLS 122
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETR-YKIIGGIARGIL 437
              +V L G   E     +  E +   S+ + I    K++    E R    +G    G+ 
Sbjct: 123 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLE 178
Query: 438 YLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMD---QSQGDTSRIVGTFG 493
           YLH     RI+H D+KA N+LL +D     + DFG A   + D   +S      I GT  
Sbjct: 179 YLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 235
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           +MAPE V       K D++S   ++L +++G
Sbjct: 236 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 105/222 (47%), Gaps = 17/222 (7%)
Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSK--NSVQGELEFKNEVL 372
           F    D  + +     +G G +G V   R    GQ++A+K++    + V        E+ 
Sbjct: 47  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK 106
Query: 373 LVARLQHRNLVRLLGF-----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYK 427
           ++   +H N++ +         + E + + +   +  S + + I  + + + L+   RY 
Sbjct: 107 ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSS-QPLTLE-HVRY- 163
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF--EMDQSQGDT 485
            +  + RG+ Y+H     ++IHRDLK SN+L++ +   KI DFGMAR       + Q   
Sbjct: 164 FLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 220
Query: 486 SRIVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQK 526
           +  V T  Y APE +   H ++   D++S G +  E+++ ++
Sbjct: 221 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRL---- 385
           L +GGF  VY+ + +  G+E A+KRL  N  +       EV  + +L  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 386 -LGFSFEET---ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
            +G    +T   E LL+ E      V+ F+     R  L  +T  KI     R + ++H 
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVE-FLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMA 473
             +  IIHRDLK  N+LL      K+ DFG A
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 105/222 (47%), Gaps = 17/222 (7%)
Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSK--NSVQGELEFKNEVL 372
           F    D  + +     +G G +G V   R    GQ++A+K++    + V        E+ 
Sbjct: 46  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK 105
Query: 373 LVARLQHRNLVRLLGF-----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYK 427
           ++   +H N++ +         + E + + +   +  S + + I  + + + L+   RY 
Sbjct: 106 ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSS-QPLTLE-HVRY- 162
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF--EMDQSQGDT 485
            +  + RG+ Y+H     ++IHRDLK SN+L++ +   KI DFGMAR       + Q   
Sbjct: 163 FLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 219
Query: 486 SRIVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQK 526
           +  V T  Y APE +   H ++   D++S G +  E+++ ++
Sbjct: 220 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVK-----RLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +G+G F  V +      GQ+ AVK     + + +      + K E  +   L+H ++V L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL----YLHE 441
           L     +    +++EF+  + +    F+ +KR    +     +     R IL    Y H+
Sbjct: 94  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 150
Query: 442 DSRLRIIHRDLKASNILLDA--DMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           ++   IIHRD+K   +LL +  +  P K+  FG+A   ++ +S       VGT  +MAPE
Sbjct: 151 NN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVGTPHFMAPE 205
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISG 524
            V R  +    DV+  GV++  ++SG
Sbjct: 206 VVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVK-----RLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
           +G+G F  V +      GQ+ AVK     + + +      + K E  +   L+H ++V L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL----YLHE 441
           L     +    +++EF+  + +    F+ +KR    +     +     R IL    Y H+
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 442 DSRLRIIHRDLKASNILLDA--DMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           ++   IIHRD+K   +LL +  +  P K+  FG+A   ++ +S       VGT  +MAPE
Sbjct: 149 NN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVGTPHFMAPE 203
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISG 524
            V R  +    DV+  GV++  ++SG
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQ 378
           R+  +  +   ++G+G FG V++ +    G + AVK+     V+ E+    E++  A L 
Sbjct: 54  REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK-----VRLEVFRVEELVACAGLS 108
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETR-YKIIGGIARGIL 437
              +V L G   E     +  E +   S+ + I    K++    E R    +G    G+ 
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLE 164
Query: 438 YLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMD---QSQGDTSRIVGTFG 493
           YLH     RI+H D+KA N+LL +D     + DFG A   + D   +S      I GT  
Sbjct: 165 YLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           +MAPE V       K D++S   ++L +++G
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNS--------VQGELEFKNEVLLV 374
           + +     LG G  G V         +++A+K +SK              L  + E+ ++
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKI-IG 430
            +L H  ++++  F F+  +  ++ E +        +FD +   KR++   E   K+   
Sbjct: 69  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGE----LFDKVVGNKRLK---EATCKLYFY 120
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTS- 486
            +   + YLHE+    IIHRDLK  N+LL   + D + KI+DFG +++       G+TS 
Sbjct: 121 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL------GETSL 171
Query: 487 --RIVGTFGYMAPEY---VTRGHFSIKSDVFSFGVLVLEIISG 524
              + GT  Y+APE    V    ++   D +S GV++   +SG
Sbjct: 172 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNS--------VQGELEFKNEVLLV 374
           + +     LG G  G V         +++A+K +SK              L  + E+ ++
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKI-IG 430
            +L H  ++++  F F+  +  ++ E +        +FD +   KR++   E   K+   
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGE----LFDKVVGNKRLK---EATCKLYFY 121
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTS- 486
            +   + YLHE+    IIHRDLK  N+LL   + D + KI+DFG +++       G+TS 
Sbjct: 122 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL------GETSL 172
Query: 487 --RIVGTFGYMAPEY---VTRGHFSIKSDVFSFGVLVLEIISG 524
              + GT  Y+APE    V    ++   D +S GV++   +SG
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQ 378
           R+  +  +   ++G+G FG V++ +    G + AVK+     V+ E+    E++  A L 
Sbjct: 70  REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK-----VRLEVFRVEELVACAGLS 124
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETR-YKIIGGIARGIL 437
              +V L G   E     +  E +   S+ + I    K++    E R    +G    G+ 
Sbjct: 125 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLE 180
Query: 438 YLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMD---QSQGDTSRIVGTFG 493
           YLH     RI+H D+KA N+LL +D     + DFG A   + D   +S      I GT  
Sbjct: 181 YLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 237
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           +MAPE V       K D++S   ++L +++G
Sbjct: 238 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNS--------VQGELEFKNEVLLV 374
           + +     LG G  G V         +++A+K +SK              L  + E+ ++
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKI-IG 430
            +L H  ++++  F F+  +  ++ E +        +FD +   KR++   E   K+   
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGE----LFDKVVGNKRLK---EATCKLYFY 121
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTS- 486
            +   + YLHE+    IIHRDLK  N+LL   + D + KI+DFG +++       G+TS 
Sbjct: 122 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL------GETSL 172
Query: 487 --RIVGTFGYMAPEY---VTRGHFSIKSDVFSFGVLVLEIISG 524
              + GT  Y+APE    V    ++   D +S GV++   +SG
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNS--------VQGELEFKNEVLLV 374
           + +     LG G  G V         +++A+K +SK              L  + E+ ++
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKI-IG 430
            +L H  ++++  F F+  +  ++ E +        +FD +   KR++   E   K+   
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGE----LFDKVVGNKRLK---EATCKLYFY 121
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTS- 486
            +   + YLHE+    IIHRDLK  N+LL   + D + KI+DFG +++       G+TS 
Sbjct: 122 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL------GETSL 172
Query: 487 --RIVGTFGYMAPEY---VTRGHFSIKSDVFSFGVLVLEIISG 524
              + GT  Y+APE    V    ++   D +S GV++   +SG
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNS--------VQGELEFKNEVLLV 374
           + +     LG G  G V         +++A+K +SK              L  + E+ ++
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKI-IG 430
            +L H  ++++  F F+  +  ++ E +        +FD +   KR++   E   K+   
Sbjct: 76  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGE----LFDKVVGNKRLK---EATCKLYFY 127
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTS- 486
            +   + YLHE+    IIHRDLK  N+LL   + D + KI+DFG +++       G+TS 
Sbjct: 128 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL------GETSL 178
Query: 487 --RIVGTFGYMAPEY---VTRGHFSIKSDVFSFGVLVLEIISG 524
              + GT  Y+APE    V    ++   D +S GV++   +SG
Sbjct: 179 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQ 378
           R+  +  +   +LG+G FG V++      G + AVK++     + E     E++  A L 
Sbjct: 70  REEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLT 124
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
              +V L G   E     +  E +   S+ + + +   +  L  +     +G    G+ Y
Sbjct: 125 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKE---QGCLPEDRALYYLGQALEGLEY 181
Query: 439 LHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMDQSQGD---TSRIVGTFGY 494
           LH  SR RI+H D+KA N+LL +D     + DFG A   + D    D      I GT  +
Sbjct: 182 LH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETH 238
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           MAPE V       K DV+S   ++L +++G
Sbjct: 239 MAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQH--RNL 382
           LG GGFG+VY G R+S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 383 VRLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           +RLL + FE  +   L++    P   +  FI    +R  L  E        +   + + H
Sbjct: 76  IRLLDW-FERPDSFVLILERMEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCH 131
Query: 441 EDSRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
                 ++HRD+K  NIL+D +    K+ DFG   L + D    D     GT  Y  PE+
Sbjct: 132 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSPPEW 184
Query: 500 VTRGHFSIKS-DVFSFGVLVLEIISG 524
           +    +  +S  V+S G+L+ +++ G
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQ 378
           R+  +  +   +LG+G FG V++      G + AVK++     + E     E++  A L 
Sbjct: 89  REEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLT 143
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
              +V L G   E     +  E +   S+ + + +   +  L  +     +G    G+ Y
Sbjct: 144 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKE---QGCLPEDRALYYLGQALEGLEY 200
Query: 439 LHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMD---QSQGDTSRIVGTFGY 494
           LH  SR RI+H D+KA N+LL +D     + DFG A   + D   +S      I GT  +
Sbjct: 201 LH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETH 257
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           MAPE V       K DV+S   ++L +++G
Sbjct: 258 MAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 18/199 (9%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391
           LG+G FG V++   +  ++  + +  K     ++  K E+ ++   +HRN++ L   SFE
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE-SFE 71
Query: 392 ETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI--IGGIARGILYLHEDSRLRII 448
             E L +I+EF+  S +D  IF+ I     +   R  +  +  +   + +LH  +   I 
Sbjct: 72  SMEELVMIFEFI--SGLD--IFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IG 124
Query: 449 HRDLKASNILLDA--DMIPKISDFGMARLFEMDQSQGDTSRIVGTFG-YMAPEYVTRGHF 505
           H D++  NI+         KI +FG AR  +     GD  R++ T   Y APE       
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLK----PGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 506 SIKSDVFSFGVLVLEIISG 524
           S  +D++S G LV  ++SG
Sbjct: 181 STATDMWSLGTLVYVLLSG 199

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNS--------VQGELEFKNEVLLVARLQHRNL 382
           LG G  G V         +++A++ +SK              L  + E+ ++ +L H  +
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKI-IGGIARGILY 438
           +++  F F+  +  ++ E +        +FD +   KR++   E   K+    +   + Y
Sbjct: 217 IKIKNF-FDAEDYYIVLELMEGGE----LFDKVVGNKRLK---EATCKLYFYQMLLAVQY 268
Query: 439 LHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTS---RIVGTF 492
           LHE+    IIHRDLK  N+LL   + D + KI+DFG +++       G+TS    + GT 
Sbjct: 269 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL------GETSLMRTLCGTP 319
Query: 493 GYMAPEY---VTRGHFSIKSDVFSFGVLVLEIISG 524
            Y+APE    V    ++   D +S GV++   +SG
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 323 TNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN--------EVLL 373
           +  +ST + LG G FG V+        +E+ VK + K  V  +   ++        E+ +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
           ++R++H N++++L   FE      +      S +D F F   +  +LD      I   + 
Sbjct: 83  LSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAF-IDRHPRLDEPLASYIFRQLV 140
Query: 434 RGILYLHEDSRLR-IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF 492
             + YL    RL+ IIHRD+K  NI++  D   K+ DFG A   E  +         GT 
Sbjct: 141 SAVGYL----RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTI 193
Query: 493 GYMAPEYVTRGHF-SIKSDVFSFGVLVLEII 522
            Y APE +    +   + +++S GV +  ++
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNS--------VQGELEFKNEVLLVARLQHRNL 382
           LG G  G V         +++A++ +SK              L  + E+ ++ +L H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKI-IGGIARGILY 438
           +++  F F+  +  ++ E +        +FD +   KR++   E   K+    +   + Y
Sbjct: 203 IKIKNF-FDAEDYYIVLELMEGGE----LFDKVVGNKRLK---EATCKLYFYQMLLAVQY 254
Query: 439 LHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTS---RIVGTF 492
           LHE+    IIHRDLK  N+LL   + D + KI+DFG +++       G+TS    + GT 
Sbjct: 255 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL------GETSLMRTLCGTP 305
Query: 493 GYMAPEY---VTRGHFSIKSDVFSFGVLVLEIISG 524
            Y+APE    V    ++   D +S GV++   +SG
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLS--------HGQEIAVKRLSKNSVQGELEF 367
           F  IR+    F  +  LGQG F  ++KG           H  E+ +K L K        F
Sbjct: 2   FHKIRNEDLIF--NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF 59
Query: 368 KNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYK 427
                ++++L H++LV   G  F   E +L+ EFV   S+D ++      + + W  + +
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLE 117
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILL---------DADMIPKISDFGMA-RLFE 477
           +   +A  + +L E++   +IH ++ A NILL         +   I K+SD G++  +  
Sbjct: 118 VAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI-KLSDPGISITVLP 173
Query: 478 MDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISG 524
            D  Q    RI     ++ PE +    + ++ +D +SFG  + EI SG
Sbjct: 174 KDILQ---ERI----PWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 106/209 (50%), Gaps = 20/209 (9%)
Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR---LLG 387
           LG GG G V+    +   + +A+K++     Q       E+ ++ RL H N+V+   +LG
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 388 FSFEE--------TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            S  +        TE   +Y  +    ++  + + +++  L  E     +  + RG+ Y+
Sbjct: 79  PSGSQLTDDVGSLTELNSVY--IVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYI 136
Query: 440 HEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEMDQS-QGDTSRIVGTFGYMAP 497
           H  +   ++HRDLK +N+ ++  D++ KI DFG+AR+ +   S +G  S  + T  Y +P
Sbjct: 137 HSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSP 193
Query: 498 E-YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
              ++  +++   D+++ G +  E+++G+
Sbjct: 194 RLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGF 388
           +G+G FG V   R    Q++ A+K LSK  +  + +  F  E   +    +   V  L  
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 142
Query: 389 SFEETERL-LIYEFVPNSSVDKFI--FDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
           +F++ + L ++ E++P   +   +  +D  ++    W   Y      A  +L L     +
Sbjct: 143 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----TAEVVLALDAIHSM 193
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMA-RLFEMDQSQGDTSRIVGTFGYMAPEYVTR-- 502
            +IHRD+K  N+LLD     K++DFG   ++ E      DT+  VGT  Y++PE +    
Sbjct: 194 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA--VGTPDYISPEVLKSQG 251
Query: 503 --GHFSIKSDVFSFGVLVLEIISG 524
             G++  + D +S GV + E++ G
Sbjct: 252 GDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 39/242 (16%)
Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAV--YKGRLSHGQEIAVKRLSKNSVQGELEF 367
           E+L F    +     ++    KLG+GGF  V   +G L  G   A+KR+  +  Q   E 
Sbjct: 15  ENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEA 73
Query: 368 KNEVLLVARLQHRNLVRLLGFSFEET----ERLLIYEFVPNSSVDKFIFDAIKRVQ---- 419
           + E  +     H N++RL+ +   E     E  L+  F    +    +++ I+R++    
Sbjct: 74  QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGT----LWNEIERLKDKGN 129
Query: 420 -LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478
            L  +    ++ GI RG+  +H        HRDLK +NILL  +  P + D G      M
Sbjct: 130 FLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLG-----SM 181
Query: 479 DQS----QG--------DTSRIVGTFGYMAPE-YVTRGHFSI--KSDVFSFGVLVLEIIS 523
           +Q+    +G        D +    T  Y APE +  + H  I  ++DV+S G ++  ++ 
Sbjct: 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF 241
Query: 524 GQ 525
           G+
Sbjct: 242 GE 243

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 117/254 (46%), Gaps = 43/254 (16%)
Query: 310 ESLQFDFSTIRDA--TNNFSTDNKLGQGGFGAVYKGRLSHG-QEIAVKRLSKNSVQGELE 366
           E+L F  + I++    +N+   + +G+G +G VY     +  + +A+K++++   +  ++
Sbjct: 12  ENLYFQGAIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNR-MFEDLID 70
Query: 367 FKN---EVLLVARLQHRNLVRLLGFSFEET----ERLLIYEFVPNSSVDKFIFDAIKRVQ 419
            K    E+ ++ RL+   ++RL      E     + L I   + +S + K     I   +
Sbjct: 71  CKRILREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTE 130
Query: 420 LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479
              +T   I+  +  G  ++HE     IIHRDLK +N LL+ D   KI DFG+AR    D
Sbjct: 131 QHVKT---ILYNLLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSD 184
Query: 480 Q------------------------SQGDTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSF 514
           +                         +  TS +V T  Y APE +  + +++   D++S 
Sbjct: 185 KDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTNSIDIWST 243
Query: 515 GVLVLEIISGQKNN 528
           G +  E+++  K++
Sbjct: 244 GCIFAELLNMMKSH 257

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 29/179 (16%)
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQL-----------DWETRYK---------IIG 430
           EE E LL Y   PN    K ++D  K V L           D   R K         ++ 
Sbjct: 69  EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLH 128
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNIL-LDADMIP---KISDFGMARLFEMDQSQGDTS 486
            I + + YLH      ++HRDLK SNIL +D    P   +I DFG A+  ++    G   
Sbjct: 129 TIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAK--QLRAENGLLM 183
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSN 545
               T  ++APE + R  +    D++S G+L+  +++G    +    +  E++LT + +
Sbjct: 184 TPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGS 242

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 29/179 (16%)
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQL-----------DWETRYK---------IIG 430
           EE E LL Y   PN    K ++D  K V L           D   R K         ++ 
Sbjct: 69  EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLH 128
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNIL-LDADMIP---KISDFGMARLFEMDQSQGDTS 486
            I + + YLH      ++HRDLK SNIL +D    P   +I DFG A+  ++    G   
Sbjct: 129 TIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAK--QLRAENGLLM 183
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSN 545
               T  ++APE + R  +    D++S G+L+  +++G    +    +  E++LT + +
Sbjct: 184 TPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGS 242

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 109/237 (45%), Gaps = 23/237 (9%)
Query: 305 EINTVESLQF------DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLS 357
           E N +E L++          +R    +F     +G+G FG V   +L +  ++ A+K L+
Sbjct: 49  EKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN 108
Query: 358 KNSVQGELE---FKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFD 413
           K  +    E   F+ E  ++     +  +  L ++F++   L L+ ++     +   +  
Sbjct: 109 KWEMLKRAETACFREERDVLVNGDSK-WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK 167
Query: 414 AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473
              R+  +    Y     +A  ++ +    +L  +HRD+K  NIL+D +   +++DFG  
Sbjct: 168 FEDRLPEEMARFY-----LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 222
Query: 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQ 525
            L  M+     +S  VGT  Y++PE +      +G +  + D +S GV + E++ G+
Sbjct: 223 -LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELE---FKNE--VLLVARLQ 378
           +F     +G+G FG V   ++ + + I A+K L+K  +    E   F+ E  VL+    Q
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 134
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
               +  L ++F++   L L+ ++     +   +     ++  D    Y  IG +   I 
Sbjct: 135 ---WITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY--IGEMVLAID 189
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
            +H+   L  +HRD+K  N+LLD +   +++DFG   L   D     +S  VGT  Y++P
Sbjct: 190 SIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGTPDYISP 245
Query: 498 EYVT-----RGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       G +  + D +S GV + E++ G+
Sbjct: 246 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELE---FKNE--VLLVARLQ 378
           +F     +G+G FG V   ++ + + I A+K L+K  +    E   F+ E  VL+    Q
Sbjct: 91  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 150
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
               +  L ++F++   L L+ ++     +   +     ++  D    Y  IG +   I 
Sbjct: 151 ---WITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY--IGEMVLAID 205
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
            +H+   L  +HRD+K  N+LLD +   +++DFG   L   D     +S  VGT  Y++P
Sbjct: 206 SIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGTPDYISP 261
Query: 498 EYVT-----RGHFSIKSDVFSFGVLVLEIISGQ 525
           E +       G +  + D +S GV + E++ G+
Sbjct: 262 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 34/228 (14%)
Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLS--------HGQEIAVKRLSKNSVQGELEF 367
           F  IR+    F  +  LGQG F  ++KG           H  E+ +K L K        F
Sbjct: 2   FHKIRNEDLIF--NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF 59
Query: 368 KNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYK 427
                ++++L H++LV   G      E +L+ EFV   S+D ++      + + W  + +
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLE 117
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILL---------DADMIPKISDFGMA-RLFE 477
           +   +A  + +L E++   +IH ++ A NILL         +   I K+SD G++  +  
Sbjct: 118 VAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI-KLSDPGISITVLP 173
Query: 478 MDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISG 524
            D  Q    RI     ++ PE +    + ++ +D +SFG  + EI SG
Sbjct: 174 KDILQ---ERI----PWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 40/226 (17%)
Query: 332 LGQGGFG-AVYKGRLSHGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFS 389
           LG G  G  V++G    G+ +AVKR+  +      +E K   LL     H N++R   + 
Sbjct: 23  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRY--YC 76
Query: 390 FEETERLLIYEF------VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            E T+R L          + +    K + D   ++Q ++     ++  IA G+ +LH   
Sbjct: 77  SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP-ISLLRQIASGVAHLHS-- 133
Query: 444 RLRIIHRDLKASNILLDA-------------DMIPKISDFGMARLFEMDQS--QGDTSRI 488
            L+IIHRDLK  NIL+               ++   ISDFG+ +  +  QS  + + +  
Sbjct: 134 -LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 489 VGTFGYMAPEYV-------TRGHFSIKSDVFSFGVLVLEIISGQKN 527
            GT G+ APE +       T+   +   D+FS G +   I+S  K+
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 82/168 (48%), Gaps = 13/168 (7%)
Query: 363 GELEFKNEVLLVARLQHRNLVRLLGFSF-EETERL-LIYEFVPNSSVDKFIFDAIKRVQL 420
           GE   K E+ L+ RL+H+N+++L+   + EE +++ ++ E+      +  + D++   + 
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRF 106
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
                +     +  G+ YLH      I+H+D+K  N+LL      KIS  G+A       
Sbjct: 107 PVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163
Query: 481 SQGDTSRIV-GTFGYMAPEYVTRG--HFS-IKSDVFSFGVLVLEIISG 524
           +  DT R   G+  +  PE +  G   FS  K D++S GV +  I +G
Sbjct: 164 AD-DTCRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 329 DNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLL 386
           ++ LG+G    V     L   QE AVK + K           EV ++ + Q HRN++ L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
            F  EE    L++E +   S+   I    KR   +      ++  +A  + +LH      
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQDVASALDFLHNKG--- 131
Query: 447 IIHRDLKASNILLDA--DMIP-KISDFGMARLFEMDQSQGDTSRI--------VGTFGYM 495
           I HRDLK  NIL +    + P KI DFG+    +++   GD S I         G+  YM
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLN---GDCSPISTPELLTPCGSAEYM 188
Query: 496 APEYV-----TRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
           APE V         +  + D++S GV++  ++SG      R G +
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 12/179 (6%)
Query: 326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRN-- 381
           +S   ++G GG   V++      Q  A+K   L +   Q    ++NE+  + +LQ  +  
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 73
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           ++RL  + +E T++  IY  +   ++D   +   K+    WE R      +   +  +H+
Sbjct: 74  IIRL--YDYEITDQY-IYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 129
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                I+H DLK +N L+   M+ K+ DFG+A   + D +       VGT  YM PE +
Sbjct: 130 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 184

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 12/179 (6%)
Query: 326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRN-- 381
           +S   ++G GG   V++      Q  A+K   L +   Q    ++NE+  + +LQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           ++RL  + +E T++  IY  +   ++D   +   K+    WE R      +   +  +H+
Sbjct: 118 IIRL--YDYEITDQY-IYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 173
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                I+H DLK +N L+  D + K+ DFG+A   + D +       VGT  YM PE +
Sbjct: 174 HG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 12/179 (6%)
Query: 326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRN-- 381
           +S   ++G GG   V++      Q  A+K   L +   Q    ++NE+  + +LQ  +  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           ++RL  + +E T++  IY  +   ++D   +   K+    WE R      +   +  +H+
Sbjct: 90  IIRL--YDYEITDQY-IYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 145
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                I+H DLK +N L+  D + K+ DFG+A   + D +       VGT  YM PE +
Sbjct: 146 HG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 332 LGQGGFG-AVYKGRLSHGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFS 389
           LG G  G  V++G    G+ +AVKR+  +      +E K   LL     H N++R   + 
Sbjct: 41  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRY--YC 94
Query: 390 FEETERLLIYEF------VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            E T+R L          + +    K + D   ++Q ++     ++  IA G+ +LH   
Sbjct: 95  SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP-ISLLRQIASGVAHLHS-- 151
Query: 444 RLRIIHRDLKASNILLDA-------------DMIPKISDFGMARLFEMDQS--QGDTSRI 488
            L+IIHRDLK  NIL+               ++   ISDFG+ +  +  Q   + + +  
Sbjct: 152 -LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 489 VGTFGYMAPEYV---TRGHFSIKSDVFSFGVLVLEIISGQKN 527
            GT G+ APE +   T+   +   D+FS G +   I+S  K+
Sbjct: 211 SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 106/233 (45%), Gaps = 29/233 (12%)
Query: 304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV- 361
           D IN +  L       R    ++     +G+G FG V   R    +++ A+K LSK  + 
Sbjct: 61  DTINKIRDL-------RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 113
Query: 362 -QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFI--FDAIKR 417
            + +  F  E   +    +   V  L ++F++   L ++ E++P   +   +  +D  ++
Sbjct: 114 KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK 173
Query: 418 VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM-ARLF 476
               W   Y      A  +L L     +  IHRD+K  N+LLD     K++DFG   ++ 
Sbjct: 174 ----WARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 224
Query: 477 EMDQSQGDTSRIVGTFGYMAPEYVTR----GHFSIKSDVFSFGVLVLEIISGQ 525
           +    + DT+  VGT  Y++PE +      G++  + D +S GV + E++ G 
Sbjct: 225 KEGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 275

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 12/179 (6%)
Query: 326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRN-- 381
           +S   ++G GG   V++      Q  A+K   L +   Q    ++NE+  + +LQ  +  
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           ++RL  + +E T++  IY  +   ++D   +   K+    WE R      +   +  +H+
Sbjct: 71  IIRL--YDYEITDQY-IYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 126
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                I+H DLK +N L+  D + K+ DFG+A   + D +       VGT  YM PE +
Sbjct: 127 HG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 84/179 (46%), Gaps = 12/179 (6%)
Query: 326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRN-- 381
           +S   ++G GG   V++      Q  A+K ++      +    ++NE+  + +LQ  +  
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 69
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           ++RL  + +E T++  IY  +   ++D   +   K+    WE R      +   +  +H+
Sbjct: 70  IIRL--YDYEITDQY-IYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 125
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                I+H DLK +N L+   M+ K+ DFG+A   + D +       VGT  YM PE +
Sbjct: 126 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 180

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 106/233 (45%), Gaps = 29/233 (12%)
Query: 304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV- 361
           D IN +  L       R    ++     +G+G FG V   R    +++ A+K LSK  + 
Sbjct: 61  DTINKIRDL-------RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 113
Query: 362 -QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFI--FDAIKR 417
            + +  F  E   +    +   V  L ++F++   L ++ E++P   +   +  +D  ++
Sbjct: 114 KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK 173
Query: 418 VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM-ARLF 476
               W   Y      A  +L L     +  IHRD+K  N+LLD     K++DFG   ++ 
Sbjct: 174 ----WARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 224
Query: 477 EMDQSQGDTSRIVGTFGYMAPEYVTR----GHFSIKSDVFSFGVLVLEIISGQ 525
           +    + DT+  VGT  Y++PE +      G++  + D +S GV + E++ G 
Sbjct: 225 KEGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 275

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 332 LGQGGFG-AVYKGRLSHGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFS 389
           LG G  G  V++G    G+ +AVKR+  +      +E K   LL     H N++R   + 
Sbjct: 41  LGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRY--YC 94
Query: 390 FEETERLLIYEF------VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            E T+R L          + +    K + D   ++Q ++     ++  IA G+ +LH   
Sbjct: 95  SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP-ISLLRQIASGVAHLHS-- 151
Query: 444 RLRIIHRDLKASNILLDA-------------DMIPKISDFGMARLFEMDQS--QGDTSRI 488
            L+IIHRDLK  NIL+               ++   ISDFG+ +  +  Q   + + +  
Sbjct: 152 -LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 489 VGTFGYMAPEYV---TRGHFSIKSDVFSFGVLVLEIISGQKN 527
            GT G+ APE +   T+   +   D+FS G +   I+S  K+
Sbjct: 211 SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 106/233 (45%), Gaps = 29/233 (12%)
Query: 304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV- 361
           D IN +  L       R    ++     +G+G FG V   R    +++ A+K LSK  + 
Sbjct: 56  DTINKIRDL-------RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 108
Query: 362 -QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFI--FDAIKR 417
            + +  F  E   +    +   V  L ++F++   L ++ E++P   +   +  +D  ++
Sbjct: 109 KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK 168
Query: 418 VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM-ARLF 476
               W   Y      A  +L L     +  IHRD+K  N+LLD     K++DFG   ++ 
Sbjct: 169 ----WARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219
Query: 477 EMDQSQGDTSRIVGTFGYMAPEYVTR----GHFSIKSDVFSFGVLVLEIISGQ 525
           +    + DT+  VGT  Y++PE +      G++  + D +S GV + E++ G 
Sbjct: 220 KEGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 12/179 (6%)
Query: 326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRN-- 381
           +S   ++G GG   V++      Q  A+K   L +   Q    ++NE+  + +LQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           ++RL  + +E T++  IY  +   ++D   +   K+    WE R      +   +  +H+
Sbjct: 118 IIRL--YDYEITDQY-IYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 173
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                I+H DLK +N L+  D + K+ DFG+A   + D +       VGT  YM PE +
Sbjct: 174 HG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 29/158 (18%)
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQ-----------LDWETRYK---------IIG 430
           EE E LL Y   PN    K ++D  K V            LD   R K         ++ 
Sbjct: 64  EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLF 123
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNIL-LDADMIP---KISDFGMARLFEMDQSQGDTS 486
            I + + YLH      ++HRDLK SNIL +D    P   +I DFG A+  ++    G   
Sbjct: 124 TITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK--QLRAENGLLM 178
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
               T  ++APE + R  +    D++S GVL+  +++G
Sbjct: 179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 12/179 (6%)
Query: 326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRN-- 381
           +S   ++G GG   V++      Q  A+K   L +   Q    ++NE+  + +LQ  +  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           ++RL  + +E T++  IY  +   ++D   +   K+    WE R      +   +  +H+
Sbjct: 90  IIRL--YDYEITDQY-IYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQ 145
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                I+H DLK +N L+  D + K+ DFG+A   + D         VGT  YM PE +
Sbjct: 146 HG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAI 200
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	551
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-126
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-122
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-107
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-83
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-66
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-58
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-56
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-56
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-55
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-54
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-53
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-50
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-44
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-43
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-43
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-42
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-42
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-42
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-42
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-41
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-41
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-41
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-41
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-41
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-41
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-41
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-41
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-41
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-40
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-40
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-40
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-40
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-40
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-40
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-40
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-40
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-40
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-40
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-40
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-39
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-39
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-39
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-39
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-39
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-39
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-39
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-38
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-38
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-38
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-38
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-38
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-38
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-38
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-37
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-37
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-37
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-37
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-37
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-36
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-36
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-36
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-36
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-36
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-36
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-36
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-36
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-35
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-35
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-35
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-35
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-35
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-35
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-35
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-35
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-34
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-34
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-33
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-33
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-33
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-33
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-32
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-32
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-32
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-31
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-31
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-31
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-31
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-31
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-31
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-31
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-30
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-30
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-30
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-29
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-28
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-28
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-28
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-28
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-28
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-27
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-27
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-27
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-27
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-27
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-27
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-27
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-27
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-27
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-26
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-26
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-26
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-26
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-26
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-25
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-25
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-25
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-25
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-25
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-24
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-24
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	6e-24
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	7e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-24
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-23
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-23
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-23
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-22
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-22
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	9e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-20
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-20
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-20
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-19
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-19
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-19
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-19
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-19
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-18
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-18
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-18
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-18
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-18
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-18
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-05
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	1e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  371 bits (954), Expect = e-126
 Identities = 99/249 (39%), Positives = 140/249 (56%), Gaps = 17/249 (6%)

Query: 305 EINTVESLQFDFSTIRDATNNFS------TDNKLGQGGFGAVYKGRLSHGQEIAVKRLSK 358
           E++      F F  +++ TNNF         NK+G+GGFG VYKG ++    +AVK+L+ 
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAA 64

Query: 359 ----NSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDA 414
                + + + +F  E+ ++A+ QH NLV LLGFS +  +  L+Y ++PN S+   +   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124

Query: 415 IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474
                L W  R KI  G A GI +LHE+     IHRD+K++NILLD     KISDFG+AR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181

Query: 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGE 534
             E       TSRIVGT  YMAPE +  G  + KSD++SFGV++LEII+G          
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH--R 238

Query: 535 EAEDLLTYV 543
           E + LL   
Sbjct: 239 EPQLLLDIK 247

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  361 bits (929), Expect = e-122
 Identities = 101/234 (43%), Positives = 151/234 (64%), Gaps = 5/234 (2%)

Query: 314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG-ELEFKNEVL 372
           F    ++ A++NFS  N LG+GGFG VYKGRL+ G  +AVKRL +   QG EL+F+ EV 
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGG 431
           +++   HRNL+RL GF    TERLL+Y ++ N SV   + +  + +  LDW  R +I  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
            ARG+ YLH+    +IIHRD+KA+NILLD +    + DFG+A+L +   +   T+ + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGT 198

Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKN--NSFRIGEEAEDLLTYV 543
            G++APEY++ G  S K+DVF +GV++LE+I+GQ+    +    ++   LL +V
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  323 bits (831), Expect = e-107
 Identities = 89/239 (37%), Positives = 141/239 (58%), Gaps = 6/239 (2%)

Query: 304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
             +   ES +     + +ATNNF     +G G FG VYKG L  G ++A+KR +  S QG
Sbjct: 19  SYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG 78

Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ-LDW 422
             EF+ E+  ++  +H +LV L+GF  E  E +LIY+++ N ++ + ++ +      + W
Sbjct: 79  IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSW 138

Query: 423 ETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF-EMDQS 481
           E R +I  G ARG+ YLH  +   IIHRD+K+ NILLD + +PKI+DFG+++   E+DQ+
Sbjct: 139 EQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195

Query: 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL 540
              T  + GT GY+ PEY  +G  + KSDV+SFGV++ E++  +      +  E  +L 
Sbjct: 196 HLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  262 bits (671), Expect = 1e-83
 Identities = 63/244 (25%), Positives = 108/244 (44%), Gaps = 22/244 (9%)

Query: 307 NTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE 366
           +    +      +   +          +G FG V+K +L   + +AVK       Q   +
Sbjct: 7   HHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-Q 64

Query: 367 FKNEVLLVARLQHRNLVRLLGFSFE----ETERLLIYEFVPNSSVDKFIFDAIKRVQLDW 422
            + EV  +  ++H N+++ +G        + +  LI  F    S+  F+    K   + W
Sbjct: 65  NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSW 120

Query: 423 ETRYKIIGGIARGILYLHED-------SRLRIIHRDLKASNILLDADMIPKISDFGMARL 475
                I   +ARG+ YLHED        +  I HRD+K+ N+LL  ++   I+DFG+A  
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180

Query: 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGH-----FSIKSDVFSFGVLVLEIISGQKNNSF 530
           FE  +S GDT   VGT  YMAPE +           ++ D+++ G+++ E+ S       
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

Query: 531 RIGE 534
            + E
Sbjct: 241 PVDE 244

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  217 bits (554), Expect = 3e-66
 Identities = 61/240 (25%), Positives = 101/240 (42%), Gaps = 30/240 (12%)

Query: 312 LQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEV 371
           ++   S      +N      +G+G +GAVYKG L   + +AVK  S  + Q  +  K  +
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NI 58

Query: 372 LLVARLQHRNLVRLLGFSFE-----ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRY 426
             V  ++H N+ R +            E LL+ E+ PN S+ K++         DW +  
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114

Query: 427 KIIGGIARGILYLHED------SRLRIIHRDLKASNILLDADMIPKISDFGMARLF---- 476
           ++   + RG+ YLH +       +  I HRDL + N+L+  D    ISDFG++       
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 477 --EMDQSQGDTSRIVGTFGYMAPEY-------VTRGHFSIKSDVFSFGVLVLEIISGQKN 527
                +        VGT  YMAPE                + D+++ G++  EI     +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  207 bits (530), Expect = 6e-63
 Identities = 68/239 (28%), Positives = 117/239 (48%), Gaps = 10/239 (4%)

Query: 290 RRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQ 349
                    ++   + +    ++  D   I     + +   K+G G FG V++    HG 
Sbjct: 5   HHHHPMSDYDIPTTENLYFQGAMDGDDMDIP--WCDLNIKEKIGAGSFGTVHRAEW-HGS 61

Query: 350 EIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSV 407
           ++AVK L +     E   EF  EV ++ RL+H N+V  +G   +     ++ E++   S+
Sbjct: 62  DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121

Query: 408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467
            + +  +  R QLD   R  +   +A+G+ YLH      I+HR+LK+ N+L+D     K+
Sbjct: 122 YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKV 180

Query: 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
            DFG++R      +   +    GT  +MAPE V R    + KSDV+SFGV++ E+ + Q
Sbjct: 181 CDFGLSR--LKASTFLSSKSAAGTPEWMAPE-VLRDEPSNEKSDVYSFGVILWELATLQ 236

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  196 bits (499), Expect = 2e-58
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 11/204 (5%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
                +  +G+G FG V K +    +++A+K++   S +    F  E+  ++R+ H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKA--FIVELRQLSRVNHPNIV 64

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +L G         L+ E+    S+   +  A                  ++G+ YLH   
Sbjct: 65  KLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 444 RLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
              +IHRDLK  N+LL A   + KI DFG A        Q   +   G+  +MAPE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEG 177

Query: 503 GHFSIKSDVFSFGVLVLEIISGQK 526
            ++S K DVFS+G+++ E+I+ +K
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK 201

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  195 bits (497), Expect = 3e-58
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 18/210 (8%)

Query: 330 NKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
             LG+G FG   K      G+ + +K L +   + +  F  EV ++  L+H N+++ +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
            +++     I E++   ++   I       Q  W  R      IA G+ YLH    + II
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNII 130

Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR------------IVGTFGYMA 496
           HRDL + N L+  +    ++DFG+ARL   +++Q +  R            +VG   +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQK 526
           PE +    +  K DVFSFG+++ EII    
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  190 bits (486), Expect = 5e-57
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 21/208 (10%)

Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRL----SKNSVQGELEFKNEVLLVARLQHRNLVRL 385
             +G GGFG VY+     G E+AVK       ++  Q     + E  L A L+H N++ L
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
            G   +E    L+ EF     +       +   ++  +        IARG+ YLH+++ +
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPL----NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 446 RIIHRDLKASNILLDADMIP--------KISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
            IIHRDLK+SNIL+   +          KI+DFG+AR       +       G + +MAP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWMAP 183

Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +    FS  SDV+S+GVL+ E+++G+
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  188 bits (480), Expect = 7e-56
 Identities = 64/213 (30%), Positives = 111/213 (52%), Gaps = 27/213 (12%)

Query: 330 NKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL-------EFKNEVLLVARLQHRN 381
            ++G+GGFG V+KGR +     +A+K L     +GE        EF+ EV +++ L H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 382 LVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           +V+L G          ++ EFVP   +   + D  K   + W  + +++  IA GI Y+ 
Sbjct: 85  IVKLYGLM---HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 441 EDSRLRIIHRDLKASNILLD-----ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            +    I+HRDL++ NI L      A +  K++DFG+++     QS    S ++G F +M
Sbjct: 140 -NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWM 193

Query: 496 APE--YVTRGHFSIKSDVFSFGVLVLEIISGQK 526
           APE        ++ K+D +SF +++  I++G+ 
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEG 226

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  187 bits (478), Expect = 1e-55
 Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 13/201 (6%)

Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRNLVRLLG 387
            ++G G FG VYKG+  HG ++AVK L+  +   +    FKNEV ++ + +H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
           +S    +  ++ ++   SS+   +       + + +    I    ARG+ YLH      I
Sbjct: 88  YSTAP-QLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLH---AKSI 141

Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE---YVTRGH 504
           IHRDLK++NI L  D   KI DFG+A             ++ G+  +MAPE         
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 505 FSIKSDVFSFGVLVLEIISGQ 525
           +S +SDV++FG+++ E+++GQ
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  184 bits (470), Expect = 1e-54
 Identities = 45/204 (22%), Positives = 83/204 (40%), Gaps = 19/204 (9%)

Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRNLVRLLG 387
            KL +   G ++KGR   G +I VK L           +F  E   +    H N++ +LG
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 388 FSFEETERLL--IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
                       I  ++P  S+   + +      +D     K    +ARG+ +LH    L
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLEPL 133

Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-- 503
            I    L + ++++D DM  +IS   +   F+           +    ++APE   +   
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYAPAWVAPE-ALQKKP 184

Query: 504 --HFSIKSDVFSFGVLVLEIISGQ 525
                  +D++SF VL+ E+++ +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  180 bits (459), Expect = 9e-53
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 27/214 (12%)

Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNE--VLLVARLQHRNLVRLLG 387
             +G+G +G V++G    G+ +AVK  S    + E  +  E  +     L+H N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 388 ----FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
                    T+  LI  +    S+    +D ++   LD  +  +I+  IA G+ +LH + 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 444 RLR-----IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI--VGTFGYMA 496
                   I HRDLK+ NIL+  +    I+D G+A +     +Q D      VGT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 497 PE------YVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE       V       + D+++FG+++ E+   
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  179 bits (457), Expect = 3e-52
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 22/210 (10%)

Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRNLVRLLG 387
             +G+G FG VY GR  HG E+A++ +       +    FK EV+   + +H N+V  +G
Sbjct: 39  ELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
                    +I       ++   + D   ++ LD     +I   I +G+ YLH      I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151

Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI---VGTFGYMAPE------ 498
           +H+DLK+ N+  D +    I+DFG+  +  + Q+     ++    G   ++APE      
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 499 ---YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
                 +  FS  SDVF+ G +  E+ + +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHARE 240

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  178 bits (454), Expect = 1e-51
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 29/216 (13%)

Query: 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNE--VLLVARLQHRNLVRLL 386
             ++G+G +G V+ G+   G+++AVK         E  +  E  +     ++H N++  +
Sbjct: 42  VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97

Query: 387 G----FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
                 +   T+  LI ++  N S+    +D +K   LD ++  K+      G+ +LH +
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTE 153

Query: 443 SRLR-----IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI--VGTFGYM 495
                    I HRDLK+ NIL+  +    I+D G+A  F  D ++ D      VGT  YM
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213

Query: 496 APE------YVTRGHFSIKSDVFSFGVLVL-EIISG 524
            PE              I +D++SFG L+L E+   
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFG-LILWEVARR 248

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  176 bits (447), Expect = 1e-50
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 27/220 (12%)

Query: 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNE--VLLVARLQHRNLVRLL 386
              +G+G FG V++G+   G+E+AVK  S    + E  +  E  +     L+H N++  +
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102

Query: 387 G----FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
                 +   T+  L+ ++  + S+    FD + R  +  E   K+    A G+ +LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 158

Query: 443 -----SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI--VGTFGYM 495
                 +  I HRDLK+ NIL+  +    I+D G+A   +      D +    VGT  YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 496 APE------YVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529
           APE       +       ++D+++ G++  EI        
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  160 bits (406), Expect = 2e-44
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 15/206 (7%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRN 381
            +     ++G+G FG V+ GRL +    +AVK   +      + +F  E  ++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           +VRL+G   ++    ++ E V       F+    +  +L  +T  +++G  A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLES 231

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY----MAP 497
                 IHRDL A N L+    + KISDFGM+R        G  +   G         AP
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA----DGVYAASGGLRQVPVKWTAP 284

Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
           E +  G +S +SDV+SFG+L+ E  S
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFS 310

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  153 bits (389), Expect = 5e-43
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 11/202 (5%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
           +  +   ++G G FG V+ G   +  ++A+K + +     E +F  E  ++ +L H  LV
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +L G   E+    L+ EF+ +  +  ++    +R     ET   +   +  G+ YL    
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYL---E 121

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVT 501
              +IHRDL A N L+  + + K+SDFGM R    DQ    TS     F     +PE  +
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFS 178

Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
              +S KSDV+SFGVL+ E+ S
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS 200

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  153 bits (389), Expect = 9e-43
 Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 11/202 (5%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
            + +   +LG G FG V  G+     ++A+K + + S+  + EF  E  ++  L H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLV 82

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +L G   ++    +I E++ N  +  ++ +   R +   +   ++   +   + YL    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYL---E 137

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVT 501
             + +HRDL A N L++   + K+SDFG++R    D+    TS +   F      PE + 
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLM 194

Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
              FS KSD+++FGVL+ EI S
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  151 bits (383), Expect = 3e-42
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 11/202 (5%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
              +   +LG G FG V  G+     ++AVK + + S+  + EF  E   + +L H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLV 66

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +  G   +E    ++ E++ N  +  ++        L+     ++   +  G+ +L    
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFL---E 121

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVT 501
             + IHRDL A N L+D D+  K+SDFGM R    DQ     S +   F     APE   
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFH 178

Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
              +S KSDV++FG+L+ E+ S
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS 200

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  152 bits (385), Expect = 3e-42
 Identities = 63/205 (30%), Positives = 106/205 (51%), Gaps = 14/205 (6%)

Query: 329 DNKLGQGGFGAVYKGRLSHGQE---IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVR 384
           D +LG G FG+V +G     ++   +A+K L + + + +  E   E  ++ +L +  +VR
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           L+G    E   +L+ E      + KF+    KR ++      +++  ++ G+ YL     
Sbjct: 75  LIGVCQAEA-LMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EE 128

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTR 502
              +HRDL A N+LL      KISDFG+++    D S   T+R  G +   + APE +  
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWYAPECINF 187

Query: 503 GHFSIKSDVFSFGVLVLEIIS-GQK 526
             FS +SDV+S+GV + E +S GQK
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQK 212

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  152 bits (387), Expect = 4e-42
 Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 13/202 (6%)

Query: 329 DNKLGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGE-LEFKNEVLLVARLQHRNLV 383
           +  +G G  G V  GRL     +++  A+K L     + +  +F +E  ++ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           RL G        +++ E++ N S+D F+       Q        ++ G+  G+ YL   S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYL---S 168

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVT 501
            L  +HRDL A N+L+D++++ K+SDFG++R+ E D      +   G       APE + 
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
              FS  SDV+SFGV++ E+++
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  152 bits (387), Expect = 5e-42
 Identities = 60/208 (28%), Positives = 112/208 (53%), Gaps = 14/208 (6%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGE-LEFKNEVLLVARL 377
           +  +    +G G FG VYKG L          +A+K L     + + ++F  E  ++ + 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
            H N++RL G   +    ++I E++ N ++DKF+ +  K  +        ++ GIA G+ 
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 161

Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--M 495
           YL   + +  +HRDL A NIL++++++ K+SDFG++R+ E D  +   +   G       
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWT 217

Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           APE ++   F+  SDV+SFG+++ E+++
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMT 245

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  152 bits (386), Expect = 1e-41
 Identities = 61/207 (29%), Positives = 107/207 (51%), Gaps = 13/207 (6%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGE-LEFKNEVLLVARLQ 378
            N S D  +G G FG V  GRL    +    +A+K L     + +  +F  E  ++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N++RL G   +    +++ E++ N S+D F+       Q        ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKY 162

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MA 496
           L   S +  +HRDL A NIL++++++ K+SDFG+ R+ E D  +   +   G       +
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE-DDPEAAYTTRGGKIPIRWTS 218

Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           PE +    F+  SDV+S+G+++ E++S
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS 245

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  151 bits (383), Expect = 1e-41
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 13/210 (6%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE-----IAVKRLSKNSVQGEL-EFKNEVLLVARL 377
             F     LG G FG VYKG      E     +A+K L + +      E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
            + ++ RLLG     T   LI + +P   +  ++ +   +  +  +        IA+G+ 
Sbjct: 75  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131

Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YL      R++HRDL A N+L+      KI+DFG+A+L   ++ +           +MA 
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
           E +    ++ +SDV+S+GV V E+++ G K
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  150 bits (382), Expect = 2e-41
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 25/227 (11%)

Query: 330 NKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLV 383
             LG+G FG V            G+ +AVK L  ++       +K E+ ++  L H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 384 RLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           +  G   +       L+ E+VP  S+  ++     R  +           I  G+ YLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG-----YMA 496
                 IHRDL A N+LLD D + KI DFG+A+         +  R V   G     + A
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYR-VREDGDSPVFWYA 205

Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTY 542
           PE +    F   SDV+SFGV + E+++    + S          +  
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  149 bits (379), Expect = 2e-41
 Identities = 69/196 (35%), Positives = 108/196 (55%), Gaps = 11/196 (5%)

Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            +LG G FG V+ G  +   ++AVK L + S+  +  F  E  L+ +LQH+ LVRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVV 77

Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            +E    +I E++ N S+  F+      ++L       +   IA G+ ++        IH
Sbjct: 78  TQE-PIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI---EERNYIH 132

Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVTRGHFSI 507
           RDL+A+NIL+   +  KI+DFG+ARL E ++    T+R    F     APE +  G F+I
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTI 189

Query: 508 KSDVFSFGVLVLEIIS 523
           KSDV+SFG+L+ EI++
Sbjct: 190 KSDVWSFGILLTEIVT 205

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  150 bits (380), Expect = 2e-41
 Identities = 62/227 (27%), Positives = 111/227 (48%), Gaps = 23/227 (10%)

Query: 330 NKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLV 383
             LG+G FG V   R      + G+++AVK L   S    + + K E+ ++  L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 384 RLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           +  G   E+      LI EF+P+ S+ +++     + +++ + + K    I +G+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGS 144

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ-----SQGDTSRIVGTFGYMA 496
               + +HRDL A N+L++++   KI DFG+ +  E D+          S +     + A
Sbjct: 145 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV----FWYA 197

Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTY 542
           PE + +  F I SDV+SFGV + E+++    ++S           T+
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  150 bits (382), Expect = 2e-41
 Identities = 62/237 (26%), Positives = 109/237 (45%), Gaps = 39/237 (16%)

Query: 310 ESLQFDFSTIRDAT----NNFSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNS 360
                     +D T     +    ++LG+G FG+V   R      + G  +AVK+L  + 
Sbjct: 5   HHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG 64

Query: 361 VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRV 418
              + +F+ E+ ++  L    +V+  G S+    +   L+ E++P+  +  F+     R 
Sbjct: 65  PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRA 122

Query: 419 QLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478
           +LD          I +G+ YL      R +HRDL A NIL++++   KI+DFG+A+L  +
Sbjct: 123 RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179

Query: 479 DQSQGDTSRIVGTFGY------------MAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           D+             Y             APE ++   FS +SDV+SFGV++ E+ +
Sbjct: 180 DKDY-----------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  148 bits (377), Expect = 4e-41
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 11/203 (5%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
            + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 71

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           V+LLG    E    +I EF+   ++  ++ +   R ++       +   I+  + YL   
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYV 500
            +   IHRDL A N L+  + + K++DFG++RL   D     T+     F     APE +
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESL 184

Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               FSIKSDV++FGVL+ EI +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  149 bits (378), Expect = 4e-41
 Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 21/206 (10%)

Query: 330 NKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
            +LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 385 LLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
             G  +    R   LI E++P  S+  ++     + ++D     +    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGT- 132

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ-----SQGDTSRIVGTFGYMAP 497
              R IHRDL   NIL++ +   KI DFG+ ++   D+      +   S I     + AP
Sbjct: 133 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI----FWYAP 186

Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
           E +T   FS+ SDV+SFGV++ E+ +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  148 bits (375), Expect = 9e-41
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 16/206 (7%)

Query: 329 DNKLGQGGFGAVYKGRL-SHGQEI--AVKRLSKNSVQGEL--EFKNEVLLVARLQHRNLV 383
           D +LG G FG V KG           AVK L   +    L  E   E  ++ +L +  +V
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           R++G    E+  +L+ E      ++K++    +   +  +   +++  ++ G+ YL    
Sbjct: 82  RMIGICEAES-WMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---E 134

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVT 501
               +HRDL A N+LL      KISDFG+++    D++    ++  G +   + APE + 
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHGKWPVKWYAPECIN 193

Query: 502 RGHFSIKSDVFSFGVLVLEIIS-GQK 526
              FS KSDV+SFGVL+ E  S GQK
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQK 219

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  149 bits (377), Expect = 1e-40
 Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 21/206 (10%)

Query: 330 NKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
            +LG+G FG+V   R      + G+ +AVK+L  ++ +   +F+ E+ ++  LQH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 385 LLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
             G  +    R   LI E++P  S+  ++     + ++D     +    I +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGT- 163

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ-----SQGDTSRIVGTFGYMAP 497
              R IHRDL   NIL++ +   KI DFG+ ++   D+      +   S I     + AP
Sbjct: 164 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI----FWYAP 217

Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
           E +T   FS+ SDV+SFGV++ E+ +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  151 bits (382), Expect = 2e-40
 Identities = 65/196 (33%), Positives = 103/196 (52%), Gaps = 11/196 (5%)

Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            KLG G FG V+    +   ++AVK + K        F  E  ++  LQH  LV+L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            +E    +I EF+   S+  F+    +  +            IA G+ ++    +   IH
Sbjct: 253 TKEP-IYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307

Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVTRGHFSI 507
           RDL+A+NIL+ A ++ KI+DFG+AR+ E ++    T+R    F     APE +  G F+I
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTI 364

Query: 508 KSDVFSFGVLVLEIIS 523
           KSDV+SFG+L++EI++
Sbjct: 365 KSDVWSFGILLMEIVT 380

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  147 bits (374), Expect = 3e-40
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 31/217 (14%)

Query: 330 NKLGQGGFGAVYKGRLSHGQE------IAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
            +LG+G FG V+     +         +AVK L + S     +F+ E  L+  LQH+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKF------------IFDAIKRVQLDWETRYKIIGG 431
           R  G   E    L+++E++ +  +++F              + +    L       +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
           +A G++YL   + L  +HRDL   N L+   ++ KI DFGM+R    D    D  R VG 
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VGG 218

Query: 492 FG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                  +M PE +    F+ +SDV+SFGV++ EI +
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  153 bits (388), Expect = 3e-40
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 14/206 (6%)

Query: 328 TDNKLGQGGFGAVYKGRLSHGQE---IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLV 383
            D +LG G FG+V +G     ++   +A+K L + + + +  E   E  ++ +L +  +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           RL+G    E   +L+ E      + KF+    KR ++      +++  ++ G+ YL    
Sbjct: 400 RLIGVCQAEA-LMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---E 453

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVT 501
               +HR+L A N+LL      KISDFG+++    D S   T+R  G +     APE + 
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWYAPECIN 512

Query: 502 RGHFSIKSDVFSFGVLVLEIIS-GQK 526
              FS +SDV+S+GV + E +S GQK
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQK 538

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  151 bits (384), Expect = 3e-40
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 11/197 (5%)

Query: 330 NKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
           +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 284

Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
              E    +I EF+   ++  ++ +   R ++       +   I+  + YL    +   I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340

Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVTRGHFS 506
           HR+L A N L+  + + K++DFG++RL   D     T+     F     APE +    FS
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 507 IKSDVFSFGVLVLEIIS 523
           IKSDV++FGVL+ EI +
Sbjct: 398 IKSDVWAFGVLLWEIAT 414

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  146 bits (371), Expect = 4e-40
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 32/218 (14%)

Query: 330 NKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
            +LG+G FG V+               +AVK L   ++    +F+ E  L+  LQH ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLDWETRYKIIG 430
           +  G   +    ++++E++ +  ++KF                   + +L       I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
            IA G++YL   +    +HRDL   N L+ A+++ KI DFGM+R    D    D  R VG
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYR-VG 192

Query: 491 TFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                   +M PE +    F+ +SDV+SFGV++ EI +
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  145 bits (369), Expect = 5e-40
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 18/208 (8%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQ 378
                   +G+G FG V++G         +  A+K     +      +F  E L + +  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H ++V+L+G   E     +I E      +  F+    ++  LD  +       ++  + Y
Sbjct: 75  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 131

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT---FGYM 495
           L      R +HRD+ A N+L+ ++   K+ DFG++R  E         +         +M
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWM 184

Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           APE +    F+  SDV+ FGV + EI+ 
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILM 212

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  145 bits (369), Expect = 6e-40
 Identities = 49/227 (21%), Positives = 89/227 (39%), Gaps = 41/227 (18%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRL--------SHGQEIAVKRLSKNSVQGELEFKNEVLLVA 375
            +   +  LGQG F  ++KG           H  E+ +K L K        F     +++
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 376 RLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARG 435
           +L H++LV   G      E +L+ EFV   S+D ++     +  ++   + ++   +A  
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAA 125

Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIP--------KISDFGMARLFEMDQSQGDTSR 487
           + +L       +IH ++ A NILL  +           K+SD G++              
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175

Query: 488 IVGTFGY------MAPE-YVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
                        + PE      + ++ +D +SFG  + EI S G K
Sbjct: 176 -----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  146 bits (371), Expect = 6e-40
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 13/205 (6%)

Query: 329 DNKLGQGGFGAVYKGRLSHGQE-----IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNL 382
              LG G FG V+KG      E     + +K +   S +       + +L +  L H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           VRLLG     +   L+ +++P  S+   +     R  L  +        IA+G+ YL   
Sbjct: 78  VRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL--- 131

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
               ++HR+L A N+LL +    +++DFG+A L   D  Q   S       +MA E +  
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191

Query: 503 GHFSIKSDVFSFGVLVLEIIS-GQK 526
           G ++ +SDV+S+GV V E+++ G +
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAE 216

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  145 bits (369), Expect = 7e-40
 Identities = 61/213 (28%), Positives = 90/213 (42%), Gaps = 17/213 (7%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL---EFKNEVLLVAR 376
            +     KLG G FG V +G      G+ +  AVK L  + +       +F  EV  +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L HRNL+RL G         ++ E  P  S+   +     +      T  +    +A G+
Sbjct: 78  LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 134

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY-- 494
            YL      R IHRDL A N+LL    + KI DFG+ R    +       +      +  
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY-VMQEHRKVPFAW 190

Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
            APE +    FS  SD + FGV + E+ + GQ+
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  145 bits (369), Expect = 7e-40
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 21/207 (10%)

Query: 329 DNKLGQGGFGAVYKGRLSHG----QEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLV 383
           +  +G+G FG VY G L          AVK L++ +  GE+ +F  E +++    H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 384 RLLGFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
            LLG     E   L++  ++ +  +  FI +  +      +        +A+G+ YL   
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLAS- 146

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG------YMA 496
              + +HRDL A N +LD     K++DFG+AR    D    +   +    G      +MA
Sbjct: 147 --KKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMA 200

Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            E +    F+ KSDV+SFGVL+ E+++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  146 bits (371), Expect = 8e-40
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 13/210 (6%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE-----IAVKRLSKNSVQGEL-EFKNEVLLVARL 377
             F     LG G FG VYKG      E     +A+K L + +      E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
            + ++ RLLG     T   LI + +P   +  ++ +   +  +  +        IA+G+ 
Sbjct: 75  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131

Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YL      R++HRDL A N+L+      KI+DFG+A+L   ++ +           +MA 
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
           E +    ++ +SDV+S+GV V E+++ G K
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  145 bits (368), Expect = 1e-39
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 13/203 (6%)

Query: 329 DNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLV 383
           D  +G+G FG VY G      +     A+K LS+ +   ++  F  E LL+  L H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 384 RLLGFSFEETERLLI-YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
            L+G          +   ++ +  + +FI     +     +        +ARG+ YL   
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYL--- 140

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYV 500
           +  + +HRDL A N +LD     K++DFG+AR     +               + A E +
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200

Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               F+ KSDV+SFGVL+ E+++
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT 223

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  144 bits (366), Expect = 1e-39
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 33/219 (15%)

Query: 330 NKLGQGGFGAVYKGRL------SHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNL 382
            +LG+  FG VYKG L         Q +A+K L          EF++E +L ARLQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLDWETRYKII 429
           V LLG   ++    +I+ +  +  + +F               D   +  L+      ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
             IA G+ YL   S   ++H+DL   N+L+   +  KISD G+ R         D  ++ 
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY----AADYYKL- 186

Query: 490 GTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                    +MAPE +  G FSI SD++S+GV++ E+ S
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  144 bits (365), Expect = 2e-39
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 18/208 (8%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRL--SHGQEI--AVKRLSKN-SVQGELEFKNEVLLVARLQ 378
            +   +  LG+G FG VY+G      G++I  AVK   K+ ++  + +F +E +++  L 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H ++V+L+G   EE    +I E  P   +  ++     +  L   T       I + + Y
Sbjct: 72  HPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAY 128

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT---FGYM 495
           L     +  +HRD+   NIL+ +    K+ DFG++R  E +    D  +   T     +M
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE----DYYKASVTRLPIKWM 181

Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +PE +    F+  SDV+ F V + EI+S
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILS 209

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  143 bits (364), Expect = 3e-39
 Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 17/203 (8%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
                   +G+G FG V  G    G ++AVK +  ++      F  E  ++ +L+H NLV
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLV 77

Query: 384 RLLGFSFEETERLLI-YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +LLG   EE   L I  E++   S+  ++     R  L  +   K    +   + YL   
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 133

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYV 500
                +HRDL A N+L+  D + K+SDFG+ +       +  +++  G       APE +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEAL 186

Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
               FS KSDV+SFG+L+ EI S
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYS 209

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  144 bits (366), Expect = 4e-39
 Identities = 68/213 (31%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 330 NKLGQGGFGAVYKGRL------SHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNL 382
             LG G FG VY+G++          ++AVK L +  S Q EL+F  E L++++  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFI----FDAIKRVQLDWETRYKIIGGIARGILY 438
           VR +G S +   R ++ E +    +  F+        +   L       +   IA G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 439 LHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY- 494
           L        IHRD+ A N LL       + KI DFGMAR    D  +    R  G     
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYR-KGGCAML 207

Query: 495 ----MAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               M PE    G F+ K+D +SFGVL+ EI S
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  145 bits (368), Expect = 5e-39
 Identities = 66/296 (22%), Positives = 125/296 (42%), Gaps = 18/296 (6%)

Query: 241 LSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNL 300
           +SP            +   S+++G +V         I ++  L T ++ +   +      
Sbjct: 1   MSPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQG 60

Query: 301 RKADEINTVESLQFDFSTIRDATNNFSTDN-----KLGQGGFGAVYKGRLSHG----QEI 351
                I+           ++      S+        +G+G FG VY G L          
Sbjct: 61  ANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC 120

Query: 352 AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLLGFSFE-ETERLLIYEFVPNSSVDK 409
           AVK L++ +  GE+ +F  E +++    H N++ LLG     E   L++  ++ +  +  
Sbjct: 121 AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 180

Query: 410 FIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD 469
           FI +  +      +        +A+G+ +L   +  + +HRDL A N +LD     K++D
Sbjct: 181 FIRN--ETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVAD 235

Query: 470 FGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           FG+AR     +     ++        +MA E +    F+ KSDV+SFGVL+ E+++
Sbjct: 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  143 bits (363), Expect = 8e-39
 Identities = 50/234 (21%), Positives = 100/234 (42%), Gaps = 25/234 (10%)

Query: 308 TVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGEL-- 365
            + +    F ++      +S   ++G GG   V++      Q  A+K ++      +   
Sbjct: 12  DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD 71

Query: 366 EFKNEVLLVARLQHRNL--VRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDW 422
            ++NE+  + +LQ  +   +RL  +     + + ++ E   N  ++ ++    K+  +D 
Sbjct: 72  SYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECG-NIDLNSWL---KKKKSIDP 126

Query: 423 ETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482
             R      +   +  +H+     I+H DLK +N L+   M+ K+ DFG+A   + D + 
Sbjct: 127 WERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTS 182

Query: 483 GDTSRIVGTFGYMAPE-----------YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
                 VGT  YM PE             ++   S KSDV+S G ++  +  G+
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  144 bits (366), Expect = 1e-38
 Identities = 68/213 (31%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 330 NKLGQGGFGAVYKGRL------SHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNL 382
             LG G FG VY+G++          ++AVK L +  S Q EL+F  E L++++  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFI----FDAIKRVQLDWETRYKIIGGIARGILY 438
           VR +G S +   R ++ E +    +  F+        +   L       +   IA G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 439 LHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY- 494
           L        IHRD+ A N LL       + KI DFGMAR    D  +    R  G     
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYR-KGGCAML 248

Query: 495 ----MAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               M PE    G F+ K+D +SFGVL+ EI S
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  146 bits (371), Expect = 1e-38
 Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 17/197 (8%)

Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
             +G+G FG V  G    G ++AVK +  ++      F  E  ++ +L+H NLV+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 390 FEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
            EE   L ++ E++   S+  ++     R  L  +   K    +   + YL        +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 311

Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVTRGHFS 506
           HRDL A N+L+  D + K+SDFG+ +       +  +++  G       APE +    FS
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 364

Query: 507 IKSDVFSFGVLVLEIIS 523
            KSDV+SFG+L+ EI S
Sbjct: 365 TKSDVWSFGILLWEIYS 381

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  142 bits (360), Expect = 1e-38
 Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 28/220 (12%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
            +F     +G GGFG V+K +    G+   +KR+  N+     + + EV  +A+L H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDK---FI----------FDAIKR---VQLDWETRY 426
           V   G  ++  +         +S       FI             I++    +LD     
Sbjct: 67  VHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125

Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486
           ++   I +G+ Y+H     ++I+RDLK SNI L      KI DFG+    +   + G  +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK---NDGKRT 179

Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK 526
           R  GT  YM+PE ++   +  + D+++ G+++ E++    
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  142 bits (361), Expect = 2e-38
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 27/213 (12%)

Query: 330 NKLGQGGFGAVYKGRLSHGQE------IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNL 382
            +LGQG FG VY+G      +      +A+K +++ +   E  EF NE  ++      ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKF-------IFDAIKRVQLDWETRYKIIGGIARG 435
           VRLLG   +    L+I E +    +  +       + +             ++ G IA G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY- 494
           + YL+     + +HRDL A N ++  D   KI DFGM R    D  + D  R  G  G  
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR-KGGKGLL 202

Query: 495 ----MAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
               M+PE +  G F+  SDV+SFGV++ EI +
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  142 bits (359), Expect = 2e-38
 Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 31/228 (13%)

Query: 323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN 381
            ++F     LGQG FG V K R     +  A+K++     +      +EV+L+A L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQY 63

Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFI----------FDAIKRVQLDWETRY--KII 429
           +VR    ++ E    +            FI          +D I    L+ +     ++ 
Sbjct: 64  VVRYYA-AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE------------ 477
             I   + Y+H      IIHRDLK  NI +D     KI DFG+A+               
Sbjct: 123 RQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 478 MDQSQGDTSRIVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEIISG 524
           +  S  + +  +GT  Y+A E +   GH++ K D++S G++  E+I  
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  141 bits (358), Expect = 2e-38
 Identities = 59/240 (24%), Positives = 108/240 (45%), Gaps = 24/240 (10%)

Query: 296 QKQNLRKADEINTVESLQFDFSTIRDATNNFS-TDNKLGQGGFGAVYKGR-LSHGQEIAV 353
           Q++  ++ D+I  +E+              F   D ++G+G F  VYKG       E+A 
Sbjct: 1   QEERNQQQDDIEELETKAVG----MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAW 56

Query: 354 K--RLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF---SFEETERLLIY-EFVPNSSV 407
              +  K +      FK E  ++  LQH N+VR       + +  + +++  E + + ++
Sbjct: 57  CELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL 116

Query: 408 DKFIFDAIKRVQ-LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIP 465
             ++    KR + +  +        I +G+ +LH  +   IIHRDLK  NI +       
Sbjct: 117 KTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSV 171

Query: 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           KI D G+A L    +       ++GT  +MAPE     +     DV++FG+ +LE+ + +
Sbjct: 172 KIGDLGLATL----KRASFAKAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSE 226

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  142 bits (360), Expect = 3e-38
 Identities = 55/244 (22%), Positives = 101/244 (41%), Gaps = 22/244 (9%)

Query: 290 RRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHG 348
             + ++        + +   E L+      R+  +  +   ++G+G FG V++ +    G
Sbjct: 24  SAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTG 83

Query: 349 QEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY-EFVPNSSV 407
            + AVK++     +       E++  A L    +V L G +  E   + I+ E +   S+
Sbjct: 84  FQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYG-AVREGPWVNIFMELLEGGSL 137

Query: 408 DKFI--FDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465
            + I     +   +  +            G+ YLH     RI+H D+KA N+LL +D   
Sbjct: 138 GQLIKQMGCLPEDRALYYLGQ-----ALEGLEYLHTR---RILHGDVKADNVLLSSDGSR 189

Query: 466 -KISDFGMARLFEMDQSQGDTSR---IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
             + DFG A   + D           I GT  +MAPE V       K D++S   ++L +
Sbjct: 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM 249

Query: 522 ISGQ 525
           ++G 
Sbjct: 250 LNGC 253

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  145 bits (367), Expect = 3e-38
 Identities = 65/196 (33%), Positives = 105/196 (53%), Gaps = 11/196 (5%)

Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            EE    ++ E++   S+  F+        L       +   IA G+ Y+    R+  +H
Sbjct: 249 SEEP-IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 303

Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVTRGHFSI 507
           RDL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F     APE    G F+I
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTI 360

Query: 508 KSDVFSFGVLVLEIIS 523
           KSDV+SFG+L+ E+ +
Sbjct: 361 KSDVWSFGILLTELTT 376

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  141 bits (358), Expect = 3e-38
 Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 20/209 (9%)

Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKN--SVQGELEFKNEVLLVARL-QHR 380
           +F   ++LG G +G V+K R    G+  AVKR        +       EV    ++ QH 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 381 NLVRLLGFSFEETERLLIY-EFVPNSSVDKFIFDAIKR--VQLDWETRYKIIGGIARGIL 437
             VRL   ++EE   L +  E    S     +    +     L     +  +      + 
Sbjct: 118 CCVRLEQ-AWEEGGILYLQTELCGPS-----LQQHCEAWGASLPEAQVWGYLRDTLLALA 171

Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           +LH      ++H D+K +NI L      K+ DFG+        + G      G   YMAP
Sbjct: 172 HLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAP 225

Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQK 526
           E + +G +   +DVFS G+ +LE+    +
Sbjct: 226 E-LLQGSYGTAADVFSLGLTILEVACNME 253

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  146 bits (369), Expect = 4e-38
 Identities = 65/196 (33%), Positives = 105/196 (53%), Gaps = 11/196 (5%)

Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            EE    ++ E++   S+  F+        L       +   IA G+ Y+    R+  +H
Sbjct: 332 SEEP-IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386

Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVTRGHFSI 507
           RDL+A+NIL+  +++ K++DFG+ARL E ++    T+R    F     APE    G F+I
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTI 443

Query: 508 KSDVFSFGVLVLEIIS 523
           KSDV+SFG+L+ E+ +
Sbjct: 444 KSDVWSFGILLTELTT 459

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  140 bits (354), Expect = 1e-37
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 12/208 (5%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE---FKNEVLLVARLQH 379
            NF  + K+G+G F  VY+   L  G  +A+K++    +           E+ L+ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 380 RNLVRLLGFSFEETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWETR-YKIIGGIARGIL 437
            N+++    SF E   L I  E      + + I    K+ +L  E   +K    +   + 
Sbjct: 92  PNVIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           ++H     R++HRD+K +N+ + A  + K+ D G+ R F    +   +  +VGT  YM+P
Sbjct: 151 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 205

Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E +    ++ KSD++S G L+ E+ + Q
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQ 233

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  139 bits (353), Expect = 1e-37
 Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 13/200 (6%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           LG+G +G VY GR LS+   IA+K + +   +       E+ L   L+H+N+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 391 EETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
           E    + I+ E VP  S+   +      ++ + +T       I  G+ YLH++   +I+H
Sbjct: 90  EN-GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145

Query: 450 RDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV---TRGHF 505
           RD+K  N+L++    + KISDFG ++         +T    GT  YMAPE +    RG+ 
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGY- 202

Query: 506 SIKSDVFSFGVLVLEIISGQ 525
              +D++S G  ++E+ +G+
Sbjct: 203 GKAADIWSLGCTIIEMATGK 222

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  140 bits (355), Expect = 2e-37
 Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 11/206 (5%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV-QGELEF-KNEVLLVARLQHR 380
             +    K+G+G FG     +    G++  +K ++ + +   E E  + EV ++A ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 381 NLVRLLGFSFEETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
           N+V+    SFEE   L I  ++     + K I    K V    +        I   + ++
Sbjct: 84  NIVQYRE-SFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHV 141

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
           H+    +I+HRD+K+ NI L  D   ++ DFG+AR+             +GT  Y++PE 
Sbjct: 142 HDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEI 196

Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
                ++ KSD+++ G ++ E+ + +
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLK 222

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  140 bits (354), Expect = 3e-37
 Identities = 49/218 (22%), Positives = 95/218 (43%), Gaps = 25/218 (11%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRN 381
             +S   ++G GG   V++      Q  A+K ++      +    ++NE+  + +LQ  +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 382 L--VRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
              +RL  +     + + ++ E   N  ++ ++    K+  +D   R      +   +  
Sbjct: 69  DKIIRLYDY-EITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHT 123

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           +H+     I+H DLK +N L+   M+ K+ DFG+A   + D +       VGT  YM PE
Sbjct: 124 IHQ---HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

Query: 499 -----------YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
                        ++   S KSDV+S G ++  +  G+
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  138 bits (351), Expect = 4e-37
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 27/219 (12%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKN--SVQGELEFKNEVLLVARL 377
           N       LG+G FG+V +G L         +AVK +  +  S +   EF +E   +   
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 378 QHRNLVRLLGFSFEE-----TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG-- 430
            H N++RLLG   E       + ++I  F+    +  ++  +             ++   
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 431 -GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
             IA G+ YL   S    +HRDL A N +L  DM   ++DFG+++        GD  R  
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYR-Q 205

Query: 490 GTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           G        ++A E +    ++ KSDV++FGV + EI +
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  138 bits (350), Expect = 8e-37
 Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 41/227 (18%)

Query: 330 NKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNL 382
             +G+G FG V++ R            +AVK L + +      +F+ E  L+A   + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKF---------------------IFDAIKRVQLD 421
           V+LLG         L++E++    +++F                        +     L 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
              +  I   +A G+ YL   S  + +HRDL   N L+  +M+ KI+DFG++R    +  
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NIY 225

Query: 482 QGDTSRIVGTFGY-----MAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             D  +            M PE +    ++ +SDV+++GV++ EI S
Sbjct: 226 SADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  137 bits (348), Expect = 1e-36
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 36/228 (15%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRL--------SHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
           +  +    LG+G FG V                  +AVK L  ++ + +L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPN-------------SSVDKFIFDAIKRVQL 420
             + +H+N++ LLG   ++    +I E+                     +  + +   Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            ++        +ARG+ YL   +  + IHRDL A N+L+  + + KI+DFG+AR    D 
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207

Query: 481 SQGDTSRIVGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +  D  +   T G     +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 208 NNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  137 bits (348), Expect = 1e-36
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 28/220 (12%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHG----QEIAVKRLSKN--SVQGELEFKNEVLLVARL 377
             F+    LG+G FG+V + +L        ++AVK L  +  +     EF  E   +   
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 378 QHRNLVRLLGFSFEETER------LLIYEFVPNSSVDKFIFD---AIKRVQLDWETRYKI 428
            H ++ +L+G S     +      ++I  F+ +  +  F+           L  +T  + 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
           +  IA G+ YL   S    IHRDL A N +L  DM   ++DFG++R        GD  R 
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYR- 194

Query: 489 VGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            G        ++A E +    +++ SDV++FGV + EI++
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  143 bits (361), Expect = 2e-36
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 22/210 (10%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQ 378
                   +G+G FG V++G         +  A+K     +      +F  E L + +  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H ++V+L+G   E     +I E      +  F+    ++  LD  +       ++  + Y
Sbjct: 450 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAY 506

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG----- 493
           L      R +HRD+ A N+L+ ++   K+ DFG++R  E      D++    + G     
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME------DSTYYKASKGKLPIK 557

Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +MAPE +    F+  SDV+ FGV + EI+ 
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILM 587

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  138 bits (350), Expect = 2e-36
 Identities = 50/249 (20%), Positives = 102/249 (40%), Gaps = 23/249 (9%)

Query: 292 RKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEI 351
           + ++Q  +       +  ++       I      +S   ++G GG   V++      Q  
Sbjct: 24  KFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIY 83

Query: 352 AVKRLSKNSVQGEL--EFKNEVLLVARLQHRNL--VRLLGFSFEETERLLIYEFVPNSSV 407
           A+K ++      +    ++NE+  + +LQ  +   +RL  +   +    ++ E   N  +
Sbjct: 84  AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDL 142

Query: 408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467
           + ++    K+  +D   R      +   +  +H+     I+H DLK +N L+   M+ K+
Sbjct: 143 NSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDGML-KL 195

Query: 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPE-----------YVTRGHFSIKSDVFSFGV 516
            DFG+A   + D +       VG   YM PE             ++   S KSDV+S G 
Sbjct: 196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 255

Query: 517 LVLEIISGQ 525
           ++  +  G+
Sbjct: 256 ILYYMTYGK 264

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  137 bits (346), Expect = 2e-36
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 22/218 (10%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRN 381
           + +   + LGQG    V++GR    G   A+K  +  S    ++    E  ++ +L H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 382 LVRLLGFSFEETERL--LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
           +V+L     E T R   LI EF P  S+   + +      L       ++  +  G+ +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 440 HEDSRLRIIHRDLKASNILL----DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            E     I+HR++K  NI+     D   + K++DFG AR  E D  Q  +  + GT  Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTEEYL 182

Query: 496 APEYVTRG--------HFSIKSDVFSFGVLVLEIISGQ 525
            P+   R          +    D++S GV      +G 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  136 bits (346), Expect = 2e-36
 Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 41/233 (17%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHG------QEIAVKRLSKNSVQGEL-EFKNEVLLVAR 376
            N      LG+G FG V K    H         +AVK L +N+   EL +  +E  ++ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPN---------------------SSVDKFIFDAI 415
           + H ++++L G   ++   LLI E+                         S +    D  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 416 KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475
               L           I++G+ YL   + ++++HRDL A NIL+      KISDFG++R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198

Query: 476 FEMDQSQGDTSRIVGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
              D  + D+     + G     +MA E +    ++ +SDV+SFGVL+ EI++
Sbjct: 199 ---DVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  135 bits (343), Expect = 3e-36
 Identities = 65/213 (30%), Positives = 115/213 (53%), Gaps = 13/213 (6%)

Query: 317 STIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG---ELEFKNEVL 372
           + I +   +F   N LG+G F  VY+   +  G E+A+K + K ++         +NEV 
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63

Query: 373 LVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG 431
           +  +L+H +++ L  + FE++  + L+ E   N  +++++ + +K    + E R+  +  
Sbjct: 64  IHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-ENEARH-FMHQ 120

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
           I  G+LYLH      I+HRDL  SN+LL  +M  KI+DFG+A   +M   +  T  + GT
Sbjct: 121 IITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGT 175

Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
             Y++PE  TR    ++SDV+S G +   ++ G
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  136 bits (345), Expect = 3e-36
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 34/218 (15%)

Query: 329 DNKLGQGGFGAVYKGRLSHGQE---IAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRNLV 383
            + +G+G FG V K R+         A+KR+ + + + +  +F  E+ ++ +L  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLDWETRYKIIG 430
            LLG         L  E+ P+ ++  F                      L  +       
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
            +ARG+ YL   S+ + IHRDL A NIL+  + + KI+DFG++R         +      
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYV-KK 198

Query: 491 TFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           T G     +MA E +    ++  SDV+S+GVL+ EI+S
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  135 bits (342), Expect = 4e-36
 Identities = 54/224 (24%), Positives = 100/224 (44%), Gaps = 29/224 (12%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRN 381
            +F     LG+GGFG V++ +        A+KR+   + +   E    EV  +A+L+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 382 LVRLLGFSFEE----------TERLLIY---EFVPNSSVDKFIFDAIKRVQLDWETRYKI 428
           +VR    ++ E          + ++ +Y   +     ++  ++       + +      I
Sbjct: 65  IVRYFN-AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT--- 485
              IA  + +LH      ++HRDLK SNI    D + K+ DFG+    + D+ +      
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 486 -------SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
                  +  VGT  YM+PE +    +S K D+FS G+++ E++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  136 bits (345), Expect = 8e-36
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 36/228 (15%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRL--------SHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
           +  +    LG+G FG V                  +AVK L  ++ + +L +  +E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPN-------------SSVDKFIFDAIKRVQL 420
             + +H+N++ LLG   ++    +I E+                     +  + +   Q+
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
            ++        +ARG+ YL   +  + IHRDL A N+L+  + + KI+DFG+AR    D 
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 253

Query: 481 SQGDTSRIVGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +  D  +   T G     +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 254 NNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  135 bits (342), Expect = 1e-35
 Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 37/236 (15%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG---ELEFKNEVLLVARLQHRNLVRLLG 387
           LG+GGF   ++       +  A K + K+ +       +   E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQ--LDWETRYKIIGGIARGILYLHEDSR 444
           F FE+ + + ++ E     S+     +  KR +   + E RY +   I  G  YLH   R
Sbjct: 109 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQ-IVLGCQYLH---R 159

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
            R+IHRDLK  N+ L+ D+  KI DFG+A   E D  +     + GT  Y+APE +++  
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 217

Query: 505 FSIKSDVFSFGVLVLEIISGQ---------------KNNSFR----IGEEAEDLLT 541
            S + DV+S G ++  ++ G+               K N +     I   A  L+ 
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 273

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  134 bits (339), Expect = 1e-35
 Identities = 62/228 (27%), Positives = 92/228 (40%), Gaps = 36/228 (15%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE------IAVKRLSKNSVQGEL-EFKNEVLLVAR 376
           N  S    LG G FG V +       +      +AVK L  ++   E     +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPN---------------SSVDKFIFDAIKRVQL 420
           L  H N+V LLG        L+I E+                   S           + L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
           D E        +A+G+ +L   +    IHRDL A NILL    I KI DFG+AR    D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR----DI 195

Query: 481 SQGDTSRIVGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                   V         +MAPE +    ++ +SDV+S+G+ + E+ S
Sbjct: 196 KNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  136 bits (343), Expect = 2e-35
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 22/218 (10%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRN 381
           + +   + LGQG    V++GR    G   A+K  +  S    ++    E  ++ +L H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 382 LVRLLGFSFEETERL--LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
           +V+L     E T R   LI EF P  S+   + +      L       ++  +  G+ +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 440 HEDSRLRIIHRDLKASNILL----DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            E     I+HR++K  NI+     D   + K++DFG AR  E D  Q  +  + GT  Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTEEYL 182

Query: 496 APEYVTRG--------HFSIKSDVFSFGVLVLEIISGQ 525
            P+   R          +    D++S GV      +G 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  134 bits (340), Expect = 2e-35
 Identities = 65/276 (23%), Positives = 111/276 (40%), Gaps = 50/276 (18%)

Query: 290 RRRKKKQKQNLRKADEINTVESLQFDFSTIRDAT---------NNFSTDNKLGQGGFGAV 340
           + +K+ + ++  +  ++      ++ +   R+            N      LG G FG V
Sbjct: 2   KYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKV 61

Query: 341 YKGRLSHGQE------IAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRNLVRLLGFSFEE 392
                    +      +AVK L + +   E     +E+ ++ +L  H N+V LLG     
Sbjct: 62  MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121

Query: 393 TERLLIYEFVPN--------SSVDKFIFDAIKRVQLDWETRYKIIGG------------I 432
               LI+E+           S  +KF  D I+          + +              +
Sbjct: 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181

Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF 492
           A+G+ +L        +HRDL A N+L+    + KI DFG+AR    D         V   
Sbjct: 182 AKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR----DIMSDSNYV-VRGN 233

Query: 493 G-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
                 +MAPE +  G ++IKSDV+S+G+L+ EI S
Sbjct: 234 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  133 bits (336), Expect = 3e-35
 Identities = 65/253 (25%), Positives = 111/253 (43%), Gaps = 39/253 (15%)

Query: 317 STIRDATN--NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG---ELEFKNE 370
             + D  +   +     LG+GGF   ++       +  A K + K+ +       +   E
Sbjct: 6   EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 65

Query: 371 VLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQ--LDWETRYK 427
           + +   L H+++V   GF FE+ + + ++ E     S+     +  KR +   + E RY 
Sbjct: 66  ISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYY 120

Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
           +   I  G  YLH   R R+IHRDLK  N+ L+ D+  KI DFG+A   E D  +     
Sbjct: 121 LRQ-IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-- 174

Query: 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ---------------KNNSFR- 531
           + GT  Y+APE +++   S + DV+S G ++  ++ G+               K N +  
Sbjct: 175 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI 234

Query: 532 ---IGEEAEDLLT 541
              I   A  L+ 
Sbjct: 235 PKHINPVAASLIQ 247

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  133 bits (337), Expect = 3e-35
 Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 35/227 (15%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNSVQGEL-EFKNEVLLVAR 376
           +       LG+G FG V +            + +AVK L + +   E     +E+ ++  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 377 L-QHRNLVRLLGFSFEETE-RLLIYEFVPN-------------SSVDKFIFDAIKRVQLD 421
           +  H N+V LLG   +     ++I EF                    K   + + +  L 
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            E        +A+G+ +L   +  + IHRDL A NILL    + KI DFG+AR    D  
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIY 199

Query: 482 QGDTSRIVGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           +                +MAPE +    ++I+SDV+SFGVL+ EI S
Sbjct: 200 KDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  132 bits (334), Expect = 4e-35
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 10/210 (4%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV-QGELEF-KNEVLLVARLQHR 380
            ++     +G G +G   K R  S G+ +  K L   S+ + E +   +EV L+  L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 381 NLVRLLG-FSFEETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWETR-YKIIGGIARGIL 437
           N+VR            L I  E+     +   I    K  Q   E    +++  +   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 438 YLHE--DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
             H   D    ++HRDLK +N+ LD     K+ DFG+AR+   D S   T   VGT  YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183

Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +PE + R  ++ KSD++S G L+ E+ +  
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  134 bits (340), Expect = 4e-35
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 36/223 (16%)

Query: 329 DNKLGQGGFGAVYKGRL--------SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-Q 378
              LG+G FG V             +   ++AVK L  ++ + +L +  +E+ ++  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 379 HRNLVRLLGFSFEETERLLIYEFV-------------PNSSVDKFIFDAIKRVQLDWETR 425
           H+N++ LLG   ++    +I E+              P      +        QL  +  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485
                 +ARG+ YL   +  + IHRDL A N+L+  D + KI+DFG+AR    D    D 
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDY 246

Query: 486 SRIVGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
            +   T G     +MAPE +    ++ +SDV+SFGVL+ EI +
Sbjct: 247 YK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  133 bits (337), Expect = 4e-35
 Identities = 63/269 (23%), Positives = 105/269 (39%), Gaps = 44/269 (16%)

Query: 288 FLRRRKKKQKQNLRKADEINTVESLQFDFSTI---------RDATNNFSTDNKLGQGGFG 338
           +  ++K K +   +  +          D + +         R+   N      LG G FG
Sbjct: 4   YKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRN---NLQFGKTLGAGAFG 60

Query: 339 AVYKGRLSHGQE------IAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRNLVRLLGFSF 390
            V +       +      +AVK L   +   E     +E+ +++ L QH N+V LLG   
Sbjct: 61  KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120

Query: 391 EETERLLIYEFVPN-----------SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
                L+I E+                ++     AI                +A+G+ +L
Sbjct: 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL 180

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG-----Y 494
              +    IHRD+ A N+LL    + KI DFG+AR    D         V         +
Sbjct: 181 ---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYI-VKGNARLPVKW 232

Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           MAPE +    ++++SDV+S+G+L+ EI S
Sbjct: 233 MAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  135 bits (342), Expect = 5e-35
 Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 23/212 (10%)

Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEV-LLVARLQHRNLV 383
           +F   + LG G  G +    +   +++AVKR+             EV LL    +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVI 81

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETR--YKIIGGIARGILYLHE 441
           R      +   + +  E    +       + +++            ++     G+ +LH 
Sbjct: 82  RYFCTEKDRQFQYIAIELCAATL-----QEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136

Query: 442 DSRLRIIHRDLKASNILL-----DADMIPKISDFGMARLFEMDQ-SQGDTSRIVGTFGYM 495
              L I+HRDLK  NIL+        +   ISDFG+ +   + + S    S + GT G++
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 496 APEYVTR---GHFSIKSDVFSFGVLVLEIISG 524
           APE ++     + +   D+FS G +   +IS 
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  132 bits (333), Expect = 1e-34
 Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 29/222 (13%)

Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
           ++    KLG+GGF  V     L  G   A+KR+  +  Q   E + E  +     H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 384 RLLGFSFEETER----LLIYEFVPNSSVDKFIFDAIKRVQ-----LDWETRYKIIGGIAR 434
           RL+ +   E        L+  F    ++    ++ I+R++     L  +    ++ GI R
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTL----WNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF--------EMDQSQGDTS 486
           G+  +H        HRDLK +NILL  +  P + D G             +    Q   +
Sbjct: 146 GLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 487 RIVGTFGYMAPEYV-TRGHFSI--KSDVFSFGVLVLEIISGQ 525
           +   T  Y APE    + H  I  ++DV+S G ++  ++ G+
Sbjct: 203 Q-RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  128 bits (325), Expect = 9e-34
 Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 38/230 (16%)

Query: 323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKR--LSKNSVQGELEFKNEVLLVARL-Q 378
           T  F    K+G G FG+V+K      G   A+KR          E     EV   A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 379 HRNLVRLLGFSFEETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWETR-YKIIGGIARGI 436
           H ++VR    ++ E + +LI  E+    S+   I +  + +    E     ++  + RG+
Sbjct: 70  HSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIP-------------------KISDFGMARLFE 477
            Y+H      ++H D+K SNI +    IP                   KI D G      
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFS--IKSDVFSFGVLVLEIISGQ 525
             Q +       G   ++A E V + +++   K+D+F+  + V+     +
Sbjct: 186 SPQVE------EGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  127 bits (322), Expect = 2e-33
 Identities = 64/217 (29%), Positives = 114/217 (52%), Gaps = 20/217 (9%)

Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLL 373
              ++ D    ++   K+GQG  G VY    ++ GQE+A+++++      +    NE+L+
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 374 VARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI 432
           +   ++ N+V  L  S+   + L ++ E++   S+     D +    +D E     I  +
Sbjct: 71  MRENKNPNIVNYLD-SYLVGDELWVVMEYLAGGSLT----DVVTETCMD-E---GQIAAV 121

Query: 433 ARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
            R  L    +LH +   ++IHRD+K+ NILL  D   K++DFG       +QS+  T  +
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--M 176

Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           VGT  +MAPE VTR  +  K D++S G++ +E+I G+
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  128 bits (323), Expect = 3e-33
 Identities = 63/237 (26%), Positives = 115/237 (48%), Gaps = 14/237 (5%)

Query: 291 RRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQ 349
             +    Q+     E     +L+       D      +  K+G+G  G V   R    G+
Sbjct: 14  GTENLYFQSGVVTHE-QFKAALR-MVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGR 71

Query: 350 EIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVD 408
           ++AVK +     Q      NEV+++   QH N+V +   S+   E L ++ EF+   ++ 
Sbjct: 72  QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK-SYLVGEELWVLMEFLQGGALT 130

Query: 409 KFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS 468
               D + +V+L+ E    +   + + + YLH      +IHRD+K+ +ILL  D   K+S
Sbjct: 131 ----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLS 183

Query: 469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           DFG       D  +  +  +VGT  +MAPE ++R  ++ + D++S G++V+E++ G+
Sbjct: 184 DFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  126 bits (320), Expect = 3e-33
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 20/208 (9%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQG---ELEFKNEVLLVARLQH 379
            +F     LG+G FG VY  R       +A+K L K  ++    E + + EV + + L+H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQL--DWETRYKIIGGIARGI 436
            N++RL G+ F +  R+ LI E+ P  +V    +  ++++    +  T    I  +A  +
Sbjct: 69  PNILRLYGY-FHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTA-TYITELANAL 122

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            Y H     R+IHRD+K  N+LL +    KI+DFG +       S+     + GT  Y+ 
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTD--LCGTLDYLP 175

Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +       K D++S GVL  E + G
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  133 bits (335), Expect = 3e-33
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 21/214 (9%)

Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNL 382
            +    +LG GGFG V +      G+++A+K+  +       E +  E+ ++ +L H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 383 VRLLGFSFEETER--------LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
           V        +  +        LL  E+     + K++        L       ++  I+ 
Sbjct: 75  VSA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 435 GILYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
            + YLHE    RIIHRDLK  NI+L      +I KI D G A+  +           VGT
Sbjct: 133 ALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEF--VGT 186

Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
             Y+APE + +  +++  D +SFG L  E I+G 
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  128 bits (322), Expect = 7e-33
 Identities = 57/239 (23%), Positives = 110/239 (46%), Gaps = 19/239 (7%)

Query: 293 KKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEI 351
           KK ++  L +         L           ++F   ++LG G  G V+K      G  +
Sbjct: 2   KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61

Query: 352 AVKRLSKNSVQGELEF-KNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF 410
           A K +              E+ ++       +V   G  + + E  +  E +   S+D+ 
Sbjct: 62  ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 121

Query: 411 IFDAIKRVQLDWETRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPK 466
           +    K+     E   +I+G ++  ++    YL E    +I+HRD+K SNIL+++    K
Sbjct: 122 L----KKAGRIPE---QILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIK 172

Query: 467 ISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           + DFG++   ++  S  ++   VGT  YM+PE +   H+S++SD++S G+ ++E+  G+
Sbjct: 173 LCDFGVSG--QLIDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  124 bits (313), Expect = 4e-32
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 25/218 (11%)

Query: 311 SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FK 368
           S + +        + F    KLG G FG V+     S G E  +K ++K+  Q  +E  +
Sbjct: 9   SGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE 68

Query: 369 NEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY- 426
            E+ ++  L H N++++    FE+   + ++ E          + + I   Q   +    
Sbjct: 69  AEIEVLKSLDHPNIIKIFEV-FEDYHNMYIVMETCEGGE----LLERIVSAQARGK-ALS 122

Query: 427 -----KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEM 478
                +++  +   + Y H      ++H+DLK  NIL          KI DFG+A LF+ 
Sbjct: 123 EGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179

Query: 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGV 516
           D+   +     GT  YMAPE V +   + K D++S GV
Sbjct: 180 DEHSTN---AAGTALYMAPE-VFKRDVTFKCDIWSAGV 213

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  127 bits (322), Expect = 6e-32
 Identities = 69/227 (30%), Positives = 109/227 (48%), Gaps = 30/227 (13%)

Query: 311 SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE--LEF 367
           S + +          ++    LG+G FG V K +     QE AVK ++K S + +     
Sbjct: 9   SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68

Query: 368 KNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY 426
             EV L+ +L H N+++L     E++    ++ E          +FD I +       R+
Sbjct: 69  LREVELLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGE----LFDEIIK-----RKRF 118

Query: 427 ------KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFE 477
                 +II  +  GI Y+H+     I+HRDLK  NILL   + D   KI DFG++  F+
Sbjct: 119 SEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175

Query: 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
            +    D    +GT  Y+APE V RG +  K DV+S GV++  ++SG
Sbjct: 176 QNTKMKD---RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  123 bits (312), Expect = 7e-32
 Identities = 63/225 (28%), Positives = 111/225 (49%), Gaps = 21/225 (9%)

Query: 308 TVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE 366
               L    +   D    F+   K+G+G FG V+KG      + +A+K +     + E+E
Sbjct: 6   VQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE 65

Query: 367 -FKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWET 424
             + E+ ++++     + +  G S+ +  +L +I E++   S      D ++   LD E 
Sbjct: 66  DIQQEITVLSQCDSPYVTKYYG-SYLKDTKLWIIMEYLGGGSAL----DLLEPGPLD-E- 118

Query: 425 RYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
               I  I R IL    YLH +   + IHRD+KA+N+LL      K++DFG+A      Q
Sbjct: 119 --TQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173

Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            + +T   VGT  +MAPE + +  +  K+D++S G+  +E+  G+
Sbjct: 174 IKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  126 bits (318), Expect = 2e-31
 Identities = 67/248 (27%), Positives = 105/248 (42%), Gaps = 30/248 (12%)

Query: 290 RRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHG 348
                   +               F  S     +  +    KLG G +G V   R     
Sbjct: 3   HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTH 62

Query: 349 QEIAVKRLSKNSVQGE--LEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNS 405
            E A+K + K SV      +   EV ++  L H N+++L  F FE+     L+ E     
Sbjct: 63  VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF-FEDKRNYYLVMECYKGG 121

Query: 406 SVDKFIFDAIKRVQLDWETRY------KIIGGIARGILYLHEDSRLRIIHRDLKASNILL 459
                +FD I         ++       II  +  G+ YLH+     I+HRDLK  N+LL
Sbjct: 122 E----LFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLL 169

Query: 460 ---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGV 516
              + D + KI DFG++ +FE  +   +    +GT  Y+APE V R  +  K DV+S GV
Sbjct: 170 ESKEKDALIKIVDFGLSAVFENQKKMKE---RLGTAYYIAPE-VLRKKYDEKCDVWSIGV 225

Query: 517 LVLEIISG 524
           ++  +++G
Sbjct: 226 ILFILLAG 233

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  128 bits (322), Expect = 2e-31
 Identities = 39/204 (19%), Positives = 81/204 (39%), Gaps = 26/204 (12%)

Query: 331 KLGQGGFGAVYKG---RLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLL 386
            +  GG G +Y      ++ G+ + +K L  +           E   +A + H ++V++ 
Sbjct: 87  CIAHGGLGWIYLALDRNVN-GRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 387 --GFSFEETERLLIY---EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
                 +     + Y   E+V   S+        K  +L        +  I   + YLH 
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPALSYLH- 199

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
              + +++ DLK  NI+L  + + K+ D G      ++        + GT G+ APE + 
Sbjct: 200 --SIGLVYNDLKPENIMLTEEQL-KLIDLGAVS--RINS----FGYLYGTPGFQAPE-IV 249

Query: 502 RGHFSIKSDVFSFGVLVLEIISGQ 525
           R   ++ +D+++ G  +  +    
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDL 273

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  122 bits (307), Expect = 3e-31
 Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 24/218 (11%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRN 381
           +++     +G G    V         +++A+KR++    Q  ++    E+  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 382 LVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYK-----IIGGIARG 435
           +V     SF   + L L+ + +   SV     D IK +    E +        I  I R 
Sbjct: 75  IVSYYT-SFVVKDELWLVMKLLSGGSV----LDIIKHIVAKGEHKSGVLDESTIATILRE 129

Query: 436 IL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM-ARLFEMDQSQGDTSR--I 488
           +L    YLH++     IHRD+KA NILL  D   +I+DFG+ A L        +  R   
Sbjct: 130 VLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186

Query: 489 VGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQ 525
           VGT  +MAPE + +   +  K+D++SFG+  +E+ +G 
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  122 bits (308), Expect = 3e-31
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 28/207 (13%)

Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH 379
           +    F     LG G F  V+  +    G+  A+K + K+    +   +NE+ ++ +++H
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65

Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------KIIGGI 432
            N+V L    +E T    L+ + V    +    FD I          Y       +I  +
Sbjct: 66  ENIVTLEDI-YESTTHYYLVMQLVSGGEL----FDRILE-----RGVYTEKDASLVIQQV 115

Query: 433 ARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIV 489
              + YLHE     I+HRDLK  N+L    + +    I+DFG++++ +     G  S   
Sbjct: 116 LSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTAC 168

Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGV 516
           GT GY+APE + +  +S   D +S GV
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGV 195

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  121 bits (305), Expect = 5e-31
 Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 30/219 (13%)

Query: 311 SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE--F 367
           S + +          ++    LG+G FG V K +     QE AVK ++K S + +     
Sbjct: 9   SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68

Query: 368 KNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY 426
             EV L+ +L H N+++L     E++    ++ E          +FD I +       R+
Sbjct: 69  LREVELLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGE----LFDEIIK-----RKRF 118

Query: 427 ------KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFE 477
                 +II  +  GI Y+H+     I+HRDLK  NILL   + D   KI DFG++  F+
Sbjct: 119 SEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175

Query: 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGV 516
            +    D    +GT  Y+APE V RG +  K DV+S GV
Sbjct: 176 QNTKMKD---RIGTAYYIAPE-VLRGTYDEKCDVWSAGV 210

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  125 bits (315), Expect = 5e-31
 Identities = 71/231 (30%), Positives = 109/231 (47%), Gaps = 31/231 (13%)

Query: 308 TVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE 366
                 F   +    ++ +     LG+G FG V   +    GQE AVK +SK  V+ + +
Sbjct: 10  HATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 69

Query: 367 ---FKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDW 422
                 EV L+ +L H N+++L  F FE+     L+ E          +FD I       
Sbjct: 70  KESLLREVQLLKQLDHPNIMKLYEF-FEDKGYFYLVGEVYTGGE----LFDEIIS----- 119

Query: 423 ETRY------KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMA 473
             R+      +II  +  GI Y+H+    +I+HRDLK  N+LL     D   +I DFG++
Sbjct: 120 RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176

Query: 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
             FE  +   D    +GT  Y+APE V  G +  K DV+S GV++  ++SG
Sbjct: 177 THFEASKKMKD---KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  123 bits (311), Expect = 8e-31
 Identities = 59/238 (24%), Positives = 97/238 (40%), Gaps = 46/238 (19%)

Query: 320 RDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEV-LLVARLQ 378
           +   N   ++  LG G  G V       G+ +AVKR+  +          E+ LL     
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDD 67

Query: 379 HRNLVRLLGFSFEETERL--LIYEFVPNSSVDKFIFDAIKRVQLDWETRY--------KI 428
           H N++R   +  E T+R   +  E    +     + D ++   +  E            +
Sbjct: 68  HPNVIRY--YCSETTDRFLYIALELCNLN-----LQDLVESKNVSDENLKLQKEYNPISL 120

Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLD-------------ADMIPKISDFGMARL 475
           +  IA G+ +LH    L+IIHRDLK  NIL+               ++   ISDFG+ + 
Sbjct: 121 LRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 476 FEMDQS--QGDTSRIVGTFGYMAPE-------YVTRGHFSIKSDVFSFGVLVLEIISG 524
            +  QS  + + +   GT G+ APE         T+   +   D+FS G +   I+S 
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  122 bits (307), Expect = 9e-31
 Identities = 26/245 (10%), Positives = 52/245 (21%), Gaps = 45/245 (18%)

Query: 317 STIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE---FKNEVL 372
           S +            L  G    V+  R +   ++ A+K  +  +     E         
Sbjct: 55  SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATF 114

Query: 373 LVARLQHRNLVRLLGF--------------------------SFEETERLLIYEFVP--- 403
             ARL   +                                  +     LL+        
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDL 174

Query: 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM 463
                   F  + R        + +   + R    L       ++H      N+ +  D 
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDG 231

Query: 464 IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH---FSIKSDVFSFGVLVLE 520
              + D             G            AP          F+   + +  G+ +  
Sbjct: 232 RLMLGDVSALW------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285

Query: 521 IISGQ 525
           +    
Sbjct: 286 VWCLF 290

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  120 bits (302), Expect = 1e-30
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 28/211 (13%)

Query: 317 STIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVA 375
           ST  D    ++ +N +G+G +G V            A K++ K  V+    FK E+ ++ 
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61

Query: 376 RLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------KI 428
            L H N++RL    FE+   + L+ E          +F+ +       +  +      +I
Sbjct: 62  SLDHPNIIRLYET-FEDNTDIYLVMELCTGGE----LFERVVH-----KRVFRESDAARI 111

Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDT 485
           +  +   + Y H+   L + HRDLK  N L      D   K+ DFG+A  F+  +     
Sbjct: 112 MKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT- 167

Query: 486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGV 516
              VGT  Y++P+ V  G +  + D +S GV
Sbjct: 168 --KVGTPYYVSPQ-VLEGLYGPECDEWSAGV 195

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  120 bits (303), Expect = 1e-30
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 30/224 (13%)

Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNS-------VQGELEFKN 369
           ++    ++     +LG+G +G V K R    GQ +AVKR+           +  +L+   
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI-- 58

Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
               +  +     V   G  F E +  +  E + ++S+DKF    I + Q   E    I+
Sbjct: 59  ---SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPE---DIL 111

Query: 430 GGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485
           G IA  I+    +LH  S+L +IHRD+K SN+L++A    K+ DFG++    +       
Sbjct: 112 GKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKD 167

Query: 486 SRIVGTFGYMAPE----YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
               G   YMAPE     + +  +S+KSD++S G+ ++E+   +
Sbjct: 168 I-DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  120 bits (302), Expect = 1e-30
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 15/201 (7%)

Query: 331 KLGQGGFGAVYKG---RLSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQHRNLVR 384
           KLG GG   VY      L    ++A+K +     + E     F+ EV   ++L H+N+V 
Sbjct: 18  KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
           ++    E+    L+ E++   ++ ++I        L  +T       I  GI + H    
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---D 129

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
           +RI+HRD+K  NIL+D++   KI DFG+A+    + S   T+ ++GT  Y +PE      
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEA 188

Query: 505 FSIKSDVFSFGVLVLEIISGQ 525
               +D++S G+++ E++ G+
Sbjct: 189 TDECTDIYSIGIVLYEMLVGE 209

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  120 bits (302), Expect = 3e-30
 Identities = 54/217 (24%), Positives = 89/217 (41%), Gaps = 23/217 (10%)

Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGF 388
            L +GGF  VY+ + +  G+E A+KRL  N  +       EV  + +L  H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 389 SFEETER-------LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           +    E         L+   +    + +F+     R  L  +T  KI     R + ++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI----------VGT 491
             +  IIHRDLK  N+LL      K+ DFG A           +++             T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 492 FGYMAPEYV-TRGHFSI--KSDVFSFGVLVLEIISGQ 525
             Y  PE +    +F I  K D+++ G ++  +   Q
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  118 bits (298), Expect = 4e-30
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 20/208 (9%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQG---ELEFKNEVLLVARLQH 379
           ++F     LG+G FG VY  R       +A+K L K+ ++    E + + E+ + + L+H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQL--DWETRYKIIGGIARGI 436
            N++R+  + F + +R+ L+ EF P       ++  +++     +  +    +  +A  +
Sbjct: 74  PNILRMYNY-FHDRKRIYLMLEFAPRGE----LYKELQKHGRFDEQRSA-TFMEELADAL 127

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            Y H     ++IHRD+K  N+L+      KI+DFG +        +  T    GT  Y+ 
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTM--CGTLDYLP 180

Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
           PE +       K D++  GVL  E + G
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  119 bits (299), Expect = 5e-30
 Identities = 64/241 (26%), Positives = 117/241 (48%), Gaps = 30/241 (12%)

Query: 291 RRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQ 349
           + +   ++ L+K DE +  +               F    KLG+G +G+VYK      GQ
Sbjct: 6   QLRNPPRRQLKKLDEDSLTK----------QPEEVFDVLEKLGEGSYGSVYKAIHKETGQ 55

Query: 350 EIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD 408
            +A+K++    V+ +L+    E+ ++ +    ++V+  G  F+ T+  ++ E+    SV 
Sbjct: 56  IVAIKQVP---VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS 112

Query: 409 KFIFDAIKRVQLDWETRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMI 464
             I    K +  D       I  I +  L    YLH     R IHRD+KA NILL+ +  
Sbjct: 113 DIIRLRNKTLTEDE------IATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGH 163

Query: 465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
            K++DFG+A       ++ +T  ++GT  +MAPE +    ++  +D++S G+  +E+  G
Sbjct: 164 AKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

Query: 525 Q 525
           +
Sbjct: 222 K 222

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  120 bits (303), Expect = 5e-30
 Identities = 55/243 (22%), Positives = 97/243 (39%), Gaps = 31/243 (12%)

Query: 290 RRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFS----TDNKLGQGGFGAVYKGR- 344
           + R K     +   D+       ++    +     +         +LG G FG V++   
Sbjct: 13  KVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVE 72

Query: 345 LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVP 403
            + G+    K ++      +   KNE+ ++ +L H  L+ L    FE+   + LI EF+ 
Sbjct: 73  KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-FEDKYEMVLILEFL- 130

Query: 404 NSSVDKFIFDAIKRVQLDWETRY------KIIGGIARGILYLHEDSRLRIIHRDLKASNI 457
            S  +  +FD I       + +         +     G+ ++HE     I+H D+K  NI
Sbjct: 131 -SGGE--LFDRI----AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENI 180

Query: 458 LL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSF 514
           +     A  + KI DFG+A     D+          T  + APE V R      +D+++ 
Sbjct: 181 MCETKKASSV-KIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAI 236

Query: 515 GVL 517
           GVL
Sbjct: 237 GVL 239

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  119 bits (299), Expect = 8e-30
 Identities = 49/227 (21%), Positives = 93/227 (40%), Gaps = 35/227 (15%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEF--------------- 367
           N++     L QG F  +         +  A+K+  K+ ++ + +F               
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 368 --KNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFI-----FDAIKRVQ 419
             KNE+ ++  +++   +   G      + + +IYE++ N S+ KF       D      
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 420 LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479
           +  +    II  +     Y+H  +   I HRD+K SNIL+D +   K+SDFG +      
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV-- 203

Query: 480 QSQGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISG 524
                     GT+ +M PE+ +    +   K D++S G+ +  +   
Sbjct: 204 --DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  121 bits (306), Expect = 8e-30
 Identities = 63/260 (24%), Positives = 106/260 (40%), Gaps = 41/260 (15%)

Query: 289 LRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSH 347
           +               +   +    +          ++    KLG G +G V   +  + 
Sbjct: 1   MHHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNG 60

Query: 348 GQEIAVKRLSKNSVQG-------------ELEFKNEVLLVARLQHRNLVRLLGFSFEETE 394
             E A+K + K+                   E  NE+ L+  L H N+++L    FE+ +
Sbjct: 61  HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-FEDKK 119

Query: 395 RL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------KIIGGIARGILYLHEDSRLRI 447
              L+ EF         +F+ I         ++       I+  I  GI YLH+     I
Sbjct: 120 YFYLVTEFYEGGE----LFEQIIN-----RHKFDECDAANIMKQILSGICYLHK---HNI 167

Query: 448 IHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
           +HRD+K  NILL   ++ +  KI DFG++  F  D    D    +GT  Y+APE V +  
Sbjct: 168 VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD---RLGTAYYIAPE-VLKKK 223

Query: 505 FSIKSDVFSFGVLVLEIISG 524
           ++ K DV+S GV++  ++ G
Sbjct: 224 YNEKCDVWSCGVIMYILLCG 243

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  118 bits (297), Expect = 1e-29
 Identities = 65/247 (26%), Positives = 113/247 (45%), Gaps = 42/247 (17%)

Query: 299 NLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH---GQEIAVKR 355
           ++  + ++       +DF+       +     ++G+G +G+V K    H   GQ +AVKR
Sbjct: 2   SIESSGKLKISPEQHWDFTA-----EDLKDLGEIGRGAYGSVNKMV--HKPSGQIMAVKR 54

Query: 356 LSKNS-------VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD 408
           +           +  +L+               +V+  G  F E +  +  E + ++S D
Sbjct: 55  IRSTVDEKEQKQLLMDLDVVMRSS-----DCPYIVQFYGALFREGDCWICMELM-STSFD 108

Query: 409 KFIFDAIKRVQLDWETRY--KIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAD 462
           KF     K V    +     +I+G I    +    +L E+  L+IIHRD+K SNILLD  
Sbjct: 109 KFY----KYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRS 162

Query: 463 MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE----YVTRGHFSIKSDVFSFGVLV 518
              K+ DFG++   ++  S   T R  G   YMAPE      +R  + ++SDV+S G+ +
Sbjct: 163 GNIKLCDFGISG--QLVDSIAKT-RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITL 219

Query: 519 LEIISGQ 525
            E+ +G+
Sbjct: 220 YELATGR 226

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  117 bits (294), Expect = 2e-29
 Identities = 61/237 (25%), Positives = 109/237 (45%), Gaps = 28/237 (11%)

Query: 299 NLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLS 357
           ++RK+ E   V           D    +    +LG G FG VYK +    G   A K + 
Sbjct: 1   SMRKSREYEHVRRDL-------DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE 53

Query: 358 KNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKR 417
             S +   ++  E+ ++A   H  +V+LLG  + + +  ++ EF P  +VD  + +  + 
Sbjct: 54  TKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG 113

Query: 418 VQLDWETRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473
           +          I  + R +L    +LH     RIIHRDLKA N+L+  +   +++DFG++
Sbjct: 114 LTEPQ------IQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS 164

Query: 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS-----IKSDVFSFGVLVLEIISGQ 525
                   + D+   +GT  +MAPE V            K+D++S G+ ++E+   +
Sbjct: 165 AKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  118 bits (297), Expect = 2e-29
 Identities = 35/235 (14%), Positives = 75/235 (31%), Gaps = 36/235 (15%)

Query: 317 STIRDATNNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNSVQGELEFKNE 370
           +  +  +      + LG+G F  VY+            Q+  +K     +     EF   
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIG 114

Query: 371 VLLVARLQ---HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ------LD 421
             L+ RL+       ++       +   +L+ E     +    + +AI   +      + 
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT----LLNAINLYKNTPEKVMP 170

Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP-----------KISDF 470
                     +   I  +H+     IIH D+K  N +L    +             + D 
Sbjct: 171 QGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL 227

Query: 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           G +   ++       +    T G+   E ++   ++ + D F     V  ++ G 
Sbjct: 228 GQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  118 bits (297), Expect = 3e-29
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 27/204 (13%)

Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
             S    LG G FG V+K    + G ++A K +    ++ + E KNE+ ++ +L H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------KIIGGIARGI 436
           +L    FE    + L+ E+V        +FD I    +D             +  I  GI
Sbjct: 150 QLYDA-FESKNDIVLVMEYVDGGE----LFDRI----IDESYNLTELDTILFMKQICEGI 200

Query: 437 LYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
            ++H+   + I+H DLK  NIL    DA  I KI DFG+AR ++  +         GT  
Sbjct: 201 RHMHQ---MYILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKV---NFGTPE 253

Query: 494 YMAPEYVTRGHFSIKSDVFSFGVL 517
           ++APE V     S  +D++S GV+
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVI 277

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  114 bits (288), Expect = 2e-28
 Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 34/231 (14%)

Query: 312 LQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNS-------VQG 363
           L       +   N+     ++G G  G V+K R    G  IAVK++ ++        +  
Sbjct: 13  LTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILM 72

Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
           +L+      ++       +V+  G     T+  +  E +  +  +K        +    E
Sbjct: 73  DLDV-----VLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIP---E 123

Query: 424 TRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479
              +I+G +   I+    YL E     +IHRD+K SNILLD     K+ DFG++    + 
Sbjct: 124 ---RILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISG--RLV 176

Query: 480 QSQGDTSRIVGTFGYMAPE-----YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
             +       G   YMAPE       T+  + I++DV+S G+ ++E+ +GQ
Sbjct: 177 DDKAKDR-SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  113 bits (286), Expect = 2e-28
 Identities = 48/202 (23%), Positives = 84/202 (41%), Gaps = 17/202 (8%)

Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE--LE-FKNEVLLVARLQHRNLVRLL 386
            +G+GG G VY+       + +A+K +S+            + E     RLQ  ++V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI- 99

Query: 387 GFSFEETERLLIY---EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
              F E +  L Y     +    +   +    ++  L       I+  I   +   H   
Sbjct: 100 -HDFGEIDGQL-YVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA- 153

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
                HRD+K  NIL+ AD    + DFG+A     D+        VGT  YMAPE  +  
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSES 210

Query: 504 HFSIKSDVFSFGVLVLEIISGQ 525
           H + ++D+++   ++ E ++G 
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  117 bits (295), Expect = 4e-28
 Identities = 56/288 (19%), Positives = 108/288 (37%), Gaps = 41/288 (14%)

Query: 238 PSPLSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQK 297
           P   + P         + +G +    G +V                      R +     
Sbjct: 93  PCEPTAPVLIPGDERKRRRGYDVDEQGKIV----------------------RGKGTVSS 130

Query: 298 QNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRL 356
                  +I      Q          +++    +LG G FG V++    + G   A K +
Sbjct: 131 NYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV 190

Query: 357 SKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAI 415
                  +   + E+  ++ L+H  LV L    FE+   + +IYEF+  S  +  +F+ +
Sbjct: 191 MTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-FEDDNEMVMIYEFM--SGGE--LFEKV 245

Query: 416 --KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDF 470
             +  ++  +   + +  + +G+ ++HE      +H DLK  NI+     ++ + K+ DF
Sbjct: 246 ADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNEL-KLIDF 301

Query: 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLV 518
           G+    +  QS        GT  + APE          +D++S GVL 
Sbjct: 302 GLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  113 bits (286), Expect = 4e-28
 Identities = 50/209 (23%), Positives = 84/209 (40%), Gaps = 28/209 (13%)

Query: 320 RDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ 378
           ++    +     LG+G FG V++    S  +    K +           K E+ ++   +
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIAR 59

Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------KIIGG 431
           HRN++ L   SFE  E L +I+EF+  S +D  IF+ I                   +  
Sbjct: 60  HRNILHLHE-SFESMEELVMIFEFI--SGLD--IFERI----NTSAFELNEREIVSYVHQ 110

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRI 488
           +   + +LH      I H D++  NI+     +  I KI +FG AR  +   +      +
Sbjct: 111 VCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTI-KIIEFGQARQLKPGDNFRL---L 163

Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
                Y APE       S  +D++S G L
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTL 192

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  114 bits (286), Expect = 4e-28
 Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 21/219 (9%)

Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NE 370
           +     D    FS   ++G G FGAVY  R + + + +A+K++S +  Q   +++    E
Sbjct: 45  ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 104

Query: 371 VLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
           V  + +L+H N ++  G    E    L+ E+   S+ D  + +  K+   + E    +  
Sbjct: 105 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTH 161

Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM-ARLFEMDQSQGDTSRIV 489
           G  +G+ YLH      +IHRD+KA NILL    + K+ DFG  + +     +  ++   V
Sbjct: 162 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANS--FV 211

Query: 490 GTFGYMAPEYV---TRGHFSIKSDVFSFGVLVLEIISGQ 525
           GT  +MAPE +     G +  K DV+S G+  +E+   +
Sbjct: 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  113 bits (284), Expect = 5e-28
 Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 21/207 (10%)

Query: 331 KLGQGGFGAVYKG---RLSHGQEIAVKRLSKNSVQGELE----FKNEVLLVARLQHRNLV 383
            LG GG   V+     R    +++AVK L +  +  +      F+ E    A L H  +V
Sbjct: 19  ILGFGGMSEVHLARDLRD--HRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 384 RLLGFSFEETERLLIY----EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            +      ET    +     E+V   ++   +        +  +   ++I    + + + 
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFS 132

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGTFGYMAPE 498
           H   +  IIHRD+K +NI++ A    K+ DFG+AR + +   S   T+ ++GT  Y++PE
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
                    +SDV+S G ++ E+++G+
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGE 216

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  112 bits (283), Expect = 9e-28
 Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 36/217 (16%)

Query: 320 RDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL------EFKNEVL 372
           +   + +    +LG G F  V K R  S G E A K + K   +         E + EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67

Query: 373 LVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY----- 426
           ++ ++ H N++ L    +E    + LI E V        +FD + +     +        
Sbjct: 68  ILRQVLHHNVITLHDV-YENRTDVVLILELVSGGE----LFDFLAQ-----KESLSEEEA 117

Query: 427 -KIIGGIARGILYLHEDSRLRIIHRDLKASNILL-----DADMIPKISDFGMARLFEMDQ 480
              I  I  G+ YLH     +I H DLK  NI+L         I K+ DFG+A   E   
Sbjct: 118 TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHI-KLIDFGLAHEIEDGV 173

Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
              +   I GT  ++APE V      +++D++S GV+
Sbjct: 174 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  111 bits (281), Expect = 1e-27
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 26/208 (12%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQ----GELEFKNEVLLVARLQHRNLVRLL 386
           LG+G +G V +          AVK L K  ++    GE   K E+ L+ RL+H+N+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 387 GFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLD-WETRYK---IIGGIARGILYLH 440
              + E ++   ++ E+      +  + D++   +    +       +I G+     YLH
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126

Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG--DTSRIVGTFGYMAPE 498
                 I+H+D+K  N+LL      KIS  G+A       +     TS+  G+  +  PE
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPAFQPPE 181

Query: 499 YV--TRGHFSIKSDVFSFGVLVLEIISG 524
                      K D++S GV +  I +G
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  113 bits (284), Expect = 1e-27
 Identities = 33/238 (13%), Positives = 64/238 (26%), Gaps = 54/238 (22%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSK----------------------------NSVQ 362
           LGQ    A  +      G+   V                                    +
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 363 GELEFKNEVLLVARLQHRNLVRLLGF--SFEETERLLIYEFVPNSSVDKF--IFDAI-KR 417
             L F     LV   Q + ++R+           R  +Y  + ++       +       
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 418 VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477
             L    R ++   + R +  LH      ++H  L+  +I+LD      ++ F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256

Query: 478 MDQSQGDTSRIVGTFGYMAPEYV-----------TRGHFSIKSDVFSFGVLVLEIISG 524
                G       + G+  PE              R   +   D ++ G+++  I   
Sbjct: 257 -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  111 bits (279), Expect = 2e-27
 Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 37/219 (16%)

Query: 317 STIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL------EFKN 369
           S + D   ++    +LG G F  V K R    G+E A K + K  +          E + 
Sbjct: 1   SMVED---HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIER 57

Query: 370 EVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY-- 426
           EV ++  ++H N++ L    FE    + LI E V        +FD +       +     
Sbjct: 58  EVNILREIRHPNIITLHDI-FENKTDVVLILELVSGGE----LFDFLAE-----KESLTE 107

Query: 427 ----KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEM 478
               + +  I  G+ YLH     RI H DLK  NI+L    +P    K+ DFG+A   E 
Sbjct: 108 DEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164

Query: 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
                +   I GT  ++APE V      +++D++S GV+
Sbjct: 165 GNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  113 bits (285), Expect = 2e-27
 Identities = 56/252 (22%), Positives = 101/252 (40%), Gaps = 38/252 (15%)

Query: 294 KKQKQNLRKADEINTVESLQFDFSTIRDATNN-----------FSTDNKLGQGGFGAVYK 342
           K +++ L    EI    S    F       ++           +     LG G  G V  
Sbjct: 94  KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL 153

Query: 343 GR-LSHGQEIAVKRLSKNSVQG--------ELEFKNEVLLVARLQHRNLVRLLGFSFEET 393
                  +++A++ +SK              L  + E+ ++ +L H  ++++  F F+  
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAE 212

Query: 394 ERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDL 452
           +  ++ E +        +FD +    +L   T       +   + YLHE     IIHRDL
Sbjct: 213 DYYIVLELMEGGE----LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDL 265

Query: 453 KASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE---YVTRGHFS 506
           K  N+LL   + D + KI+DFG +++            + GT  Y+APE    V    ++
Sbjct: 266 KPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYN 322

Query: 507 IKSDVFSFGVLV 518
              D +S GV++
Sbjct: 323 RAVDCWSLGVIL 334

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  112 bits (283), Expect = 2e-27
 Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 29/217 (13%)

Query: 313 QFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE--FKN 369
           +F  +     ++N+    +LG+G F  V +    + G E A K ++   +        + 
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77

Query: 370 EVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY-- 426
           E  +  +LQH N+VRL     +E     L+++ V        +F+ I   +      Y  
Sbjct: 78  EARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGE----LFEDIVARE-----FYSE 127

Query: 427 ----KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMD 479
                 I  I   I Y H      I+HR+LK  N+LL         K++DFG+A      
Sbjct: 128 ADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184

Query: 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGV 516
           ++        GT GY++PE + +  +S   D+++ GV
Sbjct: 185 EA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  111 bits (280), Expect = 2e-27
 Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 14/200 (7%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV--QGELEF-KNEVLLVARLQHRNLVRLLG 387
           LG+G F  V   R        A+K L K  +  + ++ +   E  +++RL H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96

Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRL 445
           F+F++ E+L     +  N      +   I+++    ET  +     I   + YLH     
Sbjct: 97  FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEYLHG---K 149

Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
            IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  Y++PE +T    
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 209

Query: 506 SIKSDVFSFGVLVLEIISGQ 525
              SD+++ G ++ ++++G 
Sbjct: 210 CKSSDLWALGCIIYQLVAGL 229

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  112 bits (282), Expect = 2e-27
 Identities = 49/250 (19%), Positives = 101/250 (40%), Gaps = 39/250 (15%)

Query: 290 RRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHG 348
           +    + K       +    E    D++  ++    +   + +G+G    V +    + G
Sbjct: 60  KLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG 119

Query: 349 QEIAVKRLSKNSVQG--------ELEFKNEVLLVARL-QHRNLVRLLGFSFEETERL-LI 398
            E AVK +   + +             + E  ++ ++  H +++ L+   +E +  + L+
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS-YESSSFMFLV 178

Query: 399 YEFVPNSSVDKFIFDAIKRVQLDWETRY------KIIGGIARGILYLHEDSRLRIIHRDL 452
           ++ +        +FD +                  I+  +   + +LH      I+HRDL
Sbjct: 179 FDLMRKGE----LFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDL 226

Query: 453 KASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE------YVTRGHFS 506
           K  NILLD +M  ++SDFG +   E  +   +   + GT GY+APE        T   + 
Sbjct: 227 KPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCGTPGYLAPEILKCSMDETHPGYG 283

Query: 507 IKSDVFSFGV 516
            + D+++ GV
Sbjct: 284 KEVDLWACGV 293

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  111 bits (280), Expect = 3e-27
 Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 29/239 (12%)

Query: 289 LRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSH 347
           L  +              + V     D S     ++ F  +++LG+G    VY+ +    
Sbjct: 18  LYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGT 77

Query: 348 GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSS 406
            +  A+K L K   +  +  + E+ ++ RL H N+++L    FE    + L+ E V    
Sbjct: 78  QKPYALKVLKKTVDKKIV--RTEIGVLLRLSHPNIIKLKEI-FETPTEISLVLELVTGGE 134

Query: 407 VDKFIFDAIKRVQLDWETRY------KIIGGIARGILYLHEDSRLRIIHRDLKASNILL- 459
           +    FD I       +  Y        +  I   + YLHE     I+HRDLK  N+L  
Sbjct: 135 L----FDRIVE-----KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYA 182

Query: 460 --DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGV 516
               D   KI+DFG++++ E          + GT GY APE +    +  + D++S G+
Sbjct: 183 TPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  112 bits (281), Expect = 3e-27
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 36/216 (16%)

Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL------EFKNEVLL 373
              + +    +LG G F  V K R  S G E A K + K   +         E + EV +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68

Query: 374 VARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------ 426
           + ++ H N++ L    +E    + LI E V        +FD + +     +         
Sbjct: 69  LRQVLHPNIITLHDV-YENRTDVVLILELVSGGE----LFDFLAQ-----KESLSEEEAT 118

Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILL-----DADMIPKISDFGMARLFEMDQS 481
             I  I  G+ YLH     +I H DLK  NI+L         I K+ DFG+A   E    
Sbjct: 119 SFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHI-KLIDFGLAHEIEDGVE 174

Query: 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
             +   I GT  ++APE V      +++D++S GV+
Sbjct: 175 FKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  109 bits (276), Expect = 4e-27
 Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 19/202 (9%)

Query: 323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE--LEFKNEVLLVARLQH 379
           ++N+    +LG+G F  V +    + G E A K ++   +      + + E  +  +LQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGIL 437
            N+VRL     +E     L+++ V        +F+ I  R           I  I   I 
Sbjct: 65  PNIVRLHDS-IQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIA 119

Query: 438 YLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           Y H      I+HR+LK  N+LL         K++DFG+A      ++        GT GY
Sbjct: 120 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGY 173

Query: 495 MAPEYVTRGHFSIKSDVFSFGV 516
           ++PE + +  +S   D+++ GV
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGV 195

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  110 bits (278), Expect = 5e-27
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 34/215 (15%)

Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL------EFKNEVLL 373
           +  + + T  +LG G F  V K R  S G + A K + K   +         + + EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 374 VARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------ 426
           +  +QH N++ L    +E    + LI E V        +FD +       +         
Sbjct: 68  LKEIQHPNVITLHEV-YENKTDVILILELVAGGE----LFDFLAE-----KESLTEEEAT 117

Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DADMIPKISDFGMARLFEMDQSQ 482
           + +  I  G+ YLH    L+I H DLK  NI+L          KI DFG+A   +     
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174

Query: 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
            +   I GT  ++APE V      +++D++S GV+
Sbjct: 175 KN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  110 bits (276), Expect = 7e-27
 Identities = 67/230 (29%), Positives = 104/230 (45%), Gaps = 30/230 (13%)

Query: 314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVL 372
            D S +RD    F     +G G +G VYKGR +  GQ  A+K +       E E K E+ 
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEIN 72

Query: 373 LVARL-QHRNLVRLLG------FSFEETERLLIYEFVPNSSV-DKFIFDAIKRVQLDWET 424
           ++ +   HRN+    G          + +  L+ EF    SV D  +    K   L  E 
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLK-E- 128

Query: 425 RYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
             + I  I R IL    +LH+    ++IHRD+K  N+LL  +   K+ DFG++   +   
Sbjct: 129 --EWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183

Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFS-----IKSDVFSFGVLVLEIISGQ 525
            + +T   +GT  +MAPE +            KSD++S G+  +E+  G 
Sbjct: 184 GRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  111 bits (279), Expect = 7e-27
 Identities = 46/230 (20%), Positives = 86/230 (37%), Gaps = 30/230 (13%)

Query: 315 DFSTIRDATNNFSTDNKLGQG--GFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL--EFKN 369
             S+       +     +G+G      V   R    G+ + V+R++  +   E+    + 
Sbjct: 16  GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75

Query: 370 EVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDW--ETRY 426
           E+ +     H N+V     +F     L ++  F+   S      D I    +D   E   
Sbjct: 76  ELHVSKLFNHPNIVPYRA-TFIADNELWVVTSFMAYGSA----KDLICTHFMDGMNEL-- 128

Query: 427 KIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482
             I  I +G+L    Y+H       +HR +KAS+IL+  D    +S             +
Sbjct: 129 -AIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184

Query: 483 GDT-----SRIVGTFGYMAPEYVTRGH--FSIKSDVFSFGVLVLEIISGQ 525
                      V    +++PE + +    +  KSD++S G+   E+ +G 
Sbjct: 185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  112 bits (280), Expect = 7e-27
 Identities = 32/238 (13%), Positives = 66/238 (27%), Gaps = 53/238 (22%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQ--------- 378
           LGQ    A  +      G+   V               + K EVL +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 379 ----------------HRNLVRLLGF--SFEETERLLIYEFVPNSSVD--KFIFDAIK-R 417
                            + ++R+           R  +Y  + ++     + +       
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 418 VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477
             L    R ++   + R +  LH      ++H  L+  +I+LD      ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 259

Query: 478 MDQSQGDTSRIVGTFGYMAPEYVT----------RGHFSIKSDVFSFGVLVLEIISGQ 525
                G ++      G+  PE                 +   D ++ G+ +  I    
Sbjct: 260 ---RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  112 bits (281), Expect = 1e-26
 Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 28/212 (13%)

Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLV 374
           T    T  +    +LG+G F  V +   +  GQE A   ++   +      + + E  + 
Sbjct: 5   TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARIC 64

Query: 375 ARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------K 427
             L+H N+VRL      E     LI++ V        +F+ I          Y       
Sbjct: 65  RLLKHPNIVRLHDS-ISEEGHHYLIFDLVTGGE----LFEDIVA-----REYYSEADASH 114

Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGD 484
            I  I   +L+ H+   + ++HR+LK  N+LL         K++DFG+A   E +Q    
Sbjct: 115 CIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171

Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGV 516
                GT GY++PE + +  +    D+++ GV
Sbjct: 172 G--FAGTPGYLSPEVLRKDPYGKPVDLWACGV 201

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  109 bits (274), Expect = 1e-26
 Identities = 56/208 (26%), Positives = 85/208 (40%), Gaps = 35/208 (16%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFS 389
           LG+G    V     L   QE AVK + K           EV ++ + Q HRN++ L+ F 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF- 79

Query: 390 FEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------KIIGGIARGILYLHED 442
           FEE +R  L++E +   S    I   I + +      +       ++  +A  + +LH  
Sbjct: 80  FEEEDRFYLVFEKMRGGS----ILSHIHKRR-----HFNELEASVVVQDVASALDFLHN- 129

Query: 443 SRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSR-----IVGTFGY 494
               I HRDLK  NIL    +     KI DF +    +++      S        G+  Y
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187

Query: 495 MAPEYVTRGHFSIKS-----DVFSFGVL 517
           MAPE V              D++S GV+
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVI 215

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  113 bits (284), Expect = 1e-26
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 22/212 (10%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV---QGELEFKNE--VL-LVAR 376
           N+FS    +G+GGFG VY  R +   ++ A+K L K  +   QGE    NE  +L LV+ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 377 LQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIAR 434
                +V +  ++F   ++L  I + +        +   + +  +  E   +     I  
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGD----LHYHLSQHGVFSEADMRFYAAEIIL 303

Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           G+ ++H      +++RDLK +NILLD     +ISD G+A  F   +        VGT GY
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGY 356

Query: 495 MAPEYVTRGHFSIKS-DVFSFGVLVLEIISGQ 525
           MAPE + +G     S D FS G ++ +++ G 
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  109 bits (274), Expect = 2e-26
 Identities = 50/208 (24%), Positives = 82/208 (39%), Gaps = 27/208 (12%)

Query: 326 FSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL-----EFKNEVLLVARLQH 379
           +     +G+G F  V +      GQ+ AVK +              + K E  +   L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------KIIGGI 432
            ++V LL   +     L +++EF+  +     +   I + + D    Y        +  I
Sbjct: 86  PHIVELLET-YSSDGMLYMVFEFMDGAD----LCFEIVK-RADAGFVYSEAVASHYMRQI 139

Query: 433 ARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIV 489
              + Y H+     IIHRD+K   +LL   +     K+  FG+A               V
Sbjct: 140 LEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RV 194

Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
           GT  +MAPE V R  +    DV+  GV+
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVI 222

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  108 bits (272), Expect = 2e-26
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 27/210 (12%)

Query: 323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE--------FKNEVLL 373
            + +     LG G  G V         +++A+K +SK                 + E+ +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGI 432
           + +L H  ++++  F F+  +  ++ E +        +FD +    +L   T       +
Sbjct: 69  LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGE----LFDKVVGNKRLKEATCKLYFYQM 123

Query: 433 ARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIV 489
              + YLHE     IIHRDLK  N+LL   + D + KI+DFG +++            + 
Sbjct: 124 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 177

Query: 490 GTFGYMAPE---YVTRGHFSIKSDVFSFGV 516
           GT  Y+APE    V    ++   D +S GV
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  109 bits (274), Expect = 2e-26
 Identities = 50/232 (21%), Positives = 95/232 (40%), Gaps = 37/232 (15%)

Query: 300 LRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSK 358
           ++     + V+ L  +     D    +     +G G +    +    +   E AVK + K
Sbjct: 1   MQTVGVHSIVQQLHRNSIQFTD---GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK 57

Query: 359 NSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIK 416
           +          E+ ++ R  QH N++ L    +++ + + ++ E +        + D I 
Sbjct: 58  SKRDP----TEEIEILLRYGQHPNIITLKDV-YDDGKYVYVVTELMKGGE----LLDKIL 108

Query: 417 RVQLDWETRY------KIIGGIARGILYLHEDSRLRIIHRDLKASNILL-----DADMIP 465
           R +      +       ++  I + + YLH      ++HRDLK SNIL      + + I 
Sbjct: 109 RQK-----FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESI- 159

Query: 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
           +I DFG A+    +     T     T  ++APE + R  +    D++S GVL
Sbjct: 160 RICDFGFAKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVL 209

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  107 bits (269), Expect = 5e-26
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 30/213 (14%)

Query: 323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG---------ELEFKNEVL 372
             N+     LG+G    V +       +E AVK +                      EV 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 373 LVARL-QHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKII 429
           ++ ++  H N+++L    +E      L+++ +        +FD + ++V L  +   KI+
Sbjct: 76  ILRKVSGHPNIIQLKDT-YETNTFFFLVFDLMKKGE----LFDYLTEKVTLSEKETRKIM 130

Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
             +   I  LH+   L I+HRDLK  NILLD DM  K++DFG +   +  +   +   + 
Sbjct: 131 RALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VC 184

Query: 490 GTFGYMAPE------YVTRGHFSIKSDVFSFGV 516
           GT  Y+APE            +  + D++S GV
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  108 bits (271), Expect = 5e-26
 Identities = 54/269 (20%), Positives = 96/269 (35%), Gaps = 62/269 (23%)

Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVK-----RLSKNSVQG 363
           E+L F   ++ +    +     +GQG +G V            A+K     ++ + + + 
Sbjct: 12  ENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD 71

Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDW 422
               K EV L+ +L H N+ RL    +E+ + + L+ E          + D +     D 
Sbjct: 72  VERIKTEVRLMKKLHHPNIARLYEV-YEDEQYICLVMELCHGGH----LLDKLNVFIDDS 126

Query: 423 ETRY-----------------------------------------KIIGGIARGILYLHE 441
             +                                           I+  I   + YLH 
Sbjct: 127 TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186

Query: 442 DSRLRIIHRDLKASNILL--DADMIPKISDFGMARLFEMDQSQGDT--SRIVGTFGYMAP 497
                I HRD+K  N L   +     K+ DFG+++ F    +      +   GT  ++AP
Sbjct: 187 ---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

Query: 498 EYVTRGHFSI--KSDVFSFGVLVLEIISG 524
           E +   + S   K D +S GVL+  ++ G
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMG 272

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  108 bits (272), Expect = 9e-26
 Identities = 58/221 (26%), Positives = 105/221 (47%), Gaps = 22/221 (9%)

Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKN-EVLL 373
           D  T       ++    +G G FG V++ +L    E+A+K+     V  +  FKN E+ +
Sbjct: 31  DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKK-----VLQDKRFKNRELQI 85

Query: 374 VARLQHRNLVRLLGFSFEETERL------LIYEFVPNSSVDKFIFDAIKRVQLDWETRYK 427
           +  ++H N+V L  F +   ++       L+ E+VP  +V +      K  Q       K
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIK 144

Query: 428 IIG-GIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDT 485
           +    + R + Y+H    + I HRD+K  N+LLD    + K+ DFG A++    +   + 
Sbjct: 145 LYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NV 199

Query: 486 SRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           S I  +  Y APE +    +++   D++S G ++ E++ GQ
Sbjct: 200 SYIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  105 bits (265), Expect = 9e-26
 Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 19/193 (9%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFS 389
           LG+G +G V         + +AVK +         E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 390 FEETERLLIYEFVPNSSVDKFIFDAI-KRVQLD-WETRYK---IIGGIARGILYLHEDSR 444
            E   + L  E+         +FD I   + +   + +     ++ G+     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-RG 503
           + I HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE +  R 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 504 HFSIKSDVFSFGV 516
             +   DV+S G+
Sbjct: 184 FHAEPVDVWSCGI 196

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  106 bits (266), Expect = 2e-25
 Identities = 35/146 (23%), Positives = 61/146 (41%), Gaps = 14/146 (9%)

Query: 388 FSFEETERLLI-YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
                   L I  +     ++  ++         +      I   IA  + +LH      
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KG 184

Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS----------RIVGTFGYMA 496
           ++HRDLK SNI    D + K+ DFG+    + D+ +                VGT  YM+
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEII 522
           PE +   ++S K D+FS G+++ E++
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELL 270

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  106 bits (266), Expect = 2e-25
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 28/204 (13%)

Query: 328 TDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHR-NLV 383
           T  +LG+G F  V +    S GQE A K L K     +   E  +E+ ++   +    ++
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92

Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------KIIGGIARGI 436
            L    +E T  + LI E+         IF        +           ++I  I  G+
Sbjct: 93  NLHEV-YENTSEIILILEYAAGGE----IFS---LCLPELAEMVSENDVIRLIKQILEGV 144

Query: 437 LYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
            YLH+     I+H DLK  NILL         KI DFGM+R         +   I+GT  
Sbjct: 145 YYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPE 198

Query: 494 YMAPEYVTRGHFSIKSDVFSFGVL 517
           Y+APE +     +  +D+++ G++
Sbjct: 199 YLAPEILNYDPITTATDMWNIGII 222

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  105 bits (264), Expect = 3e-25
 Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 39/237 (16%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN------EV----LLVARLQHR 380
           LG+GGFG V+ G  L+   ++A+K + +N V G     +      EV     + A   H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLD-WETRYKIIGGIARGILY 438
            ++RLL +   +   +L+ E  P  + D  +FD I ++  L    +R    G +   I +
Sbjct: 99  GVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSR-CFFGQVVAAIQH 154

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
            H      ++HRD+K  NIL+D      K+ DFG   L  +           GT  Y  P
Sbjct: 155 CH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL--LHDEPYTDF--DGTRVYSPP 207

Query: 498 EYVTRGHFS-IKSDVFSFGVL--VL-----------EIISGQKNNSFRIGEEAEDLL 540
           E+++R  +  + + V+S G+L   +           EI+  + +    +  +   L+
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCALI 264

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  105 bits (264), Expect = 3e-25
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 30/213 (14%)

Query: 317 STIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVA 375
           S      +    D  LG+G F    K       Q  AVK +SK         + E+  + 
Sbjct: 4   SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA---NTQKEITALK 60

Query: 376 RLQ-HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------K 427
             + H N+V+L    F +     L+ E +        +F+ IK+ +      +       
Sbjct: 61  LCEGHPNIVKLHEV-FHDQLHTFLVMELLNGGE----LFERIKKKK-----HFSETEASY 110

Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGD 484
           I+  +   + ++H+   + ++HRDLK  N+L    + ++  KI DFG ARL   D     
Sbjct: 111 IMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167

Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
           T     T  Y APE + +  +    D++S GV+
Sbjct: 168 T--PCFTLHYAAPELLNQNGYDESCDLWSLGVI 198

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  105 bits (264), Expect = 3e-25
 Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 19/193 (9%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFS 389
           LG+G +G V         + +AVK +         E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 390 FEETERLLIYEFVPNSSVDKFIFDAI-KRVQLD-WETRYK---IIGGIARGILYLHEDSR 444
            E   + L  E+         +FD I   + +   + +     ++ G+     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123

Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-RG 503
           + I HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE +  R 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 504 HFSIKSDVFSFGV 516
             +   DV+S G+
Sbjct: 184 FHAEPVDVWSCGI 196

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  108 bits (271), Expect = 4e-25
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 31/208 (14%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLG 387
           LG+GGFG V   ++    ++ A K+L K  +   +GE    NE  ++ ++  R +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 250

Query: 388 FSFEETERL-LIYEFVPN-------SSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILY 438
           +++E  + L L+   +           + +  F          E R       I  G+  
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---------EARAVFYAAEICCGLED 301

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMAP 497
           LH     RI++RDLK  NILLD     +ISD G+A    +   +G T +  VGT GYMAP
Sbjct: 302 LHR---ERIVYRDLKPENILLDDHGHIRISDLGLAV--HV--PEGQTIKGRVGTVGYMAP 354

Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E V    ++   D ++ G L+ E+I+GQ
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  105 bits (263), Expect = 4e-25
 Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 37/235 (15%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQHR--NL 382
           LG GGFG+VY G  +S    +A+K + K+ +    E  N      EV+L+ ++      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLD-WETRYKIIGGIARGILYLH 440
           +RLL +       +LI E  P    D  +FD I +R  L     R      +   + + H
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELAR-SFFWQVLEAVRHCH 166

Query: 441 EDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
                 ++HRD+K  NIL+D +    K+ DFG   L  +  +        GT  Y  PE+
Sbjct: 167 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL--LKDTVYTDF--DGTRVYSPPEW 219

Query: 500 VTRGHFS-IKSDVFSFGVL--VL-----------EIISGQKNNSFRIGEEAEDLL 540
           +    +    + V+S G+L   +           EII GQ     R+  E + L+
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 274

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  104 bits (262), Expect = 6e-25
 Identities = 58/241 (24%), Positives = 103/241 (42%), Gaps = 33/241 (13%)

Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN--------EVLLVA 375
            +ST + LG G FG V+        +E+ VK + K  V  +   ++        E+ +++
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 376 RLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIAR 434
           R++H N++++L     +    L+ E    S +D  +F  I +  +LD      I   +  
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKH-GSGLD--LFAFIDRHPRLDEPLASYIFRQLVS 141

Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
            + YL       IIHRD+K  NI++  D   K+ DFG A   E  +    T    GT  Y
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTF--CGTIEY 195

Query: 495 MAPEYVT-RGHFSIKSDVFSFGVL--VL-----------EIISGQKNNSFRIGEEAEDLL 540
            APE +    +   + +++S GV    L           E +    +  + + +E   L+
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLV 255

Query: 541 T 541
           +
Sbjct: 256 S 256

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  107 bits (268), Expect = 8e-25
 Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 16/202 (7%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLG 387
           LG+GGFG V+  ++    ++ A K+L+K  +   +G      E  ++A++  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251

Query: 388 FSFEETERL-LIYEFVPNSSVDKF--IFDAIKRVQLDWETRYKI-IGGIARGILYLHEDS 443
           ++FE    L L+   +     D    I++  +      E R       I  G+ +LH+  
Sbjct: 252 YAFETKTDLCLVMTIMNGG--DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-- 307

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
              II+RDLK  N+LLD D   +ISD G+A   +  Q++  T    GT G+MAPE +   
Sbjct: 308 -RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGE 364

Query: 504 HFSIKSDVFSFGVLVLEIISGQ 525
            +    D F+ GV + E+I+ +
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  103 bits (258), Expect = 2e-24
 Identities = 50/229 (21%), Positives = 86/229 (37%), Gaps = 41/229 (17%)

Query: 310 ESLQFDFSTIRDATNNFS-----TDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG 363
             L+  F          +     +   LG G  G V +      GQ+ A+K L  +    
Sbjct: 10  SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--- 66

Query: 364 ELEFKNEVLLVARLQ-HRNLVRLLGFSFEETER-----LLIYEFVPNSSVDKFIFDAIKR 417
             + + EV    +     ++V +L   +E         L+I E +        +F  I+ 
Sbjct: 67  --KARQEVDHHWQASGGPHIVCILDV-YENMHHGKRCLLIIMECMEGGE----LFSRIQE 119

Query: 418 VQLDWETRY------KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKIS 468
                +  +      +I+  I   I +LH      I HRD+K  N+L    + D + K++
Sbjct: 120 RG---DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLT 173

Query: 469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
           DFG A+       Q        T  Y+APE +    +    D++S GV+
Sbjct: 174 DFGFAKETT----QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  101 bits (254), Expect = 4e-24
 Identities = 54/221 (24%), Positives = 89/221 (40%), Gaps = 49/221 (22%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV-------------------QGELEFKNEV 371
           +G+G +G V      +     A+K LSK  +                    G ++ +  +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 372 LLVAR-------LQHRNLVRLLGFSFE------ETERLLIYEFVPNSSVDKFIFDAIKRV 418
             V +       L H N+V+L     E      E    +++E V    V     +     
Sbjct: 81  EQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK 132

Query: 419 QLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478
            L  +        + +GI YLH     +IIHRD+K SN+L+  D   KI+DFG++  F+ 
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSI---KSDVFSFGV 516
             +    +  VGT  +MAPE ++           DV++ GV
Sbjct: 190 SDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGV 228

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  104 bits (260), Expect = 4e-24
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 25/221 (11%)

Query: 317 STIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN-EVLLV 374
              R    +++    +G G FG VY+ +L   G+ +A+K+     V  +  FKN E+ ++
Sbjct: 47  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIM 101

Query: 375 ARLQHRNLVRLLGFSFEETERL------LIYEFVPNSSVDKFIFDAIKRVQL--DWETRY 426
            +L H N+VRL  F +   E+       L+ ++VP  +V +      +  Q       + 
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKL 160

Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDT 485
             +  + R + Y+H      I HRD+K  N+LLD D  + K+ DFG A+     +     
Sbjct: 161 -YMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--V 214

Query: 486 SRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
           S I  +  Y APE +     ++   DV+S G ++ E++ GQ
Sbjct: 215 SYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  101 bits (254), Expect = 8e-24
 Identities = 67/199 (33%), Positives = 97/199 (48%), Gaps = 31/199 (15%)

Query: 332 LGQGGFGAVYKGRLSH---GQEIAVKRLSKNSVQGELEFK--NEVLLVARLQHRNLVRLL 386
           +G+G F  V   R  H   G+E+A+K + K  +      K   EV ++  L H N+V+L 
Sbjct: 23  IGKGNFAKVKLAR--HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL- 79

Query: 387 GFSFE--ETERL--LIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKIIGGIARGILYL 439
              FE  ETE+   LI E+         +FD +    R++   E R      I   + Y 
Sbjct: 80  ---FEVIETEKTLYLIMEYASGGE----VFDYLVAHGRMKEK-EAR-SKFRQIVSAVQYC 130

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
           H   + RI+HRDLKA N+LLDADM  KI+DFG +  F +   + D     G   Y APE 
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAF--CGAPPYAAPEL 184

Query: 500 VT-RGHFSIKSDVFSFGVL 517
              + +   + DV+S GV+
Sbjct: 185 FQGKKYDGPEVDVWSLGVI 203

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  101 bits (254), Expect = 2e-23
 Identities = 53/244 (21%), Positives = 93/244 (38%), Gaps = 37/244 (15%)

Query: 290 RRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHG 348
               +      ++  + +    LQ   + I D  +   T   LG G  G V +       
Sbjct: 30  HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID--DYKVTSQVLGLGINGKVLQIFNKRTQ 87

Query: 349 QEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETER-----LLIYEFV 402
           ++ A+K L         + + EV L  R     ++VR++   +E         L++ E +
Sbjct: 88  EKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDV-YENLYAGRKCLLIVMECL 141

Query: 403 PNSSVDKFIFDAIKRVQLDWETRY------KIIGGIARGILYLHEDSRLRIIHRDLKASN 456
                   +F  I+      +  +      +I+  I   I YLH    + I HRD+K  N
Sbjct: 142 DGGE----LFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 191

Query: 457 ILL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFS 513
           +L      + I K++DFG A+      S         T  Y+APE +    +    D++S
Sbjct: 192 LLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLGPEKYDKSCDMWS 248

Query: 514 FGVL 517
            GV+
Sbjct: 249 LGVI 252

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  100 bits (251), Expect = 3e-23
 Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 27/226 (11%)

Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN----E 370
               R   + F  +   GQG FG V  G+    G  +A+K+     V  +  F+N     
Sbjct: 15  DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK-----VIQDPRFRNRELQI 69

Query: 371 VLLVARLQHRNLVRLLGF-------SFEETERLLIYEFVPNSSVDKFIFDAIKRVQL--D 421
           +  +A L H N+V+L  +          +    ++ E+VP  ++ +   +  +R      
Sbjct: 70  MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPP 128

Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPKISDFGMARLFEMDQ 480
              +   +  + R I  LH  S + + HRD+K  N+L++ AD   K+ DFG A+     +
Sbjct: 129 ILIKV-FLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186

Query: 481 SQGDTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
                + I   + Y APE +    H++   D++S G +  E++ G+
Sbjct: 187 PN--VAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 97.6 bits (244), Expect = 9e-23
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 26/186 (13%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---------EVLL 373
            NF    K+G+G +G VYK R    G+ +A+K++        L+ +          E+ L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-------LDTETEGVPSTAIREISL 55

Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD-KFIFDAIKRVQLDWETRYKIIGGI 432
           +  L H N+V+LL     E +  L++EF+     D K   DA     +        +  +
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQL 112

Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF 492
            +G+ + H     R++HRDLK  N+L++ +   K++DFG+AR F     +  T  +V T 
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TL 167

Query: 493 GYMAPE 498
            Y APE
Sbjct: 168 WYRAPE 173

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 98.0 bits (245), Expect = 1e-22
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 34/196 (17%)

Query: 319 IRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN-------- 369
           ++     +   + LG+G F  VYK R  +  Q +A+K++         E K+        
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALR 61

Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD--KFIFDAIKRVQLDWETRYK 427
           E+ L+  L H N++ LL     ++   L+++F+     D    I D    + L       
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET---DLEVIIKD--NSLVLTPSHIKA 116

Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD--- 484
            +    +G+ YLH+     I+HRDLK +N+LLD + + K++DFG+A+ F      G    
Sbjct: 117 YMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF------GSPNR 167

Query: 485 --TSRIVGTFGYMAPE 498
             T ++V T  Y APE
Sbjct: 168 AYTHQVV-TRWYRAPE 182

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 46/212 (21%)

Query: 313 QFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKN- 369
             +     +  + +    K+GQG FG V+K R    GQ++A+K++    ++ E E F   
Sbjct: 7   SVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPIT 62

Query: 370 ---EVLLVARLQHRNLVRLLGFSFEETERL--------LIYEFVP-------NSSVDKFI 411
              E+ ++  L+H N+V L+     +            L+++F         ++ + KF 
Sbjct: 63  ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT 122

Query: 412 FDAIKRV--QLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD 469
              IKRV   L              G+ Y+H +   +I+HRD+KA+N+L+  D + K++D
Sbjct: 123 LSEIKRVMQML------------LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 167

Query: 470 FGMARLFEMDQSQGD---TSRIVGTFGYMAPE 498
           FG+AR F + ++      T+R+V T  Y  PE
Sbjct: 168 FGLARAFSLAKNSQPNRYTNRVV-TLWYRPPE 198

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 95.4 bits (238), Expect = 4e-22
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 34/201 (16%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQHRNLVRLLG 387
           LG G FG V  G     G ++AVK L++  ++      + K E+  +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76

Query: 388 FSFE--ETER--LLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYK---IIGGIARGIL 437
             ++   T     ++ E+V        +FD I    RV+   E R     I+  +     
Sbjct: 77  --YQVISTPTDFFMVMEYVSGGE----LFDYICKHGRVEEM-EARRLFQQILSAVD---- 125

Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           Y H   R  ++HRDLK  N+LLDA M  KI+DFG++ +   D     TS   G+  Y AP
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTS--CGSPNYAAP 179

Query: 498 EYVT-RGHFSIKSDVFSFGVL 517
           E ++ R +   + D++S GV+
Sbjct: 180 EVISGRLYAGPEVDIWSCGVI 200

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 96.1 bits (240), Expect = 4e-22
 Identities = 58/192 (30%), Positives = 91/192 (47%), Gaps = 24/192 (12%)

Query: 322 ATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLS-KNSVQGELEFKN----EVLLVA 375
           AT+ +    ++G G +G VYK R    G  +A+K +   N   G          EV L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 376 RLQ---HRNLVRLL----GFSFEETERL-LIYEFVPNSSVD-KFIFDAIKRVQLDWETRY 426
           RL+   H N+VRL+        +   ++ L++E V     D +   D      L  ET  
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPGLPAETIK 123

Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486
            ++    RG+ +LH +    I+HRDLK  NIL+ +    K++DFG+AR++    +   T 
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TP 178

Query: 487 RIVGTFGYMAPE 498
            +V T  Y APE
Sbjct: 179 VVV-TLWYRAPE 189

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 96.1 bits (240), Expect = 4e-22
 Identities = 52/184 (28%), Positives = 91/184 (49%), Gaps = 24/184 (13%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKN---------EVLLV 374
             +    K+G+G +G VYK + S G+ +A+KR+        L+ ++         E+ L+
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR-------LDAEDEGIPSTAIREISLL 73

Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
             L H N+V L+     E    L++EF+    + K + +   +  L        +  + R
Sbjct: 74  KELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDE--NKTGLQDSQIKIYLYQLLR 130

Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           G+ + H+    RI+HRDLK  N+L+++D   K++DFG+AR F     +  T  +V T  Y
Sbjct: 131 GVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV-TLWY 185

Query: 495 MAPE 498
            AP+
Sbjct: 186 RAPD 189

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 97.0 bits (242), Expect = 4e-22
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 34/199 (17%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
           +G G FG     R     + +AVK + + +   E   + E++    L+H N+VR      
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQREIINHRSLRHPNIVRF----K 82

Query: 391 E--ETER--LLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYK---IIGGIARGILYLH 440
           E   T     +I E+         +++ I    R   D E R+    ++ G++    Y H
Sbjct: 83  EVILTPTHLAIIMEYASGGE----LYERICNAGRFSED-EARFFFQQLLSGVS----YCH 133

Query: 441 EDSRLRIIHRDLKASNILLDADMIP--KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
               ++I HRDLK  N LLD    P  KI DFG ++   +  SQ  ++  VGT  Y+APE
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST--VGTPAYIAPE 187

Query: 499 YVT-RGHFSIKSDVFSFGV 516
            +  + +    +DV+S GV
Sbjct: 188 VLLRQEYDGKIADVWSCGV 206

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 94.9 bits (237), Expect = 8e-22
 Identities = 50/184 (27%), Positives = 90/184 (48%), Gaps = 24/184 (13%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKN---------EVLLV 374
             +    K+G+G +G VYK + ++G+  A+K++        LE ++         E+ ++
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR-------LEKEDEGIPSTTIREISIL 54

Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
             L+H N+V+L      +   +L++E +    + K +        L+  T    +  +  
Sbjct: 55  KELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDV--CEGGLESVTAKSFLLQLLN 111

Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           GI Y H+    R++HRDLK  N+L++ +   KI+DFG+AR F     +  T  IV T  Y
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV-TLWY 166

Query: 495 MAPE 498
            AP+
Sbjct: 167 RAPD 170

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 29/192 (15%)

Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN--------EV 371
            +++ F    KLG G +  VYKG   + G  +A+K +        L+ +         E+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-------LDSEEGTPSTAIREI 54

Query: 372 LLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD-KFIFDAIKRVQLDWETRYKIIG 430
            L+  L+H N+VRL      E +  L++EF+ N   D K   D+             ++ 
Sbjct: 55  SLMKELKHENIVRLYDVIHTENKLTLVFEFMDN---DLKKYMDSRTVGNTPRGLELNLVK 111

Query: 431 GIA----RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486
                  +G+ + HE+   +I+HRDLK  N+L++     K+ DFG+AR F        +S
Sbjct: 112 YFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSS 167

Query: 487 RIVGTFGYMAPE 498
            +V T  Y AP+
Sbjct: 168 EVV-TLWYRAPD 178

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 24/184 (13%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN--------EVLLV 374
             +   +KLG+G +  VYKG+       +A+K +        LE +         EV L+
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-------LEHEEGAPCTAIREVSLL 54

Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
             L+H N+V L      E    L++E++ +  + +++ D      ++       +  + R
Sbjct: 55  KDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDD--CGNIINMHNVKLFLFQLLR 111

Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           G+ Y H     +++HRDLK  N+L++     K++DFG+AR      ++   + +V T  Y
Sbjct: 112 GLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV-TLWY 166

Query: 495 MAPE 498
             P+
Sbjct: 167 RPPD 170

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 95.2 bits (237), Expect = 2e-21
 Identities = 53/186 (28%), Positives = 86/186 (46%), Gaps = 26/186 (13%)

Query: 331 KLGQGGFGAVYKGRLSH---GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLG 387
           K+G+G +G VYK +       ++ A+K++    +   +    E+ L+  L+H N++ L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 85

Query: 388 FSFEETERL--LIYEFVPNSSVD--KFI------FDAIKRVQLDWETRYKIIGGIARGIL 437
                 +R   L++++  +   D    I          K VQL       ++  I  GI 
Sbjct: 86  VFLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLF-EMDQSQGDTSRIVGTF 492
           YLH +    ++HRDLK +NIL+  +       KI+D G ARLF    +   D   +V TF
Sbjct: 143 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199

Query: 493 GYMAPE 498
            Y APE
Sbjct: 200 WYRAPE 205

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 92.6 bits (231), Expect = 4e-21
 Identities = 44/185 (23%), Positives = 87/185 (47%), Gaps = 25/185 (13%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---------EVLL 373
             +    K+G+G +G V+K +     + +A+KR+        L+  +         E+ L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-------LDDDDEGVPSSALREICL 54

Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
           +  L+H+N+VRL      + +  L++EF     + K+         LD E     +  + 
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDS--CNGDLDPEIVKSFLFQLL 111

Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ + H      ++HRDLK  N+L++ +   K+++FG+AR F     +  ++ +V T  
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV-TLW 166

Query: 494 YMAPE 498
           Y  P+
Sbjct: 167 YRPPD 171

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 93.4 bits (233), Expect = 5e-21
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 28/214 (13%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN----EVLLVARLQ 378
             +     +G+G +G V K R    G+ +A+K+    S   +   K     E+ L+ +L+
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDK-MVKKIAMREIKLLKQLR 82

Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H NLV LL    ++    L++EFV + ++   +        LD++   K +  I  GI +
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGF 139

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
            H      IIHRD+K  NIL+    + K+ DFG AR       +     +  T  Y APE
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVA-TRWYRAPE 194

Query: 499 -------YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
                  Y      ++  DV++ G LV E+  G+
Sbjct: 195 LLVGDVKYGK----AV--DVWAIGCLVTEMFMGE 222

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 94.3 bits (235), Expect = 5e-21
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 24/205 (11%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV--QGELEF-KNEVLLVARLQHRNLVRLLG 387
           +G+G FG V   + +  +++ A+K ++K     + E+     E+ ++  L+H  LV L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81

Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLHEDSRL 445
           +SF++ E + ++ + +        +   +++     E   K+ I  +   + YL      
Sbjct: 82  YSFQDEEDMFMVVDLLLGGD----LRYHLQQNVHFKEETVKLFICELVMALDYLQN---Q 134

Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR--- 502
           RIIHRD+K  NILLD      I+DF +A +   +      + + GT  YMAPE  +    
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKG 191

Query: 503 -GH-FSIKSDVFSFGVLVLEIISGQ 525
            G+ F++  D +S GV   E++ G+
Sbjct: 192 AGYSFAV--DWWSLGVTAYELLRGR 214

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 92.2 bits (230), Expect = 7e-21
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 30/215 (13%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---EVLLVARLQH 379
             +    K+G+G +G V+K R    GQ +A+K+    S    +  K    E+ ++ +L+H
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61

Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            NLV LL     +    L++E+  + +V   +     +  +       I     + + + 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFC 118

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD--TSRIVGTFGYMAP 497
           H   +   IHRD+K  NIL+    + K+ DFG ARL        D     +  T  Y +P
Sbjct: 119 H---KHNCIHRDVKPENILITKHSVIKLCDFGFARLL---TGPSDYYDDEVA-TRWYRSP 171

Query: 498 E-------YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           E       Y       +  DV++ G +  E++SG 
Sbjct: 172 ELLVGDTQYGP----PV--DVWAIGCVFAELLSGV 200

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 92.7 bits (231), Expect = 9e-21
 Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 39/203 (19%)

Query: 332 LGQGGFGAVYKGRLSH---GQEIAVKRLSKNSV-QGELEFK--NEVLLVARLQHRNLVRL 385
           LG+G FG V      H    Q++A+K +S+  + + ++  +   E+  +  L+H ++++L
Sbjct: 17  LGEGSFGKVKLAT--HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 386 LGFSFE--ETER--LLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYK---IIGGIARG 435
               ++   T    +++ E+         +FD I   KR+  D E R     II  I   
Sbjct: 75  ----YDVITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTED-EGRRFFQQIICAIE-- 122

Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
             Y H   R +I+HRDLK  N+LLD ++  KI+DFG++ +   D +   TS   G+  Y 
Sbjct: 123 --YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTS--CGSPNYA 174

Query: 496 APEYVT-RGHFSIKSDVFSFGVL 517
           APE +  + +   + DV+S G++
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIV 197

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 93.7 bits (233), Expect = 1e-20
 Identities = 52/264 (19%), Positives = 110/264 (41%), Gaps = 31/264 (11%)

Query: 279 ALVALITCVFLRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFG 338
            L+ ++ C++        ++     + +   +        +R    +F     +G+G FG
Sbjct: 29  TLLDILICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFG 88

Query: 339 AVYKGRLSHGQEI-AVKRLSKNSV--QGELE-FKNEVLLVARLQHRNLVRLLGFSFEETE 394
            V   +L +  ++ A+K L+K  +  + E   F+ E  ++     + +  L  ++F++  
Sbjct: 89  EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDN 147

Query: 395 RL-LIYEFVPN----SSVDKF--IFDAIKRVQLDWETRYKI-IGGIARGILYLHEDSRLR 446
            L L+ ++       + + KF              E   +  +  +   I  +H+   L 
Sbjct: 148 NLYLVMDYYVGGDLLTLLSKFEDRLP---------EEMARFYLAEMVIAIDSVHQ---LH 195

Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
            +HRD+K  NIL+D +   +++DFG      M+     +S  VGT  Y++PE +      
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGTPDYISPEILQAMEGG 254

Query: 507 IKS-----DVFSFGVLVLEIISGQ 525
                   D +S GV + E++ G+
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGE 278

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 94.1 bits (234), Expect = 1e-20
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 38/203 (18%)

Query: 332 LGQGGFGAVYKGRLSH---GQEIAVKRLSKNSVQGELEF---KNEVLLVARLQHRNLVRL 385
           LG G FG V  G+  H   G ++AVK L++  ++        + E+  +   +H ++++L
Sbjct: 24  LGVGTFGKVKVGK--HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 386 LGFSFE--ETER--LLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYK---IIGGIARG 435
               ++   T     ++ E+V        +FD I    R+    E+R     I+ G+   
Sbjct: 82  ----YQVISTPSDIFMVMEYVSGGE----LFDYICKNGRLDEK-ESRRLFQQILSGVD-- 130

Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
             Y H   R  ++HRDLK  N+LLDA M  KI+DFG++ +   D     TS   G+  Y 
Sbjct: 131 --YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTS--CGSPNYA 182

Query: 496 APEYVT-RGHFSIKSDVFSFGVL 517
           APE ++ R +   + D++S GV+
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVI 205

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 63/273 (23%), Positives = 120/273 (43%), Gaps = 38/273 (13%)

Query: 270 VVSTSTFIIALVALIT-CVF--LRRRKKKQKQNLRKADEINTVESLQF---DFSTIRDAT 323
            V++   +  L AL+    F  LR+ K       R  D IN +  L+    D+  ++   
Sbjct: 19  EVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVK--- 75

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV--QGELE-FKNEVLLVARLQH 379
                   +G+G FG V   R    +++ A+K LSK  +  + +   F  E  ++A    
Sbjct: 76  -------VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGIL 437
             +V+L  ++F++   L ++ E++P       + + +    +  E   +     +   + 
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGD----LVNLMSNYDVP-EKWARFYTAEVVLALD 182

Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMA 496
            +H    +  IHRD+K  N+LLD     K++DFG     +M++         VGT  Y++
Sbjct: 183 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKEGMVRCDTAVGTPDYIS 237

Query: 497 PEYVTR----GHFSIKSDVFSFGVLVLEIISGQ 525
           PE +      G++  + D +S GV + E++ G 
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 36/195 (18%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR--LSHGQEIAVKRLSKNSVQGELEFKN---------EVL 372
             +    ++G+G +G V+K R   + G+ +A+KR+        ++            EV 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-------VQTGEEGMPLSTIREVA 63

Query: 373 LVARLQ---HRNLVRLL----GFSFEETERL-LIYEFVPNSSVD-KFIFDAIKRVQLDWE 423
           ++  L+   H N+VRL         +   +L L++E V     D     D +    +  E
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTE 120

Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
           T   ++  + RG+ +LH     R++HRDLK  NIL+ +    K++DFG+AR++    +  
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL- 176

Query: 484 DTSRIVGTFGYMAPE 498
            TS +V T  Y APE
Sbjct: 177 -TSVVV-TLWYRAPE 189

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 92.5 bits (230), Expect = 2e-20
 Identities = 56/241 (23%), Positives = 105/241 (43%), Gaps = 19/241 (7%)

Query: 297 KQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKR 355
            Q+   AD +   E +      +R   ++F     +G+G F  V   ++    ++ A+K 
Sbjct: 34  AQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKI 93

Query: 356 LSKNSV--QGELE-FKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFI 411
           ++K  +  +GE+  F+ E  ++     R + +L  F+F++   L L+ E+     +   +
Sbjct: 94  MNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL 152

Query: 412 FDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471
               +R+  +    Y  +  I   I  +H    L  +HRD+K  NILLD     +++DFG
Sbjct: 153 SKFGERIPAEMARFY--LAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFG 207

Query: 472 MARLFEMDQSQGDTSRIVGTFGYMAPE-------YVTRGHFSIKSDVFSFGVLVLEIISG 524
                  D +   +   VGT  Y++PE           G +  + D ++ GV   E+  G
Sbjct: 208 SCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

Query: 525 Q 525
           Q
Sbjct: 267 Q 267

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 91.7 bits (228), Expect = 6e-20
 Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 15/200 (7%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEF---KNEVLLVARLQHRNLVRLLG 387
           LG+G FG V   +        A+K L K  +  + E      E  ++   +H  L  L  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214

Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRL 445
           +SF+  +RL  + E+         +F  + R ++  E R +  G  I   + YLH  S  
Sbjct: 215 YSFQTHDRLCFVMEYANGGE----LFFHLSRERVFSEDRARFYGAEIVSALDYLH--SEK 268

Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
            +++RDLK  N++LD D   KI+DFG+ +   +           GT  Y+APE +    +
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGAT-MKTFCGTPEYLAPEVLEDNDY 326

Query: 506 SIKSDVFSFGVLVLEIISGQ 525
               D +  GV++ E++ G+
Sbjct: 327 GRAVDWWGLGVVMYEMMCGR 346

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 89.6 bits (223), Expect = 8e-20
 Identities = 55/191 (28%), Positives = 79/191 (41%), Gaps = 33/191 (17%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---------EVLL 373
           + +    KLG+G +G VYK       + +A+KR+        LE +          EV L
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-------LEHEEEGVPGTAIREVSL 86

Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD-KFIFDAIKRVQLDWETRYKIIGGI 432
           +  LQHRN++ L           LI+E+  N   D K   D  K   +        +  +
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAEN---DLKKYMD--KNPDVSMRVIKSFLYQL 141

Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIP-----KISDFGMARLFEMDQSQGDTSR 487
             G+ + H     R +HRDLK  N+LL           KI DFG+AR F     +  T  
Sbjct: 142 INGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFTHE 197

Query: 488 IVGTFGYMAPE 498
           I+ T  Y  PE
Sbjct: 198 II-TLWYRPPE 207

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 22/204 (10%)

Query: 332 LGQGGFGAVY---KGRLSHGQEI-AVKRLSKNSVQ--GELEFKNE--VLLVARLQHRNLV 383
           LGQG FG V+   K   S  +++ A+K L K +++    +  K E  +L+     H  +V
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN--HPFIV 89

Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLHE 441
           +L  ++F+   +L LI +F+        +F  + +  +  E   K  +  +A  + +LH 
Sbjct: 90  KLH-YAFQTEGKLYLILDFLRGGD----LFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
              L II+RDLK  NILLD +   K++DFG+++   +D  +       GT  YMAPE V 
Sbjct: 145 ---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKK-AYSFCGTVEYMAPEVVN 199

Query: 502 RGHFSIKSDVFSFGVLVLEIISGQ 525
           R   +  +D +SFGVL+ E+++G 
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGT 223

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 23/210 (10%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV--QGELE-FKNEVLLVARLQH 379
           + F     LG G FG V   +        A+K L K  V    ++E   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
             LV+L  FSF++   L ++ E+V        +F  ++R+    E   +     I     
Sbjct: 101 PFLVKLE-FSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 155

Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
           YLH    L +I+RDLK  N+L+D     +++DFG A+     + +G T  + GT   +AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAP 207

Query: 498 EYVT-RGHFSIKS-DVFSFGVLVLEIISGQ 525
           E +  +G+   K+ D ++ GVL+ E+ +G 
Sbjct: 208 EIILSKGY--NKAVDWWALGVLIYEMAAGY 235

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 88.1 bits (219), Expect = 5e-19
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 25/205 (12%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKNEV--------LLVARLQHRNL 382
           +G+G FG V   R    +   AVK L K ++      K E         +L+  ++H  L
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK----KKEEKHIMSERNVLLKNVKHPFL 101

Query: 383 VRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLH 440
           V L  FSF+  ++L  + +++        +F  ++R +   E R +     IA  + YLH
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGE----LFYHLQRERCFLEPRARFYAAEIASALGYLH 156

Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
               L I++RDLK  NILLD+     ++DFG+ +   ++ +   TS   GT  Y+APE +
Sbjct: 157 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNST-TSTFCGTPEYLAPEVL 211

Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
            +  +    D +  G ++ E++ G 
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGL 236

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 86.9 bits (216), Expect = 7e-19
 Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 16/200 (8%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEF---KNEVLLVARLQHRNLVRLLG 387
           LG+G FG V   R        A+K L K  +  + E      E  ++   +H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71

Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLHEDSRL 445
           ++F+  +RL  + E+         +F  + R ++  E R +     I   + YLH     
Sbjct: 72  YAFQTHDRLCFVMEYANGGE----LFFHLSRERVFTEERARFYGAEIVSALEYLHS---R 124

Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
            +++RD+K  N++LD D   KI+DFG+ +   +           GT  Y+APE +    +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGAT-MKTFCGTPEYLAPEVLEDNDY 182

Query: 506 SIKSDVFSFGVLVLEIISGQ 525
               D +  GV++ E++ G+
Sbjct: 183 GRAVDWWGLGVVMYEMMCGR 202

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 87.5 bits (217), Expect = 8e-19
 Identities = 49/245 (20%), Positives = 94/245 (38%), Gaps = 53/245 (21%)

Query: 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHR 380
           +  +S    LG G FG V +      G+  A+K+     V  +  +KN E+ ++  L H 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK-----VLQDPRYKNRELDIMKVLDHV 60

Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDW------------------ 422
           N+++L+ + +   +        P+        +                           
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 423 -ETRYKIIGG-------------------IARGILYLHEDSRLRIIHRDLKASNILLDA- 461
            +T +K++                     + R + ++H    L I HRD+K  N+L+++ 
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177

Query: 462 DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLE 520
           D   K+ DFG A+     +     + I   F Y APE +     ++   D++S G +  E
Sbjct: 178 DNTLKLCDFGSAKKLIPSEP--SVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVFGE 234

Query: 521 IISGQ 525
           +I G+
Sbjct: 235 LILGK 239

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 86.4 bits (215), Expect = 8e-19
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 23/202 (11%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV--QGELE-FKNEVLLVARLQHRNLVRLLG 387
           LG G FG V+  R  H     A+K L K  V    ++E   +E L+++ + H  ++R+  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW- 72

Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLHEDSRL 445
            +F++ +++ +I +++        +F  +++ Q       K     +   + YLH     
Sbjct: 73  GTFQDAQQIFMIMDYIEGGE----LFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---K 125

Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GH 504
            II+RDLK  NILLD +   KI+DFG A+          T  + GT  Y+APE V+   +
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKPY 180

Query: 505 FSIKS-DVFSFGVLVLEIISGQ 525
              KS D +SFG+L+ E+++G 
Sbjct: 181 --NKSIDWWSFGILIYEMLAGY 200

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 88.9 bits (220), Expect = 9e-19
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 27/206 (13%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKNEV--------LLVARLQHRNL 382
           LG+G FG V         E+ AVK L K+ V       ++V        +L    +   L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ----DDDVECTMVEKRVLALPGKPPFL 404

Query: 383 VRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLH 440
            +L    F+  +RL  + E+V        +   I++V    E         IA G+ +L 
Sbjct: 405 TQLH-SCFQTMDRLYFVMEYVNGGD----LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459

Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD-TSRIVGTFGYMAPEY 499
                 II+RDLK  N++LD++   KI+DFGM +    +   G  T    GT  Y+APE 
Sbjct: 460 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---NIWDGVTTKTFCGTPDYIAPEI 513

Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +    +    D ++FGVL+ E+++GQ
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 27/206 (13%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKNEV--------LLVARLQHRNL 382
           LG+G FG V+        +  A+K L K+ V       ++V        +L    +H  L
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM----DDDVECTMVEKRVLSLAWEHPFL 80

Query: 383 VRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLH 440
             +   +F+  E L  + E++        +   I+       +R       I  G+ +LH
Sbjct: 81  THMF-CTFQTKENLFFVMEYLNGGD----LMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135

Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD-TSRIVGTFGYMAPEY 499
                 I++RDLK  NILLD D   KI+DFGM +    +      T+   GT  Y+APE 
Sbjct: 136 S---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE---NMLGDAKTNTFCGTPDYIAPEI 189

Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +    ++   D +SFGVL+ E++ GQ
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 25/205 (12%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKNEV--------LLVARLQHRNL 382
           LG+G FG V   R+    ++ AVK L K+ +       ++V        +L     H  L
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ----DDDVECTMTEKRILSLARNHPFL 86

Query: 383 VRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLH 440
            +L    F+  +RL  + EFV        +   I++ +   E R +     I   +++LH
Sbjct: 87  TQLF-CCFQTPDRLFFVMEFVNGGD----LMFHIQKSRRFDEARARFYAAEIISALMFLH 141

Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
           +     II+RDLK  N+LLD +   K++DFGM +    +     T+   GT  Y+APE +
Sbjct: 142 D---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDYIAPEIL 196

Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
               +    D ++ GVL+ E++ G 
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGH 221

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 86.1 bits (214), Expect = 2e-18
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 25/205 (12%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKNEV--------LLVARLQHRNL 382
           LG+G FG V         E+ AVK L K+ V       ++V        +L    +   L
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ----DDDVECTMVEKRVLALPGKPPFL 83

Query: 383 VRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLH 440
            +L    F+  +RL  + E+V        +   I++V    E         IA G+ +L 
Sbjct: 84  TQLH-SCFQTMDRLYFVMEYVNGGD----LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138

Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                 II+RDLK  N++LD++   KI+DFGM +   +      T    GT  Y+APE +
Sbjct: 139 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVT-TKTFCGTPDYIAPEII 193

Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
               +    D ++FGVL+ E+++GQ
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 3/92 (3%)

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
           +A+G+ +L   +  + IHRDL A NILL    + KI DFG+AR    D            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258

Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
             +MAPE +    ++I+SDV+SFGVL+ EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 85.0 bits (211), Expect = 4e-18
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 25/205 (12%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKNEV--------LLVARLQHRNL 382
           +G+G +  V   RL     I A+K + K  V        ++        +      H  L
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND----DEDIDWVQTEKHVFEQASNHPFL 72

Query: 383 VRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLH 440
           V L    F+   RL  + E+V        +   ++R +   E   +     I+  + YLH
Sbjct: 73  VGLH-SCFQTESRLFFVIEYVNGGD----LMFHMQRQRKLPEEHARFYSAEISLALNYLH 127

Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
           E     II+RDLK  N+LLD++   K++D+GM +          TS   GT  Y+APE +
Sbjct: 128 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEIL 182

Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
               +    D ++ GVL+ E+++G+
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGR 207

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 85.1 bits (211), Expect = 5e-18
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 25/205 (12%)

Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKNEV--------LLVARLQHRNL 382
           +G+G +  V   RL     I A++ + K  V        ++        +      H  L
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND----DEDIDWVQTEKHVFEQASNHPFL 115

Query: 383 VRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLH 440
           V L    F+   RL  + E+V        +   ++R +   E   +     I+  + YLH
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGD----LMFHMQRQRKLPEEHARFYSAEISLALNYLH 170

Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
           E     II+RDLK  N+LLD++   K++D+GM +          TS   GT  Y+APE +
Sbjct: 171 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEIL 225

Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
               +    D ++ GVL+ E+++G+
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGR 250

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 84.1 bits (209), Expect = 6e-18
 Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 20/204 (9%)

Query: 332 LGQGGFGAVY---KGRLSHGQEI-AVKRLSKNSV---QGELEF-KNEVLLVARLQHRNLV 383
           LG+GG+G V+   K   ++  +I A+K L K  +     +    K E  ++  ++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLHE 441
            L+ ++F+   +L LI E++        +F  ++R  +  E      +  I+  + +LH+
Sbjct: 85  DLI-YAFQTGGKLYLILEYLSGGE----LFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
                II+RDLK  NI+L+     K++DFG+ +   +      T    GT  YMAPE + 
Sbjct: 140 ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTV-THTFCGTIEYMAPEILM 194

Query: 502 RGHFSIKSDVFSFGVLVLEIISGQ 525
           R   +   D +S G L+ ++++G 
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGA 218

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 84.4 bits (209), Expect = 8e-18
 Identities = 60/247 (24%), Positives = 104/247 (42%), Gaps = 51/247 (20%)

Query: 301 RKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKN 359
           ++ +   +VE     F         +     +G G  G V     +   + +A+K+LS+ 
Sbjct: 6   KRDNNFYSVEIGDSTF----TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR- 60

Query: 360 SVQGELEFKN---------EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF 410
                  F+N         E++L+  + H+N++ LL              F P  S+++F
Sbjct: 61  ------PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEF 102

Query: 411 -----IFD-------AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 458
                + +        + +++LD E    ++  +  GI +LH      IIHRDLK SNI+
Sbjct: 103 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 159

Query: 459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLV 518
           + +D   KI DFG+AR              V T  Y APE +    +    D++S G ++
Sbjct: 160 VKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVILGMGYKENVDIWSVGCIM 216

Query: 519 LEIISGQ 525
            E+I G 
Sbjct: 217 GEMIKGG 223

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 83.9 bits (208), Expect = 8e-18
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 28/210 (13%)

Query: 332 LGQGGFGAVY---KGRLSHGQEI-AVKRLSKNSVQGELEF----KNE--VLLVARLQHRN 381
           LG G +G V+   K       ++ A+K L K ++  + +     + E  VL   R Q   
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPF 120

Query: 382 LVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYL 439
           LV L  ++F+   +L LI +++        +F  + + +   E   +I +G I   + +L
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGE----LFTHLSQRERFTEHEVQIYVGEIVLALEHL 175

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
           H+   L II+RD+K  NILLD++    ++DFG+++ F  D+++       GT  YMAP+ 
Sbjct: 176 HK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDI 231

Query: 500 VT---RGHFSIKS-DVFSFGVLVLEIISGQ 525
           V     GH   K+ D +S GVL+ E+++G 
Sbjct: 232 VRGGDSGH--DKAVDWWSLGVLMYELLTGA 259

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 82.9 bits (205), Expect = 9e-18
 Identities = 21/199 (10%), Positives = 55/199 (27%), Gaps = 41/199 (20%)

Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL---EFKNEVLLVARLQHRNLVRLL 386
             G       ++    +  +++A+  +    V  +    E  +  L ++R+    + R+L
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
                    L++ E++   S+ +                 + +  +A      H   R  
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
           +       S + +  D        G   L                   M          +
Sbjct: 150 VALSIDHPSRVRVSID--------GDVVL--------------AYPATMPDA-------N 180

Query: 507 IKSDVFSFGVLVLEIISGQ 525
            + D+   G  +  ++  +
Sbjct: 181 PQDDIRGIGASLYALLVNR 199

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 82.0 bits (203), Expect = 4e-17
 Identities = 53/228 (23%), Positives = 94/228 (41%), Gaps = 28/228 (12%)

Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE--FKN---- 369
            + +    + ++    +  G +GAV  G  S G  +A+KR+      G       +    
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 370 -----EVLLVARLQHRNLVRLLG-FSFEETERL----LIYEFVPNSSVDKFIFDAIKRVQ 419
                E+ L+    H N++ L   F   E   +    L+ E +  + + + I    +R+ 
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVI--HDQRIV 130

Query: 420 L-DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478
           +     +Y  +  I  G+  LHE     ++HRDL   NILL  +    I DF +AR    
Sbjct: 131 ISPQHIQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTA 186

Query: 479 DQSQGDTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
           D ++      V    Y APE V     F+   D++S G ++ E+ + +
Sbjct: 187 DANKTHY---VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 82.6 bits (204), Expect = 6e-17
 Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 47/225 (20%)

Query: 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN---------EVL 372
              +     +G G  G V     +   + +A+K+LS+        F+N         E++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAKRAYRELV 113

Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-----IFD-------AIKRVQL 420
           L+  + H+N++ LL              F P  ++++F     + +        + +++L
Sbjct: 114 LMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 161

Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
           D E    ++  +  GI +LH      IIHRDLK SNI++ +D   KI DFG+AR      
Sbjct: 162 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218

Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
                   V T  Y APE +    +    D++S G ++ E++  +
Sbjct: 219 MMTPY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 55/233 (23%), Positives = 105/233 (45%), Gaps = 50/233 (21%)

Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN----- 369
             T  +    + +   +G G +G+V        G+++A+K+LS+        F++     
Sbjct: 16  NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-------PFQSEIFAK 68

Query: 370 ----EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-----IFD------- 413
               E+LL+  +QH N++ LL              F P SS+  F     +         
Sbjct: 69  RAYRELLLLKHMQHENVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQ 116

Query: 414 AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473
            I  ++   E    ++  + +G+ Y+H      ++HRDLK  N+ ++ D   KI DFG+A
Sbjct: 117 KIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173

Query: 474 RLFEMDQSQGDTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
           R  + + +       V T  Y APE + +  H++   D++S G ++ E+++G+
Sbjct: 174 RHADAEMTG-----YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 53/229 (23%), Positives = 100/229 (43%), Gaps = 51/229 (22%)

Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN---------E 370
           +    +     +G G +GAV        G ++A+K+L +        F++         E
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-------PFQSELFAKRAYRE 74

Query: 371 VLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-----IFD--------AIKR 417
           + L+  ++H N++ LL              F P+ ++D F     +           +K 
Sbjct: 75  LRLLKHMRHENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKH 122

Query: 418 VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477
            +L  +    ++  + +G+ Y+H      IIHRDLK  N+ ++ D   KI DFG+AR  +
Sbjct: 123 EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD 179

Query: 478 MDQSQGDTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
            + +       V T  Y APE +     ++   D++S G ++ E+I+G+
Sbjct: 180 SEMTG-----YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 46/243 (18%), Positives = 96/243 (39%), Gaps = 48/243 (19%)

Query: 290 RRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHG 348
            +++ +Q++    +    ++     D+       + +   + +G G +G V +       
Sbjct: 23  SQQEGQQRKQHHSSKPTASMPRPHSDW----QIPDRYEIRHLIGTGSYGHVCEAYDKLEK 78

Query: 349 QEIAVKRLSKNSVQGELEFKN---------EVLLVARLQHRNLVRLL----GFSFEETER 395
           + +A+K++ +        F++         E+ ++ RL H ++V++L        E+ + 
Sbjct: 79  RVVAIKKILR-------VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131

Query: 396 L-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKA 454
           L ++ E    S   K        V L       ++  +  G+ Y+H  S   I+HRDLK 
Sbjct: 132 LYVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVH--SA-GILHRDLKP 184

Query: 455 SNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP--------------EYV 500
           +N L++ D   K+ DFG+AR  +  ++      I      M                 +V
Sbjct: 185 ANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHV 244

Query: 501 -TR 502
            TR
Sbjct: 245 VTR 247

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 45/226 (19%), Positives = 98/226 (43%), Gaps = 36/226 (15%)

Query: 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN---------EVL 372
            + +     LG GG G V+    +   + +A+K++            +         E+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60

Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDK-FIFD--------AIKRVQLDWE 423
           ++ RL H N+V++         +L               + +         +++  L  E
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120

Query: 424 -TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEMDQS 481
             R   +  + RG+ Y+H  +   ++HRDLK +N+ ++  D++ KI DFG+AR+ +   S
Sbjct: 121 HARL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 482 QGDT-SRIVGTFGYMAPE-YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
                S  + T  Y +P   ++  +++   D+++ G +  E+++G+
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 49/236 (20%), Positives = 102/236 (43%), Gaps = 51/236 (21%)

Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN----- 369
              + D    ++  + +G+G +G V     +     +A+K++S         F++     
Sbjct: 19  RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQ 70

Query: 370 ----EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-----IFD------- 413
               E+ ++ R +H N++ +              + +   ++++      + D       
Sbjct: 71  RTLREIKILLRFRHENIIGIN-------------DIIRAPTIEQMKDVYIVQDLMETDLY 117

Query: 414 AIKRVQL--DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471
            + + Q   +    Y  +  I RG+ Y+H  +   ++HRDLK SN+LL+     KI DFG
Sbjct: 118 KLLKTQHLSNDHICY-FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 173

Query: 472 MARLFEMDQSQGDT-SRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
           +AR+ + D       +  V T  Y APE +     ++   D++S G ++ E++S +
Sbjct: 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 45/203 (22%), Positives = 75/203 (36%), Gaps = 56/203 (27%)

Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGF 388
            LG G  G V +       ++ A+K L         + + EV L  R  Q  ++VR++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDV 79

Query: 389 SFEETER-----LLIYEFVPNSSVDKFIFDAIKRVQLDWETRY------KIIGGIARGIL 437
            +E         L++ E +        +F  I+      +  +      +I+  I   I 
Sbjct: 80  -YENLYAGRKCLLIVMECLDGGE----LFSRIQDRG---DQAFTEREASEIMKSIGEAIQ 131

Query: 438 YLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
           YLH    + I HRD+K  N+L      + I K++DFG                       
Sbjct: 132 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG----------------------- 165

Query: 495 MAPEYVTRGHFSIKSDVFSFGVL 517
            A E  T   +    D++S GV+
Sbjct: 166 FAKE-TTGEKYDKSCDMWSLGVI 187

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 46/222 (20%), Positives = 99/222 (44%), Gaps = 25/222 (11%)

Query: 309 VESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEF 367
            ES   ++       +++    KLG+G +  V++   +++ +++ VK L       + + 
Sbjct: 25  YESHVVEW----GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKI 77

Query: 368 KNEVLLVARLQ-HRNLVRLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWET 424
           K E+ ++  L+   N++ L     +   R   L++E V N+   +     +     D++ 
Sbjct: 78  KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-QTLT----DYDI 132

Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPKISDFGMARLFEMDQSQG 483
           R+  +  I + + Y H  S   I+HRD+K  N+++D      ++ D+G+A  +   Q   
Sbjct: 133 RF-YMYEILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 187

Query: 484 DTSRIVGTFGYMAPE-YVTRGHFSIKSDVFSFGVLVLEIISG 524
              R V +  +  PE  V    +    D++S G ++  +I  
Sbjct: 188 -NVR-VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.1 bits (185), Expect = 8e-15
 Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 51/227 (22%)

Query: 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN---------EVL 372
              +   + +G G +G+V     +  G  +AVK+LS+        F++         E+ 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80

Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-----IFD--------AIKRVQ 419
           L+  ++H N++ LL              F P  S+++F     +           +K  +
Sbjct: 81  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128

Query: 420 LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479
           L  +    +I  I RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    +
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185

Query: 480 QSQGDTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
            +       V T  Y APE +    H++   D++S G ++ E+++G+
Sbjct: 186 MTG-----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 55/244 (22%), Positives = 97/244 (39%), Gaps = 64/244 (26%)

Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN------- 369
            + + +++F   + LG+G +G V        G+ +A+K++          F         
Sbjct: 5   IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRT 56

Query: 370 --EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-----IFD--------A 414
             E+ ++   +H N++ +                    S + F     I +         
Sbjct: 57  LREIKILKHFKHENIITIF-------------NIQRPDSFENFNEVYIIQELMQTDLHRV 103

Query: 415 IKRVQL-DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473
           I    L D   +Y  I    R +  LH  +   +IHRDLK SN+L++++   K+ DFG+A
Sbjct: 104 ISTQMLSDDHIQY-FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159

Query: 474 RLFEMDQSQGDTSRIVGTFGYMAPEYV-TR-----------GHFSIKSDVFSFGVLVLEI 521
           R+   D+S  D S   G    M  E+V TR             +S   DV+S G ++ E+
Sbjct: 160 RII--DESAADNSEPTGQQSGM-VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

Query: 522 ISGQ 525
              +
Sbjct: 217 FLRR 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 72.5 bits (178), Expect = 8e-14
 Identities = 45/258 (17%), Positives = 97/258 (37%), Gaps = 76/258 (29%)

Query: 324 NNFSTDNK------LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN------- 369
            N    +       +G+G +G VY     +  + +A+K++++        F++       
Sbjct: 20  KNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRI 72

Query: 370 --EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-----IFD--------A 414
             E+ ++ RL+   ++RL              + +    + KF     + +         
Sbjct: 73  LREITILNRLKSDYIIRLY-------------DLIIPDDLLKFDELYIVLEIADSDLKKL 119

Query: 415 IKRVQL--DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472
            K      +   +  I+  +  G  ++HE     IIHRDLK +N LL+ D   K+ DFG+
Sbjct: 120 FKTPIFLTEEHIKT-ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGL 175

Query: 473 ARLFEMDQSQGDTSRIVGTFGYMAP---------EYV-TR-----------GHFSIKSDV 511
           AR    ++     + +                   +V TR            +++   D+
Sbjct: 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDI 235

Query: 512 FSFGVLVLEIISGQKNNS 529
           +S G +  E+++  +++ 
Sbjct: 236 WSTGCIFAELLNMLQSHI 253

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 65.9 bits (161), Expect = 9e-12
 Identities = 45/228 (19%), Positives = 88/228 (38%), Gaps = 54/228 (23%)

Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV---QGELEFK-------NEVLLVARLQH 379
           KLG G F  V+  + + +   +A+K +  + V     E E K        +      +  
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 380 RNLVRLLG-FSFEETER--------LL---IYEFVPNSSVDKFIFDAIKRVQLDWETRYK 427
            ++++LL  F+ +            +L   +   +            +K+          
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ---------- 135

Query: 428 IIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIP------KISDFGMARLFE 477
               I++ +L    Y+H   R  IIH D+K  N+L++    P      KI+D G A  ++
Sbjct: 136 ----ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189

Query: 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
              +    +R      Y +PE +    +   +D++S   L+ E+I+G 
Sbjct: 190 EHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 57/240 (23%), Positives = 102/240 (42%), Gaps = 70/240 (29%)

Query: 330 NKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN---------EVLLVARLQ- 378
            KLG+G +G V+K      G+ +AVK++          F+N         E++++  L  
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-------AFQNSTDAQRTFREIMILTELSG 67

Query: 379 HRNLVRLLGF----SFEETERLLIYEFVPNSSVDKFIFD-------AIKRVQL--DWETR 425
           H N+V LL      +  +     +Y           +FD       A+ R  +      +
Sbjct: 68  HENIVNLLNVLRADNDRD-----VY----------LVFDYMETDLHAVIRANILEPVHKQ 112

Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485
           Y ++  + + I YLH  S   ++HRD+K SNILL+A+   K++DFG++R F   +   + 
Sbjct: 113 Y-VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168

Query: 486 SRIVGTFGYMAP--------EYV-TR-----------GHFSIKSDVFSFGVLVLEIISGQ 525
             +                 +YV TR             ++   D++S G ++ EI+ G+
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 64.5 bits (156), Expect = 2e-11
 Identities = 37/260 (14%), Positives = 73/260 (28%), Gaps = 67/260 (25%)

Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRL---SKNSVQGE-----LEFKNEVLL 373
            T       K+G+G FG V++    H   +A+K +     + V G       E   E+++
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 374 ---------VARLQHRNLVRLLGF------------------------------SFEETE 394
                        +    + L                                  F++ +
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKA 454
             ++ EF           + ++       T   I+  +   +        LR  HRDL  
Sbjct: 137 LFIVLEFEFGGI----DLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190

Query: 455 SNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP--EYVTRGHFSIKSDVF 512
            N+LL    + K+      +              + + G      +Y           VF
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSST-----------IPSCGLQVSIIDYTLSRLERDGIVVF 239

Query: 513 SFGVLVLEIISGQKNNSFRI 532
               +  ++ +G  +  F I
Sbjct: 240 CDVSMDEDLFTGDGDYQFDI 259

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 52/217 (23%), Positives = 85/217 (39%), Gaps = 42/217 (19%)

Query: 330 NKLGQGGFGAVYKGR-LSHGQEIAVKRLSKN----SVQGELEFKNEVLLVARLQHR---- 380
           + +G+G FG V K       + +A+K + KN      Q     + EV L+  +       
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLNQA----QIEVRLLELMNKHDTEM 114

Query: 381 --NLVRLLG-FSFEE-----TERLLI--YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
              +V L   F F        E L    Y+ + N++      +  +          K   
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTR----------KFAQ 164

Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIP--KISDFGMARLFEMDQSQGDTSRI 488
            +   +L+L     L IIH DLK  NILL        KI DFG +        Q     I
Sbjct: 165 QMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYI 219

Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
              F Y +PE +    + +  D++S G +++E+ +G+
Sbjct: 220 QSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 36/211 (17%)

Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR------NLVR 384
           +G+G FG V K       Q +A+K + +N  +   +   E+ ++  L+ +      N++ 
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163

Query: 385 LLG-FSFEE-----TERLLI--YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           +L  F+F        E L +  YE +  +    F    ++          K    I + +
Sbjct: 164 MLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVR----------KFAHSILQCL 213

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIP--KISDFGMARLFEMDQSQGDTSRIVGTFGY 494
             LH   + RIIH DLK  NILL        K+ DFG +      + Q   + I   F Y
Sbjct: 214 DALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF-Y 265

Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            APE +    + +  D++S G ++ E+++G 
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 46/265 (17%), Positives = 89/265 (33%), Gaps = 88/265 (33%)

Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH-------RNL 382
           KLG G F  V+    +   + +A+K +       E    +E+ L+  +++       R +
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102

Query: 383 VRLLGFSFE-------------ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
           V  L   F+             E     + +++  S+        +K+          II
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK----------II 152

Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDAD--------------------------- 462
             + +G+ YLH  ++ RIIH D+K  NILL  +                           
Sbjct: 153 QQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210

Query: 463 ----------------------MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                                 +  KI+D G A       ++      + T  Y + E +
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLEVL 265

Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
               ++  +D++S   +  E+ +G 
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGD 290

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 35/229 (15%), Positives = 83/229 (36%), Gaps = 34/229 (14%)

Query: 295 KQKQNLRKADEINTVESLQFDFSTIRDAT-NNFSTDNKLGQGGFGAVYKGR--------- 344
              +NL       ++E+L    + + D +   +   +   +   G +Y+           
Sbjct: 13  LGTENLYFQSMTTSLEALPTG-TVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDS 71

Query: 345 LSHGQEIAVKRLSKNS-VQGELEF------KNEVLLVARLQHRNLV---RLLGFSFEETE 394
               Q+ ++K  +K+  +  E  F        +V    +L    L+     +GF   + +
Sbjct: 72  GPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDK 131

Query: 395 -RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLK 453
            R L+   +  S       D   +  L   +  ++   +   + +LHE+     +H ++ 
Sbjct: 132 YRFLVLPSLGRSLQS--ALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVT 186

Query: 454 ASNILLDADMIPKI--SDFGMARLF-----EMDQSQGDTSRIVGTFGYM 495
           A NI +D +   ++  + +G A  +      +   +G  S   G   ++
Sbjct: 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 37/158 (23%), Positives = 66/158 (41%), Gaps = 13/158 (8%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH-RN 381
           N +    K+G G FG +Y G  ++ G+E+A+K     +   +L    E  +   +Q    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVG 66

Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           +  +     E    +++ E +  S  D F F      +   +T   +   +   I Y+H 
Sbjct: 67  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS 123

Query: 442 DSRLRIIHRDLKASNILLDADMIPK---ISDFGMARLF 476
            +    IHRD+K  N L+          I DFG+A+ +
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 43/183 (23%), Positives = 77/183 (42%), Gaps = 20/183 (10%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
           N F    K+G G FG +Y G  +   +E+A+K  +  +   +L +  E  +   LQ    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTG 64

Query: 383 V-RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           +  +  F  E    +L+ + +  S  D  +F+   R +L  +T   +   +   + ++H 
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLLGPSLED--LFNFCSR-KLSLKTVLMLADQMINRVEFVHS 121

Query: 442 DSRLRIIHRDLKASNILLDADMIPK---ISDFGMARLFEMDQSQG------DTSRIVGTF 492
            S    +HRD+K  N L+          I DFG+A+ +  D S        +   + GT 
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTSTHQHIPYRENKNLTGTA 177

Query: 493 GYM 495
            Y 
Sbjct: 178 RYA 180

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 36/184 (19%), Positives = 74/184 (40%), Gaps = 20/184 (10%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
            ++    ++G+G FG +++G  L + Q++A+K   + S   +L  +     +       +
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL-LAGCTGI 68

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
             +  F  E    +L+ + +  S  D  + D   R +   +T       +   +  +HE 
Sbjct: 69  PNVYYFGQEGLHNVLVIDLLGPSLED--LLDLCGR-KFSVKTVAMAAKQMLARVQSIHEK 125

Query: 443 SRLRIIHRDLKASNILLDADMIPK-----ISDFGMARLFEMDQSQG------DTSRIVGT 491
           S   +++RD+K  N L+            + DFGM + +  D          +   + GT
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY-RDPVTKQHIPYREKKNLSGT 181

Query: 492 FGYM 495
             YM
Sbjct: 182 ARYM 185

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 34/159 (21%), Positives = 61/159 (38%), Gaps = 13/159 (8%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
            NF    K+G G FG +  G+ L   + +A+K     S   +L  +             +
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGI 67

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
            ++  F        ++ E +  S  D  +FD   R     +T   I   +   + Y+H  
Sbjct: 68  PQVYYFGPCGKYNAMVLELLGPSLED--LFDLCDR-TFSLKTVLMIAIQLISRMEYVHSK 124

Query: 443 SRLRIIHRDLKASNILLDADMIPK-----ISDFGMARLF 476
           +   +I+RD+K  N L+            I DF +A+ +
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 48.2 bits (115), Expect = 4e-06
 Identities = 33/179 (18%), Positives = 63/179 (35%), Gaps = 35/179 (19%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR------LSHGQEIAVKRLSKNSVQGELEFK-----NEVL 372
             +     +GQGGFG +Y         +       VK    ++     E K      +  
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG- 431
            + +      ++ LG              + + +   + F  + R   D +  Y+     
Sbjct: 95  QIQKWIRTRKLKYLGVPK------YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR 148

Query: 432 --------IARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKI--SDFGMARLF 476
                   ++  IL    Y+HE      +H D+KASN+LL+     ++   D+G+A  +
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 52/237 (21%), Positives = 89/237 (37%), Gaps = 68/237 (28%)

Query: 331 KLGQGGFGAVYKG--RLSHGQEIAVKRLSKN----SVQGELEFKNEVLLVARLQHR---- 380
            LG+G FG V +     + G+ +AVK + KN            ++E+ ++  L       
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCEAA----RSEIQVLEHLNTTDPNS 75

Query: 381 --NLVRLLG-FSFEE-----TERLLI--YEFVPNSSVDKFIFDAIKRV--QLDWETRYKI 428
               V++L  F          E L +  Y+F+  +    F  D I+++  Q+        
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQI-------- 127

Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILL-DADMIP------------------KISD 469
                + + +LH     ++ H DLK  NIL   +D                     K+ D
Sbjct: 128 ----CKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180

Query: 470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQ 525
           FG A        +  ++ +     Y APE V     +S   DV+S G +++E   G 
Sbjct: 181 FGSA----TYDDEHHSTLVSTRH-YRAPE-VILALGWSQPCDVWSIGCILIEYYLGF 231

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 45/238 (18%), Positives = 82/238 (34%), Gaps = 70/238 (29%)

Query: 331 KLGQGGFGAVYKG--RLSHGQEIAVKRLSKN----SVQGELEFKNEVLLVARLQHR---- 380
            LG+G FG V +         ++A+K + +N         LE    VL   +++ +    
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII-RNVGKYREAARLEIN--VL--KKIKEKDKEN 80

Query: 381 --NLVRLLG-FSFEE-----TERLLI--YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
               V +   F+F        E L    +EF+  ++   +    ++              
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRH------------- 127

Query: 431 GIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIP-------------------KI 467
            +A  +     +LHE    ++ H DLK  NIL                          ++
Sbjct: 128 -MAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183

Query: 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +DFG A        +  T+ +     Y  PE +    ++   DV+S G ++ E   G 
Sbjct: 184 ADFGSA----TFDHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 50/233 (21%), Positives = 95/233 (40%), Gaps = 56/233 (24%)

Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKN----SVQGELEFKNEVLLVARLQHR----- 380
           K+G G FG V   + + + +  AVK + +N    +   ++E    +L   ++Q+      
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSAKIEAD--IL--KKIQNDDINNN 96

Query: 381 NLVRLLG-FSFEE-----TERLLI--YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI 432
           N+V+  G F + +      E L    YE +  ++ + F  + IK               I
Sbjct: 97  NIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIK----------LYCIEI 146

Query: 433 ARGILYLHEDSRLRIIHRDLKASNILL--DADMIPKISDFGMARLFEMDQSQGDTSRI-V 489
            + + YL +   + + H DLK  NILL         I+   +    ++   +  ++ I +
Sbjct: 147 LKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203

Query: 490 GTFG-----------------YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
             FG                 Y APE +    + + SD++SFG ++ E+ +G 
Sbjct: 204 IDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 31/180 (17%), Positives = 66/180 (36%), Gaps = 40/180 (22%)

Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRN 381
           N +    K+G GGFG +Y     +  ++ A   +  +    G L   +E+    R+  ++
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF--SELKFYQRVAKKD 94

Query: 382 LV---------------RLLGFSFEETE----RLLIYEFVPNSSVDKFIFDAIKRVQLDW 422
            +                  G    E +    R ++ E +        I       +   
Sbjct: 95  CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQK--ISGQNGTFKK-- 150

Query: 423 ETRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKI--SDFGMARLF 476
                 +  +   +L    Y+HE+     +H D+KA+N+LL      ++  +D+G++  +
Sbjct: 151 ----STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 35/200 (17%), Positives = 72/200 (36%), Gaps = 29/200 (14%)

Query: 291 RRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTD-------NKLGQGGFGAVYKG 343
           +     +    +  +        F   ++  + +              +G+G   AV+  
Sbjct: 52  KYLSDLRVVQNRQKDYEGST-FTFIGLSLY-SLHRLVRSGKVDAIGKLMGEGKESAVFNC 109

Query: 344 RLSHGQEIAVK--RLSKNS--------VQGELEFKNEVLLVARLQHRNLVRLLGFSFEET 393
                 E  VK  ++   S          G+L F    +  AR + R L +L G +  + 
Sbjct: 110 YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK- 168

Query: 394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLK 453
               +Y +  N+ + + I DA +  ++  E   +++  I   +   +      I+H DL 
Sbjct: 169 ----VYAWEGNAVLMELI-DAKELYRVRVENPDEVLDMILEEVAKFYHR---GIVHGDLS 220

Query: 454 ASNILLDADMIPKISDFGMA 473
             N+L+  + I  I DF  +
Sbjct: 221 QYNVLVSEEGI-WIIDFPQS 239

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.1 bits (98), Expect = 4e-04
 Identities = 62/497 (12%), Positives = 121/497 (24%), Gaps = 183/497 (36%)

Query: 82  VLDMMKNCPNQKEAISWEGMDF----PCVVRYSSRSFFGKLELKPTEIAHNVNNITSSLT 137
           V DM K+       +S E +D        V   +   F  L  K  E+   V      + 
Sbjct: 38  VQDMPKS------ILSKEEIDHIIMSKDAVS-GTLRLFWTLLSKQEEM---VQKFVEEVL 87

Query: 138 QFDRIWRSLMDRVLAKASLGTS--KLKFATDEANLTSSETIYALMQCTPDISQSDCEFCL 195
           + +  +  LM   +       S     +      L +   ++A       +S+      L
Sbjct: 88  RINYKF--LMSP-IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYN----VSRLQPYLKL 140

Query: 196 RQSMADVQS----CCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLSPPSTTTDTT 251
           RQ++ +++        G  GS   G + +             D      +          
Sbjct: 141 RQALLELRPAKNVLIDGVLGS---GKTWV-----------ALDVCLSYKV---------Q 177

Query: 252 IAKDKG------GNSISSGTVVIIVVSTSTFIIALVALITCVF---------LRRRKKKQ 296
              D         N  S  TV+ ++         L+  I   +         ++ R    
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEMLQK-------LLYQIDPNWTSRSDHSSNIKLRIHSI 230

Query: 297 KQNLRKA-------------DEINTVESLQ-FDFS-----TIRDATN------------- 324
           +  LR+                +   ++   F+ S     T R                 
Sbjct: 231 QAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290

Query: 325 ------NFSTDNKLGQ------------------------GGFGAVYKG----------- 343
                   + D                                    +            
Sbjct: 291 LDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHV 350

Query: 344 ---RLSHGQEIAVKRLSKNSVQGELE----FKNEVLLVARLQHRNLVRLLGFSFEETERL 396
              +L+   E ++  L     +   +    F     +   L    L  +     +    +
Sbjct: 351 NCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL----LSLIWFDVIKSDVMV 406

Query: 397 LIYEFVPNSSVDKFIFDAIKRVQLDW-ETRYKIIGGIARGILYLH---EDSRLRIIHRDL 452
           ++ +    S V+K              E+   I        +YL    +      +HR  
Sbjct: 407 VVNKLHKYSLVEK-----------QPKESTISIPS------IYLELKVKLENEYALHR-- 447

Query: 453 KASNILLDADMIPKISD 469
                ++D   IPK  D
Sbjct: 448 ----SIVDHYNIPKTFD 460

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	551
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.97
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.94
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.87
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.87
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.65
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.19
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.02
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.99
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.66
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.59
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.48
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.36
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.28
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.27
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.03
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.0
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.99
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.85
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.71
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.35
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.34
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.24
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.22
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.19
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.02
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.83
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.81
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.77
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.07
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.11
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	92.12
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.74
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.98
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	86.09
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	83.48

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.5e-49  Score=391.81  Aligned_cols=204  Identities=28%  Similarity=0.477  Sum_probs=179.5

Q ss_pred             cCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      ++|.+.++||+|+||+||+|++.      ++..||||+++....+..++|.+|++++++++|||||+++|++.+++..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56788899999999999999853      467899999988777777789999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhc----------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEE
Q 008854          398 IYEFVPNSSVDKFIFDAI----------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI  467 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl  467 (551)
                      ||||+++|+|.++|+...          ....++|.++++|+.||++||.|||+++   ||||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999997531          2357999999999999999999999987   999999999999999999999


Q ss_pred             eecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       468 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      +|||+++...............||+.|||||.+.++.++.++|||||||++|||+| |+.||..
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~  233 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ  233 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            99999987654433333445679999999999999999999999999999999999 8999963

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.8e-48  Score=391.89  Aligned_cols=203  Identities=28%  Similarity=0.477  Sum_probs=171.6

Q ss_pred             cCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      ++|.+.++||+|+||+||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+....+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45677889999999999999864      467899999988777777789999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhc------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCe
Q 008854          398 IYEFVPNSSVDKFIFDAI------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP  465 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~  465 (551)
                      ||||+++|+|.++|+...            ...+++|.++++|+.||++||.|||+.+   ||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            999999999999997532            2346999999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       466 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ||+|||+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||.
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~  262 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY  262 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCC
Confidence            9999999987654443334455689999999999999999999999999999999999 899986

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.8e-48  Score=388.27  Aligned_cols=202  Identities=31%  Similarity=0.493  Sum_probs=176.5

Q ss_pred             CCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      ++++.++||+|+||+||+|++.      +++.||||+++... ....++|.+|+.++++++|||||+++|++.+....+|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3556789999999999999863      46789999997643 3345689999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhc-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC
Q 008854          398 IYEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI  464 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~  464 (551)
                      ||||+++|+|.++|....             ....++|.++++|+.||++||.|||+.+   ||||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence            999999999999996431             1346999999999999999999999987   999999999999999999


Q ss_pred             eEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       465 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      +||+|||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.||.
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~  249 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC  249 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCC
Confidence            99999999987654444444556789999999999999999999999999999999999 899985

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.1e-48  Score=382.13  Aligned_cols=199  Identities=29%  Similarity=0.523  Sum_probs=168.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .+++.+.++||+|+||+||+|++.  ..||||+++..  ..+..+.|.+|+.++++++|||||+++|++.+ +..+||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            356778899999999999999974  46999999754  33445679999999999999999999998864 56899999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++|+|.++|+.  ....++|.++++|+.||++||.|||+++   ||||||||+||||++++++||+|||+|+......
T Consensus       112 y~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            9999999999974  3467999999999999999999999987   9999999999999999999999999998765433


Q ss_pred             CcccccccccCCCccccccccc---CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTR---GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .........||+.|||||++.+   +.|+.++|||||||++|||+||+.||.
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~  238 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS  238 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC
Confidence            3334556789999999999864   468999999999999999999999996

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=8.6e-48  Score=381.15  Aligned_cols=201  Identities=28%  Similarity=0.412  Sum_probs=182.0

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|+||+||+++. .+++.||||++.+..   ......+.+|++++++++|||||++++++.+++..+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4688999999999999999984 578999999997642   234557899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++|+|.+++.+   ...+++.++..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+...
T Consensus       112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999963   467999999999999999999999998   999999999999999999999999999987655


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .........+||+.|||||++.+..++.++||||+||++|||++|+.||..
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~  236 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA  236 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            444556678999999999999999999999999999999999999999963

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.4e-47  Score=383.09  Aligned_cols=201  Identities=22%  Similarity=0.369  Sum_probs=173.0

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ++|++.++||+|+||+||+++. .+|+.||||++.+..  ......+.+|+.++++++|||||++++++.+.+..+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5899999999999999999984 568999999997653  3345578999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++|+|.++|... +...+++.+++.++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+++.+....
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            99999999999642 3456899999999999999999999988   9999999999999999999999999998654221


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        ......+||+.|||||++.+..|+.++|||||||++|||++|+.||..
T Consensus       180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~  227 (350)
T 4b9d_A          180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA  227 (350)
T ss_dssp             --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence              123456899999999999999999999999999999999999999963

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.7e-47  Score=383.21  Aligned_cols=198  Identities=26%  Similarity=0.433  Sum_probs=179.0

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .+.|+..++||+|+||+||+|+. .+|+.||||++..........+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            35688899999999999999985 46899999999766545555789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++|+|.+++..    ..+++.++..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+++.+.... 
T Consensus       153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  224 (346)
T 4fih_A          153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  224 (346)
T ss_dssp             CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred             CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence            999999998853    46999999999999999999999998   9999999999999999999999999998765332 


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.
T Consensus       225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~  271 (346)
T 4fih_A          225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF  271 (346)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence             23455789999999999999999999999999999999999999995

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.8e-46  Score=384.96  Aligned_cols=198  Identities=26%  Similarity=0.433  Sum_probs=179.9

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .+.|+..++||+|+||+||+|+. .+|+.||||++..........+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            46799999999999999999985 46899999999876555556789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++|+|.+++.    ...+++.++..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+++.+.... 
T Consensus       230 ~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-  301 (423)
T 4fie_A          230 LEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  301 (423)
T ss_dssp             CTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred             CCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence            99999999885    346999999999999999999999998   9999999999999999999999999998765332 


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.
T Consensus       302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~  348 (423)
T 4fie_A          302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF  348 (423)
T ss_dssp             -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence             23456789999999999999999999999999999999999999995

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.6e-46  Score=376.44  Aligned_cols=197  Identities=26%  Similarity=0.336  Sum_probs=171.7

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .+.|++.++||+|+||+||+++. .+|+.||||+++....     ..+|+.++++++|||||++++++.+++..+|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            35678889999999999999985 4689999999976532     24799999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC-CeEEeecCCccccccCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQ  480 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~  480 (551)
                      +++|+|.++|.+   ...+++.++..++.||+.||.|||+++   ||||||||+||||+.++ .+||+|||+++.+..+.
T Consensus       132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            999999999974   457999999999999999999999987   99999999999999987 69999999998765432


Q ss_pred             Cc---ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQ---GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..   ......+||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~  258 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ  258 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence            21   123346899999999999999999999999999999999999999964

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.6e-46  Score=365.76  Aligned_cols=194  Identities=28%  Similarity=0.427  Sum_probs=168.0

Q ss_pred             CcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEec----CCceEEEE
Q 008854          327 STDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFE----ETERLLIY  399 (551)
Q Consensus       327 ~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~  399 (551)
                      ...++||+|+||+||+|.. .++..||+|++...  .......|.+|+.++++++|||||++++++..    +...+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            5667899999999999985 46889999999754  33345579999999999999999999999865    34578999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC-CCCCeEEeecCCcccccc
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPKISDFGMARLFEM  478 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~Dfgla~~~~~  478 (551)
                      ||+++|+|.++|.+   ...+++..+..++.||+.||.|||+++ ++||||||||+||||+ +++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999974   467999999999999999999999875 4699999999999997 479999999999986432


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                          ......+||+.|||||++.+ +++.++|||||||++|||+||+.||.
T Consensus       185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~  230 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS  230 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence                23345689999999998864 69999999999999999999999995

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.9e-46  Score=377.94  Aligned_cols=216  Identities=29%  Similarity=0.405  Sum_probs=184.4

Q ss_pred             cccChhHHHhhhcCCCcCcccCcCCceeEEEeecCC------CCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCC-CCcc
Q 008854          312 LQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQH-RNLV  383 (551)
Q Consensus       312 ~~~~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv  383 (551)
                      +.++.++.+...++|++.++||+|+||+||+|++..      ++.||||+++.... ...+.|.+|+.+|.+++| ||||
T Consensus        52 lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV  131 (353)
T 4ase_A           52 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV  131 (353)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEE
Confidence            334445555667889999999999999999997532      35799999977543 345579999999999975 8999


Q ss_pred             ceeeEEecC-CceEEEEEccCCCChhHHhhhhcc-------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 008854          384 RLLGFSFEE-TERLLIYEFVPNSSVDKFIFDAIK-------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIH  449 (551)
Q Consensus       384 ~l~~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH  449 (551)
                      +++|+|.+. ...+|||||+++|+|.++|+....             ...++|.+++.++.||++||.|||+++   |||
T Consensus       132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiH  208 (353)
T 4ase_A          132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH  208 (353)
T ss_dssp             CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eec
Confidence            999999764 568999999999999999975322             345899999999999999999999987   999


Q ss_pred             ccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCC
Q 008854          450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNN  528 (551)
Q Consensus       450 ~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~  528 (551)
                      |||||+||||++++.+||+|||+++.+..+..........||+.|||||++.++.++.++|||||||++|||+| |+.||
T Consensus       209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf  288 (353)
T 4ase_A          209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  288 (353)
T ss_dssp             SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence            99999999999999999999999987655544444556789999999999999999999999999999999998 99999


Q ss_pred             CC
Q 008854          529 SF  530 (551)
Q Consensus       529 ~~  530 (551)
                      ..
T Consensus       289 ~~  290 (353)
T 4ase_A          289 PG  290 (353)
T ss_dssp             TT
T ss_pred             CC
Confidence            63

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.3e-45  Score=358.77  Aligned_cols=197  Identities=24%  Similarity=0.436  Sum_probs=162.0

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|+||+||+++. .+|+.||||++.+...   .....+.+|+.++++++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999984 5689999999976532   23457899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+ +|+|.+++.+   ...+++.++..++.||+.||+|||+++   |+||||||+||||++++++||+|||+++.....
T Consensus        93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 6789888863   567999999999999999999999988   999999999999999999999999999865432


Q ss_pred             CCcccccccccCCCcccccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                         ......+||+.|||||++.+..+ +.++||||+||++|||++|+.||..
T Consensus       166 ---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~  214 (275)
T 3hyh_A          166 ---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD  214 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence               22345689999999999998876 5799999999999999999999963

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.1e-46  Score=371.13  Aligned_cols=199  Identities=30%  Similarity=0.373  Sum_probs=169.7

Q ss_pred             cCCCcCcccCcCCceeEEEeec----CCCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~----~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      ++|++.+.||+|+||+||+++.    ..++.||||++++...  .....+.+|++++++++|||||++++++.+++..+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5799999999999999999974    2467899999976422  233468899999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+++|+|.+++.+   ...+++.++..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999973   467999999999999999999999988   9999999999999999999999999998643


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...  ......+||+.|||||.+.+..++.++||||+||++|||++|+.||..
T Consensus       178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~  228 (304)
T 3ubd_A          178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG  228 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC
Confidence            322  234457899999999999999999999999999999999999999963

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.9e-45  Score=366.95  Aligned_cols=199  Identities=25%  Similarity=0.397  Sum_probs=163.9

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCC----ceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET----ERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~  399 (551)
                      ++|.+.++||+|+||+||+|++ +|+.||||+++..... ...++.|+..+.+++|||||+++|++.+.+    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4577889999999999999998 5899999999754322 223456777778899999999999998654    578999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-----SRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      ||+++|+|.++|+.    .+++|..+++++.|+++||+|||++     ..++||||||||+||||+.++++||+|||+++
T Consensus        81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999963    4689999999999999999999986     23469999999999999999999999999998


Q ss_pred             ccccCCCc--ccccccccCCCcccccccccC------CCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          475 LFEMDQSQ--GDTSRIVGTFGYMAPEYVTRG------HFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       475 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                      ........  ......+||+.|||||++.+.      .++.++|||||||++|||+||+.|+
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~  218 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  218 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence            76543322  123346899999999998754      4678999999999999999998765

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.8e-44  Score=358.39  Aligned_cols=200  Identities=27%  Similarity=0.461  Sum_probs=161.7

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCC--------
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEET--------  393 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  393 (551)
                      ++|++.+.||+|+||+||+++. .+|+.||||+++.... ...+.+.+|+.++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            3588899999999999999984 4789999999976543 34457899999999999999999999987543        


Q ss_pred             ----ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEee
Q 008854          394 ----ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD  469 (551)
Q Consensus       394 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~D  469 (551)
                          ..++||||+++|+|.+++.........++..++.++.||++||+|||+++   ||||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                26899999999999999976444445677888999999999999999988   99999999999999999999999


Q ss_pred             cCCccccccCCCc----------ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          470 FGMARLFEMDQSQ----------GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       470 fgla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ||+++.+......          ......+||+.|||||.+.+..++.++|||||||++|||++   ||.
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~  228 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS  228 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence            9999876543221          12234579999999999999999999999999999999996   653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-42  Score=353.44  Aligned_cols=201  Identities=24%  Similarity=0.386  Sum_probs=171.8

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEec------CC
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFE------ET  393 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  393 (551)
                      .++|++.++||+|+||+||+|+. .+|+.||||++++..  ....+.+.+|+.+|++++|||||++++++..      ..
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            36799999999999999999984 578999999997643  2334568899999999999999999998764      35


Q ss_pred             ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCc
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA  473 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla  473 (551)
                      ..+|||||++ |+|.+++.   +...+++.++..++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||++
T Consensus       133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            6799999996 67888886   4567999999999999999999999988   999999999999999999999999999


Q ss_pred             cccccCC--CcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          474 RLFEMDQ--SQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       474 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +.+....  ........+||+.|||||++.+. .++.++||||+||++|||++|+.||..
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g  265 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG  265 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence            8764322  12234567899999999998775 569999999999999999999999963

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.3e-41  Score=365.64  Aligned_cols=198  Identities=28%  Similarity=0.389  Sum_probs=172.4

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHH---HHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFK---NEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      ++|++.+.||+|+||+||+++. .+|+.||||++.+...   .....+.   +++.+++.++|||||++++++.+.+..+
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            5789999999999999999984 4689999999975421   2222333   4467778889999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      |||||+++|+|.++|..   ...+++..+..++.||+.||.|||+++   ||||||||+||||+.+|++||+|||+|+.+
T Consensus       269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999974   467999999999999999999999988   999999999999999999999999999875


Q ss_pred             ccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ...    .....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||...
T Consensus       343 ~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~  394 (689)
T 3v5w_A          343 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  394 (689)
T ss_dssp             SSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred             CCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            432    2345689999999999975 57999999999999999999999999643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.6e-41  Score=346.17  Aligned_cols=202  Identities=22%  Similarity=0.341  Sum_probs=171.3

Q ss_pred             HHHhhhcCCCcCcccCcCCceeEEEeec----CCCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeEEecC
Q 008854          318 TIRDATNNFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEE  392 (551)
Q Consensus       318 ~i~~~~~~f~~~~~LG~G~~g~Vyk~~~----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  392 (551)
                      .+....++|++.++||+|+||+||+|+.    ..++.||||++.+..  ....+.+|+++|..+ +||||+++++++.+.
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            3344568899999999999999999974    246789999987653  345688999999998 699999999999999


Q ss_pred             CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC-CCeEEeecC
Q 008854          393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFG  471 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~Dfg  471 (551)
                      +..++||||+++++|.+++.      .+++.++..++.||+.||.|||+.+   |+||||||+|||++.+ +.+||+|||
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            99999999999999999873      4899999999999999999999998   9999999999999877 799999999


Q ss_pred             CccccccCCC--------------------------cccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhC
Q 008854          472 MARLFEMDQS--------------------------QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISG  524 (551)
Q Consensus       472 la~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG  524 (551)
                      +|+.......                          .......+||+.|||||++.+. .++.++||||+||++|||++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            9986532211                          0112345799999999999875 589999999999999999999


Q ss_pred             CCCCCC
Q 008854          525 QKNNSF  530 (551)
Q Consensus       525 ~~p~~~  530 (551)
                      +.||..
T Consensus       244 ~~Pf~~  249 (361)
T 4f9c_A          244 RYPFYK  249 (361)
T ss_dssp             CSSSSC
T ss_pred             CCCCCC
Confidence            999953

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.9e-41  Score=361.26  Aligned_cols=198  Identities=24%  Similarity=0.404  Sum_probs=179.3

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      ++|++.+.||+|+||+||+++. .+|+.||+|++..........+.+|+.+|++++|||||++++++.+....+|||||+
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            5799999999999999999985 468999999998876666678899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC--CCeEEeecCCccccccCC
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD--MIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~--~~~kl~Dfgla~~~~~~~  480 (551)
                      ++|+|.++|.+  +...+++.++..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+++.+....
T Consensus       237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            99999998864  3457999999999999999999999998   9999999999999854  899999999998765332


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                         .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.
T Consensus       312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~  357 (573)
T 3uto_A          312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG  357 (573)
T ss_dssp             ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence               2345689999999999999999999999999999999999999995

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=9.8e-40  Score=329.23  Aligned_cols=226  Identities=37%  Similarity=0.669  Sum_probs=194.2

Q ss_pred             cChhHHHhhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCC
Q 008854          314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET  393 (551)
Q Consensus       314 ~~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  393 (551)
                      +.+.++...+++|+..+.||+|+||.||+|+..+++.||||++..........+.+|+.++++++||||+++++++...+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            44556667889999999999999999999998889999999998776666678999999999999999999999999999


Q ss_pred             ceEEEEEccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCC
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM  472 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl  472 (551)
                      ..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence            9999999999999999986432 2246899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCCcCcccHHHH
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY  542 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~~~~~~~l~~~  542 (551)
                      ++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||....+.+..++..|
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~  255 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW  255 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence            9865433222233445689999999999999999999999999999999999999976555444444444

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.8e-40  Score=347.25  Aligned_cols=211  Identities=22%  Similarity=0.306  Sum_probs=182.1

Q ss_pred             cChhHHHhhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh---cHHHHHHHHHHHhcCCCCCccceeeEE
Q 008854          314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFS  389 (551)
Q Consensus       314 ~~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~  389 (551)
                      +.+.+++...++|++.++||+|+||+||+++.. +++.||+|++++....   ....+.+|..++..++||||+++++++
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            445666677889999999999999999999965 4788999999763221   122388999999999999999999999


Q ss_pred             ecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEee
Q 008854          390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD  469 (551)
Q Consensus       390 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~D  469 (551)
                      .+....++||||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcc
Confidence            999999999999999999999974  2467999999999999999999999987   99999999999999999999999


Q ss_pred             cCCccccccCCCcccccccccCCCcccccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       470 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ||+++....... ......+||+.|+|||++.     ...++.++|||||||++|||++|+.||..
T Consensus       219 FGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~  283 (437)
T 4aw2_A          219 FGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA  283 (437)
T ss_dssp             CTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             hhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence            999976543322 2233468999999999987     56789999999999999999999999963

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-38  Score=322.00  Aligned_cols=217  Identities=45%  Similarity=0.792  Sum_probs=189.1

Q ss_pred             cccChhHHHhhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEe
Q 008854          312 LQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSF  390 (551)
Q Consensus       312 ~~~~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~  390 (551)
                      ..+++.++....++|+..+.||+|+||.||+++..+++.||||++..... .....+.+|+.++.+++||||+++++++.
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   97 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM   97 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence            45788999999999999999999999999999988899999999976532 22336899999999999999999999999


Q ss_pred             cCCceEEEEEccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEee
Q 008854          391 EETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD  469 (551)
Q Consensus       391 ~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~D  469 (551)
                      .....++||||+++++|.+++.... ....+++..+..++.|++.||.|||+...++|+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D  177 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD  177 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence            9999999999999999999997643 234599999999999999999999998333499999999999999999999999


Q ss_pred             cCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       470 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||+
T Consensus       178 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          178 FGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             CSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             CccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence            999987643322 22334568999999999999999999999999999999999999995

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.6e-38  Score=314.28  Aligned_cols=200  Identities=28%  Similarity=0.468  Sum_probs=179.8

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ..++|++.++||+|+||+||++.. .+++.||||++..........+.+|+.++++++||||+++++++...+..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            457899999999999999999984 5789999999977655566778999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            9999999999863    36899999999999999999999987   9999999999999999999999999998654332


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  218 (297)
T 3fxz_A          171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN  218 (297)
T ss_dssp             --CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             --cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence              223456799999999999999999999999999999999999999953

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.9e-38  Score=314.06  Aligned_cols=203  Identities=29%  Similarity=0.502  Sum_probs=178.7

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .++|.+.++||+|+||+||++.. .+++.||+|++..........+.+|+.++.+++||||+++++++.++...++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            35788899999999999999985 46899999999777666777899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++..  ....+++.+++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        89 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            999999999975  3567999999999999999999999988   99999999999999999999999999986543222


Q ss_pred             cc------------cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QG------------DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..            ......||+.|+|||.+.+..++.++||||||+++|||++|..|+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~  224 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD  224 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence            11            11245799999999999999999999999999999999999998864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.9e-38  Score=318.59  Aligned_cols=199  Identities=24%  Similarity=0.295  Sum_probs=176.6

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|+||+||+++.. +|+.||+|++++..   ......+.+|+.++..++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57889999999999999999854 68999999997642   234557889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        85 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            99999999998863   457899999999999999999999987   999999999999999999999999999753322


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       159 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  207 (337)
T 1o6l_A          159 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  207 (337)
T ss_dssp             --TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             --CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC
Confidence              1234456899999999999999999999999999999999999999963

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9.6e-38  Score=314.72  Aligned_cols=209  Identities=27%  Similarity=0.448  Sum_probs=182.9

Q ss_pred             ccChhHHHhhhcC----------CCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCC
Q 008854          313 QFDFSTIRDATNN----------FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN  381 (551)
Q Consensus       313 ~~~~~~i~~~~~~----------f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  381 (551)
                      .+++++++.+++.          |...++||+|+||.||+|+.. +|+.||||++..........+.+|+.++.+++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            3555666655543          666789999999999999865 78999999998776666678999999999999999


Q ss_pred             ccceeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC
Q 008854          382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA  461 (551)
Q Consensus       382 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~  461 (551)
                      |+++++++...+..++||||+++++|.+++.    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~  176 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL  176 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence            9999999999999999999999999999875    346999999999999999999999987   999999999999999


Q ss_pred             CCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          462 DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       462 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ++.+||+|||++.......  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       177 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~  243 (321)
T 2c30_A          177 DGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS  243 (321)
T ss_dssp             TCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999998654332  123456799999999999999999999999999999999999999853

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.3e-38  Score=317.30  Aligned_cols=199  Identities=29%  Similarity=0.457  Sum_probs=177.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      .++|++.+.||+|+||.||+++. .+|+.||||++.+.  .......+.+|+.+++.++||||+++++++......++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46899999999999999999985 57899999999765  3334557889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            99999999999864   456999999999999999999999987   999999999999999999999999999865432


Q ss_pred             CCcccccccccCCCcccccccccCCCC-cchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFS-IKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .   ......||+.|+|||.+.+..++ .++||||||+++|||++|+.||..
T Consensus       168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  216 (328)
T 3fe3_A          168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG  216 (328)
T ss_dssp             C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence            2   23456799999999999888775 799999999999999999999963

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6.7e-38  Score=322.12  Aligned_cols=205  Identities=27%  Similarity=0.427  Sum_probs=177.5

Q ss_pred             hcCCCcCcccCcCCceeEEEeec--------CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcC-CCCCccceeeEEecC
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL--------SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEE  392 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~--------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  392 (551)
                      .++|.+.+.||+|+||.||+++.        .++..||||+++... ......+.+|+.++.++ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            46788999999999999999974        234579999997653 33455789999999999 899999999999999


Q ss_pred             CceEEEEEccCCCChhHHhhhhc-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee
Q 008854          393 TERLLIYEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL  459 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll  459 (551)
                      +..++||||+++++|.+++....             ....+++.+++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            99999999999999999997532             1245899999999999999999999987   9999999999999


Q ss_pred             CCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          460 DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       460 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      +.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~  308 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG  308 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence            9999999999999986654333333444567889999999999999999999999999999999 9999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.8e-38  Score=323.46  Aligned_cols=206  Identities=17%  Similarity=0.185  Sum_probs=177.2

Q ss_pred             HHHhhhcCCCcCcccCcCCceeEEEee------cCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC---CCCccceeeE
Q 008854          318 TIRDATNNFSTDNKLGQGGFGAVYKGR------LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ---HRNLVRLLGF  388 (551)
Q Consensus       318 ~i~~~~~~f~~~~~LG~G~~g~Vyk~~------~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~  388 (551)
                      +++...++|.+.++||+|+||+||+|.      ...++.||||+++...   ..++.+|++++..++   |+||++++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            334456789999999999999999994      4568899999997654   346777788777776   9999999999


Q ss_pred             EecCCceEEEEEccCCCChhHHhhhhc--ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC-----
Q 008854          389 SFEETERLLIYEFVPNSSVDKFIFDAI--KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-----  461 (551)
Q Consensus       389 ~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~-----  461 (551)
                      +...+..++||||+++|+|.+++....  ....+++..++.++.||++||.|||+.+   |+||||||+||||+.     
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCc
Confidence            999999999999999999999997532  3456999999999999999999999987   999999999999998     


Q ss_pred             ------CCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          462 ------DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       462 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                            ++.+||+|||+++.+.............||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  286 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV  286 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence                  89999999999976543333334455679999999999999999999999999999999999999884

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.8e-37  Score=308.98  Aligned_cols=216  Identities=44%  Similarity=0.673  Sum_probs=188.6

Q ss_pred             ccccChhHHHhhhcCCCcC------cccCcCCceeEEEeecCCCCEEEEEEeecCC----hhcHHHHHHHHHHHhcCCCC
Q 008854          311 SLQFDFSTIRDATNNFSTD------NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS----VQGELEFKNEVLLVARLQHR  380 (551)
Q Consensus       311 ~~~~~~~~i~~~~~~f~~~------~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~  380 (551)
                      ...|.+.++..++++|...      ++||+|+||.||+|.. +++.||||++....    ......+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4568889999999999887      8999999999999987 67899999996532    23355789999999999999


Q ss_pred             CccceeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC
Q 008854          381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD  460 (551)
Q Consensus       381 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~  460 (551)
                      ||+++++++......++||||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence            999999999999999999999999999999976545667999999999999999999999987   99999999999999


Q ss_pred             CCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          461 ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       461 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      .++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||...
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~  237 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEH  237 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccC
Confidence            999999999999986554333333445678999999998764 5899999999999999999999999743

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-38  Score=327.96  Aligned_cols=211  Identities=23%  Similarity=0.299  Sum_probs=182.0

Q ss_pred             cChhHHHhhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEE
Q 008854          314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFS  389 (551)
Q Consensus       314 ~~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~  389 (551)
                      +.+++++...++|++.+.||+|+||+||+++. .+++.||||++.+...   .....+.+|..++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            44556666778999999999999999999986 4689999999976422   1223478999999999999999999999


Q ss_pred             ecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEee
Q 008854          390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD  469 (551)
Q Consensus       390 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~D  469 (551)
                      .+.+..++||||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++++||+|
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence            999999999999999999999974  2347999999999999999999999987   99999999999999999999999


Q ss_pred             cCCccccccCCCcccccccccCCCcccccccc-------cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-------RGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       470 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ||+++....... ......+||+.|+|||++.       ...++.++|||||||++|||++|+.||..
T Consensus       206 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  272 (412)
T 2vd5_A          206 FGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA  272 (412)
T ss_dssp             CTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             chhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence            999987543322 1233468999999999987       45789999999999999999999999964

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.1e-38  Score=329.11  Aligned_cols=207  Identities=22%  Similarity=0.304  Sum_probs=178.7

Q ss_pred             hhHHHhhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEec
Q 008854          316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFE  391 (551)
Q Consensus       316 ~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  391 (551)
                      +.+++...++|++.++||+|+||+||+++.. +++.||+|++++...   .....+.+|+.++..++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            4455566789999999999999999999854 588999999975321   122347899999999999999999999999


Q ss_pred             CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          392 ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       392 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                      ....++||||+++|+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence            9999999999999999998853    46899999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCCCcccccccccCCCcccccccccCC----CCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH----FSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +++...... .......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||..
T Consensus       214 ~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  275 (410)
T 3v8s_A          214 TCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  275 (410)
T ss_dssp             TCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             eeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC
Confidence            998654322 12234568999999999997665    78999999999999999999999963

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=319.59  Aligned_cols=201  Identities=26%  Similarity=0.404  Sum_probs=176.5

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|+||.||+++. .+++.||+|++.+..   ......+.+|+.++..++||||+++++++.+....++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            5788999999999999999985 458899999997542   233457889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+...
T Consensus        95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            99999999999863   457999999999999999999999988   999999999999999999999999999865432


Q ss_pred             CCcccccccccCCCccccccccc---CCCCcchhhHhHHHHHHHHHhCCCCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTR---GHFSIKSDVFSFGVLVLEIISGQKNNSFRIG  533 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvll~elltG~~p~~~~~~  533 (551)
                         .......||+.|+|||++..   ..++.++||||||+++|||++|+.||.....
T Consensus       169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~  222 (384)
T 4fr4_A          169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS  222 (384)
T ss_dssp             ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT
T ss_pred             ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC
Confidence               23445689999999999864   4589999999999999999999999974433

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.2e-38  Score=320.44  Aligned_cols=200  Identities=28%  Similarity=0.364  Sum_probs=171.9

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  397 (551)
                      -++|++.+.||+|+||+||+++. .+++.||||++++..   ......+.+|..++..+ +||||+++++++......++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            46799999999999999999985 468999999997642   23345678899999988 69999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+++++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       102 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            9999999999999874   456999999999999999999999987   9999999999999999999999999997532


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..  .......+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       176 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~  226 (353)
T 3txo_A          176 CN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA  226 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC
Confidence            21  2234456899999999999999999999999999999999999999964

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.4e-37  Score=309.51  Aligned_cols=201  Identities=26%  Similarity=0.438  Sum_probs=172.2

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      .++|++.++||+|+||.||+++. ..++.||+|++....   ......+.+|+.++.+++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            46899999999999999999984 468899999986543   23345789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|.+++..   ..++++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            999999999999864   457999999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .. ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       164 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  214 (294)
T 4eqm_A          164 TS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG  214 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             cc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            22 1223445799999999999999999999999999999999999999964

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.3e-38  Score=323.38  Aligned_cols=200  Identities=26%  Similarity=0.359  Sum_probs=175.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh---cHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  397 (551)
                      -++|++.++||+|+||+||+++.. +++.||+|++++....   ....+.+|..++.++ +||||+++++++.+....++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            357889999999999999999854 5788999999865322   223578899999877 89999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            9999999999999874   457999999999999999999999988   9999999999999999999999999997532


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..  .......+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~  255 (396)
T 4dc2_A          205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  255 (396)
T ss_dssp             CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            21  2234557899999999999999999999999999999999999999964

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.3e-38  Score=314.84  Aligned_cols=207  Identities=31%  Similarity=0.487  Sum_probs=171.1

Q ss_pred             HhhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          320 RDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       320 ~~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      ....++|++.++||+|+||+||+++. .++.||||++....  ......+.+|+.++++++||||+++++++......++
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            34456889999999999999999987 67899999997653  3334578999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+++++|.+++........+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            9999999999999975433345999999999999999999999875 359999999999999999999999999997543


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~  241 (309)
T 3p86_A          191 STF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN  241 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred             ccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            221  223345789999999999999999999999999999999999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-37  Score=312.28  Aligned_cols=196  Identities=28%  Similarity=0.414  Sum_probs=175.5

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|+||.||+++. .+|+.||+|++++..   ......+.+|..++..++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            5788999999999999999985 468999999997642   234456889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.... 
T Consensus        86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-  158 (318)
T 1fot_A           86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-  158 (318)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence            99999999999873   456899999999999999999999987   99999999999999999999999999986432 


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                          ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  205 (318)
T 1fot_A          159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD  205 (318)
T ss_dssp             ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence                23346799999999999999999999999999999999999999953

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.4e-38  Score=315.42  Aligned_cols=203  Identities=26%  Similarity=0.438  Sum_probs=176.0

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .++|++.++||+|+||+||+++.. +++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999854 789999999975532 233568899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999885   3456999999999999999999999987   9999999999999999999999999998765443


Q ss_pred             CcccccccccCCCcccccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      .........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  211 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP  211 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence            3333455689999999999988775 78999999999999999999999643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.4e-37  Score=315.25  Aligned_cols=200  Identities=30%  Similarity=0.417  Sum_probs=177.5

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh------cHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ------GELEFKNEVLLVARLQHRNLVRLLGFSFEETE  394 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  394 (551)
                      ..++|++.+.||+|+||.||+++.. +|+.||+|++++....      ....+.+|+.++.+++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            4567999999999999999999854 6899999999765322      34678999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC----CeEEeec
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM----IPKISDF  470 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~kl~Df  470 (551)
                      .++||||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            999999999999999986   3467999999999999999999999987   99999999999998877    7999999


Q ss_pred             CCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       471 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      |+++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~  220 (361)
T 2yab_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  220 (361)
T ss_dssp             SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            9998754322   23456799999999999999999999999999999999999999963

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.3e-38  Score=315.75  Aligned_cols=202  Identities=30%  Similarity=0.487  Sum_probs=172.2

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCC----ceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET----ERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV  398 (551)
                      .++|++.++||+|+||+||+|+.. ++.||||++..... ....+.+|+.++.+++||||+++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            467899999999999999999874 78999999976543 3345677999999999999999999998754    36899


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhC-------CCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-------SRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                      |||+++++|.+++..    ..+++..++.++.|++.||.|||+.       ..++|+||||||+|||++.++.+||+|||
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            999999999999863    4589999999999999999999987       01139999999999999999999999999


Q ss_pred             CccccccCCCcccccccccCCCccccccccc-----CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-----GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +++.+.............||+.|+|||.+.+     ..++.++||||||+++|||++|+.||..
T Consensus       177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~  240 (322)
T 3soc_A          177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG  240 (322)
T ss_dssp             TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred             cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence            9987665444434455679999999999876     3566789999999999999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.6e-37  Score=314.54  Aligned_cols=199  Identities=26%  Similarity=0.355  Sum_probs=175.6

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ++|++.+.||+|+||.||+++.. +++.||+|++.+..   ......+.+|..++.++ +||||+++++++......++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            56888999999999999999854 58899999997653   23344678899999988 899999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            999999999999864   356999999999999999999999987   99999999999999999999999999975322


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .  ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       163 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          163 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             C--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            1  1234456899999999999999999999999999999999999999964

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.1e-37  Score=314.92  Aligned_cols=201  Identities=27%  Similarity=0.384  Sum_probs=176.2

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  396 (551)
                      ..++|.+.+.||+|+||.||+++.. +++.||||++++..   ......+..|..++..+ +||||+++++++.+....+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            4578999999999999999999864 68899999997642   23345678899998876 8999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        95 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            99999999999999864   456999999999999999999999987   999999999999999999999999999754


Q ss_pred             ccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...  ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       169 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  220 (345)
T 1xjd_A          169 MLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG  220 (345)
T ss_dssp             CCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence            322  1234556899999999999999999999999999999999999999963

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.8e-38  Score=323.48  Aligned_cols=204  Identities=29%  Similarity=0.468  Sum_probs=175.5

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ..++|.+.++||+|+||.||+|+.. +++.||||+++.... .....+.+|+.++++++||||+++++++......++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3467888999999999999999965 689999999976532 33346889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       192 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          192 ELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             ECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             EcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            99999999999974  3446899999999999999999999988   999999999999999999999999999864322


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ..........+++.|+|||.+.++.++.++||||||+++|||++ |+.||..
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~  318 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN  318 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            21111222345778999999999999999999999999999998 9988853

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.3e-37  Score=316.33  Aligned_cols=202  Identities=30%  Similarity=0.548  Sum_probs=164.0

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC----CCCEEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS----HGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      .++|++.+.||+|+||.||+|+..    .+..||||+++.. .......+.+|+.++.+++||||+++++++......++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            457899999999999999999864    4678999999765 33445679999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+++++|.+++..  ....+++.+++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999974  3457999999999999999999999987   9999999999999999999999999998765


Q ss_pred             cCCCcc-cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          478 MDQSQG-DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       478 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~  252 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW  252 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTT
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCC
Confidence            332211 1222345778999999999999999999999999999998 999985

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4e-37  Score=313.67  Aligned_cols=196  Identities=24%  Similarity=0.307  Sum_probs=175.9

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|+||.||+++.. +|+.||+|++.+..   ......+.+|+.++..++||||+++++++.+....++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57889999999999999999854 68999999997642   234457889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.... 
T Consensus       121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-  193 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC-
Confidence            99999999999874   356999999999999999999999988   99999999999999999999999999986532 


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                          ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       194 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  240 (350)
T 1rdq_E          194 ----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA  240 (350)
T ss_dssp             ----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC
Confidence                23346799999999999999999999999999999999999999963

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.3e-37  Score=318.46  Aligned_cols=216  Identities=29%  Similarity=0.413  Sum_probs=182.8

Q ss_pred             cccChhHHHhhhcCCCcCcccCcCCceeEEEeec------CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcC-CCCCcc
Q 008854          312 LQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLV  383 (551)
Q Consensus       312 ~~~~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv  383 (551)
                      +.++....+...++|++.++||+|+||.||++++      .+++.||||+++... ......+.+|+.++.++ +||||+
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            3455666667788999999999999999999963      345789999997653 33445799999999999 799999


Q ss_pred             ceeeEEecCCc-eEEEEEccCCCChhHHhhhhcc----------------------------------------------
Q 008854          384 RLLGFSFEETE-RLLIYEFVPNSSVDKFIFDAIK----------------------------------------------  416 (551)
Q Consensus       384 ~l~~~~~~~~~-~~lV~e~~~~gsL~~~l~~~~~----------------------------------------------  416 (551)
                      ++++++...+. .++||||+++++|.+++.....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            99999987654 8899999999999999975322                                              


Q ss_pred             -----------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          417 -----------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       417 -----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                                       ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                             122899999999999999999999987   999999999999999999999999999866544


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ..........||+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  298 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  298 (359)
T ss_dssp             TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCc
Confidence            33334455678999999999999999999999999999999998 9999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.2e-37  Score=310.81  Aligned_cols=203  Identities=25%  Similarity=0.455  Sum_probs=172.3

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCc------
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETE------  394 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  394 (551)
                      .++|++.++||+|+||.||+++.. +++.||||+++.... .....+.+|+.++++++||||+++++++.+...      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            357889999999999999999865 789999999976533 345679999999999999999999999865432      


Q ss_pred             ---------------------------------------------------eEEEEEccCCCChhHHhhhhcccCCCCHH
Q 008854          395 ---------------------------------------------------RLLIYEFVPNSSVDKFIFDAIKRVQLDWE  423 (551)
Q Consensus       395 ---------------------------------------------------~~lV~e~~~~gsL~~~l~~~~~~~~l~~~  423 (551)
                                                                         .++||||+++++|.+++..........+.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                               78999999999999999865555567888


Q ss_pred             HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc----------ccccccccCCC
Q 008854          424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ----------GDTSRIVGTFG  493 (551)
Q Consensus       424 ~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~~  493 (551)
                      .++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999987   999999999999999999999999999876543211          12234579999


Q ss_pred             cccccccccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       494 y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                      |+|||.+.+..++.++||||||+++|||++|..|+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~  276 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ  276 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence            99999999999999999999999999999998765

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.4e-37  Score=311.57  Aligned_cols=200  Identities=27%  Similarity=0.360  Sum_probs=167.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeec----CCCCEEEEEEeecCCh----hcHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLLGFSFEETE  394 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  394 (551)
                      .++|++.+.||+|+||.||+++.    .+++.||+|++++...    .....+.+|+.++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46789999999999999999985    4789999999976532    233457889999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            9999999999999999863   456899999999999999999999987   9999999999999999999999999997


Q ss_pred             ccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ......  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  223 (327)
T 3a62_A          170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG  223 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence            543221  123446799999999999999999999999999999999999999963

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7e-37  Score=307.01  Aligned_cols=203  Identities=28%  Similarity=0.450  Sum_probs=172.7

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChh--cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ...++|++.++||+|+||+||+++..+++.||+|++......  ....+.+|+.++++++||||+++++++......++|
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            345789999999999999999999888999999999754322  235688999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++ +|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        98 ~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           98 FEFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             EECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EcCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            999985 77777754  3456999999999999999999999987   99999999999999999999999999986542


Q ss_pred             CCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ..  .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       172 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  223 (311)
T 3niz_A          172 PV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV  223 (311)
T ss_dssp             CC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             Cc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence            22  22334578999999999876 56899999999999999999999999643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.3e-37  Score=314.43  Aligned_cols=200  Identities=27%  Similarity=0.316  Sum_probs=176.3

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  397 (551)
                      -++|++.+.||+|+||.||+++.. +++.||||++++..   ......+.+|..++..+ +||||+++++++...+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            467899999999999999999865 47889999997642   23445688999999988 79999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        99 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            9999999999999874   356999999999999999999999987   9999999999999999999999999997532


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..  ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       173 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~  223 (353)
T 2i0e_A          173 WD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG  223 (353)
T ss_dssp             CT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence            21  1234456899999999999999999999999999999999999999964

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.7e-37  Score=310.96  Aligned_cols=202  Identities=29%  Similarity=0.505  Sum_probs=172.9

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC----CCCEEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS----HGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      .++|.+.+.||+|+||.||+|+..    .+..||||+++.. .......+.+|+.++.+++||||+++++++......++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            457888999999999999999863    3446999999765 33445679999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999864  3457999999999999999999999987   9999999999999999999999999998765


Q ss_pred             cCCCc-ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          478 MDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       478 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~  256 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW  256 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence            33221 12233456778999999999999999999999999999999 999984

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=7.6e-37  Score=309.32  Aligned_cols=203  Identities=19%  Similarity=0.245  Sum_probs=176.6

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .++|++.++||+|+||.||+++. .+++.||||++.....  ...+.+|+.+++++ +||||+++++++......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46799999999999999999984 5789999999976532  23588999999999 89999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC-----eEEeecCCccc
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI-----PKISDFGMARL  475 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~-----~kl~Dfgla~~  475 (551)
                      |+ +++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999998752  467999999999999999999999987   999999999999998887     99999999987


Q ss_pred             cccCCCcc-----cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCC
Q 008854          476 FEMDQSQG-----DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIG  533 (551)
Q Consensus       476 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~~  533 (551)
                      +.......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~  222 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA  222 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence            54332211     13456899999999999999999999999999999999999999975433

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.7e-37  Score=308.05  Aligned_cols=200  Identities=29%  Similarity=0.443  Sum_probs=176.9

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh------cHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ------GELEFKNEVLLVARLQHRNLVRLLGFSFEETE  394 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  394 (551)
                      ..++|.+.+.||+|+||.||+++.. +++.||+|++......      ....+.+|+.++.+++||||+++++++.....
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3457889999999999999999854 6899999999765321      35678999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC----CeEEeec
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM----IPKISDF  470 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~kl~Df  470 (551)
                      .++||||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           89 VILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            999999999999999986   3467999999999999999999999987   99999999999999887    8999999


Q ss_pred             CCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       471 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      |+++......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  219 (326)
T 2y0a_A          163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  219 (326)
T ss_dssp             TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence            9998754322   23345799999999999999999999999999999999999999953

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-37  Score=309.31  Aligned_cols=200  Identities=22%  Similarity=0.329  Sum_probs=176.8

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ..++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++..++||||+++++++.+.+..++|||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            3578999999999999999999854 57889999997554 334568899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC--CCCeEEeecCCcccccc
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--DMIPKISDFGMARLFEM  478 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~--~~~~kl~Dfgla~~~~~  478 (551)
                      |+++++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++.+..
T Consensus        82 ~~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             eCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            9999999999863  3456999999999999999999999987   999999999999987  78999999999987643


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  205 (321)
T 1tki_A          157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA  205 (321)
T ss_dssp             TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence            22   23345789999999999998899999999999999999999999964

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=8.3e-37  Score=312.92  Aligned_cols=199  Identities=27%  Similarity=0.429  Sum_probs=175.5

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ..++|++.+.||+|+||.||++.. .+++.||+|++....  ......+.+|+.++++++||||+++++++.+....++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            456799999999999999999985 468999999997653  33445788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC---CeEEeecCCccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM---IPKISDFGMARL  475 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl~Dfgla~~  475 (551)
                      |||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+||+|||++..
T Consensus       107 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999999886   3457899999999999999999999987   99999999999998654   599999999986


Q ss_pred             cccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .....   ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus       181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~  231 (362)
T 2bdw_A          181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW  231 (362)
T ss_dssp             CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            54322   2334679999999999999999999999999999999999999985

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.5e-37  Score=312.55  Aligned_cols=203  Identities=24%  Similarity=0.320  Sum_probs=175.7

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC-----hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-----VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      .++|++.+.||+|+||+||++.. .+++.||||++....     ......+.+|+.++++++||||+++++++...+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45788999999999999999985 468999999996432     123567899999999999999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC---eEEeecCC
Q 008854          397 LIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI---PKISDFGM  472 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~kl~Dfgl  472 (551)
                      +||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988886532 2346899999999999999999999987   999999999999987654   99999999


Q ss_pred             ccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ++......  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  235 (351)
T 3c0i_A          180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG  235 (351)
T ss_dssp             CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence            98754322  223345799999999999999999999999999999999999999953

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.8e-37  Score=307.00  Aligned_cols=202  Identities=26%  Similarity=0.423  Sum_probs=175.9

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCC--ceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEET--ERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV  398 (551)
                      .++|.+.++||+|+||+||+++.. +++.||||++.... ......+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            467899999999999999999854 58999999997643 334567889999999999999999999988765  67899


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee----CCCCCeEEeecCCcc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DADMIPKISDFGMAR  474 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~kl~Dfgla~  474 (551)
                      |||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999986555556999999999999999999999987   9999999999999    788889999999998


Q ss_pred             ccccCCCcccccccccCCCcccccccc--------cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVT--------RGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ......   ......||+.|+|||.+.        +..++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  225 (319)
T 4euu_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (319)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            754332   223457899999999886        57889999999999999999999999964

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.5e-37  Score=300.97  Aligned_cols=201  Identities=30%  Similarity=0.502  Sum_probs=176.8

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      .++|++.+.||+|+||.||+++..+++.||+|++..... ....+.+|+.++.+++||||+++++++.+....++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            357888999999999999999988889999999976543 3457999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++++|.+++..  ....+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++...... .
T Consensus        88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  161 (269)
T 4hcu_A           88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y  161 (269)
T ss_dssp             TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred             CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc-c
Confidence            99999999864  3456899999999999999999999988   9999999999999999999999999998654321 1


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~  210 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN  210 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC
Confidence            12233456788999999999999999999999999999999 8988853

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.1e-37  Score=310.80  Aligned_cols=203  Identities=25%  Similarity=0.431  Sum_probs=168.5

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCce--
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETER--  395 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  395 (551)
                      ..++|++.++||+|+||.||+++. .+++.||||++.....   .....+.+|+.++.+++||||+++++++......  
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            457899999999999999999984 5788999999976532   2344688999999999999999999998765543  


Q ss_pred             --EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCc
Q 008854          396 --LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA  473 (551)
Q Consensus       396 --~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla  473 (551)
                        ++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             ccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence              899999999999999874   457999999999999999999999987   999999999999999999999999999


Q ss_pred             cccccCCCc-ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          474 RLFEMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       474 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  221 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG  221 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            865433221 223445789999999999999999999999999999999999999964

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-37  Score=317.32  Aligned_cols=205  Identities=34%  Similarity=0.532  Sum_probs=176.5

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER  395 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  395 (551)
                      .++|++.++||+|+||+||+|++.      +++.||||+++.. .......+.+|+.++.+++||||+++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467889999999999999999843      3568999999754 344555789999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhhc----ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC---CeEEe
Q 008854          396 LLIYEFVPNSSVDKFIFDAI----KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM---IPKIS  468 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl~  468 (551)
                      ++||||+++++|.+++....    ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999997542    1245899999999999999999999988   99999999999999554   59999


Q ss_pred             ecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       469 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      |||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~  289 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS  289 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999986544333333445678999999999999999999999999999999998 9888853

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-37  Score=312.84  Aligned_cols=208  Identities=27%  Similarity=0.454  Sum_probs=178.2

Q ss_pred             HhhhcCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecC
Q 008854          320 RDATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE  392 (551)
Q Consensus       320 ~~~~~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  392 (551)
                      ....++|++.+.||+|+||.||+++..      +++.||||+++... ......+.+|+.++.+++||||+++++++...
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            345678999999999999999999864      34789999997653 33455789999999999999999999999999


Q ss_pred             CceEEEEEccCCCChhHHhhhhcc---------------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEecc
Q 008854          393 TERLLIYEFVPNSSVDKFIFDAIK---------------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRD  451 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~D  451 (551)
                      ...++||||+++++|.+++.....                     ...+++.+++.++.||++||.|||+.+   |+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            999999999999999999975321                     257999999999999999999999987   99999


Q ss_pred             CCCCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          452 LKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       452 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      |||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999986643332233344567899999999999999999999999999999999 9989853

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=312.91  Aligned_cols=195  Identities=29%  Similarity=0.407  Sum_probs=168.8

Q ss_pred             cCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCCCC
Q 008854          328 TDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSS  406 (551)
Q Consensus       328 ~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  406 (551)
                      ..+.||+|+||.||+++. .+|+.||+|+++.........+.+|+.++.+++||||+++++++...+..++||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            357899999999999984 5689999999988776667789999999999999999999999999999999999999999


Q ss_pred             hhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee--CCCCCeEEeecCCccccccCCCccc
Q 008854          407 VDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL--DADMIPKISDFGMARLFEMDQSQGD  484 (551)
Q Consensus       407 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~  484 (551)
                      |.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||+  +.++.+||+|||+++.+....   .
T Consensus       173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~  244 (373)
T 2x4f_A          173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K  244 (373)
T ss_dssp             EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred             HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence            9998864  3456899999999999999999999987   9999999999999  677899999999998764332   2


Q ss_pred             ccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       485 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  290 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG  290 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence            2345699999999999999999999999999999999999999963

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6e-37  Score=314.73  Aligned_cols=199  Identities=24%  Similarity=0.305  Sum_probs=167.1

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHHH-HhcCCCCCccceeeEEecCCceEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLL-VARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ++|++.+.||+|+||.||+++.. +++.||||++++...   .....+.+|..+ ++.++||||+++++++...+..++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            56888999999999999999854 578899999976532   233456677776 5778999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       118 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          118 LDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            999999999999864   456899999999999999999999987   99999999999999999999999999985332


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .  .......+||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       192 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~  241 (373)
T 2r5t_A          192 H--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  241 (373)
T ss_dssp             C--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             C--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            2  2234557899999999999999999999999999999999999999953

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.4e-37  Score=309.93  Aligned_cols=211  Identities=26%  Similarity=0.444  Sum_probs=162.7

Q ss_pred             hHHHhhhcCCCcCcccCcCCceeEEEeecCCCC----EEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEe
Q 008854          317 STIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQ----EIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSF  390 (551)
Q Consensus       317 ~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  390 (551)
                      +++....++|++.+.||+|+||.||+++.....    .||||+++..  .......+.+|+.++++++||||+++++++.
T Consensus        16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            334445678999999999999999999865432    7999999765  3344567999999999999999999999998


Q ss_pred             cCCce------EEEEEccCCCChhHHhhhhcc---cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC
Q 008854          391 EETER------LLIYEFVPNSSVDKFIFDAIK---RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA  461 (551)
Q Consensus       391 ~~~~~------~lV~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~  461 (551)
                      .....      ++||||+++++|.+++.....   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~  172 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAE  172 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECT
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcC
Confidence            77655      899999999999999975322   226899999999999999999999987   999999999999999


Q ss_pred             CCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          462 DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       462 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~  242 (323)
T 3qup_A          173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG  242 (323)
T ss_dssp             TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            99999999999987654333233334456889999999999999999999999999999999 8988863

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-36  Score=313.45  Aligned_cols=200  Identities=25%  Similarity=0.359  Sum_probs=177.6

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .++|++.+.||+|+||.||++.. .+++.||+|++..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            46799999999999999999985 46889999999877665666899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC--CCCeEEeecCCccccccC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--DMIPKISDFGMARLFEMD  479 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~--~~~~kl~Dfgla~~~~~~  479 (551)
                      +++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++.....
T Consensus       130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999998864  3446899999999999999999999987   999999999999974  468999999999875432


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .   ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  252 (387)
T 1kob_A          205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG  252 (387)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence            2   22345789999999999999999999999999999999999999963

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.1e-36  Score=298.68  Aligned_cols=201  Identities=29%  Similarity=0.453  Sum_probs=177.1

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ..++|++.+.||+|+||.||+++..++..||+|+++.... ...++.+|+.++.+++||||+++++++......++||||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            3467889999999999999999988888999999976543 345789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........
T Consensus        85 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           85 ISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             CTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             cCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            999999999975  2446999999999999999999999987   99999999999999999999999999986543322


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                       .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       160 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~  207 (268)
T 3sxs_A          160 -VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD  207 (268)
T ss_dssp             -EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             -hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcc
Confidence             12233456778999999999899999999999999999999 999985

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.6e-37  Score=311.32  Aligned_cols=202  Identities=29%  Similarity=0.487  Sum_probs=167.0

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCE----EEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQE----IAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      .++|+..++||+|+||+||+|+.. +++.    ||+|.+... .......+.+|+.++.+++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            357889999999999999999853 4443    688887543 3345568999999999999999999999998754 78


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +|+||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            99999999999999975  3467999999999999999999999987   999999999999999999999999999876


Q ss_pred             ccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      .............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  222 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG  222 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC
Confidence            54443333444567889999999999999999999999999999999 9999964

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.2e-37  Score=309.34  Aligned_cols=198  Identities=23%  Similarity=0.429  Sum_probs=173.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      -++|.+.+.||+|+||.||++.. .+++.||+|++.+...   .....+.+|+.+++.++||||+++++++......++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36789999999999999999985 5789999999975421   2234688999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+ +|+|.+++..   ...+++.++..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 7888888864   456999999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCCcccccccccCCCcccccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..   ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..
T Consensus       161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~  210 (336)
T 3h4j_B          161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD  210 (336)
T ss_dssp             SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred             Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence            22   2344579999999999988776 6899999999999999999999963

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-36  Score=326.51  Aligned_cols=202  Identities=30%  Similarity=0.430  Sum_probs=178.2

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      .++|++.+.||+|+||.||+++. .+|+.||+|++.+..   ......+.+|+.++.+++||||+++++++.+....++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            46788999999999999999985 468999999997642   23445688999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++|+|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus       263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            9999999999998743 2345999999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ..   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~  388 (576)
T 2acx_A          339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR  388 (576)
T ss_dssp             TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred             Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence            22   223458999999999999999999999999999999999999999754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.5e-37  Score=307.14  Aligned_cols=206  Identities=30%  Similarity=0.405  Sum_probs=178.2

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec------CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE  394 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  394 (551)
                      ..++|.+.+.||+|+||.||++..      .+++.||||++.... ......+.+|+.++++++||||+++++++.....
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            456788999999999999999974      245789999997653 3445678999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcc---------------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCC
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIK---------------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLK  453 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk  453 (551)
                      .++||||+++++|.+++.....                     ...+++.+++.++.||++||.|||+.+   |+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence            9999999999999999975322                     234899999999999999999999987   9999999


Q ss_pred             CCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          454 ASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       454 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      |+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999987654433333444567889999999999999999999999999999999 9999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.4e-37  Score=305.86  Aligned_cols=202  Identities=29%  Similarity=0.503  Sum_probs=171.2

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-----CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecC--Cce
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TER  395 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  395 (551)
                      .++|++.++||+|+||+||++++     .+++.||||++..........+.+|+.++.+++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46788999999999999999973     35789999999877766667899999999999999999999998654  457


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            8999999999999999752  345899999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCc-ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          476 FEMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~  218 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK  218 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccC
Confidence            6433221 12233456778999999999999999999999999999999998875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-37  Score=311.07  Aligned_cols=207  Identities=29%  Similarity=0.418  Sum_probs=175.8

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeec------CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcC-CCCCccceeeEEecC
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEE  392 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  392 (551)
                      ...++|.+.+.||+|+||.||+++.      ..+..||||++.... ......+.+|+.++.++ +||||+++++++...
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            3467899999999999999999985      245679999997542 23345789999999999 899999999999999


Q ss_pred             CceEEEEEccCCCChhHHhhhhcc--------------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccC
Q 008854          393 TERLLIYEFVPNSSVDKFIFDAIK--------------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDL  452 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl  452 (551)
                      +..++||||+++++|.+++.....                    ...+++..++.++.||+.||.|||+.+   |+||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence            999999999999999999975321                    134899999999999999999999987   999999


Q ss_pred             CCCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          453 KASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       453 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            99999999999999999999987654433333445567889999999999999999999999999999998 9999864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=314.66  Aligned_cols=206  Identities=28%  Similarity=0.414  Sum_probs=178.2

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC--------CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcC-CCCCccceeeEEec
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS--------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFE  391 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  391 (551)
                      ..++|.+.++||+|+||.||+++..        .+..||||+++... ......+.+|++++.++ +||||+++++++..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            3468889999999999999999742        23579999997653 33446789999999999 89999999999999


Q ss_pred             CCceEEEEEccCCCChhHHhhhhcc-------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCee
Q 008854          392 ETERLLIYEFVPNSSVDKFIFDAIK-------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL  458 (551)
Q Consensus       392 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIl  458 (551)
                      .+..++||||+++++|.+++.....             ...+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence            9999999999999999999975321             245999999999999999999999987   999999999999


Q ss_pred             eCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       459 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      |+.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~  296 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  296 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999987654333333445567889999999999999999999999999999999 9998863

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.1e-36  Score=301.99  Aligned_cols=199  Identities=25%  Similarity=0.433  Sum_probs=169.9

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChh--cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ++|++.++||+|+||+||+++..+++.||+|++......  ....+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            478889999999999999999878999999999765322  235788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++ +|.+++..  ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (288)
T ss_dssp             CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence            986 88888764  3467899999999999999999999987   9999999999999999999999999998654221 


Q ss_pred             cccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                       .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  203 (288)
T 1ob3_A          155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG  203 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence             12234568999999999876 4589999999999999999999999863

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=319.00  Aligned_cols=201  Identities=26%  Similarity=0.381  Sum_probs=175.2

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      ...++|++.++||+|+||.||++.. .+|+.+|+|++.....  .....+.+|+.++++++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            3457899999999999999999974 5788999999976542  334568999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC---CCCCeEEeecCCcc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---ADMIPKISDFGMAR  474 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~kl~Dfgla~  474 (551)
                      ||||+++++|.+.+..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||++.
T Consensus        88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            9999999999998864   467999999999999999999999987   99999999999998   46789999999997


Q ss_pred             ccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ......  .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.
T Consensus       162 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~  214 (444)
T 3soa_A          162 EVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW  214 (444)
T ss_dssp             CCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence            654322  22334679999999999999999999999999999999999999984

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.5e-37  Score=324.64  Aligned_cols=204  Identities=30%  Similarity=0.495  Sum_probs=176.8

Q ss_pred             HHhhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          319 IRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       319 i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      .+...++|.+.++||+|+||+||+|.+.++..||||+++... .....+.+|+.++++++||||+++++++. ....++|
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            344567888999999999999999998888999999997654 34668999999999999999999999986 5678999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++|+|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       261 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             ECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             EeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            9999999999999743 2346899999999999999999999987   99999999999999999999999999986542


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ... .......+|+.|+|||.+....++.++||||||+++|||++ |+.||.
T Consensus       337 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~  387 (454)
T 1qcf_A          337 NEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP  387 (454)
T ss_dssp             HHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             Cce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCC
Confidence            211 11223346789999999999999999999999999999999 999985

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.6e-36  Score=299.92  Aligned_cols=198  Identities=25%  Similarity=0.414  Sum_probs=170.1

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ++|++.++||+|+||+||+++. .+++.||+|++.....  .....+.+|+.++++++||||+++++++..+...++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            4788999999999999999985 4688999999976532  234578899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++ +|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9986 45444432  3467999999999999999999999987   9999999999999999999999999998654322


Q ss_pred             CcccccccccCCCcccccccccCC-CCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                        .......||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+.
T Consensus       156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~  203 (292)
T 3o0g_A          156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_dssp             --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred             --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence              2234457899999999987765 7999999999999999999998863

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-36  Score=302.20  Aligned_cols=198  Identities=28%  Similarity=0.411  Sum_probs=166.9

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChh--------------------------cHHHHHHHHHHHh
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ--------------------------GELEFKNEVLLVA  375 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~  375 (551)
                      .++|++.+.||+|+||.||+++. .+++.||||++......                          ....+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            36789999999999999999984 46889999999764321                          1245889999999


Q ss_pred             cCCCCCccceeeEEec--CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCC
Q 008854          376 RLQHRNLVRLLGFSFE--ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLK  453 (551)
Q Consensus       376 ~l~h~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk  453 (551)
                      +++||||+++++++..  ....++||||+++++|.+++    ....+++..+..++.||++||.|||+.+   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999986  56789999999999998764    3457999999999999999999999987   9999999


Q ss_pred             CCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCC---CCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          454 ASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH---FSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       454 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      |+|||++.++.+||+|||+++.+....  .......||+.|+|||.+.+..   .+.++||||||+++|||++|+.||.
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             HHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            999999999999999999998654322  1233457899999999987665   4788999999999999999999985

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.8e-36  Score=301.76  Aligned_cols=202  Identities=29%  Similarity=0.452  Sum_probs=160.6

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .++|++.++||+|+||.||++... +++.||+|+++.... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467899999999999999999854 689999999976532 233578899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhc---ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          401 FVPNSSVDKFIFDAI---KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      |++ ++|.+++....   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 58999886532   1245899999999999999999999987   9999999999999999999999999998654


Q ss_pred             cCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...  .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  211 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG  211 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            322  12334578999999999876 4689999999999999999999999964

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.5e-37  Score=324.84  Aligned_cols=200  Identities=24%  Similarity=0.289  Sum_probs=166.6

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC---ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN---SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      .++|++.++||+|+||.||+++. .+++.||||++.+.   .......+.+|+.++..++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46789999999999999999984 46899999999764   223344678899999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      |||+++++|.+++..   ...+++..+..++.||+.||.|||+ .+   |+||||||+||||+.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999999863   4579999999999999999999998 66   9999999999999999999999999997533


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..  ........||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       301 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  351 (446)
T 4ejn_A          301 KD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  351 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence            22  1223456899999999999999999999999999999999999999953

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.2e-36  Score=300.77  Aligned_cols=201  Identities=27%  Similarity=0.465  Sum_probs=174.1

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ..++|++.++||+|+||.||++...++..||+|++..... ...++.+|+.++.+++||||+++++++......++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            3567888999999999999999988888999999976543 345789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       101 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  174 (283)
T 3gen_A          101 MANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-  174 (283)
T ss_dssp             CTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred             cCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence            999999999975  2456999999999999999999999987   9999999999999999999999999998654321 


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~  223 (283)
T 3gen_A          175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE  223 (283)
T ss_dssp             HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            112233456788999999999999999999999999999998 999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.1e-36  Score=323.42  Aligned_cols=204  Identities=28%  Similarity=0.409  Sum_probs=179.3

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      .++|...+.||+|+||.||+++.. +|+.||+|++.+...   .....+.+|+.++.+++||||+++++++......++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367888999999999999999864 689999999976422   3345788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          399 YEFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      |||+++++|..++..... ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999875322 456999999999999999999999987   9999999999999999999999999998654


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~  392 (543)
T 3c4z_A          341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR  392 (543)
T ss_dssp             TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred             CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence            322  2234458999999999999999999999999999999999999999653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2e-36  Score=310.55  Aligned_cols=203  Identities=19%  Similarity=0.254  Sum_probs=169.6

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCC------CCEEEEEEeecCChhcH-----------HHHHHHHHHHhcCCCCCccc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNSVQGE-----------LEFKNEVLLVARLQHRNLVR  384 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~------g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~  384 (551)
                      ..++|.+.++||+|+||.||+|....      ++.||||++........           ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            45689999999999999999998654      47899999977643211           12345667788899999999


Q ss_pred             eeeEEecC----CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC
Q 008854          385 LLGFSFEE----TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD  460 (551)
Q Consensus       385 l~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~  460 (551)
                      +++++...    ...+|||||+ +++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99998764    3478999999 9999999875  3467999999999999999999999987   99999999999999


Q ss_pred             --CCCCeEEeecCCccccccCCCc-----ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          461 --ADMIPKISDFGMARLFEMDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       461 --~~~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        .++.+||+|||+++.+......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence              8899999999999876433221     112345699999999999999999999999999999999999999973

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.8e-37  Score=310.60  Aligned_cols=201  Identities=24%  Similarity=0.388  Sum_probs=168.6

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCC--CCccceeeEEecCCceEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQH--RNLVRLLGFSFEETERLL  397 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l  397 (551)
                      ..++|++.++||+|+||.||++...+++.||||++....  ......+.+|+.++.+++|  |||+++++++......++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            456799999999999999999998889999999997653  3344678999999999986  999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||| +.+++|.+++..   ...+++.++..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++.+.
T Consensus        87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            999 568899999874   467999999999999999999999987   99999999999997 6789999999998765


Q ss_pred             cCCCcccccccccCCCccccccccc-----------CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTR-----------GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ............||+.|+|||.+.+           ..++.++||||||+++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  222 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  222 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence            4433333445679999999999865           6789999999999999999999999963

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8.5e-37  Score=308.35  Aligned_cols=203  Identities=29%  Similarity=0.439  Sum_probs=170.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCE----EEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQE----IAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      .++|++.++||+|+||+||+|+.. +++.    ||+|.+.... ......+.+|+.++.+++||||+++++++. +...+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            357888999999999999999853 4443    7888875442 223345788999999999999999999886 45688


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            99999999999999874  2456899999999999999999999987   999999999999999999999999999877


Q ss_pred             ccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFR  531 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~~  531 (551)
                      .............+|..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  221 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL  221 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc
Confidence            55444444455678889999999999999999999999999999999 99999643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-36  Score=303.53  Aligned_cols=197  Identities=25%  Similarity=0.305  Sum_probs=164.7

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC--hhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  398 (551)
                      .++|++.++||+|+||+||+|+.. +++.||||++....  ......+..|+..+.++ +||||+++++++.++...++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            367999999999999999999865 78999999986542  23333455555555555 899999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+ +++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       136 ~e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 6788888865  3457999999999999999999999987   99999999999999999999999999876543


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ..   ......||+.|+|||++.+ .++.++||||||+++|||++|+.|+.
T Consensus       210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~  256 (311)
T 3p1a_A          210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH  256 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred             CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            22   2334568999999998875 78999999999999999999977663

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.4e-36  Score=324.14  Aligned_cols=203  Identities=30%  Similarity=0.496  Sum_probs=177.1

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCC-CCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ...+|++.++||+|+||.||+|++.. +..||||+++.... ...+|.+|+.++++++||||+++++++......++|||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            34568888999999999999999654 78999999976543 45679999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++......
T Consensus       297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            99999999999753 3456899999999999999999999987   9999999999999999999999999998754322


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                       ........+++.|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus       373 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~  422 (495)
T 1opk_A          373 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG  422 (495)
T ss_dssp             -EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             -eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC
Confidence             122233456789999999999999999999999999999999 8888853

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-36  Score=307.76  Aligned_cols=210  Identities=28%  Similarity=0.397  Sum_probs=179.5

Q ss_pred             HHHhhhcCCCcCcccCcCCceeEEEeecCC------CCEEEEEEeecCC-hhcHHHHHHHHHHHhcC-CCCCccceeeEE
Q 008854          318 TIRDATNNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFS  389 (551)
Q Consensus       318 ~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  389 (551)
                      ..+...++|.+.+.||+|+||.||++....      ...||+|++.... ......+.+|+.++.++ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            344556789999999999999999998532      2479999997653 33455789999999999 899999999999


Q ss_pred             ecCCceEEEEEccCCCChhHHhhhhcc-----------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCee
Q 008854          390 FEETERLLIYEFVPNSSVDKFIFDAIK-----------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL  458 (551)
Q Consensus       390 ~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIl  458 (551)
                      ...+..++||||+++++|.+++.....           ...+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence            999999999999999999999975321           346899999999999999999999987   999999999999


Q ss_pred             eCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       459 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  269 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG  269 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence            99999999999999986654433333344567889999999999999999999999999999999 8888864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=309.70  Aligned_cols=199  Identities=27%  Similarity=0.419  Sum_probs=160.9

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ...++|++.+.||+|+||.||+++.. +++.||||+++...  ....+.+|+.++.+++||||+++++++......++||
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            34578999999999999999999965 57889999997653  3346889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC---CCCeEEeecCCcccc
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLF  476 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~Dfgla~~~  476 (551)
                      ||+++++|.+++..   ...+++.++..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++..
T Consensus       128 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          128 ELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             CCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99999999998863   456899999999999999999999987   999999999999975   889999999999865


Q ss_pred             ccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...   .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       202 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  252 (349)
T 2w4o_A          202 EHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD  252 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             Ccc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            432   123345789999999999999999999999999999999999999853

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.2e-36  Score=310.30  Aligned_cols=205  Identities=19%  Similarity=0.267  Sum_probs=177.2

Q ss_pred             hhcCCCcCcccCcC--CceeEEEeecC-CCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          322 ATNNFSTDNKLGQG--GFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       322 ~~~~f~~~~~LG~G--~~g~Vyk~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      ..++|++.++||+|  +||.||+++.. +++.||||++....  ......+.+|+.++++++||||+++++++...+..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            45689999999999  99999999954 68999999997653  333456888999999999999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +||||+++++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            999999999999998753 3356999999999999999999999987   999999999999999999999999998654


Q ss_pred             ccCCC-----cccccccccCCCccccccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          477 EMDQS-----QGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       477 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....     ........||+.|+|||.+.+  ..++.++||||||+++|||++|+.||..
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  239 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  239 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            32211     112233478999999999987  6789999999999999999999999964

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.1e-36  Score=295.32  Aligned_cols=199  Identities=24%  Similarity=0.375  Sum_probs=176.3

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ..++|++.++||+|+||.||++... ++..+|+|++..........+.+|++++++++||||+++++++......++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            4567999999999999999999854 577899999987655667789999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee---CCCCCeEEeecCCccccc
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFE  477 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~Dfgla~~~~  477 (551)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||++..+.
T Consensus        87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            9999999998864   456899999999999999999999987   9999999999999   788999999999998654


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...   ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||..
T Consensus       161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~  209 (277)
T 3f3z_A          161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA  209 (277)
T ss_dssp             TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCC
Confidence            322   23345789999999987654 89999999999999999999999964

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.9e-36  Score=307.14  Aligned_cols=199  Identities=26%  Similarity=0.385  Sum_probs=166.2

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ..++|++.++||+|+||+||+++.. +++.||||++...... ...+.+|+.++++++||||+++++++......++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            3568999999999999999999854 7899999999765432 3468899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC--eEEeecCCcccccc
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI--PKISDFGMARLFEM  478 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~--~kl~Dfgla~~~~~  478 (551)
                      |+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.  +||+|||+++....
T Consensus        97 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           97 YASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            9999999999863   456999999999999999999999987   999999999999987765  99999999974322


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcc-hhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIK-SDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .   .......||+.|+|||.+.+..++.+ +||||||+++|||++|+.||..
T Consensus       171 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  220 (361)
T 3uc3_A          171 H---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED  220 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred             c---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence            1   22334579999999999988887665 8999999999999999999964

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.2e-36  Score=316.75  Aligned_cols=197  Identities=30%  Similarity=0.488  Sum_probs=171.2

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCC-ceEEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET-ERLLIYE  400 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e  400 (551)
                      ..++|++.++||+|+||.||+|... ++.||||+++...  ....|.+|+.++++++||||+++++++.... ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3467888999999999999999974 7899999997654  3457999999999999999999999987765 6899999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..... 
T Consensus       268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  342 (450)
T ss_dssp             CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence            99999999999753 3345799999999999999999999987   999999999999999999999999999853321 


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                          .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~  389 (450)
T 1k9a_A          343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  389 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                122356889999999999999999999999999999999 9999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.1e-36  Score=307.60  Aligned_cols=209  Identities=26%  Similarity=0.304  Sum_probs=181.6

Q ss_pred             ccccChhHHHhhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-----CCCccc
Q 008854          311 SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-----HRNLVR  384 (551)
Q Consensus       311 ~~~~~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~  384 (551)
                      ...+.+.+.....++|.+.++||+|+||+||+++. .+++.||||+++.. ......+..|+.++..++     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            44566666677789999999999999999999985 56889999999753 233456788999999986     999999


Q ss_pred             eeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC---
Q 008854          385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---  461 (551)
Q Consensus       385 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~---  461 (551)
                      +++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.   
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence            999999999999999999 99999998753 3346999999999999999999999987   999999999999976   


Q ss_pred             ----------------------CCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHH
Q 008854          462 ----------------------DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVL  519 (551)
Q Consensus       462 ----------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~  519 (551)
                                            ++.+||+|||+++....     ......||+.|+|||.+.+..++.++||||||+++|
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  250 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA  250 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence                                  78999999999976432     123457899999999999999999999999999999


Q ss_pred             HHHhCCCCCCC
Q 008854          520 EIISGQKNNSF  530 (551)
Q Consensus       520 elltG~~p~~~  530 (551)
                      ||++|+.||..
T Consensus       251 ell~g~~pf~~  261 (360)
T 3llt_A          251 ELYTGSLLFRT  261 (360)
T ss_dssp             HHHHSSCSCCC
T ss_pred             HHHHCCCCCCC
Confidence            99999999964

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.4e-36  Score=306.15  Aligned_cols=212  Identities=27%  Similarity=0.457  Sum_probs=181.2

Q ss_pred             hhHHHhhhcCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeE
Q 008854          316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGF  388 (551)
Q Consensus       316 ~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~  388 (551)
                      .++.+...++|++.+.||+|+||.||+|+..      .++.||+|++.... ......+.+|+.++++++||||++++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            3445566788999999999999999999753      36789999997653 3344578999999999999999999999


Q ss_pred             EecCCceEEEEEccCCCChhHHhhhhcc-------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC
Q 008854          389 SFEETERLLIYEFVPNSSVDKFIFDAIK-------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA  461 (551)
Q Consensus       389 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~  461 (551)
                      +......++||||+++++|.+++.....       ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~  173 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE  173 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcC
Confidence            9999999999999999999999975321       256799999999999999999999987   999999999999999


Q ss_pred             CCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          462 DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       462 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  243 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG  243 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred             CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence            99999999999986544333233344567889999999999999999999999999999999 8888853

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.2e-35  Score=295.65  Aligned_cols=202  Identities=18%  Similarity=0.286  Sum_probs=175.8

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .++|++.+.||+|+||.||++.. .+++.||||++.....  ...+.+|+.++.++ +|+|++++++++......++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999984 5789999999975532  23578899999999 79999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC-----eEEeecCCccc
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI-----PKISDFGMARL  475 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~-----~kl~Dfgla~~  475 (551)
                      |+ +++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        87 ~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 9999999974  2456999999999999999999999987   999999999999987776     99999999987


Q ss_pred             cccCCCc-----ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC
Q 008854          476 FEMDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRI  532 (551)
Q Consensus       476 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~  532 (551)
                      .......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  222 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  222 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence            6543221     12345679999999999999999999999999999999999999997543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.5e-36  Score=302.75  Aligned_cols=206  Identities=30%  Similarity=0.426  Sum_probs=178.5

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec------CCCCEEEEEEeecCCh-hcHHHHHHHHHHHhcC-CCCCccceeeEEecCC
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFSFEET  393 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  393 (551)
                      ..++|++.+.||+|+||.||+++.      .+++.||||++..... .....+.+|+.++.++ +||||+++++++...+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            456889999999999999999974      3467899999976543 3456789999999999 8999999999999999


Q ss_pred             ceEEEEEccCCCChhHHhhhhcc---------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCee
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIK---------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL  458 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIl  458 (551)
                      ..++||||+++++|.+++.....               ...+++..++.++.||++||.|||+.+   |+||||||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence            99999999999999999975321               225899999999999999999999987   999999999999


Q ss_pred             eCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       459 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  250 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG  250 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            99999999999999987654433333344567889999999999999999999999999999999 9999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.8e-36  Score=302.20  Aligned_cols=191  Identities=27%  Similarity=0.387  Sum_probs=151.4

Q ss_pred             CcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEEEccCCCC
Q 008854          329 DNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEFVPNSS  406 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gs  406 (551)
                      .++||+|+||.||+++.. +++.||||++.+.   ....+.+|+.++..+. ||||+++++++.+....++||||+++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            378999999999999854 6899999999754   3456789999999997 9999999999999999999999999999


Q ss_pred             hhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC---CeEEeecCCccccccCCCcc
Q 008854          407 VDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM---IPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       407 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl~Dfgla~~~~~~~~~~  483 (551)
                      |.+++..   ...+++.++..++.||+.||.|||+.+   |+||||||+|||++.++   .+||+|||+++......  .
T Consensus        93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~  164 (325)
T 3kn6_A           93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--Q  164 (325)
T ss_dssp             HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--C
Confidence            9999874   467999999999999999999999987   99999999999997765   89999999998654322  2


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  211 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS  211 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence            23345789999999999999999999999999999999999999964

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6.9e-36  Score=300.17  Aligned_cols=203  Identities=27%  Similarity=0.370  Sum_probs=170.1

Q ss_pred             hcCCCcC-cccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEE
Q 008854          323 TNNFSTD-NKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       323 ~~~f~~~-~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      .+.|.+. +.||+|+||.||+++. .+++.||||++..........+.+|+.++.++ +||||+++++++...+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4567774 7899999999999984 47899999999877655667899999999985 7999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC---eEEeecCCcccc
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI---PKISDFGMARLF  476 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~kl~Dfgla~~~  476 (551)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||++...
T Consensus        91 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           91 EKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999874   356899999999999999999999987   999999999999998776   999999998765


Q ss_pred             ccCCC-----cccccccccCCCccccccccc-----CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          477 EMDQS-----QGDTSRIVGTFGYMAPEYVTR-----GHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       477 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      .....     ........||+.|+|||.+.+     ..++.++||||||+++|||++|+.||...
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  229 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR  229 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence            42211     112234568999999999875     56889999999999999999999999754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.2e-36  Score=294.17  Aligned_cols=199  Identities=34%  Similarity=0.545  Sum_probs=164.2

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCCh----hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      .++|++.++||+|+||.||++... ++.||||++.....    .....+.+|+.+++.++||||+++++++......++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357889999999999999999974 88999999876432    2345788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC--------CCCeEEeec
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--------DMIPKISDF  470 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~--------~~~~kl~Df  470 (551)
                      |||+++++|.+++.    ...+++..++.++.|+++||.|||+.+..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999874    457999999999999999999999987556999999999999986        778999999


Q ss_pred             CCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       471 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      |+++......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  216 (271)
T 3dtc_A          161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG  216 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred             Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9997654322    2245689999999999999999999999999999999999999963

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.1e-36  Score=313.03  Aligned_cols=200  Identities=24%  Similarity=0.385  Sum_probs=168.9

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCC--CCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQ--HRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV  398 (551)
                      .++|++.+.||+|+||.||++....++.||||++....  ......+.+|+.++.+++  ||||+++++++......++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            45699999999999999999998789999999997643  334567899999999996  59999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      || +.+++|.+++..   ...+++.++..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++.+..
T Consensus       135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 678899999874   457899999999999999999999987   99999999999995 58999999999987654


Q ss_pred             CCCcccccccccCCCccccccccc-----------CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTR-----------GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...........||+.|+|||++.+           ..++.++|||||||++|||++|+.||..
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~  269 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  269 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence            333333345679999999999865           4689999999999999999999999963

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.4e-36  Score=329.64  Aligned_cols=201  Identities=27%  Similarity=0.314  Sum_probs=176.2

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  396 (551)
                      ..++|++.+.||+|+||.||+++.. +++.||||++++..   ......+..|..++..+ +||+|+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3467999999999999999999854 57889999997642   22344678899999988 6999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      |||||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            99999999999999974   356999999999999999999999987   999999999999999999999999999853


Q ss_pred             ccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...  ........||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       493 ~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~  544 (674)
T 3pfq_A          493 IWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG  544 (674)
T ss_dssp             CCT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC
Confidence            322  2234557899999999999999999999999999999999999999964

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-36  Score=307.45  Aligned_cols=211  Identities=24%  Similarity=0.320  Sum_probs=174.1

Q ss_pred             hhHHHhhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC-----ChhcHHHHHHHHHHHhcCCCCCccceeeEE
Q 008854          316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN-----SVQGELEFKNEVLLVARLQHRNLVRLLGFS  389 (551)
Q Consensus       316 ~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  389 (551)
                      -.++....++|++.++||+|+||.||+++. .+++.||+|++.+.     .......+.+|+.++++++||||+++++++
T Consensus        18 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   97 (345)
T 3hko_A           18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY   97 (345)
T ss_dssp             CBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence            345567788999999999999999999985 46789999999754     223445789999999999999999999999


Q ss_pred             ecCCceEEEEEccCCCChhHHhhhhcc-------------------------------------cCCCCHHHHHHHHHHH
Q 008854          390 FEETERLLIYEFVPNSSVDKFIFDAIK-------------------------------------RVQLDWETRYKIIGGI  432 (551)
Q Consensus       390 ~~~~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~i  432 (551)
                      .+....++||||+++++|.+++.....                                     ...+++..+..++.||
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A           98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence            999999999999999999998852110                                     1123577788999999


Q ss_pred             HHHHHHHhhCCCCCeEeccCCCCCeeeCCCC--CeEEeecCCccccccCCCc--ccccccccCCCccccccccc--CCCC
Q 008854          433 ARGILYLHEDSRLRIIHRDLKASNILLDADM--IPKISDFGMARLFEMDQSQ--GDTSRIVGTFGYMAPEYVTR--GHFS  506 (551)
Q Consensus       433 a~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~--~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~  506 (551)
                      +.||.|||+.+   |+||||||+|||++.++  .+||+|||+++.+......  .......||+.|+|||.+.+  ..++
T Consensus       178 ~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  254 (345)
T 3hko_A          178 FSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG  254 (345)
T ss_dssp             HHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC
T ss_pred             HHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC
Confidence            99999999987   99999999999998776  8999999999865432211  12345678999999999865  6789


Q ss_pred             cchhhHhHHHHHHHHHhCCCCCC
Q 008854          507 IKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       507 ~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .++||||||+++|||++|+.||.
T Consensus       255 ~~~DiwslG~il~el~~g~~pf~  277 (345)
T 3hko_A          255 PKCDAWSAGVLLHLLLMGAVPFP  277 (345)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCC
Confidence            99999999999999999999985

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.3e-36  Score=293.81  Aligned_cols=203  Identities=27%  Similarity=0.444  Sum_probs=177.2

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467889999999999999999854 68999999997543 3345678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|.+++.   ....+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++..+....
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            999999999885   3456899999999999999999999987   9999999999999999999999999998665433


Q ss_pred             CcccccccccCCCcccccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      .........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  211 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP  211 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence            3333445678999999999987765 78999999999999999999999754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.6e-36  Score=301.89  Aligned_cols=221  Identities=27%  Similarity=0.403  Sum_probs=169.2

Q ss_pred             ccccccccChhHHHhhhcCCCcCcccCcCCceeEEEeecC----CCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCC
Q 008854          307 NTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLS----HGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHR  380 (551)
Q Consensus       307 ~~~~~~~~~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~  380 (551)
                      ...+.++-.+.++....++|.+.+.||+|+||.||++...    .+..||+|+++..  .......+.+|+.++++++||
T Consensus        17 ~~~eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~   96 (313)
T 3brb_A           17 RGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP   96 (313)
T ss_dssp             -------CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCT
T ss_pred             CchHhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCC
Confidence            3444555556666667788999999999999999999753    2447999999754  333445789999999999999


Q ss_pred             CccceeeEEecCCc-----eEEEEEccCCCChhHHhhhhc---ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccC
Q 008854          381 NLVRLLGFSFEETE-----RLLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDL  452 (551)
Q Consensus       381 niv~l~~~~~~~~~-----~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl  452 (551)
                      ||+++++++.....     .++||||+++++|.+++....   ....+++..++.++.||++||.|||+.+   |+||||
T Consensus        97 ~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~di  173 (313)
T 3brb_A           97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDL  173 (313)
T ss_dssp             TBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCC
T ss_pred             CeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence            99999999987553     489999999999999985421   3456999999999999999999999987   999999


Q ss_pred             CCCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          453 KASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       453 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ||+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       174 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  252 (313)
T 3brb_A          174 AARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG  252 (313)
T ss_dssp             SGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCcc
Confidence            99999999999999999999986644332223334567889999999999999999999999999999999 8888864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.9e-36  Score=308.79  Aligned_cols=202  Identities=27%  Similarity=0.438  Sum_probs=162.5

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCC-CCCccceeeEEecCC--c
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEET--E  394 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  394 (551)
                      ...++|++.++||+|+||.||++.. .+++.||||++.+.  .......+.+|+.++.++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3457899999999999999999984 56899999999654  3344556889999999997 999999999997544  6


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .++||||++ ++|..++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            799999998 588888753    47899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccccCC-------------------CcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQ-------------------SQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .+....                   .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            653211                   1112334579999999999876 6789999999999999999999999964

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.3e-36  Score=303.65  Aligned_cols=206  Identities=27%  Similarity=0.429  Sum_probs=176.0

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec--------CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcC-CCCCccceeeEEec
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL--------SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFE  391 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~--------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  391 (551)
                      ..++|.+.+.||+|+||.||+++.        .++..||||++.... ......+.+|+.++.++ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            357889999999999999999985        246789999997653 33455789999999999 89999999999999


Q ss_pred             CCceEEEEEccCCCChhHHhhhhcc-------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCee
Q 008854          392 ETERLLIYEFVPNSSVDKFIFDAIK-------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL  458 (551)
Q Consensus       392 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIl  458 (551)
                      .+..++||||+++++|.+++.....             ...+++..++.++.||++||.|||+.+   |+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence            9999999999999999999975321             235899999999999999999999987   999999999999


Q ss_pred             eCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       459 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  262 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG  262 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence            99999999999999987654333233344567889999999999999999999999999999999 9999863

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.2e-36  Score=319.05  Aligned_cols=202  Identities=30%  Similarity=0.499  Sum_probs=170.7

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ...++|++.++||+|+||.||+|.+.++..||||+++.... ....|.+|+.++++++||||+++++++.+ ...++|||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            34567888999999999999999988888899999976543 35579999999999999999999999876 67899999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus       259 ~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          259 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             CCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             hhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            99999999999642 3356899999999999999999999987   9999999999999999999999999998654322


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      . .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       335 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~  383 (452)
T 1fmk_A          335 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP  383 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             e-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCC
Confidence            1 12223456789999999999999999999999999999999 899985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1e-35  Score=299.83  Aligned_cols=200  Identities=30%  Similarity=0.421  Sum_probs=176.9

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh------cHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ------GELEFKNEVLLVARLQHRNLVRLLGFSFEETE  394 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  394 (551)
                      ..++|++.+.||+|+||.||+++.. +++.||+|++......      ....+.+|+.++.+++||||+++++++.....
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3467899999999999999999854 6899999999765321      35679999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC----CeEEeec
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM----IPKISDF  470 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~kl~Df  470 (551)
                      .++||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence            9999999999999999863   457899999999999999999999987   99999999999999888    7999999


Q ss_pred             CCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       471 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      |+++......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  220 (321)
T 2a2a_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  220 (321)
T ss_dssp             TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence            9998654322   23345789999999999999999999999999999999999999963

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.6e-36  Score=294.21  Aligned_cols=201  Identities=29%  Similarity=0.525  Sum_probs=156.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      -++|.+.+.||+|+||.||+++. .+++.||||++.....   .....+.+|+.++.+++||||+++++++......++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35788999999999999999985 5789999999965421   2245789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|.+++..  ....+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999874  3467999999999999999999999987   99999999999999999999999999986542


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       165 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  214 (278)
T 3cok_A          165 PH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT  214 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            22  122345789999999999998999999999999999999999999964

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.6e-36  Score=315.02  Aligned_cols=198  Identities=26%  Similarity=0.471  Sum_probs=175.3

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|.+.+.||+|+||.||+|+.. +|+.||||++.+...   .....+.+|+.+++.++||||+++++++......++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57889999999999999999854 789999999975422   23457889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++.   +...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        96 E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            9999999999986   3467999999999999999999999987   999999999999999999999999999875432


Q ss_pred             CCcccccccccCCCcccccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .   ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..
T Consensus       170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~  218 (476)
T 2y94_A          170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD  218 (476)
T ss_dssp             C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence            2   2334579999999999988765 6899999999999999999999964

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.5e-36  Score=305.14  Aligned_cols=195  Identities=30%  Similarity=0.479  Sum_probs=170.5

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      .+.|+..+.||+|+||.||+++. .+++.||||++.....   .....+.+|+.++.+++||||+++++++......++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            34588889999999999999984 5789999999976432   2335688999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||++ |+|.+++..  ....+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99997 678777753  3467999999999999999999999987   99999999999999999999999999976432


Q ss_pred             CCCcccccccccCCCcccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                            .....||+.|+|||.+.   ...++.++||||||+++|||++|+.||.
T Consensus       207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  254 (348)
T 1u5q_A          207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  254 (348)
T ss_dssp             ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                  22357899999999884   5678999999999999999999999985

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.6e-36  Score=302.06  Aligned_cols=217  Identities=29%  Similarity=0.414  Sum_probs=182.8

Q ss_pred             ccccChhHHHhhhcCCCcCcccCcCCceeEEEeec------CCCCEEEEEEeecCCh-hcHHHHHHHHHHHhcC-CCCCc
Q 008854          311 SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNL  382 (551)
Q Consensus       311 ~~~~~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni  382 (551)
                      .+.+.........++|.+.+.||+|+||.||+++.      .+++.||||++..... .....+.+|+.++.++ +||||
T Consensus        14 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i   93 (316)
T 2xir_A           14 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV   93 (316)
T ss_dssp             GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             hccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCe
Confidence            34455566666778999999999999999999973      3567899999976533 3445789999999999 69999


Q ss_pred             cceeeEEecCC-ceEEEEEccCCCChhHHhhhhcc-------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 008854          383 VRLLGFSFEET-ERLLIYEFVPNSSVDKFIFDAIK-------------RVQLDWETRYKIIGGIARGILYLHEDSRLRII  448 (551)
Q Consensus       383 v~l~~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii  448 (551)
                      +++++++...+ ..++||||+++++|.+++.....             ...+++..++.++.||++||.|||+.+   |+
T Consensus        94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~  170 (316)
T 2xir_A           94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI  170 (316)
T ss_dssp             CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence            99999987755 48999999999999999975321             123889999999999999999999987   99


Q ss_pred             eccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCC
Q 008854          449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKN  527 (551)
Q Consensus       449 H~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p  527 (551)
                      ||||||+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus       171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p  250 (316)
T 2xir_A          171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP  250 (316)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999986654433333445667899999999999999999999999999999998 9999


Q ss_pred             CCC
Q 008854          528 NSF  530 (551)
Q Consensus       528 ~~~  530 (551)
                      |..
T Consensus       251 ~~~  253 (316)
T 2xir_A          251 YPG  253 (316)
T ss_dssp             STT
T ss_pred             Ccc
Confidence            864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.5e-35  Score=292.86  Aligned_cols=199  Identities=27%  Similarity=0.427  Sum_probs=175.2

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ..++|++.++||+|+||.||++.. .+++.||+|++....  ......+.+|+.++.+++||||+++++++......++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            457899999999999999999985 468899999997543  33445788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC---eEEeecCCccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI---PKISDFGMARL  475 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~kl~Dfgla~~  475 (551)
                      |||+++++|.+.+..   ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||++..
T Consensus        84 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           84 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            999999999988864   456999999999999999999999987   999999999999987665   99999999976


Q ss_pred             cccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .....   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  208 (284)
T 3kk8_A          158 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW  208 (284)
T ss_dssp             CCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCC
Confidence            54322   2234578999999999999999999999999999999999999984

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-35  Score=297.02  Aligned_cols=200  Identities=25%  Similarity=0.366  Sum_probs=169.2

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ++|++.++||+|+||+||+++.. +++.||+|++.....  .....+.+|+.++.+++||||+++++++......++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57889999999999999999864 589999999866532  234568899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            999999998875   3466999999999999999999999987   9999999999999999999999999998654322


Q ss_pred             CcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                        .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  206 (311)
T 4agu_A          157 --DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK  206 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             --cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence              12334578999999999876 67899999999999999999999998643

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.7e-36  Score=296.74  Aligned_cols=195  Identities=25%  Similarity=0.412  Sum_probs=170.7

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCC-C-------CEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSH-G-------QEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE  394 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~-g-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  394 (551)
                      .++|.+.+.||+|+||.||+++... +       ..||+|++..........+.+|+.++++++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4578889999999999999998543 3       4699999987666667789999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC--------eE
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI--------PK  466 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~--------~k  466 (551)
                      .++||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            9999999999999999975  3344899999999999999999999988   999999999999998887        99


Q ss_pred             EeecCCccccccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          467 ISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       467 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                      |+|||++.....      .....+|+.|+|||.+.+ ..++.++||||||+++|||++|..|+
T Consensus       162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~  218 (289)
T 4fvq_A          162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP  218 (289)
T ss_dssp             ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence            999999865321      223467899999999987 77899999999999999999966544

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.1e-36  Score=304.57  Aligned_cols=199  Identities=26%  Similarity=0.383  Sum_probs=174.3

Q ss_pred             hhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChh--------cHHHHHHHHHHHhcCCCCCccceeeEEecC
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQ--------GELEFKNEVLLVARLQHRNLVRLLGFSFEE  392 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  392 (551)
                      ..++|++.++||+|+||.||+++ ..+++.||||++......        ....+.+|+.++++++||||+++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            45789999999999999999998 456889999999765321        223577899999999999999999999999


Q ss_pred             CceEEEEEccCCC-ChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          393 TERLLIYEFVPNS-SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       393 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                      ...++||||+..| +|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999877 9999886   3456999999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCCCcccccccccCCCcccccccccCCC-CcchhhHhHHHHHHHHHhCCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      +++......   ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.
T Consensus       176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  231 (335)
T 3dls_A          176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC  231 (335)
T ss_dssp             TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred             cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchh
Confidence            998654322   2334678999999999988876 889999999999999999999985

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.1e-36  Score=293.41  Aligned_cols=201  Identities=30%  Similarity=0.490  Sum_probs=176.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      .++|++.+.||+|+||.||++...+++.||+|++..... ....+.+|+.++.+++||||+++++++......++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            357888999999999999999988888999999976543 3457899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++++|.+++..  ....+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++...... .
T Consensus        86 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~  159 (267)
T 3t9t_A           86 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y  159 (267)
T ss_dssp             TTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred             CCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-c
Confidence            99999999874  3456899999999999999999999987   9999999999999999999999999998653221 1


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  208 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN  208 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC
Confidence            12233456789999999998999999999999999999999 8988863

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.4e-36  Score=296.69  Aligned_cols=201  Identities=32%  Similarity=0.551  Sum_probs=161.1

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ..++|++.++||+|+||+||+++..  ..||+|+++...  ......+.+|+.++++++||||++++++. .....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            4578999999999999999999864  469999997553  33456789999999999999999999965 556689999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence            99999999999864  3466999999999999999999999987   999999999999999999999999999865433


Q ss_pred             CCcccccccccCCCcccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..........||+.|+|||.+.   +..++.++||||||+++|||++|+.||..
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  227 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN  227 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc
Confidence            3333344567899999999886   66788999999999999999999999964

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.5e-36  Score=297.57  Aligned_cols=198  Identities=27%  Similarity=0.423  Sum_probs=164.9

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhc--CCCCCccceeeEEecC----Cce
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR--LQHRNLVRLLGFSFEE----TER  395 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~  395 (551)
                      ..++|++.++||+|+||+||+|+. +++.||||++...   ....+..|.+++..  ++||||+++++++...    ...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            457899999999999999999987 6899999999654   23445556666555  8999999999987542    457


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEeccCCCCCeeeCCCCCeEE
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH--------EDSRLRIIHRDLKASNILLDADMIPKI  467 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiH~Dlk~~NIll~~~~~~kl  467 (551)
                      ++||||+++++|.+++.    ...+++..++.++.||+.||.|||        +.+   |+||||||+|||++.++.+||
T Consensus        82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred             EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence            89999999999999984    357999999999999999999999        655   999999999999999999999


Q ss_pred             eecCCccccccCCCc--ccccccccCCCcccccccccC------CCCcchhhHhHHHHHHHHHhC----------CCCCC
Q 008854          468 SDFGMARLFEMDQSQ--GDTSRIVGTFGYMAPEYVTRG------HFSIKSDVFSFGVLVLEIISG----------QKNNS  529 (551)
Q Consensus       468 ~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~Gvll~elltG----------~~p~~  529 (551)
                      +|||+++........  .......||+.|+|||.+.+.      .++.++||||||+++|||++|          +.||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            999999865433222  112345799999999999876      556799999999999999999          77775


Q ss_pred             C
Q 008854          530 F  530 (551)
Q Consensus       530 ~  530 (551)
                      .
T Consensus       235 ~  235 (301)
T 3q4u_A          235 D  235 (301)
T ss_dssp             T
T ss_pred             c
Confidence            3

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-35  Score=293.43  Aligned_cols=198  Identities=30%  Similarity=0.475  Sum_probs=171.7

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      .++|++.+.||+|+||.||++... ++..||+|++.....   .....+.+|+.++++++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467889999999999999999854 577899999965422   2345688999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            999999999999864   356899999999999999999999987   99999999999999999999999999864332


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .    ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  209 (279)
T 3fdn_A          162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA  209 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC
Confidence            2    22345789999999999999999999999999999999999999863

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-36  Score=308.61  Aligned_cols=202  Identities=28%  Similarity=0.391  Sum_probs=172.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeec----CCCCEEEEEEeecCC----hhcHHHHHHHHHHHhcC-CCCCccceeeEEecCC
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNS----VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEET  393 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  393 (551)
                      .++|++.++||+|+||.||+++.    .+++.||||++++..    ......+.+|+.++.++ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            35789999999999999999986    468999999986532    12234577899999999 6999999999999999


Q ss_pred             ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCc
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA  473 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla  473 (551)
                      ..++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999999974   356999999999999999999999987   999999999999999999999999999


Q ss_pred             cccccCCCcccccccccCCCccccccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      +.+..... .......||+.|+|||.+.+  ..++.++||||||+++|||++|+.||...
T Consensus       207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  265 (355)
T 1vzo_A          207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD  265 (355)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence            86543222 22334679999999999985  35789999999999999999999999643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.2e-36  Score=302.26  Aligned_cols=202  Identities=29%  Similarity=0.487  Sum_probs=165.5

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCE----EEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQE----IAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      .++|++.++||+|+||.||+++.. +++.    |++|.+... .......+.+|+.++.+++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            467899999999999999999843 4443    577777543 3345668999999999999999999999998754 78


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +|+||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            99999999999999875  3456999999999999999999999987   999999999999999999999999999876


Q ss_pred             ccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      .............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~  222 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG  222 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            54433333344567889999999999999999999999999999999 9999864

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8.1e-36  Score=303.09  Aligned_cols=198  Identities=23%  Similarity=0.368  Sum_probs=170.6

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ..++|++.+.||+|+||.||+++.. +++.||||++.+....    ..+|++++.++ +||||+++++++.+....++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4567999999999999999999854 6889999999765432    34677888777 7999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC-C---CeEEeecCCccc
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-M---IPKISDFGMARL  475 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~-~---~~kl~Dfgla~~  475 (551)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+.++ +   .+||+|||+++.
T Consensus        96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999998863   457999999999999999999999987   9999999999998443 3   599999999986


Q ss_pred             cccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      .....  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       170 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  223 (342)
T 2qr7_A          170 LRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG  223 (342)
T ss_dssp             CBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             CcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence            54332  2234467899999999998888999999999999999999999999743

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.8e-36  Score=295.21  Aligned_cols=202  Identities=25%  Similarity=0.397  Sum_probs=162.2

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCC----CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      ..++|++.+.||+|+||.||+|....    +..||+|++.... ......+.+|+.++++++||||+++++++. ++..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            35678899999999999999998542    4569999987643 334557899999999999999999999974 56788


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        92 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence            99999999999999874  3456999999999999999999999987   999999999999999999999999999865


Q ss_pred             ccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       167 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~  220 (281)
T 1mp8_A          167 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG  220 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             Ccccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCc
Confidence            43221 12233456789999999999999999999999999999997 9989864

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.2e-35  Score=292.26  Aligned_cols=198  Identities=32%  Similarity=0.621  Sum_probs=169.0

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcH-------HHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGE-------LEFKNEVLLVARLQHRNLVRLLGFSFEETE  394 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  394 (551)
                      .++|++.+.||+|+||.||+++. .+++.||+|++........       ..+.+|+.++.+++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            46789999999999999999985 5789999999965432211       57889999999999999999999986554 


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC-----eEEee
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI-----PKISD  469 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~-----~kl~D  469 (551)
                       ++||||+++++|.+++.+  ....+++..++.++.|++.||.|||+.+ ++|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             799999999999998864  4557999999999999999999999875 34999999999999988776     99999


Q ss_pred             cCCccccccCCCcccccccccCCCccccccc--ccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYV--TRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       470 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ||+++....     ......||+.|+|||.+  ....++.++||||||+++|||++|+.||..
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  230 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE  230 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            999974322     23345789999999998  455678999999999999999999999964

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-35  Score=295.92  Aligned_cols=201  Identities=29%  Similarity=0.461  Sum_probs=168.1

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh-----hcHHHHHHHHHHHhcC---CCCCccceeeEEecC
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV-----QGELEFKNEVLLVARL---QHRNLVRLLGFSFEE  392 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~  392 (551)
                      ..++|++.++||+|+||+||+++. .+++.||||++.....     .....+.+|+.+++++   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457899999999999999999984 5689999999964321     1123566777777666   499999999999775


Q ss_pred             C-----ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEE
Q 008854          393 T-----ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI  467 (551)
Q Consensus       393 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl  467 (551)
                      .     ..++||||+. ++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     4689999997 5999988743 2344999999999999999999999998   999999999999999999999


Q ss_pred             eecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       468 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +|||+++.....   .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       162 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  221 (308)
T 3g33_A          162 ADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG  221 (308)
T ss_dssp             CSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred             eeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999865422   223456789999999999999999999999999999999999999953

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-35  Score=294.44  Aligned_cols=202  Identities=26%  Similarity=0.397  Sum_probs=171.3

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ..++|.+.++||+|+||.||+++. .++..+|+|++.... ......+.+|++++++++||||+++++++......++||
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            346788999999999999999985 468899999997653 334567899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee---CCCCCeEEeecCCccc
Q 008854          400 EFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARL  475 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~Dfgla~~  475 (551)
                      ||+++++|.+++.... ....+++..++.++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++.
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            9999999999986532 3467999999999999999999999987   9999999999999   5567899999999986


Q ss_pred             cccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +....   ......||+.|+|||.+. +.++.++||||||+++|||++|+.||..
T Consensus       177 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~  227 (285)
T 3is5_A          177 FKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG  227 (285)
T ss_dssp             -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence            54322   233457899999999875 5689999999999999999999999863

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.2e-36  Score=311.71  Aligned_cols=199  Identities=17%  Similarity=0.198  Sum_probs=163.7

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC---ChhcHHHHHHHH---HHHhcCCCCCcccee-------e
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN---SVQGELEFKNEV---LLVARLQHRNLVRLL-------G  387 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~  387 (551)
                      ..++|.+.++||+|+||+||+|+. .+|+.||||++...   .......+.+|+   +++++++||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            457889999999999999999995 56899999999743   333456788999   556666899999998       5


Q ss_pred             EEecCC-----------------ceEEEEEccCCCChhHHhhhhcc----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 008854          388 FSFEET-----------------ERLLIYEFVPNSSVDKFIFDAIK----RVQLDWETRYKIIGGIARGILYLHEDSRLR  446 (551)
Q Consensus       388 ~~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  446 (551)
                      ++...+                 ..++||||+ +|+|.+++.....    ...+++..++.++.||++||.|||+.+   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            555443                 278999999 6899999975321    122446888999999999999999987   


Q ss_pred             eEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccC-----------CCCcchhhHhHH
Q 008854          447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-----------HFSIKSDVFSFG  515 (551)
Q Consensus       447 iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~S~G  515 (551)
                      |+||||||+||||+.++.+||+|||+++....     ......| +.|+|||.+.+.           .++.++||||||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            99999999999999999999999999985321     2334567 999999999887           899999999999


Q ss_pred             HHHHHHHhCCCCCCC
Q 008854          516 VLVLEIISGQKNNSF  530 (551)
Q Consensus       516 vll~elltG~~p~~~  530 (551)
                      +++|||++|+.||..
T Consensus       301 ~il~elltg~~Pf~~  315 (377)
T 3byv_A          301 LVIYWIWCADLPITK  315 (377)
T ss_dssp             HHHHHHHHSSCCC--
T ss_pred             HHHHHHHHCCCCCcc
Confidence            999999999999963

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.9e-36  Score=315.02  Aligned_cols=196  Identities=27%  Similarity=0.351  Sum_probs=164.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCC------
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET------  393 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  393 (551)
                      .++|++.++||+|+||+||++.. .+++.||||++.+.  .......+.+|+.+++.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            57899999999999999999984 46889999999765  3334557889999999999999999999996553      


Q ss_pred             ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCc
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA  473 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla  473 (551)
                      ..++||||++++ |.+.+.     ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            469999999875 544442     34899999999999999999999987   999999999999999999999999999


Q ss_pred             cccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +.....   .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g  265 (464)
T 3ttj_A          212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  265 (464)
T ss_dssp             -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence            865432   223456899999999999999999999999999999999999999964

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.6e-35  Score=291.89  Aligned_cols=200  Identities=26%  Similarity=0.403  Sum_probs=176.3

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      .++|.+.+.||+|+||.||++... +++.+|+|++....   ......+.+|+.++++++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467889999999999999999864 57889999997642   23455788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|.+++..   ...+++.+++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999998763   457999999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  217 (294)
T 2rku_A          168 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET  217 (294)
T ss_dssp             TT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             Cc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            22  223345789999999999999999999999999999999999999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.5e-35  Score=298.85  Aligned_cols=200  Identities=26%  Similarity=0.407  Sum_probs=176.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecC---ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN---SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      .++|.+.+.||+|+||.||+++.. +++.||+|++...   .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            457888999999999999999854 5788999999764   223455788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|.+++..   ...+++.+++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999998863   457999999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       194 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  243 (335)
T 2owb_A          194 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET  243 (335)
T ss_dssp             TT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             Cc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence            22  223345789999999999999999999999999999999999999964

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.5e-36  Score=296.17  Aligned_cols=205  Identities=30%  Similarity=0.482  Sum_probs=178.9

Q ss_pred             HhhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          320 RDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       320 ~~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      +...++|++.++||+|+||.||++... ++..||+|++.... .....+.+|+.++++++||||+++++++......++|
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   87 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   87 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence            345678899999999999999999865 47889999997654 3455789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|.+++... ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           88 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            9999999999999753 3456999999999999999999999987   99999999999999999999999999987553


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      .. ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       164 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~  215 (288)
T 3kfa_A          164 DT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG  215 (288)
T ss_dssp             SS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             Cc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            32 222334567889999999999999999999999999999999 8888863

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.8e-35  Score=290.84  Aligned_cols=198  Identities=29%  Similarity=0.456  Sum_probs=172.6

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh------cHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ------GELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      ++|++.+.||+|+||.||+++.. +++.||+|+++.....      ....+.+|+.++++++||||+++++++......+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            56889999999999999999865 6899999999764321      3567999999999999999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC----CeEEeecCC
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM----IPKISDFGM  472 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~kl~Dfgl  472 (551)
                      +||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||+++.++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            99999999999999864   457899999999999999999999987   99999999999998877    899999999


Q ss_pred             ccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +.......   ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  213 (283)
T 3bhy_A          159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  213 (283)
T ss_dssp             CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence            98654322   22345689999999999999999999999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.1e-35  Score=296.59  Aligned_cols=201  Identities=30%  Similarity=0.493  Sum_probs=171.7

Q ss_pred             cCCCcCcccCcCCceeEEEeec-----CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecC--Cce
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TER  395 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  395 (551)
                      +.|++.++||+|+||.||++++     .+++.||+|++.... ......+.+|+.++.+++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588899999999999999983     467899999997543 33456789999999999999999999999876  567


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            899999999999999964  3456999999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCc-ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          476 FEMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ....... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  230 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS  230 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence            6543221 22334567888999999999999999999999999999999998753

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=297.17  Aligned_cols=197  Identities=28%  Similarity=0.449  Sum_probs=164.7

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccC
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      ++|++.+.||+|+||.||+++.. ++.||||++....  ....+.+|++++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            56788899999999999999874 7889999996543  3457899999999999999999999876  45799999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC-eEEeecCCccccccCCCc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI-PKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~-~kl~Dfgla~~~~~~~~~  482 (551)
                      +++|.+++........+++..++.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999976433446889999999999999999999943334999999999999998886 799999999754321   


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  205 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE  205 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence              2234689999999999999999999999999999999999999964

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.9e-35  Score=306.96  Aligned_cols=196  Identities=24%  Similarity=0.311  Sum_probs=159.9

Q ss_pred             cCCCcC-cccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHH-hcCCCCCccceeeEEec----CCceE
Q 008854          324 NNFSTD-NKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLV-ARLQHRNLVRLLGFSFE----ETERL  396 (551)
Q Consensus       324 ~~f~~~-~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~  396 (551)
                      ++|.+. +.||+|+||+||++.. .+++.||||++...     ..+.+|+.++ +..+||||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            455555 6899999999999985 46889999999643     3567788876 44589999999998865    55678


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC---CCCeEEeecCCc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMA  473 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~Dfgla  473 (551)
                      +||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            999999999999999752 2346999999999999999999999987   999999999999997   789999999999


Q ss_pred             cccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      +.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  266 (400)
T 1nxk_A          212 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_dssp             EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             cccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence            864422   2234567899999999999999999999999999999999999999643

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.8e-35  Score=296.43  Aligned_cols=200  Identities=22%  Similarity=0.351  Sum_probs=165.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh---cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      -++|++.+.||+|+||.||++... +++.||+|++......   ....+.+|+.++.+++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            367999999999999999999854 6889999999765322   235788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            999999999999874   356999999999999999999999987   99999999999999999999999999976543


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .. ........|++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       187 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (309)
T 2h34_A          187 EK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQ  236 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred             cc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCC
Confidence            22 122334568999999999999999999999999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.8e-35  Score=295.65  Aligned_cols=198  Identities=27%  Similarity=0.439  Sum_probs=173.1

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ..++|.+.+.||+|+||.||+++.. +|+.||+|++..........+.+|+.++.+++||||+++++++......++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3467889999999999999999854 689999999987654455678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee---CCCCCeEEeecCCccccc
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFE  477 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~Dfgla~~~~  477 (551)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||++   +.++.+||+|||+++...
T Consensus        87 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           87 LVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             cCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            9999999998864   456899999999999999999999987   9999999999999   788999999999987533


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .    .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       161 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  208 (304)
T 2jam_A          161 N----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY  208 (304)
T ss_dssp             C----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             C----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            2    12334568999999999999999999999999999999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.1e-35  Score=293.22  Aligned_cols=202  Identities=33%  Similarity=0.527  Sum_probs=174.4

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ..++|++.+.||+|+||.||++...++..||+|++.... .....+.+|++++++++||||+++++++. .+..++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence            446788999999999999999998888899999997654 23567899999999999999999999986 4568899999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++... ....+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++........
T Consensus        89 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            9999999998642 2236899999999999999999999987   99999999999999999999999999987543221


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                       .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  213 (279)
T 1qpc_A          165 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG  213 (279)
T ss_dssp             -ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             -ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence             12233456789999999998899999999999999999999 8888853

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9.5e-36  Score=300.84  Aligned_cols=202  Identities=29%  Similarity=0.484  Sum_probs=176.0

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-----CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEec--CCce
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE--ETER  395 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  395 (551)
                      .++|++.++||+|+||.||++++     .+++.||||++..........+.+|++++++++||||+++++++..  ....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            35788899999999999999983     4678899999988776666789999999999999999999999874  4567


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            8999999999999999752  346999999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCc-ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          476 FEMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ....... .......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~  231 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC  231 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence            6433221 12334567888999999999999999999999999999999999874

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.8e-36  Score=309.63  Aligned_cols=202  Identities=27%  Similarity=0.429  Sum_probs=174.8

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCC--ceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEET--ERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV  398 (551)
                      .++|.+.++||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            467899999999999999999854 58999999997643 234567889999999999999999999998765  67899


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee----CCCCCeEEeecCCcc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DADMIPKISDFGMAR  474 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~kl~Dfgla~  474 (551)
                      |||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999976544555999999999999999999999987   9999999999999    778889999999998


Q ss_pred             ccccCCCcccccccccCCCccccccccc--------CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTR--------GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ......   ......||+.|+|||.+.+        ..++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~  225 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            654322   2334578999999998865        5678899999999999999999999964

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2e-35  Score=309.97  Aligned_cols=200  Identities=25%  Similarity=0.436  Sum_probs=166.9

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecC-----C
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-----T  393 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  393 (551)
                      ..++|.+.+.||+|+||.||+++. .+++.||||++...  .......+.+|+.++++++||||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            357899999999999999999985 46788999999764  333455789999999999999999999998766     5


Q ss_pred             ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCc
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA  473 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla  473 (551)
                      ..++||||+. ++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       104 ~~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            6899999987 58998886   3466999999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCc--------------------ccccccccCCCccccccc-ccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          474 RLFEMDQSQ--------------------GDTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       474 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                      +........                    ......+||+.|+|||.+ ....++.++||||||+++|||++|..|+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            876432211                    123456889999999986 5667999999999999999999865554

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.4e-35  Score=297.30  Aligned_cols=200  Identities=29%  Similarity=0.432  Sum_probs=169.4

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ++|++.+.||+|+||.||+++.. +++.||||++.....  .....+.+|+.++.+++||||+++++++......++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            57889999999999999999854 589999999866532  234467899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus       105 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          105 FVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             CCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             cCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            999999988765   3456999999999999999999999987   9999999999999999999999999997654322


Q ss_pred             CcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                        .......||+.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus       179 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  228 (331)
T 4aaa_A          179 --EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD  228 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             --cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence              123345689999999998775 7899999999999999999999998643

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-35  Score=312.36  Aligned_cols=195  Identities=24%  Similarity=0.419  Sum_probs=154.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecC-----Cc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-----TE  394 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  394 (551)
                      .++|++.++||+|+||+||+++. .+++.||||++.+.  .......+.+|+.++.+++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            46899999999999999999984 46899999999764  333456789999999999999999999998543     46


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .++||||+ +++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            89999987 478888875   3467999999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCCCc-------------------------ccccccccCCCccccccc-ccCCCCcchhhHhHHHHHHHHHhC
Q 008854          475 LFEMDQSQ-------------------------GDTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISG  524 (551)
Q Consensus       475 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~S~Gvll~elltG  524 (551)
                      ........                         ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            76422111                         123345789999999976 566799999999999999999994

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.9e-36  Score=322.78  Aligned_cols=202  Identities=30%  Similarity=0.500  Sum_probs=175.3

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ...++|++.++||+|+||.||+|.+.++..||||+++.... ...+|.+|+.++++++||||+++++++.+ ...+||||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            34567889999999999999999988888899999976543 35579999999999999999999999876 67899999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|.++|... ....+++.+++.++.||++||.|||+.+   |+||||||+||||++++.+||+|||+++......
T Consensus       342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            99999999999642 3356899999999999999999999987   9999999999999999999999999998654221


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                       ........++..|+|||.+....++.++||||||+++|||++ |+.||.
T Consensus       418 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~  466 (535)
T 2h8h_A          418 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP  466 (535)
T ss_dssp             -HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSST
T ss_pred             -eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence             111223456789999999999999999999999999999999 898885

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4e-35  Score=291.39  Aligned_cols=200  Identities=29%  Similarity=0.470  Sum_probs=171.1

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccC
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      .|.....||+|+||.||+|.. .+++.||||++..........+.+|+.++..++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            455566999999999999984 5688999999987665556679999999999999999999999999999999999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC-CCCeEEeecCCccccccCCCc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      +++|.+++........+++..+..++.|++.||.|||+.+   |+|+||||+||+++. ++.+||+|||++.......  
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--  177 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--  177 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence            9999999976444456789999999999999999999987   999999999999987 8999999999998654321  


Q ss_pred             ccccccccCCCcccccccccCC--CCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGH--FSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .......|++.|+|||.+.+..  ++.++||||||+++|||++|+.||.
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  226 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY  226 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence            1233457899999999987653  7899999999999999999999985

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.1e-35  Score=290.83  Aligned_cols=197  Identities=27%  Similarity=0.440  Sum_probs=174.3

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|+||.||+++.. +++.||+|++....   ......+.+|+.++.+++||||+++++++......++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57889999999999999999854 57789999996542   123457899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            99999999999874   356899999999999999999999987   999999999999999999999999998754321


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                          ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       168 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  214 (284)
T 2vgo_A          168 ----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS  214 (284)
T ss_dssp             ----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC
Confidence                22345789999999999999999999999999999999999999964

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.6e-35  Score=309.52  Aligned_cols=200  Identities=24%  Similarity=0.399  Sum_probs=163.4

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh--------hcHHHHHHHHHHHhcCCCCCccceeeEEec
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV--------QGELEFKNEVLLVARLQHRNLVRLLGFSFE  391 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  391 (551)
                      ...++|.+.++||+|+||+||++.. .+++.||||++.+...        .....+.+|+.++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4567899999999999999999984 4688999999975421        112247899999999999999999999754


Q ss_pred             CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC---CeEEe
Q 008854          392 ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM---IPKIS  468 (551)
Q Consensus       392 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl~  468 (551)
                       ...++||||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+||+
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             -CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence             55789999999999998875   3567999999999999999999999987   99999999999997544   59999


Q ss_pred             ecCCccccccCCCcccccccccCCCcccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       469 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      |||+++.....   .......||+.|+|||++.   ...++.++||||||+++|||++|+.||..
T Consensus       285 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~  346 (419)
T 3i6u_A          285 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE  346 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            99999875432   2234567999999999985   36788999999999999999999999964

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2e-35  Score=289.64  Aligned_cols=196  Identities=23%  Similarity=0.367  Sum_probs=169.5

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecC--CceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~  399 (551)
                      ++|++.++||+|+||.||+++.. ++.||||+++...  ......+.+|+.++++++||||+++++++...  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            57888999999999999999984 8899999997653  34455799999999999999999999999877  6789999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++... ....+++..++.++.||++||.|||+.+ ++|+||||||+|||++.++.++|.|||+.....  
T Consensus        89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--  164 (271)
T ss_dssp             ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred             cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence            999999999999752 2336899999999999999999999864 459999999999999999999999998875422  


Q ss_pred             CCcccccccccCCCcccccccccCCCCc---chhhHhHHHHHHHHHhCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSI---KSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDv~S~Gvll~elltG~~p~~  529 (551)
                           .....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||.
T Consensus       165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  212 (271)
T 3kmu_A          165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA  212 (271)
T ss_dssp             -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred             -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence                 22346899999999998765544   8999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.8e-35  Score=291.70  Aligned_cols=199  Identities=27%  Similarity=0.443  Sum_probs=176.7

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .+.|+..++||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++.+++||||+++++++......++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            45688899999999999999984 468899999997653 3345679999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|.+++.    ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999885    357999999999999999999999987   9999999999999999999999999998654322


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  221 (303)
T 3a7i_A          174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE  221 (303)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence              223445789999999999999999999999999999999999999863

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-35  Score=292.37  Aligned_cols=201  Identities=30%  Similarity=0.500  Sum_probs=171.9

Q ss_pred             cCCCcCc-ccCcCCceeEEEeecC---CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          324 NNFSTDN-KLGQGGFGAVYKGRLS---HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       324 ~~f~~~~-~LG~G~~g~Vyk~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ++|.+.+ .||+|+||.||+|...   .+..||||+++... ......+.+|+.++.+++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4556665 8999999999999743   57789999997753 34456789999999999999999999999 45668999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|.+++..  ....+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999999999999864  3456999999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCCc-ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          479 DQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       479 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      .... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  216 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK  216 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            3221 12233456889999999998899999999999999999998 9999864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=300.56  Aligned_cols=208  Identities=26%  Similarity=0.347  Sum_probs=162.5

Q ss_pred             HhhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-CCCccceeeEEe-------
Q 008854          320 RDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSF-------  390 (551)
Q Consensus       320 ~~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-------  390 (551)
                      .....+|++.++||+|+||.||+++. .+++.||||++..........+.+|+.++.++. ||||+++++++.       
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            34456899999999999999999985 478999999997776666678999999999996 999999999984       


Q ss_pred             -cCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEee
Q 008854          391 -EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD  469 (551)
Q Consensus       391 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~D  469 (551)
                       .....++||||+. |+|.+++........+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+|
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence             2334789999996 789998876555667999999999999999999999874 3599999999999999999999999


Q ss_pred             cCCccccccCCCcc----------cccccccCCCccccccc---ccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          470 FGMARLFEMDQSQG----------DTSRIVGTFGYMAPEYV---TRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       470 fgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ||+++.........          ......||+.|+|||.+   .+..++.++||||||+++|||++|+.||.
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  254 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE  254 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence            99998754322111          11244689999999998   56778999999999999999999999985

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=299.81  Aligned_cols=199  Identities=25%  Similarity=0.427  Sum_probs=164.3

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhc-HHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQG-ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ++|.+.++||+|+||+||+++.. +++.||+|++....... ...+.+|+.++++++||||+++++++......++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            47888999999999999999854 68899999997543221 11356799999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      ++ ++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            98 588888764  3456999999999999999999999987   9999999999999999999999999997543221 


Q ss_pred             cccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                       .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  203 (324)
T 3mtl_A          155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG  203 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence             22334578999999999876 5789999999999999999999999964

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-35  Score=303.86  Aligned_cols=199  Identities=25%  Similarity=0.381  Sum_probs=175.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .++|++.++||+|+||.||++... +++.||+|++.... ......+.+|+.++.+++||||+++++++......++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            467899999999999999999854 68899999997653 3345578999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++......
T Consensus       112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999864   35689999999999999999999985 6   999999999999999999999999999755322


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                          ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                223457899999999999999999999999999999999999999643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.5e-35  Score=302.08  Aligned_cols=208  Identities=24%  Similarity=0.329  Sum_probs=170.5

Q ss_pred             cChhHHHhhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChh-----------cHHHHHHHHHHHhcCCCCCc
Q 008854          314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ-----------GELEFKNEVLLVARLQHRNL  382 (551)
Q Consensus       314 ~~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni  382 (551)
                      ....++....++|.+.+.||+|+||.||++...+++.||||++......           ....+.+|+.++.+++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            3456778889999999999999999999999888999999999653211           12578999999999999999


Q ss_pred             cceeeEEecC-----CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCe
Q 008854          383 VRLLGFSFEE-----TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI  457 (551)
Q Consensus       383 v~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NI  457 (551)
                      +++++++...     ...++||||++ ++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI  165 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI  165 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence            9999998542     35789999998 678877764  3457999999999999999999999987   99999999999


Q ss_pred             eeCCCCCeEEeecCCccccccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          458 LLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       458 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      |++.++.+||+|||+++.....   .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  236 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG  236 (362)
T ss_dssp             EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             EEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence            9999999999999999754322   22334578999999998876 6789999999999999999999999964

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.8e-35  Score=300.30  Aligned_cols=205  Identities=22%  Similarity=0.430  Sum_probs=177.1

Q ss_pred             hHHHhhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh--------hcHHHHHHHHHHHhcC-CCCCcccee
Q 008854          317 STIRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--------QGELEFKNEVLLVARL-QHRNLVRLL  386 (551)
Q Consensus       317 ~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~  386 (551)
                      .......++|.+.+.||+|+||.||+++.. +|+.||||++.....        .....+.+|+.++.++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            334455678999999999999999999864 789999999976531        1134578899999999 799999999


Q ss_pred             eEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeE
Q 008854          387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPK  466 (551)
Q Consensus       387 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~k  466 (551)
                      +++......++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+|+||||+|||++.++.+|
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence            999999999999999999999999874   456999999999999999999999987   99999999999999999999


Q ss_pred             EeecCCccccccCCCcccccccccCCCccccccccc------CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          467 ISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR------GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       467 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      |+|||++..+....   ......||+.|+|||++.+      ..++.++||||||+++|||++|+.||..
T Consensus       241 l~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  307 (365)
T 2y7j_A          241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH  307 (365)
T ss_dssp             ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence            99999998654322   2344679999999998863      3688999999999999999999999853

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-35  Score=301.47  Aligned_cols=195  Identities=26%  Similarity=0.411  Sum_probs=164.5

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCC------
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET------  393 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  393 (551)
                      .++|++.+.||+|+||.||++.. .+|+.||||++...  .......+.+|+.++++++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46789999999999999999985 56899999999654  2233456889999999999999999999997653      


Q ss_pred             ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCc
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA  473 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla  473 (551)
                      ..++||||+ +++|.+++..    ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 8899998853    56899999999999999999999987   999999999999999999999999999


Q ss_pred             cccccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +.....     .....+|+.|+|||.+.+ ..++.++||||+|+++|||++|+.||..
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  228 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG  228 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence            864422     334578999999999877 6899999999999999999999999964

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-35  Score=323.40  Aligned_cols=201  Identities=30%  Similarity=0.488  Sum_probs=166.7

Q ss_pred             cCCCcCc-ccCcCCceeEEEeecC---CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          324 NNFSTDN-KLGQGGFGAVYKGRLS---HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       324 ~~f~~~~-~LG~G~~g~Vyk~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      +++.+.+ +||+|+||.||+|.+.   ++..||||+++... .....++.+|++++++++||||+++++++.. +..++|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            3344444 7999999999999753   45679999997653 3356689999999999999999999999976 568999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            999999999999864  3556999999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCCc-ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          479 DQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       479 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      .... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~  542 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK  542 (613)
T ss_dssp             -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            3221 11223345789999999999999999999999999999998 9999964

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-35  Score=298.21  Aligned_cols=202  Identities=31%  Similarity=0.536  Sum_probs=167.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCC-----CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSH-----GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~-----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      .++|...+.||+|+||.||+|....     +..||||+++... ......+.+|+.++.+++||||+++++++......+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3567788999999999999998542     2359999997653 334557899999999999999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999874  3467999999999999999999999987   999999999999999999999999999876


Q ss_pred             ccCCCc-ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          477 EMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       477 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~  252 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW  252 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcc
Confidence            433211 11223346788999999999999999999999999999999 999985

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.1e-35  Score=298.36  Aligned_cols=206  Identities=33%  Similarity=0.530  Sum_probs=171.8

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec------CCCCEEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE  394 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  394 (551)
                      ..++|.+.+.||+|+||.||+++.      .++..||||++... .......+.+|+.++.+++||||+++++++.....
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            356899999999999999999984      24678999999754 33455678999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcc----cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC---CCCeEE
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIK----RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKI  467 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl  467 (551)
                      .++||||+++++|.+++.....    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999975321    145899999999999999999999987   999999999999984   456999


Q ss_pred             eecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       468 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      +|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  248 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS  248 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            99999986544333333445567899999999999999999999999999999998 8888863

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.8e-35  Score=290.69  Aligned_cols=202  Identities=27%  Similarity=0.449  Sum_probs=169.9

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCC----CCEEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      ..++|.+.+.||+|+||.||+++..+    +..||+|++... .......+.+|+.++++++||||+++++++.+ ...+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            35678899999999999999998532    235999999765 33445679999999999999999999999764 4568


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +||||+++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            99999999999999975  3456899999999999999999999987   999999999999999999999999999865


Q ss_pred             ccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~  217 (281)
T 3cc6_A          164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW  217 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence            43221 12233456889999999999999999999999999999998 9999853

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.7e-35  Score=289.88  Aligned_cols=199  Identities=27%  Similarity=0.405  Sum_probs=169.6

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEec----CCce
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFE----ETER  395 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  395 (551)
                      ...|.+.+.||+|+||.||+|.. .++..||+|++...  .......+.+|+.++++++||||+++++++..    ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            34577888999999999999985 46788999999754  33445578999999999999999999998865    3457


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC-CCCCeEEeecCCcc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPKISDFGMAR  474 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~Dfgla~  474 (551)
                      ++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+ ++|+||||||+|||++ +++.+||+|||++.
T Consensus       105 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            899999999999999964   366899999999999999999999875 3599999999999997 78999999999997


Q ss_pred             ccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....    ......||+.|+|||.+. +.++.++||||||+++|||++|+.||..
T Consensus       181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~  231 (290)
T 1t4h_A          181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSE  231 (290)
T ss_dssp             GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence            54322    233456899999999876 5589999999999999999999999963

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-35  Score=303.88  Aligned_cols=200  Identities=28%  Similarity=0.474  Sum_probs=159.0

Q ss_pred             CCCcCcccCcCCceeEEEeecC--CC--CEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEec-CCceEEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS--HG--QEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFE-ETERLLI  398 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~--~g--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV  398 (551)
                      .|.+.+.||+|+||+||+|++.  ++  ..||||.++... ......+.+|+.++++++||||+++++++.. ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4667789999999999999853  22  358999987543 3445679999999999999999999998765 4577899


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999964  3456899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCCc--ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          479 DQSQ--GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       479 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ....  .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~  298 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP  298 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCC
Confidence            2211  12233457889999999999999999999999999999999 566664

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.7e-35  Score=298.14  Aligned_cols=202  Identities=24%  Similarity=0.456  Sum_probs=170.7

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecC-------
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEE-------  392 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  392 (551)
                      .++|++.++||+|+||.||+++. .+++.||||++.....  .....+.+|+.++++++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            36789999999999999999985 5789999999865432  2244678999999999999999999998763       


Q ss_pred             -CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          393 -TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       393 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                       +..++||||+++ +|.+.+..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence             457899999985 67666654  3456999999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCCC--cccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          472 MARLFEMDQS--QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       472 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +++.+.....  ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  231 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG  231 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCC
Confidence            9987643221  222344578999999998876 5689999999999999999999999864

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.3e-35  Score=291.53  Aligned_cols=201  Identities=24%  Similarity=0.455  Sum_probs=165.2

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC---ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN---SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.++||+|+||.||++.. .+++.||+|++...   .......+.+|+.++++++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            5688999999999999999984 57899999999753   2334557889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          400 EFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      ||+++++|.+++.... ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            9999999999987532 3456899999999999999999999987   99999999999999999999999999976543


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ..  .......|++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       189 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  237 (310)
T 2wqm_A          189 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY  237 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            22  12234568999999999999999999999999999999999999985

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-35  Score=299.25  Aligned_cols=200  Identities=26%  Similarity=0.420  Sum_probs=163.5

Q ss_pred             hhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChh--cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ..++|++.++||+|+||+||+++ ..+++.||||++......  ....+.+|+.++++++||||+++++++......++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            34679999999999999999998 447889999999765332  234678999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee-----CCCCCeEEeecCCc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-----DADMIPKISDFGMA  473 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll-----~~~~~~kl~Dfgla  473 (551)
                      |||+++ +|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+     +.++.+||+|||++
T Consensus       112 ~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            999984 89988863   456999999999999999999999987   9999999999999     45556999999999


Q ss_pred             cccccCCCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +.+....  .......||+.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       185 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  240 (329)
T 3gbz_A          185 RAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG  240 (329)
T ss_dssp             HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            8654322  223345689999999998874 589999999999999999999999863

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.6e-35  Score=288.92  Aligned_cols=198  Identities=25%  Similarity=0.341  Sum_probs=170.5

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC--hhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  397 (551)
                      ..++|++.+.||+|+||+||+++.. +++.||+|++....  ......+.+|+.++.++ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3567899999999999999999864 78999999997642  33455788999999999 89999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC--------------
Q 008854          398 IYEFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD--------------  462 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~--------------  462 (551)
                      ||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999975422 366899999999999999999999987   9999999999999844              


Q ss_pred             -----CCeEEeecCCccccccCCCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          463 -----MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       463 -----~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                           ..+||+|||++......      ....||+.|+|||.+.+. .++.++||||||+++|||++|+.++
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~  231 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP  231 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence                 47999999999865432      123589999999998766 6678999999999999999999765

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-35  Score=301.44  Aligned_cols=200  Identities=19%  Similarity=0.248  Sum_probs=165.0

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC----CCCEEEEEEeecCChhc-----------HHHHHHHHHHHhcCCCCCccceee
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS----HGQEIAVKRLSKNSVQG-----------ELEFKNEVLLVARLQHRNLVRLLG  387 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~----~g~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~  387 (551)
                      .++|.+.++||+|+||.||++...    .+..+|+|++.......           ...+.+|+.++..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467899999999999999999864    56789999997653211           123667889999999999999999


Q ss_pred             EEec----CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC
Q 008854          388 FSFE----ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM  463 (551)
Q Consensus       388 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~  463 (551)
                      ++..    ....++||||+ +++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9987    67789999999 9999999864   237999999999999999999999987   99999999999999887


Q ss_pred             --CeEEeecCCccccccCCCc-----ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          464 --IPKISDFGMARLFEMDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       464 --~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                        .+||+|||+++.+......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~  261 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE  261 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence              9999999999876432211     11244579999999999999999999999999999999999999995

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-35  Score=298.67  Aligned_cols=202  Identities=26%  Similarity=0.394  Sum_probs=166.1

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhc-----HHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQG-----ELEFKNEVLLVARLQHRNLVRLLGFSFEETE  394 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  394 (551)
                      ...++|++.+.||+|+||.||+++.. +|+.||||++.......     ...+.+|+.++.+++||||+++++++.....
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999864 58999999997542211     2357899999999999999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .++||||+++ +|..++..  ....+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence            9999999986 78887754  3456889999999999999999999988   9999999999999999999999999998


Q ss_pred             ccccCCCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .+....  .......||+.|+|||.+.+. .++.++||||||+++|||++|..||..
T Consensus       161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~  215 (346)
T 1ua2_A          161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG  215 (346)
T ss_dssp             TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            654322  223345789999999998764 589999999999999999999988753

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.3e-35  Score=290.27  Aligned_cols=196  Identities=28%  Similarity=0.489  Sum_probs=171.7

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEec---------
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE---------  391 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  391 (551)
                      ..++|++.+.||+|+||.||+++.. +++.||+|++.....    .+.+|++++.+++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4567899999999999999999865 789999999976542    46789999999999999999998754         


Q ss_pred             -------CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC
Q 008854          392 -------ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI  464 (551)
Q Consensus       392 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~  464 (551)
                             ....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+|+||||+|||+++++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   34478999999999999999753 3467999999999999999999999987   999999999999999999


Q ss_pred             eEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       465 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                      +||+|||++.......   ......||+.|+|||.+.+..++.++||||||+++|||++|..|+
T Consensus       161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~  221 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA  221 (284)
T ss_dssp             EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred             EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence            9999999998654332   223456899999999999999999999999999999999999876

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.6e-34  Score=287.29  Aligned_cols=202  Identities=20%  Similarity=0.312  Sum_probs=172.8

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEE-ecCCceEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS-FEETERLLIY  399 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~  399 (551)
                      ..++|++.+.||+|+||.||+++. .+++.||||++......  ..+.+|+.++..++|++++..+..+ ......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            357899999999999999999984 67899999998765432  3588999999999998877777665 5566778999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee---CCCCCeEEeecCCcccc
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLF  476 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~Dfgla~~~  476 (551)
                      ||+ +++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Eec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            999 9999999864  3457999999999999999999999987   9999999999999   48889999999999876


Q ss_pred             ccCCCc-----ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          477 EMDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       477 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  218 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL  218 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence            543221     1234567999999999999999999999999999999999999999754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.2e-34  Score=288.07  Aligned_cols=203  Identities=20%  Similarity=0.307  Sum_probs=169.3

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEE-ecCCceEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS-FEETERLLIY  399 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~  399 (551)
                      ..++|++.+.||+|+||.||+++. .+++.||||++......  ..+.+|+.++..++|++++..++.+ ......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999984 57889999987654322  2578899999999998888777766 5566779999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee---CCCCCeEEeecCCcccc
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLF  476 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~Dfgla~~~  476 (551)
                      ||+ +++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 9999999864  3456999999999999999999999988   9999999999999   78899999999999876


Q ss_pred             ccCCCc-----ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC
Q 008854          477 EMDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRI  532 (551)
Q Consensus       477 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~  532 (551)
                      ......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence            543221     12335678999999999999999999999999999999999999997543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.5e-35  Score=294.08  Aligned_cols=202  Identities=26%  Similarity=0.429  Sum_probs=171.1

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ..++|++.+.||+|+||.||+++.. +++.||+|++..........+.+|+.++.+++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            4578999999999999999999865 588999999987666667789999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        97 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             eCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            9999999998864  3456999999999999999999999987   9999999999999999999999999976432111


Q ss_pred             CcccccccccCCCccccccc-----ccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYV-----TRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        .......||+.|+|||.+     .+..++.++||||||+++|||++|+.|+..
T Consensus       172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  224 (302)
T 2j7t_A          172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE  224 (302)
T ss_dssp             --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc
Confidence              112335689999999988     366789999999999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.9e-35  Score=295.70  Aligned_cols=209  Identities=25%  Similarity=0.374  Sum_probs=176.9

Q ss_pred             ChhHHHhhhcCCCcC-cccCcCCceeEEEeecC-CCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCC-CCCccceeeEE
Q 008854          315 DFSTIRDATNNFSTD-NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQ-HRNLVRLLGFS  389 (551)
Q Consensus       315 ~~~~i~~~~~~f~~~-~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  389 (551)
                      .+...+...++|.+. ++||+|+||.||+++.. +++.||+|++....  ......+.+|+.++.+++ ||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            345556677788887 88999999999999854 68999999997643  234567899999999995 69999999999


Q ss_pred             ecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC---CCCeE
Q 008854          390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPK  466 (551)
Q Consensus       390 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~k  466 (551)
                      ......++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+|
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence            9999999999999999999988542 3467999999999999999999999987   999999999999988   78999


Q ss_pred             EeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          467 ISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       467 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      |+|||+++......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       175 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  235 (327)
T 3lm5_A          175 IVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG  235 (327)
T ss_dssp             ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999998654322   23345789999999999999999999999999999999999999853

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.2e-35  Score=294.53  Aligned_cols=205  Identities=25%  Similarity=0.342  Sum_probs=172.5

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEec----CCceE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE----ETERL  396 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  396 (551)
                      ..++|++.+.||+|+||.||+++. .+++.||||++..........+.+|+.++++++||||+++++++..    ....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            356899999999999999999985 5789999999987766667789999999999999999999999873    34678


Q ss_pred             EEEEccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          397 LIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      +||||+++++|.+++.... ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            9999999999999987532 2467999999999999999999999987   99999999999999999999999999875


Q ss_pred             cccCCCc-------ccccccccCCCcccccccccCC---CCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          476 FEMDQSQ-------GDTSRIVGTFGYMAPEYVTRGH---FSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       476 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .......       .......||+.|+|||.+....   ++.++||||||+++|||++|+.||.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  247 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD  247 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence            4321110       0112345799999999987543   6899999999999999999999984

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-35  Score=296.84  Aligned_cols=202  Identities=29%  Similarity=0.506  Sum_probs=174.0

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-----CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCC--ce
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET--ER  395 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  395 (551)
                      .++|++.++||+|+||.||+++.     .+++.||||++..........+.+|+.++++++||||+++++++....  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688899999999999999983     368899999998766666678999999999999999999999987654  67


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++||||+++++|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            899999999999999975  3456999999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCc-ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          476 FEMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~  249 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK  249 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence            6543221 11223456778999999999899999999999999999999998875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1e-34  Score=289.96  Aligned_cols=203  Identities=24%  Similarity=0.359  Sum_probs=170.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC----hhcHHHHHHHHHHHhcCCCCCccceeeEEe--cCCce
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS----VQGELEFKNEVLLVARLQHRNLVRLLGFSF--EETER  395 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  395 (551)
                      .++|.+.+.||+|+||.||++.. .+++.||+|++....    ......+.+|+.++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            46899999999999999999985 468899999997542    234567899999999999999999999984  44578


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++||||++++ |.+++... ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999987 66666542 3567999999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCcccccccccCCCcccccccccCC--CCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGH--FSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..............||+.|+|||.+.+..  ++.++||||||+++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG  215 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence            64333333334557899999999987644  37899999999999999999999864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=290.76  Aligned_cols=201  Identities=28%  Similarity=0.458  Sum_probs=171.7

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ...++|++.+.||+|+||.||++... +|+.||+|++....  ....+.+|+.++.+++||||+++++++......++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34578999999999999999999854 58999999997653  3357889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++......
T Consensus       104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99999999999863  3567999999999999999999999987   999999999999999999999999999765432


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .  .......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       179 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  227 (314)
T 3com_A          179 M--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD  227 (314)
T ss_dssp             B--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             c--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            2  223345789999999999999999999999999999999999999863

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-35  Score=290.06  Aligned_cols=199  Identities=29%  Similarity=0.427  Sum_probs=169.0

Q ss_pred             CCCcCcccCcCCceeEEEeecC-CC---CEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCce-EEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLS-HG---QEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER-LLI  398 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~-~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lV  398 (551)
                      .|...++||+|+||+||+|... ++   ..+|+|++.... ......+.+|+.++++++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4556789999999999999843 22   369999997643 34456789999999999999999999999876655 899


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+.+++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999974  3567899999999999999999999987   99999999999999999999999999976543


Q ss_pred             CC--CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          479 DQ--SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       479 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                      ..  .........+|+.|+|||.+.+..++.++||||||+++|||++|+.|+
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~  228 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP  228 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence            22  112234456789999999999999999999999999999999976665

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.1e-35  Score=311.19  Aligned_cols=199  Identities=29%  Similarity=0.474  Sum_probs=169.3

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ..++|++.++||+|+||+||+++.. ++..||+|++.+..  ......+.+|+.+++.++||||+++++++......++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3457899999999999999999854 68899999997653  23345789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC---CCeEEeecCCccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARL  475 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~kl~Dfgla~~  475 (551)
                      |||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.+   +.+||+|||+++.
T Consensus       115 ~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            999999999988863   456999999999999999999999987   9999999999999764   4599999999987


Q ss_pred             cccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +....   ......||+.|+|||++. +.++.++||||||+++|||++|+.||..
T Consensus       189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~  239 (494)
T 3lij_A          189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG  239 (494)
T ss_dssp             CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence            65322   234457999999999875 5689999999999999999999999963

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.3e-35  Score=294.23  Aligned_cols=199  Identities=28%  Similarity=0.442  Sum_probs=169.9

Q ss_pred             cCC-CcCcccCcCCceeEEEeec-----CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecC--Cc
Q 008854          324 NNF-STDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TE  394 (551)
Q Consensus       324 ~~f-~~~~~LG~G~~g~Vyk~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  394 (551)
                      ++| ++.++||+|+||+||++.+     .+++.||||+++... ......+.+|+.++++++||||+++++++...  ..
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            344 8899999999999988753     257889999998653 34456789999999999999999999999874  56


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .++||||+++++|.+++..    ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence            7899999999999999853    45999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccccCCCc-ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          475 LFEMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       475 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ........ .......+|..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~  238 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ  238 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence            76543221 12334467888999999999999999999999999999999998875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.2e-34  Score=297.30  Aligned_cols=202  Identities=23%  Similarity=0.384  Sum_probs=171.4

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecC-----Cc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-----TE  394 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  394 (551)
                      ..++|++.++||+|+||.||+++. .+++.||||++.... ......+.+|+.++.+++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            356899999999999999999984 467889999997543 23345788999999999999999999998754     35


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .++||||+. ++|.+++.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence            789999998 58888875    346999999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCCCc-ccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          475 LFEMDQSQ-GDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       475 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ........ .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  235 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK  235 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence            75433221 12344579999999998754 45899999999999999999999999643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.4e-34  Score=309.72  Aligned_cols=199  Identities=30%  Similarity=0.450  Sum_probs=171.4

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh-------------hcHHHHHHHHHHHhcCCCCCccceee
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-------------QGELEFKNEVLLVARLQHRNLVRLLG  387 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~  387 (551)
                      ..++|.+.++||+|+||+||+++.. +++.||+|++.+...             .....+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999854 578999999976432             22456889999999999999999999


Q ss_pred             EEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC---C
Q 008854          388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM---I  464 (551)
Q Consensus       388 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~---~  464 (551)
                      ++.+....++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999998864   467999999999999999999999987   99999999999998776   6


Q ss_pred             eEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       465 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +||+|||++..+....   ......||+.|+|||.+. +.++.++||||+|+++|||++|+.||..
T Consensus       188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~  249 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG  249 (504)
T ss_dssp             EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999998764332   234457999999999876 5689999999999999999999999964

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.6e-35  Score=290.03  Aligned_cols=202  Identities=27%  Similarity=0.444  Sum_probs=167.3

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCC----CEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEe-cCCceE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHG----QEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSF-EETERL  396 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~  396 (551)
                      ..+|++.++||+|+||.||+|+..+.    ..+|+|.+.... ......+.+|+.++++++||||+++++++. .+...+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            45688889999999999999985322    258999987643 334567899999999999999999999865 455778


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            99999999999999964  3456899999999999999999999987   999999999999999999999999999865


Q ss_pred             ccCCC--cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCC-CCC
Q 008854          477 EMDQS--QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK-NNS  529 (551)
Q Consensus       477 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~-p~~  529 (551)
                      .....  ........+|+.|+|||.+.+..++.++||||||+++|||++|.. |+.
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~  234 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP  234 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCc
Confidence            43221  112334567889999999999999999999999999999999554 443

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-35  Score=295.39  Aligned_cols=210  Identities=31%  Similarity=0.506  Sum_probs=172.4

Q ss_pred             cChhHHHhhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeEEec
Q 008854          314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFE  391 (551)
Q Consensus       314 ~~~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  391 (551)
                      +++..+....++|++.+.||+|+||.||+++. .+++.||||++..... ....+.+|+.++.++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            45556667789999999999999999999985 5789999999976543 345788999999999 79999999999976


Q ss_pred             ------CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCe
Q 008854          392 ------ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP  465 (551)
Q Consensus       392 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~  465 (551)
                            ....++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+   |+|+||||+|||++.++.+
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence                  45789999999999999998753 3457899999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCccccccCCCcccccccccCCCcccccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       466 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ||+|||++.......  .......||+.|+|||.+.     +..++.++||||||+++|||++|+.||..
T Consensus       169 kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  236 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  236 (326)
T ss_dssp             EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             EEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            999999997654221  1233457899999999986     56789999999999999999999999853

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=6.5e-35  Score=310.93  Aligned_cols=198  Identities=31%  Similarity=0.466  Sum_probs=172.1

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ..++|++.++||+|+||+||+++.. +++.||||++.+..  ......+.+|+.++++++||||+++++++......++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4567999999999999999999854 68999999996532  23456789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC---CCCCeEEeecCCccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---ADMIPKISDFGMARL  475 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~kl~Dfgla~~  475 (551)
                      |||+++++|.+.+..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||+++.
T Consensus       100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            999999999998864   457999999999999999999999987   99999999999995   456799999999986


Q ss_pred             cccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      +....   ......||+.|+|||++.+ .++.++||||+|+++|||++|+.||.
T Consensus       174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~  223 (486)
T 3mwu_A          174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY  223 (486)
T ss_dssp             BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            54322   2334579999999998865 58999999999999999999999995

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.2e-35  Score=289.79  Aligned_cols=206  Identities=28%  Similarity=0.422  Sum_probs=172.0

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEec--CCceEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFE--ETERLL  397 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  397 (551)
                      .++|++.+.||+|+||.||+++.. +++.||+|++....  ......+.+|+.++++++||||+++++++..  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357889999999999999999854 68999999997653  3344578999999999999999999998754  567899


Q ss_pred             EEEccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          398 IYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      ||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999997543 2345999999999999999999999875  2349999999999999999999999999998


Q ss_pred             ccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .......  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  218 (279)
T 2w5a_A          165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA  218 (279)
T ss_dssp             HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence            6543211  12335689999999999999999999999999999999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.9e-35  Score=311.78  Aligned_cols=199  Identities=31%  Similarity=0.465  Sum_probs=175.1

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      ..++|++.++||+|+||.||+++.. +++.||||++.+..   ......+.+|+.++++++||||+++++++......++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3467899999999999999999854 78999999997643   3346679999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee---CCCCCeEEeecCCcc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMAR  474 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~Dfgla~  474 (551)
                      ||||+.+++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++
T Consensus       104 v~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999999886   3467999999999999999999999987   9999999999999   567899999999998


Q ss_pred             ccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .+....   ......||+.|+|||.+.+ .++.++||||+|+++|||++|+.||..
T Consensus       178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~  229 (484)
T 3nyv_A          178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG  229 (484)
T ss_dssp             HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC
Confidence            654322   2334579999999998865 689999999999999999999999963

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=8.3e-35  Score=286.37  Aligned_cols=199  Identities=25%  Similarity=0.440  Sum_probs=166.9

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      .++|.+.+.||+|+||.||+++.. +++.||||++....   ......+.+|+.++++++||||+++++++......++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367889999999999999999864 78999999997542   22345788999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            999999999999874   356899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCCcccccccccCCCcccccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..   ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||..
T Consensus       164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  213 (276)
T 2h6d_A          164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD  213 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            21   2234568999999999987765 6899999999999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.6e-35  Score=299.29  Aligned_cols=196  Identities=28%  Similarity=0.433  Sum_probs=154.3

Q ss_pred             hhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecC------
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------  392 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  392 (551)
                      ..++|++.+.||+|+||.||++. ..+|+.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            34789999999999999999998 456889999999754  233455788999999999999999999998754      


Q ss_pred             CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCC
Q 008854          393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM  472 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl  472 (551)
                      ...++|+|++ +++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred             CeEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence            4578999998 688888874    356999999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ++.....     .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  232 (367)
T 2fst_X          179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  232 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9864321     234578999999999877 6889999999999999999999999964

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.4e-35  Score=292.93  Aligned_cols=206  Identities=26%  Similarity=0.417  Sum_probs=158.3

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ..++|++.+.||+|+||.||++.. .+++.||||++.... .....++.+|+.++.+++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            457899999999999999999985 468899999986543 233456889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhc-----ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          400 EFVPNSSVDKFIFDAI-----KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      ||+++++|.+++....     ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            9999999999986421     2355899999999999999999999987   9999999999999999999999999997


Q ss_pred             ccccCCC---cccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQS---QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .......   ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  229 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK  229 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            6543211   112234578999999999876 5689999999999999999999999864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-34  Score=290.88  Aligned_cols=201  Identities=23%  Similarity=0.411  Sum_probs=165.3

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEe-----------
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF-----------  390 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  390 (551)
                      .++|.+.++||+|+||.||++... +++.||+|++..........+.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468999999999999999999865 48899999998776666778999999999999999999999874           


Q ss_pred             ---cCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC-CCCCeE
Q 008854          391 ---EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPK  466 (551)
Q Consensus       391 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~k  466 (551)
                         .....++||||++ ++|.+++.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3456789999998 68988874    356899999999999999999999987   99999999999997 567999


Q ss_pred             EeecCCccccccCCC-cccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          467 ISDFGMARLFEMDQS-QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       467 l~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      |+|||+++....... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  228 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA  228 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence            999999986543211 122334567999999998865 67899999999999999999999999643

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-34  Score=292.42  Aligned_cols=199  Identities=26%  Similarity=0.441  Sum_probs=162.2

Q ss_pred             HHHhhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhc--CCCCCccceeeEEecC---
Q 008854          318 TIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR--LQHRNLVRLLGFSFEE---  392 (551)
Q Consensus       318 ~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~---  392 (551)
                      ......++|++.++||+|+||.||+++.. ++.||||++....   ...+..|.+++..  ++||||+++++++...   
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            33455678999999999999999999875 8999999996543   2344455555554  4899999999999877   


Q ss_pred             -CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEeccCCCCCeeeCCCCCeE
Q 008854          393 -TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS-----RLRIIHRDLKASNILLDADMIPK  466 (551)
Q Consensus       393 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiH~Dlk~~NIll~~~~~~k  466 (551)
                       ...++||||+++++|.+++..    ..+++..++.++.|++.||.|||+..     .++|+||||||+|||++.++.+|
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence             678999999999999999853    46899999999999999999999871     12399999999999999999999


Q ss_pred             EeecCCccccccCCCcc--cccccccCCCcccccccccCCCCcc------hhhHhHHHHHHHHHhC
Q 008854          467 ISDFGMARLFEMDQSQG--DTSRIVGTFGYMAPEYVTRGHFSIK------SDVFSFGVLVLEIISG  524 (551)
Q Consensus       467 l~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDv~S~Gvll~elltG  524 (551)
                      |+|||+++.+.......  ......||+.|+|||.+.+...+.+      +||||||+++|||++|
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence            99999997654332211  1234579999999999987766655      9999999999999999

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.4e-34  Score=297.67  Aligned_cols=196  Identities=27%  Similarity=0.357  Sum_probs=161.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCC------
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET------  393 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  393 (551)
                      .++|++.+.||+|+||.||++.. .+++.||||++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46899999999999999999984 46889999999764  2334456889999999999999999999997654      


Q ss_pred             ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCc
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA  473 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla  473 (551)
                      ..++||||+++ +|.+++.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            67999999975 6777664     35899999999999999999999987   999999999999999999999999999


Q ss_pred             cccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +.....   .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       175 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  228 (371)
T 2xrw_A          175 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG  228 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            865422   123345789999999999999999999999999999999999999964

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-34  Score=299.31  Aligned_cols=200  Identities=24%  Similarity=0.376  Sum_probs=166.2

Q ss_pred             HhhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecC------
Q 008854          320 RDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------  392 (551)
Q Consensus       320 ~~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  392 (551)
                      +...++|++.++||+|+||+||+++. .+|+.||||++......    ..+|+.+++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999984 57899999999765322    34799999999999999999998543      


Q ss_pred             --------------------------------CceEEEEEccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHH
Q 008854          393 --------------------------------TERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYL  439 (551)
Q Consensus       393 --------------------------------~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yL  439 (551)
                                                      ...++||||++ ++|.+.+.... ....+++..+..++.||++||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            23779999998 58887776432 356799999999999999999999


Q ss_pred             hhCCCCCeEeccCCCCCeeeC-CCCCeEEeecCCccccccCCCcccccccccCCCcccccccccC-CCCcchhhHhHHHH
Q 008854          440 HEDSRLRIIHRDLKASNILLD-ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVL  517 (551)
Q Consensus       440 H~~~~~~iiH~Dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvl  517 (551)
                      |+.+   |+||||||+|||++ .++.+||+|||+++.+....   ......+|+.|+|||.+.+. .++.++||||+|++
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9987   99999999999997 68899999999998654322   23345689999999988765 58999999999999


Q ss_pred             HHHHHhCCCCCCC
Q 008854          518 VLEIISGQKNNSF  530 (551)
Q Consensus       518 l~elltG~~p~~~  530 (551)
                      +|||++|+.||..
T Consensus       232 l~ell~g~~pf~~  244 (383)
T 3eb0_A          232 FGELILGKPLFSG  244 (383)
T ss_dssp             HHHHHHSSCSSCC
T ss_pred             HHHHHhCCCCCCC
Confidence            9999999999964

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.9e-35  Score=298.28  Aligned_cols=201  Identities=29%  Similarity=0.477  Sum_probs=159.7

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEec-----CCceEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE-----ETERLL  397 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~l  397 (551)
                      -++|++.++||+|+||.||+|+. +++.||||++...... ......|+..+..++||||+++++.+..     ....++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ-NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchh-hHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            36788999999999999999987 6799999999754322 1122344444556899999999985532     235689


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS------RLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                      ||||+++++|.+++..    ...++..++.++.||++||.|||+..      .++|+||||||+|||++.++.+||+|||
T Consensus        90 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             EECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            9999999999999853    34589999999999999999999881      1139999999999999999999999999


Q ss_pred             CccccccCCC------cccccccccCCCccccccccc-------CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          472 MARLFEMDQS------QGDTSRIVGTFGYMAPEYVTR-------GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       472 la~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      +++.+.....      ........||+.|+|||.+.+       ..++.++||||||+++|||++|+.|+.
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            9987643221      112234579999999999876       456789999999999999999987763

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.1e-35  Score=321.04  Aligned_cols=194  Identities=30%  Similarity=0.469  Sum_probs=163.3

Q ss_pred             cccCcCCceeEEEeecC---CCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLS---HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~---~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      ++||+|+||.||+|.+.   .++.||||+++....  ....++.+|+.++.+++||||+++++++.. ...++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999642   457899999976432  345689999999999999999999999864 557899999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc-c
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-G  483 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~  483 (551)
                      ++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus       454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            99999996   3467999999999999999999999987   999999999999999999999999999876543221 1


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~  575 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG  575 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            2233456789999999999999999999999999999998 9999963

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.1e-35  Score=291.10  Aligned_cols=201  Identities=30%  Similarity=0.471  Sum_probs=168.3

Q ss_pred             hcCCCcCc-ccCcCCceeEEEeec---CCCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          323 TNNFSTDN-KLGQGGFGAVYKGRL---SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       323 ~~~f~~~~-~LG~G~~g~Vyk~~~---~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      .++|.+.+ .||+|+||.||++..   ..++.||||+++....  .....+.+|+.++.+++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45677777 999999999999953   3467899999976532  2345789999999999999999999998 566788


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +||||+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            99999999999999974   456999999999999999999999987   999999999999999999999999999866


Q ss_pred             ccCCCc-ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          477 EMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       477 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ...... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  223 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG  223 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence            433221 11223346788999999998889999999999999999999 9999863

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.1e-34  Score=285.58  Aligned_cols=200  Identities=26%  Similarity=0.387  Sum_probs=173.6

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh---------hcHHHHHHHHHHHhcCC-CCCccceeeEE
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---------QGELEFKNEVLLVARLQ-HRNLVRLLGFS  389 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~  389 (551)
                      ...++|++.+.||+|+||.||++... +++.||||++.....         .....+.+|+.++.++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34578999999999999999999864 688999999975431         12345789999999996 99999999999


Q ss_pred             ecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEee
Q 008854          390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD  469 (551)
Q Consensus       390 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~D  469 (551)
                      ......++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence            999999999999999999999874   457999999999999999999999987   99999999999999999999999


Q ss_pred             cCCccccccCCCcccccccccCCCcccccccc------cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT------RGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       470 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ||++.......   ......|++.|+|||.+.      ...++.++||||||+++|||++|+.||.
T Consensus       168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  230 (298)
T 1phk_A          168 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW  230 (298)
T ss_dssp             CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc
Confidence            99998654322   233457899999999885      4568899999999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.6e-35  Score=301.88  Aligned_cols=198  Identities=24%  Similarity=0.405  Sum_probs=165.6

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCc------eE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE------RL  396 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~  396 (551)
                      ..+|.+.++||+|+||+||+++...+..+|+|++......    ..+|+.+++.++||||+++++++.....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            3568899999999999999999877777999998654322    2369999999999999999999865433      67


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC-CCCCeEEeecCCccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPKISDFGMARL  475 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~Dfgla~~  475 (551)
                      +||||++++.+............+++..+..++.||++||.|||+.+   |+||||||+||||+ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999988655554433334567999999999999999999999987   99999999999999 799999999999987


Q ss_pred             cccCCCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          476 FEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +....   ......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       192 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  244 (394)
T 4e7w_A          192 LIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG  244 (394)
T ss_dssp             CCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            54322   22345789999999998764 589999999999999999999999964

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.4e-34  Score=290.70  Aligned_cols=193  Identities=20%  Similarity=0.378  Sum_probs=169.1

Q ss_pred             hcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-CCCccceeeEEec--CCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFE--ETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV  398 (551)
                      .++|++.++||+|+||+||+++ ..+++.||||+++...   ...+.+|+.++.+++ ||||+++++++..  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            3678999999999999999997 4578999999997543   457899999999997 9999999999987  5678999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC-CeEEeecCCccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFE  477 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~  477 (551)
                      |||+++++|.+++.      .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++ .+||+|||+++...
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999998874      3889999999999999999999987   99999999999999777 89999999998654


Q ss_pred             cCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...   ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       183 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~  233 (330)
T 3nsz_A          183 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  233 (330)
T ss_dssp             TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            332   2334578999999999877 6789999999999999999999999953

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9.5e-35  Score=293.50  Aligned_cols=200  Identities=30%  Similarity=0.501  Sum_probs=168.4

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCE--EEEEEeecCC-hhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQE--IAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ++|++.+.||+|+||.||+++.. ++..  +|+|+++... ......+.+|+.++.++ +||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57888999999999999999854 4554  4999987542 23345689999999999 899999999999999999999


Q ss_pred             EEccCCCChhHHhhhhc-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCe
Q 008854          399 YEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP  465 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~  465 (551)
                      |||+++++|.+++....             ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999997531             2347999999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       466 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ||+|||+++.....   .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~  243 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC  243 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCC
Confidence            99999998743221   12233456889999999998899999999999999999998 999985

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7.3e-35  Score=296.75  Aligned_cols=200  Identities=25%  Similarity=0.400  Sum_probs=174.9

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhc-----------------HHHHHHHHHHHhcCCCCCccce
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG-----------------ELEFKNEVLLVARLQHRNLVRL  385 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l  385 (551)
                      .++|.+.+.||+|+||.||++.. +++.||||++.......                 ...+.+|+.++.+++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999998 89999999997542211                 1679999999999999999999


Q ss_pred             eeEEecCCceEEEEEccCCCChhHH------hhhhcccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCee
Q 008854          386 LGFSFEETERLLIYEFVPNSSVDKF------IFDAIKRVQLDWETRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNIL  458 (551)
Q Consensus       386 ~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlk~~NIl  458 (551)
                      ++++...+..++||||+++++|.++      +.. .....+++..++.++.||+.||.|||+ .+   |+||||||+|||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      432 125679999999999999999999998 76   999999999999


Q ss_pred             eCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccC-CCCc-chhhHhHHHHHHHHHhCCCCCCCC
Q 008854          459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSI-KSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       459 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ++.++.+||+|||++......    ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||...
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  255 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK  255 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999865432    23345789999999999877 6666 999999999999999999999643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.8e-35  Score=303.57  Aligned_cols=196  Identities=27%  Similarity=0.431  Sum_probs=162.2

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecC----C--ceE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE----T--ERL  396 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~--~~~  396 (551)
                      .+|++.+.||+|+||.||+++.. +++.||||++.....    ...+|++++++++||||+++++++...    +  ..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888899999999999999964 689999999975432    234799999999999999999988542    1  256


Q ss_pred             EEEEccCCCChhHHhhhh-cccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC-CCeEEeecCCcc
Q 008854          397 LIYEFVPNSSVDKFIFDA-IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMAR  474 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~Dfgla~  474 (551)
                      +||||+++ +|.+++... .....+++..+..++.||++||.|||+.+   |+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999986 555555432 23567999999999999999999999987   9999999999999965 568999999998


Q ss_pred             ccccCCCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .+....   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus       206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~  259 (420)
T 1j1b_A          206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG  259 (420)
T ss_dssp             ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            654322   22345789999999998764 789999999999999999999999964

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-35  Score=300.18  Aligned_cols=199  Identities=18%  Similarity=0.241  Sum_probs=170.2

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCC---------CCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccc---------
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSH---------GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR---------  384 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  384 (551)
                      .++|.+.+.||+|+||.||+++...         ++.||+|++...     ..+.+|+.++.+++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4689999999999999999998653         789999999765     25789999999999999988         


Q ss_pred             ------eeeEEec-CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCe
Q 008854          385 ------LLGFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI  457 (551)
Q Consensus       385 ------l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NI  457 (551)
                            +++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  5666665 67789999999 99999999753 2467999999999999999999999987   99999999999


Q ss_pred             eeCCCC--CeEEeecCCccccccCCCc-----ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          458 LLDADM--IPKISDFGMARLFEMDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       458 ll~~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      |++.++  .+||+|||+++.+......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  9999999999866433211     122345799999999999999999999999999999999999999974


Q ss_pred             C
Q 008854          531 R  531 (551)
Q Consensus       531 ~  531 (551)
                      .
T Consensus       271 ~  271 (352)
T 2jii_A          271 C  271 (352)
T ss_dssp             G
T ss_pred             C
Confidence            3

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.1e-34  Score=292.47  Aligned_cols=200  Identities=25%  Similarity=0.394  Sum_probs=167.6

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh--------hcHHHHHHHHHHHhcCCCCCccceeeEEecC
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV--------QGELEFKNEVLLVARLQHRNLVRLLGFSFEE  392 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  392 (551)
                      ..++|.+.+.||+|+||.||+++. .+++.||||++.....        .....+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            456799999999999999999985 4578999999965421        1223588999999999999999999998765


Q ss_pred             CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC---eEEee
Q 008854          393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI---PKISD  469 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~kl~D  469 (551)
                      . .++||||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4 899999999999999886   3467999999999999999999999987   999999999999987664   99999


Q ss_pred             cCCccccccCCCcccccccccCCCcccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       470 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ||+++.....   .......||+.|+|||.+.   ...++.++||||||+++|||++|+.||...
T Consensus       161 fg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  222 (322)
T 2ycf_A          161 FGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH  222 (322)
T ss_dssp             CTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred             Cccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            9999865422   1123456899999999874   567899999999999999999999999643

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.4e-34  Score=301.35  Aligned_cols=199  Identities=22%  Similarity=0.290  Sum_probs=170.4

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcC------CCCCccceeeEEecCCc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARL------QHRNLVRLLGFSFEETE  394 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~  394 (551)
                      ...+|++.++||+|+||+||++.. .+++.||||++.... .....+.+|+.++..+      +|+||+++++++.....
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            356799999999999999999974 458899999997643 3334677788877776      57799999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC--eEEeecCC
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI--PKISDFGM  472 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~--~kl~Dfgl  472 (551)
                      .++||||+. ++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.  +||+|||+
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence            999999996 6888888653 3345999999999999999999999987   999999999999999987  99999999


Q ss_pred             ccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      +.....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       249 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          249 SCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             CEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            975432     223457899999999999999999999999999999999999998643

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.6e-34  Score=301.72  Aligned_cols=202  Identities=21%  Similarity=0.318  Sum_probs=171.6

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCC-CccceeeEEecCCceEEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR-NLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e  400 (551)
                      .++|++.++||+|+||.||+++. .+++.||||++......  ..+.+|++++..++|+ +|..+..+.......+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            47899999999999999999984 57899999998765432  2478899999999875 45555566677778899999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee---CCCCCeEEeecCCccccc
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFE  477 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~Dfgla~~~~  477 (551)
                      |+ +++|.+++..  ....+++..++.|+.||+.||.|||+.+   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 9999999864  2457999999999999999999999987   9999999999999   688999999999998765


Q ss_pred             cCCCc-----ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC
Q 008854          478 MDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRI  532 (551)
Q Consensus       478 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~  532 (551)
                      .....     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~  217 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK  217 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            43321     12235679999999999999999999999999999999999999997543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.8e-35  Score=287.03  Aligned_cols=196  Identities=30%  Similarity=0.490  Sum_probs=164.3

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecC-CceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-TERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~  401 (551)
                      .++|++.+.||+|+||.||+++. .++.||||+++...  ....+.+|+.++.+++||||+++++++... ...++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            46788999999999999999987 47899999997653  345789999999999999999999997654 468999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++++|.+++... ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++......  
T Consensus        97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            9999999998753 2234889999999999999999999987   999999999999999999999999998754322  


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                         .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  217 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  217 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence               123357889999999999999999999999999999998 9999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.3e-35  Score=300.16  Aligned_cols=197  Identities=10%  Similarity=0.088  Sum_probs=152.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHH---HHHhcCCCCCcccee-------eE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEV---LLVARLQHRNLVRLL-------GF  388 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  388 (551)
                      ..+|...++||+|+||.||+++. .+++.||||++.....   .....+.+|+   .+|.. +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            45588999999999999999985 4788999999987643   2344577774   55555 799988754       44


Q ss_pred             EecC-----------------CceEEEEEccCCCChhHHhhhhcccCCCCHHHH------HHHHHHHHHHHHHHhhCCCC
Q 008854          389 SFEE-----------------TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETR------YKIIGGIARGILYLHEDSRL  445 (551)
Q Consensus       389 ~~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~  445 (551)
                      +...                 ...++||||++ ++|.+++...  ...+.+..+      +.++.||++||.|||+.+  
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--  214 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--  214 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence            4332                 23789999999 8999999753  223455556      788899999999999987  


Q ss_pred             CeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCccccccccc--CCCCcchhhHhHHHHHHHHHh
Q 008854          446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIIS  523 (551)
Q Consensus       446 ~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvll~ellt  523 (551)
                       |+||||||+||||+.++.+||+|||+++.....     .....+|+.|+|||.+.+  ..++.++||||||+++|||++
T Consensus       215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             -EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             -CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence             999999999999999999999999999864321     213456799999999987  789999999999999999999


Q ss_pred             CCCCCCCC
Q 008854          524 GQKNNSFR  531 (551)
Q Consensus       524 G~~p~~~~  531 (551)
                      |+.||...
T Consensus       289 g~~Pf~~~  296 (371)
T 3q60_A          289 LFLPFGLV  296 (371)
T ss_dssp             SSCSTTBC
T ss_pred             CCCCCCCc
Confidence            99999644

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=301.81  Aligned_cols=202  Identities=28%  Similarity=0.470  Sum_probs=154.0

Q ss_pred             cCCCc-CcccCcCCceeEEEeecC---CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEec--CCceEE
Q 008854          324 NNFST-DNKLGQGGFGAVYKGRLS---HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE--ETERLL  397 (551)
Q Consensus       324 ~~f~~-~~~LG~G~~g~Vyk~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  397 (551)
                      +.|++ .++||+|+||+||+++..   +++.||||++.....  ...+.+|+.++++++||||+++++++..  ....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34555 458999999999999854   578899999976532  2367899999999999999999999954  667899


Q ss_pred             EEEccCCCChhHHhhhhc------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee----CCCCCeEE
Q 008854          398 IYEFVPNSSVDKFIFDAI------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DADMIPKI  467 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~kl  467 (551)
                      ||||+.+ +|.+++....      ....+++..+..++.||+.||.|||+.+   |+||||||+||||    +.++.+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999975 7777765321      1235999999999999999999999988   9999999999999    77889999


Q ss_pred             eecCCccccccCCC-cccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          468 SDFGMARLFEMDQS-QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       468 ~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      +|||+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            99999987643221 122345678999999999887 45899999999999999999999999643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.5e-34  Score=297.90  Aligned_cols=201  Identities=24%  Similarity=0.318  Sum_probs=169.8

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC--------CCCccceeeEEe---
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ--------HRNLVRLLGFSF---  390 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  390 (551)
                      .++|++.++||+|+||+||+++. .+++.||||++.... .....+.+|+.++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            57899999999999999999984 568899999997542 33457889999999985        788999999987   


Q ss_pred             -cCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCCeeeCCCC-----
Q 008854          391 -EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDADM-----  463 (551)
Q Consensus       391 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlk~~NIll~~~~-----  463 (551)
                       .....++||||+ +++|.+.+... ....+++..+..++.||+.||.|||++ +   |+||||||+||||+.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence             556789999999 55555555432 335699999999999999999999998 6   99999999999999775     


Q ss_pred             --------------------------------------------CeEEeecCCccccccCCCcccccccccCCCcccccc
Q 008854          464 --------------------------------------------IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY  499 (551)
Q Consensus       464 --------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~  499 (551)
                                                                  .+||+|||++......     .....||+.|+|||.
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999865422     234578999999999


Q ss_pred             cccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCCc
Q 008854          500 VTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGE  534 (551)
Q Consensus       500 ~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~~~  534 (551)
                      +.+..++.++||||||+++|||++|+.||.....+
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  299 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGE  299 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCccc
Confidence            99999999999999999999999999999755443

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.3e-34  Score=292.47  Aligned_cols=201  Identities=24%  Similarity=0.403  Sum_probs=169.2

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecC-----Cc
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-----TE  394 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  394 (551)
                      ..++|.+.+.||+|+||.||+++.. +|+.||||++.... ......+.+|+.++++++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            4578999999999999999999854 68899999997543 33445688999999999999999999987654     56


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .++||||+. ++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            799999997 588888753    46999999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCCCcc--------cccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQSQG--------DTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .........        ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  225 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG  225 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence            754322111        1233578999999998764 7789999999999999999999999964

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1e-34  Score=287.82  Aligned_cols=202  Identities=29%  Similarity=0.393  Sum_probs=159.3

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh-hc-HHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV-QG-ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ..++|++.++||+|+||+||+++. .+++.||+|++..... .. ...+.++...++.++||||+++++++...+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            356889999999999999999985 5788999999976532 22 22345566668889999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          399 YEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      |||++ ++|.+++.... ....+++..++.++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++..
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99997 48888776432 346799999999999999999999997 6   999999999999999999999999999865


Q ss_pred             ccCCCcccccccccCCCccccccc----ccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYV----TRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ....   ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||..
T Consensus       161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (290)
T 3fme_A          161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS  215 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence            4322   22334689999999996    566789999999999999999999999963

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=9.2e-35  Score=291.68  Aligned_cols=207  Identities=24%  Similarity=0.387  Sum_probs=170.5

Q ss_pred             hhHHHhhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCC--CCCccceeeEEec
Q 008854          316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQ--HRNLVRLLGFSFE  391 (551)
Q Consensus       316 ~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~  391 (551)
                      +..+....++|++.+.||+|+||.||++...+++.||||++....  ......+.+|+.++.+++  ||||+++++++..
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred             eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence            344445567899999999999999999998889999999997543  334567899999999997  5999999999999


Q ss_pred             CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          392 ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       392 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                      ....++||| +.+++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++ ++.+||+|||
T Consensus       100 ~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Dfg  171 (313)
T 3cek_A          100 DQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFG  171 (313)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred             CCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeecc
Confidence            999999999 678899999874   457899999999999999999999987   99999999999996 4899999999


Q ss_pred             CccccccCCCcccccccccCCCccccccccc-----------CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-----------GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +++...............||+.|+|||.+.+           ..++.++||||||+++|||++|+.||..
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  241 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence            9987654333223345578999999999865           4788999999999999999999999863

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.9e-34  Score=293.72  Aligned_cols=206  Identities=24%  Similarity=0.364  Sum_probs=158.9

Q ss_pred             hHHHhhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCc-
Q 008854          317 STIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE-  394 (551)
Q Consensus       317 ~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  394 (551)
                      .......++|++.++||+|+||.||+++. .+++.||||++...... .....+|++.+..++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            34455668999999999999999999985 46899999998665322 2356778888899999999999999865333 


Q ss_pred             ------eEEEEEccCCCChhHHhhh-hcccCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeEeccCCCCCeeeCC-CCC
Q 008854          395 ------RLLIYEFVPNSSVDKFIFD-AIKRVQLDWETRYKIIGGIARGILYLH--EDSRLRIIHRDLKASNILLDA-DMI  464 (551)
Q Consensus       395 ------~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~iiH~Dlk~~NIll~~-~~~  464 (551)
                            .++||||++++ |...+.. ......+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence                  68999999875 4444432 234567899999999999999999999  766   999999999999997 899


Q ss_pred             eEEeecCCccccccCCCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       465 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +||+|||+++......   ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       171 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  234 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG  234 (360)
T ss_dssp             EEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence            9999999998654322   22345689999999998665 489999999999999999999999964

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.1e-34  Score=290.45  Aligned_cols=198  Identities=26%  Similarity=0.424  Sum_probs=167.8

Q ss_pred             hhHHHhhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhc--CCCCCccceeeEEecCC
Q 008854          316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR--LQHRNLVRLLGFSFEET  393 (551)
Q Consensus       316 ~~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~  393 (551)
                      ........++|.+.+.||+|+||.||+++. +++.||||++...   ....+.+|.+++..  ++||||+++++++....
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            333455678899999999999999999997 5899999999653   34567788888877  78999999999998776


Q ss_pred             ----ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEeccCCCCCeeeCC
Q 008854          394 ----ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH--------EDSRLRIIHRDLKASNILLDA  461 (551)
Q Consensus       394 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiH~Dlk~~NIll~~  461 (551)
                          ..++||||+++++|.+++..    ..+++..++.++.|++.||.|||        +.+   |+||||||+|||++.
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK  182 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred             CccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence                78999999999999999853    46899999999999999999999        555   999999999999999


Q ss_pred             CCCeEEeecCCccccccCCCcc--cccccccCCCcccccccccC------CCCcchhhHhHHHHHHHHHhC
Q 008854          462 DMIPKISDFGMARLFEMDQSQG--DTSRIVGTFGYMAPEYVTRG------HFSIKSDVFSFGVLVLEIISG  524 (551)
Q Consensus       462 ~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~Gvll~elltG  524 (551)
                      ++.+||+|||+++.........  ......||+.|+|||.+.+.      .++.++||||||+++|||++|
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            9999999999998765432211  23445789999999998765      334789999999999999999

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.6e-34  Score=293.10  Aligned_cols=195  Identities=26%  Similarity=0.437  Sum_probs=166.0

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCce---
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER---  395 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  395 (551)
                      ..++|.+.+.||+|+||.||++.. .+|+.||||++....  ......+.+|+.+++.++||||+++++++......   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            356889999999999999999984 468899999997643  23345788999999999999999999999877654   


Q ss_pred             ---EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCC
Q 008854          396 ---LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM  472 (551)
Q Consensus       396 ---~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl  472 (551)
                         ++||||+. ++|.+++.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence               99999998 57777653     34899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ++.....     .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  244 (371)
T 4exu_A          191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  244 (371)
T ss_dssp             C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence            9764322     234578999999999887 7889999999999999999999999964

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.3e-34  Score=287.12  Aligned_cols=202  Identities=30%  Similarity=0.439  Sum_probs=162.6

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC--CCC--EEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS--HGQ--EIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER  395 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~--~g~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  395 (551)
                      .++|++.++||+|+||+||++++.  +++  .||||+++...   ......+.+|+.++.+++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            467889999999999999999843  333  68999987542   234557899999999999999999999987754 8


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++||||+++++|.+++...  ...+++..+..++.|+++||.|||+.+   |+|+||||+||+++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            8999999999999998752  356899999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCc-ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          476 FEMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  227 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG  227 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            6433221 12233467889999999998889999999999999999999 9999853

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.3e-34  Score=290.26  Aligned_cols=202  Identities=27%  Similarity=0.458  Sum_probs=169.7

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeec--CCCCEEEEEEeecCCh--hcHHHHHHHHHHHhcC---CCCCccceeeEEe---
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRL--SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARL---QHRNLVRLLGFSF---  390 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~--~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---  390 (551)
                      ...++|++.+.||+|+||.||+++.  .+++.||+|++.....  .....+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            3557899999999999999999986  4678899999865322  1122456777766665   8999999999987   


Q ss_pred             --cCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEe
Q 008854          391 --EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS  468 (551)
Q Consensus       391 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~  468 (551)
                        .....++||||++ ++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence              4567789999998 6999988653 3345899999999999999999999987   9999999999999999999999


Q ss_pred             ecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       469 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      |||+++......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  221 (326)
T 1blx_A          163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG  221 (326)
T ss_dssp             SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence            999997654221   23345789999999999999999999999999999999999999964

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.9e-34  Score=287.47  Aligned_cols=199  Identities=24%  Similarity=0.347  Sum_probs=171.6

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec--CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCC------ccceeeEEecCC
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL--SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN------LVRLLGFSFEET  393 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~--~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~  393 (551)
                      ..++|++.++||+|+||.||++..  .+++.||||+++... .....+.+|+.++..++|++      ++++++++...+
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            356899999999999999999975  367899999997543 33456888999998887654      999999999999


Q ss_pred             ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC------------
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA------------  461 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~------------  461 (551)
                      ..++||||+ +++|.+++... ...++++..+..++.||++||.|||+.+   |+||||||+|||++.            
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred             cEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence            999999999 88999988653 3346899999999999999999999987   999999999999987            


Q ss_pred             -------CCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          462 -------DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       462 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                             ++.+||+|||+++....     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                   67899999999976432     223457899999999999999999999999999999999999999754

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.8e-34  Score=281.30  Aligned_cols=200  Identities=30%  Similarity=0.448  Sum_probs=173.2

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      ...++|++.++||+|+||.||+++.. +++.||+|++....  ......+.+|+.++++++||||+++++++......++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            44578999999999999999999864 68999999997542  2345678999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC---CCeEEeecCCcc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMAR  474 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~kl~Dfgla~  474 (551)
                      ||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+|+||||+||+++.+   +.+||+|||++.
T Consensus        99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            9999999999998864   356899999999999999999999987   9999999999999764   479999999998


Q ss_pred             ccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ......   ......+|+.|+|||.+.+ .++.++||||||+++|||++|+.||..
T Consensus       173 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~  224 (287)
T 2wei_A          173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG  224 (287)
T ss_dssp             TBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence            654322   2234468999999998765 489999999999999999999999853

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1e-33  Score=285.95  Aligned_cols=201  Identities=28%  Similarity=0.407  Sum_probs=151.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC-hhcHHHHHHHHH-HHhcCCCCCccceeeEEecCCceEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-VQGELEFKNEVL-LVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      .++|+..+.||+|+||.||++.. .+++.||||++.... .....++..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            46788999999999999999986 468899999997653 233345555655 778889999999999999999999999


Q ss_pred             EccCCCChhHHhhhh--cccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          400 EFVPNSSVDKFIFDA--IKRVQLDWETRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       400 e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      ||+++ +|.+++...  .....+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99985 777777532  1256789999999999999999999997 6   999999999999999999999999999765


Q ss_pred             ccCCCcccccccccCCCccccccc----ccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYV----TRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ....   ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||..
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK  231 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            4322   22334689999999998    466789999999999999999999999853

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1e-33  Score=282.02  Aligned_cols=196  Identities=28%  Similarity=0.489  Sum_probs=161.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEec----------
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE----------  391 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  391 (551)
                      .++|++.+.||+|+||.||+++. .+++.||||++... ......+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            46788999999999999999985 47899999999653 2344578999999999999999999998865          


Q ss_pred             ---CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEe
Q 008854          392 ---ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS  468 (551)
Q Consensus       392 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~  468 (551)
                         ....++||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence               3457899999999999999975  3446788999999999999999999987   9999999999999999999999


Q ss_pred             ecCCccccccCCC------------cccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhC
Q 008854          469 DFGMARLFEMDQS------------QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISG  524 (551)
Q Consensus       469 Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG  524 (551)
                      |||++........            ........||+.|+|||.+.+. .++.++||||||+++|||+++
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p  227 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP  227 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSC
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhc
Confidence            9999976542210            1122345689999999998764 789999999999999999983

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.4e-33  Score=291.36  Aligned_cols=205  Identities=22%  Similarity=0.299  Sum_probs=171.3

Q ss_pred             hHHHhhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-CC-----CccceeeEE
Q 008854          317 STIRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HR-----NLVRLLGFS  389 (551)
Q Consensus       317 ~~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~  389 (551)
                      .......++|++.++||+|+||+||+|+.. +++.||||+++... ....++.+|+.++..++ |+     +|+++++++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            333455689999999999999999999854 67889999997542 33446778888888875 44     499999999


Q ss_pred             ecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC--CCCCeEE
Q 008854          390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--ADMIPKI  467 (551)
Q Consensus       390 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~--~~~~~kl  467 (551)
                      ......++||||++ ++|.+++... ....+++..+..++.|++.||.|||.+. .+|+||||||+||||+  .++.+||
T Consensus       126 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          126 MFRNHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             EETTEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             ccCCceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEE
Confidence            99999999999996 5999988753 3356999999999999999999999531 2499999999999994  4778999


Q ss_pred             eecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       468 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +|||+++.....     .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       203 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          203 VDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             CCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999865322     2345789999999999999999999999999999999999999974

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-33  Score=288.90  Aligned_cols=194  Identities=26%  Similarity=0.439  Sum_probs=164.9

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCc-----
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE-----  394 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  394 (551)
                      .++|...+.||+|+||.||+++. .+|+.||||++....  ......+.+|+.++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            46788999999999999999985 468999999997643  2334578899999999999999999999987654     


Q ss_pred             -eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCc
Q 008854          395 -RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA  473 (551)
Q Consensus       395 -~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla  473 (551)
                       .++||||+. ++|.+++.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999998 57777653     35899999999999999999999987   999999999999999999999999999


Q ss_pred             cccccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +.....     .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  226 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  226 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            764322     234578999999999876 6789999999999999999999999964

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8.1e-34  Score=311.94  Aligned_cols=202  Identities=25%  Similarity=0.402  Sum_probs=168.9

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecCC----CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER  395 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  395 (551)
                      ...++|++.+.||+|+||.||+|....    +..||+|+++... ......+.+|+.++++++||||+++++++. ++..
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            345678888999999999999998532    4579999987643 333457899999999999999999999985 4568


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ++||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       466 ~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             EEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             EEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence            999999999999999974  3456899999999999999999999987   99999999999999999999999999986


Q ss_pred             cccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ..... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       541 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  594 (656)
T 2j0j_A          541 MEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ  594 (656)
T ss_dssp             CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             cCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCC
Confidence            54322 122233456789999999999999999999999999999997 998985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-34  Score=286.52  Aligned_cols=199  Identities=26%  Similarity=0.471  Sum_probs=163.6

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChh------cHHHHHHHHHHHhcC----CCCCccceeeEE
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ------GELEFKNEVLLVARL----QHRNLVRLLGFS  389 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~~~  389 (551)
                      ...++|++.+.||+|+||.||+++. .+++.||||++......      ....+.+|+.++.++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            3457899999999999999999984 56889999999765332      122356789998888    899999999999


Q ss_pred             ecCCceEEEEEc-cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC-CCCCeEE
Q 008854          390 FEETERLLIYEF-VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPKI  467 (551)
Q Consensus       390 ~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl  467 (551)
                      ...+..++|||+ +.+++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+||+++ .++.+||
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence            999999999999 789999999874   456999999999999999999999987   99999999999999 8899999


Q ss_pred             eecCCccccccCCCcccccccccCCCcccccccccCCCC-cchhhHhHHHHHHHHHhCCCCCC
Q 008854          468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS-IKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       468 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      +|||+++.....    ......|+..|+|||.+.+..+. .++||||||+++|||++|+.||.
T Consensus       182 ~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  240 (312)
T 2iwi_A          182 IDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE  240 (312)
T ss_dssp             CCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence            999999865432    22345689999999998877664 58999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.4e-34  Score=288.12  Aligned_cols=203  Identities=26%  Similarity=0.408  Sum_probs=167.3

Q ss_pred             HhhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          320 RDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       320 ~~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      ....++|++.+.||+|+||.||+|+..  ..+|+|+++....  .....+.+|+.++.+++||||+++++++......++
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            344578999999999999999999874  3599999875422  223457889999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||++....
T Consensus       107 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             ECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             EeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            9999999999999864  3446899999999999999999999987   99999999999998 6799999999987543


Q ss_pred             cCC---CcccccccccCCCccccccccc---------CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          478 MDQ---SQGDTSRIVGTFGYMAPEYVTR---------GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       478 ~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...   .........||+.|+|||.+..         ..++.++||||||+++|||++|+.||..
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  245 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT  245 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            211   1122334568999999998864         4578999999999999999999999863

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.7e-34  Score=287.62  Aligned_cols=200  Identities=26%  Similarity=0.420  Sum_probs=171.5

Q ss_pred             HhhhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCChh------cHHHHHHHHHHHhcCC--CCCccceeeEEe
Q 008854          320 RDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQ------GELEFKNEVLLVARLQ--HRNLVRLLGFSF  390 (551)
Q Consensus       320 ~~~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~  390 (551)
                      ....++|++.+.||+|+||.||+++ ..+++.||||++......      ....+.+|+.++.+++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            3456789999999999999999998 457889999999765321      1234678999999996  599999999999


Q ss_pred             cCCceEEEEEccCC-CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC-CCCCeEEe
Q 008854          391 EETERLLIYEFVPN-SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPKIS  468 (551)
Q Consensus       391 ~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~  468 (551)
                      ..+..++|||++.+ ++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++ +++.+||+
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence            99999999999986 899999874   457899999999999999999999987   99999999999999 78999999


Q ss_pred             ecCCccccccCCCcccccccccCCCcccccccccCCC-CcchhhHhHHHHHHHHHhCCCCCC
Q 008854          469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       469 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      |||+++.....    ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.
T Consensus       193 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  250 (320)
T 3a99_A          193 DFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE  250 (320)
T ss_dssp             CCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             eCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence            99999865432    2234568999999999887766 688999999999999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.7e-33  Score=289.35  Aligned_cols=199  Identities=21%  Similarity=0.328  Sum_probs=167.7

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-----------CCCccceeeEEe
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-----------HRNLVRLLGFSF  390 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  390 (551)
                      .++|.+.++||+|+||+||+++. .+++.||||++.... .....+.+|+.++.+++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            46799999999999999999984 578899999997543 33456888999988886           899999999987


Q ss_pred             cCC----ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCCeeeC-----
Q 008854          391 EET----ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLD-----  460 (551)
Q Consensus       391 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlk~~NIll~-----  460 (551)
                      ...    ..++||||+ +++|.+++... ....+++..+..++.||+.||.|||+. +   |+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            644    678999999 89999998753 345699999999999999999999997 7   99999999999994     


Q ss_pred             -CCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC
Q 008854          461 -ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRI  532 (551)
Q Consensus       461 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~  532 (551)
                       .++.+||+|||++......     .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence             4458999999999865422     233478999999999999999999999999999999999999997543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.5e-33  Score=305.40  Aligned_cols=201  Identities=28%  Similarity=0.470  Sum_probs=172.8

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEec------CCc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFE------ETE  394 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  394 (551)
                      -++|++.++||+|+||.||++.. .+|+.||||++... .......+.+|+.++.+++||||+++++++..      ...
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36899999999999999999985 46889999999765 33445678999999999999999999998765      667


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCC---eEEeecC
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI---PKISDFG  471 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~kl~Dfg  471 (551)
                      .++||||+++++|.+++........+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            7899999999999999986544457999999999999999999999987   999999999999997765   8999999


Q ss_pred             CccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ++.......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~  224 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL  224 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence            998654322   2344678999999999999999999999999999999999999984

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.2e-33  Score=284.12  Aligned_cols=198  Identities=20%  Similarity=0.314  Sum_probs=168.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CC-CEEEEEEeecCChhcHHHHHHHHHHHhcCCCCC------ccceeeEEecCCc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HG-QEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN------LVRLLGFSFEETE  394 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  394 (551)
                      .++|++.+.||+|+||+||++... ++ +.||+|+++... .....+.+|+.++++++|++      ++.+.+++.....
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            578999999999999999999853 34 689999997543 33456888999999987766      8999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee---------------
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---------------  459 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll---------------  459 (551)
                      .++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 56666666542 3356999999999999999999999987   9999999999999               


Q ss_pred             ----CCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          460 ----DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       460 ----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                          +.++.+||+|||+++....     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                5678999999999976432     123457899999999999999999999999999999999999999743

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-33  Score=312.32  Aligned_cols=191  Identities=20%  Similarity=0.359  Sum_probs=164.7

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC--CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCc-----
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS--HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE-----  394 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~--~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  394 (551)
                      .++|++.++||+|+||.||++...  +++.||||++.... ......+.+|+.++.+++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999864  58899999987543 3344578899999999999999999999987655     


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .+|||||+++++|.+++.     ..+++.+++.++.||++||.|||+.+   |+||||||+|||++.+ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            699999999999988764     26999999999999999999999987   9999999999999886 89999999998


Q ss_pred             ccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .....      ....||+.|+|||.+.++. +.++||||||+++|||++|..|+.
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~  277 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRN  277 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEET
T ss_pred             hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCc
Confidence            65422      3457999999999887654 899999999999999999998875

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.9e-33  Score=283.83  Aligned_cols=197  Identities=23%  Similarity=0.285  Sum_probs=146.3

Q ss_pred             hhcCCCcCc-ccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEec----CCce
Q 008854          322 ATNNFSTDN-KLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE----ETER  395 (551)
Q Consensus       322 ~~~~f~~~~-~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  395 (551)
                      ..++|.+.+ .||+|+||+||+++.. +++.||||++....    ....+....+..++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            356788855 6999999999999854 68999999997542    122233344667799999999999875    3447


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC---CCCeEEeecCC
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGM  472 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~Dfgl  472 (551)
                      ++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            8999999999999999753 2357999999999999999999999987   999999999999976   45599999999


Q ss_pred             ccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ++.....    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (336)
T 3fhr_A          178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS  231 (336)
T ss_dssp             CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            9764422    23345789999999999888999999999999999999999999853

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.1e-33  Score=294.82  Aligned_cols=200  Identities=26%  Similarity=0.327  Sum_probs=156.0

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEEEcc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      +.|...+.||+|+||+||.....+|+.||||++....   ...+.+|+.++.++ +||||+++++++......++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            4455568899999999987666679999999997542   34578899999876 8999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccC----CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC-------------CCe
Q 008854          403 PNSSVDKFIFDAIKRV----QLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-------------MIP  465 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~-------------~~~  465 (551)
                      . ++|.+++.......    ..++..++.++.||+.||.|||+.+   |+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 69999987532111    1133456789999999999999987   9999999999999654             489


Q ss_pred             EEeecCCccccccCCCc--ccccccccCCCccccccccc-------CCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          466 KISDFGMARLFEMDQSQ--GDTSRIVGTFGYMAPEYVTR-------GHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       466 kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ||+|||+++........  .......||+.|+|||++.+       ..++.++||||||+++|||++ |+.||..
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  242 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD  242 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence            99999999876543221  12234579999999999865       678999999999999999999 8999863

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5e-33  Score=279.32  Aligned_cols=199  Identities=27%  Similarity=0.438  Sum_probs=151.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChh-cH-HHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ-GE-LEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      -++|++.+.||+|+||.||+++.. +++.||||++...... .. ..+.++..+++.++||||+++++++......++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            357888899999999999999864 6899999999765332 22 23455566788889999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      ||+ ++.+..+...  ....+++..+..++.|+++||.|||+. +   |+|+||||+|||++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 4455544432  346799999999999999999999985 6   99999999999999999999999999976543


Q ss_pred             CCCcccccccccCCCcccccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..   ......||+.|+|||.+.     ...++.++||||||+++|||++|+.||..
T Consensus       178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (318)
T 2dyl_A          178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN  231 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence            22   223456899999999984     56788999999999999999999999964

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-33  Score=294.09  Aligned_cols=199  Identities=24%  Similarity=0.394  Sum_probs=158.3

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ...+|...+.||+|+||+|+.....+++.||||++......   .+.+|+.+++++ +||||+++++++.+....++|||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            34568888999999999966554557899999999765332   356899999999 79999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC-----CCCeEEeecCCccc
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-----DMIPKISDFGMARL  475 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~-----~~~~kl~Dfgla~~  475 (551)
                      |+. ++|.+++...  ...+.+..++.++.||+.||.|||+.+   |+||||||+|||++.     ...+||+|||+++.
T Consensus        99 ~~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           99 LCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             CCS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             CCC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            996 5999998742  334555567789999999999999987   999999999999953     33688999999987


Q ss_pred             cccCCC-cccccccccCCCcccccccc---cCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          476 FEMDQS-QGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       476 ~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ...... ........||+.|+|||.+.   ...++.++||||||+++|||++ |+.||.
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~  231 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG  231 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence            653321 12334567999999999987   4677889999999999999999 888885

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.8e-34  Score=291.20  Aligned_cols=191  Identities=17%  Similarity=0.175  Sum_probs=158.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCCh--------hcHHHHHHHHHHHhcCC---------CCCccce
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV--------QGELEFKNEVLLVARLQ---------HRNLVRL  385 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~niv~l  385 (551)
                      .++|++.++||+|+||+||+++. +|+.||||++.....        .....+.+|+.++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            45788999999999999999997 689999999976532        22357888988888885         6666666


Q ss_pred             eeEE-----------------ec-------------CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHH
Q 008854          386 LGFS-----------------FE-------------ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARG  435 (551)
Q Consensus       386 ~~~~-----------------~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~  435 (551)
                      .+++                 ..             ....++||||+++|++.+.+.    ...+++..+..++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence            6543                 32             678899999999997666653    2568999999999999999


Q ss_pred             HHHHh-hCCCCCeEeccCCCCCeeeCCCC--------------------CeEEeecCCccccccCCCcccccccccCCCc
Q 008854          436 ILYLH-EDSRLRIIHRDLKASNILLDADM--------------------IPKISDFGMARLFEMDQSQGDTSRIVGTFGY  494 (551)
Q Consensus       436 L~yLH-~~~~~~iiH~Dlk~~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y  494 (551)
                      |.||| +.+   |+||||||+||||+.++                    .+||+|||+++....       ....||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence            99999 887   99999999999999887                    899999999986542       234799999


Q ss_pred             ccccccccCCCCcchhhHhHHHH-HHHHHhCCCCCC
Q 008854          495 MAPEYVTRGHFSIKSDVFSFGVL-VLEIISGQKNNS  529 (551)
Q Consensus       495 ~aPE~~~~~~~~~~sDv~S~Gvl-l~elltG~~p~~  529 (551)
                      +|||.+.+.. +.++||||++.. .+++++|..||.
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence            9999998766 899999998766 778899998884

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=1e-31  Score=265.92  Aligned_cols=172  Identities=10%  Similarity=0.053  Sum_probs=150.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      .++|++.+.||+|+||.||+++.. +++.||||++.....   .....+.+|+.++.+++||||+++++++...+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367899999999999999999864 489999999976533   2335789999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++++|.+++..    . ....++.+++.|++.||.|||+.+   |+||||||+|||++.++.+||+++        
T Consensus       110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~--------  173 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP--------  173 (286)
T ss_dssp             EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSC--------
T ss_pred             EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEec--------
Confidence            999999999999843    2 356678999999999999999988   999999999999999999999744        


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                                    +|++|       ++.++||||||+++|||++|+.||...
T Consensus       174 --------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~  205 (286)
T 3uqc_A          174 --------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEA  205 (286)
T ss_dssp             --------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCC
T ss_pred             --------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                          33433       688999999999999999999999743

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.97  E-value=8.1e-32  Score=280.80  Aligned_cols=199  Identities=18%  Similarity=0.196  Sum_probs=154.2

Q ss_pred             hhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCC-CCccce---------ee
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQH-RNLVRL---------LG  387 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l---------~~  387 (551)
                      ...+|...+.||+|+||+||+++ ..+|+.||||++.....   ...+.+.+|+.++..++| +|....         +.
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            34457778999999999999999 55789999999974422   234578999999999987 322111         11


Q ss_pred             E------------Eec-----CCceEEEEEccCCCChhHHhhhh----cccCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 008854          388 F------------SFE-----ETERLLIYEFVPNSSVDKFIFDA----IKRVQLDWETRYKIIGGIARGILYLHEDSRLR  446 (551)
Q Consensus       388 ~------------~~~-----~~~~~lV~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  446 (551)
                      .            ...     ....+++|++ .+++|.+++...    .....+++..++.++.||++||.|||+.+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hcccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence            1            111     1234566665 478999888521    12445788899999999999999999987   


Q ss_pred             eEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCccccccc----------ccCCCCcchhhHhHHH
Q 008854          447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV----------TRGHFSIKSDVFSFGV  516 (551)
Q Consensus       447 iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv~S~Gv  516 (551)
                      |+||||||+||||+.++.+||+|||+++.....     .....| +.|+|||.+          ....++.++|||||||
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence            999999999999999999999999998764322     334567 999999998          5566889999999999


Q ss_pred             HHHHHHhCCCCCCC
Q 008854          517 LVLEIISGQKNNSF  530 (551)
Q Consensus       517 ll~elltG~~p~~~  530 (551)
                      ++|||++|+.||..
T Consensus       306 il~elltg~~Pf~~  319 (413)
T 3dzo_A          306 AIYWIWCADLPNTD  319 (413)
T ss_dssp             HHHHHHHSSCCCCT
T ss_pred             HHHHHHHCCCCCCC
Confidence            99999999999964

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=9.5e-31  Score=260.74  Aligned_cols=173  Identities=24%  Similarity=0.336  Sum_probs=149.0

Q ss_pred             cCCCcC-cccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHH-hcCCCCCccceeeEEec----CCceE
Q 008854          324 NNFSTD-NKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLV-ARLQHRNLVRLLGFSFE----ETERL  396 (551)
Q Consensus       324 ~~f~~~-~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~  396 (551)
                      ++|.+. +.||+|+||.||++.. .+++.||+|+++..     ..+.+|+.++ +.++||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456666 7799999999999985 56899999999643     3567788887 66689999999999876    56788


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC---CCCeEEeecCCc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMA  473 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~Dfgla  473 (551)
                      +||||+++++|.+++... ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            999999999999999753 3346999999999999999999999987   999999999999998   789999999998


Q ss_pred             cccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ....                        +..++.++||||||+++|||++|+.||.
T Consensus       168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~  199 (299)
T 3m2w_A          168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFY  199 (299)
T ss_dssp             EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            6432                        2346789999999999999999999985

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=9.8e-30  Score=274.57  Aligned_cols=184  Identities=18%  Similarity=0.212  Sum_probs=130.3

Q ss_pred             ccCcCCceeEEEee-cCCCCEEEEEEeecCCh----------hcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEE
Q 008854          331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV----------QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       331 ~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  398 (551)
                      .++.|+.|.+..++ ..-|+.+++|.+.+...          ...++|.+|+++|+++ .|+||+++++++.++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            45667777666654 33589999999976521          2234699999999999 699999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||++|++|.++|.+   ..+++..   +|+.||+.||.|||+++   ||||||||+||||++++++||+|||+++....
T Consensus       321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            999999999999974   4566654   48899999999999998   99999999999999999999999999987643


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK  526 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~  526 (551)
                      +.  ......+||+.|||||.+.+ .+..++|+||+|+++++|.+|..
T Consensus       392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred             CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence            32  23445789999999998865 46778999999999887766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.4e-27  Score=256.43  Aligned_cols=188  Identities=15%  Similarity=0.225  Sum_probs=146.8

Q ss_pred             CCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChh--------cHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ--------GELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      .+...++||+|+||+||++.. .++.+++|+.......        ..+.+.+|++++++++||||+++..++...+..+
T Consensus       337 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~  415 (540)
T 3en9_A          337 RKIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR  415 (540)
T ss_dssp             -----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred             cCCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence            334567999999999999965 5788999987543211        1234789999999999999997777777888889


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      |||||+++++|.+++.+           +..++.|++++|.|||+.+   |+||||||+|||+++  .+||+|||+++..
T Consensus       416 lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~  479 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS  479 (540)
T ss_dssp             EEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred             EEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence            99999999999999863           5689999999999999987   999999999999998  9999999999876


Q ss_pred             ccCCCcc-----cccccccCCCccccccccc--CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          477 EMDQSQG-----DTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       477 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .......     ......||+.|||||++..  ..|+...|+||..+-.++.+.++.++.
T Consensus       480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            4322111     1235689999999999976  567888999999999999998887763

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.94  E-value=6.5e-27  Score=193.74  Aligned_cols=99  Identities=24%  Similarity=0.452  Sum_probs=90.4

Q ss_pred             CcCCCCCcccCCCcHHHHHHHHHHHhhhcccCC-CCceeeeecC-CCceeEEEEeccCCCChhhhHHHHHHHHHHHHhcC
Q 008854           12 QTCYDTGNFTTNSTYGKNRDLFLSSLASTVTAN-KGFYTATIGQ-IPDEVYGLALCRGDSSPESCASCLNFTVLDMMKNC   89 (551)
Q Consensus        12 ~~C~~~~~~~~~s~~~~nl~~l~~~l~~~~~~~-~~~~~~~~g~-~~~~vyg~~~C~~d~~~~~C~~Cl~~a~~~~~~~C   89 (551)
                      +.|++ ++|+++|+|++||+.||++|+++++.+ .+|++...|. ++++||||+|||||+++++|..||+.|+.+++++|
T Consensus         8 ~~Cn~-~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~~C   86 (108)
T 3a2e_A            8 SACNT-QKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFSIC   86 (108)
T ss_dssp             EEECS-SBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHHHT
T ss_pred             eecCC-CccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHHHC
Confidence            67975 799999999999999999999988765 4567766664 46999999999999999999999999999999999


Q ss_pred             CCccceeEecCCCcceEEEEccccc
Q 008854           90 PNQKEAISWEGMDFPCVVRYSSRSF  114 (551)
Q Consensus        90 ~~~~~a~~~~~~~~~C~~ry~~~~f  114 (551)
                      |++++|+||++   .|+||||+++|
T Consensus        87 ~~~~g~~i~~~---~C~lRY~~~~F  108 (108)
T 3a2e_A           87 NNAIGARVQLV---DCFIQYEQRSF  108 (108)
T ss_dssp             TSBSSEEEEET---TEEEEEESSCC
T ss_pred             CCCceEEEECC---CEEEEEeCCcC
Confidence            99999999999   99999999998

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=1.3e-23  Score=206.97  Aligned_cols=151  Identities=17%  Similarity=0.112  Sum_probs=120.5

Q ss_pred             HHhhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCCh------------------hcHHHHHHHHHHHhcCCCC
Q 008854          319 IRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV------------------QGELEFKNEVLLVARLQHR  380 (551)
Q Consensus       319 i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~  380 (551)
                      +......|.+.+.||+|+||.||++...+|+.||+|+++....                  .....+.+|+.++++++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            3444556777799999999999999987789999999965321                  12446889999999999  


Q ss_pred             CccceeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC
Q 008854          381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD  460 (551)
Q Consensus       381 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~  460 (551)
                      | +++.+++. .+..++||||+++++|.+ +..         .....++.|++.||.|||+.+   |+||||||+|||++
T Consensus       163 ~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~  227 (282)
T 1zar_A          163 G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS  227 (282)
T ss_dssp             T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence            4 66666543 356799999999999988 421         224469999999999999987   99999999999999


Q ss_pred             CCCCeEEeecCCccccccCCCcccccccccCCCccccccccc
Q 008854          461 ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR  502 (551)
Q Consensus       461 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  502 (551)
                       ++.+||+|||+++.               +..++|||++..
T Consensus       228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             -TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             -CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence             99999999999863               335789998743

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.87  E-value=3.2e-22  Score=165.55  Aligned_cols=101  Identities=26%  Similarity=0.477  Sum_probs=88.9

Q ss_pred             eeccccccccchhHHHHHHHHHHHHHHHHhccCCCccceeeeeccCCCccceeeeccccCCCChhchHHHHHHhHHhhhh
Q 008854          125 IAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPDISQSDCEFCLRQSMADVQS  204 (551)
Q Consensus       125 ~~~~~~~~~~~~~~f~~~~~~l~~~l~~~a~~~~~~~~~a~~~~~~~~~~~vy~laQC~~dl~~~~C~~Cl~~~~~~~~~  204 (551)
                      ..|+..+++.+ +.|+.++..||..|..+|+.+  ..+|+++.....+.++||||+||+|||++++|..||+.|+.++++
T Consensus         8 ~~Cn~~~~t~~-s~f~~nl~~ll~~L~~~a~~s--~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~   84 (108)
T 3a2e_A            8 SACNTQKIPSG-SPFNRNLRAMLADLRQNTAFS--GYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFS   84 (108)
T ss_dssp             EEECSSBCCTT-CTHHHHHHHHHHHHHHHGGGT--TSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHH
T ss_pred             eecCCCccCCC-ChHHHHHHHHHHHHHhhCccc--cCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHH
Confidence            35677777765 789999999999999988754  234788776656678999999999999999999999999999999


Q ss_pred             hcCCCcCceeeCcccccccccCcc
Q 008854          205 CCYGKKGSYIMGPSCIFRWEMYPF  228 (551)
Q Consensus       205 ~~~~~~g~~v~~~~C~lr~~~~~F  228 (551)
                      +|+++.||+|++++|++|||.++|
T Consensus        85 ~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           85 ICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             HTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HCCCCceEEEECCCEEEEEeCCcC
Confidence            999999999999999999999998

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=2.9e-19  Score=173.61  Aligned_cols=137  Identities=17%  Similarity=0.182  Sum_probs=106.1

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCE--EEEEEeecCChh------------------------cHHHHHHHHHHHhcC
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQE--IAVKRLSKNSVQ------------------------GELEFKNEVLLVARL  377 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  377 (551)
                      -|++.+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|+.++.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            356788999999999999987 67888  999987543111                        113578999999999


Q ss_pred             CCCCc--cceeeEEecCCceEEEEEccCC-C----ChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEe
Q 008854          378 QHRNL--VRLLGFSFEETERLLIYEFVPN-S----SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH-EDSRLRIIH  449 (551)
Q Consensus       378 ~h~ni--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiH  449 (551)
                      +|+++  ..++..    ...+|||||+.+ |    +|.++...      .++..+..++.|++.+|.||| +.+   |+|
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH  194 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH  194 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence            88864  333332    367899999952 4    56655432      224457789999999999999 776   999


Q ss_pred             ccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          450 RDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       450 ~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      |||||+|||+++  .++|+|||++...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999988  9999999999753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.65  E-value=6.8e-17  Score=163.49  Aligned_cols=139  Identities=14%  Similarity=0.180  Sum_probs=98.6

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCCh--------------hcHHH--------HHHHHHHHhcCCCC
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV--------------QGELE--------FKNEVLLVARLQHR  380 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~h~  380 (551)
                      ..-|++.++||+|++|.||+|...+|+.||||+++....              .....        ...|...|.++.+.
T Consensus        94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            344889999999999999999988999999998753210              00111        23455556555444


Q ss_pred             CccceeeEEecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC
Q 008854          381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD  460 (551)
Q Consensus       381 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~  460 (551)
                      ++.-..-+..  ...+|||||+++.+|..+..       .  .....++.||+.+|.+||+.+   ||||||||.||||+
T Consensus       174 gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~  239 (397)
T 4gyi_A          174 GFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR  239 (397)
T ss_dssp             TCSCCCEEEE--ETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             CCCCCeeeec--cCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence            3321111111  23479999999988765432       1  123567899999999999987   99999999999998


Q ss_pred             CCC----------CeEEeecCCccc
Q 008854          461 ADM----------IPKISDFGMARL  475 (551)
Q Consensus       461 ~~~----------~~kl~Dfgla~~  475 (551)
                      +++          .+.|+||+-+..
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCCcccccccccceEEEEeCCccc
Confidence            876          389999987643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.31  E-value=5.5e-12  Score=122.29  Aligned_cols=145  Identities=17%  Similarity=0.124  Sum_probs=112.4

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .-..|.....++.|+.+.||+.... ++.+++|+...........+.+|+.+++.+. |..+.+++++....+..++|||
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            3356777888898999999999854 6899999987532122235888999999885 6778889999988888999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhC--------------------------------------
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED--------------------------------------  442 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------------  442 (551)
                      |+++.+|.+.+.        +......++.+++++|..||+.                                      
T Consensus        91 ~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           91 EADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             CCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             ecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999999877531        1122346788999999999981                                      


Q ss_pred             ------------------CCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          443 ------------------SRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       443 ------------------~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                                        ..+.++|+|++|.||+++++..+.|+||+.+..
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                              114489999999999998766677999988753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.19  E-value=2.3e-11  Score=117.36  Aligned_cols=138  Identities=17%  Similarity=0.130  Sum_probs=100.4

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCC--ccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~  401 (551)
                      ..+.+....+.|..+.||+....+|..+++|+.....   ...+.+|+.+++.+.+.+  +.+++++...++..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            3444433334566699999987778889999976542   235778888888886544  45688888877788999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS--------------------------------------  443 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--------------------------------------  443 (551)
                      +++.+|.  ...      .+   ...++.++++.|..||+..                                      
T Consensus        97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            9998874  211      11   2256677778888888643                                      


Q ss_pred             -----------------CCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          444 -----------------RLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       444 -----------------~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                                       .+.++|+|++|.||+++++..+.|+||+.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                             12399999999999998876677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.02  E-value=7.7e-10  Score=112.32  Aligned_cols=142  Identities=16%  Similarity=0.225  Sum_probs=106.6

Q ss_pred             cCcccCcCCceeEEEeecCCCCEEEEEEee--cCC-hhcHHHHHHHHHHHhcCC--CCCccceeeEEecC---CceEEEE
Q 008854          328 TDNKLGQGGFGAVYKGRLSHGQEIAVKRLS--KNS-VQGELEFKNEVLLVARLQ--HRNLVRLLGFSFEE---TERLLIY  399 (551)
Q Consensus       328 ~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lV~  399 (551)
                      ..+.|+.|.++.||+.... +..+++|+..  ... ......+.+|..+++.+.  +..+.+++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3577899999999999875 4688888876  322 122346788999999887  45578888888766   3478999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCC------------------------------------
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS------------------------------------  443 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------  443 (551)
                      ||+++..+.+..     ...++..++..++.++++.|..||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998875421     234678888899999999999999731                                    


Q ss_pred             -------------------CCCeEeccCCCCCeeeCCCCC--eEEeecCCccc
Q 008854          444 -------------------RLRIIHRDLKASNILLDADMI--PKISDFGMARL  475 (551)
Q Consensus       444 -------------------~~~iiH~Dlk~~NIll~~~~~--~kl~Dfgla~~  475 (551)
                                         .+.++|+|+++.|||+++++.  +.|.||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               256999999999999997753  68999999864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.99  E-value=3.2e-10  Score=112.38  Aligned_cols=183  Identities=19%  Similarity=0.266  Sum_probs=120.7

Q ss_pred             CcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-CCC--ccceeeEEecCC---ceEEEEEcc
Q 008854          329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRN--LVRLLGFSFEET---ERLLIYEFV  402 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~e~~  402 (551)
                      .+.++.|....||+..    ..+++|+....  .....+.+|..++..+. +..  +.+++.......   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4668999999999874    56888886432  33457889999998874 333  334444433332   347899999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhC----------------------------------------
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED----------------------------------------  442 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------------  442 (551)
                      ++.+|.....     ..++..++..++.++++.|..||+.                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9998875432     2366777777888888888888851                                        


Q ss_pred             ---------------CCCCeEeccCCCCCeeeCC--CCCeEEeecCCccccccCCCcccccccccCCCc---ccccccc-
Q 008854          443 ---------------SRLRIIHRDLKASNILLDA--DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY---MAPEYVT-  501 (551)
Q Consensus       443 ---------------~~~~iiH~Dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y---~aPE~~~-  501 (551)
                                     ..+.++|+|++|.||++++  +..+.|+||+.+..-.....      .......   ..|+... 
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCCHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccCHHHHHH
Confidence                           1245899999999999998  45678999999865321100      0000011   1222111 


Q ss_pred             ---c-CC---------CCcchhhHhHHHHHHHHHhCCCCC
Q 008854          502 ---R-GH---------FSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       502 ---~-~~---------~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                         . +.         .....+.|+++.++|++.+|+.++
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence               0 01         112368999999999999998766

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.48  E-value=9.4e-07  Score=87.32  Aligned_cols=136  Identities=20%  Similarity=0.168  Sum_probs=91.9

Q ss_pred             CcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCC---CccceeeEEe-cCCceEEEEEccCC
Q 008854          329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR---NLVRLLGFSF-EETERLLIYEFVPN  404 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~e~~~~  404 (551)
                      .+.++.|....||+.    +..+++|+-.  .......+.+|..+|..+.+.   .+.+.+.+.. ..+..++||||+++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888888999987    5778888853  223345788999999998753   3556666664 34557899999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhC------------------------------------------
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED------------------------------------------  442 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------  442 (551)
                      .+|.....     ..++..+...++.++++.|..||+.                                          
T Consensus        98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            98876321     1123333444444444444444432                                          


Q ss_pred             ---------------CCCCeEeccCCCCCeeeCC---CCC-eEEeecCCccc
Q 008854          443 ---------------SRLRIIHRDLKASNILLDA---DMI-PKISDFGMARL  475 (551)
Q Consensus       443 ---------------~~~~iiH~Dlk~~NIll~~---~~~-~kl~Dfgla~~  475 (551)
                                     ..+.++|+|+++.||++++   ++. ..|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           2345799999999999987   455 48999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.36  E-value=2e-06  Score=83.17  Aligned_cols=135  Identities=16%  Similarity=0.193  Sum_probs=94.2

Q ss_pred             ccCcCCce-eEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEEEccCCCCh
Q 008854          331 KLGQGGFG-AVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEFVPNSSV  407 (551)
Q Consensus       331 ~LG~G~~g-~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL  407 (551)
                      .+..|..+ .||+.... ++..+++|+-...   ....+.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34445544 68987654 4667999986543   2346788988888774 33467788888888889999999999888


Q ss_pred             hHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhC---------------------------------------------
Q 008854          408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED---------------------------------------------  442 (551)
Q Consensus       408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------------------  442 (551)
                      .+.....       ......+..+++..|.-||..                                             
T Consensus       108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            7654321       112234555566666666642                                             


Q ss_pred             ----------CCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          443 ----------SRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       443 ----------~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                                ..+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                      112279999999999999887778999988753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.28  E-value=8.2e-07  Score=89.68  Aligned_cols=80  Identities=6%  Similarity=0.042  Sum_probs=54.7

Q ss_pred             Cccc-CcCCceeEEEeecC-------CCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCC-C--CCccceeeEEecC--
Q 008854          329 DNKL-GQGGFGAVYKGRLS-------HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQ-H--RNLVRLLGFSFEE--  392 (551)
Q Consensus       329 ~~~L-G~G~~g~Vyk~~~~-------~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--  392 (551)
                      .+.| +.|....+|+....       ++..+++|+.....   ......+.+|..+++.+. +  -.+.+++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88889999998764       26678898865432   101235677888887774 2  3466777776654  


Q ss_pred             -CceEEEEEccCCCChh
Q 008854          393 -TERLLIYEFVPNSSVD  408 (551)
Q Consensus       393 -~~~~lV~e~~~~gsL~  408 (551)
                       ...++||||+++..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3468999999987764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.03  E-value=3.4e-05  Score=76.99  Aligned_cols=141  Identities=16%  Similarity=0.220  Sum_probs=79.5

Q ss_pred             cccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-----CCCcccee-e--EEecCCceEEEEEc
Q 008854          330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-----HRNLVRLL-G--FSFEETERLLIYEF  401 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lV~e~  401 (551)
                      +.|+.|..+.||+....+| .+++|+....    ...+..|..++..|.     .|.++... |  +....+..++||||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677899999987554 5899998652    123334444444442     34443311 1  12245567899999


Q ss_pred             cCCCChh-----------H---HhhhhcccC-----------CCCHHHHH------------------------------
Q 008854          402 VPNSSVD-----------K---FIFDAIKRV-----------QLDWETRY------------------------------  426 (551)
Q Consensus       402 ~~~gsL~-----------~---~l~~~~~~~-----------~l~~~~~~------------------------------  426 (551)
                      +++.++.           .   -++......           ...|...+                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9987653           0   112111100           11332211                              


Q ss_pred             -HHHHHHHHHHHHHhh----------CCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          427 -KIIGGIARGILYLHE----------DSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       427 -~i~~~ia~~L~yLH~----------~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                       .+...+.+.+.+|+.          .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             111223445666663          1235699999999999998888999999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.00  E-value=2.5e-05  Score=79.98  Aligned_cols=75  Identities=13%  Similarity=0.123  Sum_probs=48.6

Q ss_pred             CcccCcCCceeEEEeecC-CCCEEEEEEeecCCh-------hcHHHHHHHHHHHhcCCC--CCc-cceeeEEecCCceEE
Q 008854          329 DNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-------QGELEFKNEVLLVARLQH--RNL-VRLLGFSFEETERLL  397 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~ni-v~l~~~~~~~~~~~l  397 (551)
                      .+.||.|..+.||++... +++.++||.......       .....+..|.+++..+.+  |.. .+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467999999999999754 468899998653211       112346778888877642  333 345543  3455689


Q ss_pred             EEEccCCC
Q 008854          398 IYEFVPNS  405 (551)
Q Consensus       398 V~e~~~~g  405 (551)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.99  E-value=2.5e-05  Score=76.22  Aligned_cols=80  Identities=20%  Similarity=0.284  Sum_probs=57.8

Q ss_pred             CCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCC---CccceeeEEecCCceEEEEEc
Q 008854          325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR---NLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .....+.+|.|..+.||+.++.+|+.+++|+...........|..|...|+.|...   .+.+++++    +..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence            44556789999999999999999999999987654433334578898888877422   24445543    245789999


Q ss_pred             cCCCChh
Q 008854          402 VPNSSVD  408 (551)
Q Consensus       402 ~~~gsL~  408 (551)
                      ++.+...
T Consensus        92 l~~~~~~   98 (288)
T 3f7w_A           92 VDERPPT   98 (288)
T ss_dssp             CCCCCCC
T ss_pred             ecccCCC
Confidence            9876543

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.85  E-value=8.2e-05  Score=73.31  Aligned_cols=140  Identities=18%  Similarity=0.159  Sum_probs=93.1

Q ss_pred             CcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC---CCCccceeeEEecCCceEEEEEccC
Q 008854          327 STDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ---HRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       327 ~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      ...+.|+.|....+|+... ++..+++|+....   ....+..|...|+.|.   ...+.+++.+....+..++||||++
T Consensus        39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3456799999999999986 5678999987643   2446788888888774   3567888888887788999999999


Q ss_pred             CCChhH--------H---hhhhcccC-------------------CCCHHHHH---HHH----------------HHHHH
Q 008854          404 NSSVDK--------F---IFDAIKRV-------------------QLDWETRY---KII----------------GGIAR  434 (551)
Q Consensus       404 ~gsL~~--------~---l~~~~~~~-------------------~l~~~~~~---~i~----------------~~ia~  434 (551)
                      +..+..        .   |+......                   .-+|....   ++.                ..+..
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            886521        1   12111100                   11454322   111                11111


Q ss_pred             H-HHHHhh-CCCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          435 G-ILYLHE-DSRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       435 ~-L~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                      - ...|.. ...+.++|+|+.+.||+++.++ +.|.|+.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1 223432 2356799999999999999887 8899984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.71  E-value=0.00014  Score=74.93  Aligned_cols=78  Identities=13%  Similarity=0.139  Sum_probs=47.4

Q ss_pred             CCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccccc--cCCCcccccccccC---CCCcchhhHhHHHHH
Q 008854          444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV--GTFGYMAPEYVTRG---HFSIKSDVFSFGVLV  518 (551)
Q Consensus       444 ~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~sDv~S~Gvll  518 (551)
                      .+.++|+|+++.|||+++++ ++|+||+.+..-....   ......  -...|.+|+.....   .-....++......+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~---Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF---DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH---HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH---HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            34699999999999998876 9999999886422110   000000  01245566544311   112345566778888


Q ss_pred             HHHHhCC
Q 008854          519 LEIISGQ  525 (551)
Q Consensus       519 ~elltG~  525 (551)
                      |+.++++
T Consensus       307 ~~~y~~~  313 (420)
T 2pyw_A          307 WNLFNKR  313 (420)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            8877764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.35  E-value=0.00022  Score=69.85  Aligned_cols=72  Identities=8%  Similarity=0.179  Sum_probs=45.2

Q ss_pred             CcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCc-cceeeEEecCCceEEEEEcc-CCCC
Q 008854          329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL-VRLLGFSFEETERLLIYEFV-PNSS  406 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~-~~gs  406 (551)
                      .+.|+.|....+|+.     +.+++|+....... .....+|..++..+....+ .+++++  ....-++|+||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            678989999999998     56888887653211 1123567777766643333 345543  344457899999 6655


Q ss_pred             hh
Q 008854          407 VD  408 (551)
Q Consensus       407 L~  408 (551)
                      +.
T Consensus        95 l~   96 (301)
T 3dxq_A           95 MS   96 (301)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.34  E-value=0.00056  Score=67.50  Aligned_cols=143  Identities=16%  Similarity=0.145  Sum_probs=78.2

Q ss_pred             cccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCC--ccceeeE------EecCCceEEEEEc
Q 008854          330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLGF------SFEETERLLIYEF  401 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~e~  401 (551)
                      +.|+.|....+|+....+| .+++|+......  ...+..|+.++..+....  +.+++..      ....+..+++|+|
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~  104 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  104 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence            4577788899999987555 688998865311  123455666666553212  2333321      1223456899999


Q ss_pred             cCCCChhH----H----------hhhhccc---C---CC---CHHHHHHH------------HHHHHHHHHHHhhC----
Q 008854          402 VPNSSVDK----F----------IFDAIKR---V---QL---DWETRYKI------------IGGIARGILYLHED----  442 (551)
Q Consensus       402 ~~~gsL~~----~----------l~~~~~~---~---~l---~~~~~~~i------------~~~ia~~L~yLH~~----  442 (551)
                      +++..+..    .          ++.....   .   ..   .|...+.-            ...+.+.+..|+..    
T Consensus       105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~  184 (322)
T 2ppq_A          105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  184 (322)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence            99866421    1          1111000   0   01   13221110            01134445555431    


Q ss_pred             CCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          443 SRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       443 ~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ....++|+|+.+.|||++++..+.|+||+.+..
T Consensus       185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            234599999999999998876668999988753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.24  E-value=0.0019  Score=64.05  Aligned_cols=141  Identities=18%  Similarity=0.140  Sum_probs=71.4

Q ss_pred             cccCcCCcee-EEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCC--CCccceeeEEecCCceEEEEEccCCCC
Q 008854          330 NKLGQGGFGA-VYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH--RNLVRLLGFSFEETERLLIYEFVPNSS  406 (551)
Q Consensus       330 ~~LG~G~~g~-Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gs  406 (551)
                      +.|+.|.... +|+....+++.+++|.......   ..+..|+.++..+..  -.+.+++.+....  -+++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence            4565555444 6677654467787776543221   123445555555532  2345566553332  378999998776


Q ss_pred             hhHHhhhhc--------------------c---cCCCCHHHHH-------H-------------HHHHHHHHHHHHh---
Q 008854          407 VDKFIFDAI--------------------K---RVQLDWETRY-------K-------------IIGGIARGILYLH---  440 (551)
Q Consensus       407 L~~~l~~~~--------------------~---~~~l~~~~~~-------~-------------i~~~ia~~L~yLH---  440 (551)
                      +.+.+....                    .   ...++.....       .             ....+...+..|.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654432100                    0   0112111100       0             0011112222221   


Q ss_pred             hCCCCCeEeccCCCCCeeeCCC----CCeEEeecCCccc
Q 008854          441 EDSRLRIIHRDLKASNILLDAD----MIPKISDFGMARL  475 (551)
Q Consensus       441 ~~~~~~iiH~Dlk~~NIll~~~----~~~kl~Dfgla~~  475 (551)
                      ......++|+|+.+.||+++.+    ..+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1223469999999999999875    6789999998864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.22  E-value=0.0027  Score=62.75  Aligned_cols=142  Identities=17%  Similarity=0.144  Sum_probs=80.8

Q ss_pred             cccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCC--ccceeeE-----EecCCceEEEEEcc
Q 008854          330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLGF-----SFEETERLLIYEFV  402 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lV~e~~  402 (551)
                      ..|+ |....||+....+|+.+++|+...... ....+..|..++..+....  +.+++..     ....+..++||||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 778899998877777899999864321 2345667777777664222  3444433     11234557899999


Q ss_pred             CCCChhH----H----------hhhhcc------cCCCCHHHH----HHHH---------------HHHHHHHHHHhh--
Q 008854          403 PNSSVDK----F----------IFDAIK------RVQLDWETR----YKII---------------GGIARGILYLHE--  441 (551)
Q Consensus       403 ~~gsL~~----~----------l~~~~~------~~~l~~~~~----~~i~---------------~~ia~~L~yLH~--  441 (551)
                      ++..+..    .          ++....      ....++...    ..++               ..+...+..+..  
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8865421    1          111100      111222211    0010               011112222221  


Q ss_pred             --CCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          442 --DSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       442 --~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                        .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence              1234589999999999999 4 899999988754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.19  E-value=0.00072  Score=69.80  Aligned_cols=73  Identities=18%  Similarity=0.273  Sum_probs=49.3

Q ss_pred             CcccCcCCceeEEEeecCC--------CCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCc-cceeeEEecCCceEEEE
Q 008854          329 DNKLGQGGFGAVYKGRLSH--------GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL-VRLLGFSFEETERLLIY  399 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~  399 (551)
                      .+.|+.|....||+....+        ++.+++|+.....  ....+.+|..++..+...++ .++++.+..    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3568888889999998643        4789999884421  11345678888888753344 556665432    3899


Q ss_pred             EccCCCCh
Q 008854          400 EFVPNSSV  407 (551)
Q Consensus       400 e~~~~gsL  407 (551)
                      ||+++.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.02  E-value=0.0018  Score=65.41  Aligned_cols=142  Identities=18%  Similarity=0.209  Sum_probs=82.7

Q ss_pred             CcccCcCCceeEEEeecC--------CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCC-ccceeeEEecCCceEEEE
Q 008854          329 DNKLGQGGFGAVYKGRLS--------HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN-LVRLLGFSFEETERLLIY  399 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~--------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~  399 (551)
                      .+.|..|-...+|+....        +++.+++|+.... ......+.+|..+++.+...+ ..++++.+..    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            356777888889998764        2478999986332 223446678988888875323 3556666543    3999


Q ss_pred             EccCCCChhHH-----------------hhhh-c-ccCCCC--HHHHHHHHHHHHH-------------------HHHH-
Q 008854          400 EFVPNSSVDKF-----------------IFDA-I-KRVQLD--WETRYKIIGGIAR-------------------GILY-  438 (551)
Q Consensus       400 e~~~~gsL~~~-----------------l~~~-~-~~~~l~--~~~~~~i~~~ia~-------------------~L~y-  438 (551)
                      ||+++.+|..-                 |+.. . ......  |.++.++..++..                   .+.. 
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998665421                 0110 0 011122  3445555443321                   1223 


Q ss_pred             ---Hhh-CCCCCeEeccCCCCCeeeCCC----CCeEEeecCCccc
Q 008854          439 ---LHE-DSRLRIIHRDLKASNILLDAD----MIPKISDFGMARL  475 (551)
Q Consensus       439 ---LH~-~~~~~iiH~Dlk~~NIll~~~----~~~kl~Dfgla~~  475 (551)
                         |.. .....++|+|+.+.||+++++    +.+.|+||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               322 223458999999999999876    7899999988753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.83  E-value=0.0043  Score=64.36  Aligned_cols=74  Identities=12%  Similarity=0.076  Sum_probs=47.7

Q ss_pred             CcccCcCCceeEEEeecCC-CCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCc-cceeeEEecCCceEEEEEccCCCC
Q 008854          329 DNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL-VRLLGFSFEETERLLIYEFVPNSS  406 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~gs  406 (551)
                      .+.|+.|-...+|+....+ +..+++|+...... ......+|..++..|...++ .++++.+.  +  .+||||+++.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4578888889999998754 47788988754321 11122578888888865555 45666652  2  35999998755


Q ss_pred             h
Q 008854          407 V  407 (551)
Q Consensus       407 L  407 (551)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.81  E-value=0.0015  Score=65.82  Aligned_cols=73  Identities=11%  Similarity=0.071  Sum_probs=43.5

Q ss_pred             cccCcCCceeEEEeecCC---------CCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCC-ccceeeEEecCCceEEEE
Q 008854          330 NKLGQGGFGAVYKGRLSH---------GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN-LVRLLGFSFEETERLLIY  399 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~  399 (551)
                      +.|+.|....+|+....+         +..+++|+...... .......|..++..+...+ ..++++..    .-++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence            567788888999987643         26788888754321 1112356777777775333 34566543    237899


Q ss_pred             EccCCCCh
Q 008854          400 EFVPNSSV  407 (551)
Q Consensus       400 e~~~~gsL  407 (551)
                      ||+++.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99997654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.77  E-value=0.0088  Score=59.48  Aligned_cols=32  Identities=25%  Similarity=0.387  Sum_probs=27.9

Q ss_pred             CCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          444 RLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       444 ~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      ...++|+|+.+.||++++++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            34699999999999999888899999987754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.11  E-value=0.059  Score=55.09  Aligned_cols=74  Identities=14%  Similarity=0.079  Sum_probs=47.7

Q ss_pred             CcccCcCCceeEEEeecCC--------CCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCC-ccceeeEEecCCceEEEE
Q 008854          329 DNKLGQGGFGAVYKGRLSH--------GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN-LVRLLGFSFEETERLLIY  399 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~  399 (551)
                      .+.|..|-...+|+....+        ++.+++|+..... .......+|..+++.+...+ ..++++.+    .-++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence            4567778888999988653        5789999875432 11113457777777774333 34555533    237899


Q ss_pred             EccCCCCh
Q 008854          400 EFVPNSSV  407 (551)
Q Consensus       400 e~~~~gsL  407 (551)
                      ||+++.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=92.12  E-value=0.54  Score=42.92  Aligned_cols=104  Identities=11%  Similarity=0.041  Sum_probs=66.7

Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      .-+|.++|..  ...++++.+++.++.|.+..|.-+-.... + ..+=+.|..|++..+|++.+.+ ..+.         
T Consensus        32 ~vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           32 ALSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             cccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---------
Confidence            4478898874  57899999999999999999877622110 1 1222456899999999987753 1110         


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKN  527 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p  527 (551)
                           .....+.+||... ...+.+.=|||+|+++|.-+-=..|
T Consensus        98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                 1122466888653 3456788999999999987764443

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.74  E-value=0.66  Score=46.90  Aligned_cols=29  Identities=28%  Similarity=0.391  Sum_probs=24.7

Q ss_pred             eEeccCCCCCeee------CCCCCeEEeecCCccc
Q 008854          447 IIHRDLKASNILL------DADMIPKISDFGMARL  475 (551)
Q Consensus       447 iiH~Dlk~~NIll------~~~~~~kl~Dfgla~~  475 (551)
                      ++|+|+.+.|||+      +++..++++||..+..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4567899999988753

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.98  E-value=0.09  Score=54.51  Aligned_cols=61  Identities=8%  Similarity=0.114  Sum_probs=18.6

Q ss_pred             CcCcccCcCCceeEEEeecCC-CCEEEE------EEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEe
Q 008854          327 STDNKLGQGGFGAVYKGRLSH-GQEIAV------KRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSF  390 (551)
Q Consensus       327 ~~~~~LG~G~~g~Vyk~~~~~-g~~vav------K~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~  390 (551)
                      .+.++||   ||.||+|.+.. ..+|||      |..+....  +....+.+|..++..++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            4456777   99999999754 357888      76654322  22346888999999999999999988754

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=86.09  E-value=0.09  Score=34.49  Aligned_cols=16  Identities=44%  Similarity=0.563  Sum_probs=6.9

Q ss_pred             HHHHHHhhhheeehhh
Q 008854          280 LVALITCVFLRRRKKK  295 (551)
Q Consensus       280 vv~l~~~~~~rrr~~~  295 (551)
                      ++++.+++++|||+.+
T Consensus        26 ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B           26 VVALGIGLFMRRRHIV   41 (44)
T ss_dssp             HHHHHHHHHHHTTTCC
T ss_pred             HHHHHHHHHhhhhHhh
Confidence            3334444444444433

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=83.48  E-value=0.12  Score=33.78  Aligned_cols=16  Identities=38%  Similarity=0.667  Sum_probs=7.1

Q ss_pred             HHHHHHhhhheeehhh
Q 008854          280 LVALITCVFLRRRKKK  295 (551)
Q Consensus       280 vv~l~~~~~~rrr~~~  295 (551)
                      ++++.+++++|||+.+
T Consensus        25 ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           25 IVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHTTCSS
T ss_pred             HHHHHHHHHhhhhhhh
Confidence            3334444455444443

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	551
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-62
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-60
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-59
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-57
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-57
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-56
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-56
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-56
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-55
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-55
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-55
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-55
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-55
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-54
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-53
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-53
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-52
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-52
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-52
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-50
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-49
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-49
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-48
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-48
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-47
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-47
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-46
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-45
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-41
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-30
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-26

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 1e-63
 Identities = 58/206 (28%), Positives = 107/206 (51%), Gaps = 9/206 (4%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
              +   ++G G FG VYKG+      + +  ++  + Q    FKNEV ++ + +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
             +G+S    +  ++ ++   SS+   +       + +      I    A+G+ YLH  S
Sbjct: 68  LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-- 501
              IIHRDLK++NI L  D+  KI DFG+A +           ++ G+  +MAPE +   
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 502 -RGHFSIKSDVFSFGVLVLEIISGQK 526
            +  +S +SDV++FG+++ E+++GQ 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQL 207

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 3e-62
 Identities = 50/206 (24%), Positives = 98/206 (47%), Gaps = 11/206 (5%)

Query: 322 ATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQH 379
             ++F   ++LG G  G V+K      G  +A K +              E+ ++     
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
             +V   G  + + E  +  E +   S+D+ +    K  ++  +   K+   + +G+ YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
               + +I+HRD+K SNIL+++    K+ DFG++            +  VGT  YM+PE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174

Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +   H+S++SD++S G+ ++E+  G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 2e-60
 Identities = 66/203 (32%), Positives = 107/203 (52%), Gaps = 7/203 (3%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
                  +LG G FG V+ G  +   ++AVK L + S+  +  F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLV 71

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           RL      +    +I E++ N S+  F+      ++L       +   IA G+ ++ E +
Sbjct: 72  RLYAV-VTQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
               IHRDL+A+NIL+   +  KI+DFG+ARL E ++             + APE +  G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYG 185

Query: 504 HFSIKSDVFSFGVLVLEIISGQK 526
            F+IKSDV+SFG+L+ EI++  +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR 208

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 5e-59
 Identities = 58/226 (25%), Positives = 107/226 (47%), Gaps = 9/226 (3%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
           +  +   ++G G FG V+ G   +  ++A+K + + ++  E +F  E  ++ +L H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLV 63

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +L G   E+    L++EF+ +  +  ++    +R     ET   +   +  G   +    
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEG---MAYLE 118

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
              +IHRDL A N L+  + + K+SDFGM R    DQ    ++       + +PE  +  
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177

Query: 504 HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLHI 549
            +S KSDV+SFGVL+ E+ S  K           +++  +S    +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK--IPYENRSNSEVVEDISTGFRL 221

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 5e-57
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 9/224 (4%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
            +   + KLGQG FG V+ G  +    +A+K L   ++  E  F  E  ++ +L+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLV 75

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +L      E    ++ E++   S+  F+     +          +   IA G+ Y+    
Sbjct: 76  QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE--- 130

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
           R+  +HRDL+A+NIL+  +++ K++DFG+ARL E ++             + APE    G
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189

Query: 504 HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNL 547
            F+IKSDV+SFG+L+ E+ +  +      G    ++L  V    
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQVERGY 231

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 6e-57
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 9/205 (4%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRN 381
            ++     LG+G +G V         + +AVK +         E  K E+ +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           +V+  G   E   + L  E+     +   I      + +      +    +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
              + I HRD+K  N+LLD     KISDFG+A +F  +  +   +++ GT  Y+APE + 
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 502 RGHF-SIKSDVFSFGVLVLEIISGQ 525
           R  F +   DV+S G+++  +++G+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE 203

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 1e-56
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 7/203 (3%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
            + +   +LG G FG V  G+     ++A+K + + S   E EF  E  ++  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           +L G   ++    +I E++ N  +  ++ +   R +   +   ++   +   + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
             + +HRDL A N L++   + K+SDFG++R    D+    +        +  PE +   
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYS 176

Query: 504 HFSIKSDVFSFGVLVLEIISGQK 526
            FS KSD+++FGVL+ EI S  K
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK 199

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  188 bits (479), Expect = 4e-56
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 19/212 (8%)

Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVAR 376
           D    FS   ++G G FGAVY  R + + + +A+K++S +  Q      +   EV  + +
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71

Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L+H N ++  G    E    L+ E+   S+ D      + +  L       +  G  +G+
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGL 128

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            YLH      +IHRD+KA NILL    + K+ DFG A +          +  VGT  +MA
Sbjct: 129 AYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMA 179

Query: 497 PEYV---TRGHFSIKSDVFSFGVLVLEIISGQ 525
           PE +     G +  K DV+S G+  +E+   +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERK 211

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 9e-56
 Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 15/226 (6%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
                   +G+G FG V  G    G ++AVK +  ++      F  E  ++ +L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLV 63

Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +LLG   EE   L ++ E++   S+  ++     R  L  +   K    +   + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
                +HRDL A N+L+  D + K+SDFG+ +     Q  G          + APE +  
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALRE 174

Query: 503 GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLH 548
             FS KSDV+SFG+L+ EI S  +          +D++  V     
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGR--VPYPRIPLKDVVPRVEKGYK 218

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 1e-55
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 12/211 (5%)

Query: 322 ATNNFS-TDNKLGQGGFGAVYKGRL---SHGQEIAVKRLSKNSVQGELE-FKNEVLLVAR 376
             +N    D +LG G FG+V +G         ++A+K L + + + + E    E  ++ +
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L +  +VRL+G   +    +L+ E      + KF+    KR ++      +++  ++ G+
Sbjct: 66  LDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD-TSRIVGTFGYM 495
            YL        +HRDL A N+LL      KISDFG+++    D S     S       + 
Sbjct: 123 KYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISGQK 526
           APE +    FS +SDV+S+GV + E +S  +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ 210

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 2e-55
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 10/209 (4%)

Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRN 381
           ++     +G G +G   K R  S G+ +  K L   S+         +EV L+  L+H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 382 LVRLLGFSFEETERLL--IYEFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGILY 438
           +VR      + T   L  + E+     +   I    K R  LD E   +++  +   +  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 439 LHE--DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            H   D    ++HRDLK +N+ LD     K+ DFG+AR+   D S       VGT  YM+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMS 182

Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           PE + R  ++ KSD++S G L+ E+ +  
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM 211

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 2e-55
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 13/211 (6%)

Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH 379
           +  + +    +LG G FG VYK +        A K +   S +   ++  E+ ++A   H
Sbjct: 9   NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68

Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            N+V+LL   + E    ++ EF    +VD  + +      L       +       + YL
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYL 126

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
           H+    +IIHRDLKA NIL   D   K++DFG++        + D+   +GT  +MAPE 
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEV 181

Query: 500 V-----TRGHFSIKSDVFSFGVLVLEIISGQ 525
           V         +  K+DV+S G+ ++E+   +
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIE 212

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  186 bits (473), Expect = 2e-55
 Identities = 64/227 (28%), Positives = 112/227 (49%), Gaps = 9/227 (3%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
            + +  +KLG G +G VY+G    +   +AVK L +++++ E EF  E  ++  ++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 75

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           V+LLG    E    +I EF+   ++  ++ +   R ++       +   I+  + YL   
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE-- 132

Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
            +   IHRDL A N L+  + + K++DFG++RL   D              + APE +  
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190

Query: 503 GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLHI 549
             FSIKSDV++FGVL+ EI +     S   G +   +   +  +  +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGM--SPYPGIDLSQVYELLEKDYRM 235

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  186 bits (472), Expect = 3e-55
 Identities = 63/230 (27%), Positives = 112/230 (48%), Gaps = 22/230 (9%)

Query: 314 FDFSTIRDATNNFST---------DNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNS 360
           F F    +A   F+          +  +G G FG V  G L         +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 361 VQGEL-EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ 419
            + +  +F +E  ++ +  H N++ L G   + T  ++I EF+ N S+D F+     +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 420 LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479
                   ++ GIA G+ YL     +  +HRDL A NIL++++++ K+SDFG++R  E D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 480 QSQGDTSRIVG---TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK 526
            S    +  +G      + APE +    F+  SDV+S+G+++ E++S  +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 7e-55
 Identities = 59/209 (28%), Positives = 108/209 (51%), Gaps = 10/209 (4%)

Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR 376
           ++ D    ++   K+GQG  G VY    ++ GQE+A+++++      +    NE+L++  
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
            ++ N+V  L       E  ++ E++   S    + D +    +D      +     + +
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECLQAL 129

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            +LH     ++IHRD+K+ NILL  D   K++DFG       +QS+   S +VGT  +MA
Sbjct: 130 EFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMA 184

Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           PE VTR  +  K D++S G++ +E+I G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  184 bits (467), Expect = 1e-54
 Identities = 60/263 (22%), Positives = 110/263 (41%), Gaps = 33/263 (12%)

Query: 312 LQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNSVQGEL 365
           L     ++    NN      +G+G FG V++ R            +AVK L + +     
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 366 -EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFD----------- 413
            +F+ E  L+A   + N+V+LLG         L++E++    +++F+             
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 414 ----------AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM 463
                     +     L    +  I   +A G+ YL E    + +HRDL   N L+  +M
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENM 177

Query: 464 IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
           + KI+DFG++R                   +M PE +    ++ +SDV+++GV++ EI S
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237

Query: 524 GQKNNSFRIGEEAEDLLTYVSNN 546
                 +  G   E+++ YV + 
Sbjct: 238 YGLQPYY--GMAHEEVIYYVRDG 258

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 3e-54
 Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 23/222 (10%)

Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
            +G+G FG V++G+   G+E+AVK  S    +     + E+     L+H N++  +    
Sbjct: 10  SIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67

Query: 391 EE----TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED---- 442
           ++    T+  L+ ++  + S    +FD + R  +  E   K+    A G+ +LH +    
Sbjct: 68  KDNGTWTQLWLVSDYHEHGS----LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 443 -SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD--TSRIVGTFGYMAPEY 499
             +  I HRDLK+ NIL+  +    I+D G+A   +      D   +  VGT  YMAPE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 500 ------VTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
                 +       ++D+++ G++  EI             +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 6e-54
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 13/204 (6%)

Query: 329 DNKLGQGGFGAVYKGRLSH---GQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRNLV 383
           D +LG G FG V KG        + +AVK L   +    L  E   E  ++ +L +  +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
           R++G   E    +L+ E      ++K++    +   +  +   +++  ++ G+ YL    
Sbjct: 72  RMIGI-CEAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE--- 124

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS-RIVGTFGYMAPEYVTR 502
               +HRDL A N+LL      KISDFG+++    D++             + APE +  
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 503 GHFSIKSDVFSFGVLVLEIISGQK 526
             FS KSDV+SFGVL+ E  S  +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQ 208

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 5e-53
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 14/206 (6%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQH 379
            +F     LG+G FG VY  R       +A+K L K  +     E + + EV + + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            N++RL G+  + T   LI E+ P  +V + +    K  + D +     I  +A  + Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
           H     R+IHRD+K  N+LL +    KI+DFG +      +     + + GT  Y+ PE 
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175

Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +       K D++S GVL  E + G+
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK 201

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 5e-53
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 17/206 (8%)

Query: 329 DNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRL 385
           D ++G+G F  VYKG  +    E+A   L    +       FK E  ++  LQH N+VR 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 386 LGFSFEETER----LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
                   +     +L+ E + + ++  ++    +   +  +        I +G+ +LH 
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 442 DSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
            +   IIHRDLK  NI +       KI D G+A L            ++GT  +MAPE  
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMY 185

Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQK 526
               +    DV++FG+ +LE+ + + 
Sbjct: 186 -EEKYDESVDVYAFGMCMLEMATSEY 210

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-52
 Identities = 63/251 (25%), Positives = 100/251 (39%), Gaps = 27/251 (10%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNSVQGELE-FKNEVLLVAR 376
           N  S    LG G FG V +              +AVK L  ++   E E   +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFD---------------AIKRVQL 420
           L  H N+V LLG        L+I E+     +  F+                     + L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
           D E        +A+G+ +L        IHRDL A NILL    I KI DFG+AR  + D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL 540
           +            +MAPE +    ++ +SDV+S+G+ + E+ S   +    +  +     
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKFY 258

Query: 541 TYVSNNLHILY 551
             +     +L 
Sbjct: 259 KMIKEGFRMLS 269

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 3e-52
 Identities = 61/233 (26%), Positives = 118/233 (50%), Gaps = 14/233 (6%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE-----IAVKRLSKNSVQGEL-EFKNEVLLVARL 377
           +  +    +G G FG VYKG L          +A+K L     + +  +F  E  ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
            H N++RL G   +    ++I E++ N ++DKF+ +  K  +        ++ GIA G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124

Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT-SRIVGTFGYMA 496
           YL     +  +HRDL A NIL++++++ K+SDFG++R+ E D     T S       + A
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLHI 549
           PE ++   F+  SDV+SFG+++ E+++  +           +++  +++   +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE--RPYWELSNHEVMKAINDGFRL 232

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 4e-52
 Identities = 59/250 (23%), Positives = 107/250 (42%), Gaps = 17/250 (6%)

Query: 309 VESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSVQGE 364
           V+++Q           +F  +  +G+G FG VY G L          AVK L++ +  GE
Sbjct: 14  VQAVQHVVIGPSSLIVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 71

Query: 365 LE-FKNEVLLVARLQHRNLVRLLGFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDW 422
           +  F  E +++    H N++ LLG     E   L++  ++ +  +  FI +      +  
Sbjct: 72  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 131

Query: 423 ETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482
              + +          +   +  + +HRDL A N +LD     K++DFG+AR     +  
Sbjct: 132 LIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186

Query: 483 GDTSR--IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL 540
              ++        +MA E +    F+ KSDV+SFGVL+ E+++              D+ 
Sbjct: 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDIT 244

Query: 541 TYVSNNLHIL 550
            Y+     +L
Sbjct: 245 VYLLQGRRLL 254

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 7e-52
 Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 31/231 (13%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSVQGELE-FKNEVLLVAR 376
            N      LG G FG V               ++AVK L + +   E E   +E+ ++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ---------------- 419
           L  H N+V LLG         LI+E+     +  ++    ++                  
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 420 ----LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475
               L +E        +A+G+ +L        +HRDL A N+L+    + KI DFG+AR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK 526
              D +            +MAPE +  G ++IKSDV+S+G+L+ EI S   
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 3e-50
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 10/205 (4%)

Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQHR 380
           +F     LG+G F  V   R L+  +E A+K L K  +  E        E  +++RL H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
             V+L     ++ +      +  N  + K+I    K    D          I   + YLH
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125

Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                 IIHRDLK  NILL+ DM  +I+DFG A++   +  Q   +  VGT  Y++PE +
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
           T       SD+++ G ++ ++++G 
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGL 207

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 5e-50
 Identities = 58/230 (25%), Positives = 109/230 (47%), Gaps = 14/230 (6%)

Query: 326 FSTDNKLGQGGFGAVYKGR-LSHGQE----IAVKRLSK-NSVQGELEFKNEVLLVARLQH 379
           F     LG G FG VYKG  +  G++    +A+K L +  S +   E  +E  ++A + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
            ++ RLLG     +   LI + +P   +  ++ +   +  +  +        IA+G+ YL
Sbjct: 71  PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
                 R++HRDL A N+L+      KI+DFG+A+L   ++ +           +MA E 
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNLHI 549
           +    ++ +SDV+S+GV V E+++         G  A ++ + +     +
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS--KPYDGIPASEISSILEKGERL 232

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 5e-50
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 26/244 (10%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHG---QEIAVKRLSKN-SVQGELEFKNEVLLVARL-Q 378
           N+    + +G+G FG V K R+       + A+KR+ +  S     +F  E+ ++ +L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-------------FDAIKRVQLDWETR 425
           H N++ LLG         L  E+ P+ ++  F+                     L  +  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485
                 +ARG+ YL +    + IHRDL A NIL+  + + KI+DFG++R  E+       
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---K 183

Query: 486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSN 545
           +       +MA E +    ++  SDV+S+GVL+ EI+S     +   G    +L   +  
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--TPYCGMTCAELYEKLPQ 241

Query: 546 NLHI 549
              +
Sbjct: 242 GYRL 245

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  170 bits (432), Expect = 8e-49
 Identities = 48/205 (23%), Positives = 92/205 (44%), Gaps = 11/205 (5%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
           +++    +LG G FG V++    + G   A K +       +   + E+  ++ L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           V L     ++ E ++IYEF+    + + + D  +  ++  +   + +  + +G+ ++HE 
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE- 142

Query: 443 SRLRIIHRDLKASNILLDADM--IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
                +H DLK  NI+         K+ DFG+    +  QS        GT  + APE  
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVA 197

Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
                   +D++S GVL   ++SG 
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 9e-49
 Identities = 59/211 (27%), Positives = 87/211 (41%), Gaps = 14/211 (6%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSV---QGELEFKNEVLLVAR 376
            +     KLG G FG V +G           +AVK L  + +   +   +F  EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           L HRNL+RL G         ++ E  P  S+   +     +      T  +    +A G+
Sbjct: 68  LDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD-TSRIVGTFGYM 495
            YL      R IHRDL A N+LL    + KI DFG+ R    +             F + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISGQK 526
           APE +    FS  SD + FGV + E+ +  +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 3e-48
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 7/212 (3%)

Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVA 375
            + D    ++  + +G+G +G V       +   +A+K++S    Q   +    E+ ++ 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 376 RLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARG 435
           R +H N++ +       T   +   ++    +   ++  +K   L  +     +  I RG
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121

Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT-SRIVGTFGY 494
           + Y+H      ++HRDLK SN+LL+     KI DFG+AR+ + D       +  V T  Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 495 MAPEYVTRGHFSIKS-DVFSFGVLVLEIISGQ 525
            APE +       KS D++S G ++ E++S +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 5e-48
 Identities = 54/228 (23%), Positives = 94/228 (41%), Gaps = 14/228 (6%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSVQGELE-FKNEVLLVARLQ 378
                   +G+G FG V++G           +A+K     +     E F  E L + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H ++V+L+G    E    +I E      +  F+        LD  +       ++  + Y
Sbjct: 67  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           L      R +HRD+ A N+L+ ++   K+ DFG++R  E        S+      +MAPE
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPE 179

Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNN 546
            +    F+  SDV+ FGV + EI+          G +  D++  + N 
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV--KPFQGVKNNDVIGRIENG 225

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (417), Expect = 3e-47
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 17/217 (7%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKN-SVQGELEFKNEVLLVAR 376
              +   +LGQG FG VY+G             +A+K +++  S++  +EF NE  ++  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIF-------DAIKRVQLDWETRYKII 429
               ++VRLLG   +    L+I E +    +  ++        +             ++ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
           G IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R            + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK 526
               +M+PE +  G F+  SDV+SFGV++ EI +  +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 8e-47
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 25/225 (11%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR------LSHGQEIAVKRLSKNSVQGELE--FKNEVLLVA 375
           +       LG+G FG V +         +  + +AVK L + +   E         +L+ 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 376 RLQHRNLVRLLGFSFEETERLLI-YEFVPNSSVDKFIF-------------DAIKRVQLD 421
              H N+V LLG   +    L++  EF    ++  ++              + + +  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
            E        +A+G+ +L      + IHRDL A NILL    + KI DFG+AR    D  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK 526
                       +MAPE +    ++I+SDV+SFGVL+ EI S   
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  164 bits (415), Expect = 2e-46
 Identities = 49/198 (24%), Positives = 87/198 (43%), Gaps = 11/198 (5%)

Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
           +LG G FG V++    + G+    K ++      +   KNE+ ++ +L H  L+ L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
            ++ E +LI EF+    +   I    +  ++        +     G+ ++HE     I+H
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVH 150

Query: 450 RDLKASNILLDADMIP--KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            D+K  NI+ +       KI DFG+A     D+          T  + APE V R     
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGF 207

Query: 508 KSDVFSFGVLVLEIISGQ 525
            +D+++ GVL   ++SG 
Sbjct: 208 YTDMWAIGVLGYVLLSGL 225

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 2e-45
 Identities = 61/249 (24%), Positives = 110/249 (44%), Gaps = 28/249 (11%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRL--------SHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
           +       LG+G FG V             +   ++AVK L  ++ + +L +  +E+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIF-------------DAIKRVQL 420
             + +H+N++ LLG   ++    +I E+    ++ +++                    QL
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
             +        +ARG+ YL      + IHRDL A N+L+  D + KI+DFG+AR      
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL 540
               T+       +MAPE +    ++ +SDV+SFGVL+ EI +     S   G   E+L 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEELF 247

Query: 541 TYVSNNLHI 549
             +     +
Sbjct: 248 KLLKEGHRM 256

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  159 bits (404), Expect = 1e-44
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 18/210 (8%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQ- 378
           N+FS    +G+GGFG VY  R +  G+  A+K L K  +   QGE    NE ++++ +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 379 --HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
                +V +        +   I + +    +   +    +               I  G+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
            ++H      +++RDLK +NILLD     +ISD G+A  F   +        VGT GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173

Query: 497 PEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
           PE + +G  +   +D FS G ++ +++ G 
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  155 bits (393), Expect = 4e-44
 Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 15/212 (7%)

Query: 323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQ 378
           ++ +     LG GG   V+  R L   +++AVK L  +  +     L F+ E    A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 379 HRNLVRLLGFSFEETERL----LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
           H  +V +      ET       ++ E+V   ++   +        +  +   ++I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122

Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD-TSRIVGTFG 493
            + + H+     IIHRD+K +NI++ A    K+ DFG+AR      +    T+ ++GT  
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           Y++PE         +SDV+S G ++ E+++G+
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (390), Expect = 2e-43
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 14/210 (6%)

Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQ 378
           D  + +   + LG G F  V         + +A+K ++K +++G+    +NE+ ++ +++
Sbjct: 6   DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65

Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H N+V L           LI + V    +   I   +++         ++I  +   + Y
Sbjct: 66  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKY 122

Query: 439 LHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
           LH+     I+HRDLK  N+L    D D    ISDFG++++ +        S   GT GY+
Sbjct: 123 LHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYV 176

Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           APE + +  +S   D +S GV+   ++ G 
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGY 206

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  154 bits (390), Expect = 3e-43
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 15/207 (7%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQH 379
            +F     LG G FG V+  R   +G+  A+K L K  V   +      +E L+++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
             ++R+ G   +  +  +I +++    +   +  + +      +     +       L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
                  II+RDLK  NILLD +   KI+DFG A+             + GT  Y+APE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEV 172

Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQK 526
           V+   ++   D +SFG+L+ E+++G  
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-42
 Identities = 45/198 (22%), Positives = 82/198 (41%), Gaps = 12/198 (6%)

Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
            LG+G FG V++    S  +    K +       ++  K E+ ++   +HRN++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70

Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
               E ++I+EF+    + + I       +L+       +  +   + +LH      I H
Sbjct: 71  ESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125

Query: 450 RDLKASNILLDAD--MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
            D++  NI+         KI +FG AR  +   +      +     Y APE       S 
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVST 182

Query: 508 KSDVFSFGVLVLEIISGQ 525
            +D++S G LV  ++SG 
Sbjct: 183 ATDMWSLGTLVYVLLSGI 200

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 4e-42
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 13/207 (6%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN----EVLLVARLQ 378
            +F     LG+G FG V+        Q  A+K L K+ V  + + +     + +L    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
           H  L  +      +     + E++    +   I       + D          I  G+ +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118

Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
           LH      I++RDLK  NILLD D   KI+DFGM +   +  ++ +T    GT  Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173

Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            +    ++   D +SFGVL+ E++ GQ
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  148 bits (375), Expect = 2e-41
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 26/218 (11%)

Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE---------FKNEVLLV 374
           N+     LG+G    V +       +E AVK +                      EV ++
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 375 ARLQ-HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
            ++  H N+++L       T   L+++ +    +  ++    ++V L  +   KI+  + 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120

Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
             I  LH+   L I+HRDLK  NILLD DM  K++DFG +   +  +       + GT  
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPS 174

Query: 494 YMAPEYVT------RGHFSIKSDVFSFGVLVLEIISGQ 525
           Y+APE +          +  + D++S GV++  +++G 
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 2e-41
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 16/214 (7%)

Query: 322 ATNNFSTDNKLGQGGFGAVYKGR--LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARL 377
           A   +    ++G+G +G V+K R   + G+ +A+KR+   + +    L    EV ++  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 378 ---QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ---LDWETRYKIIGG 431
              +H N+VRL                +    VD+ +   + +V    +  ET   ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
           + RG+ +LH     R++HRDLK  NIL+ +    K++DFG+AR++    +    + +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178

Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
             Y APE + +  ++   D++S G +  E+   +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 6e-41
 Identities = 51/203 (25%), Positives = 95/203 (46%), Gaps = 15/203 (7%)

Query: 330 NKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELE-----FKNEVLLVARLQHRNLV 383
           + LG+G F  VYK R  +  Q +A+K++         +        E+ L+  L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
            LL     ++   L+++F+     D  +      + L        +    +G+ YLH+  
Sbjct: 64  GLLDAFGHKSNISLVFDFMET---DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV-TR 502
              I+HRDLK +N+LLD + + K++DFG+A+ F         +  V T  Y APE +   
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGA 175

Query: 503 GHFSIKSDVFSFGVLVLEIISGQ 525
             + +  D+++ G ++ E++   
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  147 bits (371), Expect = 7e-41
 Identities = 34/213 (15%), Positives = 84/213 (39%), Gaps = 18/213 (8%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
            ++    ++G+G FG +++G  L + Q++A+K   + S     + ++E      L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTG 62

Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
           +  + +  +E    ++   +   S++  +       +   +T       +   +  +HE 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE- 119

Query: 443 SRLRIIHRDLKASNILLDADMIP-----KISDFGMARLFEMDQSQG-----DTSRIVGTF 492
               +++RD+K  N L+            + DFGM + +    ++      +   + GT 
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            YM+         S + D+ + G + +  + G 
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (372), Expect = 8e-41
 Identities = 44/227 (19%), Positives = 82/227 (36%), Gaps = 18/227 (7%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
           N +    K+G G FG +Y G  ++ G+E+A+K     +   +     E  +   +Q    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 64

Query: 383 VRLLGFSFEETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           +  + +   E +  ++  E +  S  D F F      +   +T   +   +   I Y+H 
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 442 DSRLRIIHRDLKASNIL---LDADMIPKISDFGMARLFEMDQSQGD-----TSRIVGTFG 493
                 IHRD+K  N L        +  I DFG+A+ +   ++           + GT  
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL 540
           Y +         S + D+ S G +++    G                
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  146 bits (370), Expect = 1e-40
 Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 11/205 (5%)

Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRN 381
             +    K+G+G +G VYK + ++G+  A+K  RL K           E+ ++  L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           +V+L      +   +L++E +                 L+  T    +  +  GI Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE-YV 500
               R++HRDLK  N+L++ +   KI+DFG+AR F +   +      + T  Y AP+  +
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173

Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
               +S   D++S G +  E+++G 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-40
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 11/205 (5%)

Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRN 381
           NF    K+G+G +G VYK R    G+ +A+K++  ++           E+ L+  L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           +V+LL     E +  L++EF+      K   DA     +        +  + +G+ + H 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE-YV 500
               R++HRDLK  N+L++ +   K++DFG+AR F +          V T  Y APE  +
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILL 175

Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
              ++S   D++S G +  E+++ +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-40
 Identities = 51/214 (23%), Positives = 98/214 (45%), Gaps = 17/214 (7%)

Query: 320 RDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQ 378
           R    +++    +G G FG VY+ +L   G+ +A+K++ ++    +     E+ ++ +L 
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLD 71

Query: 379 HRNLVRLLGFSFEETER------LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI 432
           H N+VRL  F +   E+       L+ ++VP +        +  +  L        +  +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131

Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMDQSQGDTSRIVGT 491
            R + Y+H      I HRD+K  N+LLD D  + K+ DFG A+     + + + S I   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSR 186

Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +            ++   DV+S G ++ E++ GQ
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-39
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 20/213 (9%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE------FKNEVLLVAR 376
           + +     LG GGFG+VY G  +S    +A+K + K+ +    E         EV+L+ +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 377 LQ--HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
           +      ++RLL +       +LI E               +R  L  E        +  
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLE 121

Query: 435 GILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
            + + H      ++HRD+K  NIL+D +    K+ DFG   L +        +   GT  
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRV 174

Query: 494 YMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
           Y  PE++    +    + V+S G+L+ +++ G 
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-39
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 20/213 (9%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL------EFKNEVLLVAR 376
           + + T  +LG G F  V K R  S G + A K + K   +         + + EV ++  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
           +QH N++ L      +T+ +LI E V    +  F+    ++  L  E   + +  I  G 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNG- 125

Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEMDQSQGDTSRIVGTF 492
             ++    L+I H DLK  NI+L    +P    KI DFG+A   +          I GT 
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180

Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            ++APE V      +++D++S GV+   ++SG 
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 3e-38
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 12/206 (5%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE---FKNEVLLVARLQH 379
           N+F     LG+G FG V   R  + G+  A+K L K  +  + E      E  ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
             L  L            + E+         +F  + R ++  E R +     A  +  L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANG----GELFFHLSRERVFTEERARFY--GAEIVSAL 118

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
                  +++RD+K  N++LD D   KI+DFG+ +    D +        GT  Y+APE 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEV 176

Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +    +    D +  GV++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 4e-37
 Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 21/207 (10%)

Query: 328 TDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRL 385
           T   LG G  G V +       ++ A+K L         + + EV L  R  Q  ++VR+
Sbjct: 16  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRI 70

Query: 386 LG----FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
           +             L++ E +    +   I D   +         +I+  I   I YLH 
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS 129

Query: 442 DSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
              + I HRD+K  N+L  +   + I K++DFG A+      S         T  Y+APE
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPE 183

Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
            +    +    D++S GV++  ++ G 
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGY 210

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-36
 Identities = 50/219 (22%), Positives = 100/219 (45%), Gaps = 20/219 (9%)

Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARL 377
           D  + +    K+GQG FG V+K R    GQ++A+K++   + +         E+ ++  L
Sbjct: 7   DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66

Query: 378 QHRNLVRLLGFSFEETER--------LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
           +H N+V L+     +            L+++F  +             V+       +++
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVM 123

Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT--SR 487
             +  G   L+   R +I+HRD+KA+N+L+  D + K++DFG+AR F + ++      + 
Sbjct: 124 QMLLNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 488 IVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
            V T  Y  PE +     +    D++  G ++ E+ +  
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 8e-36
 Identities = 53/228 (23%), Positives = 102/228 (44%), Gaps = 14/228 (6%)

Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHR 380
             +    K+G+G +G V+K +     + +A+KR+  +     +      E+ L+  L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
           N+VRL      + +  L++EF      D   +       LD E     +  + +G+ + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQ---DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE-Y 499
                 ++HRDLK  N+L++ +   K+++FG+AR F +       S  V T  Y  P+  
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVL 173

Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYVSNNL 547
                +S   D++S G +  E+ +  +      G + +D L  +   L
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR--PLFPGNDVDDQLKRIFRLL 219

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  134 bits (339), Expect = 8e-36
 Identities = 57/240 (23%), Positives = 96/240 (40%), Gaps = 18/240 (7%)

Query: 293 KKKQKQNLRKADEINTVESLQFDFSTIRDAT---NNFSTDNKLGQGGFGAVYKGR-LSHG 348
           KK  +Q   K       E     + T    T   + F     LG G FG V   +    G
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66

Query: 349 QEIAVKRLSKNSVQGELE---FKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS 405
              A+K L K  V    +     NE  ++  +    LV+L     + +   ++ E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126

Query: 406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465
            +   +    +  +            I     YLH    L +I+RDLK  N+L+D     
Sbjct: 127 EMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYI 180

Query: 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +++DFG A+     + +G T  + GT   +APE +    ++   D ++ GVL+ E+ +G 
Sbjct: 181 QVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 8e-35
 Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 13/213 (6%)

Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL--EFKNEVLLV 374
           T  +    +     +G G +GAV        G ++A+K+L +             E+ L+
Sbjct: 12  TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71

Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEF-VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
             ++H N++ LL     +       +F +    +   +   +K  +L  +    ++  + 
Sbjct: 72  KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 131

Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           +G+ Y+H      IIHRDLK  N+ ++ D   KI DFG+AR     Q+  + +  V T  
Sbjct: 132 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRW 183

Query: 494 YMAPE-YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           Y APE  +    ++   D++S G ++ E+I+G+
Sbjct: 184 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  126 bits (317), Expect = 5e-33
 Identities = 50/255 (19%), Positives = 107/255 (41%), Gaps = 27/255 (10%)

Query: 299 NLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLS 357
           N  +  E    ES   ++       +++    KLG+G +  V++   +++ +++ VK L 
Sbjct: 14  NTHRPREYWDYESHVVEWGNQ----DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK 69

Query: 358 KNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERL--LIYEFVPNSSVDKFIFDA 414
               +   + K E+ ++  L+   N++ L     +   R   L++E V N+   +     
Sbjct: 70  PVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-- 124

Query: 415 IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMA 473
                L        +  I + + Y H    + I+HRD+K  N+++D +    ++ D+G+A
Sbjct: 125 ----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177

Query: 474 RLFEMDQSQGDTSRIVGTFGYMAPE-YVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRI 532
             +   Q     +  V +  +  PE  V    +    D++S G ++  +I  +    F  
Sbjct: 178 EFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK--EPFFH 232

Query: 533 GEEAEDLLTYVSNNL 547
           G +  D L  ++  L
Sbjct: 233 GHDNYDQLVRIAKVL 247

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 1e-31
 Identities = 58/240 (24%), Positives = 108/240 (45%), Gaps = 27/240 (11%)

Query: 297 KQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH----GQEIA 352
           K  LR A+     E +  +         NF     LG G +G V+  R       G+  A
Sbjct: 6   KHELRTANLTGHAEKVGIE---------NFELLKVLGTGAYGKVFLVRKISGHDTGKLYA 56

Query: 353 VKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI-YEFVPNSSV 407
           +K L K ++    +     + E  ++  ++    +  L ++F+   +L +  +++    +
Sbjct: 57  MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL 116

Query: 408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467
              +    +R +         +G I   + +LH+   L II+RD+K  NILLD++    +
Sbjct: 117 FTHLS---QRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVL 170

Query: 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH--FSIKSDVFSFGVLVLEIISGQ 525
           +DFG+++ F  D+++       GT  YMAP+ V  G        D +S GVL+ E+++G 
Sbjct: 171 TDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 8e-31
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 11/212 (5%)

Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKN--SVQGELEFKNEVLLV 374
           TI +    +   + +G G +G+V        G  +AVK+LS+   S+        E+ L+
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71

Query: 375 ARLQHRNLVRLLG-FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
             ++H N++ LL  F+   +       ++    +   + + +K  +L  +    +I  I 
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131

Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
           RG+ Y+H      IIHRDLK SN+ ++ D   KI DFG+AR  + +     T  +   + 
Sbjct: 132 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWY 184

Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
                 +   H++   D++S G ++ E+++G+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (300), Expect = 2e-30
 Identities = 54/225 (24%), Positives = 103/225 (45%), Gaps = 25/225 (11%)

Query: 315 DFSTIRDATNNFSTDNK------LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV--QGEL 365
            F ++    + F+   +      +G G  G V         + +A+K+LS+         
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61

Query: 366 EFKNEVLLVARLQHRNLVRLLGF-----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQL 420
               E++L+  + H+N++ LL       + EE + + +   + ++++ + I     +++L
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-----QMEL 116

Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
           D E    ++  +  GI +LH      IIHRDLK SNI++ +D   KI DFG+AR      
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173

Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
                +  V T  Y APE +    +    D++S G ++ E++  +
Sbjct: 174 M---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  120 bits (300), Expect = 2e-30
 Identities = 41/210 (19%), Positives = 82/210 (39%), Gaps = 18/210 (8%)

Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
           KLG G F  V+  + + +   +A+K +  + V  E   ++E+ L+ R+   +  +     
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMG 78

Query: 390 FEETERLLIY-------------EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
                +LL +              F         +    +   +      +I   +  G+
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 437 LYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
            Y+H   R  IIH D+K  N+L++  D    +    +A L          +  + T  Y 
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
           +PE +    +   +D++S   L+ E+I+G 
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  102 bits (256), Expect = 5e-26
 Identities = 37/201 (18%), Positives = 71/201 (35%), Gaps = 25/201 (12%)

Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVK--RLSKNS--------VQGELEFKNEVLLVARLQH 379
             +G+G   AV+        E  VK  ++   S          G+L F    +  AR + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
           R L +L G +  +     +Y +  N+ + + I               +++  I   +   
Sbjct: 66  RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119

Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
           +      I+H DL   N+L+  +    I DF  +     +  +    R V         Y
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNI----ITY 171

Query: 500 VTRGHFSIKSDVFSFGVLVLE 520
            +R  +  + D+ S    +L+
Sbjct: 172 FSR-TYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	551
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.98
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.56
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.99
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.6
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.0
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.43
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.32

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=365.37  Aligned_cols=202  Identities=26%  Similarity=0.439  Sum_probs=177.0

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ++|++.++||+|+||+||+|+. .+|+.||||++..... +..+.+.+|+.++++++||||+++++++.+.+..+|||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            5789999999999999999985 4689999999976532 3345689999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++|+|.+++.   +...+++.++..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.....
T Consensus        85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            99999999985   3457999999999999999999999987   99999999999999999999999999987755444


Q ss_pred             cccccccccCCCcccccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      .......+||+.|||||++.+..+ +.++|||||||++|||++|+.||...
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~  209 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP  209 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCC
Confidence            444556789999999999988876 57899999999999999999999643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=361.87  Aligned_cols=198  Identities=28%  Similarity=0.478  Sum_probs=179.3

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .++|++.++||+|+||+||+|+. .+|+.||||+++.......+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            45799999999999999999984 56899999999876555567899999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +++|+|.+++.+    ..+++.++..++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++.+.... 
T Consensus        99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-  170 (293)
T d1yhwa1          99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (293)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence            999999988753    46999999999999999999999987   9999999999999999999999999998764332 


Q ss_pred             cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                       .......||+.|||||.+.+..++.++|||||||++|||++|+.||.
T Consensus       171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~  217 (293)
T d1yhwa1         171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL  217 (293)
T ss_dssp             -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCC
Confidence             23445689999999999999999999999999999999999999995

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=360.84  Aligned_cols=200  Identities=32%  Similarity=0.542  Sum_probs=168.5

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .++|++.++||+|+||+||+|+++  ..||||+++..  ..+..+.|.+|+.++.+++|||||++++++.+ ...++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467899999999999999999864  46999999754  33455689999999999999999999998754 56899999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+++|+|.+++..  ....+++..++.++.||++||+|||+++   ||||||||+||||+.++.+||+|||+++......
T Consensus        84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999999974  3456999999999999999999999987   9999999999999999999999999998765444


Q ss_pred             CcccccccccCCCccccccccc---CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTR---GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .........||+.|||||++.+   ..++.++|||||||++|||+||+.||..
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~  211 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN  211 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC
Confidence            3344456789999999999864   3589999999999999999999999963

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-45  Score=355.35  Aligned_cols=197  Identities=30%  Similarity=0.477  Sum_probs=176.5

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|+||+||+++. .+++.||+|++.+..   ......+.+|+.++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            4688899999999999999985 468899999997542   233557899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++|+|.+++..   ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999873   457999999999999999999999987   999999999999999999999999999765422


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                          ......||+.|||||.+.+..++.++|||||||++|||++|+.||+.
T Consensus       160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  206 (263)
T d2j4za1         160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA  206 (263)
T ss_dssp             ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence                23456799999999999999999999999999999999999999963

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-45  Score=355.93  Aligned_cols=198  Identities=30%  Similarity=0.499  Sum_probs=166.4

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccC
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      ++|++.++||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++||||++++|++...+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            4688889999999999999998888899999997654 345689999999999999999999999999999999999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      +|+|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+||||++++++||+|||+++....... .
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~  157 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  157 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence            9999999874  3466899999999999999999999987   99999999999999999999999999987643322 2


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                      ......||+.|||||++.+..++.++|||||||++|||+|++.|+
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~  202 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP  202 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCC
Confidence            233457899999999999999999999999999999999965544

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-45  Score=360.23  Aligned_cols=201  Identities=28%  Similarity=0.417  Sum_probs=175.5

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|+||+||+|+. .+++.||||++.+..   ......+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            4689999999999999999985 568999999997542   233457899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++|+|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999886   3467999999999999999999999988   999999999999999999999999999877644


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..........||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  212 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA  212 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC
Confidence            444445566899999999999999999999999999999999999999963

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-45  Score=359.71  Aligned_cols=200  Identities=28%  Similarity=0.414  Sum_probs=177.1

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      +.|++.++||+|+||+||+|+. .+++.||||+++.......+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4688899999999999999985 468899999998776666668999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++|+|.+++.+  ....+++.++..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++......  
T Consensus        92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence            99999998864  3457999999999999999999999988   9999999999999999999999999997643221  


Q ss_pred             ccccccccCCCcccccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .......||+.|||||++.     +..++.++|||||||++|||++|+.||..
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~  217 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE  217 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC
Confidence            1233467999999999884     45689999999999999999999999963

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-45  Score=355.83  Aligned_cols=205  Identities=28%  Similarity=0.423  Sum_probs=165.9

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEec--CCceEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFE--ETERLLI  398 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV  398 (551)
                      ++|++.+.||+|+||+||+++. .+|+.||||++....  ......+.+|++++++++|||||++++++.+  ....++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5789999999999999999984 568999999997653  2334568899999999999999999999865  3457899


Q ss_pred             EEccCCCChhHHhhhhc-ccCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          399 YEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      |||+++|+|.+++.+.. ....+++..++.++.||+.||.|||+.+  ..+|+||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999987543 3567999999999999999999999864  23599999999999999999999999999987


Q ss_pred             cccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +....  .......||+.|||||.+.+..++.++|||||||++|||++|+.||..
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~  216 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA  216 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence            65332  223456899999999999999999999999999999999999999963

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-45  Score=366.95  Aligned_cols=200  Identities=25%  Similarity=0.379  Sum_probs=177.3

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ..++|++.++||+|+||+||+|+. .+|+.||+|+++... ......+.+|+.+|++++|||||++++++.+.+..++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            356899999999999999999985 578999999997653 233457899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      ||+++|+|.+++.+   ...+++..+..++.||++||.|||+. +   |+||||||+||||++++.+||+|||+|+.+..
T Consensus        84 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             ECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            99999999999974   45699999999999999999999974 5   99999999999999999999999999986543


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      .    .....+||+.|||||++.+.+++.++||||+||++|||++|+.||...
T Consensus       158 ~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         158 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             H----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             C----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            2    233468999999999999999999999999999999999999999643

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-45  Score=356.24  Aligned_cols=199  Identities=33%  Similarity=0.531  Sum_probs=174.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      .++|++.++||+|+||+||+|++++++.||||+++... ...+.|.+|+.++.+++|||||+++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            45788889999999999999999888899999997654 345679999999999999999999998754 5678999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++|+|.+++... ...+++|..+++|+.||++||.|||+.+   |+||||||+||||++++.+||+|||+++.+..... 
T Consensus        90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-  164 (272)
T d1qpca_          90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (272)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-
Confidence            999999987643 3446999999999999999999999987   99999999999999999999999999987654322 


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                      .......||+.|||||.+.++.++.++|||||||++|||+||+.|+
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~  210 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP  210 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence            2234457899999999999999999999999999999999976655

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7e-45  Score=357.71  Aligned_cols=203  Identities=30%  Similarity=0.479  Sum_probs=178.4

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecC-CCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ...++|++.++||+|+||+||+|++. +++.||||+++.... ..++|.+|+.++++++|||||++++++.+.+..++||
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            34567888999999999999999864 588999999976543 4567999999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++|+|.+++... ....+++..++.++.||++||.|||+++   |+||||||+||||++++.+||+|||+++....+
T Consensus        93 E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          93 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             ecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            999999999998753 3467999999999999999999999987   999999999999999999999999999876543


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .. .......|++.|||||++.++.++.++|||||||++|||++|+.|+.
T Consensus       169 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~  217 (287)
T d1opja_         169 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY  217 (287)
T ss_dssp             SS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             Cc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence            22 22334568999999999999999999999999999999999877763

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-44  Score=347.16  Aligned_cols=200  Identities=28%  Similarity=0.462  Sum_probs=179.6

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccC
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      ++|++.++||+|+||+||+|+++++++||||++++... ...+|.+|+.++.+++||||++++|++.+.+..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57899999999999999999998888999999987543 45689999999999999999999999999999999999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      +|+|..++..  ....+++..+.+++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.+..... .
T Consensus        83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~  156 (258)
T d1k2pa_          83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T  156 (258)
T ss_dssp             TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-C
T ss_pred             CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-e
Confidence            9999999764  4567899999999999999999999987   99999999999999999999999999987654322 2


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||+.
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~  204 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER  204 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC
Confidence            3334578999999999999999999999999999999998 8888863

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-44  Score=358.70  Aligned_cols=201  Identities=30%  Similarity=0.530  Sum_probs=163.0

Q ss_pred             cCCCcCcccCcCCceeEEEeecCC-CC---EEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSH-GQ---EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~-g~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ++|++.++||+|+||+||+|++.. ++   .||||++... .....+.|.+|+.+|++++|||||+++|++...+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            456777899999999999998642 32   5899988665 334456799999999999999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++|+|.+++..  ....++|.+++.++.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999998864  3457999999999999999999999987   99999999999999999999999999987654


Q ss_pred             CCCcc---cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          479 DQSQG---DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       479 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      .....   ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~  235 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW  235 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCC
Confidence            33221   1223467999999999999999999999999999999998 899985

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=345.65  Aligned_cols=194  Identities=28%  Similarity=0.427  Sum_probs=167.2

Q ss_pred             CcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEec----CCceEEEE
Q 008854          327 STDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFE----ETERLLIY  399 (551)
Q Consensus       327 ~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~  399 (551)
                      +..++||+|+||+||+|+. .+++.||+|++...  .......+.+|++++++++|||||++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            5667899999999999985 46889999999764  33344578999999999999999999999864    34578999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC-CCCCeEEeecCCcccccc
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPKISDFGMARLFEM  478 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~Dfgla~~~~~  478 (551)
                      ||+++|+|.+++.+   ...+++..+..++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+++....
T Consensus        92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999974   467999999999999999999999875 4599999999999996 578999999999986432


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .    ......||+.|||||.+.+ +++.++|||||||++|||++|+.||.
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~  213 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS  213 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCC
Confidence            2    2345689999999998865 69999999999999999999999995

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-44  Score=356.18  Aligned_cols=199  Identities=26%  Similarity=0.383  Sum_probs=161.5

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChh-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ..+.|++.+.||+|+||+||+++. .+++.||||++.+.... ....+.+|+.++++++||||+++++++.+++..+|||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            456799999999999999999985 46899999999765432 3446889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC---CCCCeEEeecCCcccc
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---ADMIPKISDFGMARLF  476 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~kl~Dfgla~~~  476 (551)
                      ||+++|+|.+++.   ....+++.++..++.||+.||.|||+.+   |+||||||+|||+.   +++.+||+|||+++..
T Consensus        87 E~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             eccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            9999999999996   3567999999999999999999999987   99999999999994   5789999999999865


Q ss_pred             ccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ....   .....+||+.|||||.+.+..++.++|||||||++|||++|+.||.
T Consensus       161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~  210 (307)
T d1a06a_         161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY  210 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCC
Confidence            4322   2344679999999999999999999999999999999999999995

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-44  Score=350.28  Aligned_cols=201  Identities=30%  Similarity=0.493  Sum_probs=172.1

Q ss_pred             cCCCcCc-ccCcCCceeEEEeecC---CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 008854          324 NNFSTDN-KLGQGGFGAVYKGRLS---HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       324 ~~f~~~~-~LG~G~~g~Vyk~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ++|.+.+ +||+|+||+||+|.+.   ++..||||+++... ....++|.+|++++++++|||||+++|++.. +..+||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4555666 4999999999999753   34579999997653 3445679999999999999999999999865 467899


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++|+|.+++..  .+..+++..+++++.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++.+..
T Consensus        87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            999999999998754  3467999999999999999999999987   99999999999999999999999999987654


Q ss_pred             CCC-cccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          479 DQS-QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       479 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ... ........||+.|||||.+.++.++.++|||||||++|||+| |+.||..
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~  215 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK  215 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCC
Confidence            332 222334568999999999999999999999999999999998 8999963

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.7e-44  Score=353.85  Aligned_cols=194  Identities=30%  Similarity=0.485  Sum_probs=171.8

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      +.|+..++||+|+||+||+|+. .+++.||||++.....   .....+.+|+.++++++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            4588999999999999999984 5788999999976543   23346889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++|+|..++.   ...++++.++..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.... 
T Consensus        95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            9999999987664   3567999999999999999999999988   99999999999999999999999999986432 


Q ss_pred             CCcccccccccCCCccccccccc---CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTR---GHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                           .....||+.|||||++.+   +.++.++|||||||++|||++|+.||.
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~  215 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence                 234579999999999853   468999999999999999999999985

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-43  Score=353.84  Aligned_cols=199  Identities=24%  Similarity=0.297  Sum_probs=178.4

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|+||+||+++. .+|+.||||++++..   ......+.+|+.+|++++||||+++++++.+.+..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5689999999999999999984 578999999997642   234567889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus        85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            99999999999873   567899999999999999999999998   999999999999999999999999999865432


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .  ......+||+.|||||++.+..++.++||||+||++|||++|+.||..
T Consensus       159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~  207 (337)
T d1o6la_         159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  207 (337)
T ss_dssp             T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC
Confidence            2  234457899999999999999999999999999999999999999964

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.9e-43  Score=356.50  Aligned_cols=199  Identities=24%  Similarity=0.393  Sum_probs=178.9

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      ++|++.+.||+|+||+||+++. .+|+.||||++........+.+.+|+.++++++|||||++++++.+++..+|||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            4799999999999999999985 568999999998776666678999999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC--CCCeEEeecCCccccccCC
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--DMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~  480 (551)
                      ++|+|.+++.+  ....+++..+..++.||+.||.|||+.+   ||||||||+|||++.  ++.+||+|||+++.+....
T Consensus       106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            99999998864  3456999999999999999999999988   999999999999964  6789999999998764322


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                         ......||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus       181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  227 (350)
T d1koaa2         181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG  227 (350)
T ss_dssp             ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC
Confidence               23456899999999999999999999999999999999999999963

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=355.97  Aligned_cols=206  Identities=29%  Similarity=0.424  Sum_probs=174.5

Q ss_pred             hhcCCCcCcccCcCCceeEEEeecCC-C-----CEEEEEEeecCC-hhcHHHHHHHHHHHhcC-CCCCccceeeEEecCC
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRLSH-G-----QEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEET  393 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~~~-g-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  393 (551)
                      ..++|++.++||+|+||+||+|+... +     ..||+|++.... ......+.+|+.++.++ +|||||++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            34678899999999999999998532 2     269999986543 23345789999999998 8999999999999999


Q ss_pred             ceEEEEEccCCCChhHHhhhhcc--------------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCC
Q 008854          394 ERLLIYEFVPNSSVDKFIFDAIK--------------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLK  453 (551)
Q Consensus       394 ~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk  453 (551)
                      ..++||||+++|+|.++|.....                    ...+++..++.++.||++||.|||+++   |||||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence            99999999999999999975321                    235899999999999999999999987   9999999


Q ss_pred             CCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          454 ASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       454 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      |+|||++.++.+||+|||+++...............||+.|||||.+.++.++.++|||||||++|||+| |+.||..
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            9999999999999999999987655444334445678999999999999999999999999999999998 8999863

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.7e-43  Score=350.77  Aligned_cols=195  Identities=28%  Similarity=0.428  Sum_probs=175.6

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.+.||+|+||+||+++. .+|+.||||++++..   ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4688999999999999999985 568999999997542   234557899999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+++|+|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999999886   4566889999999999999999999987   999999999999999999999999999875422


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                           .....||+.|||||++.+..++.++|||||||++|||++|+.||.
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~  202 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY  202 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCC
Confidence                 334689999999999999999999999999999999999999996

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-43  Score=347.01  Aligned_cols=201  Identities=30%  Similarity=0.521  Sum_probs=166.3

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCC-----CEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHG-----QEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      +.|+..++||+|+||+||+|+++..     ..||||++.... .....+|.+|+.++.+++|||||+++|++.+....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577889999999999999986532     369999997653 3344579999999999999999999999999999999


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+.++++.+++..  ....++|.++++++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999998764  4467999999999999999999999987   9999999999999999999999999998765


Q ss_pred             cCCCc-ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          478 MDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       478 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ..... .......||+.|||||.+.++.++.++|||||||++|||++|+.|+.
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~  214 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY  214 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence            43222 22334568999999999999999999999999999999999776654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=347.43  Aligned_cols=193  Identities=31%  Similarity=0.482  Sum_probs=164.0

Q ss_pred             cccCcCCceeEEEeecCC---CCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccCC
Q 008854          330 NKLGQGGFGAVYKGRLSH---GQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN  404 (551)
Q Consensus       330 ~~LG~G~~g~Vyk~~~~~---g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  404 (551)
                      ++||+|+||+||+|.+.+   ++.||||+++....  ...++|.+|+.++++++|||||+++|++.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999997543   46799999975432  234579999999999999999999999865 467899999999


Q ss_pred             CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc-c
Q 008854          405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-G  483 (551)
Q Consensus       405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~  483 (551)
                      |+|.+++.   +...+++..+++++.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus        92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            99999986   3567999999999999999999999987   999999999999999999999999999876543322 2


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ......||+.|||||.+.+..++.++|||||||++|||+| |+.||.
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~  212 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR  212 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCC
Confidence            2334578999999999999999999999999999999998 899986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.9e-43  Score=354.50  Aligned_cols=198  Identities=25%  Similarity=0.373  Sum_probs=178.5

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEcc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV  402 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  402 (551)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++.........+.+|+.++++++|||||++++++.+++..+|||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5799999999999999999984 579999999998876666667899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC--CCCCeEEeecCCccccccCC
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--ADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~--~~~~~kl~Dfgla~~~~~~~  480 (551)
                      ++|+|.+++..  ...++++.++..++.||+.||.|||+.+   |+||||||+||||+  .++.+||+|||+++.+....
T Consensus       109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            99999887753  3456999999999999999999999987   99999999999998  67899999999998765332


Q ss_pred             CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                         ......||+.|||||++.+..++.++|||||||++|||++|+.||.
T Consensus       184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~  229 (352)
T d1koba_         184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA  229 (352)
T ss_dssp             ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence               2344678999999999999999999999999999999999999995

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-42  Score=343.74  Aligned_cols=199  Identities=30%  Similarity=0.446  Sum_probs=176.9

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh------hcHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV------QGELEFKNEVLLVARLQHRNLVRLLGFSFEETER  395 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  395 (551)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++++...      ...+.+.+|+.++++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46799999999999999999985 5789999999975422      2356799999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC----CeEEeecC
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM----IPKISDFG  471 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~kl~Dfg  471 (551)
                      +|||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            999999999999999874   457999999999999999999999988   99999999999998776    59999999


Q ss_pred             CccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  218 (293)
T d1jksa_         163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  218 (293)
T ss_dssp             TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC
Confidence            998754322   23445789999999999999999999999999999999999999963

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-43  Score=345.50  Aligned_cols=199  Identities=30%  Similarity=0.494  Sum_probs=169.1

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEccC
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP  403 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  403 (551)
                      ++|++.++||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|++. .++.++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence            5788999999999999999999888899999997654 34568999999999999999999999985 456899999999


Q ss_pred             CCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCcc
Q 008854          404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG  483 (551)
Q Consensus       404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  483 (551)
                      +|+|..++... ....++|.+++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++....... .
T Consensus        95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~  169 (285)
T d1fmka3          95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  169 (285)
T ss_dssp             TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence            99999988753 3456999999999999999999999987   99999999999999999999999999987643322 2


Q ss_pred             cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       484 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ......||+.|+|||++.++.++.++||||||+++|||++|+.|+.
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~  215 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY  215 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCC
Confidence            2334578999999999999999999999999999999999877664

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.8e-43  Score=347.50  Aligned_cols=209  Identities=26%  Similarity=0.443  Sum_probs=178.3

Q ss_pred             HHHhhhcCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCCh-hcHHHHHHHHHHHhcCCCCCccceeeEEe
Q 008854          318 TIRDATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSF  390 (551)
Q Consensus       318 ~i~~~~~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~  390 (551)
                      +++-..++|++.++||+|+||+||+|+..      +++.||||+++.... +...+|.+|+.++++++||||+++++++.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            34445678999999999999999999853      357899999976543 34557999999999999999999999999


Q ss_pred             cCCceEEEEEccCCCChhHHhhhhc---------------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEe
Q 008854          391 EETERLLIYEFVPNSSVDKFIFDAI---------------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH  449 (551)
Q Consensus       391 ~~~~~~lV~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH  449 (551)
                      .....++||||+++|+|.+++....                     ....+++..++.|+.|++.||+|||+.+   |||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence            9999999999999999999996421                     1235899999999999999999999987   999


Q ss_pred             ccCCCCCeeeCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCC-CC
Q 008854          450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK-NN  528 (551)
Q Consensus       450 ~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~-p~  528 (551)
                      |||||+||||+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|.. ||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            99999999999999999999999987654444444455678999999999999999999999999999999999965 55


Q ss_pred             C
Q 008854          529 S  529 (551)
Q Consensus       529 ~  529 (551)
                      .
T Consensus       244 ~  244 (301)
T d1lufa_         244 Y  244 (301)
T ss_dssp             T
T ss_pred             C
Confidence            4

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-42  Score=350.25  Aligned_cols=195  Identities=24%  Similarity=0.313  Sum_probs=176.2

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~  399 (551)
                      ++|++.++||+|+||+||+++. .+|+.||||++.+..   ......+.+|+.++++++||||+++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            4789999999999999999985 578999999997542   233456889999999999999999999999999999999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccC
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD  479 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  479 (551)
                      ||+.+|+|..++..   ...+++..+..++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+++.+.. 
T Consensus       121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-  193 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred             ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence            99999999999864   457999999999999999999999988   99999999999999999999999999987542 


Q ss_pred             CCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       480 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                          ......||+.|||||++.+..++.++|||||||++|||++|+.||.
T Consensus       194 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~  239 (350)
T d1rdqe_         194 ----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF  239 (350)
T ss_dssp             ----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCC
Confidence                2334689999999999999999999999999999999999999996

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-42  Score=346.27  Aligned_cols=201  Identities=28%  Similarity=0.482  Sum_probs=168.2

Q ss_pred             cCCCcCcccCcCCceeEEEeecC-CCC----EEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS-HGQ----EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      .+|++.++||+|+||+||+|++. +|+    +||+|+++.. ..+..++|.+|+.++++++|||||+++|++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            35889999999999999999853 444    5899988654 334566899999999999999999999999864 5678


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ++||+.+++|.+++..  ....+++..+++++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8999999999998865  4567999999999999999999999987   9999999999999999999999999999876


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      ............||+.|||||.+.++.++.++|||||||++|||+| |+.||..
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~  216 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG  216 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC
Confidence            5444444455678999999999999999999999999999999999 7888763

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.6e-42  Score=348.40  Aligned_cols=198  Identities=28%  Similarity=0.389  Sum_probs=171.5

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHH---HHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFK---NEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++.+...   .....+.   +|+.+++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            5789999999999999999985 4689999999965421   2222333   4577788889999999999999999999


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +||||+++|+|.++|..   ...+++..+..++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+++.+
T Consensus        84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999874   467899999999999999999999988   999999999999999999999999999865


Q ss_pred             ccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ...    ......||+.|||||++.. ..++.++|||||||++|||++|+.||...
T Consensus       158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~  209 (364)
T d1omwa3         158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  209 (364)
T ss_dssp             SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence            432    2345679999999999875 56899999999999999999999999643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-42  Score=341.23  Aligned_cols=199  Identities=28%  Similarity=0.393  Sum_probs=174.0

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC---hhcHHHHHHHHHHHh-cCCCCCccceeeEEecCCceEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVA-RLQHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ++|++.+.||+|+||+||+|+. .+++.||||++++..   ......+..|..++. .++||||+++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            4788999999999999999985 468999999997542   223345666766655 68999999999999999999999


Q ss_pred             EEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccccc
Q 008854          399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM  478 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  478 (551)
                      |||+++|+|.+++..   ...+++.++..++.||+.||.|||+++   |+||||||+|||+++++++||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999873   456899999999999999999999997   99999999999999999999999999986543


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~  205 (320)
T d1xjda_         156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG  205 (320)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC
Confidence            22  234456899999999999999999999999999999999999999963

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.8e-42  Score=336.26  Aligned_cols=202  Identities=26%  Similarity=0.426  Sum_probs=168.2

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh---hcHHHHHHHHHHHhcCCCCCccceeeEEecCC----c
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEET----E  394 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  394 (551)
                      .++|++.+.||+|+||+||+++. .+|+.||||++++...   .....+.+|++++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999984 5789999999976533   23446899999999999999999999987644    3


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .+|||||+++++|.+++..   ...+++.++..++.||++||.|||+.+   |+||||||+|||++.++..+|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            7899999999999998863   457999999999999999999999987   9999999999999999999999999987


Q ss_pred             ccccCC-CcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQ-SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...... .........||+.|||||.+.+..++.++|||||||++|||+||+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  216 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG  216 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC
Confidence            553322 22234456899999999999999999999999999999999999999963

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-42  Score=338.96  Aligned_cols=206  Identities=29%  Similarity=0.396  Sum_probs=165.4

Q ss_pred             hhhcCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcC-CCCCccceeeEEecC
Q 008854          321 DATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEE  392 (551)
Q Consensus       321 ~~~~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  392 (551)
                      ...++|++.++||+|+||+||+|+..      +++.||||+++... ......+.+|..++.++ +|+||+.+++++...
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            34567999999999999999999742      34689999997653 33455678888888777 689999999998765


Q ss_pred             -CceEEEEEccCCCChhHHhhhhcc-------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCee
Q 008854          393 -TERLLIYEFVPNSSVDKFIFDAIK-------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL  458 (551)
Q Consensus       393 -~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIl  458 (551)
                       ...++||||+++|+|.++|.....             ...+++.+++.++.||++||.|||+++   |+||||||+|||
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL  166 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL  166 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcccee
Confidence             467899999999999999975321             345899999999999999999999987   999999999999


Q ss_pred             eCCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCC-CCC
Q 008854          459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK-NNS  529 (551)
Q Consensus       459 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~-p~~  529 (551)
                      |++++++||+|||+++...............||+.|||||.+.++.++.++|||||||++|||++|.. ||.
T Consensus       167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence            99999999999999987655444444556789999999999999999999999999999999999765 564

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.9e-41  Score=331.06  Aligned_cols=199  Identities=26%  Similarity=0.384  Sum_probs=174.6

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChh---------cHHHHHHHHHHHhcCC-CCCccceeeEEec
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---------GELEFKNEVLLVARLQ-HRNLVRLLGFSFE  391 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  391 (551)
                      .++|++.+.||+|+||+||+++. .+|+.||||++++....         ....+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            36899999999999999999985 57899999999765321         1235789999999997 9999999999999


Q ss_pred             CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecC
Q 008854          392 ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG  471 (551)
Q Consensus       392 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg  471 (551)
                      .+..+|||||+++|+|.++|..   ...+++.++..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence            9999999999999999999974   457999999999999999999999987   9999999999999999999999999


Q ss_pred             CccccccCCCcccccccccCCCccccccccc------CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTR------GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      +++.+....   ......||+.|+|||.+.+      ..++.++||||+||++|||++|+.||..
T Consensus       156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~  217 (277)
T d1phka_         156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH  217 (277)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC
Confidence            998765432   2344679999999998853      3568899999999999999999999963

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-42  Score=333.95  Aligned_cols=201  Identities=25%  Similarity=0.399  Sum_probs=162.0

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCC----CCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  397 (551)
                      .++|++.+.||+|+||+||+|+...    +..||||+++... ......+.+|+.++++++||||+++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3578899999999999999998542    3468999886543 333457999999999999999999999985 467899


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE  477 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  477 (551)
                      ||||+++|+|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+||++++++.+||+|||+++.+.
T Consensus        85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999998764  4567999999999999999999999987   9999999999999999999999999998765


Q ss_pred             cCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                      .... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus       160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~  212 (273)
T d1mp8a_         160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG  212 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC
Confidence            3322 23345678999999999999999999999999999999998 8888864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-41  Score=337.65  Aligned_cols=200  Identities=23%  Similarity=0.330  Sum_probs=176.2

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ..++|++.+.||+|+||+||+|+. .+++.||||+++....+ ...+.+|+.+|++++||||+++++++.+.+..+||||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            346899999999999999999985 46889999999776533 4468899999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC--CCeEEeecCCcccccc
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD--MIPKISDFGMARLFEM  478 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~--~~~kl~Dfgla~~~~~  478 (551)
                      |+++++|.+++..  ....+++.++..++.||++||.|||+.+   |+||||||+|||++.+  ..+||+|||+++....
T Consensus        82 ~~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             cCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            9999999999864  3446999999999999999999999987   9999999999999854  4899999999986543


Q ss_pred             CCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ..   ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||..
T Consensus       157 ~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~  205 (321)
T d1tkia_         157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA  205 (321)
T ss_dssp             TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC
Confidence            22   23445789999999999999999999999999999999999999964

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-42  Score=331.05  Aligned_cols=195  Identities=30%  Similarity=0.493  Sum_probs=163.2

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecC-CceEEEEEcc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-TERLLIYEFV  402 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~~  402 (551)
                      ++|++.++||+|+||.||+|++ .|++||||++++..  ..+.+.+|++++++++||||++++|++.+. +..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            4577889999999999999998 47899999997653  345799999999999999999999998654 5679999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++|+|.++|... ....++|..+++++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence            999999999753 2345899999999999999999999987   999999999999999999999999999864322   


Q ss_pred             ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008854          483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF  530 (551)
Q Consensus       483 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~~  530 (551)
                        .....+|..|+|||++.++.++.++||||||+++|||+| |+.|+..
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~  203 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  203 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC
Confidence              223467889999999999999999999999999999999 6766653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-42  Score=332.78  Aligned_cols=200  Identities=31%  Similarity=0.448  Sum_probs=162.2

Q ss_pred             cCCCcCcccCcCCceeEEEeecC--CC--CEEEEEEeecCC---hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLS--HG--QEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL  396 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~--~g--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  396 (551)
                      ++|++.+.||+|+||+||+|++.  ++  .+||||++++..   .+..++|.+|+.++++++||||++++|++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56888999999999999999853  22  368999987642   2334579999999999999999999999965 4678


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcccc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF  476 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~  476 (551)
                      +||||+++++|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus        87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999998875  3456999999999999999999999987   999999999999999999999999999876


Q ss_pred             ccCCCcc-cccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          477 EMDQSQG-DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       477 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      ....... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~  216 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI  216 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC
Confidence            5443222 2334567889999999999999999999999999999998 899985

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-41  Score=334.91  Aligned_cols=200  Identities=25%  Similarity=0.396  Sum_probs=163.5

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecCC----ceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET----ERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~  399 (551)
                      ++|.+.++||+|+||+||+|++ +|+.||||+++..... ....+.|+..+.+++||||+++++++...+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4567789999999999999997 6889999999654322 223445666667889999999999997654    478999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-----SRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      ||+++|+|.++|++    ..++|..+++++.|++.||+|||+.     +.++|+||||||+||||+.++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999964    4689999999999999999999974     23469999999999999999999999999998


Q ss_pred             ccccCCCc--ccccccccCCCcccccccccC------CCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          475 LFEMDQSQ--GDTSRIVGTFGYMAPEYVTRG------HFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       475 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      ........  .......||+.|||||++.+.      .++.++|||||||++|||+||..|+.
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~  219 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence            76543322  233456899999999998754      36779999999999999999988764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-40  Score=330.46  Aligned_cols=196  Identities=28%  Similarity=0.463  Sum_probs=168.6

Q ss_pred             CcccCcCCceeEEEeecCCC----CEEEEEEeecC-ChhcHHHHHHHHHHHhcCCCCCccceeeEEec-CCceEEEEEcc
Q 008854          329 DNKLGQGGFGAVYKGRLSHG----QEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFE-ETERLLIYEFV  402 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~  402 (551)
                      .++||+|+||+||+|++.+.    ..||||++++. ......+|.+|++++++++||||++++|++.. +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            47899999999999986432    25899999754 44455679999999999999999999999875 55789999999


Q ss_pred             CCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCCc
Q 008854          403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ  482 (551)
Q Consensus       403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  482 (551)
                      ++++|.+++..  ....+++..+++++.|+++||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999874  4556889999999999999999999987   999999999999999999999999999876543222


Q ss_pred             --ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          483 --GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       483 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                        .......||+.|+|||.+....++.++||||||+++|||++|+.|+.
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~  235 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY  235 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCC
Confidence              12334578999999999999999999999999999999999888875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-41  Score=333.85  Aligned_cols=204  Identities=28%  Similarity=0.480  Sum_probs=177.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeecC------CCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER  395 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  395 (551)
                      .++|++.++||+|+||+||+|.+.      +++.||||++++.. .+....|.+|+.++++++||||+++++++......
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            467888999999999999999753      35689999997653 34445689999999999999999999999999999


Q ss_pred             EEEEEccCCCChhHHhhhhc-------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEe
Q 008854          396 LLIYEFVPNSSVDKFIFDAI-------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS  468 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~  468 (551)
                      ++||||+++|+|.+++....       ....+++..+.+++.|+++||.|||+.+   |+||||||+||||+.++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            99999999999999986431       2245799999999999999999999987   9999999999999999999999


Q ss_pred             ecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCC-CCCC
Q 008854          469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ-KNNS  529 (551)
Q Consensus       469 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~-~p~~  529 (551)
                      |||+++.+.............||+.|+|||.+.+..++.++||||||+++|||+||+ .|+.
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~  237 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ  237 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC
Confidence            999998776554444455567899999999999999999999999999999999996 5553

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-41  Score=331.96  Aligned_cols=204  Identities=28%  Similarity=0.426  Sum_probs=172.5

Q ss_pred             hcCCCcCcccCcCCceeEEEeecCC--------CCEEEEEEeecCCh-hcHHHHHHHHHHHhcC-CCCCccceeeEEecC
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRLSH--------GQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFSFEE  392 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~~~--------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  392 (551)
                      .++|++.+.||+|+||.||+|+...        +..||||++++... ....++.+|...+.++ +|||||++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4678889999999999999997422        24799999977643 3446788899988888 799999999999999


Q ss_pred             CceEEEEEccCCCChhHHhhhhc-------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee
Q 008854          393 TERLLIYEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL  459 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll  459 (551)
                      ...++||||+++|+|.+++....             ....+++.+++.++.||+.||+|||+.+   ||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            99999999999999999997532             1245899999999999999999999988   9999999999999


Q ss_pred             CCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008854          460 DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS  529 (551)
Q Consensus       460 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~ellt-G~~p~~  529 (551)
                      +.++.+||+|||+++...............+|+.|+|||.+.++.++.++||||||+++|||++ |+.||.
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~  239 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  239 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence            9999999999999987765555455566788999999999999999999999999999999998 677775

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-41  Score=331.58  Aligned_cols=195  Identities=26%  Similarity=0.357  Sum_probs=164.8

Q ss_pred             cCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhc-----HHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          328 TDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQG-----ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       328 ~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      .+++||+|+||+||+|+. .+|+.||||+++......     ...+.+|+.++++++|||||++++++..++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            357899999999999985 468999999997543221     23588999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +.++++..+..   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-  154 (299)
T d1ua2a_          82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-  154 (299)
T ss_dssp             CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred             hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-
Confidence            99987776653   4567899999999999999999999988   9999999999999999999999999998654332 


Q ss_pred             cccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                       ......+||+.|+|||.+... .++.++|||||||++|||++|+.||..
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~  203 (299)
T d1ua2a_         155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG  203 (299)
T ss_dssp             -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence             223345799999999988654 679999999999999999999999853

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-41  Score=332.86  Aligned_cols=203  Identities=30%  Similarity=0.424  Sum_probs=176.3

Q ss_pred             hcCCCcCcccCcCCceeEEEeec------CCCCEEEEEEeecCCh-hcHHHHHHHHHHHhcC-CCCCccceeeEEecCCc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETE  394 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  394 (551)
                      .++|++.++||+|+||.||+|++      .+++.||||+++.... ....++.+|+.++.++ +|||||++++++.+...
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            46788899999999999999974      3456899999976543 3445789999999999 69999999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhc---------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeee
Q 008854          395 RLLIYEFVPNSSVDKFIFDAI---------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL  459 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll  459 (551)
                      .++||||+++|+|.++++...               ....+++..++.++.||++||.|||+++   |+||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            999999999999999997532               2336899999999999999999999988   9999999999999


Q ss_pred             CCCCCeEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008854          460 DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNN  528 (551)
Q Consensus       460 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~  528 (551)
                      +.++.+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+|++.|+
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~  247 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP  247 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCC
Confidence            999999999999998766544444445578999999999999999999999999999999999955554

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-41  Score=335.79  Aligned_cols=194  Identities=25%  Similarity=0.323  Sum_probs=166.9

Q ss_pred             cCCCcCc-ccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhc-CCCCCccceeeEEec----CCceE
Q 008854          324 NNFSTDN-KLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVAR-LQHRNLVRLLGFSFE----ETERL  396 (551)
Q Consensus       324 ~~f~~~~-~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~  396 (551)
                      ++|.+.+ .||+|+||+||+|+. .+++.||||++++.     ..+.+|+.++.+ .+||||+++++++.+    ....+
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            5788765 599999999999984 57899999999653     356789988655 589999999999865    35679


Q ss_pred             EEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC---CCCeEEeecCCc
Q 008854          397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMA  473 (551)
Q Consensus       397 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~Dfgla  473 (551)
                      +||||+++|+|.++|.+. ....+++.++..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus        86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence            999999999999999742 2356999999999999999999999988   999999999999985   557999999999


Q ss_pred             cccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      +......   ......||+.|||||++.+..++.++|||||||++|||++|+.||.
T Consensus       162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~  214 (335)
T d2ozaa1         162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY  214 (335)
T ss_dssp             EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCE
T ss_pred             eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCC
Confidence            8754332   2345679999999999999999999999999999999999999995

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-40  Score=329.27  Aligned_cols=200  Identities=27%  Similarity=0.444  Sum_probs=169.5

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++....  .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5789999999999999999984 5789999999965432  234578999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      |+.++.+. ++.. .....+++..+..++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~-~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKK-FMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHH-HHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhh-hhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99765444 3432 24567999999999999999999999988   9999999999999999999999999998654322


Q ss_pred             CcccccccccCCCcccccccccCC-CCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                        .......||+.|+|||.+.... ++.++||||+||++|||++|+.||..
T Consensus       157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~  205 (298)
T d1gz8a_         157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG  205 (298)
T ss_dssp             --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence              2344457999999999877665 57899999999999999999999963

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-41  Score=332.20  Aligned_cols=200  Identities=30%  Similarity=0.487  Sum_probs=168.5

Q ss_pred             cCCCcCcccCcCCceeEEEeecCC-CC--EEEEEEeecC-ChhcHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSH-GQ--EIAVKRLSKN-SVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLI  398 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV  398 (551)
                      ++|++.++||+|+||+||+|++.+ +.  .||||+++.. ..+..++|.+|++++.++ +|||||+++|++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            577888999999999999998653 33  4788888654 333455799999999999 799999999999999999999


Q ss_pred             EEccCCCChhHHhhhh-------------cccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCe
Q 008854          399 YEFVPNSSVDKFIFDA-------------IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP  465 (551)
Q Consensus       399 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~  465 (551)
                      |||+++|+|.++|+..             .....+++..+++++.||++||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999753             23467999999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCC-CCC
Q 008854          466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK-NNS  529 (551)
Q Consensus       466 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~-p~~  529 (551)
                      ||+|||+++.....   .......||..|+|||.+.++.++.++|||||||++|||++|.. ||.
T Consensus       167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~  228 (309)
T d1fvra_         167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC  228 (309)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence            99999999764322   22234568999999999999999999999999999999999775 554

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.5e-40  Score=324.56  Aligned_cols=199  Identities=25%  Similarity=0.413  Sum_probs=171.3

Q ss_pred             cCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCCh--hcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEEc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF  401 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  401 (551)
                      ++|++.++||+|+||+||+|+.++|+.||||+++....  .....+.+|+.++++++||||+++++++...+..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57899999999999999999988899999999976532  2345789999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCCC
Q 008854          402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS  481 (551)
Q Consensus       402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  481 (551)
                      +.++.+..+..   ....+++..+..++.||+.||+|||+.+   ||||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-  154 (286)
T d1ob3a_          82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (286)
T ss_dssp             CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence            98887776654   4577999999999999999999999987   9999999999999999999999999998754322 


Q ss_pred             cccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          482 QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       482 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                       .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~  203 (286)
T d1ob3a_         155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG  203 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence             22334568999999999875 4568999999999999999999999963

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-40  Score=325.85  Aligned_cols=197  Identities=26%  Similarity=0.422  Sum_probs=168.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChh------cHHHHHHHHHHHhcCC--CCCccceeeEEecCC
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ------GELEFKNEVLLVARLQ--HRNLVRLLGFSFEET  393 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  393 (551)
                      .++|++.++||+|+||+||+|+. .+|+.||||++.+....      ....+.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            46799999999999999999984 57899999999754211      1224678999999986  899999999999999


Q ss_pred             ceEEEEEccCC-CChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCC-CCeEEeecC
Q 008854          394 ERLLIYEFVPN-SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFG  471 (551)
Q Consensus       394 ~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~Dfg  471 (551)
                      ..++||||+.+ +++.+++.   +...+++.++..++.||++||.|||+.+   |+||||||+|||++.+ +.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            99999999976 57777765   3467999999999999999999999988   9999999999999854 799999999


Q ss_pred             CccccccCCCcccccccccCCCcccccccccCCC-CcchhhHhHHHHHHHHHhCCCCCC
Q 008854          472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      +++.....    ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.
T Consensus       157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~  211 (273)
T d1xwsa_         157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE  211 (273)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCC
Confidence            99864322    2345679999999999987765 567999999999999999999996

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-39  Score=324.22  Aligned_cols=200  Identities=27%  Similarity=0.435  Sum_probs=166.2

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CC-CCEEEEEEeecCCh--hcHHHHHHHHHHHhcC---CCCCccceeeEEec----
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SH-GQEIAVKRLSKNSV--QGELEFKNEVLLVARL---QHRNLVRLLGFSFE----  391 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~-g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  391 (551)
                      .++|++.++||+|+||+||+++. .+ ++.||||+++....  .....+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999985 34 56799999965422  1222456677766655   89999999999853    


Q ss_pred             -CCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeec
Q 008854          392 -ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF  470 (551)
Q Consensus       392 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df  470 (551)
                       ....+++|||++++.+.....  .....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             245789999999887765443  24567899999999999999999999988   999999999999999999999999


Q ss_pred             CCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       471 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      |+++.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~  217 (305)
T d1blxa_         161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG  217 (305)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCC
Confidence            998764322   234456899999999999999999999999999999999999999964

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1e-38  Score=314.83  Aligned_cols=202  Identities=18%  Similarity=0.295  Sum_probs=173.1

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCC-CCccceeeEEecCCceEEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH-RNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e  400 (551)
                      .++|++.++||+|+||+||+|+. .+|+.||||++.....  ...+.+|++++..++| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            46899999999999999999984 4688999999866432  2246788999999975 899999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCC-----CCCeEEeecCCccc
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-----DMIPKISDFGMARL  475 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~-----~~~~kl~Dfgla~~  475 (551)
                      |+ +++|.+++..  ....+++.++..++.|++.||.|||+.+   |+||||||+|||++.     ++.+||+|||+++.
T Consensus        82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            98 6899888764  3457999999999999999999999988   999999999999974     57899999999987


Q ss_pred             cccCCCc-----ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC
Q 008854          476 FEMDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRI  532 (551)
Q Consensus       476 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~~  532 (551)
                      +......     .......||+.|||||.+.+..++.++||||||+++|||++|+.||....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~  217 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  217 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence            6533221     12345679999999999999999999999999999999999999997443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-38  Score=321.15  Aligned_cols=202  Identities=24%  Similarity=0.373  Sum_probs=168.3

Q ss_pred             hhcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCC-hhcHHHHHHHHHHHhcCCCCCccceeeEEecCC----ce
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEET----ER  395 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  395 (551)
                      .+.+|++.++||+|+||+||+|+ ..+|+.||||++.+.. ....+.+.+|+.+|++++||||+++++++....    ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            34679999999999999999998 4579999999997653 333457899999999999999999999987543    34


Q ss_pred             EEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       396 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      +++++|+.+++|.+++..    ..+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+++.
T Consensus        86 ~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence            566677889999999853    46999999999999999999999987   99999999999999999999999999986


Q ss_pred             cccCCC-cccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          476 FEMDQS-QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       476 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...... ........||+.|+|||.+.. ..++.++||||+|+++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~  215 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG  215 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCC
Confidence            543322 223445679999999999854 5678999999999999999999999964

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-38  Score=317.76  Aligned_cols=201  Identities=24%  Similarity=0.438  Sum_probs=167.2

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecC--ChhcHHHHHHHHHHHhcCCCCCccceeeEEec--------C
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFE--------E  392 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  392 (551)
                      ++|++.++||+|+||+||+|+. .+|+.||||++...  .......+.+|+.+|++++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6899999999999999999985 57899999998654  22334578899999999999999999998865        3


Q ss_pred             CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCC
Q 008854          393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM  472 (551)
Q Consensus       393 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl  472 (551)
                      ...++||||+.++.+..+..   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence            45789999999887765543   4567899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccccCCC--cccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          473 ARLFEMDQS--QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       473 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ++.+.....  ........||+.|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~  224 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG  224 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence            986653322  1223345799999999998765 689999999999999999999999863

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-38  Score=320.82  Aligned_cols=196  Identities=26%  Similarity=0.419  Sum_probs=164.1

Q ss_pred             CCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCccceeeEEecC------CceEE
Q 008854          325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------TERLL  397 (551)
Q Consensus       325 ~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  397 (551)
                      +|+..++||+|+||+||+|+. .+|+.||||++.+...    ...+|+.+|++++||||+++++++...      ...+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            577789999999999999995 4689999999976542    234799999999999999999998543      23689


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC-CeEEeecCCcccc
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLF  476 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~~  476 (551)
                      ||||++++.+..+.........+++.++..++.||+.||+|||+.+   |+||||||+|||++.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987755554443335667999999999999999999999987   99999999999999775 8999999999876


Q ss_pred             ccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          477 EMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ....   ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus       174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~  225 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG  225 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence            4332   2334578999999998765 5789999999999999999999999964

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-37  Score=307.62  Aligned_cols=198  Identities=25%  Similarity=0.396  Sum_probs=173.2

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE  400 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  400 (551)
                      ++|+++++||+|+||+||+|+. .+++.||||+++...  ......+.+|+.++++++||||+++++++......++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            4789999999999999999984 578899999997653  2335678999999999999999999999999999999999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCccccccCC
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ  480 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  480 (551)
                      ++.+++|..++.   ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999888775   4567899999999999999999999987   9999999999999999999999999998765332


Q ss_pred             CcccccccccCCCcccccccccCC-CCcchhhHhHHHHHHHHHhCCCCCC
Q 008854          481 SQGDTSRIVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQKNNS  529 (551)
Q Consensus       481 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvll~elltG~~p~~  529 (551)
                      .  ......+++.|+|||.+.... ++.++|||||||++|||++|+.||.
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  203 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred             c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence            2  233345788999999887664 6899999999999999999999984

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.2e-38  Score=309.55  Aligned_cols=201  Identities=20%  Similarity=0.298  Sum_probs=166.4

Q ss_pred             hcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCcccee-eEEecCCceEEEEE
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLL-GFSFEETERLLIYE  400 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~-~~~~~~~~~~lV~e  400 (551)
                      .++|++.++||+|+||+||+|+. .+|+.||||++......  .++..|++++++++|+|++..+ .+..+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            35799999999999999999984 56889999998765432  3578899999999887766555 45567778889999


Q ss_pred             ccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeC---CCCCeEEeecCCccccc
Q 008854          401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---ADMIPKISDFGMARLFE  477 (551)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~kl~Dfgla~~~~  477 (551)
                      |+. ++|...+..  ....+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+++.+.
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LLG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CCC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EcC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            984 556555543  4567999999999999999999999988   99999999999875   45679999999998765


Q ss_pred             cCCCc-----ccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          478 MDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       478 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      .....     .......||+.|||||.+.+..++.++||||||+++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~  216 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL  216 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccccc
Confidence            43221     1234568999999999999999999999999999999999999999643

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-38  Score=318.25  Aligned_cols=196  Identities=26%  Similarity=0.401  Sum_probs=163.0

Q ss_pred             hhcCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecCC-----
Q 008854          322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEET-----  393 (551)
Q Consensus       322 ~~~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  393 (551)
                      ..++|++.++||+|+||+||+|.. .+|+.||||++++..  ....+.+.+|+.+|++++|||||++++++...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            357899999999999999999984 568999999997642  233456889999999999999999999997654     


Q ss_pred             -ceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCC
Q 008854          394 -ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM  472 (551)
Q Consensus       394 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl  472 (551)
                       ..++||||+ +.+|..+..    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence             468999999 556666653    457999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCccccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ++.....     .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus       168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~  221 (346)
T d1cm8a_         168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG  221 (346)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence            9865422     334678999999999876 4568999999999999999999999964

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-38  Score=317.41  Aligned_cols=201  Identities=28%  Similarity=0.405  Sum_probs=171.4

Q ss_pred             cCCCcCcccCcCCceeEEEeec----CCCCEEEEEEeecCC----hhcHHHHHHHHHHHhcCCC-CCccceeeEEecCCc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNS----VQGELEFKNEVLLVARLQH-RNLVRLLGFSFEETE  394 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  394 (551)
                      ++|++.++||+|+||+||+++.    .+|+.||||++++..    ......+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999973    247899999986532    1223467899999999976 899999999999999


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .++||||+.+++|.+++..   ...+.+.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            9999999999999999874   456788999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccCCCcccccccccCCCcccccccccC--CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRG--HFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      .+..... .......|++.|++||.+.+.  .++.++|||||||+||||++|+.||...
T Consensus       178 ~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~  235 (322)
T d1vzoa_         178 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD  235 (322)
T ss_dssp             ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             hhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            7643322 223456799999999998654  4688999999999999999999999644

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.3e-37  Score=309.30  Aligned_cols=193  Identities=20%  Similarity=0.362  Sum_probs=166.7

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-CCCccceeeEEecC--CceEEEE
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEE--TERLLIY  399 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~  399 (551)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++...   ...+.+|+.+|.+++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999985 578999999997643   347889999999995 99999999998744  4578999


Q ss_pred             EccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCC-CeEEeecCCcccccc
Q 008854          400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEM  478 (551)
Q Consensus       400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~~  478 (551)
                      ||+++++|..+.      ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++ .+||+|||+++....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999987653      35899999999999999999999998   99999999999998655 689999999987553


Q ss_pred             CCCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          479 DQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       479 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                      ..   ......+|+.|+|||.+.+. .++.++||||+|++++||++|+.||...
T Consensus       183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~  233 (328)
T d3bqca1         183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  233 (328)
T ss_dssp             TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence            32   23455789999999998765 5799999999999999999999999644

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-37  Score=309.12  Aligned_cols=195  Identities=27%  Similarity=0.351  Sum_probs=158.8

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecC------Cc
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------TE  394 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  394 (551)
                      ++|++.++||+|+||+||+|+. .+|+.||||++.+..  ......+.+|+.++++++||||+++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            6799999999999999999985 468999999997653  33345688999999999999999999998643      56


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .++||||+.++.+.. +     ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~~-~-----~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQV-I-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHHH-H-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHHh-h-----hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            799999997765543 3     245899999999999999999999998   9999999999999999999999999988


Q ss_pred             ccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      .....   .......+|+.|+|||.+.+..++.++||||+||+++||++|+.||..
T Consensus       168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~  220 (355)
T d2b1pa1         168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence            65432   233455789999999999999999999999999999999999999863

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-37  Score=309.81  Aligned_cols=196  Identities=27%  Similarity=0.418  Sum_probs=165.6

Q ss_pred             hcCCCcCcccCcCCceeEEEee-cCCCCEEEEEEeecCC--hhcHHHHHHHHHHHhcCCCCCccceeeEEecC-----Cc
Q 008854          323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-----TE  394 (551)
Q Consensus       323 ~~~f~~~~~LG~G~~g~Vyk~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  394 (551)
                      .++|++.++||+|+||+||+|+ ..+|+.||||++++..  ......+.+|+++|++++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            5789999999999999999998 4579999999997653  33445688999999999999999999998643     34


Q ss_pred             eEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       395 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .+++++|+.+++|.+++.    ...+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            567788889999999884    346999999999999999999999988   9999999999999999999999999987


Q ss_pred             ccccCCCcccccccccCCCcccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008854          475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSF  530 (551)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvll~elltG~~p~~~  530 (551)
                      ...     .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus       170 ~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~  221 (348)
T d2gfsa1         170 HTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  221 (348)
T ss_dssp             CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence            543     223345789999999987665 568999999999999999999999963

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.98  E-value=1e-32  Score=280.25  Aligned_cols=199  Identities=21%  Similarity=0.292  Sum_probs=161.7

Q ss_pred             cCCCcCcccCcCCceeEEEeec-CCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-----------CCCccceeeEEec
Q 008854          324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-----------HRNLVRLLGFSFE  391 (551)
Q Consensus       324 ~~f~~~~~LG~G~~g~Vyk~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  391 (551)
                      ++|++.++||+|+||+||+|+. .+|+.||||++++.... ...+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~-~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH-HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc-hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            4599999999999999999985 57899999999765432 346788888888775           5789999988764


Q ss_pred             C--CceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCeeeCCCCC----
Q 008854          392 E--TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDADMI----  464 (551)
Q Consensus       392 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlk~~NIll~~~~~----  464 (551)
                      .  ...++++++...+..............+++..+..++.||++||.|||+ .+   |+||||||+||||+.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence            3  4556777777666555444444466788999999999999999999998 54   999999999999986653    


Q ss_pred             --eEEeecCCccccccCCCcccccccccCCCcccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008854          465 --PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR  531 (551)
Q Consensus       465 --~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvll~elltG~~p~~~~  531 (551)
                        ++|+|||.+.....     ......||+.|+|||.+....++.++||||+|++++||++|+.||...
T Consensus       169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence              89999999975432     223457999999999999999999999999999999999999998744

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=1.5e-23  Score=192.24  Aligned_cols=164  Identities=16%  Similarity=0.185  Sum_probs=120.0

Q ss_pred             CcCcccCcCCceeEEEeecCCCCEEEEEEeecCCh------------------hcHHHHHHHHHHHhcCCCCCccceeeE
Q 008854          327 STDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV------------------QGELEFKNEVLLVARLQHRNLVRLLGF  388 (551)
Q Consensus       327 ~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~  388 (551)
                      .+.++||+|+||+||+|+..+|++||||+++....                  ........|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            35689999999999999988899999998753210                  011234578889999999999988765


Q ss_pred             EecCCceEEEEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCCeeeCCCCCeEEe
Q 008854          389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS  468 (551)
Q Consensus       389 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~  468 (551)
                      .    ..+++|||+++..+..          ++......++.|++++|.|||+.+   |+||||||+|||+++++ ++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence            3    3479999998865433          333445678999999999999987   99999999999998654 8999


Q ss_pred             ecCCccccccCCCcccccccccCCCcccc------cccccCCCCcchhhHhHHHHHH
Q 008854          469 DFGMARLFEMDQSQGDTSRIVGTFGYMAP------EYVTRGHFSIKSDVFSFGVLVL  519 (551)
Q Consensus       469 Dfgla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~sDv~S~Gvll~  519 (551)
                      |||++.........          .|...      |. ..+.|+.++|+||+.--++
T Consensus       145 DFG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         145 DFPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             ECCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence            99999754321110          11111      11 2356788999999864443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.56  E-value=1.5e-07  Score=88.39  Aligned_cols=148  Identities=17%  Similarity=0.140  Sum_probs=99.2

Q ss_pred             HHhhhcCCCcCcccCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEE
Q 008854          319 IRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLL  397 (551)
Q Consensus       319 i~~~~~~f~~~~~LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  397 (551)
                      ++..-..|+..+..+.++...||+... +++.+++|+...........+.+|...+..+. +--+.+++.+....+..++
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            334445666666555555678998875 56778889886654434445677888877664 3335677888777888899


Q ss_pred             EEEccCCCChhHHhhhhcccCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------
Q 008854          398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS----------------------------------  443 (551)
Q Consensus       398 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------  443 (551)
                      ||+++++.++.+....     ...   ...++.++++.+..||+..                                  
T Consensus        88 v~~~l~G~~~~~~~~~-----~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          88 LMSEADGVLCSEEYED-----EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEECCSSEEHHHHTTT-----CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEecccccccccccc-----ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            9999999887654321     011   2223455555555555321                                  


Q ss_pred             ----------------------CCCeEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          444 ----------------------RLRIIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       444 ----------------------~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                                            .+.++|+|+.|.|||+++++..-|.||+.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                  12279999999999999877777999988753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.99  E-value=1.8e-05  Score=73.22  Aligned_cols=75  Identities=17%  Similarity=0.152  Sum_probs=53.1

Q ss_pred             ccCcCCc-eeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCC--CCccceeeEEecCCceEEEEEccCCCCh
Q 008854          331 KLGQGGF-GAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH--RNLVRLLGFSFEETERLLIYEFVPNSSV  407 (551)
Q Consensus       331 ~LG~G~~-g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL  407 (551)
                      .+..|.. ..||+....++..+++|........   .+..|...++.+..  -.+.+++.+..+.+..++||+++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455543 6799998878888999987654322   35667777666643  3356678887888888999999988765


Q ss_pred             h
Q 008854          408 D  408 (551)
Q Consensus       408 ~  408 (551)
                      .
T Consensus        94 ~   94 (255)
T d1nd4a_          94 L   94 (255)
T ss_dssp             T
T ss_pred             c
Confidence            4

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.60  E-value=0.00014  Score=71.77  Aligned_cols=76  Identities=13%  Similarity=0.104  Sum_probs=46.7

Q ss_pred             CcccCcCCceeEEEeecCC-CCEEEEEEeecC------C-hhcHHHHHHHHHHHhcCC-C--CCccceeeEEecCCceEE
Q 008854          329 DNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKN------S-VQGELEFKNEVLLVARLQ-H--RNLVRLLGFSFEETERLL  397 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~-g~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l  397 (551)
                      .+.||.|....||+....+ ++.++||.-...      . .........|.+.|..+. +  ..+.+++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3568999999999998654 678999965321      1 111223445777666552 2  334455543  4556789


Q ss_pred             EEEccCCCC
Q 008854          398 IYEFVPNSS  406 (551)
Q Consensus       398 V~e~~~~gs  406 (551)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999998754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.00  E-value=0.0018  Score=61.76  Aligned_cols=136  Identities=15%  Similarity=0.136  Sum_probs=77.5

Q ss_pred             ceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCc--cceee-----EEecCCceEEEEEccCCCChhH
Q 008854          337 FGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL--VRLLG-----FSFEETERLLIYEFVPNSSVDK  409 (551)
Q Consensus       337 ~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lV~e~~~~gsL~~  409 (551)
                      .-.||+....+|..+++|+..... ....++..|+..+..|....+  +..+.     ........+.+++++++..+..
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            357999999999999999986543 244567788888777643222  11111     2234556788999988644321


Q ss_pred             ----Hh----------hhhc------ccCCCCHH----------------------HHHHHHHHHHHHHHHH-hhCCCCC
Q 008854          410 ----FI----------FDAI------KRVQLDWE----------------------TRYKIIGGIARGILYL-HEDSRLR  446 (551)
Q Consensus       410 ----~l----------~~~~------~~~~l~~~----------------------~~~~i~~~ia~~L~yL-H~~~~~~  446 (551)
                          .+          +...      .+..+++.                      .....+.++...+.-+ .......
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                11          1000      01111211                      1122222333222221 2223445


Q ss_pred             eEeccCCCCCeeeCCCCCeEEeecCCccc
Q 008854          447 IIHRDLKASNILLDADMIPKISDFGMARL  475 (551)
Q Consensus       447 iiH~Dlk~~NIll~~~~~~kl~Dfgla~~  475 (551)
                      +||+|+.+.|||++++  ..+.||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            8999999999999754  45889988763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.43  E-value=0.0041  Score=60.85  Aligned_cols=73  Identities=18%  Similarity=0.271  Sum_probs=48.9

Q ss_pred             CcccCcCCceeEEEeecCCC--------CEEEEEEeecCChhcHHHHHHHHHHHhcCCCCCc-cceeeEEecCCceEEEE
Q 008854          329 DNKLGQGGFGAVYKGRLSHG--------QEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL-VRLLGFSFEETERLLIY  399 (551)
Q Consensus       329 ~~~LG~G~~g~Vyk~~~~~g--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~  399 (551)
                      .+.|+.|-.-.+|+....++        +.|.+++....  .......+|..+++.+.-.++ .++++++.    -.+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence            35788888889999876432        45666666532  234456788888888753344 46666653    26899


Q ss_pred             EccCCCCh
Q 008854          400 EFVPNSSV  407 (551)
Q Consensus       400 e~~~~gsL  407 (551)
                      ||+++.+|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.32  E-value=0.016  Score=54.28  Aligned_cols=157  Identities=13%  Similarity=0.069  Sum_probs=79.5

Q ss_pred             ChhHHHhhhcCCCcCcc-----cCcCCceeEEEeecCCCCEEEEEEeecCChhcHHHHHHHHHHHhcCCCCC--ccceee
Q 008854          315 DFSTIRDATNNFSTDNK-----LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLG  387 (551)
Q Consensus       315 ~~~~i~~~~~~f~~~~~-----LG~G~~g~Vyk~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~  387 (551)
                      +.++++..-.+|.+.+.     |..|---+.|+.+..+| .+++|+.......  .++..|+.++..|.+.+  +...+-
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~--~~l~~~~~~l~~L~~~g~pvp~pi~   80 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK--NDLPFFLGLMQHLAAKGLSCPLPLP   80 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C--CHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCH--HHHHHHHHHHHhhhhccccccccce
Confidence            34556666667766433     45666688999987654 5899998654222  23444555666553222  111111


Q ss_pred             ------EEecCCceEEEEEccCCCChhHH--------------hhhhcc------cCCC------------------CHH
Q 008854          388 ------FSFEETERLLIYEFVPNSSVDKF--------------IFDAIK------RVQL------------------DWE  423 (551)
Q Consensus       388 ------~~~~~~~~~lV~e~~~~gsL~~~--------------l~~~~~------~~~l------------------~~~  423 (551)
                            +.........++.++.+......              ++....      ....                  ...
T Consensus        81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (316)
T d2ppqa1          81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  160 (316)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence                  11223445566766665433211              000000      0000                  001


Q ss_pred             HHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCCeeeCCCCCeEEeecCCcc
Q 008854          424 TRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDADMIPKISDFGMAR  474 (551)
Q Consensus       424 ~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~  474 (551)
                      .....+..+...+.-.+. .-+.++||+|+.++||+++.+...-|.||+.+.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            111222222222332222 223459999999999999988877899999875